PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Birse, KM; Burgener, A; Westmacott, GR; McCorrister, S; Novak, RM; Ball, TB				Birse, Kenzie M.; Burgener, Adam; Westmacott, Garrett R.; McCorrister, Stuart; Novak, Richard M.; Ball, T. Blake			Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; ANTI-HIV-1 ACTIVITY; HIV-1 INFECTION; MICROBICIDE; IDENTIFICATION; INFLAMMATION; PROTECTION; INHIBITOR; S100A8/A9; CYTOKINE	Female genital tract secretions are commonly sampled by lavage of the ectocervix and vaginal vault or via a sponge inserted into the endocervix for evaluating inflammation status and immune factors critical for HIV microbicide and vaccine studies. This study uses a proteomics approach to comprehensively compare the efficacy of these methods, which sample from different compartments of the female genital tract, for the collection of immune factors. Matching sponge and lavage samples were collected from 10 healthy women and were analyzed by tandem mass spectrometry. Data was analyzed by a combination of differential protein expression analysis, hierarchical clustering and pathway analysis. Of the 385 proteins identified, endocervical sponge samples collected nearly twice as many unique proteins as cervicovaginal lavage (111 vs. 61) with 55% of proteins common to both (213). Each method/site identified 73 unique proteins that have roles in host immunity according to their gene ontology. Sponge samples enriched for specific inflammation pathways including acute phase response proteins (p = 3.37x10(-24)) and LXR/RXR immune activation pathways (p = 8.82x10(-22)) while the role IL-17A in psoriasis pathway (p = 5.98x10(-24)) and the complement system pathway (p = 3.91x10(-3)) were enriched in lavage samples. Many host defense factors were differentially enriched (p<0.05) between sites including known/potential antimicrobial factors (n = 21), S100 proteins (n = 9), and immune regulatory factors such as serpins (n = 7). Immunoglobulins (n = 6) were collected at comparable levels in abundance in each site although 25% of those identified were unique to sponge samples. This study demonstrates significant differences in types and quantities of immune factors and inflammation pathways collected by each sampling technique. Therefore, clinical studies that measure mucosal immune activation or factors assessing HIV transmission should utilize both collection methods to obtain the greatest representation of immune factors secreted into the female genital tract.	[Birse, Kenzie M.; Burgener, Adam; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Birse, Kenzie M.; Burgener, Adam; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Prote Grp, Winnipeg, MB, Canada; [Westmacott, Garrett R.; McCorrister, Stuart] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mass Spectrometry Core Facil, Winnipeg, MB, Canada; [Novak, Richard M.] Univ Illinois, Infect Dis Sect, Chicago, IL USA; [Ball, T. Blake] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Burgener, Adam; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada	University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi; Public Health Agency of Canada	Ball, TB (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	tball@cc.umanitoba.ca			National Institutes of Health; HIV Vaccine Trials Network; Public Health Agency of Canada	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Vaccine Trials Network; Public Health Agency of Canada	This work was funded through the National Institutes of Health (http://www.nih.gov/), HIV Vaccine Trials Network (http://www.hvtn.org/), and the Public Health Agency of Canada (http://www.phac-aspc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Broliden K, 2010, J INFECT DIS, V202, pS351, DOI 10.1086/655964; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Burgener A, 2012, AIDS; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Habte HH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-269; Hirbod T, 2008, CURR HIV RES, V6, P28, DOI 10.2174/157016208783571964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikemoto M, 2007, CLIN CHIM ACTA, V376, P197, DOI 10.1016/j.cca.2006.08.018; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Keller MJ, 2009, SEX TRANSM DIS, V36, pS92, DOI 10.1097/OLQ.0b013e318199417d; Klasse PJ, 2006, PLOS MED, V3, P1501, DOI 10.1371/journal.pmed.0030351; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031996; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Otsuka K, 2009, EUR J HEART FAIL, V11, P229, DOI 10.1093/eurjhf/hfn049; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rodriguez RM, 2012, ADV EXP MED BIOL, V739, P237, DOI 10.1007/978-1-4614-1704-0_15; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Sokal DC, 2013, ANTIVIR THER, V18, P301, DOI 10.3851/IMP2311; Sroussi HY, 2006, J DENT RES, V85, P829, DOI 10.1177/154405910608500910; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; UNAIDS, 2011, WORLD REF DAY 2019 H; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560	44	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79505	10.1371/journal.pone.0079505	http://dx.doi.org/10.1371/journal.pone.0079505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244515	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800086
J	Campling, BG; Kuryatov, A; Lindstrom, J				Campling, Barbara G.; Kuryatov, Alexander; Lindstrom, Jon			Acute Activation, Desensitization and Smoldering Activation of Human Acetylcholine Receptors	PLOS ONE			English	Article							ALPHA-4-BETA-2 NICOTINIC RECEPTORS; PARTIAL AGONISTS VARENICLINE; SAZETIDINE-A; SUBUNITS CONTRIBUTE; RB-86(+) EFFLUX; LOW-SENSITIVITY; ALPHA 4; PHARMACOLOGY; EXPRESSION; CHEMISTRY	The behavioral effects of nicotine and other nicotinic agonists are mediated by AChRs in the brain. The relative contribution of acute activation versus chronic desensitization of AChRs is unknown. Sustained "smoldering activation'' occurs over a range of agonist concentrations at which activated and desensitized AChRs are present in equilibrium. We used a fluorescent dye sensitive to changes in membrane potential to examine the effects of acute activation and chronic desensitization by nicotinic AChR agonists on cell lines expressing human alpha 4 beta 2, alpha 3 beta 4 and alpha 7 AChRs. We examined the effects of acute and prolonged application of nicotine and the partial agonists varenicline, cytisine and sazetidine-A on these AChRs. The range of concentrations over which nicotine causes smoldering activation of alpha 4 beta 2 AChRs was centered at 0.13 mu M, a level found in smokers. However, nicotine produced smoldering activation of alpha 3 beta 4 and alpha 7 AChRs at concentrations well above levels found in smokers. The alpha 4 beta 2 expressing cell line contains a mixture of two stoichiometries, namely (alpha 4 beta 2)(2)beta 2 and (alpha 4 beta 2)(2)alpha(4). The (alpha 4 beta 2)(2)beta 2 stoichiometry is more sensitive to activation by nicotine. Sazetidine-A activates and desensitizes only this stoichiometry. Varenicline, cytisine and sazetidine-A were partial agonists on this mixture of alpha 4 beta 2 AChRs, but full agonists on alpha 3 beta 4 and alpha 7 AChRs. It has been reported that cytisine and varenicline are most efficacious on the (alpha 4 beta 2)(2)alpha 4 stoichiometry. In this study, we distinguish the dual effects of activation and desensitization of AChRs by these nicotinic agonists and define the range of concentrations over which smoldering activation can be sustained.	[Campling, Barbara G.; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Campling, Barbara G.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	jslkk@mail.med.upenn.edu			National Institutes of Health [NS11232]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support provided by grant NS11232 from the National Institutes of Health (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSharari SD, 2012, J PHARMACOL EXP THER, V342, P742, DOI 10.1124/jpet.112.194506; Astroug Henri, 2010, Interdiscip Toxicol, V3, P15, DOI 10.2478/v10102-010-0003-5; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Cahill Kate, 2016, Cochrane Database Syst Rev, pCD006103, DOI 10.1002/14651858.CD006103.pub7; Caldarone BJ, 2011, PSYCHOPHARMACOLOGY, V217, P199, DOI 10.1007/s00213-011-2271-y; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Conroy WG, 2003, MOL PHARMACOL, V63, P419, DOI 10.1124/mol.63.2.419; Cucchiaro G, 2008, ANESTHESIOLOGY, V109, P512, DOI 10.1097/ALN.0b013e3181834490; Dunlop J, 2007, BIOCHEM PHARMACOL, V74, P1172, DOI 10.1016/j.bcp.2007.07.006; Etter JF, 2006, ARCH INTERN MED, V166, P1553, DOI 10.1001/archinte.166.15.1553; Faessel HM, 2010, CLIN PHARMACOKINET, V49, P799, DOI 10.2165/11537850-000000000-00000; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P441, DOI 10.1124/jpet.112.198085; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P434, DOI 10.1124/jpet.112.198069; Jia L, 2003, J NEUROCHEM, V84, P753, DOI 10.1046/j.1471-4159.2003.01578.x; Kozikowski AP, 2009, CHEMMEDCHEM, V4, P1279, DOI 10.1002/cmdc.200900079; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062246; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Levin ED, 2010, J PHARMACOL EXP THER, V332, P933, DOI 10.1124/jpet.109.162073; Lindstrom JM, 2002, CURRENT CLIN NEUROLO, P15; Liu Y, 2013, J MED CHEM, V56, P3000, DOI 10.1021/jm4000374; LUETJE CW, 1991, J NEUROSCI, V11, P837; Lummis SCR, 2011, J PHARMACOL EXP THER, V339, P125, DOI 10.1124/jpet.111.185306; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, J PHARMACOL EXP THER, V337, P367, DOI 10.1124/jpet.110.177485; Papke RL, 2010, J MOL NEUROSCI, V40, P77, DOI 10.1007/s12031-009-9261-0; PENG X, 1994, MOL PHARMACOL, V45, P546; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Rezvani AH, 2010, PSYCHOPHARMACOLOGY, V211, P161, DOI 10.1007/s00213-010-1878-8; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Turner JR, 2010, J PHARMACOL EXP THER, V334, P665, DOI 10.1124/jpet.110.166280; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	57	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79653	10.1371/journal.pone.0079653	http://dx.doi.org/10.1371/journal.pone.0079653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244538	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800096
J	Mao, QH; Ruan, JP; Cai, XT; Lu, WG; Ye, J; Yang, J; Yang, Y; Sun, XY; Cao, JL; Cao, P				Mao, Qinghong; Ruan, Jiaping; Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Junli; Cao, Peng			Antinociceptive Effects of Analgesic-Antitumor Peptide (AGAP), a Neurotoxin from the Scorpion Buthus martensii Karsch, on Formalin-Induced Inflammatory Pain through a Mitogen-Activated Protein Kinases-Dependent Mechanism in Mice	PLOS ONE			English	Article							TERMINAL PARTIAL SEQUENCE; ESCHERICHIA-COLI; NEUROPATHIC PAIN; SPINAL NEURONS; VENOM; PURIFICATION; CONTRIBUTES; EXPRESSION; HYPERSENSITIVITY; BMK	In the present study, we investigated the anti-nociceptive effect and the underlying mechanism of the analgesic-antitumor peptide (AGAP), a neurotoxin from the scorpion Buthus martensii Karsch. AGAP in doses of 0.2, 1 and 5 mu g was injected intraplantarly (i.pl.) before formalin injection 10 min at the same site. The suppression by intraplantar injection of AGAP on formalin-induced spontaneous nociceptive behaviors was investigated. The results show that AGAP could dose-dependently inhibit formalin-induced two-phase spontaneous flinching response. To investigate the mechanism of action of treatment with AGAP in inflammatory pain, the expressions of peripheral and spinal phosphorylated mitogen-activated protein kinases (phospho-MAPKs) including p-p38, p-ERK and p-JNK were examined. We found that formalin increased the expressions of peripheral and spinal MAPKs, which were prevented by pre-intraplantar injection of AGAP in inflammation pain model in mice. AGAP could also decrease the expression of spinal Fos induced by formalin. Furthermore, combinations the lower doses of the inhibitors of MAPKs (U0126, SP600125, or SB203580 0.1 mg) with the lower dose of AGAP (0.2 mu g), the results suggested that AGAP could potentiate the effects of the inhibitors of MAPKs on the inflammatory pain. The present results indicate that pre-intraplantar injection of AGAP prevents the inflammatory pain induced by formalin through a MAPKs-mediated mechanism in mice.	[Mao, Qinghong; Ruan, Jiaping; Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Peng] China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China; [Cai, Xueting; Lu, Wuguang; Ye, Juan; Yang, Jie; Yang, Yang; Sun, Xiaoyan; Cao, Peng] Jiangsu Prov Inst Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Cao, Junli] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Jiangsu Key Lab Anesthesiol, Xuzhou, Peoples R China	China Academy of Chinese Medical Sciences; Xuzhou Medical University	Ruan, JP (corresponding author), China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China.	jpruan@163.com; pcao79@yahoo.com	Sheng, Lei/HDO-1972-2022	Cao, Jun-Li/0000-0002-8932-4743; , Peng/0000-0002-2044-3074	National Natural Science Foundation of China [81102834, 81302694]; Natural Science Foundation of Jiangsu Province [SBK201241903, SBK201342382, SBK201342799]; Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	This work was supported by the National Natural Science Foundation of China (81102834, 81302694), Natural Science Foundation of Jiangsu Province (SBK201241903, SBK201342382, SBK201342799), and Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao P, 2010, BIOTECHNOL PROGR, V26, P1240, DOI 10.1002/btpr.433; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Liu T, 2008, J ETHNOPHARMACOL, V117, P332, DOI 10.1016/j.jep.2008.02.003; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Liu YF, 2002, PREP BIOCHEM BIOTECH, V32, P317, DOI 10.1081/PB-120015456; Ma R, 2010, BIOCHEM BIOPH RES CO, V394, P330, DOI 10.1016/j.bbrc.2010.02.179; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Wang ZY, 2006, NEUROPHARMACOLOGY, V51, P764, DOI 10.1016/j.neuropharm.2006.05.024; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zhao YL, 2011, J CELL BIOCHEM, V112, P2424, DOI 10.1002/jcb.23166; ZHOU XH, 1989, BIOCHEM J, V257, P509, DOI 10.1042/bj2570509	21	24	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78239	10.1371/journal.pone.0078239	http://dx.doi.org/10.1371/journal.pone.0078239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244296	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800007
J	Qi, L; Zhu, ZF; Li, F; Wang, RF				Qi, Liang; Zhu, Zheng-Feng; Li, Feng; Wang, Ren-Fa			MR Imaging of Patients with Lateral Epicondylitis of the Elbow: Is the Common Extensor Tendon an Isolated Lesion?	PLOS ONE			English	Article							POSTEROLATERAL ROTATORY INSTABILITY; TENNIS ELBOW; MEDIAL EPICONDYLITIS	Objective: To investigate whether an injury of the common extensor tendon (CET) is associated with other abnormalities in the elbow joint and find the potential relationships between these imaging features by using a high-resolution magnetic resonance imaging (MRI). Methods: Twenty-three patients were examined with 3.0 T MR. Two reviewers were recruited for MR images evaluation. Image features were recorded in terms of (1) the injury degree of CET; (2) associated injuries in the elbow joint. Spearman's rank correlation analysis was performed to analyze the relationships between the injury degree of CET and associated abnormalities of the elbow joint, correlations were considered significant at p<0.05. Results: Total 24 elbows in 23 patients were included. Various degrees of injuries were found in total 24 CETs (10 mild, 7 moderate and 7 severe). Associated abnormalities were detected in accompaniments of the elbow joints including ligaments, tendons, saccussynovialis and muscles. A significantly positive correlation (r = 0.877, p<0.01) was found in injuries of CET and lateral ulnar collateral ligament (LUCL). Conclusion: Injury of the CET is not an isolated lesion for lateral picondylitis, which is mostly accompanied with other abnormalities, of which the LUCL injury is the most commonly seen in lateral epicondylitis, and there is a positive correlation between the injury degree in CET and LUCL.	[Qi, Liang] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Zheng-Feng] Huazhong Univ Sci & Technol, Union Hosp, Inst Cardiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Feng; Wang, Ren-Fa] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430074, Peoples R China	Nanjing Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, RF (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430074, Peoples R China.	wangrenfa52@126.com			Priority Academic Program Development of Jiangsu Highter Education Institution [JX10231801]	Priority Academic Program Development of Jiangsu Highter Education Institution	This study was supported by The Priority Academic Program Development of Jiangsu Highter Education Institution (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisset L, 2011, CLIN EVID; BOYD HB, 1973, J BONE JOINT SURG AM, VA 55, P1183, DOI 10.2106/00004623-197355060-00005; Bredella MA, 1999, AM J ROENTGENOL, V173, P1379, DOI 10.2214/ajr.173.5.10541124; Bunata RE, 2007, J BONE JOINT SURG AM, V89A, P1955, DOI 10.2106/JBJS.F.00727; Ciccotti MC, 2004, CLIN SPORT MED, V23, P693, DOI 10.1016/j.csm.2004.04.011; Ciccotti MC, 2004, CLIN SPORTS MED, V23, pxi; COEL M, 1993, AM J ROENTGENOL, V161, P1019, DOI 10.2214/ajr.161.5.8273602; Cohen MS, 2008, J SHOULDER ELB SURG, V17, P954, DOI 10.1016/j.jse.2008.02.021; COONRAD RW, 1973, J BONE JOINT SURG AM, VA 55, P1177, DOI 10.2106/00004623-197355060-00004; Degreef Ilse, 2005, Acta Orthop Belg, V71, P154; Gleason T F, 1983, J Bone Joint Surg Am, V65, P1031; Jacobson JA, 2005, SEMIN MUSCULOSKEL R, V9, P346, DOI 10.1055/s-2005-923379; Kijowski R, 2005, SKELETAL RADIOL, V34, P196, DOI 10.1007/s00256-005-0896-9; Kumar S, 2011, ANN ROY COLL SURG, V93, P432, DOI 10.1308/rcsann.2011.93.6.432; Lattermann C, 2010, J SHOULDER ELB SURG, V19, P651, DOI 10.1016/j.jse.2010.02.008; Lee BPH, 2003, J SHOULDER ELB SURG, V12, P476, DOI 10.1016/S1058-2746(03)00091-0; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; Olivieri I, 2004, CLIN RHEUMATOL, V23, P275, DOI 10.1007/s10067-004-0870-2; POTTER HG, 1995, RADIOLOGY, V196, P43, DOI 10.1148/radiology.196.1.7784585; Thornton Raymond, 2003, Top Magn Reson Imaging, V14, P69, DOI 10.1097/00002142-200302000-00006; Walz DM, 2010, RADIOGRAPHICS, V30, P167, DOI 10.1148/rg.301095078; Wixom SM, 2012, J HAND THER, V25, P421; Wixom Steven M, 2012, J Hand Ther, V25, P418, DOI 10.1016/j.jht.2012.06.007	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79498	10.1371/journal.pone.0079498	http://dx.doi.org/10.1371/journal.pone.0079498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244512	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800083
J	Rusconi, S; Vitiello, P; Adorni, F; Colella, E; Foca, E; Capetti, A; Meraviglia, P; Abeli, C; Bonora, S; D'Annunzio, M; Di Biagio, A; Di Pietro, M; Butini, L; Orofino, G; Colafigli, M; d'Ettorre, G; Francisci, D; Parruti, G; Soria, A; Buonomini, AR; Tommasi, C; Mosti, S; Bai, F; Stuppino, SDN; Morosi, M; Montano, M; Tau, P; Merlini, E; Marchetti, G				Rusconi, Stefano; Vitiello, Paola; Adorni, Fulvio; Colella, Elisa; Foca, Emanuele; Capetti, Amedeo; Meraviglia, Paola; Abeli, Clara; Bonora, Stefano; D'Annunzio, Marco; Di Biagio, Antonio; Di Pietro, Massimo; Butini, Luca; Orofino, Giancarlo; Colafigli, Manuela; d'Ettorre, Gabriella; Francisci, Daniela; Parruti, Giustino; Soria, Alessandro; Buonomini, Anna Rita; Tommasi, Chiara; Mosti, Silvia; Bai, Francesca; Stuppino, Silvia Di Nardo; Morosi, Manuela; Montano, Marco; Tau, Pamela; Merlini, Esther; Marchetti, Giulia			Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial	PLOS ONE			English	Article							T-CELL RECOVERY; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; VIRAL SUPPRESSION; ADDING MARAVIROC; INTERLEUKIN-7; ACTIVATION; RECONSTITUTION	Background: Immunological non-responders (INRs) lacked CD4 increase despite HIV-viremia suppression on HAART and had an increased risk of disease progression. We assessed immune reconstitution profile upon intensification with maraviroc in INRs. Methods: We designed a multi-centric, randomized, parallel, open label, phase 4 superiority trial. We enrolled 97 patients on HAART with CD4+<= 200/mu L and/or CD4+ recovery <= 25% and HIV-RNA<50 cp/mL. Patients were randomized 1: 1 to HAART+maraviroc or continued HAART. CD4+ and CD8+CD45+RA/RO, Ki67 expression and plasma IL-7 were quantified at W0, W12 and W48. Results: By W48 both groups displayed a CD4 increase without a significant inter-group difference. A statistically significant change in CD8 favored patients in arm HAART+maraviroc versus HAART at W12 (p=.009) and W48 (p=.025). The CD4>200/mu L and CD4>200/mu L + CD4 gain >= 25% end-points were not satisfied at W12 (p=.24 and p=.619) nor at W48 (p=.076 and p=.236). Patients continuing HAART displayed no major changes in parameters of T-cell homeostasis and activation. Maraviroc-receiving patients experienced a significant rise in circulating IL-7 by W48 (p=.01), and a trend in temporary reduction in activated HLA-DR+CD38+CD4+ by W12 (p=.06) that was not maintained at W48. Conclusions: Maraviroc intensification in INRs did not have a significant advantage in reconstituting CD4 T-cell pool, but did substantially expand CD8. It resulted in a low rate of treatment discontinuations.	[Rusconi, Stefano; Vitiello, Paola; Colella, Elisa; Stuppino, Silvia Di Nardo; Morosi, Manuela; Tau, Pamela] Univ Milan, DIBIC Luigi Sacco, Div Clin Malattie Infett, Milan, Italy; [Adorni, Fulvio] ITB CNR, Segrate, MI, Italy; [Foca, Emanuele] Univ Brescia, Clin Malattie Infett & Tropicali, Brescia, Italy; [Capetti, Amedeo] Osped L Sacco, Div Malattie Infett 1, Milan, Italy; [Meraviglia, Paola] Osped L Sacco, Div Malattie Infett 2, Milan, Italy; [Vitiello, Paola; Abeli, Clara] Osped L Sacco, Div Malattie Infett 2, Busto Arsizio, VA, Italy; [Bonora, Stefano] Univ Turin, Osped Amedeo Savoia, Clin Malattie Infett, Turin, Italy; [D'Annunzio, Marco] AO Univ Policlin, Clin Malattie Infett, Bari, Italy; [Di Biagio, Antonio] Univ Genoa, Osped San Martino, Clin Malattie Infett, Genoa, Italy; [Di Pietro, Massimo] Osped S Maria Annunziata, Div Malattie Infett, Florence, Italy; [Butini, Luca] AO Univ, Serv Immunol Clin & Tipizzazione, Torrette Di Ancona, Italy; [Orofino, Giancarlo] Osped Amedeo Savoia, Div A Malattie Infett, Turin, Italy; [Colafigli, Manuela] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy; [d'Ettorre, Gabriella] Univ Roma La Sapienza, UO Malattie Infett, Rome, Italy; [Francisci, Daniela] Monteluce Policlin, Clin Malattie Infett, Perugia, Italy; [Parruti, Giustino] Osped Santo Spirito, Div Clin Malattie Infett, Pescara, Italy; [Soria, Alessandro] Osped San Gerardo, Div Clin Malattie Infett, Monza, Italy; [Buonomini, Anna Rita; Montano, Marco] Policlin Tor Vergata, Clin Malattie Infett, Rome, Italy; [Tommasi, Chiara] III Div Malattie Infett INMI Lazzaro Spallanzani, Rome, Italy; [Mosti, Silvia] IV Div Malattie Infett INMI Lazzaro Spallanzani, Rome, Italy; [Bai, Francesca; Merlini, Esther; Marchetti, Giulia] Univ Milan, Polo Univ San Paolo, Dipartimento Sci Salute, Clin Malattie Infett, Milan, Italy	University of Milan; Luigi Sacco Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Brescia; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Turin; University of Genoa; IRCCS AOU San Martino IST; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; San Gerardo Hospital; University of Rome Tor Vergata; Policlin Tor Vergata; University of Milan	Rusconi, S (corresponding author), Univ Milan, DIBIC Luigi Sacco, Div Clin Malattie Infett, Milan, Italy.	stefano.rusconi@unimi.it	Gori, Andrea/AAC-6078-2022; d'Ettorre, Gabriella/K-4511-2016; Rusconi, Stefano/H-9263-2012; Bai, Francesca/K-4823-2018; Di Biagio, Antonio/J-4901-2019; Buonomini, Anna Rita/AAC-7325-2022; Colafigli, Manuela/K-5167-2018; Adorni, Fulvio/P-7064-2018; Adorni, Fulvio/GOH-0583-2022; Marchetti, Giulia/GPX-7655-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	Rusconi, Stefano/0000-0002-0375-9990; Di Biagio, Antonio/0000-0003-1436-5089; Buonomini, Anna Rita/0000-0001-7503-2742; Colafigli, Manuela/0000-0003-1610-6347; Adorni, Fulvio/0000-0001-6264-6876; Adorni, Fulvio/0000-0001-6264-6876; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; meraviglia, paola/0000-0002-3356-7199; FOCA', Emanuele/0000-0003-4395-5379; SORIA, Alessandro/0000-0002-4447-2574; d'Ettorre, Gabriella/0000-0002-3571-5677	Pfizer, Inc., New York, NY, USA; Anlaids Lombardy Onlus, Milan, Italy	Pfizer, Inc., New York, NY, USA(Pfizer); Anlaids Lombardy Onlus, Milan, Italy	This work has been funded by Pfizer, Inc., New York, NY, USA through an Investigator Initiated Research grant (to S. R.) and by Anlaids Lombardy Onlus, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; Cossarini F, 2012, J ANTIMICROB CHEMOTH, V67, P2474, DOI 10.1093/jac/dks216; Cuzin L, 2012, JAIDS-J ACQ IMM DEF, V61, P557, DOI 10.1097/QAI.0b013e318273015f; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gulick RM, 2007, AIDS, V21, P813, DOI 10.1097/QAD.0b013e32805e8753; Hammer SM, 2010, HIV CLIN TRIALS, V11, P312, DOI 10.1310/hct1105-312; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; LAPADULA G, 2012, 19 C RETR OPP INF SE; Levy Y, 2012, CLIN INFECT DIS, V55, P291, DOI 10.1093/cid/cis383; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; MASSANELLA M, 18 C RETR OPP INF BO, P2011; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Monforte AD, 1999, AIDS, V13, P1669, DOI 10.1097/00002030-199909100-00010; NDHLOVU L, 2012, 19 C RETR OPP INF SE; Renaud M, 1999, AIDS, V13, P669, DOI 10.1097/00002030-199904160-00007; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Shalekoff S, 2001, J CLIN IMMUNOL, V21, P390, DOI 10.1023/A:1013121625962; Sieg SF, 2012, CURR HIV RES, V10, P341, DOI 10.2174/157016212800792432; Stepanyuk O, 2009, AIDS, V23, P1911, DOI 10.1097/QAD.0b013e32832f3c65; Street E, 2009, HIV MED, V10, P337, DOI 10.1111/j.1468-1293.2009.00692.x; Svicher V, 2012, NEW MICROBIOL, V35, P17; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Wilkin TJ, 2012, J INFECT DIS, V206, P534, DOI 10.1093/infdis/jis376; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	30	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80157	10.1371/journal.pone.0080157	http://dx.doi.org/10.1371/journal.pone.0080157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244635	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800129
J	Sekihara, K; Harashima, N; Tongu, M; Tamaki, Y; Uchida, N; Inomata, T; Harada, M				Sekihara, Kazumasa; Harashima, Nanae; Tongu, Miki; Tamaki, Yukihisa; Uchida, Nobue; Inomata, Taisuke; Harada, Mamoru			Pifithrin-mu, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SMALL-MOLECULE INHIBITOR; RANDOMIZED-TRIAL; HSP70; APOPTOSIS; SURVIVAL; FAMILY; RADIOTHERAPY; QUERCETIN; STRESS	Hyperthermia (HT) improves the efficacy of anti-cancer radiotherapy and chemotherapy. However, HT also inevitably evokes stress responses and increases the expression of heat-shock proteins (HSPs) in cancer cells. Among the HSPs, HSP70 is known as a pro-survival protein. In this study, we investigated the sensitizing effect of pifithrin (PFT)-mu, a small molecule inhibitor of HSP70, when three human prostate cancer cell lines (LNCaP, PC-3, and DU-145) were treated with HT (43 degrees C for 2 h). All cell lines constitutively expressed HSP70, and HT further increased its expression in LNCaP and DU-145. Knockdown of HSP70 with RNA interference decreased the viability and colony-forming ability of cancer cells. PFT-mu decreased the viabilities of all cell lines at one-tenth the dose of Quercetin, a well-known HSP inhibitor. The combination therapy with suboptimal doses of PFT-mu and HT decreased the viability of cancer cells most effectively when PFT-mu was added immediately before HT, and this combination effect was abolished by pre-knockdown of HSP70, suggesting that the effect was mediated via HSP70 inhibition. The combination therapy induced cell death, partially caspase-dependent, and decreased proliferating cancer cells, with decreased expression of c-Myc and cyclin D1 and increased expression of p21(WAF1/Cip), indicating arrest of cell growth. Additionally, the combination therapy significantly decreased the colony-forming ability of cancer cells compared to therapy with either alone. Furthermore, in a xenograft mouse model, the combination therapy significantly inhibited PC-3 tumor growth. These findings suggest that PFT-mu can effectively enhance HT-induced antitumor effects via HSP70 inhibition by inducing cell death and arrest of cell growth, and that PFT-mu is a promising agent for use in combination with HT to treat prostate cancer.	[Sekihara, Kazumasa; Harashima, Nanae; Harada, Mamoru] Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan; [Sekihara, Kazumasa; Tamaki, Yukihisa; Inomata, Taisuke] Shimane Univ, Fac Med, Dept Radiat Oncol, Matsue, Shimane, Japan; [Tongu, Miki] Shimane Univ, Dept Expt Anim, Izumo, Shimane, Japan; [Uchida, Nobue] Tottori Prefectural Cent Hosp, Dept Radiat Oncol, Tottori, Japan	Shimane University; Shimane University; Shimane University	Harada, M (corresponding author), Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan.	haramamo@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [18591449, 23701074]; Shimane University "S-TAKUMI Medical Nanotechnology" Project	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shimane University "S-TAKUMI Medical Nanotechnology" Project	This study was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 18591449 to M. Harada and no. 23701074 to N. Harashima), and from Shimane University "S-TAKUMI Medical Nanotechnology" Project (to M. Harada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Asea A, 2001, INT J HYPERTHER, V17, P347, DOI 10.1080/02656730110053146; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Colombo R, 2003, J CLIN ONCOL, V21, P4270, DOI 10.1200/JCO.2003.01.089; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davenport EL, 2010, LEUKEMIA, V24, P1804, DOI 10.1038/leu.2010.168; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Galluzzi L, 2009, MOL CELL, V36, P176, DOI 10.1016/j.molcel.2009.10.003; Gleave ME, 1999, CAN MED ASSOC J, V160, P225; GRESS TM, 1994, CANCER RES, V54, P547; Haveman J, 2005, ONCOL REP, V14, P561; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kalapurakal JA, 2003, INT J RADIAT ONCOL, V57, P654, DOI 10.1016/S0360-3016(03)00625-4; Kampinga HH, 2001, INT J RADIAT BIOL, V77, P399, DOI 10.1080/09553000010024687; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kouloulias V, 2005, AM J CLIN ONCOL-CANC, V28, P91, DOI 10.1097/01.coc.0000139939.60056.42; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michalakis J, 2007, ANN SURG ONCOL, V14, P1220, DOI 10.1245/s10434-006-9305-4; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Morishima Y, 2000, J BIOL CHEM, V66, P535; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Nylandsted J, 2002, CANCER RES, V62, P7139; OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roigas J, 1998, PROSTATE, V34, P195; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tso CL, 2000, CANCER J, V6, P220; van der Zee J, 2000, LANCET, V355, P1119, DOI 10.1016/S0140-6736(00)02059-6	42	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78772	10.1371/journal.pone.0078772	http://dx.doi.org/10.1371/journal.pone.0078772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244355	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800014
J	Aiken, AM; Wanyoro, AK; Mwangi, J; Juma, F; Mugoya, IK; Scott, JAG				Aiken, Alexander M.; Wanyoro, Anthony K.; Mwangi, Jonah; Juma, Francis; Mugoya, Isaac K.; Scott, J. Anthony G.			Changing Use of Surgical Antibiotic Prophylaxis in Thika Hospital, Kenya: A Quality Improvement Intervention with an Interrupted Time Series Design	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTION; ANTIMICROBIAL PROPHYLAXIS; SITE INFECTIONS; AFRICA; SURVEILLANCE; COUNTRIES; RESISTANT; SURGERY; BENEFIT	Introduction: In low-income countries, Surgical Site Infection (SSI) is a common form of hospital-acquired infection. Antibiotic prophylaxis is an effective method of preventing these infections, if given immediately before the start of surgery. Although several studies in Africa have compared pre-operative versus post-operative prophylaxis, there are no studies describing the implementation of policies to improve prescribing of surgical antibiotic prophylaxis in African hospitals. Methods: We conducted SSI surveillance at a typical Government hospital in Kenya over a 16 month period between August 2010 and December 2011, using standard definitions of SSI and the extent of contamination of surgical wounds. As an intervention, we developed a hospital policy that advised pre-operative antibiotic prophylaxis and discouraged extended post-operative antibiotics use. We measured process, outcome and balancing effects of this intervention in using an interrupted time series design. Results: From a starting point of near-exclusive post-operative antibiotic use, after policy introduction in February 2011 there was rapid adoption of the use of pre-operative antibiotic prophylaxis (60% of operations at 1 week; 98% at 6 weeks) and a substantial decrease in the use of post-operative antibiotics (40% of operations at 1 week; 10% at 6 weeks) in Clean and Clean-Contaminated surgery. There was no immediate step-change in risk of SSI, but overall, there appeared to be a moderate reduction in the risk of superficial SSI across all levels of wound contamination. There were marked reductions in the costs associated with antibiotic use, the number of intravenous injections performed and nursing time spent administering these. Conclusion: Implementation of a locally developed policy regarding surgical antibiotic prophylaxis is an achievable quality improvement target for hospitals in low-income countries, and can lead to substantial benefits for individual patients and the institution.	[Aiken, Alexander M.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, London WC1, England; [Aiken, Alexander M.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Wanyoro, Anthony K.; Mwangi, Jonah; Juma, Francis] Thika Level 5 Hosp, Thika, Kenya; [Wanyoro, Anthony K.] Kenyatta Univ, Nairobi, Kenya; [Mugoya, Isaac K.] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX1 2JD, England	University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Kenyatta University; University of Oxford	Scott, JAG (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	alexander.aiken@lshtm.ac.uk	Aiken, Alexander/AAP-7661-2021	Aiken, Alexander/0000-0003-3372-9036	KEMRI-Wellcome Trust; Wellcome Trust of Great Britain [085042, 081835]; National Institute for Health Research [CL-2012-18-002] Funding Source: researchfish	KEMRI-Wellcome Trust(Wellcome Trust); Wellcome Trust of Great Britain(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	Surveillance at Thika Hospital was funded by the KEMRI-Wellcome Trust Research Programme as part of the Training Fellowship for AA. AA and JAGS are supported by research fellowships from the Wellcome Trust of Great Britain (grant numbers 085042 and 081835 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2013, J HOSP INFECT, V83, P140, DOI 10.1016/j.jhin.2012.11.003; Aiken AM, 2012, INT J SURG, V10, P242, DOI 10.1016/j.ijsu.2012.04.004; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; Davey P, 2009, COCHRANE DB SYST REV; Goff DA, 2012, CLIN INFECT DIS; Hedrick TL, 2012, LANCET INFECT DIS, V12, P357, DOI 10.1016/S1473-3099(12)70019-1; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kayihura V, 2003, ACTA OBSTET GYN SCAN, V82, P636, DOI 10.1034/j.1600-0412.2003.00205.x; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Owens SM, 2009, OBSTET GYNECOL, V114, P573, DOI 10.1097/AOG.0b013e3181b490f1; Reggiori A, 1996, BRIT J SURG, V83, P356, DOI 10.1002/bjs.1800830319; Saxer F, 2009, ANN SURG, V249, P322, DOI 10.1097/SLA.0b013e31819782fd; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	21	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78942	10.1371/journal.pone.0078942	http://dx.doi.org/10.1371/journal.pone.0078942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244390	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000327221600084
J	Coggins, SA; Wynn, JL; Hill, ML; Slaughter, JC; Ozdas-Weitkamp, A; Jalloh, O; Waitman, LR; Carnevale, RJ; Weitkamp, JH				Coggins, Sarah A.; Wynn, James L.; Hill, Melissa L.; Slaughter, James C.; Ozdas-Weitkamp, Asli; Jalloh, Osman; Waitman, L. Russell; Carnevale, Randy J.; Weitkamp, Joren-Hendrik			Use of a Computerized C-Reactive Protein (CRP) Based Sepsis Evaluation in Very Low Birth Weight (VLBW) Infants: A Five-Year Experience	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ONSET NEONATAL SEPSIS; UNNECESSARY ANTIBIOTIC-THERAPY; PHYSICIAN ORDER ENTRY; L-CARNITINE INFUSIONS; BLOOD-CELL COUNT; NECROTIZING ENTEROCOLITIS; HEMODIALYSIS-PATIENTS; NEWBORN-INFANTS; GESTATIONAL-AGE	Background: Serial C-reactive protein (CRP) values may be useful for decision-making regarding duration of antibiotics in neonates. However, established standard of practice for its use in preterm very low birth weight (< 1500 g, VLBW) infants are lacking. Objective: Evaluate compliance with a CRP-guided computerized decision support (CDS) algorithm and compare characteristics and outcomes of compliant versus non-compliant cases. Measure correlation between CRPs and white blood count (WBC) indices. Methods: We examined 3 populations: 1) all preterm VLBW infants born at Vanderbilt 2006-2011 - we assessed provider compliance with CDS algorithm and measured relevant outcomes; 2) all patients with positive blood culture results admitted to the Vanderbilt NICU 2006-2012 - we tested the correlation between CRP and WBC results within 7 days of blood culture phlebotomy; 3) 1,000 randomly selected patients out of the 7,062 patients admitted to the NICU 2006-2012 we correlated time-associated CRP values and absolute neutrophil counts. Results: Of 636 VLBW infants in cohort 1), 569 (89%) received empiric antibiotics for suspected early-onset sepsis. In 409 infants (72%) the CDS algorithm was followed; antibiotics were discontinued <= 48 hours in 311 (55%) with normal serial CRPs and continued in 98 (17%) with positive CRPs, resulting in significant reduction in antibiotic exposure (p<0.001) without increase in complications or subsequent infections. One hundred sixty (28%) were considered non-compliant because antibiotics were continued beyond 48 hours despite negative serial CRPs and blood cultures. Serial CRPs remained negative in 38 (12%) of 308 blood culture-positive infants from cohort 2, but only 4 patients had clinically probable sepsis with single organisms and no immunodeficiency besides extreme prematurity. Leukopenia of any cell type was not linked with CRPs in cohorts 2 and 3. Conclusions: CDS/CRP-guided antibiotic use is safe and effective in culture-negative VLBW infants. CRP results are not affected by low WBC indices.	[Coggins, Sarah A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Wynn, James L.; Hill, Melissa L.; Weitkamp, Joren-Hendrik] Vanderbilt Univ, Dept Pediat, Monroe J Carell Childrens Hosp Vanderbilt, Nashville, TN 37203 USA; [Slaughter, James C.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Ozdas-Weitkamp, Asli; Jalloh, Osman; Waitman, L. Russell; Carnevale, Randy J.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Weitkamp, JH (corresponding author), Vanderbilt Univ, Dept Pediat, Monroe J Carell Childrens Hosp Vanderbilt, Nashville, TN 37203 USA.	hendrik.weitkamp@vanderbilt.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020; Coggins, Sarah/GRS-5951-2022	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Wynn, James/0000-0001-7052-4836; Coggins, Sarah/0000-0003-3938-6337; Slaughter, James/0000-0002-8770-980X	United States Government (National Institutes of Health (NIH) [K08GM106143, K08HD061607]; non-profit organizations Thrasher Research Foundation; Vanderbilt University School of Medicine Emphasis Program; Darlene Batey Hoffman Summer Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM106143] Funding Source: NIH RePORTER	United States Government (National Institutes of Health (NIH); non-profit organizations Thrasher Research Foundation; Vanderbilt University School of Medicine Emphasis Program; Darlene Batey Hoffman Summer Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Wynn receives support from the United States Government (National Institutes of Health (NIH), K08GM106143), and the non-profit organizations Thrasher Research Foundation and The Gerber Foundation for his work in neonatal sepsis and immunology. Dr. Weitkamp receives support from the United States Government (NIH, K08HD061607) for his work in necrotizing enterocolitis and immune development. Ms. Coggins was supported by the Vanderbilt University School of Medicine Emphasis Program and a Darlene Batey Hoffman Summer Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander VN, 2011, J PEDIATR-US, V159, P392, DOI 10.1016/j.jpeds.2011.02.035; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; BERNARD PA, 1981, LARYNGOSCOPE, V91, P1985; Berrington JE, 2005, CLIN EXP IMMUNOL, V140, P289, DOI 10.1111/j.1365-2249.2005.02767.x; Bizzarro MJ, 2008, PEDIATRICS, V121, P689, DOI 10.1542/peds.2007-2171; Christensen RD, 2010, J PERINATOL, V30, P540, DOI 10.1038/jp.2009.196; Christensen RD, 2012, PEDIATRICS, V129, pE1165, DOI 10.1542/peds.2011-2661; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Duranay M, 2006, NEPHROL DIAL TRANSPL, V21, P3211, DOI 10.1093/ndt/gfl356; Fanaroff AA, 1998, PEDIATR INFECT DIS J, V17, P593, DOI 10.1097/00006454-199807000-00004; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; Franz AR, 1999, PEDIATRICS, V104, P447, DOI 10.1542/peds.104.3.447; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GERDES JS, 1987, PEDIATR INFECT DIS J, V6, P443, DOI 10.1097/00006454-198705000-00005; Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10; HAMMERSCHLAG MR, 1977, NEW ENGL J MED, V296, P1268, DOI 10.1056/NEJM197706022962206; Hofer N, 2011, CLIN CHEM LAB MED, V49, P297, DOI 10.1515/CCLM.2011.048; Hornik CP, 2012, PEDIATR INFECT DIS J, V31, P803, DOI 10.1097/INF.0b013e31825691e4; Hornik CP, 2012, PEDIATR INFECT DIS J, V31, P799, DOI 10.1097/INF.0b013e318256905c; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Longhurst CA, 2010, PEDIATRICS, V126, P14, DOI 10.1542/peds.2009-3271; MANROE BL, 1979, J PEDIATR-US, V95, P89, DOI 10.1016/S0022-3476(79)80096-7; Norberg A, 2003, JAMA-J AM MED ASSOC, V289, P726, DOI 10.1001/jama.289.6.726; Ozdas A, 2006, J AM MED INFORM ASSN, V13, P188, DOI 10.1197/jamia.M1656; Patel SJ, 2010, CLIN PERINATOL, V37, P547, DOI 10.1016/j.clp.2010.06.004; PHILIP AGS, 1980, PEDIATRICS, V65, P1036; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; POURCYROUS M, 1993, PEDIATRICS, V92, P431; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10242; SABEL KG, 1974, ACTA PAEDIATR SCAND, V63, P381, DOI 10.1111/j.1651-2227.1974.tb04814.x; SANTOLAYA ME, 1994, CLIN INFECT DIS, V18, P589, DOI 10.1093/clinids/18.4.589; Savica V, 2005, J RENAL NUTR, V15, P225, DOI 10.1053/j.jrn.2004.10.002; Stavroulaki P, 1999, INT J PEDIATR OTORHI, V50, P177, DOI 10.1016/S0165-5876(99)00247-5; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Taylor JA, 2008, PEDIATRICS, V121, P123, DOI 10.1542/peds.2007-0919; Turner MA, 2004, ARCH DIS CHILD-FETAL, V89, pF272, DOI 10.1136/adc.2002.011288; Weitkamp JH, 2008, J PERINATOL, V28, P405, DOI 10.1038/sj.jp.7211914; Weitkamp JH, 2005, NEOREVIEWS, V6, pe508	42	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78602	10.1371/journal.pone.0078602	http://dx.doi.org/10.1371/journal.pone.0078602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244325	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600035
J	Hammouda, O; Chtourou, H; Aloui, A; Chahed, H; Kallel, C; Miled, A; Chamari, K; Chaouachi, A; Souissi, N				Hammouda, Omar; Chtourou, Hamdi; Aloui, Asma; Chahed, Henda; Kallel, Choumous; Miled, Abdelhedi; Chamari, Karim; Chaouachi, Anis; Souissi, Nizar			Concomitant Effects of Ramadan Fasting and Time-Of-Day on Apolipoprotein AI, B, Lp-a and Homocysteine Responses during Aerobic Exercise in Tunisian Soccer Players	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; C-REACTIVE PROTEIN; PHYSICAL PERFORMANCE; ANTIOXIDANT STATUS; DIURNAL-VARIATIONS; BODY-COMPOSITION; MUSCLE INJURY; LIPID-LEVELS; PLASMA; WEIGHT	Objective: To examine the time-of-day and Ramadan fasting (RF) effects on serum apolipoprotein-AI (Apo-AI) and B (Apo-B), lipoprotein particles-a (Lp-a), high-sensitive C-reactive-protein (hs-CRP), and homocysteine (Hcy) during the Yo-Yo intermittent recovery test (YYIRT). Design: Performance and biochemical measures were completed at two times-of-day (07: 00 and 17: 00 h), 1-week before RF (BR), the second week of RF (SWR), and the fourth week of RF (ER). Setting: For each session, subjects performed the YYIRT, and blood samples were taken before and 3-min after the test for biochemical measures. Participants: Fifteen soccer players. Main Outcome Measures: Total distance during the YYIRT, core temperature, body composition, dietary intakes, lipid (HDL-C, LDL-C, Apo-AI, B and Lp-a) and inflammatory (hs-CRP and Hcy) profiles. Results: Performances during the YYIRT were higher in the evening than the morning BR (P < 0.05), but this fluctuation was not observed during RF. Moreover, LDL-C, ApoB, and Lp-a were stable throughout the daytime BR. However, during RF, they decreased at 17: 00 h (P < 0.05). Likewise, HDL-C and Apo-AI increased after the exercise and were higher at 17: 00 h BR (P < 0.001). Moreover, these parameters increased during RF (P < 0.01). Furthermore, Hcy and hs-CRP increased during the exercise (P < 0.01) with higher evening levels BR. During ER, the diurnal pattern of Hcy was inversed (P < 0.001). Conclusions: This study concluded that caloric restriction induced by RF seems to ameliorate lipid and inflammatory markers of cardiovascular health during intermittent exercise performed in the evening.	[Hammouda, Omar; Chtourou, Hamdi; Aloui, Asma; Chaouachi, Anis; Souissi, Nizar] CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Chahed, Henda; Miled, Abdelhedi] CHU Farhat Hached, Biochem Res Lab, Sousse, Tunisia; [Kallel, Choumous] CHU Habib Bourguiba, Res Lab Hematol, Sfax, Tunisia; [Souissi, Nizar] Manouba Univ, High Inst Sport & Phys Educ Ksar Said, Manouba, Tunisia; [Hammouda, Omar; Chtourou, Hamdi] Sfax Univ, High Inst Sport & Phys Educ Sfax, Sfax, Tunisia; [Chamari, Karim] Qatar Orthoped & Sports Med Hosp, Aspetar, Res & Educ Ctr, Doha, Qatar	Centre National de la Medecine Sciences des Sports; Universite de Sousse; Hopital Farhat Hached; Universite de Sfax; Hopital Habib Bourguiba; Universite de la Manouba; Universite de Sfax; Aspetar Orthopaedic & Sports Medicine Hospital	Hammouda, O (corresponding author), CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia.	omarham007@yahoo.fr	CHAMARI, Karim/AAJ-7938-2021; Nizar, Souissi/AAF-4490-2019; Aloui, Asma/J-1300-2019; Chtourou, Hamdi/GVU-1967-2022; HAMMOUDA, Omar/AGE-5171-2022	CHAMARI, Karim/0000-0001-9178-7678; Nizar, Souissi/0000-0003-1227-8221; Aloui, Asma/0000-0001-5054-1540; Chtourou, Hamdi/0000-0002-5482-9151; HAMMOUDA, Omar/0000-0002-5002-687X	Ministry of Higher Education and Scientific Research, Tunisia	Ministry of Higher Education and Scientific Research, Tunisia	This study was conducted with financial support from the Ministry of Higher Education and Scientific Research, Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlouni A, 1997, ANN NUTR METAB, V41, P242, DOI 10.1159/000177999; Adlouni A, 1998, CLIN CHIM ACTA, V271, P179, DOI 10.1016/S0009-8981(97)00245-3; Afrasiabi A, 2003, SAUDI MED J, V24, P184; Aksungar FB, 2007, ANN NUTR METAB, V51, P88, DOI 10.1159/000100954; Bogdan A, 2001, LIFE SCI, V68, P1607, DOI 10.1016/S0024-3205(01)00966-3; Bouhlel E, 2006, DIABETES METAB, V32, P617, DOI 10.1016/S1262-3636(07)70317-8; Bouhlel E, 2008, INT J SPORT NUTR EXE, V18, P617, DOI 10.1123/ijsnem.18.6.617; Bremner WF, 2000, AM J CARDIOL, V86, P1153, DOI 10.1016/S0002-9149(00)01181-4; Castagna C, 2009, J STRENGTH COND RES, V23, P1954, DOI 10.1519/JSC.0b013e3181b7f743; Chaouachi A, 2008, INT J SPORTS MED, V29, P282, DOI 10.1055/s-2007-965338; Chaouachi A, 2009, APPL PHYSIOL NUTR ME, V34, P907, DOI 10.1139/H09-095; Chennaoui M, 2009, APPL PHYSIOL NUTR ME, V34, P587, DOI 10.1139/H09-014; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dominguez-Rodriguez A, 2006, REV ESP CARDIOL, V59, P1204; ELATI J, 1995, AM J CLIN NUTR, V62, P302, DOI 10.1093/ajcn/62.2.302; Finch GM, 1998, APPETITE, V31, P159, DOI 10.1006/appe.1998.0164; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GENEST JJ, 1991, ATHEROSCLEROSIS, V90, P149, DOI 10.1016/0021-9150(91)90109-G; HALLAK MH, 1988, AM J CLIN NUTR, V48, P1197, DOI 10.1093/ajcn/48.5.1197; Hammouda O, 2013, J SPORT SCI, V31, P963, DOI 10.1080/02640414.2012.757345; Hammouda Omar, 2012, Asian J Sports Med, V3, P239, DOI 10.5812/asjsm.34544; Hammouda O, 2012, BIOL RHYTHM RES, V43, P431, DOI 10.1080/09291016.2011.599638; Hammouda O, 2011, CHRONOBIOL INT, V28, P958, DOI 10.3109/07420528.2011.613683; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Haouari-Oukerro F, 1994, BIOCH CLIN, V18, P363; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hourani HM Al, 2009, JORDAN J BIOL SCI, V2, P103; KUUSI T, 1984, METABOLISM, V33, P527, DOI 10.1016/0026-0495(84)90007-6; LAMONFAVA S, 1989, J CLIN ENDOCR METAB, V68, P17, DOI 10.1210/jcem-68-1-17; Lamri-Senhadji MY, 2009, SINGAP MED J, V50, P288; MIETTINEN TA, 1980, ANN CLIN RES, V12, P295; POSTIGLIONE A, 1994, NUTR METAB CARDIOVAS, V4, P233; Reilly T, 2007, CHRONOBIOL INT, V24, P507, DOI 10.1080/07420520701420709; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Romon M, 1997, AM J CLIN NUTR, V65, P934, DOI 10.1093/ajcn/65.4.934; Stannard SR, 2008, J SCI MED SPORT, V11, P510, DOI 10.1016/j.jsams.2007.03.003; Stannard SR, 2010, J SCI MED SPORT, V13, P465, DOI 10.1016/j.jsams.2010.03.002; Trabelsi K, 2012, INT J SPORT NUTR EXE, V22, P11, DOI 10.1123/ijsnem.22.1.11; Tsai AC, 2003, J NUTR BIOCHEM, V14, P541, DOI 10.1016/S0955-2863(03)00105-0; Van Proeyen K, 2011, EUR J APPL PHYSIOL, V111, P1297, DOI 10.1007/s00421-010-1753-7; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Waterhouse J, 2007, CHRONOBIOL INT, V24, P63, DOI 10.1080/07420520601142551; Zare A, 2011, SINGAP MED J, V52, P491; Ziaee V., 2006, SMJ Singapore Medical Journal, V47, P409	44	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79873	10.1371/journal.pone.0079873	http://dx.doi.org/10.1371/journal.pone.0079873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244572	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600156
J	Liu, Y; Huang, PW; Jiang, BM; Tan, M; Morrow, AL; Jiang, X				Liu, Yang; Huang, Pengwei; Jiang, Baoming; Tan, Ming; Morrow, Ardythe L.; Jiang, Xi			Poly-LacNAc as an Age-Specific Ligand for Rotavirus P[11] in Neonates and Infants	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; N-ACETYLLACTOSAMINE; NOROVIRUS; STRAIN; SUSCEPTIBILITY; VP8(STAR); PROTEIN; GLYCOSYLATION; GENOTYPE; PATTERNS	Rotavirus (RV) P[11] is an unique genotype that infects neonates. The mechanism of such age-specific host restriction remains unknown. In this study, we explored host mucosal glycans as a potential age-specific factor for attachment of P[11] RVs. Using in vitro binding assays, we demonstrated that VP8* of a P[11] RV (N155) could bind saliva of infants (60.3%, N = 151) but not of adults (0%, N = 48), with a significantly negative correlation between binding of VP8* and ages of infants (P<0.01). Recognition to the infant saliva did not correlate with the ABO, secretor and Lewis histo-blood group antigens (HBGAs) but with the binding of the lectin Lycopersicon esculentum (LEA) that is known to recognize the oligomers of N-acetyllactosamine (LacNAc), a precursor of human HBGAs. Direct evidence of LacNAc involvement in P[11] binding was obtained from specific binding of VP8* with homopolymers of LacNAc in variable lengths through a glycan array analysis of 611 glycans. These results were confirmed by strong binding of VP8* to the Lec2 cell line that expresses LacNAc oligomers but not to the Lec8 cell line lacking the LacNAc. In addition, N155 VP8* and authentic P[11] RVs (human 116E and bovine B223) hemagglutinated human red blood cells that are known to express poly-LacNAc. The potential role of poly-LacNAc in host attachment and infection of RVs has been obtained by abrogation of 116E replication by the PAA-conjugated poly-LacNAc, human milk, and LEA positive infant saliva. Overall, our results suggested that the poly-LacNAc could serve as an age-specific receptor for P[11] RVs and well explained the epidemiology that P[11] RVs mainly infect neonates and young children.	[Liu, Yang; Huang, Pengwei; Tan, Ming; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Morrow, Ardythe L.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Morrow, Ardythe L.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Tan, Ming; Morrow, Ardythe L.; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Jiang, Baoming] Ctr Dis Control & Prevent, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA	Jiang, X (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	jason.jiang@cchmc.org	liu, liu yang/Y-8494-2019	liu, yang/0000-0001-5241-5433	National Institute of Health, the National Institute of Allergy and Infectious Diseases [R01 AI37093, R01 AI055649]; National Institute of Child Health and Human Development [P01 HD13021]; NIGMS - The Consortium for Functional Glycomics [GM62116, GM098791]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037093, R01AI089634, R01AI055649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791, U54GM062116] Funding Source: NIH RePORTER	National Institute of Health, the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS - The Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health, the National Institute of Allergy and Infectious Diseases (R01 AI37093 and R01 AI055649) to XJ, National Institute of Child Health and Human Development (P01 HD13021) to ALM and XJ, and in part by NIGMS - The Consortium for Functional Glycomics GM62116 and GM098791. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciarlet M, 2002, J VIROL, V76, P4087, DOI 10.1128/JVI.76.8.4087-4095.2002; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Di Virgilio S, 1999, GLYCOBIOLOGY, V9, P353, DOI 10.1093/glycob/9.4.353; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; FUKUDA M, 1984, J BIOL CHEM, V259, P4782; Gazal S, 2012, VET J, V193, P299, DOI 10.1016/j.tvjl.2011.11.018; GENTSCH JR, 1993, VIROLOGY, V194, P424, DOI 10.1006/viro.1993.1280; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hemmerich S, 2000, GLYCOBIOLOGY, V10, P849, DOI 10.1093/glycob/10.9.849; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Huang PW, 2012, J VIROL, V86, P4833, DOI 10.1128/JVI.05507-11; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu Y, 2012, J VIROL, V86, P9899, DOI 10.1128/JVI.00979-12; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ramani S, 2013, J VIROL, V87, P7255, DOI 10.1128/JVI.03518-12; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; Rolsma MD, 1998, J VIROL, V72, P9079, DOI 10.1128/JVI.72.11.9079-9091.1998; Saeland E, 2012, INT J CANCER, V131, P117, DOI 10.1002/ijc.26354; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Twu YC, 2010, BLOOD, V115, P2491, DOI 10.1182/blood-2009-07-231993; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; YOLKEN RH, 1987, J CLIN INVEST, V79, P148, DOI 10.1172/JCI112775; Zheng TQ, 2011, ANGEW CHEM INT EDIT, V50, P4113, DOI 10.1002/anie.201100265; Zhou DP, 2003, CURR PROTEIN PEPT SC, V4, P1, DOI 10.2174/1389203033380304	34	36	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78113	10.1371/journal.pone.0078113	http://dx.doi.org/10.1371/journal.pone.0078113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244290	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600017
J	Liu, YL; Kong, XS; Liu, YF; Chen, YY				Liu, Yaolin; Kong, Xuesong; Liu, Yanfang; Chen, Yiyun			Simulating the Conversion of Rural Settlements to Town Land Based on Multi-Agent Systems and Cellular Automata	PLOS ONE			English	Article							AGENT-BASED MODEL; URBAN-GROWTH; VALIDATION; OPTIMIZATION; DESIGN; FORM	Rapid urbanization in China has triggered the conversion of land from rural to urban use, particularly the conversion of rural settlements to town land. This conversion is the result of the joint effects of the geographic environment and agents involving the government, investors, and farmers. To understand the dynamic interaction dominated by agents and to predict the future landscape of town expansion, a small town land-planning model is proposed based on the integration of multi-agent systems (MAS) and cellular automata (CA). The MAS-CA model links the decision-making behaviors of agents with the neighbor effect of CA. The interaction rules are projected by analyzing the preference conflicts among agents. To better illustrate the effects of the geographic environment, neighborhood, and agent behavior, a comparative analysis between the CA and MAS-CA models in three different towns is presented, revealing interesting patterns in terms of quantity, spatial characteristics, and the coordinating process. The simulation of rural settlements conversion to town land through modeling agent decision and human-environment interaction is very useful for understanding the mechanisms of rural-urban land-use change in developing countries. This process can assist town planners in formulating appropriate development plans.	[Liu, Yaolin; Kong, Xuesong; Liu, Yanfang; Chen, Yiyun] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China; [Liu, Yaolin; Kong, Xuesong; Liu, Yanfang; Chen, Yiyun] Wuhan Univ, Minist Educ, Key Lab Geog Informat Syst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Kong, XS (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China.	xuesongk@gmail.com	CHEN, YIYUN/AAD-9501-2019	CHEN, YIYUN/0000-0002-7442-3239; Kong, Xuesong/0000-0003-3290-025X; Liu, Yaolin/0000-0002-4619-5099	China's National Scientific and Technical Supporting Programs during the 12th Five-year Plan [2012BAJ22B02]	China's National Scientific and Technical Supporting Programs during the 12th Five-year Plan	This research is supported by China's National Scientific and Technical Supporting Programs during the 12th Five-year Plan (No. 2012BAJ22B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Brown DG, 2005, INT J GEOGR INF SCI, V19, P153, DOI 10.1080/13658810410001713399; Brown DG, 2004, ENVIRON MODELL SOFTW, V19, P1097, DOI 10.1016/j.envsoft.2003.11.012; Dabbaghian V, 2010, MATH COMPUT MODEL, V52, P1752, DOI 10.1016/j.mcm.2010.07.002; Ettema D, 2011, COMPUT ENVIRON URBAN, V35, P1, DOI 10.1016/j.compenvurbsys.2010.06.005; Feitosa FF, 2011, COMPUT ENVIRON URBAN, V35, P104, DOI 10.1016/j.compenvurbsys.2010.06.001; Feng YJ, 2011, LANDSCAPE URBAN PLAN, V102, P188, DOI 10.1016/j.landurbplan.2011.04.004; Firman T, 2000, LAND USE POLICY, V17, P13, DOI 10.1016/S0264-8377(99)00037-X; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Kamusoko C, 2009, APPL GEOGR, V29, P435, DOI 10.1016/j.apgeog.2008.10.002; Le QB, 2010, ECOL INFORM, V5, P203, DOI 10.1016/j.ecoinf.2010.02.001; Li X, 2006, INT J GEOGR INF SCI, V20, P1109, DOI 10.1080/13658810600816870; Li X, 2011, INT J GEOGR INF SCI, V25, P575, DOI 10.1080/13658816.2010.481262; Ligmann-Zielinska A, 2007, ENVIRON PLANN B, V34, P316, DOI 10.1068/b32088; Ligtenberg A, 2004, J ENVIRON MANAGE, V72, P43, DOI 10.1016/j.jenvman.2004.02.007; Ligtenberg A, 2001, LANDSCAPE URBAN PLAN, V56, P21, DOI 10.1016/S0169-2046(01)00162-1; Ligtenberg A, 2010, COMPUT ENVIRON URBAN, V34, P424, DOI 10.1016/j.compenvurbsys.2010.04.005; Liu XP, 2006, SCI CHINA SER D, V49, P1184, DOI 10.1007/s11430-006-1184-9; Long HL, 2010, LAND USE POLICY, V27, P457, DOI 10.1016/j.landusepol.2009.06.006; Magliocca N, 2011, COMPUT ENVIRON URBAN, V35, P183, DOI 10.1016/j.compenvurbsys.2011.01.002; Maithani S, 2010, J INDIAN SOC REMOT, V38, P604, DOI 10.1007/s12524-010-0053-3; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; Mena CF, 2011, APPL GEOGR, V31, P210, DOI 10.1016/j.apgeog.2010.04.005; Mitsova D, 2011, LANDSCAPE URBAN PLAN, V99, P141, DOI 10.1016/j.landurbplan.2010.10.001; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P191, DOI 10.1016/S0167-8809(01)00183-9; Rao A. S., 1995, ICMAS-95 Proceedings. First International Conference on Multi-Agent Systems, P312; Saarloos DJM, 2008, COMPUT ENVIRON URBAN, V32, P29, DOI 10.1016/j.compenvurbsys.2007.03.001; Sang LL, 2011, MATH COMPUT MODEL, V54, P938, DOI 10.1016/j.mcm.2010.11.019; Sante I, 2010, LANDSCAPE URBAN PLAN, V96, P108, DOI 10.1016/j.landurbplan.2010.03.001; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Stevens D, 2007, ENVIRON MODELL SOFTW, V22, P761, DOI 10.1016/j.envsoft.2006.02.004; Tian GJ, 2011, ECOL MODEL, V222, P1129, DOI 10.1016/j.ecolmodel.2010.12.018; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; Wang Y., 2010, COMPUT GEOSCI, V37, P111; WHITE R, 1993, ENVIRON PLANN A, V25, P1175, DOI 10.1068/a251175; Wu FL, 2002, INT J GEOGR INF SCI, V16, P795, DOI 10.1080/13658810210157769; Wu FL, 2000, URBAN STUD, V37, P2441, DOI 10.1080/00420980020080631; Yang QS, 2008, COMPUT GEOSCI-UK, V34, P592, DOI 10.1016/j.cageo.2007.08.003; Yang Y, 2011, J GEOINFORMATION SCI, V13, P374; Zhang HHI, 2010, J GEOGR SCI, V20, P540, DOI 10.1007/s11442-010-0540-z	40	22	24	7	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79300	10.1371/journal.pone.0079300	http://dx.doi.org/10.1371/journal.pone.0079300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244472	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600122
J	Winther, TN; Heiberg, IL; Bang-Berthelsen, CH; Pociot, F; Hogh, B				Winther, Thilde Nordmann; Heiberg, Ida Louise; Bang-Berthelsen, Claus Heiner; Pociot, Flemming; Hogh, Birthe			Hepatitis B Surface Antigen Quantity Positively Correlates with Plasma Levels of microRNAs Differentially Expressed in Immunological Phases of Chronic Hepatitis B in Children	PLOS ONE			English	Article							VIRUS INFECTION; NATURAL-HISTORY; SERUM; CELLS; REPLICATION; BIOMARKERS	Background and Aim: Children with chronic hepatitis B (CHB) are at high risk of progressive liver disease. It is suggested that a newly-identified panel of 16 microRNAs is important in the pathogenesis of CHB in children. Subviral hepatitis B surface antigen (HBsAg) particles are produced in large excess over infectious virions. Interestingly, circulating HBsAg particles have been shown to carry microRNAs. A thorough characterisation of the identified microRNAs and HBsAg over time in plasma from children with CHB may provide useful information about the natural course of childhood CHB. Patients and Methods: A cohort of 42 children with CHB was followed over time. Three to five blood samples were obtained from each child at minimum intervals of half a year; in total 180 blood samples. Plasma levels of the 16 microRNAs previously identified were analysed by quantitative real-time polymerase-chain-reaction. Plasma HBsAg was quantified using ARCHITECT (R) HBsAg assay. Results: The presence of 14/16 plasma microRNAs in children with CHB was confirmed. All 14 microRNAs were significantly differentially expressed in different immunological phases of the disease. MicroRNA plasma levels were highest in immune-tolerant children, lower in immune-active children, and reached the lowest values in immune-inactive children, p<0.001. Plasma levels of four microRNAs decreased significantly over time in immune-tolerant and immune-active children whereas the microRNA plasma levels were stable in immune-inactive children, p<0.004. HBsAg quantity was positively correlated with plasma levels of 11/14 microRNAs, p<0.004. Conclusion: This is the first study to characterise plasma microRNAs and HBsAg over time in children with CHB. Our data suggest that plasma levels of selected microRNAs and HBsAg are inversely correlated with immunological control of CHB in children. Further studies are, however, needed to advance the understanding of microRNAs and HBsAg in the pathogenesis of CHB in children.	[Winther, Thilde Nordmann; Heiberg, Ida Louise; Hogh, Birthe] Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Diagnost Unit, Glostrup, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Ctr Noncoding RNA Technol & Hlth, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Winther, TN (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark.	thildewinther@gmail.com		Pociot, Flemming/0000-0003-3274-5448; /0000-0003-4541-2538	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research [09-067036/DSF]	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	TNW was the recipient of a PhD scholarship from the Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. CHBB and FP were supported by the Danish Council for Strategic Research (09-067036/DSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Carey I, 2011, J VIROL, V85, P2416, DOI 10.1128/JVI.01449-10; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Deguchi M, 2004, J VIROL METHODS, V115, P217, DOI 10.1016/j.jviromet.2003.10.002; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; GANEM D, 1991, CURR TOP MICROBIOL, V168, P61; Haber BA, 2009, PEDIATRICS, V124, pE1007, DOI 10.1542/peds.2009-0567; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Marcellin P, 1997, HEPATOLOGY, V26, pS133, DOI 10.1002/hep.510260723; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Mukaide M, 2003, J GASTROEN HEPATOL, V18, P1264, DOI 10.1046/j.1440-1746.2003.03204.x; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Paganelli M, 2012, J HEPATOL, V57, P885, DOI 10.1016/j.jhep.2012.03.036; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; SSI Statens Serum Institut Copenhagen Denmark, MAND NOT SYST; Tuaillon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032143; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Winther TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058236; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	36	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80384	10.1371/journal.pone.0080384	http://dx.doi.org/10.1371/journal.pone.0080384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244683	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600208
J	Zeng, GQ; Liu, R; Liao, HX; Zhang, XF; Qian, YX; Liu, BH; Wu, QH; Zhao, J; Gu, WW; Li, HT				Zeng, Guang-qiao; Liu, Rong; Liao, Hai-xing; Zhang, Xin-feng; Qian, Yuan-xin; Liu, Bao-hua; Wu, Qing-hong; Zhao, Jin; Gu, Wei-wang; Li, Hong-tao			Single Intraperitoneal Injection of Monocrotaline as a Novel Large Animal Model of Chronic Pulmonary Hypertension in Tibet Minipigs	PLOS ONE			English	Article							RIGHT HEART CATHETERIZATION; ARTERIAL-HYPERTENSION; CARDIOPULMONARY BYPASS; VASCULAR-RESISTANCE; DOPPLER-ECHOCARDIOGRAPHY; NONINVASIVE ASSESSMENT; SURVIVAL RATE; RABBIT MODEL; DIAGNOSIS; PIG	Objective: The purpose of this study was to establish an animal model of chronic pulmonary hypertension with a single-dose intraperitoneal injection of monocrotaline (MCT) in young Tibet minipigs, so as to enable both invasive and noninvasive measurements and hence facilitate future studies. Methods: Twenty-four minipigs (8-week-old) were randomized to receive single-dose injection of 12.0 mg/kg MCT (MCT group, n = 12) or placebo (control group, n = 12 each). On day 42, all animals were evaluated for pulmonary hypertension with conventional transthoracic echocardiography, right heart catheterization (RHC), and pathological changes. Findings of these studies were compared between the two groups. Results: At echocardiography, the MCT group showed significantly higher pulmonary arterial mean pressure (PAMP) compared with the controls (P<0.001). The pulmonary valve curve showed v-shaped signals with reduction of a-waves in minipigs treated with MCT. In addition, the MCT group had longer pulmonary artery pre-ejection phases, and shorter acceleration time and ejection time. RHC revealed higher mean pulmonary arterial pressure (mPAP) in the MCT group than in the control group (P<0.01). A significant and positive correlation between the mPAP values and the PAMP values (R = 0.974, P<0.0001), and a negative correlation between the mPAP and ejection time (R = 0.680, P<0.0001) was noted. Pathology demonstrated evidence of pulmonary vascular remodeling and higer index of right ventricular hypertrophy in MCT-treated minipigs. Conclusion: A chronic pulmonary hypertension model can be successfully established in young minipigs at six weeks after MCT injection. These minipig models exhibited features of pulmonary arterial hypertension that can be evaluated by both invasive (RHC) and noninvasive (echocardiography) measurements, and may be used as an easy and stable tool for future studies on pulmonary hypertension.	[Zeng, Guang-qiao; Liu, Rong; Liao, Hai-xing; Zhang, Xin-feng; Qian, Yuan-xin; Liu, Bao-hua; Zhao, Jin; Li, Hong-tao] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zeng, Guang-qiao; Liu, Rong; Zhao, Jin; Li, Hong-tao] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wu, Qing-hong; Gu, Wei-wang] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Southern Medical University - China	Li, HT (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	gyhongtao@126.com			Guangdong Department of Science and Technology Program Funds [2009B060300028, 2012B060300032]; Guangzhou Medical University [2008C33]	Guangdong Department of Science and Technology Program Funds; Guangzhou Medical University	This work was supported by Guangdong Department of Science and Technology Program Funds (RMB:150000; Program No.: 2009B060300028 and RMB:100000; Program No.: 2012B060300032) and Guangzhou Medical University Scientific Grant (RMB: 30000; Program No.: 2008C33), http://pro.gdstc.gov.cn/stms/main.jsp, http://www.gzhmc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2003, AM J CARDIOL, V92, P1373, DOI 10.1016/j.amjcard.2003.08.037; Akhavein F, 2007, J APPL PHYSIOL, V103, P287, DOI 10.1152/japplphysiol.01509.2005; ALLEN JR, 1972, EXP MOL PATHOL, V17, P220, DOI 10.1016/0014-4800(72)90071-8; BERG R, 1987, ANAT HISTOL EMBRYOL, V16, P265; Bonnell MR, 2004, ANN THORAC SURG, V77, P238, DOI 10.1016/S0003-4975(03)01489-9; Bossone E, 2005, CHEST, V127, P1836, DOI 10.1378/chest.127.5.1836; Carteaux JP, 1999, EUR J CARDIO-THORAC, V15, P346, DOI 10.1016/S1010-7940(99)00017-2; Celermajer DS, 2008, INT J CARDIOL, V125, P294, DOI 10.1016/j.ijcard.2007.04.184; Chen HM, 2008, CHINESE J ULTRASOUND, V24, P486; Chen HM, 2008, ULTRASOUND MED BIOL, V34, P221, DOI 10.1016/j.ultrasmedbio.2007.06.011; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; CLEMENT DL, 1994, J HYPERTENS, V12, pS49; Fitzgerald KP, 2011, CARDIOL CLIN, V29, P223, DOI 10.1016/j.ccl.2011.01.006; Fitzgerald Robert K, 2004, Pediatr Crit Care Med, V5, P571, DOI 10.1097/01.PCC.0000137357.52609.F0; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Geiger R, 2006, PEDIATR RES, V59, P147, DOI 10.1203/01.pdr.0000191813.60977.bf; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gust R, 2001, EXP LUNG RES, V27, P1, DOI 10.1080/019021401459734; Habib G, 2010, EUR RESPIR REV, V19, P288, DOI 10.1183/09059180.00008110; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Jormalainen M, 2007, ACTA ANAESTH SCAND, V51, P178, DOI 10.1111/j.1399-6576.2006.01185.x; Litwin SE, 2010, CIRC-CARDIOVASC IMAG, V3, P132, DOI 10.1161/CIRCIMAGING.110.945121; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Mutschler D, 2006, J INTERF CYTOK RES, V26, P661, DOI 10.1089/jir.2006.26.661; OKADA M, 1995, TRANSPLANTATION, V60, P9, DOI 10.1097/00007890-199507150-00002; OWALL A, 1991, ACTA ANAESTH SCAND, V35, P350; Pancholy SB, 2011, CATHETER CARDIO INTE, V78, P809, DOI 10.1002/ccd.23037; Petrossian E, 1999, J THORAC CARDIOV SUR, V117, P314, DOI 10.1016/S0022-5223(99)70429-0; Raoul W, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-8; Roldan CA, 2004, ULTIMATE ECHO GUIDE; ROSENKRANTZ JG, 1973, J SURG RES, V15, P67, DOI 10.1016/0022-4804(73)90165-0; Sandra L, 2002, HLTH SCI ASIAN ELSEV, V9, P582; Sawamura F, 2009, J PHARMACOL SCI, V111, P235, DOI 10.1254/jphs.09110FP; Scapellato F, 2001, J AM COLL CARDIOL, V37, P1813, DOI 10.1016/S0735-1097(01)01271-2; Selimovic N, 2007, J HEART LUNG TRANSPL, V26, P927, DOI 10.1016/j.healun.2007.06.008; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Thibault HB, 2010, CIRC-CARDIOVASC IMAG, V3, P157, DOI 10.1161/CIRCIMAGING.109.887109; Wang J, 2013, J THORAC DIS, V5, P169, DOI 10.3978/j.issn.2072-1439.2013.02.04; Wang L, 2004, EXP LUNG RES, V30, P31, DOI 10.1080/01902140490252821; Wang W, 2010, J THORAC CARDIOV SUR, V140, P395, DOI 10.1016/j.jtcvs.2009.04.071; Wang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-26; Willens HJ, 2008, INT J CARDIOVAS IMAG, V24, P703, DOI 10.1007/s10554-008-9306-4; Zhao Jin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P867	45	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78965	10.1371/journal.pone.0078965	http://dx.doi.org/10.1371/journal.pone.0078965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244396	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600089
J	Cheng, YY; Li, BB; Li, DB; Chen, JJ; Li, WW; Tong, ZH; Wu, C; Yu, HQ				Cheng, Yuan-Yuan; Li, Bing-Bing; Li, Dao-Bo; Chen, Jie-Jie; Li, Wen-Wei; Tong, Zhong-Hua; Wu, Chao; Yu, Han-Qing			Promotion of Iron Oxide Reduction and Extracellular Electron Transfer in Shewanella oneidensis by DMSO	PLOS ONE			English	Article							OUTER-MEMBRANE CYTOCHROMES; RESPIRATORY FLEXIBILITY; MICROBIAL REDUCTION; EXCHANGE; CYMA; IRON(III); REACTIVITY; GEOBACTER; MOLECULES; MECHANISM	The dissimilatory metal reducing bacterium Shewanella oneidensis MR-1, known for its capacity of reducing iron and manganese oxides, has great environmental impacts. The iron oxides reducing process is affected by the coexistence of alternative electron acceptors in the environment, while investigation into it is limited so far. In this work, the impact of dimethyl sulphoxide (DMSO), a ubiquitous chemical in marine environment, on the reduction of hydrous ferric oxide (HFO) by S. oneidensis MR-1 was investigated. Results show that DMSO promoted HFO reduction by both wild type and Delta dmsE, but had no effect on the HFO reduction by Delta dmsB, indicating that such a promotion was dependent on the DMSO respiration. With the DMSO dosing, the levels of extracellular flavins and omcA expression were significantly increased in WT and further increased in Delta dmsE. Bioelectrochemical analysis show that DMSO also promoted the extracellular electron transfer of WT and Delta dmsE. These results demonstrate that DMSO could stimulate the HFO reduction through metabolic and genetic regulation in S. oneidensis MR-1, rather than compete for electrons with HFO. This may provide a potential respiratory pathway to enhance the microbial electron flows for environmental and engineering applications.	[Cheng, Yuan-Yuan; Li, Dao-Bo; Chen, Jie-Jie; Li, Wen-Wei; Tong, Zhong-Hua; Wu, Chao; Yu, Han-Qing] Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China; [Li, Bing-Bing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, C (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China.	benny928@mail.ustc.edu.cn; hqyu@ustc.edu.cn	Li, Wen-Wei/B-6332-2015; Tong, Zhong-Hua/F-6873-2010; Cheng, Yuanyuan/C-4836-2014; Chen, Jie-Jie/D-9181-2014; Yu, Han-Qing/F-7925-2010	Li, Wen-Wei/0000-0001-9280-0045; Cheng, Yuanyuan/0000-0003-3437-5495; 	Natural Science Foundation of China [21107105, 21007064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors wish to thank the Natural Science Foundation of China (21107105 and 21007064) for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; Belchik SM, 2011, APPL ENVIRON MICROB, V77, P4035, DOI 10.1128/AEM.02463-10; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bewley KD, 2012, BIOCHEM SOC T, V40, P1268, DOI 10.1042/BST20120106; Biffinger JC, 2009, BIOTECHNOL BIOENG, V103, P524, DOI 10.1002/bit.22266; Bishop ME, 2011, GEOCHIM COSMOCHIM AC, V75, P5229, DOI 10.1016/j.gca.2011.06.034; Braibant M, 2002, ANTIMICROB AGENTS CH, V46, P3050, DOI 10.1128/AAC.46.9.3050-3053.2002; Bretschger O, 2008, APPL ENVIRON MICROB, V74, P553, DOI 10.1128/AEM.02560-07; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; Campbell KM, 2006, ENVIRON SCI TECHNOL, V40, P5950, DOI 10.1021/es0600476; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; Cooper DC, 2006, ENVIRON SCI TECHNOL, V40, P1884, DOI 10.1021/es051778t; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Dewan A, 2008, ENVIRON SCI TECHNOL, V42, P7643, DOI 10.1021/es800775d; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Kopf SH, 2013, ENVIRON SCI TECHNOL, V47, P2602, DOI 10.1021/es3049459; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Li SL, 2010, BIOSENS BIOELECTRON, V25, P2651, DOI 10.1016/j.bios.2010.04.038; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Marritt SJ, 2012, BIOCHEM SOC T, V40, P1217, DOI 10.1042/BST20120150; Marritt SJ, 2012, BIOCHEM J, V444, P465, DOI 10.1042/BJ20120197; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; MEYER FK, 1982, INORG CHEM, V21, P774, DOI 10.1021/ic00132a060; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1992, APPL ENVIRON MICROB, V58, P439, DOI 10.1128/AEM.58.2.439-443.1992; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Shi L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00050; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; SWADDLE TW, 1981, INORG CHEM, V20, P4212, DOI 10.1021/ic50226a036; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wu C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01945; Zhao JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009109	46	11	11	4	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78466	10.1371/journal.pone.0078466	http://dx.doi.org/10.1371/journal.pone.0078466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244312	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900017
J	Williams, G; Zentar, MP; Gajendra, S; Sonego, M; Doherty, P; Lalli, G				Williams, Gareth; Zentar, Marc P.; Gajendra, Sangeetha; Sonego, Martina; Doherty, Patrick; Lalli, Giovanna			Transcriptional Basis for the Inhibition of Neural Stem Cell Proliferation and Migration by the TGF beta-Family Member GDF11	PLOS ONE			English	Article							ZONE-DERIVED NEUROBLASTS; SUBVENTRICULAR ZONE; NS CELLS; ADULT NEUROGENESIS; POSTNATAL BRAIN; MUSCLE GROWTH; SELF-RENEWAL; MYOSTATIN; EGF; MICE	Signalling through EGF, FGF and endocannabinoid (eCB) receptors promotes adult neurogenesis, and this can be modelled in culture using the Cor-1 neural stem cell line. In the present study we show that Cor-1 cells express a TGF beta receptor complex composed of the ActRIIB/ALK5 subunits and that a natural ligand for this receptor complex, GDF11, activates the canonical Smad2/3 signalling cascade and significantly alters the expression of similar to 4700 gene transcripts within a few hours of treatment. Many of the transcripts regulated by GDF11 are also regulated by the EGF, FGF and eCB receptors and by the MAPK pathway -however, in general in the opposite direction. This can be explained to some extent by the observation that GDF11 inhibits expression of, and signalling through, the EGF receptor. GDF11 regulates expression of numerous cell-cycle genes and suppresses Cor-1 cell proliferation; interestingly we found down-regulation of Cyclin D2 rather than p27kip1 to be a good molecular correlate of this. GDF11 also inhibited the expression of numerous genes linked to cytoskeletal regulation including Fascin and LIM and SH3 domain protein 1 (LASP1) and this was associated with an inhibition of Cor-1 cell migration in a scratch wound assay. These data demonstrate GDF11 to be a master regulator of neural stem cell transcription that can suppress cell proliferation and migration by regulating the expression of numerous genes involved in both these processes, and by suppressing transcriptional responses to factors that normally promote proliferation and/or migration.	[Williams, Gareth; Zentar, Marc P.; Gajendra, Sangeetha; Sonego, Martina; Doherty, Patrick; Lalli, Giovanna] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	University of London; King's College London	Lalli, G (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London, England.	giovanna.lalli@kcl.ac.uk		Williams, Gareth/0000-0001-9205-4943; Doherty, Patrick/0000-0002-0407-5689	Wolfson CARD	Wolfson CARD	The work was supported by the Wolfson CARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frinchi M, 2008, NEUROSCI LETT, V447, P20, DOI 10.1016/j.neulet.2008.09.059; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Khodosevich K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.007.2009; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nomura T, 2008, BIOCHEM BIOPH RES CO, V365, P863, DOI 10.1016/j.bbrc.2007.11.087; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Santos R, 2012, ADV EXP MED BIOL, V723, P671, DOI 10.1007/978-1-4614-0631-0_85; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sonego M, 2013, J NEUROSCI, V33, P12171, DOI 10.1523/JNEUROSCI.0653-13.2013; Sutterlin P, 2013, MOL CELL NEUROSCI, V52, P20, DOI 10.1016/j.mcn.2012.10.006; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thies RS, 2001, GROWTH FACTORS, V18, P251; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	39	19	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78478	10.1371/journal.pone.0078478	http://dx.doi.org/10.1371/journal.pone.0078478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244313	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900018
J	Assaneo, MF; Trevisan, MA; Mindlin, GB				Assaneo, Maria Florencia; Trevisan, Marcos A.; Mindlin, Gabriel B.			Discrete Motor Coordinates for Vowel Production	PLOS ONE			English	Article							TRACT AREA FUNCTIONS	Current models of human vocal production that capture peripheral dynamics in speech require large dimensional measurements of the neural activity, which are mapped into equally complex motor gestures. In this work we present a motor description for vowels as points in a discrete low-dimensional space. We monitor the dynamics of 3 points at the oral cavity using Hall-effect transducers and magnets, describing the resulting signals during normal utterances in terms of active/inactive patterns that allow a robust vowel classification in an abstract binary space. We use simple matrix algebra to link this representation to the anatomy of the vocal tract and to recent reports of highly tuned neuronal activations for vowel production, suggesting a plausible global strategy for vowel codification and motor production.	[Assaneo, Maria Florencia; Trevisan, Marcos A.; Mindlin, Gabriel B.] Univ Buenos Aires, Dept Phys, Dynam Syst Lab, Buenos Aires, DF, Argentina; [Trevisan, Marcos A.] Univ Buenos Aires, Dept Phys, Integrat Neurocience Lab, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Trevisan, MA (corresponding author), Univ Buenos Aires, Dept Phys, Dynam Syst Lab, Buenos Aires, DF, Argentina.	marcos@df.uba.ar	Trevisan, Marcos/Y-7158-2019; Assaneo, M Florencia/AAI-1525-2020	Mindlin, Gabo/0000-0002-7808-5708; Assaneo, M florencia/0000-0002-2793-7827	Universidad de Buenos Aires (UBA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Universidad de Buenos Aires (UBA)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially funded by Universidad de Buenos Aires (UBA) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feng YQ, 2011, J NEUROPHYSIOL, V106, P667, DOI 10.1152/jn.00638.2010; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; International Phonetic Association, 1999, HDB INT PHONETIC ASS; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Ladefoged P, 1980, PRELIMINARIES LINGUI; Meyer P., 2010, QUASIARTICULATORY SP, P523; Ramsden E, 2001, HALL EFFECT SENSORS; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Story BH, 1998, J PHONETICS, V26, P223, DOI 10.1006/jpho.1998.0076; Tankus A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1995; Titze IR, 1994, PRINCIPLES VOICE PRO	11	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80373	10.1371/journal.pone.0080373	http://dx.doi.org/10.1371/journal.pone.0080373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244681	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800144
J	Bird, CW; Gardiner, AS; Bolognani, F; Tanner, DC; Chen, CY; Lin, WJ; Yoo, S; Twiss, JL; Perrone-Bizzozero, N				Bird, Clark W.; Gardiner, Amy S.; Bolognani, Federico; Tanner, Daniel C.; Chen, Ching-Yi; Lin, Wei-Jye; Yoo, Soonmoon; Twiss, Jeffery L.; Perrone-Bizzozero, Nora			KSRP Modulation of GAP-43 mRNA Stability Restricts Axonal Outgrowth in Embryonic Hippocampal Neurons	PLOS ONE			English	Article							BINDING PROTEIN HUD; SPLICING REGULATORY PROTEIN; SPINAL MUSCULAR-ATROPHY; DENTATE GRANULE CELLS; 3 UNTRANSLATED REGION; POSTTRANSCRIPTIONAL REGULATION; BETA-ACTIN; NERVE REGENERATION; NEURITE OUTGROWTH; GENE-EXPRESSION	The KH-type splicing regulatory protein (KSRP) promotes the decay of AU-rich element (ARE)-containing mRNAs. Although KSRP is expressed in the nervous system, very little is known about its role in neurons. In this study, we examined whether KSRP regulates the stability of the ARE-containing GAP-43 mRNA. We found that KSRP destabilizes this mRNA by binding to its ARE, a process that requires the presence of its fourth KH domain (KH4). Furthermore, KSRP competed with the stabilizing factor HuD for binding to these sequences. We also examined the functional consequences of KSRP overexpression and knockdown on the differentiation of primary hippocampal neurons in culture. Overexpression of full length KSRP or KSRP without its nuclear localization signal hindered axonal outgrowth in these cultures, while overexpression of a mutant protein without the KH4 domain that has less affinity for binding to GAP-43's ARE had no effect. In contrast, depletion of KSRP led to a rise in GAP-43 mRNA levels and a dramatic increase in axonal length, both in KSRP shRNA transfected cells and neurons cultured from Ksrp(+/-) and Ksrp(-/-) embryos. Finally we found that overexpression of GAP-43 rescued the axonal outgrowth deficits seen with KSRP overexpression, but only when cells were transfected with GAP-43 constructs containing 3' UTR sequences targeting the transport of this mRNA to axons. Together, our results suggest that KSRP is an important regulator of mRNA stability and axonal length that works in direct opposition to HuD to regulate the levels of GAP-43 and other ARE-containing neuronal mRNAs.	[Bird, Clark W.; Gardiner, Amy S.; Bolognani, Federico; Tanner, Daniel C.; Perrone-Bizzozero, Nora] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Chen, Ching-Yi; Lin, Wei-Jye] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Yoo, Soonmoon] Alfred I duPont Hosp Children, Wilmington, DE USA; [Twiss, Jeffery L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of New Mexico; University of Alabama System; University of Alabama Birmingham; Nemours Alfred I. duPont Hospital for Children; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Perrone-Bizzozero, N (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	nbizzozero@salud.unm.edu	Lin, Wei-Jye/AGW-1054-2022	Lin, Wei-Jye/0000-0002-6057-7325; Bird, Clark/0000-0001-7712-6531; Chen, Ching-Yi/0000-0002-1978-6424; Gardiner, Amy S./0000-0002-8179-4919; Yoo, Soonmoon/0000-0002-1645-6809	NIH [5R01NS030255, R01NS041596, P20GM103464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596, R01NS030255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (5R01NS030255 to NPB and R01NS041596 to JLT and P20GM103464 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Bolognani F, 2006, J NEUROCHEM, V96, P790, DOI 10.1111/j.1471-4159.2005.03607.x; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Giovarelli M, 2013, BBA-GENE REGUL MECH, V1829, P469, DOI 10.1016/j.bbagrm.2013.02.008; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Kohn DT, 1996, MOL BRAIN RES, V36, P240, DOI 10.1016/0169-328X(95)00239-O; Li XL, 2012, GLIA, V60, P1773, DOI 10.1002/glia.22396; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero NI, 2011, ASN NEURO, V3, DOI 10.1042/AN20110015; Rehbein M, 2002, J NEUROCHEM, V82, P1039, DOI 10.1046/j.1471-4159.2002.01058.x; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsai KC, 1997, J NEUROSCI, V17, P1950; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Yoo S, 2013, J NEUROCHEM, V15, DOI [10.1111/jnc.12266, DOI 10.1111/JNC.12266.[]; Yoo S, 2010, EXP NEUROL, V223, P19, DOI 10.1016/j.expneurol.2009.08.011	50	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79255	10.1371/journal.pone.0079255	http://dx.doi.org/10.1371/journal.pone.0079255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244461	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800049
J	Liu, H; Yin, FX; Bai, CL; Shen, QY; Wei, ZY; Li, XX; Liang, H; Bou, S; Li, GP				Liu, Hui; Yin, Feng-Xia; Bai, Chun-Ling; Shen, Qi-Yuan; Wei, Zhu-Ying; Li, Xin-Xin; Liang, Hao; Bou, Shorgan; Li, Guang-Peng			TFIIB Co-Localizes and Interacts with a-Tubulin during Oocyte Meiosis in the Mouse and Depletion of TFIIB Causes Arrest of Subsequent Embryo Development	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; NUCLEAR; MATURATION; ACTIVATION; DYNAMICS	TFIIB (transcription factor IIB) is a transcription factor that provides a bridge between promoter-bound TFIID and RNA polymerase II, and it is a target of various transcriptional activator proteins that stimulate the pre-initiation complex assembly. The localization and/or attachment matrix of TFIIB in the cytoplast is not well understood. This study focuses on the function of TFIIB and its interrelationship with alpha-tubulins in a mouse model. During oocyte maturation TFIIB distributes throughout the entire nucleus of the germinal vesicle (GV). After progression to GV breakdown (GVBD), TFIIB and alpha-tubulin co-localize and accumulate in the vicinity of the condensed chromosomes. During the MII stage, the TFIIB signals are more concentrated at the equatorial plate and the kinetochores. Colcemid treatment of oocytes disrupts the microtubule (MT) system, although the TFIIB signals are still present with the altered MT state. Injection of oocytes with TFIIB antibodies and siRNAs causes abnormal spindle formation and irregular chromosome alignment. These findings suggest that TFIIB dissociates from the condensed chromatids and then tightly binds to microtubules from GVBD to the MII phase. The assembly and disassembly of TFIIB may very well be associated with and driven by microtubules. TFIIB maintains its contact with the a-tubulins and its colocalization forms a unique distribution pattern. Depletion of Tf2b in oocytes results in a significant decrease in TFIIB expression, although polar body extrusion does not appear to be affected. Knockdown of Tf2b dramatically affects subsequent embryo development with more than 85% of the embryos arrested at the 2-cell stage. These arrested embryos still maintain apparently normal morphology for at least 96h without any obvious degeneration. Analysis of the effects of TFIIB in somatic cells by co-transfection of BiFC plasmids pHA-Tf2b and pFlag-Tuba1 alpha further confirms a direct interaction between TFIIB and a-tubulins.	[Liu, Hui; Yin, Feng-Xia; Bai, Chun-Ling; Shen, Qi-Yuan; Wei, Zhu-Ying; Li, Xin-Xin; Liang, Hao; Bou, Shorgan; Li, Guang-Peng] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China	Inner Mongolia University	Bou, S (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China.	xurg@imu.edu.cn; gpengli@imu.edu.cn						ALMOUZNI G, 1995, EMBO J, V14, P1752, DOI 10.1002/j.1460-2075.1995.tb07164.x; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Bellier S, 1997, EMBO J, V16, P6250, DOI 10.1093/emboj/16.20.6250; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; Gao TL, 2007, CELL RES, V17, P135, DOI 10.1038/cr.2007.2; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Li GP, 2005, THERIOGENOLOGY, V63, P2434, DOI 10.1016/j.theriogenology.2004.09.056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839, DOI 10.1071/RD09277; MESSING SM, 1992, J CELL SCI, V100, P67; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Parfenov VN, 2003, J CELL BIOCHEM, V89, P720, DOI 10.1002/jcb.10545; Schatten H, 2011, MOL REPROD DEV, V78, P757, DOI 10.1002/mrd.21380; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; SUSAN LB, 2007, BIOL REPROD, V76, P949, DOI DOI 10.1095/BI0LREPR0D.106.057141.PUBMED:17287496; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Weinzierl ROJ, 2011, TRANSCR-AUSTIN, V2, P254, DOI 10.4161/trns.2.6.18076; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	29	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80039	10.1371/journal.pone.0080039	http://dx.doi.org/10.1371/journal.pone.0080039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244602	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800111
J	Sullivan, S; Bentall, RP; Fernyhough, C; Pearson, RM; Zammit, S				Sullivan, Sarah; Bentall, Richard P.; Fernyhough, Charles; Pearson, Rebecca M.; Zammit, Stanley			Cognitive Styles and Psychotic Experiences in a Community Sample	PLOS ONE			English	Article							PERSECUTORY DELUSIONS; SITUATIONAL ATTRIBUTIONS; CAUSAL ATTRIBUTIONS; GENDER DIFFERENCES; POSITIVE SYMPTOMS; SELF; PARANOIA; SCHIZOPHRENIA; DEPRESSION; MODEL	Introduction: In clinical populations paranoid delusions are associated with making global, stable and external attributions for negative events. Paranoia is common in community samples but it is not known whether it is associated with a similar cognitive style. This study investigates the association between cognitive style and paranoia in a large community sample of young adults. Methods: 2694 young adults (mean age 17.8, SD 4.6) from the ALSPAC cohort provided data on psychotic experiences and cognitive style. Psychotic experiences were assessed using a semi-structured interview and cognitive style was assessed using the Cognitive Styles Questionnaire-Short Form (CSQ-SF) on the same occasion. Logistic regression was used to investigate associations between paranoia and CSQ-SF scores, both total and domain-related (global, stable, self, external). The role of concurrent self-reported depressive symptoms in the association was explored. Results: Paranoia was associated with Total CSQ-SF scores (adjusted OR 1.69 95% CI 1.29, 2.22), as well as global (OR 1.56 95% CI 1.17, 2.08), stable (OR 1.56 95% CI 1.17, 2.08) and self (OR 1.37 95% CI 1.05, 1.79) domains, only Total score and global domain associations remained after additional adjustment for self-reported depression. There was no association between paranoia and external cognitive style (OR 1.10 95% CI 0.83, 1.47). Conclusion: Paranoid ideation in a community sample is associated with a global rather than an external cognitive style. An external cognitive style may be a characteristic of more severe paranoid beliefs. Further work is required to determine the role of depression in the association between cognitive style and paranoia.	[Sullivan, Sarah; Pearson, Rebecca M.; Zammit, Stanley] Univ Bristol, Acad Ctr Mental Hlth Res, Bristol, Avon, England; [Bentall, Richard P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Fernyhough, Charles] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Zammit, Stanley] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales	University of Bristol; University of Liverpool; Durham University; Cardiff University	Sullivan, S (corresponding author), Univ Bristol, Acad Ctr Mental Hlth Res, Bristol, Avon, England.	sarah.sullivan@bristol.ac.uk	Fernyhough, Charles/A-1057-2010	Fernyhough, Charles/0000-0002-3822-710X; Zammit, Stanley/0000-0002-2647-9211; Sullivan, Sarah/0000-0002-1446-8478; Pearson, Rebecca/0000-0001-8527-3400	UK Medical Research Council; Wellcome Trust [092731]; Medical Research Council [G0701503, G9815508] Funding Source: researchfish; MRC [G0701503] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council and the Wellcome Trust (grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Beck A.T., 2009, SCHIZOPHRENIA COGNIT; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; BENTALL RP, 1994, BEHAV RES THER, V32, P331, DOI 10.1016/0005-7967(94)90131-7; Bentall RP, 2013, SOCIAL COGNITION PAR; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brakoulias V, 2008, AUSTRALAS PSYCHIATRY, V16, P87, DOI 10.1080/10398560701633176; Brakoulias Vlasios, 2008, Cogn Neuropsychiatry, V13, P148, DOI 10.1080/13546800801900587; CANDIDO CL, 1990, BRIT J MED PSYCHOL, V63, P355, DOI 10.1111/j.2044-8341.1990.tb01630.x; Collip I, 2011, PSYCHOL MED, V41, P911, DOI 10.1017/S0033291710001558; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Combs DR, 2013, COGN NEUROPSYCHIATRY; Compton M, 2012, EARLY INTERV PSYCHIA, V6, P53; Fear C, 1996, BRIT J PSYCHIAT, V168, P61, DOI 10.1192/bjp.168.1.61; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Fornells-Ambrojo M, 2005, BRIT J CLIN PSYCHOL, V44, P521, DOI 10.1348/014466505X35326; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Freeman D, 2003, BEHAV RES THER, V41, P923, DOI 10.1016/S0005-7967(02)00104-3; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Freeman D, 2005, BRIT J PSYCHIAT, V186, P427, DOI 10.1192/bjp.186.5.427; Freeman D, 2000, BRIT J CLIN PSYCHOL, V39, P407, DOI 10.1348/014466500163400; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; HADDOCK G, 1995, PERS INDIV DIFFER, V19, P301, DOI 10.1016/0191-8869(95)00063-C; Haeffel GJ, 2010, COGNITIVE THER RES, V34, P92, DOI 10.1007/s10608-008-9224-8; Hankin BL, 2001, PSYCHOL BULL, V127, P773, DOI 10.1037//0033-2909.127.6.773; Harrison G, 2001, BRIT J PSYCHIAT, V179, P346, DOI 10.1192/bjp.179.4.346; Horwood J, 2008, EUR PSYCHIAT, V23, pS282, DOI 10.1016/j.eurpsy.2008.01.595; JABLENSKY A, 1992, PSYCHOL MED, P1; Janssen I, 2006, PSYCHOL MED, V36, P771, DOI 10.1017/S0033291706007422; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Jorgensen P, 1994, PSYCHOPATHOLOGY, V27; KANEY S, 1989, BRIT J MED PSYCHOL, V62, P191, DOI 10.1111/j.2044-8341.1989.tb02826.x; KANEY S, 1992, J NERV MENT DIS, V180, P773, DOI 10.1097/00005053-199212000-00006; KANEY S, 1992, BRIT J CLIN PSYCHOL, V31, P85, DOI 10.1111/j.2044-8260.1992.tb00971.x; Kinderman P, 1996, PERS INDIV DIFFER, V20, P261, DOI 10.1016/0191-8869(95)00186-7; Kinderman P, 1997, J ABNORM PSYCHOL, V106, P341, DOI 10.1037/0021-843X.106.2.341; Kounali S D, 2013, AM J PSYCHI IN PRESS; Lee DA, 2004, PSYCHOL PSYCHOTHER-T, V77, P525, DOI 10.1348/1476083042555361; McKay R, 2005, PSYCHIAT RES, V136, P233, DOI 10.1016/j.psychres.2005.06.004; Meins E, 2012, PERS INDIV DIFFER, V52, P581, DOI 10.1016/j.paid.2011.11.026; Melo S, 2009, PSYCHOL PSYCHOTHER-T, V82, P247, DOI 10.1348/147608308X398337; Morrison AP, 2003, BEHAV COGN PSYCHOTH, V31, P235, DOI 10.1017/S1352465803003011; Pearson R, 2013, NY TIMES BK REV, P18; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Reivich K, 1995, BGM SMEP; RING N, 1991, ACTA PSYCHIAT SCAND, V84, P489, DOI 10.1111/j.1600-0447.1991.tb03182.x; Rutten BPF, 2008, PERSECUTORY DELUSION, P53; Sullivan S, 2012, COGN NEUROPSYCHIATRY; TROWER P, 1995, CLIN PSYCHOL-SCI PR, V2, P263, DOI 10.1111/j.1468-2850.1995.tb00044.x; Udachina A, 2012, J NERV MENT DIS, V200, P777, DOI 10.1097/NMD.0b013e318266ba57; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751	54	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80055	10.1371/journal.pone.0080055	http://dx.doi.org/10.1371/journal.pone.0080055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244608	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000327143800115
J	Tsegai, ZJ; Kivell, TL; Gross, T; Nguyen, NH; Pahr, DH; Smaers, JB; Skinner, MM				Tsegai, Zewdi J.; Kivell, Tracy L.; Gross, Thomas; Nguyen, N. Huynh; Pahr, Dieter H.; Smaers, Jeroen B.; Skinner, Matthew M.			Trabecular Bone Structure Correlates with Hand Posture and Use in Hominoids	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; FINITE-ELEMENT MODELS; FEMORAL-HEAD; POSITIONAL BEHAVIOR; LOCOMOTOR BEHAVIOR; KNUCKLE-WALKING; PAN-TROGLODYTES; CANCELLOUS BONE; MU-CT; ARCHITECTURE	Bone is capable of adapting during life in response to stress. Therefore, variation in locomotor and manipulative behaviours across extant hominoids may be reflected in differences in trabecular bone structure. The hand is a promising region for trabecular analysis, as it is the direct contact between the individual and the environment and joint positions at peak loading vary amongst extant hominoids. Building upon traditional volume of interest-based analyses, we apply a whole-epiphysis analytical approach using high-resolution microtomographic scans of the hominoid third metacarpal to investigate whether trabecular structure reflects differences in hand posture and loading in knuckle-walking (Gorilla, Pan), suspensory (Pongo, Hylobates and Symphalangus) and manipulative (Homo) taxa. Additionally, a comparative phylogenetic method was used to analyse rates of evolutionary changes in trabecular parameters. Results demonstrate that trabecular bone volume distribution and regions of greatest stiffness (i.e., Young's modulus) correspond with predicted loading of the hand in each behavioural category. In suspensory and manipulative taxa, regions of high bone volume and greatest stiffness are concentrated on the palmar or distopalmar regions of the metacarpal head, whereas knuckle-walking taxa show greater bone volume and stiffness throughout the head, and particularly in the dorsal region; patterns that correspond with the highest predicted joint reaction forces. Trabecular structure in knuckle-walking taxa is characterised by high bone volume fraction and a high degree of anisotropy in contrast to the suspensory brachiators. Humans, in which the hand is used primarily for manipulation, have a low bone volume fraction and a variable degree of anisotropy. Finally, when trabecular parameters are mapped onto a molecular-based phylogeny, we show that the rates of change in trabecular structure vary across the hominoid clade. Our results support a link between inferred behaviour and trabecular structure in extant hominoids that can be informative for reconstructing behaviour in fossil primates.	[Tsegai, Zewdi J.; Smaers, Jeroen B.; Skinner, Matthew M.] UCL, Dept Anthropol, London, England; [Kivell, Tracy L.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Tsegai, Zewdi J.; Kivell, Tracy L.; Nguyen, N. Huynh; Skinner, Matthew M.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Gross, Thomas; Pahr, Dieter H.] Vienna Univ Technol, Inst Lightweight Design & Struct Biomech, A-1040 Vienna, Austria; [Smaers, Jeroen B.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University of London; University College London; University of Kent; Max Planck Society; Technische Universitat Wien; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Skinner, MM (corresponding author), UCL, Dept Anthropol, London, England.	m.skinner@ucl.ac.uk	Tsegai, Zewdi/AAB-9996-2019; Kivell, Tracy/D-1225-2010; Skinner, Matthew/D-1104-2010	Tsegai, Zewdi/0000-0001-9041-4829; Skinner, Matthew/0000-0001-8321-3543; Smaers, Jeroen/0000-0003-1741-9839; Pahr, Dieter/0000-0002-5822-2082; Nguyen, Nhu Huynh/0000-0001-5493-3752	Max Planck Society	Max Planck Society(Max Planck Society)	This research was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badrian A, 1977, Oryx, V13, P463; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Coleman MN, 2008, AM J PHYS ANTHROPOL, V135, P404, DOI 10.1002/ajpa.20761; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Currey J.D., 2002, BONES STRUCTURE MECH; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Fajardo RJ, 2007, ANAT REC, V290, P422, DOI 10.1002/ar.20493; FLEAGLE J, 1974, NATURE, V248, P259, DOI 10.1038/248259a0; FLEAGLE JG, 1976, FOLIA PRIMATOL, V26, P245, DOI 10.1159/000155756; Griffin NL, 2010, J HUM EVOL, V59, P202, DOI 10.1016/j.jhevol.2010.06.006; Gross T, PAL ELEC UNPUB; Hollihn U., 1984, P85; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Inouye S. E., 2004, J ANTHROPOL SCI, P67; INOUYE SE, 1990, AM J PHYS ANTHROPOL, V81, P243; Isaksson H, 2011, OSTEOPOROSIS INT, V22, P167, DOI 10.1007/s00198-010-1219-0; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jenkins F.A. Jr., 1975, P213; Jones L.A., 2006, HUMAN HAND FUNCTION; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kivell TL, 2011, J ANAT, V218, P209, DOI 10.1111/j.1469-7580.2010.01314.x; Kothari M, 1998, BONE, V22, P437, DOI 10.1016/S8756-3282(98)00031-3; Lazenby RA, 2008, J HUM EVOL, V54, P875, DOI 10.1016/j.jhevol.2007.12.001; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P196, DOI 10.1002/ajpa.21385; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P215, DOI 10.1002/ajpa.21390; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.3.CO;2-7; Loken B, 2013, AM J PRIMATOL UNPUB; Macho GA, 2010, FOLIA PRIMATOL, V81, P292, DOI 10.1159/000322631; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Maga M, 2006, AM J PHYS ANTHROPOL, V129, P410, DOI 10.1002/ajpa.20276; Martin RB, 2010, SKELETAL TISSUE MECH; Marzke MW, 1996, INT J PRIMATOL, V17, P117, DOI 10.1007/BF02696162; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Pahr DH, 2008, BIOMECH MODEL MECHAN, V7, P463, DOI 10.1007/s10237-007-0109-7; Pahr DH, 2009, J BIOMECH, V42, P455, DOI 10.1016/j.jbiomech.2008.11.028; Pahr DH, 2009, COMPUT METHOD BIOMEC, V12, P45, DOI [10.1080/10255840802144105, 10.1080/10255840903065399]; PAOLI G, 1993, AM J PHYS ANTHROPOL, V92, P263, DOI 10.1002/ajpa.1330920304; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; RAUX P, 1975, J BIOMECH, V8, P1, DOI 10.1016/0021-9290(75)90037-8; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P1090, DOI 10.1111/j.1558-5646.2009.00616.x; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Rose M.D., 1988, P299; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF CB, 1992, ANNU REV ANTHROPOL, V21, P407; Ryan TM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0172; Ryan TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041037; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2005, J MORPHOL, V265, P249, DOI 10.1002/jmor.10315; Ryan TM, 2005, AM J PHYS ANTHROPOL, V126, P82, DOI 10.1002/ajpa.10414; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Ryan TM, 2002, J HUM EVOL, V43, P241, DOI 10.1006/jhev.2002.0575; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schilling A-M, 2012, THESIS U STUDI PISA; Schilling A-M, 2013, J MORPH IN PRESS; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Skedros JG, 2007, J THEOR BIOL, V244, P15, DOI 10.1016/j.jtbi.2006.06.029; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Smaers JB, 2009, EVOL ECOL RES, V11, P991; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sode M, 2008, BONE, V42, P728, DOI 10.1016/j.bone.2007.12.004; Stephens NB, 2012, THESIS U LONDON UK; SUSMAN RL, 1980, AM J PHYS ANTHROPOL, V53, P69, DOI 10.1002/ajpa.1330530111; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P215, DOI 10.1002/ajpa.1330500211; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Treece G M, 1999, Med Image Anal, V3, P141, DOI 10.1016/S1361-8415(99)80004-8; Treece GM, 1999, COMPUT GRAPH-UK, V23, P583, DOI 10.1016/S0097-8493(99)00076-X; Treece GM, 2000, IEEE T MED IMAGING, V19, P1106, DOI 10.1109/42.896787; Tuttle R.H., 1985, P261; TUTTLE RH, 1969, SCIENCE, V166, P953, DOI 10.1126/science.166.3908.953; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Wolff J, 1892, GESETZ TRANSFORMATIO; Wunderlich RE, 2009, AM J PHYS ANTHROPOL, V139, P394, DOI 10.1002/ajpa.20994; Zeininger A, 2011, J HUM EVOL, V60, P703, DOI 10.1016/j.jhevol.2011.01.002; Zylstra M, 2000, AM J PHYS ANTHROPOL, P331; ZYSSET PK, 1995, MECH MATER, V21, P243, DOI 10.1016/0167-6636(95)00018-6; Zysset PK, 2003, J BIOMECH, V36, P1469, DOI 10.1016/S0021-9290(03)00128-3	90	79	79	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78781	10.1371/journal.pone.0078781	http://dx.doi.org/10.1371/journal.pone.0078781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244359	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327143800017
J	Banks, JM; Herman, CT; Bailey, RC				Banks, Jessica M.; Herman, Christine T.; Bailey, Ryan C.			Bromelain Decreases Neutrophil Interactions with P-Selectin, but Not E-Selectin, In Vitro by Proteolytic Cleavage of P-Selectin Glycoprotein Ligand-1	PLOS ONE			English	Article							EXPRESSED E-SELECTIN; SIALYL-LEWIS-X; PSGL-1; ADHESION; ANTIBODY; MOLECULES	Stem bromelain, a cysteine protease isolated from pineapples, is a natural anti-inflammatory treatment, yet its mechanism of action remains unclear. Curious as to whether bromelain might affect selectin-mediated leukocyte rolling, we studied the ability of bromelain-treated human neutrophils to tether to substrates presenting immobilized P-selectin or E-selectin under shear stress. Bromelain treatment attenuated P-selectin-mediated tethering but had no effect on neutrophil recruitment on E-selectin substrates. Flow cytometric analysis of human neutrophils, using two antibodies against distinct epitopes within the P-selectin glycoprotein ligand-1 (PSGL-1) active site, revealed that bromelain cleaves PSGL-1 to remove one of two sites required for P-selectin binding, while leaving the region required for E-selectin binding intact. These findings suggest one molecular mechanism by which bromelain may exert its anti-inflammatory effects is via selective cleavage of PSGL-1 to reduce P-selectin-mediated neutrophil recruitment.	[Banks, Jessica M.; Herman, Christine T.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Bailey, RC (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	baileyrc@illinois.edu		Bailey, Ryan/0000-0003-1021-4267	Roy J. Carver Charitable Trust; Camille and Henry Dreyfus Foundation; National Science Foundation [DMR 1105300]; National Institutes of Health, National Center for Complementary & Alternative Medicine [F31AT006286]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT006286] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, National Center for Complementary & Alternative Medicine; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was funded by the Roy J. Carver Charitable Trust, the Camille and Henry Dreyfus Foundation, the National Science Foundation (DMR 1105300), and a pre-doctoral fellowship from the National Institutes of Health, National Center for Complementary & Alternative Medicine (Award Number F31AT006286). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary & Alternative Medicine or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1994, J CELL BIOL, V127, P1485, DOI 10.1083/jcb.127.5.1485; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bonder CS, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P14, DOI 10.1002/352760779X.ch2; Borges E, 1997, J BIOL CHEM, V272, P28786, DOI 10.1074/jbc.272.45.28786; de Giuli-Morghen C., 1978, DRUGS EXPT CLIN RES, V4, P1; Fitzhugh DJ, 2008, CLIN IMMUNOL, V128, P66, DOI 10.1016/j.clim.2008.02.015; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Hale LP, 2002, CLIN IMMUNOL, V104, P183, DOI 10.1006/clim.2002.5254; Hamann A, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P1, DOI 10.1002/352760779X; Herman CT, 2011, INTEGR BIOL-UK, V3, P779, DOI 10.1039/c0ib00151a; Kummitha CM, 2012, J IMMUNOL METHODS, V384, P43, DOI 10.1016/j.jim.2012.07.003; Maurer HR, 2001, CELL MOL LIFE SCI, V58, P1234, DOI 10.1007/PL00000936; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Onken JE, 2008, CLIN IMMUNOL, V126, P345, DOI 10.1016/j.clim.2007.11.002; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zou XY, 2005, AM J PHYSIOL-CELL PH, V289, pC415, DOI 10.1152/ajpcell.00289.2004	24	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78988	10.1371/journal.pone.0078988	http://dx.doi.org/10.1371/journal.pone.0078988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244398	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600090
J	Cedraschi, C; Delezay, S; Marty, M; Berenbaum, F; Bouhassira, D; Henrotin, Y; Laroche, F; Perrot, S				Cedraschi, Christine; Delezay, Sylvie; Marty, Marc; Berenbaum, Francis; Bouhassira, Didier; Henrotin, Yves; Laroche, Francoise; Perrot, Serge			"Let's Talk about OA Pain": A Qualitative Analysis of the Perceptions of People Suffering from OA. Towards the Development of a Specific Pain OA-Related Questionnaire, the Osteoarthritis Symptom Inventory Scale (OASIS)	PLOS ONE			English	Article							NEUROPATHIC PAIN; MCGILL PAIN; HEALTH-CARE; KNEE PAIN; OF-LIFE; HIP; REPLACEMENT; SATURATION; ABNORMALITIES; VALIDATION	Introduction: Pain is the primary outcome measurement in osteoarthritis, and its assessment is mostly based on its intensity. The management of this difficult chronic condition could be improved by using pain descriptors to improve analyses of painful sensations. This should help to define subgroups of patients based on pain phenotype, for more adapted treatment. This study draws upon patients' descriptions of their pain, to identify and understand their perception of osteoarthritis pain and to categorize pain dimensions. Methods: This qualitative study was conducted with representative types of patients suffering from osteoarthritis. Two focus groups were conducted with a sample of 14 participants, with either recent or chronic OA, at one or multiple sites. Focus groups were semi-structured and used open-ended questions addressing personal experiences to explore the experiences of patients with OA pain and the meanings they attributed to these pains. Results: Two main points emerged from content analyses: -A major difficulty in getting patients to describe their osteoarthritis pain: perception that nobody wants to hear about it; necessity to preserve one's self and social image; notion of self-imposed stoicism; and perception of osteoarthritis as a complex, changing, illogical disease associated with aging. -Osteoarthritis pains were numerous and differed in intensity, duration, depth, type of occurrence, impact and rhythm, but also in painful sensations and associated symptoms. Based on analyses of the verbatim interviews, seven dimensions of OA pain emerged: pain sensory description, OA-related symptoms, pain variability profile, pain-triggering factors, pain and physical activity, mood and image, general physical symptoms. Summary: In osteoarthritis, pain analysis should not be restricted to intensity. Our qualitative study identified pain descriptors and defined seven dimensions of osteoarthritis pain. Based on these dimensions, we aim to develop a specific questionnaire on osteoarthritis pain quality for osteoarthritis pain phenotyping: the OsteoArthritis Symptom Inventory Scale (OASIS).	[Cedraschi, Christine] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Ctr Multidisciplinary Pain, Geneva, Switzerland; [Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland; [Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [Delezay, Sylvie] Thelaine, Fontenay Sous Bois, France; [Marty, Marc] Hop Henri Mondor, Dept Rheumatol, F-94010 Creteil, France; [Berenbaum, Francis] Hop St Antoine, Dept Rheumatol, F-75571 Paris, France; [Bouhassira, Didier; Perrot, Serge] INSERM, U987, Pain Ctr, Boulogne, France; [Henrotin, Yves] Univ Liege, Inst Pathol, CHU, Bone & Cartilage Res Unit, Liege, Belgium; [Henrotin, Yves] Princess Paola Hosp, Vivalia, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium; [Laroche, Francoise] Hop St Antoine, Pain Ctr, F-75571 Paris, France; [Perrot, Serge] Univ Paris 05, Hotel Dieu, Pain Ctr, Serv Med Interne & Therapeut, Paris, France	University of Geneva; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Perrot, S (corresponding author), INSERM, U987, Pain Ctr, Boulogne, France.	serge.perrot@htd.aphp.fr	Bouhassira, Didier/Y-8403-2018; Berenbaum, Francis/AAO-5690-2020	Bouhassira, Didier/0000-0001-6446-8719; Berenbaum, Francis/0000-0001-8252-7815; Henrotin, Yves/0000-0003-1073-449X	Caisse Nationale de Prevoyance (CNP) insurance company foundation; APICIL insurance company foundation	Caisse Nationale de Prevoyance (CNP) insurance company foundation; APICIL insurance company foundation	The authors received a grant from the Caisse Nationale de Prevoyance (CNP) and APICIL insurance company foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; BURCKHARDT CS, 1984, PAIN, V19, P305, DOI 10.1016/0304-3959(84)90007-1; Cheraghi-Sohi S, 2013, ARTHRIT CARE RES, V65, P920, DOI 10.1002/acr.21897; Courvoisier DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023138; Croft P, 2005, ARTHRITIS RHEUM-US, V52, P2350, DOI 10.1002/art.21218; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Dekker J, 2009, CURR OPIN RHEUMATOL, V21, P520, DOI 10.1097/BOR.0b013e32832e6eaa; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Dwamena F, 2012, COCHRANE DB SYST REV, V12; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Fernandez E, 2011, J PAIN, V12, P444, DOI 10.1016/j.jpain.2010.10.011; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gaskell G., 2000, QUALITATIVE RES TEXT, P38, DOI DOI 10.4135/9781849209731; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P409, DOI 10.1016/j.joca.2007.12.015; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Hochman JR, 2011, OSTEOARTHR CARTILAGE, V19, P647, DOI 10.1016/j.joca.2011.03.007; Jeffery AE, 2011, ARTHRIT CARE RES, V63, P286, DOI 10.1002/acr.20360; Jinks C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-148; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KUZEL AJ, 1992, RES METH PR, V3, P31; LEQUESNE MG, 1987, SCAND J RHEUMATOL, P85; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BRIT MED J, V320, P320, DOI DOI 10.1136/BMJ.320.7226.50.PUBMED:10617534; McHugh GA, 2012, DISABIL REHABIL, V34, P1351, DOI 10.3109/09638288.2011.644022; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; National Collaborating Centre for Chronic Conditions (UK), 2008, OSTEOARTHRITIS NATL; O'Brien T, 2012, J PAIN, V3, P23; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Perrot S, 2009, CLIN J PAIN, V25, P767, DOI 10.1097/AJP.0b013e3181b43d4f; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-6; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; SPENCER J, 1994, ANAL QUALITATIVE DAT; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Williams ACD, 2000, PAIN, V85, P457, DOI 10.1016/S0304-3959(99)00299-7; Wilson D, 2009, PHYSIOTHER RES INT, V14, P56, DOI 10.1002/pri.424; Woolhead G, 2010, ARTHRIT CARE RES, V62, P944, DOI 10.1002/acr.20164; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343	52	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79988	10.1371/journal.pone.0079988	http://dx.doi.org/10.1371/journal.pone.0079988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244589	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600167
J	Harmel-Laws, E; Mann, EA; Cohen, MB; Steinbrecher, KA				Harmel-Laws, Eleana; Mann, Elizabeth A.; Cohen, Mitchell B.; Steinbrecher, Kris A.			Guanylate Cyclase C Deficiency Causes Severe Inflammation in a Murine Model of Spontaneous Colitis	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; SODIUM-INDUCED COLITIS; INTESTINAL INFLAMMATION; EPITHELIAL-CELLS; COLONIC INJURY; MECONIUM ILEUS; GOBLET CELLS; MICE; SUSCEPTIBILITY; RECEPTOR	Background: Guanylate Cyclase C (GC-C; Gucy2c) is a transmembrane receptor expressed in intestinal epithelial cells. Activation of GC-C by its secreted ligand guanylin stimulates intestinal fluid secretion. Familial mutations in GC-C cause chronic diarrheal disease or constipation and are associated with intestinal inflammation and infection. Here, we investigated the impact of GC-C activity on mucosal immune responses. Methods: We utilized intraperitoneal injection of lipopolysaccharide to elicit a systemic cytokine challenge and then measured pro-inflammatory gene expression in colonic mucosa. GC-C+/+ and GC-C-/- mice were bred with interleukin (IL)-10 deficient animals and colonic inflammation were assessed. Immune cell influx and cytokine/chemokine expression was measured in the colon of wildtype, IL-10(-/-), GC-C+/+ IL-10(-/-) and GC-C-/- IL-10(-/-) mice. GC-C and guanylin production were examined in the colon of these animals and in a cytokine-treated colon epithelial cell line. Results: Relative to GC-C+/+ animals, intraperitoneal lipopolysaccharide injection into GC-C-/- mice increased proinflammatory gene expression in both whole colon tissue and in partially purified colonocyte isolations. Spontaneous colitis in GC-C-/- IL-10(-/-) animals was significantly more severe relative to GC-C+/+ IL-10(-/-) mice. Unlike GC-C+/+ IL-10(-/-) controls, colon pathology in GC-C-/- IL-10(-/-) animals was apparent at an early age and was characterized by severely altered mucosal architecture, crypt abscesses, and hyperplastic subepithelial lesions. F4/80 and myeloperoxidase positive cells as well as proinflammatory gene expression were elevated in GC-C-/- IL-10(-/-) mucosa relative to control animals. Guanylin was diminished early in colitis in vivo and tumor necrosis factor alpha suppressed guanylin mRNA and protein in intestinal goblet cell-like HT29-18-N2 cells. Conclusions: The GC-C signaling pathway blunts colonic mucosal inflammation that is initiated by systemic cytokine burst or loss of mucosal immune cell immunosuppression. These data as well as the apparent intestinal inflammation in human GC-C mutant kindred underscore the importance of GC-C in regulating the response to injury and inflammation within the gut.	[Cohen, Mitchell B.; Steinbrecher, Kris A.] Univ Cincinnati, Dept Pediat, Coll Med Cincinnati, Cincinnati, OH 45221 USA; [Harmel-Laws, Eleana; Mann, Elizabeth A.; Cohen, Mitchell B.; Steinbrecher, Kris A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Steinbrecher, KA (corresponding author), Univ Cincinnati, Dept Pediat, Coll Med Cincinnati, Cincinnati, OH 45221 USA.	kris.steinbrecher@cchmc.org		Cohen, Mitchell/0000-0002-4412-350X	Crohn's and Colitis Foundation of America; NIH [DK047318]; PHS [DK P30DK078392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047318, R01DK047318, P30DK078392] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Crohn's and Colitis Foundation of America (KAS), NIH DK047318 (MBC/KAS), and, in part, by PHS Grant DK P30DK078392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berglund M, 2009, CELL IMMUNOL, V259, P27, DOI 10.1016/j.cellimm.2009.05.009; Brierley SM, 2012, CURR OPIN PHARMACOL, V12, P632, DOI 10.1016/j.coph.2012.10.005; COHEN MB, 1995, BIOCHEM BIOPH RES CO, V209, P803, DOI 10.1006/bbrc.1995.1571; COHEN MB, 1988, GASTROENTEROLOGY, V94, P367, DOI 10.1016/0016-5085(88)90423-4; Cohen MB, 2002, INFECT GASTROINTESTI, P579; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; GUARINO A, 1987, PEDIATR RES, V21, P551, DOI 10.1203/00006450-198706000-00009; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Houdeau E, 2007, GASTROENTEROLOGY, V132, P982, DOI 10.1053/j.gastro.2006.12.028; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Itoh H, 1999, BIOCHEM J, V341, P461, DOI 10.1042/0264-6021:3410461; LI ZP, 1995, GASTROENTEROLOGY, V109, P1863, DOI 10.1016/0016-5085(95)90753-X; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Mann EA, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-135; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Steinbrecher KA, 2002, AM J PHYSIOL-CELL PH, V283, pC1729, DOI 10.1152/ajpcell.00010.2002; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Steinbrecher KA, 2011, CURR OPIN GASTROEN, V27, P139, DOI 10.1097/MOG.0b013e328341ead5; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; TAL A, 1985, CLIN PEDIATR, V24, P460, DOI 10.1177/000992288502400809; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Verhaeghe C, 2007, BIOCHEM BIOPH RES CO, V356, P745, DOI 10.1016/j.bbrc.2007.02.166; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011	45	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79180	10.1371/journal.pone.0079180	http://dx.doi.org/10.1371/journal.pone.0079180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244444	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600115
J	Timmons, A; Gooberman-Hill, R; Sharp, L				Timmons, Aileen; Gooberman-Hill, Rachael; Sharp, Linda			"It's at a Time in Your Life When You Are Most Vulnerable": A Qualitative Exploration of the Financial Impact of a Cancer Diagnosis and Implications for Financial Protection in Health	PLOS ONE			English	Article							BREAST-CANCER; ECONOMIC-IMPACT; POPULATION; COSTS; FAMILIES; CARE; BENEFITS; HARDSHIP; BURDEN; ACCESS	Although cancer patients may incur a wide range of cancer-related out-of-pocket costs and experience reduced income, the consequences of this financial burden are poorly understood. We investigated: financial adjustments needed to cope with the cancer-related financial burden; financial distress (defined as a reaction to the state of personal finances); and factors that increase risk of financial difficulties. Two sets of semi-structured face-to-face interviews were conducted with 20 patients with breast, lung and prostate cancer and 21 hospital-based oncology social workers (OSWs) in Ireland, which has a mixed public-private healthcare system. Participants were asked about: strategies to cope with the cancer-related financial burden; the impact of the financial burden on the family budget, other aspects of daily life, and wellbeing. OSWs were also asked about patient groups they thought were more likely to experience financial difficulties. The two interview sets were analysed separately using a thematic approach. Financial adjustments included: using savings; borrowing money; relying on family and friends for direct and indirect financial help; and cutting back on household spending. Financial distress was common. Financial difficulties were more likely for patients who were older or younger, working at diagnosis, lacked social support, had dependent children, had low income or had few savings. These issues often interacted with one another. As has been seen in predominantly publically and predominantly privately-funded healthcare settings, a complex mixed public-private healthcare system does not always provide adequate financial protection post-cancer. Our findings highlight the need for a broader set of metrics to measure the financial impact of cancer (and to assess financial protection in health more generally); these should include: out-of-pocket direct medical and non-medical costs; changes in income; financial adjustments (including financial coping strategies and household consumption patterns); and financial distress. In the interim, cancer patients require financial information and advice intermittently post diagnosis.	[Timmons, Aileen; Sharp, Linda] Natl Canc Registry, Cork, Ireland; [Gooberman-Hill, Rachael] Univ Bristol, Sch Clin Sci, Orthopaed Surg Res Grp, Bristol, Avon, England	University of Bristol	Timmons, A (corresponding author), Natl Canc Registry, Cork, Ireland.	a.timmons@ncri.ie		Gooberman-Hill, Rachael/0000-0003-3353-2882	Irish Cancer Society (ICS)	Irish Cancer Society (ICS)	The study was funded by the Irish Cancer Society (ICS). Representatives of the ICS were on the study advisory group. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Allirajah D, 2005, FREE POINT DELIVERY; Amir Z, 2011, PSYCHOONCOLOGY  0718, DOI [10.1002/pon.2021, DOI 10.1002/P0N.2021.[]; Amir Ziv, 2007, J Cancer Surviv, V1, P129, DOI 10.1007/s11764-007-0021-2; Arndt V, 2004, J CLIN ONCOL, V22, P4829, DOI 10.1200/JCO.2004.02.018; Arozullah Ahsan M, 2004, J Support Oncol, V2, P271; Bagwell D.C., 2006, P 2006 ASS FIN COUNS, P77; Baldwin LM, 2008, J RURAL HEALTH, V24, P390, DOI 10.1111/j.1748-0361.2008.00186.x; Banthin JS, 2006, JAMA-J AM MED ASSOC, V296, P2712, DOI 10.1001/jama.296.22.2712; Bouknight RR, 2006, J CLIN ONCOL, V24, P345, DOI 10.1200/JCO.2004.00.4929; Bradley CJ, 2012, J CLIN ONCOL, V30, P1579, DOI 10.1200/JCO.2011.40.7247; Bradley S, 2007, J NEURO-ONCOL, V85, P329, DOI 10.1007/s11060-007-9425-0; Brooks J, 2011, EUR J ONCOL NURS, V15, P302, DOI 10.1016/j.ejon.2010.10.005; Cancer Breast Prescription Carefor change, 2006, BREAST CANC CAR PRES; Ceilleachair AO, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-62; Chapple A, 2004, BRIT J GEN PRACT, V54, P589; Chirikos TN, 2002, CANCER PRACT, V10, P248, DOI 10.1046/j.1523-5394.2002.105004.x; Cohn RJ, 2003, J PEDIAT HEMATOL ONC, V25, P854, DOI 10.1097/00043426-200311000-00007; Drolet M, 2005, CAN MED ASSOC J, V173, P765, DOI 10.1503/cmaj.050178; Eiser C, 2007, CHILD CARE HLTH DEV, V33, P455, DOI 10.1111/j.1365-2214.2006.00710.x; FAGGIANO F, 1997, IARC SCI PUBLICATION, V138; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Galbraith AA, 2005, HEALTH SERV RES, V40, P1722, DOI 10.1111/j.1475-6773.2005.00421.x; Gordon L, 2007, PSYCHO-ONCOL, V16, P1130, DOI 10.1002/pon.1182; Health Service Executive, 2008, HLTH SERV EX ANN REP; Housser E, 2013, CURR ONCOL, V20, P158, DOI 10.3747/co.20.1197; Lauzier S, 2005, PSYCHO-ONCOLOGY, V14, P351, DOI 10.1002/pon.851; Lauzier S, 2008, J NATL CANCER I, V100, P321, DOI 10.1093/jnci/djn028; Lauzier S, 2010, QUAL LIFE RES, V19, P177, DOI 10.1007/s11136-009-9575-y; Longo CJ, 2006, SUPPORT CARE CANCER, V14, P1077, DOI 10.1007/s00520-006-0088-8; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Markman M, 2010, J ONCOL PRACT, V6, P69, DOI 10.1200/JOP.091074; Mathews M, 2009, CURR ONCOL, V16, P213; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; Miedema B, 2008, CURR ONCOL, V15, P173; Moffatt SS, 2012, PLOS ONE, V7, P1; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Murh T, 2004, USERS MANUAL ATLAS T; ONeill B., 2006, J FINANC COUNS PLAN, V17, P46; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Quinn A, 2002, MACMILLAN CANC RELIE; Ruger JP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001294; Sabatino SA, 2006, CANCER-AM CANCER SOC, V106, P2466, DOI 10.1002/cncr.21879; Shankaran V, 2012, J CLIN ONCOL, V30, P1608, DOI 10.1200/JCO.2011.37.9511; Sharp L, 2010, FINANCIAL IMPACT CAN; Sharp L, 2012, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3055, DOI 10.1002/P0N.3055.[]; Sharp L, 2011, J CANCER SURVIV, V5, P382, DOI 10.1007/s11764-011-0183-9; Smith S, 2011, HEALTH ECON POLICY L, V6, P205, DOI 10.1017/S1744133110000289; Strauss A., 1990, BASICS QUALITATIVE R; Timmons A, 2013, SUPPORT CARE CANCER, V21, P107, DOI 10.1007/s00520-012-1498-4; Valtorta NK, 2013, MATURITAS, V14, DOI [10.1016/j.maturitas.2013.01.015, DOI 10.1016/J.MATURITAS.2013.01.015.[]; Wagner Lisa, 2004, Clin J Oncol Nurs, V8, P279, DOI 10.1188/04.CJON.279-287; Weaver KE, 2010, CANCER-AM CANCER SOC, V116, P4395, DOI 10.1002/cncr.25368; Wilson K, 2008, PSYCHO-ONCOLOGY, V17, P421, DOI 10.1002/pon.1265; World Health Organization Europe, 2006, HIGHL HLTH IR 2004	54	55	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77549	10.1371/journal.pone.0077549	http://dx.doi.org/10.1371/journal.pone.0077549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244279	Green Published, gold			2022-12-27	WOS:000327221600009
J	Zheng, S; Li, Y; Han, J; Zhang, HB; Zeng, W; Xu, CL; Jia, YX; Wang, JG; Guo, KQ; Jiao, YQ; Meng, X				Zheng, Shuai; Li, Yan; Han, Jie; Zhang, Haibo; Zeng, Wen; Xu, Chunlei; Jia, Yixin; Wang, Jiangang; Guo, Kequan; Jiao, Yuqing; Meng, Xu			Long-Term Results of a Minimally Invasive Surgical Pulmonary Vein Isolation and Ganglionic Plexi Ablation for Atrial Fibrillation	PLOS ONE			English	Article							TRANSVENOUS CATHETER ABLATION; FOLLOW-UP; AUTONOMIC DENERVATION; METAANALYSIS; MANAGEMENT; STRATEGY; EFFICACY; RHYTHM; TRIAL	Background: Ganglionated plexi (GP) ablation has been become an adjunct to pulmonary vein isolation (PVI). This study describes the long-term results of minimally invasive surgical PVI, ablation of GPs, and exclusion of the left atrial appendage for atrial fibrillation (AF). Methods: Long-term follow-up of 55 months was performed in 139 consecutive patients (age 58.3 +/- 20.8 years) with symptomatic, drug-refractory lone AF who underwent minimally invasive surgical PVI, GPs ablation, and exclusion of the left atrial appendage. Success was defined as freedom from AF, atrial flutter, or atrial tachycardia off antiarrhythmic drugs. Results: AF was paroxysmal in 77.7%, persistent in 12.2% and long-standing persistent in 10.1%. Single-procedure success rate was 71.7%, 59.4% and 46.6% at 12, 24 and 60 months respectively. Single-procedure success rate was 72.9%, 62.6% and 51.8% for paroxysmal AF, 64.7%, 35.3%, and 28.2% for persistent AF, 71.4%, 64.3% and 28.6% for long-standing persistent AF at 12, 24 and 60 months respectively. Duration of AF>24 months (hazard ratio [HR]: 3.09, 95% confidence interval [CI]: 1.51 to 6.32; p = 0.002), left atrial diameter >= 40 mm (HR: 4.03, 95% CI: 1.88 to 8.65; p<0.001), early recurrence of AF (HR: 4.66, 95% CI: 2.25 to 9.63; p<0.001) independently predicted long-term recurrence of AF. There was no procedure-related death. One patient converted to median sternotomy because of uncontrolled bleeding. Two patients underwent perioperative cerebrovascular events. Conclusions: At nearly 5-year of clinical follow-up, single-procedure success rate of minimally invasive surgical PVI with GP ablation was 51.8% for paroxysmal AF, 28.2% for persistent AF, 28.6% for long-standing persistent AF after initial procedure. Patients with AF duration <= 24 months, left atrial diameter <40 mm and no early recurrence of AF, had favorable outcomes.	[Zheng, Shuai; Li, Yan; Han, Jie; Zhang, Haibo; Zeng, Wen; Xu, Chunlei; Jia, Yixin; Wang, Jiangang; Guo, Kequan; Jiao, Yuqing; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Atrial Fibrillat Ctr, Beijing, Peoples R China	Capital Medical University	Meng, X (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Atrial Fibrillat Ctr, Beijing, Peoples R China.	mxu@263.net	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [81270215]; Chinese Postdoctoral Science Foundation [2013M530664]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was partly supported by National Natural Science Foundation of China (Grant No. 81270215) and Chinese Postdoctoral Science Foundation (Grant No. 2013M530664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagge L, 2009, J THORAC CARDIOV SUR, V137, P1265, DOI 10.1016/j.jtcvs.2008.12.017; Beukema WP, 2008, EUR J CARDIO-THORAC, V34, P771, DOI 10.1016/j.ejcts.2008.07.026; Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047; Calkins H, 2012, J AM COLL CARDIOL, V60, P62, DOI 10.1016/j.jacc.2012.01.068; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Cui YQ, 2010, J THORAC CARDIOV SUR, V139, P326, DOI 10.1016/j.jtcvs.2009.04.029; Edgerton JR, 2007, J INTERV CARD ELECTR, V20, P89, DOI 10.1007/s10840-007-9177-y; Edgerton JR, 2010, J THORAC CARDIOV SUR, V140, P823, DOI 10.1016/j.jtcvs.2009.11.065; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Gaynor SL, 2005, J THORAC CARDIOV SUR, V129, P104, DOI 10.1016/j.jtcvs.2004.08.042; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Han FT, 2009, CIRC-ARRHYTHMIA ELEC, V2, P370, DOI 10.1161/CIRCEP.109.854828; Klotsche J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-63; Krul SPJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P262, DOI 10.1161/CIRCEP.111.961862; Mehall JR, 2007, ANN THORAC SURG, V83, P538, DOI 10.1016/j.athoracsur.2006.09.022; Nanthakumar K, 2004, CIRCULATION, V109, P1226, DOI 10.1161/01.CIR.0000121423.78120.49; Oral H, 2002, J AM COLL CARDIOL, V40, P100, DOI 10.1016/S0735-1097(02)01939-3; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Pison L, 2012, J AM COLL CARDIOL, V60, P54, DOI 10.1016/j.jacc.2011.12.055; Pokushalov E, 2009, HEART RHYTHM, V6, P1257, DOI 10.1016/j.hrthm.2009.05.018; Sakamoto S, 2010, J THORAC CARDIOV SUR, V139, P444, DOI 10.1016/j.jtcvs.2009.04.056; Scherlag BJ, 2005, J AM COLL CARDIOL, V45, P1878, DOI 10.1016/j.jacc.2005.01.057; Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060; Wang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022122; Wolf RK, 2005, J THORAC CARDIOV SUR, V130, P797, DOI 10.1016/j.jtcvs.2005.03.041; Yilmaz A, 2010, EUR J CARDIO-THORAC, V38, P356, DOI 10.1016/j.ejcts.2010.01.058; Zhang YJ, 2012, J CARDIOVASC ELECTR, V23, P592, DOI 10.1111/j.1540-8167.2011.02270.x; Zhou J, 2007, J CARDIOVASC ELECTR, V18, P83, DOI 10.1111/j.1540-8167.2006.00679.x; Zhou QN, 2011, PACE, V34, P1687, DOI 10.1111/j.1540-8159.2011.03220.x	31	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79755	10.1371/journal.pone.0079755	http://dx.doi.org/10.1371/journal.pone.0079755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244556	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600150
J	Gegenbauer, K; Nagy, Z; Smolenski, A				Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert			Cyclic Nucleotide Dependent Dephosphorylation of Regulator of G-Protein Signaling 18 in Human Platelets	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; IN-VITRO; PHOSPHORYLATION; BINDING; SPINOPHILIN; MEGAKARYOPOIESIS; PHOSPHATASES; RAP1GAP2; CLONING; GEFI	Regulator of G-protein signaling 18 (RGS18) is a GTPase-activating protein that turns off Gq signaling in platelets. RGS18 is regulated by binding to the adaptor protein 14-3-3 via phosphorylated serine residues S49 and S218 on RGS18. In this study we confirm that thrombin, thromboxane A2, or ADP stimulate the interaction of RGS18 and 14-3-3 by increasing the phosphorylation of S49. Cyclic AMP-and cyclic GMP-dependent kinases (PKA, PKG) inhibit the interaction of RGS18 and 14-3-3 by phosphorylating S216. To understand the effect of S216 phosphorylation we studied the phosphorylation kinetics of S49, S216, and S218 using Phos-tag gels and phosphorylation site-specific antibodies in transfected cells and in platelets. Cyclic nucleotide-induced detachment of 14-3-3 from RGS18 coincides initially with double phosphorylation of S216 and S218. This is followed by dephosphorylation of S49 and S218. Dephosphorylation of S49 and S218 might be mediated by protein phosphatase 1 (PP1) which is linked to RGS18 by the regulatory subunit PPP1R9B (spinophilin). We conclude that PKA and PKG induced S216 phosphorylation triggers the dephosphorylation of the 14-3-3 binding sites of RGS18 in platelets.	[Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Gegenbauer, Kristina; Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gegenbauer, Kristina] Natl Childrens Res Ctr, Dublin, Ireland; [Gegenbauer, Kristina] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	University College Dublin; University College Dublin; National Children's Research Centre (NCRC); Trinity College Dublin; Trinity College Dublin	Smolenski, A (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 2, Ireland.	albert.smolenski@ucd.ie	Nagy, Zoltan/ABE-3429-2020	Nagy, Zoltan/0000-0001-6517-2071; Smolenski, Albert/0000-0001-9210-9406	Science Foundation Ireland [08/IN.1/B1855]; UCD School of Medicine and Medical Science, University College Dublin	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); UCD School of Medicine and Medical Science, University College Dublin	This work was supported by Science Foundation Ireland, http://www.sfi.ie/, grant number 08/IN.1/B1855, and by UCD School of Medicine and Medical Science, University College Dublin, http://www.ucd.ie/medicine/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Astuti P, 2010, J BIOL CHEM, V285, P34364, DOI 10.1074/jbc.M110.138412; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Burkhart JM, 2012, BLOOD; BUTT E, 1994, J BIOL CHEM, V269, P14509; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Cohen PTW, 2002, J CELL SCI, V115, P241; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Guidetti GF, 2013, BIOCHEM J, V453, P115, DOI 10.1042/BJ20130131; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Louwette S, 2012, J THROMB HAEMOST, V10, P2215, DOI 10.1111/j.1538-7836.2012.04903.x; Louwette S, 2012, J THROMBOSIS HAEMOST; Louwette S, 2012, FASEB J, V26, P2125, DOI 10.1096/fj.11-198739; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	38	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80251	10.1371/journal.pone.0080251	http://dx.doi.org/10.1371/journal.pone.0080251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244663	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900072
J	Hou, Y; Yuan, W; Kang, J; Liu, Y				Hou, Yang; Yuan, Wen; Kang, Jian; Liu, Yang			Influences of Endplate Removal and Bone Mineral Density on the Biomechanical Properties of Lumbar Spine	PLOS ONE			English	Article							STRUCTURAL-PROPERTIES; COMPRESSIVE STRENGTH; CANCELLOUS BONE; FUSION; GRAFT; CONSTRUCTS	Purpose: To investigate (1) effects of endplate removal and bone mineral density (BMD) on biomechanical properties of lumbar vertebrae (2) whether the distributions of mechanical strength and stiffness of endplate are affected by BMD. Methods: A total of thirty-one lumbar spines (L1-L5) collected from fresh cadavers were used in this study. Bone density was measured using lateral DEXA scans and parts of samples were performed with partial or entire endplate removal. All the specimens were divided into three BMD groups. According to endplate integrity of the lumbar vertebrae, each BMD group was then divided into three subgroups: subgroup A: intact endplate; subgroup B: central region of endplate removal; subgroup C: entire endplate removal. The axial compression test was conducted with material testing system at a speed of 2mm/min. The experimental results were statistically analyzed using SPSS 17.0. Results: (1) Significant differences of biomechanical properties occurred among normal BMD, osteoporotic and serious osteoporotic group (P<0.05). (2) Spearman analysis showed that BMD was positively correlated with the failure load and stiffness of lumbar vertebrae. (3) For each BMD group, significant differences of biomechanical properties were found between subgroup A and C, and between subgroup B and C (P<0.05). (4) For each BMD group, there was no statistical difference of biomechanical properties between subgroup A and B (P>0.05). Conclusions: Entire endplate removal can significantly decrease the structural properties of lumbar vertebrae with little change in biomechanical properties by preservation of peripheral region of the endplate. BMD is positively correlated to the structural properties of the lumbar vertebrae.	[Hou, Yang; Yuan, Wen; Liu, Yang] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Kang, Jian] Eighty Eighth Mil Hosp, Dept Orthopaed Surg, Tai An, Shandong, Peoples R China	Naval Medical University	Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	Alexzandersuper@163.com						AMSTUTZ H C, 1969, Journal of Bone and Joint Surgery British Volume, V51-B, P540; Belkoff SM, 1999, BONE, V25, p23S, DOI 10.1016/S8756-3282(99)00128-3; CLOSKEY RF, 1993, SPINE, V18, P1011, DOI 10.1097/00007632-199306150-00010; Cripton PA, 2000, J BIOMECH, V33, P1559, DOI 10.1016/S0021-9290(00)00145-7; Fan Shi-cai, 2001, CHIN J CLIN ANAT, V19, P74; Fields AJ, 2010, J BIOMECH, V43, P3126, DOI 10.1016/j.jbiomech.2010.08.002; Grant JP, 2001, SPINE, V26, P889, DOI 10.1097/00007632-200104150-00012; Hollowell JP, 1996, SPINE, V21, P1032, DOI 10.1097/00007632-199605010-00007; Hosford WF, 2010, MECH BEHAV MAT, P47; Hou Y, 2009, SPINE, V34, pE427, DOI 10.1097/BRS.0b013e3181a2ea0a; JAYASINGHE JAP, 1994, ANAT EMBRYOL, V189, P259; Jost B, 1998, Eur Spine J, V7, P132; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KOZAK JA, 1994, CLIN ORTHOP RELAT R, P45; Lim TH, 2001, SPINE, V26, P951, DOI 10.1097/00007632-200104150-00021; Lowe TG, 2004, SPINE, V29, P2389, DOI 10.1097/01.brs.0000143623.18098.e5; Moore RJ, 2000, EUR SPINE J, V9, P92, DOI 10.1007/s005860050217; Pearcy M J, 1983, Eng Med, V12, P183, DOI 10.1243/EMED_JOUR_1983_012_052_02; Polikeit A, 2003, EUR SPINE J, V12, P556, DOI 10.1007/s00586-003-0556-5; RIEBEL GD, 1995, SPINE, V20, P2198, DOI 10.1097/00007632-199510001-00004; ROBERTS S, 1989, SPINE, V14, P166, DOI 10.1097/00007632-198902000-00005; Spiegel M.R., 1992, THEORY PROBLEMS PROB, V2nd ed., P294; Steffen T, 2000, SPINE, V25, P1077, DOI 10.1097/00007632-200005010-00007; Steffen T, 1998, OPTIMAL IMPLANT ENDP, P23	24	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76843	10.1371/journal.pone.0076843	http://dx.doi.org/10.1371/journal.pone.0076843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244269	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900003
J	Sacks-Davis, R; Aitken, CK; Higgs, P; Spelman, T; Pedrana, AE; Bowden, S; Bharadwaj, M; Nivarthi, UK; Suppiah, V; George, J; Grebely, J; Drummer, HE; Hellard, M				Sacks-Davis, Rachel; Aitken, Campbell K.; Higgs, Peter; Spelman, Tim; Pedrana, Alisa E.; Bowden, Scott; Bharadwaj, Mandvi; Nivarthi, Usha K.; Suppiah, Vijayaprakash; George, Jacob; Grebely, Jason; Drummer, Heidi E.; Hellard, Margaret			High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GLOBAL EPIDEMIOLOGY; INFECTION; USERS; SEROCONVERSION; VACCINATION; PERSISTENCE; GENOTYPES; INSIGHTS; IMPACT	Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95% CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95% CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95% CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95% CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95% CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95% CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95% CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95% CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear. Conclusions: Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required.	[Sacks-Davis, Rachel; Aitken, Campbell K.; Higgs, Peter; Spelman, Tim; Pedrana, Alisa E.; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Aitken, Campbell K.; Spelman, Tim; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Aitken, Campbell K.; Hellard, Margaret] Burnet Inst, Ctr Excellence Injecting Drug Use, Melbourne, Vic, Australia; [Higgs, Peter] Curtin Univ, Natl Drug Res Inst, Melbourne, Vic, Australia; [Bowden, Scott] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Bharadwaj, Mandvi; Nivarthi, Usha K.; Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Suppiah, Vijayaprakash; George, Jacob] Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2006, Australia; [Suppiah, Vijayaprakash; George, Jacob] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Suppiah, Vijayaprakash] Univ S Australia, Sch Pharm, Adelaide, SA 5001, Australia; [Grebely, Jason] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Drummer, Heidi E.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Drummer, Heidi E.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	Burnet Institute; Monash University; Burnet Institute; Curtin University; Victorian Infectious Diseases Reference Laboratory; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of South Australia; University of New South Wales Sydney; Kirby Institute; Burnet Institute; Monash University	Sacks-Davis, R (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	rachelsd@burnet.edu.au	Bharadwaj, Mandvi/C-4446-2014; Higgs, Peter/P-7816-2019; Sacks-Davis, Rachel/H-3277-2019; George, jacob/P-1496-2014; Suppiah, Vijay/D-4174-2011	Higgs, Peter/0000-0002-5587-5379; Suppiah, Vijay/0000-0001-5496-935X; Pedrana, Alisa/0000-0002-1998-5722; Sacks-Davis, Rachel/0000-0003-0860-2762; Drummer, Heidi/0000-0002-0042-6277; Aitken, Campbell/0000-0002-0923-4837	Australia's National Health and Medical Research Council [331312, 1041897, 1020175, 1006759]; Victorian Department of Human Services; Australian Centre for HIV and Hepatitis Virology Research (ACH2); Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Robert W. Storr Bequest	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Human Services; Australian Centre for HIV and Hepatitis Virology Research (ACH2); Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Robert W. Storr Bequest	This work was supported by Australia's National Health and Medical Research Council [project grant 331312, postgraduate scholarship to RSD, training fellowship to PH, RD Wright Career Development Award to HED, senior research fellowship 1041897 to HED, Career Development Fellowship to JGr, project grant 1020175 to HED, project grant 1006759 to JGe, Senior Research Fellowship to MH]; the Victorian Department of Human Services [public health research grant, 2008-09]; the Australian Centre for HIV and Hepatitis Virology Research (ACH2); the Victorian Operational Infrastructure Support Program; the Burnet Institute; the Centre for Research Excellence into Injecting Drug Use; and the Robert W. Storr Bequest to the Medical Foundation of the University of Sydney [to JGe]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Backmund M, 2004, CLIN INFECT DIS, V39, P1540, DOI 10.1086/425361; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Corson S, 2011, INT J DRUG POLICY, V22, P102, DOI 10.1016/j.drugpo.2010.10.007; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; Currie SL, 2008, DRUG ALCOHOL DEPEN, V93, P148, DOI 10.1016/j.drugalcdep.2007.09.011; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Gyarmathy VA, 2010, AIDS BEHAV, V14, P141, DOI 10.1007/s10461-008-9518-6; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hahn JA, 2001, HEPATOLOGY, V34, P180, DOI 10.1053/jhep.2001.25759; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Judd A, 2005, J VIRAL HEPATITIS, V12, P655, DOI 10.1111/j.1365-2893.2005.00643.x; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Marufu M, 2012, J MED VIROL, V84, P1737, DOI 10.1002/jmv.23389; McCaw R, 1997, J VIRAL HEPATITIS, V4, P351, DOI 10.1046/j.1365-2893.1997.00060.x; McDonald SA, 2012, INT J DRUG POLICY, V23, P353, DOI 10.1016/j.drugpo.2012.02.003; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stoove MA, 2005, DRUG ALCOHOL DEPEN, V77, P81, DOI 10.1016/j.drugalcdep.2004.07.002; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Vickerman P, 2012, J INFECT DIS, V205, P1342, DOI 10.1093/infdis/jis213	43	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80216	10.1371/journal.pone.0080216	http://dx.doi.org/10.1371/journal.pone.0080216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244654	gold, Green Published, Green Accepted			2022-12-27	WOS:000327162900068
J	Anderson, RC; Young, W; Clerens, S; Cookson, AL; McCann, MJ; Armstrong, KM; Roy, NC				Anderson, Rachel C.; Young, Wayne; Clerens, Stefan; Cookson, Adrian L.; McCann, Mark J.; Armstrong, Kelly M.; Roy, Nicole C.			Human Oral Isolate Lactobacillus fermentum AGR1487 Reduces Intestinal Barrier Integrity by Increasing the Turnover of Microtubules in Caco-2 Cells	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; EPITHELIAL BARRIER; IN-VIVO; ENTEROLACTONE; INFLAMMATION; EXPRESSION; MICROBIOTA; PREVENTS; BACTERIA; MODEL	Lactobacillus fermentum is found in fermented foods and thought to be harmless. In vivo and clinical studies indicate that some L. fermentum strains have beneficial properties, particularly for gastrointestinal health. However, L. fermentum AGR1487 decreases trans-epithelial electrical resistance (TEER), a measure of intestinal barrier integrity. The hypothesis was that L. fermentum AGR1487 decreases the expression of intestinal cell tight junction genes and proteins, thereby reducing barrier integrity. Transcriptomic and proteomic analyses of Caco-2 cells (model of human intestinal epithelial cells) treated with L. fermentum AGR1487 were used to obtain a global view of the effect of the bacterium on intestinal epithelial cells. Specific functional characteristics by which L. fermentum AGR1487 reduces intestinal barrier integrity were examined using confocal microscopy, cell cycle progression and adherence bioassays. The effects of TEER-enhancing L. fermentum AGR1485 were investigated for comparison. L. fermentum AGR1487 did not alter the expression of Caco-2 cell tight junction genes (compared to L. fermentum AGR1485) and tight junction proteins were not able to be detected. However, L. fermentum AGR1487 increased the expression levels of seven tubulin genes and the abundance of three microtubule-associated proteins, which have been linked to tight junction disassembly. Additionally, Caco-2 cells treated with L. fermentum AGR1487 did not have defined and uniform borders of zona occludens 2 around each cell, unlike control or AGR1485 treated cells. L. fermentum AGR1487 cells were required for the negative effect on barrier integrity (bacterial supernatant did not cause a decrease in TEER), suggesting that a physical interaction may be necessary. Increased adherence of L. fermentum AGR1487 to Caco-2 cells (compared to L. fermentum AGR1485) was likely to facilitate this cell-to-cell interaction. These findings illustrate that bacterial strains of the same species can cause contrasting host responses and suggest that food-safe status should be given to individual strains not species.	[Anderson, Rachel C.; Young, Wayne; McCann, Mark J.; Armstrong, Kelly M.; Roy, Nicole C.] AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand; [Young, Wayne; Cookson, Adrian L.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Clerens, Stefan] AgRes Lincoln, Food & Biobased Prod Grp, Prot & Biomat Team, Lincoln, NE USA; [Cookson, Adrian L.; Roy, Nicole C.] AgRes Grasslands, Anim Hlth & Nutr Grp, Rumen Microbiol Team, Palmerston North, New Zealand; [McCann, Mark J.; Roy, Nicole C.] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand	AgResearch - New Zealand; Massey University; AgResearch - New Zealand; University of Auckland	Anderson, RC (corresponding author), AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand.	rachel.anderson@agresearch.co.nz	Cookson, Adrian/R-6617-2019; Clerens, Stefan/L-5755-2013; Roy, Nicole C/AAP-5016-2020	Clerens, Stefan/0000-0003-4703-6353; McCann, Mark/0000-0001-8247-2199; roy, nicole clemence/0000-0002-6744-9705; Anderson, Rachel/0000-0003-2191-0655; Young, Wayne/0000-0003-0464-2062	New Zealand Foundation of Research, Science and Technology (FRST) Food-Microbe-Host Interactions Programme [C02X0703]; FRST Postdoctoral Fellowship [AGRX0602]; Bridge to Employment Fellowship [AGRX0902]	New Zealand Foundation of Research, Science and Technology (FRST) Food-Microbe-Host Interactions Programme; FRST Postdoctoral Fellowship(New Zealand Foundation for Research, Science and Technology); Bridge to Employment Fellowship	This research was funded by the New Zealand Foundation of Research, Science and Technology (FRST) Food-Microbe-Host Interactions Programme (C02X0703), and during much of this research RA held FRST Postdoctoral (AGRX0602) and Bridge to Employment (AGRX0902) Fellowships. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Anderson RC, 2010, FEMS MICROBIOL LETT, V309, P184, DOI 10.1111/j.1574-6968.2010.02038.x; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; Dal Bello F, 2006, SYST APPL MICROBIOL, V29, P69, DOI 10.1016/j.syapm.2005.07.002; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2006, INFECT IMMUN, V74, P6075, DOI 10.1128/IAI.00721-06; Hummel S, 2012, APPL ENVIRON MICROB, V78, P1140, DOI 10.1128/AEM.06983-11; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Maldonado J, 2012, J PEDIATR GASTR NUTR, V54, P55, DOI 10.1097/MPG.0b013e3182333f18; Mane J, 2009, INFLAMM BOWEL DIS, V15, P1155, DOI 10.1002/ibd.20908; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; McCann MJ, 2013, MOL NUTR FOOD RES, V57, P212, DOI 10.1002/mnfr.201200362; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Miyauchi E, 2012, AM J PHYSIOL-GASTR L, V303, pG1029, DOI 10.1152/ajpgi.00003.2012; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Olivares M, 2007, NUTRITION, V23, P254, DOI 10.1016/j.nut.2007.01.004; Ormerod MG, 2000, A PRACTICAL APPROACH, P83; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sharma R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/305879; Smith CL, 2008, NUTR CANCER, V60, P757, DOI 10.1080/01635580802192841; Thirabunyanon M, 2009, BIOTECHNOL LETT, V31, P571, DOI 10.1007/s10529-008-9902-3; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; YAP AS, 1995, EXP CELL RES, V218, P540, DOI 10.1006/excr.1995.1189; Zoumpopoulou G., 2008, International Journal of Food Microbiology, V121, P18, DOI 10.1016/j.ijfoodmicro.2007.10.013	34	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78774	10.1371/journal.pone.0078774	http://dx.doi.org/10.1371/journal.pone.0078774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244356	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800015
J	Eder, AB; Rothermund, K; De Houwer, J				Eder, Andreas B.; Rothermund, Klaus; De Houwer, Jan			Affective Compatibility between Stimuli and Response Goals: A Primer for a New Implicit Measure of Attitudes	PLOS ONE			English	Article							METHOD-SPECIFIC VARIANCE; ASSOCIATION TEST; INTERGROUP BIAS; IAT; MODEL; CATEGORIZATION; ACTIVATION; COGNITION; DIRECTION; CATEGORY	We examined whether a voluntary response becomes associated with the (affective) meaning of intended response effects. Four experiments revealed that coupling a keypress with positive or negative consequences produces affective compatibility effects when the keypress has to be executed in response to positively or negatively evaluated stimulus categories. In Experiment 1, positive words were evaluated faster with a keypress that turned the words ON (versus OFF), whereas negative words were evaluated faster with a keypress that turned the words OFF (versus ON). Experiment 2 showed that this compatibility effect is reversed if an aversive tone is turned ON and OFF with keypresses. Experiment 3 revealed that keypresses acquire an affective meaning even when the association between the responses and their effects is variable and intentionally reconfigured before each trial. Experiment 4 used affective response effects to assess implicit in-group favoritism, showing that the measure is sensitive to the valence of categories and not to the valence of exemplars. Results support the hypothesis that behavioral reactions become associated with the affective meaning of the intended response goal, which has important implications for the understanding and construction of implicit attitude measures.	[Eder, Andreas B.] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany; [Rothermund, Klaus] Univ Jena, Dept Psychol, Jena, Germany; [De Houwer, Jan] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	University of Wurzburg; Friedrich Schiller University of Jena; Ghent University	Eder, AB (corresponding author), Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany.	andreas.eder@psychologie.uni-wuerzburg.de	De Houwer, Jan/ABF-6866-2021	De Houwer, Jan/0000-0003-0488-5224; Eder, Andreas/0000-0002-4722-5114	German Research Foundation [ED 201/2-1]; Ghent University [BOF09/01M00209]	German Research Foundation(German Research Foundation (DFG)); Ghent University(Ghent University)	This research was supported by German Research Foundation Grant (www.dgps.de/en) ED 201/2-1 to Andreas Eder. Jan De Houwer is supported by Methusalem Grant BOF09/01M00209 from Ghent University (www.ugent.be/en/research/research-ugent/topresearch/methusalem_laureates.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2004, J EXP PSYCHOL HUMAN, V30, P365, DOI 10.1037/0096-1523.30.2.365; Ashburn-Nardo L, 2001, J PERS SOC PSYCHOL, V81, P789, DOI 10.1037//0022-3514.81.5.789; Banse R, 2010, DEVELOPMENTAL SCI, V13, P298, DOI 10.1111/j.1467-7687.2009.00880.x; De Houwer J, 2002, COGNITION EMOTION, V16, P643, DOI 10.1080/02699930143000419; De Houwer J, 2003, PSYCHOLOGY OF EVALUATION, P219; De Houwer J, 2003, EXP PSYCHOL, V50, P77, DOI 10.1026//1618-3169.50.2.77; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; De Houwer J, 2001, COGNITION EMOTION, V15, P189, DOI 10.1080/0269993004200051; De Houwer J, 1998, COGNITION EMOTION, V12, P45, DOI 10.1080/026999398379772; De Houwer J., 2009, ATTITUDES INSIGHTS N, P361; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Eder AB, 2013, J EXP PSY B IN PRESS; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Eder AB, 2012, SOC COGN AFFECT NEUR, V7, P436, DOI 10.1093/scan/nsr033; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Gast A, 2010, Q J EXP PSYCHOL, V63, P479, DOI 10.1080/17470210903049963; Gawronski B., 2011, COGNITIVE METHODS SO, P78; Govan CL, 2004, J EXP SOC PSYCHOL, V40, P357, DOI 10.1016/j.jesp.2003.07.002; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hampe B, 2005, COGN LINGUIST, V16, P81, DOI 10.1515/cogl.2005.16.1.81; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Hommel B, 2010, EFFORTLESS ATTENTION, P121, DOI DOI 10.7551/MITPRESS/9780262013840.003.0006; Kelley K, 2007, J STAT SOFTW, V20, P1; Klauer KC, 2002, PERS SOC PSYCHOL B, V28, P802, DOI 10.1177/0146167202289009; Klinger MR, 2000, J EXP PSYCHOL LEARN, V26, P441, DOI 10.1037//0278-7393.26.2.441; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kramer UM, 2008, J COGNITIVE NEUROSCI, V20, P1464, DOI 10.1162/jocn.2008.20103; Lakoff George, 2003, METAPHOR WE LIVE BY; McFarland SG, 2002, SOC COGNITION, V20, P483, DOI 10.1521/soco.20.6.483.22977; Meissner F, 2013, J PERS SOC PSYCHOL, V104, P45, DOI 10.1037/a0030734; Memelink J, 2006, EUR J COGN PSYCHOL, V18, P579, DOI 10.1080/09541440500423228; Mierke J, 2003, J PERS SOC PSYCHOL, V85, P1180, DOI 10.1037/0022-3514.85.6.1180; Mierke J, 2001, Z EXP PSYCHOL, V48, P107, DOI 10.1026//0949-3946.48.2.107; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Proctor RW, 2004, PSYCHON B REV, V11, P841, DOI 10.3758/BF03196710; Rothermund K, 2005, J EXP PSYCHOL GEN, V134, P426, DOI 10.1037/0096-3445.134.3.426; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Rothermund K, 2009, Q J EXP PSYCHOL, V62, P84, DOI 10.1080/17470210701822975; SCHWIBBE M, 1981, Z EXP ANGEW PSYCHOL, V28, P486; Seibt B, 2008, J EXP SOC PSYCHOL, V44, P713, DOI 10.1016/j.jesp.2007.04.013; Smith ER, 1996, J PERS SOC PSYCHOL, V71, P888, DOI 10.1037/0022-3514.71.5.888; Steffens MC, 2008, BRIT J SOC PSYCHOL, V47, P217, DOI 10.1348/014466607X226998; Teige-Mocigemba S, 2008, EUR J PSYCHOL ASSESS, V24, P237, DOI 10.1027/1015-5759.24.4.237; Tukey JW, 1977, EXPLORATORY DATA ANA; Voss A, 2013, J EXP PSYCHOL GEN, V142, P536, DOI 10.1037/a0029459; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wenke D, 2005, J EXP PSYCHOL HUMAN, V31, P803, DOI 10.1037/0096-1523.31.4.803; ZANNA MP, 1970, J PERS SOC PSYCHOL, V14, P321, DOI 10.1037/h0028991	52	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79210	10.1371/journal.pone.0079210	http://dx.doi.org/10.1371/journal.pone.0079210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244450	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800042
J	Harvey, A; Yen, TY; Aizman, I; Tate, C; Case, C				Harvey, Adam; Yen, Ten-Yang; Aizman, Irina; Tate, Ciara; Case, Casey			Proteomic Analysis of the Extracellular Matrix Produced by Mesenchymal Stromal Cells: Implications for Cell Therapy Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LATENT TGF-BETA; TANDEM MASS-SPECTROMETRY; STEM-CELLS; PROTEIN IDENTIFICATION; PLASMA FIBRONECTIN; STATISTICAL-MODEL; BRAIN-INJURY; SB623 CELLS; IN-VITRO	Mesenchymal stromal cells (MSCs) transiently transfected with notch1 intracellular domain (NICD) are beneficial for neurological disorders as observed in several preclinical studies. Extracellular matrix (ECM) derived from NICD-transfected MSCs has been previously shown to support in vitro neural cell growth and survival better than that of un-transfected MSCs. To understand the underlying mechanism(s) by which NICD-transfected MSC-derived ECM supports neural cell growth and survival, we investigated the differences in NICD-transfected MSC-and MSC-derived ECM protein quantity and composition. To compare the ECM derived from MSCs and NICD-transfected MSCs, the proteins were sequentially solubilized using sodium dodecyl sulfate (SDS) and urea, quantified, and compared across four human donors. We then analyzed ECM proteins using either in-gel digests or in-solution surfactant-assisted trypsin digests (SAISD) coupled with reverse phase nano-liquid chromatography and tandem mass spectrometry (nLC-MS/MS). Analyses using nLC-MS/MS identified key components of ECM from NICD-transfected MSCs and un-transfected MSCs and revealed significant differences in their respective compositions. This work provides a reproducible method for identifying and comparing in vitro cell-derived ECM proteins, which is crucial for exploring the mechanisms underlying cellular therapy.	[Harvey, Adam; Aizman, Irina; Tate, Ciara; Case, Casey] SanBio Inc, Mountain View, CA USA; [Harvey, Adam] Univ Calif San Francisco, Dept Biol, San Francisco, CA 94143 USA; [Yen, Ten-Yang] Univ Calif San Francisco, Dept Chem & Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Case, C (corresponding author), SanBio Inc, Mountain View, CA USA.	Casey.Case@san-bio.com			SanBio Inc.; National Science Foundation Science Master's Program Award [DGE-1011717]; National Science Foundation grant [CHE-0619163]; Direct For Mathematical & Physical Scien [1228656] Funding Source: National Science Foundation; Division Of Graduate Education [1011717] Funding Source: National Science Foundation	SanBio Inc.; National Science Foundation Science Master's Program Award; National Science Foundation grant(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	Funding for this research project was provided by SanBio Inc. (AH, IA, CT, CC), the National Science Foundation Science Master's Program Award DGE-1011717 (AH) and the National Science Foundation grant CHE-0619163 (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Allen Matthew, 1994, Clinical Materials, V16, P189; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arcinas A, 2009, J PROTEOME RES, V8, P3958, DOI 10.1021/pr900278c; Bruno V, 1998, J NEUROSCI, V18, P9594; Byron A, 2013, INT J EXP PATHOL; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GIESE A, 1994, CANCER RES, V54, P3897; Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; Heng BC, 2009, BIOL PROCED ONLINE, V11, P161, DOI 10.1007/s12575-009-9001-4; Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kwon SH, 2013, TISSUE ENG PT A, V19, P49, DOI [10.1089/ten.tea.2012.0245, 10.1089/ten.TEA.2012.0245]; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; McDonald CA, 2009, MOL CELL PROTEOMICS, V8, P287, DOI 10.1074/mcp.M800272-MCP200; Mimura T, 2005, J NEUROPATH EXP NEUR, V64, P1108, DOI 10.1097/01.jnen.0000190068.03009.b5; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Newman AC, 2013, ARTERIOSCL THROM VAS, V33, P513, DOI 10.1161/ATVBAHA.112.300782; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OHNO M, 1979, J SUPRAMOL STR CELL, V12, P457, DOI 10.1002/jss.400120405; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Rigato F, 2002, J NEUROSCI, V22, P6596; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; Song HJ, 2012, MOL BIOL REP, V39, P4017, DOI 10.1007/s11033-011-1182-7; Spahr CS, 2001, PROTEOMICS, V1, P93, DOI 10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; Strelau J, 2000, J NEUROSCI, V20, P8597; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Tate CC, 2010, CELL TRANSPLANT, V19, P973, DOI 10.3727/096368910X494885; TRIPATHI BJ, 1991, INVEST OPHTH VIS SCI, V32, P181; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wong JWH, 2010, METHODS MOL BIOL, V604, P273, DOI 10.1007/978-1-60761-444-9_18; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	54	37	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79283	10.1371/journal.pone.0079283	http://dx.doi.org/10.1371/journal.pone.0079283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244468	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800054
J	Preussel, K; Hohle, M; Stark, K; Werber, D				Preussel, Karina; Hoehle, Michael; Stark, Klaus; Werber, Dirk			Shiga Toxin-Producing Escherichia coli O157 Is More Likely to Lead to Hospitalization and Death than Non-O157 Serogroups - Except O104	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; UNITED-STATES; RISK-FACTORS; BLOODY DIARRHEA; INFECTIONS; GERMANY; VIRULENCE; OUTBREAK; DETERMINANTS; SURVEILLANCE	The clinical spectrum following infection with Shiga toxin-producing Escherichia coli (STEC) is wide ranging and includes hemorrhagic colitis and life-threatening hemolytic uremic syndrome (HUS). Severity of STEC illness depends on patients' age and strongly on the infecting strains' virulence. Serogroup O157 is often assumed to be more virulent than others. Age-adjusted population-based data supporting this view are lacking thus far. We conducted a large retrospective cohort study among patients of community-acquired gastroenteritis or HUS diagnosed with STEC infection, reported in Germany January 2004 through December 2011. Age-adjusted risks for reported hospitalization and death, as proxies for disease severity, were estimated for STEC serogroups separately, and compared with STEC O157 (reference group) using Poisson regression models with robust error estimation. A total of 8,400 case-patients were included in the analysis; for 2,454 (29%) and 30 (0.4%) hospitalization and death was reported, respectively. Highest risks for hospitalization, adjusted for age and region of residence, were estimated for STEC O104 (68%; risk ratio [RR], 1.33; 95% confidence interval [CI], 1.19-1.45), followed by STEC O157 (46%). Hospitalization risks for the most prevalent non-O157 serogroups (O26, O103, O91, O145, O128, O111) were consistently and markedly lower than for O157, with the highest RR for O145 (0.54; 95% CI, 0.41-0.70) and the lowest for O103 (0.27; 95% CI, 0.20-0.35). Mortality risk of O104 was similar to O157 (1.2% each), but the group of all other non-O157 STEC had only 1/10 the risk (RR, 0.09; 95% CI, 0.02-0.32) compared to O157. The study provides population-based and age-adjusted evidence for the exceptional high virulence of STEC O157 in relation to non-O157 STEC other than O104. Timely diagnosis and surveillance of STEC infections should prioritize HUS-associated E. coli, of which STEC O157 is the most important serogroup.	[Preussel, Karina; Hoehle, Michael; Stark, Klaus; Werber, Dirk] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Preussel, Karina] Charite, Berlin Sch Publ Hlth, D-13353 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Preussel, K (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	PreusselK@rki.de	Höhle, Michael/AFM-0575-2022; Werber, Dirk/L-2264-2019	Höhle, Michael/0000-0002-0423-6702; Werber, Dirk/0000-0002-8076-788X				[Anonymous], 2022, ZULETZT GEANDERT DUR; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blanco JE, 2004, J CLIN MICROBIOL, V42, P311, DOI 10.1128/JCM.42.1.311-319.2004; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Buvens G, 2012, J CLIN MICROBIOL, V50, P1336, DOI 10.1128/JCM.05317-11; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Clogher P, 2012, CLIN INFECT DIS, V54, pS446, DOI 10.1093/cid/cis246; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Hadler JL, 2011, CLIN INFECT DIS, V53, P269, DOI 10.1093/cid/cir377; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; Hermos CR, 2011, J CLIN MICROBIOL, V49, P955, DOI 10.1128/JCM.02119-10; Hickey CA, 2011, ARCH PEDIAT ADOL MED, V165, P884, DOI 10.1001/archpediatrics.2011.152; Holtz LR, 2009, GASTROENTEROLOGY, V136, P1887, DOI 10.1053/j.gastro.2009.02.059; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Lathrop S, 2009, EMERG INFECT DIS, V15, P1289, DOI [10.3201/eid1508.081616, 10.3201/eid1508.08151515]; Lockary VM, 2007, EMERG INFECT DIS, V13, P1262; Loos S, 2012, CLIN INFECT DIS, V55, P753, DOI 10.1093/cid/cis531; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; McPherson M, 2009, CLIN INFECT DIS, V49, P249, DOI 10.1086/599370; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Nielsen S, 2011, ZOONOSES PUBLIC HLTH, V58, P567, DOI 10.1111/j.1863-2378.2011.01405.x; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Soborg B, 2013, EURO SURVEILL, V18; Souza MRSM, 2010, MEM I OSWALDO CRUZ, V105, P318, DOI 10.1590/S0074-02762010000300013; Stigi KA, 2012, EMERG INFECT DIS, V18, P477, DOI 10.3201/eid1803.111358; Verweyen HM, 1999, INFECTION, V27, P341, DOI 10.1007/s150100050040; Werber D, 2004, J INFECT DIS, V189, P1335, DOI 10.1086/382282; Werber D, 2013, AM J EPIDEMIOL; Werber D, 2008, EMERG INFECT DIS, V14, P1803, DOI 10.3201/eid1411.080361; Werber D, 2008, CLIN INFECT DIS, V46, P1189, DOI 10.1086/587670; Werber D, 2007, AM J EPIDEMIOL, V165, P425, DOI 10.1093/aje/kwk023; Wylie JL, 2013, J CLIN MICROBIOL, V51, P466, DOI 10.1128/JCM.02329-12; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78180	10.1371/journal.pone.0078180	http://dx.doi.org/10.1371/journal.pone.0078180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244292	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800006
J	Shaw, LM; Turner, AS; Herry, L; Griffiths, S; Laurie, DA				Shaw, Lindsay M.; Turner, Adrian S.; Herry, Laurence; Griffiths, Simon; Laurie, David A.			Mutant Alleles of Photoperiod-1 in Wheat (Triticum aestivum L.) That Confer a Late Flowering Phenotype in Long Days	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; EUROPEAN WINTER WHEATS; FLORAL INDUCTION; GENES; BARLEY; CONSTANS; TIME; FT; PPD-A1A; ADAPTABILITY	Flowering time in wheat and barley is known to be modified by mutations in the Photoperiod-1 (Ppd-1) gene. Semidominant Ppd-1a mutations conferring an early flowering phenotype are well documented in wheat but gene sequencing has also identified candidate loss of function mutations for Ppd-A1 and Ppd-D1. By analogy to the recessive ppd-H1 mutation in barley, loss of function mutations in wheat are predicted to delay flowering under long day conditions. To test this experimentally, introgression lines were developed in the spring wheat variety 'Paragon'. Plants lacking a Ppd-B1 gene were identified from a gamma irradiated 'Paragon' population. These were crossed with the other introgression lines to generate plants with candidate loss of function mutations on one, two or three genomes. Lines lacking Ppd-B1 flowered 10 to 15 days later than controls under long days. Candidate loss of function Ppd-A1 alleles delayed flowering by 1 to 5 days while candidate loss of function Ppd-D1 alleles did not affect flowering time. Loss of Ppd-A1 gave an enhanced effect, and loss of Ppd-D1 became detectable in lines where Ppd-B1 was absent, indicating effects may be buffered by functional Ppd-1 alleles on other genomes. Expression analysis revealed that delayed flowering was associated with reduced expression of the TaFT1 gene and increased expression of TaCO1. A survey of the GEDIFLUX wheat collection grown in the UK and North Western Europe between the 1940s and 1980s and the A. E. Watkins global collection of landraces from the 1920s and 1930s showed that the identified candidate loss of function mutations for Ppd-D1 were common and widespread, while the identified candidate Ppd-A1 loss of function mutation was rare in countries around the Mediterranean and in the Far East but was common in North Western Europe. This may reflect a possible benefit of the latter in northern locations.	[Shaw, Lindsay M.; Turner, Adrian S.; Herry, Laurence; Griffiths, Simon; Laurie, David A.] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Shaw, LM (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	lindsay.shaw@csiro.au	Shaw, Lindsay/I-3365-2012	Shaw, Lindsay/0000-0001-8078-2409	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E007295/1, BB/F014031/1]; BBSRC [BBS/E/J/000CA393, BB/F014031/1, BB/E007295/1, BBS/E/J/000CA471, BB/H012370/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012370/1, BB/F014031/1, BBS/E/J/000CA393, BB/E007295/1, BBS/E/J/000CA471] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financially supported by research grants BB/E007295/1 and BB/F014031/1 from the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk) and by grant-in-aid to the John Innes Centre from the same source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bentley AR, 2011, PLANT BREEDING, V130, P10, DOI 10.1111/j.1439-0523.2010.01802.x; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Iqbal M, 2007, GENOME, V50, P511, DOI 10.1139/G07-028; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kitagawa S, 2012, GENES GENET SYST, V87, P161, DOI 10.1266/ggs.87.161; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; MCINTOSH RA, 2003, CATALOGUE GENE SYMBO; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Thomas B., 1997, PHOTOPERIODISM PLANT; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Welsh J. R., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P879; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; WORLAND AJ, 1994, EUPHYTICA, V80, P219, DOI 10.1007/BF00039653; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Worland AJ, 1999, J GENETICS BREEDING, V53, P165173; Worland AJ, 2001, WORLD WHEAT BOOK HIS; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y	37	58	59	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79459	10.1371/journal.pone.0079459	http://dx.doi.org/10.1371/journal.pone.0079459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244507	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800078
J	Triana-Baltzer, G; Pavlicek, A; Goulart, A; Huang, H; Pirie-Shepherd, S; Levin, N				Triana-Baltzer, Gallen; Pavlicek, Adam; Goulart, Ariadne; Huang, Hanhua; Pirie-Shepherd, Steven; Levin, Nancy			Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; TIE2 RECEPTOR; CELL-CELL; ANGIOGENESIS; BEVACIZUMAB; EXPRESSION; PATHWAY; METASTASIS; BIOMARKERS	The clinical efficacy of anti-angiogenic therapies has been difficult to predict, and biomarkers that can predict responsiveness are sorely needed in this era of personalized medicine. CVX-060 is an angiopoietin-2 (Ang2) targeting therapeutic, consisting of two peptides that bind Ang2 with high affinity and specificity, covalently fused to a scaffold antibody. In order to optimize the use of this compound in the clinic the construction of a predictive model is described, based on the efficacy of CVX-060 in 13 cell line and 2 patient-derived xenograft models. Pretreatment size tumors from each of the models were profiled for the levels of 27 protein markers of angiogenesis, SNP haplotype in 5 angiogenesis genes, and somatic mutation status for 11 genes implicated in tumor growth and/or vascularization. CVX-060 efficacy was determined as tumor growth inhibition (TGI%) at termination of each study. A predictive statistical model was constructed based on the correlation of these efficacy data with the marker profiles, and the model was subsequently tested by prospective analysis in 11 additional models. The results reveal a range of CVX-060 efficacy in xenograft models of diverse tissue types (0-64% TGI, median = 27%) and define a subset of 3 proteins (Ang1, EGF, Emmprin), the levels of which may be predictive of TGI by Ang2 blockade. The direction of the associations is such that better efficacy correlates with high levels of target and low levels of compensatory/antagonizing molecules. This effort has revealed a set of candidate predictive markers for CVX-060 efficacy that will be further evaluated in ongoing clinical trials.	[Triana-Baltzer, Gallen; Goulart, Ariadne; Huang, Hanhua; Levin, Nancy] Pfizer Worldwide Res & Dev, CovX Res, San Diego, CA USA; [Pavlicek, Adam; Pirie-Shepherd, Steven] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Pirie-Shepherd, S (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA.	Steven.Pirie-Shepherd@pfizer.com			Pfizer, Inc.	Pfizer, Inc.(Pfizer)	This work was supported by Pfizer, Inc. All authors were employees of Pfizer at the time of this work and played roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Bozec A, 2006, CURR OPIN ONCOL, V18, P330, DOI 10.1097/01.cco.0000228737.78003.06; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerger A, 2011, CANCER J, V17, P134, DOI 10.1097/PPO.0b013e318212db3c; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Hanrahan EO, 2010, J CLIN ONCOL, V28, P193, DOI 10.1200/JCO.2009.22.4279; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Jahangiri A, 2012, BBA-REV CANCER, V1825, P86, DOI 10.1016/j.bbcan.2011.10.004; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marti HH, 2005, EXP SUPPL, V94, P163; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; Newbold RF, 2010, ANTICANCER RES, V30, P3309; Newman JR, 2009, CANCER LETT, V274, P313, DOI 10.1016/j.canlet.2008.09.033; Pusztai L, 2007, CLIN CANCER RES, V13, P6080, DOI 10.1158/1078-0432.CCR-07-0809; Rosen LS, 2012, J CLIN ONCOL S, V30, P2; Rosen LS, 2010, J CLIN ONCOL S15S, V28; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Simon R, 2007, CANCER INFORM, V3, P11; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Xu CF, 2011, J CLIN ONCOL, V29, P2557, DOI 10.1200/JCO.2010.32.9110; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	50	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80132	10.1371/journal.pone.0080132	http://dx.doi.org/10.1371/journal.pone.0080132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244628	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800126
J	Yang, J; Wilksch, JJ; Tan, JWH; Hocking, DM; Webb, CT; Lithgow, T; Robins-Browne, RM; Strugnell, RA				Yang, Ji; Wilksch, Jonathan J.; Tan, Jason W. H.; Hocking, Dianna M.; Webb, Chaille T.; Lithgow, Trevor; Robins-Browne, Roy M.; Strugnell, Richard A.			Transcriptional Activation of the mrkA Promoter of the Klebsiella pneumoniae Type 3 Fimbrial Operon by the c-di-GMP-Dependent MrkH Protein	PLOS ONE			English	Article							COLI RNA-POLYMERASE; SECONDARY STRUCTURE PREDICTION; INTENSIVE-CARE-UNIT; ESCHERICHIA-COLI; BIOFILM FORMATION; ALPHA-SUBUNIT; CELLULOSE SYNTHESIS; CONTACT SITE; PILZ DOMAIN; EXPRESSION	The Gram-negative bacterial pathogen Klebsiella pneumoniae forms biofilms to facilitate colonization of biotic and abiotic surfaces. The formation of biofilms by K. pneumoniae requires the expression of type 3 fimbriae: elongate proteinaceous filaments extruded by a chaperone-usher system in the bacterial outer membrane. The expression of the mrkABCDF cluster that encodes this fimbrial system is strongly positively regulated by MrkH, a transcriptional activator that responds to the second messenger, c-di-GMP. In this study, we analyzed the mechanism by which the MrkH protein activates transcriptional initiation from the mrkA promoter. A mutational analysis supported by electrophoretic mobility shift assays demonstrated that a 12-bp palindromic sequence (the MrkH box) centered at -78.5 is the binding site of MrkH. Deletion of half a turn, but not a full turn, of DNA located between the MrkH box and the mrkA promoter destroyed the ability of MrkH to activate mrkA transcription. In addition, a 10-bp AT-rich sequence (the UP element) centered at -63.5 contributed significantly to MrkH-dependent mrkA transcription. In vivo analysis of rpoA mutants showed that the R265 and E273 determinants in the C-terminal domain of RNA polymerase a subunit are needed for MrkH-mediated activation of mrkA transcription. Furthermore, results from mutagenesis of the mrkH gene suggest that the N-terminal region of the protein is involved in transcriptional activation. Taken together, our results suggest that MrkH activates mrkA expression by interacting directly with RNA polymerase, to overcome the inefficient transcriptional initiation caused by the presence of defective core promoter elements.	[Yang, Ji; Wilksch, Jonathan J.; Tan, Jason W. H.; Hocking, Dianna M.; Robins-Browne, Roy M.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Webb, Chaille T.; Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	University of Melbourne; Monash University	Wilksch, JJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	wilkschj@unimelb.edu.au	Lithgow, Trevor J/H-5925-2017; Robinsbrowne, Roy/ABF-8434-2020	Lithgow, Trevor J/0000-0002-0102-7884; Robinsbrowne, Roy/0000-0001-9179-7884; Webb, Chaille/0000-0003-0918-0282; Strugnell, Richard/0000-0003-0614-5641	Australian National Health and Medical Research Council [606788]; Australian Research Council [DP130100957]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Work in the authors' laboratories was supported by research grants from the Australian National Health and Medical Research Council (Program Grant 606788) and the Australian Research Council (Project Grant DP130100957). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carter HD, 2004, J BACTERIOL, V186, P2829, DOI 10.1128/JB.186.9.2829-2840.2004; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; KIMURA M, 1995, J MOL BIOL, V248, P756, DOI 10.1006/jmbi.1995.0258; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Langley JM, 2001, AM J INFECT CONTROL, V29, P94, DOI 10.1067/mic.2001.111537; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Marschall J, 2009, INFECT CONT HOSP EP, V30, P1050, DOI 10.1086/606165; Mathai D, 2001, DIAGN MICR INFEC DIS, V40, P129, DOI 10.1016/S0732-8893(01)00254-1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt JH, 2005, CURR PROTOC MICROBIO, V1; Miller JH., 1972, EXPT MOL GENETICS; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Sligl W, 2006, INT J INFECT DIS, V10, P320, DOI 10.1016/j.ijid.2005.07.003; Sohn AH, 2001, J PEDIATR-US, V139, P821, DOI 10.1067/mpd.2001.119442; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; TARKKANEN AM, 1990, MOL MICROBIOL, V4, P1353, DOI 10.1111/j.1365-2958.1990.tb00714.x; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Yang J, 2005, MICROBIOL-SGM, V151, P1199, DOI 10.1099/mic.0.27734-0; Yang J, 2009, J MOL BIOL, V394, P591, DOI 10.1016/j.jmb.2009.10.033; Yasuno K, 2001, J MOL BIOL, V306, P213, DOI 10.1006/jmbi.2000.4369; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	63	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79038	10.1371/journal.pone.0079038	http://dx.doi.org/10.1371/journal.pone.0079038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244411	Green Published, gold			2022-12-27	WOS:000327143800023
J	Zaleskiewicz, T; Gasiorowska, A; Kesebir, P				Zaleskiewicz, Tomasz; Gasiorowska, Agata; Kesebir, Pelin			Saving Can Save from Death Anxiety: Mortality Salience and Financial Decision-Making	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; SELF-ESTEEM; CONSPICUOUS CONSUMPTION; MATERIALISM; THOUGHTS; ACCESSIBILITY; VALIDATION; THREAT	Four studies tested the idea that saving money can buffer death anxiety and constitute a more effective buffer than spending money. Saving can relieve future-related anxiety and provide people with a sense of control over their fate, thereby rendering death thoughts less threatening. Study 1 found that participants primed with both saving and spending reported lower death fear than controls. Saving primes, however, were associated with significantly lower death fear than spending primes. Study 2 demonstrated that mortality primes increase the attractiveness of more frugal behaviors in save-or-spend dilemmas. Studies 3 and 4 found, in two different cultures (Polish and American), that the activation of death thoughts prompts people to allocate money to saving as opposed to spending. Overall, these studies provided evidence that saving protects from existential anxiety, and probably more so than spending.	[Zaleskiewicz, Tomasz; Gasiorowska, Agata] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland; [Kesebir, Pelin] Univ Colorado, Colorado Springs, CO 80907 USA	SWPS University of Social Sciences & Humanities; University of Colorado System; University of Colorado at Colorado Springs	Zaleskiewicz, T (corresponding author), Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland.	tzaleskiewicz@swps.edu.pl	Gasiorowska, Agata/AAM-1514-2020	Gasiorowska, Agata/0000-0002-3354-1095; Zaleskiewicz, Tomasz/0000-0002-4232-6151	Polish Ministry of Science and Higher Education [NN106 1332 37]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Tomasz Zaleskiewicz and Agata Gasiorowska involvement in the study was supported by the Polish Ministry of Science and Higher Education grant no. NN106 1332 37; http://www.nauka.gov.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt J, 2004, J CONSUM PSYCHOL, V14, P198, DOI 10.1207/s15327663jcp1403_2; Bakshi GS, 1996, AM ECON REV, V86, P133; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Dechesne M, 2000, EUR J SOC PSYCHOL, V30, P813, DOI 10.1002/1099-0992(200011/12)30:6<813::AID-EJSP17>3.0.CO;2-M; Diener E., 2008, HAPPINESS UNLOCKING; Dittmar H., 2011, PSYCHOL STUD, V56, P71, DOI [DOI 10.1007/S12646-011-0065-2, 10.1007/s12646-011-0065-2]; Dittmar H., 2010, CONSUMER CULTURE IDE; Dittmar H, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P745, DOI 10.1007/978-1-4419-7988-9_31; Dittmar H, 2010, BRIT J PSYCHOL, V101, P751, DOI 10.1348/000712609X484658; Fromm Erich, 1976, HAVE BE; FROST RO, 1993, BEHAV RES THER, V31, P367, DOI 10.1016/0005-7967(93)90094-B; Furnham Adrian., 1998, PSYCHOL MONEY; Gailliot MT, 2006, J PERS SOC PSYCHOL, V91, P49, DOI 10.1037/0022-3514.91.1.49; Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Griskevicius V, 2007, J PERS SOC PSYCHOL, V93, P85, DOI 10.1037/0022-3514.93.1.85; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524; Hirschberger G, 2002, EUR J SOC PSYCHOL, V32, P609, DOI 10.1002/ejsp.110; HIRSCHMAN EC, 1990, J CONSUM RES, V17, P31, DOI 10.1086/208534; Kasser M, 2013, METAANALYSIS M UNPUB; Kasser T, 2000, PSYCHOL SCI, V11, P348, DOI 10.1111/1467-9280.00269; Kasser T., 2004, PSYCHOL CONSUMER CUL, P11, DOI [10.1037/10658-002, DOI 10.1037/10658-002]; Kasser T, 2011, SOC PERSONAL PSYCHOL, V5, P865, DOI 10.1111/j.1751-9004.2011.00396.x; Kasser Tim., 2003, HIGH PRICE MAT; Kesebir P., 2012, OXFORD LIB PSYCHOL O, P43, DOI [10.1093/oxfordhb/9780195399820.013.0004, DOI 10.1093/OXFORDHB/9780195399820.013.0004]; Kivetz R, 2006, J CONSUM RES, V33, P273, DOI 10.1086/506308; Lea Stephen E. G., 1987, INDIVIDUAL EC SURVEY; Liu W, 2007, ORGAN BEHAV HUM DEC, V102, P212, DOI 10.1016/j.obhdp.2006.02.004; LUNT PK, 1991, J ECON PSYCHOL, V12, P621, DOI 10.1016/0167-4870(91)90003-C; Maheswaran D, 2004, J CONSUM PSYCHOL, V14, P213, DOI 10.1207/s15327663jcp1403_3; Mandel N, 1999, ADV CONSUM RES, V26, P527; Maslow A.H., 1954, MOTIVATION PERSONALI; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590; Pryor J.H., 2007, AM FRESHMAN 40 YEAR; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T., 2010, HDB SOCIAL PSYCHOL, P724, DOI DOI 10.1002/9780470561119.SOCPSY001020; Rindfleisch A, 2009, J CONSUM RES, V36, P1, DOI 10.1086/595718; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schimel J, 2007, J PERS SOC PSYCHOL, V92, P789, DOI 10.1037/0022-3514.92.5.789; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; SOLOMON S, 1991, ADV EXP SOC PSYCHOL, V24, P93; Solomon Sheldon, 2004, PSYCHOL CONSUMER CUL, P127, DOI [10.1037/10658-008, DOI 10.1037/10658-008]; Stillman TF, 2012, J ECON PSYCHOL, V33, P1, DOI 10.1016/j.joep.2011.08.012; Sundie JM, 2011, J PERS SOC PSYCHOL, V100, P664, DOI 10.1037/a0021669; TEMPLER DI, 1970, J GEN PSYCHOL, V82, P165, DOI 10.1080/00221309.1970.9920634; The Futures Company, 2009, UND CONS ATT SAV 200; TNS Poland, 2012, POST POL WOB OSZCZ K; WARNERYD KE, 1989, J ECON PSYCHOL, V10, P515, DOI 10.1016/0167-4870(89)90041-x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yalom ID., 1980, EXISTENTIAL PSYCHOTH; Zaleskiewicz T, 2013, J ECON PSYCHOL, V36, P55, DOI 10.1016/j.joep.2013.02.008	56	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79407	10.1371/journal.pone.0079407	http://dx.doi.org/10.1371/journal.pone.0079407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244497	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800073
J	Qin, HX; Bollag, WB				Qin, Haixia; Bollag, Wendy B.			The Caveolin-1 Scaffolding Domain Peptide Decreases Phosphatidylglycerol Levels and Inhibits Calcium-Induced Differentiation in Mouse Keratinocytes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHOLIPASE-D; EPIDERMAL DIFFERENTIATION; TERMINAL DIFFERENTIATION; FUNCTIONAL INTERACTION; EXTRACELLULAR CALCIUM; MEMBRANE ATTACHMENT; SENSING RECEPTOR; SKIN HYDRATION; HAIR FOLLICLE	Phospholipase D2 (PLD2) has been found localized in low-density caveolin-rich membrane microdomains. Our previous study suggested that PLD2 and aquaporin 3 (AQP3) interact in these domains to inhibit keratinocyte proliferation and promote differentiation by cooperating to produce phosphatidylglycerol. To examine the effect of membrane microdomain localization on the PLD2/AQP3 signaling module and keratinocyte proliferation and differentiation, we treated mouse keratinocytes with 3 mu M cell-permeable caveolin-1 scaffolding domain peptide or a negative control peptide and stimulated cell differentiation using a moderately elevated extracellular calcium concentration (125 uM) to maximally promote differentiation and phosphatidylglycerol production. Cell proliferation, differentiation, total PLD activity, phosphatidylglycerol levels, and AQP3 activity were monitored. The caveolin-1 scaffolding domain peptide itself had no effect on phosphatidylglycerol levels or keratinocyte proliferation or differentiation but prevented the changes induced by a moderately elevated calcium concentration, whereas a negative control did not. The caveolin-1 scaffolding domain peptide had little effect on total PLD activity or glycerol uptake (AQP3 activity). We conclude that the caveolin-1 scaffolding domain peptide disrupts the functional association between AQP3 and PLD2 and prevents both the inhibited proliferation and the stimulated differentiation in response to elevated extracellular calcium levels. The interaction of caveolin-1 and PLD2 is indirect (i.e., lipid mediated); together with the proliferation-promoting effects of caveolin-1 knockout on epidermal keratinocytes, we propose that the caveolin-1 scaffolding domain pepetide exerts a dominant-negative effect on caveolin-1 to alter lipid rafts in these cells.	[Bollag, Wendy B.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Qin, Haixia; Bollag, Wendy B.] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Med Coll Georgia, Dept Med Dermatol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Cell Biol & Anat, Augusta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollag, WB (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA USA.	WB@gru.edu		Bollag, Wendy/0000-0003-3146-162X	National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases) [AR45212]; Veterans Administration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045212, R29AR045212] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by award #AR45212 from the National Institutes of Health (National Institute of Arthritis and Musculo-skeletal and Skin Diseases). WBB is supported by a Research Career Scientist and a Merit Award from the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Banno Y, 2002, J BIOCHEM, V131, P301, DOI 10.1093/oxfordjournals.jbchem.a003103; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.20095; Bollag W B, 1998, Methods Mol Biol, V105, P151; Bollag WB, 2007, J INVEST DERMATOL, V127, P2823, DOI 10.1038/sj.jid.5700921; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Campbell L, 2002, BRIT J DERMATOL, V147, P701, DOI 10.1046/j.1365-2133.2002.05009.x; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Forslind B, 1987, Acta Derm Venereol Suppl (Stockh), V134, P1; Frohman MA, 1999, CHEM PHYS LIPIDS, V98, P127, DOI 10.1016/S0009-3084(99)00025-0; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Griner RD, 1999, J BIOL CHEM, V274, P4663, DOI 10.1074/jbc.274.8.4663; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hara M, 2003, P NATL ACAD SCI USA, V100, P7360, DOI 10.1073/pnas.1230416100; Hara M, 2002, J BIOL CHEM, V277, P46616, DOI 10.1074/jbc.M209003200; Hara-Chikuma M, 2005, BIOL CELL, V97, P479; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; HENNINGS H, 1983, J CELL PHYSIOL, V116, P265, DOI 10.1002/jcp.1041160303; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; LEE E, 1991, CARCINOGENESIS, V12, P1651, DOI 10.1093/carcin/12.9.1651; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; MENON GK, 1992, CELL TISSUE RES, V270, P503, DOI 10.1007/BF00645052; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MENON GK, 1994, J INVEST DERMATOL, V102, P789, DOI 10.1111/1523-1747.ep12377921; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; Nozawa Y, 2002, BBA-MOL CELL BIOL L, V1585, P77, DOI 10.1016/S1388-1981(02)00327-X; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V290, pH46, DOI 10.1152/ajpheart.00769.2005; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PILLAI S, 1991, J CELL PHYSIOL, V146, P94, DOI 10.1002/jcp.1041460113; PUNNONEN K, 1993, J INVEST DERMATOL, V101, P719, DOI 10.1111/1523-1747.ep12371682; Qin HX, 2011, ARCH BIOCHEM BIOPHYS, V508, P138, DOI 10.1016/j.abb.2011.01.014; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Roelandt T, 2009, J INVEST DERMATOL, V129, P927, DOI 10.1038/jid.2008.328; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; SEVERS NJ, 1988, J CELL SCI, V90, P341; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; SU MJ, 1994, J BIOL CHEM, V269, P14723; Trimmer C, 2013, AM J TRANSL RES, V5, P80; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2012, J INVEST DERMATOL, V132, P2350, DOI 10.1038/jid.2012.159; Tu CL, 1999, J INVEST DERMATOL, V113, P340, DOI 10.1046/j.1523-1747.1999.00698.x; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Voss KE, 2011, ARCH DERMATOL RES, V303, P591, DOI 10.1007/s00403-011-1136-x; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; YUSPA SH, 1974, EXP CELL RES, V86, P95, DOI 10.1016/0014-4827(74)90653-3; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zheng XJ, 2003, BBA-MOL CELL RES, V1643, P25, DOI 10.1016/j.bbamcr.2003.08.006; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	70	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80946	10.1371/journal.pone.0080946	http://dx.doi.org/10.1371/journal.pone.0080946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236206	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700209
J	Detert, JA; Adams, EL; Lescher, JD; Lyons, JA; Moyer, JR				Detert, Julia A.; Adams, Erin L.; Lescher, Jacob D.; Lyons, Jeri-Anne; Moyer, James R., Jr.			Pretreatment with Apoaequorin Protects Hippocampal CA1 Neurons from Oxygen-Glucose Deprivation	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; TUMOR-NECROSIS-FACTOR; AGING-RELATED CHANGES; AGE-RELATED-CHANGES; IN-VITRO ISCHEMIA; BRAIN-INJURY; INTRACELLULAR CALCIUM; CEREBRAL-ISCHEMIA; MESSENGER-RNA; CALBINDIN D-28K	Ischemic stroke affects,795,000 people each year in the U.S., which results in an estimated annual cost of $73.7 billion. Calcium is pivotal in a variety of neuronal signaling cascades, however, during ischemia, excess calcium influx can trigger excitotoxic cell death. Calcium binding proteins help neurons regulate/buffer intracellular calcium levels during ischemia. Aequorin is a calcium binding protein isolated from the jellyfish Aequorea victoria, and has been used for years as a calcium indicator, but little is known about its neuroprotective properties. The present study used an in vitro rat brain slice preparation to test the hypothesis that an intra-hippocampal infusion of apoaequorin (the calcium binding component of aequorin) protects neurons from ischemic cell death. Bilaterally cannulated rats received an apoaequorin infusion in one hemisphere and vehicle control in the other. Hippocampal slices were then prepared and subjected to 5 minutes of oxygen-glucose deprivation (OGD), and cell death was assayed by trypan blue exclusion. Apoaequorin dose-dependently protected neurons from OGD - doses of 1% and 4% (but not 0.4%) significantly decreased the number of trypan blue-labeled neurons. This effect was also time dependent, lasting up to 48 hours. This time dependent effect was paralleled by changes in cytokine and chemokine expression, indicating that apoaequorin may protect neurons via a neuroimmunomodulatory mechanism. These data support the hypothesis that pretreatment with apoaequorin protects neurons against ischemic cell death, and may be an effective neurotherapeutic.	[Detert, Julia A.; Adams, Erin L.; Lescher, Jacob D.; Moyer, James R., Jr.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Lescher, Jacob D.; Moyer, James R., Jr.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Lyons, Jeri-Anne] Univ Wisconsin, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Adams, Erin L.] Quincy Biosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Moyer, JR (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	jrmoyer@uwm.edu			Quincy Bioscience	Quincy Bioscience	Quincy Bioscience funded this work (http://quincybioscience.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelHamid KM, 1997, NEUROSCIENCE, V81, P673, DOI 10.1016/S0306-4522(97)00162-0; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; Celio MR, 1996, GUIDEBOOK CALCIUM BI, P15; CHARD PS, 1995, P NATL ACAD SCI USA, V92, P5144, DOI 10.1073/pnas.92.11.5144; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi JH, 2010, CELL MOL NEUROBIOL, V30, P1, DOI 10.1007/s10571-009-9425-z; Cobbold PH, 1991, CELLULAR CALCIUM PRA, P55; Cronberg T, 2005, BRAIN RES, V1049, P120, DOI 10.1016/j.brainres.2005.05.003; deJong GI, 1996, NEUROBIOL AGING, V17, P459, DOI 10.1016/0197-4580(96)00030-9; DERENZIS FA, 1973, STAIN TECHNOL, V48, P135, DOI 10.3109/10520297309116602; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; DUBINSKY JM, 1993, NEUROSCI LETT, V150, P129, DOI 10.1016/0304-3940(93)90518-P; Fan YF, 2007, J CEREBR BLOOD F MET, V27, P719, DOI 10.1038/sj.jcbfm.9600373; FREUND TF, 1990, EXP BRAIN RES, V83, P55; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Gary DS, 2000, MOL BRAIN RES, V75, P89, DOI 10.1016/S0169-328X(99)00299-5; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HADLEY MN, 1989, NEUROSURGERY, V25, P63, DOI 10.1227/00006123-198907000-00011; Hasko G, 1998, BRIT J PHARMACOL, V124, P1099, DOI 10.1038/sj.bjp.0701934; HOF PR, 1991, EXP NEUROL, V111, P293, DOI 10.1016/0014-4886(91)90096-U; Hwang IK, 2003, BRAIN RES, V971, P250, DOI 10.1016/S0006-8993(03)02480-6; Hwang IK, 2006, BRAIN RES, V1106, P197, DOI 10.1016/j.brainres.2006.05.098; IACOPINO A, 1992, MOL BRAIN RES, V13, P251, DOI 10.1016/0169-328X(92)90033-8; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Khachaturian Z.S., 1984, HDB STUDIES PSYCHIAT, P7; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Klapstein GJ, 1998, NEUROSCIENCE, V85, P361, DOI 10.1016/S0306-4522(97)00632-5; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krzywkowski P, 1996, LIFE SCI, V59, P421, DOI 10.1016/0024-3205(96)00321-9; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Levin SG, 2011, EXP NEUROL, V232, P329, DOI 10.1016/j.expneurol.2011.09.004; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; LLEDO PM, 1992, NEURON, V9, P943, DOI 10.1016/0896-6273(92)90246-A; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; LYSKO PG, 1989, BRAIN RES, V499, P258, DOI 10.1016/0006-8993(89)90773-7; Mahesh VB, 2006, MOL CELL ENDOCRINOL, V246, P1, DOI 10.1016/j.mce.2005.11.017; Mallard C, 2007, SEMIN FETAL NEONAT M, V12, P280, DOI 10.1016/j.siny.2007.01.014; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; Mikkonen M, 1999, NEUROSCIENCE, V92, P515, DOI 10.1016/S0306-4522(99)00047-0; Moran DL, 2013, FOOD CHEM TOXICOL, V57, P1, DOI 10.1016/j.fct.2013.02.047; Moyer JR, 2011, NEUROBIOL AGING, V32, P1693, DOI 10.1016/j.neurobiolaging.2009.10.001; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; MOYER JR, 2007, ADV TECHNIQUES PATCH, V38, P169; NEWMAN GC, 1989, J NEUROSCI METH, V28, P23, DOI 10.1016/0165-0270(89)90006-X; Nikonenko I, 2005, MOL PHARMACOL, V68, P84, DOI 10.1124/mol.104.010066; Oh MM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.002.2010; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Pera J, 2004, J NEUROSCI RES, V78, P132, DOI 10.1002/jnr.20232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POHORECKI R, 1990, BRAIN RES, V528, P133, DOI 10.1016/0006-8993(90)90205-P; RALEYSUSMAN KM, 1990, BRAIN RES, V515, P27, DOI 10.1016/0006-8993(90)90572-S; RAMI A, 1992, J NEUROSCI RES, V31, P89, DOI 10.1002/jnr.490310113; Sama Diana M, 2013, Ageing Res Rev, V12, P982, DOI 10.1016/j.arr.2013.05.008; Shimomura O, 1996, BIOCHEM BIOPH RES CO, V221, P77, DOI 10.1006/bbrc.1996.0548; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMON RP, 1993, NEUROSCI LETT, V163, P135, DOI 10.1016/0304-3940(93)90364-Q; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; SUTHERLAND MK, 1993, MOL BRAIN RES, V18, P32, DOI 10.1016/0169-328X(93)90171-K; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; TAYLOR CP, 1995, J NEUROSCI METH, V59, P121, DOI 10.1016/0165-0270(94)00202-R; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toma S, 2005, PROTEIN SCI, V14, P409, DOI 10.1110/ps.041067805; TYMIANSKI M, 1993, NEURON, V11, P221, DOI 10.1016/0896-6273(93)90180-Y; TYMIANSKI M, 1994, J CEREBR BLOOD F MET, V14, P911, DOI 10.1038/jcbfm.1994.122; UEMATSU D, 1991, NEUROLOGY, V41, P88, DOI 10.1212/WNL.41.1.88; Urra X, 2013, J NEUROL, V260, P1687, DOI 10.1007/s00415-013-6919-x; VILLA A, 1994, EUR J NEUROSCI, V6, P1491, DOI 10.1111/j.1460-9568.1994.tb01010.x; Wang XK, 2000, J CEREBR BLOOD F MET, V20, P15, DOI 10.1097/00004647-200001000-00004; Wang XK, 2000, J NEUROSCI RES, V59, P238, DOI 10.1002/(SICI)1097-4547(20000115)59:2<238::AID-JNR10>3.0.CO;2-G; WHITTINGHAM TS, 1984, J NEUROSCI, V4, P793; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5; Xu GP, 2002, BRAIN RES, V952, P153, DOI 10.1016/S0006-8993(02)02988-8; Yang J, 2013, J NEUROCHEM, V124, P523, DOI 10.1111/jnc.12111; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028	93	3	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79002	10.1371/journal.pone.0079002	http://dx.doi.org/10.1371/journal.pone.0079002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244400	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600092
J	Du, CYQ; Choi, RCY; Zheng, KYZ; Dong, TTX; Lau, DTW; Tsim, KWK				Du, Crystal Y. Q.; Choi, Roy C. Y.; Zheng, Ken Y. Z.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.			Yu Ping Feng San, an Ancient Chinese Herbal Decoction Containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, Regulates the Release of Cytokines in Murine Macrophages	PLOS ONE			English	Article							DANGGUI-BUXUE-TANG; NF-KAPPA-B; ANGELICAE-SINENSIS; NO PRODUCTION; CELLS; ERYTHROPOIETIN; EXPRESSION; COMPONENTS; MEDICINE; ALPHA	Yu Ping Feng San (YPFS), a Chinese herbal decoction, is composed of Astragali Radix (AR; Huangqi), Atractylodis Macrocephalae Rhizoma (AMR; Baizhu) and Saposhnikoviae Radix (SR; Fangfeng) in a weight ratio of 1:2:1. Clinically, YPFS has been widely used to regulate immune functions; however, the action mechanism of it is not known. Here, we addressed this issue by providing detail analyses of chemical and biological properties of YPFS. By using rapid resolution liquid chromatography coupled with mass spectrometry, fifteen chemicals deriving from different herbs of YPFS were determined, and which served as a control for the standardization of the herbal extract of YPFS. In general, the amounts of chosen chemical markers were higher in a preparation of YPFS as compared to that of single herb or two-herb compositions. In order to reveal the immune functions of YPFS, the standardized extract was applied onto cultured murine macrophages. The treatment of YPFS stimulated the mRNA and protein expressions of pro-inflammatory cytokines via activation of NF-kappa B by enhancing I kappa B alpha degradation. In contrast, the application of YPFS suppressed the expressions of pro-inflammatory cytokines significantly in the lipopolysaccharide (LPS)-induced chronic inflammation model. In addition, YPFS could up regulate the phagocytic activity in cultured macrophages. These results therefore supported the bi-directional immunemodulatory roles of YPFS in regulating the releases of cytokines from macrophages.	[Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Du, Crystal Y. Q.; Zheng, Ken Y. Z.] Hanshan Normal Univ, Dept Biol, Chaozhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hanshan Normal University	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Du, Crystal Yingqing/AAH-5824-2020	Du, Crystal Yingqing/0000-0003-1353-4477; Lau, Tai Wai David/0000-0002-3443-1808; Zheng, Yuzhong/0000-0001-7208-0642; Tsim, Karl/0000-0003-4808-1674	 [661110];  [662911];  [663012];  [UIM/208];  [UIM/214];  [GHP/030/09SZ];  [Z0315];  [TUYF12SC03];  [GHP/032/09SZ]	; ; ; ; ; ; ; ; 	This research was supported by Research Grants (661110, 662911, 663012, UIM/208, UIM/214, GHP/030/09SZ, Z0315 and TUYF12SC03 to KWKT and GHP/032/09SZ to RCYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ashley JW, 2011, ASSAY DRUG DEV TECHN, V9, P40, DOI 10.1089/adt.2010.0307; Chen X, 2000, J Tradit Chin Med, V20, P302; Chiu SC, 2009, PHYTOTHER RES, V23, P363, DOI 10.1002/ptr.2633; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Dong HY, 2008, NAT PROD RES, V22, P1418, DOI 10.1080/14786410801931629; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Gao QT, 2008, PLANTA MED, V74, P392, DOI 10.1055/s-2008-1034322; Gao QT, 2007, FEBS LETT, V581, P233, DOI 10.1016/j.febslet.2006.12.018; Gao QT, 2006, PLANTA MED, V72, P1227, DOI 10.1055/s-2006-947186; Gao Qiutao, 2007, Chin Med, V2, P12, DOI 10.1186/1749-8546-2-12; Guo WX, 2012, INFLAMMATION, V35, P1764, DOI 10.1007/s10753-012-9495-9; Hong M, 2011, J PHARMACEUT BIOMED, V54, P87, DOI 10.1016/j.jpba.2010.08.016; Hoo RLC, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-67; Huang HL, 2005, J ETHNOPHARMACOL, V97, P21, DOI 10.1016/j.jep.2004.09.058; Kang SR, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/248592; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KISO Y, 1985, PLANTA MED, V51, P97, DOI 10.1055/s-2007-969416; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lee JC, 2007, PHYTOMEDICINE, V14, P390, DOI 10.1016/j.phymed.2006.09.012; Li CQ, 2007, PHYTOTHER RES, V21, P347, DOI 10.1002/ptr.2040; Lv T, 2006, WORLD J GASTROENTERO, V12, P2195, DOI 10.3748/wjg.v12.i14.2195; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Ning Lian, 2002, Zhongguo Zhongyao Zazhi, V27, P50; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; SAKURAI T, 1994, BIOL PHARM BULL, V17, P1364, DOI 10.1248/bpb.17.1364; STRUGALA GJ, 1985, DIGESTION, V32, P255, DOI 10.1159/000199246; Tai J, 2007, ONCOL REP, V18, P227; Tanton DW, 2007, DRUG FREE APPROACH H; Toda S, 1998, PHYTOTHER RES, V12, P59, DOI 10.1002/(SICI)1099-1573(19980201)12:1&lt;59::AID-PTR182&gt;3.0.CO;2-R; WU DZ, 1999, PHARM CLIN CHIN MAT, V15, P3; Wu JH, 2010, J NUTR BIOCHEM, V21, P613, DOI 10.1016/j.jnutbio.2009.03.010; Xue Bao-yun, 2000, Zhongguo Zhongyao Zazhi, V25, P297; You Y, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-54; Yu L, 2000, CHINESE J NEPHROLOGY, V16, P282; Yu S, 2012, EVID-BASED COMPL ALT, V2012; Zhang XP, 2007, J PANCREAS, V8, P704; Zhao B, 2012, J ASIAN NAT PROD RES, V14, P886, DOI 10.1080/10286020.2012.702756; Zheng KYZ, 2011, J AGR FOOD CHEM, V59, P1697, DOI 10.1021/jf104018u; Zheng KYZ, 2010, J ETHNOPHARMACOL, V132, P259, DOI 10.1016/j.jep.2010.08.029	41	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78622	10.1371/journal.pone.0078622	http://dx.doi.org/10.1371/journal.pone.0078622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244327	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600037
J	Kashimura, A; Okawa, K; Ishikawa, K; Kida, Y; Iwabuchi, K; Matsushima, Y; Sakaguchi, M; Sugahara, Y; Oyama, F				Kashimura, Akinori; Okawa, Kazuaki; Ishikawa, Kotarou; Kida, Yuta; Iwabuchi, Kokoro; Matsushima, Yudai; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka			Protein A-Mouse Acidic Mammalian Chitinase-V5-His Expressed in Periplasmic Space of Escherichia coli Possesses Chitinase Functions Comparable to CHO-Expressed Protein	PLOS ONE			English	Article							HUMAN CHITOTRIOSIDASE; GLYCOSYL HYDROLASES; ENZYMATIC-ACTIVITY; INFLAMMATION; TISSUE; PURIFICATION; QUANTITIES; ACTIVATION; INHIBITOR; EVOLUTION	Acidic mammalian chitinase (AMCase) has been shown to be associated with asthma in mouse models, allergic inflammation and food processing. Here, we describe an E. coli-expression system that allows for the periplasmic production of active AMCase fused to Protein A at the N-terminus and V5 epitope and (His)(6) tag (V5-His) at the C-terminus (Protein A-AMCase-V5-His) in E. coli. The mouse AMCase cDNA was cloned into the vector pEZZ18, which is an expression vector containing the Staphylococcus Protein A promoter, with the signal sequence and truncated form of Protein A for extracellular expression in E. coli. Most of the Protein A-AMCase-V5-His was present in the periplasmic space with chitinolytic activity, which was measured using a chromogenic substrate, 4-nitrophenyl N, N9-diacetyl-b-D-chitobioside. The Protein A-AMCase-V5-His was purified from periplasmic fractions using an IgG Sepharose column followed by a Ni Sepharose chromatography. The recombinant protein showed a robust peak of activity with a maximum observed activity at pH 2.0, where an optimal temperature was 54 degrees C. When this protein was preincubated between pH 1.0 and pH 11.0 on ice for 1 h, full chitinolytic activity was retained. This protein was also heat-stable till 54uC, both at pH 2.0 and 7.0. The chitinolytic activity of the recombinant AMCase against 4-nitrophenyl N, N9-diacetyl-b-D-chitobioside was comparable to the CHO-expressed AMCase. Furthermore, the recombinant AMCase bound to chitin beads, cleaved colloidal chitin and released mainly N, N9-diacetylchitobiose fragments. Thus, the E. coli-expressed Protein A-mouse AMCase-V5-His fusion protein possesses chitinase functions comparable to the CHO-expressed AMCase. This recombinant protein can be used to elucidate detailed biomedical functions of the mouse AMCase.	[Kashimura, Akinori; Okawa, Kazuaki; Ishikawa, Kotarou; Kida, Yuta; Iwabuchi, Kokoro; Matsushima, Yudai; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan	Kogakuin University	Oyama, F (corresponding author), Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan.	f-oyama@cc.kogakuin.ac.jp	Oyama, Fumitaka/Q-4268-2019	Oyama, Fumitaka/0000-0002-1095-8306	Research Institute of Science and Technology, Kogakuin University	Research Institute of Science and Technology, Kogakuin University	This work was supported by the Project Research Grant from the Research Institute of Science and Technology, Kogakuin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueter CL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003080; Bussink AP, 2008, FEBS LETT, V582, P931, DOI 10.1016/j.febslet.2008.02.032; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Bussink AP, 2006, INT REV CYTOL, V252, P71, DOI 10.1016/S0074-7696(06)52001-7; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen L, 2009, CLIN EXP DERMATOL, V34, P55, DOI 10.1111/j.1365-2230.2008.03092.x; Chou YT, 2006, BIOCHEMISTRY-US, V45, P4444, DOI 10.1021/bi0525977; Eide KB, 2012, BIOCHEMISTRY-US, V51, P487, DOI 10.1021/bi2015585; Goedken ER, 2011, PROTEIN EXPRES PURIF, V75, P55, DOI 10.1016/j.pep.2010.08.013; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hussain M, 2013, J MOL EVOL, V76, P240, DOI 10.1007/s00239-013-9553-4; JACKSON P, 1990, BIOCHEM J, V270, P705, DOI 10.1042/bj2700705; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kanneganti Manasa, 2012, J Epithel Biol Pharmacol, V5, P1; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; Kumari A, 2012, BIOTECHNOL LETT; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Ober C, 2009, CURR OPIN ALLERGY CL, V9, P401, DOI 10.1097/ACI.0b013e3283306533; Ohno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067399; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; OYAMA F, 1993, J BIOCHEM, V114, P813, DOI 10.1093/oxfordjournals.jbchem.a124261; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Seibold MA, 2009, J BIOL CHEM, V284, P19650, DOI 10.1074/jbc.M109.012443; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Tiwary E, 2010, J AGR FOOD CHEM, V58, P8380, DOI 10.1021/jf100803g; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	41	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78669	10.1371/journal.pone.0078669	http://dx.doi.org/10.1371/journal.pone.0078669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244337	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600046
J	Lee, WY; Tolar, P				Lee, Wing-Yiu; Tolar, Pavel			Activation of the B Cell Receptor Leads to Increased Membrane Proximity of the Ig alpha Cytoplasmic Domain	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NON-ITAM TYROSINE; ANTIGEN RECEPTOR; LIVING CELLS; BETA; COMPLEX; BINDING; MICROCLUSTERS; ASSOCIATION; INITIATION	Binding of antigen to the B cell receptor (BCR) induces conformational changes in BCR's cytoplasmic domains that are concomitant with phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs). Recently, reversible folding of the CD3 epsilon and xi chain ITAMs into the plasma membrane has been suggested to regulate T cell receptor signaling. Here we show that the Ig alpha and Ig beta cytoplasmic domains of the BCR do not associate with plasma membrane in resting B cells. However, antigen binding and ITAM phosphorylation specifically increased membrane proximity of Ig alpha, but not Ig beta. Thus, BCR activation is accompanied by asymmetric conformational changes, possibly promoting the binding of Ig alpha and Ig beta to differently localized signaling complexes.	[Lee, Wing-Yiu; Tolar, Pavel] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Tolar, P (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	ptolar@nimr.mrc.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Tolar, Pavel/0000-0003-4693-7299	Medical Research Council UK [U117597138]; MRC [MC_U117597138] Funding Source: UKRI; Medical Research Council [MC_U117597138] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by Medical Research Council UK, Unit Programme number U117597138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kraus M, 1999, IMMUNITY, V11, P537, DOI 10.1016/S1074-7613(00)80129-6; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; Reichlin A, 2004, J EXP MED, V199, P855, DOI 10.1084/jem.20031140; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Schamel WWA, 2000, MOL IMMUNOL, V37, P253, DOI 10.1016/S0161-5890(00)00025-0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Siegers GM, 2006, INT IMMUNOL, V18, P1385, DOI 10.1093/intimm/dxl072; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Torres RM, 1999, IMMUNITY, V11, P527, DOI 10.1016/S1074-7613(00)80128-4; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WIENANDS J, 1995, INT IMMUNOL, V7, P1701, DOI 10.1093/intimm/7.11.1701; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79148	10.1371/journal.pone.0079148	http://dx.doi.org/10.1371/journal.pone.0079148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244439	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600114
J	Poczobutt, JM; Gijon, M; Amin, J; Hanson, D; Li, H; Walker, D; Weiser-Evans, M; Lu, X; Murphy, RC; Nemenoff, RA				Poczobutt, Joanna M.; Gijon, Miguel; Amin, Jay; Hanson, Dwight; Li, Howard; Walker, Deandra; Weiser-Evans, Mary; Lu, Xian; Murphy, Robert C.; Nemenoff, Raphael A.			Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; EXPRESSION; PHOSPHORYLATION; MACROPHAGES; METABOLISM; ACTIVATION; DEFICIENT; RECEPTORS; ROLES	Eicosanoids are bioactive lipid mediators derived from arachidonic acid(1) (AA), which is released by cytosolic phospholipase A(2) (cPLA(2)). AA is metabolized through three major pathways, cyclooxygenase (COX), lipoxygenase (LO) and cytochrome P450, to produce a family of eicosanoids, which individually have been shown to have pro-or anti-tumorigenic activities in cancer. However, cancer progression likely depends on complex changes in multiple eicosanoids produced by cancer cells and by tumor microenvironment and a systematic examination of the spectrum of eicosanoids in cancer has not been performed. We used liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) to quantitate eicosanoids produced during lung tumor progression in an orthotopic immunocompetent mouse model of lung cancer, in which Lewis lung carcinoma (LLC) cells are injected into lungs of syngeneic mice. The presence of tumor increased products of both the cyclooxygenase and the lipoxygenase pathways in a time-dependent fashion. Comparing tumors grown in cPLA(2) knockout vs wild-type mice, we demonstrated that prostaglandins (PGE(2), PGD(2) and PGF(2a)) were produced by both cancer cells and the tumor microenvironment (TME), but leukotriene (LTB4, LTC4, LTD4, LTE4) production required cPLA(2) expression in the TME. Using flow cytometry, we recovered tumor-associated neutrophils and 2 types of tumor-associated macrophages from tumor-bearing lungs and we defined their distinct eicosanoid profiles by LC/MS/MS. The combination of flow cytometry and LC/MS/MS unravels the complexity of eicosanoid production in lung cancer and provides a rationale to develop therapeutic strategies that target select cell populations to inhibit specific classes of eicosanoids.	[Poczobutt, Joanna M.; Amin, Jay; Hanson, Dwight; Li, Howard; Walker, Deandra; Weiser-Evans, Mary; Nemenoff, Raphael A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Gijon, Miguel; Murphy, Robert C.; Nemenoff, Raphael A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Lu, Xian] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Li, Howard] Vet Affairs Med Ctr, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nemenoff, RA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	Raphael.Nemenoff@ucdenver.edu	Li, Howard/AAM-3544-2021	Li, Howard/0000-0002-1230-2941	NIH [R01 CA162226 R01 CA108610 P50 CA058187]; NATIONAL CANCER INSTITUTE [R01CA108610, P50CA058187, R01CA162226, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH R01 CA162226 R01 CA108610 P50 CA058187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; GRONICH J, 1994, J CLIN INVEST, V93, P1224, DOI 10.1172/JCI117076; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Hida T, 1998, CANCER RES, V58, P3761; Horn L, 2009, EXPERT OPIN THER TAR, V13, P675, DOI 10.1517/14728220902915567; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Keith RL, 2002, CANCER RES, V62, P734; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028133; Meyer AM, 2004, CARCINOGENESIS, V25, P1517, DOI 10.1093/carcin/bgh150; Moody TW, 2001, ANTICANCER RES, V21, P1749; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Soriano AF, 1999, CANCER RES, V59, P6178; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wolff H, 1998, CANCER RES, V58, P4997	37	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79633	10.1371/journal.pone.0079633	http://dx.doi.org/10.1371/journal.pone.0079633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244531	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600139
J	Wang, F; Xu, J; Zhu, Q; Qin, XJ; Cao, Y; Lou, JF; Xu, YQ; Ke, X; Li, Q; Xie, EF; Zhang, LX; Sun, RH; Chen, L; Fang, BL; Pan, SY				Wang, Fang; Xu, Jian; Zhu, Quan; Qin, Xuejun; Cao, Yan; Lou, Jiangfang; Xu, Yuqiao; Ke, Xing; Li, Qing; Xie, Erfu; Zhang, Lixia; Sun, Ruihong; Chen, Liang; Fang, Bingliang; Pan, Shiyang			Downregulation of IFNG in CD4(+) T Cells in Lung Cancer through Hypermethylation: A Possible Mechanism of Tumor-Induced Immunosuppression	PLOS ONE			English	Article							DNA METHYLATION; GAMMA PROMOTER; MONONUCLEAR-CELLS; INTERFERON-GAMMA; CPG METHYLATION; IN-VITRO; GENE; CYTOKINE; EXPRESSION; DEMETHYLATION	Tumor survival is significantly correlated with the immune response of patients. IFNG plays an important role in the tumor host response and decreased IFNG expression is often observed in lung cancer. Studies have shown that CpG island hypermethylation plays a critical role in transcriptional silencing of IFNG gene expression. However, there is limited understanding regarding the molecular mechanisms of altered methylation, and whether the tumor microenvironment has any effect on DNA methylation and IFNG production. In the current study, we demonstrate that plasma and intra-cellular IFNG levels are significantly lower in lung cancer patients. Hypermethylation of the IFNG promoter in CD4(+) T cells and plasma IFNG was negatively correlated. CD4(+) T cells from healthy individuals co-cultured with SPC-A1 cells generated lower levels of IFNG after activation, elevated expression of DNA methyltransferases (DNMTs), and exhibited hypermethylation of the IFNG promoter. In conclusion, decreased IFNG expression of CD4(+) T cells co-cultured with lung cancer cell is associated with IFNG promoter hypermethylation. Our study suggests that interaction between lung cancer cells and CD4(+) T cells induces DNMT expression and IFNG promoter hypermethylation in CD4(+) T cell, which may serve as an important mechanism of tumor-induced immunosuppression.	[Wang, Fang; Xu, Jian; Qin, Xuejun; Cao, Yan; Lou, Jiangfang; Xu, Yuqiao; Ke, Xing; Li, Qing; Xie, Erfu; Zhang, Lixia; Sun, Ruihong; Pan, Shiyang] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Wang, Fang; Xu, Jian; Qin, Xuejun; Cao, Yan; Lou, Jiangfang; Xu, Yuqiao; Ke, Xing; Li, Qing; Xie, Erfu; Zhang, Lixia; Sun, Ruihong; Pan, Shiyang] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Quan; Chen, Liang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	Nanjing Medical University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Pan, SY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	sypan@njmu.edu.cn			National Natural Science Foundation of China [81371894, 81272324, 81201359, 81101322]; Key Laboratory for Laboratory Medicine of Jiangsu Province of China [XK201114]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Laboratory Medicine of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by National Natural Science Foundation of China (No. 81371894, 81272324, 81201359, 81101322), Key Laboratory for Laboratory Medicine of Jiangsu Province of China (No. XK201114), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaker HA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-33; Bhutia SK, 2010, CELL BIOL INT, V34, P553, DOI 10.1042/CBI20090206; Brand S, 2012, J ALLERGY CLIN IMMUN, V129, P1602, DOI 10.1016/j.jaci.2011.12.963; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Fan XP, 2011, TOHOKU J EXP MED, V224, P13, DOI 10.1620/tjem.224.13; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Franci G, 2010, EPIGENOMICS-UK, V2, P731, DOI 10.2217/EPI.10.62; Gamper CJ, 2009, J IMMUNOL, V183, P2267, DOI 10.4049/jimmunol.0802960; Gonsky R, 2009, J INTERF CYTOK RES, V29, P407, DOI 10.1089/jir.2008.0109; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Hashimoto S, 2013, J IMMUNOL, V190, P4076, DOI 10.4049/jimmunol.1202267; Huang YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038890; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Janson PCJ, 2008, J IMMUNOL, V181, P2878, DOI 10.4049/jimmunol.181.4.2878; Jeltsch A, 2006, CURR TOP MICROBIOL, V301, P203; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Mehta NT, 2011, EPIGENETICS-US, V6, P517, DOI 10.4161/epi.6.4.14516; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Mishra A, 2012, CANCER CELL, V22, P645, DOI 10.1016/j.ccr.2012.09.009; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Pan SY, 2009, BIOMED PHARMACOTHER, V63, P463, DOI 10.1016/j.biopha.2008.09.006; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; Sengupta N, 2010, PATHOL RES PRACT, V206, P1, DOI 10.1016/j.prp.2009.10.001; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Singh KP, 2012, CANCER LETT, V316, P62, DOI 10.1016/j.canlet.2011.10.022; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tang XM, 2004, MOL CANCER RES, V2, P685; Tommasi S, 2013, NUCLEIC ACIDS RES, V41, P182, DOI 10.1093/nar/gks1051; Walton EL, 2011, EPIGENETICS-US, V6, P1373, DOI 10.4161/epi.6.11.17978; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; White GP, 2006, PEDIAT ALLERG IMM-UK, V17, P557, DOI 10.1111/j.1399-3038.2006.00465.x; Wilop S, 2011, EPIGENETICS-US, V6, P1047, DOI 10.4161/epi.6.8.16167; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Yano S, 2003, J IMMUNOL, V171, P2510, DOI 10.4049/jimmunol.171.5.2510; Yen CH, 2013, TOXICOL APPL PHARM, V266, P67, DOI 10.1016/j.taap.2012.11.003; Yi TZ, 2012, CHEMOTHERAPY, V58, P19, DOI 10.1159/000333077; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	50	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79064	10.1371/journal.pone.0079064	http://dx.doi.org/10.1371/journal.pone.0079064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244422	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600107
J	Yang, Y; Wei, FX; Zhuo, R; Fan, FF; Liu, HH; Zhang, C; Ma, L; Jiang, ML; Zhang, XY				Yang, Yang; Wei, Fuxiang; Zhuo, Rui; Fan, Fangfang; Liu, Huahua; Zhang, Chen; Ma, Li; Jiang, Mulan; Zhang, Xiaoyu			Enhancing the Laccase Production and Laccase Gene Expression in the White-Rot Fungus Trametes velutina 5930 with Great Potential for Biotechnological Applications by Different Metal Ions and Aromatic Compounds	PLOS ONE			English	Article							CERIPORIOPSIS-SUBVERMISPORA; TRANSCRIPTION; PUBESCENS; BIOREMEDIATION; INDUSTRIAL; ACE1; PCR	Laccase is useful for various biotechnological and industrial applications. The white-rot fungus Trametes velutina 5930 and its laccase, isolated from the Shennongjia Nature Reserve in China by our laboratory, has great potential for practical application in environmental biotechnology. However, the original level of laccase produced by Trametes velutina 5930 was relatively low in the absence of any inducer. Therefore, in order to enhance the laccase production by Trametes velutina 5930 and make better use of this fungus in the field of environmental biotechnology, the regulation of laccase production and laccase gene expression in Trametes velutina 5930 were investigated in this study. Different metal ions such as Cu2+ and Fe2+ could stimulate the laccase synthesis and laccase gene transcription in Trametes velutina 5930. Some aromatic compounds structurally related to lignin, such as tannic acid, syringic acid, cinnamic acid, gallic acid and guaiacol, could also enhance the level of laccase activity and laccase gene transcription. We also found that there existed a positive synergistic effect of aromatic compound and metal ion on the laccase production and laccase gene transcription in Trametes velutina 5930. Taken together, our study may contribute to the improvement of laccase productivity by Trametes velutina 5930.	[Yang, Yang; Wei, Fuxiang; Zhuo, Rui; Fan, Fangfang; Liu, Huahua; Zhang, Chen; Ma, Li; Zhang, Xiaoyu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Yang; Zhuo, Rui; Fan, Fangfang; Jiang, Mulan] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Oil Crops Biol, Minist Agr China, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yang, Y (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	yangyang@mail.hust.edu.cn; zhangxiaoyu@mail.hust.edu.cn	Zhang, xiaoyu/A-6515-2015; fan, fang/GQY-9173-2022; Zhang, xiaoyu/GXA-3206-2022; Fan, Fang/GRO-2696-2022; Zhuo, Rui/AFS-3081-2022	Zhuo, Rui/0000-0002-7119-2850; Wei, Fuxiang/0000-0002-6200-6219	National Natural Sciences Foundation of China [31070069, 31370122, 31170104]; National High Technology Research and Development Program of China [2012AA022301D]; Fundamental Research Funds for the Central Universities [HUST 2013TS082]; Major State Basic Research Development Program of China [2014CB138301]; Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program of China(National Basic Research Program of China); Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China	This work was supported by the National Natural Sciences Foundation of China (numbers 31070069, 31370122 and 31170104), National High Technology Research and Development Program of China (number 2012AA022301D), The Fundamental Research Funds for the Central Universities (HUST 2013TS082), Major State Basic Research Development Program of China (2014CB138301), Open Fund of Key Laboratory of Oil Crops Biology of Ministry of Agriculture in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Cambria MT, 2011, APPL BIOCHEM BIOTECH, V163, P415, DOI 10.1007/s12010-010-9049-2; Carbajo JM, 2002, CAN J MICROBIOL, V48, P1041, DOI 10.1139/W02-107; Colao MC, 2003, APPL MICROBIOL BIOT, V63, P153, DOI 10.1007/s00253-003-1429-x; Collins PJ, 1997, APPL ENVIRON MICROB, V63, P3444, DOI 10.1128/AEM.63.9.3444-3450.1997; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Cullen D, 2004, MYCOTA, V3, P249; De Souza CGM, 2004, J BASIC MICROB, V44, P129; Elisashvili V, 2009, J BIOTECHNOL, V144, P37, DOI 10.1016/j.jbiotec.2009.06.020; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Galhaup C, 2001, APPL MICROBIOL BIOT, V56, P225, DOI 10.1007/s002530100636; Gonzalez T, 2003, APPL ENVIRON MICROB, V69, P7083, DOI 10.1128/AEM.69.12.7083-7090.2003; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Manubens A, 2007, FEMS MICROBIOL LETT, V275, P139, DOI 10.1111/j.1574-6968.2007.00874.x; Alvarez JM, 2009, FUNGAL GENET BIOL, V46, P104, DOI 10.1016/j.fgb.2008.10.002; Osma JF, 2007, CHEMOSPHERE, V67, P1677, DOI 10.1016/j.chemosphere.2006.11.051; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Saparrat M, 2010, FUNGAL BIOL-UK, V114, P999, DOI 10.1016/j.funbio.2010.09.010; Sethuraman A, 1998, CAN J MICROBIOL, V44, P872, DOI 10.1139/cjm-44-9-872; Soden DM, 2001, MICROBIOL-SGM, V147, P1755, DOI 10.1099/00221287-147-7-1755; Strong PJ, 2011, CRIT REV ENV SCI TEC, V41, P373, DOI 10.1080/10643380902945706; Terron MC, 2004, FUNGAL GENET BIOL, V41, P954, DOI 10.1016/j.fgb.2004.07.002; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; THORVALDSEN JL, 1993, J BIOL CHEM, V268, P12512; Wang SM, 2007, APPL ENVIRON MICROB, V73, P5048, DOI 10.1128/AEM.02973-06; Xiao YZ, 2006, APPL MICROBIOL BIOT, V71, P493, DOI 10.1007/s00253-005-0188-2; Yang Y, 2011, BIOCHEM ENG J, V57, P13, DOI 10.1016/j.bej.2011.07.006	32	42	52	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79307	10.1371/journal.pone.0079307	http://dx.doi.org/10.1371/journal.pone.0079307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244475	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600123
J	Jernberg, E; Thysell, E; Ylitalo, EB; Rudolfsson, S; Crnalic, S; Widmark, A; Bergh, A; Wikstrom, P				Jernberg, Emma; Thysell, Elin; Ylitalo, Erik Bovinder; Rudolfsson, Stina; Crnalic, Sead; Widmark, Anders; Bergh, Anders; Wikstrom, Pernilla			Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants	PLOS ONE			English	Article							SPINAL-CORD COMPRESSION; ADRENAL ANDROGENS; TESTOSTERONE; GROWTH; GENES; DIHYDROTESTOSTERONE; IDENTIFICATION; LOCALIZATION; PROGRESSION; CARCINOMA	Background: Intra-tumoral steroidogenesis and constitutive androgen receptor (AR) activity have been associated with castration-resistant prostate cancer (CRPC). This study aimed to examine if CRPC bone metastases expressed higher levels of steroid-converting enzymes than untreated bone metastases. Steroidogenic enzyme levels were also analyzed in relation to expression of constitutively active AR variants (AR-Vs) and to clinical and pathological variables. Methodology/Principal Findings: Untreated, hormone-naive (HN, n = 9) and CRPC bone metastases samples (n = 45) were obtained from 54 patients at metastasis surgery. Non-malignant and malignant prostate samples were acquired from 13 prostatectomy specimens. Transcript and protein levels were analyzed by real-time RT-PCR, immunohistochemistry and immunoblotting. No differences in steroidogenic enzyme levels were detected between CRPC and HN bone metastases. Significantly higher levels of SRD5A1, AKR1C2, AKR1C3, and HSD17B10 mRNA were however found in bone metastases than in non-malignant and/or malignant prostate tissue, while the CYP11A1, CYP17A1, HSD3B2, SRD5A2, and HSD17B6 mRNA levels in metastases were significantly lower. A sub-group of metastases expressed very high levels of AKR1C3, which was not due to gene amplification as examined by copy number variation assay. No association was found between AKR1C3 expression and nuclear AR staining, tumor cell proliferation or patient outcome after metastases surgery. With only one exception, high AR-V protein levels were found in bone metastases with low AKR1C3 levels, while metastases with high AKR1C3 levels primarily contained low AR-V levels, indicating distinct mechanisms behind castration-resistance in individual bone metastases. Conclusions/Significance: Induced capacity of converting adrenal-gland derived steroids into more potent androgens was indicated in a sub-group of PC bone metastases. This was not associated with CRPC but merely with the advanced stage of metastasis. Sub-groups of bone metastases could be identified according to their expression levels of AKR1C3 and AR-Vs, which might be of relevance for patient response to 2nd line androgen-deprivation therapy.	[Jernberg, Emma; Thysell, Elin; Ylitalo, Erik Bovinder; Bergh, Anders; Wikstrom, Pernilla] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden; [Rudolfsson, Stina; Crnalic, Sead] Umea Univ, Dept Surg & Perioperat Sci Orthoped & Urol & Andr, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden	Umea University; Umea University; Umea University	Wikstrom, P (corresponding author), Umea Univ, Dept Med Biosci Pathol, Umea, Sweden.	pernilla.wikstrom@medbio.umu.se	Crnalic, Sead/AAF-3475-2021	Rudolfsson, Stina/0000-0001-8241-1089	Swedish Research Council; Swedish Cancer Society; Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Cancer Research Foundation in Northern Sweden, Lion's Cancer Research Foundation, and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Crnalic S, 2010, ENDOCR-RELAT CANCER, V17, P885, DOI 10.1677/ERC-10-0059; Crnalic S, 2012, SPINE, V37, P2168, DOI 10.1097/BRS.0b013e31826011bc; Crnalic S, 2012, ACTA ORTHOP, V83, P80, DOI 10.3109/17453674.2011.590761; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hamid ARAH, 2012, MOL MED, V18, P1449, DOI 10.2119/molmed.2012.00296; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hornberg E, 2011, PLOS ONE, V6; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Labrie F, 2011, NAT REV UROL, V8, P73, DOI 10.1038/nrurol.2010.231; Levine AC, 1996, J CLIN ENDOCR METAB, V81, P384, DOI 10.1210/jc.81.1.384; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Mitsiades N, 2012, CANCER RES, V72, P6142, DOI 10.1158/0008-5472.CAN-12-1335; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mizokami A, 2004, CANCER RES, V64, P765, DOI 10.1158/0008-5472.CAN-03-0130; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel E, 2010, CANCER RES, V70, P8247, DOI 10.1158/0008-5472.CAN-10-1458; Penning TM, 2007, MOL CELL ENDOCRINOL, V265, P77, DOI 10.1016/j.mce.2006.12.007; Penning TM, 2009, ANN NY ACAD SCI, V1155, P33, DOI 10.1111/j.1749-6632.2009.03700.x; PETERZIEL H, 1995, INT J CANCER, V63, P544, DOI 10.1002/ijc.2910630415; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b	36	65	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e77407	10.1371/journal.pone.0077407	http://dx.doi.org/10.1371/journal.pone.0077407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244276	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900006
J	Sjoestroem, C; Khosravi, S; Zhang, GH; Martinka, M; Li, G				Sjoestroem, Cecilia; Khosravi, Shahram; Zhang, Guohong; Martinka, Magdalena; Li, Gang			C-Terminal Tensin-Like Protein Is a Novel Prognostic Marker for Primary Melanoma Patients	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; K-RAS MUTATIONS; TUMOR PROGRESSION; COLORECTAL-CANCER; CELL MOTILITY; CTEN; BRAF; ONCOGENE; PROMOTES; GENE	Background: C-terminal tensin-like protein (Cten) is a focal adhesion protein originally identified as a tumor suppressor in prostate cancer. It has since been found to be overexpressed and function as an oncogene in numerous other cancers, but the expression status of Cten in melanoma is still unknown. Methods: Using tissue microarrays containing 562 melanocytic lesions, we evaluated Cten protein expression by immunohistochemistry. The association between Cten expression and patient survival was examined using Kaplan-Meier survival analysis, and univariate and multivariate Cox regression analyses were used to estimate the crude and adjusted hazard ratios. Results: Strong Cten expression was detected in 7%, 24%, 41%, and 46% of normal nevi, dysplastic nevi, primary melanoma, and metastatic melanoma samples, respectively, and Cten expression was found to be significantly higher in dysplastic nevi compared to normal nevi (P = 0.046), and in primary melanoma compared to dysplastic nevi (P = 0.003), but no difference was observed between metastatic and primary melanoma. Cten staining also correlated with AJCC stages (P = 0.015) and primary tumor thickness (P = 0.002), with Cten expression being induced in the transition from thin (<1mm) to thick (>= 1mm) melanomas. Strong Cten expression was significantly associated with a worse 5-year overall (P = 0.008) and disease-specific survival (P = 0.004) for primary melanoma patients, and multivariate Cox regression analysis revealed that Cten expression was an independent prognostic marker for these patients (P = 0.038 for overall survival; P = 0.021 for disease-specific survival). Conclusion: Our findings indicate that induction of Cten protein expression is a relatively early event in melanoma progression, and that Cten has the potential to serve as a prognostic marker for primary melanoma patients.	[Sjoestroem, Cecilia; Khosravi, Shahram; Zhang, Guohong; Li, Gang] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Sjoestroem, C (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada.	cecilia.sjoestroem@alumni.ubc.ca			Canadian Institutes of Health Research [MOP-93810, MOP-110974]; Canadian Dermatology Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation	This project is funded by grants from the Canadian Institutes of Health Research (MOP-93810 and MOP-110974) and Canadian Dermatology Foundation to G. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi S, 2013, PANCREAS, V42, P135, DOI 10.1097/MPA.0b013e3182557ceb; Al-Ghamdi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020919; Albasri A, 2011, ONCOGENE, V30, P2997, DOI 10.1038/onc.2011.26; Albasri A, 2011, BREAST CANCER RES TR, V126, P47, DOI 10.1007/s10549-010-0890-3; Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; American Cancer Society Inc, 2011, CANC FACTS FIG 2011, P20; BALCH CM, 1978, ANN SURG, V188, P732, DOI 10.1097/00000658-197812000-00004; Berwick M, 2011, MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION, P35, DOI 10.1007/978-3-7091-0371-5_3; Brose MS, 2002, CANCER RES, V62, P6997; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Hung SY, 2013, MOL CARCINOGEN, DOI [10.1002/mc.22034, DOI 10.1002/MC.22034.PUBMED:23625726]; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI [10.1016/S1357-2725(03)00171-7, DOI 10.1016/S1357-2725(03)00171-7.PUBMED:14592531]; Martuszewska D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004350; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sakashita K, 2008, ANN SURG ONCOL, V15, P2606, DOI 10.1245/s10434-008-9989-8; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Wasif N, 2011, J SURG ONCOL, V104, P111, DOI 10.1002/jso.21903; Yuen ST, 2002, CANCER RES, V62, P6451	26	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80492	10.1371/journal.pone.0080492	http://dx.doi.org/10.1371/journal.pone.0080492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244691	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900081
J	Tang, WM; Yang, HM; Mahapatra, T; Huan, XP; Yan, HJ; Li, JJ; Fu, GF; Zhao, JK; Detels, R				Tang, Weiming; Yang, Haitao; Mahapatra, Tanmay; Huan, Xiping; Yan, Hongjing; Li, Jianjun; Fu, Gengfeng; Zhao, Jinkou; Detels, Roger			Feasibility of Recruiting a Diverse Sample of Men Who Have Sex with Men: Observation from Nanjing, China	PLOS ONE			English	Article							HARD-TO-REACH; HIDDEN POPULATIONS; HIV-INFECTION; RESPONDENT; PREVALENCE; BEHAVIOR	Background: Respondent-driven-sampling (RDS) has well been recognized as a method for sampling from most hard-to-reach populations like commercial sex workers, drug users and men who have sex with men. However the feasibility of this sampling strategy in terms of recruiting a diverse spectrum of these hidden populations has not been understood well yet in developing countries. Methods: In a cross sectional study in Nanjing city of Jiangsu province of China, 430 MSM were recruited including 9 seeds in 14 weeks of study period using RDS. Information regarding socio-demographic characteristics and sexual risk behavior were collected and testing was done for HIV and syphilis. Duration, completion, participant characteristics and the equilibrium of key factors were used for assessing feasibility of RDS. Homophily of key variables, socio-demographic distribution and social network size were used as the indicators of diversity. Results: In the study sample, adjusted HIV and syphilis prevalence were 6.6% and 14.6% respectively. Majority (96.3%) of the participants were recruited by members of their own social network. Although there was a tendency for recruitment within the same self-identified group (homosexuals recruited 60.0% homosexuals), considerable cross-group recruitment (bisexuals recruited 52.3% homosexuals) was also seen. Homophily of the self-identified sexual orientations was 0.111 for homosexuals. Upon completion of the recruitment process, participant characteristics and the equilibrium of key factors indicated that RDS was feasible for sampling MSM in Nanjing. Participants recruited by RDS were found to be diverse after assessing the homophily of key variables in successive waves of recruitment, the proportion of characteristics after reaching equilibrium and the social network size. The observed design effects were nearly the same or even better than the theoretical design effect of 2. Conclusion: RDS was found to be an efficient and feasible sampling method for recruiting a diverse sample of MSM in a reasonable time.	[Tang, Weiming; Mahapatra, Tanmay; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Yang, Haitao; Huan, Xiping; Yan, Hongjing; Li, Jianjun; Fu, Gengfeng] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Impact Results & Evaluat Dept, Geneva, Switzerland	University of California System; University of California Los Angeles; Jiangsu Provincial Center for Disease Control & Prevention	Zhao, JK (corresponding author), Global Fund Fight AIDS TB & Malaria, Impact Results & Evaluat Dept, Geneva, Switzerland.	button.zhao@gmail.com		Zhao, Jinkou/0000-0001-9184-3385; Tang, Weiming/0000-0002-9026-707X	Jiangsu Science & Technology Department (Jiangsu Provincial Technologies Research Program) [BE2009685]; Jiangsu Health Department (Jiangsu Province's Outstanding Medical Academic Leader Program) [RC2011087, RC 2011086];  [RC2011086]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	Jiangsu Science & Technology Department (Jiangsu Provincial Technologies Research Program); Jiangsu Health Department (Jiangsu Province's Outstanding Medical Academic Leader Program); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by Jiangsu Science & Technology Department (Jiangsu Provincial Technologies Research Program http://www.jstd.gov.cn/, grant number is BE2009685), this program provided the funding for the study recruitment, behavioral measures, intervention and study follow up. The study was also funded by Jiangsu Health Department (Jiangsu Province's Outstanding Medical Academic Leader Program, grant numbers: RC2011087, RC 2011086), with the website http://www.jswst.gov.cn/gb/jsswst/index.html. These two programs provided the funding for STD treatment (RC2011087), serologic measures(RC2011086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; [曹淦 CAO Gan], 2007, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V27, P637; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Henry G. T, 1990, APPL SOCIAL RES METH; Johnston LG, 2007, CONDUCTING RESPONDEN; Kogan SM, 2011, J ADOLESCENT RES, V26, P30, DOI 10.1177/0743558410384734; Li A, 2009, AIDS BEHAV, V13, P318, DOI 10.1007/s10461-008-9448-3; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Meng X, 2010, SHORT REPORT EXPLORA; Montano D.M., 2008, HLTH BEHAV HLTH ED T, P67; Montealegre JR, 2013, AIDS BEHAV, V17, P719, DOI 10.1007/s10461-012-0306-y; Paquette DM, 2011, INT J DRUG POLICY, V22, P267, DOI 10.1016/j.drugpo.2011.03.007; Platt L, 2006, J URBAN HEALTH, V83, pI39, DOI 10.1007/s11524-006-9101-2; Poon AFY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006777; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Shen P, 2010, CHONGQING MED, V8; Szwarcwald CL, 2011, JAIDS-J ACQ IMM DEF, V57, pS129, DOI 10.1097/QAI.0b013e31821e9a36; Tang W, 2013, AIDS BEHAV, P1; US Census Bureau, 2002, 63RV US CENS BUR; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Wang JC, 2005, DRUG ALCOHOL DEPEN, V78, P147, DOI 10.1016/j.drugalcdep.2004.10.011; Yeka W, 2006, J URBAN HEALTH, V83, pI60, DOI 10.1007/s11524-006-9103-0; Zhao JK, 2007, ACAD MED S, V83, P39	30	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e77645	10.1371/journal.pone.0077645	http://dx.doi.org/10.1371/journal.pone.0077645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244280	gold, Green Published			2022-12-27	WOS:000327143800004
J	Araneda, L; Sim, SC; Bae, JJ; Chakraborty, N; Curley, J; Chang, T; Inoue, M; Warnke, S; Jung, G				Araneda, Loreto; Sim, Sung-Chur; Bae, Jin-Joo; Chakraborty, Nanda; Curley, Joe; Chang, Taehyun; Inoue, Maiko; Warnke, Scott; Jung, Geunhwa			Comparative Genome Analysis between Agrostis stolonifera and Members of the Pooideae Subfamily, including Brachypodium distachyon	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; CHROMOSOMAL REARRANGEMENTS; SSR MARKERS; RICE; RESISTANCE; MODEL; WHEAT; QTL; CONSTRUCTION; SEQUENCES	Creeping bentgrass (Agrostis stolonifera, allotetraploid 2n = 4x = 28) is one of the major cool-season turfgrasses. It is widely used on golf courses due to its tolerance to low mowing and aggressive growth habit. In this study, we investigated genome relationships of creeping bentgrass relative to the Triticeae (a consensus map of Triticum aestivum, T. tauschii, Hordeum vulgare, and H. spontaneum), oat, rice, and ryegrass maps using a common set of 229 EST-RFLP markers. The genome comparisons based on the RFLP markers revealed large-scale chromosomal rearrangements on different numbers of linkage groups (LGs) of creeping bentgrass relative to the Triticeae (3 LGs), oat (4 LGs), and rice (8 LGs). However, we detected no chromosomal rearrangement between creeping bentgrass and ryegrass, suggesting that these recently domesticated species might be closely related, despite their memberships to different Pooideae tribes. In addition, the genome of creeping bentgrass was compared with the complete genome sequence of Brachypodium distachyon in Pooideae subfamily using both sequences of the above-mentioned mapped EST-RFLP markers and sequences of 8,470 publicly available A. stolonifera ESTs (AgEST). We discovered large-scale chromosomal rearrangements on six LGs of creeping bentgrass relative to B. distachyon. Also, a total of 24 syntenic blocks based on 678 orthologus loci were identified between these two grass species. The EST orthologs can be utilized in further comparative mapping of Pooideae species. These results will be useful for genetic improvement of Agrostis species and will provide a better understanding of evolution within Pooideae species.	[Araneda, Loreto; Inoue, Maiko; Jung, Geunhwa] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Sim, Sung-Chur] Sejong Univ, Dept Bioresources Engn, Seoul, South Korea; [Bae, Jin-Joo] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Chakraborty, Nanda; Curley, Joe] Syngenta Seeds Inc, Stanton, MN USA; [Chang, Taehyun] Kyungpook Natl Univ, Sch Ecol & Environm Syst, Sangju, South Korea; [Warnke, Scott] USDA ARS, Floral & Nursery Plants Res Unit, Beltsville, MD USA	University of Massachusetts System; University of Massachusetts Amherst; Sejong University; University of Wisconsin System; University of Wisconsin Madison; Syngenta; Kyungpook National University; United States Department of Agriculture (USDA)	Jung, G (corresponding author), Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.	jung@umass.edu	Chang, Taehyun/S-1364-2019	Sim, Sung-Chur/0000-0001-7672-6260	United States Golf Association; National Institute of Food and Agriculture; United States Department of Agriculture; Massachusetts Agricultural Experiment Station; Stockbridge School of Agriculture [MAS00925]	United States Golf Association; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture(United States Department of Agriculture (USDA)); Massachusetts Agricultural Experiment Station; Stockbridge School of Agriculture	This work was supported by the United States Golf Association, National Institute of Food and Agriculture, United States Department of Agriculture, the Massachusetts Agricultural Experiment Station and the Stockbridge School of Agriculture under Project Number MAS00925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bonos SA, 2002, CROP SCI, V42, P192, DOI 10.2135/cropsci2002.0192; Chakraborty N, 2006, THEOR APPL GENET, V113, P1421, DOI 10.1007/s00122-006-0387-y; Chakraborty N, 2005, THEOR APPL GENET, V111, P795, DOI 10.1007/s00122-005-2065-x; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Drader T, 2010, GENOME, V53, P406, DOI [10.1139/G10-014, 10.1139/g10-014]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Feltus FA, 2006, PLANT PHYSIOL, V140, P1183, DOI 10.1104/pp.105.074203; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gaut BS, 2002, NEW PHYTOL, P154; He SB, 2009, CROP SCI, V49, P2285, DOI 10.2135/cropsci2009.01.0034; Jones ES, 2002, GENOME, V45, P282, DOI 10.1139/G01-144; JONES K., 1956, Journal of Genetics, V54, P394, DOI 10.1007/BF02982955; JONES K., 1956, Journal of Genetics, V54, P377, DOI 10.1007/BF02982954; JONES K., 1956, Journal of Genetics, V54, P370, DOI 10.1007/BF02982953; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Pacurar DI, 2009, NOT BOT HORTI AGROBO, V37, P17; Pfeifer M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/pp.112.207282; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Renvoize S. A., 1992, Grass evolution and domestication., P3; Rotter D, 2007, MOL GENET GENOMICS, V278, P197, DOI 10.1007/s00438-007-0240-2; Rotter D, 2010, GENET RESOUR CROP EV, V57, P1065, DOI 10.1007/s10722-010-9548-6; Rotter D, 2009, CROP SCI, V49, P1609, DOI 10.2135/cropsci2008.12.0714; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schejbel B, 2008, PLANT BREEDING, V127, P368, DOI 10.1111/j.1439-0523.2007.01477.x; Sim S, 2007, PHYTOPATHOLOGY, V97, P767, DOI 10.1094/PHYTO-97-6-0767; Sim S, 2005, THEOR APPL GENET, V110, P1011, DOI 10.1007/s00122-004-1916-1; Sim SC, 2009, GENOME, V52, P431, DOI [10.1139/G09-019, 10.1139/g09-019]; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Studer B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-177; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; VANDEYNZE AE, 1995, MOL GEN GENET, V248, P744, DOI 10.1007/BF02191715; VANDEYNZE AE, 1995, GENOME, V38, P45, DOI 10.1139/g95-006; VANDEYNZE AE, 1995, MOL GEN GENET, V249, P349, DOI 10.1007/BF00290536; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang Z, 2005, CROP SCI, V45, P399, DOI 10.2135/cropsci2005.0399; Warnke SE, 1998, CROP SCI, V38, P801, DOI 10.2135/cropsci1998.0011183X003800030030x; Watson L., 1992, The grass genera of the world.; Watson L., 1990, REPROD VERSATILITY G, P1	48	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79425	10.1371/journal.pone.0079425	http://dx.doi.org/10.1371/journal.pone.0079425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244501	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600130
J	Ye, YC; Xie, HZ; Zeng, Y; Zhao, XL; Tian, Z; Zhang, SY				Ye, Yicong; Xie, Hongzhi; Zeng, Yong; Zhao, Xiliang; Tian, Zhuang; Zhang, Shuyang			Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; CLINICAL-OUTCOMES; NOBORI STENT; PACLITAXEL; THROMBOSIS; LEADERS; TRIAL; PHARMACOKINETICS; INTERVENTION	Backgrounds: Drug-eluting stents (DES) with biodegradable polymers have been developed to address the risk of thrombosis associated with first-generation DES. We aimed to determine the efficacy and safety of biodegradable polymer biolimus-eluting stents (BES) versus durable polymer DES. Methods: Systematic database searches of MEDLINE (1950 to June 2013), EMBASE (1966 to June 2013), the Cochrane Central Register of Controlled Trials (Issue 6 of 12, June 2013), and a review of related literature were conducted. All randomized controlled trials comparing biodegradable polymer BES versus durable polymer DES were included. Results: Eight randomized controlled trials investigating 11,015 patients undergoing percutaneous coronary interventions were included in the meta-analysis. The risk of major adverse cardiac events did not differ significantly between the patients treated with the biodegradable polymer BES and the durable polymer DES (Relative risk [RR], 0.970; 95% CI, 0.848-1.111; p = 0.662). However, biodegradable polymer BES was associated with reduced risk of very late ST compared with the durable polymer DES, while the risk of early or late ST was similar (RR for early or late ST, 1.167; 95% CI 0.755-1.802; p = 0.487; RR 0.273; 95% CI 0.115-0.652; p = 0.003; p for interaction = 0.003). Conclusions: In this meta-analysis of randomized controlled trials, treatments with biodegradable polymer BES did not significantly reduce the risk of major adverse cardiac events, but demonstrated a significantly lower risk of very late ST when compared to durable polymer DES. This conclusion requires confirmation by further studies with long-term follow-up.	[Zhang, Shuyang] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100021, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhang, SY (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100021, Peoples R China.	Zhangebmg@gmail.com	Ye, Yicong/AFV-8932-2022	zhao, xiliang/0000-0001-5290-7155; Ye, Yicong/0000-0002-9433-6140; Zhang, Shuyang/0000-0002-1532-0029				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Chevalier Bernard, 2007, EuroIntervention, V2, P426; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hagiwara H, 2012, EUROINTERVENTION, V8, P743, DOI 10.4244/EIJV8I6A114; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Jensen LO, 2010, EUROINTERVENTION, V5, P898, DOI 10.4244/; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kadota K, 2012, CATHETER CARDIO INTE, V80, P789, DOI 10.1002/ccd.23280; Lefevre T, 2010, EUROINTERVENTION, V6, pJ123, DOI 10.4244/EIJV6SUPJA20; Li Y, 2011, J MOL MED, V89, P545, DOI 10.1007/s00109-011-0729-3; Ma XD, 2011, J BIOMED MATER RES A, V96A, P632, DOI 10.1002/jbm.a.33016; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Nishio S, 2012, CIRCULATION, V125, P2343, DOI 10.1161/CIRCULATIONAHA.110.000901; Ostojic M, 2008, CATHETER CARDIO INTE, V72, P901, DOI 10.1002/ccd.21775; Ostojic MC, 2011, EUR J CLIN PHARMACOL, V67, P389, DOI 10.1007/s00228-010-0895-1; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Rossi F, 2012, MOL PHARM       0529, V29; Separham A, 2012, EUROINTERVENTION, V8, pN134; SERRUYS P, 2012, J AM COLL CARDIOL S, V60, pB13; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tamai H, 2000, CIRCULATION, V102, P399; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78667	10.1371/journal.pone.0078667	http://dx.doi.org/10.1371/journal.pone.0078667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244335	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600044
J	Cammarota, S; Falconio, LM; Bruzzese, D; Catapano, AL; Casula, M; Citarella, A; De Luca, L; Flacco, ME; Manzoli, L; Masulli, M; Menditto, E; Mezzetti, A; Riegler, S; Novellino, E; Riccardi, G				Cammarota, Simona; Falconio, Lucio Marcello; Bruzzese, Dario; Catapano, Alberico Luigi; Casula, Manuela; Citarella, Anna; De Luca, Luigi; Flacco, Maria Elena; Manzoli, Lamberto; Masulli, Maria; Menditto, Enrica; Mezzetti, Andrea; Riegler, Salvatore; Novellino, Ettore; Riccardi, Gabriele			Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study	PLOS ONE			English	Article							REGULAR HUMAN INSULIN; POSTPRANDIAL HYPERGLYCEMIA; DIABETIC-PATIENTS; GLYCEMIC CONTROL; GLUCOSE CONTROL; BLOOD-GLUCOSE; NPH INSULIN; TYPE-2; HYPOGLYCEMIA; REDUCTION	Background: Few studies are available evaluating the impact of rapid-acting insulin analogues on long-term diabetes outcomes. Our aim was to compare the use of rapid-acting insulin analogues versus human regular insulin in relation to the occurrence of diabetic complications in a cohort of diabetic patients through the analysis of administrative databases. Methods: A population-based cohort study was conducted using administrative data from four local health authorities in the Abruzzo Region (900,000 inhabitants). Diabetic patients free of macrovascular disease at baseline and treated either with human regular insulin or rapid-acting insulin analogues were followed for a maximum of 3 years. The incidence of diabetic complications was ascertained by hospital discharge claims. Hazard ratios (HRs) and 95% CIs of any diabetic complication and macrovascular, microvascular and metabolic complications were estimated separately using Cox proportional hazard models adjusted for patients' characteristics and anti-diabetic drug use. Propensity score matching was also used to adjust for significant difference in the baseline characteristics between the two treatment groups. Results: A total of 2,286 patients were included: 914 receiving human regular insulin and 1,372 rapid-acting insulin analogues. During the follow-up, 286 (31.3%) incident events occurred in the human regular insulin group and 235 (17.1%) in the rapid-acting insulin analogue group. After propensity score-based matched-pair analyses, rapid-acting insulin analogues users had a HR of 0.73 (0.58-0.92) for any diabetes-related complication and HRs of 0.73 (0.55-0.93) and 0.55 (0.32-0.96) for macrovascular and metabolic complications respectively, as compared with human regular insulin users. No difference between the two groups was found for microvascular complications. Conclusions: Our findings suggest that the use of rapid-acting insulin analogues is associated with a lower risk of cardiovascular and metabolic complications compared with human regular insulin use.	[Cammarota, Simona; Falconio, Lucio Marcello; De Luca, Luigi; Menditto, Enrica; Riegler, Salvatore; Novellino, Ettore] Univ Naples Federico II, Ctr Pharmacoecon & Drug Utilizat CIRFF, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Prevent Med Sci, Naples, Italy; [Catapano, Alberico Luigi; Casula, Manuela] Univ Milan, Dept Pharmacol Sci, Epidemiol & Prevent Pharmacol Ctr SEFAP, Milan, Italy; [Catapano, Alberico Luigi] Multimed IRCCS, SS Giovanni, Milan, Italy; [Citarella, Anna] Karolinska Inst, Dept Med, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Flacco, Maria Elena; Manzoli, Lamberto] Univ G dAnnunzio, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy; [Masulli, Maria; Riccardi, Gabriele] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Mezzetti, Andrea] Univ G dAnnunzio, Clin Res Ctr, Chieti, Italy	University of Naples Federico II; University of Naples Federico II; University of Milan; IRCCS Multimedica; Karolinska Institutet; G d'Annunzio University of Chieti-Pescara; University of Naples Federico II; G d'Annunzio University of Chieti-Pescara	Riccardi, G (corresponding author), Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy.	riccardi@unina.it	de Luca, Luigi/F-6577-2012; Manzoli, Lamberto/K-1895-2018; Catapano, alberico/AAC-2827-2019; Flacco, Maria Elena/E-3306-2017; Casula, Manuela/AAC-4470-2019	de Luca, Luigi/0000-0002-1638-0429; Manzoli, Lamberto/0000-0002-8129-9344; Catapano, alberico/0000-0002-7593-2094; Flacco, Maria Elena/0000-0003-1404-4314; Casula, Manuela/0000-0002-5124-5361; Bruzzese, Dario/0000-0001-9911-4646; Novellino, Ettore/0000-0002-2181-2142; orlando, valentina/0000-0002-8209-8878; menditto, enrica/0000-0001-8633-5650	"Federico II" University of Naples, Italy	"Federico II" University of Naples, Italy	The study was supported by funds provided by "Federico II" University of Naples, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JH, 1997, DIABETES, V46, P265, DOI 10.2337/diabetes.46.2.265; Annuzzi G, 2001, NUTR METAB CARDIOVAS, V11, P168; Brod M, 2012, CURR MED RES OPIN, V28, P1947, DOI 10.1185/03007995.2012.743457; Cammarota S, 2014, NUTR METAB CARDIOVAS, V24, P10, DOI 10.1016/j.numecd.2013.04.002; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dailey G, 2004, DIABETES CARE, V27, P2363, DOI 10.2337/diacare.27.10.2363; Giorda C, 2006, DIABETIC MED, V23, P377, DOI 10.1111/j.1464-5491.2006.01851.x; Gough SCL, 2007, DIABETES RES CLIN PR, V77, P1, DOI 10.1016/j.diabres.2006.10.015; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Heller S, 2002, INT J OBESITY, V26, pS31, DOI 10.1038/sj.ijo.0802175; Hermansen K, 2004, DIABETOLOGIA, V47, P622, DOI 10.1007/s00125-004-1365-z; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Kress S, 2012, INT J CLIN PHARM TH, V50, P821, DOI 10.5414/CP201653; Lakey WC, 2013, DIABETOLOGIA, V56, P1226, DOI 10.1007/s00125-013-2890-4; Lindholm A, 1999, DIABETES CARE, V22, P801, DOI 10.2337/diacare.22.5.801; Lo-Ciganic Weihsuan, 2011, J Diabetes Sci Technol, V5, P486; Mannucci E, 2009, DIABETES OBES METAB, V11, P53, DOI 10.1111/j.1463-1326.2008.00934.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; POTTER J, 1982, BRIT MED J, V285, P1180, DOI 10.1136/bmj.285.6349.1180; Raz I, 2011, DIABETES CARE, V34, P1511, DOI 10.2337/dc10-2375; Raz I, 2009, DIABETES CARE, V32, P381, DOI 10.2337/dc08-1671; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; *UKPDS GROUP, 1998, LANCET, V352, P37853, DOI DOI 10.1016/S0140-6736(98)07019-6.PUBMED:9742976; UY J, 2012, OBESITY SILVER SPRIN, V5, P1; 2007, EUR HEART J SC, P90415	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79762	10.1371/journal.pone.0079762	http://dx.doi.org/10.1371/journal.pone.0079762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244557	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900051
J	Diana, V; Bossolasco, P; Moscatelli, D; Silani, V; Cova, L				Diana, Valentina; Bossolasco, Patrizia; Moscatelli, Davide; Silani, Vincenzo; Cova, Lidia			Dose Dependent Side Effect of Superparamagnetic Iron Oxide Nanoparticle Labeling on Cell Motility in Two Fetal Stem Cell Populations	PLOS ONE			English	Article							MAGNETIC NANOPARTICLES; CHORIONIC VILLI; CULTURES; BRAIN; 6-HYDROXYDOPAMINE; DIFFERENTIATION; STABILITY; MIGRATION; THERAPY; TISSUE	Multipotent stem cells (SCs) could substitute damaged cells and also rescue degeneration through the secretion of trophic factors able to activate the endogenous SC compartment. Therefore, fetal SCs, characterized by high proliferation rate and devoid of ethical concern, appear promising candidate, particularly for the treatment of neurodegenerative diseases. Super Paramagnetic Iron Oxide nanoparticles (SPIOn), routinely used for pre-clinical cell imaging and already approved for clinical practice, allow tracking of transplanted SCs and characterization of their fate within the host tissue, when combined with Magnetic Resonance Imaging (MRI). In this work we investigated how SPIOn could influence cell migration after internalization in two fetal SC populations: human amniotic fluid and chorial villi SCs were labeled with SPIOn and their motility was evaluated. We found that SPIOn loading significantly reduced SC movements without increasing production of Reactive Oxygen Species (ROS). Moreover, motility impairment was directly proportional to the amount of loaded SPIOn while a chemoattractant-induced recovery was obtained by increasing serum levels. Interestingly, the migration rate of SPIOn labeled cells was also significantly influenced by a degenerative surrounding. In conclusion, this work highlights how SPIOn labeling affects SC motility in vitro in a dose-dependent manner, shedding the light on an important parameter for the creation of clinical protocols. Establishment of an optimal SPIOn dose that enables both a good visualization of grafted cells by MRI and the physiological migration rate is a main step in order to maximize the effects of SC therapy in both animal models of neurodegeneration and clinical studies.	[Diana, Valentina; Bossolasco, Patrizia; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Dept Neurol, Cusano Milanino, Italy; [Diana, Valentina; Bossolasco, Patrizia; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Neurosci Lab, Cusano Milanino, Italy; [Moscatelli, Davide] Politecn Milan, Dept Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy; [Silani, Vincenzo] Univ Milan, Dino Ferrari Ctr, Dept Fisiopatol Med Chirurg & Trapianti, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Polytechnic University of Milan; University of Milan	Cova, L (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol, Cusano Milanino, Italy.	l.cova@auxologico.it	Cova, Lidia/K-6459-2016; Bossolasco, Patrizia/AAA-5275-2020; Silani, Vincenzo/P-4421-2017; Moscatelli, Davide/G-8795-2013	Cova, Lidia/0000-0002-1504-1556; Bossolasco, Patrizia/0000-0002-1596-7818; Silani, Vincenzo/0000-0002-7698-3854; Moscatelli, Davide/0000-0003-2759-9781				Arora P, 2012, J CELL MOL MED, V16, P1991, DOI 10.1111/j.1582-4934.2012.01534.x; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Bellova A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065103; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Bigini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032326; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Bulte JWM, 2004, CURR PHARM BIOTECHNO, V5, P567; Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972; Calzarossa C, 2013, NEUROSCIENCE, V234, P158, DOI 10.1016/j.neuroscience.2012.12.038; Chaudhari P, 2012, ANTIOXID REDOX SIGNA; Cho EC, 2010, TRENDS MOL MED, V16, P561, DOI 10.1016/j.molmed.2010.09.004; Cova L, 2012, APOPTOSIS, V17, P289, DOI 10.1007/s10495-011-0679-9; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dusek P, 2012, CURR OPIN NEUROL, V25, P499, DOI 10.1097/WCO.0b013e3283550cac; Eifler AC, 2011, METHODS MOL BIOL, V726, P325, DOI 10.1007/978-1-61779-052-2_21; Filippi M-D, 2011, STEM CELL MIGRATION; Hartman NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015856; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Janowski M, 2012, ADV DRUG DELIVER REV, V64, P1488, DOI 10.1016/j.addr.2012.07.008; Jasmin, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-4; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Khaleghian A., 2010, AFR J BIOCH RES, V4, P99; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Li MZ, 2012, TRENDS NEUROSCI, V35, P619, DOI 10.1016/j.tins.2012.06.003; Li XP, 2011, J NEURAL TRANSM, V118, P473, DOI 10.1007/s00702-010-0518-0; Liu J, 2011, FREE RADICAL BIO MED, V51, P2158, DOI 10.1016/j.freeradbiomed.2011.10.434; Luther EM, 2013, ACTA BIOMATER, V9, P8454, DOI 10.1016/j.actbio.2013.05.022; MESSINA LM, 1992, P NATL ACAD SCI USA, V89, P12018, DOI 10.1073/pnas.89.24.12018; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Nejadnik H, 2012, CELL TRANSPLANT, V21, P2555, DOI 10.3727/096368912X653156; Park EJ, 2010, TOXICOLOGY, V275, P65, DOI 10.1016/j.tox.2010.06.002; Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Poloni A, 2008, CYTOTHERAPY, V10, P690, DOI 10.1080/14653240802419310; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schlachter EK, 2011, INT J NANOMED, V6, P1793, DOI 10.2147/IJN.S23638; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJH, 2010, SMALL, V6, P2136, DOI 10.1002/smll.201000763; Stratmeyer ME, 2010, BIOMED MICRODEVICES, V12, P569, DOI 10.1007/s10544-008-9261-9; Welling MM, 2011, J CELL PHYSIOL, V226, P1444, DOI 10.1002/jcp.22539; Winer JL, 2012, WORLD NEUROSURG, V78, P709, DOI 10.1016/j.wneu.2011.08.013; Wu XY, 2010, INT J NANOMED, V5, P385; Xu CJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494001; Yang FY, 2012, CELL TRANSPLANT, V21, P1805, DOI 10.3727/096368912X652986	49	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78435	10.1371/journal.pone.0078435	http://dx.doi.org/10.1371/journal.pone.0078435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244310	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900016
J	Gustchina, E; Li, M; Ghirlando, R; Schuck, P; Louis, JM; Pierson, J; Rao, P; Subramaniam, S; Gustchina, A; Clore, GM; Wlodawer, A				Gustchina, Elena; Li, Mi; Ghirlando, Rodolfo; Schuck, Peter; Louis, John M.; Pierson, Jason; Rao, Prashant; Subramaniam, Sriram; Gustchina, Alla; Clore, G. Marius; Wlodawer, Alexander			Complexes of Neutralizing and Non-Neutralizing Affinity Matured Fabs with a Mimetic of the Internal Trimeric Coiled-Coil of HIV-1 gp41	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY; DESIGN; ULTRACENTRIFUGATION; INHIBITORS; ACCURACY; POTENT; ENTRY	A series of mini-antibodies (monovalent and bivalent Fabs) targeting the conserved internal trimeric coiled-coil of the N-heptad repeat (N-HR) of HIV-1 gp41 has been previously constructed and reported. Crystal structures of two closely related monovalent Fabs, one (Fab 8066) broadly neutralizing across a wide panel of HIV-1 subtype B and C viruses, and the other (Fab 8062) non-neutralizing, representing the extremes of this series, were previously solved as complexes with 5-Helix, a gp41 pre-hairpin intermediate mimetic. Binding of these Fabs to covalently stabilized chimeric trimers of N-peptides of HIV1 gp41 (named (CCIZN36)(3) or 3-H) has now been investigated using X-ray crystallography, cryo-electron microscopy, and a variety of biophysical methods. Crystal structures of the complexes between 3-H and Fab 8066 and Fab 8062 were determined at 2.8 and 3.0 angstrom resolution, respectively. Although the structures of the complexes with the neutralizing Fab 8066 and its non-neutralizing counterpart Fab 8062 were generally similar, small differences between them could be correlated with the biological properties of these antibodies. The conformations of the corresponding CDRs of each antibody in the complexes with 3-H and 5-Helix are very similar. The adaptation to a different target upon complex formation is predominantly achieved by changes in the structure of the trimer of N-HR helices, as well as by adjustment of the orientation of the Fab molecule relative to the N-HR in the complex, via rigid-body movement. The structural data presented here indicate that binding of three Fabs 8062 with high affinity requires more significant changes in the structure of the N-HR trimer compared to binding of Fab 8066. A comparative analysis of the structures of Fabs complexed to different gp41 intermediate mimetics allows further evaluation of biological relevance for generation of neutralizing antibodies, as well as provides novel structural insights into immunogen design.	[Gustchina, Elena; Louis, John M.; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Li, Mi; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA; [Li, Mi] SAIC Frederick, Basic Res Program, Frederick, MD USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, NIH, Lab Cellular Imaging & Macromol Biophys, Bethesda, MD USA; [Pierson, Jason] FEI Co, Hillsboro, OR USA; [Rao, Prashant; Subramaniam, Sriram] NCI, Ctr Canc Res, Cell Biol Lab, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Thermo Fisher Scientific; FEI Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gustchina, A (corresponding author), NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA.	gustchia@mail.nih.gov; mariusc@mail.nih.gov; wlodawer@nih.gov	Clore, G. Marius/A-3511-2008; Schuck, Peter/AAA-6888-2020; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Schuck, Peter/0000-0002-8859-6966; Clore, G Marius/0000-0003-3809-1027; Subramaniam, Sriram/0000-0003-4231-4115; Louis, John M/0000-0002-0052-1899	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Programs of the NIDDK; Intramural Research Programs of the NIBIB; National Cancer Institute, Center for Cancer Research; AIDS Targeted Antiviral Program of the Office of the Director of the NIH; Federal funds from the National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029038, ZIADK033007] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Programs of the NIDDK; Intramural Research Programs of the NIBIB; National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIDS Targeted Antiviral Program of the Office of the Director of the NIH; Federal funds from the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the use of beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. This project was supported in part by the Intramural Research Programs of the NIDDK (to G. M. C), NIBIB (to P. S.), and the National Cancer Institute, Center for Cancer Research (to S. S. and A. W.), by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to S. S. and G. M. C.), and with Federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E (to M. L.). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJORATH J, 1995, J BIOL CHEM, V270, P22081, DOI 10.1074/jbc.270.38.22081; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Bianchi E, 2010, P NATL ACAD SCI USA, V107, P10655, DOI 10.1073/pnas.1004261107; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Gustchina E, 2009, VIROLOGY, V393, P112, DOI 10.1016/j.virol.2009.07.019; Harris AK, 2013, J VIROL, V87, P7191, DOI 10.1128/JVI.03284-12; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Karle IL, 2003, P NATL ACAD SCI USA, V100, P13946, DOI 10.1073/pnas.2336106100; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson JK, 2008, IEEE T DIELECT EL IN, V15, P1, DOI 10.1109/T-DEI.2008.4446730; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	43	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78187	10.1371/journal.pone.0078187	http://dx.doi.org/10.1371/journal.pone.0078187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244293	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900010
J	Isberg, V; Paine, J; Leth-Petersen, S; Kristensen, JL; Gloriam, DE				Isberg, Vignir; Paine, James; Leth-Petersen, Sebastian; Kristensen, Jesper L.; Gloriam, David E.			Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors	PLOS ONE			English	Article							DRUG DEVELOPMENT; HALLUCINOGENS; DERIVATIVES; AGONISTS; ANALOGS; BIOLOGY; POTENT; PROBES; ROLES	Serotonergic ligands have proven effective drugs in the treatment of migraine, pain, obesity, and a wide range of psychiatric and neurological disorders. There is a clinical need for more highly 5-HT2 receptor subtype-selective ligands and the most attention has been given to the phenethylamine class. Conformationally constrained phenethylamine analogs have demonstrated that for optimal activity the free lone pair electrons of the 2-oxygen must be oriented syn and the 5-oxygen lone pairs anti relative to the ethylamine moiety. Also the ethyl linker has been constrained providing information about the bioactive conformation of the amine functionality. However, combined 1,2-constriction by cyclization has only been tested with one compound. Here, we present three new 1,2-cyclized phenylethylamines, 9-11, and describe their synthetic routes. Ligand docking in the 5-HT2B crystal structure showed that the 1,2-heterocyclized compounds can be accommodated in the binding site. Conformational analysis showed that 11 can only bind in a higher-energy conformation, which would explain its absent or low affinity. The amine and 2-oxygen interactions with D3.32 and S3.36, respectively, can form but shift the placement of the core scaffold. The constraints in 9-11 resulted in docking poses with the 4-bromine in closer vicinity to 5.46, which is polar only in the human 5-HT2A subtype, for which 9-11 have the lowest affinity. The new ligands, conformational analysis and docking expand the structure-activity relationships of constrained phenethylamines and contributes towards the development of 5-HT2 receptor subtype-selective ligands.	[Isberg, Vignir; Paine, James; Leth-Petersen, Sebastian; Kristensen, Jesper L.; Gloriam, David E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen	Gloriam, DE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	david.gloriam@sund.ku.dk	Kristensen, Jesper/AAP-4439-2021; Kristensen, Jesper/E-3581-2010; Gloriam, David E./A-1904-2011; Isberg, Vignir/A-2882-2011	Kristensen, Jesper/0000-0002-5613-1267; Kristensen, Jesper/0000-0002-5613-1267; Gloriam, David E./0000-0002-4299-7561; Isberg, Vignir/0000-0002-1042-040X	Carlsberg Foundation; Lundbeck-Foundation	Carlsberg Foundation(Carlsberg Foundation); Lundbeck-Foundation(Lundbeckfonden)	VI and JP were supported by the Lundbeck- and DEG by the Carlsberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLID; [Anonymous], 2012, SITEMAP; [Anonymous], 2013, MAESTR; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Braden MR, 2007, MOL PHARMACOL, V72, P1200, DOI 10.1124/mol.107.039255; Braden MR, 2007, BIOPHYSICAL BASIS HA; BRADSHER CK, 1978, J ORG CHEM, V43, P3800, DOI 10.1021/jo00413a047; Chambers JJ, 2001, J MED CHEM, V44, P1003, DOI 10.1021/jm000491y; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Goadsby P J, 2007, Handb Exp Pharmacol, P129; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Gray JA, 2007, MOL PSYCHIATR, V12, P904, DOI 10.1038/sj.mp.4002062; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Katzman MA, 2009, CNS DRUGS, V23, P103, DOI 10.2165/00023210-200923020-00002; McLean TH, 2006, J MED CHEM, V49, P5794, DOI 10.1021/jm060656o; Moltzen EK, 2006, CURR TOP MED CHEM, V6, P1801, DOI 10.2174/156802606778249810; Monte AP, 1996, J MED CHEM, V39, P2953, DOI 10.1021/jm960199j; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nichols DE, 1995, MED CHEM RES, V5; Parker MA, 1998, J MED CHEM, V41, P5148, DOI 10.1021/jm9803525; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; SELANDER H, 1972, ACTA CHEM SCAND, V26, P2433, DOI 10.3891/acta.chem.scand.26-2433; Wacker D., 2013, SCIENCE; Whiteside MS, 2002, BIOORGAN MED CHEM, V10, P3301, DOI 10.1016/S0968-0896(02)00209-2; Wubbels GG, 2008, J ORG CHEM, V73, P1925, DOI 10.1021/jo702468d	30	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78515	10.1371/journal.pone.0078515	http://dx.doi.org/10.1371/journal.pone.0078515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244317	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900022
J	Pan, S; Yu, ZX; Ma, YT; Liu, F; Yang, YN; Ma, X; Fu, ZY; Li, XM; Xie, X; Chen, Y; Chen, B; He, CH				Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Liu, Fen; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; Chen, Bangdang; He, Chun-Hui			Appropriate Body Mass Index and Waist Circumference Cutoffs for Categorization of Overweight and Central Adiposity among Uighur Adults in Xinjiang	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; OBESITY; FAT; NUTRITION; STATEMENT; TAIWANESE; COUNCIL	Objective: The current overweight and central adiposity guidelines based on Western populations were not consistent with many studied based on the Asian populations. Uighur people live in Xinjiang Uighur Autonomous Region which is located in the center of Asia. Their overweight and central cutoffs were largely unknown. We aimed to identify cutoffs for body mass index (BMI; in kg/m(2)) and waist circumference (WC; in cm) for categorization of overweight and central adiposity among Uighur adults in Xinjiang. Methods: 4767 Uighur participants were selected from the Cardiovascular Risk Survey (CRS) which was carried out from October 2007 to March 2010. The age of the participants were from 35 to 101 years old with the mean age of 50.09 years. Anthropometric data, blood pressure, serum concentration of serum total cholesterol, triglyceride, low density lipoprotein (LDL), high density lipoprotein (HDL) and fasting glucose were documented. The prevalence, sensitivity, specificity and distance on the receiver operating characteristic (ROC) curve of each BMI and waist circumference values were calculated. Results: The prevalence of hypertension, hypercholesterolemia and hypertriglyceridemia were higher with higher BMI for both men and women. The prevalence of hypertension and hypercholesterolemia were higher with higher waist circumference for both men and women. In women, the prevalence of hypertriglyceridemia was noticed to increase as the waist circumference increased. The shortest distance in the receiver operating characteristic curves for hypertension, dyslipidemia, diabetes, or >= 2 of these risk factors suggested a BMI cutoff of 26 and a waist circumference cutoff of 90 cm for both men and women. Conclusions: Higher cutoffs for BMI and waist circumference are needed in the identification of Uighur patients at high risk of cardiovascular disease.	[Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; He, Chun-Hui] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Pan, Shuo; Yu, Zi-Xiang; Ma, Yi-Tong; Liu, Fen; Yang, Yi-Ning; Ma, Xiang; Fu, Zhen-Yan; Li, Xiao-Mei; Xie, Xiang; Chen, You; Chen, Bangdang; He, Chun-Hui] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Science and Technology Planning Project of Xinjiang Uygur Autonomous Region [201233138]	Science and Technology Planning Project of Xinjiang Uygur Autonomous Region	This work was supported by Science and Technology Planning Project of Xinjiang Uygur Autonomous Region (201233138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 1992, AM J HYPERTENS, V5, P207; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Government Office for Science, 2008, FOR TACKL OB FUT 3 C; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Li G, 2002, Obes Rev, V3, P167, DOI 10.1046/j.1467-789X.2002.00067.x; Logue J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c154; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Moon O R, 2002, Obes Rev, V3, P191; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Samsen Maiyadhaj, 2012, Journal of the Medical Association of Thailand, V95, P1156; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Walker A., 2003, COST DOING NOTHING E; WHO, 1998, OBES RES, V6, pS51; WHO, 2000, ASIA PACIFIC PERSPEC, P1; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	36	21	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80185	10.1371/journal.pone.0080185	http://dx.doi.org/10.1371/journal.pone.0080185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244645	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900066
J	Shigaki, K; Wang, Z; Tanimoto, J; Fukuda, E				Shigaki, Keizo; Wang, Zhen; Tanimoto, Jun; Fukuda, Eriko			Effect of Initial Fraction of Cooperators on Cooperative Behavior in Evolutionary Prisoner's Dilemma Game	PLOS ONE			English	Article							NETWORKS; DYNAMICS; COEVOLUTION; INVASION; STRATEGY	We investigate the influence of initial fraction of cooperators on the evolution of cooperation in spatial prisoner's dilemma games. Compared with the results of heterogeneous networks, we find that there is a relatively low initial fraction of cooperators to guarantee higher equilibrium cooperative level. While this interesting phenomenon is contrary to the commonly shared knowledge that higher initial fraction of cooperators can provide better environment for the evolution of cooperation. To support our outcome, we explore the time courses of cooperation and find that the whole course can be divided into two sequent stages: enduring (END) and expanding (EXP) periods. At the end of END period, thought there is a limited number of cooperator clusters left for the case of low initial setup, these clusters can smoothly expand to hold the whole system in the EXP period. However, for high initial fraction of cooperators, superfluous cooperator clusters hinder their effective expansion, which induces many remaining defectors surrounding the cooperator clusters. Moreover, through intensive analysis, we also demonstrate that when the tendency of three cooperation cluster characteristics (cluster size, cluster number and cluster shape) are consistent within END and EXP periods, the state that maximizes cooperation can be favored.	[Shigaki, Keizo; Tanimoto, Jun; Fukuda, Eriko] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon, Hong Kong, Peoples R China	Kyushu University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wang, Z (corresponding author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan.	zhenwang0@gmail.com; tanimoto@cm.kyushu-u.ac.jp		Tanimoto, Jun/0000-0002-4092-3219	JSPS [23651156]; Kurata-Hitachi Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurata-Hitachi Foundation	This work was supported by the Grant-in-Aid for Scientific Research by JSPS, awarded to Prof. Tanimoto (#23651156) and by the Kurata-Hitachi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio C, 2012, PHYS REV E, V85; [Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Cheng HY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123014; Cong R, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/3/030203; Du WB, 2009, PHYSICA A, V388, P5005, DOI 10.1016/j.physa.2009.08.026; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Genki I, 2013, PLOS ONE, V8; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Lozada M, 2011, J THEOR BIOL, V289, P12, DOI 10.1016/j.jtbi.2011.08.016; Maynard-Smith J, 1995, NATURE, V374, P227; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Mendeli HV, 2001, PHYS REV E, V64, P05915; Miyaji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071961; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Shigaki K, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/40008; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Suzuki S, 2011, J THEOR BIOL, V287, P42, DOI 10.1016/j.jtbi.2011.07.019; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanabe S, 2012, J THEOR BIOL, V293, P151, DOI 10.1016/j.jtbi.2011.10.020; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wang Z, 2011, PHYSICA A, V390, P1234, DOI 10.1016/j.physa.2010.12.003; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu G, 2008, CHINESE PHYS LETT, V25, P2307, DOI 10.1088/0256-307X/25/6/105; Wu Z.-X., 2009, PHYS REV E, V80; Xia CY, 2012, PHYSICA A, V391, P6440, DOI 10.1016/j.physa.2012.07.065; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2012, CHAOS SOLITON FRACT, V45, P1239, DOI 10.1016/j.chaos.2012.06.014; Xu ZJ, 2010, J THEOR BIOL, V264, P19, DOI 10.1016/j.jtbi.2010.01.025; Yang HX, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/10006; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023; Zhang J, 2011, PHYSICA A, V390, P2258, DOI 10.1016/j.physa.2011.02.045; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	62	45	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76942	10.1371/journal.pone.0076942	http://dx.doi.org/10.1371/journal.pone.0076942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244270	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900004
J	Zhang, ZX; Zhang, SL; Huang, X; Orwig, KE; Sheng, Y				Zhang, Zhengxing; Zhang, Siliang; Huang, Xin; Orwig, Kyle E.; Sheng, Yi			Rapid Assembly of Customized TALENs into Multiple Delivery Systems	PLOS ONE			English	Article							EFFECTOR NUCLEASES TALENS; MEDIATED BAC TRANSGENESIS; HIGH-EFFICIENCY; GENE KNOCKOUT; FUNCTIONAL-ANALYSIS; GENOME; MOUSE; GENERATION; ENDONUCLEASE; PIGGYBAC	Transcriptional activator-like effector nucleases (TALENs) have become a powerful tool for genome editing. Here we present an efficient TALEN assembly approach in which TALENs are assembled by direct Golden Gate ligation into Gateway (R) Entry vectors from a repeat variable di-residue (RVD) plasmid array. We constructed TALEN pairs targeted to mouse Ddx3 subfamily genes, and demonstrated that our modified TALEN assembly approach efficiently generates accurate TALEN moieties that effectively introduce mutations into target genes. We generated "user friendly" TALEN Entry vectors containing TALEN expression cassettes with fluorescent reporter genes that can be efficiently transferred via Gateway (LR) recombination into different delivery systems. We demonstrated that the TALEN Entry vectors can be easily transferred to an adenoviral delivery system to expand application to cells that are difficult to transfect. Since TALENs work in pairs, we also generated a TALEN Entry vector set that combines a TALEN pair into one PiggyBac transposon-based destination vector. The approach described here can also be modified for construction of TALE transcriptional activators, repressors or other functional domains.	[Zhang, Zhengxing; Zhang, Siliang; Huang, Xin; Orwig, Kyle E.; Sheng, Yi] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA; [Huang, Xin] Univ Pittsburgh, Womens Canc Res Ctr, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA.	shengy@upmc.edu		Orwig, Kyle/0000-0002-7952-8419	National Institutes of Health [RR31300, HD055475]; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (www.nih.gov) to YS (RR31300) and KEO (HD055475) and by Magee-Womens Research Institute and Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Baxter S, 2012, NUCLEIC ACIDS RES, V40, P7985, DOI 10.1093/nar/gks502; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Engler C, 2011, METHODS MOL BIOL, V729, P167, DOI 10.1007/978-1-61779-065-2_11; Friddle CJ, 2003, COLD SPRING HARB SYM, V68, P311, DOI 10.1101/sqb.2003.68.311; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Jacoby K, 2012, NUCLEIC ACIDS RES, V40, P4954, DOI 10.1093/nar/gkr1303; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li M, 2012, AM J STEM CELLS, V1, P75; Li RB, 2013, DIS MODEL MECH, V6, P828, DOI 10.1242/dmm.010827; Li Ting, 2013, Methods Mol Biol, V978, P63, DOI 10.1007/978-1-62703-293-3_5; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Sung YH, 2012, BMB REP, V45, P686, DOI 10.5483/BMBRep.2012.45.12.242; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, pW110, DOI 10.1093/nar/gks365; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Uhde-Stone C, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-3; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066459; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	69	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80281	10.1371/journal.pone.0080281	http://dx.doi.org/10.1371/journal.pone.0080281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244669	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327162900076
J	Dey, M; Patra, S; Su, LY; Segall, AM				Dey, Mamon; Patra, Sukanya; Su, Leo Y.; Segall, Anca M.			Tumor Cell Death Mediated by Peptides That Recognize Branched Intermediates of DNA Replication and Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SITE-SPECIFIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; CYTOCHROME-C; TYROSINE RECOMBINASES; HOLLIDAY JUNCTIONS; COLORECTAL-CANCER; PROSTATE-CANCER; INHIBITORS; DAMAGE	Effective treatments for cancer are still needed, both for cancers that do not respond well to current therapeutics and for cancers that become resistant to available treatments. Herein we investigated the effect of a structure-selective d-amino acid peptide wrwycr that binds replication fork mimics and Holliday Junction (HJs) intermediates of homologous recombination (HR) in vitro, and inhibits their resolution by HJ-processing enzymes. We predicted that treating cells with HJ-binding compounds would lead to accumulation of DNA damage. As cells repair endogenous or exogenous DNA damage, collapsed replication forks and HJ intermediates will accumulate and serve as targets for the HJ-binding peptides. Inhibiting junction resolution will lead to further accumulation of DNA breaks, eventually resulting in amplification of the damage and causing cell death. Both peptide wrwycr and the related wrwyrggrywrw entered cancer cells and reduced cell survival in a dose-and time-dependent manner. Early markers for DNA damage, gamma H2AX foci and 53BP1 foci, increased with dose and/or time exposure to the peptides. DNA breaks persisted at least 48 h, and both checkpoint proteins Chk1 and Chk2 were activated. The passage of the cells from S to G2/M was blocked even after 72 h. Apoptosis, however, was not induced in either HeLa or PC3 cells. Based on colony-forming assays, about 35% peptide-induced cytotoxicity was irreversible. Finally, sublethal doses of peptide wrwycr (50-100 mu M) in conjunction with sublethal doses of several DNA damaging agents (etoposide, doxorubicin, and HU) reduced cell survival at least additively and sometimes synergistically. Taken together, the results suggest that the peptides merit further investigation as proof-of-principle molecules for a new class of anti-cancer therapeutics, in particular in combination with other DNA damaging therapies.	[Segall, Anca M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Segall, AM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	asegall@mail.sdsu.edu		Segall, Anca/0000-0002-8454-5248	National Institutes of Health [R01 AI058253, R21 AI061351]; pilot project; National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program [U54CA132384, U54CA132379]; NATIONAL CANCER INSTITUTE [U54CA132384, U54CA132379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058253, R21AI061351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project; National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants R01 AI058253 and R21 AI061351 to AMS, and also funded in part by a pilot project to AMS and WIlliam Wachsman that was part of the National Cancer Institute, Comprehensive Partnerships to Reduce Cancer Health Disparities Program, grants U54CA132384 (PIs Klonoff and Maloy) and U54CA132379 (PIs Navarro and Carethers). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Barakat K, 2012, CURR TOP MED CHEM, V12, P1376, DOI 10.2174/156802612801319070; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Calderon-Montano JM, 2012, PHARMACOL REP, V64, P1515, DOI 10.1016/S1734-1140(12)70949-0; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Chan SC, 1998, J PEPT SCI, V4, P413, DOI 10.1002/(SICI)1099-1387(1998110)4:7<413::AID-PSC160>3.3.CO;2-X; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Evers B, 2010, TRENDS PHARMACOL SCI, V31, P372, DOI 10.1016/j.tips.2010.06.001; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Firsanov DV, 2011, CLIN EPIGENETICS, V2, P283, DOI 10.1007/s13148-011-0044-4; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GINGRICH JR, 1991, J UROLOGY, V146, P915, DOI 10.1016/S0022-5347(17)37960-0; Goldstein JC, 2005, AGING CELL, V4, P217, DOI 10.1111/j.1474-9726.2005.00163.x; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gunderson CW, 2009, J BACTERIOL, V191, P2169, DOI 10.1128/JB.01559-08; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hwang SL, 2013, BIOCHEM BIOPH RES CO, V430, P1246, DOI 10.1016/j.bbrc.2012.12.066; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jarver P, 2006, BBA-BIOMEMBRANES, V1758, P260, DOI 10.1016/j.bbamem.2006.02.012; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kepple KV, 2008, NUCLEIC ACIDS RES, V36, P5319, DOI 10.1093/nar/gkn512; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; Lassmann M, 2010, J NUCL MED, V51, P1318, DOI 10.2967/jnumed.109.071357; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; Lossaint G, 2011, ONCOGENE, V30, P4261, DOI 10.1038/onc.2011.135; McKeage K, 2012, DRUGS, V72, P1559, DOI 10.2165/11209660-000000000-00000; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Ozcan L, 2012, CURR ATHEROSCLER REP; Pilatus U, 1997, MAGNET RESON MED, V37, P825, DOI 10.1002/mrm.1910370605; Raftery L, 2010, CANCER J, V16, P214, DOI 10.1097/PPO.0b013e3181ddc5ac; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rajeev L, 2007, J BIOL CHEM, V282, P31228, DOI 10.1074/jbc.M705370200; Ranjit DK, 2010, BIOORG MED CHEM LETT, V20, P4531, DOI 10.1016/j.bmcl.2010.06.029; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rideout MC, 2013, PEPTIDES, V40, P112, DOI 10.1016/j.peptides.2012.12.025; Rideout MC, 2011, MOL DIVERS, V15, P989, DOI 10.1007/s11030-011-9333-2; Rideout MC, 2013, PEPTIDES; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Su LY, 2010, ANTIMICROB AGENTS CH, V54, P1888, DOI 10.1128/AAC.01610-09; Su LY, 2009, EFFECTS HOLLIDAY JUN, P1; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Thede GL, 2011, J BACTERIOL, V193, P2149, DOI 10.1128/JB.01296-10; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WHARTON W, 1978, CANCER RES, V38, P3764; Yitzhaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044896; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	65	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78751	10.1371/journal.pone.0078751	http://dx.doi.org/10.1371/journal.pone.0078751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244353	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800012
J	Heard, I; Tondeur, L; Arowas, L; Res, MF; Demazoin, MC; Favre, M				Heard, Isabelle; Tondeur, Laura; Arowas, Laurence; Res, Michael Falguie; Demazoin, Marie-Christine; Favre, Michel			Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; INTRAEPITHELIAL NEOPLASIA; NORMAL CYTOLOGY; PREVALENCE; WOMEN; GRADE; METAANALYSIS; AGE; WORLDWIDE; LESIONS	Background: Knowledge of prevalence rates and distribution of human papillomavirus (HPV) genotypes prior high HPV vaccine coverage is necessary to assess its expected impact on HPV ecology and on cervical lesions and cancers. Methods: Residual specimens of cervical cytology (N = 6,538) were obtained from 16 sites participating in organised cervical cancer screening pilot programs throughout France, anonymised and tested for HPV DNA using the PapilloCheck (R) genotyping test. Samples were stratified according to age of women and cytological grades. Results: The age-standardised prevalence rates of HPV 16 and/or 18 (with or without other high-risk types) was 47.2% (95% Confidence Interval, CI: 42.4-52.1) in high-grade squamous intraepithelial lesions (HSILs), 20.2% in low-grade SIL (95% CI: 16.7-23.7) and 3.9% (95% CI: 2.8-5.1) in normal cytology. Overall HR HPV were detected in 13.7% (95% I CI: 11.7-15.6) of normal cytology. In women below 30 years of age, 64% of HSILs were associated with HPV16 and/ or 18. In our study population, HPV16 was the most commonly detected type in all cervical grades with prevalence rates ranking from 3.0% in normal cytology to 50.9% in HSILs. HPV16 was also detected in 54% (27/50) of invasive cervical cancers including 5 adenocarcinomas. Conclusion: HPV16 was strongly associated with cervical precancer and cancer. The high prevalence rates of HPV16/18 infection among women below 30 years of age with HSILs suggests that the impact of vaccination would be primarily observed among young women.	[Heard, Isabelle; Arowas, Laurence; Res, Michael Falguie; Demazoin, Marie-Christine; Favre, Michel] Inst Pasteur, French HPV Reference Lab, Paris, France; [Heard, Isabelle] Univ Paris 06, Grp Hosp Pitie Salpetriere, INSERM U943, Paris, France; [Tondeur, Laura] Inst Pasteur, Emerging Dis Epidemiol Expertise Unit, Paris, France; [Favre, Michel] Inst Pasteur, Genet Papillomavirus & Human Canc Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Heard, I (corresponding author), Inst Pasteur, French HPV Reference Lab, Paris, France.	isabelle.heard@pasteur.fr			Institut Pasteur; French Institut National du Cancer [2010-05]; French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV)	Institut Pasteur(European Commission); French Institut National du Cancer(Institut National du Cancer (INCA) France); French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV)	This study was funded by the Institut Pasteur and by grants from the French Institut National du Cancer (INCa no 2010-05) and by the French Institut de Veille Sanitaire (InVS: Etude Genotypage des HPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2009, J WOMENS HEALTH, V18, P1341, DOI 10.1089/jwh.2008.1223; Arbyn M, 2009, CANCER EPIDEM BIOMAR, V18, P321, DOI 10.1158/1055-9965.EPI-08-0510; Baandrup L, 2012, GYNECOL ONCOL, V124, P281, DOI 10.1016/j.ygyno.2011.10.020; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gravitt PE, 2013, J INFECT DIS, V207, P272, DOI 10.1093/infdis/jis660; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Pretet JL, 2008, GYNECOL ONCOL, V110, P179, DOI 10.1016/j.ygyno.2008.04.012; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79372	10.1371/journal.pone.0079372	http://dx.doi.org/10.1371/journal.pone.0079372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244490	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800066
J	Tong, JY; Ding, JD; Shen, XB; Chen, L; Bian, YP; Ma, GS; Yao, YY; Yang, F				Tong, Jiayi; Ding, Jiandong; Shen, Xiangbo; Chen, Long; Bian, Yeping; Ma, Genshan; Yao, Yuyu; Yang, Fang			Mesenchymal Stem Cell Transplantation Enhancement in Myocardial Infarction Rat Model under Ultrasound Combined with Nitric Oxide Microbubbles	PLOS ONE			English	Article							OXIDATIVE STRESS; DESTRUCTION; DYSFUNCTION; DELIVERY	Objective:This study evaluated the effects of ultrasound combined with the homemade nitric oxide (NO) micro-bubble destruction on the in vitro proliferation, apoptosis, and migration of mesenchymal stem cells (MSCs). Furthermore, we studied whether or not irradiation of the NO microbubble combined with bone-marrow derived MSC infusion had a better effect on treating myocardial infarction. The possible mechanism of MSC delivery into the infarcted myocardium was also investigated. Methods:The murine bone marrow-derived MSCs were isolated, cultured, irradiated, and combined with different concentrations of NO microbubbles. MTT proliferation assay, annexin V-FITC apoptosis detection, migration assay, and RT-PCR were performed 24 h after the irradiation. The NO micro-bubbles was a intravenously injected, followed by the infusion of MSCs, which were labeled by CM-Dil. Myocardium was harvested 48 h later and the distribution of MSCs was observed by laser scanning confocal microscope after frozen sectioning. Echocardiography, histological examination, RT-PCR, and western blotting were performed four weeks after the cell transplantation. Results:Ultrasound combined with 1:70 NO micro-bubbles had no significant impact on the proliferation or apoptosis of MSCs. Transwell chamber findings demonstrated that MSCs migrated more efficiently in group that underwent ultrasound combined with 1:70 NO micro-bubbles. The Real-time PCR results indicated that the expression of CXCR4 was much higher in the group undergoing ultrasound combined with 1:70 NO micro-bubbles. The normalized fluorescence intensity greatly increased in the group of US+NO micro-bubbles and the cardiac function was also markedly improved. Immunohistochemical staining showed that the capillary density was much greater in the group of US+NO micro-bubbles as compared to that of the other groups. RT-PCR and western blotting also revealed a higher SDF-1 and VEGF expression in the group of US+NO micro-bubbles. Conclusions:NO micro-bubbles could be used in the cell transplantation, which efficiently promoted the MSC homing into the infarcted myocardium.	[Tong, Jiayi; Ding, Jiandong; Shen, Xiangbo; Chen, Long; Ma, Genshan; Yao, Yuyu] Southeast Univ, Inst Cardiol, Nanjing, Jiangsu, Peoples R China; [Bian, Yeping] Jiangsu Prov Official Hosp, Nanjing, Jiangsu, Peoples R China; [Yang, Fang] Southeast Univ, Sch Biol Sci & Med Engn, Jiangsu Key Lab Biomat & Devices, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Tong, JY (corresponding author), Southeast Univ, Inst Cardiol, Nanjing, Jiangsu, Peoples R China.	jytong88@aliyun.com; yangfang2080@seu.edu.cn			National Natural Science Foundation of China [81070265]; Specialized Research Fund for the Doctoral Program of Higher Education [20090092120059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was support by National Natural Science Foundation of China (No. 81070265) and Specialized Research Fund for the Doctoral Program of Higher Education (NO. 20090092120059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bertuglia S, 2003, AM J PHYSIOL-HEART C, V285, pH1064, DOI 10.1152/ajpheart.00124.2003; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dorner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056841; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Kang Shih-Tsung, 2012, Chang Gung Med J, V35, P125; Laing ST, 2009, CARDIOVASC RES, V83, P626, DOI 10.1093/cvr/cvp192; Li P, 2003, ULTRASOUND MED BIOL, V29, P1341, DOI 10.1016/S0301-5629(03)00988-8; MacFarlane NG, 2000, AM J PHYSIOL-CELL PH, V278, pC739, DOI 10.1152/ajpcell.2000.278.4.C739; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Panovsky R, 2008, ECHOCARDIOGR-J CARD, V25, P888, DOI 10.1111/j.1540-8175.2008.00696.x; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Schachinger V, 2006, HERZ, V31, P127, DOI 10.1007/s00059-006-2794-x; Song J, 2002, CIRCULATION, V106, P1550, DOI 10.1161/01.CIR.0000028810.33423.95; ter Haar G, 2009, MED BIOL ENG COMPUT, V47, P893, DOI 10.1007/s11517-009-0507-3; Terada LS, 2002, CRIT CARE MED, V30, pS186, DOI 10.1097/00003246-200205001-00003; Teupe C, 2002, CIRCULATION, V105, P1104, DOI 10.1161/hc0902.104720; Tiemann K, 2000, ECHOCARDIOGR-J CARD, V17, P17, DOI 10.1111/j.1540-8175.2000.tb00989.x; Zen K, 2006, J MOL CELL CARDIOL, V40, P799, DOI 10.1016/j.yjmcc.2006.03.012; Zhong SG, 2012, ULTRASONICS, V52, P281, DOI 10.1016/j.ultras.2011.08.013	22	34	39	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80186	10.1371/journal.pone.0080186	http://dx.doi.org/10.1371/journal.pone.0080186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244646	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800135
J	Chipaux, M; Colonnese, MT; Mauguen, A; Fellous, L; Mokhtari, M; Lezcano, O; Milh, M; Dulac, O; Chiron, C; Khazipov, R; Kaminska, A				Chipaux, Mathilde; Colonnese, Matthew T.; Mauguen, Audrey; Fellous, Laure; Mokhtari, Mostafa; Lezcano, Oscar; Milh, Mathieu; Dulac, Olivier; Chiron, Catherine; Khazipov, Rustem; Kaminska, Anna			Auditory Stimuli Mimicking Ambient Sounds Drive Temporal "Delta-Brushes'' in Premature Infants	PLOS ONE			English	Article							CRITICAL PERIOD PLASTICITY; OCULAR DOMINANCE COLUMNS; EARLY MOTOR-ACTIVITY; MONTHS POST TERM; BARREL CORTEX; BINOCULAR COMPETITION; SOMATOSENSORY CORTEX; EVOKED-POTENTIALS; RECEPTIVE-FIELDS; SPINDLE BURSTS	In the premature infant, somatosensory and visual stimuli trigger an immature electroencephalographic (EEG) pattern, "delta-brushes,'' in the corresponding sensory cortical areas. Whether auditory stimuli evoke delta-brushes in the premature auditory cortex has not been reported. Here, responses to auditory stimuli were studied in 46 premature infants without neurologic risk aged 31 to 38 postmenstrual weeks (PMW) during routine EEG recording. Stimuli consisted of either low-volume technogenic "clicks'' near the background noise level of the neonatal care unit, or a human voice at conversational sound level. Stimuli were administrated pseudo-randomly during quiet and active sleep. In another protocol, the cortical response to a composite stimulus ("click'' and voice) was manually triggered during EEG hypoactive periods of quiet sleep. Cortical responses were analyzed by event detection, power frequency analysis and stimulus locked averaging. Before 34 PMW, both voice and "click'' stimuli evoked cortical responses with similar frequency-power topographic characteristics, namely a temporal negative slow-wave and rapid oscillations similar to spontaneous delta-brushes. Responses to composite stimuli also showed a maximal frequency-power increase in temporal areas before 35 PMW. From 34 PMW the topography of responses in quiet sleep was different for "click'' and voice stimuli: responses to "clicks'' became diffuse but responses to voice remained limited to temporal areas. After the age of 35 PMW auditory evoked delta-brushes progressively disappeared and were replaced by a low amplitude response in the same location. Our data show that auditory stimuli mimicking ambient sounds efficiently evoke delta-brushes in temporal areas in the premature infant before 35 PMW. Along with findings in other sensory modalities (visual and somatosensory), these findings suggest that sensory driven delta-brushes represent a ubiquitous feature of the human sensory cortex during fetal stages and provide a potential test of functional cortical maturation during fetal development.	[Chipaux, Mathilde; Mauguen, Audrey; Dulac, Olivier; Chiron, Catherine; Kaminska, Anna] INSERM, U663, Paris, France; [Chipaux, Mathilde; Mauguen, Audrey; Dulac, Olivier; Chiron, Catherine; Kaminska, Anna] Univ Paris 05, Paris, France; [Chipaux, Mathilde] Neurospin, CEA, Gif Sur Yvette, France; [Chipaux, Mathilde] Fdn Ophtalmol A de Rothschild, Dept Pediat Neurosurg, Paris, France; [Colonnese, Matthew T.; Milh, Mathieu; Khazipov, Rustem] Aix Marseille Univ, INSERM, Inmed U901, Marseille, France; [Colonnese, Matthew T.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Colonnese, Matthew T.] George Washington Univ, Inst Neurosci, Washington, DC USA; [Fellous, Laure; Mokhtari, Mostafa; Lezcano, Oscar] Cochin St Vincent de Paul Hosp, AP HP, Dept Neonatal Care Unit, Paris, France; [Mokhtari, Mostafa] Kremlin Bicetre Hosp, Dept Neonatal Intens Care Unit, AP HP, Le Kremlin Bicetre, France; [Khazipov, Rustem] Kazan Fed Univ, Neurobiol Lab, Kazan, Russia; [Kaminska, Anna] Cochin St Vincent de Paul Hosp, AP HP, Dept Clin Neurophysiol, Paris, France; [Kaminska, Anna] Necker Enfants Malad Hosp, AP HP, Dept Clin Neurophysiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; George Washington University; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Kazan Federal University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Kaminska, A (corresponding author), INSERM, U663, Paris, France.	anna.kaminska@nck.aphp.fr	Chiron, Catherine/E-8506-2016; Khazipov, Roustem/M-1834-2016	Chiron, Catherine/0000-0002-9096-1694; Khazipov, Roustem/0000-0002-6763-2841; Mauguen, Audrey/0000-0003-3236-6093; Colonnese, Matthew/0000-0002-2480-1270; Kaminska, Anna/0000-0003-3805-6651	French Agency for Research (ANR); Government of the Russian Federation [11.G34.31.0075]; Fondation pour la Recherche Medicale [DEQ20110421301];  [ANR-09-MNPS-006 Delta-Brush]	French Agency for Research (ANR)(French National Research Agency (ANR)); Government of the Russian Federation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported by the French Agency for Research (ANR) (www.agence-nationale-recherche.fr): AK, CC, RK) and ANR-09-MNPS-006 Delta-Brush (to AK, CC, RK), the Government of the Russian Federation (Grant 11.G34.31.0075 to RK), and Fondation pour la Recherche Medicale (DEQ20110421301 to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams R M, 2000, J Perinatol, V20, pS31; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; CURZIDASCALOVA L, 1993, PEDIATR RES, V34, P624, DOI 10.1203/00006450-199311000-00013; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; Dehaene-Lambertz G, 2006, TRENDS NEUROSCI, V29, P367, DOI 10.1016/j.tins.2006.05.011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DREYFUS-BRISAC C, 1962, World Neurol, V3, P5; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Fabrizi L, 2011, JOVE-J VIS EXP, DOI 10.3791/3118; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Fox K, 2000, CURR OPIN NEUROBIOL, V10, P494, DOI 10.1016/S0959-4388(00)00112-4; Furman M, 2012, J NEUROPHYSIOL, V107, P3200, DOI 10.1152/jn.00943.2011; Gelman A., 2007, DATA ANAL USING REGR; Granier-Deferre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017304; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HEPPER PG, 1994, ARCH DIS CHILD-FETAL, V71, pF81, DOI 10.1136/fn.71.2.F81; Holst M, 2005, CLIN NEUROPHYSIOL, V116, P1949, DOI 10.1016/j.clinph.2005.04.008; Horton JC, 1996, J NEUROSCI, V16, P7228; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; KURTZBERG D, 1984, DEV MED CHILD NEUROL, V26, P466; Lecanuet JP, 2000, DEV PSYCHOBIOL, V36, P29, DOI 10.1002/(SICI)1098-2302(200001)36:1<29::AID-DEV4>3.3.CO;2-A; Lengle JM, 2001, CLIN NEUROPHYSIOL, V112, P785, DOI 10.1016/S1388-2457(01)00532-6; Lickliter R, 2000, J Perinatol, V20, pS45; Mahmoudzadeh M, 2013, P NATL ACAD SCI USA, V110, P4846, DOI 10.1073/pnas.1212220110; Marcano-Reik AJ, 2008, EUR J NEUROSCI, V28, P1457, DOI 10.1111/j.1460-9568.2008.06461.x; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; Minlebaev M, 2007, J NEUROPHYSIOL, V97, P692, DOI 10.1152/jn.00759.2006; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; Minlebaev M, 2009, CEREB CORTEX, V19, P688, DOI 10.1093/cercor/bhn115; Mitra P., 2007, OBSERVED BRAIN DYNAM; MONOD N, 1971, BIOL NEONATE, V17, P292; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Nunes ML, 1997, ELECTROEN CLIN NEURO, V102, P186, DOI 10.1016/S0013-4694(96)95191-7; Pena M, 2012, J NEUROSCI, V32, P11159, DOI 10.1523/JNEUROSCI.6516-11.2012; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; ROTTEVEEL JJ, 1987, HEARING RES, V27, P85, DOI 10.1016/0378-5955(87)90028-1; ROTTEVEEL JJ, 1987, HEARING RES, V27, P95, DOI 10.1016/0378-5955(87)90029-3; Schleussner E, 2004, EXP NEUROL, V190, pS59, DOI 10.1016/j.expneurol.2004.04.008; SHAHIDULLAH S, 1994, EARLY HUM DEV, V36, P13, DOI 10.1016/0378-3782(94)90029-9; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Stjerna S, 2012, JOVE-J VIS EXP, DOI 10.3791/3774; Thomas K A, 2000, J Perinatol, V20, pS94; TURKEWITZ G, 1972, DEV MED CHILD NEUROL, V14, P487; Vanhatalo S, 2005, CLIN EEG NEUROSCI, V36, P311, DOI 10.1177/155005940503600411; WEITZMAN E D, 1968, Developmental Psychobiology, V1, P79, DOI 10.1002/dev.420010203; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wu CS, 2011, EUR J NEUROSCI, V34, P1663, DOI 10.1111/j.1460-9568.2011.07892.x; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Yang JW, 2013, CEREB CORTEX, V23, P1299, DOI 10.1093/cercor/bhs103; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	73	43	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79028	10.1371/journal.pone.0079028	http://dx.doi.org/10.1371/journal.pone.0079028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244408	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600096
J	Escolar, G; Fernandez-Gallego, V; Arellano-Rodrigo, E; Roquer, J; Reverter, JC; Sanz, VV; Molina, P; Lopez-Vilchez, I; Diaz-Ricart, M; Galan, AM				Escolar, Gines; Fernandez-Gallego, Victor; Arellano-Rodrigo, Eduardo; Roquer, Jaume; Carles Reverter, Joan; Veronica Sanz, Victoria; Molina, Patricia; Lopez-Vilchez, Irene; Diaz-Ricart, Maribel; Maria Galan, Ana			Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; FACTOR XA INHIBITORS; THROMBIN GENERATION ASSAY; ORAL ANTICOAGULANTS; RABBIT MODEL; TRANSFUSION MEDICINE; HEALTHY-SUBJECTS; RIVAROXABAN; DABIGATRAN	Apixaban is a new oral anticoagulant with a specific inhibitory action on FXa. No information is available on the reversal of the antihemostatic action of apixaban in experimental or clinical settings. We have evaluated the effectiveness of different factor concentrates at reversing modifications of hemostatic mechanisms induced by moderately elevated concentrations of apixaban (200 ng/ml) added in vitro to blood from healthy donors (n = 10). Effects on thrombin generation (TG) and thromboelastometry (TEM) parameters were assessed. Modifications in platelet adhesive, aggregating and procoagulant activities were evaluated in studies with blood circulating through damaged vascular surfaces, at a shear rate of 600 s(-1). The potential of prothrombin complex concentrates (PCCs; 50 IU/kg), activated prothrombin complex concentrates (aPCCs; 75 IU/kg), or activated recombinant factor VII (rFVIIa; 270 mu g/kg), at reversing the antihemostatic actions of apixaban, were investigated. Apixaban interfered with TG kinetics. Delayed lag phase, prolonged time to peak and reduced peak values, were improved by the different concentrates, though modifications in TG patterns were diversely affected depending on the activating reagents. Apixaban significantly prolonged clotting times (CTs) in TEM studies. Prolongations in CTs were corrected by the different concentrates with variable efficacies (rFVIIa >= aPCC>PCC). Apixaban significantly reduced fibrin and platelet interactions with damaged vascular surfaces in perfusion studies (p<0.05 and p<0.01, respectively). Impairments in fibrin formation were normalized by the different concentrates. Only rFVIIa significantly restored levels of platelet deposition. Alterations in hemostasis induced by apixaban were variably compensated by the different factor concentrates investigated. However, effects of these concentrates were not homogeneous in all the tests, with PCCs showing more efficacy in TG, and rFVIIa being more effective on TEM and perfusion studies. Our results indicate that rFVIIa, PCCs and aPCCs have the potential to restore platelet and fibrin components of the hemostasis previously altered by apixaban.	[Escolar, Gines; Arellano-Rodrigo, Eduardo; Carles Reverter, Joan; Veronica Sanz, Victoria; Molina, Patricia; Lopez-Vilchez, Irene; Diaz-Ricart, Maribel; Maria Galan, Ana] Univ Barcelona, Hosp Clin, Dept Hemotherapy Hemostasis, Ctr Diagnost Biomed,Inst Invest Biomed August Pi, Barcelona, Spain; [Fernandez-Gallego, Victor] Bristol Myers Squibb, Madrid, Spain; [Roquer, Jaume] Hosp Univ del Mar, Dept Neurol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; Bristol-Myers Squibb; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Escolar, G (corresponding author), Univ Barcelona, Hosp Clin, Dept Hemotherapy Hemostasis, Ctr Diagnost Biomed,Inst Invest Biomed August Pi, Barcelona, Spain.	gescolar@clinic.ub.es	Arellano-Rodrigo, Eduardo/H-4094-2015; Escolar, Gines/I-1530-2015; Escolar, Gines/ABF-9003-2021; Roquer, Jaume/G-8919-2017; Arellano-Rodrigo, Eduardo/R-7079-2019; Albaladejo, Gines Escolar/AAC-9695-2020	Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Escolar, Gines/0000-0002-6658-0381; Roquer, Jaume/0000-0001-5992-2606; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Albaladejo, Gines Escolar/0000-0002-6658-0381; Reverter, Joan Carles/0000-0002-1274-4782; DIAZ-RICART, MARIBEL/0000-0003-1122-0052	Spanish Government [CP04-00112, PS09/00664, SAF2009-10365, RD06/0009/1003-0015]; BMS-Pfizer	Spanish Government(Spanish GovernmentEuropean Commission); BMS-Pfizer(Pfizer)	This work was partially supported by grants FIS (CP04-00112, PS09/00664), SAF2009-10365, and Red HERACLES RD06/0009/1003-0015 from the Spanish Government and by an investigator sponsored award from BMS-Pfizer. Dr A. M. Galan belongs to the Miguel Servet Researcher's stabilization program of "Instituto de Salud Carlos III'' from the Spanish government and "Direccio d'Estrategia i Coordinacio del Departament de Salut'' from the Generalitat de Catalunya. Dr Fernandez-Gallego is employed by Bristol-Myers Squibb, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Anderson L, 2006, TRANSFUSION MED, V16, P31, DOI 10.1111/j.1365-3148.2006.00645.x; Bauer KA, 2012, AM J HEMATOL, V87, pS119, DOI 10.1002/ajh.23165; Bauer Kenneth A, 2010, Rev Neurol Dis, V7, P1; Caballo C, 2012, BLOOD TRANSFUS, V10, P1; Crowther MA, 2009, J THROMB HAEMOST, V7, P107, DOI 10.1111/j.1538-7836.2009.03429.x; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Dinkelaar J, 2013, J THROMB HAEMOST, V11, P1111, DOI 10.1111/jth.12236; Dzik W, 2012, TRANSFUSION, V52, p45S, DOI 10.1111/j.1537-2995.2012.03690.x; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; ESCOLAR G, 1994, TRANSFUSION, V34, P542, DOI 10.1046/j.1537-2995.1994.34694295074.x; Escolar G, 2001, TRANSFUS MED REV, V15, P144, DOI 10.1053/tm.rv.2001.22617; Frost C, 2013, BRIT J CLIN PHARMACO, V75, P476, DOI 10.1111/j.1365-2125.2012.04369.x; Galan AM, 2003, TRANSFUSION, V43, P885, DOI 10.1046/j.1537-2995.2003.00427.x; Galan AM, 2011, TRANSFUSION, V51, P808, DOI 10.1111/j.1537-2995.2010.02914.x; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Garcia D, 2010, BLOOD, V115, P15, DOI 10.1182/blood-2009-09-241851; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; He K, 2011, EUR J DRUG METAB PH, V36, P129, DOI 10.1007/s13318-011-0037-x; Hemker HC, 2012, J THROMB HAEMOST, V10, P1470, DOI 10.1111/j.1538-7836.2012.04802.x; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Key Nigel, 2006, Clin Adv Hematol Oncol, V4, P34; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Lopez-Vilchez I, 2011, AM J PATHOL, V178, P2938, DOI 10.1016/j.ajpath.2011.02.026; Mann KG, 2012, J THROMB HAEMOST, V10, P1463, DOI 10.1111/j.1538-7836.2012.04799.x; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Martin AC, 2012, EUR HEART J, V33, P496; Martin AC, 2012, CARDIOVASC RES, V93, pS73; Miesbach W, 2012, THROMB HAEMOSTASIS, V108, P625, DOI 10.1160/TH12-05-0319; Pengo V, 2011, THROMB HAEMOSTASIS, V106, P868, DOI 10.1160/TH11-05-0358; Perzborn E., 2008, PATHOPHYSIOL HAEMO T, V36, pA40; Pragst I, 2012, J THROMB HAEMOST, V10, P1841, DOI 10.1111/j.1538-7836.2012.04859.x; Siegal DM, 2013, EUR HEART J, V34, P489, DOI 10.1093/eurheartj/ehs408; Tinel H, 2007, J THROMB HAEMOST S2, V5, pA652; Tonda R, 2003, J HEPATOL, V39, P954, DOI 10.1016/S0168-8278(03)00454-9; Varadi K, 2004, HAEMOPHILIA, V10, P17, DOI 10.1111/j.1365-2516.2004.00936.x; Weitz JI, 2010, THROMB HAEMOSTASIS, V103, P62, DOI 10.1160/TH09-07-0434; Wienen W, 2005, J THROMB HAEMOST S1, V3, pA1703; Wong Pancras C, 2013, Hosp Pract (1995), V41, P19, DOI 10.3810/hp.2013.02.1009; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741	42	101	102	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78696	10.1371/journal.pone.0078696	http://dx.doi.org/10.1371/journal.pone.0078696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244342	Green Published, gold			2022-12-27	WOS:000327221600051
J	Latus, J; Klein, R; Koetter, I; Schwab, M; Fritz, P; Kimmel, M; Alscher, MD; Braun, N				Latus, Joerg; Klein, Reinhild; Koetter, Ina; Schwab, Matthias; Fritz, Peter; Kimmel, Martin; Alscher, M. Dominik; Braun, Niko			Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments	PLOS ONE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; IMMUNE-COMPLEXES; GLOBULIN FACTORS; HUMAN SERA; IMMUNOGENICITY; THERAPY; REACTIVATION; HEPATITIS	Background: Millions of patients are treated with therapeutic monoclonal antibodies (Tmabs) for miscellaneous diseases. We investigated sera from six patients who received immune globulin, from one patient with refractory anti-neutrophil-cytoplasmic antibody (ANCA)-associated granulomatosis with polyangiitis (GPA) who developed two episodes of acute cholestatic liver disease, one after treatment with rituximab and a second after adalimumab and a healthy control group. Methods: Three sera from the patient and six sera from patients who received immune globulin were analyzed for antibodies to rituximab and adalimumab by ELISA. Additionally, sera from the patients and from nine healthy blood donors were coated with the Fab fragment of an unrelated humanized monoclonal antibody, with human Fc proteins as well as a mouse IgG globulin. Results: Viral serology for hepatitis A, B, C and autoantibodies specific for autoimmune liver disorders were negative. In all three sera from the patient antibodies to rituximab could be detected, but also antibodies to adalimumab were present even at time points when the patient had not yet received adalimumab, indicating cross reactivity between both substances. Testing against an unrelated human Fab fragment revealed positive results, indicating that the patient had antibodies against human Fab fragments in general. The Fc proteins were negative, and patients' sera did also not react with mouse IgG globulins. Remarkably, 2 out of 5 patients which were treated with immune globulin had antibodies against human Fab fragments in general whereas in none of the samples from healthy controls antibodies to Fab fragment could be detected. Conclusion: This is the first study demonstrating cholestatic liver disease induced by two different Tmabs. Cross - reacting antibodies to Fab2 fragments in general are probably involved. Further studies must show if these Fab2 antibodies in general are related with drug-induced side effects and accelerated drug clearance in patients on Tmab therapy.	[Latus, Joerg; Koetter, Ina; Kimmel, Martin; Alscher, M. Dominik; Braun, Niko] Robert Bosch Hosp Stuttgart, Div Nephrol, Dept Internal Med, Stuttgart, Germany; [Klein, Reinhild] Univ Hosp Tuebingen, Dept Internal Med 2, Tubingen, Germany; [Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schwab, Matthias] Univ Tubingen, Stuttgart, Germany; [Fritz, Peter] Inst Digital Med, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Latus, J (corresponding author), Robert Bosch Hosp Stuttgart, Div Nephrol, Dept Internal Med, Stuttgart, Germany.	Joerg.latus@rbk.de	Kimmel, Martin/AAM-2514-2021; Schwab, Matthias/ABH-7449-2020; Koetter, Ina/O-3121-2019	Koetter, Ina/0000-0002-9262-005X				Aarden L, 2008, CURR OPIN IMMUNOL, V20, P431, DOI 10.1016/j.coi.2008.06.011; Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Del Prete CJ, 2010, CANCER BIOTHER RADIO, V25, P747, DOI 10.1089/cbr.2010.0806; Fleischmann RA, 2009, SEMIN ARTHRITIS RHEU, V38, P265, DOI 10.1016/j.semarthrit.2008.01.001; Grasland A, 2011, EUR J CLIN PHARM; Johansson AG, 2000, INT ARCH ALLERGY IMM, V121, P329, DOI 10.1159/000024347; Lovdal T, 2000, J CELL SCI, V113, P3255; Matteucci P, 2002, BLOOD, V100, P1104, DOI 10.1182/blood-2002-04-1271; Ng HJ, 2001, ANN HEMATOL, V80, P549, DOI 10.1007/s002770100346; Ng PC, 2003, ARCH DIS CHILD, V88, P337, DOI 10.1136/adc.88.4.337; OSTERLAND CK, 1963, VOX SANG, V8, P133; PERSSELIN JE, 1985, J CLIN INVEST, V76, P723, DOI 10.1172/JCI112027; Pichler WJ, 2004, ALLERGY, V59, P809, DOI 10.1111/j.1398-9995.2004.00547.x; Qazilbash MH, 2005, AM J HEMATOL, V80, P43, DOI 10.1002/ajh.20413; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Shankar G, 2006, TRENDS BIOTECHNOL, V24, P274, DOI 10.1016/j.tibtech.2006.04.001; Sokolove J, 2010, ANN RHEUM DIS, V69, P1612, DOI 10.1136/ard.2009.112136; Suzan F, 2001, NEW ENGL J MED, V345, P1000, DOI 10.1056/NEJM200109273451315; WILLIAMS RC, 1965, ANN NY ACAD SCI, V124, P860, DOI 10.1111/j.1749-6632.1965.tb19008.x; Winkler U, 1999, BLOOD, V94, P2217, DOI 10.1182/blood.V94.7.2217.419k02_2217_2224	23	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78856	10.1371/journal.pone.0078856	http://dx.doi.org/10.1371/journal.pone.0078856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244376	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600072
J	Peri, E; Frati, F; Salerno, G; Conti, E; Colazza, S				Peri, Ezio; Frati, Francesca; Salerno, Gianandrea; Conti, Eric; Colazza, Stefano			Host Chemical Footprints Induce Host Sex Discrimination Ability in Egg Parasitoids	PLOS ONE			English	Article							TRISSOLCUS-BASALIS HYMENOPTERA; NEZARA-VIRIDULA; FORAGING BEHAVIOR; INFOCHEMICAL USE; PLANT; CUES; PENTATOMIDAE; SPECIFICITY; KAIROMONES; LOCATION	Trissolcus egg parasitoids, when perceiving the chemical footprints left on a substrate by pentatomid host bugs, adopt a motivated searching behaviour characterized by longer searching time on patches were signals are present. Once in contact with host chemical footprints, Trissolcus wasps search longer on traces left by associated hosts rather than non-associated species, and, in the former case, they search longer on traces left by females than males. Based on these evidences, we hypothesized that only associated hosts induce the ability to discriminate host sex in wasps. To test this hypothesis we investigated the ability of Trissolcus basalis, T. brochymenae, and Trissolcus sp. to distinguish female from male Nezara viridula, Murgantia histrionica, and Graphosoma semipunctatum footprints. These three pentatomid bugs were selected according to variable association levels. Bioassays were conducted on filter paper sheets, and on Brassica oleracea (broccoli) leaves. The results confirmed our hypothesis showing that wasps spent significantly more time on female rather than male traces left by associated hosts on both substrates. No differences were observed in the presence of traces left by non-associated hosts. The ecological consequences for parasitoid host location behaviour are discussed.	[Peri, Ezio; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Frati, Francesca; Salerno, Gianandrea; Conti, Eric] Univ Perugia, Dipartimento Sci Agr & Ambientali, I-06100 Perugia, Italy	University of Palermo; University of Perugia	Peri, E (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	ezio.peri@unipa.it	Conti, Eric/G-6400-2014; Salerno, Gianandrea/G-9296-2011	Salerno, Gianandrea/0000-0002-8357-7598; colazza, stefano/0000-0001-8023-7814; PERI, Ezio/0000-0002-1095-7258; Frati, Francesca/0000-0002-9891-9757				Alborn HT, 1995, J CHEM ECOL, V21, P1697, DOI 10.1007/BF02033670; ANDOW DA, 1990, OECOLOGIA, V82, P162, DOI 10.1007/BF00323530; Borges M, 2003, PHYSIOL ENTOMOL, V28, P349, DOI 10.1111/j.1365-3032.2003.00350.x; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Colazza S., 1999, 12 INT ENT INS WORKS; Colazza S, 2007, J CHEM ECOL, V33, P1405, DOI 10.1007/s10886-007-9300-7; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Colazza S, 2009, NATURWISSENSCHAFTEN, V96, P975, DOI 10.1007/s00114-009-0548-3; Conti E, 2004, BIOL CONTROL, V29, P435, DOI 10.1016/j.biocontrol.2003.08.009; Conti E, 2003, J CHEM ECOL, V29, P115, DOI 10.1023/A:1021980614512; Conti E, 2010, J EXP BIOL, V213, P3911, DOI 10.1242/jeb.045922; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Eigenbrode SD, 2002, INTEGR COMP BIOL, V42, P1091, DOI 10.1093/icb/42.6.1091; ESPELIE KE, 1991, ARCH INSECT BIOCHEM, V17, P223, DOI 10.1002/arch.940170406; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Frati F, 2013, INSECT SCI, V20, P753, DOI 10.1111/j.1744-7917.2012.01575.x; Gentry GL, 2006, ENTOMOL EXP APPL, V121, P115, DOI 10.1111/j.1570-8703.2006.00472.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; KOTLER BP, 1995, EVOL ECOL, V9, P18, DOI 10.1007/BF01237693; Lo Giudice D, 2011, J CHEM ECOL, V37, P622, DOI 10.1007/s10886-011-9957-9; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; McAuslane HJ, 2000, FLA ENTOMOL, V83, P428, DOI 10.2307/3496718; Meiners T, 2000, ENTOMOL EXP APPL, V95, P151, DOI 10.1023/A:1004098802806; Meiners T, 2013, CHEM ECOLOGY INSECT, P191, DOI DOI 10.1002/9781118409589.CH9; OBRYCKI JJ, 1986, INTERACTIONS PLANT R, P61; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Powell W, 1998, BIOL CONTROL, V11, P104, DOI 10.1006/bcon.1997.0584; Powell W, 2003, PEST MANAG SCI, V59, P149, DOI 10.1002/ps.550; Puente ME, 2008, J CHEM ECOL, V34, P945, DOI 10.1007/s10886-008-9471-x; Rogers ME, 2002, ENTOMOL EXP APPL, V102, P307, DOI 10.1023/A:1019537701902; Romeis J, 1998, ENTOMOL EXP APPL, V87, P275, DOI 10.1023/A:1003275419997; Rostas M, 2008, NATURWISSENSCHAFTEN, V95, P997, DOI 10.1007/s00114-008-0411-y; Safavi M., 1968, Entomophaga, V13, P381; Salerno G, 2006, EUR J ENTOMOL, V103, P311, DOI 10.14411/eje.2006.040; Salerno G, 2009, J EXP BIOL, V212, P1825, DOI 10.1242/jeb.028308; Salerno G, 2012, INVERTEBR BIOL, V131, P144, DOI 10.1111/j.1744-7410.2012.00258.x; Schreiber SJ, 2002, EVOL ECOL RES, V4, P701; StatSoft, 2001, STAT PER WINDOWS USE; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vinson S. B., 1977, Biological control by augmentation of natural enemies. Insect and mite control with parasites and predators., P237; Vinson S.B., 1991, Redia, V74, P15; Vinson SB, 2010, PROG BIOL CONTROL, V9, P25, DOI 10.1007/978-1-4020-9110-0_2; Vinson SB, 1998, BIOL CONTROL, V11, P79, DOI 10.1006/bcon.1997.0601; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	48	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79054	10.1371/journal.pone.0079054	http://dx.doi.org/10.1371/journal.pone.0079054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244417	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600103
J	Salomon, C; Kobayashi, M; Ashman, K; Sobrevia, L; Mitchell, MD; Rice, GE				Salomon, Carlos; Kobayashi, Miharu; Ashman, Keith; Sobrevia, Luis; Mitchell, Murray D.; Rice, Gregory E.			Hypoxia-Induced Changes in the Bioactivity of Cytotrophoblast-Derived Exosomes	PLOS ONE			English	Article							EXTRAVILLOUS TROPHOBLAST CELLS; BREAST-CANCER CELLS; NORMAL-PREGNANCY; IN-VITRO; INVASION; PREECLAMPSIA; OXYGEN; INHIBITION; TRIMESTER; MECHANISM	Migration of extravillous trophoblasts (EVT) into decidua and myometrium is a critical process in the conversion of maternal spiral arterioles and establishing placenta perfusion. EVT migration is affected by cell-to-cell communication and oxygen tension. While the release of exosomes from placental cells has been identified as a significant pathway in materno-fetal communication, the role of placental-derived exosomes in placentation has yet to be established. The aim of this study was to establish the effect of oxygen tension on the release and bioactivity of cytotrophoblast (CT)-derived exosomes on EVT invasion and proliferation. CT were isolated from first trimester fetal tissue (n = 12) using a trypsin-deoxyribonucleasedispase/ Percoll method. CT were cultured under 8%, 3% or 1% O2 for 48 h. Exosomes from CT-conditioned media were isolated by differential and buoyant density centrifugation. The effect of oxygen tension on exosome release (mg exosomal protein/10(6)cells/48 h) and bioactivity were established. HTR-8/SVneo (EVT) were used as target cells to establish the effect (bioactivity) of exosomes on invasion and proliferation as assessed by real-time, live-cell imaging (Incucyte (TM)). The release and bioactivity of CT-derived exosomes were inversely correlated with oxygen tension (p<0.001). Under low oxygen tensions (i.e. 1% O2), CT-derived exosomes promoted EVT invasion and proliferation. Proteomic analysis of exosomes identified oxygen-dependent changes in protein content. We propose that in response to changes in oxygen tension, CTs modify the bioactivity of exosomes, thereby, regulating EVT phenotype. Exosomal induction of EVT migration may represent a normal process of placentation and/or an adaptive response to placental hypoxia.	[Salomon, Carlos; Kobayashi, Miharu; Ashman, Keith; Sobrevia, Luis; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Brisbane, Qld, Australia; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol, Santiago, Chile	University of Queensland; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Brisbane, Qld, Australia.	c.salomongallo@uq.edu.au	Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Mitchell, Murray/A-8639-2010; RICE, GREGORY E/F-2412-2010	Salomon, Carlos F/0000-0003-4474-0046; Mitchell, Murray/0000-0002-6167-7176; RICE, GREGORY E/0000-0001-7177-0246; Sobrevia, Luis/0000-0001-5802-2243	University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC; CIEF grant (University of Queensland); Department of Employment, Economic Development and Innovation, Queensland Government; Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; CONICYT [ACT-73 PIA]; FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC	University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIEF grant (University of Queensland); Department of Employment, Economic Development and Innovation, Queensland Government; Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government(Australian GovernmentDepartment of Industry, Innovation and Science); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC	CS holds a Postdoctoral Fellowship at The University of Queensland Centre for Clinical Research, Brisbane, Australia. GER was in receipt of an NHMRC Principal Research Fellowship. The work described herein was partially funded by a CIEF grant (University of Queensland), a Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government) and a Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government). This investigation was supported by CONICYT (ACT-73 PIA, Pasantia Doctoral en el Extranjero BECAS Chile), FONDECYT (1110977). CS holds CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Crocker IP, 2005, J PATHOL, V206, P476, DOI 10.1002/path.1801; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1998, BLOOD, V91, P3300, DOI 10.1182/blood.V91.9.3300.3300_3300_3307; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Lash GE, 2006, BIOL REPROD, V74, P403, DOI 10.1095/biolreprod.105.047332; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Lyall F, 2006, AUST NZ J OBSTET GYN, V46, P266, DOI 10.1111/j.1479-828X.2006.00589.x; Maloyan A, 2012, PLACENTA, V33, P456, DOI 10.1016/j.placenta.2012.01.016; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Soares MJ, 2012, J REPROD DEVELOP, V58, P283, DOI 10.1262/jrd.2011-039; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thon JN, 2012, BLOOD, V120, P1975, DOI 10.1182/blood-2012-04-420968; Vitoratos N, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/145487; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zhang HC, 2012, STEM CELLS DEV; Zhao HB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099937	37	114	118	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79636	10.1371/journal.pone.0079636	http://dx.doi.org/10.1371/journal.pone.0079636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244532	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600140
J	Ekvall, MT; Bianco, G; Linse, S; Linke, H; Backman, J; Hansson, LA				Ekvall, Mikael T.; Bianco, Giuseppe; Linse, Sara; Linke, Heiner; Backman, Johan; Hansson, Lars-Anders			Three-Dimensional Tracking of Small Aquatic Organisms Using Fluorescent Nanoparticles	PLOS ONE			English	Article							PARTIAL MIGRATION; QUANTUM DOTS; MATE; COPEPODS; DELIVERY; BEHAVIOR; 3D	Tracking techniques are vital for the understanding of the biology and ecology of organisms. While such techniques have provided important information on the movement and migration of large animals, such as mammals and birds, scientific advances in understanding the individual behaviour and interactions of small (mm-scale) organisms have been hampered by constraints, such as the sizes of existing tracking devices, in existing tracking methods. By combining biology, chemistry and physics we here present a method that allows three-dimensional (3D) tracking of individual mm-sized aquatic organisms. The method is based on in-vivo labelling of the organisms with fluorescent nanoparticles, so-called quantum dots, and tracking of the organisms in 3D via the quantum-dot fluorescence using a synchronized multiple camera system. It allows for the efficient and simultaneous study of the behaviour of one as well as multiple individuals in large volumes of observation, thus enabling the study of behavioural interactions at the community scale. The method is non-perturbing we demonstrate that the labelling is not affecting the behavioural response of the organisms - and is applicable over a wide range of taxa, including cladocerans as well as insects, suggesting that our methodological concept opens up for new research fields on individual behaviour of small animals. Hence, this offers opportunities to focus on important biological, ecological and behavioural questions never before possible to address.	[Ekvall, Mikael T.; Bianco, Giuseppe; Hansson, Lars-Anders] Lund Univ, Dept Biol, Lund, Sweden; [Linse, Sara] Lund Univ, Dept Chem, Lund, Sweden; [Linke, Heiner] Lund Univ, Nanometer Struct Consortium NmC LU, Lund, Sweden; [Linke, Heiner] Lund Univ, Lund, Sweden; [Backman, Johan] Lund Univ, Dept Biol, Ctr Anim Movement Res, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Ekvall, MT (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Mikael.Ekvall@biol.lu.se	Linke, Heiner/A-5825-2010; Hansson, Lars-Anders/HCI-2735-2022	Linke, Heiner/0000-0003-4451-4006; Ekvall, Mikael/0000-0002-4452-0580; Linse, Sara/0000-0001-9629-7109; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council (VR) [621-2010-5404]; Centre for Animal Movement Research (CAnMove) through the Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University; Royal Physiographic Society in Lund	Swedish Research Council (VR)(Swedish Research Council); Centre for Animal Movement Research (CAnMove) through the Linnaeus grant from the Swedish Research Council; Lund University; Royal Physiographic Society in Lund	This study was founded by the Swedish Research Council (VR) (http://www.vr.se) for project funding to L.-A. H. (grant nr: 621-2010-5404) and the Centre for Animal Movement Research (CAnMove) through the Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University. Funding was also received from the Royal Physiographic Society in Lund (http://www.fysiografen.se/) through a grant to M. T. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bagoien E, 2005, MAR ECOL PROG SER, V300, P105, DOI 10.3354/meps300105; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Bianco G, 2013, LIMNOL OCEANOGR-METH, V11, P278, DOI 10.4319/lom.2013.11.278; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Burger W, 2004, DIGITAL IMAGE PROCES; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Doall MH, 1998, PHILOS T ROY SOC B, V353, P681, DOI 10.1098/rstb.1998.0234; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2009, PHOTOCH PHOTOBIO SCI, V8, P1266, DOI 10.1039/b908825c; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; HAYS GC, 1995, LIMNOL OCEANOGR, V40, P469, DOI 10.4319/lo.1995.40.3.0469; Ji MY, 2012, J MOL HISTOL, V43, P517, DOI 10.1007/s10735-012-9424-0; Kim KS, 2012, NANOMED-NANOTECHNOL, V8, P1070, DOI 10.1016/j.nano.2012.05.014; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013516; Liu Y, 2012, BIOCHEM BIOPH RES CO, V425, P769, DOI 10.1016/j.bbrc.2012.07.150; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Salditt Tim, 2002, J Biotechnol, V90, P55; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Strickler JR, 1998, PHILOS T R SOC B, V353, P671, DOI 10.1098/rstb.1998.0233; Titelman J, 2001, MAR ECOL PROG SER, V213, P203, DOI 10.3354/meps213203; Tsuda A, 1998, PHILOS T ROY SOC B, V353, P713, DOI 10.1098/rstb.1998.0237; Usami M, 2004, ULTRA SMALL RFID CHI, P241	29	36	36	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78498	10.1371/journal.pone.0078498	http://dx.doi.org/10.1371/journal.pone.0078498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244316	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900021
J	Tian, ZC; Liu, GY; Yin, H; Luo, JX; Guan, GQ; Luo, J; Xie, JR; Shen, H; Tian, MY; Zheng, JF; Yuan, XS; Wang, FF				Tian, Zhan-Cheng; Liu, Guang-Yuan; Yin, Hong; Luo, Jian-Xun; Guan, Gui-Quan; Luo, Jin; Xie, Jun-Ren; Shen, Hui; Tian, Mei-Yuan; Zheng, Jin-feng; Yuan, Xiao-song; Wang, Fang-fang			RPS8-a New Informative DNA Marker for Phylogeny of Babesia and Theileria Parasites in China	PLOS ONE			English	Article							UNNAMED BOVINE BABESIA; GENOME SEQUENCE; TRANSMISSION; EVOLUTION; GENE; PATHOGEN; SHEEP; SPP.	Piroplasmosis is a serious debilitating and sometimes fatal disease. Phylogenetic relationships within piroplasmida are complex and remain unclear. We compared the intron-exon structure and DNA sequences of the RPS8 gene from Babesia and Theileria spp. isolates in China. Similar to 18S rDNA, the 40S ribosomal protein S8 gene, RPS8, including both coding and non-coding regions is a useful and novel genetic marker for defining species boundaries and for inferring phylogenies because it tends to have little intra-specific variation but considerable inter-specific difference. However, more samples are needed to verify the usefulness of the RPS8 (coding and non-coding regions) gene as a marker for the phylogenetic position and detection of most Babesia and Theileria species, particularly for some closely related species.	[Tian, Zhan-Cheng; Liu, Guang-Yuan; Yin, Hong; Luo, Jian-Xun; Guan, Gui-Quan; Luo, Jin; Xie, Jun-Ren; Shen, Hui; Tian, Mei-Yuan; Zheng, Jin-feng; Yuan, Xiao-song; Wang, Fang-fang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Tian, ZC (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	tianzhancheng@caas.cn; liuguangyuan2002@sina.com	Luo, jian/HGE-7331-2022; Yin, Hong/AAC-5784-2020		National Natural Sciences Foundation of China [31201899, 30972182]; Natural Science Foundation of Gansu Province [096RJZA128]; Science Fund for Creative Research Groups Of Gansu Province [1210RJIA006]; Key Project of Gansu Province [092NKDA031]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province; Science Fund for Creative Research Groups Of Gansu Province(Science Fund for Creative Research Groups); Key Project of Gansu Province	This work was supported, in part, by the National Natural Sciences Foundation of China (numbers 31201899 and 30972182), the Natural Science Foundation of Gansu Province (number 096RJZA128), the Science Fund for Creative Research Groups Of Gansu Province (number 1210RJIA006), Key Project of Gansu Province (092NKDA031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MTEP, 2006, ANN NY ACAD SCI, V1081, P509, DOI 10.1196/annals.1373.076; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bai Q., 1990, Chinese Journal of Veterinary Medicine, V16, P2; Bai Q., 1991, CHIN J VET SCI TECHN, V1, P20; Bai Q., 1987, CHIN J VET SCI TECHN, V9, P25; Bai Qi, 1994, Chinese Journal of Veterinary Science & Technology, V24, P9; Bai Qi, 2002, Acta Veterinaria et Zootechnica Sinica, V33, P73; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Chen K, 2010, BIOPHYS J, V99, P3930, DOI 10.1016/j.bpj.2010.09.062; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Criado-Fornelio A, 2003, VET PARASITOL, V114, P173, DOI 10.1016/S0304-4017(03)00141-9; DRUMMOND AJ, 2009, GENEIOUS V4 7; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 2004, INFERRING PHYLOGENIE, P90415, DOI DOI 10.1016/J.YMPEV.2004.07.003; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gou HT, 2012, ACTA TROP, V124, P92, DOI 10.1016/j.actatropica.2012.07.001; Guan G.Q., 2001, J CHIN VET SCI TECHN, V31, P35; Guan GQ, 2002, PARASITOL RES, V88, pS22, DOI 10.1007/s00436-001-0564-5; Guan GQ, 2009, EXP PARASITOL, V122, P261, DOI 10.1016/j.exppara.2009.05.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kuttler K.L., 1988, P1; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; Liu AH, 2010, EXP PARASITOL, V126, P476, DOI 10.1016/j.exppara.2010.05.024; Luo Jin, 2011, Scientia Agricultura Sinica, V44, P3694; Luo JX, 1997, TROP ANIM HEALTH PRO, V29, p4S, DOI 10.1007/BF02632906; Luo JX, 2005, VET PARASITOL, V133, P1, DOI 10.1016/j.vetpar.2005.02.014; Luo JX, 2005, PARASITOL RES, V95, P145, DOI 10.1007/s00436-004-1268-4; Luo JX, 2003, VET PARASITOL, V116, P115, DOI 10.1016/S0304-4017(03)00262-0; Luo JX, 2006, CHIN J PARASITOL PAR, V24, pS48; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; SCHEIN E, 1981, TROPENMED PARASITOL, V32, P223; Schnittger L, 2003, PARASITOL RES, V91, P398, DOI 10.1007/s00436-003-0979-2; Tian ZC, 2013, INFECT GENET EVOL, V18, P13, DOI 10.1016/j.meegid.2013.04.002; Tian ZC, 2013, INFECT GENET EVOL, V13, P36, DOI 10.1016/j.meegid.2012.09.001; Vishwanath P, 2004, MOL PHYLOGENET EVOL, V33, P615, DOI 10.1016/j.ympev.2004.07.003; Voigt O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-69; Yin H, 1997, TROP ANIM HEALTH PRO, V29, p11S, DOI 10.1007/BF02632908; Yin H, 1996, VET PARASITOL, V67, P89, DOI 10.1016/S0304-4017(96)01022-9; Yin H, 2002, PARASITOL RES, V88, pS25, DOI 10.1007/s00436-001-0565-4; Yin Hong, 1997, Chinese Journal of Veterinary Science & Technology, V27, P7; Yin H, 2007, PARASITOL RES, V101, pS191	48	21	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79860	10.1371/journal.pone.0079860	http://dx.doi.org/10.1371/journal.pone.0079860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244571	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900056
J	Balogh, P; Szabo, A; Katz, S; Liko, I; Patocs, A; Kiss, AL				Balogh, Petra; Szabo, Arnold; Katz, Sandor; Liko, Istvan; Patocs, Attila; Kiss, Anna L.			Estrogen Receptor Alpha Is Expressed in Mesenteric Mesothelial Cells and Is Internalized in Caveolae upon Freund's Adjuvant Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; TGF-BETA; ER-ALPHA; MESSENGER-RNA; BREAST-CANCER; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; PATHWAY ACTIVATION; MCF-7 CELLS	Transformation of epithelial cells into connective tissue cells (epithelial-mesenchymal transition, EMT) is a complex mechanism involved in tumor metastasis, and in normal embryogenesis, while type II EMT is mainly associated with inflammatory events and tissue regenaration. In this study we examined type II EMT at the ultrastructural and molecular level during the inflammatory process induced by Freund's adjuvant treatment in rat mesenteric mesothelial cells. We found that upon the inflammatory stimulus mesothelial cells lost contact with the basal lamina and with each other, and were transformed into spindle-shaped cells. These morphological changes were accompanied by release of interleukins IL-1alpha, -1beta and IL-6 and by secretion of transforming growth factor beta (TGF-beta) into the peritoneal cavity. Mesothelial cells also expressed estrogen receptor alpha (ER-alpha) as shown by immunolabeling at the light and electron microscopical levels, as well as by quantitative RT-PCR. The mRNA level of ER-alpha showed an inverse correlation with the secretion of TGF-beta. At the cellular and subcellular levels ER-alpha was colocalized with the coat protein caveolin-1 and was found in the plasma membrane of mesothelial cells, in caveolae close to multivesicular bodies (MVBs) or in the membrane of these organelles, suggesting that ER-alpha is internalized via caveola-mediated endocytosis during inflammation. We found asymmetric, thickened, electron dense areas on the limiting membrane of MVBs (MVB plaques) indicating that these sites may serve as platforms for collecting and organizing regulatory proteins. Our morphological observations and biochemical data can contribute to form a potential model whereby ER-alpha and its caveola-mediated endocytosis might play role in TGF-beta induced type II EMT in vivo.	[Balogh, Petra; Szabo, Arnold; Katz, Sandor; Kiss, Anna L.] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Liko, Istvan] R Gedeon Plc, Pharmacol & Drug Safety Res, Budapest, Hungary; [Patocs, Attila] HSA SE Lendulet Hereditary Endocrine Tumors Res G, Budapest, Hungary	Semmelweis University	Balogh, P (corresponding author), Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary.	balogh.petra@med.semmelweis-univ.hu		Szabo, Arnold/0000-0001-7685-9231; Liko, Istvan/0000-0001-7668-4726; Patocs, Attila/0000-0001-7506-674X	OTKA: Hungarian Scientific Research Fund; KTIA-AIK: Research and Technology Innovation Fund; National Developmental Agency; TAMOP: Hungary's Renewal Program	OTKA: Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); KTIA-AIK: Research and Technology Innovation Fund; National Developmental Agency; TAMOP: Hungary's Renewal Program	This work was funded by "OTKA: Hungarian Scientific Research Fund," "KTIA-AIK: Research and Technology Innovation Fund, National Developmental Agency," "TAMOP: Hungary's Renewal Program, National Developmental Agency.: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; [Anonymous], 2010, NIH INTR GUIDL 2010; Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Baran J, 2007, J CELL COMMUN SIGNAL, V1, P195, DOI 10.1007/s12079-008-0017-3; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DOUVDEVANI A, 1994, KIDNEY INT, V46, P993, DOI 10.1038/ki.1994.359; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feldmann M., 2001, CYTOKINE REFERENCE, P291, DOI DOI 10.1006/RWCY.2000.0204; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Katz S, 2012, PATHOL ONCOL RES, V18, P641, DOI 10.1007/s12253-011-9489-1; Katz S, 2011, APMIS, V119, P782, DOI 10.1111/j.1600-0463.2011.02803.x; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; OFFNER FA, 1995, CYTOKINE, V7, P542, DOI 10.1006/cyto.1995.0073; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Planas-Silva MD, 2007, J STEROID BIOCHEM, V104, P11, DOI 10.1016/j.jsbmb.2006.09.039; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; TOPLEY N, 1993, KIDNEY INT, V43, P226, DOI 10.1038/ki.1993.36; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008	69	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79508	10.1371/journal.pone.0079508	http://dx.doi.org/10.1371/journal.pone.0079508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244516	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327143800087
J	Cheng, YF; Wang, Q; Li, ZJ; Cui, JM; Hu, SW; Zhao, HX; Chen, MS				Cheng, Yufeng; Wang, Qian; Li, Zhanjie; Cui, Jianmin; Hu, Shengwu; Zhao, Huixian; Chen, Mingshun			Cytological and Comparative Proteomic Analyses on Male Sterility in Brassica napus L. Induced by the Chemical Hybridization Agent Monosulphuron Ester Sodium	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; AMINO-ACID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; MATURE POLLEN; ANTHER DEVELOPMENT; GENE-EXPRESSION; FLOWERING TIME; PROTEINS; CMS; LYCOPERSICON	Male sterility induced by a chemical hybridization agent (CHA) is an important tool for utilizing crop heterosis. Monosulphuron ester sodium (MES), a new acetolactate synthase-inhibitor herbicide belonging to the sulphonylurea family, has been developed as an effective CHA to induce male sterility in rapeseed (Brassica napus L.). To understand MES-induced male sterility in rapeseed better, comparative cytological and proteomic analyses were conducted in this study. Cytological analysis indicated that defective tapetal cells and abnormal microspores were gradually generated in the developing anthers of MES-treated plants at various development stages, resulting in unviable microspores and male sterility. A total of 141 differentially expressed proteins between the MES-treated and control plants were revealed, and 131 of them were further identified by MALDI-TOF/TOF MS. Most of these proteins decreased in abundance in tissues of MES-treated rapeseed plants, and only a few increased. Notably, some proteins were absent or induced in developing anthers after MES treatment. These proteins were involved in several processes that may be crucial for tapetum and microspore development. Downregulation of these proteins may disrupt the coordination of developmental and metabolic processes, resulting in defective tapetum and abnormal microspores that lead to male sterility in MES-treated plants. Accordingly, a simple model of CHA-MES-induced male sterility in rapeseed was established. This study is the first cytological and dynamic proteomic investigation on CHA-MES-induced male sterility in rapeseed, and the results provide new insights into the molecular events of male sterility.	[Cheng, Yufeng; Wang, Qian; Li, Zhanjie; Cui, Jianmin; Hu, Shengwu; Zhao, Huixian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cheng, Yufeng; Wang, Qian; Li, Zhanjie; Zhao, Huixian] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Cui, Jianmin; Hu, Shengwu] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Chen, Mingshun] Kansas State Univ, USDA ARS, Kansas City, KS USA	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Kansas State University; United States Department of Agriculture (USDA)	Hu, SW (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	swhu83251@nwsuaf.edu.cn; huixianzhao212@nwsuaf.edu.cn	Hu, Shengwu/ABD-5969-2021; Hu, shengwu/A-1053-2010	Hu, shengwu/0000-0001-6859-6873	China Agriculture Research System [CARS-13]; National Key Technology RD Program [2010BAD01B02]; Northwest AF University	China Agriculture Research System; National Key Technology RD Program(National Key Technology R&D Program); Northwest AF University	This work was supported by the earmarked fund for China Agriculture Research System (CARS-13), the National Key Technology R&D Program (2010BAD01B02) and a grant of Northwest A&F University to SW Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Cui JM, 2011, THESIS NW A F U; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Das M, 2010, PLANT MOL BIOL, V72, P545, DOI 10.1007/s11103-009-9590-y; Drakakaki G, 2006, PLANT PHYSIOL, V142, P1480, DOI 10.1104/pp.106.086363; Fu TD, 1995, BREEDING UTILIZATION; Gaston S, 2002, PHYSIOL PLANTARUM, V114, P524, DOI 10.1034/j.1399-3054.2002.1140404.x; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gonzalez-Melendi P, 2008, J EXP BOT, V59, P827, DOI 10.1093/jxb/erm365; Guan CY, 1997, ACTA AGRONOMICA SINI, V23, P514; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Hou GZ., 1990, OIL CROP CHINA, V2, P7; Imin N, 2001, PROTEOMICS, V1, P1149, DOI 10.1002/1615-9861(200109)1:9<1149::AID-PROT1149>3.3.CO;2-I; Ishiguro S, 2010, PLANT CELL PHYSIOL, V51, P896, DOI 10.1093/pcp/pcq068; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Jorrin-Novo JV, 2009, J PROTEOMICS, V72, P285, DOI 10.1016/j.jprot.2009.01.026; Kawanabe T, 2006, PLANT CELL PHYSIOL, V47, P784, DOI 10.1093/pcp/pcj039; Kerim T, 2003, PROTEOMICS, V3, P738, DOI 10.1002/pmic.200300424; Lee YT, 2002, FEBS LETT, V512, P180, DOI 10.1016/S0014-5793(02)02253-6; Li Li, 2011, Acta Agronomica Sinica, V37, P1134, DOI 10.1016/S1875-2780(11)60031-X; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Mihr C, 2001, J PLANT PHYSIOL, V158, P787, DOI 10.1078/0176-1617-00292; Miki-Hirosige H, 2004, SEX PLANT REPROD, V16, P209, DOI 10.1007/s00497-003-0197-1; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; RHODES D, 1987, PLANT PHYSIOL, V84, P775, DOI 10.1104/pp.84.3.775; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; SERNYK JL, 1983, CAN J PLANT SCI, V63, P407, DOI 10.4141/cjps83-046; Sheoran IS, 2007, J EXP BOT, V58, P3525, DOI 10.1093/jxb/erm199; Sheoran IS, 2006, SEX PLANT REPROD, V19, P185, DOI 10.1007/s00497-006-0035-3; Sheoran IS, 2010, BOTANY, V88, P217, DOI 10.1139/B09-085; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wang DX, 2010, PLANT J, V63, P939, DOI 10.1111/j.1365-313X.2010.04294.x; Wei WL, 2009, PLANT BREEDING, V128, P426, DOI 10.1111/j.1439-0523.2008.01592.x; Wen L, 2007, BOT STUD, V48, P293; Xiao ZD, 2013, CZECH J GENET PLANT, V49, P16, DOI 10.17221/33/2012-CJGPB; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Ye Jing-Xiu, 2009, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V25, P949; Yu C, 2006, PLANT BREEDING, V125, P61, DOI 10.1111/j.1439-0523.2006.01180.x; Yu CY, 2009, PLANT BREEDING, V128, P538, DOI 10.1111/j.1439-0523.2008.01594.x; Zabalza A, 2005, J AGR FOOD CHEM, V53, P7486, DOI 10.1021/jf050654x; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953; Zhao CF, 2005, PROTEOMICS, V5, P961, DOI 10.1002/pmic.200401131; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhou Q, 2007, PESTIC BIOCHEM PHYS, V89, P89, DOI 10.1016/j.pestbp.2007.04.004	53	50	51	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80191	10.1371/journal.pone.0080191	http://dx.doi.org/10.1371/journal.pone.0080191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244648	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800136
J	Eisenring, CV; Neidert, MC; Bove, DS; Held, L; Sarnthein, J; Krayenbuhl, N				Eisenring, Christian Valentin; Neidert, Marian Christoph; Bove, Daniel Sabanes; Held, Leonhard; Sarnthein, Johannes; Krayenbuhl, Niklaus			Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP VENOUS THROMBOSIS; INTRACRANIAL MENINGIOMAS; BRAIN-TUMORS; PROPHYLAXIS; PREVENTION; HEMORRHAGE; SAFETY	Background: Meningiomas are associated with the highest postoperative rate of venous thromboembolic events (VTE) among all intracranial tumors. The aim of this study is to compare two entirely different VTE prophylaxis regimens in 724 consecutive patients undergoing meningioma surgery. Methods: Two cohorts at a single institution treated with different regimens to prevent VTE were reviewed retrospectively. Cohort A (n = 482; 314 females, mean age 57 years, range: 11-87 years) received our institutional regimen during the years 1999-2006, consisting of low-molecular-weight heparin (LMWH) and compression stockings. For cohort B (n = 242; 163 females, mean age 56.8 years, range: 16-90 years), during the years 2008-2010, the management included intraoperative 10 degrees-20 degrees leg elevation with intermittent pneumatic compression (IPC), heparin and LMWH administration. We compared the incidence of the endpoints pulmonary embolism (PE), deep venous thrombosis (DVT), hemorrhage and death, taking into account several known associated risk factors. Results: For all endpoints, we observed a more favorable outcome with the new regimen. The difference in incidence of PEs (cohort A: 38/482, 8%; cohort B: 6/242, 2.5%) reached statistical significance (p = 0.002). In general, patients with skull base meningiomas had a higher risk for PE (OR 2.77). Regarding VTE prophylaxis, an adjusted subgroup analysis suggests that the new regimen is particularly beneficial for patients with skull base meningiomas. Conclusions: We recommend perioperative prophylaxis using a management composed of intraoperative leg-elevation, IPC, early heparin administration and LMWH to reduce the risk for PE.	[Eisenring, Christian Valentin; Neidert, Marian Christoph; Sarnthein, Johannes; Krayenbuhl, Niklaus] Univ Spital Zurich, Neurochirurg Klin, Zurich, Switzerland; [Bove, Daniel Sabanes; Held, Leonhard] Univ Zurich, Inst Sozial & Praventivmed, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Krayenbuhl, N (corresponding author), Univ Spital Zurich, Neurochirurg Klin, Zurich, Switzerland.	niklaus.krayenbuehl@usz.ch	Held, Leonhard/E-8159-2010; Sarnthein, Johannes/E-7959-2010; Eisenring, Christian/GLU-7719-2022	Held, Leonhard/0000-0002-8686-5325; Sarnthein, Johannes/0000-0001-9141-381X; Eisenring, Christian/0000-0002-0208-3220; Krayenbuehl, Niklaus/0000-0003-1089-221X				Agnelli G, 1999, THROMB HAEMOSTASIS, V82, P925; ALMEFTY O, 1991, MENINGIOMAS; Black P, 1998, ACTA NEUROCHIR, V140, P1013, DOI 10.1007/s007010050209; Black Peter, 2007, Clin Neurosurg, V54, P91; Cage TA, 2009, J NEURO-ONCOL, V93, P151, DOI 10.1007/s11060-009-9886-4; Carman TL, 2003, SOUTH MED J, V96, P17, DOI 10.1097/01.SMJ.0000047628.44490.B2; Caroli M, 2005, J NEUROSURG, V102, P290, DOI 10.3171/jns.2005.102.2.0290; Chaichana KL, 2013, NEUROL RES, V35, P206, DOI 10.1179/1743132812Y.0000000126; Chen CM, 2011, NEUROSURG REV, V34, P281, DOI 10.1007/s10143-011-0321-x; Chibbaro S, 2008, SURG NEUROL, V70, P117, DOI 10.1016/j.surneu.2007.06.081; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerber DE, 2007, CANCER, V109, P300, DOI 10.1002/cncr.22405; Gerlach R, 2003, NEUROSURGERY, V53, P1028, DOI 10.1227/01.NEU.0000088565.15719.22; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Greenberg M.S, 2010, HDB NEUROSURGERY; Keller E, 2011, NEUROINTENSIV, P810; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Koray Ozduman RF, 2010, ACTA NEUROCHIR, V800; Macdonald RL, 1999, NEUROSURGERY, V45, P245, DOI 10.1097/00006123-199908000-00008; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Raabe A, 2000, ZBL NEUROCHIR, V61, P103, DOI 10.1055/s-2000-8267; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7; Riffaud L, 2007, PRESSE MED, V36, P197, DOI 10.1016/j.lpm.2006.11.009; Roser F, 2007, J CLIN NEUROSCI, V14, P224, DOI 10.1016/j.jocn.2005.12.004; Samandouras G., 2010, NEUROSURGEONS HDB; SAWAYA R, 1984, NEUROSURGERY, V15, P566, DOI 10.1227/00006123-198410000-00019; SAWAYA R, 1989, J NEUROSURG, V70, pA314; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Stienen M N, 2010, Praxis (Bern 1994), V99, P1479, DOI 10.1024/1661-8157/a000321; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12183	32	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79170	10.1371/journal.pone.0079170	http://dx.doi.org/10.1371/journal.pone.0079170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244441	Green Published, gold			2022-12-27	WOS:000327143800036
J	Jin, EH; Zhang, E; Ko, Y; Sim, WS; Moon, DE; Yoon, KJ; Hong, JH; Lee, WH				Jin, Eun-Heui; Zhang, Enji; Ko, Youngkwon; Sim, Woo Seog; Moon, Dong Eon; Yoon, Keon Jung; Hong, Jang Hee; Lee, Won Hyung			Genome-Wide Expression Profiling of Complex Regional Pain Syndrome	PLOS ONE			English	Article							NEUROPATHIC PAIN; GENE-EXPRESSION; METALLOPROTEINASES; NERVE; MEDIATORS; TISSUE; PHASE	Complex regional pain syndrome (CRPS) is a chronic, progressive, and devastating pain syndrome characterized by spontaneous pain, hyperalgesia, allodynia, altered skin temperature, and motor dysfunction. Although previous gene expression profiling studies have been conducted in animal pain models, there genome-wide expression profiling in the whole blood of CRPS patients has not been reported yet. Here, we successfully identified certain pain-related genes through genome-wide expression profiling in the blood from CRPS patients. We found that 80 genes were differentially expressed between 4 CRPS patients (2 CRPS I and 2 CRPS II) and 5 controls (cut-off value: 1.5-fold change and p<0.05). Most of those genes were associated with signal transduction, developmental processes, cell structure and motility, and immunity and defense. The expression levels of major histocompatibility complex class I A subtype (HLA-A29.1), matrix metalloproteinase 9 (MMP9), alanine aminopeptidase N (ANPEP), L-histidine decarboxylase (HDC), granulocyte colony-stimulating factor 3 receptor (G-CSF3R), and signal transducer and activator of transcription 3 (STAT3) genes selected from the microarray were confirmed in 24 CRPS patients and 18 controls by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). We focused on the MMP9 gene that, by qRT-PCR, showed a statistically significant difference in expression in CRPS patients compared to controls with the highest relative fold change (4.0+/-1.23 times and p = 1.4x10(-4)). The up-regulation of MMP9 gene in the blood may be related to the pain progression in CRPS patients. Our findings, which offer a valuable contribution to the understanding of the differential gene expression in CRPS may help in the understanding of the pathophysiology of CRPS pain progression.	[Jin, Eun-Heui; Lee, Won Hyung] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Taejon, South Korea; [Zhang, Enji; Ko, Youngkwon; Lee, Won Hyung] Chungnam Natl Univ, Dept Anesthesia & Pain Med, Taejon, South Korea; [Sim, Woo Seog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Moon, Dong Eon] Catholic Univ, Coll Med, Dept Anaesthesiol & Pain Med, Seoul, South Korea; [Yoon, Keon Jung] Catholic Univ, Coll Med, Dept Anaesthesiol & Pain Med, Seoul, South Korea; [Hong, Jang Hee] Chungnam Natl Univ, Coll Med, Dept Phamacol, Taejon, South Korea; [Jin, Eun-Heui; Hong, Jang Hee; Lee, Won Hyung] Chungnam Natl Univ Hosp, Clin Trials Ctr, Taejon, South Korea	Chungnam National University; Chungnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea; Chungnam National University; Chungnam National University; Chungnam National University Hospital	Jin, EH (corresponding author), Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Taejon, South Korea.	sowha1219@hotmail.com; whlee@cnu.ac.kr		Hong, Jang-Hee/0000-0002-0623-5455; Ko, YoungKwon/0000-0002-0178-6346	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A070001]; Chungnam National University Hospital Research Fund	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Chungnam National University Hospital Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A070001) and Chungnam National University Hospital Research Fund, 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backonja MM, 2008, J NEUROIMMUNOL, V195, P157, DOI 10.1016/j.jneuroim.2008.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett G, 1998, PAIN, V77, P315, DOI 10.1016/S0304-3959(98)00114-6; Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; CUNHA FQ, 1991, BRIT J PHARMACOL, V104, P765, DOI 10.1111/j.1476-5381.1991.tb12502.x; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Hirden RN, 2006, CLIN J PAIN, V22, P415; Imamura K, 2008, HEADACHE, V48, P135, DOI 10.1111/j.1526-4610.2007.00958.x; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Ko J, 2002, J BIOCHEM MOL BIOL, V35, P420; Kramer HH, 2011, PAIN, V152, P285, DOI 10.1016/j.pain.2010.09.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WY, 2002, EUR J NEUROSCI, V15, P1037, DOI 10.1046/j.1460-9568.2002.01940.x; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; van de Beek WJT, 2003, PAIN, V103, P93, DOI 10.1016/S0304-3959(02)00444-X; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Wong GY, 1997, HAND CLIN, V13, P319; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yoshida A, 2005, EUR J PHARMACOL, V522, P55, DOI 10.1016/j.ejphar.2005.08.037	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79435	10.1371/journal.pone.0079435	http://dx.doi.org/10.1371/journal.pone.0079435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244504	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800076
J	Jing, D; Li, FJ; Jiang, MG; Cai, J; Wu, Y; Xie, KN; Wu, XM; Tang, C; Liu, J; Guo, W; Shen, GH; Luo, EP				Jing, Da; Li, Feijiang; Jiang, Maogang; Cai, Jing; Wu, Yan; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping			Pulsed Electromagnetic Fields Improve Bone Microstructure and Strength in Ovariectomized Rats through a Wnt/Lrp5/beta-Catenin Signaling-Associated Mechanism	PLOS ONE			English	Article							INDUCED OSTEOPOROSIS; KNEE OSTEOARTHRITIS; FRACTURE REPAIR; RANK; MASS; OSTEOCLASTOGENESIS; STIMULATION; OSTEOBLASTS; METABOLISM; DISORDERS	Growing evidence has demonstrated that pulsed electromagnetic field (PEMF), as an alternative noninvasive method, could promote remarkable in vivo and in vitro osteogenesis. However, the exact mechanism of PEMF on osteopenia/osteoporosis is still poorly understood, which further limits the extensive clinical application of PEMF. In the present study, the efficiency of PEMF on osteoporotic bone microarchitecture and bone quality together with its associated signaling pathway mechanisms was systematically investigated in ovariectomized (OVX) rats. Thirty rats were equally assigned to the Control, OVX and OVX+PEMF groups. The OVX+PEMF group was subjected to daily 8-hour PEMF exposure with 15 Hz, 2.4 mT (peak value). After 10 weeks, the OVX+PEMF group exhibited significantly improved bone mass and bone architecture, evidenced by increased BMD, Tb.N, Tb.Th and BV/TV, and suppressed Tb.Sp and SMI levels in the MicroCT analysis. Three-point bending test suggests that PEMF attenuated the biomechanical strength deterioration of the OVX rat femora, evidenced by increased maximum load and elastic modulus. RT-PCR analysis demonstrated that PEMF exposure significantly promoted the overall gene expressions of Wnt1, LRP5 and b-catenin in the canonical Wnt signaling, but did not exhibit obvious impact on either RANKL or RANK gene expressions. Together, our present findings highlight that PEMF attenuated OVX-induced deterioration of bone microarchitecture and strength in rats by promoting the activation of Wnt/LRP5/b-catenin signaling rather than by inhibiting RANKL-RANK signaling. This study enriches our basic knowledge to the osteogenetic activity of PEMF, and may lead to more efficient and scientific clinical application of PEMF in inhibiting osteopenia/osteoporosis.	[Jing, Da; Li, Feijiang; Jiang, Maogang; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Shen, Guanghao; Luo, Erping] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Cai, Jing] Fourth Mil Med Univ, Dept Endocrinol, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Yan] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shen, GH (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.	ghlulu@fmmu.edu.cn; luoerping@fmmu.edu.cn	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China [50377044, 51077128, 31000381]; Doctoral Thesis Foundation of the Fourth Military Medical University [2012D01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Thesis Foundation of the Fourth Military Medical University	The authors acknowledge support from the National Natural Science Foundation of China (grant numbers 50377044, 51077128, and 31000381) and the Doctoral Thesis Foundation of the Fourth Military Medical University (number 2012D01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623; BASSETT CAL, 1974, SCIENCE, V184, P575; BASSETT CAL, 1974, ANN NY ACAD SCI, V238, P242, DOI 10.1111/j.1749-6632.1974.tb26794.x; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; Campbell GM, 2008, OSTEOPOROSIS INT, V19, P1409, DOI 10.1007/s00198-008-0581-7; Chang K, 2003, BIOELECTROMAGNETICS, V24, P189, DOI 10.1002/bem.10078; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eyres KS, 1996, BONE, V18, P505, DOI 10.1016/8756-3282(96)00070-1; Ferreri SL, 2011, BONE, V48, P1095, DOI 10.1016/j.bone.2011.01.002; Garland D E, 1999, J Spinal Cord Med, V22, P239; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Jiang GZ, 2008, J BONE MINER METAB, V26, P130, DOI 10.1007/s00774-007-0811-7; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2010, BONE, V46, P487, DOI 10.1016/j.bone.2009.09.021; Kamei Y, 2005, J NUTR SCI VITAMINOL, V51, P110, DOI 10.3177/jnsv.51.110; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Ke HZ, 1998, BONE, V23, P249, DOI 10.1016/S8756-3282(98)00102-1; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Ko BS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/367698; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; Miyagawa K, 2011, J BONE MINER METAB, V29, P422, DOI 10.1007/s00774-010-0241-9; Musette P, 2010, OSTEOPOROSIS INT, V21, P723, DOI 10.1007/s00198-009-1097-5; Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rizzoli R, 2011, CALCIFIED TISSUE INT, V89, P91, DOI 10.1007/s00223-011-9499-8; RUBIN CT, 1989, J BONE JOINT SURG AM, V71A, P411, DOI 10.2106/00004623-198971030-00016; Shen WW, 2010, BIOELECTROMAGNETICS, V31, P113, DOI 10.1002/bem.20535; TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504; Thamsborg G, 2005, OSTEOARTHR CARTILAGE, V13, P575, DOI 10.1016/j.joca.2005.02.012; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang J, 2002, REV SCI INSTRUM, V73, P2175, DOI 10.1063/1.1471352; We SR, 2013, RHEUMATOLOGY, V52, P815, DOI 10.1093/rheumatology/kes063; Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756	47	47	52	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79377	10.1371/journal.pone.0079377	http://dx.doi.org/10.1371/journal.pone.0079377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244491	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800067
J	Li, V; Chui, L; Louie, L; Simor, A; Golding, GR; Louie, M				Li, Vincent; Chui, Linda; Louie, Lisa; Simor, Andrew; Golding, George R.; Louie, Marie			Cost-Effectiveness and Efficacy of spa, SCCmec, and PVL Genotyping of Methicillin-Resistant Staphylococcus aureus as Compared to Pulsed-Field Gel Electrophoresis	PLOS ONE			English	Article							EPIDEMIOLOGIC SURVEILLANCE; RAPID IDENTIFICATION; ECONOMIC BURDEN; TYPING METHODS; IMPACT; MEC	Pulsed-field gel electrophoresis (PFGE) is a valuable molecular typing assay used for methicillin-resistant Staphylococcus aureus (MRSA) surveillance and genotyping. However, there are several limitations associated with PFGE. In Alberta, Canada, the significant increase in the number of MRSA isolates submitted to the Provincial Laboratory for Public Health (ProvLab) for PFGE typing led to the need for an alternative genotyping method. In this study, we describe the transition from PFGE to Staphylococcus protein A (spa), Staphylococcal cassette chromosome (SCCmec), and Panton-Valentine leukocidin (PVL) typing. A total of 1915 clinical MRSA isolates collected from 2005 to 2009 were used to develop and validate an algorithm for assigning PFGE epidemic types using spa, SCCmec, and PVL typing and the resulting data was used to populate a new Alberta MRSA typing database. An additional 12620 clinical MRSA isolates collected from 2010 to 2012 as part of ongoing routine molecular testing at ProvLab were characterized using the new typing algorithm and the Alberta MRSA typing database. Switching to spa, SCCmec, and PVL from PFGE typing substantially reduced hands-on and turn-around times while maintaining historical PFGE epidemic type designations. This led to an approximate $77,000 reduction in costs from 2010 to 2012. PFGE typing is still required for a small subset of MRSA isolates that have spa types that are rare, novel, or associated with more than one PFGE epidemic type.	[Li, Vincent; Chui, Linda] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Chui, Linda] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Louie, Lisa; Simor, Andrew] Sunnybrook Hlth Sci Ctr, Dept Microbiol, Toronto, ON M4N 3M5, Canada; [Golding, George R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Louie, Marie] Prov Lab Publ Hlth, Calgary, AB, Canada; [Louie, Marie] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Alberta; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Public Health Agency of Canada; University of Calgary	Chui, L (corresponding author), Prov Lab Publ Hlth, Edmonton, AB, Canada.	Linda.Chui@albertahealthservices.ca			Alberta Health	Alberta Health	Alberta Health provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Golding George R, 2008, Can J Infect Dis Med Microbiol, V19, P273; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holland JL, 2000, J CLIN MICROBIOL, V38, P4108, DOI 10.1128/JCM.38.11.4108-4113.2000; Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871; Kock R, 2010, EURO SURVEILL, V15; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lee BY, 2013, CLIN MICROBIOL INFEC, V19, P528, DOI 10.1111/j.1469-0691.2012.03914.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Simor AE, 2002, J INFECT DIS, V186, P652, DOI 10.1086/342292; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Tang YW, 2000, J CLIN MICROBIOL, V38, P1347, DOI 10.1128/JCM.38.4.1347-1351.2000; Trindade P. A., 2003, Braz J Infect Dis, V7, P32, DOI 10.1590/S1413-86702003000100005	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79149	10.1371/journal.pone.0079149	http://dx.doi.org/10.1371/journal.pone.0079149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244440	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800035
J	Peng, C; Gu, P; Zhou, J; Huang, JH; Wang, W				Peng, Chen; Gu, Peng; Zhou, Jing; Huang, Jianhua; Wang, Wei			Inhibition of Rho-Kinase by Fasudil Suppresses Formation and Progression of Experimental Abdominal Aortic Aneurysms	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; LONG-TERM INHIBITION; CARDIOVASCULAR PHYSIOLOGY; IN-VIVO; ANGIOGENESIS; ACTIVATION; GTPASES; INFLAMMATION; METASTASIS; EXPRESSION	Objective: Accumulating evidence suggests that inflammatory cell infiltration is crucial pathogenesis during the initiation and progression of abdominal aortic aneurysm (AAA). Given Rho-kinase (ROCK), an important kinase control the actin cytoskeleton, regulates the inflammatory cell infiltration, thus, we investigate the possibility and mechanism of preventing experimental AAA progression via targeting ROCK in mice porcine pancreatic elastase (PPE) model. Methods and Results: AAA was created in 10-week-old male C57BL/6 mice by transient intraluminal porcine pancreatic elastase infusion into the infrarenal aorta. The mRNA level of RhoA, RhoC, ROCK1 and ROCK2 were elevated in aneurismal aorta. Next, PPE infusion mice were orally administrated with vehicle or ROCK inhibitor (Fasudil at dose of 200 mg/kg/day) during the period of day 1 prior to PPE infusion to day 14 after PPE infusion. PPE infusion mice treated with Fasudil produced significantly smaller aneurysms as compare to PPE infusion mice treated with vehicle. AAAs developed in all vehicle-treated groups within 14 days, whereas AAAs developed in six mice (66%, 6/9) treated with Fasudil within 14 days. Furthermore, our semi-quantitative histological analysis revealed that blood vessels and macrophages were significantly reduced in Fasudil treated mice during the AAA progression. Finally, when mice with existing AAAs were treated with Fasudil, the enlargement was nearly completely suppressed. Conclusion: Fasudil inhibits experimental AAA progression and stabilize existing aneurysms, through mechanisms likely related to impaired mural macrophage infiltration and angiogenesis. These findings suggest that ROCK inhibitor may hold substantial translational value for AAA diseases.	[Peng, Chen; Gu, Peng; Huang, Jianhua; Wang, Wei] Cent S Univ, Xiangya Hosp, Dept Vasc Surg, Changsha, Hunan, Peoples R China; [Zhou, Jing] Cent S Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Wang, W (corresponding author), Cent S Univ, Xiangya Hosp, Dept Vasc Surg, Changsha, Hunan, Peoples R China.	wangweicsu@gmail.com	Gu, Peng/GPW-7040-2022					Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bergoeing MP, 2006, EXPERT OPIN THER TAR, V10, P547, DOI 10.1517/14728222.10.4.547; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Chapple KS, 2007, ANN VASC SURG, V21, P61, DOI 10.1016/j.avsg.2006.10.008; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Daugherty Alan, 2002, Curr Atheroscler Rep, V4, P222, DOI 10.1007/s11883-002-0023-5; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P1157, DOI 10.1517/13543784.14.9.1157; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Iida Y, 2013, ARTERIOSCL THROM VAS, V33, P718, DOI 10.1161/ATVBAHA.112.300329; Iida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049642; Ikegaki I, 2001, EUR J PHARMACOL, V427, P69, DOI 10.1016/S0014-2999(01)01181-5; Jones GE, 2000, METHOD ENZYMOL, V325, P449; Kroll J, 2009, AM J PHYSIOL-HEART C, V296, pH893, DOI 10.1152/ajpheart.01038.2008; Leeper NJ, 2013, ARTERIOSCL THROM VAS, V33, pE1, DOI 10.1161/ATVBAHA.112.300399; Liu J, 2013, CELL BIOCH BIOPHYS; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; Miyata K, 2000, ARTERIOSCL THROM VAS, V20, P2351, DOI 10.1161/01.ATV.20.11.2351; Nanda Sudip, 2009, Recent Pat Cardiovasc Drug Discov, V4, P150; Paik DC, 2004, EXP MOL MED, V36, P524, DOI 10.1038/emm.2004.67; Powell JT, 1998, LANCET, V352, P1649; Raja Shahzad G, 2012, Recent Pat Cardiovasc Drug Discov, V7, P100; Shi JJ, 2013, J CARDIOVASC PHARM, V62, P341, DOI 10.1097/FJC.0b013e3182a3718f; Shimokawa H, 2002, J CARDIOVASC PHARM, V39, P319, DOI 10.1097/00005344-200203000-00001; Sho E, 2004, J VASC SURG, V39, P1312, DOI 10.1016/j.jvs.2004.01.036; Sho E, 2004, ARTERIOSCL THROM VAS, V24, P1916, DOI 10.1161/01.ATV.0000142805.20398.74; Sho E, 2004, EXP MOL PATHOL, V76, P108, DOI 10.1016/j.yexmp.2003.11.003; Stasinopoulos I, 2009, CANCER BIOL THER, V8, P31, DOI 10.4161/cbt.8.1.7079; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Thompson MM, 1996, EUR J VASC ENDOVASC, V11, P464, DOI 10.1016/S1078-5884(96)80183-3; Thompson RW, 2002, CARDIOVASC SURG, V10, P389, DOI 10.1016/S0967-2109(02)00042-X; Wang W, 2004, BRIT J CANCER, V90, P2349, DOI 10.1038/sj.bjc.6601749; Wang W, 2003, WORLD J GASTROENTERO, V9, P1950, DOI 10.3748/wjg.v9.i9.1950; Wang W, 2008, CANCER SCI, V99, P2012, DOI 10.1111/j.1349-7006.2008.00902.x; Wang W, 2008, CLIN CANCER RES, V14, P6804, DOI 10.1158/1078-0432.CCR-07-4820; Wang W, 2009, DIGEST DIS SCI, V54, P2729, DOI 10.1007/s10620-008-0667-2; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527; Zhou Q, 2012, CIRCULATION, V126, P2236, DOI 10.1161/CIRCULATIONAHA.111.086041; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	56	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80145	10.1371/journal.pone.0080145	http://dx.doi.org/10.1371/journal.pone.0080145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244631	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800127
J	Skuk, VG; Schweinberger, SR				Skuk, Verena G.; Schweinberger, Stefan R.			Adaptation Aftereffects in Vocal Emotion Perception Elicited by Expressive Faces and Voices	PLOS ONE			English	Article							SEX-DIFFERENCES; AUDITORY ADAPTATION; CROSSMODAL BINDING; FEAR; RECOGNITION; IDENTIFICATION; IDENTITY; SIGNALS; SPEECH; GENDER	The perception of emotions is often suggested to be multimodal in nature, and bimodal as compared to unimodal (auditory or visual) presentation of emotional stimuli can lead to superior emotion recognition. In previous studies, contrastive aftereffects in emotion perception caused by perceptual adaptation have been shown for faces and for auditory affective vocalization, when adaptors were of the same modality. By contrast, crossmodal aftereffects in the perception of emotional vocalizations have not been demonstrated yet. In three experiments we investigated the influence of emotional voice as well as dynamic facial video adaptors on the perception of emotion-ambiguous voices morphed on an angry-to-happy continuum. Contrastive aftereffects were found for unimodal (voice) adaptation conditions, in that test voices were perceived as happier after adaptation to angry voices, and vice versa. Bimodal (voice + dynamic face) adaptors tended to elicit larger contrastive aftereffects. Importantly, crossmodal (dynamic face) adaptors also elicited substantial aftereffects in male, but not in female participants. Our results (1) support the idea of contrastive processing of emotions (2), show for the first time crossmodal adaptation effects under certain conditions, consistent with the idea that emotion processing is multimodal in nature, and (3) suggest gender differences in the sensory integration of facial and vocal emotional stimuli.	[Skuk, Verena G.; Schweinberger, Stefan R.] Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Thuringia, Germany; [Skuk, Verena G.; Schweinberger, Stefan R.] Univ Jena, DFG Res Unit, Person Percept Inst Psychol, Jena, Thuringia, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Skuk, VG (corresponding author), Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Thuringia, Germany.	verena.skuk@uni-jena.de	Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft (DFG) [Schw 511/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de) to S. R. S. (grant reference Schw 511/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 1998, J COGNITIVE NEUROSCI, V10, P109; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2013, COGNITION EMOTION, DOI DOI 10.1080/026999300378824; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Boersma P., 2020, PRAAT DOING PHONETIC; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Calvert GA, 1998, TRENDS COGN SCI, V2, P247, DOI 10.1016/S1364-6613(98)01189-9; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Dael N, 2012, EMOTION, V12, P1085, DOI 10.1037/a0025737; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Elmes DG, 1981, METHODS EXPT PSYCHOL; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Hagan CC, 2009, P NATL ACAD SCI USA, V106, P20010, DOI 10.1073/pnas.0905792106; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Kawahara H, 2009, DEV EXPLORATORY RES, P111; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Montepare J, 1999, J NONVERBAL BEHAV, V23, P133, DOI 10.1023/A:1021435526134; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schweinberger SR, 2008, CURR BIOL, V18, P684, DOI 10.1016/j.cub.2008.04.015; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Sebe N, 2006, INT C PATT RECOG, P1136; Skuk VG, 2013, HEARING RES, V296, P131, DOI 10.1016/j.heares.2012.11.004; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Wolff N, NEUROSCIENC IN PRESS; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zaske R, 2011, HEARING RES, V282, P283, DOI 10.1016/j.heares.2011.06.008; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011; Zaske R, 2009, EUR J NEUROSCI, V30, P527, DOI 10.1111/j.1460-9568.2009.06839.x	42	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81691	10.1371/journal.pone.0081691	http://dx.doi.org/10.1371/journal.pone.0081691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236215	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700218
J	Chow, AKM; Ng, L; Lam, CSC; Wong, SKM; Wan, TMH; Cheng, NSM; Yau, TCC; Poon, RTP; Pang, RWC				Chow, Ariel Ka-Man; Ng, Lui; Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Cheng, Nathan Shiu-Man; Yau, Thomas Chung-Cheung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi			The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LONG-TERM SAFETY; PHASE-III; PROTEIN EXPRESSION; LIVER-CANCER; STEM-CELLS; APOPTOSIS; SURVIVAL; EFFICACY; INSIGHTS	Acquired resistance towards sorafenib treatment was found in HCC patients, which results in poor prognosis. To investigate the enhanced metastatic potential of sorafenib resistance cells, sorafenib-resistant (SorR) cell lines were established by long-term exposure of the HCC cells to the maximum tolerated dose of sorafenib. Cell proliferation assay and qPCR of ABC transporter genes (ABCC1-3) were first performed to confirm the resistance of cells. Migration and invasion assays, and immunoblotting analysis on the expression of epithelial to mesenchymal transition (EMT) regulatory proteins were performed to study the metastatic potential of SorR cells. The expression of CD44 and CD133 were studied by flow cytometry and the gene expressions of pluripotency factors were studied by qPCR to demonstrate the enrichment of cancer stem cells (CSCs) in SorR cells. Control (CTL) and SorR cells were also injected orthotopically to the livers of NOD-SCID mice to investigate the development of lung metastasis. Increased expressions of ABCC1-3 were found in SorR cells. Enhanced migratory and invasive abilities of SorR cells were observed. The changes in expression of EMT regulatory proteins demonstrated an activation of the EMT process in SorR cells. Enriched proportion of CD44(+) and CD44(+) CD133(+) cells were also observed in SorR cells. All (8/8) mice injected with SorR cells demonstrated lung metastasis whereas only 1/8 mouse injected with CTL cells showed lung metastasis. HCC cells with sorafenib resistance demonstrated a higher metastatic potential, which may be due to the activated EMT process. Enriched CSCs were also demonstrated in the sorafenib resistant cells. This study suggests that advanced HCC patients with acquired sorafenib resistance may have enhanced tumor growth or distant metastasis, which raises the concern of long-term sorafenib treatment in advanced HCC patients who have developed resistance of sorafenib.	[Chow, Ariel Ka-Man; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi] Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Chow, Ariel Ka-Man; Ng, Lui; Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Cheng, Nathan Shiu-Man; Yau, Thomas Chung-Cheung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi] Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Pang, RWC (corresponding author), Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Ng, Lui/AAG-4397-2019; Wan, Timothy/AAA-2432-2021; Chow, Ariel/HGF-2363-2022; Yau, Thomas Chung Cheung/B-3429-2011	Ng, Lui/0000-0002-9010-2654; Wan, Timothy/0000-0002-9235-2913; Yau, Thomas Chung Cheung/0000-0002-7114-0305; Chow, Ariel/0000-0002-5729-5415; /0000-0003-2801-5717	Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong	Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong	This study is supported by the Central Allocation Group Research Grant "Molecular Pathology of Liver Cancer - A Multidisciplinary Study" from the Research Grant Council of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2011, CLIN LUNG CANCER, V12, P212, DOI 10.1016/j.cllc.2011.03.021; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Birchmeier W, 1995, EXS, V74, P1; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chow AKM, 2012, CURR CANCER DRUG TAR, V12, P1233; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ezzoukhry Z, 2012, INT J CANCER, V131, P2961, DOI 10.1002/ijc.27604; Fuchs CS, 2002, CANCER, V94, P3186, DOI 10.1002/cncr.10607; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Gish RG, 2007, J CLIN ONCOL, V25, P3069, DOI 10.1200/JCO.2006.08.4046; Hoffmann K, 2010, ANTICANCER RES, V30, P4503; Hutson TE, 2010, EUR J CANCER, V46, P2432, DOI 10.1016/j.ejca.2010.06.121; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lopez PM, 2006, ALIMENT PHARM THER, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x; Masugi Y, 2010, HUM PATHOL, V41, P1061, DOI 10.1016/j.humpath.2010.01.016; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Nakano M, 2013, ONCOLOGY-BASEL, V84, P108, DOI 10.1159/000342650; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Pang RWC, 2012, CURR CANCER DRUG TAR, V12, P1081; Signoriello S, 2012, SCI WORLD J, DOI 10.1100/2012/564706; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tai WT, 2012, MOL CANCER THER, V11, P452, DOI 10.1158/1535-7163.MCT-11-0412; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Xin HW, 2013, GUT, V62, P1777, DOI 10.1136/gutjnl-2012-303261; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yao X, 2012, ONCOTARGETS THER, V5, P255, DOI 10.2147/OTT.S36213; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	39	82	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78675	10.1371/journal.pone.0078675	http://dx.doi.org/10.1371/journal.pone.0078675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244338	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600047
J	Lin, YS; Chen, YJ; Cohen, SN; Cheng, TH				Lin, Yu-Shiuan; Chen, Yin-Ju; Cohen, Stanley N.; Cheng, Tzu-Hao			Identification of TSG101 Functional Domains and p21 Loci Required for TSG101-Mediated p21 Gene Regulation	PLOS ONE			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; HUMAN BREAST; TRANSCRIPTIONAL REGULATION; ABERRANT TRANSCRIPTS; PROTEIN; CANCER; EXPRESSION; OVEREXPRESSION; ACTIVATION	TSG101 (tumor susceptibility gene 101) is a multi-domain protein known to act in the cell nucleus, cytoplasm, and periplasmic membrane. Remarkably, TSG101, whose location within cells varies with the stage of the cell cycle, affects biological events as diverse as cell growth and proliferation, gene expression, cytokinesis, and endosomal trafficking. The functions of TSG101 additionally are recruited for viral and microvesicle budding and for intracellular survival of invading bacteria. Here we report that the TSG101 protein also interacts with and down-regulates the promoter of the p21 CIP1/WAF1 tumor suppressor gene, and identify a p21 locus and TSG101 domains that mediate this interaction. TSG101 deficiency in Saos-2 human osteosarcoma cells was accompanied by an increased abundance of p21 mRNA and protein and the retardation of cell proliferation. A cis-acting element in the p21 promoter that interacts with TSG101 and is required for promoter repression was located using chromatin immunoprecipitation (ChIP) analysis and p21-driven luciferase reporter gene expression, respectively. Additional analysis of TSG101 deletion mutants lacking specific domains established the role of the central TSG101 domains in binding to the p21 promoter and demonstrated the additional essentiality of the TSG101 C-terminal steadiness box (SB) in the repression of p21 promoter activity. Neither binding of TSG101 to the p21 promoter nor repression of this promoter required the TSG101 N-terminal UEV domain, which mediates the ubiquitin-recognition functions of TSG101 and its actions as a member of ESCRT endocytic trafficking complexes, indicating that regulation of the p21 promoter by TSG101 is independent of its role in such trafficking.	[Lin, Yu-Shiuan; Chen, Yin-Ju; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	National Yang Ming Chiao Tung University; Stanford University	Cheng, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	thcheng@ym.edu.tw			National Science Council [NSC-93-2320-B-010-026, NSC-102-2325-B-010-017]; 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China; National Foundation for Cancer Research	National Science Council(Ministry of Science and Technology, Taiwan); 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China; National Foundation for Cancer Research	This work was supported by the National Science Council (NSC-93-2320-B-010-026 and NSC-102-2325-B-010-017) and the 'Aim for the Top University Plan' grant from the Ministry of Education of the Republic of China to THC and by an award from the National Foundation for Cancer Research to SNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2001, J BIOL CHEM, V276, P25813, DOI 10.1074/jbc.M102240200; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Carney ME, 1998, J SOC GYNECOL INVEST, V5, P281, DOI 10.1016/s1071-5576(98)00018-5; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen YJ, 1999, EUR J CANCER, V35, P302, DOI 10.1016/S0959-8049(98)00356-6; Cheng TH, 2000, GENE DEV, V14, P452; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Feng GH, 2000, CANCER RES, V60, P1736; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hampl M, 1998, BIOCHEM BIOPH RES CO, V248, P753, DOI 10.1006/bbrc.1998.9038; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hsu HS, 2011, ANN SURG ONCOL, V18, P1469, DOI 10.1245/s10434-010-1428-y; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kameyama T, 2012, NUCLEIC ACIDS RES, V40, P7896, DOI 10.1093/nar/gks520; Kao CL, 2009, CANCER LETT, V286, P250, DOI 10.1016/j.canlet.2009.05.031; Klaes R, 1999, EUR J CANCER, V35, P733, DOI 10.1016/S0959-8049(99)00016-7; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee MP, 1997, CANCER RES, V57, P3131; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Lin PM, 1998, BRIT J HAEMATOL, V102, P753, DOI 10.1046/j.1365-2141.1998.00815.x; Liu FL, 2010, MOL BIOL REP, V37, P2829, DOI 10.1007/s11033-009-9835-5; Liu RT, 2002, ONCOGENE, V21, P4830, DOI 10.1038/sj.onc.1205612; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; McDonald B, 2008, MOL BIOL CELL, V19, P754, DOI 10.1091/mbc.E07-09-0957; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moyret-Lalle C, 2001, CANCER RES, V61, P486; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Oh Y, 1998, ONCOGENE, V17, P1141, DOI 10.1038/sj.onc.1202029; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Sun ZJ, 1999, CANCER-AM CANCER SOC, V86, P689, DOI 10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P; Teng SC, 2004, J BIOL CHEM, V279, P14649, DOI 10.1074/jbc.M308842200; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; WALDMAN T, 1995, CANCER RES, V55, P5187; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; Willeke F, 1998, MOL CARCINOGEN, V23, P195; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337; Zhu G, 2004, INT J CANCER, V109, P541, DOI 10.1002/ijc.20014	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79674	10.1371/journal.pone.0079674	http://dx.doi.org/10.1371/journal.pone.0079674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244542	gold, Green Published			2022-12-27	WOS:000327221600145
J	Lin, ZZ; Shau, WY; Hsu, C; Shao, YY; Yeh, YC; Kuo, RNC; Hsu, CH; Yang, JCH; Cheng, AL; Lai, MS				Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu			Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACETIC-ACID INJECTION; THERMAL ABLATION; CLINICAL-TRIALS; CIRRHOSIS; METAANALYSIS; MANAGEMENT; THERAPIES; SURVIVAL; ICD-9-CM	Background: Randomized trials suggest that radiofrequency ablation (RFA) may be more effective than percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma (HCC). However, the survival advantage of RFA needs confirmation in daily practice. Methods: We conducted a population-based cohort study using the Taiwan Cancer Registry, National Health Insurance claim database and National Death Registry data from 2004 through 2009. Patients receiving PEI or RFA as first-line treatment for newly-diagnosed stage I-II HCC were enrolled. Results: A total of 658 patients receiving RFA and 378 patients receiving PEI treatment were included for final analysis. The overall survival (OS) rates of patients in the RFA and PEI groups at 5-year were 55% and 42%, respectively (p < 0.01). Compared to patients that received PEI, those that received RFA had lower risks of overall mortality and first-line treatment failure (FTF), with adjusted hazard ratios (HRs) [95% confidence interval (CI)] of 0.60 (0.50-0.73) for OS and 0.54 (0.46-0.64) for FTF. The favorable outcomes for the RFA group were consistently significant for patients with tumors > 2 cm as well as for those with tumors < 2 cm. Consistent results were also observed in other subgroup analyses defined by gender, age, tumor stage, and co-morbidity status. Conclusion: RFA provides better survival benefits than PEI for patients with unresectable stage I-II HCC, irrespective of tumors > 2 cm or <= 2 cm, in contemporary clinical practice.	[Lin, Zhong-Zhe; Hsu, Chiun; Shao, Yu-Yun; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Zhong-Zhe; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Shau, Wen-Yi] Ctr Drug Evaluat, Div Hlth Technol Assessment, Taipei, Taiwan; [Hsu, Chiun; Shao, Yu-Yun; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan; [Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Ctr Comparat Effectiveness Res, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Kuo, Raymond Nien-Chen; Lai, Mei-Shu] Taiwan Canc Registry, Dept Hlth, Taipei, Taiwan; [Kuo, Raymond Nien-Chen] Natl Taiwan Univ, Grad Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 10764, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Cheng, AL (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	alcheng@ntu.edu.tw; mslai@cph.ntu.edu.tw	Shao, Yu-Yun/K-6434-2012; Kuo, Raymond N./N-2558-2018; Yang, James Chih-Hsin/W-1587-2019	Shao, Yu-Yun/0000-0001-7334-1912; Kuo, Raymond N./0000-0003-4980-853X; Lai, Mei-shu/0000-0001-6130-3468; Cheng, Ann-Lii/0000-0002-9152-6512; HSU, CHIH-HUNG/0000-0003-0495-973X; Hsu, Chiun/0000-0002-1122-0055; Yang, James Chih-Hsin/0000-0002-5586-5138	Department of Health, Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001, DOH102-TD-B-111-001]; National Science Council, Taiwan [NSC 101-2314-B-002-164, NSC 102-2314-B-002-128-MY2]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001, DOH102-TD-B-111-001 from the Department of Health, Taiwan; NSC 101-2314-B-002-164, NSC 102-2314-B-002-128-MY2 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 2010UREAU NAT HLTH I; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunello F, 2008, SCAND J GASTROENTERO, V43, P727, DOI 10.1080/00365520701885481; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Clark TWI, 2007, TECH VASC INTERV RAD, V10, P58, DOI 10.1053/j.tvir.2007.08.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Greene FL, 2002, AJCC CANC STAGING MA, P131; Kuo SH, 2005, LUNG CANCER, V48, P275, DOI 10.1016/j.lungcan.2004.10.004; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Lin ZZ, 2012, ONCOLOGIST, V17, P970, DOI 10.1634/theoncologist.2011-0411; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; Livraghi T, 2001, HEPATO-GASTROENTEROL, V48, P20; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Orlando A, 2009, AM J GASTROENTEROL, V104, P514, DOI 10.1038/ajg.2008.80; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARKIN DM, 2005, CANC INCIDENCE 5 CON, V8; Poon RTP, 2002, ANN SURG, V235, P466, DOI 10.1097/00000658-200204000-00004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rossi S, 1995, Cancer J Sci Am, V1, P73; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892	33	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80276	10.1371/journal.pone.0080276	http://dx.doi.org/10.1371/journal.pone.0080276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244668	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600199
J	Matsubara, K; Malay, AD; Curtis, FA; Sharples, GJ; Heddle, JG				Matsubara, Kazuko; Malay, Ali D.; Curtis, Fiona A.; Sharples, Gary J.; Heddle, Jonathan G.			Structural and Functional Characterization of the Red beta Recombinase from Bacteriophage lambda	PLOS ONE			English	Article							DNA-BINDING; HOMOLOGOUS RECOMBINATION; DOMAIN-STRUCTURE; RAD52; PROTEIN; EXONUCLEASE; SEQUENCE; IDENTIFICATION; MECHANISM; INVASION	The Red system of bacteriophage lambda is responsible for the genetic rearrangements that contribute to its rapid evolution and has been successfully harnessed as a research tool for genome manipulation. The key recombination component is Red beta, a ring-shaped protein that facilitates annealing of complementary DNA strands. Red beta shares functional similarities with the human Rad52 single-stranded DNA (ssDNA) annealing protein although their evolutionary relatedness is not well established. Alignment of Rad52 and Red beta sequences shows an overall low level of homology, with 15% identity in the N-terminal core domains as well as important similarities with the Rad52 homolog Sak from phage ul36. Key conserved residues were chosen for mutagenesis and their impact on oligomer formation, ssDNA binding and annealing was probed. Two conserved regions were identified as sites important for binding ssDNA; a surface basic cluster and an intersubunit hydrophobic patch, consistent with findings for Rad52. Surprisingly, mutation of Red beta residues in the basic cluster that in Rad52 are involved in ssDNA binding disrupted both oligomer formation and ssDNA binding. Mutations in the equivalent of the intersubunit hydrophobic patch in Rad52 did not affect Red beta oligomerization but did impair DNA binding and annealing. We also identified a single amino acid substitution which had little effect on oligomerization and DNA binding but which inhibited DNA annealing, indicating that these two functions of Red beta can be separated. Taken together, the results provide fresh insights into the structural basis for Red beta function and the important role of quaternary structure.	[Matsubara, Kazuko; Malay, Ali D.; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan; [Curtis, Fiona A.; Sharples, Gary J.] Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England	RIKEN; Durham University	Heddle, JG (corresponding author), RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan.	heddle@riken.jp	Sharples, Gary/B-8638-2016; Heddle, Jonathan/AAP-7167-2020; Heddle, Jonathan G/H-4586-2014; Malay, Ali/N-9136-2015	Sharples, Gary/0000-0003-2495-0062; Malay, Ali/0000-0003-0885-5524	RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan); Biotechnology and Biological Sciences Research Council [BB/C514523/1, BB/FO20503/1]; Biotechnology and Biological Sciences Research Council [BB/F020503/1] Funding Source: researchfish; BBSRC [BB/F020503/1] Funding Source: UKRI	RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was suported by RIKEN (Rikagaku Kenkyusho) (Institute of Physical and Chemical Research, Japan)(www.riken.go.jp/en/) funding to JGH and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grants BB/C514523/1 and BB/FO20503/1 to GJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CASSUTO E, 1971, NATURE-NEW BIOL, V229, P13, DOI 10.1038/newbio229013a0; CHIU SK, 1990, J BIOL CHEM, V265, P21262; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Hillyar C.R., 2012, BIOSCI HORIZ, V5, DOI [DOI 10.1093/biohorizons/hzs001, 10.1093/biohorizons/hzs001]; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Karakousis G, 1998, J MOL BIOL, V276, P721, DOI 10.1006/jmbi.1997.1573; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Lloyd JA, 2005, J MOL BIOL, V345, P239, DOI 10.1016/j.jmb.2004.10.065; Lloyd JA, 2002, J BIOL CHEM, V277, P46172, DOI 10.1074/jbc.M207262200; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Murphy KC, 2012, ADV VIRUS RES, V83, P367, DOI 10.1016/B978-0-12-394438-2.00008-6; Mythili E, 1996, GENE, V182, P81, DOI 10.1016/S0378-1119(96)00518-5; Nardozzi JD, 2012, J BIOL CHEM, V287, P37259, DOI 10.1074/jbc.M112.389965; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Ranatunga W, 2001, J BIOL CHEM, V276, P15876, DOI 10.1074/jbc.M011747200; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Rybalchenko N, 2004, P NATL ACAD SCI USA, V101, P17056, DOI 10.1073/pnas.0408046101; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Scaltriti E, 2010, J STRUCT BIOL, V170, P462, DOI 10.1016/j.jsb.2009.12.021; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stahl MM, 1997, GENETICS, V147, P961; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu ZR, 2006, J BIOL CHEM, V281, P25205, DOI 10.1074/jbc.M512450200; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	49	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78869	10.1371/journal.pone.0078869	http://dx.doi.org/10.1371/journal.pone.0078869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244379	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000327221600075
J	Ozeki, N; Mogi, M; Kawai, R; Yamaguchi, H; Hiyama, T; Nakata, K; Nakamura, H				Ozeki, Nobuaki; Mogi, Makio; Kawai, Rie; Yamaguchi, Hideyuki; Hiyama, Taiki; Nakata, Kazuhiko; Nakamura, Hiroshi			Mouse-Induced Pluripotent Stem Cells Differentiate into Odontoblast-Like Cells with Induction of Altered Adhesive and Migratory Phenotype of Integrin	PLOS ONE			English	Article							DENTIN PHOSPHOPROTEIN; GENE-EXPRESSION; SIALOPROTEIN; PULP; ACTIVATION; PROTEINS	Methods for differentiating induced pluripotent stem (iPS) cells into odontoblasts generally require epithelial-mesenchymal interactions. Here, we sought to characterize the cells produced by a 'hanging drop' technique for differentiating mouse iPS cells into odontoblast-like cells that requires no such interaction. Cells were cultured by the hanging drop method on a collagen type-I (Col-I) scaffold (CS) combined with bone morphogenetic protein (BMP)-4 (CS/BMP-4) without an epithelial-mesenchymal interaction. We evaluated the expression of odontoblast-related mRNA and protein, and the proliferation rate of these cells using reverse-transcription polymerase chain reaction, immunofluorescence staining, and BrdU cell proliferation enzyme-linked immunosorbent assay, respectively. The differentiated cells strongly expressed the mRNA for dentin sialophosphoprotein (DSPP) and dentin matrix protein-1 (Dmp-1), which are markers of mature odontoblasts. Osteopontin and osteocalcin were not expressed in the differentiated cells, demonstrating that the differentiated iPS cells bore little resemblance to osteoblasts. Instead, they acquired odontoblast-specific properties, including the adoption of an odontoblastic phenotype, typified by high alkaline phosphatase (ALP) activity and calcification capacity. The cell-surface expression of proteins such as integrins alpha 2, alpha 6, alpha V and alpha V beta 3 was rapidly up-regulated. Interestingly, antibodies and siRNAs against integrin alpha 2 suppressed the expression of DSPP and Dmp-1, reduced the activity of ALP and blocked calcification, suggesting that integrin alpha 2 in iPS cells mediates their differentiation into odontoblast-like cells. The adhesion of these cells to fibronectin and Col-I, and their migration on these substrata, was significantly increased following differentiation into odontoblast-like cells. Thus, we have demonstrated that integrin alpha 2 is involved in the differentiation of mouse iPS cells into odontoblast-like cells using the hanging drop culture method, and that these cells have the appropriate physiological and functional characteristics to act as odontoblasts in tissue engineering and regenerative therapies for the treatment of dentin and/or dental pulp damage.	[Ozeki, Nobuaki; Kawai, Rie; Yamaguchi, Hideyuki; Hiyama, Taiki; Nakata, Kazuhiko; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Aichi Gakuin University	Ozeki, N (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Endodont, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	ozeki@g.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22791853]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant (No. 22791853 to N.O.) from the program Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; BEGUEKIRN C, 1994, INT J DEV BIOL, V38, P405; BEGUEKIRN C, 1992, INT J DEV BIOL, V36, P491; BESSHO K, 1991, J DENT RES, V70, P171, DOI 10.1177/00220345910700030301; Dani C, 1997, J CELL SCI, V110, P1279; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ike M, 1998, J Oral Implantol, V24, P124, DOI 10.1563/1548-1336(1998)024<0124:RDRMFA>2.3.CO;2; Jiang Zhong-ming, 2006, Shanghai Kou Qiang Yi Xue, V15, P177; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kawai R, 2013, MOUSE ES CELLS HAVE; Liu H, 2005, ARCH ORAL BIOL, V50, P923, DOI 10.1016/j.albchoralbio.2005.03.003; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Noguchi F, 2009, J ENDODONT, V35, P668, DOI 10.1016/j.joen.2009.01.016; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Ozeki N, 2007, BIOCHEM BIOPH RES CO, V353, P54, DOI 10.1016/j.bbrc.2006.11.110; Ozeki N, 2006, EXP CELL RES, V312, P4162, DOI 10.1016/j.yexcr.2006.09.017; Ritchie H H, 1995, Connect Tissue Res, V33, P73, DOI 10.3109/03008209509016985; RUTHERFORD RB, 1993, ARCH ORAL BIOL, V38, P571, DOI 10.1016/0003-9969(93)90121-2; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yao CC, 1996, J CELL SCI, V109, P3139; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	35	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80026	10.1371/journal.pone.0080026	http://dx.doi.org/10.1371/journal.pone.0080026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244598	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600174
J	Permanyer, M; Pauls, E; Badia, R; Este, JA; Ballana, E				Permanyer, Marc; Pauls, Eduardo; Badia, Roger; Este, Jose A.; Ballana, Ester			The Cortical Actin Determines Different Susceptibility of Naive and Memory CD4+T Cells to HIV-1 Cell-to-Cell Transmission and Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PREFERENTIAL INFECTION; ENTRY; REPLICATION; SPREAD; ASSOCIATION; SYNAPSES; CONTACTS; FUSION	Memory CD4+ T cells are preferentially infected by HIV-1 compared to naive cells. HIV-1 fusion and entry is a dynamic process in which the cytoskeleton plays an important role by allowing virion internalization and uncoating. Here, we evaluate the role of the cortical actin in cell-to-cell transfer of virus antigens and infection of target CD4+ T cells. Using different actin remodeling compounds we demonstrate that efficiency of HIV-internalization was proportional to the actin polymerization of the target cell. naive (CD45RA+) and memory (CD45RA-) CD4+ T cells could be phenotypically differentiated by the degree of cortical actin density and their capacity to capture virus. Thus, the higher cortical actin density of memory CD4+ T cells was associated to increased efficiency of HIV-antigen internalization and the establishment of a productive infection. Conversely, the lower cortical actin density in naive CD4+ T cells restricted viral antigen transfer and consequently HIV-1 infection. In conclusion, the cortical actin density differentially affects the susceptibility to HIV-1 infection in naive and memory CD4+ T cells by modulating the efficiency of HIV antigen internalization.	[Permanyer, Marc; Pauls, Eduardo; Badia, Roger; Este, Jose A.; Ballana, Ester] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Este, JA (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain.	jaeste@irsicaixa.es	Badia, Roger/T-6929-2017; Este, Jose/B-5509-2008; Guix, Ester Ballana/R-4117-2018; sourisseau, marion/M-7542-2014	Badia, Roger/0000-0003-3982-7577; Este, Jose/0000-0002-1436-5823; Pauls, Eduardo/0000-0002-2511-0711; Ballana, Ester/0000-0002-5215-7363	Spanish Ministry of Commerce and Competitiveness (MINECO) [BFU2012-06958]; Gala Against AIDS	Spanish Ministry of Commerce and Competitiveness (MINECO); Gala Against AIDS	This work was supported by the Spanish Ministry of Commerce and Competitiveness (MINECO), project BFU2012-06958 and Gala Against AIDS. MP and EP are research fellows from MINECO. MP is a research fellow from Fondo de Investigacion Sanitaria (FIS). The authors declare no competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bosch B, 2005, ANTIMICROB AGENTS CH, V49, P4296, DOI 10.1128/AAC.49.10.4296-4304.2005; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Garcia-Exposito L, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-39; Gordon-Alonso M, 2013, J BIOL CHEM, V288, P28382, DOI 10.1074/jbc.M113.494906; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Helbert MR, 1997, CLIN EXP IMMUNOL, V107, P300, DOI 10.1111/j.1365-2249.1997.280-ce1170.x; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Moncunill G, 2008, MOL PHARMACOL, V73, P1264, DOI 10.1124/mol.107.042911; Permanyer M, 2012, J BIOL CHEM, V287, P32017, DOI 10.1074/jbc.M112.343293; Permanyer M, 2012, J VIROL, V86, P8773, DOI 10.1128/JVI.01044-12; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005; Ugolini S, 1997, J IMMUNOL, V159, P3000; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Xu Xuehua, 2012, Commun Integr Biol, V5, P381, DOI 10.4161/cib.20165; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79221	10.1371/journal.pone.0079221	http://dx.doi.org/10.1371/journal.pone.0079221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244453	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600117
J	Zhang, YW; Zhang, LH; Zhao, XN; Huang, SJ; Zhao, JM				Zhang, Yanwen; Zhang, Lihui; Zhao, Xingnan; Huang, Shengjun; Zhao, Jimin			Effects of Tidal Action on Pollination and Reproductive Allocation in an Estuarine Emergent Wetland Plant-Sagittaria graminea (Alismataceae)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; TRADE-OFFS; LATIFOLIA ALISMATACEAE; CLONAL GROWTH; ASEXUAL REPRODUCTION; RESOURCE-ALLOCATION; GENETIC DIVERSITY; AQUATIC PLANT; POPULATIONS; PLASTICITY	In estuarine wetlands, the daily periodic tidal activity has a profound effect on plant growth and reproduction. We studied the effects of tidal action on pollination and reproductive allocation of Sagittaria graminea. Results showed that the species had very different reproductive allocation in tidal and non-tidal habitats. In the tidal area, seed production was only 9.7% of that in non-tidal habitat, however, plants produced more male flowers and nearly twice the corms compared to those in non-tidal habitat. An experiment showed that the time available for effective pollination determined the pollination rate and pollen deposition in the tidal area. A control experiment suggested that low pollen deposition from low visitation frequency is not the main cause of very low seed sets or seed production in this plant in tidal habitat. The negative effects of tides (water) on pollen germination may surpass the influence of low pollen deposition from low visitation frequency. The length of time from pollen deposition to flower being submerged by water affected pollen germination rate on stigmas; more than three hours is necessary to allow pollen germination and complete fertilization to eliminate the risk of pollen grains being washed away by tidal water.	[Zhang, Yanwen; Huang, Shengjun] Eastern Liaoning Univ, Dept Biol, Dandong, Peoples R China; [Zhang, Yanwen; Zhang, Lihui; Zhao, Xingnan; Zhao, Jimin] Changchun Normal Univ, Dept Biol, Changchun, Peoples R China	Liaodong University; Changchun Normal University	Zhang, YW (corresponding author), Eastern Liaoning Univ, Dept Biol, Dandong, Peoples R China.	yanwen0209@163.com			National Science Foundation of China [30970200, 30970554]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China to Yanwen Zhang (30970200) and to Jimin Zhao (30970554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin Andrew H., 2004, Urban Ecosystems, V7, P125, DOI 10.1023/B:UECO.0000036265.86125.34; Bishop EJ, 2010, BOTANY, V88, P231, DOI 10.1139/B10-005; Brown JS, 2005, AM J BOT, V92, P495, DOI 10.3732/ajb.92.3.495; Cain ML, 1997, J ECOL, V85, P883, DOI 10.2307/2960609; CAIN ML, 1995, CAN J BOT, V73, P505, DOI 10.1139/b95-051; CHEPLICK GP, 1995, AM J BOT, V82, P621, DOI 10.2307/2445420; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Eckert CG, 2000, CAN J BOT, V78, P437, DOI 10.1139/b00-019; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Han B, 2011, J SYST EVOL, V49, P379, DOI 10.1111/j.1759-6831.2011.00141.x; Harder LD, 2005, P ROY SOC B-BIOL SCI, V272, P2651, DOI 10.1098/rspb.2005.3268; Hnatiuk R.J., 1990, CENSUS AUSTR VASCULA; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Kearns C. A., 1993, TECHNIQUES POLLINATI; Lambertini C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-52; Liu F, 2008, PLANT ECOL, V199, P217, DOI 10.1007/s11258-008-9426-x; Liu F, 2009, PLANT SYST EVOL, V277, P61, DOI 10.1007/s00606-008-0103-2; Mao YY, 2009, NEW PHYTOL, V183, P892, DOI 10.1111/j.1469-8137.2009.02925.x; Martins EP, 2000, TRENDS ECOL EVOL, V15, P296, DOI 10.1016/S0169-5347(00)01880-2; Mendez M, 1999, PLANT BIOLOGY, V1, P115, DOI 10.1055/s-2007-978497; Mendoza A, 1998, AM J BOT, V85, P521, DOI 10.2307/2446436; Mitchell RJ, 1997, OECOLOGIA, V109, P382, DOI 10.1007/s004420050097; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Neely JS, 2006, THESIS WASHINGTON ST; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Piquot Y, 1998, OIKOS, V82, P139, DOI 10.2307/3546924; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Reekie EG, 1999, LIFE HIST EVOLUTION; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Reusch TBH, 2000, HEREDITY, V85, P459, DOI 10.1046/j.1365-2540.2000.00783.x; Ronsheim ML, 2000, AM J BOT, V87, P1769, DOI 10.2307/2656827; Saikkonen K, 1998, ECOLOGY, V79, P1620, DOI 10.1890/0012-9658(1998)079[1620:IEOPAH]2.0.CO;2; Sarkissian TS, 2001, ECOLOGY, V82, P360, DOI 10.1890/0012-9658(2001)082[0360:GVISLA]2.0.CO;2; Sullivan G, 1994, THESIS BINGHAMTON U; Suzuki A, 2001, NEW PHYTOL, V152, P307, DOI 10.1046/j.0028-646X.2001.00251.x; Thiele J, 2009, BASIC APPL ECOL, V10, P340, DOI 10.1016/j.baae.2008.04.002; Thompson FL, 2004, J EVOLUTION BIOL, V17, P581, DOI 10.1111/j.1420-9101.2004.00701.x; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Van Drunen WE, 2012, NEW PHYTOL, V196, P606, DOI 10.1111/j.1469-8137.2012.04260.x; van Kleunen M, 2002, EVOLUTION, V56, P2168, DOI 10.1554/0014-3820(2002)056[2168:ELHESO]2.0.CO;2; Wang XF, 2002, ANN BOT-LONDON, V89, P791, DOI 10.1093/aob/mcf136; Wang XF, 2001, ALCHERINGA, V25, P155; Wang XF, 2006, AQUAT BOT, V85, P233, DOI 10.1016/j.aquabot.2006.05.005; Wang XF, 2012, NEW PHYTOL, V193, P253, DOI 10.1111/j.1469-8137.2011.03912.x; Wang Xiao-Fan, 1998, Acta Botanica Yunnanica, V20, P315; WIKBERG S, 1995, OIKOS, V72, P293, DOI 10.2307/3546232; Yatskievych K., 2000, FIELD GUIDE INDIANA; Zhang YW, 2008, ECOL RES, V23, P873, DOI 10.1007/s11284-007-0451-3; Zhang Yan-Wen, 2010, Wuhan Zhiwuxue Yanjiu, V28, P631, DOI 10.3724/SP.J.1142.2010.50631; Zhang YW, 2011, J LIAODONG U, V18, P39; Zhao XN, 2011, THESIS NE NORMAL U	52	4	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78956	10.1371/journal.pone.0078956	http://dx.doi.org/10.1371/journal.pone.0078956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244393	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600086
J	Kahles, A; Sarqume, F; Savolainen, P; Arvestad, L				Kahles, Andre; Sarqume, Fahad; Savolainen, Peter; Arvestad, Lars			Excap: Maximization of Haplotypic Diversity of Linked Markers	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CODING REGION; MTDNA; IDENTIFICATION; SEQUENCE; GENOME	Genetic markers, defined as variable regions of DNA, can be utilized for distinguishing individuals or populations. As long as markers are independent, it is easy to combine the information they provide. For nonrecombinant sequences like mtDNA, choosing the right set of markers for forensic applications can be difficult and requires careful consideration. In particular, one wants to maximize the utility of the markers. Until now, this has mainly been done by hand. We propose an algorithm that finds the most informative subset of a set of markers. The algorithm uses a depth first search combined with a branch-and-bound approach. Since the worst case complexity is exponential, we also propose some data-reduction techniques and a heuristic. We implemented the algorithm and applied it to two forensic caseworks using mitochondrial DNA, which resulted in marker sets with significantly improved haplotypic diversity compared to previous suggestions. Additionally, we evaluated the quality of the estimation with an artificial dataset of mtDNA. The heuristic is shown to provide extensive speedup at little cost in accuracy.	[Kahles, Andre] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm Bioinformat Ctr, Stockholm, Sweden; [Sarqume, Fahad] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Savolainen, Peter] KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Stockholm, Sweden; [Arvestad, Lars] Stockholm Univ, Swedish eSci Res Ctr, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Arvestad, Lars] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; Royal Institute of Technology; Stockholm University; Swedish e-Science Research Centre (SeRC); Royal Institute of Technology	Arvestad, L (corresponding author), Stockholm Univ, Swedish eSci Res Ctr, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden.	arve@nada.su.se	Kahles, Andre/ABB-8343-2020	Kahles, Andre/0000-0002-3411-0692; Arvestad, Lars/0000-0001-5341-1733	Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW); Knuth and Alice Wallenberg Foundation	Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW); Knuth and Alice Wallenberg Foundation	The work of AK was funded through a scholarship of the Klaus Murmann Fellowship Programme of the Foundation of German Business (Stiftung der Deutschen Wirtschaft, SDW). PS is a Royal Academy of Sciences Research Fellow supported by a grant from the Knuth and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson H, 2007, FORENSIC SCI INT-GEN, V1, P35, DOI 10.1016/j.fsigen.2006.10.002; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anjum GM, 2010, ELECTROPHORESIS, V31, P309, DOI 10.1002/elps.200900325; Coble MD, 2006, INT J LEGAL MED, V120, P27, DOI 10.1007/s00414-005-0044-z; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026723; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCL ACIDS RES; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lutz S, 1996, INT J LEGAL MED, V109, P205, DOI 10.1007/BF01225519; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Ruiz-Pesini E, 2006, NUCL ACIDS RES; Szibor R, 2000, FORENSIC SCI INT, V113, P71, DOI 10.1016/S0379-0738(00)00266-8	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79012	10.1371/journal.pone.0079012	http://dx.doi.org/10.1371/journal.pone.0079012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244403	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900030
J	Li, QT; Zhang, PX; Yin, XF; Han, N; Kou, YH; Deng, JX; Jiang, BG				Li, Qing Tian; Zhang, Pei Xun; Yin, Xiao Feng; Han, Na; Kou, Yu Hui; Deng, Jiu Xu; Jiang, Bao Guo			Functional Recovery of Denervated Skeletal Muscle with Sensory or Mixed Nerve Protection: A Pilot Study	PLOS ONE			English	Article							SCHWANN-CELL DENERVATION; PERIPHERAL-NERVE; NEUROTROPHIC FACTOR; CONTRIBUTING FACTORS; SATELLITE CELLS; STEM-CELLS; RAT MODEL; REGENERATION; REPAIR; REINNERVATION	Functional recovery is usually poor following peripheral nerve injury when reinnervation is delayed. Early innervation by sensory nerve has been indicated to prevent atrophy of the denervated muscle. It is hypothesized that early protection with sensory axons is adequate to improve functional recovery of skeletal muscle following prolonged denervation of mixed nerve injury. In this study, four groups of rats received surgical denervation of the tibial nerve. The proximal and distal stumps of the tibial nerve were ligated in all animals except for those in the immediate repair group. The experimental groups underwent denervation with nerve protection of peroneal nerve (mixed protection) or sural nerve (sensory protection). The experimental and unprotected groups had a stage II surgery in which the trimmed proximal and distal tibial nerve stumps were sutured together. After 3 months of recovery, electrophysiological, histological and morphometric parameters were assessed. It was detected that the significant muscle atrophy and a good preserved structure of the muscle were observed in the unprotected and protective experimental groups, respectively. Significantly fewer numbers of regenerated myelinated axons were observed in the sensory-protected group. Enhanced recovery in the mixed protection group was indicated by the results of the muscle contraction force tests, regenerated myelinated fiber, and the results of the histological analysis. Our results suggest that early axons protection by mixed nerve may complement sensory axons which are required for promoting functional recovery of the denervated muscle natively innervated by mixed nerve.	[Li, Qing Tian; Zhang, Pei Xun; Yin, Xiao Feng; Han, Na; Kou, Yu Hui; Deng, Jiu Xu; Jiang, Bao Guo] Peking Univ, Peoples Hosp, Dept Trauma & Orthopead, Beijing 100871, Peoples R China	Peking University	Zhang, PX (corresponding author), Peking Univ, Peoples Hosp, Dept Trauma & Orthopead, Beijing 100871, Peoples R China.	zhangpeixun@126.com; jiangbaoguo@vip.sina.com			National Natural Science Fund [31171150, 31271284, 81171146, 30971526, 30801169]; Beijing City Science and Technology New Star Classification [A-2008-10]; Educational Ministry New Century Excellent Talents Support Project [BMU 20110270]; National 973 Program [2014CB542206]; National Natural Science Youth Science Fund [31100860]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Beijing City Science and Technology New Star Classification; Educational Ministry New Century Excellent Talents Support Project; National 973 Program(National Basic Research Program of China); National Natural Science Youth Science Fund	This study was supported by National Natural Science Fund (31171150, 31271284, 81171146, 30971526, 30801169), Beijing City Science and Technology New Star Classification (A-2008-10), Educational Ministry New Century Excellent Talents Support Project (BMU 20110270), National 973 Program (2014CB542206) and National Natural Science Youth Science Fund (31100860). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; Aydin MA, 2004, PLAST RECONSTR SURG, V113, P1712, DOI 10.1097/01.PRS.0000118049.93654.CA; Bain JR, 2008, J NEUROSURG, V109, P955, DOI 10.3171/JNS/2008/109/11/0955; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155; Colbert SH, 2008, HAND CLIN, V24, P341, DOI 10.1016/j.hcl.2008.07.001; Dedkov EI, 2003, J HISTOCHEM CYTOCHEM, V51, P853, DOI 10.1177/002215540305100701; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fujiwara T, 2007, J NEUROSURG, V107, P821, DOI 10.3171/JNS-07/10/0821; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hoke A, 2000, NEUROREPORT, V11, P1651; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Hynes NM, 1997, J RECONSTR MICROSURG, V13, P337, DOI 10.1055/s-2007-1006413; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kale SS, 2011, J HAND SURG-AM, V36A, P1631, DOI 10.1016/j.jhsa.2011.06.029; Kawabuchi M, 2001, ANAT RECORD, V264, P183, DOI 10.1002/ar.1159; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Rueger MA, 2008, NEUROSCI LETT, V434, P253, DOI 10.1016/j.neulet.2008.01.073; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Soler-Martin C, 2012, NEUROPATH APPL NEURO, V38, P61, DOI 10.1111/j.1365-2990.2011.01178.x; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Veltri K, 2005, J RECONSTR MICROSURG, V21, P57, DOI 10.1055/s-2005-862783; Yoshimura K, 2002, PLAST RECONSTR SURG, V109, P212, DOI 10.1097/00006534-200201000-00032; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1; Zhao CN, 2004, J NEUROTRAUM, V21, P1468, DOI 10.1089/neu.2004.21.1468; Zuijdendorp HM, 2010, J PLAST RECONSTR AES, V63, P1949, DOI 10.1016/j.bjps.2010.01.018	37	58	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79746	10.1371/journal.pone.0079746	http://dx.doi.org/10.1371/journal.pone.0079746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244555	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900050
J	Olsson, S; Frellsen, J; Boomsma, W; Mardia, KV; Hamelryck, T				Olsson, Simon; Frellsen, Jes; Boomsma, Wouter; Mardia, Kanti V.; Hamelryck, Thomas			Inference of Structure Ensembles of Flexible Biomolecules from Sparse, Averaged Data	PLOS ONE			English	Article							MACROMOLECULAR STRUCTURE DETERMINATION; MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-STRUCTURE; PROBABILISTIC MODEL; DISTANCE RESTRAINTS; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; REFINEMENT; ENERGY; STATE	We present the theoretical foundations of a general principle to infer structure ensembles of flexible biomolecules from spatially and temporally averaged data obtained in biophysical experiments. The central idea is to compute the Kullback-Leibler optimal modification of a given prior distribution tau(x) with respect to the experimental data and its uncertainty. This principle generalizes the successful inferential structure determination method and recently proposed maximum entropy methods. Tractability of the protocol is demonstrated through the analysis of simulated nuclear magnetic resonance spectroscopy data of a small peptide.	[Olsson, Simon; Frellsen, Jes; Hamelryck, Thomas] Univ Copenhagen, Bioinformat Ctr, Dept Biol, Fac Sci, Copenhagen, Denmark; [Boomsma, Wouter] Univ Copenhagen, Struct Biol & NMR Lab, Dept Biol, Fac Sci, Copenhagen, Denmark; [Mardia, Kanti V.] Univ Leeds, Sch Math, Dept Stat, Leeds LS2 9JT, W Yorkshire, England	University of Copenhagen; University of Copenhagen; University of Leeds	Olsson, S (corresponding author), Univ Copenhagen, Bioinformat Ctr, Dept Biol, Fac Sci, Copenhagen, Denmark.	solsson@binf.ku.dk; thamelry@binf.ku.dk	Olsson, Simon/O-5804-2019; Boomsma, Wouter/K-2903-2014; Hamelryck, Thomas/A-3923-2012; Frellsen, Jes/K-4337-2014	Olsson, Simon/0000-0002-3927-7897; Boomsma, Wouter/0000-0002-8257-3827; Hamelryck, Thomas/0000-0003-2917-3602; Frellsen, Jes/0000-0001-9224-1271	Danish Council for Independent Research (Technology and Production Sciences, FTP) [274-09-0184]	Danish Council for Independent Research (Technology and Production Sciences, FTP)(Det Frie Forskningsrad (DFF))	SO and JF acknowledge funding from the Danish Council for Independent Research. http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-technology-and-production-sciences?set_language = en&cl = en (Technology and Production Sciences, FTP, 274-09-0184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bertini I, 2010, J AM CHEM SOC, V132, P13553, DOI 10.1021/ja1063923; BONVIN AMJJ, 1994, J BIOMOL NMR, V4, P143, DOI 10.1007/BF00178343; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Boomsma W, 2013, J COMPUT CHEM, V34, P1697, DOI 10.1002/jcc.23292; BRUNGER AT, 1993, Q REV BIOPHYS, V26, P49, DOI 10.1017/S0033583500003966; Cavalli A, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793625; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen Y, 2007, BIOPHYS J, V93, P2300, DOI [10.1529/biophysj.107.104174, 10.1529/biophysj.l07.104174]; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DIACONIS P, 1982, J AM STAT ASSOC, V77, P822, DOI 10.2307/2287313; Donald B.R, 2011, ALGORITHMS STRUCTURA; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fisher CK, 2010, J AM CHEM SOC, V132, P14919, DOI 10.1021/ja105832g; GRONENBORN AM, 1985, PROG NUCL MAG RES SP, V17, P1, DOI 10.1016/0079-6565(85)80004-2; Groth M, 1999, J BIOMOL NMR, V15, P315, DOI 10.1023/A:1008349424452; Guerry P, 2013, ANGEW CHEM INT EDIT, V52, P3181, DOI 10.1002/anie.201209669; Habeck M, 2006, P NATL ACAD SCI USA, V103, P1756, DOI 10.1073/pnas.0506412103; Habeck M, 2011, J STRUCT BIOL, V173, P541, DOI 10.1016/j.jsb.2010.09.016; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Hamelryck Thomas, 2012, BAYESIAN METHODS STR; Harder T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-306; Irback Anders, 2009, PMC Biophys, V2, P2, DOI 10.1186/1757-5036-2-2; JACK A, 1978, ACTA CRYSTALLOGR A, V34, P931, DOI 10.1107/S0567739478001904; JARDETZKY O, 1980, BIOCHIM BIOPHYS ACTA, V621, P227, DOI 10.1016/0005-2795(80)90174-9; Jaynes E.T., 2003, PROBABILITY THEORY L; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; KEMMINK J, 1993, J MOL BIOL, V230, P312, DOI 10.1006/jmbi.1993.1144; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; KULLBACK S, 1968, INFORM THEORY STAT; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g; McCullagh P, 1989, GEN LINEAR MODELS; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024; Olsson S, 2011, J MAGN RESON, V213, P182, DOI 10.1016/j.jmr.2011.08.039; Pitera JW, 2012, J CHEM THEORY COMPUT, V8, P3445, DOI 10.1021/ct300112v; Rieping W, 2005, J AM CHEM SOC, V127, P16026, DOI 10.1021/ja055092c; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Roux B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4792208; Shehu A, 2006, PROTEINS, V65, P164, DOI 10.1002/prot.21060; Teilum K, 2011, BBA-PROTEINS PROTEOM, V1814, P969, DOI 10.1016/j.bbapap.2010.11.005; TORDA AE, 1990, J MOL BIOL, V214, P223, DOI 10.1016/0022-2836(90)90157-H; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Wang Lincong, 2006, Comput Syst Bioinformatics Conf, P67	47	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79439	10.1371/journal.pone.0079439	http://dx.doi.org/10.1371/journal.pone.0079439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244505	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900040
J	Wu, ZY; Song, LX; Liu, SQ; Huang, DJ				Wu, Ziyun; Song, Lixia; Liu, Shao Quan; Huang, Dejian			Independent and Additive Effects of Glutamic Acid and Methionine on Yeast Longevity	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIC RESTRICTION; DIETARY RESTRICTION; STRESS RESISTANCE; RHESUS-MONKEYS; BUDDING YEAST; EXTENSION; SURVIVAL; SCH9	It is established that glucose restriction extends yeast chronological and replicative lifespan, but little is known about the influence of amino acids on yeast lifespan, although some amino acids were reported to delay aging in rodents. Here we show that amino acid composition greatly alters yeast chronological lifespan. We found that non-essential amino acids (to yeast) methionine and glutamic acid had the most significant impact on yeast chronological lifespan extension, restriction of methionine and/or increase of glutamic acid led to longevity that was not the result of low acetic acid production and acidification in aging media. Remarkably, low methionine, high glutamic acid and glucose restriction additively and independently extended yeast lifespan, which could not be further extended by buffering the medium (pH 6.0). Our preliminary findings using yeasts with gene deletion demonstrate that glutamic acid addition, methionine and glucose restriction prompt yeast longevity through distinct mechanisms. This study may help to fill a gap in yeast model for the fast developing view that nutrient balance is a critical factor to extend lifespan.	[Wu, Ziyun; Liu, Shao Quan; Huang, Dejian] Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore; [Wu, Ziyun; Song, Lixia; Liu, Shao Quan; Huang, Dejian] Natl Univ Singapore Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; National University of Singapore	Huang, DJ (corresponding author), Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore.	chmhdj@nus.edu.sg	Liu, shao quan/D-3172-2016; Huang, Dejian/A-7439-2010; Wu, Ziyun/C-1592-2009	Liu, shao quan/0000-0003-0868-2731; Wu, Ziyun/0000-0001-8239-1890; Huang, Dejian/0000-0002-2305-3960	National University of Singapore Virtual Institute for the Study of Aging (VISA) [R-143-000-437-290]	National University of Singapore Virtual Institute for the Study of Aging (VISA)	The authors are grateful for the financial support of National University of Singapore Virtual Institute for the Study of Aging (VISA) (grant number: R-143-000-437-290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Javitt DC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002804; Jiang JC, 2000, FASEB J, V14, P2135; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lee YJ, 2012, J BIOL CHEM, V287, P44221, DOI 10.1074/jbc.M112.375360; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Mirisola MG, 2012, CELL CYCLE, V11, P3532, DOI 10.4161/cc.22042; Murakami C, 2012, CELL CYCLE, V11, P3087, DOI 10.4161/cc.21465; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; ORENTREICH N, 1993, J NUTR, V123, P269; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064448; Wu ZY, 2011, EXP GERONTOL, V46, P915, DOI 10.1016/j.exger.2011.08.002; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	56	53	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79319	10.1371/journal.pone.0079319	http://dx.doi.org/10.1371/journal.pone.0079319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244480	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900036
J	Bursztyka, P; Saffray, D; Lafont-Lecuelle, C; Brin, A; Pageat, P				Bursztyka, Piotr; Saffray, Dominique; Lafont-Lecuelle, Celine; Brin, Antoine; Pageat, Patrick			Chemical Compounds Related to the Predation Risk Posed by Malacophagous Ground Beetles Alter Self-Maintenance Behavior of Naive Slugs (Deroceras reticulatum)	PLOS ONE			English	Article							PARDOSA-MILVINA ARANEAE; PTEROSTICHUS-MELANARIUS COLEOPTERA; FRESH-WATER SNAILS; CARABID BEETLES; ANTIPREDATOR BEHAVIOR; GENERALIST PREDATOR; MOLLUSCICIDAL BAITS; BIOLOGICAL-CONTROL; LYMNAEA-STAGNALIS; TERRESTRIAL SLUG	Evidence that terrestrial gastropods are able to detect chemical cues from their predators is obvious yet scarce, despite the scientific relevance of the topic to enhancing our knowledge in this area. This study examines the influence of cuticular extracts from predacious ground beetles (Carabus auratus, Carabus hispanus, Carabus nemoralis and Carabus coriaceus), and a neutral insect species (Musca domestica) on the shelter-seeking behavior of naive slugs (Deroceras reticulatum). Slugs, known to have a negative phototactic response, were exposed to light, prompting them to make a choice between either a shelter treated with a cuticular extract or a control shelter treated with pure ethyl alcohol. Their behavioral responses were recorded for one hour in order to determine their first shelter choice, their final position, and to compare the percentage of time spent in the control shelters with the time spent in the treated shelters. The test proved to be very effective: slugs spent most of the experiment in a shelter. They spent significantly more time in the control shelter than in the shelter treated with either C. nemoralis (Z = 2.43; p = 0.0151; Wilcoxon matched-pairs signed-ranks test) or C. coriaceus cuticular extracts (Z = 3.31; p<0.01; Wilcoxon matched-pairs signed-ranks test), with a seemingly stronger avoidance effect when presented with C. coriaceus extracts. The other cuticular extracts had no significant effect on any of the behavioral items measured. Although it cannot be entirely excluded that the differences observed, are partly due to the intrinsic properties of the vehicle employed to build the cuticular extracts, the results suggest that slugs can innately discriminate amongst different potential predators and adjust their behavioral response according to the relevance of the threat conveyed by their predator's chemical cues.	[Bursztyka, Piotr; Saffray, Dominique; Lafont-Lecuelle, Celine; Pageat, Patrick] Res Inst Semiochem & Appl Ethol, Dept Agron Aquaculture, St Saturnin Les Apt, Vaucluse, France; [Bursztyka, Piotr; Brin, Antoine] Engn Sch Purpan, Biodiversite Syst Agr & Nat UMR Dynafor 1201, Toulouse, Haute Garonne, France		Bursztyka, P (corresponding author), Res Inst Semiochem & Appl Ethol, Dept Agron Aquaculture, St Saturnin Les Apt, Vaucluse, France.	p.bursztyka@group-irsea.com		Brin, Antoine/0000-0003-3479-3005				Altena C. O. v. R., 1960, Basteria, V24, P21; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Armsworth CG, 2005, ANIM BEHAV, V69, P805, DOI 10.1016/j.anbehav.2004.07.009; ASTERAKI EJ, 1993, ENTOMOPHAGA, V38, P193, DOI 10.1007/BF02372553; Ayre K, 2001, J APPL ENTOMOL, V125, P389, DOI 10.1046/j.1439-0418.2001.00568.x; Ayre K, 1995, THESIS U NEWCASTLE U; BAILEY SER, 1991, ANN APPL BIOL, V119, P163, DOI 10.1111/j.1744-7348.1991.tb04855.x; Barker G. M., 2002, MOLLUSCS CROP PESTS; Barker GM, 2004, NATURAL ENEMIES TERR, DOI [10.1079/9780851993195.0000, DOI 10.1079/9780851993195.0000]; Barnes MC, 2002, J INSECT BEHAV, V15, P269, DOI 10.1023/A:1015493118836; Bell RD, 2006, ETHOLOGY, V112, P903, DOI 10.1111/j.1439-0310.2006.01244.x; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; BOURNE NB, 1988, J MOLLUS STUD, V54, P327, DOI 10.1093/mollus/54.3.327; Chapman R. F., 1998, INSECTS STRUCTURE FU, P636; Chapman RF., 1998, INSECTS STRUCTURE FU, P478; CHASE R, 1982, J COMP PHYSIOL, V148, P225, DOI 10.1007/BF00619129; CHASE R, 1986, CHEM SENSES, V11, P411, DOI 10.1093/chemse/11.4.411; Chivers DP, 1996, ANIM BEHAV, V52, P315, DOI 10.1006/anbe.1996.0177; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Corfield GS, 2008, J VET EMERG CRIT CAR, V18, P68, DOI 10.1111/j.1476-4431.2007.00271.x; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; DAINTON BH, 1985, J EXP BIOL, V118, P439; DAINTON BH, 1954, J EXP BIOL, V31, P188; DAINTON BH, 1954, J EXP BIOL, V31, P165; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; DEYRUPOLSEN I, 1986, MALACOLOGIA, V27, P307; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DIGWEED SC, 1994, COLEOPTS BULL, V48, P361; EAKIN RM, 1975, AM ZOOL, V15, P851; EDMUNDS M, 1974, DEFENCE ANIMAL SURVE; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Gawleta N, 2005, APIDOLOGIE, V36, P325, DOI 10.1051/apido:2005018; Grewal PS, 2001, BIOL CONTROL, V22, P72, DOI 10.1006/bcon.2001.0958; GRUTTKE H, 1994, SERIES ENTOM, V51, P299; Guy AG, 2008, ANIM BEHAV, V76, P585, DOI 10.1016/j.anbehav.2008.04.004; HAMILTON PV, 1984, ANIM BEHAV, V32, P51, DOI 10.1016/S0003-3472(84)80323-1; Hara T.J., 1992, Fish and Fisheries Series, V6, P1; Hatteland BA, 2010, B ENTOMOL RES, V100, P559, DOI 10.1017/S0007485309990629; HENGEVELD R, 1980, NETH J ZOOL, V30, P555, DOI 10.1163/002829679X00188; HOMEIDA A M, 1982, Journal of Veterinary Pharmacology and Therapeutics, V5, P77, DOI 10.1111/j.1365-2885.1982.tb00500.x; Hommay G, 2003, ANN APPL BIOL, V142, P333, DOI 10.1111/j.1744-7348.2003.tb00258.x; Hommay G, 1998, ANN APPL BIOL, V132, P167, DOI 10.1111/j.1744-7348.1998.tb05193.x; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; Johnson Ian P., 1992, P144; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; KENNEDY PJ, 1994, SERIES ENTOM, V51, P439; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; Kiesecker JM, 1996, ANIM BEHAV, V52, P1237, DOI 10.1006/anbe.1996.0271; Kiss L, 2005, J MOLLUS STUD, V71, P221, DOI 10.1093/mollus/eyi030; KOHN AJ, 1961, AM ZOOL, V1, P291; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; LABAUNE C., 1999, COURRIER SCI PARC NA, V3, P102; Lefcort H, 2006, J ETHOL, V24, P97, DOI 10.1007/s10164-005-0168-0; Lehmann LM, 2004, ETHOLOGY, V110, P323, DOI 10.1111/j.1439-0310.2004.00972.x; LEWIS R D, 1969, Malacologia, V7, P295; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LYTH M, 1982, J MOLLUS STUD, V48, P214; Mair J, 2002, BIOCONTROL SCI TECHN, V12, P325, DOI 10.1080/09583150220128112; Mair J, 2001, AGR FOREST ENTOMOL, V3, P99, DOI 10.1046/j.1461-9563.2001.00093.x; Martin TJ, 1986, P 1986 BRIGHT CROP P, P441; McKemey AR, 2001, BIOCONTROL SCI TECHN, V11, P81, DOI 10.1080/09583150020029763; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; NEWELL PF, 1966, MED BIOL ILLUS, V16, P146; Newell PF, 1968, MEASUREMENT ENV FACT, P141; NIEMELA JK, 1994, ECOGRAPHY, V17, P166, DOI 10.1111/j.1600-0587.1994.tb00090.x; Nordlund DA, 1976, J CHEM ECOL, V2, P211, DOI 10.1007/BF00987744; Oberholzer F, 2003, BIOCONTROL SCI TECHN, V13, P99, DOI 10.1080/0958315021000054421; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; PAKARINEN E, 1994, J MOLLUS STUD, V60, P19, DOI 10.1093/mollus/60.1.19; PAKARINEN E, 1994, J MOLLUS STUD, V60, P149, DOI 10.1093/mollus/60.2.149; Persons MH, 2001, J CHEM ECOL, V27, P2493, DOI 10.1023/A:1013679532070; Persons MH, 2001, ANIM BEHAV, V61, P43, DOI 10.1006/anbe.2000.1594; Puttlitz MH, 1999, ETHOLOGY, V105, P449, DOI 10.1046/j.1439-0310.1999.00416.x; Riecken U, 1996, ANN ZOOL FENN, V33, P109; ROLLO CD, 1994, NATURWISSENSCHAFTEN, V81, P409, DOI 10.1007/BF01132695; ROLLO CD, 1991, MALACOLOGIA, V33, P199; ROLLO CD, 1995, ENVIRON ENTOMOL, V24, P116, DOI 10.1093/ee/24.1.116; Rostas M, 2009, J CHEM ECOL, V35, P20, DOI 10.1007/s10886-009-9590-z; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; Sih A., 1987, PREDATION DIRECT IND; Skodowski J.J.W., 2005, P 11 EUR CAR M AARH, P291; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; SOUTH A, 1992, TERRESTRIAL SLUGS BI; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Stout JC, 1998, BEHAV ECOL SOCIOBIOL, V43, P317, DOI 10.1007/s002650050497; Sturani M., 1962, Memorie della Societa Entomologica Italiana, V41, P85; Symondson W. O. C., 1989, Monograph - British Crop Protection Council, P295; Symondson William O.C., 2004, P37, DOI 10.1079/9780851993195.0037; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Symondson WOC, 2002, ECOLOGY, V83, P137, DOI 10.2307/2680127; SYMONDSON WOC, 1993, ANN APPL BIOL, V123, P449, DOI 10.1111/j.1744-7348.1993.tb04107.x; Symondson WOC, 1996, J APPL ECOL, V33, P741, DOI 10.2307/2404945; SYMONDSON WOC, 1994, ENTOMOPHAGA, V39, P323, DOI 10.1007/BF02373037; Talarico F, 2007, J ZOOL SYST EVOL RES, V45, P33, DOI 10.1111/j.1439-0469.2006.00394.x; Turin H, 2003, GENUS CARABUS EUROPE, P141; Turner AM, 1996, ANIM BEHAV, V51, P747, DOI 10.1006/anbe.1996.0079; Turner AM, 2006, ANIM BEHAV, V72, P1443, DOI 10.1016/j.anbehav.2006.05.010; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VERMEIJ GJ, 1982, AM NAT, V120, P701, DOI 10.1086/284025; WAHLE RA, 1992, OIKOS, V65, P52, DOI 10.2307/3544887; WAREING DR, 1985, J MOLLUS STUD, V51, P257; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wisenden BD, 2001, ANIM BEHAV, V62, P761, DOI 10.1006/anbe.2001.1797; Witjes S, 2009, J CHEM ECOL, V35, P1320, DOI 10.1007/s10886-009-9720-7; Woelfling Mirko, 2009, Communicative & Integrative Biology, V2, P353; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zaitseva O V, 1999, Neurosci Behav Physiol, V29, P581, DOI 10.1007/BF02461151; Zaitseva O V, 1994, Neurosci Behav Physiol, V24, P47, DOI 10.1007/BF02355652; Zieger MV, 2009, ACTA ZOOL-STOCKHOLM, V90, P189, DOI 10.1111/j.1463-6395.2008.00369.x	120	6	6	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79361	10.1371/journal.pone.0079361	http://dx.doi.org/10.1371/journal.pone.0079361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244487	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000327143800064
J	Conroy, BR; Walz, JM; Sajda, P				Conroy, Bryan R.; Walz, Jennifer M.; Sajda, Paul			Fast Bootstrapping and Permutation Testing for Assessing Reproducibility and Interpretability of Multivariate fMRI Decoding Models	PLOS ONE			English	Article							PATTERN-ANALYSIS; BRAIN; CLASSIFICATION; REGRESSION; SELECTION; STATES	Multivariate decoding models are increasingly being applied to functional magnetic imaging (fMRI) data to interpret the distributed neural activity in the human brain. These models are typically formulated to optimize an objective function that maximizes decoding accuracy. For decoding models trained on full-brain data, this can result in multiple models that yield the same classification accuracy, though some may be more reproducible than others-i.e. small changes to the training set may result in very different voxels being selected. This issue of reproducibility can be partially controlled by regularizing the decoding model. Regularization, along with the cross-validation used to estimate decoding accuracy, typically requires retraining many (often on the order of thousands) of related decoding models. In this paper we describe an approach that uses a combination of bootstrapping and permutation testing to construct both a measure of cross-validated prediction accuracy and model reproducibility of the learned brain maps. This requires re-training our classification method on many re-sampled versions of the fMRI data. Given the size of fMRI datasets, this is normally a time-consuming process. Our approach leverages an algorithm called fast simultaneous training of generalized linear models (FaSTGLZ) to create a family of classifiers in the space of accuracy vs. reproducibility. The convex hull of this family of classifiers can be used to identify a subset of Pareto optimal classifiers, with a single-optimal classifier selectable based on the relative cost of accuracy vs. reproducibility. We demonstrate our approach using full-brain analysis of elastic-net classifiers trained to discriminate stimulus type in an auditory and visual oddball event-related fMRI design. Our approach and results argue for a computational approach to fMRI decoding models in which the value of the interpretation of the decoding model ultimately depends upon optimizing a joint space of accuracy and reproducibility.	[Conroy, Bryan R.; Walz, Jennifer M.; Sajda, Paul] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Conroy, BR (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	bc2468@columbia.edu	Walz, Jennifer/J-7052-2015	Walz, Jennifer/0000-0003-3578-7264	National Institutes of Health grant [R01-MH085092]; National Science Foundation Graduate Research Fellowship Program; Army Research Laboratories [W911NF-10-2-0022]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085092] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Army Research Laboratories; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant R01-MH085092, the National Science Foundation Graduate Research Fellowship Program, and by the Army Research Laboratories under Cooperative Agreement Number W911NF-10-2-0022. The views and conclusions are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Conroy BR, 2013, ARXIV13078430CSLG; Conroy Bryan, 2012, JMLR Workshop Conf Proc, V22, P246; Conroy Bryan R, 2009, Adv Neural Inf Process Syst, V22, P378; Conroy BR, 2013, NEUROIMAGE, V81, P400, DOI 10.1016/j.neuroimage.2013.05.009; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Deb K., 2009, MULTIOBJECTIVE OPTIM, V1st; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Etzel JA, 2009, BRAIN RES, V1282, P114, DOI 10.1016/j.brainres.2009.05.090; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hastie T., 2009, UNSUPERVISED LEARNIN; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mumford JA, 2012, NEUROIMAGE, V59, P2636, DOI 10.1016/j.neuroimage.2011.08.076; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Rasmussen PM, 2012, PATTERN RECOGN, V45, P2085, DOI 10.1016/j.patcog.2011.09.011; Ryali S, 2010, NEUROIMAGE, V51, P752, DOI 10.1016/j.neuroimage.2010.02.040; Sabuncu MR, 2010, CEREB CORTEX, V20, P130, DOI 10.1093/cercor/bhp085; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Walz JM, 2013, NEUROIMAGE IN PRESS; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79271	10.1371/journal.pone.0079271	http://dx.doi.org/10.1371/journal.pone.0079271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244465	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800051
J	Hess, D; Brucker, C; Hegner, F; Balmert, A; Bleckmann, H				Hess, David; Bruecker, Christoph; Hegner, Franziska; Balmert, Alexander; Bleckmann, Horst			Vortex Formation with a Snapping Shrimp Claw	PLOS ONE			English	Article								Snapping shrimp use one oversized claw to generate a cavitating high speed water jet for hunting, defence and communication. This work is an experimental investigation about the jet generation. Snapping shrimp (Alpheus-bellulus) were investigated by using an enlarged transparent model reproducing the closure of the snapper claw. Flow inside the model was studied using both High-Speed Particle Image Velocimetry (HS-PIV) and flow visualization. During claw closure a channel-like cavity was formed between the plunger and the socket featuring a nozzle-type contour at the orifice. Closing the mechanism led to the formation of a leading vortex ring with a dimensionless formation number of approximate Delta T*approximate to 4. This indicates that the claw might work at maximum efficiency, i.e. maximum vortex strength was achieved by a minimum of fluid volume ejected. The subsequent vortex cavitation with the formation of an axial reentrant jet is a reasonable explanation for the large penetration depth of the water jet. That snapping shrimp can reach with their claw-induced flow. Within such a cavitation process, an axial reentrant jet is generated in the hollow cylindrical core of the cavitated vortex that pushes the front further downstream and whose length can exceed the initial jet penetration depth by several times.	[Hess, David; Bruecker, Christoph; Hegner, Franziska] Tech Univ Freiberg, Inst Mech & Fluid Dynam, Freiberg, Saxony, Germany; [Balmert, Alexander; Bleckmann, Horst] Univ Bonn, Inst Zool, Bonn, North Rhine Wes, Germany	Technical University Freiberg; University of Bonn	Hess, D (corresponding author), Tech Univ Freiberg, Inst Mech & Fluid Dynam, Freiberg, Saxony, Germany.	David.Hess@imfd.tu-freiberg.de		Bruecker, Christoph/0000-0001-5834-3020	Deutsche Forschungsgemeinschaft [BR 1494/16-1, BL 242/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study is funded by the Deutsche Forschungsgemeinschaft: BR 1494/16-1 and BL 242/17-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt REA, 2002, ANNU REV FLUID MECH, V34, P143, DOI 10.1146/annurev.fluid.34.082301.114957; Belyakov GV, 2005, J EXPT THEORETICAL P, V102, P862; Brooks WK, 1891, MEM NAT AKAD SCI WAS, V5, P319; Dabiri JO, 2005, J FLUID MECH, V538, P111, DOI 10.1017/S002211200500515X; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Gharib M, 1998, J FLUID MECH, V360, P121, DOI 10.1017/S0022112097008410; Herberholz J, 1999, J COMP PHYSIOL A, V185, P41, DOI 10.1007/s003590050364; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Vogel S, 1996, LIFE MOVING FLUIDS P; VOLZ P., 1938, ZEITSCHR MORPH U OKOL TIERE, V34, P272, DOI 10.1007/BF00408760	10	14	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e77120	10.1371/journal.pone.0077120	http://dx.doi.org/10.1371/journal.pone.0077120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244273	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327143800002
J	Ji, R; Yu, HX; Fu, Q; Chen, HD; Ye, WF; Li, SH; Lou, YG				Ji, Rui; Yu, Haixin; Fu, Qiang; Chen, Hongdan; Ye, Wenfeng; Li, Shaohui; Lou, Yonggen			Comparative Transcriptome Analysis of Salivary Glands of Two Populations of Rice Brown Planthopper, Nilaparvata lugens, That Differ in Virulence	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; ALKALINE-PHOSPHATASE; CHEMOSENSORY PROTEINS; ACYRTHOSIPHON-PISUM; PROTEOMIC ANALYSIS; DEFENSE RESPONSES; MYZUS-PERSICAE; PHLOEM SAP; EXPRESSION; IDENTIFICATION	Background: The brown planthopper (BPH), Nilaparvata lugens (Stal), a destructive rice pest in Asia, can quickly overcome rice resistance by evolving new virulent populations. Herbivore saliva plays an important role in plant-herbivore interactions, including in plant defense and herbivore virulence. However, thus far little is known about BPH saliva at the molecular level, especially its role in virulence and BPH-rice interaction. Methodology/Principal Findings: Using cDNA amplification in combination with Illumina short-read sequencing technology, we sequenced the salivary-gland transcriptomes of two BPH populations with different virulence; the populations were derived from rice variety TN1 (TN1 population) and Mudgo (M population). In total, 37,666 and 38,451 unigenes were generated from the salivary glands of these populations, respectively. When combined, a total of 43,312 unigenes were obtained, about 18 times more than the number of expressed sequence tags previously identified from these glands. Gene ontology annotations and KEGG orthology classifications indicated that genes related to metabolism, binding and transport were significantly active in the salivary glands. A total of 352 genes were predicted to encode secretory proteins, and some might play important roles in BPH feeding and BPH-rice interactions. Comparative analysis of the transcriptomes of the two populations revealed that the genes related to 'metabolism,' 'digestion and absorption,' and 'salivary secretion' might be associated with virulence. Moreover, 67 genes encoding putative secreted proteins were differentially expressed between the two populations, suggesting these genes may contribute to the change in virulence. Conclusions/Significance: This study was the first to compare the salivary-gland transcriptomes of two BPH populations having different virulence traits and to find genes that may be related to this difference. Our data provide a rich molecular resource for future functional studies on salivary glands and will be useful for elucidating the molecular mechanisms underlying BPH feeding and virulence differences.	[Ji, Rui; Yu, Haixin; Chen, Hongdan; Ye, Wenfeng; Lou, Yonggen] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Qiang] China Natl Rice Res Inst, Res & Dev Ctr Rice Prod Technol, Hangzhou, Zhejiang, Peoples R China; [Li, Shaohui] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Lou, YG (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	yglou@zju.edu.cn	Ye, Wenfeng/ACL-7903-2022	Ye, Wenfeng/0000-0003-0750-3236; Ji, Rui/0000-0003-2920-5766	National Basic Research Program of China [2010CB126200]; Innovation Research Team Program of the National Natural Science Foundation of China [31021003]; China Agriculture Research System [CARS-01-25]	National Basic Research Program of China(National Basic Research Program of China); Innovation Research Team Program of the National Natural Science Foundation of China; China Agriculture Research System	The study was jointly sponsored by the National Basic Research Program of China (2010CB126200; http://www.most.gov.cn/index.htm), the Innovation Research Team Program of the National Natural Science Foundation of China (31021003; http://www.nsfc.gov.cn/Portal0/default152.htm), and the China Agriculture Research System (CARS-01-25; http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2012, INSECT BIOCHEM MOLEC, V42, P796, DOI 10.1016/j.ibmb.2012.07.008; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; CLARIDGE MF, 1984, ENTOMOL EXP APPL, V36, P107, DOI 10.1007/BF00569950; CLARIDGE MF, 1980, ENTOMOL EXP APPL, V27, P23, DOI 10.1007/BF00377236; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; DENHOLLANDER J, 1981, ENTOMOL EXP APPL, V29, P76, DOI 10.1007/BF00300752; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Feng GH, 1996, INSECT BIOCHEM MOLEC, V26, P419, DOI 10.1016/0965-1748(95)00087-9; Funk CJ, 2001, ARCH INSECT BIOCHEM, V46, P165, DOI 10.1002/arch.1026; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; GIVOVICH A, 1994, J CHEM ECOL, V20, P1923, DOI 10.1007/BF02066233; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hayashi H, 2000, AUST J PLANT PHYSIOL, V27, P489; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Konishi H, 2009, APPL ENTOMOL ZOOL, V44, P525, DOI 10.1303/aez.2009.525; KUMAR D, 1980, Z MIKROSK ANAT FORSC, V94, P669; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutti NS, 2006, THESIS KANSAS STATE; Nathan SS, 2007, PESTIC BIOCHEM PHYS, V88, P260, DOI 10.1016/j.pestbp.2006.12.004; Nathan SS, 2006, PESTIC BIOCHEM PHYS, V84, P98, DOI 10.1016/j.pestbp.2005.05.006; Ngernyuang N, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0138; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Ross MK, 2010, J PESTIC SCI, V35, P257, DOI 10.1584/jpestics.R10-07; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Shukle RH, 2009, J INSECT PHYSIOL, V55, P104, DOI 10.1016/j.jinsphys.2008.10.008; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P13; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P13; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P195; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P67; Sogawa K., 1965, Japanese Journal of Applied Entomology and Zoology, V9, P275; SRIVASTAVA J P, 1967, Applied Entomology and Zoology, V2, P85; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tang M, 2010, APPL ENVIRON MICROB, V76, P1740, DOI 10.1128/AEM.02240-09; Tenberge KB, 1999, MYCOL RES, V103, P1103, DOI 10.1017/S095375629800820X; Tunaz H, 2004, COMP BIOCHEM PHYS B, V139, P27, DOI 10.1016/j.cbpc.2004.05.010; Wang X, 2006, THESIS ZHEJIANG U; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yan Y, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.0109; Zhang MJ, 2010, APPL BIOCHEM BIOTECH, V160, P1407, DOI 10.1007/s12010-009-8602-3	77	59	69	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79612	10.1371/journal.pone.0079612	http://dx.doi.org/10.1371/journal.pone.0079612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244529	Green Published, Green Submitted			2022-12-27	WOS:000327143800093
J	Ma, QQ; Song, HX; Zhou, SQ; Yang, WQ; Li, DS; Chen, JS				Ma, Qing-qing; Song, Hui-xing; Zhou, Shi-qiang; Yang, Wan-qin; Li, De-sheng; Chen, Jin-song			Genetic Structure in Dwarf Bamboo (Bashania fangiana) Clonal Populations with Different Genet Ages	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; PLANT; DYNAMICS; TRAITS; AFLP; MARKERS; REPENS; LONG; SIZE	Amplified fragment length polymorphism (AFLP) fingerprints were used to reveal genotypic diversity of dwarf bamboo (Bashania fangiana) clonal populations with two different genet ages (<= 30 years versus >70 years) at Wolong National Natural Reserve, Sichuan province, China. We generated AFLP fingerprints for 96 leaf samples, collected at 30 m intervals in the two populations, using ten selective primer pairs. A total of 92 genotypes were identified from the both populations. The mean proportion of distinguishable genotypes (G/N) was 0.9583 (0.9375 to 0.9792) and Simpson's index of diversity (D) was 0.9982 (0.9973 to 0.9991). So, two B. fangiana populations were multiclonal and highly diverse. The largest single clone may occur over a distance of about 30 m. Our results demonstrated that the genotypic diversity and genet density of B. fangiana clonal population did not change significantly (47 versus 45) with genet aging and low partitioned genetic differentiation was between the two populations (Gst = 0.0571). The analysis of molecular variance consistently showed that a large proportion of the genetic variation (87.79%) existed among the individuals within populations, whereas only 12.21% were found among populations. In addition, the high level of genotypic diversity in the two populations implies that the further works were needed to investigate the reasons for the poor seed set in B. fangiana after flowering.	[Ma, Qing-qing; Song, Hui-xing] Sichuan Agr Univ, Sch Landscape Architecture, Wenjiang, Sichuan, Peoples R China; [Zhou, Shi-qiang; Li, De-sheng] China Conservat & Res Ctr Giant Panda, Wenchuan, Sichuan, Peoples R China; [Yang, Wan-qin] Sichuan Agr Univ, Inst Ecol Forestry, Wenjiang, Sichuan, Peoples R China; [Chen, Jin-song] Sichuan Normal Univ, Coll Life Sci, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Normal University	Song, HX (corresponding author), Sichuan Agr Univ, Sch Landscape Architecture, Wenjiang, Sichuan, Peoples R China.	Huixingsong@aliyun.com; cjs74@163.com	Shiqiang, Zhou/G-1331-2019	Shiqiang, Zhou/0000-0002-5537-3205	National Science Fund of China [31170502]; Key Projects in the National Science & Technology Pillar Program [2011BAC09B05]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program	This research was supported by National Science Fund of China (31170502) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAC09B05). In this study, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P869, DOI 10.2307/2260154; ANTONOVICS J, 1984, EVOLUTION, V38, P103, DOI 10.1111/j.1558-5646.1984.tb00263.x; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Campbell J. J. N., 1983, J AM BAMBOO SOC, V4, P1; COOK RE, 1983, AM SCI, V71, P244; DESTEVEN D, 1989, J ECOL, V77, P579, DOI 10.2307/2260771; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; FAGER EW, 1972, AM NAT, V106, P293, DOI 10.1086/282772; Grabherr G, 1997, ECOSY WORLD, V3, P97; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Harper J. L, 1977, POPULATION BIOL PLAN; HARTNETT DC, 1985, J ECOL, V73, P407, DOI 10.2307/2260483; HARTNETT DC, 1987, AM J BOT, V74, P1239, DOI 10.2307/2444159; Isagi Y, 2004, MOL ECOL, V13, P2017, DOI 10.1111/j.1365-294X.2004.02197.x; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Koshy KC, 2001, CURR SCI INDIA, V81, P375; Li XL, 2001, ACTA PHYTOTAXON SIN, V39, P433; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; MAKITA A, 1992, ECOL RES, V7, P245, DOI 10.1007/BF02347093; McLellan AJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P185; Miyazaki Y, 2009, J PLANT RES, V122, P523, DOI 10.1007/s10265-009-0241-9; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Numata M., 1970, Biological Conservation, V2, P227, DOI 10.1016/0006-3207(70)90120-5; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Oinonen E., 1967, ACTA FOR FENN, V83, P1, DOI DOI 10.14214/AFF.7180; PIELOU E C, 1969, P286; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pornon A, 1997, PLANT ECOL, V130, P1, DOI 10.1023/A:1009724216796; Schaller G.B., 1985, GIANT PANDAS WOLONG; SCHMID B, 1990, EVOL TREND PLANT, V4, P25; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Shiqiang Z, 1996, J BAMBOO RES, V4, P9; SIMMONDS N W, 1980, Kew Bulletin, V35, P235, DOI 10.2307/4114566; SOANE ID, 1979, NEW PHYTOL, V82, P557, DOI 10.1111/j.1469-8137.1979.tb02682.x; Sole M, 2004, INT J PLANT SCI, V165, P437, DOI 10.1086/382801; Stocklin J, 2009, BOT HELV, V119, P125, DOI 10.1007/s00035-009-0065-1; Suyama Y, 2000, MOL ECOL, V9, P901, DOI 10.1046/j.1365-294x.2000.00943.x; TAYLOR AH, 1987, J APPL ECOL, V24, P419, DOI 10.2307/2403884; TAYLOR DR, 1988, AM J BOT, V75, P401, DOI 10.2307/2443987; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Till-Bottraud I, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P23; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; Verburg R, 2000, PLANT BIOLOGY, V2, P646, DOI 10.1055/s-2000-16633; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WATKINSON AR, 1993, J ECOL, V81, P707, DOI 10.2307/2261668; WIDEN B, 1994, FOLIA GEOBOT PHYTOTX, V29, P245, DOI 10.1007/BF02803799; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang HQ, 2012, INT J MOL SCI, V13, P4446, DOI 10.3390/ijms13044446; ZHANG W, 1990, Forest Research, V3, P250; Zisheng Q, 1993, BAMBOO WOLONG GIANT	59	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78784	10.1371/journal.pone.0078784	http://dx.doi.org/10.1371/journal.pone.0078784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244360	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800018
J	Wei, DD; Chen, EH; Ding, TB; Chen, SC; Dou, W; Wang, JJ				Wei, Dan-Dan; Chen, Er-Hu; Ding, Tian-Bo; Chen, Shi-Chun; Dou, Wei; Wang, Jin-Jun			De Novo Assembly, Gene Annotation, and Marker Discovery in Stored-Product Pest Liposcelis entomophila (Enderlein) Using Transcriptome Sequences	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PSOCIDS PSOCOPTERA LIPOSCELIDIDAE; HEAT-SHOCK PROTEINS; HUMAN-BODY LOUSE; RYANODINE RECEPTOR; DIAMONDBACK MOTH; FIELD POPULATIONS; SNP DETECTION; EXPRESSION; RESISTANCE	Background: As a major stored-product pest insect, Liposcelis entomophila has developed high levels of resistance to various insecticides in grain storage systems. However, the molecular mechanisms underlying resistance and environmental stress have not been characterized. To date, there is a lack of genomic information for this species. Therefore, studies aimed at profiling the L. entomophila transcriptome would provide a better understanding of the biological functions at the molecular levels. Methodology/Principal Findings: We applied Illumina sequencing technology to sequence the transcriptome of L. entomophila. A total of 54,406,328 clean reads were obtained and that de novo assembled into 54,220 unigenes, with an average length of 571 bp. Through a similarity search, 33,404 (61.61%) unigenes were matched to known proteins in the NCBI non-redundant (Nr) protein database. These unigenes were further functionally annotated with gene ontology (GO), cluster of orthologous groups of proteins (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. A large number of genes potentially involved in insecticide resistance were manually curated, including 68 putative cytochrome P450 genes, 37 putative glutathione S-transferase (GST) genes, 19 putative carboxyl/cholinesterase (CCE) genes, and other 126 transcripts to contain target site sequences or encoding detoxification genes representing eight types of resistance enzymes. Furthermore, to gain insight into the molecular basis of the L. entomophila toward thermal stresses, 25 heat shock protein (Hsp) genes were identified. In addition, 1,100 SSRs and 57,757 SNPs were detected and 231 pairs of SSR primes were designed for investigating the genetic diversity in future. onclusions/Significance: We developed a comprehensive transcriptomic database for L. entomophila. These sequences and putative molecular markers would further promote our understanding of the molecular mechanisms underlying insecticide resistance or environmental stress, and will facilitate studies on population genetics for psocids, as well as providing useful information for functional genomic research in the future.	[Wei, Dan-Dan; Chen, Er-Hu; Ding, Tian-Bo; Chen, Shi-Chun; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			Fundamental Research Funds for the Central Universities, China [XDJK2013C051, XDJK2013A005]; Doctor Foundation Project of Southwest University [SWU112046]; National Natural Sciences Foundation [31000860]; Specialized Research Fund for the Doctoral Program of Higher Education [20100182120022]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Doctor Foundation Project of Southwest University; National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded in part by the Fundamental Research Funds for the Central Universities, China (XDJK2013C051; XDJK2013A005), the Doctor Foundation Project of Southwest University (SWU112046), the National Natural Sciences Foundation (31000860), and the Specialized Research Fund for the Doctoral Program of Higher Education (20100182120022). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahmedani MS, 2010, APPL ENTOMOL ZOOL, V45, P89, DOI 10.1303/aez.2010.89; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020308; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Ding W, 2002, J STORED PROD RES, V38, P229, DOI 10.1016/S0022-474X(01)00017-0; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dou W, 2010, AGR SCI CHINA, V9, P1008, DOI 10.1016/S1671-2927(09)60184-X; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fernandez-Silva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055990; Gautam SG, 2013, J ECON ENTOMOL, V106, P491, DOI 10.1603/EC12253; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Guedes RNC, 2008, J ECON ENTOMOL, V101, P1974, DOI 10.1603/0022-0493-101.6.1974; Guo L, 2012, PEST MANAG SCI, V68, P1605, DOI 10.1002/ps.3357; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hlavica P, 2011, J INORG BIOCHEM, V105, P1354, DOI 10.1016/j.jinorgbio.2011.05.003; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Isaacs AK, 2012, CHEM RES TOXICOL, V25, P1571, DOI 10.1021/tx300326m; Jiang HB, 2012, J ECON ENTOMOL, V105, P560, DOI 10.1603/EC11324; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu QN, 2013, J INSECT PHYSIOL, V59, P848, DOI 10.1016/j.jinsphys.2013.06.001; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Nayak MK, 2007, PEST MANAG SCI, V63, P104, DOI 10.1002/ps.1313; Nayak MK, 2010, PEST MANAG SCI, V66, P295, DOI 10.1002/ps.1873; Nayak MK, 1998, J ECON ENTOMOL, V91, P1208, DOI 10.1093/jee/91.5.1208; Nayak MK, 2003, J STORED PROD RES, V39, P343, DOI 10.1016/S0022-474X(02)00029-2; Oakeshott J.G., 2010, P229; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; Opit GP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.13901; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Reid WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047163; Rozen S, 2000, Methods Mol Biol, V132, P365; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao Y, 2013, INSECT BIOCHEM MOLEC, V43, P820, DOI 10.1016/j.ibmb.2013.06.006; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033883; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; [魏丹丹 WEI Dandan], 2011, [生态学报, Acta Ecologica Sinica], V31, P4182; Wu SA, 2009, ARCH INSECT BIOCHEM, V70, P136, DOI 10.1002/arch.20285; Xiao LS, 2010, ARCH INSECT BIOCHEM, V75, P158, DOI 10.1002/arch.20378; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yang QQ, 2012, J STORED PROD RES, V48, P120, DOI 10.1016/j.jspr.2011.10.007; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063168; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	78	28	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80046	10.1371/journal.pone.0080046	http://dx.doi.org/10.1371/journal.pone.0080046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244605	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800112
J	Weng, ZY; Li, XB; Li, YQ; Lin, JX; Peng, F; Niu, WQ				Weng, Zhiyuan; Li, Xiaobo; Li, Yuqiong; Lin, Jinxiu; Peng, Feng; Niu, Wenquan			The Association of Four Common Polymorphisms from Four Candidate Genes (COX-1, COX-2, ITGA2B, ITGA2) with Aspirin Insensitivity: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; IIIA POLYMORPHISM; IN-VITRO; RESISTANCE; RESPONSIVENESS; INHIBITORS; RECEPTORS; GENETICS; RISK	Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensitivity. To generate more information, we aimed to evaluate the association of four common polymorphisms (rs3842787, rs20417, rs201184269, rs1126643) from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity via a meta-analysis. Methods and Results: In total, there were 4 (353/595), 6 (344/698), 10 (588/878) and 7 (209/676) articles (patients/controls) qualified for rs3842787, rs20417, rs20118426 and rs1126643, respectively. The data were extracted in duplicate and analyzed by STATA software (Version 11.2). The risk estimate was expressed as odds ratio (OR) and 95% confidence interval (95% CI). Analyses of the full data set indicated significant associations of rs20417 (OR; 95% CI; P: 1.86; 1.44-2.41; <0.0005) and rs1126643 (2.37; 1.44-3.89; 0.001) with aspirin insensitivity under allelic model. In subgroup analyses, the risk estimate for rs1126643 was greatly potentiated among patients with aspirin semi-resistance relative to those with aspirin resistance, especially under dominant model (aspirin semi-resistance: 5.44; 1.42-20.83; 0.013 versus aspirin resistance: 1.96; 1.07-3.6; 0.03). Further grouping articles by ethnicity observed a stronger prediction of all, but rs20417, examined polymorphisms for aspirin insensitivity in Chinese than in Caucasians. Finally, meta-regression analyses observed that the differences in percentage of coronary artery disease (P = 0.034) and averaged platelet numbers (P = 0.012) between two groups explained a large part of heterogeneity for rs20417 and rs1126643, respectively. Conclusion: Our findings provide strong evidence that COX-2 and ITGA2 genetic defects might increase the risk of having aspirin insensitivity, especially for aspirin semi-resistance and in Chinese populations.	[Weng, Zhiyuan; Lin, Jinxiu; Peng, Feng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China; [Li, Xiaobo; Li, Yuqiong; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Li, Xiaobo; Li, Yuqiong] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China	Fujian Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Peng, F (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China.	pengfeng@medmail.com.cn; niuwenquan_shcn@163.com			Shanghai Rising Star Program [11QA1405500]	Shanghai Rising Star Program	This work was supported by the Shanghai Rising Star Program (11QA1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bernardo E, 2006, PLATELETS, V17, P586, DOI 10.1080/09537100600881412; Buchanan MR, 2006, CAN J CARDIOL, V22, P149, DOI 10.1016/S0828-282X(06)70255-0; Cambria-Kiely JA, 2002, J THROMB THROMBOLYS, V14, P51, DOI 10.1023/A:1022066305399; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; Fontana P, 2006, J THROMB HAEMOST, V4, P813, DOI 10.1111/j.1538-7836.2006.01867.x; Gonzalez-Conejero R, 2005, STROKE, V36, P276, DOI 10.1161/01.STR.0000151362.65339.f9; Grinstein J, 2012, CLIN CARDIOL, V35, P673, DOI 10.1002/clc.22031; Kim SH, 2013, IMMUNOL ALLERGY CLIN, V33, P177, DOI 10.1016/j.iac.2012.10.003; Kranzhofer R, 2006, PLATELETS, V17, P163, DOI 10.1080/09537100500441101; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Kunicki TJ, 2009, THROMB HAEMOSTASIS, V101, P123, DOI 10.1160/TH08-05-0287; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Li A, 2010, SHANDONG MED J, P80; Li ChunXiao, 2011, Progress in Modern Biomedicine, V11, P2324; Li XL, 2012, CLIN APPL THROMB HEM; Macchi L, 2003, J AM COLL CARDIOL, V42, P1115, DOI 10.1016/S0735-1097(03)00921-5; Mao X, 2011, MODERN PRACTICAL MED, V23, P18; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nissen SE, 2012, EUR HEART J, V33, P2631, DOI 10.1093/eurheartj/ehs147; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Niu WQ, 2012, INT J CARDIOL, V157, P243, DOI 10.1016/j.ijcard.2011.12.098; Niu WQ, 2012, MOL CELL ENDOCRINOL, V358, P9, DOI 10.1016/j.mce.2012.02.010; Palikhe NS, 2008, J CLIN PHARM THER, V33, P465, DOI 10.1111/j.1365-2710.2008.00961.x; Pamukcu B, 2005, AM HEART J, V149, P675, DOI 10.1016/j.ahj.2004.10.007; Papp E, 2005, ANN PHARMACOTHER, V39, P1013, DOI 10.1345/aph.1E227; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Su G, 2007, CHINESE J HEMORHEOLO, P43; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Wang B, 2012, CHINESE J GERIATRIC, V14, P3; [王毅盟 Wang Yimeng], 2012, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V32, P301; Wu W, 2006, CLIN FACTORS ASPIRIN; Xin X, 2009, J MODERN LAB MED, V24, P3; Zhang J, 2009, CHINESE J GERIATRIC, V11, P3; Zhao Y, 2011, MOL CARDIOLOGY CHINA, P164; Zhou Q, 2010, CLIN STUDY BOTH ASPI, P12	38	37	44	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78093	10.1371/journal.pone.0078093	http://dx.doi.org/10.1371/journal.pone.0078093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244288	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800005
J	Xu, ZS; Xue, W; Xiong, AS; Lin, YQ; Xu, J; Zhu, B; Zhao, W; Peng, RH; Yao, QH				Xu, Zhi-Sheng; Xue, Wei; Xiong, Ai-Sheng; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong			Characterization of a Bifunctional O- and N-Glucosyltransferase from Vitis vinifera in Glucosylating Phenolic Compounds and 3,4-dichloroaniline in Pichia pastoris and Arabidopsis thaliana	PLOS ONE			English	Article							TRANSGENIC ARABIDOPSIS; MEDICAGO-TRUNCATULA; CHLORINATED PHENOLS; CRYSTAL-STRUCTURES; METABOLISM; XENOBIOTICS; PLANTS; GLYCOSYLTRANSFERASE; PHYTOREMEDIATION; SEQUENCES	2,4,5-Trichlorophenol, 2,6-dimethylphenol, 3-methylcatechol, phenol, hydroquinone, catechol, and 3,4-dichloroaniline are present in the environment and are risky to humans and animals because of their wide applications in many industries. In this study, a putative uridine diphosphate glucose-dependent glycosyltransferase from Vitis vinifera (VvUGT72B1) displayed high O-glucosyltransferase or N-glucosyltransferase activity toward all these xenbiotics and was able to enhance the resistance of P. pastoris to them. Compared with wild-type Arabidopsis plants, VvUGT72B1-transgenic Arabidopsis plants showed higher resistance to all the xenobiotics except for phenol and exhibited higher removal efficiencies against all xenobiotics. Glucosides of 3-methylcatechol, 2,6-dimethylphenol, phenol, and 3,4-dichloroaniline were exported to the surrounding media by Arabidopsis plants while transgenic Arabidopsis plants exported more glucosides than wild-type Arabidopsis plants. Our findings have the potential to provide a broader spectrum remediation strategy for the phytoremoval and degradation of phenolic compounds and 3,4-dichloroaniline than previous works.	[Xu, Zhi-Sheng; Xue, Wei; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong] Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China; [Xu, Zhi-Sheng; Xiong, Ai-Sheng; Lin, Ya-Qiu; Yao, Quan-Hong] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Xue, Wei] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University; Shanghai Ocean University	Peng, RH (corresponding author), Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China.	pengrihe69@yahoo.com; yaoquanhong_sh@aliyun.com		Xiong, Ai-Sheng/0000-0002-7900-5001	Key Project Fund of the Shanghai Municipal Committee of Agriculture [2009-6-4, 2011-1-8]; International Scientific and Technological Cooperation [2010DFA62320, 11230705900]; National Natural Science Foundation [31071486]	Key Project Fund of the Shanghai Municipal Committee of Agriculture; International Scientific and Technological Cooperation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2009-6-4), the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2011-1-8), the International Scientific and Technological Cooperation (2010DFA62320, 11230705900), and the National Natural Science Foundation (31071486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiu S, 1988, NATURE, V12, P138; Bozena B, 2004, CELL BIOL INT, V28, P557, DOI [10.1016/j.cellbi.2004.04.013, DOI 10.1016/J.CELLBI.2004.04.013.PUBMED:15261164]; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dietz AC, 2001, ENVIRON HEALTH PERSP, V109, P163, DOI 10.2307/3434854; Eapen S, 2007, BIOTECHNOL ADV, V25, P442, DOI 10.1016/j.biotechadv.2007.05.001; George ESB, 2007, BRAZ ARCH BIOL TECHN, V50, P839; GOERLITZ DF, 1985, ENVIRON SCI TECHNOL, V19, P955, DOI 10.1021/es00140a012; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Hard GC, 1997, TOXICOL PATHOL, V25, P132, DOI 10.1177/019262339702500202; Hubner A, 1998, APPL ENVIRON MICROB, V64, P2086; Joachim A, 2000, PHYTOCHEMISTRY, V53, P187, DOI [10.1016/S0031-9422(99)00539-7, DOI 10.1016/S0031-9422(99)00539-7.PUBMED:10680170]; Karns S, 1983, APPL ENVIRON MICROB, V46, P1182; Lao SH, 2003, PHYTOCHEMISTRY, V63, P653, DOI 10.1016/S0031-9422(03)00289-9; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Liao Y, 2006, PLANT PHYSIOL, V142, P620, DOI 10.1104/pp.106.085936; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; SANDERMANN H, 1991, ARCH BIOCHEM BIOPHYS, V287, P341, DOI 10.1016/0003-9861(91)90488-5; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Sharma HA, 1997, ENVIRON TOXICOL CHEM, V16, P346, DOI [10.1002/etc.5620160233, 10.1897/1551-5028(1997)016&lt;0346:ACOTTA&gt;2.3.CO;2]; Su ZH, 2012, ENVIRON SCI TECHNOL, V46, P4016, DOI 10.1021/es203753b; Tobias H, 1976, BIOORGAN MED CHEM, V10, P1731; Wendy O, 2006, EMBO J, V25, P1396, DOI [10.1038/sj.emboj.7600970, DOI 10.1038/SJ.EMB0J.7600970.PUBMED:16482224]; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xu ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066878	30	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80449	10.1371/journal.pone.0080449	http://dx.doi.org/10.1371/journal.pone.0080449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244688	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800146
J	Cakir, B; Kilickaya, O				Cakir, Birsen; Kilickaya, Ozan			Whole-Genome Survey of the Putative ATP-Binding Cassette Transporter Family Genes in Vitis vinifera	PLOS ONE			English	Article							PLANT ABC TRANSPORTERS; RESISTANCE-ASSOCIATED PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; CONDUCTANCE REGULATOR CFTR; HEAVY-METAL RESISTANCE; DROSOPHILA-WHITE GENE; ACID BETA-OXIDATION; ARABIDOPSIS-THALIANA; MULTIDRUG-RESISTANCE; PLEIOTROPIC DRUG	The ATP-binding cassette (ABC) protein superfamily constitutes one of the largest protein families known in plants. In this report, we performed a complete inventory of ABC protein genes in Vitis vinifera, the whole genome of which has been sequenced. By comparison with ABC protein members of Arabidopsis thaliana, we identified 135 putative ABC proteins with 1 or 2 NBDs in V. vinifera. Of these, 120 encode intrinsic membrane proteins, and 15 encode proteins missing TMDs. V. vinifera ABC proteins can be divided into 13 subfamilies with 79 "full-size,'' 41 "half-size,'' and 15 "soluble'' putative ABC proteins. The main feature of the Vitis ABC superfamily is the presence of 2 large subfamilies, ABCG (pleiotropic drug resistance and white-brown complex homolog) and ABCC (multidrug resistance-associated protein). We identified orthologs of V. vinifera putative ABC transporters in different species. This work represents the first complete inventory of ABC transporters in V. vinifera. The identification of Vitis ABC transporters and their comparative analysis with the Arabidopsis counterparts revealed a strong conservation between the 2 species. This inventory could help elucidate the biological and physiological functions of these transporters in V. vinifera.	[Cakir, Birsen] Ege Univ, Fac Agr, Dept Hort, Izmir, Turkey; [Kilickaya, Ozan] Ege Univ, Dept Biotechnol, Grad Sch Nat & Appl Sci, Izmir, Turkey	Ege University; Ege University	Cakir, B (corresponding author), Ege Univ, Fac Agr, Dept Hort, Izmir, Turkey.	birsencakir@hotmail.com	Kılıçkaya, Ozan/J-7416-2015	Kılıçkaya, Ozan/0000-0003-2710-2149				Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; Bairoch A, 1992, NUCL ACIDS RES, V20; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bunting KD, 2002, STEM CELLS, V20, P274, DOI 10.1634/stemcells.20-3-274; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Chen HM, 1996, AM J HUM GENET, V59, P66; Crouzet J, 2006, FEBS LETT, V580, P1123, DOI 10.1016/j.febslet.2005.12.043; Datta RS, 2009, NUCLEIC ACIDS RES, V37, pW84, DOI 10.1093/nar/gkp373; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Footitt S, 2006, J EXP BOT, V57, P2805, DOI 10.1093/jxb/erl045; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Kaneda M, 2011, J EXPT BOT; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Moons A, 2003, FEBS LETT, V553, P370, DOI 10.1016/S0014-5793(03)01060-3; Moons A, 2008, PLANTA, V229, P53, DOI 10.1007/s00425-008-0810-5; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Smart CC, 1996, J BIOL CHEM, V271, P19351, DOI 10.1074/jbc.271.32.19351; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tamura K, 2011, MOL BIOL EVOLUTION; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ukitsu H, 2007, PLANT CELL PHYSIOL, V48, P1524, DOI 10.1093/pcp/pcm139; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Windsor B, 2003, NAT BIOTECHNOL, V21, P428, DOI 10.1038/nbt809; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yamaguchi H, 2002, J EXP BOT, V53, P727, DOI 10.1093/jexbot/53.369.727; Young J, 1999, BBA-BIOMEMBRANES, V1461, P177, DOI 10.1016/S0005-2736(99)00158-3; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	83	39	45	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78860	10.1371/journal.pone.0078860	http://dx.doi.org/10.1371/journal.pone.0078860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244377	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600073
J	De Baets, L; Van Deun, S; Desloovere, K; Jaspers, E				De Baets, Liesbet; Van Deun, Sara; Desloovere, Kaat; Jaspers, Ellen			Dynamic Scapular Movement Analysis: Is It Feasible and Reliable in Stroke Patients during Arm Elevation?	PLOS ONE			English	Article							POSTSTROKE SHOULDER PAIN; IPSILATERAL SHOULDER; MUSCLE-ACTIVITY; KINEMATICS; PEOPLE; MOTION; IMPINGEMENT; RELIABILITY; GAIT	Knowledge of three-dimensional scapular movements is essential to understand post-stroke shoulder pain. The goal of the present work is to determine the feasibility and the within and between session reliability of a movement protocol for three-dimensional scapular movement analysis in stroke patients with mild to moderate impairment, using an optoelectronic measurement system. Scapular kinematics of 10 stroke patients and 10 healthy controls was recorded on two occasions during active anteflexion and abduction from 0 degrees to 60 degrees and from 0 degrees to 120 degrees. All tasks were executed unilaterally and bilaterally. The protocol's feasibility was first assessed, followed by within and between session reliability of scapular total range of motion (ROM), joint angles at start position and of angular waveforms. Additionally, measurement errors were calculated for all parameters. Results indicated that the protocol was generally feasible for this group of patients and assessors. Within session reliability was very good for all tasks. Between sessions, scapular angles at start position were measured reliably for most tasks, while scapular ROM was more reliable during the 120 degrees tasks. In general, scapular angles showed higher reliability during anteflexion compared to abduction, especially for protraction. Scapular lateral rotations resulted in smallest measurement errors. This study indicates that scapular kinematics can be measured reliably and with precision within one measurement session. In case of multiple test sessions, further methodological optimization is required for this protocol to be suitable for clinical decision-making and evaluation of treatment efficacy.	[De Baets, Liesbet; Van Deun, Sara] Univ Hasselt, Biomed Res Inst, Rehabil Res Ctr, Diepenbeek, Belgium; [Desloovere, Kaat; Jaspers, Ellen] Katholieke Univ Leuven, Dept Rehabil Sci, B-3001 Heverlee, Belgium; [Desloovere, Kaat] Univ Hosp Pellenberg, Clin Mot Anal Lab, Pellenberg, Belgium; [Jaspers, Ellen] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	Hasselt University; KU Leuven; KU Leuven; University Hospital Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	De Baets, L (corresponding author), Univ Hasselt, Biomed Res Inst, Rehabil Res Ctr, Diepenbeek, Belgium.	liesbet.debaets@uhasselt.be	Desloovere, Kaat/F-3240-2014	Desloovere, Kaat/0000-0002-8507-5276; Jaspers, Ellen/0000-0003-2359-9469; De Baets, Liesbet/0000-0002-1370-2090				Baker K, 2011, STROKE, V42, P1787, DOI 10.1161/STROKEAHA.110.608505; BROCKLEHURST JC, 1978, BRIT MED J, V1, P1307, DOI 10.1136/bmj.1.6123.1307; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chae J, 2007, ARCH PHYS MED REHAB, V88, P298, DOI 10.1016/j.apmr.2006.12.007; Dayanidhi S, 2005, CLIN BIOMECH, V20, P600, DOI 10.1016/j.clinbiomech.2005.03.002; De Baets L, 2013, J ELECTROMYOGR KINES, V23, P3, DOI 10.1016/j.jelekin.2012.06.007; Dromerick AW, 2008, ARCH PHYS MED REHAB, V89, P1589, DOI 10.1016/j.apmr.2007.10.051; Hardwick DD, 2011, J NEUROL PHYS THER, V35, P18, DOI 10.1097/NPT.0b013e318208efa1; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485, DOI 10.2519/jospt.2006.2146; Lindgren I, 2007, STROKE, V38, P343, DOI 10.1161/01.STR.0000254598.16739.4e; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Meskers CGM, 2007, J BIOMECH, V40, P941, DOI 10.1016/j.jbiomech.2006.02.011; Meskers CGM, 2005, AM J PHYS MED REHAB, V84, P97, DOI 10.1097/01.PHM.0000150792.26793.E9; Mottram S. L., 1997, Man Ther, V2, P123, DOI 10.1054/math.1997.0292; Niessen M, 2008, J REHABIL MED, V40, P482, DOI 10.2340/16501977-0201; Niessen MH, 2009, ARCH PHYS MED REHAB, V90, P1557, DOI 10.1016/j.apmr.2009.04.004; Patterson TS, 2011, J MOTOR BEHAV, V43, P121, DOI 10.1080/00222895.2010.548422; Roy CW., 1994, CLIN REHABIL, V8, P334, DOI [DOI 10.1177/026921559400800410, 10.1177/026921559400800410]; Roy JS, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-49; Ryeson S., 1997, PHYS THERAPY SHOULDE, P205; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Thigpen Charles A, 2005, Res Sports Med, V13, P181, DOI 10.1080/15438620500222489; van Andel C, 2009, GAIT POSTURE, V29, P123, DOI 10.1016/j.gaitpost.2008.07.012; van Sint Jan S., 2007, COLOR ATLAS SKELETAL; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woltring H. J., 1995, 3 DIMENSIONAL ANAL H; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	32	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79046	10.1371/journal.pone.0079046	http://dx.doi.org/10.1371/journal.pone.0079046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244414	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600101
J	Ensoy, C; Aerts, M; Welby, S; Van der Stede, Y; Faes, C				Ensoy, Chellafe; Aerts, Marc; Welby, Sarah; Van der Stede, Yves; Faes, Christel			A Dynamic Spatio-Temporal Model to Investigate the Effect of Cattle Movements on the Spread of Bluetongue BTV-8 in Belgium	PLOS ONE			English	Article							NORTH-WESTERN EUROPE; INFECTIOUS-DISEASES; VIRUS SEROTYPE-8; RISK; EPIDEMIOLOGY; TRANSMISSION; TIME; FRAMEWORK; FARMS	When Bluetongue Virus Serotype 8 (BTV-8) was first detected in Northern Europe in 2006, several guidelines were immediately put into place with the goal to protect farms and stop the spreading of the disease. This however did not prevent further rapid spread of BTV-8 across Northern Europe. Using information on the 2006 Bluetongue outbreak in cattle farms in Belgium, a spatio-temporal transmission model was formulated. The model quantifies the local transmission of the disease between farms within a municipality, the short-distance transmission between farms across neighbouring municipalities and the transmission as a result of cattle movement. Different municipality-level covariates such as farm density, land composition variables, temperature and precipitation, were assessed as possibly influencing each component of the transmission process. Results showed a significant influence of the different covariates in each model component, particularly the significant effect of temperature and precipitation values in the number of infected farms. The model which allowed us to predict the dynamic spreading of BTV for different movement restriction scenarios, also affirmed the significant impact of cattle movement in the 2006 BTV outbreak pattern. Simulation results further showed the importance of considering the size of restriction zones in the formulation of guidelines for animal infectious diseases.	[Ensoy, Chellafe; Aerts, Marc; Faes, Christel] Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Welby, Sarah; Van der Stede, Yves] Vet & Agrochem Res Ctr, Brussels, Belgium; [Van der Stede, Yves] Univ Ghent, Lab Vet Immunol, Merelbeke, Belgium	Hasselt University; Ghent University	Ensoy, C (corresponding author), Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium.	chellafe.ensoy@uhasselt.be	Faes, Christel/E-1384-2017; Van der Stede, Yves/I-4626-2016	Faes, Christel/0000-0002-1878-9869; Van der Stede, Yves/0000-0001-7294-3698	IAP Research Network P7/06 of the Belgian State (Belgian Science Policy); Flemish Research Council [G064710]	IAP Research Network P7/06 of the Belgian State (Belgian Science Policy); Flemish Research Council(FWO)	Support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy) and the Flemish Research Council (G064710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Bivand RS, 2008, USE R, P1; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Di Gialleonardo L, 2011, RES VET SCI, V91, P316, DOI 10.1016/j.rvsc.2010.12.017; Diekmann O, 2000, MATH METHODOLOGY INF; Faes C, 2013, PREV VET MED, V110, P149, DOI 10.1016/j.prevetmed.2012.11.026; FAO, 2001, STAT FOOD AGR; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Held L, 2005, STAT MODEL, V5, P187, DOI 10.1191/1471082X05st098oa; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Hooten MB, 2010, SPAT SPATIO-TEMPORAL, V1, P177, DOI 10.1016/j.sste.2010.03.003; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; Kupferschmidt K, 2012, NEW ANIMAL VIRUS TAK; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; Peeters A., 2010, COUNTRY PASTURE FORA; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2004, REV SCI TECH OIE, V23, P761, DOI 10.20506/rst.23.3.1515; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schley D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005481; Schrodle B, 2012, BIOMETRICS, V68, P736, DOI 10.1111/j.1541-0420.2011.01717.x; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Turner J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00319; Vandenbussche F, 2008, VET MICROBIOL, V129, P15, DOI 10.1016/j.vetmic.2007.10.029; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; WARD MP, 1995, PREV VET MED, V24, P129, DOI 10.1016/0167-5877(94)00458-U; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	32	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78591	10.1371/journal.pone.0078591	http://dx.doi.org/10.1371/journal.pone.0078591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244324	gold, Green Published			2022-12-27	WOS:000327221600034
J	He, WJ; Xie, QH; Wang, YY; Chen, J; Zhao, M; Davis, LS; Breyer, MD; Gu, GQ; Hao, CM				He, Wenjuan; Xie, Qionghong; Wang, Yingying; Chen, Jing; Zhao, Min; Davis, Linda S.; Breyer, Matthew D.; Gu, Guoqiang; Hao, Chuan-Ming			Generation of a Tenascin-C-CreER2 Knockin Mouse Line for Conditional DNA Recombination in Renal Medullary Interstitial Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; TENASCIN; EXPRESSION; CYCLOOXYGENASE-2; HYPERTENSION; SURVIVAL; KIDNEY; ADULT; RATS	Renal medullary interstitial cells (RMIC) are specialized fibroblast-like cells that exert important functions in maintaining body fluid homeostasis and systemic blood pressure. Here, we generated a RMIC specific tenascin-C promoter driven inducible CreER2 knockin mouse line with an EGFP reporter. Similar as endogenous tenascin-C expression, the reporter EGFP expression in the tenascin-C-CreER2(+/-) mice was observed in the inner medulla of the kidney, and co-localized with COX2 but not with AQP2 or AQP1, suggesting selective expression in RMICs. After recombination (tenascin-C-CreER2(+/-)/ROSA26-lacZ(+/-) mice + tamoxifen), beta-gal activity was restricted to the cells in the inner medulla of the kidney, and didn't colocalize with AQP2, consistent with selective Cre recombinase activity in RMICs. Cre activity was not obvious in other major organs or without tamoxifen treatment. This inducible RMIC specific Cre mouse line should therefore provide a novel tool to manipulate genes of interest in RMICs.	[Xie, Qionghong; Chen, Jing; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China; [He, Wenjuan] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [He, Wenjuan; Wang, Yingying; Zhao, Min; Davis, Linda S.; Hao, Chuan-Ming] Vanderbilt Univ, Med Ctr, Sch Med, Div Nephrol, Nashville, TN 37232 USA; [Breyer, Matthew D.] Eli Lilly & Co, Lilly Res Labs, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Gu, Guoqiang] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Fudan University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Vanderbilt University; Eli Lilly; Vanderbilt University	Hao, CM (corresponding author), Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China.	chuanminghao@fudan.edu.cn	wang, yingying/GRS-3058-2022; Chen, Jing/AAM-2184-2021	Breyer, Matthew/0000-0003-1880-371X	Natural Science Foundation of China [81130075]; National Basic Research Program of China [2011CB94001]; NIH [R01 DK071876985];  [985III-YFX0302]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	Funding was provided by Natural Science Foundation of China 81130075, National Basic Research Program of China 2011CB94001, NIH R01 DK071876985, and Project of China 985III-YFX0302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599; Brellier F, 2009, SCAND J MED SCI SPOR, V19, P511, DOI 10.1111/j.1600-0838.2009.00916.x; BULGER RE, 1967, LAB INVEST, V16, P124; BULGER RE, 1966, AM J ANAT, V118, P685, DOI 10.1002/aja.1001180302; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hao CM, 2004, HYPERTENSION, V44, P396, DOI 10.1161/01.HYP.0000140925.73081.4c; Harris RC, 2002, J HYPERTENS, V20, pS3; Haugan K, 1997, J PHARMACOL EXP THER, V280, P1415; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Mackie EJ, 1999, J CELL SCI, V112, P3847; NATALI PG, 1991, INT J CANCER, V47, P811, DOI 10.1002/ijc.2910470603; Tompers DM, 2004, STEM CELLS, V22, P243, DOI 10.1634/stemcells.22-3-243; Truong LD, 1996, NEPHRON, V72, P579, DOI 10.1159/000188943	20	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79839	10.1371/journal.pone.0079839	http://dx.doi.org/10.1371/journal.pone.0079839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244568	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600154
J	Inanobe, A; Nakagawa, A; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Kurachi, Yoshihisa			Conformational Changes Underlying Pore Dilation in the Cytoplasmic Domain of Mammalian Inward Rectifier K+ Channels	PLOS ONE			English	Article							G-BETA-GAMMA; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; MECHANISM; PIP2; SUBUNIT; BINDING; G(BETA-GAMMA)	The cytoplasmic domain of inward rectifier K+ (Kir) channels associates with cytoplasmic ligands and undergoes conformational change to control the gate present in its transmembrane domain. Ligand-operated activation appears to cause dilation of the pore at the cytoplasmic domain. However, it is still unclear how the cytoplasmic domain supports pore dilation and how alterations to this domain affect channel activity. In the present study, we focused on 2 spatially adjacent residues, i.e., Glu236 and Met313, of the G protein-gated Kir channel subunit Kir3.2. In the closed state, these pore-facing residues are present on adjacent beta D and beta H strands, respectively. We mutated both residues, expressed them with the m(2)-muscarinic receptor in Xenopus oocytes, and measured the acetylcholine-dependent K+ currents. The dose-response curves of the Glu236 mutants tended to be shifted to the right. In comparison, the slopes of the concentration-dependent curves were reduced and the single-channel properties were altered in the Met313 mutants. The introduction of arginine at position 236 conferred constitutive activity and caused a leftward shift in the conductance-voltage relationship. The crystal structure of the cytoplasmic domain of the mutant showed that the arginine contacts the main chains of the beta H and beta I strands of the adjacent subunit. Because the beta H strand forms a beta sheet with the beta I and beta D strands, the immobilization of the pore-forming beta sheet appears to confer unique properties to the mutant. These results suggest that the G protein association triggers pore dilation at the cytoplasmic domain in functional channels, and the pore-constituting structural elements contribute differently to these conformational changes.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Lab Supramol Crystallog, Suita, Osaka 565, Japan	Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C23590301, 22136002]; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AI was supported by a Grant-in-Aid for Scientific Research (C23590301) and YK by a Grant-in-Aid for Scientific Research on Innovative Areas (22136002) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hosoya Y, 1996, J GEN PHYSIOL, V108, P485, DOI 10.1085/jgp.108.6.485; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 1999, J NEUROSCI, V19, P1006; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Inanobe A, 2011, J BIOL CHEM, V286, P41801, DOI 10.1074/jbc.M111.278531; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Inanobe A, 2010, J BIOL CHEM, V285, P38517, DOI 10.1074/jbc.M110.161703; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Medina I, 2000, J BIOL CHEM, V275, P29709, DOI 10.1074/jbc.M004989200; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; YAMADA M, 1994, BIOCHEM BIOPH RES CO, V200, P1484, DOI 10.1006/bbrc.1994.1618; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	47	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79844	10.1371/journal.pone.0079844	http://dx.doi.org/10.1371/journal.pone.0079844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244570	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600155
J	Schulte, EC; Stahl, I; Czamara, D; Ellwanger, DC; Eck, S; Graf, E; Mollenhauer, B; Zimprich, A; Lichtner, P; Haubenberger, D; Pirker, W; Brucke, T; Bereznai, B; Molnar, MJ; Peters, A; Gieger, C; Muller-Myhsok, B; Trenkwalder, C; Winkelmann, J				Schulte, Eva C.; Stahl, Immanuel; Czamara, Darina; Ellwanger, Daniel C.; Eck, Sebastian; Graf, Elisabeth; Mollenhauer, Brit; Zimprich, Alexander; Lichtner, Peter; Haubenberger, Dietrich; Pirker, Walter; Bruecke, Thomas; Bereznai, Benjamin; Molnar, Maria J.; Peters, Annette; Gieger, Christian; Mueller-Myhsok, Bertram; Trenkwalder, Claudia; Winkelmann, Juliane			Rare Variants in PLXNA4 and Parkinson's Disease	PLOS ONE			English	Article							AXON GUIDANCE; MUTATIONS; GENE; PATHWAY; PLEXIN-A4; RISK; ASSOCIATION; COMPLEX; SEMA5A; SERVER	Approximately 20% of individuals with Parkinson's disease (PD) report a positive family history. Yet, a large portion of causal and disease-modifying variants is still unknown. We used exome sequencing in two affected individuals from a family with late-onset familial PD followed by frequency assessment in 975 PD cases and 1014 ethnically-matched controls and linkage analysis to identify potentially causal variants. Based on the predicted penetrance and the frequencies, a variant in PLXNA4 proved to be the best candidate and PLXNA4 was screened for additional variants in 862 PD cases and 940 controls, revealing an excess of rare non-synonymous coding variants in PLXNA4 in individuals with PD. Although we cannot conclude that the variant in PLXNA4 is indeed the causative variant, these findings are interesting in the light of a surfacing role of axonal guidance mechanisms in neurodegenerative disorders but, at the same time, highlight the difficulties encountered in the study of rare variants identified by next-generation sequencing in diseases with autosomal dominant or complex patterns of inheritance.	[Schulte, Eva C.; Stahl, Immanuel; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany; [Schulte, Eva C.; Stahl, Immanuel; Eck, Sebastian; Graf, Elisabeth; Lichtner, Peter; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, Munich, Germany; [Czamara, Darina; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Czamara, Darina; Mueller-Myhsok, Bertram; Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Ellwanger, Daniel C.] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Chair Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Mollenhauer, Brit; Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Mollenhauer, Brit; Trenkwalder, Claudia] Univ Gottingen, Neurochirurg Klin, D-37073 Gottingen, Germany; [Zimprich, Alexander; Haubenberger, Dietrich; Pirker, Walter] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Lichtner, Peter; Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-80290 Munich, Germany; [Bruecke, Thomas] Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria; [Bereznai, Benjamin; Molnar, Maria J.] Semmelweis Univ, Dept Neurol, Ctr Mol Neurol, H-1085 Budapest, Hungary; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany; [Winkelmann, Juliane] Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; University of Munich; Technical University of Munich; University of Gottingen; Medical University of Vienna; Technical University of Munich; Wilhelminenspital; Semmelweis University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany.	winkelmann@lrz.tum.de	Schulte, Eva C./AAT-2410-2021; Mollenhauer, Brit/F-8863-2010; Peters, Annette/A-6117-2011; Zimprich, Alexander/A-5232-2017; Pirker, Walter/P-2966-2019; Trenkwalder, Claudia/ABD-6559-2021; Trenkwalder, Claudia/AHD-1232-2022	Peters, Annette/0000-0001-6645-0985; Zimprich, Alexander/0000-0002-1668-5177; Trenkwalder, Claudia/0000-0001-6407-1199; Schulte, Eva Christina/0000-0003-3105-5672; Haubenberger, Dietrich/0000-0002-6233-8168; Ellwanger, Daniel/0000-0002-3481-8455; Winkelmann, Juliane/0000-0003-2667-9691; Gieger, Christian/0000-0001-6986-9554	Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; NINDS Intramural Competitive Fellowship; Austrian Science Fund (Erwin Schroedinger Fellowship) [J2783-B09]; NINDS Intramural Research Program; Hungarian National Innovation Office [TAMOP-4-2-1/B-03/11 KMR-2010-001]; German Bundesministerium fur Bildung und Forschung [03.2007-02.2011 FKZ 01ET0713]; Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC 1010 SyNergy]	Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; NINDS Intramural Competitive Fellowship; Austrian Science Fund (Erwin Schroedinger Fellowship); NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hungarian National Innovation Office; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The study was funded in its majority through institutional funding from Technische Universitat Munchen and Helmholtz Zentrum Munchen, Munich, Germany. Dr. DH received an NINDS Intramural Competitive Fellowship and research support from the Austrian Science Fund (Erwin Schroedinger Fellowship, project#J2783-B09) and the NINDS Intramural Research Program. Dr. BB and Dr. MJM received support from the Hungarian National Innovation Office (TAMOP-4-2-1/B-03/11 KMR-2010-001). Recruitment and management of the KORA cohort is funded by both institutional (Helmholtz Zentrum Munchen, Munich, Germany) and government funding from the German Bundesministerium fur Bildung und Forschung (03.2007-02.2011 FKZ 01ET0713). DC was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bialecka M, 2006, NEUROSCI LETT, V399, P121, DOI 10.1016/j.neulet.2006.01.038; BONIFATI V, 1995, CAN J NEUROL SCI, V22, P272, DOI 10.1017/S0317167100039469; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jung G, 2011, ANN M AM SOC HUM GEN; Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Korner S, 2012, ANN M GERM SOC NEUR; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002707; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schulte EC, 2012, NEUROGENETICS, V13, P281, DOI 10.1007/s10048-012-0334-9; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Waimey KE, 2008, DEV BIOL, V315, P448, DOI 10.1016/j.ydbio.2008.01.002; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	38	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79145	10.1371/journal.pone.0079145	http://dx.doi.org/10.1371/journal.pone.0079145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244438	Green Published, gold			2022-12-27	WOS:000327221600113
J	Siena, S; Van Cutsem, E; Li, MY; Jungnelius, U; Romano, A; Beck, R; Bencardino, K; Elez, ME; Prenen, H; Sanchis, M; Sartore-Bianchi, A; Tejpar, S; Gandhi, A; Shi, T; Tabernero, J				Siena, Salvatore; Van Cutsem, Eric; Li, Mingyu; Jungnelius, Ulf; Romano, Alfredo; Beck, Robert; Bencardino, Katia; Elena Elez, Maria; Prenen, Hans; Sanchis, Mireia; Sartore-Bianchi, Andrea; Tejpar, Sabine; Gandhi, Anita; Shi, Tao; Tabernero, Josep			Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; MONOCLONAL-ANTIBODY; PLUS DEXAMETHASONE; THERAPY; TRIAL; EGFR; IMMUNOGLOBULIN; POLYMORPHISM; CLEARANCE	This study aimed to assess the efficacy and safety of combination treatment with lenalidomide and cetuximab in KRAS-mutant metastatic colorectal cancer patients. This was a phase II multicenter, open-label trial comprising a safety lead-in phase (phase IIa) to determine the maximum tolerated dose, and a randomized proof of concept phase (phase IIb) to determine the response rate of lenalidomide plus cetuximab combination therapy. Phase IIa treatment comprised oral lenalidomide (starting dose 25 mg/day) and intravenous cetuximab (400 mg/m(2) followed by weekly 250 mg/m(2)) in 28-day cycles. In phase IIb patients were randomized to either the phase IIa treatment schedule of lenalidomide plus cetuximab combination therapy or lenalidomide 25 mg/day monotherapy. Eight patients were enrolled into phase IIa. One patient developed a dose-limiting toxicity and the maximum tolerated dose of lenalidomide was determined at 25 mg/day. Forty-three patients were enrolled into phase IIb proof of concept. Best response was stable disease in 9 patients and study enrollment was terminated prematurely due to lack of efficacy in both treatment arms and failure to achieve the planned response objective. The majority of adverse events were grade 1 and 2. In both phases, the adverse events most commonly attributed to any study drugs were fatigue, rash and other skin disorders, diarrhea, nausea, and stomatitis. Thirty-nine deaths occurred; none was related to study drug. The combination of lenalidomide and cetuximab appeared to be well tolerated but did not have clinically meaningful activity in KRAS-mutant metastatic colorectal cancer patients.	[Siena, Salvatore; Bencardino, Katia; Sartore-Bianchi, Andrea] Osped Niguarda Ca Granda, Milan, Italy; [Van Cutsem, Eric; Prenen, Hans; Tejpar, Sabine] Katholieke Univ Leuven Hosp, Louvain, Belgium; [Van Cutsem, Eric; Prenen, Hans; Tejpar, Sabine] Katholieke Univ Leuven, Louvain, Belgium; [Li, Mingyu; Jungnelius, Ulf; Romano, Alfredo; Beck, Robert; Gandhi, Anita; Shi, Tao] Celgene Corp, Summit, NJ USA; [Elena Elez, Maria; Sanchis, Mireia; Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; Bristol-Myers Squibb; Celgene Corporation; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Siena, S (corresponding author), Osped Niguarda Ca Granda, Milan, Italy.	Salvatore.Siena@OspedaleNiguarda.it	SIENA, SALVATORE/AAC-5806-2019; Van+Cutsem, Eric/ABE-1762-2021; Tabernero, Josep/AAG-5026-2019; Élez, Elena/AAH-2945-2019; Sartore-Bianchi, Andrea/AAB-9848-2019	SIENA, SALVATORE/0000-0002-2681-2846; Tabernero, Josep/0000-0002-2495-8139; Sartore-Bianchi, Andrea/0000-0003-0780-0409; , Tao/0000-0001-5489-2655; Prenen, Hans/0000-0001-8802-7352	Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	This study was funded by Celgene Corporation. Cetuximab was provided by Merck KGaA. Medical writing services were provided by Kim Grootscholten, MSc, of Excerpta Medica BV, funded by Celgene Corporation. Celgene Corporation had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. However, the authors are fully responsible for content and editorial decisions for this manuscript.	Bendell JC, 2012, J CLIN ONCOL S15, V30; Bendell JC, 2011, J CLIN ONCOL, V29, P4394, DOI 10.1200/JCO.2011.36.1980; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dahut WL, 2009, J CLIN PHARMACOL, V49, P650, DOI 10.1177/0091270009335001; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dredge K, 2002, BRIT J CANCER, V87, P1166, DOI 10.1038/sj.bjc.6600607; Ferlay J, 2010, IARC CANCERBASE; Gibson TB, 2006, CLIN COLORECTAL CANC, V6, P29, DOI 10.3816/CCC.2006.n.01; Grothey A, 2012, LANCET IN PRESS; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; Miller AA, 2007, J THORAC ONCOL, V2, P445, DOI 10.1097/01.JTO.0000268679.33238.67; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Nishio M, 2009, EUR J HAEMATOL, V82, P143, DOI 10.1111/j.1600-0609.2008.01174.x; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; REILLY AF, 1994, CLIN DIAGN LAB IMMUN, V1, P640, DOI 10.1128/CDLI.1.6.640-644.1994; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; SANDERS LAM, 1994, J INFECT DIS, V170, P854, DOI 10.1093/infdis/170.4.854; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2012, J CLIN PATHOL, V65, P218, DOI 10.1136/jclinpath-2011-200353; Sharma RA, 2006, EUR J CANCER, V42, P2318, DOI 10.1016/j.ejca.2006.05.018; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weinberg RA., 2007, BIOL CANC, V11, P399; Wu L, 2011, CANCER IMMUNOL IMMUN, V60, P61, DOI 10.1007/s00262-010-0919-9; Yan L, 2008, CANCER J, V14, P178, DOI 10.1097/PPO.0b013e318172d71a; Yesmin K, 2010, CLIN ENDOCRINOL, V73, P119, DOI 10.1111/j.1365-2265.2010.03780.x; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e62264	10.1371/journal.pone.0062264	http://dx.doi.org/10.1371/journal.pone.0062264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244261	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600001
J	Zhou, YP; Wang, JJ; Zhou, I; Lou, HB; Li, CZ; Chen, ZR; Zhang, ZH; Liu, SW; Wu, SG; Tan, WL; Jiang, SB; Zhou, C				Zhou, Yuanping; Wang, Junjie; Zhou, Ivan; Lou, Haibo; Li, Chang-Zheng; Chen, Zhen-Rui; Zhang, Zhe-Huan; Liu, Shuwen; Wu, Shuguang; Tan, Wanlong; Jiang, Shibo; Zhou, Chen			Simultaneous Expression of Displayed and Secreted Antibodies for Antibody Screen	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; AFFINITY; PHAGE; CONSTRUCTION	The display of full-length antibody on the cell surface was achieved by fusing a transmembrane domain of the platelet-derived growth factor receptor (PDGFR) to the C-terminus of the heavy chain constant region. We also incorporated a furin cleavage site between the constant region and PDGFR transmembrane domain to obtain secreted antibodies. As a result, antibodies can be expressed simultaneously on the cell surface in a membrane-anchored version for screening and selecting through fluorescence-activated cell sorting (FACS) analysis, as well as in conditioned medium in a secreted version for function analysis.	[Zhou, Yuanping; Wang, Junjie; Lou, Haibo; Li, Chang-Zheng; Chen, Zhen-Rui; Zhang, Zhe-Huan; Tan, Wanlong] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhou, Ivan; Liu, Shuwen; Wu, Shuguang] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Li, Chang-Zheng; Zhou, Chen] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Lindsley F Kimball Res Inst, New York, NY USA; [Zhou, Chen] Dgen Biotech Ltd, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Fudan University; Fudan University; Fudan University	Jiang, SB (corresponding author), Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	shibojiang@fudan.edu.cn; czhou0068@gmail.com	Li, Changzheng/F-4465-2014; Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Natural Science Foundation of China [81173098]; Dgen Biotech Ltd., Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dgen Biotech Ltd., Hong Kong	This work was partly supported by grants from the National Natural Science Foundation of China (#81173098 to SJ) and from Dgen Biotech Ltd., Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2007, J IMMUNOL METHODS, V327, P40, DOI 10.1016/j.jim.2007.07.007; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown DT, 2004, United States Patent, Patent No. 7223390; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; de Bruin R, 1999, NAT BIOTECHNOL, V17, P397, DOI 10.1038/7959; Feldhaus MJ, 2004, J IMMUNOL METHODS, V290, P69, DOI 10.1016/j.jim.2004.04.009; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; He Wei, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P308; Higuchi K, 1997, J IMMUNOL METHODS, V202, P193, DOI 10.1016/S0022-1759(97)00010-0; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Invitrogen, 2006, FLP IN SYST GEN STAB; Li CZ, 2012, CELL MOL IMMUNOL, V9, P184, DOI 10.1038/cmi.2011.55; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zhou Chen, 2012, Methods Mol Biol, V907, P293, DOI 10.1007/978-1-61779-974-7_17; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Zhou I, 2011, ACTA BIOCH BIOPH SIN, V43, P232, DOI 10.1093/abbs/gmq126; Zhou Y, 2010, ACTA BIOCH BIOPH SIN, V42, P575, DOI 10.1093/abbs/gmq055	22	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80005	10.1371/journal.pone.0080005	http://dx.doi.org/10.1371/journal.pone.0080005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244593	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600170
J	El Alaoui, S; Hedman, E; Ljotsson, B; Bergstrom, J; Andersson, E; Ruck, C; Andersson, G; Lindefors, N				El Alaoui, Samir; Hedman, Erik; Ljotsson, Brjann; Bergstrom, Jan; Andersson, Erik; Ruck, Christian; Andersson, Gerhard; Lindefors, Nils			Predictors and Moderators of Internet- and Group-Based Cognitive Behaviour Therapy for Panic Disorder	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; DEPRESSION; AGORAPHOBIA; SENSITIVITY; SCALE; METAANALYSIS; MEDIATORS; EFFICACY	Internet-based cognitive behaviour therapy (ICBT) can be equally effective as traditional face-to-face cognitive behaviour therapy (CBT) for treating panic disorder (PD). However, little is known about the predictors and moderators of outcome of ICBT when delivered in psychiatric outpatient settings. This study investigated a selection of outcome predictors and moderators of ICBT for panic disorder based on data from a randomised controlled trial where therapist-guided ICBT was compared with group CBT (GCBT) for panic disorder. Participants (N = 104) received 10 weeks of ICBT or GCBT and were assessed before and after treatment, and after six months. Multiple regression analyses were used to test for significant predictors of treatment outcome. Predictors of positive treatment response for both modalities were having low levels of symptom severity and work impairment. In addition, anxiety sensitivity was found to have a small negative relationship with treatment outcome, suggesting that anxiety sensitivity may slightly enhance treatment response. Treatment modality had a moderating effect on the relationship between domestic impairment and outcome and on the relationship between initial age of onset of panic symptoms and treatment outcome, favouring ICBT for patients having had an early onset of PD symptoms and for patients having a high domestic functional impairment. These results suggest that both ICBT and GCBT are effective treatment modalities for PD and that it is possible to predict a significant proportion of the long-term outcome variance based on clinical variables.	[El Alaoui, Samir; Andersson, Erik; Ruck, Christian; Andersson, Gerhard; Lindefors, Nils] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Ljotsson, Brjann; Bergstrom, Jan] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden; [Bergstrom, Jan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University; Linkoping University	El Alaoui, S (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	samir.el.alaoui@ki.se	Rück, Christian/J-4396-2012; Andersson, Gerhard/J-8529-2012; El Alaoui, Samir/I-3504-2012	Rück, Christian/0000-0002-8742-0168; Andersson, Gerhard/0000-0003-4753-6745; El Alaoui, Samir/0000-0002-6590-1606; Ljotsson, Brjann/0000-0001-8086-1668; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Andersson, Erik/0000-0003-0088-8719	Stockholm County Council	Stockholm County Council(Stockholm County Council)	The Stockholm County Council funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Andersson G, 2008, COMPUT HUM BEHAV, V24, P1790, DOI 10.1016/j.chb.2008.02.003; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benitez CIP, 2009, DEPRESS ANXIETY, V26, P335, DOI 10.1002/da.20423; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; CLUM GA, 1993, J CONSULT CLIN PSYCH, V61, P317, DOI 10.1037/0022-006X.61.2.317; Cohen J, 1983, APPL MULTIPLE REGRES; Craske M. G., 1990, THERAPISTS GUIDE MAS; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Dow MGT, 2007, PSYCHOL MED, V37, P1493, DOI 10.1017/S0033291707000670; EMMELKAMP PMG, 1992, BRIT J PSYCHIAT, V160, P51, DOI 10.1192/bjp.160.1.51; Eskildsen A, 2010, NORD J PSYCHIAT, V64, P94, DOI 10.3109/08039480903426929; Fava GA, 2001, PSYCHOL MED, V31, P891, DOI 10.1017/S0033291701003592; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; HAFNER RJ, 1983, BEHAV RES THER, V21, P375, DOI 10.1016/0005-7967(83)90006-2; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Hedman E, 2012, ACTA PSYCHIAT SCAND, V126, P126, DOI 10.1111/j.1600-0447.2012.01834.x; Hedman E., 2013, ACTA PSYCHIAT SCAND; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; HOLLOWAY W, 1987, J ABNORM PSYCHOL, V96, P330, DOI 10.1037/0021-843X.96.4.330; IBM, 2012, IBM SPSS STAT WIND; Jaccard J., 2003, INTERACTION EFFECTS; Jose P. E., 2008, MODGRAPH I PROGRAMME; Keeley ML, 2008, CLIN PSYCHOL REV, V28, P118, DOI 10.1016/j.cpr.2007.04.003; KEIJSERS GPJ, 1994, BEHAV THER, V25, P689, DOI 10.1016/S0005-7894(05)80204-7; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Lecrubier Y, 1998, J CLIN PSYCHIAT, V59, P11; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Liebowitz MR, 1997, J CLIN PSYCHIAT, V58, P5; Little RJA, 1999, J RHEUMATOL, V26, P1654; MAVISSAKALIAN M, 1986, J CLIN PSYCHIAT, V47, P117; McCusker J, 2000, J NERV MENT DIS, V188, P3, DOI 10.1097/00005053-200001000-00002; Meuret AE, 2010, J CONSULT CLIN PSYCH, V78, P691, DOI 10.1037/a0019552; Mitte K, 2005, J AFFECT DISORDERS, V88, P27, DOI 10.1016/j.jad.2005.05.003; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; ORourke D, 1996, BRIT J PSYCHIAT, V168, P462, DOI 10.1192/bjp.168.4.462; Ramnero Jonas, 2004, Cognitive Behaviour Therapy, V33, P176, DOI 10.1080/16506070410031691; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Ronalds G, 1997, BRIT J PSYCHIAT, V171, P427, DOI 10.1192/bjp.171.5.427; Scheibe G, 1997, PSYCHOPATHOLOGY, V30, P177, DOI 10.1159/000285045; Sharp DM, 1999, CLIN PSYCHOL PSYCHOT, V6, P336; Shear MK, 1997, AM J PSYCHIAT, V154, P1571, DOI 10.1176/ajp.154.11.1571; Shear MK, 2001, J PSYCHIAT RES, V35, P293, DOI 10.1016/S0022-3956(01)00028-0; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shinoda N, 1999, COMPR PSYCHIAT, V40, P39, DOI 10.1016/S0010-440X(99)90075-5; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; STEKETEE G, 1995, CLIN PSYCHOL REV, V15, P317, DOI 10.1016/0272-7358(95)00017-J; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875; Zinbarg RE, 1999, LEA SER PER CLIN PSY, P83	52	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79024	10.1371/journal.pone.0079024	http://dx.doi.org/10.1371/journal.pone.0079024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244406	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900031
J	Wilson, BJ; Nicholas, FW; James, JW; Wade, CM; Raadsma, HW; Thomson, PC				Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Raadsma, Herman W.; Thomson, Peter C.			Genetic Correlations among Canine Hip Dysplasia Radiographic Traits in a Cohort of Australian German Shepherd Dogs, and Implications for the Design of a More Effective Genetic Control Program	PLOS ONE			English	Article							BREEDING VALUES; ELBOW DYSPLASIA; SELECTION; LOCI; OSTEOARTHRITIS; POPULATIONS; ROTTWEILERS; LAXITY; JOINTS	Canine hip dysplasia (CHD) is a common musculoskeletal disease in pedigree dog populations. It can cause severe pain and dysfunction which may require extensive medication and/or surgical treatment and often ultimately requires humane euthanasia. CHD has been found to be moderately heritable and, given its impact on welfare, should be considered an imperative breeding priority. The British Veterinary Association/Kennel Club scoring method is one of several measures used to assess the genetic propensity of potential breeding stock for dysplastic changes to the hips based on radiographic examination. It is a complex measure composed of nine ordinal traits, intended to evaluate both early and late dysplastic changes. It would be highly desirable if estimated breeding values (EBVs) for these nine traits were consolidated into a simpler, EBV-based, selection index more easily usable by breeders. A multivariate analysis on the phenotype scores from an Australian cohort of 13,124 German Shepherd Dogs (GSDs) returned genetic correlations between 0.48-0.97 for the nine traits which fell into two trait groups, Group 1 reflecting early changes ("laxity") and Group 2 reflecting late changes ("osteoarthritis"). Principal components analysis of the ordinal EBVs suggested the same pattern, with strong differentiation between "laxity" and "osteoarthritis" traits in the second component. Taking account of all results, we recommend interim use of two selection indexes: the first being the average of ordinal EBVs for "laxity" traits and the second being the average of ordinal EBVs for "osteoarthritis" traits. The correlation between these two selection indexes (0.771-0.774) is sufficiently less than unity enabling the selection of dogs with different genetic propensity for laxity and for osteoarthritic CHD changes in GSDs; this may also be applicable in other breeds. Dogs with low propensity for severe osteoarthritic change in the presence of laxity may be of interest both in molecular research and breeding programs.	[Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Raadsma, Herman W.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Wilson, BJ (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bethany.wilson@sydney.edu.au	Nicholas, Frank William/AAE-5566-2022; Nicholas, Frank/AGY-8318-2022; Thomson, Peter/V-7290-2019	Nicholas, Frank William/0000-0002-9178-3965; Nicholas, Frank/0000-0002-9178-3965; Thomson, Peter/0000-0003-4428-444X; Wade, Claire/0000-0003-3413-4771				Biery DN, 2006, BSAVA MANUAL CANINE, P119; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Gibbs C, 1997, VET REC, V141, P275; Gilmour A., 2006, ASREML USER GUIDE RE; GUNAWAN B, 1986, AUST J AGR RES, V37, P539, DOI 10.1071/AR9860539; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; HAYES JF, 1981, BIOMETRICS, V37, P483, DOI 10.2307/2530561; Hedberg K, 2000, REV HD SCHEME NBC M; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; MORGAN JP, 2000, HEREDITARY BONE JOIN, P109; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; POPOVITCH CA, 1995, J AM VET MED ASSOC, V206, P648; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Thomson PC, 2010, VET J, V183, P243, DOI 10.1016/j.tvjl.2009.12.002; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Willis M.B., 1989, GENETICS DOG; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wilson BJ, 2013, PLOS ONE UNPUB; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	32	6	6	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78929	10.1371/journal.pone.0078929	http://dx.doi.org/10.1371/journal.pone.0078929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244386	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900027
J	Iascone, DM; Padidam, S; Pyfer, MS; Zhang, XH; Zhao, LJ; Chin, J				Iascone, Daniel M.; Padidam, Sneha; Pyfer, Mark S.; Zhang, Xiaohong; Zhao, Lijuan; Chin, Jeannie			Impairments in Neurogenesis Are Not Tightly Linked to Depressive Behavior in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURAL STEM-CELLS; DEPLETION; DEFICITS; NEURONS	Alzheimer's disease (AD), the most common cause of dementia, is also associated with depression. Although the precise mechanisms that lead to depression in AD are unknown, the impairments in adult hippocampal neurogenesis observed in AD may play a role. Adult-born neurons play a critical role in regulating both cognition and mood, and reduced hippocampal neurogenesis is associated with depression in other neurological disorders. To assess the relationship between Alzheimer's disease, neurogenesis, and depression, we studied human amyloid precursor protein (hAPP) transgenic mice, a well-characterized model of AD. We report that reductions in hippocampal neurogenesis are evident early in disease progression in hAPP mice, but a mild depressive phenotype manifests only in later stages of disease. We found that hAPP mice exhibited a reduction in BrdU-positive cells in the subgranular zone of the dentate gyrus in the hippocampus, as well as a reduction in doublecortin-expressing cells, relative to nontransgenic controls at 5-7 months of age. These alterations in neurogenesis appeared to worsen with age, as the magnitude of reduction in doublecortin-expressing cells was greater in hAPP mice at 13-15 months of age. Only 13-15 month old hAPP mice exhibited depressive behavior in the tail suspension test. However, mice at both age groups exhibited deficits in spatial memory, which was observed in the Morris water maze test for hippocampus-dependent memory. These findings indicate that neurogenesis impairments are accompanied by cognitive deficits, but are not tightly linked to depressive behavior in hAPP mice.	[Chin, Jeannie] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Chin, J (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.	Jeannie.Chin@jefferson.edu		Chin, Jeannie/0000-0001-9902-3744; Iascone, Daniel Maxim/0000-0002-8629-7639	Alzheimer's Association [NIRG-11-205769]; Margaret Q. Landenberger Research Foundation	Alzheimer's Association(Alzheimer's Association); Margaret Q. Landenberger Research Foundation	The Chin lab is grateful for support from the Alzheimer's Association grant NIRG-11-205769 (www.alz.org) and the Margaret Q. Landenberger Research Foundation (no public URL), from whom funds were used to partially support lab staff and animal maintenance during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Becker C, 2008, MOL PSYCHIATR, V13, P1079, DOI 10.1038/sj.mp.4002097; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; David DJ, 2010, NEUROSCIENTIST, V16, P578, DOI 10.1177/1073858409360281; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Holtzman DM, 2011, SCI TRANSL MED, V3; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rodriguez JJ, 2011, J ANAT, V219, P78, DOI 10.1111/j.1469-7580.2011.01343.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Tarawneh R, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A006148; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79651	10.1371/journal.pone.0079651	http://dx.doi.org/10.1371/journal.pone.0079651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244537	Green Published, gold			2022-12-27	WOS:000327143800095
J	Kurth, F; Rimmer, K; Premkumar, L; Mohanty, B; Duprez, W; Halili, MA; Shouldice, SR; Heras, B; Fairlie, DP; Scanlon, MJ; Martin, JL				Kurth, Fabian; Rimmer, Kieran; Premkumar, Lakshmanane; Mohanty, Biswaranjan; Duprez, Wilko; Halili, Maria A.; Shouldice, Stephen R.; Heras, Begona; Fairlie, David P.; Scanlon, Martin J.; Martin, Jennifer L.			Comparative Sequence, Structure and Redox Analyses of Klebsiella pneumoniae DsbA Show That Anti-Virulence Target DsbA Enzymes Fall into Distinct Classes	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; FUNCTIONAL-CHARACTERIZATION; DESTABILIZING DISULFIDE; SUBSTRATE-SPECIFICITY; BACTERIAL VIRULENCE; OXIDOREDUCTASE DSBA; PILUS BIOGENESIS; FOLDING CATALYST	Bacterial DsbA enzymes catalyze oxidative folding of virulence factors, and have been identified as targets for antivirulence drugs. However, DsbA enzymes characterized to date exhibit a wide spectrum of redox properties and divergent structural features compared to the prototypical DsbA enzyme of Escherichia coli DsbA (EcDsbA). Nonetheless, sequence analysis shows that DsbAs are more highly conserved than their known substrate virulence factors, highlighting the potential to inhibit virulence across a range of organisms by targeting DsbA. For example, Salmonella enterica typhimurium (SeDsbA, 86 % sequence identity to EcDsbA) shares almost identical structural, surface and redox properties. Using comparative sequence and structure analysis we predicted that five other bacterial DsbAs would share these properties. To confirm this, we characterized Klebsiella pneumoniae DsbA (KpDsbA, 81 % identity to EcDsbA). As expected, the redox properties, structure and surface features (from crystal and NMR data) of KpDsbA were almost identical to those of EcDsbA and SeDsbA. Moreover, KpDsbA and EcDsbA bind peptides derived from their respective DsbBs with almost equal affinity, supporting the notion that compounds designed to inhibit EcDsbA will also inhibit KpDsbA. Taken together, our data show that DsbAs fall into different classes; that DsbAs within a class may be predicted by sequence analysis of binding loops; that DsbAs within a class are able to complement one another in vivo and that compounds designed to inhibit EcDsbA are likely to inhibit DsbAs within the same class.	[Kurth, Fabian; Premkumar, Lakshmanane; Duprez, Wilko; Halili, Maria A.; Shouldice, Stephen R.; Heras, Begona; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Rimmer, Kieran; Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Parkville, Vic, Australia; [Scanlon, Martin J.] Monash Univ, ARC Ctr Excellence Coherent Xray Sci, Parkville, Vic, Australia	University of Queensland; Monash University; Monash University	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Parkville, Vic, Australia.	martin.scanlon@monash.edu; j.martin@imb.uq.edu.au	Mohanty, Biswaranjan/E-2080-2018; Halili, Maria A/J-8362-2014; Fairlie, David P/F-8865-2014; Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Mohanty, Biswaranjan/0000-0002-6921-343X; Halili, Maria A/0000-0003-4407-5269; Fairlie, David P/0000-0002-7856-8566; Heras, Begona/0000-0003-3469-7988; Scanlon, Martin/0000-0002-9230-7506; Martin, Jennifer L./0000-0002-9225-8863	ARC, Australian Laureate Fellowship [FL0992138]; NHMRC [APP1009785]	ARC, Australian Laureate Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an ARC (www.arc.gov.au) Australian Laureate Fellowship (FL0992138) to JLM-which also supported PhD scholarships to FK and WD-and an NHMRC (www.nhmrc.gov.au) Project Grant (APP1009785) to MJS and BH. JLM is also an Honorary NHMRC Research Fellow (455829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barczak AK, 2009, CURR OPIN MICROBIOL, V12, P490, DOI 10.1016/j.mib.2009.06.012; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horne J, 2007, J MOL BIOL, V371, P703, DOI 10.1016/j.jmb.2007.05.067; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ireland PM, 2013, ANTIOXID REDOX  0920; Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YM, 2003, CURR OPIN PHARMACOL, V3, P513, DOI 10.1016/j.coph.2003.04.001; Li ZW, 2006, NUCLEIC ACIDS RES, V34, pD277, DOI 10.1093/nar/gkj124; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Miki T, 2008, MICROB PATHOGENESIS, V44, P151, DOI 10.1016/j.micpath.2007.09.001; Mohanty B, 2010, ACTA CRYSTALLOGR F, V66, P1381, DOI 10.1107/S1744309110020956; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Sauvonnet N, 1998, MOL MICROBIOL, V27, P661, DOI 10.1046/j.1365-2958.1998.00722.x; Schirra HJ, 1998, BIOCHEMISTRY-US, V37, P6263, DOI 10.1021/bi980136y; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Souli M, 2008, Euro Surveill, V13; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; ZavYalov VP, 1997, BIOCHEM J, V324, P571, DOI 10.1042/bj3240571; Zhang HZ, 1996, MOL MICROBIOL, V21, P787, DOI 10.1046/j.1365-2958.1996.431403.x	76	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80210	10.1371/journal.pone.0080210	http://dx.doi.org/10.1371/journal.pone.0080210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244651	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800137
J	Ydreborg, M; Westin, J; Rembeck, K; Lindh, M; Norrgren, H; Holmberg, A; Wejstal, R; Norkrans, G; Cardell, K; Weiland, O; Lagging, M				Ydreborg, Magdalena; Westin, Johan; Rembeck, Karolina; Lindh, Magnus; Norrgren, Hans; Holmberg, Anna; Wejstal, Rune; Norkrans, Gunnar; Cardell, Kristina; Weiland, Ola; Lagging, Martin			Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Transient Elastography in Chronic Hepatitis C Infection	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GENOME-WIDE ASSOCIATION; VIRUS GENOTYPE 2; GENETIC-VARIATION; PEGINTERFERON ALPHA-2A; VIROLOGICAL RESPONSE; INTERFERON-ALPHA; VIRAL KINETICS; PLUS RIBAVIRIN; UP-REGULATION	Background and Aims: Recently, several genome-wide association studies have revealed that single nucleotide polymorphisms (SNPs) in proximity to IL28B predict spontaneous clearance of hepatitis C virus (HCV) infection as well as outcome following pegylated interferon and ribavirin therapy among genotype 1 infected patients. Additionally the presence of the otherwise favorable IL28B genetic variants in the context of HCV genotype 3 infection reportedly entail more pronounced liver fibrosis and steatosis. The present study aimed to evaluate the impact of IL28B SNP variability on liver stiffness as accessed by transient elastography. Methods: Seven hundred and seventy-one Swedish HCV infected patients sequentially undergoing liver stiffness measurement by means of Fibroscan (R) in the context of a real-life trial had samples available for IL28B genotyping (rs12979860) and HCV genotyping. Results: CCrs12979860 was more common among HCV genotype 2 or 3 infected treatment-naive patients than among those infected with genotype 1 (P<0.0001). Additionally CCrs12979860 among HCV genotype 3 infected patients was associated with higher liver stiffness values (P = 0.004), and higher AST to platelet ratio index (APRI; p = 0.02) as compared to carriers of the T allele. Among HCV genotype 1 infected patients, CCrs12979860 was significantly associated with higher viral load (P = 0.001), with a similar non-significant trend noted among HCV genotype 3 infected patients. Conclusion: This study confirms previous reports that the CCrs12979860 SNP is associated with more pronounced liver pathology in patients chronically infected with HCV genotype 3 as compared to genotype 1, suggesting that IL28B genetic variants differently regulates the course of HCV infection across HCV genotypes.	[Ydreborg, Magdalena; Westin, Johan; Rembeck, Karolina; Lindh, Magnus; Wejstal, Rune; Norkrans, Gunnar; Lagging, Martin] Univ Gothenburg, Inst Biomed, Dept Infect Diseases Virol, Gothenburg, Sweden; [Norrgren, Hans; Holmberg, Anna] Skane Univ Hosp, Dept Infect Dis, Lund, Sweden; [Cardell, Kristina] Linkoping Univ Hosp, Dept Infect Dis, S-58185 Linkoping, Sweden; [Weiland, Ola] Karolinska Univ Hosp, Karolinska Inst, Dept Infect Dis, Karolinska, Sweden	University of Gothenburg; Lund University; Skane University Hospital; Linkoping University; Karolinska Institutet; Karolinska University Hospital	Lagging, M (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Diseases Virol, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Lagging, Martin/D-7734-2015	Lagging, Martin/0000-0002-7995-3626; Weiland, Ola/0000-0002-6934-9724; Norrgren, Hans/0000-0001-5780-530X	Swedish Medical Research Council [2427, 3821]; ALF Funds at the Sahlgrenska University Hospital [Diarienr ALFGBG-143271]; Merck Sharp & Dohme (Sweden) AB	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); ALF Funds at the Sahlgrenska University Hospital; Merck Sharp & Dohme (Sweden) AB(Merck & Company)	This work was supported by the Swedish Medical Research Council (Diarienr 2008: 2427 and 2011: 3821), and ALF Funds at the Sahlgrenska University Hospital (Diarienr ALFGBG-143271). An unrestricted grant from Merck Sharp & Dohme (Sweden) AB also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Ackefors M, 2013, J VIRAL HEP IN PRESS; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Arena U, 2008, GUT, V57, P1288, DOI 10.1136/gut.2008.149708; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Boursier J, 2013, J GASTROENTEROLOGY; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepatitis C-globalprevalence(update), 1999, WKLY EPIDEMIOL REC, V74, P425; Hofer H, 2002, AM J GASTROENTEROL, V97, P2880, DOI 10.1111/j.1572-0241.2002.07056.x; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Noureddin M, 2013, HEPATOLOGY IN PRESS; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rembeck K, 2012, HEPATOLOGY, V56, P394, DOI 10.1002/hep.25598; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sanchez-Conde M, 2011, J VIRAL HEPATITIS, V18, pE278, DOI 10.1111/j.1365-2893.2010.01407.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024; STENKVIST J, 2013, VIRAL HEPATITIS, V20, P193; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	53	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80172	10.1371/journal.pone.0080172	http://dx.doi.org/10.1371/journal.pone.0080172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244641	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800131
J	Zhao, LH; Cui, XZ; Yuan, HJ; Liang, B; Zheng, LL; Liu, YX; Luo, MJ; Tan, JH				Zhao, Li-Hua; Cui, Xiang-Zhong; Yuan, Hong-Jie; Liang, Bo; Zheng, Liang-Liang; Liu, Yu-Xiang; Luo, Ming-Jiu; Tan, Jing-He			Restraint Stress Inhibits Mouse Implantation: Temporal Window and the Involvement of HB-EGF, Estrogen and Progesterone	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO IMPLANTATION; GROWTH-FACTOR; EMOTIONAL ADJUSTMENT; BIOMEDICAL-RESEARCH; PREGNANCY OUTCOMES; IVF; BLASTOCYSTS; GENE; UTERUS	It is known that psychological stress affects reproduction in women, but it is unknown whether the effect is by impairing implantation. Although studies suggest that long periods of auditory or restraint stress may inhibit implantation in rats and mice, the exact stage of pregnancy at which stress impairs implantation is unclear. Furthermore, whether stress impairs implantation by decreasing the heparin-binding epidermal growth factor-like growth factor (HB-EGF), estrogen and/or progesterone and whether by acting on embryos or on the uterus need further investigations. In this study, a 24-h restraint stress was initiated at 15:30 of day 3 (regimen 1) or at 07:30 (regimen 2) or 15:30 of day 4 (regimen 3) of pregnancy (vaginal plug = day 1) to observe effects of restraint stress applied at different peri-implantation stages on implantation. Among the three regimens, whereas regimens 1 and 3 affected neither term pregnancy nor litter size, regimen 2 reduced both. Further observations indicated that regimen 2 of restraint stress also delayed blastocyst hatching and the attachment reaction, decreased serum concentrations of progesterone and estradiol, and down regulated the expression of HB-EGF in both the endometrium and blastocysts. Taken together, the results suggested that restraint stress inhibited mouse implantation in a temporal window-dependent manner and by impairing blastocyst activation and hatching and uterine receptivity via down-regulating HB-EGF, estrogen and progesterone. Thus, the stress applied within the implantation window impaired implantation by acting on both embryos and the uterus.	[Zhao, Li-Hua; Cui, Xiang-Zhong; Yuan, Hong-Jie; Liang, Bo; Zheng, Liang-Liang; Liu, Yu-Xiang; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Luo, Mingjiu/AAU-8570-2021		National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Al-Inany HG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub2; Albina ML, 2002, EXP BIOL MED, V227, P779, DOI 10.1177/153537020222700909; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; DAS SK, 1995, MOL ENDOCRINOL, V9, P691, DOI 10.1210/me.9.6.691; DAS SK, 1994, DEVELOPMENT, V120, P1071; Davies I J, 1972, Vitam Horm, V30, P223, DOI 10.1016/S0083-6729(08)60797-9; Dawson A. A., 2005, Archives of Gynecology and Obstetrics, V273, P3, DOI 10.1007/s00404-005-0010-5; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Enders A C, 1976, J Reprod Fertil Suppl, P1; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Golub MS, 2004, BIRTH DEFECTS RES B, V71, P26, DOI 10.1002/bdrb.10058; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klonoff-Cohen H, 2004, FERTIL STERIL, V81, P982, DOI 10.1016/j.fertnstert.2003.08.050; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048083; MACNIVEN E, 1992, PHYSIOL BEHAV, V52, P159, DOI 10.1016/0031-9384(92)90446-9; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Paria BC, 1998, ENDOCRINOLOGY, V139, P5235, DOI 10.1210/en.139.12.5235; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Polinder S, 2008, HUM REPROD, V23, P316, DOI 10.1093/humrep/dem372; PSYCHOYOS A, 1986, ANN NY ACAD SCI, V476, P36, DOI 10.1111/j.1749-6632.1986.tb20920.x; Raab G, 1996, DEVELOPMENT, V122, P637; SAUER MJ, 1979, J REPROD FERTIL, V56, P725; Schroder AK, 2004, REPROD BIOMED ONLINE, V8, P600, DOI 10.1016/S1472-6483(10)61110-8; SUGINO N, 1994, J REPROD FERTIL, V101, P23; SURANI MAH, 1977, J CELL SCI, V25, P265; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WIEBOLD JL, 1986, J REPROD FERTIL, V78, P185, DOI 10.1530/jrf.0.0780185; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zhang SY, 2011, BIOL REPROD, V84, P672, DOI 10.1095/biolreprod.110.087890; Zhang XH, 2013, MOL CELL ENDOCRINOL, V381, P272, DOI 10.1016/j.mce.2013.08.011; Zondek B, 1967, EFFECTS EXTERNAL STI, V26, P4	43	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80472	10.1371/journal.pone.0080472	http://dx.doi.org/10.1371/journal.pone.0080472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244689	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800147
J	DeSimone, DC; Baddour, LM; Lahr, BD; Chung, HH; Wilson, WR; Steckelberg, JM				DeSimone, Daniel C.; Baddour, Larry M.; Lahr, Brian D.; Chung, Heath H.; Wilson, Walter R.; Steckelberg, James M.		Mayo Cardiovasc Infections	Euthermic Endocarditis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; CLINICAL-FEATURES; ELDERLY-PATIENTS; Q-FEVER; ASSOCIATION; BACTEREMIA; PROGNOSIS; MORTALITY; DIAGNOSIS; SURVIVAL	Background: Most patients with infective endocarditis (IE) manifest fever. Comparison of endocarditis patients with and without fever, and whether the lack of fever in IE is a marker for poorer outcomes, such as demonstrated in other severe infectious diseases, have not been defined. Methods and Results: Cases from the Mayo Clinic, Rochester, Minnesota, Division of Infectious Diseases IE registry, a single-center database that contains all cases of IE treated at our center. Diagnosis date between 1970 and 2006, which met the modified Duke criteria for definite endocarditis, without fever was included. There were 240 euthermic endocarditis cases included in this analysis, with 282 febrile controls selected by frequency matching on gender and decade of diagnosis. Euthermic patients had a median age of 63.6 years (+/- 16.1) as compared to 59.0 years (+/- 16.4) in the febrile control group (p=0.001). Median (IQR) symptom duration prior to diagnosis was 4.0 (1.0, 12.0) weeks in the euthermic group compared to 3.0 (1.0, 8.0) weeks in the febrile controls (p=0.006). From unadjusted analyses, survival rates were 87% in euthermic cases versus 83% in febrile controls across 28-day follow-up (p=0.164), and 72% in euthermic group cases versus 69% in febrile controls across 1-year follow-up (p=0.345). Also unadjusted, the 1-year cumulative incidence rate of valve surgery was higher in euthermic cases versus febrile controls (50% vs. 39%, p=0.004). Conclusions: Patients with euthermic endocarditis are older, and lack of fever was associated with longer symptom duration and delayed diagnosis prior to IE diagnosis. Despite a higher unadjusted rate of valve surgery in euthermic patients, the result was not significant when adjusting for baseline confounders. Differences in survival rates at both 28-days and 365-days were not statistically significant between the two groups.	[DeSimone, Daniel C.; Baddour, Larry M.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Lahr, Brian D.; Wilson, Walter R.; Steckelberg, James M.] Mayo Clin, Rochester, MN USA; [Chung, Heath H.] Univ Hawaii, John A Burns Sch Med, Handicap Int, Honolulu, HI 96822 USA	Mayo Clinic; Mayo Clinic; University of Hawaii System	DeSimone, DC (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	desimone.daniel@mayo.edu			Baddour Family Fund award	Baddour Family Fund award	This work was supported by the Baddour Family Fund award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahkee S, 1997, SOUTHERN MED J, V90, P296, DOI 10.1097/00007611-199703000-00006; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bradley SF, 2002, CLIN INFECT DIS, V34, P211, DOI 10.1086/338150; BRYANT RE, 1971, ARCH INTERN MED, V127, P120, DOI 10.1001/archinte.127.1.120; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cecchi Enrico, 2004, Ital Heart J, V5, P249; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Guerrero MLF, 2012, MEDICINE, V91, P152, DOI 10.1097/MD.0b013e31825631ea; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; Groeneveld ABJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1189, DOI 10.1128/CDLI.8.6.1189-1195.2001; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Landais C, 2007, CLIN INFECT DIS, V44, P1337, DOI 10.1086/515401; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marik PE, 2000, CHEST, V117, P855, DOI 10.1378/chest.117.3.855; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; Ortega M, 2007, EUR J CLIN MICROBIOL, V26, P453, DOI 10.1007/s10096-007-0304-6; Scott JW, 2008, AM J MED SCI, V336, P53, DOI 10.1097/MAJ.0b013e31815cff75; TERPENNING MS, 1987, AM J MED, V83, P626, DOI 10.1016/0002-9343(87)90890-4; WEINSTEIN MP, 1978, AM J MED, V64, P592, DOI 10.1016/0002-9343(78)90578-8; Werner GS, 1996, AM J MED, V100, P90, DOI 10.1016/S0002-9343(96)90017-0; Yusuf SW, 2006, MEDICINE, V85, P86, DOI 10.1097/01.md.0000208503.06288.7b	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80144	10.1371/journal.pone.0080144	http://dx.doi.org/10.1371/journal.pone.0080144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244630	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600185
J	Ma, CC; Dong, X; Li, RD; Liu, L				Ma, Chengcheng; Dong, Xiao; Li, Rudong; Liu, Lei			A Computational Study Identifies HIV Progression-Related Genes Using mRMR and Shortest Path Tracing	PLOS ONE			English	Article							IMMUNE ACTIVATION; T-CELLS; INFECTION; EXPRESSION; PREDICTION; APOPTOSIS; TISSUE; ACID; CD4; CLASSIFICATION	Since statistical relationships between HIV load and CD4+ T cell loss have been demonstrated to be weak, searching for host factors contributing to the pathogenesis of HIV infection becomes a key point for both understanding the disease pathology and developing treatments. We applied Maximum Relevance Minimum Redundancy (mRMR) algorithm to a set of microarray data generated from the CD4+ T cells of viremic non-progressors (VNPs) and rapid progressors (RPs) to identify host factors associated with the different responses to HIV infection. Using mRMR algorithm, 147 gene had been identified. Furthermore, we constructed a weighted molecular interaction network with the existing protein-protein interaction data from STRING database and identified 1331 genes on the shortest-paths among the genes identified with mRMR. Functional analysis shows that the functions relating to apoptosis play important roles during the pathogenesis of HIV infection. These results bring new insights of understanding HIV progression.	[Ma, Chengcheng; Dong, Xiao; Li, Rudong] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Ma, Chengcheng; Dong, Xiao; Li, Rudong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dong, Xiao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fudan University	Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	liulei@scbit.org	Li, Rudong/HGA-8169-2022		Ministry of Science and Technology Grant of P.R. China [2012AA02A602]	Ministry of Science and Technology Grant of P.R. China	This work was funded by a Ministry of Science and Technology Grant of P.R. China. No. 2012AA02A602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bakri Y, 2001, J IMMUNOL, V166, P3780, DOI 10.4049/jimmunol.166.6.3780; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Chapuis AG, 2000, NAT MED, V6, P762, DOI 10.1038/77489; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Jay N, 2013, BIOINFORMATICS; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Janneh O, 2009, J ANTIMICROB CHEMOTH, V64, P1002, DOI 10.1093/jac/dkp335; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Knox C, 2011, VIRUS RES, V160, P15, DOI 10.1016/j.virusres.2011.06.013; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007; Mundra PA, 2010, IEEE T NANOBIOSCI, V9, P31, DOI 10.1109/TNB.2009.2035284; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rizzardi GP, 2002, J CLIN INVEST, V109, P681, DOI 10.1172/JCI200214522; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78057	10.1371/journal.pone.0078057	http://dx.doi.org/10.1371/journal.pone.0078057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244287	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600015
J	Ma, MJ; Zhou, XH; Qi, W; Liu, K; Jia, P; Du, GZ				Ma, Miaojun; Zhou, Xianhui; Qi, Wei; Liu, Kun; Jia, Peng; Du, Guozhen			Seasonal Dynamics of the Plant Community and Soil Seed Bank along a Successional Gradient in a Subalpine Meadow on the Tibetan Plateau	PLOS ONE			English	Article							VEGETATION SUCCESSION; LONG-TERM; SIZE; RESTORATION; ABUNDANCE; MASS; GRASSLANDS; EMERGENCE; NUMBER; NICHE	Background: Knowledge about how change the importance of soil seed bank and relationship between seed mass and abundance during vegetation succession is crucial for understanding vegetation dynamics. Many studies have been conducted, but their ecological mechanisms of community assembly are not fully understood. Methodology: We examined the seasonal dynamics of the vegetation and soil seed bank as well as seed size distribution along a successional gradient. We also explored the potential role of the soil seed bank in plant community regeneration, the relationship between seed mass and species abundance, and the relative importance of deterministic and stochastic processes along a successional gradient. Principal Findings: Species richness of seed bank increased (shallow layer and the total) and seed density decreased (each layer and the total) significantly with succession. Species richness and seed density differed significantly between different seasons and among soil depths. Seed mass showed a significant negative relationship with relative abundance in the earliest successional stage, but the relationships were not significant in later stages. Seed mass showed no relationship with relative abundance in the whole successional series in seed bank. Results were similar for both July 2005 and April 2006. Conclusions: The seed mass and abundance relationship was determined by a complex interaction between small and larger seeded species and environmental factors. Both stochastic processes and deterministic processes were important determinants of the structure of the earliest stage. The importance of seed bank decreased with succession. The restoration of abandoned farmed and grazed meadows to the species-rich subalpine meadow in Tibetan Plateau can be successfully achieved from the soil seed bank. However, at least 20 years are required to fully restore an abandoned agricultural meadow to a natural mature subalpine meadow.	[Ma, Miaojun; Zhou, Xianhui; Qi, Wei; Liu, Kun; Jia, Peng; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozdu@lzu.edu.cn	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X	Natural Science Foundation of China [41101527, 40930533]; Research Fund for the Doctoral Program of Higher Education of China [20110211120026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The study was funded by the Natural Science Foundation of China (Grant No. 41101527 and 40930533), the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110211120026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker JP, 2002, APPL VEG SCI, V5, P107, DOI 10.1658/1402-2001(2002)005[0107:EOLTCI]2.0.CO;2; Bekker RM, 2000, J ECOL, V88, P594, DOI 10.1046/j.1365-2745.2000.00485.x; Bisteau E, 2005, APPL VEG SCI, V8, P167, DOI 10.1658/1402-2001(2005)008[0167:VASBIA]2.0.CO;2; Bossuyt B, 2004, J VEG SCI, V15, P449, DOI 10.1111/j.1654-1103.2004.tb02283.x; Caballero I, 2008, OIKOS, V117, P1788, DOI 10.1111/j.1600-0706.2008.17138.x; Chu CJ, 2007, ANN BOT-LONDON, V100, P807, DOI 10.1093/aob/mcm166; Coomes DA, 2002, OIKOS, V96, P421, DOI 10.1034/j.1600-0706.2002.960304.x; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Eriksson O, 2005, OECOLOGIA, V144, P98, DOI 10.1007/s00442-005-0001-z; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Guo QF, 2003, OIKOS, V101, P639, DOI 10.1034/j.1600-0706.2003.12428.x; Harper J. L., 1977, Population biology of plants.; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Kalamees R, 1998, ACTA OECOL, V19, P175, DOI 10.1016/S1146-609X(98)80021-0; Kalamees R, 2012, APPL VEG SCI, V15, P208, DOI 10.1111/j.1654-109X.2011.01169.x; KIIRIKKI M, 1993, ANN BOT FENN, V30, P139; Klimes L, 2010, APPL VEG SCI, V13, P403, DOI 10.1111/j.1654-109X.2010.01084.x; Leishman MR, 2001, OIKOS, V94, P151, DOI 10.1034/j.1600-0706.2001.10392.x; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2012, ECOL ENG, V44, P18, DOI 10.1016/j.ecoleng.2012.03.017; Ma MJ, 2011, PLANT SOIL, V346, P19, DOI 10.1007/s11104-011-0790-2; Ma MJ, 2010, PLANT SOIL, V336, P291, DOI 10.1007/s11104-010-0480-5; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Ma MJ, 2009, ARCT ANTARCT ALP RES, V41, P469, DOI 10.1657/1938-4246-41.4.999; Mabry CM, 2004, OIKOS, V107, P497, DOI 10.1111/j.0030-1299.2004.13314.x; Martinez-Duro E, 2010, APPL VEG SCI, V13, P234, DOI 10.1111/j.1654-109X.2009.01064.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Murray BR, 2005, OIKOS, V110, P191, DOI 10.1111/j.0030-1299.2005.13943.x; Murray BR, 2003, OIKOS, V101, P643, DOI 10.1034/j.1600-0706.2003.12717.x; Ortega M, 1997, J BIOGEOGR, V24, P177, DOI 10.1046/j.1365-2699.1997.00080.x; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Royo AA, 2013, J VEG SCI, V24, P724, DOI 10.1111/jvs.12011; Scott AJ, 2010, THESIS LA TROBE U ME; Scott AJ, 2012, J VEG SCI, V23, P721, DOI 10.1111/j.1654-1103.2011.01382.x; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Torok P, 2009, FOLIA GEOBOT, V44, P31, DOI 10.1007/s12224-009-9027-z; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; van de Voorde TFJ, 2012, OIKOS, V121, P1251, DOI 10.1111/j.1600-0706.2011.19964.x; Wagner M, 2003, ANN BOT FENN, V40, P87; Wearne LJ, 2006, PLANT ECOL, V183, P361, DOI 10.1007/s11258-005-9046-7; Welling P, 2004, ARCT ANTARCT ALP RES, V36, P229, DOI 10.1657/1523-0430(2004)036[0229:TASSBI]2.0.CO;2; Westhoff V., 1973, CLASSIFICATION PLANT, V5, P617, DOI [10.1007/978-94-010-2701-4_20, DOI 10.1007/978-94-009-9183-5_9]; Zhang H, 2013, OIKOS, V122, P952, DOI 10.1111/j.1600-0706.2012.20828.x; Zhang ST, 2004, FOLIA GEOBOT, V39, P129, DOI 10.1007/BF02805242	45	20	22	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80220	10.1371/journal.pone.0080220	http://dx.doi.org/10.1371/journal.pone.0080220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244655	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600194
J	McFarland, BC; Hong, SW; Rajbhandari, R; Twitty, GB; Gray, GK; Yu, H; Benveniste, EN; Nozell, SE				McFarland, Braden C.; Hong, Suk W.; Rajbhandari, Rajani; Twitty, George B., Jr.; Gray, G. Kenneth; Yu, Hao; Benveniste, Etty N.; Nozell, Susan E.			NF-kappa B-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma	PLOS ONE			English	Article							SIGNAL TRANSDUCER; CANCER; INHIBITION; GROWTH; EGFR; INTERLEUKIN-6; EXPRESSION; AZD1480; GLIOMAS; DIFFERENTIATION	Glioblastoma (GBM) is the most aggressive, neurologically destructive and deadly tumor of the central nervous system (CNS). In GBM, the transcription factors NF-kappa B and STAT3 are aberrantly activated and associated with tumor cell proliferation, survival, invasion and chemoresistance. In addition, common activators of NF-kappa B and STAT3, including TNF-alpha and IL-6, respectively, are abundantly expressed in GBM tumors. Herein, we sought to elucidate the signaling crosstalk that occurs between the NF-kappa B and STAT3 pathways in GBM tumors. Using cultured GBM cell lines as well as primary human GBM xenografts, we elucidated the signaling crosstalk between the NF-kappa B and STAT3 pathways utilizing approaches that either a) reduce NF-kappa B p65 expression, b) inhibit NF-kappa B activation, c) interfere with IL-6 signaling, or d) inhibit STAT3 activation. Using the clinically relevant human GBM xenograft model, we assessed the efficacy of inhibiting NF-kappa B and/or STAT3 alone or in combination in mice bearing intracranial xenograft tumors in vivo. We demonstrate that TNF-alpha-induced activation of NF-kappa B is sufficient to induce IL-6 expression, activate STAT3, and elevate STAT3 target gene expression in GBM cell lines and human GBM xenografts in vitro. Moreover, the combined inhibition of NF-kappa B and STAT3 signaling significantly increases survival of mice bearing intracranial tumors. We propose that in GBM, the activation of NF-kappa B ensures subsequent STAT3 activation through the expression of IL-6. These data verify that pharmacological interventions to effectively inhibit the activity of both NF-kappa B and STAT3 transcription factors must be used in order to reduce glioma size and aggressiveness.	[McFarland, Braden C.; Hong, Suk W.; Rajbhandari, Rajani; Twitty, George B., Jr.; Gray, G. Kenneth; Yu, Hao; Benveniste, Etty N.; Nozell, Susan E.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	McFarland, BC (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	bdcox@uab.edu		McFarland, Braden C./0000-0002-7517-9688; Gray, G. Kenneth/0000-0003-4969-670X	National Institutes of Health [T32NS048039, R01CA158534, R01CA138517]; American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri; Southeastern Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA158534, P50CA097247, R01CA138517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri; Southeastern Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by grants from the National Institutes of Health (T32NS048039 to B. C. M., R01CA158534 to E.N.B., and R01CA138517 to S.E.N.); American Brain Tumor Association Basic Research Fellowship in Honor of Paul Fabbri to B. C. M. (www.abta.org); and Southeastern Brain Tumor Foundation funding to E.N.B. (www.sbtf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella NS, 2006, J NEUROSCI METH, V153, P183, DOI 10.1016/j.jneumeth.2005.10.026; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kesanakurti D, 2012, ONCOGENE, DOI [10.1038/onc.2012.546, DOI 10.1038/0NC.2012.546.[]; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; McFarland BC, 2011, MOL CANCER THER, V10, P2384, DOI 10.1158/1535-7163.MCT-11-0480; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Repovic P, 2003, ONCOGENE, V22, P8117, DOI 10.1038/sj.onc.1206922; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Tchirkov A, 2007, BRIT J CANCER, V96, P474, DOI 10.1038/sj.bjc.6603586; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhao XY, 2011, J NEURO-ONCOL, V102, P367, DOI 10.1007/s11060-010-0346-y	51	92	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78728	10.1371/journal.pone.0078728	http://dx.doi.org/10.1371/journal.pone.0078728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244348	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600055
J	Wang, ZL; Hou, J; Lu, LL; Qi, ZH; Sun, JM; Gao, W; Meng, J; Wang, Y; Sun, HZ; Gu, HY; Xin, YH; Guo, XM; Yang, G				Wang, Ziliang; Hou, Jing; Lu, Lili; Qi, Zihao; Sun, Jianmin; Gao, Wen; Meng, Jiao; Wang, Yan; Sun, Huizhen; Gu, Hongyu; Xin, Yuhu; Guo, Xiaomao; Yang, Gong			Small Ribosomal Protein Subunit S7 Suppresses Ovarian Tumorigenesis through Regulation of the PI3K/AKT and MAPK Pathways	PLOS ONE			English	Article							CANCER GROWTH; CELL-CYCLE; P53; ACTIVATION; EXPRESSION; APOPTOSIS; BINDING; MODEL; GENE; MDM2	Small ribosomal protein subunit S7 (RPS7) has been reported to be associated with various malignancies, but the role of RPS7 in ovarian cancer remains unclear. In this study, we found that silencing of RPS7 by a specific shRNA promoted ovarian cancer cell proliferation, accelerated cell cycle progression, and slightly reduced cell apoptosis and response to cisplatin treatment. Knockdown of RPS7 resulted in increased expression of P85 alpha, P110 alpha, and AKT2. Although the basal levels of ERK1/2, MEK1/2, and P38 were inconsistently altered in ovarian cancer cells, the phosphorylated forms of MEK1/2 (Ser217/221), ERK1/2 (Thr202/Tyr204), JNK1/2 (Thr183/Tyr185), and P38 (Thr180/Tyr182) were consistently reduced after RPS7 was silenced. Both the in vitro anchorage-independent colony formation and in vivo animal tumor formation capability of cells were enhanced after RPS7 was depleted. We also showed that silencing of RPS7 enhanced ovarian cancer cell migration and invasion. In sum, our results suggest that RPS7 suppresses ovarian tumorigenesis and metastasis through PI3K/AKT and MAPK signal pathways. Thus, RPS7 may be used as a potential marker for diagnosis and treatment of ovarian cancer.	[Wang, Ziliang; Qi, Zihao; Meng, Jiao; Wang, Yan; Sun, Huizhen; Gu, Hongyu; Xin, Yuhu; Yang, Gong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Canc Inst, Shanghai 200433, Peoples R China; [Hou, Jing; Guo, Xiaomao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Sun, Jianmin; Gao, Wen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Gynecol Oncol, Shanghai 200433, Peoples R China; [Lu, Lili] Shanghai Normal Univ, Life & Environm Sci Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Normal University	Guo, XM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr,Dept Radiat Oncol, Shanghai 200433, Peoples R China.	guoxm1800@126.com; yanggong@fudan.edu.cn			National Nature Science Foundation of China [91129721]; Young Backbone Foundation of Fudan University [11L-38B]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Backbone Foundation of Fudan University	This work was supported by National Nature Science Foundation of China (#91129721) for Gong Yang and Young Backbone Foundation of Fudan University (11L-38B) for Ziliang Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1984, IN VITRO CELL DEV B, V20, P743; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; Bee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022672; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chien CC, 2012, GASTROENTEROLOGIST, V2012; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Gou YW, 2010, BIOCHEM BIOPH RES CO, V393, P788, DOI 10.1016/j.bbrc.2010.02.083; Guo XY, 2011, J CELL MOL MED, V15, P296, DOI 10.1111/j.1582-4934.2009.00969.x; Kobayashi T, 2006, INT J MOL MED, V18, P161; Kobayashi Y, 2010, J TOXICOL SCI, V35, P827, DOI 10.2131/jts.35.827; KONDOH N, 1992, CANCER RES, V52, P791; Li CD, 2012, MOL CELL BIOCHEM, V370, P127, DOI 10.1007/s11010-012-1404-x; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Morgan RJ, 2012, J NATL COMPR CANC NE, V10, P1339, DOI 10.6004/jnccn.2012.0140; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221; Wu Li-Ming, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P344; Wu Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026401; Yang G, 2003, ONCOGENE, V22, P5694, DOI 10.1038/sj.onc.1206858; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang G, 2011, CLIN CANCER RES, V17, P2181, DOI 10.1158/1078-0432.CCR-10-3265; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	29	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79117	10.1371/journal.pone.0079117	http://dx.doi.org/10.1371/journal.pone.0079117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244431	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600110
J	Duan, JP; Xu, HF; Guo, HZ; O'Brochta, DA; Wang, F; Ma, SY; Zhang, LY; Zha, XF; Zhao, P; Xia, QY				Duan, Jianping; Xu, Hanfu; Guo, Huizhen; O'Brochta, David A.; Wang, Feng; Ma, Sanyuan; Zhang, Liying; Zha, Xingfu; Zhao, Ping; Xia, Qingyou			New Insights into the Genomic Organization and Splicing of the Doublesex Gene, a Terminal Regulator of Sexual Differentiation in the Silkworm Bombyx mori	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RNA-BINDING; LETHAL; EVOLUTION; CHROMOSOME; MECHANISM; HONEYBEE; REVEALS; ENCODES; PROTEIN	Sex-determination mechanisms differ among organisms. The primary mechanism is diverse, whereas the terminal regulator is relatively-conserved. We analyzed the transcripts of the Bombyx mori doublesex gene (Bmdsx), and reported novel results concerning the genomic organization and expression of Bmdsx. Bmdsx consists of nine exons and eight introns, of which two exons are novel and have not been reported previously. Bmdsx transcripts are spliced to generate seventeen alternatively-spliced forms and eleven putative trans-spliced variants. Thirteen of the alternatively-spliced forms and five of the putative trans-spliced forms are reported here for the first time. Sequence analysis predicts that ten female-specific, six male-specific splice forms and one splice form found in males and females will result in four female-specific, two male-specific Dsx proteins and one Dsx protein common to males and females. The Dsx proteins are expected to be functional and regulate downstream target genes. Some of the predicted Dsx proteins are described here for the first time. Therefore the expression of the dsx gene in B. mori results in a variety of cis- and trans-spliced transcripts and multiple Dsx proteins. These findings show that in B. mori there is a complicated pattern of dsx splicing, and that the regulation of splicing and sex-specific functions of lepidopteran dsx have evolved complexity.	[Duan, Jianping; Xu, Hanfu; Guo, Huizhen; Wang, Feng; Ma, Sanyuan; Zhang, Liying; Zha, Xingfu; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Duan, Jianping] Nanyang Normal Univ, Henan Prov Key Lab Funiu Mt Insect Biol, Nanyang, Peoples R China; [O'Brochta, David A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	Southwest University - China; Nanyang Normal College; University System of Maryland; University of Maryland College Park	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Feng/P-7961-2019; Ma, Sanyuan/L-8057-2019	Wang, Feng/0000-0001-7633-8284; Ma, Sanyuan/0000-0002-0364-5686; Xia, Qingyou/0000-0002-9263-2886; Zha, Xingfu/0000-0003-2085-5260	Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306]; National Natural Science Foundation of China [31000981]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306] (http://www.most.gov.cn/) and the National Natural Science Foundation of China [31000981] (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Bopp D, 1996, DEVELOPMENT, V122, P971; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Duan JP, 2013, BIOCHEM BIOPH RES CO, V431, P630, DOI 10.1016/j.bbrc.2012.12.062; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fujii T, 2007, SEMIN CELL DEV BIOL, V18, P379, DOI 10.1016/j.semcdb.2007.02.008; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Niimi T, 2006, GENOME, V49, P263, DOI 10.1139/G05-108; ONEIL MT, 1992, GENETICS, V131, P113; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Penalva LOF, 1996, GENETICS, V144, P1653; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Shao W, 2012, RNA, V18, P1395, DOI 10.1261/rna.029751.111; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Shukla JN, 2010, INSECT BIOCHEM MOLEC, V40, P672, DOI 10.1016/j.ibmb.2010.06.008; Shukla JN, 2011, GENETICA, V139, P23, DOI 10.1007/s10709-010-9479-3; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Suzuki MG, 2010, MOL CELL BIOL, V30, P5776, DOI 10.1128/MCB.00444-10; Suzuki MG, 2010, J GENET, V89, P357, DOI 10.1007/s12041-010-0047-5; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Vincent S, 2001, CELL, V106, P399, DOI 10.1016/S0092-8674(01)00468-8; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Wang Z, 2009, INSECT MOL BIOL, V18, P795, DOI 10.1111/j.1365-2583.2009.00943.x; Willhoeft U, 1996, GENETICS, V144, P737; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	48	9	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79703	10.1371/journal.pone.0079703	http://dx.doi.org/10.1371/journal.pone.0079703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244545	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900044
J	Fu, GH; Bai, ZY; Xia, JH; Liu, F; Liu, P; Yue, GH				Fu, Gui Hong; Bai, Zhi Yi; Xia, Jun Hong; Liu, Feng; Liu, Peng; Yue, Gen Hua			Analysis of Two Lysozyme Genes and Antimicrobial Functions of Their Recombinant Proteins in Asian Seabass	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; C-TYPE LYSOZYME; ORANGE-SPOTTED GROUPER; LYTIC ACTIVITY; MOLECULAR-CLONING; LINKAGE MAP; EXPRESSION PATTERN; GROWTH TRAITS; CDNA CLONING; SEQUENCE	Lysozymes are important proteins of the innate immune system for the defense against bacterial infection. We cloned and analyzed chicken-type (c-type) and goose-type (g-type) lysozymes from Asian seabass (Lates calcarifer). The deduced amino acid sequence of the c-type lysozyme contained 144 residues and possessed typical structure residues, conserved catalytic residues (Glu(50) and Asp(67)) and a "GSTDYGIFQINS" motif. The deduced g-type lysozyme contained 187 residues and possessed a goose egg white lysozyme (GEWL) domain containing three conserved catalytic residues (Glu(71), Asp(84), Asp(95)) essential for catalytic activity. Real time quantitative PCR (qRT-PCR) revealed that the two lysozyme genes were constitutively expressed in all the examined tissues. The c-type lysozyme was most abundant in liver, while the g-type lysozyme was predominantly expressed in intestine and weakly expressed in muscle. The c-type and g-type transcripts were up-regulated in the kidney, spleen and liver in response to a challenge with Vibrio harveyi. The up-regulation of the c-type lysozyme was much stronger than that of the g-type lysozyme in kidney and spleen. The recombinant proteins of the c-type and g-type lysozymes showed lytic activities against the bacterial pathogens Vibrio harveyi and Photobacterium damselae in a dosage-dependent manner. We identified single nucleotide polymorphisms (SNPs) in the two lysozyme genes. There were significant associations of these polymorphisms with resistance to the big belly disease. These results suggest that the c-and g-type genes play an important role in resistance to bacterial pathogens in fish. The SNP markers in the two genes associated with the resistance to bacterial pathogens may facilitate the selection of Asian seabass resistant to bacterial diseases.	[Fu, Gui Hong; Bai, Zhi Yi; Xia, Jun Hong; Liu, Feng; Liu, Peng; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Yue, Gen Hua] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Bai, Zhi Yi] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China	National University of Singapore; National University of Singapore; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation Singapore [NRF-CRP002-001]	National Research Foundation Singapore(National Research Foundation, Singapore)	This research is supported by the National Research Foundation Singapore under its Competitive Research Program (CRP Award number NRF-CRP002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fernandez-Trujillo MA, 2008, FISH SHELLFISH IMMUN, V25, P697, DOI 10.1016/j.fsi.2008.08.004; Beintema J J, 1996, EXS, V75, P75; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; DAUTIGNY A, 1991, J MOL EVOL, V32, P187, DOI 10.1007/BF02515392; Gibson-Kueh S, 2004, J FISH DIS, V27, P731, DOI 10.1111/j.1365-2761.2004.00594.x; Harikrishnan R, 2011, FISH SHELLFISH IMMUN, V31, P588, DOI 10.1016/j.fsi.2011.06.019; He CB, 2012, COMP BIOCHEM PHYS B, V162, P34, DOI 10.1016/j.cbpb.2012.02.002; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Hikima J, 1997, MOL MAR BIOL BIOTECH, V6, P339; Hikima J, 2001, BBA-GENE STRUCT EXPR, V1520, P35, DOI 10.1016/S0167-4781(01)00248-2; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; Holtje J V, 1996, EXS, V75, P65; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; Jimenez-Cantizano RM, 2008, FISH SHELLFISH IMMUN, V25, P57, DOI 10.1016/j.fsi.2007.12.009; Jolles J, 2008, EUR J BIOCHEM, V54, P19; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Larsen AN, 2009, FISH SHELLFISH IMMUN, V26, P122, DOI 10.1016/j.fsi.2008.03.021; Li H, 2008, FISH SHELLFISH IMMUN, V25, P143, DOI 10.1016/j.fsi.2008.04.001; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; Liu F, 2002, MECH DEVELOP, V113, P69, DOI 10.1016/S0925-4773(01)00658-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai WJ, 2009, PROG NAT SCI-MATER, V19, P837, DOI 10.1016/j.pnsc.2008.10.008; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Park SI, 2009, FISH PATHOL, V44, P19, DOI 10.3147/jsfp.44.19; Sarder MRI, 2001, DEV COMP IMMUNOL, V25, P37, DOI 10.1016/S0145-305X(00)00040-9; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Savan R, 2003, FISH SHELLFISH IMMUN, V15, P263, DOI 10.1016/S1050-4648(02)00159-6; Sha ZX, 2012, FISH SHELLFISH IMMUN, V32, P914, DOI 10.1016/j.fsi.2012.01.010; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Sun BJ, 2006, AQUACULTURE, V252, P106, DOI 10.1016/j.aquaculture.2005.07.046; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Wang LL, 2007, AQUAC RES, V38, P409, DOI 10.1111/j.1365-2109.2007.01683.x; Wei SN, 2012, FISH SHELLFISH IMMUN, V33, P186, DOI 10.1016/j.fsi.2012.03.027; Whang I, 2011, FISH SHELLFISH IMMUN, V30, P532, DOI 10.1016/j.fsi.2010.11.025; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148; Ye X, 2010, DEV COMP IMMUNOL, V34, P501, DOI 10.1016/j.dci.2009.12.009; Yin ZX, 2003, DIS AQUAT ORGAN, V55, P117, DOI 10.3354/dao055117; Yu LP, 2013, FISH SHELLFISH IMMUN, V34, P46, DOI 10.1016/j.fsi.2012.10.007; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Yue GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052721; Zhang SH, 2012, DEV COMP IMMUNOL, V36, P241, DOI 10.1016/j.dci.2011.06.014; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zheng WB, 2007, IMMUNOL LETT, V113, P107, DOI 10.1016/j.imlet.2007.08.001; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	53	36	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79743	10.1371/journal.pone.0079743	http://dx.doi.org/10.1371/journal.pone.0079743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244553	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900049
J	Kumakura, N; Otsuki, H; Tsuzuki, M; Takeda, A; Watanabe, Y				Kumakura, Naoyoshi; Otsuki, Hiroka; Tsuzuki, Masayuki; Takeda, Atsushi; Watanabe, Yuichiro			Arabidopsis AtRRP44A Is the Functional Homolog of Rrp44/Dis3, an Exosome Component, Is Essential for Viability and Is Required for RNA Processing and Degradation	PLOS ONE			English	Article							CYTOPLASMIC MESSENGER-RNA; TURNIP CRINKLE VIRUS; HUMAN PM-SCL; RIBOSOMAL-RNA; YEAST EXOSOME; POSTEMBRYONIC DEVELOPMENT; ARTIFICIAL MICRORNAS; DECAPPING PROTEINS; STRESS GRANULES; QUALITY CONTROL	The RNA exosome is a multi-subunit complex that is responsible for 3' to 5' degradation and processing of cellular RNA. Rrp44/Dis3 is the catalytic center of the exosome in yeast and humans. However, the role of Rrp44/Dis3 homologs in plants is still unidentified. Here, we show that Arabidopsis AtRRP44A is the functional homolog of Rrp44/Dis3, is essential for plant viability and is required for RNA processing and degradation. We characterized AtRRP44A and AtRRP44B/SOV, two predicted Arabidopsis Rrp44/Dis3 homologs. AtRRP44A could functionally replace S. cerevisiae Rrp44/Dis3, but AtRRP44B/SOV could not. rrp44a knock-down mutants showed typical phenotypes of exosome function deficiency, 5.8S rRNA 3' extension and rRNA maturation by-product over-accumulation, but rrp44b mutants did not. Conversely, AtRRP44B/SOV mutants showed elevated levels of a selected mRNA, on which rrp44a did not have detectable effects. Although T-DNA insertion mutants of AtRRP44B/SOV had no obvious phenotype, those of AtRRP44A showed defects in female gametophyte development and early embryogenesis. These results indicate that AtRRP44A and AtRRP44B/SOV have independent roles for RNA turnover in plants.	[Kumakura, Naoyoshi; Otsuki, Hiroka; Tsuzuki, Masayuki; Takeda, Atsushi; Watanabe, Yuichiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	solan@bio.c.u-tokyo.ac.jp	Kumakura, Naoyoshi/T-4348-2019; Perry, George/A-8611-2009; Kumakura, Naoyoshi/G-3146-2016	Kumakura, Naoyoshi/0000-0003-0259-2444; Perry, George/0000-0002-6547-0172; Kumakura, Naoyoshi/0000-0003-0259-2444; Watanabe, Yuichiro/0000-0002-7139-4903; Tsuzuki, Masayuki/0000-0002-0642-1143	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23012008, J1307-57091]; Japan Society for the Promotion of Science for young scientists [10J09702]; Grants-in-Aid for Scientific Research [24658283] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Science Research on Priority Areas (Grant No. 23012008 to YW, URL: http://www.bio.nagoya-u.ac.jp/similar to yas/tokutei_plant_meristems/) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Grant-in-Aid for Scientific Research on Priority Areas, "Perceptive Plants", (J1307-57091 to YW, URL: http://esplant.net) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The Japan Society for the Promotion of Science for young scientists (No. 10J09702 to NK, URL: http://kaken.nii.ac.jp/d/p/10J09702/2010/3/ja.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Golisz A, 2013, NUCLEIC ACIDS RES, V41, P6232, DOI 10.1093/nar/gkt296; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; HEATON LA, 1989, VIROLOGY, V170, P214, DOI 10.1016/0042-6822(89)90368-1; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Iwasaki S, 2007, FEBS LETT, V581, P2455, DOI 10.1016/j.febslet.2007.04.051; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moreno AB, 2013, NUCLEIC ACIDS RES, V41, P4699, DOI 10.1093/nar/gkt152; Motomura K, 2012, RNA BIOL, V9, P644, DOI 10.4161/rna.19877; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Perea-Resa C, 2012, PLANT CELL, V24, P4930, DOI 10.1105/tpc.112.103697; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yang M, 2013, PLANT PHYSIOL, V161, P165, DOI 10.1104/pp.112.206706; Zhang WP, 2010, P NATL ACAD SCI USA, V107, P15981, DOI 10.1073/pnas.1007060107	49	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79219	10.1371/journal.pone.0079219	http://dx.doi.org/10.1371/journal.pone.0079219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244451	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900035
J	Nanyonjo, A; Makumbi, F; Etou, P; Tomson, G; Kallander, K				Nanyonjo, Agnes; Makumbi, Fredrick; Etou, Patrick; Tomson, Goran; Kallander, Karin		inSCALE Study Grp	Perceived Quality of Care for Common Childhood Illnesses: Facility versus Community Based Providers in Uganda	PLOS ONE			English	Article							HEALTH-CARE; FEBRILE CHILDREN; CASE-MANAGEMENT; SERVICES; SATISFACTION; INTERVENTION; PERCEPTIONS; EXPERIENCES; ACHIEVE; PEOPLE	Objective: To compare caretakers' perceived quality of care (PQC) for under-fives treated for malaria, pneumonia and diarrhoea by community health workers (CHWs) and primary health facility workers (PHFWs). Methods: Caretaker rated PQC for children aged (2-59) months treated by either CHWs or PHFWs for a bought of malaria, pneumonia or diarrhoea was cross-sectionally compared in quality domains of accessibility, continuity, comprehensiveness, integration, clinical interaction, interpersonal treatment and trust. Child samples were randomly drawn from CHW (419) and clinic (399) records from eight Midwestern Uganda districts. An overall PQC score was predicted through factor analysis. PQC scores were compared for CHWs and PHFWs using Wilcoxon rank-sum test. Multinomial logistic regression models were used to specify the association between categorized PQC and service providers for each quality domain. Finally, overall PQC was dichotomized into "high" and "low" based on median score and relative risks (RR) for PQC-service provider association were modeled in a "modified" Poisson regression model. Results: Mean (SD) overall PQC was significantly higher for CHWs 0.58 (0.66) compared to PHFWs -0.58 (0.94), p<0.0001. In "modified" Poisson regression, the proportion of caretakers reporting high PQC was higher for CHWS compared to PHFWs, RR=3.1, 95%CI(2.5-3.8). In multinomial models PQC was significantly higher for CHWs compared to PHFWs in all domains except for continuity. Conclusion: PQC was significantly higher for CHWs compared to PHFWs in this resource constrained setting. CHWs should be tapped human resources for universal health coverage while scaling up basic child intervention as PQC might improve intervention utilization.	[Nanyonjo, Agnes; Tomson, Goran; Kallander, Karin] Karolinska Inst, Div Global Hlth, IHCAR, Stockholm, Sweden; [Makumbi, Fredrick; Kallander, Karin] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Nanyonjo, Agnes; Etou, Patrick; Kallander, Karin] Malaria Consortium, Kampala, Uganda; [Tomson, Goran] Med Management Ctr, Stockholm, Sweden	Karolinska Institutet; Makerere University	Nanyonjo, A (corresponding author), Karolinska Inst, Div Global Hlth, IHCAR, Stockholm, Sweden.	agnes.nanyonjo@ki.se		Tomson, Goran/0000-0001-9222-3604; Kirkwood, Betty/0000-0001-5274-6072; Nanyonjo, Agnes/0000-0002-2036-9548; Kallander, Karin/0000-0002-5778-5780	Bill & Melinda Gates Foundation [OPP1002407]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation grants number OPP1002407 to Malaria Consortium for the inSCALE project (http://www.malariaconsortium.org/inscale/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acharya LB, 2000, HEALTH POLICY PLANN, V15, P223, DOI 10.1093/heapol/15.2.223; Baltussen R, 2006, INT J QUAL HEALTH C, V18, P30, DOI 10.1093/intqhc/mzi079; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Brenner JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027997; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Chopra M, 2005, ARCH DIS CHILD, V90, P397, DOI 10.1136/adc.2004.059147; Dawson P, 2001, COMMUNITY BASED IMCI; de Sousa A, 2012, B WORLD HEALTH ORGAN, V90, P183, DOI 10.2471/BLT.11.093989; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fotso JC, 2012, HEALTH POLICY PLANN, V27, P505, DOI 10.1093/heapol/czr074; George Asha, 2009, J Health Care Poor Underserved, V20, P99, DOI 10.1353/hpu.0.0205; Gilroy KE, 2012, QUALITY SICK CHILD C; Gouws E, 2005, SOC SCI MED, V61, P613, DOI 10.1016/j.socscimed.2004.12.019; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Harzheim Erno, 2006, Cad. Saúde Pública, V22, P1649, DOI 10.1590/S0102-311X2006000800013; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Jensen HI, 2010, SOC SCI MED, V70, P1882, DOI 10.1016/j.socscimed.2010.02.035; Jeppsson A., 2004, DECENTRALIZATION NAT; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lee JH, 2009, INT J QUAL HEALTH C, V21, P103, DOI 10.1093/intqhc/mzp007; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Ministry of Health (MOH), 2008, MACR INT INC UG SERV; Morris SK, 2008, PUBLIC HEALTH NURS, V25, P370, DOI 10.1111/j.1525-1446.2008.00719.x; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Nanyonjo A, 2012, AM J TROP MED HYG, V87, P97, DOI 10.4269/ajtmh.2012.11-0763; Opondo C, 2009, TROP MED INT HEALTH, V14, P1165, DOI 10.1111/j.1365-3156.2009.02358.x; Ozawa S, 2011, HEALTH POLICY PLANN, V26, pi20, DOI 10.1093/heapol/czr045; Patel A, 2010, HEALTH POLICY PLANN, V25, P61, DOI 10.1093/heapol/czp039; Rademakers J, 2011, BMJ QUAL SAF, V20, P326, DOI 10.1136/bmjqs.2010.042358; Rodriguez HP, 2007, J GEN INTERN MED, V22, P787, DOI 10.1007/s11606-007-0182-8; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-131; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tsai J, 2010, MED CARE, V48, P628, DOI 10.1097/MLR.0b013e3181dbdf76; WHO/UNICEF, 2012, JOINT STAT INT COMM; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; World Bank, 2010, AFR DEV FORUM, P1, DOI 10.1596/978-0-8213-8041-3; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	48	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79943	10.1371/journal.pone.0079943	http://dx.doi.org/10.1371/journal.pone.0079943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244581	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900058
J	Broggi, S; Martegani, E; Colombo, S				Broggi, Serena; Martegani, Enzo; Colombo, Sonia			Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PREDOMINANT RAS ACTIVATION; RAS/CAMP PATHWAY; YEAST; CAMP; LOCALIZATION; PKA; GLUCOSE; STRESS; CELL	Using an eGFP-RBD3 probe, which specifically binds Ras-GTP, we recently showed that the fluorescent probe was localized to the plasma membrane and to the nucleus in wild type cells growing exponentially on glucose medium, indicating the presence of active Ras in these cellular compartments. To investigate the nuclear function of Ras-GTP, we generated a strain where Ras2 is fused to the nuclear export signal (NES) from the HIV virus, in order to exclude this protein from the nucleus. Our results show that nuclear active Ras2 is required for invasive growth development in haploid yeast, while the expression of the NES-Ras2 protein does not cause growth defects either on fermentable or non-fermentable carbon sources and does not influence protein kinase A (PKA) activity related phenotypes analysed. Moreover, we show that the cAMP/PKA pathway controls invasive growth influencing the localization of active Ras. In particular, we show that PKA activity plays a role in the localization of active Ras and influences the ability of the cells to invade the agar: high PKA activity leads to a predominant nuclear accumulation of active Ras and induces invasive growth, while low PKA activity leads to plasma membrane localization of active Ras and to a defective invasive growth phenotype.	[Broggi, Serena; Martegani, Enzo; Colombo, Sonia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Martegani, Enzo; Colombo, Sonia] SysBio Ctr Syst Biol, Milan, Italy	University of Milano-Bicocca	Colombo, S (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	Sonia.Colombo@unimib.i		Martegani, Enzo/0000-0001-9196-4224; Migliaccio, Antimo/0000-0002-4197-2055; Colombo, Sonia/0000-0001-5104-508X	UniCellsys; Program SysBioNet, Italian Roadmap Research Infrastructure	UniCellsys; Program SysBioNet, Italian Roadmap Research Infrastructure	This work was supported by UniCellsys and by founding of Program SysBioNet, Italian Roadmap Research Infrastructure 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; Belotti F, 2011, FEBS LETT, V585, P3914, DOI 10.1016/j.febslet.2011.10.032; Broggi S, 2013, INT J BIOCHEM CELL B, V45, P384, DOI 10.1016/j.biocel.2012.10.013; Casado C, 2011, BIOCHEM J, V438, P523, DOI 10.1042/BJ20110607; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen RE, 2010, GENETICS, V185, P855, DOI 10.1534/genetics.110.115808; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Dong JA, 2011, FEBS LETT, V585, P1127, DOI 10.1016/j.febslet.2011.03.057; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hu Y, 2010, FEMS YEAST RES, V10, P177, DOI 10.1111/j.1567-1364.2009.00598.x; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lorenz MC, 2000, GENETICS, V154, P609; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Magherini F, 2006, INT J BIOCHEM CELL B, V38, P444, DOI 10.1016/j.biocel.2005.10.004; MITSUZAWA H, 1993, GENETICS, V135, P321; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; PURWIN C, 1986, J BIOL CHEM, V261, P8744; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tisi R, 2008, BBA-MOL CELL RES, V1783, P2363, DOI 10.1016/j.bbamcr.2008.09.004; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; WILSON RB, 1993, FEBS LETT, V325, P191, DOI 10.1016/0014-5793(93)81071-7	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79274	10.1371/journal.pone.0079274	http://dx.doi.org/10.1371/journal.pone.0079274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244466	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800052
J	Dalrymple, KA; Gomez, J; Duchaine, B				Dalrymple, Kirsten A.; Gomez, Jesse; Duchaine, Brad			The Dartmouth Database of Children's Faces: Acquisition and Validation of a New Face Stimulus Set	PLOS ONE			English	Article							OWN-AGE BIAS; MEMORY TEST; FACIAL EXPRESSIONS; RECOGNITION; ADULTS; PERCEPTION; IDENTIFICATION; PARTICIPANTS; ACCURACY; RACE	Facial identity and expression play critical roles in our social lives. Faces are therefore frequently used as stimuli in a variety of areas of scientific research. Although several extensive and well-controlled databases of adult faces exist, few databases include children's faces. Here we present the Dartmouth Database of Children's Faces, a set of photographs of 40 male and 40 female Caucasian children between 6 and 16 years-of-age. Models posed eight facial expressions and were photographed from five camera angles under two lighting conditions. Models wore black hats and black gowns to minimize extra-facial variables. To validate the images, independent raters identified facial expressions, rated their intensity, and provided an age estimate for each model. The Dartmouth Database of Children's Faces is freely available for research purposes and can be downloaded by contacting the corresponding author by email.	[Dalrymple, Kirsten A.; Gomez, Jesse; Duchaine, Brad] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Dalrymple, Kirsten A.] UCL, Inst Cognit Neurosci, London, England	Dartmouth College; University of London; University College London	Dalrymple, KA (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	kirsten.dalrymple@dartmouth.edu		Gomez, Jesse/0000-0001-7982-2055; Dalrymple, Kirsten/0000-0001-8772-7787	Economic and Social Research Council, UK; Kaminsky Family Grant, Dartmouth College; Neukom Institute Grant, Dartmouth College; Economic and Social Research Council [ES/H026304/1] Funding Source: researchfish; ESRC [ES/H026304/1] Funding Source: UKRI	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Kaminsky Family Grant, Dartmouth College; Neukom Institute Grant, Dartmouth College; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by the following: Economic and Social Research Council, UK: http://www.esrc.ac.uk; Kaminsky Family Grant, Dartmouth College: http://www.dartmouth.edu; Neukom Institute Grant, Dartmouth College: http://www.dartmouth.edu/neukom/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Anzures G, 2010, DEVELOPMENTAL SCI, V13, P553, DOI 10.1111/j.1467-7687.2009.00900.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Bracovic A, 2012, J VIS, V12, P23; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Cassia VM, 2009, PSYCHOL SCI, V20, P853, DOI 10.1111/j.1467-9280.2009.02376.x; Cassia VM, 2009, Q J EXP PSYCHOL, V62, P1099, DOI 10.1080/17470210802617654; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Egger HL, 2011, INT J METH PSYCH RES, V20, P145, DOI 10.1002/mpr.343; Ekman P., 1976, PICTURES FACIAL AFFE; Golarai G, 2012, J VISION, V12, P985; Gross R, 2005, HANDBOOK OF FACE RECOGNITION, P301, DOI 10.1007/0-387-27257-7_14; Harrison V, 2009, PSYCHON B REV, V16, P264, DOI 10.3758/PBR.16.2.264; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; MCKELVIE SJ, 1993, B PSYCHONOMIC SOC, V31, P447; McKone E, 2011, COGN NEUROPSYCHOL, V28, P109, DOI 10.1080/02643294.2011.616880; Meissner CA, 2001, PSYCHOL PUBLIC POLIC, V7; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Perfect T. J, 2005, MEASURING MIND SPEED, P317, DOI [DOI 10.1093/ACPROF:OSO/9780198566427.003.0013, 10.1093/acprof:oso/9780198566427.003.0013]; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Susilo T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006460; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383	31	79	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79131	10.1371/journal.pone.0079131	http://dx.doi.org/10.1371/journal.pone.0079131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244434	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800032
J	Easson, CG; Slattery, M; Momm, HG; Olson, JB; Thacker, RW; Gochfeld, DJ				Easson, Cole G.; Slattery, Marc; Momm, Henrique G.; Olson, Julie B.; Thacker, Robert W.; Gochfeld, Deborah J.			Exploring Individual-to Population-Level Impacts of Disease on Coral Reef Sponges: Using Spatial Analysis to Assess the Fate, Dynamics, and Transmission of Aplysina Red Band Syndrome (ARBS)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; MORTALITY; PATTERNS; AUTOCORRELATION; ECOLOGY; DENSITY; CLIMATE	Background: Marine diseases are of increasing concern for coral reef ecosystems, but often their causes, dynamics and are unknown. The current study investigated the epidemiology of Aplysina Red Band Syndrome (ARBS), a disease affecting the Caribbean sponge Aplysina cauliformis, at both the individual and population levels. The fates of marked healthy and ARBS-infected sponges were examined over the course of a year. Population-level impacts and transmission mechanisms of ARBS were investigated by monitoring two populations of A. cauliformis over a three year period using digital photography and diver-collected data, and analyzing these data with GIS techniques of spatial analysis. In this study, three commonly used spatial statistics (Ripley's K, Getis-Ord General G, and Moran's Index) were compared to each other and with direct measurements of individual interactions using join-counts, to determine the ideal method for investigating disease dynamics and transmission mechanisms in this system. During the study period, Hurricane Irene directly impacted these populations, providing an opportunity to assess potential storm effects on A. cauliformis and ARBS. Results: Infection with ARBS caused increased loss of healthy sponge tissue over time and a higher likelihood of individual mortality. Hurricane Irene had a dramatic effect on A. cauliformis populations by greatly reducing sponge biomass on the reef, especially among diseased individuals. Spatial analysis showed that direct contact between A. cauliformis individuals was the likely transmission mechanism for ARBS within a population, evidenced by a significantly higher number of contact-joins between diseased sponges compared to random. Of the spatial statistics compared, the Moran's Index best represented true connections between diseased sponges in the survey area. This study showed that spatial analysis can be a powerful tool for investigating disease dynamics and transmission in a coral reef	[Easson, Cole G.; Slattery, Marc; Gochfeld, Deborah J.] Univ Mississippi, Environm Toxicol Res Program, University, MS 38677 USA; [Slattery, Marc; Gochfeld, Deborah J.] Univ Mississippi, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Slattery, Marc] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA; [Momm, Henrique G.] Middle Tennessee State Univ, Dept Geosci, Murfreesboro, TN 37130 USA; [Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	University of Mississippi; University of Mississippi; University of Mississippi; Middle Tennessee State University; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham	Easson, CG (corresponding author), Univ Mississippi, Environm Toxicol Res Program, University, MS 38677 USA.	cgeasson@uab.edu	Momm, Henrique/C-7139-2013	Momm, Henrique/0000-0003-3775-7958	National Science Foundation [OCE-0727996, OCE-1214303]; National Institute of Underwater Science and Technology [NA16RU1496]; Directorate For Geosciences [1214303] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Underwater Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work was supported by the following: National Science Foundation OCE-0727996; National Science Foundation OCE-1214303; and National Institute of Underwater Science and Technology NA16RU1496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; [Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 1997, J URBAN ECON, V42, P422, DOI 10.1006/juec.1997.2032; Anselin L, 2007, SOC INDIC RES, V82, P287, DOI 10.1007/s11205-006-9034-x; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bailey T, 1995, INTERACTIVE SPATIAL; Ban SS, 2013, CORAL REEFS, V32, P1, DOI 10.1007/s00338-012-0944-6; Bolker B. M., 1995, P399, DOI 10.1017/CBO9780511629396.016; Boots B.N., 1988, POINT PATTERN ANAL; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; Ciminiello P, 1999, J NAT PROD, V62, P590, DOI 10.1021/np9805138; Cliff A. D., 1981, SPATIAL PROCESSES MO; Cole RG, 1999, J ECOL, V87, P963, DOI 10.1046/j.1365-2745.1999.00418.x; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Engel S, 2000, MAR ECOL PROG SER, V207, P273, DOI 10.3354/meps207273; Freeman CJ, 2013, ISME J, V7, P1116, DOI 10.1038/ismej.2013.7; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Gardner B, 2008, CAN J FISH AQUAT SCI, V65, P2461, DOI 10.1139/F08-152; GETIS A, 1984, ENVIRON PLANN A, V16, P173, DOI 10.1068/a160173; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Gochfeld DJ, 2012, J CHEM ECOL, V38, P451, DOI 10.1007/s10886-012-0099-5; Goodchild M. F., 1986, SPATIAL AUTOCORRELAT; Griffith DA, 1987, A PRIMER; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; LeDrew EF, 2004, REMOTE SENS ENVIRON, V91, P271, DOI 10.1016/j.rse.2003.10.007; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lentz JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021830; Lloyd C., 2010, SPATIAL DATA ANAL IN; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Mann ME, 2009, NATURE, V460, P880, DOI 10.1038/nature08219; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mitchell A., 2005, ESRI GUIDE GIS ANAL; Moraes RM, 2005, PLANTA MED, V71, P1157, DOI 10.1055/s-2005-873166; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Olson J, FEMS MICROB IN PRESS; Olson JB, 2006, DIS AQUAT ORGAN, V71, P163, DOI 10.3354/dao071163; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Real LA, 1996, ECOLOGY, V77, P1011, DOI 10.2307/2265572; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; RODRIGUEZ AD, 1993, J NAT PROD, V56, P907, DOI 10.1021/np50096a014; Roff G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026829; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Scott L, 2005, ARCUSER ONLINE   APR; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Thacker RW, 2012, ADV MAR BIOL, V62, P57, DOI 10.1016/B978-0-12-394283-8.00002-3; Tsurumi M, 1997, INVERTEBR REPROD DEV, V32, P1, DOI 10.1080/07924259.1997.9672598; VACELET J, 1994, SPONGES TIME SPACE; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Wulff JL, 2007, J MAR BIOL ASSOC UK, V87, P1715, DOI 10.1017/S002531540705881X; Wulff JL, 2006, CORAL REEFS, V25, P419, DOI 10.1007/s00338-006-0110-0; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Zvuloni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004993	72	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79976	10.1371/journal.pone.0079976	http://dx.doi.org/10.1371/journal.pone.0079976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244583	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800106
J	Euser, AS; Evans, BE; Greaves-Lord, K; van de Wetering, BJM; Huizink, AC; Franken, IHA				Euser, Anja S.; Evans, Brittany E.; Greaves-Lord, Kirstin; van de Wetering, Ben J. M.; Huizink, Anja C.; Franken, Ingmar H. A.			Multifactorial Determinants of Target and Novelty-Evoked P300 Amplitudes in Children of Addicted Parents	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; EVENT-RELATED POTENTIALS; FAMILY-HISTORY; ANTISOCIAL-BEHAVIOR; EXTERNALIZING PSYCHOPATHOLOGY; HUMAN ELECTROENCEPHALOGRAM; CORTISOL RESPONSES; BRAIN-DEVELOPMENT; ADOLESCENT BRAIN; LIFE STRESSORS	Background: Although P300 amplitude reductions constitute a persistent finding in children of addicted parents, relatively little is known about the specificity of this finding. The major aim of this study was to investigate the association between parental rearing, adverse life events, stress-reactivity, substance use and psychopathology on the one hand, and P300 amplitude in response to both target and novel distracter stimuli on the other hand. Moreover, we assessed whether risk group status (i.e., having a parental history of Substance Use Disorders [SUD]) uniquely contributed to P300 amplitude variation above and beyond these other variables. Methods: Event-related potentials were recorded in high-risk adolescents with a parental history of SUD (HR; n=80) and normal-risk controls (NR; n=100) while performing a visual Novelty Oddball paradigm. Stress-evoked cortisol levels were assessed and parenting, life adversities, substance use and psychopathology were examined by using self-reports. Results: HR adolescents displayed smaller P300 amplitudes in response to novel-and to target stimuli than NR controls, while the latter only approached significance. Interestingly, the effect of having a parental history of SUD on target-P300 disappeared when all other variables were taken into account. Externalizing problem behavior was a powerful predictor of target-P300. In contrast, risk group status uniquely predicted novelty-P300 amplitude reductions above and beyond all other factors. Conclusion: Overall, the present findings suggest that the P300 amplitude reduction to novel stimuli might be a more specific endophenotype for SUD than the target-P300 amplitude. This pattern of results underscores the importance of conducting multifactorial assessments when examining important cognitive processes in at-risk adolescents.	[Euser, Anja S.; Franken, Ingmar H. A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [Euser, Anja S.; Evans, Brittany E.; Greaves-Lord, Kirstin; Franken, Ingmar H. A.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Evans, Brittany E.; Huizink, Anja C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care, Amsterdam, Netherlands; [van de Wetering, Ben J. M.] Bouman Mental Hlth Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Euser, AS (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	euser@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694	Netherlands Organization for Health Research and Development (ZonMW) [3116.0002]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This project is financially supported by the Netherlands Organization for Health Research and Development (ZonMW; 3116.0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardal E, 1995, EUR J CLIN CHEM CLIN, V33, P927; Achenbach T. M., 1991, MANUAL SELF REPORT 1; Amone-P'olak K, 2009, J AM ACAD CHILD PSY, V48, P1031, DOI 10.1097/CHI.0b013e3181b39595; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnow S, 2002, J STUD ALCOHOL, V63, P305, DOI 10.15288/jsa.2002.63.305; Bauer L. O., 1997, DRUG ALCOHOL DEPEN, V44, P1; Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Carlson SR, 2007, J ABNORM PSYCHOL, V116, P565, DOI 10.1037/0021-843X.116.3.565; Carlson SR, 1999, PSYCHOPHYSIOLOGY, V36, P583, DOI 10.1111/1469-8986.3650583; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Chassin L, 1999, J ABNORM PSYCHOL, V108, P106, DOI 10.1037/0021-843X.108.1.106; CONGER AJ, 1974, EDUC PSYCHOL MEAS, V34, P35, DOI 10.1177/001316447403400105; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dieleman GC, 2010, PSYCHONEUROENDOCRINO, V35, P1223, DOI 10.1016/j.psyneuen.2010.02.012; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dunn MG, 2002, CLIN PSYCHOL REV, V22, P1063, DOI 10.1016/S0272-7358(02)00132-0; Euser AS, 2012, NEUROSCI BIOBEHAV R, V36, P572, DOI 10.1016/j.neubiorev.2011.09.002; Evans BE, ORTISOL LEVELS UNPUB; Evans BE, 2011, ADDICTION; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Frangou S, 1997, SCHIZOPHR RES, V23, P45, DOI 10.1016/S0920-9964(96)00089-8; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Giancola PR, 1999, PSYCHOL SCI, V10, P203, DOI 10.1111/1467-9280.00135; GOLDSTEIN A, 1990, SCIENCE, V249, P1513, DOI 10.1126/science.2218493; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greaves-Lord K, DEV SCI IN PRESS; Hardie TL, 2002, PSYCHIAT RES, V112, P121, DOI 10.1016/S0165-1781(02)00182-8; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2007, PSYCHOPHYSIOLOGY, V44, P98, DOI 10.1111/j.1469-8986.2006.00471.x; Holguin SR, 1999, BIOL PSYCHIAT, V46, P281, DOI 10.1016/S0006-3223(98)00247-9; Holguin SR, 1998, ALCOHOL ALCOHOLISM, V33, P281; Huizink AC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-350; Hussong AM, 2008, J FAM PSYCHOL, V22, P819, DOI 10.1037/a0013704; Iacono WG, 2002, ARCH GEN PSYCHIAT, V59, P750, DOI 10.1001/archpsyc.59.8.750; Iacono WG, 2011, CHILD DEV PERSPECT, V5, P239, DOI 10.1111/j.1750-8606.2011.00205.x; Ivanov I, 2008, AM J DRUG ALCOHOL AB, V34, P239, DOI 10.1080/00952990802013334; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kimble MO, 2010, PSYCHIAT RES, V178, P501, DOI 10.1016/j.psychres.2009.10.009; Klein BS, 2001, NY TIMES BK REV, P15; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Latendresse SJ, 2008, ALCOHOL CLIN EXP RES, V32, P322, DOI 10.1111/j.1530-0277.2007.00583.x; Liu JY, 2009, NEUROIMAGE, V46, P809, DOI 10.1016/j.neuroimage.2009.02.045; Lovallo WR, 2012, BIOL PSYCHIAT, V71, P344, DOI 10.1016/j.biopsych.2011.10.018; Luck S.J., 2005, INTRO EVENT RELATED; MacMillan HL, 2009, BIOL PSYCHIAT, V66, P62, DOI 10.1016/j.biopsych.2008.12.014; Malone SM, 2001, PSYCHOPHYSIOLOGY, V38, P367, DOI 10.1017/S0048577201990912; Markus MT, 2003, PERS INDIV DIFFER, V34, P503, DOI 10.1016/S0191-8869(02)00090-9; Masten AS, 2008, PEDIATRICS, V121, pS235, DOI 10.1542/peds.2007-2243A; McEwen B, 1999, J AM ACAD CHILD PSY, V38, P101, DOI 10.1097/00004583-199901000-00027; Morgan PT, 2010, ALCOHOL CLIN EXP RES, V34, P1759, DOI 10.1111/j.1530-0277.2010.01263.x; Muller BW, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-63; OCONNOR S, 1994, PROG NEURO-PSYCHOPH, V18, P1307, DOI 10.1016/0278-5846(94)90095-7; Pandey S., 2010, J SOC SOC WORK RES, V1, P28, DOI [10.5243/jsswr.2010.2, DOI 10.5243/JSSWR.2010.2]; Patrick CJ, 2006, PSYCHOPHYSIOLOGY, V43, P84, DOI 10.1111/j.1469-8986.2006.00376.x; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; PIHL RO, 1990, J ABNORM PSYCHOL, V99, P291, DOI 10.1037/0021-843X.99.3.291; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2004, CLIN NEUROPHYSIOL, V115, P1374, DOI 10.1016/j.clinph.2004.01.026; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Rosnick CB, 2007, J AGING HEALTH, V19, P612, DOI 10.1177/0898264307300975; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SINHA R, 2008, CHRONIC STRESS DRUG, V1141, P105; Sorocco KH, 2006, INT J PSYCHOPHYSIOL, V59, P210, DOI 10.1016/j.ijpsycho.2005.10.009; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Uhart M, 2006, NEUROPSYCHOPHARMACOL, V31, P2255, DOI 10.1038/sj.npp.1301063; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; van der Stelt O, 1998, ALCOHOL CLIN EXP RES, V22, P1877, DOI 10.1097/00000374-199812000-00001; Van der Stelt O, 1998, ALCOHOL, V15, P119, DOI 10.1016/S0741-8329(97)00106-7; VANBEIJSTERVELDT CEM, 1994, HUM GENET, V94, P319, DOI 10.1007/BF00201587; Veenstra R, 2006, INT J BEHAV DEV, V30, P422, DOI 10.1177/0165025406071490; Verhulst F. C., 1997, HANDLEIDING YOUTH SE	88	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80087	10.1371/journal.pone.0080087	http://dx.doi.org/10.1371/journal.pone.0080087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244616	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800120
J	Giamberardino, A; Labib, M; Hassan, EM; Tetro, JA; Springthorpe, S; Sattar, SA; Berezovski, MV; DeRosa, MC				Giamberardino, Amanda; Labib, Mahmoud; Hassan, Eman M.; Tetro, Jason A.; Springthorpe, Susan; Sattar, Syed A.; Berezovski, Maxim V.; DeRosa, Maria C.			Ultrasensitive Norovirus Detection Using DNA Aptasensor Technology	PLOS ONE			English	Article							APTAMERS; BINDING; SERVER	DNA aptamers were developed against murine norovirus (MNV) using SELEX (Systematic Evolution of Ligands by EXponential enrichment). Nine rounds of SELEX led to the discovery of AG3, a promising aptamer with very high affinity for MNV as well as for lab-synthesized capsids of a common human norovirus (HuNoV) outbreak strain (GII.3). Using fluorescence anisotropy, AG3 was found to bind with MNV with affinity in the low picomolar range. The aptamer could cross-react with HuNoV though it was selected against MNV. As compared to a non-specific DNA control sequence, the norovirus-binding affinity of AG3 was about a million-fold higher. In further tests, the aptamer also showed nearly a million-fold higher affinity for the noroviruses than for the feline calicivirus (FCV), a virus similar in size and structure to noroviruses. AG3 was incorporated into a simple electrochemical sensor using a gold nanoparticle-modified screen-printed carbon electrode (GNPs-SPCE). The aptasensor could detect MNV with a limit of detection of approximately 180 virus particles, for possible on-site applications. The lead aptamer candidate and the aptasensor platform show promise for the rapid detection and identification of noroviruses in environmental and clinical samples.	[Giamberardino, Amanda; Hassan, Eman M.; DeRosa, Maria C.] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada; [Labib, Mahmoud; Berezovski, Maxim V.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Tetro, Jason A.; Springthorpe, Susan; Sattar, Syed A.] Univ Ottawa, Ctr Res Environm Microbiol, Ottawa, ON, Canada	Carleton University; University of Ottawa; University of Ottawa	Sattar, SA (corresponding author), Univ Ottawa, Ctr Res Environm Microbiol, Ottawa, ON, Canada.	syed.sattar@uottawa.ca; maxim.berezvoski@uottawa.ca; maria.derosa@carleton.ca	Berezovski, Maxim V./F-8961-2012; Labib, Mahmoud/P-2267-2014; Labib, Mahmoud/ABB-1104-2021; Berezovski, Maxim V./N-1247-2019	Berezovski, Maxim V./0000-0003-0514-599X; Labib, Mahmoud/0000-0003-4565-2056; Labib, Mahmoud/0000-0003-4565-2056; Berezovski, Maxim V./0000-0003-0514-599X; Tetro, Jason/0000-0001-8759-7281	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP); Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF); Ontario Ministry for Research and Innovation (MRI)	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Ontario Ministry for Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario)	Sources of Funding: Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Food Safety Research Program (FSRP), Natural Sciences and Engineering Research Council (NSERC), the Canada Foundation for Innovation (CFI), the Ontario Research Fund (ORF), Ontario Ministry for Research and Innovation (MRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Cho HS, 2012, ACS NANO, V6, P7607, DOI 10.1021/nn203833d; Cruz-Toledo J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas006; Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7; Gasparac R, 2004, J AM CHEM SOC, V126, P12270, DOI 10.1021/ja0458221; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Koo HL, 2010, DISCOV MED, V10, P61; Labib M, 2012, ANAL CHEM, V84, P1813, DOI 10.1021/ac203412m; Labib M, 2011, ANALYST, V136, P708, DOI 10.1039/c0an00741b; Lapierre MA, 2003, ANAL CHEM, V75, P6327, DOI 10.1021/ac0349429; Luttermann C, 1995, CALICIVIRUSES MOL CE, P146; McKeague M., 2011, ENV BIOSENSORS, P17, DOI DOI 10.5772/22350; McKeague M., 2012, J NUCLEIC ACIDS, V2012, DOI DOI 10.1155/2012/748913; Mergny J. L., 2009, CURR PROTOC NUCL ACI; Negri P, 2011, CHEM COMMUN, V47, P8635, DOI 10.1039/c0cc05433j; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Radi AE, 2006, J AM CHEM SOC, V128, P117, DOI 10.1021/ja053121d; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zhang J, 2007, CHEM COMMUN, P1154, DOI 10.1039/b615742d; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	71	74	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79087	10.1371/journal.pone.0079087	http://dx.doi.org/10.1371/journal.pone.0079087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244426	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800028
J	Holzer, TR; Fulford, AD; Nedderman, DM; Umberger, TS; Hozak, RR; Joshi, A; Melemed, SA; Benjamin, LE; Plowman, GD; Schade, AE; Ackermann, BL; Konrad, RJ; Nasir, A				Holzer, Timothy R.; Fulford, Angie D.; Nedderman, Drew M.; Umberger, Tara S.; Hozak, Rebecca R.; Joshi, Adarsh; Melemed, Symantha A.; Benjamin, Laura E.; Plowman, Gregory D.; Schade, Andrew E.; Ackermann, Bradley L.; Konrad, Robert J.; Nasir, Aejaz			Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							COLORECTAL-CANCER; OVARIAN-CARCINOMA; BREAST-CANCER; CONTAINING REGIMENS; TISSUE MICROARRAYS; PANCREATIC-CANCER; TARGETED THERAPY; MURINE MODEL; FACTOR VEGF; IN-SITU	A robust immunohistochemical (IHC) assay for VEGFR2 was developed to investigate its utility for patient tailoring in clinical trials. The sensitivity, specificity, and selectivity of the IHC assay were established by siRNA knockdown, immunoblotting, mass spectrometry, and pre-absorption experiments. Characterization of the assay included screening a panel of multiple human cancer tissues and an independent cohort of non-small cell lung carcinoma (NSCLC, n = 118) characterized by TTF-1, p63, CK5/6, and CK7 IHC. VEGFR2 immunoreactivity was interpreted qualitatively (VEGFR2 positive/negative) in blood vessels and by semi-quantitative evaluation using H-scores in tumor cells (0-300). Associations were determined among combinations of VEGFR2 expression in blood vessels and tumor cells, and clinico-pathologic characteristics (age, sex, race, histologic subtype, disease stage) and overall survival using Kaplan-Meier analyses and appropriate statistical models. VEGFR2 expression both in blood vessels and in tumor cells in carcinomas of the lung, cervix, larynx, breast, and others was demonstrated. In the validation cohort, 99/118 (83.9%) NSCLC tissues expressed VEGFR2 in the blood vessels and 46/118 (39.0%) showed high tumor cell positivity (H-score >= 10). Vascular and tumor cell expression were inversely correlated (p = 0.0175). High tumor cell expression of VEGFR2 was associated with a 3.7-fold reduction in median overall survival in lung squamous-cell carcinoma (SCC, n = 25, p = 0.0134). The inverse correlation between vascular and tumor cell expression of VEGFR2 and the adverse prognosis associated with high VEGFR2 expression in immunohistochemically characterized pulmonary SCC are new findings with potential therapeutic implications. The robustness of this novel IHC assay will support further evaluation of its utility for patient tailoring in clinical trials of antiangiogenic agents.	[Holzer, Timothy R.; Fulford, Angie D.; Nedderman, Drew M.; Umberger, Tara S.; Melemed, Symantha A.; Benjamin, Laura E.; Plowman, Gregory D.; Schade, Andrew E.; Ackermann, Bradley L.; Konrad, Robert J.; Nasir, Aejaz] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hozak, Rebecca R.; Joshi, Adarsh] Eli Lilly & Co, Oncol Stat Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Nasir, A (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	nasir_aejaz@lilly.com	Holzer, Timothy/M-4002-2014; Holzer, Timothy/AAH-7952-2020	Holzer, Timothy/0000-0002-4274-8741; Holzer, Timothy/0000-0002-4274-8741; Plowman, Gregory D/0000-0002-6465-309X				Adham SAI, 2010, LAB INVEST, V90, P709, DOI 10.1038/labinvest.2010.52; Amaya H, 1997, CANCER LETT, V119, P227, DOI 10.1016/S0304-3835(97)00280-2; Anagnostou VK, 2009, CLIN CANCER RES, V15, P4157, DOI 10.1158/1078-0432.CCR-09-0099; Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Ballas MS, 2010, 2010 AM SOC CLIN ONC; Belotti D, 1996, CLIN CANCER RES, V2, P1843; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bruns CJ, 2000, CANCER, V89, P488, DOI 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.3.CO;2-O; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carvajal RD, 2010, 2010 AM SOC CLIN ONC; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; COX DR, 1972, J R STAT SOC B, V34, P187; Pau ECD, 2009, CANCER-AM CANCER SOC, V115, P1701, DOI 10.1002/cncr.24193; Decaussin M, 1999, J PATHOL, V188, P369; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Douillard JY, 2007, J THORAC ONCOL, V2, P939, DOI 10.1097/JTO.0b013e318153fa2b; Duff SE, 2006, EUR J CANCER, V42, P112, DOI 10.1016/j.ejca.2005.09.018; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9; Garcia JA, 2010, 2010 AM SOC CLIN ONC; Garcia-Carbonero R, 2012, 2012 AM SOC CLIN ONC; Gasparini G, 2005, J CLIN ONCOL, V23, P1295, DOI 10.1200/JCO.2005.10.022; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Grossi F, 2010, ONCOLOGIST, V15, P1102, DOI 10.1634/theoncologist.2010-0322; Grossi F, 2009, ONCOLOGIST, V14, P497, DOI 10.1634/theoncologist.2008-0260; Gurtler J, 2010, 2010 INT LIV CANC AS; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Inoue K, 2000, CLIN CANCER RES, V6, P2635; Itakura J, 2000, INT J CANCER, V85, P27; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kollermann J, 2001, AM J CLIN PATHOL, V116, P115; Konig JE, 2000, RESPIRATION, V67, P36, DOI 10.1159/000029460; Koukourakis MI, 2000, CANCER RES, V60, P3088; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Le Chevalier T, 2005, LUNG CANCER, V47, P69, DOI 10.1016/j.lungcan.2004.10.014; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Miettinen M, 2012, AM J SURG PATHOL, V36, P629, DOI 10.1097/PAS.0b013e318243555b; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Molhoek KR, 2011, INT J CANCER, V129, P2807, DOI 10.1002/ijc.25963; Moore KN, 2012, ASCO M; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Pajares MJ, 2012, J CLIN ONCOL; Prewett M, 1999, CANCER RES, V59, P5209; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Ryden L, 2003, BREAST CANCER RES TR, V82, P147, DOI 10.1023/B:BREA.0000004357.92232.cb; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shibuya K, 2007, INT J RADIAT ONCOL, V69, P1534, DOI 10.1016/j.ijrobp.2007.07.2350; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Stewart M, 2003, HISTOPATHOLOGY, V43, P33, DOI 10.1046/j.1365-2559.2003.01644.x; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Wulfing P, 2005, BRIT J CANCER, V92, P1720, DOI 10.1038/sj.bjc.6602567; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Zhu ZP, 2002, CURR CANCER DRUG TAR, V2, P135, DOI 10.2174/1568009023333881; Zito CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031331	68	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80292	10.1371/journal.pone.0080292	http://dx.doi.org/10.1371/journal.pone.0080292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244672	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800141
J	Timon-Gomez, A; Proft, M; Pascual-Ahuir, A				Timon-Gomez, Alba; Proft, Markus; Pascual-Ahuir, Amparo			Differential Regulation of Mitochondrial Pyruvate Carrier Genes Modulates Respiratory Capacity and Stress Tolerance in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; EXPRESSION; METABOLISM; PROTEINS	Mpc proteins are highly conserved from yeast to humans and are necessary for the uptake of pyruvate at the inner mitochondrial membrane, which is used for leucine and valine biosynthesis and as a fuel for respiration. Our analysis of the yeast MPC gene family suggests that amino acid biosynthesis, respiration rate and oxidative stress tolerance are regulated by changes in the Mpc protein composition of the mitochondria. Mpc2 and Mpc3 are highly similar but functionally different: Mpc2 is most abundant under fermentative non stress conditions and important for amino acid biosynthesis, while Mpc3 is the most abundant family member upon salt stress or when high respiration rates are required. Accordingly, expression of the MPC3 gene is highly activated upon NaCl stress or during the transition from fermentation to respiration, both types of regulation depend on the Hog1 MAP kinase. Overexpression experiments show that gain of Mpc2 function leads to a severe respiration defect and ROS accumulation, while Mpc3 stimulates respiration and enhances tolerance to oxidative stress. Our results identify the regulated mitochondrial pyruvate uptake as an important determinant of respiration rate and stress resistance.	[Timon-Gomez, Alba; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Dept Biotechnol, E-46071 Valencia, Spain; [Proft, Markus] CSIC, Inst Biol Mol & Celular Plantas, Dept Mech Plant Stress Responses, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Proft, M (corresponding author), CSIC, Inst Biol Mol & Celular Plantas, Dept Mech Plant Stress Responses, Valencia, Spain.	mproft@ibmcp.upv.es; apascual@ibmcp.upv.es	Timon, Alba/AAD-6495-2020; Proft, Markus/K-2323-2014; Pascual-ahuir, Amparo/K-1338-2014	Timon, Alba/0000-0001-9811-8557; Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Economia y Competitividad grant [BFU2011-23326]; JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas	Ministerio de Economia y Competitividad grant(Spanish Government); JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas	This work was supported by Ministerio de Economia y Competitividad grant BFU2011-23326 to M.P.; A.T.-G. was supported by a JAE predoctoral grant from Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Martinez-Montanes F, 2010, OMICS, V14, P619, DOI 10.1089/omi.2010.0046; Martinez-Pastor M, 2010, OMICS, V14, P541, DOI 10.1089/omi.2010.0020; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Pan Y, 2011, EXP GERONTOL, V46, P847, DOI 10.1016/j.exger.2011.08.007; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79405	10.1371/journal.pone.0079405	http://dx.doi.org/10.1371/journal.pone.0079405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244496	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800072
J	Bojan, M; Lopez-Lopez, V; Pouard, P; Falissard, B; Journois, D				Bojan, Mirela; Lopez-Lopez, Vanessa; Pouard, Philippe; Falissard, Bruno; Journois, Didier			Limitations of Early Serum Creatinine Variations for the Assessment of Kidney Injury in Neonates and Infants with Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CONGENITAL HEART-DISEASE; CRITICALLY-ILL CHILDREN; PERITONEAL-DIALYSIS; CARDIOPULMONARY BYPASS; CARDIOTHORACIC SURGERY; RETROSPECTIVE ANALYSIS; FLUID ACCUMULATION; RIFLE CRITERIA; RISK-FACTORS	Background: Changes in kidney function, as assessed by early and even small variations in serum creatinine (Delta sCr), affect survival in adults following cardiac surgery but such associations have not been reported in infants. This raises the question of the adequate assessment of kidney function by early Delta sCr in infants undergoing cardiac surgery. Methodology: The ability of Delta sCr within 2 days of surgery to assess the severity of kidney injury, accounted for by the risk of 30-day mortality, was explored retrospectively in 1019 consecutive neonates and infants. Patients aged <= 10 days were analyzed separately because of the physiological improvement in glomerular filtration early after birth. The Kml algorithm, an implementation of k-means for longitudinal data, was used to describe creatinine kinetics, and the receiver operating characteristic and the reclassification methodology to assess discrimination and the predictive ability of the risk of death. Results: Three clusters of Delta sCr were identified: in 50% of all patients creatinine decreased, in 41.4% it increased slightly, and in 8.6% it rose abruptly. Mortality rates were not significantly different between the first and second clusters, 1.6% [0.0-4.1] vs 5.9% [1.9-10.9], respectively, in patients aged <= 10 days, and 1.6% [0.5-3.0] vs 3.8% [1.9-6.0] in older ones. Mortality rates were significantly higher when creatinine rose abruptly, 30.3% [15.1-46.2] in patients aged <= 10 days, and 15.1% [5.9-25.5] in older ones. However, only 41.3% of all patients who died had an abrupt increase in creatinine. Delta sCr improved prediction in survivors, but not in patients who died, and did not improve discrimination over a clinical mortality model. Conclusions: The present results suggest that a postoperative decrease in creatinine represents the normal course in neonates and infants with cardiac surgery, and that early creatinine variations lack sensitivity for the assessment of the severity of kidney injury.	[Bojan, Mirela; Lopez-Lopez, Vanessa; Pouard, Philippe] Necker Enfants Malades Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France; [Falissard, Bruno] Univ Paris 11, INSERM, U669, Paris, France; [Falissard, Bruno; Journois, Didier] Paris Descartes Univ, Paris, France; [Falissard, Bruno] Hop Paul Brousse, AP HP, Paris, France; [Journois, Didier] Georges Pompidou European Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Bojan, M (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, Dept Anesthesia & Crit Care, Paris, France.	mirela.bojan@nck.aphp.fr	Didier, Journois/J-3074-2019	Didier, Journois/0000-0003-1096-7373				Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Baker SG, 2003, J NATL CANCER I, V95, P511, DOI 10.1093/jnci/95.7.511; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BJORNSSON TD, 1979, CLIN PHARMACOKINET, V4, P200, DOI 10.2165/00003088-197904030-00003; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Boer DP, 2010, PEDIATR NEPHROL, V25, P2107, DOI 10.1007/s00467-010-1533-y; Boigner H, 2004, ANN THORAC SURG, V77, P61, DOI 10.1016/S0003-4975(03)01490-5; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Chan KL, 2003, ANN THORAC SURG, V76, P1443, DOI 10.1016/S0003-4975(03)01026-9; Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006; Diskin CJ, 2007, ANN CLIN BIOCHEM, V44, P16, DOI 10.1258/000456307779595940; Drukker A, 2002, CURR OPIN PEDIATR, V14, P175, DOI 10.1097/00008480-200204000-00006; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Genolini C, 2011, COMPUT METH PROG BIO, V104, pE112, DOI 10.1016/j.cmpb.2011.05.008; Gillespie RS, 2004, PEDIATR NEPHROL, V19, P1394, DOI 10.1007/s00467-004-1655-1; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Guzzetta NA, 2009, ANESTH ANALG, V108, P448, DOI 10.1213/ane.0b013e318194007a; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; KERN FH, 1992, ANN THORAC SURG, V54, P541, DOI 10.1016/0003-4975(92)90451-9; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lolekha PH, 2001, J CLIN LAB ANAL, V15, P116, DOI 10.1002/jcla.1013; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morgan CJ, 2013, J PEDIATR-US, V162, P120, DOI 10.1016/j.jpeds.2012.06.054; Ostermann ME, 2005, INTENS CARE MED, V31, P250, DOI 10.1007/s00134-004-2523-y; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Pedersen KR, 2008, KIDNEY INT, V73, pS81, DOI 10.1038/sj.ki.5002607; Pedersen KR, 2007, ACTA ANAESTH SCAND, V51, P1344, DOI 10.1111/j.1399-6576.2007.01379.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pottel H, 2008, CLIN CHIM ACTA, V396, P49, DOI 10.1016/j.cca.2008.06.017; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Szekely A, 2008, PEDIATR ANESTH, V18, P151, DOI 10.1111/j.1460-9592.2007.02398.x; Thompson LD, 2001, J THORAC CARDIOV SUR, V122, P220, DOI 10.1067/mtc.2001.114937; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79308	10.1371/journal.pone.0079308	http://dx.doi.org/10.1371/journal.pone.0079308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244476	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600124
J	Dodds, CM; Henson, RN; Suckling, J; Miskowiak, KW; Ooi, C; Tait, R; Soltesz, F; Lawrence, P; Bentley, G; Maltby, K; Skeggs, A; Miller, SR; McHugh, S; Bullmore, ET; Nathan, PJ				Dodds, Chris M.; Henson, Richard N.; Suckling, John; Miskowiak, Kamilla W.; Ooi, Cinly; Tait, Roger; Soltesz, Fruzsina; Lawrence, Phil; Bentley, Graham; Maltby, Kay; Skeggs, Andrew; Miller, Sam R.; McHugh, Simon; Bullmore, Edward T.; Nathan, Pradeep J.			Effects of the BDNF Val66Met Polymorphism and Met Allele Load on Declarative Memory Related Neural Networks	PLOS ONE			English	Article							NEUROTROPHIC-FACTOR; ALZHEIMERS-DISEASE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL ACTIVITY; COGNITIVE-ABILITIES; EPISODIC MEMORY; GENE; METAANALYSIS; RESPONSES; ASSOCIATION	It has been suggested that the BDNF Val66Met polymorphism modulates episodic memory performance via effects on hippocampal neural circuitry. However, fMRI studies have yielded inconsistent results in this respect. Moreover, very few studies have examined the effect of met allele load on activation of memory circuitry. In the present study, we carried out a comprehensive analysis of the effects of the BDNF polymorphism on brain responses during episodic memory encoding and retrieval, including an investigation of the effect of met allele load on memory related activation in the medial temporal lobe. In contrast to previous studies, we found no evidence for an effect of BDNF genotype or met load during episodic memory encoding. Met allele carriers showed increased activation during successful retrieval in right hippocampus but this was contrast-specific and unaffected by met allele load. These results suggest that the BDNF Val66Met polymorphism does not, as previously claimed, exert an observable effect on neural systems underlying encoding of new information into episodic memory but may exert a subtle effect on the efficiency with which such information can be retrieved.	[Dodds, Chris M.; Soltesz, Fruzsina; Lawrence, Phil; Bentley, Graham; Maltby, Kay; Skeggs, Andrew; Miller, Sam R.; McHugh, Simon; Bullmore, Edward T.; Nathan, Pradeep J.] GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Henson, Richard N.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Suckling, John; Ooi, Cinly; Tait, Roger; Bullmore, Edward T.; Nathan, Pradeep J.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 1TN, England; [Miskowiak, Kamilla W.] Copenhagen Univ Hosp, Dept Psychiat, Clin Affect Disorders, Copenhagen, Denmark; [Nathan, Pradeep J.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Dodds, Chris M.] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England	GlaxoSmithKline; University of Cambridge; University of Copenhagen; Monash University; University of Exeter	Dodds, CM (corresponding author), GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England.	chrismdodds@gmail.com; pn254@cam.ac.uk	Bullmore, Ed/C-1706-2012; Henson, Richard/H-8822-2019; Suckling, John/ABD-7246-2021	Bullmore, Ed/0000-0002-8955-8283; Henson, Richard/0000-0002-0712-2639; Suckling, John/0000-0002-5098-1527; Miskowiak, Kamilla/0000-0003-2572-1384	Glaxosmithkline (GSK); Lundbeck	Glaxosmithkline (GSK)(GlaxoSmithKline); Lundbeck(Lundbeck Corporation)	This study was funded by a commercial sponsor, Glaxosmithkline (GSK). CMD, FS, PL, GB, KM, AS, SRM, SMH, ETB and PJN are employees of GSK and own shares in the company. RH is a paid consultant for GSK. KM has received consultancy fees from Lundbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Banner H, 2011, EUR J NEUROSCI, V33, P968, DOI 10.1111/j.1460-9568.2010.07550.x; Beste C, 2011, NEUROPHARMACOLOGY, V60, P467, DOI 10.1016/j.neuropharm.2010.10.028; Brett M, 2002, NEUROIMAGE, V16; Cathomas F, 2010, INT J NEUROPSYCHOPH, V13, P975, DOI 10.1017/S1461145710000519; Cerasa A, 2010, BEHAV BRAIN RES, V207, P377, DOI 10.1016/j.bbr.2009.10.022; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; DEMPSTER E, 2005, GENETICS, V134, P73, DOI DOI 10.1002/AJMG.B.30150; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Dodds CM, 2013, NEUROSCI BIOBEHAV R, V37, P739, DOI 10.1016/j.neubiorev.2013.01.019; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Hansell NK, 2007, GENES BRAIN BEHAV, V6, P260, DOI 10.1111/j.1601-183X.2006.00254.x; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Henson R, 2005, IMAGING, V1, P1; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Houlihan LM, 2009, GENES BRAIN BEHAV, V8, P238, DOI 10.1111/j.1601-183X.2008.00470.x; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Kauppi K, 2012, NEUROPSYCHOLOGIA; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Sambataro F, 2010, MOL PSYCHIATR, V15, P116, DOI 10.1038/mp.2009.64; Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e74133	10.1371/journal.pone.0074133	http://dx.doi.org/10.1371/journal.pone.0074133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244264	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327221600003
J	Gorniak, SL; McIntyre, CC; Alberts, JL				Gorniak, Stacey L.; McIntyre, Cameron C.; Alberts, Jay L.			Bimanual Force Coordination in Parkinson's Disease Patients with Bilateral Subthalamic Deep Brain Stimulation	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; NUCLEUS STIMULATION; GLOBUS-PALLIDUS; MANIPULATIVE FORCES; TASK-PERFORMANCE; OBJECT RELEASE; PRECISION GRIP; ABNORMALITIES; ORGANIZATION; MOVEMENTS	Objective: Studies of bimanual actions similar to activities of daily living (ADLs) are currently lacking in evaluating fine motor control in Parkinson's disease patients implanted with bilateral subthalamic deep brain stimulators. We investigated basic time and force characteristics of a bimanual task that resembles performance of ADLs in a group of bilateral subthalamic deep brain stimulation (DBS) patients. Methods: Patients were evaluated in three different DBS parameter conditions off stimulation, on clinically derived stimulation parameters, and on settings derived from a patient-specific computational model. Model-based parameters were computed as a means to minimize spread of current to non-motor regions of the subthalamic nucleus via Cicerone Deep Brain Stimulation software. Patients were evaluated off parkinsonian medications in each stimulation condition. Results: The data indicate that DBS parameter state does not affect most aspects of fine motor control in ADL-like tasks; however, features such as increased grip force and grip symmetry varied with the stimulation state. In the absence of DBS parameters, patients exhibited significant grip force asymmetry. Overall UPDRS-III and UPDRS-III scores associated with hand function were lower while patients were experiencing clinically-derived or model-based parameters, as compared to the off-stimulation condition. Conclusion: While bilateral subthalamic DBS has been shown to alleviate gross motor dysfunction, our results indicate that DBS may not provide the same magnitude of benefit to fine motor coordination.	[Gorniak, Stacey L.] Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA; [Gorniak, Stacey L.] Univ Houston, Ctr Neuromotor & Biomech Res, Houston, TX USA; [Gorniak, Stacey L.] Univ Houston, Ctr Neuroengn & Cognit Sci, Houston, TX USA; [McIntyre, Cameron C.; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [McIntyre, Cameron C.; Alberts, Jay L.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [McIntyre, Cameron C.; Alberts, Jay L.] Louis Stokes Vet Affairs Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Gorniak, SL (corresponding author), Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA.	sgorniak@uh.edu	Ferreira, Maria Souza/J-5108-2015	Gorniak, Stacey/0000-0002-8192-850X	National Institutes of Health (NIH) [R01NS058706-01, R01NS059736]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058706, R01NS059736] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project is supported by National Institutes of Health (NIH) grant R01NS058706-01 and R01NS059736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JL, 2008, PARKINSONISM RELAT D, V14, P481, DOI 10.1016/j.parkreldis.2007.11.014; Alberts JL, 2008, BRAIN, V131, P3348, DOI 10.1093/brain/awn238; Alberts JL, 2004, MOTOR CONTROL, V8, P484, DOI 10.1123/mcj.8.4.484; Bastian AJ, 2003, MOVEMENT DISORD, V18, P1000, DOI 10.1002/mds.10493; Behari A, 2005, PARKINSONISM RELAT D, V11, P221, DOI 10.1016/j.parkreldis.2004.12.005; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; DELONG MR, 1985, J NEUROPHYSIOL, V53, P530, DOI 10.1152/jn.1985.53.2.530; Fellows SJ, 2006, PARKINSONISM RELAT D, V12, P149, DOI 10.1016/j.parkreldis.2005.12.001; Fellows SJ, 2004, MOVEMENT DISORD, V19, P560, DOI 10.1002/mds.10710; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Freund HJ, 2005, BRAIN, V128, P2222, DOI 10.1093/brain/awh634; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Gordon AM, 1998, EXP NEUROL, V153, P287, DOI 10.1006/exnr.1998.6880; Gordon AM, 1997, EXP NEUROL, V145, P477, DOI 10.1006/exnr.1997.6479; Gordon AM, 1997, NEUROSCI LETT, V232, P1, DOI 10.1016/S0304-3940(97)00556-9; Gorniak SL, 2013, EXP BRAIN RES, V229, P273, DOI 10.1007/s00221-013-3644-8; Gorniak SL, 2013, EXP BRAIN RES, V229, P261, DOI 10.1007/s00221-013-3608-z; Gorniak SL, 2013, EXP BRAIN RES, V225, P559, DOI 10.1007/s00221-012-3395-y; Ingvarsson PE, 1997, EXP NEUROL, V145, P489, DOI 10.1006/exnr.1997.6480; Kumar R, 1999, ACTA CRYSTALLOGR C, V55, P561, DOI 10.1107/S0108270198015121; LAZARUS JAC, 1992, MOVEMENT DISORD, V7, P159, DOI 10.1002/mds.870070211; Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959; Maks CB, 2009, J NEUROL NEUROSUR PS, V80, P659, DOI 10.1136/jnnp.2007.126219; Mclntyre CC, 2007, EXPERT REV MED DEVIC, V4, P615, DOI 10.1586/17434440.4.5.615; Mera T, 2011, J NEUROSCIENCE METHO; Miocinovic S, 2007, ACTA NEUROCHIR SUPPL, V97, P561; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; Nambu A, 1996, J NEUROSCI, V16, P2671; Nowak DA, 2005, EXP NEUROL, V193, P427, DOI 10.1016/j.expneurol.2005.01.003; Nowak DA, 2002, BEHAV NEUROSCI, V116, P837, DOI 10.1037//0735-7044.116.5.837; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Pradhan SD, 2010, J NEUROL PHYS THER, V34, P32, DOI 10.1097/NPT.0b013e3181d055a6; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Rodriguez-Oroz MC, 2001, BRAIN, V124, P1777, DOI 10.1093/brain/124.9.1777; Romanelli P, 2005, BRAIN RES REV, V48, P112, DOI 10.1016/j.brainresrev.2004.09.008; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Sturman MM, 2010, EXP BRAIN RES, V205, P435, DOI 10.1007/s00221-010-2370-8; Vaillancourt DE, 2006, MOVEMENT DISORD, V21, P50, DOI 10.1002/mds.20672; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; Volkmann J, 2004, ANN NEUROL, V55, P871, DOI 10.1002/ana.20091; Vrancken AMPM, 2005, J NEUROL, V252, P1487, DOI 10.1007/s00415-005-0896-7; Wenzelburger R, 2003, MOVEMENT DISORD, V18, P1162, DOI 10.1002/mds.10501; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P521, DOI 10.1152/jn.1994.72.2.521; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P494, DOI 10.1152/jn.1994.72.2.494	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78934	10.1371/journal.pone.0078934	http://dx.doi.org/10.1371/journal.pone.0078934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244388	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600082
J	Grodeland, G; Mjaaland, S; Tunheim, G; Fredriksen, AB; Bogen, B				Grodeland, Gunnveig; Mjaaland, Siri; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne			The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype	PLOS ONE			English	Article							STIMULATORY FACTOR-I; ANTIGEN-PRESENTING CELLS; CYTOTOXIC T-LYMPHOCYTES; TUMOR-ANTIGEN; DNA VACCINES; B-CELLS; SKIN ELECTROPORATION; VIRUS CHALLENGE; CD4(+); ANTIBODY	Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent. We have here tested fusion DNA vaccines which encode proteins that bivalently target influenza hemagglutinins (HA) to different surface molecules on antigen presenting cells (APC). We demonstrate that targeting to MHC class II molecules predominantly induced an antibody/Th2 response, whereas targeting to CCR1/3/5 predominantly induced a CD8+/Th1 T cell response. With respect to antibodies, the polarizing effect was even more pronounced upon intramuscular (i.m) delivery as compared to intradermal (i.d.) vaccination. Despite these differences in induced immune responses, both vaccines protected against a viral challenge with influenza H1N1. Substitution of HA with ovalbumin (OVA) demonstrated that polarization of immune responses, as a consequence of APC targeting specificity, could be extended to other antigens. Taken together, the results demonstrate that vaccination can be tailor-made to induce a particular phenotype of adaptive immune responses by specifically targeting different surface molecules on APCs.	[Grodeland, Gunnveig; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Inst Immunol, Oslo, Norway; [Grodeland, Gunnveig; Tunheim, Gro; Fredriksen, Agnete B.; Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Grodeland, Gunnveig; Mjaaland, Siri; Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, CIR, Oslo, Norway; [Mjaaland, Siri] Norwegian Inst Publ Hlth, Dept Bacteriol & Infect Immunol, Div Infect Dis Control, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Grodeland, G (corresponding author), Univ Oslo, Inst Immunol, Oslo, Norway.	gunnveig.grodeland@medisin.uio.no; bjarne.bogen@medisin.uio.no		Grodeland, Gunnveig/0000-0001-6285-3162; Mjaaland, Siri/0000-0002-3870-5861	GLOBVAC (The Research Council of Norway); Helse Sor-Ost (Regional Health Authority), Norway	GLOBVAC (The Research Council of Norway); Helse Sor-Ost (Regional Health Authority), Norway	This study was funded by GLOBVAC (The Research Council of Norway) and Helse Sor-Ost (Regional Health Authority), Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Andreasson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011580; APOSTOLOPOULOS V, 1995, P NATL ACAD SCI USA, V92, P10128, DOI 10.1073/pnas.92.22.10128; BAIER G, 1995, J VIROL, V69, P2357, DOI 10.1128/JVI.69.4.2357-2365.1995; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; CASTEN LA, 1988, J IMMUNOL, V140, P404; Chow YH, 1998, J IMMUNOL, V160, P1320; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Conway MA, 2001, VACCINE, V19, P1940, DOI 10.1016/S0264-410X(00)00433-3; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; Glimcher LH, 2000, GENE DEV, V14, P1693; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; GRUN JL, 1989, CELL IMMUNOL, V121, P134, DOI 10.1016/0008-8749(89)90011-7; HACKETT CJ, 1983, J EXP MED, V158, P294, DOI 10.1084/jem.158.2.294; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; KAWAMURA H, 1986, J IMMUNOL, V136, P58; LEES A, 1990, J IMMUNOL, V145, P3594; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; PRAT M, 1984, P NATL ACAD SCI-BIOL, V81, P4515, DOI 10.1073/pnas.81.14.4515; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; RABIN EM, 1985, P NATL ACAD SCI USA, V82, P2935, DOI 10.1073/pnas.82.9.2935; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Ruffini PA, 2010, VACCINE, V29, P191, DOI 10.1016/j.vaccine.2010.10.057; Schiavo R, 2006, BLOOD, V107, P4597, DOI 10.1182/blood-2005-08-3207; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SNIDER DP, 1987, J IMMUNOL, V139, P1609; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; Tamura M, 1998, J VIROL, V72, P9404, DOI 10.1128/JVI.72.11.9404-9406.1998; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244	55	30	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80008	10.1371/journal.pone.0080008	http://dx.doi.org/10.1371/journal.pone.0080008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244595	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600172
J	Henry, I; Antoniazza, S; Dubey, S; Simon, C; Waldvogel, C; Burri, R; Roulin, A				Henry, Isabelle; Antoniazza, Sylvain; Dubey, Sylvain; Simon, Celine; Waldvogel, Celine; Burri, Reto; Roulin, Alexandre			Multiple Paternity in Polyandrous Barn Owls (Tyto alba)	PLOS ONE			English	Article							FEMALE BROOD DESERTION; EXTRA-PAIR PATERNITY; PARENTAL INVESTMENT; OFFSPRING DESERTION; SEXUAL SELECTION; CARE; CONFLICT; BIRDS; INCREASES	In polyandrous species females produce successive clutches with several males. Female barn owls (Tyto alba) often desert their offspring and mate to produce a 2nd annual brood with a second male. We tested whether copulating during chick rearing at the 1st annual brood increases the male's likelihood to obtain paternity at the 2nd annual breeding attempt of his female mate in case she deserts their brood to produce a second brood with a different male. Using molecular paternity analyses we found that 2 out of 26 (8%) second annual broods of deserting females contained in total 6 extra-pair young out of 15 nestlings. These young were all sired by the male with whom the female had produced the 1st annual brood. In contrast, none of the 49 1st annual breeding attempts (219 offspring) and of the 20 2nd annual breeding attempts (93 offspring) of non-deserting females contained extra-pair young. We suggest that female desertion can select male counter-strategies to increase paternity and hence individual fitness. Alternatively, females may copulate with the 1st male to derive genetic benefits, since he is usually of higher quality than the 2nd male which is commonly a yearling individual.	[Henry, Isabelle; Antoniazza, Sylvain; Dubey, Sylvain; Simon, Celine; Waldvogel, Celine; Burri, Reto; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Roulin, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, Lausanne, Switzerland.	alexandre.roulin@unil.ch	Dubey, Sylvain/B-3662-2013		SNSF (Swiss Science National Science Foundation) [31003A_120517]	SNSF (Swiss Science National Science Foundation)	31003A_120517 SNSF (Swiss Science National Science Foundation; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler P., 1980, Journal fuer Ornithologie, V121, P36, DOI 10.1007/BF01643255; Bunn D. S., 1982, THE BARN OWL; Burri R, 2008, MOL ECOL RESOUR, V8, P977, DOI 10.1111/j.1755-0998.2008.02121.x; Chen TC, 2008, J NAT HIST, V42, P2991, DOI 10.1080/00222930802389817; Dale J, 1999, BEHAV ECOL SOCIOBIOL, V46, P50, DOI 10.1007/s002650050591; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; Epple W., 1985, Oekologie der Voegel, V7, P1; Frey C, 2011, J ORNITHOL, V152, P279, DOI 10.1007/s10336-010-0579-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griggio M, 2005, BEHAV ECOL, V16, P435, DOI 10.1093/beheco/ari009; Haig SM, 2003, J HERED, V94, P302, DOI 10.1093/jhered/esg072; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Korpimaki E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1093, DOI 10.1007/s00265-010-1118-6; Krakauer AH, 2008, CONDOR, V110, P1, DOI 10.1525/cond.2008.110.1.1; Lack D., 1968, pvii; Lessells CM, 2012, P ROY SOC B-BIOL SCI, V279, P1506, DOI 10.1098/rspb.2011.1690; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Muller Y, 1991, RAPACES NOCTURNES, P173; Olson VA, 2008, P ROY SOC B-BIOL SCI, V275, P301, DOI 10.1098/rspb.2007.1395; OWENS IPF, 1995, BEHAV ECOL, V6, P14, DOI 10.1093/beheco/6.1.14; Owens IPF, 2002, P ROY SOC LOND B BIO, V275, P301; Pilastro A, 2001, J AVIAN BIOL, V32, P68, DOI 10.1034/j.1600-048X.2001.320109.x; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roulin A, 2004, J AVIAN BIOL, V35, P492, DOI 10.1111/j.0908-8857.2004.03294.x; Roulin A, 2002, AUK, V119, P515, DOI 10.1642/0004-8038(2002)119[0515:ODBDBF]2.0.CO;2; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Trotschel P., 1973, Vogelwelt, V94, P64; VALLE CA, 1994, AUK, V111, P476, DOI 10.2307/4088613; Webb JN, 2002, PHILOS T R SOC B, V357, P331, DOI 10.1098/rstb.2001.0934	35	15	15	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80112	10.1371/journal.pone.0080112	http://dx.doi.org/10.1371/journal.pone.0080112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244622	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600181
J	Kammer, TW; Sumrall, CD; Zamora, S; Ausich, WI; Deline, B				Kammer, Thomas W.; Sumrall, Colin D.; Zamora, Samuel; Ausich, William I.; Deline, Bradley			Oral Region Homologies in Paleozoic Crinoids and Other Plesiomorphic Pentaradial Echinoderms	PLOS ONE			English	Article							CAMBRIAN KAILI BIOTA; PHYLOGENETIC IMPLICATIONS; GUIZHOU PROVINCE; PELMATOZOAN ARMS; BURGESS SHALE; ORDOVICIAN; EOCRINOIDS; EVOLUTION; ORIGIN; EDRIOASTEROIDEA	The phylogenetic relationships between major groups of plesiomorphic pentaradial echinoderms, the Paleozoic crinoids, blastozoans, and edrioasteroids, are poorly understood because of a lack of widely recognized homologies. Here, we present newly recognized oral region homologies, based on the Universal Elemental Homology model for skeletal plates, in a wide range of fossil taxa. The oral region of echinoderms is mainly composed of the axial, or ambulacral, skeleton, which apparently evolved more slowly than the extraxial skeleton that forms the majority of the body. Recent phylogenetic hypotheses have focused on characters of the extraxial skeleton, which may have evolved too rapidly to preserve obvious homologies across all these groups. The axial skeleton conserved homologous suites of characters shared between various edrioasteroids and specific blastozoans, and between other blastozoans and crinoids. Although individual plates can be inferred as homologous, no directly overlapping suites of characters are shared between edrioasteroids and crinoids. Six different systems of mouth (peristome) plate organization (Peristomial Border Systems) are defined. These include four different systems based on the arrangement of the interradially-positioned oral plates and their peristomial cover plates, where PBS A1 occurs only in plesiomorphic edrioasteroids, PBS A2 occurs in plesiomorphic edrioasteroids and blastozoans, and PBS A3 and PBS A4 occur in blastozoans and crinoids. The other two systems have radially-positioned uniserial oral frame plates in construction of the mouth frame. PBS B1 has both orals and uniserial oral frame plates and occurs in edrioasterid and possibly edrioblastoid edrioasteroids, whereas PBS B2 has exclusively uniserial oral frame plates and is found in isorophid edrioasteroids and imbricate and gogiid blastozoans. These different types of mouth frame construction offer potential synapomorphies to aid in parsimony-based phylogenetics for exploring branching order among stem groups on the echinoderm tree of life.	[Kammer, Thomas W.] W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA; [Sumrall, Colin D.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Zamora, Samuel] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Ausich, William I.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Deline, Bradley] Univ West Georgia, Dept Geosci, Carrollton, GA USA	West Virginia University; University of Tennessee System; University of Tennessee Knoxville; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; Ohio State University; University System of Georgia; University of West Georgia	Kammer, TW (corresponding author), W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA.	tkammer@wvu.edu	Zamora, Samuel/ABC-9333-2021	Zamora, Samuel/0000-0002-3917-4628	National Science Foundation [1036356, 1036260, 1036416]; Smithsonian Institution; Direct For Biological Sciences [1036356] Funding Source: National Science Foundation; Division Of Environmental Biology [1322141] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This publication has been supported by the National Science Foundation (www.nsf.gov) collaborative project Assembling the Echinoderm Tree of Life by grants 1036356 (West Virginia University), 1036260 (University of Tennessee), 1036416 (The Ohio State University), and Research Award Opportunity Supplements to National Science Foundation grants 1036416 and 1036356 (University of West Georgia). SZ was supported by the Springer Fund of the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausich WI, 1998, J PALEONTOL, V72, P499, DOI 10.1017/S0022336000024276; Ausich WI, 2000, LETHAIA, V33, P92; Ausich WI, 1998, PALAEONTOLOGY, V41, P193; Ausich William I., 1998, University of Kansas Paleontological Contributions New Series, V9, P1; BASSLER RAY S., 1950, JOUR WASHINGTON ACAD SCI, V40, P273; Bather F. A., 1899, Report British Association, V1898, P916; Bather FA, 1914, GEOLOGICAL MAGAZINE, V2, P259; Bather FA, 1914, GEOLOGICAL MAGAZINE, V2, P211; Beaver H.H., 1967, ECHINODERMATA, V2, p[S297, 1]; Bell B.M, 1976, STUDY N AM EDRIOASTE; BELL BM, 1978, J PALEONTOL, V52, P243; BELL BM, 1976, J PALEONTOL, V50, P1001; BOCKELIE JF, 1984, PALAEONTOLOGY, V27, P1; BRANSON E. B., 1940, JOUR PALEONTOL, V14, P89; BRETT CE, 1983, J PALEONTOL, V57, P627; Brochu Christopher A., 2008, Paleontological Society Papers, V14, P185; Carpenter P. H., 1884, ZOOLOGY, V11, P1; Clausen S, 2008, J PALEONTOL, V82, P737, DOI 10.1666/06-067.1; Clausen S, 2009, LETHAIA, V42, P283, DOI 10.1111/j.1502-3931.2008.00145.x; Conrad T.A., 1842, J ACAD NATURAL SCI P, V8, P183; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Donovan S.K., 1989, Palaeontographical Society Monographs (London), V142, P69; Donovan S.K, 1986, MONOGRAPH PALAEONTOG, V138, P1; ECKERT JD, 1987, CAN J EARTH SCI, V24, P860, DOI 10.1139/e87-085; Foerste A.F., 1938, GEOL SOC AM BULL, V49, P212; GOLDRING W, 1923, NEW YORK STATE MUSEU, V16; Guensburg T. E., 1994, FIELDIANA GEOLOGY, V29; Guensburg TE, 2001, GEOLOGY, V29, P131, DOI 10.1130/0091-7613(2001)029<0131:ECNEFT>2.0.CO;2; Guensburg TE, 2013, GEOLOGICAL SOC AM AB, V45, P10; Guensburg TE, 2007, ANN PALEONTOL, V93, P277, DOI 10.1016/j.annpal.2007.09.005; Guensburg Thomas E., 2003, Bulletins of American Paleontology, V364, P1; Guensburg TE, 2012, J PALEONTOL, V86, P455, DOI 10.1666/11-097.1; Guensburg TE, 2010, LETHAIA, V43, P432, DOI 10.1111/j.1502-3931.2010.00220.x; Guensburg TE, 2009, J PALEONTOL, V83, P350, DOI 10.1666/08-090.1; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Kesling R.V., 1968, TREATISE INVERTE BRA, V1, pS85; KESLING ROBERT V., 1960, CONTR MUS PALAEONTOL UNIV MICHIGAN, V15, P139; LANE NG, 1982, J PALEONTOL, V56, P244; LANE NG, 1982, J PALEONTOL, V56, P103; Lane NG, 1978, GEOLOGICAL SOC AM U, V2, pT301; Meek F.B., 1871, AM J SCI 3, V2, P295; Mooi R, 1998, AM ZOOL, V38, P965; Mooi R, 2008, ANNU REV ECOL EVOL S, V39, P43, DOI 10.1146/annurev.ecolsys.39.110707.173521; Moore RC, 1978, ECHINODERMATA, V2, P1; Owen D. D., 1850, J ACAD NATURAL SCI P, V2, P89; Parsley R.L., 1982, University of Kansas Paleontological Contributions Monograph, V1, P280; Parsley RL, 2006, J PALEONTOL, V80, P1058, DOI 10.1666/0022-3360(2006)80[1058:LSEITB]2.0.CO;2; PATTERSON C, 1988, MOL BIOL EVOL, V5, P603; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Regnault S, 2007, ANN PALEONTOL, V93, P215, DOI 10.1016/j.annpal.2007.06.005; Rozhnov S.V., 2002, PALEONTOL J+, V36, pS525; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; SINCLAIR GW, 1945, AM MIDL NAT, V34, P707, DOI 10.2307/2421094; SMITH A B, 1990, Memoirs of the Queensland Museum, V28, P715; SMITH AB, 1984, PALAEONTOLOGY, V27, P431; Smith AB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1197; Springer F, 1920, SMITHSONIAN I PUBLIC, V2501, P1; SPRINKLE J, 1976, SYST ZOOL, V25, P83, DOI 10.2307/2412783; SPRINKLE J, 1975, J PALEONTOL, V49, P1062; SPRINKLE J, 1982, U KANSAS PALEONTOLOG, V1, P1; Sprinkle J, 2012, GEOLOGICAL SOC AM AB, V7, P136; SPRINKLE J, 1973, SPECIAL PUBLICATION, P1; Sprinkle J, 2006, CAN J EARTH SCI, V43, P303, DOI 10.1139/E05-107; Sprinkle James, 2011, Palaeontographica Canadiana, V31, P169; Sprinkle J, 2011, J PALEONTOL, V85, P250, DOI 10.1666/10-072.1; Sumrall CD, 2003, PALAEONTOLOGY, V46, P113, DOI 10.1111/1475-4983.00290; SUMRALL CD, 1993, LETHAIA, V26, P289, DOI 10.1111/j.1502-3931.1993.tb01534.x; Sumrall CD, 2012, ACTA PALAEONTOLOGICA, DOI [10.4202/app.2011.0120, DOI 10.4202/APP.2011.0120]; Sumrall CD, 2007, PALEOBIOLOGY, V33, P149, DOI 10.1666/06053.1; Sumrall Colin D., 1999, P409; Sumrall CD, 2012, J PALEONTOL, V86, P956, DOI 10.1666/12-029R.1; Sumrall CD, 2011, J SYST PALAEONTOL, V9, P425, DOI 10.1080/14772019.2010.499137; Sumrall Colin D., 1997, Paleontological Society Papers, V3, P267; Sumrall CD, 2010, ECHINODERMS: DURHAM, P269; Sumrall Colin D., 2008, P229; Ubaghs G., 1978, pT58; Ubaghs G., 1963, NOTES MEMOIRES SERVI, V172, P25; Ubaghs G., 1967, TREATISE INVERTEBRAT, V1, pU4; Ubaghs G, 1969, 38 U KANS PAL CONTR; Ubaghs G, 1967, TREATISE INVERTEBRAT, VS, pS455; Wachsmuth C., 1897, HARVARD COLL MUSEUM, V20; Wanner J., 1916, PERMISCHEN ECHINODER, V11, P1; Whiteaves J. F., 1897, Canad Rec, Vvii, P287; Whiteaves J. F., 1887, CONTRIBUTIONS CANADI, V1, P91; WOOD E, 1909, US NATL MUSEUM B, V64; Zamora S., 2011, P ROYAL SOC B, V279, P293; Zamora S, 2013, ACTA PALAEONTOL POL, V58, P545, DOI 10.4202/app.2011.0152; Zamora S, 2013, PALAEONTOLOGY, V56, P421, DOI 10.1111/j.1475-4983.2012.01209.x; Zhao Y, 1994, ACTA PALAEONTOLOGI S, V38, P1; Zhao YL, 2010, J PALEONTOL, V84, P668, DOI 10.1666/09-159.1	91	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77989	10.1371/journal.pone.0077989	http://dx.doi.org/10.1371/journal.pone.0077989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244284	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600012
J	Shi, DY; Zheng, X; Li, L; Lin, WH; Xie, WJ; Yang, JP; Chen, SJ; Jin, WW				Shi, Dianyi; Zheng, Xu; Li, Liang; Lin, Wanhuang; Xie, Wenjun; Yang, Jianping; Chen, Shaojiang; Jin, Weiwei			Chlorophyll Deficiency in the Maize elongated mesocotyl2 Mutant Is Caused by a Defective Heme Oxygenase and Delaying Grana Stacking	PLOS ONE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; UP-REGULATION; YELLOW-GREEN-2 MUTANTS; POPULATION-SIZE; SOYBEAN PLANTS; ARABIDOPSIS; GENE; EXPRESSION; LIGHT; FAMILY	Background: Etiolated seedlings initiate grana stacking and chlorophyll biosynthesis in parallel with the first exposure to light, during which phytochromes play an important role. Functional phytochromes are biosynthesized separately for two components. One phytochrome is biosynthesized for apoprotein and the other is biosynthesized for the chromophore that includes heme oxygenase (HO). Methodology/Principal Finding: We isolated a ho1 homolog by map-based cloning of a maize elongated mesocotyl2 (elm2) mutant. cDNA sequencing of the ho1 homolog in elm2 revealed a 31 bp deletion. De-etiolation responses to red and far-red light were disrupted in elm2 seedlings, with a pronounced elongation of the mesocotyl. The endogenous HO activity in the elm2 mutant decreased remarkably. Transgenic complementation further confirmed the dysfunction in the maize ho1 gene. Moreover, non-appressed thylakoids were specifically stacked at the seedling stage in the elm2 mutant. Conclusion: The 31 bp deletion in the ho1 gene resulted in a decrease in endogenous HO activity and disrupted the de-etiolation responses to red and far-red light. The specific stacking of non-appressed thylakoids suggested that the chlorophyll biosynthesis regulated by HO1 is achieved by coordinating the heme level with the regulation of grana stacking.	[Shi, Dianyi; Li, Liang; Xie, Wenjun; Chen, Shaojiang; Jin, Weiwei] China Agr Univ, Minist Agr, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Shi, Dianyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zheng, Xu; Yang, Jianping] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Lin, Wanhuang] Hunan Agr Univ, Hunan Prov Key Lab Phytohormones & Growth Dev, Changsha, Hunan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hunan Agricultural University	Shi, DY (corresponding author), China Agr Univ, Minist Agr, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	dyshi@sibs.ac.cn; weiweijin@cau.edu.cn	Xie, Wenjun/F-7895-2015	Xie, Wenjun/0000-0001-8101-5519	National Science Foundation of China [31025018]; Ministry of Science and Technology [2012AA10A305]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Foundation of China (31025018) and the Ministry of Science and Technology (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; Balestrasse KB, 2008, BIOMETALS, V21, P433, DOI 10.1007/s10534-008-9132-0; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Cao ZY, 2011, J EXP BOT, V62, P4675, DOI 10.1093/jxb/err190; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CHRISTENSEN AH, 1989, GENE, V85, P381, DOI 10.1016/0378-1119(89)90431-9; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; Frick G, 2003, PLANT J, V35, P141, DOI 10.1046/j.1365-313X.2003.01798.x; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Han B, 2012, PLANT SCI, V184, P63, DOI 10.1016/j.plantsci.2011.12.012; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KOORNNEEF M, 1985, J PLANT PHYSIOL, V120, P153, DOI 10.1016/S0176-1617(85)80019-5; KRAEPIEL Y, 1994, MOL GEN GENET, V242, P559, DOI 10.1007/BF00285279; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; McCormac AC, 2002, PLANT J, V32, P549, DOI 10.1046/j.1365-313X.2002.01443.x; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Reinbothe S, 1996, PLANT PHYSIOL, V111, P1, DOI 10.1104/pp.111.1.1; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terry MJ, 1996, J BIOL CHEM, V271, P21681, DOI 10.1074/jbc.271.35.21681; TERRY MJ, 1995, J BIOL CHEM, V270, P11111, DOI 10.1074/jbc.270.19.11111; Terry MJ, 1997, PLANT CELL ENVIRON, V20, P740, DOI 10.1046/j.1365-3040.1997.d01-102.x; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Weller JL, 1997, PLANT J, V11, P1177, DOI 10.1046/j.1365-313X.1997.11061177.x; Weller JL, 1996, PLANT CELL, V8, P55; Wu MZ, 2011, J EXP BOT, V62, P235, DOI 10.1093/jxb/erq261; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Xuan W, 2008, PLANT PHYSIOL, V148, P881, DOI 10.1104/pp.108.125567; Yannarelli GG, 2006, PLANTA, V224, P1154, DOI 10.1007/s00425-006-0297-x; YOKOO M, 1993, JPN J BREED, V43, P1	63	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80107	10.1371/journal.pone.0080107	http://dx.doi.org/10.1371/journal.pone.0080107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244620	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600180
J	Poojari, C; Strodel, B				Poojari, Chetan; Strodel, Birgit			Stability of Transmembrane Amyloid beta-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific A beta 42 Mutations	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PARTICLE MESH EWALD; FORMS ION CHANNELS; DYNAMICS SIMULATIONS; PROTEIN FIBRILLOGENESIS; CONFORMATIONAL-CHANGES; CEREBRAL-HEMORRHAGE; LIPID-MEMBRANES; FORCE-FIELD; OLIGOMERS	Interactions of the amyloid beta-protein (A beta) with neuronal cell membranes, leading to the disruption of membrane integrity, are considered to play a key role in the development of Alzheimer's disease. Natural mutations in A beta(42), such as the Arctic mutation (E22G) have been shown to increase A beta(42) aggregation and neurotoxicity, leading to the early-onset of Alzheimer's disease. A correlation between the propensity of A beta(42) to form protofibrils and its effect on neuronal dysfunction and degeneration has been established. Using rational mutagenesis of the A beta(42) peptide it was further revealed that the aggregation of different A beta(42) mutants in lipid membranes results in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also have a variable ability to disrupt bilayer integrity. To further test the connection between A beta(42) mutation and peptide-membrane interactions, we perform molecular dynamics simulations of membrane-inserted A beta(42) variants (wild-type and E22G, D23G, E22G/D23G, K16M/K28M and K16M/E22G/D23G/K28M mutants) as beta-sheet monomers and tetramers. The effects of charged residues on transmembrane A beta(42) stability and membrane integrity are analyzed at atomistic level. We observe an increased stability for the E22G A beta(42) peptide and a decreased stability for D23G compared to wild-type A beta(42), while D23G has the largest membrane-disruptive effect. These results support the experimental observation that the altered toxicity arising from mutations in A beta is not only a result of the altered aggregation propensity, but also originates from modified A beta interactions with neuronal membranes.	[Poojari, Chetan; Strodel, Birgit] Forschungszentrum Julich, Inst Complex Syst Struct Biochem, D-52425 Julich, Germany; [Strodel, Birgit] Univ Dusseldorf, Inst Theoret & Computat Chem, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Strodel, B (corresponding author), Forschungszentrum Julich, Inst Complex Syst Struct Biochem, D-52425 Julich, Germany.	b.strodel@fz-juelich.de	Strodel, Birgit/H-5449-2013	Strodel, Birgit/0000-0002-8734-7765; Poojari, Chetan/0000-0001-6575-221X	Julich Supercomputing Centre [JICS62]; Research Centre Julich	Julich Supercomputing Centre; Research Centre Julich	Sources of funding: Research Centre Julich (http://www.fz-juelich.de), Computing time grant JICS62 from the Julich Supercomputing Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Arce FT, 2011, SOFT MATTER, V7, P5267, DOI 10.1039/c1sm05162h; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Broeckhoven Christine V., 1990, SCIENCE, V248, P1120; Buchsteiner A, 2010, BBA-BIOMEMBRANES, V1798, P1969, DOI 10.1016/j.bbamem.2010.06.024; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Clements A, 1996, J NEUROCHEM, V66, P740; Cordomi A, 2007, J PHYS CHEM B, V111, P7052, DOI 10.1021/jp0707788; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis CH, 2010, PROTEINS, V78, P2533, DOI 10.1002/prot.22763; Davis CH, 2009, J PHYS CHEM B, V113, P14480, DOI 10.1021/jp905889z; Davis CH, 2009, BIOPHYS J, V96, P785, DOI 10.1016/j.bpj.2008.09.053; de Planque MRR, 2007, J MOL BIOL, V368, P982, DOI 10.1016/j.jmb.2007.02.063; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friedman R, 2011, BIOCHEM J, V438, P415, DOI 10.1042/BJ20110369; Friedman R, 2010, J PHYS CHEM LETT, V1, P471, DOI 10.1021/jz900318t; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto M., 2004, SOC NEUR ABSTR, V218, P214; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krone MG, 2008, J MOL BIOL, V381, P221, DOI 10.1016/j.jmb.2008.05.069; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lau TL, 2006, J MOL BIOL, V356, P759, DOI 10.1016/j.jmb.2005.11.091; LEE JP, 1995, BIOCHEMISTRY-US, V34, P5191, DOI 10.1021/bi00015a033; Lemkul JA, 2008, ARCH BIOCHEM BIOPHYS, V470, P54, DOI 10.1016/j.abb.2007.11.004; Lemkul JA, 2013, BIOCHEMISTRY-US, V52, P4971, DOI 10.1021/bi400562x; Lemkul JA, 2011, PROTEIN SCI, V20, P1530, DOI 10.1002/pro.678; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pifer PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016248; Poojari C, 2013, BBA-BIOMEMBRANES, V1828, P327, DOI 10.1016/j.bbamem.2012.09.001; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Sepulveda FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011820; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Straub JE, 2002, ACCOUNTS CHEM RES, V35, P473, DOI 10.1021/ar010031e; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Wales D. J., 2020, CAMBRIDGE CLUSTER DA; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Xiao DQ, 2012, J MOL BIOL, V421, P537, DOI 10.1016/j.jmb.2011.12.035; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhao J, 2011, LANGMUIR, V27, P14876, DOI 10.1021/la2027913; Zhao LN, 2011, J PHYS CHEM B, V115, P12247, DOI 10.1021/jp2065985	105	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78399	10.1371/journal.pone.0078399	http://dx.doi.org/10.1371/journal.pone.0078399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244308	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900014
J	Ridge, PG; Mukherjee, S; Crane, PK; Kauwe, JSK				Ridge, Perry G.; Mukherjee, Shubhabrata; Crane, Paul K.; Kauwe, John S. K.		Alzheimers Dis Genetics Consortium	Alzheimer's Disease: Analyzing the Missing Heritability	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ARCHITECTURE; COMMON VARIANTS; IDENTIFIES VARIANTS; RISK-FACTORS; DEMENTIA; CLU; TRAITS; ALLELE; PICALM	Alzheimer's disease (AD) is a complex disorder influenced by environmental and genetic factors. Recent work has identified 11 AD markers in 10 loci. We used Genome-wide Complex Trait Analysis to analyze >2 million SNPs for 10,922 individuals from the Alzheimer's Disease Genetics Consortium to assess the phenotypic variance explained first by known late-onset AD loci, and then by all SNPs in the Alzheimer's Disease Genetics Consortium dataset. In all, 33% of total phenotypic variance is explained by all common SNPs. APOE alone explained 6% and other known markers 2%, meaning more than 25% of phenotypic variance remains unexplained by known markers, but is tagged by common SNPs included on genotyping arrays or imputed with HapMap genotypes. Novel AD markers that explain large amounts of phenotypic variance are likely to be rare and unidentifiable using genome-wide association studies. Based on our findings and the current direction of human genetics research, we suggest specific study designs for future studies to identify the remaining heritability of Alzheimer's disease.	[Ridge, Perry G.; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Ridge, Perry G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Mukherjee, Shubhabrata; Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA	Brigham Young University; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Washington; University of Washington Seattle	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	kauwe@byu.edu	Mukherjee, Shubhabrata/AAS-6609-2020; Tsuang, Debby/L-7234-2016; Kauwe, John/AAC-6646-2021; Hardy, John/C-2451-2009; Sonnen, Joshua/H-3738-2016	Mukherjee, Shubhabrata/0000-0003-2522-2884; Tsuang, Debby/0000-0002-4716-1894; Kauwe, John/0000-0001-8641-2468; Hardy, John/0000-0002-3122-0423; DeKosky, Steven/0000-0003-3743-2758; Sonnen, Joshua/0000-0001-9267-8705; Jun, Gyungah/0000-0002-3230-8697; Leverenz, James/0000-0002-0896-0749; Buxbaum, Joseph/0000-0001-8898-8313; Crane, Paul/0000-0003-4278-7465	National Institutes of Health [R01AG042611]; Alzheimer's Association [MNIRG-11-205368]; Charleston Conference on Alzheimer's disease; Brigham Young University Gerontology Program; NIA; NIH; National Institutes of Health, National Institute on Aging (NIH-NIA) [U01 AG032984, RC2 AG036528, U01 AG016976, U24 AG021886, U24 AG026395, U24 AG026390, P30 AG019610, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01 AG025259, R01AG33193, P50 AG008702, R37 AG015473, P30 AG028377, AG05128, AG025688]; NINDS grant [NS39764, NIMH MH60451]; Glaxo Smith Kline; NIA [AG034504, U01 AG024904, RC2 AG036535, K01 AG030514]; Medical Research Council; Higher Education Funding Council for England (HEFCE); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; Northern California Institute for Research and Education; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; GlaxoSmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co.; Medpace, Inc.; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association (LAF) [IIRG-08-89720]; Alzheimer's Association (MP-V) [IIRG-05-14147]; US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health Research; NIH-NIA [UO1 AG06781, UO1 HG004610, P30 AG10133, P50 AG005146, R01 AG020688, P50 AG005134, P50 AG016574, P50 AG005138, P01 AG002219, P30 AG08051, MO1RR00096, UL1RR02777, R01 AG031581, P30 AG010129, P50 AG016573, P50 AG016575, P50 AG016576, P50 AG016577, P50 AG016570]; NIH-N.I.A [UL1 RR029893, 5R01AG012101, 5R01AG022374, 5R01AG013616, 1RC2AG036502, 1R01AG035137, P30 AG013854, P30 AG008017, R01 AG026916, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146, R01 NS059873, P50 AG016582]; N.I.H-N.I.A [P50 AG005131, P50 AG023501, P01 AG019724, P30 AG028383, AG05144, P50 AG008671, P30 AG010124, P50 AG005133, AG030653, P50 AG005142, P30 AG012300, R01 AG027944, AG010491, AG027944, AG021547, AG019757, P50 AG005136, P50 AG005681, P01 AG03991]; NATIONAL CANCER INSTITUTE [R01CA129769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096, UL1RR029893, M01RR000645] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080295, P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080820, P50NS039764, R01NS059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017173, RC2AG036528, U01AG024904, P30AG019610, P50AG005144, RC2AG036502, U01AG006781, P50AG008671, P50AG005133, P30AG012300, P50AG005138, P30AG010129, P30AG008051, P50AG016573, P30AG028383, P50AG016582, R01AG017917, P30AG028377, P01AG019724, P01AG003991, P01AG002219, U24AG026395, R01AG019085, R01AG025259, P30AG010161, R01AG034504, R01AG019757, P50AG016574, P30AG013854, R01AG020688, R37AG015473, P50AG005131, R01AG040770, P50AG023501, P50AG005681, P50AG005134, P01AG010491, R01AG022374, R01AG026390, P30AG010124, K01AG030514, P30AG010133, U01AG010483, R01AG042611, R01AG033193, R01AG027944, R01AG026916, P30AG008017, R01AG012101, U01AG032984, R01AG030146, P30AG013846, R01AG021547, U24AG021886, R01AG015819, R01AG013616, RC2AG036535, P50AG005146, R01AG041797, P50AG005142, U01AG016976, R01AG030653, P50AG016570, P50AG025688, P50AG008702, R01AG031581, P50AG005136, R01AG035137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Charleston Conference on Alzheimer's disease; Brigham Young University Gerontology Program; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute on Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS grant; Glaxo Smith Kline(GlaxoSmithKline); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; Northern California Institute for Research and Education; Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); GlaxoSmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co.(Eli Lilly); Medpace, Inc.; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Association (LAF)(Alzheimer's Association); Alzheimer's Association (MP-V)(Alzheimer's Association); US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-N.I.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); N.I.H-N.I.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this project was provided by the National Institutes of Health (R01AG042611), the Alzheimer's Association (MNIRG-11-205368) the Charleston Conference on Alzheimer's disease and the Brigham Young University Gerontology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Contributors to the genetic analysis data included Principal Investigators on projects that were individually funded by NIA, other NIH institutes, or private entities. The National Institutes of Health, National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; NACC, U01 AG016976; NCRAD, U24 AG021886; NIA LOAD, U24 AG026395, U24 AG026390; Banner Sun Health Research Institute P30 AG019610; Boston University, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01 AG025259, R01AG33193; Columbia University, P50 AG008702, R37 AG015473; Duke University, P30 AG028377, AG05128; Emory University, AG025688; Group Health Research Institute, UO1 AG06781, UO1 HG004610; Indiana University, P30 AG10133; Johns Hopkins University, P50 AG005146, R01 AG020688; Massachusetts General Hospital, P50 AG005134; Mayo Clinic, P50 AG016574; Mount Sinai School of Medicine, P50 AG005138, P01 AG002219; New York University, P30 AG08051, MO1RR00096, UL1 RR029893, 5R01AG012101, 5R01AG022374, 5R01AG013616, 1RC2AG036502, 1R01AG035137; Northwestern University, P30 AG013854; Oregon Health & Science University, P30 AG008017, R01 AG026916; Rush University, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146; TGen, R01 NS059873; University of Alabama at Birmingham, P50 AG016582, UL1RR02777; University of Arizona, R01 AG031581; University of California, Davis, P30 AG010129; University of California, Irvine, P50 AG016573, P50, P50 AG016575, P50 AG016576, P50 AG016577; University of California, Los Angeles, P50 AG016570; University of California, San Diego, P50 AG005131; University of California, San Francisco, P50 AG023501, P01 AG019724; University of Kentucky, P30 AG028383, AG05144; University of Michigan, P50 AG008671; University of Pennsylvania, P30 AG010124; University of Pittsburgh, P50 AG005133, AG030653; University of Southern California, P50 AG005142; University of Texas Southwestern, P30 AG012300; University of Miami, R01 AG027944, AG010491, AG027944, AG021547, AG019757; University of Washington, P50 AG005136; Vanderbilt University, R01 AG019085; and Washington University, P50 AG005681, P01 AG03991. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant # NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. The TGen series was also funded by NIA grant AG034504 to AJM, The Banner Alzheimer's Foundation, The Johnnie B. Byrd Sr.; r Alzheimer's Institute, the Medical Research Council, and the state of Arizona and also includes samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University), MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council), South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer's Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN), The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. ADNI Funding for ADNI is through the Northern California Institute for Research and Education by grants from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., Alzheimer's Association, Alzheimer's Drug Discovery Foundation, the Dana Foundation, and by the National Institute of Biomedical Imaging and Bioengineering and NIA grants U01 AG024904, RC2 AG036535, K01 AG030514. The authors thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-officio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. P. S. G.-H. is supported by Wellcome Trust, Howard Hughes Medical Institute, and the Canadian Institute of Health Research.	Almeida OP, 2002, ADDICTION, V97, P15, DOI 10.1046/j.1360-0443.2002.00016.x; BALLARD C, 2011, LANCET, P90415; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Jenuth J P, 2000, Methods Mol Biol, V132, P301; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kilpinen H, 2013, TRENDS GENET, V29, P23, DOI 10.1016/j.tig.2012.10.001; Krebs Catharine E., 2012, Frontiers in Genetics, V3, P75, DOI 10.3389/fgene.2012.00075; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Patterson C, 2008, CAN MED ASSOC J, V178, P548, DOI 10.1503/cmaj.070796; Patterson C, 2007, ALZHEIMERS DEMENT, V3, P341, DOI 10.1016/j.jalz.2007.07.001; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Turton JC, 2011, J ALZHEIMERS DIS, V25, P635, DOI 10.3233/JAD-2011-110197; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; 2012, IZH ASS ANN REP ALZH, P90415	60	175	177	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79771	10.1371/journal.pone.0079771	http://dx.doi.org/10.1371/journal.pone.0079771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244562	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900054
J	Troynikov, V; Whitten, A; Gorfine, H; Putys, Z; Jakubaviciute, E; Lozys, L; Dainys, J				Troynikov, Vladimir; Whitten, Athol; Gorfine, Harry; Putys, Zilvinas; Jakubaviciute, Egle; Lozys, Linas; Dainys, Justas			Cormorant Catch Concerns for Fishers: Estimating the Size-Selectivity of a Piscivorous Bird	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; GREAT CORMORANT; YELLOW PERCH; PREDATION; POPULATIONS; LAKE; DIET; WALLEYE; MORTALITY; DENSITY	Conflict arises in fisheries worldwide when piscivorous birds target fish species of commercial value. This paper presents a method for estimating size selectivity functions for piscivores and uses it to compare predation selectivities of Great Cormorants (Phalacrocorax carbo sinensis L. 1758) with that of gill-net fishing on a European perch (Perca fluviatilis L. 1758) population in the Curonian Lagoon, Lithuania. Fishers often regard cormorants as an unwanted "satellite species'', but the degree of direct competition and overlap in size-specific selectivity between fishers and cormorants is unknown. This study showed negligible overlap in selectivity between Great Cormorants and legal-sized commercial nets. The selectivity estimation method has general application potential for use in conjunction with population dynamics models to assess fish population responses to size-selective fishing from a wide range of piscivorous predators.	[Troynikov, Vladimir; Whitten, Athol; Gorfine, Harry] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Gorfine, Harry; Putys, Zilvinas; Jakubaviciute, Egle; Lozys, Linas; Dainys, Justas] Nat Res Ctr, Lab Marine Ecol, Vilnius, Lithuania	University of Melbourne; Nature Research Center - Lithuania	Gorfine, H (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	hgorfine@unimelb.edu.au	Gorfine, Harry/GOE-3967-2022	Gorfine, Harry/0000-0001-6933-3389	Research Council of Lithuania [LEK-24/2010]; Department of Zoology, University of Melbourne	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Department of Zoology, University of Melbourne(University of Melbourne)	This study was supported by a grant from the Research Council of Lithuania under its programme 'Lithuania Ecosystems: Climate change and environmental impact' (grant no. LEK-24/2010). H. Gorfine, V. Troynikov and A. Whitten were partly supported by research funding from the Department of Zoology, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjers K, 2006, BOREAL ENVIRON RES, V11, P13; Andersen SM, 2007, ICES J MAR SCI, V64, P1235, DOI 10.1093/icesjms/fsm092; Brian SD, 2010, J GREAT LAKES RES, V36, P215, DOI 10.1016/j.jglr.2010.02.001; Britton J.R., 2003, P14; Carss DN, 1997, P 4 EUR C CORM 1 3 N, P197; Cech M, 2008, WATERBIRDS, V31, P438; Coutin P.C., 2003, P196; Dalton CM, 2009, CAN J FISH AQUAT SCI, V66, P177, DOI 10.1139/F08-198; DENIE H, 1995, ARDEA, V83, P115; Diana JS, 2006, J GREAT LAKES RES, V32, P306, DOI 10.3394/0380-1330(2006)32[306:DICPTS]2.0.CO;2; DIRKSEN S, 1995, ARDEA, V83, P167; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Engstrom H, 2003, VOGELWELT S, V124, P187; Eschbaum R., 2003, P72; Fielder DG, 2008, J GREAT LAKES RES, V34, P506, DOI 10.3394/0380-1330(2008)34[506:EOFCTT]2.0.CO;2; Fielder DG, 2010, J GREAT LAKES RES, V36, P207, DOI 10.1016/j.jglr.2009.12.015; Gremillet D, 2006, MAR BIOL, V148, P1081, DOI 10.1007/s00227-005-0130-2; Hollowed AB, 2000, ICES J MAR SCI, V57, P279, DOI 10.1006/jmsc.1999.0637; Irwin BJ, 2008, CAN J FISH AQUAT SCI, V65, P1366, DOI 10.1139/F08-062; KIRKWOOD GP, 1986, AUST J MAR FRESH RES, V37, P689; Kloskowski J, 2011, EUR J WILDLIFE RES, V57, P295, DOI 10.1007/s10344-010-0426-5; Krohn WB, 1995, COLON WATERBIRD, V18, P99, DOI 10.2307/1521529; Lehikoinen A, 2005, WATERBIRDS, V28, P511, DOI 10.1675/1524-4695(2005)28[511:PADOTG]2.0.CO;2; Leopold MF, 1998, J SEA RES, V40, P93, DOI 10.1016/S1385-1101(98)00028-8; Lilliendahl K, 2006, MAR BIOL, V149, P979, DOI 10.1007/s00227-006-0259-7; LINN IJ, 1992, J APPL ECOL, V29, P619, DOI 10.2307/2404470; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Millar RB, 1997, ICES J MAR SCI, V54, P471, DOI 10.1006/jmsc.1996.0196; Mustamaki N, 2014, AMBIO, V43, P325, DOI 10.1007/s13280-013-0429-z; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Putys Zilvinas, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0031-6; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rudstam LG, 2004, ECOL APPL, V14, P149, DOI 10.1890/03-5010; Steffens W, 2010, BULG J AGRIC SCI, V16, P322; Stewart DC, 2005, J ZOOL, V267, P191, DOI 10.1017/S0952836905007387; SUTER W, 1995, J APPL ECOL, V32, P29, DOI 10.2307/2404413; Svagzdys A, 2006, ZUVININKYSTE LIETUVO, V6, P195; Takahashi T, 2006, FISHERIES SCI, V72, P477, DOI 10.1111/j.1444-2906.2006.01175.x; Thoresson G., 1993, GUIDELINES COASTAL M, V1993, P1; Troynikov VS, 2011, J FISH BIOL, V79, P1940, DOI 10.1111/j.1095-8649.2011.03135.x; Van Eerden MR, 2003, VOGELWELT S, V124, P277; VANEERDEN MR, 1995, ARDEA, V83, P1; Wires L.R., 2003, VOGELWELT, V124, P389; Wires L.R., 2001, STATUS DOUBLE CRESTE; Yorio P, 2010, BIRD CONSERV INT, V20, P320, DOI 10.1017/S0959270910000286; Zydelis R, 2008, HYDROBIOLOGIA, V611, P45, DOI 10.1007/s10750-008-9460-7	47	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e77518	10.1371/journal.pone.0077518	http://dx.doi.org/10.1371/journal.pone.0077518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244277	Green Published, gold			2022-12-27	WOS:000327162900007
J	Ferguson, C; Wilson, J; Birch, KM; Kemi, OJ				Ferguson, Carrie; Wilson, John; Birch, Karen M.; Kemi, Ole J.			Application of the Speed-Duration Relationship to Normalize the Intensity of High-Intensity Interval Training	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HUMAN SKELETAL-MUSCLE; TERM SPRINT INTERVAL; MODERATE-INTENSITY; MITOCHONDRIAL BIOGENESIS; PHYSICAL-ACTIVITY; CRITICAL POWER; LOW-VOLUME; CARDIORESPIRATORY FITNESS; INSULIN SENSITIVITY	The tolerable duration of continuous high-intensity exercise is determined by the hyperbolic Speed-tolerable duration (S-t(LIM)) relationship. However, application of the S-t(LIM) relationship to normalize the intensity of High-Intensity Interval Training (HIIT) has yet to be considered, with this the aim of present study. Subjects completed a ramp-incremental test, and series of 4 constant-speed tests to determine the S-t(LIM) relationship. A sub-group of subjects (n = 8) then repeated 4 min bouts of exercise at the speeds predicted to induce intolerance at 4 min (WR4), 6 min (WR6) and 8 min (WR8), interspersed with bouts of 4 min recovery, to the point of exercise intolerance (fixed WR HIIT) on different days, with the aim of establishing the work rate that could be sustained for 960 s (i.e. 4 x 4 min). A sub-group of subjects (n = 6) also completed 4 bouts of exercise interspersed with 4 min recovery, with each bout continued to the point of exercise intolerance (maximal HIIT) to determine the appropriate protocol for maximizing the amount of high-intensity work that can be completed during 464 min HIIT. For fixed WR HIIT t(LIM) of HIIT sessions was 399 +/- 81 s for WR4, 892 +/- 181 s for WR6 and 1517 +/- 346 s for WR8, with total exercise durations all significantly different from each other (P<0.050). For maximal HIIT, there was no difference in t(LIM) of each of the 4 bouts (Bout 1: 229 +/- 27 s; Bout 2: 262 +/- 37 s; Bout 3: 235 +/- 49 s; Bout 4: 235 +/- 53 s; P > 0.050). However, there was significantly less high-intensity work completed during bouts 2 (153.5 +/- 40. 9 m), 3 (136.9 +/- 38.9 m), and 4 (136.7 +/- 39.3 m), compared with bout 1 (264.9 +/- 58.7 m; P > 0.050). These data establish that WR6 provides the appropriate work rate to normalize the intensity of HIIT between subjects. Maximal HIIT provides a protocol which allows the relative contribution of the work rate profile to physiological adaptations to be considered during alternative intensity-matched HIIT protocols.	[Ferguson, Carrie; Birch, Karen M.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Ferguson, Carrie; Wilson, John; Kemi, Ole J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leeds; University of Glasgow	Ferguson, C (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	C.Ferguson@leeds.ac.uk		Birch, Karen/0000-0001-7796-8640				Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Chidnok W, 2012, MED SCI SPORT EXER, V44, P966, DOI 10.1249/MSS.0b013e31823ea28a; Coats EM, 2003, J APPL PHYSIOL, V95, P483, DOI 10.1152/japplphysiol.01142.2002; Coker RH, 2006, MED SCI SPORT EXER, V38, P433, DOI 10.1249/01.mss.0000191417.48710.11; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; Ferguson C, 2007, J APPL PHYSIOL, V103, P812, DOI 10.1152/japplphysiol.01410.2006; Ferguson C, 2010, J APPL PHYSIOL, V108, P866, DOI 10.1152/japplphysiol.91425.2008; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Moholdt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041199; Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229; Moholdt T, 2011, INT J CARDIOL, V152, P388, DOI 10.1016/j.ijcard.2011.08.025; MORITANI T, 1981, ERGONOMICS, V24, P339, DOI 10.1080/00140138108924856; MORRIS JN, 1953, LANCET, V265, P1053; Murgatroyd SR, 2011, J APPL PHYSIOL, V110, P1598, DOI 10.1152/japplphysiol.01092.2010; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; O'Donovan G, 2005, J APPL PHYSIOL, V98, P1619, DOI 10.1152/japplphysiol.01310.2004; PAFFENBA.RS, 1970, NEW ENGL J MED, V282, P1109, DOI 10.1056/NEJM197005142822001; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Rossiter HB, 2010, COMPREHENSIVE PHYSL; Skiba PF, 2012, MED SCI SPORT EXER, V44, P1526, DOI 10.1249/MSS.0b013e3182517a80; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Swain DP, 2002, MED SCI SPORT EXER, V34, P1071, DOI 10.1097/00005768-200207000-00003; Thyfault JP, 2008, AM J PHYSIOL-REG I, V294, pR1103, DOI [10.1152/ajpregu.00542.2007, 10.1152/ajpregu.00924.2007]; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Turner AP, 2006, MED SCI SPORT EXER, V38, P492, DOI 10.1249/01.mss.0000188450.82733.f0; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Whyte LJ, 2013, METABOLISM, V62, P212, DOI 10.1016/j.metabol.2012.07.019; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	54	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e76420	10.1371/journal.pone.0076420	http://dx.doi.org/10.1371/journal.pone.0076420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244266	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000327143800001
J	Qin, C; Yang, B; Melvin, TM; Fan, ZX; Zhao, Y; Briffa, KR				Qin, Chun; Yang, Bao; Melvin, Thomas M.; Fan, Zexin; Zhao, Yan; Briffa, Keith R.			Radial Growth of Qilian Juniper on the Northeast Tibetan Plateau and Potential Climate Associations	PLOS ONE			English	Article							ARID NORTHWESTERN CHINA; TREE-RING CHRONOLOGY; SABINA-PRZEWALSKII; ALTITUDINAL GRADIENT; HEIHE RIVER; MOUNTAINS; ELEVATION; VARIABILITY; RECONSTRUCTION; PATTERNS	There is controversy regarding the limiting climatic factor for tree radial growth at the alpine treeline on the northeastern Tibetan Plateau. In this study, we collected 594 increment cores from 331 trees, grouped within four altitude belts spanning the range 3550 to 4020 m.a.s.l. on a single hillside. We have developed four equivalent ring-width chronologies and shown that there are no significant differences in their growth-climate responses during 1956 to 2011 or in their longer-term growth patterns during the period AD 1110-2011. The main climate influence on radial growth is shown to be precipitation variability. Missing ring analysis shows that tree radial growth at the uppermost treeline location is more sensitive to climate variation than that at other elevations, and poor tree radial growth is particularly linked to the occurrence of serious drought events. Hence water limitation, rather than temperature stress, plays the pivotal role in controlling the radial growth of Sabina przewalskii Kom. at the treeline in this region. This finding contradicts any generalisation that tree-ring chronologies from high-elevation treeline environments are mostly indicators of temperature changes.	[Qin, Chun; Yang, Bao] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China; [Melvin, Thomas M.; Briffa, Keith R.] Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Fan, Zexin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zhao, Yan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University of East Anglia; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yang, B (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China.	yangbao@lzb.ac.cn	Fan, Ze-Xin/ABG-7176-2020; Yang, Bao/O-1541-2013; Fan, Zexin/E-2344-2016; Qin, Chun/G-3720-2013; Zhao, Yan/B-1785-2014; Qin, Chun/F-9738-2018	Fan, Ze-Xin/0000-0003-4623-6783; Fan, Zexin/0000-0003-4623-6783; Qin, Chun/0000-0003-3115-2376; Zhao, Yan/0000-0003-1693-9795; Qin, Chun/0000-0003-3115-2376; Briffa, Keith/0000-0003-3323-3639	NSFC [41002050, 41071130]; Interdisciplinary Innovation Team project of the Chinese Academy of Sciences [29Y329B91]; NERC [NE/G018863/1]; K.C. Wong Education Foundation, Hong Kong; Natural Environment Research Council [NE/G018863/1] Funding Source: researchfish	NSFC(National Natural Science Foundation of China (NSFC)); Interdisciplinary Innovation Team project of the Chinese Academy of Sciences; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); K.C. Wong Education Foundation, Hong Kong; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was jointly funded by the NSFC (Grant No. 41002050, 41071130), and Interdisciplinary Innovation Team project of the Chinese Academy of Sciences (29Y329B91). KRB and TMM acknowledge support from NERC (NE/G018863/1). Bao Yang gratefully acknowledges the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, TIME SERIES ANAL APP; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F, 2001, AMBIO, V30, P162, DOI 10.1639/0044-7447(2001)030[0162:AYTRCF]2.0.CO;2; Biondi F, 2002, PAGES NEWS, V10, P1; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Carrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022813; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER., 1991, METHODS DENDROCHRONO; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Esper J, 2003, TREE-RING RES, V59, P81; Esper J, 2008, FOREST ECOL MANAG, V255, P3783, DOI 10.1016/j.foreco.2008.03.015; Esper J, 2007, TREES-STRUCT FUNCT, V21, P141, DOI 10.1007/s00468-006-0104-0; Fang KY, 2009, TREES-STRUCT FUNCT, V23, P1321, DOI 10.1007/s00468-009-0373-5; Fritts H. C., 1969, Tree-Ring Bulletin, V29, P15; Fritts H. C., 1976, TREE RINGS CLIMATE; Gou XH, 2012, DENDROCHRONOLOGIA, V30, P121, DOI 10.1016/j.dendro.2011.05.002; He MH, 2013, TREES-STRUCT FUNCT, V27, P429, DOI 10.1007/s00468-012-0813-5; Hughes MK, 2003, CLIMATIC CHANGE, V59, P233, DOI 10.1023/A:1024464909332; Kang SY, 2013, QUATERN INT, V283, P85, DOI 10.1016/j.quaint.2012.03.011; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; LaMarche V. C. Jr., 1974, Tree-ring Bulletin, V34, P1; LAMARCHE VC, 1974, SCIENCE, V183, P1043, DOI 10.1126/science.183.4129.1043; Li ZS, 2012, TREES-STRUCT FUNCT, V26, P1373, DOI 10.1007/s00468-012-0712-9; Liang EY, 2006, FOREST ECOL MANAG, V236, P268, DOI 10.1016/j.foreco.2006.09.016; Liang EY, 2010, TREES-STRUCT FUNCT, V24, P363, DOI 10.1007/s00468-009-0406-0; Morales MS, 2004, ECOLOGY, V85, P3080, DOI 10.1890/04-0139; Peng JF, 2008, DENDROCHRONOLOGIA, V26, P87, DOI 10.1016/j.dendro.2007.10.003; Qin C, 2011, GLOBAL PLANET CHANGE, V75, P143, DOI 10.1016/j.gloplacha.2010.10.013; Qin C, 2010, GLOBAL PLANET CHANGE, V72, P192, DOI 10.1016/j.gloplacha.2010.04.005; Rinn F, 2003, TSAP WIN TIME SERIES; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Splechtna BE, 2000, ANN FOREST SCI, V57, P89; Stoker Michael, 1996, V70, P1; WANG T, 2005, TREES-STRUCT FUNCT, V19, P735, DOI DOI 10.1007/s00468-005-0003-9; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069065; Yang B, 2012, HOLOCENE, V22, P773, DOI 10.1177/0959683611430411; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang B, 2010, HOLOCENE, V20, P1235, DOI 10.1177/0959683610371997; Zhang YX, 2011, DENDROCHRONOLOGIA, V29, P185, DOI 10.1016/j.dendro.2010.11.001; Zhang YX, 2011, CHINESE SCI BULL, V56, P1518, DOI 10.1007/s11434-011-4456-5; Zheng Yong-hong, 2009, Yingyong Shengtai Xuebao, V20, P507; Zhu HF, 2008, CHINESE SCI BULL, V53, P3914, DOI 10.1007/s11434-008-0400-8	46	22	25	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79362	10.1371/journal.pone.0079362	http://dx.doi.org/10.1371/journal.pone.0079362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244488	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000327143800065
J	Cuomo, O; Rispoli, V; Leo, A; Politi, GB; Vinciguerra, A; di Renzo, G; Cataldi, M				Cuomo, Ornella; Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro			The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							LONG-TERM TREATMENT; SPREADING DEPRESSION; CALCIUM-CHANNELS; UCB L059; RELEASE; MODEL; EPILEPSY; DEPOLARIZATION; ETHOSUXIMIDE; INHIBITION	The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, cerebral hemorrhage and neurotrauma. In these conditions, non-convulsive seizures (NCSs) propagate from the core of the focal lesion into perilesional tissue, enlarging the damaged area and promoting epileptogenesis. Here, we explore whether Lev neuroprotective effect is accompanied by changes in NCS generation or propagation. In particular, we performed continuous EEG recordings before and after the permanent occlusion of the middle cerebral artery (pMCAO) in rats that received Lev (100 mg/kg) or its vehicle immediately before surgery. Both in Lev-treated and in control rats, EEG activity was suppressed after pMCAO. In control but not in Lev-treated rats, EEG activity reappeared approximately 30-45 min after pMCAO. It initially consisted in single spikes and, then, evolved into spike-and-wave and polyspike-and-wave discharges. In Lev-treated rats, only rare spike events were observed and the EEG power was significantly smaller than in controls. Approximately 24 hours after pMCAO, EEG activity increased in Lev-treated rats because of the appearance of polyspike events whose power was, however, significantly smaller than in controls. In rats sacrificed 24 hours after pMCAO, the ischemic lesion was approximately 50% smaller in Lev-treated than in control rats. A similar neuroprotection was observed in rats sacrificed 72 hours after pMCAO. In conclusion, in rats subjected to pMCAO, a single Lev injection suppresses NCS occurrence for at least 24 hours. This electrophysiological effect could explain the long lasting reduction of ischemic brain damage caused by this drug.	[Cuomo, Ornella; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy; [Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	University of Naples Federico II; Magna Graecia University of Catanzaro	Cataldi, M (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy.	cataldi@unina.it	Cataldi, Mauro/AAB-3642-2019; Leo, Antonio/AAC-4052-2020; Di Renzo, Gian C./P-3819-2017; Vinciguerra, Antonio/AAA-8094-2019	Cataldi, Mauro/0000-0001-7787-3406; Leo, Antonio/0000-0002-0061-1608; Di Renzo, Gian C./0000-0003-4467-240X; Vinciguerra, Antonio/0000-0003-0746-4935; CUOMO, ORNELLA/0000-0002-6459-2530	UCB Pharma; Ricerca Finalizzata [RF-FSL-352059]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [PON_01602, 20089BARSR_002]; European Community; European Social Fund; Regione Calabria	UCB Pharma(UCB Pharma SA); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale; European Community(European Commission); European Social Fund(European Social Fund (ESF)); Regione Calabria(Regione Calabria)	The present study was partially supported by a research grant by UCB Pharma. The funding company did not have any role in designing, performing or analyzing the data but approved both the initial protocol and the final manuscript. This economical support does not alter our adherence to all the PLOS ONE policies on sharing data and materials. Additional support was received from the following grants: Ricerca Finalizzata 2009 [Grant RF-FSL-352059], and Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [Grants PON_01602 and 20089BARSR_002]. A. L. is recipient of a Ph.D. fellowship grant from the European Community, the European Social Fund and the Regione Calabria.	Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Cataldi M, 2005, J PHARMACOL EXP THER, V313, P720, DOI 10.1124/jpet.104.079327; Cataldi M, 2013, CURR NEUROPHARMACOL, V11, P276, DOI 10.2174/1570159X11311030004; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Clark WM, 1997, NEUROL RES, V19, P641; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Crepeau AZ, 2010, EXPERT REV NEUROTHER, V10, P159, DOI [10.1586/ern.10.5, 10.1586/ERN.10.3]; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Cuomo O, 2007, STROKE, V38, P3272, DOI 10.1161/STROKEAHA.107.488486; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Fukuyama K, 2012, NEUROSCI LETT, V518, P69, DOI 10.1016/j.neulet.2012.03.056; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lukyanetz EA, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.2002.24501.x; Lynch BA, 2003, P NATL ACAD SCI USA, V26, P9861; Margineanu DG, 2009, SEIZURE-EUR J EPILEP, V18, P453, DOI 10.1016/j.seizure.2009.01.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Nagarkatti N, 2008, NEUROSCI LETT, V436, P289, DOI 10.1016/j.neulet.2008.02.076; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Pignataro G, 2012, NEUROBIOL DIS, V45, P616, DOI 10.1016/j.nbd.2011.10.007; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Stratton SC, 2003, EPILEPSY RES, V53, P95, DOI 10.1016/S0920-1211(02)00254-1; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80852	10.1371/journal.pone.0080852	http://dx.doi.org/10.1371/journal.pone.0080852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236205	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700208
J	Agarwal, SK; Alonso, A; Whelton, SP; Soliman, EZ; Rose, KM; Chamberlain, AM; Simpson, RJ; Coresh, J; Heiss, G				Agarwal, Sunil K.; Alonso, Alvaro; Whelton, Seamus P.; Soliman, Elsayed Z.; Rose, Kathryn M.; Chamberlain, Alanna M.; Simpson, Ross J., Jr.; Coresh, Josef; Heiss, Gerardo			Orthostatic Change in Blood Pressure and Incidence of Atrial Fibrillation: Results from a Bi-Ethnic Population Based Study	PLOS ONE			English	Article							HYPOTENSION PREDICTS MORTALITY; ATHEROSCLEROSIS RISK; AFRICAN-AMERICANS; STROKE; ONSET; PREVALENCE; MANAGEMENT; WHITES; ADULTS	Background: Autonomic fluctuations are associated with the initiation and possibly maintenance of atrial fibrillation (AF). However, little is known about the relationship between orthostatic blood pressure change, a common manifestation of autonomic dysfunction, and incident AF. Methods: We examined whether supine-to-standing changes in systolic blood pressure (SBP) are associated with incident AF in 12,071 African American and white men and women aged 45-64 years, enrolled in the Atherosclerosis Risks in Communities (ARIC) study. Orthostatic hypotension (OH) was defined as a supine-standing drop in SBP by >= 20 mmHg or diastolic blood pressure by >= 10 mmHg. AF cases were identified based on study scheduled 12-lead ECG, hospital discharge ICD codes, and death certificates through 2009. Results: OH was seen in 603 (5%) at baseline. During an average follow-up of 18.1 years, 1438 (11.9%) study participants developed AF. Incident AF occurred more commonly among those with OH than those without, a rate of 9.3 vs. 6.3 per 1000 person years, (p<0.001). The age, gender, and race adjusted hazard ratio (95%CI) of AF among those with OH compared to those without was 1.62 (1.34, 2.14). This association was attenuated after adjustment for common AF risk factors to HR 1.40 (1.15, 1.71), a strength similar to that of diabetes or hypertension with AF in the same model. A non-linear relationship between orthostatic change in SBP and incident AF was present after multivariable adjustment. Conclusions: OH is associated with higher AF incidence. Whether interventions that decrease OH can reduce AF risk remains unknown.	[Agarwal, Sunil K.; Whelton, Seamus P.; Chamberlain, Alanna M.; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD 21218 USA; [Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent EpiCare, Winston Salem, NC USA; [Rose, Kathryn M.; Simpson, Ross J., Jr.; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol & Med, Chapel Hill, NC USA; Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Agarwal, SK (corresponding author), Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD 21218 USA.	sunilagarwal@jhu.edu	Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020	Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Chamberlain, Alanna/0000-0003-1888-9584	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-55015, 55016, 55018, 55019, 55020, 55021, 55022]; NHLBI [T32-HL-007779, IRC1HL099452-01]; American Heart Association [09SDG2280087]; National Institutes of Health/National Heart, Lung, and Blood Institute [T32HL007024]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024, T32HL007779, RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was sponsored by National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-55015, 55016, 55018, 55019, 55020, 55021, and 55022. AMC was supported by NHLBI grant T32-HL-007779. Additional funding for this study was provided by grants09SDG2280087 from the American Heart Association and IRC1HL099452-01 from NHLBI. SKA is supported by a National Institutes of Health/National Heart, Lung, and Blood Institute T32HL007024 Cardiovascular Epidemiology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Amar D, 2003, J AM COLL CARDIOL, V42, P1262, DOI 10.1016/S0735-1097(03)00955-0; [Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Avery CL, EUR J HEART FAIL; Bettoni M, 2002, CIRCULATION, V105, P2753, DOI 10.1161/01.CIR.0000018443.44005.D8; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eigenbrodt ML, 2000, STROKE, V31, P2307, DOI 10.1161/01.STR.31.10.2307; Fedorowski A, 2010, J INTERN MED, V268, P383, DOI 10.1111/j.1365-2796.2010.02261.x; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Longo DL, 2012, HARRISONS PRINCIPLES; Low P, 2008, RECHERCHE, V67; Malik M., 2004, DYNAMIC ELECTROCARDI; Masaki KH, 1998, CIRCULATION, V98, P2290, DOI 10.1161/01.CIR.98.21.2290; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Pokushalov E, 2012, J AM COLL CARDIOLOGY; Rose KM, 2006, CIRCULATION, V114, P630, DOI 10.1161/CIRCULATIONAHA.105.598722; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Vara-Gonzalez L, 2006, BLOOD PRESS MONIT, V11, P17, DOI 10.1097/01.mbp.0000189786.59994.fb; Vincenti A, 2006, EUROPACE, V8, P204, DOI 10.1093/europace/euj043	24	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79030	10.1371/journal.pone.0079030	http://dx.doi.org/10.1371/journal.pone.0079030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244409	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600097
J	Geraets, DT; van Doorn, LJ; Kleter, B; Colau, B; Harper, DM; Quint, WGV				Geraets, Daan T.; van Doorn, Leen-Jan; Kleter, Bernhard; Colau, Brigitte; Harper, Diane M.; Quint, Wim G. V.			Long-Term Follow-Up of HPV16-Positive Women: Persistence of the Same Genetic Variant and Low Prevalence of Variant Co-Infections	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; MOLECULAR VARIANTS; PARTICLE VACCINE; YOUNG-WOMEN; CLINICAL-EVALUATION; NATURAL-HISTORY; E6 VARIANTS; RISK; IDENTIFICATION	HPV16 variants correlate with geographic origin and ethnicity. The association between infection with a specific variant and the cervical disease risk remains unclear. We studied the prevalence, persistence and association with cervical intraepithelial neoplasia (CIN) of different HPV16 variants, using cervical swabs and whole tissue sections (WTS) of biopsies from 548 women in the placebo group of a HPV16/18 vaccine trial. In HPV16-positive samples, HPV16 variants were identified by a reverse hybridization assay (RHA). Laser-capture micro-dissection (LCM) was performed for localized detection of HPV. HPV16 variants were determined in 47 women. Frequency of mixed HPV16 variant infections was lower (8.5%) than for multiple HPV genotypes (39.1%). Among 35 women having consecutive HPV16 variant-positive swabs, 32 (91.4%) had the same variant while in three (8.6%) women a change in variant(s) was observed. HPV16-positive WTS were obtained from 12 women having consecutive HPV16 variant-positive swabs. The same variant was present in WTS of 10 women, while two were negative. WTS of five women were histologically normal. A single HPV16 variant was detected in four women having CIN1-3, while additional HPV genotypes were found in three other women having CIN2 and CIN3. In the WTS of one woman with mixed genotypes, the HPV16 variant was assigned to a CIN2 lesion by LCM. HPV16 variant infections can be effectively studied in cervical swabs and tissue specimens by the HPV16 variant RHA. Multiple HPV16 variants in one woman are rare. The HPV16 genotype consistently detected in follow-up samples usually involves a persistent infection with the same variant.	[Geraets, Daan T.; van Doorn, Leen-Jan; Kleter, Bernhard; Quint, Wim G. V.] DDL Diagnost Lab, Rijswijk, Netherlands; [Colau, Brigitte] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Harper, Diane M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA	DDL Diagnostic Laboratory; GlaxoSmithKline; Dartmouth College; Norris Cotton Cancer Center	Geraets, DT (corresponding author), DDL Diagnost Lab, Rijswijk, Netherlands.	daan.geraets@ddl.nl	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was funded by GlaxoSmithKline Biologicals SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho J, 2004, J INFECT DIS, V190, P46, DOI 10.1086/420787; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bozzetti, 2000, Ann Epidemiol, V10, P466, DOI 10.1016/S1047-2797(00)00147-2; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; COX JT, 1995, AM J OBSTET GYNECOL, V172, P946, DOI 10.1016/0002-9378(95)90026-8; Cuzick J, 1999, HEALTH TECHNOL ASSES, V3, pi; De Boer MA, 2005, INT J CANCER, V114, P422, DOI 10.1002/ijc.20727; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Gonzalez-Losa MD, 2004, J CLIN VIROL, V29, P95, DOI 10.1016/S1386-6532(03)00094-5; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kang S, 2005, INT J GYNECOL CANCER, V15, P107, DOI 10.1111/j.1048-891x.2005.15010.x; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Perrons C, 2005, J CLIN VIROL, V32, P278, DOI 10.1016/j.jcv.2004.08.009; Pillai MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/ijc.24322; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Sanchez GI, 2011, J CLIN VIROL, V51, P165, DOI 10.1016/j.jcv.2011.03.013; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Schlecht NF, 2005, J GEN VIROL, V86, P2709, DOI 10.1099/vir.0.81060-0; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Swan DC, 2006, J VIROL METHODS, V136, P166, DOI 10.1016/j.jviromet.2006.05.002; Swan DC, 2005, GYNECOL ONCOL, V96, P695, DOI 10.1016/j.ygyno.2004.11.045; Tornesello ML, 2004, J MED VIROL, V74, P117, DOI 10.1002/jmv.20154; van Doorn L J, 2001, Expert Rev Mol Diagn, V1, P394; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 1998, CANCER RES, V58, P829; Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706; ZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427, DOI 10.1146/annurev.micro.48.1.427	47	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80382	10.1371/journal.pone.0080382	http://dx.doi.org/10.1371/journal.pone.0080382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244682	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600207
J	Grimaldi, A; Balestrieri, ML; D'Onofrio, N; Di Domenico, G; Nocera, C; Lamberti, M; Tonini, G; Zoccoli, A; Santini, D; Caraglia, M; Pantano, F				Grimaldi, Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Di Domenico, Gilda; Nocera, Cosimo; Lamberti, Monica; Tonini, Giuseppe; Zoccoli, Alice; Santini, Daniele; Caraglia, Michele; Pantano, Francesco			The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence	PLOS ONE			English	Article							PHASE-I TRIAL; PROGENITOR CELLS; TUMOR VASCULATURE; MAMMALIAN TARGET; MYELOID CELLS; GROWTH-FACTOR; CANCER; ANGIOGENESIS; MTOR; CHEMOTHERAPY	Endothelial Progenitor Cells (EPCs), a minor subpopulation of the mononuclear cell fraction in peripheral blood, play a critical role in cancer development as they contribute to angiogenesis-mediated pathological neovascularization. In response to tumor cytokines, including VEGF, EPCs mobilize from the bone marrow into the peripheral circulation and move to the tumor bed where they incorporate into sprouting neovessels. In the present study, we evaluated the effects of everolimus (Afinitor, Novartis), a rapamycin analogue, alone or in combination with chloroquine, a 4-alkylamino substituted quinoline family member, one of the autophagy inhibitors, on EPCs biological functions. We found that either everolimus or chloroquine induce growth inhibition on EPCs in a dose-dependent manner after 72 h from the beginning of incubation. The combined administration of the two drugs to EPC was synergistic in inducing growth inhibition; in details, the maximal pharmacological synergism between everolimus and chloroquine in inducing growth inhibition on EPCs cells was recorded when chloroquine was administered 24 h before everolimus. Moreover, we have studied the mechanisms of cell death induced by the two agents alone or in combination on EPCs and we have found that the synergistic effect of combination on EPC growth inhibition was paralleled by increased apoptosis induction and reduced autophagy. These effects occurred together with biochemical features that are typical of reduced autophagic death such as increased co-immunoprecipitation between Beclin 1 and Bcl-2. Chloroquine antagonized the inhibition of the activity of AktR4EBP1 axis mediated by everolimus and at the same time it blocked the feed-back activation of Erk-1/2 induced by RAD in EPCs. These data suggest a new strategy in order to block angiogenesis in tumours in which this process plays a key role in both the sustainment and spreading of cancer cells.	[Grimaldi, Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Caraglia, Michele] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Di Domenico, Gilda; Nocera, Cosimo] S Giovanni Bosco Naples, Ctr Blood Transfus, Naples, Italy; [Lamberti, Monica] Univ Naples 2, Dept Expt Med, Sect Igiene Med Lavoro & Med Legale, Naples, Italy; [Tonini, Giuseppe; Zoccoli, Alice; Santini, Daniele; Pantano, Francesco] Campus Biomed Univ, Translat Oncol PRABB, Rome, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University Campus Bio-Medico - Rome Italy	Caraglia, M (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	michele.caraglia@unina2.it	Caraglia, Michele/AFY-9729-2022; D'Onofrio, Nunzia/M-2081-2019; Caraglia, Michele/N-5670-2015; Caraglia, Michele/AAK-4569-2020; Pantano, Francesco/D-8459-2012	Caraglia, Michele/0000-0003-2408-6091; D'Onofrio, Nunzia/0000-0002-5300-9530; Caraglia, Michele/0000-0003-2408-6091; Caraglia, Michele/0000-0003-2408-6091; Pantano, Francesco/0000-0002-2894-9686; Tonini, Giuseppe/0000-0003-4442-8677; Zoccoli, Alice/0000-0003-1991-1667; Balestrieri, Maria Luisa/0000-0001-6001-1789; Santini, Daniele/0000-0002-9118-3337	PRIN "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales"; FIRB "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers"	PRIN "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales"; FIRB "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers"	The authors are grateful to PRIN 2009 "Nanotechnological development of target-based and cytotoxic agents in the treatment of tumours: new strategies based upon biological rationales" and FIRB 2011 "Advanced technology platforms for new molecular targets and biomarkes carriers definition in nanotechnology for the diagnosis and therapy of human cancers" for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, ONCOLOGIST, V15, P236, DOI 10.1634/theoncologist.2009-0141; Banerjee S, 2012, ATHEROSCLEROSIS, V225, P91, DOI 10.1016/j.atherosclerosis.2012.08.025; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9; Bertolini Francesco, 2012, Methods Mol Biol, V904, P165, DOI 10.1007/978-1-61779-943-3_14; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Curran MP, 2012, PEDIATR DRUGS, V14, P51, DOI 10.2165/11207730-000000000-00000; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Ding YT, 2008, PATHOBIOLOGY, V75, P265, DOI 10.1159/000151706; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Franco R, 2011, CANCER BIOL THER, V11, P609, DOI 10.4161/cbt.11.6.14672; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Igreja C, 2007, HAEMATOLOGICA, V92, P469, DOI 10.3324/haematol.10723; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johnson BE, 2007, CLIN CANCER RES, V13, p4628S, DOI 10.1158/1078-0432.CCR-07-0717; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mancuso P, 2010, MICROVASC RES, V79, P224, DOI 10.1016/j.mvr.2010.02.007; Masuda H, 2013, TRENDS CARDIOVAS MED, V23, P99, DOI 10.1016/j.tcm.2012.09.007; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miriuka SG, 2006, AM J TRANSPLANT, V6, P2069, DOI 10.1111/j.1600-6143.2006.01433.x; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Naik RP, 2008, BREAST CANCER RES TR, V107, P133, DOI 10.1007/s10549-007-9519-6; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rosich L, 2012, CLIN CANCER RES, V18, P5278, DOI 10.1158/1078-0432.CCR-12-0351; Rossi M, 2012, CURR CANCER DRUG TAR, V12, P757, DOI 10.2174/156800912802429300; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Smolewski P, 2006, ANTI-CANCER DRUG, V17, P487, DOI 10.1097/00001813-200606000-00001; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tertil M, 2010, CURR PHARM DESIGN, V16, P3877, DOI 10.2174/138161210794454969; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yim Kein-Leong, 2012, Cancer Manag Res, V4, P207, DOI 10.2147/CMAR.S25979; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8	62	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79658	10.1371/journal.pone.0079658	http://dx.doi.org/10.1371/journal.pone.0079658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244540	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600143
J	Hoffmann, W; Meiboom, MF; Weitmann, K; Terschuren, C; von Boetticher, H				Hoffmann, Wolfgang; Meiboom, Merle Friederike; Weitmann, Kerstin; Terschueren, Claudia; von Boetticher, Heiner			Influence of Age, Sex and Calendar Year on Lifetime Accumulated Red Bone Marrow Dose from Diagnostic Radiation Exposure	PLOS ONE			English	Article							IONIZING-RADIATION; BREAST-CANCER; X-RAYS; GERMANY; LEUKEMIA	Our aim is to evaluate the relevance of different factors influencing lifetime accumulated red bone marrow dose, such as calendar year, age and sex. The lifetime dose was estimated for controls interviewed in person (N = 2811, 37.5% women) of the population-based representative Northern Germany Leukemia and Lymphoma Study. Data were assessed in standardized computer-assisted personal interviews. The calculation of doses is based on a comprehensive quantification model including calendar year, sex, kind of examination, and technical development. In multivariate regression models the annual red bone marrow dose was analyzed depending on age, sex and calendar year to consider simultaneously temporal changes in radiologic practice and individual risk factors. While the number of examinations continuously rises over time, the dose shows two peaks around 1950 and after 1980. Men are exposed to higher doses than woman. Until 1970 traditional examinations like conventional and mass screening examinations caused the main dose. They were then replaced by technically advanced examinations mainly computed tomography and cardiac catheter. The distribution of the red bone marrow dose over lifetime depends highly on the technical standards and radiation protection survey. To a lesser extent it is influenced by age and sex of the subjects. Thus epidemiological studies concerning the assessment of radiation exposure should consider the calendar year in which the examination was conducted.	[Hoffmann, Wolfgang; Weitmann, Kerstin; Terschueren, Claudia] Univ Med Greifswald, Dept Epidemiol Hlth Care & Community Hlth, Inst Community Med, Greifswald, Germany; [Meiboom, Merle Friederike] Hosp Links der Weser, Inst Radiol, Bremen, Germany; [von Boetticher, Heiner] Hosp Links der Weser, Inst Radiol, Bremen, Germany; [von Boetticher, Heiner] Hosp Links der Weser, Acad Radiat Protect, Bremen, Germany	Greifswald Medical School	Hoffmann, W (corresponding author), Univ Med Greifswald, Dept Epidemiol Hlth Care & Community Hlth, Inst Community Med, Greifswald, Germany.	wolfgang.hoffmann@uni-greifswald.de			Ministry of Environment, Nature Protection and Agriculture, Schleswig-Holstine; Ministry of Social Affairs, Women, Family, and Health, Lower Saxony	Ministry of Environment, Nature Protection and Agriculture, Schleswig-Holstine; Ministry of Social Affairs, Women, Family, and Health, Lower Saxony	The NLL study was funded by grants from the Ministry of Environment, Nature Protection and Agriculture, Schleswig-Holstine, and the Ministry of Social Affairs, Women, Family, and Health, Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2009, RADIAT RES, V172, P1, DOI 10.1667/RR1688.1; Behrens T, 2004, J EXPO ANAL ENV EPID, V14, P144, DOI 10.1038/sj.jea.7500305; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2010, JAMA-J AM MED ASSOC, V304, P208, DOI 10.1001/jama.2010.973; Brix G, 2005, RADIOLOGE, V45, P340, DOI 10.1007/s00117-005-1184-3; Brix G, 2009, EUR J RADIOL, V72, P342, DOI 10.1016/j.ejrad.2008.07.009; BRUCKENBERGER E, 2005, HERZBERICHT 2004 TRA; Bundesamt fur Strahlenschutz, 2002, STRAHL DURCH MED M 4; Bundesamt fur Strahlenschutz, 2010, UMW STRAHL JAHR 2009; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; Hoffmann W, 2008, AM J IND MED, V51, P246, DOI 10.1002/ajim.20551; Holthusen H, 1961, SCHRIFTENREIHE BUNDE; Kaul A, 1997, EUR RADIOL, V7, P1127, DOI 10.1007/s003300050267; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Martin CJ, 2002, PRACTICAL RAD PROTEC, P173; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Michaelis J, 1998, INT J RADIAT BIOL, V73, P377, DOI 10.1080/095530098142202; *NAT AC, 2005, BEIR 7 HLTH RISKS EX; Ron E, 1998, RADIAT RES, V150, pS30, DOI 10.2307/3579806; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Sauer R., 2006, RADIOLOGIE, P65; SHU XO, 1988, CANCER-AM CANCER SOC, V62, P635, DOI 10.1002/1097-0142(19880801)62:3<635::AID-CNCR2820620332>3.0.CO;2-3; STEWART WD, 1958, J INVEST DERMATOL, V30, P237, DOI 10.1038/jid.1958.49; THOMAS DB, 1994, CANCER CAUSE CONTROL, V5, P9, DOI 10.1007/BF01830721; Boetticher H, 2007, HEALTH PHYS, V92, P315, DOI 10.1097/01.HP.0000248478.18931.2d	25	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78027	10.1371/journal.pone.0078027	http://dx.doi.org/10.1371/journal.pone.0078027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244286	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600014
J	Koma, Y; Onishi, A; Matsuoka, H; Oda, N; Yokota, N; Matsumoto, Y; Koyama, M; Okada, N; Nakashima, N; Masuya, D; Yoshimatsu, H; Suzuki, Y				Koma, Yasuko; Onishi, Akira; Matsuoka, Hirofumi; Oda, Nao; Yokota, Naoya; Matsumoto, Yusuke; Koyama, Midori; Okada, Nobuhiko; Nakashima, Nariyasu; Masuya, Daiki; Yoshimatsu, Harukazu; Suzuki, Yujiro			Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer	PLOS ONE			English	Article							HEART-FAILURE; INFLAMMATION; SURVIVAL; POPULATION; DIAGNOSIS; MARKERS; ANEMIA; COUNT	Background: Red cell distribution width (RDW), one of many routinely examined parameters, shows the heterogeneity in erythrocyte size. We investigated the association of RDW levels with clinical parameters and prognosis of lung cancer patients. Methods: Clinical and laboratory data from 332 patients with lung cancer in a single institution were retrospectively studied by univariate analysis. Kaplan-Meier survival analysis and Cox proportional hazard models were used to examine the effect of RDW on survival. Results: The RDW levels were divided into two groups: high RDW (>=15%), n=73 vs. low RDW, n=259 (<15%). Univariate analysis showed that there were significant associations of high RDW values with cancer stage, performance status, presence of other disease, white blood cell count, hemoglobin, mean corpuscular volume, platelet count, albumin level, C-reactive protein level, and cytokeratin 19 fragment level. Kruskal-Wallis tests revealed an association of RDW values with cancer stage in patients irrespective of comorbidity (patient with/without comorbidity: p<0.0001, patient without comorbidity: p<0.0001). Stages I-IV lung cancer patients with higher RDW values had poorer prognoses than those with lower RDW values (Wilcoxon test: p=0.002). In particular, the survival rates of stage I and II patients (n=141) were lower in the high RDW group (n=19) than in the low RDW group (n=122) (Wilcoxon test: p<0.001). Moreover, multivariate analysis showed higher RDW is a significant prognostic factor (p=0.040). Conclusion: RDW is associated with several factors that reflect inflammation and malnutrition in lung cancer patients. Moreover, high levels of RDW are associated with poor survival. RDW might be used as a new and convenient marker to determine a patient's general condition and to predict the mortality risk of lung cancer patients.	[Koma, Yasuko; Matsuoka, Hirofumi; Oda, Nao; Yokota, Naoya; Matsumoto, Yusuke; Koyama, Midori; Okada, Nobuhiko; Nakashima, Nariyasu; Masuya, Daiki; Yoshimatsu, Harukazu; Suzuki, Yujiro] Shinko Hosp, Resp Ctr, Kobe, Hyogo, Japan; [Onishi, Akira] Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan	Kyoto University	Koma, Y (corresponding author), Shinko Hosp, Resp Ctr, Kobe, Hyogo, Japan.	yasukok@shinkohp.or.jp						Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Baicus C, 2011, J INVEST MED, V59, P951, DOI 10.2310/JIM.0b013e31822467a3; Beyazit Y, 2012, HEPATO-GASTROENTEROL, V59, P1469, DOI 10.5754/hge10676; de Gonzalo-Calvo D, 2012, CYTOKINE, V58, P193, DOI 10.1016/j.cyto.2012.01.005; DOUGLAS SW, 1975, BLOOD, V45, P55; FELD R, 1994, LUNG CANCER-J IASLC, V11, pS19, DOI 10.1016/0169-5002(94)91861-9; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Ferrucci Luigi, 2005, Am J Med, V118, P1288; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Grant BJB, 2003, CHEST, V124, P494, DOI 10.1378/chest.124.2.494; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Li J, 2009, ONCOLOGY-BASEL, V76, P355, DOI 10.1159/000210024; Lou YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037644; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Nathan SD, 2013, CHEST, V143, P1692, DOI 10.1378/chest.12-1368; Ozkalemkas F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-144; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Seretis Charalampos, 2013, J Clin Med Res, V5, P121, DOI 10.4021/jocmr1214w; Seyhan EC, 2013, RED BLOOD CELL DISTR, V10, P416, DOI [10.3109/15412555.2012.758697, DOI 10.3109/15412555.2012.758697]; SPEIGHTS VO, 1992, ARCH PATHOL LAB MED, V116, P258; Spell DW, 2004, CANCER DETECT PREV, V28, P37, DOI 10.1016/j.cdp.2003.10.002; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460	28	175	185	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80240	10.1371/journal.pone.0080240	http://dx.doi.org/10.1371/journal.pone.0080240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244659	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600195
J	Li, P; Sun, HJ; Zhang, LL; Ding, L; Han, Y; Zhu, GQ; Zhou, YB				Li, Peng; Sun, Hai-Jian; Zhang, Ling-Li; Ding, Lei; Han, Ying; Zhu, Guo-Qing; Zhou, Ye-Bo			Melanocortin 4 Receptors in the Paraventricular Nucleus Modulate the Adipose Afferent Reflex in Rat	PLOS ONE			English	Article							SYMPATHETIC ACTIVATION; HYPERTENSIVE-RATS; BLOOD-PRESSURE; OUTFLOW NEURONS; INDUCED OBESITY; LEPTIN SENSORS; MESSENGER-RNA; CYCLIC-AMP; SYSTEM; TISSUE	Background and Aim: Paraventricular nucleus (PVN) of hypothalamus is an important central component in modulating adipose afferent reflex (AAR). Melanocortin receptors (MC3/4Rs) expressions are found in the hypothalamic PVN. This study was designed to determine the roles of MC3/4Rs in the PVN in modulating the AAR and its downstream signaling pathway in normal rats. Methodology/Principal Findings: Renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded in anaesthetized rats. AAR was evaluated using RSNA and MAP responses to capsaicin injection into the inguinal white adipose tissue (iWAT). Microinjection of the MC3/4R agonist melanotan II (MTII) into the PVN enhanced the AAR. The MC3/4R antagonist SHU9119 or MC4R antagonist HS024 attenuated the AAR and abolished MTII-induced AAR response. The adenylate cyclase (AC) inhibitor SQ22536 or the protein kinase A (PKA) inhibitor Rp-cAMP attenuated the AAR and the effect of MTII on the AAR was abolished by pretreatment with SQ22536 or Rp-cAMP in the PVN. Furthermore, both PVN microinjection of MTII and iWAT injection of capsaicin increased the cAMP level in the PVN. SHU9119 in the PVN abolished the increase in cAMP level which induced by iWAT injection of capsaicin. Conclusion: The activation of MC4Rs rather than MC3Rs enhances the AAR, and a cAMP-PKA pathway is involved in the effects of MC4Rs in the PVN.	[Li, Peng; Sun, Hai-Jian; Zhang, Ling-Li; Ding, Lei; Han, Ying; Zhu, Guo-Qing; Zhou, Ye-Bo] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Li, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhou, YB (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	zhouyebo666@njmu.edu.cn		Zhou, Yebo/0000-0001-9465-1338; Han, Ying/0000-0001-8591-7894; Zhu, Guo-Qing/0000-0002-3132-9592	National Natural Science Foundation of China [81000106, 31171095, 31271213]; Jiangsu Higher Education Institutions of China [10KJB310004]; Nanjing Medical University of China [09JC013, 09NJMUZ04, JX10131801056]; Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions of China; Nanjing Medical University of China; Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the funds from the National Natural Science Foundation of China (81000106, 31171095 and 31271213); the Jiangsu Higher Education Institutions of China (10KJB310004); the Nanjing Medical University of China (09JC013, 09NJMUZ04 and JX10131801056) and a project funded by the Priority Academic Program Developmennt of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Crestani CC, 2010, NEUROSCI RES, V67, P317, DOI 10.1016/j.neures.2010.05.001; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; Dubinion JH, 2010, J HYPERTENS, V28, P1466, DOI 10.1097/HJH.0b013e328339f20e; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Li P, 2013, EXP PHYSIOL, V98, P435, DOI 10.1113/expphysiol.2012.067256; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Niijima A, 1999, NEUROSCI LETT, V262, P125, DOI 10.1016/S0304-3940(99)00054-3; Niijima A, 1998, J AUTONOM NERV SYST, V73, P19, DOI 10.1016/S0165-1838(98)00109-X; Olivan MV, 2001, BRAIN RES, V895, P167, DOI 10.1016/S0006-8993(01)02067-4; RAVI K, 1988, CAN J PHYSIOL PHARM, V66, P946, DOI 10.1139/y88-154; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi NF, 2010, EXP PHYSIOL, V95, P845, DOI 10.1113/expphysiol.2009.051789; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Shi Z, 2012, J APPL PHYSIOL, V112, P1008, DOI 10.1152/japplphysiol.01164.2011; Siljee-Wong JE, 2011, EUR J PHARMACOL, V660, P234, DOI 10.1016/j.ejphar.2010.10.104; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Sutton GM, 2005, ENDOCRINOLOGY, V146, P3739, DOI 10.1210/en.2005-0562; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Turcato S, 1999, BRIT J PHARMACOL, V126, P845, DOI 10.1038/sj.bjp.0702383; Valenti D, 2011, BIOCHEM J, V435, P679, DOI 10.1042/BJ20101908; Wang WZ, 2006, NEUROSCI LETT, V409, P146, DOI 10.1016/j.neulet.2006.09.032; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Xu Y, 2011, EXP PHYSIOL, V96, P1282, DOI 10.1113/expphysiol.2011.059733	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80295	10.1371/journal.pone.0080295	http://dx.doi.org/10.1371/journal.pone.0080295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244673	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600201
J	Nurmi, K; Virkanen, J; Rajamaki, K; Niemi, K; Kovanen, PT; Eklund, KK				Nurmi, Katariina; Virkanen, Juhani; Rajamaki, Kristiina; Niemi, Katri; Kovanen, Petri T.; Eklund, Kari K.			Ethanol Inhibits Activation of NLRP3 and AIM2 Inflammasomes in Human Macrophages- A Novel Anti-Inflammatory Action of Alcohol	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; NF-KAPPA-B; CATHEPSIN-B; NALP3 INFLAMMASOME; OXIDATIVE STRESS; GENE-EXPRESSION; CONSUMPTION; INTERLEUKIN-1-BETA	Objective: In the pathogenesis of coronary atherosclerosis, local macrophage-driven inflammation and secretion of proinflammatory cytokines, interleukin-1 beta (IL-1 beta) in particular, are recognized as key factors. Moderate alcohol consumption is associated with a reduced risk of coronary artery disease mortality. Here we examined in cultured human macrophages whether ethanol modulates the intracellular processes involved in the secretion of IL-1 beta. Results: Ethanol decreased dose-dependently the production of mature IL-1b induced by activators of the NLRP3 inflammasome, i.e. ATP, cholesterol crystals, serum amyloid A and nigericin. Ethanol had no significant effect on the expression of NLRP3 or IL1 beta mRNA in LPS-primed macrophages. Moreover, secretion of IL-1 beta was decreased in parallel with reduction of caspase-1 activation, demonstrating that ethanol inhibits inflammasome activation instead of synthesis of pro-IL-1 beta. Acetaldehyde, a highly reactive metabolite of ethanol, had no effect on the ATP-induced IL-1 beta secretion. Ethanol also attenuated the secretion of IL-1 beta triggered by synthetic double-stranded DNA, an activator of the AIM2 inflammasome. Ethanol conferred the inhibitory functions by attenuating the disruption of lysosomal integrity and ensuing leakage of the lysosomal protease cathepsin B and by reducing oligomerization of ASC. Conclusion: Ethanol-induced inhibition of the NLRP3 inflammasome activation in macrophages may represent a biological pathway underlying the protective effect of moderate alcohol consumption on coronary heart disease.	[Nurmi, Katariina; Rajamaki, Kristiina; Niemi, Katri; Kovanen, Petri T.; Eklund, Kari K.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Virkanen, Juhani] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Eklund, Kari K.] Univ Helsinki, Cent Hosp, Dept Med, Div Rheumatol, Helsinki, Finland	Wihuri Research Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Nurmi, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	katariina.nurmi@helsinki.fi		Nurmi, Katariina/0000-0001-5406-5334; Rajamaki, Kristiina/0000-0001-5151-1220	Wihuri Research Institute; Ida Montin Foundation; Maire Lisko Foundation	Wihuri Research Institute; Ida Montin Foundation; Maire Lisko Foundation	The study was supported by Wihuri Research Institute, maintained by the Jenny and Antti Wihuri Foundation. The study was also supported by grants from Ida Montin Foundation and Maire Lisko Foundation (K Nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabi S, 1999, J IMMUNOL, V162, P7441; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Costanzo S, 2010, J AM COLL CARDIOL, V55, P1339, DOI 10.1016/j.jacc.2010.01.006; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Cui JH, 2002, ANN NY ACAD SCI, V957, P308, DOI 10.1111/j.1749-6632.2002.tb02931.x; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hutson JL, 1999, J PATHOL, V188, P197, DOI 10.1002/(SICI)1096-9896(199906)188:2<197::AID-PATH295>3.0.CO;2-M; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Inokuchi T, 2008, CYTOKINE, V42, P198, DOI 10.1016/j.cyto.2008.01.001; International Organization for Standardization, 2003, 1729422003 ISO; Jin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035505; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KNIGHT CG, 1980, BIOCHEM J, V189, P447, DOI 10.1042/bj1890447; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Oak S, 2006, J IMMUNOL, V176, P7628, DOI 10.4049/jimmunol.176.12.7628; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Raum E, 2007, INT J CARDIOL, V121, P224, DOI 10.1016/j.ijcard.2006.08.104; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; Vazquez-Agell M, 2007, J NUTR, V137, P2279, DOI 10.1093/jn/137.10.2279	62	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78537	10.1371/journal.pone.0078537	http://dx.doi.org/10.1371/journal.pone.0078537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244322	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600032
J	Roossien, DH; Lamoureux, P; Van Vactor, D; Miller, KE				Roossien, Douglas H.; Lamoureux, Phillip; Van Vactor, David; Miller, Kyle E.			Drosophila Growth Cones Advance by Forward Translocation of the Neuronal Cytoskeletal Meshwork In Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AXONAL-TRANSPORT; MICROTUBULE DYNAMICS; EXTRACELLULAR-MATRIX; TIME-LAPSE; NEURITE OUTGROWTH; ACTIN; LAMININ; MITOCHONDRIA; REGENERATION	In vitro studies conducted in Aplysia and chick sensory neurons indicate that in addition to microtubule assembly, long microtubules in the C-domain of the growth cone move forward as a coherent bundle during axonal elongation. Nonetheless, whether this mode of microtubule translocation contributes to growth cone motility in vivo is unknown. To address this question, we turned to the model system Drosophila. Using docked mitochondria as fiduciary markers for the translocation of long microtubules, we first examined motion along the axon to test if the pattern of axonal elongation is conserved between Drosophila and other species in vitro. When Drosophila neurons were cultured on Drosophila extracellular matrix proteins collected from the Drosophila Kc167 cell line, docked mitochondria moved in a pattern indicative of bulk microtubule translocation, similar to that observed in chick sensory neurons grown on laminin. To investigate whether the C-domain is stationary or advances in vivo, we tracked the movement of mitochondria during elongation of the aCC motor neuron in stage 16 Drosophila embryos. We found docked mitochondria moved forward along the axon shaft and in the growth cone C-domain. This work confirms that the physical mechanism of growth cone advance is similar between Drosophila and vertebrate neurons and suggests forward translocation of the microtubule meshwork in the axon underlies the advance of the growth cone C-domain in vivo. These results highlight the need for incorporating en masse microtubule translocation, in addition to assembly, into models of axonal elongation.	[Roossien, Douglas H.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Lamoureux, Phillip; Miller, Kyle E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Van Vactor, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Michigan State University; Michigan State University; Harvard University; Harvard Medical School	Miller, KE (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kmiller@msu.edu		Roossien, Douglas/0000-0003-1184-2919; Miller, Kyle/0000-0003-0401-4736; Van Vactor, Jr., David L./0000-0001-8156-9482	NSF [IOS_0951019];  [NS35909]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER; Direct For Biological Sciences [0951019] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DVV was supported by NS35909 (http://grants.nih.gov/grants/oer.htm). KEM was supported by NSF grant IOS_0951019 (http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus CA, 2013, TRENDS CELL BIOL, V23, P305, DOI 10.1016/j.tcb.2013.02.001; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Ayali A, 2012, J MOL HISTOL, V43, P379, DOI 10.1007/s10735-012-9416-0; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Beadle D. J., 2006, Invertebrate Neuroscience, V6, P95, DOI 10.1007/s10158-006-0024-0; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Broadie K, 2011, DEV NEUROBIOL, V71, P1102, DOI 10.1002/dneu.20935; Campos-Ortega JA, 1997, EMBRYONIC DEV DROSOP, Vxvii; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Chang SH, 1998, J NEUROSCI, V18, P821; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; CONDIC ML, 1989, J NEUROSCI, V9, P2678; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Evans AR, 2007, DEV NEUROBIOL, V67, P1721, DOI 10.1002/dneu.20540; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; GULLBERG D, 1994, DEV DYNAM, V199, P116, DOI 10.1002/aja.1001990205; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; HIRANO S, 1991, DEVELOPMENT, V113, P1007; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; JOSHI HC, 1985, J CELL BIOL, V101, P697, DOI 10.1083/jcb.101.3.697; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Ketschek AR, 2007, DEV NEUROBIOL, V67, P1305, DOI 10.1002/dneu.20455; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kumagai C, 1997, FEBS LETT, V412, P211, DOI 10.1016/S0014-5793(97)00780-1; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; Lamoureux PL, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-140; Lee AC, 2008, DEV NEUROBIOL, V68, P1363, DOI 10.1002/dneu.20662; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MARTENSON C, 1993, NATURE, V366, P66, DOI 10.1038/366066a0; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2008, J THEOR BIOL, V255, P369, DOI 10.1016/j.jtbi.2008.09.009; Pan YA, 2003, J NEUROSCI, V23, P11479; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prokop A, 2012, NEUROMETHODS, P225; Prokop A, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-17; Prokop A, 2013, J CELL SCI, V126, P2331, DOI 10.1242/jcs.126912; Rauch P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015007; Reichardt LF, 2011, DEV NEUROBIOL, V71, P883, DOI 10.1002/dneu.20975; REINSCH SS, 1991, J CELL BIOL, V115, P365, DOI 10.1083/jcb.115.2.365; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SALVATERRA PM, 1987, J NEUROSCI, V7, P10; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sicaeros Beatriz, 2007, J Vis Exp, P226, DOI 10.3791/226; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Suter DM, 2011, ADV NEUROBIOL, V5, P45, DOI 10.1007/978-1-4419-7368-9_4; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Takagi Y, 1996, J BIOL CHEM, V271, P18074, DOI 10.1074/jbc.271.30.18074; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wagner OI, 2003, J NEUROSCI, V23, P9046; WALTER MF, 1984, J CELL BIOL, V99, P1468, DOI 10.1083/jcb.99.4.1468; WU CF, 1983, J NEUROSCI, V3, P1888; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	92	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80136	10.1371/journal.pone.0080136	http://dx.doi.org/10.1371/journal.pone.0080136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244629	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600184
J	Zhang, B; Li, Y; Zheng, XD; Zuo, XB; Zhou, FS; Liang, B; Zhu, J; Li, P; Ding, YT; Huang, ZL; Wang, BZ; Chen, ZD				Zhang, Bo; Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao; Huang, Zhonglian; Wang, Benzhong; Chen, Zhendong			A Common Variant in the SIAH2 Locus Is Associated with Estrogen Receptor-Positive Breast Cancer in the Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; DOWN-REGULATION; RISK VARIANT; IDENTIFIES 2; LIGASE; METAANALYSIS; GENETICS; HYPOXIA; ALLELES	Background: Genome-wide association studies (GWAS) have identified many loci associated with breast cancer risk. These studies have primarily been conducted in populations of European descent. Objective: To determine whether previously reported susceptibility loci in other ethnic groups are also risk factors for breast cancer in a Chinese population. Method: We genotyped 21 previously reported single nucleotide polymorphisms (SNPs) within a female Chinese cohort of 1203 breast cancer cases and 2525 healthy controls using the Sequenom iPlex platform. Fourteen SNPs passed the quality control test. These SNPs were subjected to statistical analysis for the entire cohort and were further analyzed for estrogen receptor (ER) status. The associations of the SNPs with disease susceptibility were assessed using logistic regression, adjusting for age. The Bonferroni correction was used to conservatively account for multiple testing, and the threshold for statistical significance was P<3.57x10(-3) (0.05/14). Result: Although none of the SNPs showed an overall association with breast cancer, an analysis of the ER status of the breast cancer patients revealed that the SIAH2 locus (rs6788895; P = 5.73 x 10(-4), odds ratio [OR] = 0.81) is associated with ER-positive breast cancer. Conclusion: A common variant in the SIAH2 locus is associated with ER-positive breast cancer in the Chinese Han population. The replication of published GWAS results in other ethnic groups provides important information regarding the genetic etiology of breast cancer.	[Zhang, Bo; Huang, Zhonglian; Chen, Zhendong] Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Anhui, Peoples R China; [Zhang, Bo] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; Anhui Med Univ, Dept Dermatol & Venereol, Hefei, Anhui, Peoples R China; [Li, Yang; Zheng, Xiaodong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Zhu, Jun; Li, Pan; Ding, Yantao] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Wang, Benzhong] Anhui Med Univ, Dept Galactophore Surg, Hosp 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhang, B (corresponding author), Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Anhui, Peoples R China.	alvinbo@163.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Youth Program of National Natural Science Foundation of China(2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barzan D, 2013, EUR J HUM GENET, DOI [10.1038/ejhg.2013.38, DOI 10.1038/EJHG.2013.38.[]; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elgazzar S, 2012, J HUM GENET, V57, P766, DOI 10.1038/jhg.2012.108; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kulakosky PC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290137; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79365	10.1371/journal.pone.0079365	http://dx.doi.org/10.1371/journal.pone.0079365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244489	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600127
J	Ohara, S; Sato, S; Oyama, K; Tsutsui, KI; Iijima, T				Ohara, Shinya; Sato, Sho; Oyama, Kei; Tsutsui, Ken-Ichiro; Iijima, Toshio			Rabies Virus Vector Transgene Expression Level and Cytotoxicity Improvement Induced by Deletion of Glycoprotein Gene	PLOS ONE			English	Article							TRANSNEURONAL TRACER; RECOMBINANT; TRANSCRIPTION; ATTENUATION; APOPTOSIS; VARIANTS; NETWORKS; NEURONS; REGIONS; INPUTS	The glycoprotein (G) of rabies virus (RV) is required for binding to neuronal receptors and for viral entry. G-deleted RV vector is a powerful tool for investigating the organization and function of the neural circuits. It gives the investigator the ability to genetically target initial infection to particular neurons and to control trans-synaptic propagation. In this study we have quantitatively evaluated the effect of G gene deletion on the cytotoxicity and transgene expression level of the RV vector. We compared the characteristics of the propagation-competent RV vector (rHEP5.0-CVSG-mRFP) and the G-deleted RV vector (rHEP5.0-Delta G-mRFP), both of which are based on the attenuated HEP-Flury strain and express monomeric red fluorescent protein (mRFP) as a transgene. rHEP5.0-Delta G-mRFP showed lower cytotoxicity than rHEP5.0-CVSG-mRFP, and within 16 days of infection we found no change in the basic electrophysiological properties of neurons infected with the rHEP5.0-Delta G-mRFP. The mRFP expression level of rHEP5.0-Delta G-mRFP was much higher than that of rHEP5.0-CVSG-mRFP, and 3 days after infection the retrogradely infected neurons were clearly visualized by the expressed fluorescent protein without any staining. This may be due to the low cytotoxicity and/or the presumed change in the polymerase gene (L) expression level of the G-deleted RV vector. Although the mechanisms remains to be clarified, the results of this study indicate that deletion of the G gene greatly improves the usability of the RV vector for studying the organization and function of the neural circuits by decreasing the cytotoxicity and increasing the transgene expression level.	[Ohara, Shinya; Sato, Sho; Oyama, Kei; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan	Tohoku University	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086; Oyama, Kei/0000-0002-3375-7099	Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24223004]	Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Strategic Research Program for Brain Sciences and by Grant-in-Aid for Scientific Research (KAKENHI) #24223004 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Inoue S, 2003, PATHOL INT, V53, P525, DOI 10.1046/j.1440-1827.2003.01511.x; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Ohara S, 2009, SOC NEUR ABSTR, V288, P25; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3332; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WIKTOR TJ, 1984, DEV BIOLOGICALS, V57, P199; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	36	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80245	10.1371/journal.pone.0080245	http://dx.doi.org/10.1371/journal.pone.0080245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244660	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900070
J	Tammaro, M; Barr, P; Ricci, B; Yan, H				Tammaro, Margaret; Barr, Peri; Ricci, Brett; Yan, Hong			Replication-Dependent and Transcription-Dependent Mechanisms of DNA Double-Strand Break Induction by the Topoisomerase 2-Targeting Drug Etoposide	PLOS ONE			English	Article							II-BETA; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CLEAVABLE COMPLEXES; MLL TRANSLOCATIONS; END RESECTION; REPAIR; ALPHA; GENE; PROLIFERATION	Etoposide is a DNA topoisomerase 2-targeting drug widely used for the treatment of cancer. The cytoxicity of etoposide correlates with the generation of DNA double-strand breaks (DSBs), but the mechanism of how it induces DSBs in cells is still poorly understood. Catalytically, etoposide inhibits the re-ligation reaction of Top2 after it nicks the two strands of DNA, trapping it in a cleavable complex consisting of two Top2 subunits covalently linked to the 5' ends of DNA (Top2cc). Top2cc is not directly recognized as a true DSB by cells because the two subunits interact strongly with each other to hold the two ends of DNA together. In this study we have investigated the cellular mechanisms that convert Top2ccs into true DSBs. Our data suggest that there are two mechanisms, one dependent on active replication and the other dependent on proteolysis and transcription. The relative contribution of each mechanism is affected by the concentration of etoposide. We also find that Top2 alpha is the major isoform mediating the replication-dependent mechanism and both Top2 alpha and Top2 mediate the transcription-dependent mechanism. These findings are potentially of great significance to the improvement of etoposide's efficacy in cancer therapy.	[Tammaro, Margaret; Barr, Peri; Ricci, Brett; Yan, Hong] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Yan, H (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Hong_Yan@fccc.edu			National Institute of Health [R01 GM57962-02, 2 R01 GM057962-12A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057962] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institute of Health (http://nih.gov/) to H.Y. (R01 GM57962-02 and 2 R01 GM057962-12A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanati I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008104; Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; AUSTIN CA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P283, DOI 10.1016/0167-4781(93)90215-Y; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Cornarotti M, 1996, MOL PHARMACOL, V50, P1463; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; DARPA P, 1990, CANCER RES, V50, P6919; de Campos-Nebel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012541; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Fan JR, 2008, DNA REPAIR, V7, P452, DOI 10.1016/j.dnarep.2007.12.002; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Goswami PC, 1996, MOL CELL BIOL, V16, P1500; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1988, CANCER RES, V48, P3230; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Kornberg A., 1992, DNA REPLICATION; LONG BH, 1985, CANCER RES, V45, P3106; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; OLIVE PL, 1993, INT J RADIAT BIOL, V64, P349, DOI 10.1080/09553009314551531; Pommier Y., 2011, CANC CHEMOTHERAPY BI, P392; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Smith MA, 1999, J CLIN ONCOL, V17, P569, DOI 10.1200/JCO.1999.17.2.569; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; TAN KB, 1992, CANCER RES, V52, P231; Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200	50	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79202	10.1371/journal.pone.0079202	http://dx.doi.org/10.1371/journal.pone.0079202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244448	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900034
J	Cloonan, K; Bedoukian, RH; Leal, W				Cloonan, Kevin; Bedoukian, Robert H.; Leal, Walter			Quasi-Double-Blind Screening of Semiochemicals for Reducing Navel Orangeworm Oviposition on Almonds	PLOS ONE			English	Article							TRANSITELLA WALKER LEPIDOPTERA; AMYELOIS-TRANSITELLA; MOTH LEPIDOPTERA; EGG TRAPS; PYRALIDAE OVIPOSITION; CHILO-PARTELLUS; ESSENTIAL OILS; RESPONSES; BEHAVIOR; EXTRACTS	A three-step, quasi-double-bind approach was used as a proof-of-concept study to screen twenty compounds for their ability to reduce oviposition of gravid female navel orangeworm(NOW), Ameylois transitella (Lepidoptera: Pyralidae). First, the panel of compounds, whose identity was unknown to the experimenters, was tested by electroantennogram (EAG) using antennae of two-day old gravid females as the sensing element. Of the twenty compounds tested three showed significant EAG responses. These three EAG-active compounds and a negative control were then analyzed for their ability to reduce oviposition via small-cage, two-choice laboratory assays. Two of the three compounds significantly reduced oviposition under laboratory conditions. Lastly, these two compounds were deployed in a field setting in an organic almond orchard in Arbuckle, CA using black egg traps to monitor NOW oviposition. One of these two compounds significantly reduced oviposition on black egg traps under these field conditions. Compound 9 (later identified as isophorone) showed a significant reduction in oviposition in field assays and thus has a potential as a tool to control the navel orangeworm as a pest of almonds.	[Cloonan, Kevin; Leal, Walter] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Bedoukian, Robert H.] Bedoukian Res Inc, Danbury, CT USA	University of California System; University of California Davis	Leal, W (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	Bedoukian Research Inc. (BRI); University of California-Davis [201118886]	Bedoukian Research Inc. (BRI); University of California-Davis(University of California System)	This work was supported by Bedoukian Research Inc. (BRI) under a research agreement with the University of California-Davis (number 201118886). Under the terms of the UC Davis-BRI agreement, the findings were disclosed to the sponsor prior to publication. The funder (BRI) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agboka Komi, 2009, International Journal of Tropical Insect Science, V29, P185, DOI 10.1017/S1742758409990348; AGUDELOSILVA F, 1995, FLA ENTOMOL, V78, P516, DOI 10.2307/3495537; ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Atanassov A, 2002, J ECON ENTOMOL, V95, P803, DOI 10.1603/0022-0493-95.4.803; Beck JJ, 2008, J SCI FOOD AGR, V88, P1363, DOI 10.1002/jsfa.3224; Binder BF, 1997, J AGR FOOD CHEM, V45, P980, DOI 10.1021/jf960400z; Burks CS, 2008, ENTOMOL EXP APPL, V129, P66, DOI 10.1111/j.1570-7458.2008.00754.x; Burks CS, 2011, ENVIRON ENTOMOL, V40, P706, DOI 10.1603/EN10253; Campbell BC, 2003, J TOXICOL-TOXIN REV, V22, P225, DOI 10.1081/TXR-120024093; Eilers EJ, 2009, BIOL CONTROL, V51, P388, DOI 10.1016/j.biocontrol.2009.07.010; Engle C. E., 1983, California Agriculture, V37, P19; Gajmer T, 2002, J APPL ENTOMOL, V126, P238, DOI 10.1046/j.1439-0418.2002.00649.x; GE XS, 1995, J ECON ENTOMOL, V88, P1771, DOI 10.1093/jee/88.6.1771; Gokce A, 2006, J APPL ENTOMOL, V130, P509, DOI 10.1111/j.1439-0418.2006.01101.x; Guerra PC, 2007, J APPL ENTOMOL, V131, P134, DOI 10.1111/j.1439-0418.2007.01138.x; Higbee BS, 2008, J ECON ENTOMOL, V101, P1633, DOI 10.1603/0022-0493(2008)101[1633:EOMDTO]2.0.CO;2; Higbee BS, 2011, J ECON ENTOMOL, V104, P211, DOI 10.1603/EC10162; Higbee BS, 2009, CALIF AGR, V63, P24, DOI 10.3733/ca.v063n01p24; HONDA K, 1995, ARCH INSECT BIOCHEM, V30, P1, DOI 10.1002/arch.940300102; HOUGHGOLDSTEIN J, 1992, ENVIRON ENTOMOL, V21, P837, DOI 10.1093/ee/21.4.837; Jenkins PE, 2007, J ECON ENTOMOL, V100, P855, DOI 10.1603/0022-0493(2007)100[855:RIFCOG]2.0.CO;2; JOHNSON JA, 1989, J ECON ENTOMOL, V82, P1391, DOI 10.1093/jee/82.5.1391; Kuenen LPSB, 2008, CALIF AGR, V62, P36, DOI 10.3733/ca.v062n01p36; LANDOLT PJ, 1991, J KANSAS ENTOMOL SOC, V64, P414; LEGNER EF, 1992, J ECON ENTOMOL, V85, P2153, DOI 10.1093/jee/85.6.2153; Liu ML, 2008, J INSECT PHYSIOL, V54, P656, DOI 10.1016/j.jinsphys.2008.01.002; Liu ZO, 2010, J CHEM ECOL, V36, P787, DOI 10.1007/s10886-010-9811-5; Miller JR, 2009, J ECON ENTOMOL, V102, P2056, DOI 10.1603/029.102.0606; Niu GD, 2012, J ECON ENTOMOL, V105, P410, DOI 10.1603/EC10194; Niu GD, 2009, J CHEM ECOL, V35, P951, DOI 10.1007/s10886-009-9675-8; Opender Koul, 2008, Biopesticides International, V4, P63; Park KC, 2002, CHEM SENSES, V27, P343, DOI 10.1093/chemse/27.4.343; Parra-Pedrazzoli AL, 2006, NEOTROP ENTOMOL, V35, P769, DOI 10.1590/S1519-566X2006000600008; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; RICE RE, 1976, ENVIRON ENTOMOL, V5, P697, DOI 10.1093/ee/5.4.697; RICE RE, 1984, J ECON ENTOMOL, V77, P1352, DOI 10.1093/jee/77.5.1352; Rojas JC, 2003, ENVIRON ENTOMOL, V32, P1386, DOI 10.1603/0046-225X-32.6.1386; SANDERSON JP, 1989, ENVIRON ENTOMOL, V18, P612, DOI 10.1093/ee/18.4.612; Scott IM, 2004, J ECON ENTOMOL, V97, P1390, DOI 10.1603/0022-0493-97.4.1390; SEAMAN WS, 1984, ENVIRON ENTOMOL, V13, P81, DOI 10.1093/ee/13.1.81; Seljasen R, 2006, CROP PROT, V25, P338, DOI 10.1016/j.cropro.2005.05.007; Siegel J, 2004, BIOL CONTROL, V30, P410, DOI 10.1016/j.biocontrol.2003.12.004; Singh R, 2011, ENTOMOL EXP APPL, V138, P55, DOI 10.1111/j.1570-7458.2010.01071.x; Syed Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2489; TABASHNIK BE, 1985, ENVIRON ENTOMOL, V14, P575, DOI 10.1093/ee/14.5.575; TEBBETS JS, 1978, J ECON ENTOMOL, V71, P875, DOI 10.1093/jee/71.6.875; TINGLE FC, 1986, J CHEM ECOL, V12, P1523, DOI 10.1007/BF01012369; (USDA-NASS) USDoA-NASS, 2012, CAL ALM ACR REP; VANSTEENWYK RA, 1987, J ECON ENTOMOL, V80, P1291, DOI 10.1093/jee/80.6.1291; Varshney AK, 2003, J AGR FOOD CHEM, V51, P4008, DOI 10.1021/jf0211074; WADE WILLIAM H., 1961, HILGARDIA, V31, P129; Zalom FG, 2009, UC IPM PEST MANAGEME, P61	52	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80182	10.1371/journal.pone.0080182	http://dx.doi.org/10.1371/journal.pone.0080182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244643	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800133
J	Gabel, K; Schmitt, J; Schulz, S; Nather, DJ; Soppa, J				Gaebel, Katrin; Schmitt, Jessica; Schulz, Sebastian; Naether, Daniela J.; Soppa, Joerg			A Comprehensive Analysis of the Importance of Translation Initiation Factors for Haloferax volcanii Applying Deletion and Conditional Depletion Mutants	PLOS ONE			English	Article							MESSENGER-RNA; MECHANISMS; CONSTRUCTION; EVOLUTION; GENES; DECAY; EIF2	Translation is an important step in gene expression. The initiation of translation is phylogenetically diverse, since currently five different initiation mechanisms are known. For bacteria the three initiation factors IF1 - IF3 are described in contrast to archaea and eukaryotes, which contain a considerably higher number of initiation factor genes. As eukaryotes and archaea use a non-overlapping set of initiation mechanisms, orthologous proteins of both domains do not necessarily fulfill the same function. The genome of Haloferax volcanii contains 14 annotated genes that encode (subunits of) initiation factors. To gain a comprehensive overview of the importance of these genes, it was attempted to construct single gene deletion mutants of all genes. In 9 cases single deletion mutants were successfully constructed, showing that the respective genes are not essential. In contrast, the genes encoding initiation factors aIF1, aIF2 gamma, aIF5A, aIF5B, and aIF6 were found to be essential. Factors aIF1A and aIF2 beta are encoded by two orthologous genes in H. volcanii. Attempts to generate double mutants failed in both cases, indicating that also these factors are essential. A translatome analysis of one of the single aIF2 beta deletion mutants revealed that the translational efficiency of the second ortholog was enhanced tenfold and thus the two proteins can replace one another. The phenotypes of the single deletion mutants also revealed that the two aIF1As and aIF2 beta s have redundant but not identical functions. Remarkably, the gene encoding aIF2 alpha, a subunit of aIF2 involved in initiator tRNA binding, could be deleted. However, the mutant had a severe growth defect under all tested conditions. Conditional depletion mutants were generated for the five essential genes. The phenotypes of deletion mutants and conditional depletion mutants were compared to that of the wild-type under various conditions, and growth characteristics are discussed.	[Gaebel, Katrin; Schmitt, Jessica; Schulz, Sebastian; Naether, Daniela J.; Soppa, Joerg] Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Soppa, J (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (Deutsche Forschungsgemeinschaft) [So 264/19-1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This project was funded by the German Research Council (Deutsche Forschungsgemeinschaft) through project So 264/19-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Benelli D, 2003, MOL MICROBIOL, V50, P635, DOI 10.1046/j.1365-2958.2003.03721.x; Benelli D, 2011, BIOCHEM SOC T, V39, P89, DOI 10.1042/BST0390089; Benelli D, 2009, RES MICROBIOL, V160, P493, DOI 10.1016/j.resmic.2009.06.003; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Boelens R, 2002, CURR PROTEIN PEPT SC, V3, P107, DOI 10.2174/1389203023380765; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dambeck M, 2008, ARCH MICROBIOL, V190, P341, DOI 10.1007/s00203-008-0379-1; Dev K, 2009, J MOL BIOL, V392, P701, DOI 10.1016/j.jmb.2009.07.030; Dmitriev SE, 2011, J MOL BIOL, V413, P106, DOI 10.1016/j.jmb.2011.08.026; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hasenohrl D, 2009, RNA, V15, P2288, DOI 10.1261/rna.1662609; Hasenohrl D, 2006, RNA, V12, P674, DOI 10.1261/rna.2289306; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Hernandez G, 2010, TRENDS BIOCHEM SCI, V35, P63, DOI 10.1016/j.tibs.2009.10.009; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hundt S, 2007, J BACTERIOL, V189, P6936, DOI 10.1128/JB.00559-07; Jantzer K, 2011, FEMS MICROBIOL LETT, V322, P123, DOI 10.1111/j.1574-6968.2011.02341.x; Komar AA, 2012, GENE, V502, P75, DOI 10.1016/j.gene.2012.04.039; Kozak M, 2002, MAMM GENOME, V13, P401, DOI 10.1007/s00335-002-4002-5; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; La Teana A, 2013, BIOCHEM SOC T, V41, P350, DOI 10.1042/BST20120300; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Milon P, 2012, NAT STRUCT MOL BIOL, V19, P609, DOI 10.1038/nsmb.2285; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; Pedulla N, 2005, NUCLEIC ACIDS RES, V33, P1804, DOI 10.1093/nar/gki321; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Soppa J, 2011, BIOCHEM SOC T, V39, P150, DOI 10.1042/BST0390150; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e77188	10.1371/journal.pone.0077188	http://dx.doi.org/10.1371/journal.pone.0077188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244275	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800003
J	Pinto, VB; Burden, R; Wagner, A; Moran, EE; Lee, CH				Pinto, Valerian B.; Burden, Robert; Wagner, Allyn; Moran, Elizabeth E.; Lee, Che-Hung			The Development of an Experimental Multiple Serogroups Vaccine for Neisseria meningitidis	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; OUTER-MEMBRANE PROTEIN; MENINGOCOCCAL MENINGITIS; GROUP-B; EPIDEMIOLOGY; DETERMINANT; STRAINS	A native outer membrane vesicles (NOMV) vaccine was developed from three antigenically diverse strains of Neisseria meningitidis that express the L1,8, L2, and L3,7 lipooligosaccharide (LOS) immunotypes, and whose synX, and lpxL1 genes were deleted.. Immunogenicity studies in mice showed that the vaccine induced bactericidal antibody against serogroups B, C, W, Y and X N. meningitidis strains. However, this experimental NOMV vaccine was not effective against serogroup A N. meningitidis strains. N. meningitidis capsular polysaccharide (PS) from serogroups A, C, W and Y were effective at inducing bactericidal antibody when conjugated to either tetanus toxoid or the fHbp1-fHbp2 fusion protein fHbp(1+2). The combination of the NOMV vaccine and the N. meningitidis serogroup A capsular polysaccharide (MAPS) protein conjugate was capable of inducing bactericidal antibodies against a limited number of N. meningitidis strains from serogroups A, B, C, W, Y and X tested in this study.	[Pinto, Valerian B.; Burden, Robert; Wagner, Allyn; Moran, Elizabeth E.] WRAIR, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA; [Lee, Che-Hung] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	Walter Reed Army Institute of Research (WRAIR); US Food & Drug Administration (FDA)	Pinto, VB (corresponding author), WRAIR, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA.	vpinto21@msn.com			Military Infectious Disease Research Program	Military Infectious Disease Research Program	This work was supported by the Military Infectious Disease Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMAND J, 1982, J BIOL STAND, V10, P335, DOI 10.1016/S0092-1157(82)80010-3; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bratcher HB, 2012, FUTURE MICROBIOL, V7, P873, DOI [10.2217/fmb.12.62, 10.2217/FMB.12.62]; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Christensen H, 2010, 17 INT PATH NEISS C, P41; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; FINNE J, 1983, LANCET, V2, P355; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOTSCHLICH EC, 1969, J EXP MED, V129, P1349, DOI 10.1084/jem.129.6.1349; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; JONES DM, 1992, MICROB PATHOGENESIS, V13, P219, DOI 10.1016/0882-4010(92)90022-G; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; MORAN EE, 1994, INFECT IMMUN, V62, P5290, DOI 10.1128/IAI.62.12.5290-5295.1994; Moran EE, 2012, CLIN VACCINE IMMUNOL, V19, P659, DOI 10.1128/CVI.00070-12; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mutonga DM, 2009, AM J TROP MED HYG, V80, P619; Pajon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066536; Pillai S, 2005, VACCINE, V23, P2206, DOI 10.1016/j.vaccine.2005.01.056; Pinto VB, 2011, VACCINE, V29, P7752, DOI 10.1016/j.vaccine.2011.07.124; Reisinger KS, 2009, CLIN VACCINE IMMUNOL, V16, P1810, DOI 10.1128/CVI.00207-09; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Van Den Dobbelsteen G, 2004, 14 INT PATH NEISS C, P153; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006; Zollinger WD, 2009, CLIN VACCINE IMMUNOL, V16, P1789, DOI 10.1128/CVI.00255-09	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79304	10.1371/journal.pone.0079304	http://dx.doi.org/10.1371/journal.pone.0079304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244473	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800058
J	Yan, N; Chen, N; Zhu, HH; Zhang, JG; Sim, M; Ma, Y; Wang, W				Yan, Na; Chen, Ning; Zhu, Honghua; Zhang, Jianguo; Sim, Moira; Ma, Yu; Wang, Wei			High-Frequency Stimulation of Nucleus Accumbens Changes in Dopaminergic Reward Circuit	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VENTRAL TEGMENTAL AREA; COCAINE-INDUCED REINSTATEMENT; ALCOHOL-PREFERRING AA; IN-VIVO MICRODIALYSIS; AVOIDING ANA RATS; EXTRACELLULAR GLUTAMATE; ELECTRICAL-STIMULATION; GLOBUS-PALLIDUS; RECEPTOR ACTIVATION	Deep brain stimulation (DBS) of the nucleus accumbens (NAc) is a potential remedial therapy for drug craving and relapse, but the mechanism is poorly understood. We investigated changes in neurotransmitter levels during high frequency stimulation (HFS) of the unilateral NAc on morphine-induced rats. Sixty adult Wistar rats were randomized into five groups: the control group (administration of saline), the morphine-only group (systematic administration of morphine without electrode implantation), the morphine-sham-stimulation group (systematic administration of morphine with electrode implantation but not given stimulation), the morphine-stimulation group (systematic administration of morphine with electrode implantation and stimulation) and the saline-stimulation group (administration of saline with electrode implantation and stimulation). The stimulation electrode was stereotaxically implanted into the core of unilateral NAc and microdialysis probes were unilaterally lowered into the ipsilateral ventral tegmental area (VTA), NAc, and ventral pallidum (VP). Samples from microdialysis probes in the ipsilateral VTA, NAc, and VP were analyzed for glutamate (Glu) and gamma-aminobutyric acid (GABA) by high-performance liquid chromatography (HPLC). The levels of Glu were increased in the ipsilateral NAc and VP of morphine-only group versus control group, whereas Glu levels were not significantly changed in the ipsilateral VTA. Furthermore, the levels of GABA decreased significantly in the ipsilateral NAc, VP, and VTA of morphine only group when compared with control group. The profiles of increased Glu and reduced GABA in morphine-induced rats suggest that the presence of increased excitatory neurotransmission in these brain regions. The concentrations of the Glu significantly decreased while the levels of GABA increased in ipsilateral VTA, NAc, and VP in the morphine-stimulation group compared with the morphine-only group. No significant changes were seen in the morphine-sham stimulation group compared with the morphine-only group. These findings indicated that unilateral NAc stimulation inhibits the morphine induced rats associated hyperactivation of excitatory neurotransmission in the mesocorticolimbic reward circuit.	[Yan, Na; Wang, Wei] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Beijing, Peoples R China; [Chen, Ning] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhu, Honghua] Sixth People Hosp Jinan, Dept Gastroenterol, Jinan, Peoples R China; [Zhang, Jianguo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Sim, Moira; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Syst & Intervent Res Ctr Hlth, Perth, WA, Australia; [Ma, Yu] Tsinghua Univ, Yuquan Hosp, Beijing 100084, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Edith Cowan University; Tsinghua University	Ma, Y (corresponding author), Tsinghua Univ, Yuquan Hosp, Beijing 100084, Peoples R China.	lymayu@163.com; wei.wanf@ecu.edu.au	yan, na/HDM-3747-2022; liu, li/HGC-0900-2022	wang, wei/0000-0002-1430-1360	National Natural Science Foundation of China [81070901, 81141013, 31070727]; Beijing Nova Program [2008B043]; Australia-China Sciences Research Foundation [ACSRF06444]; National "12th Five-Year" Plan for Science and Technology Support, China [2012BAI37B03]; Beijing Outstanding Talents Project [2011D003034000019]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Australia-China Sciences Research Foundation(Australian Government); National "12th Five-Year" Plan for Science and Technology Support, China; Beijing Outstanding Talents Project; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	This work was supported by grants from the National Natural Science Foundation of China (No. 81070901, No. 81141013, 31070727), Beijing Nova Program (2008B043), the Australia-China Sciences Research Foundation (ACSRF06444), National "12th Five-Year" Plan for Science and Technology Support, China (2012BAI37B03). Dr. Yu Ma was supported by the Beijing Outstanding Talents Project (No. 2011D003034000019) and Prof Wei Wang was supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MA, 2009, BRAIN RES, V1288, P95, DOI 10.1016/j.brainres.2009.06.100; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Caille S, 2004, EUR J NEUROSCI, V20, P593, DOI 10.1111/j.1460-9568.2004.03497.x; Comer SD, 2007, PSYCHOPHARMACOLOGY, V193, P235, DOI 10.1007/s00213-007-0775-2; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Dahchour A, 2000, ALCOHOL ALCOHOLISM, V35, P548, DOI 10.1093/alcalc/35.6.548; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Fattore L, 2005, PHARMACOL BIOCHEM BE, V81, P343, DOI 10.1016/j.pbb.2005.01.031; Fecteau S, 2010, SUBST USE MISUSE, V45, P1766, DOI 10.3109/10826084.2010.482434; Gao GD, 2003, STEREOT FUNCT NEUROS, V81, P96, DOI 10.1159/000075111; Haberler C, 2000, ANN NEUROL, V48, P372, DOI 10.1002/1531-8249(200009)48:3<372::AID-ANA12>3.0.CO;2-0; Hao Y, 2005, BRAIN RES, V1040, P191, DOI 10.1016/j.brainres.2005.01.072; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Hiller A, 2007, J NEUROSCI METH, V159, P286, DOI 10.1016/j.jneumeth.2006.07.023; Hu WH, 2011, MED SCI MONITOR, V17, pBR153, DOI 10.12659/MSM.881802; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Karimi Sara, 2011, Iranian Biomedical Journal, V15, P92; Kemppainen H, 2010, ALCOHOL ALCOHOLISM, V45, P111, DOI 10.1093/alcalc/agp086; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, CLIN NEUROSCI RES, V5, P89, DOI 10.1016/j.cnr.2005.08.005; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Leite-Morris KA, 2004, J PHARMACOL EXP THER, V308, P667, DOI 10.1124/jpet.103.058412; Li TL, 2004, NEUROSCI LETT, V371, P117, DOI 10.1016/j.neulet.2004.08.050; Li X, 2009, NEUROPSYCHOPHARMACOL, V34, P1783, DOI 10.1038/npp.2008.236; Lian J, 2003, J PHYSIOL-LONDON, V547, P427, DOI 10.1113/jphysiol.2002.033209; Liu HY, 2008, ADDICT BIOL, V13, P40, DOI 10.1111/j.1369-1600.2007.00088.x; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; McFarland K, 2003, J NEUROSCI, V23, P3531; Moser A, 2003, NEUROSCI LETT, V341, P57, DOI 10.1016/S0304-3940(03)00133-2; Noori HR, 2012, ADDICT BIOL, V17, P827, DOI 10.1111/j.1369-1600.2012.00485.x; Ojanen SP, 2007, EUR J PHARMACOL, V559, P38, DOI 10.1016/j.ejphar.2006.11.046; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Paxions G, 1997, RAT BRAIN STEREOTAXI; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Schiller Y, 2007, J NEUROPHYSIOL, V97, P1887, DOI 10.1152/jn.00514.2006; Sizemore GM, 2000, PSYCHOPHARMACOLOGY, V150, P391, DOI 10.1007/s002130000456; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027; STEKETEE JD, 1992, PROG NEURO-PSYCHOPH, V16, P237, DOI 10.1016/0278-5846(92)90075-P; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Tokuyama S, 2001, NEUROCHEM INT, V39, P103, DOI 10.1016/S0197-0186(01)00019-5; Tomkins DM, 2001, CAN MED ASSOC J, V164, P817; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Wang XF, 2011, EUR J PHARMACOL, V650, P200, DOI 10.1016/j.ejphar.2010.09.071; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Windels F, 2003, J NEUROSCI RES, V72, P259, DOI 10.1002/jnr.10577; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wydra K, 2013, ADDICT BIOL, V18, P307, DOI 10.1111/adb.12031; Xu JW, 2005, CHIN J STEREOTACT FU, V18, P140; Yang TT, 2004, SYNAPSE, V51, P83, DOI 10.1002/syn.10290	56	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79318	10.1371/journal.pone.0079318	http://dx.doi.org/10.1371/journal.pone.0079318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244479	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800062
J	Ding, F; Yao, J; Rettberg, JR; Chen, SH; Brinton, RD				Ding, Fan; Yao, Jia; Rettberg, Jamaica R.; Chen, Shuhua; Brinton, Roberta Diaz			Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ENERGY-METABOLISM; EXPRESSION; LACTATE; DISEASE; HIPPOCAMPAL; ASTROCYTE; OLIGODENDROCYTES; ESTRADIOL; MECHANISM	We previously demonstrated that mitochondrial bioenergetic deficits in the female brain accompanied reproductive senescence and was accompanied by a shift from an aerobic glycolytic to a ketogenic phenotype. Herein, we investigated the relationship between systems of fuel supply, transport and mitochondrial metabolic enzyme expression/activity during aging (3-15 months) in the hippocampus of nontransgenic (nonTg) background and 3xTgAD female mice. Results indicate that during female brain aging, both nonTg and 3xTgAD brains undergo significant decline in glucose transport, as detected by FDG-microPET, between 6-9 months of age just prior to the transition into reproductive senescence. The deficit in brain metabolism was sustained thereafter. Decline in glucose transport coincided with significant decline in neuronal glucose transporter expression and hexokinase activity with a concomitant rise in phosphorylated/inactivated pyruvate dehydrogenase. Lactate utilization declined in parallel to the decline in glucose transport suggesting lactate did not serve as an alternative fuel. An adaptive response in the nonTg hippocampus was a shift to transport and utilization of ketone bodies as an alternative fuel. In the 3xTgAD brain, utilization of ketone bodies as an alternative fuel was evident at the earliest age investigated and declined thereafter. The 3xTgAD adaptive response was to substantially increase monocarboxylate transporters in neurons while decreasing their expression at the BBB and in astrocytes. Collectively, these data indicate that the earliest change in the metabolic system of the aging female brain is the decline in neuronal glucose transport and metabolism followed by decline in mitochondrial function. The adaptive shift to the ketogenic system as an alternative fuel coincided with decline in mitochondrial function. Translationally, these data provide insights into the earliest events in bioenergetic aging of the female brain and provide potential targets for preventing shifts to less efficient bioenergetic fuels and transition to the ketogenic phenotype of the Alzheimer's brain.	[Ding, Fan; Yao, Jia; Chen, Shuhua; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Rettberg, Jamaica R.; Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Brinton, RD (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu		Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [R01AG032236, P01AG026572]; Eileen L. Norris Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032236, P01AG026572] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eileen L. Norris Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported herein was supported by National Institute on Aging (http://www.nia.nih.gov/) R01AG032236 (to RDB), National Institute on Aging (http://www.nia.nih.gov/) P01AG026572 (Project 1 to RDB) and Eileen L. Norris Foundation (http://ktn.org/) (to RDB). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BROCKELHURSTS TXB GE, DOI DOI 10.1016/B978-1-4160-6231-8.X0001-3; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DEVASKAR SU, 1992, PEDIATR RES, V31, P1, DOI 10.1203/00006450-199201000-00001; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059825; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; Fattoretti P, 2001, J HISTOCHEM CYTOCHEM, V49, P671, DOI 10.1177/002215540104900518; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; FINCH CE, 1984, ENDOCR REV, V5, P467, DOI 10.1210/edrv-5-4-467; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hoyer S, 1991, ANN NY ACAD SCI, V640, P53; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; Leybaert L, 2005, J CEREBR BLOOD F MET, V25, P2, DOI 10.1038/sj.jcbfm.9600001; LUNDANDERSEN H, 1979, PHYSIOL REV, V59, P305, DOI 10.1152/physrev.1979.59.2.305; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Moorthy K, 2004, BIOGERONTOLOGY, V5, P249, DOI 10.1023/B:BGEN.0000038026.89337.02; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pauwels EKJ, 2000, J CANCER RES CLIN, V126, P549, DOI 10.1007/PL00008465; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Qutub AA, 2005, BRAIN RES REV, V49, P595, DOI 10.1016/j.brainresrev.2005.03.002; Rasgon NL, 2005, NEUROBIOL AGING, V26, P229, DOI 10.1016/j.neurobiolaging.2004.03.003; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Van Kempen TA, 2011, BRAIN RES, V1379, P176, DOI 10.1016/j.brainres.2010.12.064; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; Weber MT, 2013, MENOPAUSE, V20, P511, DOI [10.1097/GME.0b013e31827655e5, 10.1097/gme.0b013e31827655e5]; Weber MT, 2013, J STEROID BIOCH MOL; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Yao J, 2011, NEUROBIOLOGY AGING; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2	60	149	152	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79977	10.1371/journal.pone.0079977	http://dx.doi.org/10.1371/journal.pone.0079977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244584	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600162
J	Encarnacion-Luevano, A; Rojas-Soto, OR; Sigala-Rodriguez, JJ				Encarnacion-Luevano, Alondra; Rojas-Soto, Octavio R.; Jesus Sigala-Rodriguez, J.			Activity Response to Climate Seasonality in Species with Fossorial Habits: A Niche Modeling Approach Using the Lowland Burrowing Treefrog (Smilisca fodiens)	PLOS ONE			English	Article							ECOLOGICAL NICHES; ANURAN AMPHIBIANS; DISTRIBUTIONS; EVOLUTION; BEHAVIOR; BIRDS; EXTINCTIONS; ECTOTHERMS; PHYSIOLOGY; PATTERNS	The importance of climatic conditions in shaping the geographic distribution of amphibian species is mainly associated to their high sensitivity to environmental conditions. How they cope with climate gradients through behavioral adaptations throughout their distribution is an important issue due to the ecological and evolutionary implications for population viability. Given their low dispersal abilities, the response to seasonal climate changes may not be migration, but behavioral and physiological adaptations. Here we tested whether shifts in climatic seasonality can predict the temporal variation of surface activity of the fossorial Lowland Burrowing Treefrog (Smilisca fodiens) across its geographical distribution. We employed Ecological Niche Modeling (ENM) to perform a monthly analysis of spatial variation of suitable climatic conditions (defined by the July conditions, the month of greatest activity), and then evaluated the geographical correspondence of monthly projections with the occurrence data per month. We found that the species activity, based on the species' occurrence data, corresponds with the latitudinal variation of suitable climatic conditions. Due to the behavioral response of this fossorial frog to seasonal climate variation, we suggest that precipitation and temperature have played a major role in the definition of geographical and temporal distribution patterns, as well as in shaping behavioral adaptations to local climatic conditions. This highlights the influence of macroclimate on shaping activity patterns and the important role of fossorials habits to meet the environmental requirements necessary for survival.	[Encarnacion-Luevano, Alondra; Jesus Sigala-Rodriguez, J.] Univ Autonoma Aguascalientes, Dept Biol, Aguascalientes, Mexico; [Rojas-Soto, Octavio R.] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico	Universidad Autonoma de Aguascalientes; Instituto de Ecologia - Mexico	Rojas-Soto, OR (corresponding author), Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.edu.mx	Rojas-Soto, Octavio/Q-6252-2018; Sigala-Rodríguez, J. Jesus/B-3617-2013	Rojas-Soto, Octavio/0000-0002-0201-1454; Sigala-Rodríguez, J. Jesus/0000-0002-5895-1568; Encarnacion-Luevano, Alondra/0000-0003-1930-375X	Consejo Nacional de Ciencia y Tecnologia [373460]; Universidad Autonoma de Aguascalientes	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Autonoma de Aguascalientes	Funding provided by Consejo Nacional de Ciencia y Tecnologia Grant number 373460(http://www.conacyt.gob.mx) and Universidad Autonoma de Aguascalientes (www.uaa.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Barve N, 2008, TOOL PARTIAL ROC; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Booth DT, 2006, CAN J ZOOL, V84, P832, DOI 10.1139/Z06-062; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; DUELLMAN W. E., 1966, NEOTROPICAL HYLID FR; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman WE, 1999, PATTERNS DISTRIBUTIO; ESRI, 1999, ARCVIEWGIS V 3 2; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; GABRIEL W, 1992, J EVOLUTION BIOL, V5, P41, DOI 10.1046/j.1420-9101.1992.5010041.x; Garmer M, 2010, IRR VARIOUS COEFFICI; Grinnell J., 1917, Auk Cambridge Mass, V34; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOFFMAN J, 1989, OECOLOGIA, V81, P510, DOI 10.1007/BF00378961; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Lutterschmidt DI, 2006, CAN J ZOOL, V84, P771, DOI 10.1139/Z06-043; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003; Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032; Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rojas-Soto OR, 2003, J BIOGEOGR, V30, P449, DOI 10.1046/j.1365-2699.2003.00836.x; Santos-Barrera G, 2010, IUCN 2012 IUCN RED L; SCACHETTIPEREIR.R, 2002, DESKTOP GARP; Sears MW, 2011, INTEGR COMP BIOL, V51, P662, DOI 10.1093/icb/icr113; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Solomon S, 2007, CONTRIBUTION WORKING; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sullivan BK, 1996, GREAT BASIN NAT, V56, P38, DOI 10.5962/bhl.part.4107; Weatherhead PJ, 2012, J THERM BIOL, V37, P273, DOI 10.1016/j.jtherbio.2011.03.008; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882	52	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78290	10.1371/journal.pone.0078290	http://dx.doi.org/10.1371/journal.pone.0078290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244301	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600024
J	Martini, T; Czepielewski, LS; Fijtman, A; Sodre, L; Wollenhaupt-Aguiar, B; Pereira, CS; Vianna-Sulzbach, M; Goi, PD; Rosa, AR; Kapczinski, F; Kunz, M; Kauer-Sant'Anna, M				Martini, Thais; Czepielewski, Leticia Sanguinetti; Fijtman, Adam; Sodre, Leonardo; Wollenhaupt-Aguiar, Bianca; Pereira, Caroline Silveira; Vianna-Sulzbach, Mireia; Goi, Pedro D.; Rosa, Adriane Ribeiro; Kapczinski, Flavio; Kunz, Mauricio; Kauer-Sant'Anna, Marcia			Bipolar Disorder Affects Behavior and Social Skills on the Internet	PLOS ONE			English	Article							PSYCHIATRIC-SYMPTOMS; RATING-SCALE; NETWORK; ADOLESCENTS; BRAIN; COGNITION; IMPACT; SPREAD; ONLINE; MANIA	Background: Bipolar disorder (BD) is a significant cause of functional, cognitive, and social impairment. However, classic studies of functioning and social skills have not investigated how BD may impact behavior on the Internet. Given that the digital age has been changing the way people communicate, this study aims to investigate the pattern of Internet use in patients with BD. Methods: This cross-sectional study assessed 30 patients with BD I or II and 30 matched controls. Patients were not in an acute mood episode, according to DSM-IV. A standard protocol examined sociodemographic variables and social behavior on the Internet, assessed by Facebook number of friends (FBN) and lifetime estimated number of offline contacts (social network number, SNN). Results: SNN (p<0.001) and FBN (p = 0.036) of patients with BD were significantly lower than those of controls. Also, variables related with Internet use were significantly lower in patients, e. g., close contacts on Facebook (p = 0.021), Internet experience (p = 0.020), and knowledge of terms associated with social networking sites (p = 0.042). Also, patients showed lower rates of the expected pattern of Internet use (based on their age generation), including a poorer knowledge of SNS (p = 0.018) and a lower frequency of Internet use (p = 0.010). Discussion: This study suggests that patients with BD show smaller social networks both in real-world settings and on the Internet. Also, patients tend to use the Internet and social networking sites less frequently and show a poorer knowledge of Internet and social media than healthy controls, below the expected for their generation. These significant differences between patients and controls suggest that the effects of BD on social relationships and functioning extend to electronic media.	[Martini, Thais; Czepielewski, Leticia Sanguinetti; Sodre, Leonardo; Vianna-Sulzbach, Mireia; Goi, Pedro D.; Rosa, Adriane Ribeiro; Kapczinski, Flavio; Kunz, Mauricio; Kauer-Sant'Anna, Marcia] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Med Psiquiatria, Porto Alegre, RS, Brazil; [Martini, Thais; Czepielewski, Leticia Sanguinetti; Fijtman, Adam; Sodre, Leonardo; Wollenhaupt-Aguiar, Bianca; Pereira, Caroline Silveira; Vianna-Sulzbach, Mireia; Goi, Pedro D.; Rosa, Adriane Ribeiro; Kapczinski, Flavio; Kunz, Mauricio; Kauer-Sant'Anna, Marcia] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Mol Psychiat, Inst Nacl Ciencias & Tecnol Translac Med, Porto Alegre, RS, Brazil; [Wollenhaupt-Aguiar, Bianca; Kauer-Sant'Anna, Marcia] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Kapczinski, Flavio; Kunz, Mauricio; Kauer-Sant'Anna, Marcia] Univ Fed Rio Grande do Sul, Dept Psiquiatria & Med Legal, Fac Med, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Kauer-Sant'Anna, M (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Med Psiquiatria, Porto Alegre, RS, Brazil.	mksantanna@gmail.com	de Aguiar, Bianca Wollenhaupt/AAI-3522-2021; Kauer-Sant'Anna, Marcia/C-7399-2013; Sodre, Leonardo/ABE-3836-2020; Kapczinski, Flávio/D-3175-2013; Kapczinski, Flavio/J-5803-2014; Kunz, Mauricio/J-3136-2012; Czepielewski, Leticia Sanguinetti/H-7996-2018; Rosa, Adriane/G-6923-2013	de Aguiar, Bianca Wollenhaupt/0000-0002-8804-2664; Kauer-Sant'Anna, Marcia/0000-0003-2548-6230; Kapczinski, Flávio/0000-0001-8738-856X; Kunz, Mauricio/0000-0003-3074-1910; Cunha Martini, Thais/0000-0003-4644-2501; Czepielewski, Leticia Sanguinetti/0000-0002-3898-0273; Rosa, Adriane/0000-0001-8629-4625	Fundo de Incentivo a Pesquisa e Eventos - Hospital de Clinicas de Porto Alegre; National Science and Technology Institute for Translational Medicine; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundo de Incentivo a Pesquisa e Eventos - Hospital de Clinicas de Porto Alegre; National Science and Technology Institute for Translational Medicine; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundo de Incentivo a Pesquisa e Eventos - Hospital de Clinicas de Porto Alegre and by the National Science and Technology Institute for Translational Medicine, with the financial support by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CNPq - http://www.cnpq.br/ CAPES - http://www.capes.gov.br/ INCT-TM - http://www.ufrgs.br/inct-tm/ FIPE-HCPA - http://www.hcpa.ufrgs.br/	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Altshuler LL, 1998, ARCH GEN PSYCHIAT, V55, P663, DOI 10.1001/archpsyc.55.7.663; Amichai-Hamburger Y, 2007, COMPUT HUM BEHAV, V23, P880, DOI 10.1016/j.chb.2006.03.002; Associacao Brasileira de Empresas de Pesquisa (ABEP), 2012, CRIT CLASS EC BRAS C; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Carpenter CJ, 2012, PERS INDIV DIFFER, V52, P482, DOI 10.1016/j.paid.2011.11.011; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Duggan N, 2012, DEMOGRAPHICS SOCIAL; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Ellison N.B., 2011, NETWORKED SELF IDENT, P124; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Gurung RAR, 2003, PSYCHOL AGING, V18, P487, DOI 10.1037/0882-7974.18.3.487; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hampton KN, 2011, SOCIAL NETWORK SITE; Heaney C.A., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ibope Brasil, 2013, AUD INT DOM TRAB JUN; International Telecommunication Union, 2012, MEAS INF SOC; Jelenchick LA, 2013, J ADOLESCENT HEALTH, V52, P128, DOI 10.1016/j.jadohealth.2012.05.008; Johnson GM, 2008, COMPUT HUM BEHAV, V24, P2094, DOI 10.1016/j.chb.2007.10.001; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kauer-Sant'Anna M, 2008, BRIT J PSYCHIAT, V192, P458, DOI 10.1192/bjp.bp.107.040295; Kauer-Sant'Anna M, 2009, COMPR PSYCHIAT, V50, P1, DOI 10.1016/j.comppsych.2008.05.013; Kelleci M, 2010, CYBERPSYCH BEH SOC N, V13, P191, DOI 10.1089/cyber.2009.0026; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kotikalapudi R, 2012, IEEE TECHNOL SOC MAG, V31, P73, DOI 10.1109/MTS.2012.2225462; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Martinez-Aran A, 2004, BIPOLAR DISORD, V6, P224, DOI 10.1111/j.1399-5618.2004.00111.x; Martinez-Aran A, 2006, BIPOLAR DISORD, V8, P1; Michalak Erin E, 2005, Health Qual Life Outcomes, V3, P72, DOI 10.1186/1477-7525-3-72; Mileva VR, 2013, NEUROPSYCH DIS TREAT, V9, P31, DOI 10.2147/NDT.S38560; O'Keeffe GS, 2011, PEDIATRICS, V127, P800, DOI 10.1542/peds.2011-0054; Park S, 2012, AUSTR NZ J PSYCHIAT, P1; Pew Research Center's Internet & American Life Project, 2011, SEPT TRACK SURV 2009; Pew Research Center's Internet & American Life Project, 2011, SEPT 2010 HLTH TRACK; Powell J, 2012, P ROY SOC B-BIOL SCI, V279, P2157, DOI 10.1098/rspb.2011.2574; Powell JL, 2010, NEUROPSYCHOLOGIA, V48, P3554, DOI 10.1016/j.neuropsychologia.2010.08.004; Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Sigman A., 2012, IMPROVING QUALITY CH, V3, P88; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; Stileman E, 2007, THESIS; Strauss W., 1992, GENERATIONS HIST AM; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Veretilo P, 2012, PSYCHIAT QUART, V83, P385, DOI 10.1007/s11126-012-9207-5; Vita A, 2010, BRIT J PSYCHIAT, V196, P245, DOI 10.1192/bjp.196.3.245b; Wechsler D., 2004, WAIS 3 ESCALA INTELI; Weiler A, 2005, J ACAD LIBR, V31, P46, DOI 10.1016/j.acalib.2004.09.009; Yen JY, 2008, PSYCHIAT CLIN NEUROS, V62, P9, DOI 10.1111/j.1440-1819.2007.01770.x; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zubieta JK, 2001, PSYCHIAT RES, V102, P9, DOI 10.1016/S0165-1781(01)00242-6	62	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79673	10.1371/journal.pone.0079673	http://dx.doi.org/10.1371/journal.pone.0079673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244541	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600144
J	Mizunoya, W; Iwamoto, Y; Shirouchi, B; Sato, M; Komiya, Y; Razin, FR; Tatsumi, R; Sato, Y; Nakamura, M; Ikeuchi, Y				Mizunoya, Wataru; Iwamoto, Yohei; Shirouchi, Bungo; Sato, Masao; Komiya, Yusuke; Razin, Farzaneh Rahimi; Tatsumi, Ryuichi; Sato, Yusuke; Nakamura, Mako; Ikeuchi, Yoshihide			Dietary Fat Influences the Expression of Contractile and Metabolic Genes in Rat Skeletal Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HEAVY-CHAIN ISOFORMS; FIBER TYPES; MESSENGER-RNA; FISH-OIL; ACIDS; FOXO1; MASS; CHOLESTEROL; COACTIVATOR	Dietary fat plays a major role in obesity, lipid metabolism, and cardiovascular diseases. To determine whether the intake of different types of dietary fats affect the muscle fiber types that govern the metabolic and contractile properties of the skeletal muscle, we fed male Wistar rats with a 15% fat diet derived from different fat sources. Diets composed of soybean oil (n-6 polyunsaturated fatty acids (PUFA)-rich), fish oil (n-3 PUFA-rich), or lard (low in PUFAs) were administered to the rats for 4 weeks. Myosin heavy chain (MyHC) isoforms were used as biomarkers to delineate the skeletal muscle fiber types. Compared with soybean oil intake, fish oil intake showed significantly lower levels of the fast-type MyHC2B and higher levels of the intermediate-type MyHC2X composition in the extensor digitorum longus (EDL) muscle, which is a fast-type dominant muscle. Concomitantly, MyHC2X mRNA levels in fish oil-fed rats were significantly higher than those observed in the soybean oil-fed rats. The MyHC isoform composition in the lard-fed rats was an intermediate between that of the fish oil and soybean oil-fed rats. Mitochondrial uncoupling protein 3, pyruvate dehydrogenase kinase 4, and porin mRNA showed significantly upregulated levels in the EDL of fish oil-fed rats compared to those observed in soybean oil-fed and lard-fed rats, implying an activation of oxidative metabolism. In contrast, no changes in the composition of MyHC isoforms was observed in the soleus muscle, which is a slow-type dominant muscle. Fatty acid composition in the serum and the muscle was significantly influenced by the type of dietary fat consumed. In conclusion, dietary fat affects the expression of genes related to the contractile and metabolic properties in the fast-type dominant skeletal muscle, where the activation of oxidative metabolism is more pronounced after fish oil intake than that after soybean oil intake.	[Mizunoya, Wataru; Iwamoto, Yohei; Komiya, Yusuke; Razin, Farzaneh Rahimi; Tatsumi, Ryuichi; Sato, Yusuke; Nakamura, Mako; Ikeuchi, Yoshihide] Kyushu Univ, Dept Bioresource Sci, Grad Sch Agr, Fukuoka 812, Japan; [Shirouchi, Bungo; Sato, Masao] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Agr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Mizunoya, W (corresponding author), Kyushu Univ, Dept Bioresource Sci, Grad Sch Agr, Fukuoka 812, Japan.	wataru_m@agr.kyushu-u.ac.jp	Mizunoya, Wataru/W-1674-2019; Shirouchi, Bungo/J-4849-2019	Mizunoya, Wataru/0000-0002-2258-1964; Shirouchi, Bungo/0000-0003-4237-5081; Nakamura, Mako/0000-0002-6129-7560; Komiya, Yusuke/0000-0003-3225-2491	Japan Society for Promotion of Science [18780096, 22580136]; Uehara Memorial Foundation; Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research [23380159] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Young Scientists (B) (#18780096), Grant-in-Aid for Scientific Research (C) (#22580136) from Japan Society for Promotion of Science, and the research grant from the Uehara Memorial Foundation. The costs of publication were supported in part by a Research Grant for Young Investigators of the Faculty of Agriculture, Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre KJ, 1996, J NUTR, V126, P653, DOI 10.1093/jn/126.3.653; Azain MJ, 2004, J ANIM SCI, V82, P916; Baillie RA, 1999, PROSTAG LEUKOTR ESS, V60, P351, DOI 10.1016/S0952-3278(99)80011-8; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Cresser J, 2010, AM J PHYSIOL-REG I, V299, pR470, DOI 10.1152/ajpregu.00431.2009; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; FITZSIMONS DP, 1990, J APPL PHYSIOL, V68, P1950, DOI 10.1152/jappl.1990.68.5.1950; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553; HA HJ, 1993, J BIOL CHEM, V268, P12143; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Lee MS, 2013, NUTRIENTS, V5, P1660, DOI 10.3390/nu5051660; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2013, J NUTR SCI VITAMINOL, V59, P289, DOI 10.3177/jnsv.59.289; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oudart H, 1997, INT J OBESITY, V21, P955, DOI 10.1038/sj.ijo.0800500; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Pette D, 1998, ACTA PHYSIOL SCAND, V162, P367, DOI 10.1046/j.1365-201X.1998.0296e.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Rivero JLL, 1998, J MUSCLE RES CELL M, V19, P733, DOI 10.1023/A:1005482816442; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Takahashi Y, 2000, BRIT J NUTR, V84, P175; Talmadge RJ, 2004, BIOCHEM BIOPH RES CO, V325, P296, DOI 10.1016/j.bbrc.2004.10.030; TERMIN A, 1989, HISTOCHEMISTRY, V92, P453, DOI 10.1007/BF00524756; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yoshihara H, 2006, J NUTR SCI VITAMINOL, V52, P183, DOI 10.3177/jnsv.52.183; Zambon A, 1999, J INTERN MED, V246, P191, DOI 10.1046/j.1365-2796.1999.00550.x; Zhang JZ, 2012, J ANIM VET ADV, V11, P1411; Zhou AL, 2012, LIPIDS, V47, P1119, DOI 10.1007/s11745-012-3729-3; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	51	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80152	10.1371/journal.pone.0080152	http://dx.doi.org/10.1371/journal.pone.0080152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244634	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600186
J	Mohri, T; Ueno, M; Nagahama, Y; Gong, ZY; Asano, M; Oshima, H; Oshima, M; Fujio, Y; Takakura, N				Mohri, Tomomi; Ueno, Masaya; Nagahama, Yumi; Gong, Zhi-Yuan; Asano, Masahide; Oshima, Hiroko; Oshima, Masanobu; Fujio, Yasushi; Takakura, Nobuyuki			Requirement of SLD5 for Early Embryogenesis	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; STEM-CELL NICHE; CHROMOSOMAL DNA; XENOPUS-LAEVIS; GINS COMPLEX; CDC45; IDENTIFICATION; MAINTENANCE; EXPRESSION; MCM2-7	SLD5 forms a GINS complex with PSF1, PSF2 and PSF3, which is essential for the initiation of DNA replication in lower eukaryotes. Although these components are conserved in mammals, their biological function is unclear. We show here that targeted disruption of SLD5 in mice causes a defect in cell proliferation in the inner cell mass, resulting in embryonic lethality at the peri-implantation stage, indicating that SLD5 is essential for embryogenesis. Moreover, this phenotype of SLD5 mutant mice is quite similar compared with that of PSF1 mutant mice. We have previously reported that haploinsufficiency of PSF1 resulted in failure of acute proliferation of bone marrow hematopoietic stem cells (HSCs) during reconstitution of bone marrow ablated by 5-FU treatment. Since SLD5 was highly expressed in bone marrow, we investigated its involvement in bone marrow reconstitution after bone marrow ablation as observed in PSF1 heterozygous mutant mice. However, heterozygous deletion of the SLD5 gene was found not to significantly affect bone marrow reconstitution. On the other hand, abundant SLD5 expression was observed in human cancer cell lines and heterozygous deletion of the gene attenuated tumor progression in a murine model of spontaneous gastric cancer. These indicated that requirement and dependency of SLD5 for cell proliferation is different in different cell types.	[Mohri, Tomomi; Ueno, Masaya; Nagahama, Yumi; Gong, Zhi-Yuan; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Mohri, Tomomi; Fujio, Yasushi] Osaka Univ, Lab Clin Sci & Biomed, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Inst Expt Anim, Kanazawa, Ishikawa, Japan; [Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Osaka University; Osaka University; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp	Oshima, Masanobu/F-9958-2014; Fujio, Yasushi/H-3421-2017; UENO, Masaya/D-8464-2015	Oshima, Masanobu/0000-0002-3304-0004; Fujio, Yasushi/0000-0003-0828-2930; UENO, Masaya/0000-0001-9177-8640	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (M.U. and N.T.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gouge CA, 2010, BIOCHEM BIOPH RES CO, V400, P145, DOI 10.1016/j.bbrc.2010.08.033; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kong LY, 2006, BIOCHEM BIOPH RES CO, V339, P1204, DOI 10.1016/j.bbrc.2005.11.136; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nagahama Y, 2010, CANCER RES, V70, P1215, DOI 10.1158/0008-5472.CAN-09-3662; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Ueno M, 2009, BLOOD, V113, P555, DOI 10.1182/blood-2008-01-136879; Walter BE, 2004, GENE EXPR PATTERNS, V5, P81, DOI 10.1016/j.modgep.2004.06.005; Walter BE, 2008, MOL VIS, V14, P906; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78961	10.1371/journal.pone.0078961	http://dx.doi.org/10.1371/journal.pone.0078961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244394	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600087
J	Nookala, AR; Shah, A; Noel, RJ; Kumar, A				Nookala, Anantha R.; Shah, Ankit; Noel, Richard J.; Kumar, Anil			HIV-1 Tat-Mediated Induction of CCL5 in Astrocytes Involves NF-kappa B, AP-1, C/EBP alpha and C/EBP gamma Transcription Factors and JAK, PI3K/Akt and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVATED PROTEIN-KINASE; INTERLEUKIN-6 GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; TNF-ALPHA; RANTES/CCL5 EXPRESSION; ACETYLCYSTEINE AMIDE; CYTOKINE PRODUCTION	The incidence of HIV-associated neurological disorders (HAND) has increased during recent years even though the highly active antiretroviral therapy (HAART) has significantly curtailed the virus replication and increased the life expectancy among HIV-1 infected individuals. These neurological deficits have been attributed to HIV proteins including HIV-1 Tat. HIV-1 Tat is known to up-regulate CCL5 expression in mouse astrocytes, but the mechanism of up-regulation is not known. The present study was undertaken with the objective of determining the mechanism(s) underlying HIV-1 Tat-mediated expression of CCL5 in astrocytes. SVGA astrocytes were transiently transfected with a plasmid encoding Tat, and expression of CCL5 was studied at the mRNA and protein levels using real time RT-PCR and multiplex cytokine bead array, respectively. HIV-1 Tat showed a time-dependent increase in the CCL5 expression with peak mRNA and protein levels, observed at 1 h and 48 h post-transfection, respectively. In order to explore the mechanism(s), pharmacological inhibitors and siRNA against different pathway(s) were used. Pre-treatment with SC514 (NF-kappa B inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kappa B in CCL5 expression. These results were further confirmed by knockdown of the respective genes using siRNA. Furthermore, p38 MAPK was found to be involved since the knockdown of p38d but not other isoforms showed partial reduction in CCL5 induction. This was further confirmed at transcriptional level that AP-1, C/EBP alpha and C/EBP gamma were involved in CCL5 up-regulation.	[Nookala, Anantha R.; Shah, Ankit; Kumar, Anil] UMKC Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA; [Noel, Richard J.] Ponce Sch Med & Hlth Sci, Dept Biochem, Ponce, PR USA	University of Missouri System; University of Missouri Kansas City	Kumar, A (corresponding author), UMKC Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA.	kumaran@umkc.edu	Nookala, Anantha Ram/ABV-0636-2022; KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022; Nookala, Anantha Ram/ABT-0475-2022		National Institute on Drug Abuse [DA025528, DA025011]; National Institute on Alcohol Abuse and Alcoholism [AA020806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050, S10RR027668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011) and National Institute on Alcohol Abuse and Alcoholism (AA020806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Aukrust P, 1998, J INFECT DIS, V177, P1091, DOI 10.1086/517402; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Bartosik-Psujek H, 2005, EUR J NEUROL, V12, P49, DOI 10.1111/j.1468-1331.2004.00951.x; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066268; Christo PP, 2009, J NEUROL SCI, V287, P79, DOI 10.1016/j.jns.2009.09.002; Conant K, 1996, J VIROL, V70, P1384, DOI 10.1128/JVI.70.3.1384-1389.1996; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fessele S, 2001, FASEB J, V15, P577; Fotheringham JA, 2012, J VIROL, V86, P10308, DOI 10.1128/JVI.00853-12; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999; GOURDOU I, 1990, CR ACAD SCI III-VIE, V311, P149; GRIFFIN DE, 1991, NEUROLOGY, V41, P69, DOI 10.1212/WNL.41.1.69; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim TA, 2003, J IMMUNOL, V170, P2629, DOI 10.4049/jimmunol.170.5.2629; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kruman II, 1999, AM J PATHOL, V155, P39, DOI 10.1016/S0002-9440(10)65096-1; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Letendre SL, 1999, J INFECT DIS, V180, P310, DOI 10.1086/314866; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mamik MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045596; MASTROIANNI CM, 1992, J NEUROL NEUROSUR PS, V55, P219, DOI 10.1136/jnnp.55.3.219; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125; Qin B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2644; Qiu L, 2009, IMMUNOLOGY, V128, pe325, DOI 10.1111/j.1365-2567.2008.02966.x; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Rentzos M, 2007, ACTA NEUROL SCAND, V116, P374, DOI 10.1111/j.1600-0404.2007.00894.x; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shea LM, 1996, J IMMUNOL, V157, P3902; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Uckun FM, 2002, DRUG METAB DISPOS, V30, P74, DOI 10.1124/dmd.30.1.74; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Wong CK, 2005, CLIN EXP IMMUNOL, V139, P90, DOI 10.1111/j.1365-2249.2005.02678.x	83	27	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78855	10.1371/journal.pone.0078855	http://dx.doi.org/10.1371/journal.pone.0078855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244375	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600071
J	Badura, S; Tesanovic, T; Pfeifer, H; Wystub, S; Nijmeijer, BA; Liebermann, M; Falkenburg, JHF; Ruthardt, M; Ottmann, OG				Badura, Susanne; Tesanovic, Tamara; Pfeifer, Heike; Wystub, Sylvia; Nijmeijer, Bart A.; Liebermann, Marcus; Falkenburg, J. H. Frederik; Ruthardt, Martin; Ottmann, Oliver G.			Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MOLECULAR-MECHANISMS; KINASE INHIBITORS; MAMMALIAN TARGET; PIK3CA GENE; IN-VITRO; MTOR; RAPAMYCIN; RESISTANCE; MUTATIONS	Purpose: Aberrant PI3K/AKT/mTOR signaling has been linked to oncogenesis and therapy resistance in various malignancies including leukemias. In Philadelphia chromosome (Ph) positive leukemias, activation of PI3K by dysregulated BCR-ABL tyrosine kinase (TK) contributes to the pathogenesis and development of resistance to ABLTK inhibitors (TKI). The PI3K pathway thus is an attractive therapeutic target in BCR-ABL positive leukemias, but its role in BCR-ABL negative ALL is conjectural. Moreover, the functional contribution of individual components of the PI3K pathway in ALL has not been established. Experimental Design: We compared the activity of the ATP-competitive pan-PI3K inhibitor NVP-BKM120, the allosteric mTORC1 inhibitor RAD001, the ATP-competitive dual PI3K/mTORC1/C2 inhibitors NVP-BEZ235 and NVP-BGT226 and the combined mTORC1 and mTORC2 inhibitors Torin 1, PP242 and KU-0063794 using long-term cultures of ALL cells (ALL-LTC) from patients with B-precursor ALL that expressed the BCR-ABL or TEL-ABL oncoproteins or were BCR-ABL negative. Results: Dual PI3K/mTOR inhibitors profoundly inhibited growth and survival of ALL cells irrespective of their genetic subtype and their responsiveness to ABL-TKI. Combined suppression of PI3K, mTORC1 and mTORC2 displayed greater antileukemic activity than selective inhibitors of PI3K, mTORC1 or mTORC1 and mTORC2. Conclusions: Inhibition of the PI3K/mTOR pathway is a promising therapeutic approach in patients with ALL. Greater antileukemic activity of dual PI3K/mTORC1/C2 inhibitors appears to be due to the redundant function of PI3K and mTOR. Clinical trials examining dual PI3K/mTORC1/C2 inhibitors in patients with B-precursor ALL are warranted, and should not be restricted to particular genetic	[Badura, Susanne; Tesanovic, Tamara; Pfeifer, Heike; Wystub, Sylvia; Liebermann, Marcus; Ruthardt, Martin; Ottmann, Oliver G.] Goethe Univ Frankfurt, Dept Med Hematol & Oncol, D-60054 Frankfurt, Germany; [Nijmeijer, Bart A.; Falkenburg, J. H. Frederik] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands	Goethe University Frankfurt; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottmann, OG (corresponding author), Goethe Univ Frankfurt, Dept Med Hematol & Oncol, D-60054 Frankfurt, Germany.	ottmann@em.uni-frankfurt.de	Ottmann, Oliver G/D-5007-2016	Ottmann, Oliver G/0000-0001-9559-1330; Ruthardt, Martin/0000-0003-1021-3811	Deutsche Krebshilfe Verbundprojekt [108690]	Deutsche Krebshilfe Verbundprojekt(Deutsche Krebshilfe)	This research was funded and supported by the Deutsche Krebshilfe Verbundprojekt 108690. OGO holds an endowed professorship of the DJCLS (H06/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Ahmad EI, 2011, ONCOTARGETS THER, V4, P115, DOI 10.2147/OTT.S12602; Baeumler J, 2008, CANCER GENET CYTOGEN, V185, P37, DOI 10.1016/j.cancergencyto.2008.05.001; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; De P, 2013, CANCER TREAT REV, V39, P403, DOI 10.1016/j.ctrv.2012.12.002; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Faderl S, 1998, BLOOD, V91, P3995, DOI 10.1182/blood.V91.11.3995; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He YL, 2010, EUR J HAEMATOL, V84, P87, DOI 10.1111/j.1600-0609.2009.01350.x; Hofmann WK, 2004, LEUKEMIA LYMPHOMA, V45, P655, DOI 10.1080/10428190310001625755; Hummerdal P, 2006, EUR J HAEMATOL, V77, P86, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2605.x; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Lebwohl D, 2011, EXPERT OPIN DRUG DIS, V6, P323, DOI 10.1517/17460441.2011.558079; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahmoud IS, 2008, BRIT J CANCER, V99, P488, DOI 10.1038/sj.bjc.6604512; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Montiel-Duarte C, 2008, LEUKEMIA RES, V32, P709, DOI 10.1016/j.leukres.2007.09.005; Muller CI, 2007, LEUKEMIA RES, V31, P27, DOI 10.1016/j.leukres.2006.04.011; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Nijimeijer BA, 2009, EXP HEMATOL, V37, P376, DOI 10.1016/j.exphem.2008.11.002; Ottmann Oliver G, 2005, Hematology Am Soc Hematol Educ Program, P118; Ottmann Oliver G, 2009, Hematology Am Soc Hematol Educ Program, P371, DOI 10.1182/asheducation-2009.1.371; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Ren SY, 2005, MOL CELL BIOL, V25, P8001, DOI 10.1128/MCB.25.18.8001-8008.2005; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shortt J, 2013, BLOOD, V121, P2964, DOI 10.1182/blood-2012-08-446096; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xing HY, 2012, LEUKEMIA RES, V36, P509, DOI 10.1016/j.leukres.2011.12.018	55	50	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80070	10.1371/journal.pone.0080070	http://dx.doi.org/10.1371/journal.pone.0080070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244612	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800118
J	Greineder, CF; Chacko, AM; Zaytsev, S; Zern, BJ; Carnemolla, R; Hood, ED; Han, JY; Ding, BS; Esmon, CT; Muzykantov, VR				Greineder, Colin F.; Chacko, Ann-Marie; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Esmon, Charles T.; Muzykantov, Vladimir R.			Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; DISSEMINATED INTRAVASCULAR COAGULATION; SOLUBLE THROMBOMODULIN; CARDIAC-ARREST; SEVERE SEPSIS; RECEPTOR; DYSFUNCTION; THROMBOSIS; EXPRESSION; PECAM-1	The use of targeted therapeutics to replenish pathologically deficient proteins on the luminal endothelial membrane has the potential to revolutionize emergency and cardiovascular medicine. Untargeted recombinant proteins, like activated protein C (APC) and thrombomodulin (TM), have demonstrated beneficial effects in acute vascular disorders, but have failed to have a major impact on clinical care. We recently reported that TM fused with an scFv antibody fragment to platelet endothelial cell adhesion molecule-1 (PECAM-1) exerts therapeutic effects superior to untargeted TM. PECAM-1 is localized to cell-cell junctions, however, whereas the endothelial protein C receptor (EPCR), the key co-factor of TM/APC, is exposed in the apical membrane. Here we tested whether anchoring TM to the intercellular adhesion molecule (ICAM-1) favors scFv/TM collaboration with EPCR. Indeed: i) endothelial targeting scFv/TM to ICAM-1 provides similar to 15-fold greater activation of protein C than its PECAM-targeted counterpart; ii) blocking EPCR reduces protein C activation by scFv/TM anchored to endothelial ICAM-1, but not PECAM-1; and iii) anti-ICAM scFv/TM fusion provides more profound anti-inflammatory effects than anti-PECAM scFv/TM in a mouse model of acute lung injury. These findings, obtained using new translational constructs, emphasize the importance of targeting protein therapeutics to the proper surface determinant, in order to optimize their microenvironment and beneficial effects.	[Greineder, Colin F.; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greineder, Colin F.; Chacko, Ann-Marie; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Ctr Targeted Therapeut & Translat Nanomed, Philadelphia, PA 19104 USA; [Chacko, Ann-Marie] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Howard Hughes Med Inst, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Greineder, Colin/0000-0001-9740-7672; Chacko, Ann-Marie/0000-0001-5140-2622	Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; American Heart Association [10FTF4150053]; National Institutes of Health [R01-HL091950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091950] Funding Source: NIH RePORTER	Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Junior Investigator Preliminary/Feasibility Grant from the Institute of Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania (CFG), as well as an American Heart Association Fellow to Faculty grant 10FTF4150053 (CFG), and National Institutes of Health Grant R01-HL091950 (VRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Chrastina A, 2010, J VASC RES, V47, P531, DOI 10.1159/000313880; Christofidou-Solomidou M, 2002, AM J PATHOL, V160, P1155, DOI 10.1016/S0002-9440(10)64935-8; CROWE JS, 1989, NUCLEIC ACIDS RES, V17, P7992, DOI 10.1093/nar/17.19.7992; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Gentry CA, 2009, CRIT CARE MED, V37, P19, DOI 10.1097/CCM.0b013e318192843b; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kim AY, 2002, CIRC RES, V90, P205, DOI 10.1161/hh0202.105097; Kowalski PS, 2011, IUBMB LIFE, V63, P648, DOI 10.1002/iub.487; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; MacGregor IR, 1997, AM J RESP CRIT CARE, V155, P47, DOI 10.1164/ajrccm.155.1.9001288; MOORE KL, 1989, BLOOD, V73, P159; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro Silvia, 2004, Current Vascular Pharmacology, V2, P281, DOI 10.2174/1570161043385736; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Newby AC, 1999, CURR OPIN CARDIOL, V14, P489, DOI 10.1097/00001573-199911000-00007; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Pasqualini R, 2000, CANCER RES, V60, P722; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; SIDO B, 1995, TRANSPLANTATION, V60, P462, DOI 10.1097/00007890-199509000-00010; Simone E, 2009, CELL TISSUE RES, V335, P283, DOI 10.1007/s00441-008-0676-7; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Tabuchi N, 2004, EUR J CARDIO-THORAC, V26, P995, DOI 10.1016/j.ejcts.2004.07.028; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; TEASDALE MS, 1994, IMMUNOL CELL BIOL, V72, P480, DOI 10.1038/icb.1994.72; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Waugh JM, 1999, CIRC RES, V84, P84; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	54	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80110	10.1371/journal.pone.0080110	http://dx.doi.org/10.1371/journal.pone.0080110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244621	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800123
J	Ranieri, M; Tamma, G; Di Mise, A; Vezzoli, G; Soldati, L; Svelto, M; Valenti, G				Ranieri, Marianna; Tamma, Grazia; Di Mise, Annarita; Vezzoli, Giuseppe; Soldati, Laura; Svelto, Maria; Valenti, Giovanna			Excessive Signal Transduction of Gain-of-Function Variants of the Calcium-Sensing Receptor (CaSR) Are Associated with Increased ER to Cytosol Calcium Gradient	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPOCALCEMIA; CA2+-SENSING RECEPTOR; R990G POLYMORPHISM; EXTRACELLULAR DOMAIN; PLASMA-MEMBRANE; MUTATION; GENE; HYPERCALCIURIA; OSCILLATIONS; TRAFFICKING	In humans, gain-of-function mutations of the calcium-sensing receptor (CASR) gene are the cause of autosomal dominant hypocalcemia or type 5 Bartter syndrome characterized by an abnormality of calcium metabolism with low parathyroid hormone levels and excessive renal calcium excretion. Functional characterization of CaSR activating variants has been so far limited at demonstrating an increased sensitivity to external calcium leading to lower Ca-EC50. Here we combine high resolution fluorescence based techniques and provide evidence that for the efficiency of calcium signaling system, cells expressing gain-of-function variants of CaSR monitor cytosolic and ER calcium levels increasing the expression of the Sarco-Endoplasmic Reticulum Calcium-ATPase (SERCA) and reducing expression of Plasma Membrane Calcium-ATPase (PMCA). Wild-type CaSR (hCaSR-wt) and its gain-of-function (hCaSR-R990G; hCaSR-N124K) variants were transiently transfected in HEK-293 cells. Basal intracellular calcium concentration was significantly lower in cells expressing hCaSR-wt and its gain of function variants compared to mock. In line, FRET studies using the D1ER probe, which detects [Ca2+]ER directly, demonstrated significantly higher calcium accumulation in cells expressing the gain of function CaSR variants compared to hCaSR-wt. Consistently, cells expressing activating CaSR variants showed a significant increase in SERCA activity and expression and a reduced PMCA expression. This combined parallel regulation in protein expression increases the ER to cytosol calcium gradient explaining the higher sensitivity of CaSR gain-of-function variants to external calcium. This control principle provides a general explanation of how cells reliably connect (and exacerbate) receptor inputs to cell function.	[Ranieri, Marianna; Tamma, Grazia; Di Mise, Annarita; Svelto, Maria; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Vezzoli, Giuseppe] Hosp San Raffaele, Inst Sci, Nephrol & Dialysis Unit, I-20132 Milan, Italy; [Soldati, Laura] Univ Milan, Dept Hlth Sci, Milan, Italy; [Svelto, Maria; Valenti, Giovanna] Univ Bari, Ctr Excellence Genom & Prote GEBCA, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Universita degli Studi di Bari Aldo Moro	Valenti, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	giovanna.valenti@uniba.it	Di Mise, Annarita/AAP-4176-2020; Vezzoli, Giuseppe/J-4147-2018; Ranieri, Marianna/J-9421-2018; Svelto, Maria/P-6186-2014; Tamma, Grazia/F-8823-2016	Vezzoli, Giuseppe/0000-0003-4481-5693; Ranieri, Marianna/0000-0003-3118-5813; Tamma, Grazia/0000-0002-8890-0278; DI MISE, Annarita/0000-0002-8132-4917; Svelto, Maria/0000-0002-5584-9541; VALENTI, GIOVANNA/0000-0003-0233-0778; Soldati, Laura/0000-0002-3447-1172				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1482, DOI 10.1210/me.2011-1370; Brown EM, 2009, ENDOCRIN METAB CLIN, V38, P437, DOI 10.1016/j.ecl.2009.01.001; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chattopadhyay N, 2006, MOL GENET METAB, V89, P189, DOI 10.1016/j.ymgme.2006.07.003; Corbetta S, 2006, EUR J ENDOCRINOL, V155, P687, DOI 10.1530/eje.1.02286; Demarchi F, 2007, CELL CYCLE, V6, P136; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Falchetti A, 2012, EUR J ENDOCRINOL, V166, P933, DOI 10.1530/EJE-11-0953; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Hu JX, 2002, J BONE MINER RES, V17, P1461, DOI 10.1359/jbmr.2002.17.8.1461; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, PLOS ONE, V7; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Richard C, 2010, J BONE MINER RES, V25, P1627, DOI 10.1002/jbmr.58; SHULL GE, 1988, J BIOL CHEM, V263, P8646; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Terranegra A, 2010, J MOL ENDOCRINOL, V45, P245, DOI 10.1677/JME-10-0034; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Theman TA, 2009, J BONE MINER RES, V24, P964, DOI 10.1359/JBMR.081233; Valenti G, CELL PHYSL BIOCH, V26, P901; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; Vezzoli G, 2002, J AM SOC NEPHROL, V13, P2517, DOI 10.1097/01.ASN.0000030077.72157.D2; Ward DT, EUR J ENDOCRINOL, V169, pK1; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	45	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79113	10.1371/journal.pone.0079113	http://dx.doi.org/10.1371/journal.pone.0079113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244430	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800030
J	Zhu, CD; Cai, Y; Ma, J; Li, N; Zhu, JF; He, YP; Redmon, P; Qiao, Y				Zhu, Chendi; Cai, Yong; Ma, Jin; Li, Na; Zhu, Jingfen; He, Yaping; Redmon, Pamela; Qiao, Yun			Predictors of Intention to Smoke among Junior High School Students in Shanghai, China: An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model	PLOS ONE			English	Article							YOUTH TOBACCO SURVEY; ADOLESCENT SMOKING; INTERVENTION; PREVALENCE; INITIATION; EXPOSURE; ADULTS	Background: Adolescent smoking is a worldwide problem that is particularly severe in low- and middle-income countries. Many endogenous and environmental factors affect the intention to smoke, so a comprehensive model is needed to understand the significance and relationship of predictors. The study aimed to test the associations among information-motivation-behavioral skills (IMB) model constructs as predictors of intention to smoke in junior high school students in Shanghai, China. Methods: We conducted a cross-sectional study of 16,500 junior high school students in Shanghai, China. Data on tobacco-related information, motivation, behavioral skills, and behaviors were collected from students. Structural equation model (SEM) was used to assess the IMB model. Results: The mean age of participants was 13.8 years old (standard deviation = 1.02; range 11-17). The experimental smoking rate among junior high school students was 6.6% and 8.7% of the participants expected that they would be smokers in 5 years. The IMB model provided acceptable fit to the data (comparative fit index = 0.984, root mean square error of approximation = 0.04). Intention to smoke was predicted by behavioral skills (beta= 0.670, P < 0.001) and motivation (beta= 0.095, P<0.001) among junior high school students. Conclusion: The IMB model provides a good understanding of the predictors of intention to smoke and it suggests future interventions among junior high school students should focus on improving motivation and behavioral skills.	[Zhu, Chendi; Cai, Yong; Ma, Jin; Li, Na; Zhu, Jingfen; He, Yaping] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Redmon, Pamela] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Qiao, Yun] Pudong Inst Hlth Dev, Shanghai, Peoples R China	Shanghai Jiao Tong University; Emory University	Cai, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.	caiyong202028@hotmail.com; majin@shsmu.edu.cn	zhu, chendi/ABB-5874-2021	zhu, chendi/0000-0003-0956-4278	Bill & Melinda Gates Foundation; Shanghai Municipal Education Commission [12ZS106]; General program for young researchers of humanities and social studies, China Ministry of Education [12YTC840001]; New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); General program for young researchers of humanities and social studies, China Ministry of Education; New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University; Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission	This study was funded by (or in part by) the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. This publication is also supported by the following: Key liberal arts innovative project, Shanghai Municipal Education Commission (12ZS106); General program for young researchers of humanities and social studies, China Ministry of Education (12YTC840001); The New Hundred Program on Outstanding Teacher of the School of Medicine of Shanghai Jiaotong University and the Young Teachers Overseas Visiting and Training Program from Shanghai Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SC., 2009, OPEN ADDICTION J, V2, P12, DOI DOI 10.2174/1874941000902010012; BAUMAN KE, 1992, PSYCHOL REP, V71, P568, DOI 10.2466/PR0.71.6.568-570; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Biglan A, 2000, TOB CONTROL, V9, P24, DOI 10.1136/tc.9.1.24; BOTVIN GJ, 1992, PSYCHOL REP, V70, P171, DOI 10.2466/PR0.70.1.171-178; Brown AK, 2010, J ADOLESCENCE, V33, P603, DOI 10.1016/j.adolescence.2009.12.003; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BRUVOLD WH, 1993, AM J PUBLIC HEALTH, V83, P872, DOI 10.2105/AJPH.83.6.872; BURTON D, 1989, J APPL SOC PSYCHOL, V19, P656, DOI 10.1111/j.1559-1816.1989.tb00345.x; Cai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062787; Cai Y, 2012, INT J ENV RES PUB HE, V9, P3421, DOI 10.3390/ijerph9103421; Chen PL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-144; Chen XG, 2001, PREV MED, V32, P437, DOI 10.1006/pmed.2001.0826; COLLINS LM, 1987, J APPL SOC PSYCHOL, V17, P554, DOI 10.1111/j.1559-1816.1987.tb00330.x; Emery S, 2012, AM J PUBLIC HEALTH, V102, P751, DOI 10.2105/AJPH.2011.300443; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Fisher WA., 1999, AIDS BEHAV, V3, P13, DOI [10.1023/A:1025411317851, DOI 10.1023/A:1025411317851]; Gao JL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-100; GODIN G, 1992, BRIT J ADDICT, V87, P1335; Gruder CL, 2013, NICOTINE TOB RES, V15, P223, DOI 10.1093/ntr/nts116; Harakeh Z, 2011, EUR ADDICT RES, V17, P316, DOI 10.1159/000330318; Higgins A, 2003, PSYCHOL HEALTH MED, V8, P173, DOI [10.1080/1354850031000087555, DOI 10.1080/1354850031000087555]; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Misovich SJ, 2003, J APPL SOC PSYCHOL, V33, P775, DOI 10.1111/j.1559-1816.2003.tb01924.x; Nichols TR, 2006, J ADOLESCENT HEALTH, V38, P369, DOI 10.1016/j.jadohealth.2005.04.016; Peto R., 2009, CVD PREV CONTROL, V4, P61, DOI [10.1016/S1875-4570(09)60224-2, DOI 10.1016/J.CVDPC.2008.12.001, 10.1016/j.cvdpc.2008.12.001]; Physicians for a Smoke-Free Canada, 2006, FILT TIPS REV CIG MA; Rigdon EE, 1996, STRUCT EQU MODELING, V3, P369, DOI 10.1080/10705519609540052; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Shell DF, 2011, AM J HEALTH BEHAV, V35, P568; Stead M, 1996, HLTH ED J, V55, P31, DOI [10.1177/001789699605500105, DOI 10.1177/001789699605500105]; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tickle JJ, 2006, BASIC APPL SOC PSYCH, V28, P117, DOI 10.1207/s15324834basp2802_2; Udry J. R., 1998, NEW PERSPECTIVES ADO, P241, DOI [10.1017/CBO9780511571138.009, DOI 10.1017/CBO9780511571138.009]; Wang MP, 2012, ADDICT BEHAV, V37, P743, DOI 10.1016/j.addbeh.2012.02.016; Warren CW, 2000, B WORLD HEALTH ORGAN, V78, P868; World Health Organization, 2013, GLOB HLTH OBS NONC D; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x; Zheng PP, 2008, ASIA-PAC J PUBLIC HE, V20, P94, DOI 10.1177/1010539507311182; Zhu C, 2012, LANCET, V379, P779, DOI 10.1016/S0140-6736(11)61933-8	42	4	4	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80482	10.1371/journal.pone.0080482	http://dx.doi.org/10.1371/journal.pone.0080482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244690	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800148
J	Ronchetti, SA; Miler, EA; Duvilanski, BH; Cabilla, JP				Ronchetti, Sonia A.; Miler, Eliana A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.			Cadmium Mimics Estrogen-Driven Cell Proliferation and Prolactin Secretion from Anterior Pituitary Cells	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER CELL; ER-ALPHA; GENE-EXPRESSION; RECEPTOR-ALPHA; IN-VITRO; GLAND; CONTAMINATION; MECHANISMS; HORMONE	Cadmium (Cd) is a heavy metal of considerable occupational and environmental concern affecting wildlife and human health. Recent studies indicate that Cd, like other heavy metals, can mimic effects of 17 beta-estradiol (E2) involving E2 receptor (ER) activation. Lactotrophs, the most abundant cell type in anterior pituitary gland, are the main target of E2, which stimulates cell proliferation and increases prolactin secretion through ER alpha. The aim of this work was to examine whether Cd at nanomolar concentrations can induce cell proliferation and prolactin release in anterior pituitary cells in culture and whether these effects are mediated through ERs. Here we show that 10 nM Cd was able to stimulate lactotroph proliferation in anterior pituitary cell cultures from female Wistar rats and also in GH3 lactosomatotroph cell line. Proliferation of somatotrophs and gonadotrophs were not affected by Cd exposure. Cd promoted cell cycle progression by increasing cyclins D1, D3 and c-fos expression. Cd enhanced prolactin synthesis and secretion. Cd E2-like effects were blocked by the pure ERs antagonist ICI 182,780 supporting that Cd acts through ERs. Further, both Cd and E2 augmented full-length ER alpha expression and its 46 kDa-splicing variant. In addition, when co-incubated Cd was shown to interact with E2 by inducing ER alpha mRNA expression which indicates an additive effect between them. This study shows for the first time that Cd at nanomolar concentration displays xenoestrogenic activities by inducing cell growth and stimulating prolactin secretion from anterior pituitary cells in an ERs-dependent manner. Cd acting as a potent xenoestrogen can play a key role in the aetiology of different pathologies of the anterior pituitary and in estrogen-responsive tissues which represent considerable risk to human health.	[Ronchetti, Sonia A.; Miler, Eliana A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1668]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5536]; Universidad de Buenos Aires [B052]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1668), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5536) and Universidad de Buenos Aires (B052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, ENDOCRINOLOGY, V138, P2128, DOI 10.1210/en.138.5.2128; Aquino NB, 2012, J ENVIRON SCI HEAL C, V30, P189, DOI 10.1080/10590501.2012.705159; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Cabrera C, 1998, Rev Environ Contam Toxicol, V154, P55; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; CHEN HT, 1987, ENDOCRINOLOGY, V120, P247, DOI 10.1210/endo-120-1-247; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; FECHNER P, 2011, PLOS ONE, V6, P23048, DOI DOI 10.1371/J0URNAL.P0NE.0023048.PUBMED:21829690; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Hofer N, 2010, ARCH TOXICOL, V84, P541, DOI 10.1007/s00204-010-0524-x; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kah M, 2012, J TOXICOL ENV HEAL B, V15, P348, DOI 10.1080/10937404.2012.705107; Lafuente A, 1999, TOXICOL LETT, V110, P209, DOI 10.1016/S0378-4274(99)00159-9; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Martin MB, 2002, ENDOCRINOLOGY, V143, P263, DOI 10.1210/en.143.1.263; MAURER RA, 1990, PROG CLIN BIOL RES, V322, P159; Miler EA, 2010, HUM EXP TOXICOL, V29, P873, DOI 10.1177/0960327110362703; Mitchner NA, 1998, ENDOCRINOLOGY, V139, P3976, DOI 10.1210/en.139.9.3976; Montanari M, 2006, CELL DEATH DIFFER, V13, P1052, DOI 10.1038/sj.cdd.4401932; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; NISWENDER GD, 1969, P SOC EXP BIOL MED, V130, P793, DOI 10.3181/00379727-130-33657; Poliandri AHB, 2006, FREE RADICAL BIO MED, V40, P679, DOI 10.1016/j.freeradbiomed.2005.09.021; Poliandri AHB, 2003, TOXICOL APPL PHARM, V190, P17, DOI 10.1016/S0041-008X(03)00191-1; Qian X, 1998, ENDOCRINOLOGY, V139, P2058, DOI 10.1210/en.139.4.2058; Rousseau J, 2002, GEN COMP ENDOCR, V126, P175, DOI 10.1006/gcen.2002.7789; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shupnik MA, 2002, J NEUROENDOCRINOL, V14, P85, DOI 10.1046/j.0007-1331.2001.00744.x; Siewit CL, 2010, MOL ENDOCRINOL, V24, P981, DOI 10.1210/me.2009-0410; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; Spady TJ, 1999, ENDOCRINE, V11, P217, DOI 10.1385/ENDO:11:3:217; Steinmetz R, 1997, ENDOCRINOLOGY, V138, P1780, DOI 10.1210/en.138.5.1780; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Takiguchi Masufumi, 2006, Environmental Sciences, V13, P107; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; Teng J, 2008, ENDOCR-RELAT CANCER, V15, P351, DOI 10.1677/erc.1.01255; Velardez MO, 2003, EUR J ENDOCRINOL, V148, P89, DOI 10.1530/eje.0.1480089; Wade MG, 1997, REPROD TOXICOL, V11, P791, DOI 10.1016/S0890-6238(97)00062-2; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	48	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81101	10.1371/journal.pone.0081101	http://dx.doi.org/10.1371/journal.pone.0081101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236210	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700213
J	Blackmore-Wright, S; Georgeson, MA; Anderson, SJ				Blackmore-Wright, Sally; Georgeson, Mark A.; Anderson, Stephen J.			Enhanced Text Spacing Improves Reading Performance in Individuals with Macular Disease	PLOS ONE			English	Article							PREFERRED RETINAL LOCUS; EYE-MOVEMENTS; LETTER-RECOGNITION; PERCEPTUAL SPAN; SPEED; PSYCHOPHYSICS; FONT; SCOTOMAS; LINE; IDENTIFICATION	The search by many investigators for a solution to the reading problems encountered by individuals with no central vision has been long and, to date, not very fruitful. Most textual manipulations, including font size, have led to only modest gains in reading speed. Previous work on spatial integrative properties of peripheral retina suggests that 'visual crowding' may be a major factor contributing to inefficient reading. Crowding refers to the fact that juxtaposed targets viewed eccentrically may be difficult to identify. The purpose of this study was to assess the combined effects of line spacing and word spacing on the ability of individuals with age-related macular degeneration (ARMD) to read short passages of text that were printed with either high (87.5%) or low contrast (17.5%) letters. Low contrast text was used to avoid potential ceiling effects and to mimic a possible reduction in letter contrast with light scatter from media opacities. For both low and high contrast text, the fastest reading speeds we measured were for passages of text with double line and double word spacing. In comparison with standard single spacing, double word/line spacing increased reading speed by approximately 26% with high contrast text (p < 0.001), and by 46% with low contrast text (p < 0.001). In addition, double line/word spacing more than halved the number of reading errors obtained with single spaced text. We compare our results with previous reading studies on ARMD patients, and conclude that crowding is detrimental to reading and that its effects can be reduced with enhanced text spacing. Spacing is particularly important when the contrast of the text is reduced, as may occur with intraocular light scatter or poor viewing conditions. We recommend that macular disease patients should employ double line spacing and double-character word spacing to maximize their reading efficiency.	[Blackmore-Wright, Sally; Georgeson, Mark A.; Anderson, Stephen J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Anderson, SJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	s.j.anderson@aston.ac.uk		Georgeson, Mark/0000-0002-8173-9522	Macular Disease Society, UK	Macular Disease Society, UK	Funded by The Macular Disease Society, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN SJ, 1995, VISION RES, V35, P1931, DOI 10.1016/0042-6989(94)00293-U; ANDERSON SJ, 1991, J PHYSIOL-LONDON, V442, P47, DOI 10.1113/jphysiol.1991.sp018781; Arditi A, 2005, VISION RES, V45, P2926, DOI 10.1016/j.visres.2005.06.013; Arditi A, 2004, ERGONOMICS, V47, P469, DOI 10.1080/0014013031000085680; Bowers Alex R, 2001, Clin Exp Optom, V84, P139; Bowers AR, 2004, OPTOMETRY VISION SCI, V81, P205, DOI 10.1097/00006324-200403000-00013; Calabrese A, 2010, INVEST OPHTH VIS SCI, V51, P1247, DOI 10.1167/iovs.09-3682; Chung STL, 2004, OPTOMETRY VISION SCI, V81, P525, DOI 10.1097/00006324-200407000-00014; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; Chung STL, 2008, OPTOMETRY VISION SCI, V85, P827, DOI 10.1097/OPX.0b013e31818527ea; Chung STL, 2012, OPTOMETRY VISION SCI, V89, P1288, DOI 10.1097/OPX.0b013e318264c9dd; Crossland MD, 2006, VISION RES, V46, P590, DOI 10.1016/j.visres.2005.05.015; Crossland MD, 2005, OPHTHALMOLOGY, V112, P1579, DOI 10.1016/j.ophtha.2005.03.027; Drieghe D, 2005, VISION RES, V45, P1693, DOI 10.1016/j.visres.2005.01.010; EHRLICH D, 1987, OPHTHAL PHYSL OPT, V7, P293, DOI 10.1111/j.1475-1313.1987.tb00746.x; ELDRED KB, 1992, OPTOMETRY VISION SCI, V69, P46, DOI 10.1097/00006324-199201000-00007; Falkenberg HK, 2007, VISION RES, V47, P126, DOI 10.1016/j.visres.2006.09.014; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fine EM, 1999, VISION RES, V39, P1039, DOI 10.1016/S0042-6989(98)00208-9; Finger RP, 2009, INVEST OPHTH VIS SCI, V50, P1366, DOI 10.1167/iovs.08-2032; Fukuzumi S, 1998, ERGONOMICS, V41, P89, DOI 10.1080/001401398187341; Greenstein VC, 2008, RETINA-J RET VIT DIS, V28, P1234, DOI 10.1097/IAE.0b013e31817c1b47; Gunning R., 1952, TECHNIQUE CLEAR WRIT; He YC, 2013, J VISION, V13, DOI 10.1167/13.7.14; Huckauf A, 2007, J VISION, V7, DOI 10.1167/7.2.18; Hussain Z, 2012, J NEUROSCI, V32, P474, DOI 10.1523/JNEUROSCI.3845-11.2012; Latham K, 1996, VISION RES, V36, P2665, DOI 10.1016/0042-6989(96)00022-3; Lawton TA, 1998, VISION RES, V38, P153, DOI 10.1016/S0042-6989(97)00140-5; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; LEGGE GE, 1989, OPTOMETRY VISION SCI, V66, P843, DOI 10.1097/00006324-198912000-00008; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; Mansfield JS, 1996, INVEST OPHTH VIS SCI, V37, P1492; Mitchell J, 2002, BRIT J OPHTHALMOL, V86, P777, DOI 10.1136/bjo.86.7.777; Mitchell J, 2008, AM J OPHTHALMOL, V146, P447, DOI 10.1016/j.ajo.2008.04.031; Mitchell Jan, 2005, Health Qual Life Outcomes, V3, P25, DOI 10.1186/1477-7525-3-25; Nilsson UL, 2003, VISION RES, V43, P1777, DOI 10.1016/S0042-6989(03)00219-0; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Patel PJ, 2011, INVEST OPHTH VIS SCI, V52, P3854, DOI 10.1167/iovs.10-6601; Paterson KB, 2013, PSYCHOL AGING, V28, P352, DOI 10.1037/a0030350; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Perea M, 2009, VISION RES, V49, P1994, DOI 10.1016/j.visres.2009.05.009; Rayner K, 2013, EXP PSYCHOL, V16, P1; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Reynolds L, 2004, J RES READ, V27, P87, DOI 10.1111/j.1467-9817.2004.00216.x; Rubin GS, 2006, OPHTHAL PHYSL OPT, V26, P545, DOI 10.1111/j.1475-1313.2006.00409.x; RUBIN GS, 1994, VISION RES, V34, P1723, DOI 10.1016/0042-6989(94)90129-5; Seiple W, 2005, INVEST OPHTH VIS SCI, V46, P2886, DOI 10.1167/iovs.04-1296; Seiple W, 2011, INVEST OPHTH VIS SCI, V52, P2938, DOI 10.1167/iovs.10-6137; Slattery TJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1275, DOI 10.3758/s13414-013-0463-8; SPRAGINS AB, 1976, MEM COGNITION, V4, P36, DOI 10.3758/BF03213252; Sun GJ, 2010, J VISION, V10, DOI 10.1167/10.5.16; Sunness JS, 2005, AM J OPHTHALMOL, V140, P1085, DOI 10.1016/j.ajo.2005.07.040; Tarita-Nistor L, 2013, CAN J OPHTHALMOL, V48, P57, DOI 10.1016/j.jcjo.2012.09.017; Van Overschelde JP, 2005, EXP PSYCHOL, V52, P213, DOI 10.1027/1618-3169.52.3.213; Vinckier F, 2011, J VISION, V11, DOI 10.1167/11.6.8	64	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80325	10.1371/journal.pone.0080325	http://dx.doi.org/10.1371/journal.pone.0080325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244676	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327221600203
J	Carville, A; Evans, TI; Reeves, RK				Carville, Angela; Evans, Tristan I.; Reeves, R. Keith			Characterization of Circulating Natural Killer Cells in Neotropical Primates	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CLASS-I MOLECULES; NK CELLS; MONOCLONAL-ANTIBODIES; COMMON MARMOSETS; RHESUS-MONKEYS; SIV INFECTION; LYMPHOCYTES; CHIMERISM; RECEPTORS	Despite extensive use of nonhuman primates as models for infectious diseases and reproductive biology, imprecise phenotypic and functional definitions exist for natural killer (NK) cells. This deficit is particularly significant in the burgeoning use of small, less expensive New World primate species. Using polychromatic flow cytometry, we identified peripheral blood NK cells as CD3-negative and expressing a cluster of cell surface molecules characteristic of NK cells (i.e., NKG2A, NKp46, NKp30) in three New World primate species - common marmosets, cotton-top tamarins, and squirrel monkeys. We then assessed subset distribution using the classical NK markers, CD56 and CD16. In all species, similar to Old World primates, only a minor subset of NK cells was CD56+, and the dominant subset was CD56-CD16+. Interestingly, CD56+ NK cells were primarily cytokine-secreting cells, whereas CD56-CD16+ NK cells expressed significantly greater levels of intracellular perforin, suggesting these cells might have greater potential for cytotoxicity. New World primate species, like Old World primates, also had a minor CD56-CD16- K cell subset that has no obvious counterpart in humans. Herein we present phenotypic profiles of New World primate NK cell subpopulations that are generally analogous to those found in humans. This conservation among species should support the further use of these species for biomedical research.	[Carville, Angela; Evans, Tristan I.; Reeves, R. Keith] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA	Harvard University	Reeves, RK (corresponding author), Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough Campus, Southborough, MA 01772 USA.	roger_reeves@hms.harvard.edu			NEPRC (NIH) [P51 OD011103]; CHAVI/HVTN (NIH) [U19 AI067854]; NIAID (NIH) [R21 AI101170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R21AI101170] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	NEPRC (NIH); CHAVI/HVTN (NIH); NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NEPRC base grant (NIH grant P51 OD011103), and CHAVI/HVTN Early Career Investigator (NIH grant U19 AI067854) and NIAID grants (NIH grant R21 AI101170), both to RKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averdam A, 2007, J IMMUNOL, V178, P7151, DOI 10.4049/jimmunol.178.11.7151; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; BIASSONI R, 2009, CURRENT PROTOCOLS IM; Bimber B, 2008, IMMUNOL RES, V40, P235, DOI 10.1007/s12026-007-8010-0; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Colantonio AD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001316; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009; Fogli M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000101; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; Huang Y, 2008, J IMMUNOL, V180, P2367, DOI 10.4049/jimmunol.180.4.2367; Jacob JR, 2004, J GEN VIROL, V85, P2525, DOI 10.1099/vir.0.80036-0; Kalkunte S, 2008, AM J REPROD IMMUNOL, V59, P425, DOI 10.1111/j.1600-0897.2008.00595.x; LaBonte ML, 2001, IMMUNOL REV, V183, P25, DOI 10.1034/j.1600-065x.2001.1830103.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435; Marvanova M, 2003, FASEB J, V17, P929, DOI 10.1096/fj.02-0681fje; MASSACESI L, 1995, ANN NEUROL, V37, P519, DOI 10.1002/ana.410370415; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; NEUBAUER RH, 1983, J IMMUNOL, V130, P1323; NEUBAUER RH, 1982, J IMMUNOGENET, V9, P209; NEUBAUER RH, 1981, J IMMUNOGENET, V8, P433; NIBLACK GD, 1977, IMMUNOLOGY, V32, P257; Ohta S, 2008, IMMUNOLOGY, V123, P566, DOI 10.1111/j.1365-2567.2007.02727.x; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2010, J MED PRIMATOL, V39, P194, DOI 10.1111/j.1600-0684.2010.00432.x; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Reeves RK, 2011, EUR J IMMUNOL, V41, P1070, DOI 10.1002/eji.201040832; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Reeves RK, 2009, AIDS RES HUM RETROV, V25, P1313, DOI 10.1089/aid.2009.0053; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Rutjens E, 2010, EUR J IMMUNOL; Rutjens E, 2007, J IMMUNOL, V178, P1702, DOI 10.4049/jimmunol.178.3.1702; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Yaguchi M, 2009, NEUROSCI RES, V65, P384, DOI 10.1016/j.neures.2009.08.016; Yoshida T, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00128	45	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78793	10.1371/journal.pone.0078793	http://dx.doi.org/10.1371/journal.pone.0078793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244365	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600063
J	Danion, F				Danion, Frederic			Superposition of Automatic and Voluntary Aspects of Grip Force Control in Humans during Object Manipulation	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; PRECISION GRIP; PARKINSONS-DISEASE; BASAL GANGLIA; ARM MOVEMENTS; LOAD FORCE; GRASPING FORCES; POWER GRIP; COORDINATION; HAND	When moving grasped objects, people automatically modulate grip force (GF) with movement-dependent load force (LF) in order to prevent object slip. However, GF can also be modulated voluntarily as when squeezing an object. Here we investigated possible interactions between automatic and voluntary GF control. Participants were asked to generate horizontal cyclic movements (between 0.6 and 2.0 Hz) of a hand-held object that was restrained by an elastic band such that the load force (LF) reached a peak once per movement cycle, and to simultaneously squeeze the object at each movement reversal (i.e., twice per cycle). Participants also performed two control tasks in which they either only moved (between 0.6 and 2.0 Hz) or squeezed (between 1.2 and 4.0 Hz) the object. The extent to which GF modulation in the simultaneous task could be predicted from the two control tasks was assessed using power spectral analyses. At all frequencies, the GF power spectra from the simultaneous task exhibited two prominent components that occurred at the cycle frequency (f) and at twice this frequency (2f), whereas the spectra from the movement and squeeze control task exhibited only single peaks at f and 2f, respectively. At lower frequencies, the magnitudes of both frequency components in the simultaneous task were similar to the magnitudes of the corresponding components in the control tasks. However, as frequency increased, the magnitudes of both components in the simultaneous task were greater than the magnitudes of the corresponding control task components. Moreover, the phase relationship between the f components of GF and LF began to drift from the value observed in the movement control task. Overall these results suggest that, at lower movement frequencies, voluntary and automatic GF control processes operate at different hierarchical levels. Several mechanisms are discussed to account for interaction effects observed at higher movement frequencies.	[Danion, Frederic] CNRS, Inst Neurosci Timone, Marseille, France; [Danion, Frederic] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Danion, F (corresponding author), CNRS, Inst Neurosci Timone, Marseille, France.	frederic.danion@univ-amu.fr	Danion, Frederic/ABS-1799-2022	Danion, Frederic/0000-0003-4296-7300				Aschersleben G, 2001, EXP BRAIN RES, V136, P331, DOI 10.1007/s002210000562; Billon M, 1996, EXP BRAIN RES, V110, P117; Boecker H, 2005, NEUROIMAGE, V25, P243, DOI 10.1016/j.neuroimage.2004.10.027; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Butler JE, 2007, RESP PHYSIOL NEUROBI, V159, P115, DOI 10.1016/j.resp.2007.06.006; Chvatal SA, 2012, J NEUROSCI, V32, P12237, DOI 10.1523/JNEUROSCI.6344-11.2012; Collins DF, 1998, J PHYSIOL-LONDON, V508, P635, DOI 10.1111/j.1469-7793.1998.00635.x; Danion F, 2004, EXP BRAIN RES, V158, P109, DOI 10.1007/s00221-004-1882-5; Danion F, 1997, EXP BRAIN RES, V116, P525, DOI 10.1007/PL00005781; Danion F, 2007, CLIN NEUROPHYSIOL, V118, P146, DOI 10.1016/j.clinph.2006.09.009; Danion F, 2007, J NEUROSCI, V27, P12839, DOI 10.1523/JNEUROSCI.3110-07.2007; Danion F, 2010, J EXP PSYCHOL HUMAN, V36, P1684, DOI 10.1037/a0020672; de Freitas PB, 2009, EXP BRAIN RES, V194, P605, DOI 10.1007/s00221-009-1738-0; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P2978, DOI 10.1152/jn.00958.2002; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; FORSSBERG H, 1979, J NEUROPHYSIOL, V42, P936, DOI 10.1152/jn.1979.42.4.936; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Gomi H, 2008, CURR OPIN NEUROBIOL, V18, P558, DOI 10.1016/j.conb.2008.11.002; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Halder P, 2007, HUM BRAIN MAPP, V28, P69, DOI 10.1002/hbm.20262; Jaric S, 2006, EXP BRAIN RES, V168, P88, DOI 10.1007/s00221-005-0070-6; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Keisker B, 2009, HUM BRAIN MAPP, V30, P2453, DOI 10.1002/hbm.20676; KILBREATH SL, 1994, J PHYSIOL-LONDON, V479, P487, DOI 10.1113/jphysiol.1994.sp020312; LATASH ML, 1991, BIOL CYBERN, V65, P401, DOI 10.1007/BF00216974; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Nowak DA, 2004, EXP BRAIN RES, V157, P241, DOI 10.1007/s00221-004-1839-8; Nowak DA, 2002, BEHAV NEUROSCI, V116, P837, DOI 10.1037//0735-7044.116.5.837; Nowak DA, 2006, EXP BRAIN RES, V173, P650, DOI 10.1007/s00221-006-0409-7; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Robertson JW, 2012, J BIOMECH, V45, P1580, DOI 10.1016/j.jbiomech.2012.04.020; Serrien DJ, 2001, EUR J NEUROSCI, V13, P1825, DOI 10.1046/j.0953-816x.2001.01548.x; Serrien DJ, 2001, EXP BRAIN RES, V136, P417, DOI 10.1007/s002210000620; Serrien DJ, 2001, NEUROPSYCHOLOGIA, V39, P1379, DOI 10.1016/S0028-3932(01)00081-1; Shim JK, 2005, J NEUROPHYSIOL, V93, P3649, DOI 10.1152/jn.01262.2004; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Sternad D, 2002, EXP BRAIN RES, V147, P162, DOI 10.1007/s00221-002-1219-1; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Venkadesan M, 2007, J BIOMECH, V40, P1653, DOI 10.1016/j.jbiomech.2007.01.022; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; Zatsiorsky VM, 2004, ROBOTICA, V22, P231, DOI 10.1017/S0263574703005344	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79341	10.1371/journal.pone.0079341	http://dx.doi.org/10.1371/journal.pone.0079341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244483	Green Published, gold			2022-12-27	WOS:000327221600126
J	Du, ZY; Dou, XB; Huang, CY; Gao, J; Hu, LF; Zhu, JZ; Qian, Y; Dou, MH; Fan, CL				Du, Zhongyan; Dou, Xiaobing; Huang, Chenyun; Gao, Jia; Hu, Linfeng; Zhu, Jiazhen; Qian, Ying; Dou, Minhua; Fan, Chunlei			Preparation, Drug Releasing Property and Pharmacodynamics of Soy Isoflavone-Loaded Chitosan Microspheres	PLOS ONE			English	Article							SENESCENCE-ACCELERATED MICE; INDUCED AGING MODEL; RATS; IMPAIRMENTS; MECHANISM	Soybean isoflavone (SIF) has anti-aging properties and many other biological functions; however, SIF is difficult to reach higher blood concentration due to its rapid metabolism. Therefore, it is of great value to design and produce a sustained-release formulation that is able to maintain a stable level of plasma concentrations. In this paper, soybean isoflavone sustained-release microsphere from chitosan and sodium alginate was prepared successfully. The important factors that determined the quality of the microspheres were the sodium alginate concentration in solution B, the ratio of soybean isoflavone to chitosan and the mixing speed. The relative yield, encapsulation efficiency and drug loading capability of SIF were much higher than the existing commercial formulations. In real gastrointestinal conditions, compared with the non-sustained release group, the release rate of SIF slowed down and the reaction time was prolonged. Animal experiments showed that sustained-release microspheres intensified the anti-aging potentials of SIF. Compared with the Non-sustained release (NSR) group mice, oral SIF/CHI microsphere treated mice were better in the Morris Water Maze Test (MWMT), the MDA level in the both plasma and brain of the sustained release(SR) group mice decreased, and SOD content was remarkably improved.	[Du, Zhongyan; Dou, Xiaobing; Huang, Chenyun; Hu, Linfeng; Qian, Ying; Dou, Minhua; Fan, Chunlei] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Jia] Zhejiang Chinese Med Univ, Coll Management, Hangzhou, Zhejiang, Peoples R China; [Zhu, Jiazhen] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Dou, XB (corresponding author), Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	xbdou77@hotmail.com			National Natural Science Foundation of China [81241145]; Natural Science Foundation of Zhejiang Province, China [LY12C07002]; Public Health Department of Zhejiang Province, China [2013KYA138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Public Health Department of Zhejiang Province, China	The study was financially supported by grants from National Natural Science Foundation of China (Project Codes: 81241145), and the Natural Science Foundation of Zhejiang Province, China (Project Code: LY12C07002). (Public Health Department of Zhejiang Province, China (Project Code: 2013KYA138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2012, TOXICOL LETT, V213, P220, DOI 10.1016/j.toxlet.2012.07.007; Atambay M, 2008, SAUDI MED J, V29, P87; Basaria S, 2009, J ENDOCRINOL INVEST, V32, P150, DOI 10.1007/BF03345705; Cai ShaoFei, 2011, Chinese Journal of Biochemical Pharmaceutics, V32, P315; Cakatay U, 2010, AGING MALE, V13, P51, DOI 10.3109/13685530903236470; Chang C, 1999, CHIN PHAR M J, V34, P796; Ding BJ, 2011, INT J DEV NEUROSCI, V29, P537, DOI 10.1016/j.ijdevneu.2011.04.002; Fukuishi N, 2001, INT ARCH ALLERGY IMM, V126, P140, DOI 10.1159/000049505; Goycoolea FM, 2009, BIOMACROMOLECULES, V10, P1736, DOI 10.1021/bm9001377; Hasegawa-Ishii S, 2011, NEUROPATHOLOGY, V31, P20, DOI 10.1111/j.1440-1789.2010.01126.x; Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P2686, DOI 10.1016/j.fct.2009.07.032; [黄岚 Huang Lan], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P1481; Jia Min, 2007, Zhong Yao Cai, V30, P185; Jiang Cai-Bin, 2007, Zhongguo Zhong Yao Za Zhi, V32, P906; Li S., 2002, J CHINESE CLIN MED, V3, P1; [李术宝 Li Shubao], 2012, [河北农业大学学报, Journal of Agricultural University of Hebei], V35, P79; Lien TF, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-15; Liu J, 2009, J BIOL CHEM, V284, P19564, DOI 10.1074/jbc.M109.005959; Luo Yun, 2012, Yaoxue Xuebao, V47, P256; Messina Mark J, 2002, Nutr Clin Care, V5, P272; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Pengc L, 1998, J MARINE SCI, V5, P21; Polkowski K, 2000, Acta Pol Pharm, V57, P223; Roehrs M, 2009, NEPHROL DIAL TRANSPL, V24, P2212, DOI 10.1093/ndt/gfp001; Tafaghodi M, 2006, J BIOMAT SCI-POLYM E, V17, P909, DOI 10.1163/156856206777996880; Wan C, 2008, S CHINA J PREV MED, V34, P30; Wang L, 2007, J SHANXI MED U, V38, P523; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Yang H, 2011, BRAIN COGNITION, V76, P206, DOI 10.1016/j.bandc.2010.10.008; Yoo DY, 2012, NEUROCHEM RES, V37, P223, DOI 10.1007/s11064-011-0597-9; Yoshiara LY, 2012, INT J FOOD SCI NUTR, V63, P978, DOI 10.3109/09637486.2012.690026; [张超兰 Zhang Chaolan], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P57; Zhao GJ, 1999, J FUNCTIONAL POLYM, V1, P65	33	3	4	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79698	10.1371/journal.pone.0079698	http://dx.doi.org/10.1371/journal.pone.0079698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244544	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600147
J	Janssen, X; Cliff, DP; Reilly, JJ; Hinkley, T; Jones, RA; Batterham, M; Ekelund, U; Brage, S; Okely, AD				Janssen, Xanne; Cliff, Dylan P.; Reilly, John J.; Hinkley, Trina; Jones, Rachel A.; Batterham, Marijka; Ekelund, Ulf; Brage, Soren; Okely, Anthony D.			Predictive Validity and Classification Accuracy of ActiGraph Energy Expenditure Equations and Cut-Points in Young Children	PLOS ONE			English	Article							RATING-SCALE CARS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; OBJECTIVE MEASUREMENT; PRESCHOOL-CHILDREN; VALIDATION; ACCELEROMETER; CALIBRATION; COSTS	Objectives: Evaluate the predictive validity of ActiGraph energy expenditure equations and the classification accuracy of physical activity intensity cut-points in preschoolers. Methods: Forty children aged 4-6 years (5.3 +/- 1.0 years) completed a similar to 150-min room calorimeter protocol involving age-appropriate sedentary, light and moderate-to vigorous-intensity physical activities. Children wore an ActiGraph GT3X on the right mid-axillary line of the hip. Energy expenditure measured by room calorimetry and physical activity intensity classified using direct observation were the criterion methods. Energy expenditure was predicted using Pate and Puyau equations. Physical activity intensity was classified using Evenson, Sirard, Van Cauwenberghe, Pate, Puyau, and Reilly, ActiGraph cut-points. Results: The Pate equation significantly overestimated VO2 during sedentary behaviors, light physical activities and total VO2 (P<0.001). No difference was found between measured and predicted VO2 during moderate-to vigorous-intensity physical activities (P = 0.072). The Puyau equation significantly underestimated activity energy expenditure during moderate-to vigorous-intensity physical activities, light-intensity physical activities and total activity energy expenditure (P<0.0125). However, no overestimation of activity energy expenditure during sedentary behavior was found. The Evenson cut-point demonstrated significantly higher accuracy for classifying sedentary behaviors and light-intensity physical activities than others. Classification accuracy for moderate-to vigorous-intensity physical activities was significantly higher for Pate than others. Conclusion: Available ActiGraph equations do not provide accurate estimates of energy expenditure across physical activity intensities in preschoolers. Cut-points of <= 25counts.15 s(-1) and >= 420 counts.15 s(-1) for classifying sedentary behaviors and moderate-to vigorous-intensity physical activities, respectively, are recommended.	[Janssen, Xanne; Cliff, Dylan P.; Jones, Rachel A.; Okely, Anthony D.] Univ Wollongong, Interdisciplinary Educ Res Inst, Wollongong, NSW, Australia; [Reilly, John J.] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Hinkley, Trina] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia; [Batterham, Marijka] Univ Wollongong, Ctr Stat & Survey Methodol, Wollongong, NSW, Australia; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf; Brage, Soren] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	University of Wollongong; University of Strathclyde; Deakin University; University of Wollongong; Norwegian School of Sport Sciences; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Janssen, X (corresponding author), Univ Wollongong, Interdisciplinary Educ Res Inst, Wollongong, NSW, Australia.	xj512@uowmail.edu.au	Ekelund, Ulf/AAE-8471-2019; Brage, Soren/C-6415-2013; Okely, Anthony D/R-1679-2018	Ekelund, Ulf/0000-0003-2115-9267; Brage, Soren/0000-0002-1265-7355; Okely, Anthony D/0000-0002-1626-8170; Janssen, Xanne/0000-0003-1355-0792; Cliff, Dylan/0000-0001-6863-3996; Batterham, Marijka/0000-0002-9520-6508; Hinkley, Trina/0000-0003-2742-8579	National Heart Foundation of Australia [GIA09S4441]; National Heart Foundation of Australia - Postdoctoral Research Fellowship [PH 09S 4603]; National Heart Foundation of Australia Career Development Fellowship [CR 11S 6099]; Medical Research Council [MC_UU_12015/3, MC_U106179473] Funding Source: researchfish; MRC [MC_U106179473, MC_UU_12015/3] Funding Source: UKRI	National Heart Foundation of Australia(National Heart Foundation of Australia); National Heart Foundation of Australia - Postdoctoral Research Fellowship(National Heart Foundation of Australia); National Heart Foundation of Australia Career Development Fellowship(National Heart Foundation of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Heart Foundation of Australia (GIA09S4441). Dylan Cliff is funded by a National Heart Foundation of Australia - Postdoctoral Research Fellowship (PH 09S 4603). Anthony Okely is supported by a National Heart Foundation of Australia Career Development Fellowship (CR 11S 6099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Beets MW, 2011, PEDIATRICS, V127, P658, DOI 10.1542/peds.2010-2021; Cliff Dylan P, 2007, J Phys Act Health, V4, P509; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; De Bock F, 2010, MED SCI SPORT EXER, V42, P2237, DOI 10.1249/MSS.0b013e3181e27b5d; DURANT RH, 1993, MED SCI SPORT EXER, V25, P1415; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; FIROUZBAKHSH S, 1993, J PEDIATR GASTR NUTR, V16, P136, DOI 10.1097/00005176-199302000-00007; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Hinkley T, 2012, MED SCI SPORT EXER, V44, P458, DOI 10.1249/MSS.0b013e318233763b; Hislop JF, 2012, PEDIATR EXERC SCI, V24, P563, DOI 10.1123/pes.24.4.563; Janssen X, 2013, BRIT J NUTR, V109, P1917, DOI 10.1017/S0007114512003820; Martin A, 2011, PEDIATR EXERC SCI, V23, P468, DOI 10.1123/pes.23.4.468; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; PUHL J, 1990, RES Q EXERCISE SPORT, V61, P26, DOI 10.1080/02701367.1990.10607475; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Reilly JJ, 2006, INT J PEDIATR OBES, V1, P161, DOI 10.1080/17477160600845051; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Ridley K, 2008, MED SCI SPORT EXER, V40, P1439, DOI 10.1249/MSS.0b013e31817279ef; Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Sirard JR, 2005, J PHYS ACT HEALTH, V2, P345, DOI DOI 10.1123/JPAH.2.3.345; Trost SG, 2006, MED SCI SPORT EXER, V38, P380, DOI 10.1249/01.mss.0000183848.25845.e0; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2012, OBESITY, V20, P2317, DOI 10.1038/oby.2011.364; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Van Cauwenberghe E, 2011, INT J PEDIATR OBES, V6, pE582, DOI 10.3109/17477166.2010.526223; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	34	107	108	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79124	10.1371/journal.pone.0079124	http://dx.doi.org/10.1371/journal.pone.0079124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244433	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600111
J	Lopes, FR; Jjingo, D; da Silva, CRM; Andrade, AC; Marraccini, P; Teixeira, JB; Carazzolle, MF; Pereira, GAG; Pereira, LFP; Vanzela, ALL; Wang, L; Jordan, IK; Carareto, CMA				Lopes, Fabricio R.; Jjingo, Daudi; da Silva, Carlos R. M.; Andrade, Alan C.; Marraccini, Pierre; Teixeira, Joao B.; Carazzolle, Marcelo F.; Pereira, Goncalo A. G.; Pereira, Luiz Filipe P.; Vanzela, Andre L. L.; Wang, Lu; King Jordan, I.; Carareto, Claudia M. A.			Transcriptional Activity, Chromosomal Distribution and Expression Effects of Transposable Elements in Coffea Genomes	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; EVOLUTION; RETROTRANSPOSONS; ACTIVATION; TOBACCO; ORIGIN; GENES; DATABASE; REVEALS; ARABICA	Plant genomes are massively invaded by transposable elements (TEs), many of which are located near host genes and can thus impact gene expression. In flowering plants, TE expression can be activated (de-repressed) under certain stressful conditions, both biotic and abiotic, as well as by genome stress caused by hybridization. In this study, we examined the effects of these stress agents on TE expression in two diploid species of coffee, Coffea canephora and C. eugenioides, and their allotetraploid hybrid C. arabica. We also explored the relationship of TE repression mechanisms to host gene regulation via the effects of exonized TE sequences. Similar to what has been seen for other plants, overall TE expression levels are low in Coffea plant cultivars, consistent with the existence of effective TE repression mechanisms. TE expression patterns are highly dynamic across the species and conditions assayed here are unrelated to their classification at the level of TE class or family. In contrast to previous results, cell culture conditions per se do not lead to the de-repression of TE expression in C. arabica. Results obtained here indicate that differing plant drought stress levels relate strongly to TE repression mechanisms. TEs tend to be expressed at significantly higher levels in non-irrigated samples for the drought tolerant cultivars but in drought sensitive cultivars the opposite pattern was shown with irrigated samples showing significantly higher TE expression. Thus, TE genome repression mechanisms may be finely tuned to the ideal growth and/or regulatory conditions of the specific plant cultivars in which they are active. Analysis of TE expression levels in cell culture conditions underscored the importance of nonsense-mediated mRNA decay (NMD) pathways in the repression of Coffea TEs. These same NMD mechanisms can also regulate plant host gene expression via the repression of genes that bear exonized TE sequences.	[Lopes, Fabricio R.; Carareto, Claudia M. A.] Univ Estadual Paulista, Univ Estadual Paulista Julio de Mesquita Filho, Dept Biol, Sao Jose do Rio Preto, Brazil; [Jjingo, Daudi; Wang, Lu; King Jordan, I.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [da Silva, Carlos R. M.; Vanzela, Andre L. L.] Univ Estadual Londrina, Dept Biol Geral, Londrina, Brazil; [Andrade, Alan C.; Marraccini, Pierre; Teixeira, Joao B.] Empresa Brasileira Pesquisa Agr Recursos Genet &, Brasilia, DF, Brazil; [Marraccini, Pierre] Ctr Cooperat Int Rech Agron Dev, UMR AGAP, Montpellier, France; [Carazzolle, Marcelo F.; Pereira, Goncalo A. G.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil; [Pereira, Luiz Filipe P.] Empresa Brasileira Pesquisa Agr Cafe, Brasilia, DF, Brazil; [King Jordan, I.] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Universidade Estadual Paulista; University System of Georgia; Georgia Institute of Technology; Universidade Estadual de Londrina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Carareto, CMA (corresponding author), Univ Estadual Paulista, Univ Estadual Paulista Julio de Mesquita Filho, Dept Biol, Sao Jose do Rio Preto, Brazil.	carareto@ibilce.unesp.br	Andrade, Alan Carvalho/C-7722-2012; Pereira, Gonçalo A. G./B-7944-2012; UNICAMP, CCES -/J-7787-2015; Carareto, Claudia M/D-2814-2012; Carazzolle, Marcelo Falsarella/C-6503-2012; Pereira, Luiz Filipe P/G-1606-2012; Marraccini, Pierre/C-1211-2015	Andrade, Alan Carvalho/0000-0001-7128-3472; Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Pereira, Luiz Filipe P/0000-0002-2075-9941; Carareto, Claudia Marcia Aparecida/0000-0002-0298-1354; Pereira, Luiz Filipe Protasio/0000-0002-4872-6607; Vanzela, Andre/0000-0002-2442-2211; Marraccini, Pierre/0000-0001-7637-6811	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/05894-1, 2007/55985-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement	This study was funded by grants provided by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/05894-1 to CMAC and fellowship 2007/55985-0 to FRL) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ( to CMAC). The authors thank the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement for the grant (ATP project "Plasticite phenotypique des perennes sous contrainte hydrique au champ" to PM and ACA) that permitted the study of C. arabica cultivars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bacci M, 2005, GENET MOL BIOL, V28, P634, DOI 10.1590/S1415-47572005000400019; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Biemont C, 2009, TRENDS GENET, V25, P333, DOI 10.1016/j.tig.2009.05.006; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cenci A, 2012, PLANT MOL BIOL, V78, P135, DOI 10.1007/s11103-011-9852-3; Courtial B, 2001, MOL GENET GENOMICS, V265, P32, DOI 10.1007/s004380000387; de Araujo PG, 2005, PLANT J, V44, P707, DOI 10.1111/j.1365-313X.2005.02579.x; Dubreuil-Tranchant C, 2011, INT J EVOL BIOL, V2011; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Ferrao R.G., 2000, REV CERES, V273, P555; Freire L. P., 2013, Coffee Science, V8, P17; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Guyot R, 2009, BMC PLANT BIOL, V25, P9; Hamon P, 2011, MOL GENET GENOMICS, V285, P447, DOI 10.1007/s00438-011-0617-0; Heslop-Harrison J. S., 1991, Technique, a Journal of Methods in Cell and Molecular Biology, V3, P109; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lashermes Philippe, 2008, V1, P203; Leroy Thierry, 2006, Braz. J. Plant Physiol., V18, P229, DOI 10.1590/S1677-04202006000100016; Lin CW, 2005, THEOR APPL GENET, V112, P114, DOI 10.1007/s00122-005-0112-2; Lopes FR, 2008, MOL GENET GENOMICS, V279, P385, DOI 10.1007/s00438-008-0319-4; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Marraccini P, 2012, J EXP BOT, V63, P4191, DOI 10.1093/jxb/ers103; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Mondego JMC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-30; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Piriyapongsa J, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-31; POUTEAU S, 1991, EMBO J, V10, P1911, DOI 10.1002/j.1460-2075.1991.tb07717.x; Rossi M, 2001, GENET MOL BIOL, V24, P147, DOI 10.1590/S1415-47572001000100020; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Vicient CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-601; Voytas DF, 1998, NAT GENET, V20, P6, DOI 10.1038/1652; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yuyama PM, 2012, GENOME, V55, P825, DOI 10.1139/gen-2012-0081; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang J, 1999, GENETICS, V153, P1403	49	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78931	10.1371/journal.pone.0078931	http://dx.doi.org/10.1371/journal.pone.0078931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244387	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600081
J	Pamaran, RR; Kamigaki, T; Hewe, TT; Flores, KMC; Mercado, ES; Alday, PP; Tan, AG; Oshitani, H; Olveda, RM; Tallo, VL				Pamaran, Rochelle R.; Kamigaki, Taro; Hewe, Teresita T.; Flores, Korrine Madeleine C.; Mercado, Edelwisa S.; Alday, Portia P.; Tan, Alvin G.; Oshitani, Hitoshi; Olveda, Remigio M.; Tallo, Veronica L.			Epidemiological Characterization of Influenza A(H1N1)pdm09 Cases from 2009 to 2010 in Baguio City, the Philippines	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; HOSPITALIZED-PATIENTS; CHILDREN; INFECTION	Background: Baguio City, Philippines experienced its first influenza A(H1N1)pdm09 [ A(H1)pdm09] case in May 2009. In spite of numerous reports describing the epidemiological and clinical features of A(H1)pdm09 cases, there are no studies about A(H1)pdm09 epidemiology in the Philippines, where year-round influenza activity was observed. Objectives: We aimed to investigate the epidemiological and clinical features of A(H1)pdm09 in pandemic and post-pandemic periods. Methods: Data were collected under enhanced surveillance of influenza-like illness (ILI) and severe acute respiratory infection (SARI) from January 2009 to December 2010. RT-PCR was used to detect A(H1)pdm09, following the protocol of the United States Centers for Disease Control and Prevention. The reproduction number was computed as a simple exponential growth rate. Differences in proportional and categorical data were examined using chi-square test or Fishers' exact test. Results and Conclusions: The outbreak was observed from week 25 to 35 in 2009 and from week 24 to 37 in 2010. The highest proportion of cases was among children aged 5-14 years. The number of ILI outpatients was 2.3-fold higher in 2009 than in 2010, while the number of inpatients was 1.8-fold higher in 2009. No significant difference in gender was observed during the two periods. The clinical condition of all patients was generally mild and self-limiting, with only 2 mortalities among inpatients in 2009. The basic reproduction number was estimated as 1.16 in 2009 and 1.05 in 2010 in the assumption of mean generation time as 2.6 days. School children played a significant role in facilitating influenza transmission.	[Pamaran, Rochelle R.; Hewe, Teresita T.; Flores, Korrine Madeleine C.; Mercado, Edelwisa S.; Alday, Portia P.; Tan, Alvin G.; Olveda, Remigio M.; Tallo, Veronica L.] Res Inst Trop Med, Manila, Philippines; [Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan	Research Institute for Tropical Medicine - Philippines; Tohoku University	Kamigaki, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019		United States Centers for Disease Prevention and Control [1U51IP000335-01]; Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000335] Funding Source: NIH RePORTER	United States Centers for Disease Prevention and Control; Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received financial support from the United States Centers for Disease Prevention and Control (grant number 1U51IP000335-01) and a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CANC REV; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention, 2009, CDC PROT REALT RT PC; Chao DY, 2011, INT J INFECT DIS, V15, pE695, DOI 10.1016/j.ijid.2011.05.012; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESILVA UC, 2009, EURO SURVEILL, V14; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; Fang LQ, 2012, AM J EPIDEMIOL, V175, P890, DOI 10.1093/aje/kwr411; Hasegawa S, 2011, PEDIAT ALLERG IMM-UK, V22, pe119, DOI 10.1111/j.1399-3038.2010.01090.x; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Ismail HIM, 2011, EMERG INFECT DIS, V17, P708, DOI 10.3201/eid1704.101212; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021828; Kim CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038166; Kloepfer KM, 2012, AM J RESP CRIT CARE, V185, P1275, DOI 10.1164/rccm.201109-1635OC; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; National Statistic Office the Philippines, 2007, 007 CENS HOUS POP; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viasus D, 2012, CLIN MICROBIOL INFEC, V18, pE55, DOI 10.1111/j.1469-0691.2011.03753.x; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wu P, 2013, INFLUENZA OTHER RESP, V7, P367, DOI 10.1111/j.1750-2659.2012.00420.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yasuda C, 2012, SE ASIAN J TROP MED, V43, P68	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79916	10.1371/journal.pone.0079916	http://dx.doi.org/10.1371/journal.pone.0079916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244578	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600159
J	Qian, ZH; Ren, L; Ding, Y; Hutchinson, JR; Ren, LQ				Qian, Zhihui; Ren, Lei; Ding, Yun; Hutchinson, John R.; Ren, Luquan			A Dynamic Finite Element Analysis of Human Foot Complex in the Sagittal Plane during Level Walking	PLOS ONE			English	Article							INVERSE DYNAMICS; BIOMECHANICAL RESPONSES; CLINICAL-APPLICATIONS; GAIT ANALYSIS; HEEL-PAD; MODEL; STRESSES; KINEMATICS; ANKLE; ARCH	The objective of this study is to develop a computational framework for investigating the dynamic behavior and the internal loading conditions of the human foot complex during locomotion. A subject-specific dynamic finite element model in the sagittal plane was constructed based on anatomical structures segmented from medical CT scan images. Three-dimensional gait measurements were conducted to support and validate the model. Ankle joint forces and moment derived from gait measurements were used to drive the model. Explicit finite element simulations were conducted, covering the entire stance phase from heel-strike impact to toe-off. The predicted ground reaction forces, center of pressure, foot bone motions and plantar surface pressure showed reasonably good agreement with the gait measurement data over most of the stance phase. The prediction discrepancies can be explained by the assumptions and limitations of the model. Our analysis showed that a dynamic FE simulation can improve the prediction accuracy in the peak plantar pressures at some parts of the foot complex by 10%-33% compared to a quasi-static FE simulation. However, to simplify the costly explicit FE simulation, the proposed model is confined only to the sagittal plane and has a simplified representation of foot structure. The dynamic finite element foot model proposed in this study would provide a useful tool for future extension to a fully muscle-driven dynamic three-dimensional model with detailed representation of all major anatomical structures, in order to investigate the structural dynamics of the human foot musculoskeletal system during normal or even pathological functioning.	[Qian, Zhihui; Ren, Lei; Ren, Luquan] Jilin Univ, Key Lab Bion Engn, Changchun 130023, Peoples R China; [Ren, Lei] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England; [Ding, Yun] Jilin Univ, Editorial Dept Journal Bion Engn, Changchun 130023, Peoples R China; [Hutchinson, John R.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England	Jilin University; University of Manchester; Jilin University; University of London; University of London Royal Veterinary College	Ren, LQ (corresponding author), Jilin Univ, Key Lab Bion Engn, Changchun 130023, Peoples R China.	lei.ren@manchester.ac.uk	ren, luquan/AAB-3592-2020; Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	International Cooperation Project of National Natural Science Foundation of China [50920105504]; Biotechnology and Biological Sciences Research Council [BB/H002782/1]; National Natural Science Foundation of China [51105167]; Fundamental Research Founds of China [Z201105]; National Science Foundation of China [51290290, 51290292]; scientific and technological development planning project of Jilin Province [20130522187JH];  [2013M530985]; BBSRC [BB/H002782/1] Funding Source: UKRI	International Cooperation Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Founds of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological development planning project of Jilin Province; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the International Cooperation Project of National Natural Science Foundation of China (No. 50920105504), a Biotechnology and Biological Sciences Research Council Grant (No. BB/H002782/1), the Project of National Natural Science Foundation of China (No. 51105167), the Fundamental Research Founds of China (No. Z201105), the Key project of National Science Foundation of China (No, 51290290 & 51290292)? the postdoctoral project (No, 2013M530985) and the scientific and technological development planning project of Jilin Province (No, 20130522187JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ABAQUS US MAN VERS 6; Cahouet V, 2002, J BIOMECH, V35, P1507, DOI 10.1016/S0021-9290(02)00176-8; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; CARRIER DR, 1994, SCIENCE, V265, P651, DOI 10.1126/science.8036513; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Chen WP, 2001, CLIN BIOMECH, V16, P614, DOI 10.1016/S0268-0033(01)00047-X; Cheung J.T.-M., 2008, SPORT ORTHOP SPORT T, V23, P264, DOI [10.1016/j.orthtr.2007.11.001, DOI 10.1016/J.ORTHTR.2007.11.001]; Cheung JTM, 2008, MED ENG PHYS, V30, P269, DOI 10.1016/j.medengphy.2007.05.002; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Cheung JTM, 2004, CLIN BIOMECH, V19, P839, DOI 10.1016/j.clinbiomech.2004.06.002; CHU TM, 1995, MED ENG PHYS, V17, P372, DOI 10.1016/1350-4533(95)97317-I; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; Dai XQ, 2006, CLIN BIOMECH, V21, P314, DOI 10.1016/j.clinbiomech.2005.10.002; Erdemir A, 2006, J BIOMECH, V39, P1279, DOI 10.1016/j.jbiomech.2005.03.007; Gefen A, 2000, J BIOMECH ENG-T ASME, V122, P630, DOI 10.1115/1.1318904; Halloran JP, 2010, J BIOMECH, V43, P2810, DOI 10.1016/j.jbiomech.2010.05.036; Halloran JP, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005333; Hannah I, 2012, PROCEDIA ENGINEER, V34, P278, DOI 10.1016/j.proeng.2012.04.048; HICKS JH, 1954, J ANAT, V88, P25; Hsu YC, 2008, ANN BIOMED ENG, V36, P1345, DOI 10.1007/s10439-008-9516-x; Isvilanonda V, 2012, CLIN BIOMECH, V27, P837, DOI 10.1016/j.clinbiomech.2012.05.005; Jacob S, 1999, J REHABIL RES DEV, V36, P252; Jacob S, 1996, MECH RES COMMUN, V23, P387, DOI 10.1016/0093-6413(96)00036-5; Jenkyn TR, 2007, J BIOMECH, V40, P3271, DOI 10.1016/j.jbiomech.2007.04.008; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Ker RF, 1996, J EXP BIOL, V199, P1501; Kuo AD, 1998, J BIOMECH ENG-T ASME, V120, P148, DOI 10.1115/1.2834295; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; Miller-Young JE, 2002, J BIOMECH, V35, P1523, DOI 10.1016/S0021-9290(02)00090-8; Nester CJ, 2007, J BIOMECH, V40, P1927, DOI 10.1016/j.jbiomech.2006.09.008; Patil KM, 1996, MED BIOL ENG COMPUT, V34, P280, DOI 10.1007/BF02511238; QIAN ZH, 2010, P 6 WORLD C BIOM SIN, V31, P297; Ren L., 2005, P INT SOC BIOM 20 C; Ren L, 2008, J BIONIC ENG, V5, P175, DOI 10.1016/S1672-6529(08)60022-0; Ren L, 2008, J BIOMECH, V41, P2750, DOI 10.1016/j.jbiomech.2008.06.001; Ren L, 2010, J BIOMECH, V43, P194, DOI 10.1016/j.jbiomech.2009.09.027; SCOTT SH, 1993, J BIOMECH, V26, P1091, DOI 10.1016/S0021-9290(05)80008-9; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; Wu LJ, 2007, CLIN BIOMECH, V22, P221, DOI 10.1016/j.clinbiomech.2006.09.009; Yarnitzky G, 2006, J BIOMECH, V39, P2673, DOI 10.1016/j.jbiomech.2005.08.021	40	38	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79424	10.1371/journal.pone.0079424	http://dx.doi.org/10.1371/journal.pone.0079424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244500	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600129
J	Ruhs, PA; Boni, L; Fuller, GG; Inglis, RF; Fischer, P				Ruehs, Patrick A.; Boeni, Lukas; Fuller, Gerald G.; Inglis, R. Fredrik; Fischer, Peter			In-Situ Quantification of the Interfacial Rheological Response of Bacterial Biofilms to Environmental Stimuli	PLOS ONE			English	Article							BETA-LACTOGLOBULIN FIBRILS; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI; DISPLACEMENT; RESISTANCE; STRENGTH; LIQUID/LIQUID; REQUIRES; SHEAR; DROP	Understanding the numerous factors that can affect biofilm formation and stability remain poorly understood. One of the major limitations is the accurate measurement of biofilm stability and cohesiveness in real-time when exposed to changing environmental conditions. Here we present a novel method to measure biofilm strength: interfacial rheology. By culturing a range of bacterial biofilms on an air-liquid interface we were able to measure their viscoelastic growth profile during and after biofilm formation and subsequently alter growth conditions by adding surfactants or changing the nutrient composition of the growth medium. We found that different bacterial species had unique viscoelastic growth profiles, which was also highly dependent on the growth media used. We also found that we could reduce biofilm formation by the addition of surfactants or changing the pH, thereby altering the viscoelastic properties of the biofilm. Using this technique we were able to monitor changes in viscosity, elasticity and surface tension online, under constant and varying environmental conditions, thereby providing a complementary method to better understand the dynamics of both biofilm formation and dispersal.	[Ruehs, Patrick A.; Boeni, Lukas; Fischer, Peter] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland; [Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Inglis, R. Fredrik] ETH, Dept Environm Sci, Zurich, Switzerland; [Inglis, R. Fredrik] ETH, Dept Environm Microbiol, Zurich, Switzerland; [Inglis, R. Fredrik] EAWAG, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Ruhs, PA (corresponding author), ETH, Dept Hlth Sci & Technol, Zurich, Switzerland.	patrick.ruehs@hest.ethz.ch	Fischer, Peter/A-8740-2011; Rühs, Patrick/H-2090-2014; Boni, Lukas/B-2690-2015	Fischer, Peter/0000-0002-2992-5037; Boni, Lukas/0000-0003-4958-0037; Fuller, Gerald/0000-0002-2924-053X	ETH Zurich [ETHIIRA TH 32-1]	ETH Zurich(ETH Zurich)	P.R. acknowledges financial support by ETH Zurich (Project ETHIIRA TH 32-1: Amyloid Protein Fibers at Surfaces and Interfaces). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, BIOTECHNOL BIOENG, V105, P924, DOI 10.1002/bit.22605; Ahimou F, 2007, APPL ENVIRON MICROB, V73, P2897, DOI 10.1128/AEM.02388-06; Angelini TE, 2009, P NATL ACAD SCI USA, V106, P18109, DOI 10.1073/pnas.0905890106; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chen X, 2000, WATER RES, V34, P4229, DOI 10.1016/S0043-1354(00)00187-1; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dueholm MS, 2010, MOL MICROBIOLOGY, V77; Erni P, 2003, REV SCI INSTRUM, V74, P4916, DOI 10.1063/1.1614433; Erni P, 2011, SOFT MATTER, V7, P7586, DOI 10.1039/c1sm05263b; Ferri JK, 2010, ADV COLLOID INTERFAC, V161, P29, DOI 10.1016/j.cis.2010.08.002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLEMMING HC, 1993, WATER SCI TECHNOL, V27, P1; Freer EM, 2004, J ADHESION, V80, P481, DOI 10.1080/00218460490477143; Gunning PA, 2004, FOOD HYDROCOLLOID, V18, P509, DOI 10.1016/j.foodhyd.2003.08.008; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liggieri L, 2010, CURR OPIN COLLOID IN, V15, P256, DOI 10.1016/j.cocis.2010.02.003; Loglio G, 2001, STUD INTERF SCI, V11, P439, DOI 10.1016/S1383-7303(01)80038-7; Maldonado-Valderrama J, 2008, LANGMUIR, V24, P6759, DOI 10.1021/la800551u; Maldonado-Valderrama J, 2010, CURR OPIN COLLOID IN, V15, P271, DOI 10.1016/j.cocis.2009.12.004; Mezzenga R, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046601; Nakano M, 1992, MOL GEN GENETICS MGG, V232; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Roth S, 2000, J AGR FOOD CHEM, V48, P1491, DOI 10.1021/jf990976z; Ruhs PA, 2013, J RHEOL, V57, P1003, DOI 10.1122/1.4802051; Ruhs PA, 2012, LANGMUIR, V28, P12536, DOI 10.1021/la3026705; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Sagis LMC, 2011, REV MOD PHYS, V83, P1367, DOI 10.1103/RevModPhys.83.1367; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Trejo M, 2013, P NATL ACAD SCI USA, V110, P2011, DOI 10.1073/pnas.1217178110; Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049	45	61	61	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78524	10.1371/journal.pone.0078524	http://dx.doi.org/10.1371/journal.pone.0078524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244319	Green Published, gold			2022-12-27	WOS:000327221600029
J	Sen, A; Ren, SM; Lerchenmuller, C; Sun, JX; Weiss, N; Most, P; Peppel, K				Sen, Anagha; Ren, Shumei; Lerchenmueller, Carolin; Sun, Jianxin; Weiss, Norbert; Most, Patrick; Peppel, Karsten			MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1	PLOS ONE			English	Article							NITRIC-OXIDE; MIR-138; CARCINOMA; EXPRESSION; GROWTH	The Ca2+ sensor S100A1 is essential for proper endothelial cell (EC) nitric oxide (NO) synthase (eNOS) activation. S100A1 levels are greatly reduced in primary human microvascular ECs subjected to hypoxia, rendering them dysfunctional. However mechanisms that regulate S100A1 levels in ECs are unknown. Here we show that ECs transfected with a S100A1-3' untranslated region (UTR) luciferase reporter construct display significantly reduced gene expression when subjected to low oxygen levels or chemical hypoxia. Bioinformatic analysis suggested that microRNA -138 (MiR-138) could target the 3'UTR of S100A1. Patients with critical limb ischemia (CLI) or mice subjected to femoral artery resection (FAR) displayed increased MiR-138 levels and decreased S100A1 protein expression. Consistent with this finding, hypoxia greatly increased MiR-138 levels in ECs, but not in skeletal muscle C2C12 myoblasts or differentiated myotubes or primary human vascular smooth muscle cells. Transfection of a MiR-138 mimic into ECs reduced S100A1-3 'UTR reporter gene expression, while transfection of an anti MiR-138 prevented the hypoxia-induced downregulation of the reporter gene. Deletion of the 22 nucleotide putative MiR-138 target site abolished the hypoxia-induced loss of reporter gene expression. Knockdown of Hif1-alpha mediated by siRNA prevented loss of hypoxia-induced reporter gene expression. Conversely, specific activation of Hif1-alpha by a selective prolyl-hydroxylase inhibitor (IOX2) reduced reporter gene expression even in the absence of hypoxia. Finally, primary ECs transfected with a MiR-138 mimic displayed reduced tube formation when plated onto Matrigel matrix and expressed less NO when stimulated with VEGF. These effects were reversed by gene transfer of S100A1 using recombinant adenovirus. We conclude that hypoxia-induced MiR-138 is an essential mediator of EC dysfunction via its ability to target the 3'UTR of S100A1.	[Sen, Anagha; Ren, Shumei; Sun, Jianxin; Most, Patrick; Peppel, Karsten] Thomas Jefferson Univ, Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA; [Lerchenmueller, Carolin; Most, Patrick] Heidelberg Univ, Dept Internal Med 3, Lab Mol & Translat Cardiol, Heidelberg, Germany; [Weiss, Norbert] Tech Univ Dresden, Dept Med 3, Ctr Vasc Med, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany	Jefferson University; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Peppel, K (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA.	Karsten.Peppel@Jefferson.edu		Lerchenmuller, Carolin/0000-0002-5620-0285; Sun, Jianxin/0000-0001-5319-912X	National Institutes of Health [R01HL07842, R01HL-092130-01, R01HL-092130-01S1, R01HL103869]; Deutsche Forschungsgemeinschaft [562/1-1]; Deutsches Herzforschungszentrum; Bundesministerium fur Bildung und Forschung [01GU0572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092130, R01HL103869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Herzforschungszentrum; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01HL07842 (KP), R01HL-092130-01 and R01HL-092130-01S1 (PM) and R01HL103869 (JS) and grants from the Deutsche Forschungsgemeinschaft (562/1-1, PM), Deutsches Herzforschungszentrum (PM) and Bundesministerium fur Bildung und Forschung (01GU0572, PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Golubovskaya VM, 2013, ANTICANCER IN PRESS; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lau JF, 2011, NAT REV CARDIOL, V8, P405, DOI 10.1038/nrcardio.2011.66; Li SS, 2013, BIOCHEM J, V452, P281, DOI 10.1042/BJ20120680; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Most P, 2013, CIRC RES, V112, P66, DOI 10.1161/CIRCRESAHA.112.275156; Murray JK, 2010, J COMB CHEM, V12, P676, DOI 10.1021/cc100073a; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Pleger ST, 2008, CIRC RES, V102, P786, DOI 10.1161/CIRCRESAHA.108.172031; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; Song T, 2011, ASIAN PAC J CANCER P, V12, P1307; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Weinberg MD, 2011, NAT REV CARDIOL, V8, P429, DOI 10.1038/nrcardio.2011.81; Yeh Y. M., 2013, INT J CANC; Zhang HJ, 2013, CELL PHYSIOL BIOCHEM, V31, P56, DOI 10.1159/000343349	28	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78684	10.1371/journal.pone.0078684	http://dx.doi.org/10.1371/journal.pone.0078684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244340	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600049
J	Sinnige, J; Braspenning, J; Schellevis, F; Stirbu-Wagner, I; Westert, G; Korevaar, J				Sinnige, Judith; Braspenning, Joze; Schellevis, Francois; Stirbu-Wagner, Irina; Westert, Gert; Korevaar, Joke			The Prevalence of Disease Clusters in Older Adults with Multiple Chronic Diseases - A Systematic Literature Review	PLOS ONE			English	Review							PRIMARY-CARE; HEALTH-STATUS; MULTIMORBIDITY; COMORBIDITY; IMPACT; DEPRESSION; MORBIDITY; PATTERNS; POPULATION; GUIDELINES	Background: Since most clinical guidelines address single diseases, treatment of patients with multimorbidity, the co-occurrence of multiple (chronic) diseases within one person, can become complicated. Information on highly prevalent combinations of diseases can set the agenda for guideline development on multimorbidity. With this systematic review we aim to describe the prevalence of disease combinations (i.e. disease clusters) in older patients with multimorbidity, as assessed in available studies. In addition, we intend to acquire information that can be supportive in the process of multimorbidity guideline development. Methods: We searched MEDLINE, Embase and the Cochrane Library for all types of studies published between January 2000 and September 2012. We included empirical studies focused on multimorbidity or comorbidity that reported prevalence rates of combinations of two or more diseases. Results: Our search yielded 3070 potentially eligible articles, of which 19 articles, representing 23 observational studies, turned out to meet all our quality and inclusion criteria after full text review. These studies provided prevalence rates of 165 combinations of two diseases (i.e. disease pairs). Twenty disease pairs, concerning 12 different diseases, were described in at least 3 studies. Depression was found to be the disease that was most commonly clustered, and was paired with 8 different diseases, in the available studies. Hypertension and diabetes mellitus were found to be the second most clustered diseases, both with 6 different diseases. Prevalence rates for each disease combination varied considerably per study, but were highest for the pairs that included hypertension, coronary artery disease, and diabetes mellitus. Conclusions: Twenty disease pairs were assessed most frequently in patients with multimorbidity. These disease combinations could serve as a first priority setting towards the development of multimorbidity guidelines, starting with the diseases with the highest observed prevalence rates and those with potential interacting treatment plans.	[Sinnige, Judith; Schellevis, Francois; Stirbu-Wagner, Irina; Korevaar, Joke] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Sinnige, Judith; Braspenning, Joze; Westert, Gert] Radboud Univ Nijmegen, Med Ctr, IQ Healthcare, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Schellevis, Francois] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Sinnige, J (corresponding author), Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.	j.sinnige@nivel.nl	Westert, G.P./H-8115-2014; Braspenning, Jozé CC/D-4268-2009; Braspenning, Jozé/AAG-7612-2021	Westert, G.P./0000-0003-3744-8207; Braspenning, Jozé CC/0000-0003-0800-0630; Braspenning, Jozé/0000-0003-0800-0630				Agborsangaya CB, 2013, QUAL LIFE RES, V22, P791, DOI 10.1007/s11136-012-0214-7; Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cabassa LJ, 2013, MED CARE, V51, P540, DOI 10.1097/MLR.0b013e31828dbb19; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Fiest KM, 2011, J AFFECT DISORDERS, V131, P172, DOI 10.1016/j.jad.2010.11.028; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Findley P, 2011, HEALTH SOC WORK, V36, P109, DOI 10.1093/hsw/36.2.109; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin Martin, 2005, Can Fam Physician, V51, P244; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Fuchs J, 2012, BUNDESGESUNDHEITSBLA, V55, P576, DOI 10.1007/s00103-012-1464-9; Gommer A, 2010, VOLKSGEZONDHEID TOEK; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Lyketsos CG, 2005, AM J GERIAT PSYCHIAT, V13, P656, DOI 10.1176/appi.ajgp.13.8.656; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Mathur R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572454; Niti M, 2007, INT J GERIATR PSYCH, V22, P1087, DOI 10.1002/gps.1789; Noel PH, 2004, ANN FAM MED, V2, P555, DOI 10.1370/afm.143; PARKERSON GR, 1993, J CLIN EPIDEMIOL, V46, P379, DOI 10.1016/0895-4356(93)90153-R; Pfaff JJ, 2009, MED J AUSTRALIA, V190, pS75, DOI 10.5694/j.1326-5377.2009.tb02475.x; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; *STROBE STAT, 2007, STRENGTH REP OBS STU; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Vyas Ami, 2012, Int J Family Med, V2012, P193168, DOI 10.1155/2012/193168; Wesseling J, 2013, RHEUMATOLOGY, V52, P180, DOI 10.1093/rheumatology/kes288; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, 2008, GLOB BURD DIS 2004 3	57	108	108	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79641	10.1371/journal.pone.0079641	http://dx.doi.org/10.1371/journal.pone.0079641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244534	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600142
J	Chen, TF; Wu, D; Moskaluk, CA; Fu, Z				Chen, Tufeng; Wu, Di; Moskaluk, Christopher A.; Fu, Zheng			Distinct Expression Patterns of ICK/MAK/MOK Protein Kinases in the Intestine Implicate Functional Diversity	PLOS ONE			English	Article							CELL-ASSOCIATED-KINASE; EPITHELIAL-CELLS; MAP KINASE; STEM-CELLS; RETINITIS-PIGMENTOSA; MOLECULAR-CLONING; CILIARY LENGTH; GENE; IDENTIFY; MICE	ICK/MRK (intestinal cell kinase/MAK-related kinase), MAK (male germ cell-associated kinase), and MOK (MAPK/MAK/MRK-overlapping kinase) are closely related serine/threonine protein kinases in the protein kinome. The biological functions and regulatory mechanisms of the ICK/MAK/MOK family are still largely elusive. Despite significant similarities in their catalytic domains, they diverge markedly in the sequence and structural organization of their C-terminal non-catalytic domains, raising the question as to whether they have distinct, overlapping, or redundant biological functions. In order to gain insights into their biological activities and lay a fundamental groundwork for functional studies, we investigated the spatio-temporal distribution patterns and the expression dynamics of ICK/MAK/MOK protein kinases in the intestine. We found that ICK/MAK/MOK proteins display divergent expression patterns along the duodenum-to-colon axis and during postnatal murine development. Furthermore, they are differentially partitioned between intestinal epithelium and mesenchyme. A significant increase in the protein level of ICK, but not MAK, was induced in human primary colon cancer specimens. ICK protein level was up-regulated whereas MOK protein level was down-regulated in mouse intestinal adenomas as compared with their adjacent normal intestinal mucosa. These data suggest distinct roles for ICK/MAK/MOK protein kinases in the regulation of intestinal neoplasia. Taken together, our findings demonstrate that the expressions of ICK/MAK/MOK proteins in the intestinal tract can be differentially and dynamically regulated, implicating a significant functional diversity within this group of protein kinases.	[Chen, Tufeng; Wu, Di; Fu, Zheng] Univ Virginia, Dept Med, Charlottesville, VA 22903 USA; [Chen, Tufeng; Wu, Di; Fu, Zheng] Univ Virginia, Digest Hlth Res Ctr, Charlottesville, VA USA; [Moskaluk, Christopher A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Chen, Tufeng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; University of Virginia; University of Virginia; Sun Yat Sen University	Fu, Z (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22903 USA.	zf6n@virginia.edu			National Institutes of Health [DK082614]; American Cancer Society Institutional Research Grant ACS-IRG [81-001-21]; Science and Technology Department of Guangdong Province, China [2010B060900030]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research Grant ACS-IRG(American Cancer Society); Science and Technology Department of Guangdong Province, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK082614 (to Z. F.) and also by a New Investigator Award (to Z. F.) from American Cancer Society Institutional Research Grant ACS-IRG #81-001-21 (Bender, T.P., University of Virginia). T.C. is a visiting scholar and partially supported by the funding program No.2010B060900030 from Science and Technology Department of Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1995, ONCOGENE, V11, P2187; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BLADT F, 1993, DIFFERENTIATION, V53, P115, DOI 10.1111/j.1432-0436.1993.tb00651.x; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; JENKINS AP, 1994, GUT, V35, P1765, DOI 10.1136/gut.35.12.1765; JINNO A, 1993, MOL CELL BIOL, V13, P4146, DOI 10.1128/MCB.13.7.4146; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013344; Lenaerts K, 2006, J PROTEOME RES, V5, P2113, DOI 10.1021/pr060183+; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Raul F, 1996, P NUTR SOC, V55, P279, DOI 10.1079/PNS19960029; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Uesaka T, 2004, FEBS LETT, V573, P147, DOI 10.1016/j.febslet.2004.07.070; Wang LY, 2011, ONCOGENE; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79359	10.1371/journal.pone.0079359	http://dx.doi.org/10.1371/journal.pone.0079359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244486	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900039
J	Guillery, E; Mouraux, A; Thonnard, JL				Guillery, Erwan; Mouraux, Andre; Thonnard, Jean-Louis			Cognitive-Motor Interference While Grasping, Lifting and Holding Objects	PLOS ONE			English	Article							PRECISION GRIP LIFTS; FORCE CONTROL; MANIPULATION; COORDINATION; ATTENTION; EFFICIENT; RESPONSES; STRATEGY; CHILDREN; SIGNALS	In daily life, object manipulation is usually performed concurrently to the execution of cognitive tasks. The aim of the present study was to determine which aspects of precision grip require cognitive resources using a motor-cognitive dual-task paradigm. Eighteen healthy participants took part in the experiment, which comprised two conditions. In the first condition, participants performed a motor task without any concomitant cognitive task. They were instructed to grip, lift and hold an apparatus incorporating strain gauges allowing a continuous measurement of the force perpendicular to each contact surface (grip force, GF) as well as the total tangential force applied on the object (load force, LF). In the second condition, participants performed the same motor task while concurrently performing a cognitive task consisting in a complex visual search combined with counting. In the dual-task condition, we found a significant increase in the duration of the preload phase (time between initial contact of the fingers with the apparatus and onset of the load force), as well as a significant increase of the grip force during the holding phase, indicating that the cognitive task interfered with the initial force scaling performed during the preload phase and the fine-tuning of grip force during the hold phase. These findings indicate that these aspects of precision grip require cognitive resources. In contrast, other aspects of the precision grip, such as the temporal coupling between grip and load forces, were not affected by the cognitive task, suggesting that they reflect more automatic processes. Taken together, our results suggest that assessing the dynamic and temporal parameters of precision grip in the context of a concurrent cognitive task may constitute a more ecological and better-suited tool to characterize motor dysfunction in patients.	[Guillery, Erwan; Mouraux, Andre; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Universite Catholique Louvain	Thonnard, JL (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	Jean-Louis.Thonnard@uclouvain.be	Mouraux, Andre/F-3724-2012	Mouraux, Andre/0000-0003-1056-5980				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Afifi M, 2012, CLIN NEUROPHYSIOL, V123, P2281, DOI 10.1016/j.clinph.2012.04.013; Andre T, 2010, J NEUROPHYSIOL, V103, P402, DOI 10.1152/jn.00901.2009; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Creem SH, 2001, J EXP PSYCHOL HUMAN, V27, P218, DOI 10.1037/0096-1523.27.1.218; Diermayr G, 2011, GERONTOLOGY, V57, P217, DOI 10.1159/000295921; Dispa D, 2013, INT J REHABIL RES, V36, P81, DOI 10.1097/MRR.0b013e32835acfd5; Duque J, 2003, BRAIN, V126, P732, DOI 10.1093/brain/awg069; Enns JT, 2009, PROG BRAIN RES, V176, P215, DOI 10.1016/S0079-6123(09)17612-4; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; FLANAGAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P944, DOI 10.1037/0096-1523.20.5.944; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Hermsdorfer J, 1999, EXP BRAIN RES, V126, P205, DOI 10.1007/s002210050730; Hesse C, 2012, VISION RES, V71, P37, DOI 10.1016/j.visres.2012.08.014; Hesse C, 2011, VISION RES, V51, P1223, DOI 10.1016/j.visres.2011.03.014; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kahneman D., 1973, ATTENTION EFFORT; Kimberley Teresa Jacobson, 2008, J Neurol Phys Ther, V32, P110, DOI 10.1097/NPT.0b013e318183d716; Li Y, 2009, BEHAV BRAIN RES, V196, P123, DOI 10.1016/j.bbr.2008.07.031; Liu G, 2008, EXP BRAIN RES, V185, P709, DOI 10.1007/s00221-007-1196-5; McBride J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00082; McDonnell MN, 2005, EXP BRAIN RES, V161, P368, DOI 10.1007/s00221-004-2081-0; McIntosh RD, 2010, EXP BRAIN RES, V206, P257, DOI 10.1007/s00221-010-2404-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pereira HS, 2001, NEUROPSYCHOLOGIA, V39, P478, DOI 10.1016/S0028-3932(00)00132-9; Pereira HS, 2000, DEV MED CHILD NEUROL, V42, P545, DOI 10.1017/S0012162200001031; Saling LL, 2007, BRAIN RES BULL, V73, P1, DOI 10.1016/j.brainresbull.2007.02.009; Schabrun SM, 2008, EUR J NEUROSCI, V27, P750, DOI 10.1111/j.1460-9568.2008.06039.x; Singhal A, 2007, J VISION, V7, DOI 10.1167/7.5.5; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spiegel MA, 2012, NEUROSCI LETT, V509, P82, DOI 10.1016/j.neulet.2011.12.033; Thonnard JL, 1997, SCAND J WORK ENV HEA, V23, P193, DOI 10.5271/sjweh.198; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; WESTLING G, 1987, EXP BRAIN RES, V66, P128; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006	45	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80125	10.1371/journal.pone.0080125	http://dx.doi.org/10.1371/journal.pone.0080125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244626	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900063
J	Rozenberg, JM; Bhattacharya, P; Chatterjee, R; Glass, K; Vinson, C				Rozenberg, Julian M.; Bhattacharya, Paramita; Chatterjee, Raghunath; Glass, Kimberly; Vinson, Charles			Combinatorial Recruitment of CREB, C/EBP beta and c-Jun Determines Activation of Promoters upon Keratinocyte Differentiation	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; INVOLUCRIN GENE PROMOTER; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; IN-VITRO; CHROMATIN ACCESSIBILITY; MEDIATED TRANSCRIPTION; SKIN TUMORIGENESIS; CELL-SURVIVAL; ONCOGENIC RAS	Background: Transcription factors CREB, C/EBP beta and Jun regulate genes involved in keratinocyte proliferation and differentiation. We questioned if specific combinations of CREB, C/EBP beta and c-Jun bound to promoters correlate with RNA polymerase II binding, mRNA transcript levels and methylation of promoters in proliferating and differentiating keratinocytes. Results: Induction of mRNA and RNA polymerase II by differentiation is highest when promoters are bound by C/EBP beta alone, C/EBP beta together with c-Jun, or by CREB, C/EBP beta and c-Jun, although in this case CREB binds with low affinity. In contrast, RNA polymerase II binding and mRNA levels change the least upon differentiation when promoters are bound by CREB either alone or in combination with C/EBP beta or c-Jun. Notably, promoters bound by CREB have relatively high levels of RNA polymerase II binding irrespective of differentiation. Inhibition of C/EBP beta or c-Jun preferentially represses mRNA when gene promoters are bound by corresponding transcription factors and not CREB. Methylated promoters have relatively low CREB binding and, accordingly, those which are bound by C/EBP beta are induced by differentiation irrespective of CREB. Composite "Half and Half'' consensus motifs and co localizing consensus DNA binding motifs are overrepresented in promoters bound by the combination of corresponding transcription factors. Conclusion: Correlational and functional data describes combinatorial mechanisms regulating the activation of promoters. Colocalization of C/EBP beta and c-Jun on promoters without strong CREB binding determines high probability of activation upon keratinocyte differentiation.	[Rozenberg, Julian M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bhattacharya, Paramita] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India; [Chatterjee, Raghunath] Indian Stat Inst, Div Biol Sci, Human Genet Unit, Kolkata, India; [Glass, Kimberly] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA; [Vinson, Charles] NCI, Lab Metab, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Saha Institute of Nuclear Physics; Indian Statistical Institute; Indian Statistical Institute Kolkata; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vinson, C (corresponding author), NCI, Lab Metab, Bethesda, MD 20892 USA.	vinsonc@dc37a.nci.nih.gov	Rozenberg, Julian M/M-8561-2018; Chatterjee, Raghunath/AAF-4959-2021; Chatterjee, Raghunath/H-3236-2013	Chatterjee, Raghunath/0000-0002-4602-0838; Rozenberg, Julian/0000-0002-7627-5217; Glass, Kimberly/0000-0003-4394-5779	National Institutes of Health, Bethesda, Maryland USA; NIH; NATIONAL CANCER INSTITUTE [ZIABC005271] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was performed and funded by the National Institutes of Health, Bethesda, Maryland USA. The source of funding was intramural budget of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Chatterjee R, 2012, G3-GENES GENOM GENET, V2, P1243, DOI 10.1534/g3.112.004002; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Cui TX, 2008, J ENDOCRINOL, V196, P89, DOI 10.1677/JOE-07-0169; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flammer JR, 2006, BIOCHEMISTRY-US, V45, P9615, DOI 10.1021/bi052521a; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Manna PR, 2009, MOL CELL ENDOCRINOL, V302, P1, DOI 10.1016/j.mce.2008.12.009; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Rozenberg J, 2009, MOL CANCER RES, V7, P654, DOI 10.1158/1541-7786.MCR-08-0011; Rutberg SE, 1999, ONCOGENE, V18, P1569, DOI 10.1038/sj.onc.1202463; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Smith C, 2004, BIOCHEM J, V380, P757, DOI 10.1042/BJ20040077; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Tran NQ, 2004, BIOCHEM J, V381, P267, DOI 10.1042/BJ20031653; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	53	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78179	10.1371/journal.pone.0078179	http://dx.doi.org/10.1371/journal.pone.0078179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244291	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900009
J	Arianoutsou, M; Delipetrou, P; Vila, M; Dimitrakopoulos, PG; Celesti-Grapow, L; Wardell-Johnson, G; Henderson, L; Fuentes, N; Ugarte-Mendes, E; Rundel, PW				Arianoutsou, Margarita; Delipetrou, Pinelopi; Vila, Montserrat; Dimitrakopoulos, Panayiotis G.; Celesti-Grapow, Laura; Wardell-Johnson, Grant; Henderson, Lesley; Fuentes, Nicol; Ugarte-Mendes, Eduardo; Rundel, Philip W.			Comparative Patterns of Plant Invasions in the Mediterranean Biome	PLOS ONE			English	Article							ALIEN PLANTS; BIOTIC HOMOGENIZATION; SPECIES RICHNESS; NONNATIVE FLORA; RESOURCE-USE; BIODIVERSITY; CONSERVATION; DIVERSITY; IMPACTS; REGIONS	The objective of this work was to compare and contrast the patterns of alien plant invasions in the world's five mediterranean-climate regions (MCRs). We expected landscape age and disturbance history to have bearing on levels of invasion. We assembled a database on naturalized alien plant taxa occurring in natural and semi-natural terrestrial habitats of all five regions (specifically Spain, Italy, Greece and Cyprus from the Mediterranean Basin, California, central Chile, the Cape Region of South Africa and Southwestern - SW Australia). We used multivariate (hierarchical clustering and NMDS ordination) trait and habitat analysis to compare characteristics of regions, taxa and habitats across the mediterranean biome. Our database included 1627 naturalized species with an overall low taxonomic similarity among the five MCRs. Herbaceous perennials were the most frequent taxa, with SW Australia exhibiting both the highest numbers of naturalized species and the highest taxonomic similarity (homogenization) among habitats, and the Mediterranean Basin the lowest. Low stress and highly disturbed habitats had the highest frequency of invasion and homogenization in all regions, and high natural stress habitats the lowest, while taxonomic similarity was higher among different habitats in each region than among regions. Our analysis is the first to describe patterns of species characteristics and habitat vulnerability for a single biome. We have shown that a broad niche (i.e. more than one habitat) is typical of naturalized plant species, regardless of their geographical area of origin, leading to potential for high homogenization within each region. Habitats of the Mediterranean Basin are apparently the most resistant to plant invasion, possibly because their landscapes are generally of relatively recent origin, but with a more gradual exposure to human intervention over a longer period.	[Arianoutsou, Margarita] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Systemat & Ecol, Athens 11528, Greece; [Delipetrou, Pinelopi] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Bot, Athens 11528, Greece; [Vila, Montserrat] Consejo Super Invest Cientifi, Estn Biol Donana, Seville, Spain; [Dimitrakopoulos, Panayiotis G.] Univ Aegean, Dept Environm, Biodivers Conservat Lab, Mitilini, Greece; [Celesti-Grapow, Laura] Sapienza Univ, Dept Environm Biol, Rome, Italy; [Wardell-Johnson, Grant] Curtin Univ, Sch Sci, Curtin Inst Biodivers & Climate, Bentley, WA, Australia; [Henderson, Lesley] Agr Res Council, Plant Protect Res Inst, Pretoria, South Africa; [Fuentes, Nicol] Univ Concepcion, Fac Ciencias Forest, Concepcion, Chile; [Fuentes, Nicol] Inst Ecol & Biodivers, Santiago, Chile; [Ugarte-Mendes, Eduardo] Univ Concepcion, Dept Bot, Concepcion, Chile; [Rundel, Philip W.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Aegean; Sapienza University Rome; Curtin University; Agricultural Research Council of South Africa; Universidad de Concepcion; Universidad de Concepcion; University of California System; University of California Los Angeles	Arianoutsou, M (corresponding author), Natl & Kapodistrian Univ Athens, Fac Biol, Dept Systemat & Ecol, Athens 11528, Greece.	marianou@biol.uoa.gr	Vila, Montserrat/D-9339-2013; CELESTI, Laura/ABA-2552-2021; Arianoutsou, Margarita/ABA-1614-2021	Vila, Montserrat/0000-0003-3171-8261; CELESTI, Laura/0000-0002-9533-6919; ARIANOUTSOU, MARGARITA/0000-0002-6743-9240; Dimitrakopoulos, Panayiotis/0000-0002-8374-4392; Fuentes, Nicol/0000-0002-3773-9832	Spanish Ministerio de Ciencia e Innovacion [CGL2009-7515, CSD2008-00040]; Junta de Andalucia [RNM-4031]; ALARM project (Assessing LArge scale environmental Risks for biodiversity with tested Methods) [GOCE-CT-2003-506675]; Project ICM [P05-002]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); ALARM project (Assessing LArge scale environmental Risks for biodiversity with tested Methods); Project ICM	MV acknowledges financial support by the Spanish Ministerio de Ciencia e Innovacion projects RIXFUTUR (CGL2009-7515) and MONTES (CSD2008-00040) and the Junta de Andalucia project RNM-4031; NF and EU by the ALARM project (Assessing LArge scale environmental Risks for biodiversity with tested Methods; GOCE-CT-2003-506675) to generate the database of Chile. NF acknowledges FONDECYT 3120125, Project ICM P05-002 and PFB-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikio S, 2012, GLOBAL ECOL BIOGEOGR, V21, P778, DOI 10.1111/j.1466-8238.2011.00711.x; Andersen MC, 2004, RISK ANAL, V24, P787, DOI 10.1111/j.0272-4332.2004.00478.x; [Anonymous], 1991, BIOGEOGRAPHY MEDITER, DOI DOI 10.1017/CBO9780511525544.002; Arianoutsou M, 2012, ISR J ECOL EVOL, V58, P195, DOI 10.1560/IJEE.58.2-3.195; Arianoutsou M, 2010, J BIOGEOGR, V37, P1811, DOI 10.1111/j.1365-2699.2010.02324.x; Aschmann H., 1991, BIOGEOGRAPHY MEDITER, P33; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Celesti-Grapow L, 2010, PLANT BIOSYST, V144, P12, DOI 10.1080/11263500903431870; Celesti-Grapow L, 2009, PLANT BIOSYST, V143, P386, DOI 10.1080/11263500902722824; Chen H, 2010, DIVERS DISTRIB, V16, P737, DOI 10.1111/j.1472-4642.2010.00679.x; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Clarke K.R., 1994, CHANGE MARINE COMMUN, V2, P117; Clarke K.R., 2006, PRIMER V6 USER MANUA; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cronquist A, 1981, INTEGRATED SYSTEM CL; D'Antonio C.M., 2000, INVASIVE SPECIES CHA, P65; Deacon H. J., 1991, BIOGEOGRAPHY MEDITER, P51; ELLENBERG H., 1967, BER GEOBOT INST EIDG TECH HOCHSCH STIFT RUBEL, V37, P56; Environment Australia, 2000, REV INT BIOG REG AUS; Fuentes N, 2013, BIOL INVASIONS, V15, P847, DOI 10.1007/s10530-012-0334-6; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gasso N, 2009, DIVERS DISTRIB, V15, P50, DOI 10.1111/j.1472-4642.2008.00501.x; Goldblatt P., 2000, CAPE PLANTS CONSPECT; Gomez-Gonzalez S, 2011, DIVERS DISTRIB, V17, P58, DOI 10.1111/j.1472-4642.2010.00728.x; Grime JP, 1988, COMP PLANT ECOLOGY; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Groves R.H., 1991, BIOGEOGRAPHY MEDITER; Harrison S, 2003, CONSERV BIOL, V17, P837, DOI 10.1046/j.1523-1739.2003.01633.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Henderson L, 2007, BOTHALIA, V37, P215, DOI 10.4102/abc.v37i2.322; Heywood VH, 1989, BIOL INVASIONS GLOBA, V37, P31; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Hulme P. E., 2008, Plant invasions: human perception, ecological impacts and management, P39; Hulme PE, 2008, GLOBAL ECOL BIOGEOGR, V17, P641, DOI 10.1111/j.1466-8238.2008.00404.x; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hussey B., 2007, W WEEDS GUIDE WEEDS, V2nd ed.; Jimenez A, 2008, J BIOGEOGR, V35, P614, DOI 10.1111/j.1365-2699.2007.01799.x; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kloot P. M., 1991, Biogeography of mediterranean invasions., P131; Kumar S, 2006, ECOLOGY, V87, P3186, DOI 10.1890/0012-9658(2006)87[3186:SHINAN]2.0.CO;2; Lambdon PW, 2008, BIOL INVASIONS, V10, P703, DOI 10.1007/s10530-007-9163-4; Lambdon PW, 2008, PRESLIA, V80, P101; Lloret F, 2004, GLOBAL ECOL BIOGEOGR, V13, P37, DOI 10.1111/j.1466-882X.2004.00064.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mittermeier RA, 2005, HOPSPOTS REVISITED E; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Mucina L, 2011, PLANT SOIL, V341, P1, DOI 10.1007/s11104-011-0734-x; NORDAL I, 1987, J BIOGEOGR, V14, P377, DOI 10.2307/2844945; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Pauchard A, 2006, BIOL INVASIONS, V8, P399, DOI 10.1007/s10530-005-6419-8; Pauchard A, 2004, DIVERS DISTRIB, V10, P371, DOI 10.1111/j.1366-9516.2004.00116.x; PIELOU E. C., 1984, INTERPRETATION ECOLO; Pignatti S., 1982, FLORA DITALIA, VVolume I; Poynton R. J., 2009, TREE PLANTING SO AFR; Pretto F, 2012, BIOL INVASIONS, V14, P2559, DOI 10.1007/s10530-012-0252-7; Pretto F, 2010, PLANT ECOL, V210, P225, DOI 10.1007/s11258-010-9751-8; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Pysek Petr, 2002, Preslia (Prague), V74, P97; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; Qian H, 2008, BASIC APPL ECOL, V9, P617, DOI 10.1016/j.baae.2007.11.004; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Richardson D. M., 1997, P535; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rundel P. W., 2011, THE ECOLOGY OF PLACE, P93; Rundel Philip W., 2001, P145; Rundel PW, 2013, BIOL INVASI IN PRESS; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Stromberg MR., 2007, CALIFORNIA GRASSLAND, P254; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Ugarte E., 2011, CHECK LIST, V7, P365, DOI DOI 10.15560/7.3.365; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x; Verlaque R, 2001, CR ACAD SCI III-VIE, V324, P1157, DOI 10.1016/S0764-4469(01)01406-8; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	87	32	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79174	10.1371/journal.pone.0079174	http://dx.doi.org/10.1371/journal.pone.0079174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244443	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800038
J	Kang, NY; Cho, C; Kim, J				Kang, Na Young; Cho, Chuloh; Kim, Jungmook			Inducible Expression of Arabidopsis Response Regulator 22 (ARR22), a Type-C ARR, in Transgenic Arabidopsis Enhances Drought and Freezing Tolerance	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; REDUNDANT NEGATIVE REGULATORS; RESPONSE REGULATORS; CYTOKININ-RECEPTOR; TRANSCRIPTION FACTOR; OSMOTIC-STRESS; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; ECTOPIC EXPRESSION; LEAF SENESCENCE	The Arabidopsis two-component signaling system, which is comprised of sensor histidine kinases, histidine phosphotransfer proteins, and response regulators, mediates cytokinin response as well as various other plant responses including abiotic stress responses. Arabidopsis response regulators (ARRs) are classified into type-A, -B, and -C. Although the roles of type-A and -B ARRs are well established in Arabidopsis plant signaling, roles of type-C ARRs, ARR22 and ARR24, remain elusive. ARR22, a preferentially cytosolic protein, interacts with certain Arabidopsis histidine phosphotransfer proteins (AHPs) and displays phosphatase activity on AHP5. ARR22 is induced by cold and dehydration. Here, we show that inducible overexpression of ARR22 in Arabidopsis enhanced dehydration, drought, and cold tolerance in a dexamethasone-dependent manner, whereas mutation of the putative phospho-accepting Asp to Asn in ARR22 (ARR22(D74N)) abolished these tolerance phenotypes. Overexpression of ARR22 decreased electrolyte leakage in dehydration-, drought-, or cold-stressed transgenic Arabidopsis plants compared with that of ARR22(D74N) or compared with wild-type plants. Transpiration rates and stomatal apertures were not affected by ARR22 overexpression. No significant difference in both dehydration and freezing tolerance was observed between wild-type and arr22 mutants with or without cytokinin preincubation, consistent with the lack of phenotypes of arr22 mutants in their vegetative development. Meta-profile analyses of the microarray data on ARR22-responsive genes indicate that ARR22 modulates expression of a variety of abiotic stress-responsive genes, which might contribute to increasing drought and freezing tolerance. Taken together, these results suggest that ARR22 plays a positive role in the stress tolerance response in part via enhancing cell membrane integrity and that phospho-histidine phosphatase activity of ARR22 may be required for this function.	[Kim, Jungmook] Chonnam Natl Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea; Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, J (corresponding author), Chonnam Natl Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea.	jungmkim@chonnam.ac.kr		Kim, Jungmook/0000-0003-1735-5564	World Class University project [R31-2009-000-20025-0]; Basic Science Research Program through the National Research Foundation of Korea [2010-0022850]; Ministry of Education, Science and Technology of Korea; Next Generation BioGreen 21 Program, RDA, Republic of Korea [PJ00823]	World Class University project; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next Generation BioGreen 21 Program, RDA, Republic of Korea	This work was supported by grants from the World Class University project (R31-2009-000-20025-0), the Basic Science Research Program through the National Research Foundation of Korea (2010-0022850) funded by the Ministry of Education, Science and Technology of Korea, and the Next Generation BioGreen 21 Program (PJ00823), RDA, Republic of Korea to J. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Gattolin S, 2006, J EXP BOT, V57, P4225, DOI 10.1093/jxb/erl205; Go YS, 2012, PLANT J, V72, P791, DOI 10.1111/j.1365-313X.2012.05120.x; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jefferson R.A, 1991, PLANT MOL BIOL, pB14; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jeon J, 2013, PLANT PHYSIOL, V161, P408, DOI 10.1104/pp.112.207621; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kang NY, 2012, J PLANT PHYSIOL, V169, P1382, DOI 10.1016/j.jplph.2012.05.007; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawaoka A, 2003, PLANT PHYSIOL, V132, P1177, DOI 10.1104/pp.102.019794; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kim J, 2007, J PLANT BIOL, V50, P139, DOI 10.1007/BF03030622; Kim J, 2013, MOL PLANT, V6, P15, DOI 10.1093/mp/sss151; Kim J, 2008, PLANT SIGNAL BEHAV, V3, P348, DOI 10.4161/psb.3.5.5375; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; Lee DJ, 2008, PLANTA, V227, P577, DOI 10.1007/s00425-007-0640-x; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Lee DJ, 2009, J EXP BOT, V60, P3935, DOI 10.1093/jxb/erp230; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; NES WD, 1981, J NAT PROD, V44, P377, DOI 10.1021/np50016a001; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Nishiyama R, 2013, P NATL ACAD SCI USA, V110, P4840, DOI 10.1073/pnas.1302265110; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peters C, 2010, PLANT CELL, V22, P2642, DOI 10.1105/tpc.109.071720; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Pils B, 2009, PLANT PHYSIOL, V151, P782, DOI 10.1104/pp.109.139188; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Suzuki M, 2006, PLANT CELL PHYSIOL, V47, P565, DOI 10.1093/pcp/pcj031; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; VANLOON LC, 1985, PLANT MOL BIOL, V4, P111, DOI 10.1007/BF02418757; Wang YF, 2010, CHEM BIODIVERS, V7, P2623, DOI 10.1002/cbdv.200900406; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wielopolska A, 2005, PLANT BIOTECHNOL J, V3, P583, DOI 10.1111/j.1467-7652.2005.00149.x; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012	87	28	30	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79248	10.1371/journal.pone.0079248	http://dx.doi.org/10.1371/journal.pone.0079248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244460	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800048
J	Mitchell, CA; Kalies, S; Cizmar, T; Heisterkamp, A; Torrance, L; Roberts, AG; Gunn-Moore, FJ; Dholakia, K				Mitchell, Claire A.; Kalies, Stefan; Cizmar, Tomas; Heisterkamp, Alexander; Torrance, Lesley; Roberts, Alison G.; Gunn-Moore, Frank J.; Dholakia, Kishan			Femtosecond Optoinjection of Intact Tobacco BY-2 Cells Using a Reconfigurable Photoporation Platform	PLOS ONE			English	Article							PLANT-CELLS; OPTICAL TRANSFECTION; GENE-TRANSFER; LASER-PULSES; DELIVERY; SINGLE; MICROINJECTION; PROTEINS; MANIPULATION; EXPRESSION	A tightly-focused ultrashort pulsed laser beam incident upon a cell membrane has previously been shown to transiently increase cell membrane permeability while maintaining the viability of the cell, a technique known as photoporation. This permeability can be used to aid the passage of membrane-impermeable biologically-relevant substances such as dyes, proteins and nucleic acids into the cell. Ultrashort-pulsed lasers have proven to be indispensable for photoporating mammalian cells but they have rarely been applied to plant cells due to their larger sizes and rigid and thick cell walls, which significantly hinders the intracellular delivery of exogenous substances. Here we demonstrate and quantify femtosecond optical injection of membrane impermeable dyes into intact BY-2 tobacco plant cells growing in culture, investigating both optical and biological parameters. Specifically, we show that the long axial extent of a propagation invariant ("diffraction-free") Bessel beam, which relaxes the requirements for tight focusing on the cell membrane, outperforms a standard Gaussian photoporation beam, achieving up to 70% optoinjection efficiency. Studies on the osmotic effects of culture media show that a hypertonic extracellular medium was found to be necessary to reduce turgor pressure and facilitate molecular entry into the cells.	[Mitchell, Claire A.; Dholakia, Kishan] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland; [Kalies, Stefan] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Cizmar, Tomas] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Heisterkamp, Alexander] Univ Jena, Inst Appl Opt, Jena, Germany; [Torrance, Lesley; Roberts, Alison G.] James Hutton Inst, Dundee, Scotland; [Torrance, Lesley; Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews; Friedrich Schiller University of Jena; James Hutton Institute; University of St Andrews	Mitchell, CA (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland.	cm97@st-andrews.ac.uk	Heisterkamp, Alexander/V-5376-2017; Cizmar, Tomas/E-7428-2019	Heisterkamp, Alexander/0000-0001-8770-0859; Cizmar, Tomas/0000-0002-5813-3602; Dholakia, Kishan/0000-0001-6534-9009; Gunn-Moore, Francis James/0000-0003-3422-3387; Mitchell, Claire/0000-0001-9960-2340; Kalies, Stefan/0000-0003-3025-264X; Torrance, Lesley/0000-0001-8327-1276	UK Engineering and Physical Sciences Research Council; James Hutton Institute; EPSRC [EP/J01771X/1, EP/H045368/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H045368/1, EP/J01771X/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); James Hutton Institute; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the UK Engineering and Physical Sciences Research Council, the James Hutton Institute, R. S. MacDonald, Dr. E. Killick and the "BRAINS" 600th Anniversary appeal for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak M, 2013, NAT PROTOC, V8, P1216, DOI 10.1038/nprot.2013.071; Antkowiak M, 2010, J BIOPHOTONICS, V3, P696, DOI 10.1002/jbio.201000052; Awazu K, 2002, NUCL INSTRUM METH A, V483, P571, DOI 10.1016/S0168-9002(02)00384-4; Badr YA, 2005, PHOTOCH PHOTOBIO SCI, V4, P803, DOI 10.1039/b503658e; BARONEPEL O, 1988, PLANTA, V175, P389, DOI 10.1007/BF00396345; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; BECK WILLIAM A., 1929, TRANS AMER MIEROSCOP SOC, V48, P204, DOI 10.2307/3222213; Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Brown CTA, 2008, J BIOPHOTONICS, V1, P183, DOI 10.1002/jbio.200810011; CAMPBELL N, 1996, BIOLOGY; Cappelleri DJ, 2010, JALA-J LAB AUTOM, V15, P329, DOI 10.1016/j.jala.2010.03.003; Chakravarty P, 2010, NAT NANOTECHNOL, V5, P607, DOI [10.1038/nnano.2010.126, 10.1038/NNANO.2010.126]; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; Cizmar T, 2010, NAT PHOTONICS, V4, P388, DOI 10.1038/NPHOTON.2010.85; DURNIN J, 1987, PHYS REV LETT, V58, P1499, DOI 10.1103/PhysRevLett.58.1499; DURNIN J, 1987, J OPT SOC AM A, V4, P651, DOI 10.1364/JOSAA.4.000651; Ferrando M, 2001, J FOOD ENG, V49, P115, DOI 10.1016/S0260-8774(00)00218-1; Geelen DNV, 2001, PLANT PHYSIOL, V127, P1375, DOI 10.1104/pp.010708; GOUDRIAAN J, 1979, ANN BOT-LONDON, V43, P783, DOI 10.1093/oxfordjournals.aob.a085693; Granath KA., 1958, J COLLOID SCI, V13, P308; Gu L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662887; GUO YD, 1995, PHYSIOL PLANTARUM, V93, P19, DOI 10.1034/j.1399-3054.1995.930104.x; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Heinemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058604; HUNOLD R, 1994, PLANT J, V5, P593, DOI 10.1046/j.1365-313X.1994.5040593.x; INDEBETOUW G, 1989, J OPT SOC AM A, V6, P150, DOI 10.1364/JOSAA.6.000150; Kajiyama S, 2006, BIOTECHNOL BIOENG, V93, P325, DOI 10.1002/bit.20709; Kajiyama S, 2008, J BIOSCI BIOENG, V106, P194, DOI 10.1263/jbb.106.194; Kalies S, 2013, J BIOPHOTONICS, V9, P1, DOI [10.1002/jbio.201200200, DOI 10.1002/JBI0.201200200]; Kohli V, 2005, BIOTECHNOL BIOENG, V92, P889, DOI 10.1002/bit.20689; Ladenburg D, 1988, NATURWISSENSCHAFTEN, V36, P1; LeBlanc ML, 2013, OPT EXPRESS, V21, P14662, DOI 10.1364/OE.21.014662; Lei M, 2008, J NEUROSCI METH, V174, P215, DOI 10.1016/j.jneumeth.2008.07.006; Lodish H, 2000, MOL CELL BIOL; Marchington RF, 2010, BIOMED OPT EXPRESS, V1, P527, DOI 10.1364/BOE.1.000527; Matsuoka H, 2005, J BIOTECHNOL, V116, P185, DOI 10.1016/j.jbiotec.2004.10.010; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mthunzi P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430733; Nagata T, 2004, BIOTECHNOL AGRIC FOR, V53, P1; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; Rendall HA, 2012, LAB CHIP, V12, P4816, DOI 10.1039/c2lc40708f; Rounds CM, 2011, PLANT PHYSIOL, V157, P175, DOI 10.1104/pp.111.182196; Rudhall AP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00858; Schinkel H, 2008, BIOTECHNOL BIOENG, V99, P244, DOI 10.1002/bit.21549; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMIT JAM, 1992, MACROMOLECULES, V25, P3585, DOI 10.1021/ma00039a044; Stevenson D, 2006, OPT EXPRESS, V14, P7125, DOI 10.1364/OE.14.007125; Stevenson DJ, 2010, J R SOC INTERFACE, V7, P863, DOI 10.1098/rsif.2009.0463; Stiles W, 1994, PRINCIPLES PLANT PHY; Tirlapur UK, 1999, PLANT J, V20, P363, DOI 10.1046/j.1365-313X.1999.t01-1-00603.x; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Torres-Mapa ML, 2011, BIOMED OPT EXPRESS, V2, P1564, DOI 10.1364/BOE.2.001564; TRAAS JA, 1987, J CELL BIOL, V105, P387, DOI 10.1083/jcb.105.1.387; Tsampoula X, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766835; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; WEBER G, 1990, PHYSIOL PLANTARUM, V79, P190, DOI 10.1111/j.1399-3054.1990.tb05885.x; Wu FS, 1999, PLANT CELL REP, V18, P381, DOI 10.1007/s002990050590; WU FS, 1995, PLANT SCI, V104, P201, DOI 10.1016/0168-9452(94)04023-A; Wymer CL, 1997, PLANT J, V12, P229, DOI 10.1046/j.1365-313X.1997.12010229.x; Yao CP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253320; Zeira E, 2003, MOL THER, V8, P342, DOI 10.1016/S1525-0016(03)00184-9	63	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79235	10.1371/journal.pone.0079235	http://dx.doi.org/10.1371/journal.pone.0079235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244456	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800046
J	Preston, CC; Maurer, MJ; Oberg, AL; Visscher, DW; Kalli, KR; Hartmann, LC; Goode, EL; Knutson, KL				Preston, Claudia C.; Maurer, Matthew J.; Oberg, Ann L.; Visscher, Daniel W.; Kalli, Kimberly R.; Hartmann, Lynn C.; Goode, Ellen L.; Knutson, Keith L.			The Ratios of CD8(+) T Cells to CD4(+) CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer	PLOS ONE			English	Article							DENDRITIC CELLS; TUMOR; INDUCTION; CARCINOMA; IMMUNITY; ANTIBODY; IL-2; CHEMOTHERAPY; CARBOPLATIN; LYMPHOCYTES	Ovarian cancer is an immune reactive malignancy with a complex immune suppressive network that blunts successful immune eradication. This suppressive microenvironment may be mediated by recruitment or induction of CD4(+) regulatory T cells (Tregs). Our study sought to investigate the association of tumor-infiltrating CD4(+)CD25(+)FOXP3(+) Tregs, and other immune factors, with clinical outcome in serous ovarian cancer patients. We performed immunofluorescence and quantification of intraepithelial tumor-infiltrating triple positive Tregs (CD4(+)CD25(+)FOXP3(+)), as well as CD4(+) CD25(+) FOXP3(-), CD3(+) and CD8(+) T cells in tumor specimens from 52 patients with high stage serous ovarian carcinoma. Thirty-one of the patients had good survival (i.e. > 60 months) and 21 had poor survival of < 18 months. Total cell counts as well as cell ratios were compared among these two outcome groups. The total numbers of CD4(+)CD25(+)FOXP3(+) Tregs, CD4(+) CD25(+) FOXP3(-), CD3(+) and CD8(+) cells were not significantly different between the groups. However, higher ratios of CD8(+)/CD4(+)CD25(+)FOXP3(+) Treg, CD8(+)/CD4(+) and CD8/CD4(+)CD25(+)FOXP3-cells were seen in the good outcome group when compared to the patients with poor outcome. These data show for the first time that the ratios of CD8(+) to both CD4(+) CD25(+) FOXP3(+) Tregs and CD4(+)CD25(+)FOXP3(-) T cells are associated with disease outcome in ovarian cancer. The association being apparent in ratios rather than absolute count of T cells suggests that the effector/ suppressor ratio may be a more important indicator of outcome than individual cell count. Thus, immunotherapy strategies that modify the ratio of CD4(+)CD25(+)FOXP3(+) Tregs or CD4(+)CD25(+)FOXP3(-) T cells to CD8(+) effector cells may be useful in improving outcomes in ovarian cancer.	[Preston, Claudia C.; Knutson, Keith L.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Maurer, Matthew J.; Oberg, Ann L.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Visscher, Daniel W.; Hartmann, Lynn C.] Mayo Clin, Div Anat Pathol, Rochester, MI USA; [Kalli, Kimberly R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Kalli, Kimberly R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Knutson, Keith L.] Vaccine & Gene Therapy Inst, Port St Lucie, FL USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Vaccine & Gene Therapy Institute of Florida	Goode, EL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	egoode@mayo.edu; kknutson@vgtifl.org		Maurer, Matthew/0000-0002-1867-0526	 [P50-CA116201];  [R01-CA122443];  [P50-CA136393]; NATIONAL CANCER INSTITUTE [P50CA136393, R01CA122443, P50CA116201] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to KLK, ELG, LCH: P50-CA116201, R01-CA122443, and P50-CA136393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen FX, 2009, INT J GYNECOL CANCER, V19, P1487, DOI 10.1111/IGC.0b013e3181bb70c6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coleman S, 2005, CANCER RES, V65, P7000, DOI 10.1158/0008-5472.CAN-04-3792; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Ebert EC, 2003, CLIN EXP IMMUNOL, V132, P424, DOI 10.1046/j.1365-2249.2003.02156.x; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goodell V, 2006, J CLIN ONCOL, V24, P762, DOI 10.1200/JCO.2005.03.2813; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Knutson KL, 2006, J IMMUNOL, V177, P84, DOI 10.4049/jimmunol.177.1.84; Knutson KL, 2004, CANCER RES, V64, P1146, DOI 10.1158/0008-5472.CAN-03-0173; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Ladoire S, 2012, ANN ONCOL, V23, P2552, DOI 10.1093/annonc/mds028; Li X, 2005, CANCER INVEST, V23, P399, DOI 10.1081/CNV-200067142; Lipson EJ, 2011, CLIN CANCER RES, V17, P6958, DOI 10.1158/1078-0432.CCR-11-1595; Magg T, 2012, EUR J IMMUNOL, V42, P1627, DOI 10.1002/eji.201141838; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Noh J, 2012, CELL IMMUNOL, V274, P109, DOI 10.1016/j.cellimm.2012.01.005; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Trimble EL, 2010, INT J GYNECOL CANCER, V20, P1284, DOI 10.1111/IGC.0b013e3181ee1c01; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	44	142	161	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80063	10.1371/journal.pone.0080063	http://dx.doi.org/10.1371/journal.pone.0080063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244610	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800116
J	Vincent, HA; Phillips, JO; Henderson, CA; Roberts, AJ; Stone, CM; Mardle, CE; Butt, LE; Gowers, DM; Pickford, AR; Callaghan, AJ				Vincent, Helen A.; Phillips, Jack O.; Henderson, Charlotte A.; Roberts, Adam J.; Stone, Carlanne M.; Mardle, Charlotte E.; Butt, Louise E.; Gowers, Darren M.; Pickford, Andrew R.; Callaghan, Anastasia J.			An Improved Method for Surface Immobilisation of RNA: Application to Small Non-Coding RNA - mRNA Pairing	PLOS ONE			English	Article							VIBRIO-CHOLERAE; ESCHERICHIA-COLI; OLIGORIBONUCLEOTIDE SYNTHESIS; HELICOBACTER-PYLORI; GENE-EXPRESSION; OUTER-MEMBRANE; ANTISENSE RNA; SOLUBLE-RNA; HFQ; BINDING	Characterisation of RNA and its intermolecular interactions is increasing in importance as the inventory of known RNA functions continues to expand. RNA-RNA interactions are central to post-transcriptional gene regulation mechanisms in bacteria, and the interactions of bacterial small non-coding RNAs (sRNAs) with their mRNA targets are the subject of much current research. The technology of surface plasmon resonance (SPR) is an attractive approach to studying these interactions since it is highly sensitive, and allows interaction measurements to be recorded in real-time. Whilst a number of approaches exist to label RNAs for surface-immobilisation, the method documented here is simple, quick, efficient, and utilises the high-affinity streptavidin-biotin interaction. Specifically, we ligate a biotinylated nucleotide to the 39 end of RNA using T4 RNA ligase. Although this is a previously recognised approach, we have optimised the method by our discovery that the incorporation of four or more adenine nucleotides at the 39 end of the RNA (a poly-A-tail) is required in order to achieve high ligation efficiencies. We use this method within the context of investigating small non-coding RNA (sRNA) mRNA interactions through the application of surface technologies, including quantitative SPR assays. We first focus on validating the method using the recently characterised Escherichia coli sRNA-mRNA pair, MicA-ompA, specifically demonstrating that the addition of the poly-A-tail to either RNA does not affect its subsequent binding interactions with partner molecules. We then apply this method to investigate the novel interactions of a Vibrio cholerae Qrr sRNA with partner mRNAs, hapR and vca0939; RNA-RNA pairings that are important in mediating pathogenic virulence. The calculated binding parameters allow insights to be drawn regarding sRNA-mRNA interaction mechanisms.	[Callaghan, Anastasia J.] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England	University of Portsmouth; University of Portsmouth	Callaghan, AJ (corresponding author), Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England.	Anastasia.Callaghan@port.ac.uk	Vincent, Helen/GZK-3422-2022; Pickford, Andy/AGB-6901-2022; Gowers, Darren/U-5947-2019	Pickford, Andy/0000-0002-7237-0030; Roberts, Adam/0000-0002-6834-549X; Gowers, Darren Matthew/0000-0001-7604-012X; Butt, Louise/0000-0003-2422-1046	Biotechnology and Biological Sciences Research Council [BB/F013140/1, BB/I532988/1]; Higher Education Innovation Fund through the University of Portsmouth; European Commission [249154]; Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary; BBSRC [BB/I532988/1, BB/F013140/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Innovation Fund through the University of Portsmouth; European Commission(European CommissionEuropean Commission Joint Research Centre); Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [BB/F013140/1 and BB/I532988/1 to AJC]; an award from the Higher Education Innovation Fund through the University of Portsmouth [to AJC]; a Marie Curie Reintegration Grant from the European Commission, FP7 [249154 to HAV] and an Institute of Biomedical and Biomolecular Science, University of Portsmouth bursary (to CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Andrade JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052866; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bardill JP, 2011, MOL MICROBIOL, V80, P1381, DOI 10.1111/j.1365-2958.2011.07655.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; Carpousis AJ, 2003, GENE DEV, V17, P2351, DOI 10.1101/gad.1147003; Caruthers MH, 2011, BIOCHEM SOC T, V39, P575, DOI 10.1042/BST0390575; Cech TR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006742; Cole K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh085; ENGLAND TE, 1978, BIOCHEMISTRY-US, V17, P2069, DOI 10.1021/bi00604a008; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025; Gao XX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng143; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Henderson CA, 2013, RNA, V19, P1089, DOI 10.1261/rna.034595.112; Henderson CA, 2013, NUCLEIC ACIDS RES, V41, P3386, DOI 10.1093/nar/gkt008; Henriksson-Peltola P, 2007, NUCLEIC ACIDS RES, V35, P3181, DOI 10.1093/nar/gkm172; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kugel JF, 2012, TRENDS BIOCHEM SCI, V37, P144, DOI 10.1016/j.tibs.2011.12.003; Kurschat WC, 2005, RNA, V11, P1909, DOI 10.1261/rna.2170705; Lalaouna D, 2013, BBA-GENE REGUL MECH, V1829, P742, DOI 10.1016/j.bbagrm.2013.02.013; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li SK, 2013, RNA, V19, P74, DOI 10.1261/rna.034116.112; LINGNER J, 1993, NUCLEIC ACIDS RES, V21, P2917, DOI 10.1093/nar/21.12.2917; Matos RG, 2010, PROTEIN J, V29, P394, DOI 10.1007/s10930-010-9265-1; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Paredes E, 2011, METHODS, V54, P251, DOI 10.1016/j.ymeth.2011.02.008; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; RICHARDSON RW, 1983, NUCLEIC ACIDS RES, V11, P6167, DOI 10.1093/nar/11.18.6167; Rieder R, 2012, RNA BIOL, V9, P520, DOI 10.4161/rna.20331; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Salim NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013028; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shetty S, 2013, NUCLEIC ACIDS RES, V41, P2526, DOI 10.1093/nar/gks1318; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Vicens Q, 2009, J INCL PHENOM MACRO, V65, P171, DOI 10.1007/s10847-009-9609-7; Viegas SC, 2011, NUCLEIC ACIDS RES, V39, P2918, DOI 10.1093/nar/gkq1239; Vincent HA, 2012, NUCLEIC ACIDS RES, V40, P8698, DOI 10.1093/nar/gks582; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79142	10.1371/journal.pone.0079142	http://dx.doi.org/10.1371/journal.pone.0079142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244437	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800034
J	Zdebik, AA; Mahmood, F; Stanescu, HC; Kleta, R; Bockenhauer, D; Russell, C				Zdebik, Anselm A.; Mahmood, Fahad; Stanescu, Horia C.; Kleta, Robert; Bockenhauer, Detlef; Russell, Claire			Epilepsy in kcnj10 Morphant Zebrafish Assessed with a Novel Method for Long-Term EEG Recordings	PLOS ONE			English	Article							SENSORINEURAL DEAFNESS; EAST SYNDROME; SEIZURE SUSCEPTIBILITY; CHANNEL GENE; MUTATIONS; TUBULOPATHY; ATAXIA; ASSOCIATION; EXPRESSION; MODEL	We aimed to develop and validate a reliable method for stable long-term recordings of EEG activity in zebrafish, which is less prone to artifacts than current invasive techniques. EEG activity was recorded with a blunt electrolyte-filled glass pipette placed on the zebrafish head mimicking surface EEG technology in man. In addition, paralysis of agarose-embedded fish using D-tubocurarine excluded movement artifacts associated with epileptic activity. This non-invasive recording technique allowed recordings for up to one hour and produced less artifacts than impaling the zebrafish optic tectum with a patch pipette. Paralyzed fish survived, and normal heartbeat could be monitored for over 1h. Our technique allowed the demonstration of specific epileptic activity in kcnj10a morphant fish (a model for EAST syndrome) closely resembling epileptic activity induced by pentylenetetrazol. This new method documented that seizures in the zebrafish EAST model were ameliorated by pentobarbitone, but not diazepam, validating its usefulness. In conclusion, non-invasive recordings in paralyzed EAST syndrome zebrafish proved stable, reliable and robust, showing qualitatively similar frequency spectra to those obtained from pentylenetetrazol-treated fish. This technique may prove particularly useful in zebrafish epilepsy models that show infrequent or conditional seizure activity.	[Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Mahmood, Fahad; Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biol Sci, London, England; [Zdebik, Anselm A.; Stanescu, Horia C.; Kleta, Robert; Bockenhauer, Detlef] UCL, Ctr Nephrol, London, England; [Kleta, Robert; Bockenhauer, Detlef] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London; University of London; University College London	Zdebik, AA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	a.zdebik@ucl.ac.uk	Bockenhauer, Detlef/AAF-6495-2020; Mahmood, Fahad/ABD-1829-2020; Russell, Claire/A-4879-2012	Bockenhauer, Detlef/0000-0001-5878-941X; Mahmood, Fahad/0000-0003-1776-8828; Russell, Claire/0000-0002-6748-9301	Peter Samuel Trust Fund [939]; David and Elaine Potter Charitable Foundation; Grocers' Charity; St Peter's Trust for Kidney, Bladder and Prostate Research; Kids Kidney Research and Garfield Weston Foundation; EU FP7 program [305608]; Royal Veterinary College (RVC); RVC	Peter Samuel Trust Fund; David and Elaine Potter Charitable Foundation; Grocers' Charity; St Peter's Trust for Kidney, Bladder and Prostate Research; Kids Kidney Research and Garfield Weston Foundation(Kidney Research UK (KRUK)); EU FP7 program(European Commission); Royal Veterinary College (RVC); RVC	UCL work was supported by grants from the Peter Samuel Trust Fund (grant number 939) (to AAZ), the David and Elaine Potter Charitable Foundation and Grocers' Charity (to RK), St Peter's Trust for Kidney, Bladder and Prostate Research (to AAZ, DB and RK), Kids Kidney Research and Garfield Weston Foundation (to DB and RK), and by the EU FP7 program (EURenOmics grant agreement number 305608 (to DB, RK)). Funding for FM was provided via a doctoral training grant from the Royal Veterinary College (RVC) (to CR). Funding for consumables and animals at the RVC (to CR and FM) was provided by a RVC start-up grant (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandulik S, 2011, PFLUG ARCH EUR J PHY, V461, P423, DOI 10.1007/s00424-010-0915-0; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Bauzano-Poley E, 2001, REV NEUROLOGIA, V32, P365, DOI 10.33588/rn.3204.2000513; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Freudenthal B, 2011, NEPHRON PHYSIOL, V119, pP40, DOI 10.1159/000330250; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Mahmood F, 2013, DIS MODEL MECH, V6, P652, DOI 10.1242/dmm.009480; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Pineda R, 2011, J NEUROSCI METH, V200, P20, DOI 10.1016/j.jneumeth.2011.06.001; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Thompson DA, 2011, J PHYSIOL-LONDON, V589, P1681, DOI 10.1113/jphysiol.2010.198531; Westmoreland BF, 1996, MAYO CLIN PROC, V71, P501, DOI 10.4065/71.5.501	20	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79765	10.1371/journal.pone.0079765	http://dx.doi.org/10.1371/journal.pone.0079765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244558	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800099
J	Aleshcheva, G; Sahana, J; Ma, X; Hauslage, J; Hemmersbach, R; Egli, M; Infanger, M; Bauer, J; Grimm, D				Aleshcheva, Ganna; Sahana, Jayashree; Ma, Xiao; Hauslage, Jens; Hemmersbach, Ruth; Egli, Marcel; Infanger, Manfred; Bauer, Johann; Grimm, Daniela			Changes in Morphology, Gene Expression and Protein Content in Chondrocytes Cultured on a Random Positioning Machine	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; THYROID-CANCER CELLS; ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; SPHEROID FORMATION; CARTILAGE; GRAVITY; WEIGHTLESSNESS; CYTOSKELETON; COLLAGEN	Tissue engineering of chondrocytes on a Random Positioning Machine (RPM) is a new strategy for cartilage regeneration. Using a three-dimensional RPM, a device designed to simulate microgravity on Earth, we investigated the early effects of RPM exposure on human chondrocytes of six different donors after 30 min, 2 h, 4 h, 16 h, and 24 h and compared the results with the corresponding static controls cultured under normal gravity conditions. As little as 30 min of RPM exposure resulted in increased expression of several genes responsible for cell motility, structure and integrity (beta-actin); control of cell growth, cell proliferation, cell differentiation and apoptosis (TGF-beta(1), osteopontin); and cytoskeletal components such as microtubules (beta-tubulin) and intermediate filaments (vimentin). After 4 hours of RPM exposure disruptions in the vimentin network were detected. These changes were less dramatic after 16 hours on the RPM, when human chondrocytes appeared to reorganize their cytoskeleton. However, the gene expression and protein content of TGF-beta(1) was enhanced during RPM culture for 24 h. Taking these results together, we suggest that chondrocytes exposed to the RPM seem to change their extracellular matrix production behaviour while they rearrange their cytoskeletal proteins prior to forming three-dimensional aggregates.	[Aleshcheva, Ganna; Infanger, Manfred] Otto Von Guericke Univ, Clin Plast Aesthet & Hand Surg, Magdeburg, Germany; [Sahana, Jayashree; Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, Aarhus C, Denmark; [Hauslage, Jens; Hemmersbach, Ruth] Deutsch Zentrum Luft & Raumfahrt, Biomed Wissensch Unterstutzungszentrum, Cologne, Germany; [Egli, Marcel] Lucerne Sch Engn & Architecture, Space Biol Grp, Hergiswil, Switzerland; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Otto von Guericke University; Aarhus University; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Aarhus C, Denmark.	daniela.grimm@farm.au.dk		Sahana, Jayashree/0000-0002-6606-6315; Hauslage, Jens/0000-0003-2184-7000; Grimm, Daniela/0000-0002-4991-3105	Helmholtz Space Life Sciences Research School (SpaceLife); German Space Agency (DLR) [50WB1124]; European Space Agency (ESA) [CORA-GBF-2013-004]; Aarhus University, Denmark; DLR; Biomedizinisches Wissenschafts-Unterstutzungszentrum, Gravitationsbiologie	Helmholtz Space Life Sciences Research School (SpaceLife); German Space Agency (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency (ESA)(European Space Agency); Aarhus University, Denmark; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Biomedizinisches Wissenschafts-Unterstutzungszentrum, Gravitationsbiologie	This study was funded by the Helmholtz Space Life Sciences Research School (SpaceLife), the German Space Agency (DLR; BMWi project 50WB1124), the European Space Agency (ESA; CORA-GBF-2013-004), Aarhus University, Denmark, the DLR, and Biomedizinisches Wissenschafts-Unterstutzungszentrum, Gravitationsbiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntz Y, 2006, MICROSC RES TECHNIQ, V69, P283, DOI 10.1002/jemt.20313; BENJAMIN M, 1994, MICROSC RES TECHNIQ, V28, P372, DOI 10.1002/jemt.1070280503; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; Boonstra J, 1999, FASEB J, V13, pS35, DOI 10.1096/fasebj.13.9001.s35; Brittberg M, 2011, CARTILAGE SURG; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Claisse D, 1999, J CELL SCI, V112, P1405; Davidson ENB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2305; Dzielska-Olczak Malgorzata, 2012, Pol Merkur Lekarski, V32, P329; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; GRIMM D, 2002, J GRAVIT PHYSL, V9, P253; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068140; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064402; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Petrigliano FA, 2013, TISSUE ENG C; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2013, BIOMATERIALS, V34, P7694, DOI 10.1016/j.biomaterials.2013.06.054; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Stamenkovic V, 2010, TISSUE ENG PT A, V16, P1729, DOI 10.1089/ten.tea.2008.0624; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016	42	57	58	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79057	10.1371/journal.pone.0079057	http://dx.doi.org/10.1371/journal.pone.0079057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244418	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600104
J	Azhar, N; Ziraldo, C; Barclay, D; Rudnick, DA; Squires, RH; Vodovotz, Y				Azhar, Nabil; Ziraldo, Cordelia; Barclay, Derek; Rudnick, David A.; Squires, Robert H.; Vodovotz, Yoram		Pediat Acute Liver Failure Study G	Analysis of Serum Inflammatory Mediators Identifies Unique Dynamic Networks Associated with Death and Spontaneous Survival in Pediatric Acute Liver Failure	PLOS ONE			English	Article							TRANSLATIONAL SYSTEMS BIOLOGY; PROINFLAMMATORY CYTOKINES; BIOMARKERS; CHILDREN; INJURY	Background: Tools to predict death or spontaneous survival are necessary to inform liver transplantation (LTx) decisions in pediatric acute liver failure (PALF), but such tools are not available. Recent data suggest that immune/inflammatory dysregulation occurs in the setting of acute liver failure. We hypothesized that specific, dynamic, and measurable patterns of immune/inflammatory dysregulation will correlate with outcomes in PALF. Methods: We assayed 26 inflammatory mediators on stored serum samples obtained from a convenience sample of 49 children in the PALF study group (PALFSG) collected within 7 days after enrollment. Outcomes were assessed within 21 days of enrollment consisting of spontaneous survivors, non-survivors, and LTx recipients. Data were subjected to statistical analysis, patient-specific Principal Component Analysis (PCA), and Dynamic Bayesian Network (DBN) inference. Findings: Raw inflammatory mediator levels assessed over time did not distinguish among PALF outcomes. However, DBN analysis did reveal distinct interferon-gamma-related networks that distinguished spontaneous survivors from those who died. The network identified in LTx patients pre-transplant was more like that seen in spontaneous survivors than in those who died, a finding supported by PCA. Interpretation: The application of DBN analysis of inflammatory mediators in this small patient sample appears to differentiate survivors from non-survivors in PALF. Patterns associated with LTx pre-transplant were more like those seen in spontaneous survivors than in those who died. DBN-based analyses might lead to a better prediction of outcome in PALF, and could also have more general utility in other complex diseases with an inflammatory etiology.	[Azhar, Nabil; Ziraldo, Cordelia; Barclay, Derek; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Azhar, Nabil; Ziraldo, Cordelia] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Azhar, Nabil; Ziraldo, Cordelia; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA; [Rudnick, David A.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Squires, Robert H.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu		bucuvalas, john/0000-0002-6767-8874; Dell Olio, Dominic/0000-0002-4448-4559	National Institutes of Health/National Institutes of Diabetes, Digestive, and Kidney Disease (NIH/NIDDK) [5U01 DK072146, 3UO1 DK072146-05S1]; NIH/National Center for Research Resources Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072146] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Diabetes, Digestive, and Kidney Disease (NIH/NIDDK); NIH/National Center for Research Resources Colorado CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by the National Institutes of Health/National Institutes of Diabetes, Digestive, and Kidney Disease (NIH/NIDDK) through a UO1 grant 5U01 DK072146 with supplemental funding from the NIH/NIDDK supplemental grant 3UO1 DK072146-05S1; it was also supported by NIH/National Center for Research Resources Colorado CTSI Grant Number UL1 RR025780. Individuals from these funding sources were not involved in data collection, analysis or interpretation; trial design; patient recruitment; or any aspect pertinent to the study. The authors were not paid to write this article by a pharmaceutical company or other agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2012, ANN BIOMED ENG, V40, P2414, DOI 10.1007/s10439-012-0565-9; An G, 2012, INT J BURNS TRAUMA, V2, P1; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Brown KE, 1997, NEW ENGL J MED, V336, P1059, DOI 10.1056/NEJM199704103361504; Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005; Bucuvalas J, 2012, J PEDIAT GA IN PRESS; Chan T, 2011, EXPERT REV MOL DIAGN, V11, P487, DOI 10.1586/ERM.11.26; Chung KF, 2012, CURR OPIN PULM MED, V18, P35, DOI 10.1097/MCP.0b013e32834d09a5; Grzegorczyk M, 2011, BIOINFORMATICS, V27, P693, DOI 10.1093/bioinformatics/btq711; Gupta RK, 2010, METAB BRAIN DIS, V25, P355, DOI 10.1007/s11011-010-9206-x; Halim SA, 2012, CLIN CHEM, V58, P45, DOI 10.1373/clinchem.2011.165787; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; Mi Q, 2010, PERS MED, V7, P549, DOI 10.2217/PME.10.45; Namas R, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.025; Narkewicz MR, 2009, J PEDIATR-US, V155, P801, DOI 10.1016/j.jpeds.2009.06.005; Poynard T, 2008, ADV CLIN CHEM, V46, P131, DOI 10.1016/S0065-2423(08)00404-6; ROLANDO N, 1990, HEPATOLOGY, V11, P49, DOI 10.1002/hep.1840110110; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Squires RH, 2008, SEMIN LIVER DIS, V28, P153, DOI 10.1055/s-2008-1073115; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Srivastava A, 2012, J PEDIATR GASTR NUTR, V55, P580, DOI 10.1097/MPG.0b013e31825f4c3e; Vodovotz Y, 2008, COMPUT BIOL, V4, P1; Vodovotz Y, 2009, SYSTEMS BIOL DRUG DI, P181; Vodovotz Y, 2010, WOUND REPAIR REGEN, V18, P3, DOI 10.1111/j.1524-475X.2009.00566.x	30	58	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78202	10.1371/journal.pone.0078202	http://dx.doi.org/10.1371/journal.pone.0078202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244295	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000327221600019
J	Gevorkian, SG; Allahverdyan, AE; Gevorgyan, DS; Simonian, AL; Hu, CK				Gevorkian, Sasun G.; Allahverdyan, Armen E.; Gevorgyan, David S.; Simonian, Aleksandr L.; Hu, Chin-Kun			Stabilization and Anomalous Hydration of Collagen Fibril under Heating	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; THERMAL-STABILITY; GLASS-TRANSITION; TENDON COLLAGEN; I COLLAGEN; WATER; HELIX; TEMPERATURE; PROTEINS; DENATURATION	Background: Type I collagen is the most common protein among higher vertebrates. It forms the basis of fibrous connective tissues (tendon, chord, skin, bones) and ensures mechanical stability and strength of these tissues. It is known, however, that separate triple-helical collagen macromolecules are unstable at physiological temperatures. We want to understand the mechanism of collagen stability at the intermolecular level. To this end, we study the collagen fibril, an intermediate level in the collagen hierarchy between triple-helical macromolecule and tendon. Methodology/ Principal Finding: When heating a native fibril sample, its Young's modulus decreases in temperature range 20-58 degrees C due to partial denaturation of triple-helices, but it is approximately constant at 58-75 degrees C, because of stabilization by inter-molecular interactions. The stabilization temperature range 58-75 degrees C has two further important features: here the fibril absorbs water under heating and the internal friction displays a peak. We relate these experimental findings to restructuring of collagen triple-helices in fibril. A theoretical description of the experimental results is provided via a generalization of the standard Zimm-Bragg model for the helix-coil transition. It takes into account intermolecular interactions of collagen triple-helices in fibril and describes water adsorption via the Langmuir mechanism. Conclusion/Significance: We uncovered an inter-molecular mechanism that stabilizes the fibril made of unstable collagen macromolecules. This mechanism can be relevant for explaining stability of collagen.	[Gevorkian, Sasun G.; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Gevorkian, Sasun G.; Allahverdyan, Armen E.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Gevorgyan, David S.] Sci Technol Ctr Organ & Pharmaceut Chem, Inst Fine Organ Chem, Yerevan, Armenia; [Simonian, Aleksandr L.] Auburn Univ, Mat Res & Educ Ctr, Auburn, AL 36849 USA	Academia Sinica - Taiwan; Yerevan Physics Institute; National Academy of Sciences of Armenia; Scientific Technological Center of Organic & Pharmaceutical Chemistry - NAS RA; Auburn University System; Auburn University	Hu, CK (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	huck@phys.sinica.edu.tw		Hu, Chin-Kun/0000-0002-3620-8319; Gevorkian, Sasun/0000-0003-1785-8700	Volkswagenstiftung [NSC 96-2911-M 001-003-MY3, AS-95-TP-A07]; National Center for Theoretical Sciences in Taiwan, NFSAT [TFP-12-02]; ANSEF [Molbio 2747]	Volkswagenstiftung(Volkswagen); National Center for Theoretical Sciences in Taiwan, NFSAT; ANSEF	The work was supported by Volkswagenstiftung, grants NSC 96-2911-M 001-003-MY3 and AS-95-TP-A07, National Center for Theoretical Sciences in Taiwan, NFSAT grant no. TFP-12-02, and ANSEF grant Molbio 2747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdyan AE, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/53002; Badasyan AV, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216564; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; Bhat RB, 1985, J SOUND VIBRATION, V102, P271; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Bull HB, 1944, J AM CHEM SOC, V66, P1499, DOI 10.1021/ja01237a025; COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523; David R, 1979, BIOPHYSIQUE GEN; DAWSON B, 1968, J MECH ENG SCI, V10, P381, DOI 10.1243/JMES_JOUR_1968_010_060_02; Doig AJ, 2002, BIOPHYS CHEM, V101, P281, DOI 10.1016/S0301-4622(02)00170-9; Donohue MD, 1998, ADV COLLOID INTERFAC, V76, P137, DOI 10.1016/S0001-8686(98)00044-X; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; ESIPOVA NG, 1981, BIOFIZIKA+, V26, P355; ESIPOVA NG, 1973, DOKL AKAD NAUK SSSR+, V211, P234; Esipova NG, 1957, BIOFIZIKA, V2, P445; FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7; Fratzl P., 2008, COLLAGEN STRUCTURE M; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gevorkian SG, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/23001; Gevorkian SG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048101; GEVORKIAN SG, 1983, BIOFIZIKA+, V28, P944; Ghosh K, 2009, J AM CHEM SOC, V131, P2306, DOI 10.1021/ja808136x; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; HALY AR, 1971, BIOPOLYMERS, V10, P1681, DOI 10.1002/bip.360100921; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Kapoor D, 1998, J MACROMOL SCI PHYS, VB37, P723, DOI 10.1080/00222349808212413; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lavis D., 1999, STAT MECH LATTICE SY, V1; LEIKIN S, 1994, P NATL ACAD SCI USA, V91, P276, DOI 10.1073/pnas.91.1.276; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Maleev AY, 1974, BIOPOLYMERS, V13, P2409; Mesropyan I, 2006, BIOFIZIKA+, V51, P151; MICHNA H, 1984, CELL TISSUE RES, V236, P465; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miles CA, 2001, BIOPHYS J, V80, P1480, DOI 10.1016/S0006-3495(01)76120-6; MOROZOV VN, 1981, BIOPOLYMERS, V20, P451, DOI 10.1002/bip.1981.360200304; MOROZOV VN, 1985, BIOPOLYMERS, V24, P1785, DOI 10.1002/bip.360240909; Mreshvili GM, 1978, BIOPHYSICS-USSR, V23, P717; Nikolaeva T. I., 2007, Biophysics, V52, P191, DOI 10.1134/S000635090702008X; Parry DA, 1984, ULTRASTRUCTURE CONNE, P34; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; PINERI MH, 1978, BIOPOLYMERS, V17, P2799, DOI 10.1002/bip.1978.360171205; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; QIAN H, 1992, J PHYS CHEM-US, V96, P3987, DOI 10.1021/j100189a015; Sandler U, 2000, PHYS REV B, V61, P16, DOI 10.1103/PhysRevB.61.16; SKOLNICK J, 1982, MACROMOLECULES, V15, P303, DOI 10.1021/ma00230a021; Sneppen K., 2005, PHYS MOL BIOL; Starikov EB, 1997, PHYS REP, V284, P2; Tiktopulo EI, 1998, BIOCHEMISTRY-US, V37, P8147, DOI 10.1021/bi980360n; Tsereteli GI, 2000, J THERM ANAL CALORIM, V62, P89, DOI 10.1023/A:1010110727782	57	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78526	10.1371/journal.pone.0078526	http://dx.doi.org/10.1371/journal.pone.0078526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244320	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600030
J	Niarchou, A; Alexandridou, A; Athanasiadis, E; Spyrou, G				Niarchou, Anastasia; Alexandridou, Anastasia; Athanasiadis, Emmanouil; Spyrou, George			C-PAmP: Large Scale Analysis and Database Construction Containing High Scoring Computationally Predicted Antimicrobial Peptides for All the Available Plant Species	PLOS ONE			English	Article							PROTEIN; CLASSIFICATION; SOFTWARE	Background: Antimicrobial peptides are a promising alternative to conventional antibiotics. Plants are an important source of such peptides; their pharmacological properties are known since antiquity. Access to relevant information, however, is not straightforward, as there are practically no major repositories of experimentally validated and/or predicted plant antimicrobial peptides. PhytAMP is the only database dedicated to plant peptides with confirmed antimicrobial action, holding 273 entries. Data on such peptides can be otherwise retrieved from generic repositories. Description: We present C-PAmP, a database of computationally predicted plant antimicrobial peptides. C-PAmP contains 15,174,905 peptides, 5-100 amino acids long, derived from 33,877 proteins of 2,112 plant species in UniProtKB/Swiss-Prot. Its web interface allows queries based on peptide/protein sequence, protein accession number and species. Users can view the corresponding predicted peptides along with their probability score, their classification according to the Collection of Anti-Microbial Peptides (CAMP), and their PhytAMP id where applicable. Moreover, users can visualise protein regions with a high concentration of predicted antimicrobial peptides. In order to identify potential antimicrobial peptides we used a classification algorithm, based on a modified version of the pseudo amino acid concept. The classifier tested all subsequences ranging from 5 to 100 amino acids of the plant proteins in UniProtKB/Swiss-Prot and stored those classified as antimicrobial with a high probability score (>90%). Its performance measures across a 10-fold cross-validation are more than satisfactory (accuracy: 0.91, sensitivity: 0.93, specificity: 0.90) and it succeeded in classifying 99.5% of the PhytAMP peptides correctly. Conclusions: We have compiled a major repository of predicted plant antimicrobial peptides using a highly performing classification algorithm. Our repository is accessible from the web and supports multiple querying options to optimise data retrieval. We hope it will greatly benefit drug design research by significantly limiting the range of plant peptides to be experimentally tested for antimicrobial activity.	[Niarchou, Anastasia; Alexandridou, Anastasia; Athanasiadis, Emmanouil; Spyrou, George] Acad Athens, Biomed Res Fdn, Athens, Greece	Academy of Athens	Spyrou, G (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	gspyrou@bioacademy.gr	Athanasiadis, Emmanouil I./AAZ-8809-2021	Athanasiadis, Emmanouil I./0000-0002-2771-5562				Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kovaleva V, 2009, PEPTIDES, V30, P2136, DOI 10.1016/j.peptides.2009.08.007; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piotto SP, 2012, INT J ANTIMICROB AG, V39, P346, DOI 10.1016/j.ijantimicag.2011.12.003; Platt JC, 2000, ADV NEUR IN, P61; Ponty Y, 2006, BIOINFORMATICS, V22, P1534, DOI 10.1093/bioinformatics/btl113; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Rogozhin EA, 2011, PLANT PHYSIOL BIOCH, V49, P131, DOI 10.1016/j.plaphy.2010.10.008; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wu TF, 2004, J MACH LEARN RES, V5, P975; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	32	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79728	10.1371/journal.pone.0079728	http://dx.doi.org/10.1371/journal.pone.0079728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244550	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600148
J	Schuurhuis, GJ; Meel, MH; Wouters, F; Min, LA; Terwijn, M; de Jonge, NA; Kelder, A; Snel, AN; Zweegman, S; Ossenkoppele, GJ; Smit, L				Schuurhuis, Gerrit J.; Meel, Michael H.; Wouters, Floris; Min, Lisa A.; Terwijn, Monique; de Jonge, Nick A.; Kelder, Angele; Snel, Alexander N.; Zweegman, Sonja; Ossenkoppele, Gert J.; Smit, Linda			Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ELEVATED ALDEHYDE DEHYDROGENASE; REPOPULATING CELLS; PROGENITOR CELLS; RESISTANCE; MARKER; GENE; 4-HYDROPEROXYCYCLOPHOSPHAMIDE; HETEROGENEITY; CHEMOTHERAPY	Persistence of leukemic stem cells (LSC) after chemotherapy is thought to be responsible for relapse and prevents the curative treatment of acute myeloid leukemia (AML) patients. LSC and normal hematopoietic stem cells (HSC) share many characteristics and co-exist in the bone marrow of AML patients. For the development of successful LSC-targeted therapy, enabling eradication of LSC while sparing HSC, the identification of differences between LSC and HSC residing within the AML bone marrow is crucial. For identification of these LSC targets, as well as for AML LSC characterization, discrimination between LSC and HSC within the AML bone marrow is imperative. Here we show that normal CD34+CD38- HSC present in AML bone marrow, identified by their lack of aberrant immunophenotypic and molecular marker expression and low scatter properties, are a distinct sub-population of cells with high ALDH activity (ALDH(bright)). The ALDH(bright) compartment contains, besides normal HSC, more differentiated, normal CD34+CD38+ progenitors. Furthermore, we show that in CD34-negative AML, containing solely normal CD34+ cells, LSC are CD34- and ALDH(low). In CD34-positive AML, LSC are also ALDH(low) but can be either CD34+ or CD34-. In conclusion, although malignant AML blasts have varying ALDH activity, a common feature of all AML cases is that LSC have lower ALDH activity than the CD34+CD38- HSC that co-exist with these LSC in the AML bone marrow. Our findings form the basis for combined functionally and immunophenotypically based identification and purification of LSC and HSC within the AML bone marrow, aiming at development of highly specific anti-LSC therapy.	[Schuurhuis, Gerrit J.; Meel, Michael H.; Wouters, Floris; Min, Lisa A.; Terwijn, Monique; de Jonge, Nick A.; Kelder, Angele; Snel, Alexander N.; Zweegman, Sonja; Ossenkoppele, Gert J.; Smit, Linda] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Smit, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands.	li.smit@vumc.nl	de Jonge, Nick/HGA-2176-2022	de Jonge, Nick/0000-0002-9901-0887; Zweegman, Sonja/0000-0002-5011-1820; Smit, Linda/0000-0003-0025-269X; Meel, Michael/0000-0001-8736-9633	Association for International Cancer Research [AICR08-0075]	Association for International Cancer Research	This work was supported by the Association for International Cancer Research (AICR08-0075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bakker ABH, 2004, CANCER RES, V64, P8443, DOI 10.1158/0008-5472.CAN-04-1659; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buggins AGS, 2001, J IMMUNOL, V167, P6021, DOI 10.4049/jimmunol.167.10.6021; Cheung AMS, 2007, LEUKEMIA, V21, P1423, DOI 10.1038/sj.leu.2404721; Christ O, 2007, HAEMATOLOGICA, V92, P1165, DOI 10.3324/haematol.11366; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Dash A, 2001, BEST PRACT RES CL HA, V14, P49, DOI 10.1053/beha.2000.0115; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Feller N, 2004, LEUKEMIA, V18, P1380, DOI 10.1038/sj.leu.2403405; Gentry T, 2007, CYTOTHERAPY, V9, P569, DOI 10.1080/14653240701466347; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Janssen JJWM, 2012, LEUKEMIA, V26, P977, DOI 10.1038/leu.2011.347; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; KASTAN MB, 1990, BLOOD, V75, P1947; Lowenberg Bob, 2003, Hematology Am Soc Hematol Educ Program, P82; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Ran D, 2009, EXP HEMATOL, V37, P1423, DOI 10.1016/j.exphem.2009.10.001; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Takebe N, 2001, MOL THER, V3, P88, DOI 10.1006/mthe.2000.0236; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Terwijn M, 2010, ASH ANN M; Van Der Pol MA, 2003, HAEMATOLOGICA, V88, P983; van Rhenen A, 2007, LEUKEMIA, V21, P1700, DOI 10.1038/sj.leu.2404754; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Wang JCY, 2010, TRENDS MOL MED, V16, P145, DOI 10.1016/j.molmed.2010.01.001; Wang JS, 2001, ACTA PHARMACOL SIN, V22, P949; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612	40	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78897	10.1371/journal.pone.0078897	http://dx.doi.org/10.1371/journal.pone.0078897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244383	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600079
J	Warrington, NM; Howe, LD; Wu, YY; Timpson, NJ; Tilling, K; Pennell, CE; Newnham, J; Davey-Smith, G; Palmer, LJ; Beilin, LJ; Lye, SJ; Lawlor, DA; Briollais, L				Warrington, Nicole M.; Howe, Laura D.; Wu, Yan Yan; Timpson, Nicholas J.; Tilling, Kate; Pennell, Craig E.; Newnham, John; Davey-Smith, George; Palmer, Lyle J.; Beilin, Lawrence J.; Lye, Stephen J.; Lawlor, Debbie A.; Briollais, Laurent			Association of a Body Mass Index Genetic Risk Score with Growth throughout Childhood and Adolescence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; FTO GENE; ADIPOSITY; OBESITY; LOCI; BMI; CHILDREN; WEIGHT; METAANALYSIS	Background: While the number of established genetic variants associated with adult body mass index (BMI) is growing, the relationships between these variants and growth during childhood are yet to be fully characterised. We examined the association between validated adult BMI associated single nucleotide polymorphisms (SNPs) and growth trajectories across childhood. We investigated the timing of onset of the genetic effect and whether it was sex specific. Methods: Children from the ALSPAC and Raine birth cohorts were used for analysis (n = 9,328). Genotype data from 32 adult BMI associated SNPs were investigated individually and as an allelic score. Linear mixed effects models with smoothing splines were used for longitudinal modelling of the growth parameters and measures of adiposity peak and rebound were derived. Results: The allelic score was associated with BMI growth throughout childhood, explaining 0.58% of the total variance in BMI in females and 0.44% in males. The allelic score was associated with higher BMI at the adiposity peak (females = 0.0163 kg/m(2) per allele, males = 0.0123 kg/m(2) per allele) and earlier age (-0.0362 years per allele in males and females) and higher BMI (0.0332 kg/m(2) per allele in females and 0.0364 kg/m(2) per allele in males) at the adiposity rebound. No gene: sex interactions were detected for BMI growth. Conclusions: This study suggests that known adult genetic determinants of BMI have observable effects on growth from early childhood, and is consistent with the hypothesis that genetic determinants of adult susceptibility to obesity act from early childhood and develop over the life course.	[Warrington, Nicole M.; Pennell, Craig E.; Newnham, John] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Wu, Yan Yan; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent] Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Howe, Laura D.; Timpson, Nicholas J.; Davey-Smith, George; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Tilling, Kate] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Palmer, Lyle J.] Univ Toronto, Ontario Inst Canc Res, Toronto, ON, Canada; [Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Bristol; University of Bristol; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Western Australia	Briollais, L (corresponding author), Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON, Canada.	laurent@lunenfeld.ca	Study, Raine/G-9547-2015; Attrill, Lauren/V-1688-2018; Warrington, Nicole/P-4868-2014; Timpson, Nicholas John/O-7548-2015; Pennell, Craig/ABD-6902-2020; Tilling, Kate/AAY-1578-2021; Briollais, Laurent/A-2941-2013; Palmer, Lyle John/N-1948-2019; Lye, Stephen J/E-7269-2013; Wu, Yanyan/H-1356-2017; Davey Smith, George/A-7407-2013; Fox, Laura J/C-6249-2016; Palmer, Lyle John/K-3196-2014	Warrington, Nicole/0000-0003-4195-775X; Timpson, Nicholas John/0000-0002-7141-9189; Pennell, Craig/0000-0002-0937-6165; Palmer, Lyle John/0000-0002-1628-3055; Lye, Stephen J/0000-0002-3305-4406; Wu, Yanyan/0000-0003-1553-1392; Davey Smith, George/0000-0002-1407-8314; Palmer, Lyle John/0000-0002-1628-3055; Tilling, Kate/0000-0002-1010-8926; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Howe, Laura/0000-0003-3357-2796; Newnham, John/0000-0001-9983-7457	UK Medical Research Council; Wellcome Trust [092731]; University of Bristol; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; MRC [G1002375, MC_UU_12013/3, MC_UU_12013/1, MC_UU_12013/5, G0600705] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, MC_UU_12013/3, MC_PC_15018, G1002375, MC_UU_12013/1, G0600705] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following funding bodies and institutions. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The following Institutions provide funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Curtin University and Women and Infants Research Foundation. This study was supported by project grants from the National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209) and the Canadian Institutes of Health Research (Grant ID MOP-82893). NM Warrington is funded by an Australian Postgraduate Award from the Australian Government of Innovation, Industry, Science and Research and a Raine Study PhD Top-Up Scholarship. LD Howe is funded by a UK Medical Research Council Population Health Scientist fellowship (G1002375). LD Howe, NJ Timpson, K Tilling, G Davey-Smith and DA Lawlor all work in a Centre that receives core funding from the University of Bristol and the UK Medical Research Council (Grant ref: G0600705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2008, PHYSIOL BEHAV, V94, P8, DOI 10.1016/j.physbeh.2007.11.016; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boyd A, 2012, INT J EPIDEMIOL; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; COMUZZIE AG, 1993, AM J HUM BIOL, V5, P725, DOI 10.1002/ajhb.1310050616; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; Dvornyk V, 2012, HUM REPROD UPDATE, V18, P198, DOI 10.1093/humupd/dmr050; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; He Q, 2002, OBES RES, V10, P135, DOI 10.1038/oby.2002.22; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108; Sovio U, 2009, ATHEROSCLEROSIS, V207, pE4, DOI 10.1016/j.atherosclerosis.2009.09.039; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053897; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	46	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79547	10.1371/journal.pone.0079547	http://dx.doi.org/10.1371/journal.pone.0079547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244521	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600133
J	Egoavil, C; Alenda, C; Castillejo, A; Paya, A; Peiro, G; Sanchez-Heras, AB; Castillejo, MI; Rojas, E; Barbera, VM; Ciguenza, S; Lopez, JA; Pinero, O; Roman, MJ; Martinez-Escoriza, JC; Guarinos, C; Perez-Carbonell, L; Aranda, FI; Soto, JL				Egoavil, Cecilia; Alenda, Cristina; Castillejo, Adela; Paya, Artemio; Peiro, Gloria; Sanchez-Heras, Ana-Beatriz; Castillejo, Maria-Isabel; Rojas, Estefania; Barbera, Victor-Manuel; Cigueenza, Sonia; Lopez, Jose-Antonio; Pinero, Oscar; Roman, Maria-Jose; Martinez-Escoriza, Juan-Carlos; Guarinos, Carla; Perez-Carbonell, Lucia; Aranda, Francisco-Ignacio; Soto, Jose-Luis			Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; LOWER UTERINE SEGMENT; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; FAMILY-HISTORY; WOMEN; RISK; MUTATIONS; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS	Background: Lynch syndrome (LS) is a hereditary condition that increases the risk for endometrial and other cancers. The identification of endometrial cancer (EC) patients with LS has the potential to influence life-saving interventions. We aimed to study the prevalence of LS among EC patients in our population. Methods: Universal screening for LS was applied for a consecutive series EC. Tumor testing using microsatellite instability (MSI), immunohistochemistry (IHC) for mismatch-repair (MMR) protein expression and MLH1-methylation analysis, when required, was used to select LS-suspicious cases. Sequencing of corresponding MMR genes was performed. Results: One hundred and seventy-three EC (average age, 63 years) were screened. Sixty-one patients (35%) had abnormal IHC or MSI results. After MLH1 methylation analysis, 27 cases were considered suspicious of LS. From these, 22 were contacted and referred for genetic counseling. Nineteen pursued genetic testing and eight were diagnosed of LS. Mutations were more frequent in younger patients (<50 yrs). Three cases had either intact IHC or MSS and reinforce the need of implement the EC screening with both techniques. Conclusion: The prevalence of LS among EC patients was 4.6% (8/173); with a predictive frequency of 6.6% in the Spanish population. Universal screening of EC for LS is recommended.	[Egoavil, Cecilia; Alenda, Cristina; Paya, Artemio; Peiro, Gloria; Rojas, Estefania; Cigueenza, Sonia; Lopez, Jose-Antonio; Pinero, Oscar; Roman, Maria-Jose; Martinez-Escoriza, Juan-Carlos; Aranda, Francisco-Ignacio] Alicante Univ Hosp, Alicante, Spain; [Egoavil, Cecilia; Guarinos, Carla; Perez-Carbonell, Lucia] Alicante Univ Hosp, Res Lab, Alicante, Spain; [Castillejo, Adela; Castillejo, Maria-Isabel; Barbera, Victor-Manuel; Soto, Jose-Luis] Elche Univ Hosp, Mol Genet Lab, Elche, Spain; [Sanchez-Heras, Ana-Beatriz] Elche Univ Hosp, Genet Counselling Canc Unit, Elche, Spain	General University Hospital of Alicante; General University Hospital of Alicante	Soto, JL (corresponding author), Elche Univ Hosp, Mol Genet Lab, Elche, Spain.	sotomartinez.jl@gmail.com	Alenda, Cristina/AAR-3433-2020; Castillo, Adela Castillejo/AAD-3477-2020; Egoavil, Cecilia/ABG-8531-2020; Soto, José Luis/AAC-6520-2020; Martinez Escoriza, Juan Carlos/C-8272-2016; Egoavil, Cecilia/X-5134-2018; Aranda, F. Ignacio/H-5029-2011; Payá, Artemio/AFX-6518-2022; ARANDA, FRANCISCO I/L-5525-2015	Castillo, Adela Castillejo/0000-0002-9581-6285; Egoavil, Cecilia/0000-0003-0166-4901; Martinez Escoriza, Juan Carlos/0000-0002-9509-9941; Egoavil, Cecilia/0000-0003-0166-4901; Aranda, F. Ignacio/0000-0003-2338-2286; ARANDA, FRANCISCO I/0000-0003-2338-2286; Castillejo Castillo, Maria Isabel/0000-0002-4545-6429; Rojas Calvente, Estefania/0000-0001-6004-525X; Soto, Jose Luis/0000-0003-0234-9188; Barbera, Victor-Manuel/0000-0002-4012-6973; Alenda, Cristina/0000-0002-0560-1759	Conselleria Sanidad Comunidad Valenciana, Spain [AP/177/10]; Biomedical Research Foundation of the Alicante University Hospital [PI14/2006, NI02/2011]; Biomedical Research Foundation of the Elche University Hospital, Spain [FIBElx-CO11/03]	Conselleria Sanidad Comunidad Valenciana, Spain; Biomedical Research Foundation of the Alicante University Hospital; Biomedical Research Foundation of the Elche University Hospital, Spain	This study was supported by Conselleria Sanidad Comunidad Valenciana, Spain (AP/177/10) (http://www.san.gva.es/); Biomedical Research Foundations of the Alicante University Hospital (PI14/2006 and NI02/2011) (http://www.dep19.san.gva.es/); and the Elche University Hospital, Spain (FIBElx-CO11/03) (http://www.dep20.san.gva.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Barrow E, 2013, FAM CANCER, V12, P229, DOI 10.1007/s10689-013-9615-1; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; Chongsuvivatwong Virasakdi, 2012, EP EP CALC R PACK VE; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Cook LS, 2013, GYNECOL ONCOL, V130, P334, DOI 10.1016/j.ygyno.2013.04.053; Deng GR, 1999, CANCER RES, V59, P2029; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Folkins AK, 2013, HISTOPATHOLOGY, V62, P2, DOI 10.1111/his.12028; Gruber SB, 1996, CANCER EPIDEM BIOMAR, V5, P411; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2007, CANCER RES, V67, P9603, DOI 10.1158/0008-5472.CAN-07-2308; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hitchins MP, 2009, J MED GENET, V46, P793, DOI 10.1136/jmg.2009.068122; Jover R, 2004, AM J CLIN PATHOL, V122, P389, DOI 10.1309/V9PGK2Y260VFVULR; Kwon JS, 2011, J CLIN ONCOL, V29, P2247, DOI 10.1200/JCO.2010.32.9979; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Lu KH, 2005, OBSTET GYNECOL, V105, P569, DOI 10.1097/01.AOG.0000154885.44002.ae; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; LYNCH HT, 1977, CANCER, V40, P1849, DOI 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U; Masuda K, 2012, ONCOL REP, V28, P1537, DOI 10.3892/or.2012.2008; MECKLIN JP, 1986, DIS COLON RECTUM, V29, P160, DOI 10.1007/BF02555012; Mills AM, 2012, INT J GYNECOL PATHOL, V31, P463, DOI 10.1097/PGP.0b013e31824a1dad; Mojtahed A, 2011, MODERN PATHOL, V24, P1004, DOI 10.1038/modpathol.2011.55; Moline J, 2013, GYNECOL ONCOL, V130, P121, DOI 10.1016/j.ygyno.2013.04.022; Ou JH, 2008, HUM MUTAT, V29, P1337, DOI 10.1002/humu.20907; Peiro G, 2013, HUM PATHOL, V44, P218, DOI 10.1016/j.humpath.2012.05.008; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Perez-Carbonell L, 2010, J MOL DIAGN, V12, P498, DOI 10.2353/jmoldx.2010.090212; Resnick K, 2009, OBSTET GYNECOL, V114, P530, DOI 10.1097/AOG.0b013e3181b11ecc; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ryan P, 2012, CANCER-AM CANCER SOC, V118, P681, DOI 10.1002/cncr.26323; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Shia J, 2003, AM J SURG PATHOL, V27, P1407, DOI 10.1097/00000478-200311000-00002; Shia JR, 2009, AM J SURG PATHOL, V33, P1639, DOI 10.1097/PAS.0b013e3181b15aa2; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Tavassoli FA, 2003, PATHOLOGY GENETICS T, P217; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Westin SN, 2008, J CLIN ONCOL, V26, P5965, DOI 10.1200/JCO.2008.18.6296; Win AK, 2013, JNCI-J NATL CANCER I, V105, P274, DOI 10.1093/jnci/djs525	44	82	83	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79737	10.1371/journal.pone.0079737	http://dx.doi.org/10.1371/journal.pone.0079737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244552	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900048
J	Vizza, D; Perri, A; Lofaro, D; Toteda, G; Lupinacci, S; Leone, F; Gigliotti, P; Papalia, T; Bonofiglio, R				Vizza, Donatella; Perri, Anna; Lofaro, Danilo; Toteda, Giuseppina; Lupinacci, Simona; Leone, Francesca; Gigliotti, Paolo; Papalia, Teresa; Bonofiglio, Renzo			Exposure to Nerve Growth Factor Worsens Nephrotoxic Effect Induced by Cyclosporine A in HK-2 Cells	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; TRANSCRIPTION FACTORS; P21WAF1 EXPRESSION; UP-REGULATION; NITRIC-OXIDE; CALCINEURIN; APOPTOSIS; INHIBITOR; PATHWAY; MODEL	Nerve growth factor is a neurotrophin that promotes cell growth, differentiation, survival and death through two different receptors: TrkA(NTR) and p75(NTR). Nerve growth factor serum concentrations increase during many inflammatory and autoimmune diseases, glomerulonephritis, chronic kidney disease, end-stage renal disease and, particularly, in renal transplant. Considering that nerve growth factor exerts beneficial effects in the treatment of major central and peripheral neurodegenerative diseases, skin and corneal ulcers, we asked whether nerve growth factor could also exert a role in Cyclosporine A-induced graft nephrotoxicity. Our hypothesis was raised from basic evidence indicating that Cyclosporine A-inhibition of calcineurin-NFAT pathway increases nerve growth factor expression levels. Therefore, we investigated the involvement of nerve growth factor and its receptors in the damage exerted by Cyclosporine A in tubular renal cells, HK-2. Our results showed that in HK-2 cells combined treatment with Cyclosporine A + nerve growth factor induced a significant reduction in cell vitality concomitant with a down-regulation of Cyclin D1 and up-regulation of p21 levels respect to cells treated with Cyclosporine A alone. Moreover functional experiments showed that the co-treatment significantly up-regulated human p21promoter activity by involvement of the Sp1 transcription factor, whose nuclear content was negatively regulated by activated NFATc1. In addition we observed that the combined exposure to Cyclosporine A + nerve growth factor promoted an up-regulation of p75 (NTR) and its target genes, p53 and BAD leading to the activation of intrinsic apoptosis. Finally, the chemical inhibition of p75(NTR) down-regulated the intrinsic apoptotic signal. We describe two new mechanisms by which nerve growth factor promotes growth arrest and apoptosis in tubular renal cells exposed to Cyclosporine A.	[Vizza, Donatella; Perri, Anna; Lofaro, Danilo; Toteda, Giuseppina; Lupinacci, Simona; Leone, Francesca; Gigliotti, Paolo; Papalia, Teresa; Bonofiglio, Renzo] Annunziata Hosp, Dept Nephrol Dialysis & Transplantat, Kidney & Transplantat Res Ctr, Cosenza, Italy		Bonofiglio, R (corresponding author), Annunziata Hosp, Dept Nephrol Dialysis & Transplantat, Kidney & Transplantat Res Ctr, Cosenza, Italy.	rbonofi@gmail.com	Perri, Anna/AAC-9203-2020; Lofaro, Danilo/J-8687-2016	Perri, Anna/0000-0002-2852-0919; Lofaro, Danilo/0000-0002-2081-463X	Associazione Sud Italia Trapiantati	Associazione Sud Italia Trapiantati	The study was supported by "Associazione Sud Italia Trapiantati": http://www.asitonline.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bonofiglio R, 2007, J NEPHROL, V20, P186; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cui YX, 2011, TOXICOL SCI, V124, P23, DOI 10.1093/toxsci/kfr217; Fang ZY, 2007, J CELL BIOCHEM, V101, P654, DOI 10.1002/jcb.21223; Frimat L, 2006, AM J TRANSPLANT, V6, P2725, DOI 10.1111/j.1600-6143.2006.01535.x; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gigliotti P, 2013, TRANSPL P; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; Khanna AK, 2005, J IMMUNOL, V174, P7610, DOI 10.4049/jimmunol.174.12.7610; Lee JH, 2011, CORNEA, V30, pS19, DOI 10.1097/ICO.0b013e3182281028; Liu BC, 2013, AM J PHYSIOL-RENAL, V305, pF304, DOI 10.1152/ajprenal.00074.2013; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Micera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047316; Moon SK, 2006, BIOCHEM BIOPH RES CO, V350, P662, DOI 10.1016/j.bbrc.2006.09.092; Mufson EJ, 2002, J COMP NEUROL, V443, P136, DOI 10.1002/cne.10122; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nam HK, 2013, AM J NEPHROL, V37, P7, DOI 10.1159/000345990; Pereira MJ, 2013, MOL CELL ENDOCRINOL, V365, P260, DOI 10.1016/j.mce.2012.10.030; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Ponticelli C, 2005, ANN NY ACAD SCI, V1051, P551, DOI 10.1196/annals.1361.099; Rana OR, 2009, J MOL CELL CARDIOL, V46, P568, DOI 10.1016/j.yjmcc.2008.12.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schmidt A, 2001, NEPHROL DIAL TRANSPL, V16, P1034, DOI 10.1093/ndt/16.5.1034; Truzzi F, 2011, CELL DEATH DIFFER, V18, P948, DOI 10.1038/cdd.2010.162; Tvrdik D, 2006, MED SCI MONITOR, V12, pBR227; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Viola JPB, 2005, BRAZ J MED BIOL RES, V38, P335, DOI 10.1590/S0100-879X2005000300003; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Williams D, 2006, ADV CHRONIC KIDNEY D, V13, P47, DOI 10.1053/j.ackd.2005.11.001; Xiao Z, 2013, AM J NEPHROL, V37, P30, DOI 10.1159/000345988; Zhu ZW, 2003, DIGEST DIS SCI, V48, P717, DOI 10.1023/A:1022880524395	41	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80113	10.1371/journal.pone.0080113	http://dx.doi.org/10.1371/journal.pone.0080113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244623	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900062
J	Cheng, SW; Tsai, HW; Lin, YJ; Cheng, PN; Chang, YC; Yen, CJ; Huang, HP; Chuang, YP; Chang, TT; Lee, CT; Chao, AN; Chou, CY; Chan, SH; Chow, NH; Ho, CL				Cheng, Shu-Wen; Tsai, Hung-Wen; Lin, Yih-Jyh; Cheng, Pin-Nan; Chang, Yu-Chung; Yen, Chia-Jui; Huang, Hsuan-Pang; Chuang, Yun-Pei; Chang, Ting-Tsung; Lee, Chung-Ta; Chao, Anning; Chou, Cheng-Yang; Chan, Shih-Huang; Chow, Nan-Haw; Ho, Chung-Liang			Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associate with Recurrence of Hepatocellular Carcinoma	PLOS ONE			English	Article							FETOPROTEIN MESSENGER-RNA; METASTATIC BREAST-CANCER; TUMOR-CELLS; PERIPHERAL-BLOOD; PROMOTES TRANSFORMATION; CLINICAL-SIGNIFICANCE; QUANTIFICATION; TRANSCRIPTION; PROGRESSION; EXPRESSION	By using an expressed sequence tag bioinformatic algorithm, we identified that Lin28 homolog B (Lin28B) may have an oncofetal expression pattern which may facilitate detecting cancer cells in adults. It is also reported to be a potential marker for cancer stem cells. Therefore, we sought to verify oncofetal-stemness characters of Lin28B and test its potential as a circulating cancer stem cell-like marker in adult HCC patients. Lin28B mRNA was examined in a panel of fetal tissue, adult tissue and tumors. Lin28B was over-expressed or knocked down in HepG2 cells to evaluate its potential as a stem cell-like marker. RT-qPCR for Lin28B was performed in the peripheral blood mononuclear cells from patients with HCC receiving surgery (n=96) and non-HCC controls (n=60) and analyzed its clinical significance. Lin28B showed an oncofetal expression pattern. Its overexpression could upregulate stemness markers (OCT4, Nanog and SOX2) and enhance tumorsphere formation in vitro. Lin28B knockdown had opposite effects. Circulating Lin28B was detected in peripheral blood mononuclear cells in 3 cases (5%) of non-HCC controls and 32 cases (33.3%) of HCC patients. In HCC patients, circulating Lin28B was associated with high tumor grade (P=0.046), large size (P=0.005), high AJCC stage (P=0.044) and BCLC stage (P=0.017). Circulating Lin28B was significantly associated with decreased recurrence-free survival (P<0.001). Circulating Lin28B separated early stage HCC into 2 recurrence-free survival curves (P=0.003). In multivariate analysis, circulating Lin28B was an independent variable associated with early recurrence (P=0.045) and recurrence in early stage HCC (P=0.006). In conclusion, the oncofetal gene Lin28B is a potential oncofetal cancer-stem-cell-like circulating tumor cell marker that correlates with HCC recurrence after hepatectomy. Circulating Lin28B could refine early AJCC stages. Our finding supports the possible use of a TNMC (C for circulating tumor cells) staging system in HCC.	[Cheng, Shu-Wen; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Chuang, Yun-Pei; Lee, Chung-Ta; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Lin, Yih-Jyh; Yen, Chia-Jui] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Hung-Wen; Cheng, Pin-Nan; Chang, Ting-Tsung; Ho, Chung-Liang] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Lin, Yih-Jyh; Chang, Yu-Chung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70101, Taiwan; [Cheng, Pin-Nan; Yen, Chia-Jui; Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Huang, Hsuan-Pang; Ho, Chung-Liang] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chao, Anning] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chao, Anning] Chang Gung Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chao, Anning] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chou, Cheng-Yang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Ho, CL (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	clh9@mail.ncku.edu.tw		Chao, An-Ning/0000-0002-4761-9244	Department of Health, Taiwan [DOH101-TD-C-111-003]; National Science Council, Taiwan [NSC 97-2320-B-006 -027 -MY3, NSC-99-2628-B-006-034-MY2]; NCKUH Research Grant (95) from National Cheng Kung University Hospital, Taiwan. [67]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NCKUH Research Grant (95) from National Cheng Kung University Hospital, Taiwan.	This was supported by grant DOH101-TD-C-111-003 from the Department of Health, Taiwan, grant NSC 97-2320-B-006 -027 -MY3 and grant NSC-99-2628-B-006-034-MY2 from the National Science Council, Taiwan, and NCKUH Research Grant (95) No. 67 from National Cheng Kung University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2001, ANN ONCOL, V12, P39, DOI 10.1023/A:1008317512253; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Andergassen U, 2013, INT J MOL SCI, V14, P1093, DOI 10.3390/ijms14011093; Aselmann H, 2001, LANGENBECK ARCH SURG, V386, P118, DOI 10.1007/s004230000199; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Crea F, 2011, J CLIN ONCOL, V29, P3487, DOI 10.1200/JCO.2011.37.0122; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dawood S, 2008, CANCER-AM CANCER SOC, V113, P2422, DOI 10.1002/cncr.23852; Elshimali YI, 2006, DIAGN MOL PATHOL, V15, P187, DOI 10.1097/01.pdm.0000213463.98763.b9; Fan ST, 2011, ANN SURG, V254, P569, DOI 10.1097/SLA.0b013e3182300a1d; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hsu CC, 2011, ONCOGENE, V30, P654, DOI 10.1038/onc.2010.451; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; Ijichi M, 2002, HEPATOLOGY, V35, P853, DOI 10.1053/jhep.2002.32100; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Liu LL, 2011, STEM CELLS DEV, V20, P2023, DOI 10.1089/scd.2011.0012; Louha M, 1997, HEPATOLOGY, V26, P998; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Minata M, 2001, J GASTROEN HEPATOL, V16, P445, DOI 10.1046/j.1440-1746.2001.02461.x; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pu YS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-39; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sarandakou A, 2007, CRIT REV CL LAB SCI, V44, P151, DOI 10.1080/10408360601003143; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Stathopoulou A, 2003, CLIN CANCER RES, V9, P5145; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wong IHN, 1999, CLIN CANCER RES, V5, P4021; Wu Wei, 2006, Hepatobiliary Pancreat Dis Int, V5, P538; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004	46	43	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80053	10.1371/journal.pone.0080053	http://dx.doi.org/10.1371/journal.pone.0080053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244607	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800114
J	Lin, SH; Beane, L; Chasse, D; Zhu, KW; Mathey-Prevot, B; Chang, JT				Lin, Shu-Hong; Beane, Lauren; Chasse, Dawn; Zhu, Kevin W.; Mathey-Prevot, Bernard; Chang, Jeffrey T.			Cross-Platform Prediction of Gene Expression Signatures	PLOS ONE			English	Article							HUMAN BREAST-CANCER; AFFYMETRIX; PROFILES; PATHWAYS; TOOL	Gene expression signatures can predict the activation of oncogenic pathways and other phenotypes of interest via quantitative models that combine the expression levels of multiple genes. However, as the number of platforms to measure genome-wide gene expression proliferates, there is an increasing need to develop models that can be ported across diverse platforms. Because of the range of technologies that measure gene expression, the resulting signal values can vary greatly. To understand how this variation can affect the prediction of gene expression signatures, we have investigated the ability of gene expression signatures to predict pathway activation across Affymetrix and Illumina microarrays. We hybridized the same RNA samples to both platforms and compared the resultant gene expression readings, as well as the signature predictions. Using a new approach to map probes across platforms, we found that the genes in the signatures from the two platforms were highly similar, and that the predictions they generated were also strongly correlated. This demonstrates that our method can map probes from Affymetrix and Illumina microarrays, and that this mapping can be used to predict gene expression signatures across platforms.	[Lin, Shu-Hong; Chang, Jeffrey T.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Beane, Lauren; Mathey-Prevot, Bernard] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Chasse, Dawn; Mathey-Prevot, Bernard] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Chasse, Dawn; Mathey-Prevot, Bernard] Duke Univ, Med Ctr, Durham, NC USA; [Zhu, Kevin W.; Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Duke University; Duke University; Duke University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chang, JT (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.	jeffrey.t.chang@uth.tmc.edu	Yamashita, Bruce/AAV-1825-2020; Lin, Shu-Hong/AAT-3905-2020	Lin, Shu-Hong/0000-0002-4020-7714; Zhu, Kevin/0000-0003-2784-3190	Cancer Prevention and Research Institute of Texas (CPRIT) [R1006]; NIH [R00LM009837, TL1TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM009837] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JTC is funded by Cancer Prevention and Research Institute of Texas (CPRIT) R1006, NIH R00LM009837, and NIH TL1TR000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Freedman JA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-58; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Liu ZD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r180; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Spang Rainer, 2002, In Silico Biology, V2, P369; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Woo Yong, 2004, J Biomol Tech, V15, P276; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79228	10.1371/journal.pone.0079228	http://dx.doi.org/10.1371/journal.pone.0079228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244455	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800045
J	Rakshambikai, R; Srinivasan, N; Nishant, KT				Rakshambikai, Ramaswamy; Srinivasan, Narayanaswamy; Nishant, Koodali Thazath			Structural Insights into Saccharomyces cerevisiae Msh4-Msh5 Complex Function Using Homology Modeling	PLOS ONE			English	Article							REPAIR PROTEIN MUTS; DNA MISMATCH-REPAIR; DOUBLE-STRAND BREAK; RECOGNIZES HOLLIDAY JUNCTIONS; MULTIPLE SEQUENCE ALIGNMENTS; CHROMOSOME SYNAPSIS; MEIOTIC CHROMOSOMES; CROSSING-OVER; I-TASSER; MEIOSIS	The Msh4-Msh5 protein complex in eukaryotes is involved in stabilizing Holliday junctions and its progenitors to facilitate crossing over during Meiosis I. These functions of the Msh4-Msh5 complex are essential for proper chromosomal segregation during the first meiotic division. The Msh4/5 proteins are homologous to the bacterial mismatch repair protein MutS and other MutS homologs (Msh2, Msh3, Msh6). Saccharomyces cerevisiae msh4/5 point mutants were identified recently that show two fold reduction in crossing over, compared to wild-type without affecting chromosome segregation. Three distinct classes of msh4/5 point mutations could be sorted based on their meiotic phenotypes. These include msh4/5 mutations that have a) crossover and viability defects similar to msh4/5 null mutants; b) intermediate defects in crossing over and viability and c) defects only in crossing over. The absence of a crystal structure for the Msh4-Msh5 complex has hindered an understanding of the structural aspects of Msh4-Msh5 function as well as molecular explanation for the meiotic defects observed in msh4/5 mutations. To address this problem, we generated a structural model of the S. cerevisiae Msh4-Msh5 complex using homology modeling. Further, structural analysis tailored with evolutionary information is used to predict sites with potentially critical roles in Msh4-Msh5 complex formation, DNA binding and to explain asymmetry within the Msh4-Msh5 complex. We also provide a structural rationale for the meiotic defects observed in the msh4/5 point mutations. The mutations are likely to affect stability of the Msh4/5 proteins and/or interactions with DNA. The Msh4-Msh5 model will facilitate the design and interpretation of new mutational data as well as structural studies of this important complex involved in meiotic chromosome segregation.	[Rakshambikai, Ramaswamy; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Nishant, Koodali Thazath] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram, Kerala, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		KT, Nishant/0000-0002-4342-7501	IISER-TVM intramural funds; Wellcome Trust-DBT India Alliance Intermediate Fellowship; Department of Biotechnology, Government of India	IISER-TVM intramural funds; Wellcome Trust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	KTN is supported by IISER-TVM intramural funds and a Wellcome Trust-DBT India Alliance Intermediate Fellowship. This research is supported by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jiricny J, 2000, CURR BIOL, V10, pR788, DOI 10.1016/S0960-9822(00)00772-7; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee SD, 2007, J MOL BIOL, V366, P53, DOI 10.1016/j.jmb.2006.10.099; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Marsischky GT, 1999, J BIOL CHEM, V274, P7200, DOI 10.1074/jbc.274.11.7200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001083; Novak JE, 2001, GENETICS, V158, P1013; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Santucci-Darmanin S, 2002, HUM MOL GENET, V11, P1697, DOI 10.1093/hmg/11.15.1697; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Segura J, 2012, BIOINFORMATICS, V28, P1845, DOI 10.1093/bioinformatics/bts269; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Snowden T, 2008, J BIOL CHEM, V283, P145, DOI 10.1074/jbc.M704060200; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tseng Q, 2011, ACTA CRYSTALLOGR F, V67, P947, DOI 10.1107/S1744309111019300; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; von Grotthuss M, 2003, PROTEINS, V53, P418, DOI 10.1002/prot.10547; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	79	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78753	10.1371/journal.pone.0078753	http://dx.doi.org/10.1371/journal.pone.0078753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244354	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000327143800013
J	Robert, J; Weber, B; Frese, L; Emmert, MY; Schmidt, D; von Eckardstein, A; Rohrer, L; Hoerstrup, SP				Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Schmidt, Doerthe; von Eckardstein, Arnold; Rohrer, Lucia; Hoerstrup, Simon P.			A Three-Dimensional Engineered Artery Model for In Vitro Atherosclerosis Research	PLOS ONE			English	Article							LIPOPROTEIN TRANSPORT; ENDOTHELIAL-CELLS; BLOOD-VESSELS; COCULTURE; RETENTION; MONOCYTES; HEART	The pathogenesis of atherosclerosis involves dysfunctions of vascular endothelial cells and smooth muscle cells as well as blood borne inflammatory cells such as monocyte-derived macrophages. In vitro experiments towards a better understanding of these dysfunctions are typically performed in two-dimensional cell culture systems. However, these models lack both the three-dimensional structure and the physiological pulsatile flow conditions of native arteries. We here describe the development and initial characterization of a tissue engineered artery equivalent, which is composed of human primary endothelial and smooth muscle cells and is exposed to flow in vitro. Histological analyses showed formation of a dense tissue composed of a tight monolayer of endothelial cells supported by a basement membrane and multiple smooth muscle cell layers. Both low (LDL) and high density lipoproteins (HDL) perfused through the artery equivalent were recovered both within endothelial cells and in the sub-endothelial intima. After activation of the endothelium with either tumour necrosis factor alpha (TNF alpha) or LDL, monocytes circulated through the model were found to adhere to the activated endothelium and to transmigrate into the intima. In conclusion, the described tissue engineered human artery equivalent model represents a significant step towards a relevant in vitro platform for the systematic assessment of pathogenic processes in atherosclerosis independently of any systemic factors.	[Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, Clin Cardiovasc Surg, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; Frese, Laura; Emmert, Maximilian Y.; Hoerstrup, Simon P.] Univ Zurich Hosp, Dept Surg Res, CH-8091 Zurich, Switzerland; [Robert, Jerome; von Eckardstein, Arnold; Rohrer, Lucia] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Robert, Jerome; Weber, Benedikt; von Eckardstein, Arnold; Rohrer, Lucia; Hoerstrup, Simon P.] Univ Zurich, Zurich Ctr Integrated Human Physiol, Zurich, Switzerland; [Schmidt, Doerthe] Univ Zurich Hosp, Ctr Cardiovasc, Dept Cardiol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Hoerstrup, SP (corresponding author), Univ Zurich, Swiss Ctr Regenerat Med, Zurich, Switzerland.	simon_philipp.hoerstrup@usz.ch	Robert, Jerome/C-6226-2018	Robert, Jerome/0000-0002-2847-9362; Weber, Benedikt/0000-0002-7217-4590	Zurich Integrative Human Physiology (ZIHP); Swiss National Science Foundation [310030-143992, 31003A-130836/I, 320030-122273]	Zurich Integrative Human Physiology (ZIHP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grant from Zurich Integrative Human Physiology (ZIHP) to Arnold von Eckardstein, Simon Hoerstrup and Lucia Rohrer and by grants from the Swiss National Science Foundation to Simon Hoerstrup [310030-143992], Arnold von Eckardstein [31003A-130836/I.] and Benedikt Weber [320030-122273]. The funders had no role in study <INF>d</INF>esign, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2000, J BIOL CHEM, V275, P10256, DOI 10.1074/jbc.275.14.10256; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GMELIGMEYLING F, 1980, J IMMUNOL METHODS, V33, P1, DOI 10.1016/0022-1759(80)90077-0; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; NAVAB M, 1988, J CLIN INVEST, V82, P1853, DOI 10.1172/JCI113802; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmidt D, 2006, ANN THORAC SURG, V82, P1465, DOI 10.1016/j.athoracsur.2006.05.066; Shen G, 2003, CELL RES, V13, P335, DOI 10.1038/sj.cr.7290178; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takaku M, 1999, ARTERIOSCL THROM VAS, V19, P2330, DOI 10.1161/01.ATV.19.10.2330; Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; Wada Y, 2000, YONSEI MED J, V41, P740, DOI 10.3349/ymj.2000.41.6.740; Weber B, 2012, BIOMATERIALS, V33, P4031, DOI 10.1016/j.biomaterials.2011.11.087; Weissman B A, 2001, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0713s05; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012	30	33	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79821	10.1371/journal.pone.0079821	http://dx.doi.org/10.1371/journal.pone.0079821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244566	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000327143800101
J	van Haren, SD; Wroblewska, A; Herczenik, E; Kaijen, PH; Ruminska, A; ten Brinke, A; Meijer, AB; Voorberg, J				van Haren, Simon D.; Wroblewska, Aleksandra; Herczenik, Eszter; Kaijen, Paul H.; Ruminska, Aleksandra; ten Brinke, Anja; Meijer, Alexander B.; Voorberg, Jan			Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII	PLOS ONE			English	Article							CLASS-II SYNTHESIS; T-CELL RESPONSES; COMPLEX CLASS-II; HEMOPHILIA-A; DENDRITIC CELLS; ANTIGEN PRESENTATION; ACQUIRED HEMOPHILIA; EPITOPE REPERTOIRE; IMMUNE-RESPONSE; C1 DOMAIN	The formation of inhibitory antibodies directed against coagulation factor VIII (FVIII) is a severe complication in the treatment of hemophilia A patients. The induction of anti-FVIII antibodies is a CD4(+) T cell-dependent process. Activation of FVIII-specific CD4+ T cells is dependent on the presentation of FVIII-derived peptides on MHC class II by antigen-presenting cells. Previously, we have shown that FVIII-pulsed human monocyte-derived dendritic cells can present peptides from several FVIII domains. In this study we show that FVIII peptides are presented on immature as well as mature dendritic cells. In immature dendritic cells half of the FVIII-loaded MHC class II molecules are retained within the cell, whereas in LPS-matured dendritic cells the majority of MHC class II/peptide complexes is present on the plasma membrane. Time-course studies revealed that presentation of FVIII-derived peptides was optimal between 12 and 24 hours after maturation but persisted for at least 96 hours. We also show that macrophages are able to internalize FVIII as efficiently as dendritic cells, however FVIII was presented on MHC class II with a lower efficiency and with different epitopes compared to dendritic cells. In total, 48 FVIII core-peptides were identified using a DCs derived of 8 different donors. Five HLA-promiscuous FVIII peptide regions were found - these were presented by at least 4 out of 8 donors. The remaining 42 peptide core regions in FVIII were presented by DCs derived from a single (30 peptides) or two to three donors (12 peptides). Overall, our findings show that a broad repertoire of FVIII peptides can be presented on HLA-DR.	[van Haren, Simon D.; Wroblewska, Aleksandra; Herczenik, Eszter; Kaijen, Paul H.; Ruminska, Aleksandra; Meijer, Alexander B.; Voorberg, Jan] Sanquin AMC Landsteiner & Creveld Lab, Dept Plasma Prot, Amsterdam, Netherlands; [ten Brinke, Anja] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University	Voorberg, J (corresponding author), Sanquin AMC Landsteiner & Creveld Lab, Dept Plasma Prot, Amsterdam, Netherlands.	j.voorberg@sanquin.nl	van Haren, Simon/K-7066-2019	van Haren, Simon/0000-0002-1791-0161; Wroblewska, Aleksandra/0000-0003-2059-6158; ten Brinke, Anja/0000-0002-0135-7496; Voorberg, Jan/0000-0003-4585-2621				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Burster T, 2007, IMMUNOLOGY, V121, P82, DOI 10.1111/j.1365-2567.2007.02540.x; Burster T, 2008, BIOCHEM BIOPH RES CO, V377, P1299, DOI 10.1016/j.bbrc.2008.10.162; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; Dasgupta S, 2007, P NATL ACAD SCI USA, V104, P8965, DOI 10.1073/pnas.0702120104; Ettinger RA, 2010, HAEMOPHILIA, V16, P44, DOI 10.1111/j.1365-2516.2008.01905.x; Ettinger RA, 2009, BLOOD, V114, P1423, DOI 10.1182/blood-2009-01-200725; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; Howson JMM, 2011, DIABETES, V60, P2635, DOI 10.2337/db11-0131; Jacquemin M, 2003, BLOOD, V101, P1351, DOI 10.1182/blood-2002-05-1369; James EA, 2007, J THROMB HAEMOST, V5, P2399, DOI 10.1111/j.1538-7836.2007.02762.x; Jones TD, 2005, J THROMB HAEMOST, V3, P991, DOI 10.1111/j.1538-7836.2005.01309.x; Moise L, 2012, CLIN IMMUNOL, V142, P320, DOI 10.1016/j.clim.2011.11.010; Navarrete A, 2009, J THROMB HAEMOST, V7, P1816, DOI 10.1111/j.1538-7836.2009.03571.x; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Pratt KP, 2004, THROMB HAEMOSTASIS, V92, P522, DOI 10.1160/TH03-12-0755; Qadura M, 2008, J THROMB HAEMOST, V6, P2095, DOI 10.1111/j.1538-7836.2008.03165.x; Ragni MV, 2009, EXP HEMATOL, V37, P744, DOI 10.1016/j.exphem.2009.02.011; Reding MT, 1999, THROMB HAEMOSTASIS, V82, P509, DOI 10.1055/s-0037-1615873; Reding MT, 2004, J THROMB HAEMOST, V2, P1385, DOI 10.1111/j.1538-7836.2004.00850.x; Reding MT, 2003, J THROMB HAEMOST, V1, P1777, DOI 10.1046/j.1538-7836.2003.00251.x; Reding MT, 2002, THROMB HAEMOSTASIS, V88, P568; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; SMOLEN JS, 1987, ANN RHEUM DIS, V46, P457, DOI 10.1136/ard.46.6.457; Steinitz KN, 2012, BLOOD, V119, P4073, DOI 10.1182/blood-2011-08-374645; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wang SF, 2011, VIRAL IMMUNOL, V24, P421, DOI 10.1089/vim.2011.0024; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wroblewska A, 2012, J THROMB HAEMOST, V12, P12065; Wroblewska A, 2012, BLOOD, V119, P5294, DOI 10.1182/blood-2011-11-391680; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	40	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80239	10.1371/journal.pone.0080239	http://dx.doi.org/10.1371/journal.pone.0080239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244658	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800139
J	Shen, Z; Qin, Y; Liu, Y; Lu, Y; Munker, S; Chen, LH; Yu, CH; Chen, P; Li, YM				Shen, Zhe; Qin, Yu'e; Liu, Yi; Lu, Yi; Munker, Stefan; Chen, Lihua; Yu, Chaohui; Chen, Peng; Li, Youming			Helicobacter pylori Infection Is Associated with the Presence of Thyroid Nodules in the Euthyroid Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DISEASE; AUTOIMMUNITY	Helicobacter pylori infection is associated with extragastric diseases. The thyroid may be one of the targets of chronic inflammation. Here, we sought to investigate whether H. pylori infections were associated with the presence of thyroid nodules. A total of 988 euthyroid subjects from China were included in this cross-sectional study. Four hundred thirty-five (44.0%) subjects were diagnosed as having thyroid nodules, and 486 (49.2%) were diagnosed with H. pylori infections. The thyroid nodules group had a higher proportion of H. pylori infections than the control group (P = 0.002). Free thyroxine (FT4) levels were lower and the prevalence of thyroid nodules was higher in patients with H. pylori infection compared to those without infection, even after adjustment for age, gender, and body mass index (BMI; all P < 0.05). The prevalence of H. pylori infection showed a decreasing trend as serum FT4 level increased (P-trend = 0.020). Stepwise logistic regression analysis showed that H. pylori infection was significantly associated with the risk of thyroid nodules (odds ratio: 1.390, 95% confidence interval: 1.059-1.824, P = 0.018). Our results suggested that H. pylori infections were positively associated with the presence of thyroid nodules in the euthyroid population, whose thyroid functions were in the reference range.	[Shen, Zhe; Liu, Yi; Lu, Yi; Chen, Lihua; Yu, Chaohui; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Yu'e; Chen, Peng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Int Hlth Care Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Munker, Stefan] Heidelberg Univ, Fac Med Mannheim, Med Clin 2, Mannheim, Germany	Zhejiang University; Zhejiang University; Ruprecht Karls University Heidelberg	Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zjulym@126.com		Ma, Han/0000-0001-9985-3035	Zhejiang Provincial Laboratory Animal Science Technology Program of China [2011C37088]; Zhejiang Provincial Natural Science Foundation of China [LY12H03011, LY13H030003]; Natural Science Foundation of Ningbo City [2012A610244]	Zhejiang Provincial Laboratory Animal Science Technology Program of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Ningbo City	This study was supported by Zhejiang Provincial Laboratory Animal Science Technology Program of China (number 2011C37088); Zhejiang Provincial Natural Science Foundation of China (numbers LY12H03011 and LY13H030003); Natural Science Foundation of Ningbo City (number 2012A610244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi V, 2012, WORLD J GASTROENTERO, V18, P1093, DOI 10.3748/wjg.v18.i10.1093; Bassi V, 2010, HELICOBACTER, V15, P558, DOI 10.1111/j.1523-5378.2010.00802.x; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Fredricks DN, 1998, CURR CLIN TOPICS INF, V18, P180; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Iyer NG, 2010, CLIN ONCOL-UK, V22, P405, DOI 10.1016/j.clon.2010.03.009; JOASOO A, 1975, LANCET, V2, P125; Junik R, 2006, ACTA RADIOL, V47, P687, DOI 10.1080/02841850600806308; Kim JY, 2012, J KOREAN SURG SOC, V82, P13, DOI 10.4174/jkss.2012.82.1.13; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Marshall TG, 2008, BIOESSAYS, V30, P173, DOI 10.1002/bies.20708; Mohan S, 1996, J CLIN ENDOCR METAB, V81, P3817, DOI 10.1210/jc.81.11.3817; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Pordeus V, 2008, CLIN REV ALLERG IMMU, V34, P283, DOI 10.1007/s12016-007-8048-8; Proal AD, 2009, ANN NY ACAD SCI, V1173, P252, DOI 10.1111/j.1749-6632.2009.04672.x; Rapoport B, 2001, J CLIN INVEST, V108, P1253, DOI 10.1172/JCI14321; Rezzonico J, 2008, THYROID, V18, P461, DOI 10.1089/thy.2007.0223; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; Shin DW, 2012, J CLIN GASTROENTEROL, V46, P840, DOI 10.1097/MCG.0b013e3182522477; Stechova K, 2009, EXP CLIN ENDOCR DIAB, V117, P423, DOI 10.1055/s-0029-1214385; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Triantafillidis John K, 2003, Hepatogastroenterology, V50 Suppl 2, pcccxviii; VALTONEN VV, 1986, ACTA MED SCAND, V219, P105; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z	28	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80042	10.1371/journal.pone.0080042	http://dx.doi.org/10.1371/journal.pone.0080042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244604	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600175
J	Tinazzi, M; Morgante, F; Peretti, A; Mariotti, C; Panzeri, M; Fiorio, M; Fasano, A				Tinazzi, Michele; Morgante, Francesca; Peretti, Alessia; Mariotti, Caterina; Panzeri, Marta; Fiorio, Mirta; Fasano, Alfonso			Impaired Temporal Processing of Tactile and Proprioceptive Stimuli in Cerebellar Degeneration	PLOS ONE			English	Article							2 PASSIVE MOVEMENTS; PARKINSONS-DISEASE; BASAL GANGLIA; MOTOR CONTROL; FUNCTIONAL NEUROANATOMY; ESSENTIAL TREMOR; NEURAL-NETWORKS; WRITERS CRAMP; DISCRIMINATION; DYSTONIA	Performance of timed motor sequences relies on the cerebellum and basal ganglia, which integrate proprioceptive information during the motor task and set internal timing mechanisms. Accordingly, these structures are also involved in other temporal processes, such as the discrimination of the different afferent information in the domain of time. In the present study we tested temporal processing of proprioceptive and tactile stimuli in 20 patients with neurodegenerative cerebellar ataxia and 20 age- and sex-matched healthy subjects. Tactile temporal discrimination threshold was defined as the value at which subjects recognized the two stimuli as asynchronous. Temporal discrimination movement threshold of the first dorsal interosseous and flexor carpi radialis was defined as the shortest interval between two paired electrical stimuli in which the subjects blindfolded perceived two separate index finger abductions and wrist flexions. Both tactile and movement temporal discrimination thresholds were higher in patients with cerebellar ataxia. No correlation was found with disease duration and severity. Our study demonstrates that temporal processing of tactile and proprioceptive stimuli is impaired in patients with cerebellar neurodegeneration and highlights the involvement of cerebellum in temporal processing of somatosensory stimuli of different type.	[Tinazzi, Michele; Peretti, Alessia; Fiorio, Mirta] Univ Verona, Dept Neurol Psychol Morphol & Motor Sci, I-37100 Verona, Italy; [Morgante, Francesca] Univ Messina, Dipartimento Med Clin & Sperimentale, Messina, Italy; [Mariotti, Caterina; Panzeri, Marta] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Fasano, Alfonso] Univ Toronto, Movement Disorders Ctr, TWH, UHN,Div Neurol, Toronto, ON, Canada	University of Verona; University of Messina; IRCCS Istituto Neurologico Besta; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Morgante, F (corresponding author), Univ Messina, Dipartimento Med Clin & Sperimentale, Messina, Italy.	fmorgante@gmail.com	TINAZZI, Michele/J-7134-2018; Morgante, Francesca/E-8717-2010; Panzeri, Marta/K-3465-2016; Mariotti, Caterina/AAP-9425-2021; Fasano, Alfonso/K-2558-2018	TINAZZI, Michele/0000-0002-2370-7063; Morgante, Francesca/0000-0002-9834-3639; Panzeri, Marta/0000-0002-3359-025X; Mariotti, Caterina/0000-0003-2405-3564; Fiorio, Mirta/0000-0002-6356-0211; Fasano, Alfonso/0000-0001-5346-0180	Neureca - Onlus, Milan	Neureca - Onlus, Milan	Francesca Morgante has received speaking honoraria from Glaxo- Smithkline, Lundbeck, Novartis, Chiesi Farmaceutici, Medtronic and has received research support from Neureca - Onlus, Milan. Alfonso Fasano has received speaking honoraria from Chiesi Farmaceutici, Medtronic, UCB Pharma and has received research support from Neureca - Onlus, Milan. The competing interests declared do not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Aglioti SM, 2003, NEUROLOGY, V60, P782, DOI 10.1212/01.WNL.0000046528.24693.5B; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Bradley D, 2009, BRAIN, V132, P2327, DOI 10.1093/brain/awp156; Butterworth S, 2003, MOVEMENT DISORD, V18, P673, DOI 10.1002/mds.10416; Conte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032979; Conte A, 2010, BRAIN, V133, P2656, DOI 10.1093/brain/awq191; Elble R, 2011, MOVEMENT DISORD, V26, P1096, DOI 10.1002/mds.23579; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Fiorio M, 2003, ANN NEUROL, V53, P630, DOI 10.1002/ana.10525; Fiorio M, 2007, NEUROSCI LETT, V417, P312, DOI 10.1016/j.neulet.2007.02.050; Fiorio M, 2007, BRAIN, V130, P134, DOI 10.1093/brain/awl283; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GRILL SE, 1994, BRAIN, V117, P1433, DOI 10.1093/brain/117.6.1433; Hagura N, 2009, CEREB CORTEX, V19, P176, DOI 10.1093/cercor/bhn068; Harrington DL, 1998, J NEUROSCI, V18, P1085; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jueptner M, 1997, NEUROIMAGE, V5, P41, DOI 10.1006/nimg.1996.0249; KEELE SW, 1990, ANN NY ACAD SCI, V608, P179, DOI 10.1111/j.1749-6632.1990.tb48897.x; Klinke I, 2010, CEREBELLUM, V9, P433, DOI 10.1007/s12311-010-0183-8; Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9; LACRUZ F, 1991, J NEUROL NEUROSUR PS, V54, P1077, DOI 10.1136/jnnp.54.12.1077; Louis ED, 2010, LANCET NEUROL, V9, P613, DOI 10.1016/S1474-4422(10)70090-9; Manganelli F, 2013, CEREBELLUM; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; MARSDEN CD, 1982, NEUROLOGY, V32, P514, DOI 10.1212/WNL.32.5.514; Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230; Molinari M, 2007, CEREBELLUM, V6, P18, DOI 10.1080/14734220601142886; Morgante F, 2011, NEUROLOGY, V77, P1191, DOI 10.1212/WNL.0b013e31822f0449; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; Orsi L, 2011, J CLIN EXP NEUROPSYC, V33, P315, DOI 10.1080/13803395.2010.518139; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Ravizza SM, 2012, COGN AFFECT BEHAV NE, V12, P193, DOI 10.3758/s13415-011-0066-6; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Restuccia D, 2001, BRAIN, V124, P757, DOI 10.1093/brain/124.4.757; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; Tesche CD, 2000, HUM BRAIN MAPP, V9, P119, DOI 10.1002/(SICI)1097-0193(200003)9:3<119::AID-HBM2>3.0.CO;2-R; Tinazzi M, 1999, NEUROREPORT, V10, P1547, DOI 10.1097/00001756-199905140-00028; Tinazzi M, 2005, EXP BRAIN RES, V166, P184, DOI 10.1007/s00221-005-2353-3; Tinazzi M, 2006, MOVEMENT DISORD, V21, P1131, DOI 10.1002/mds.20892; Tinazzi M, 2013, NEUROLOGY, V80, P76, DOI 10.1212/WNL.0b013e31827b1a54; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004	48	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78628	10.1371/journal.pone.0078628	http://dx.doi.org/10.1371/journal.pone.0078628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244328	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000327221600038
J	Zanon, A; Rakovic, A; Blankenburg, H; Doncheva, NT; Schwienbacher, C; Serafin, A; Alexa, A; Weichenberger, CX; Albrecht, M; Klein, C; Hicks, AA; Pramstaller, PP; Domingues, FS; Pichler, I				Zanon, Alessandra; Rakovic, Aleksandar; Blankenburg, Hagen; Doncheva, Nadezhda T.; Schwienbacher, Christine; Serafin, Alice; Alexa, Adrian; Weichenberger, Christian X.; Albrecht, Mario; Klein, Christine; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene			Profiling of Parkin-Binding Partners Using Tandem Affinity Purification	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN INTERACTION NETWORKS; GENE ONTOLOGY; DISEASE GENES; MITOCHONDRIAL PATHOLOGY; FUNCTIONAL SIMILARITY; UBIQUITIN LIGASE; CELL-DEATH; DROSOPHILA; MUTATIONS	Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting approximately 1-2% of the general population over age 60. It is characterized by a rather selective loss of dopaminergic neurons in the substantia nigra and the presence of a-synuclein-enriched Lewy body inclusions. Mutations in the Parkin gene (PARK2) are the major cause of autosomal recessive early-onset parkinsonism. The Parkin protein is an E3 ubiquitin ligase with various cellular functions, including the induction of mitophagy upon mitochondrial depolarizaton, but the full repertoire of Parkin-binding proteins remains poorly defined. Here we employed tandem affinity purification interaction screens with subsequent mass spectrometry to profile binding partners of Parkin. Using this approach for two different cell types (HEK293T and SH-SY5Y neuronal cells), we identified a total of 203 candidate Parkin-binding proteins. For the candidate proteins and the proteins known to cause heritable forms of parkinsonism, protein-protein interaction data were derived from public databases, and the associated biological processes and pathways were analyzed and compared. Functional similarity between the candidates and the proteins involved in monogenic parkinsonism was investigated, and additional confirmatory evidence was obtained using published genetic interaction data from Drosophila melanogaster. Based on the results of the different analyses, a prioritization score was assigned to each candidate Parkin-binding protein. Two of the top ranking candidates were tested by co-immunoprecipitation, and interaction to Parkin was confirmed for one of them. New candidates for involvement in cell death processes, protein folding, the fission/fusion machinery, and the mitophagy pathway were identified, which provide a resource for further elucidating Parkin function.	[Zanon, Alessandra; Blankenburg, Hagen; Schwienbacher, Christine; Serafin, Alice; Weichenberger, Christian X.; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Zanon, Alessandra; Blankenburg, Hagen; Schwienbacher, Christine; Serafin, Alice; Weichenberger, Christian X.; Hicks, Andrew A.; Pramstaller, Peter P.; Domingues, Francisco S.; Pichler, Irene] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Rakovic, Aleksandar; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany; [Doncheva, Nadezhda T.; Alexa, Adrian; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Albrecht, Mario] Univ Med Greifswald, Inst Biometr & Med Informat, Dept Bioinformat, Greifswald, Germany; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	European Academy of Bozen-Bolzano; University of Lubeck; University of Lubeck; Max Planck Society; Greifswald Medical School; Krankenhaus Bozen; University of Lubeck	Domingues, FS (corresponding author), Cambridge Ltd, Illumina, Cambridge, England.	francisco.domingues@eurac.edu; irene.pichler@eurac.edu	Klein, Christine/AGK-8003-2022; Albrecht, Mario/B-6694-2008; Pramstaller, Peter P/C-2357-2008; Hicks, Andrew Anthony/E-9518-2017	Albrecht, Mario/0000-0002-3103-9624; Hicks, Andrew Anthony/0000-0001-6320-0411; Zanon, Alessandra/0000-0003-2204-6176; Pramstaller, Peter P/0000-0002-9831-8302; Weichenberger, Christian X./0000-0002-2176-0274; Doncheva, Nadezhda T./0000-0002-8806-6850; Pichler, Irene/0000-0001-8251-0757; Domingues, Francisco/0000-0003-4567-4562; Blankenburg, Hagen/0000-0002-6058-1818; Klein, Christine/0000-0003-2102-3431	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; German Federal Ministry of Education and Research through the German National Genome Research Network; Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; German Federal Ministry of Education and Research through the German National Genome Research Network; Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction	The study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. Part of this study was also funded by the German Federal Ministry of Education and Research through the German National Genome Research Network and the Greifswald Approach to Individualized Medicine as well as by the German Research Foundation through the Cluster of Excellence for Multimodal Computing and Interaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Fernandes C, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-17; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Marras C, 2012, NEUROLOGY, V78, P1016, DOI 10.1212/WNL.0b013e31824d58ab; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Mukamel Z, 2004, J BIOL CHEM, V279, P36732, DOI 10.1074/jbc.M400041200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	70	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78648	10.1371/journal.pone.0078648	http://dx.doi.org/10.1371/journal.pone.0078648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244333	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600042
J	Bertrand, C; Pignalosa, A; Wanecq, E; Rancoule, C; Batut, A; Deleruyelle, S; Lionetti, L; Valet, P; Castan-Laurell, I				Bertrand, Chantal; Pignalosa, Angelica; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Lionetti, Lilla; Valet, Philippe; Castan-Laurell, Isabelle			Effects of Dietary Eicosapentaenoic Acid (EPA) Supplementation in High-Fat Fed Mice on Lipid Metabolism and Apelin/APJ System in Skeletal Muscle	PLOS ONE			English	Article							UP-REGULATES APELIN; INSULIN-RESISTANT MICE; INDUCED OBESE MICE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; SECRETION; GLUCOSE; LEPTIN	Various studies have shown that eicosapentaenoic acid (EPA) has beneficial effects on obesity and associated disorders. Apelin, the ligand of APJ receptor also exerts insulin-sensitizing effects especially by improving muscle metabolism. EPA has been shown to increase apelin production in adipose tissue but its effects in muscle have not been addressed. Thus, the effects of EPA supplementation (36 g/kg EPA) in high-fat diet (HFD) (45% fat, 20% protein, 35% carbohydrate) were studied in mice with focus on muscle lipid metabolism and apelin/APJ expression. Compared with HFD mice, HFD+EPA mice had significantly less weight gain, fat mass, lower blood glucose, insulinemia and hepatic steatosis after 10 weeks of diet. In addition, EPA prevented muscle metabolism alterations since intramuscular triglycerides were decreased and beta-oxidation increased. In soleus muscles of HFD+EPA mice, apelin and APJ expression were significantly increased compared to HFD mice. However, plasma apelin concentrations in HFD and HFD+EPA mice were similar. EPA-induced apelin expression was confirmed in differentiated C2C12 myocytes but in this model, apelin secretion was also increased in response to EPA treatment. In conclusion, EPA supplementation in HFD prevents obesity and metabolic alterations in mice, especially in skeletal muscle. Since EPA increases apelin/APJ expression in muscle, apelin may act in a paracrine/autocrine manner to contribute to these benefical effects.	[Bertrand, Chantal; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Valet, Philippe; Castan-Laurell, Isabelle] INSERM, U1048, Toulouse 4, France; [Bertrand, Chantal; Wanecq, Estelle; Rancoule, Chloe; Batut, Aurelie; Deleruyelle, Simon; Valet, Philippe; Castan-Laurell, Isabelle] Univ Toulouse, UPS, Inst Malad Metabol & Cardiovasc, Toulouse, France; [Pignalosa, Angelica; Lionetti, Lilla] Univ Naples Federico II, Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Naples Federico II	Castan-Laurell, I (corresponding author), INSERM, U1048, Toulouse 4, France.	isabelle.castan@inserm.fr	Lionetti, Lilla/AAM-1756-2021; Valet, Philippe/N-7472-2017	Lionetti, Lilla/0000-0002-4059-8030; Valet, Philippe/0000-0001-6520-7393; Castan-Laurell, Isabelle/0000-0002-0488-9789	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The funder is INSERM and has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andre A, 2011, BR J NUTR, P1; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Berta J, 2010, J THORAC ONCOL, V5, P1120, DOI 10.1097/JTO.0b013e3181e2c1ff; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brasky TM, 2013, JNCI-J NATL CANCER I, V105, P1132, DOI 10.1093/jnci/djt174; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Di Minno MND, 2012, WORLD J GASTROENTERO, V18, P5839, DOI 10.3748/wjg.v18.i41.5839; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Fan CN, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-31; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Jones TE, 2003, AM J PHYSIOL-ENDOC M, V284, pE96, DOI 10.1152/ajpendo.00316.2002; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; LILLINGTON JM, 1981, CLIN CHIM ACTA, V111, P91, DOI 10.1016/0009-8981(81)90425-3; Lorente-Cebrian S, 2010, MOL NUTR FOOD RES, V54, pS104, DOI 10.1002/mnfr.200900522; Mazzucotelli A, 2008, REGUL PEPTIDES, V150, P33, DOI 10.1016/j.regpep.2008.04.003; Murata M, 2000, BIOCHEM BIOPH RES CO, V270, P343, DOI 10.1006/bbrc.2000.2424; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; Perez-Echarri N, 2009, BRIT J NUTR, V101, P1059, DOI 10.1017/S0007114508048307; Perez-Matute P, 2005, AM J PHYSIOL-REG I, V288, pR1682, DOI 10.1152/ajpregu.00727.2004; Pope GR, 2012, PEPTIDES, V33, P139, DOI 10.1016/j.peptides.2011.12.005; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Reseland JE, 2001, J LIPID RES, V42, P743; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Wang XL, 2012, PEPTIDES, V33, P298, DOI 10.1016/j.peptides.2011.12.015; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Yamamoto T, 2011, BBA-GEN SUBJECTS, V1810, P853, DOI 10.1016/j.bbagen.2011.05.004	41	41	44	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78874	10.1371/journal.pone.0078874	http://dx.doi.org/10.1371/journal.pone.0078874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244380	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900026
J	Dierikx, CM; van der Goot, JA; Smith, HE; Kant, A; Mevius, DJ				Dierikx, Cindy M.; van der Goot, Jeanet A.; Smith, Hilde E.; Kant, Arie; Mevius, Dik J.			Presence of ESBL/AmpC -Producing Escherichia coli in the Broiler Production Pyramid: A Descriptive Study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ANTIMICROBIAL AGENTS; RESISTANCE; CHICKENS; POULTRY; ENTEROBACTERIACEAE; EPIDEMIOLOGY; TRANSMISSION; HUMANS; IMPACT	Broilers and broiler meat products are highly contaminated with extended spectrum beta-lactamase (ESBL) or plasmid-mediated AmpC beta-lactamase producing Escherichia coli and are considered to be a source for human infections. Both horizontal and vertical transmission might play a role in the presence of these strains in broilers. As not much is known about the presence of these strains in the whole production pyramid, the epidemiology of ESBL/AmpC-producing E. coli in the Dutch broiler production pyramid was examined. Cloacal swabs of Grandparent stock (GPS) birds (one(-)/two-days (breed A and B), 18 and 31 weeks old (breed A)), one-day old Parent stock birds (breed A and B) and broiler chickens of increasing age (breed A) were selectively cultured to detect ESBL/AmpC-producing isolates. ESBL/AmpC-producing isolates were found at all levels in the broiler production pyramid in both broiler breeds examined. Prevalence was already relatively high at the top of the broiler production pyramid. At broiler farms ESBL/AmpC producing E. coli were still present in the environment of the poultry house after cleaning and disinfection. Feed samples taken in the poultry house also became contaminated with ESBL/AmpC producing E. coli after one or more production weeks. The prevalence of ESBL/AmpC-positive birds at broiler farms increased within the first week from 0-24% to 96-100% independent of the use of antibiotics and stayed 100% until slaughter. In GPS breed A, prevalence at 2 days, 18 weeks and 31 weeks stayed below 50% except when beta-lactam antibiotics were administered. In that case prevalence increased to 100%. Interventions minimizing ESBL/AmpC contamination in broilers should focus on preventing horizontal and vertical spread, especially in relation to broiler production farms.	[Dierikx, Cindy M.; Kant, Arie; Mevius, Dik J.] CVI, Dept Bacteriol, Lelystad, Netherlands; [Dierikx, Cindy M.; Kant, Arie; Mevius, Dik J.] CVI, TSEs, Lelystad, Netherlands; [van der Goot, Jeanet A.] CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands; [Smith, Hilde E.] CVI, Dept Infect Biol, Lelystad, Netherlands; [Mevius, Dik J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University	Dierikx, CM (corresponding author), CVI, Dept Bacteriol, Lelystad, Netherlands.	Cindy.Dierikx@wur.nl			Dutch Ministry of Economic Affairs [WOT-01-002-003, WOT-01-002-003.04]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was financially supported by the Dutch Ministry of Economic Affairs (Grant numbers WOT-01-002-003 and WOT-01-002-003.04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlet G, 2006, MICROBES INFECT, V8, P1945, DOI 10.1016/j.micinf.2005.12.029; Bortolaia V, 2010, VET MICROBIOL, V142, P379, DOI 10.1016/j.vetmic.2009.10.024; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; COLOE PJ, 1984, J HYG-CAMBRIDGE, V92, P79, DOI 10.1017/S0022172400064056; da Costa PM, 2008, MICROB DRUG RESIST, V14, P299, DOI 10.1089/mdr.2008.0859; Diarra MS, 2007, APPL ENVIRON MICROB, V73, P6566, DOI 10.1128/AEM.01086-07; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dierikx CM, 2012, J ANTIMICROB CHEMOTH; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Egea P, 2011, EUR J CLIN MICROBIOL, V30, P1045, DOI 10.1007/s10096-011-1168-3; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Giovanardi D, 2005, AVIAN PATHOL, V34, P313, DOI 10.1080/03079450500179046; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P1244, DOI 10.1093/jac/dkn093; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; MAMBER SW, 1985, APPL ENVIRON MICROB, V50, P638, DOI 10.1128/AEM.50.3.638-648.1985; MARAN, 2012, MON ANT RES ANT US A; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Niki M, 2011, INFECTION, V39, P467, DOI 10.1007/s15010-011-0128-2; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peek HW, 2011, VET QUART, V31, P143, DOI 10.1080/01652176.2011.605247; Persoons D, 2011, EPIDEMIOL INFECT, V139, P765, DOI 10.1017/S0950268810001524; Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Saleha AA, 2009, INT J POUL SCI; Smet A, 2011, J APPL MICROBIOL, V110, P541, DOI 10.1111/j.1365-2672.2010.04907.x; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; SVA (National Veterinary Institute), 2010, SWED VET ANT RES MON	33	144	144	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79005	10.1371/journal.pone.0079005	http://dx.doi.org/10.1371/journal.pone.0079005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244401	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900029
J	Motegi, C; Nagata, T; Miki, T; Weinbauer, MG; Legendre, L; Rassoulzadegan, F				Motegi, Chiaki; Nagata, Toshi; Miki, Takeshi; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun			Interactive Effects of Viral and Bacterial Production on Marine Bacterial Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; COMMUNITY COMPOSITION; MICROBIAL DIVERSITY; INDUCED MORTALITY; DISTURBANCE; VIRUSES; BACTERIOPLANKTON; DIVERSIFICATION; BIOMASS; COMPETITION	A general model of species diversity predicts that the latter is maximized when productivity and disturbance are balanced. Based on this model, we hypothesized that the response of bacterial diversity to the ratio of viral to bacterial production (VP/BP) would be dome-shaped. In order to test this hypothesis, we obtained data on changes in bacterial communities (determined by terminal restriction fragment length polymorphism of 16S rRNA gene) along a wide VP/BP gradient (more than two orders of magnitude), using seawater incubations from NW Mediterranean surface waters, i.e., control and treatments with additions of phosphate, viruses, or both. In December, one dominant Operational Taxonomic Unit accounted for the major fraction of total amplified DNA in the phosphate addition treatment (75 +/- 20%, +/- S.D.), but its contribution was low in the phosphate and virus addition treatment (23 +/- 19%), indicating that viruses prevented the prevalence of taxa that were competitively superior in phosphate-replete conditions. In contrast, in February, the single taxon predominance in the community was held in the phosphate addition treatment even with addition of viruses. We observed statistically robust dome-shaped response patterns of bacterial diversity to VP/BP, with significantly high bacterial diversity at intermediate VP/BP. This was consistent with our model-based hypothesis, indicating that bacterial production and viral-induced mortality interactively affect bacterial diversity in seawater.	[Motegi, Chiaki; Nagata, Toshi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Motegi, Chiaki; Nagata, Toshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Motegi, Chiaki; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun] Univ Paris 06, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Motegi, Chiaki; Weinbauer, Markus G.; Legendre, Louis; Rassoulzadegan, Fereidoun] CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Miki, Takeshi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	University of Tokyo; Kyoto University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Taiwan University	Motegi, C (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	chiaki.motegi@takuvik.ulaval.ca	Weinbauer, Markus/ABC-7017-2020; Miki, Takeshi/F-8189-2010	Weinbauer, Markus/0000-0002-7697-5571; Miki, Takeshi/0000-0002-2452-8681	Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie Paris 6, France; Japan Society for the Promotion of Science [18631007, 20310010]; 21st Century Center of Excellence (COE) program (Kyoto University); project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie Paris 6, France; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE) program (Kyoto University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite	Financial support was provided by: the Centre National de la Recherche Scientifique and the Universite Pierre et Marie Curie Paris 6, France, to the Laboratoire d'Oceanographie de Villefranche; the Japan Society for the Promotion of Science, through grants 18631007 and 20310010 awarded to T.N.; and the 21st Century Center of Excellence (COE) program (Kyoto University). The project of Actions Thematiques et Incitatives sur Programme (ATIPE)-Biodiversite awarded to M. G. W. also contributed to this research. Travel expenses of C. M. to France were supported by the Kyoto University Foundation and the College doctoral franco-japonais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Ausubel FM, 1994, CURRENT PROTOCOLS MO; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Hewson I, 2007, DEEP-SEA RES PT I, V54, P811, DOI 10.1016/j.dsr.2007.02.003; Hewson I, 2007, MICROB ECOL, V53, P631, DOI 10.1007/s00248-006-9148-3; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Jara VC, 2006, MAR ECOL PROG SER, V308, P37, DOI 10.3354/meps308037; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; Kadmon R, 2006, AM NAT, V167, P939, DOI 10.1086/504602; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Kirchman D, 2001, METHOD MICROBIOL, V30, P227, DOI 10.1016/S0580-9517(01)30047-8; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Ludwig JA, 1988, STAT ECOLOGY; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Miki T, 2008, MAR ECOL PROG SER, V366, P1, DOI 10.3354/meps07597; Moeseneder MM, 2001, LIMNOL OCEANOGR, V46, P95, DOI 10.4319/lo.2001.46.1.0095; Motegi C, 2009, LIMNOL OCEANOGR, V54, P1901, DOI 10.4319/lo.2009.54.6.1901; Moyer CL, 1996, APPL ENVIRON MICROB, V62, P2501, DOI 10.1128/AEM.62.7.2501-2507.1996; Proulx M, 1998, ECOLOGY, V79, P2581, DOI 10.1890/0012-9658(1998)079[2581:ROGIOP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schwalbach MS, 2004, AQUAT MICROB ECOL, V34, P117, DOI 10.3354/ame034117; Sintes E, 2013, FEMS MICROBIOL ECOL, V83, P413, DOI 10.1111/1574-6941.12003; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Winter C, 2004, APPL ENVIRON MICROB, V70, P804, DOI 10.1128/AEM.70.2.804-813.2004; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zhang R, 2007, ENVIRON MICROBIOL, V9, P3008, DOI 10.1111/j.1462-2920.2007.01410.x; Zuur Alain F., 2009, P1	46	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76800	10.1371/journal.pone.0076800	http://dx.doi.org/10.1371/journal.pone.0076800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244268	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900002
J	Novakova, L; Valentova, JV; Havlicek, J				Novakova, Lenka; Valentova, Jaroslava Varella; Havlicek, Jan			Olfactory Performance Is Predicted by Individual Sex-Atypicality, but Not Sexual Orientation	PLOS ONE			English	Article							ODOR IDENTIFICATION; PUTATIVE PHEROMONES; GENDER-DIFFERENCES; HOMOSEXUAL-MEN; BRAIN RESPONSE; FINGER-LENGTH; AGGRESSION; BEHAVIOR; FEMALE; HORMONES	Many previous studies have reported robust sex differences in olfactory perception. However, both men and women can be expected to vary in the degree to which they exhibit olfactory performance considered typical of their own or the opposite sex. Sex-atypicality is often described in terms of childhood gender nonconformity, which, however, is not a perfect correlate of non-heterosexual orientation. Here we explored intrasexual variability in psychophysical olfactory performance in a sample of 156 individuals (83 non-heterosexual) and found the lowest odor identification scores in heterosexual men. However, when childhood gender nonconformity was entered in the model along with sexual orientation, better odor identification scores were exhibited by gender-nonconforming men, and greater olfactory sensitivity by gender-conforming women, irrespective of their sexual orientation. Thus, sex-atypicality, but not sexual orientation predicts olfactory performance, and we propose that this might not be limited to olfaction, but represent a more general phenomenon.	[Novakova, Lenka] Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic; [Valentova, Jaroslava Varella] Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic; [Valentova, Jaroslava Varella] Acad Sci Czech Republ, Prague, Czech Republic; [Havlicek, Jan] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Charles University Prague	Novakova, L (corresponding author), Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic.	lenka.novakova@fhs.cuni.cz	Valentova, Jaroslava Varella/K-8765-2012; Martinec Nováková, Lenka/F-6474-2015; Havlíček, Jan/F-8985-2011	Valentova, Jaroslava Varella/0000-0002-2113-3385; Martinec Nováková, Lenka/0000-0002-5695-2903; Havlíček, Jan/0000-0003-2374-7337	Charles University [SVV-2013-267 702]; Ministry of Education, Youth and Sports; Charles University Research Center [UNCE 204004]; Grant Agency of the Czech Republic [GACR 13-16959P]	Charles University; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Charles University Research Center; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	LN was supported by the grant SVV-2013-267 702 of the Charles University and by The Ministry of Education, Youth and Sports - Institutional Support for Longterm Development of Research Organizations - Charles University, Faculty of Humanities (Charles Univ, Fac Human 2013). JVV and JH were supported by the Charles University Research Center (UNCE 204004). JVV was further supported by the Grant Agency of the Czech Republic (GACR 13-16959P). The funding sources had no involvement in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	ALLEN LS, 1989, J NEUROSCI, V9, P497; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1996, MASCULINITY FEMININI; Baird AD, 2007, J NEUROL NEUROSUR PS, V78, P1042, DOI 10.1136/jnnp.2006.107193; Berg N, 2006, APPL ECON, V38, P757, DOI 10.1080/00036840500427114; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bocklandt S, 2007, ADV GENET, V59, P245, DOI 10.1016/S0065-2660(07)59009-7; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Cooke BM, 2005, J NEUROSCI, V25, P10759, DOI 10.1523/JNEUROSCI.2919-05.2005; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Diamond LM, 2008, DEV PSYCHOL, V44, P5, DOI 10.1037/0012-1649.44.1.5; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fergusson DM, 2005, PSYCHOL MED, V35, P971, DOI 10.1017/S0033291704004222; Field A, 2013, DISCOVERING STAT USI; Fuwa M, 2007, SOC SCI RES, V36, P512, DOI 10.1016/j.ssresearch.2006.04.005; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; GLADUE BA, 1995, PSYCHONEUROENDOCRINO, V20, P487, DOI 10.1016/0306-4530(94)00075-L; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Gur RC, 1999, J NEUROSCI, V19, P4065; Halari R, 2006, EXP BRAIN RES, V169, P1, DOI 10.1007/s00221-005-0118-7; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Hassan B, 2007, BEHAV NEUROSCI, V121, P625, DOI 10.1037/0735-7044.121.3.625; Havlicek J, 2012, PERCEPTION, V41, P1246, DOI 10.1068/p7244; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hines M, 2011, FRONT NEUROENDOCRIN, V32, P170, DOI 10.1016/j.yfrne.2011.02.006; HOCKENBERRY SL, 1987, ARCH SEX BEHAV, V16, P475, DOI 10.1007/BF01541712; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; IBM, 2011, CAT REGR OPT; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Lippa RA, 2006, PSYCHOL SCI, V17, P46, DOI 10.1111/j.1467-9280.2005.01663.x; Lippa RA, 2003, J PERS SOC PSYCHOL, V85, P179, DOI 10.1037/0022-3514.85.1.179; Lippa Richard A., 2005, GENDER NATURE NURTUR, V2nd, DOI 10.4324/9781410612946; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Manning JT., 2002, DIGIT RATIO POINTER; McCarthy MM, 2010, J NEUROENDOCRINOL, V22, P736, DOI 10.1111/j.1365-2826.2010.02021.x; MCCORMICK CM, 1991, PSYCHONEUROENDOCRINO, V16, P459, DOI 10.1016/0306-4530(91)90030-W; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mock SE, 2012, ARCH SEX BEHAV, V41, P641, DOI 10.1007/s10508-011-9761-1; Neave N, 1999, BRAIN COGNITION, V41, P245, DOI 10.1006/brcg.1999.1125; Ostrov JM, 2004, SOC DEV, V13, P255, DOI 10.1111/j.1467-9507.2004.000266.x; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; Peterson ZD, 2010, ARCH SEX BEHAV, V39, P880, DOI 10.1007/s10508-009-9546-y; Rahman Q, 2004, BEHAV NEUROSCI, V118, P243, DOI 10.1037/0735-7044.118.1.243; Rahman Q, 2003, NEUROPSYCHOLOGY, V17, P240, DOI 10.1037/0894-4105.17.2.240; Rahman Q, 2012, ARCH SEX BEHAV, V41, P623, DOI 10.1007/s10508-011-9737-1; Santtila P, 2008, BIOL PSYCHOL, V77, P102, DOI 10.1016/j.biopsycho.2007.08.006; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; SCHLAEPFER TE, 1995, PSYCHIAT RES-NEUROIM, V61, P129, DOI 10.1016/0925-4927(95)02634-A; Sergeant MJT, 2006, PERS INDIV DIFFER, V40, P475, DOI 10.1016/j.paid.2005.07.002; THYSEN B, 1968, STEROIDS, V11, P73, DOI 10.1016/S0039-128X(68)80052-2	57	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80234	10.1371/journal.pone.0080234	http://dx.doi.org/10.1371/journal.pone.0080234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244657	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900069
J	Tabashnik, BE; Fabrick, JA; Unnithan, GC; Yelich, AJ; Masson, L; Zhang, J; Bravo, A; Soberon, M				Tabashnik, Bruce E.; Fabrick, Jeffrey A.; Unnithan, Gopalan C.; Yelich, Alex J.; Masson, Luke; Zhang, Jie; Bravo, Alejandra; Soberon, Mario			Efficacy of Genetically Modified Bt Toxins Alone and in Combinations Against Pink Bollworm Resistant to Cry1Ac and Cry2Ab	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; PECTINOPHORA-GOSSYPIELLA; FIELD-RESISTANCE; LEPIDOPTERA; COTTON; CROPS; POPULATIONS; NOCTUIDAE; TOLERANCE	Evolution of resistance in pests threatens the long-term efficacy of insecticidal proteins from Bacillus thuringiensis (Bt) used in sprays and transgenic crops. Previous work showed that genetically modified Bt toxins Cry1AbMod and Cry1AcMod effectively countered resistance to native Bt toxins Cry1Ab and Cry1Ac in some pests, including pink bollworm (Pectinophora gossypiella). Here we report that Cry1AbMod and Cry1AcMod were also effective against a laboratory-selected strain of pink bollworm resistant to Cry2Ab as well as to Cry1Ab and Cry1Ac. Resistance ratios based on the concentration of toxin killing 50% of larvae for the resistant strain relative to a susceptible strain were 210 for Cry2Ab, 270 for Cry1Ab, and 310 for Cry1Ac, but only 1.6 for Cry1AbMod and 2.1 for Cry1AcMod. To evaluate the interactions among toxins, we tested combinations of Cry1AbMod, Cry1Ac, and Cry2Ab. For both the resistant and susceptible strains, the net results across all concentrations tested showed slight but significant synergism between Cry1AbMod and Cry2Ab, whereas the other combinations of toxins did not show consistent synergism or antagonism. The results suggest that the modified toxins might be useful for controlling populations of pink bollworm resistant to Cry1Ac, Cry2Ab, or both.	[Tabashnik, Bruce E.; Unnithan, Gopalan C.; Yelich, Alex J.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Fabrick, Jeffrey A.] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	University of Arizona; United States Department of Agriculture (USDA); National Research Council Canada; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu	de la Parra, Maria Alejandra Bravo/R-6740-2017	Fabrick, Jeffrey/0000-0002-3893-9545; Bravo, Alejandra/0000-0002-7573-7475	USDA-Agriculture and Food Research Initiative [2008-35302-0390]	USDA-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by USDA-Agriculture and Food Research Initiative Grant 2008-35302-0390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Beard CE, 2008, CURR MICROBIOL, V57, P175, DOI 10.1007/s00284-008-9098-8; Caccia S, 2012, APPL ENVIRON MICROB, V78, P5690, DOI 10.1128/AEM.00523-12; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Chougule NP, 2013, P NATL ACAD SCI USA, V110, P8465, DOI 10.1073/pnas.1222144110; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Finney D, 1971, PROBIT ANAL, P50; Franklin MT, 2009, APPL ENVIRON MICROB, V75, P5739, DOI 10.1128/AEM.00664-09; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Ingram W. R., 1994, P107; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Liu YB, 1998, APPL ENVIRON MICROB, V64, P1385; Liu YB, 2001, J ECON ENTOMOL, V94, P248, DOI 10.1603/0022-0493-94.1.248; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Moar WJ, 2007, SCIENCE, V318, P1561, DOI 10.1126/science.1151313; Munoz-Garay C, 2009, BBA-BIOMEMBRANES, V1788, P2229, DOI 10.1016/j.bbamem.2009.06.014; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; Porta H, 2011, INSECT BIOCHEM MOLEC, V41, P513, DOI 10.1016/j.ibmb.2011.04.013; Sainsbury F, 2012, TOXINS, V4, P455, DOI 10.3390/toxins4060455; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Software Leora, 1987, POLO PC US GUID PROB; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik Bruce E, 2012, GM Crops Food, V3, P194, DOI 10.4161/gmcr.20329; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wirth MC, 1997, P NATL ACAD SCI USA, V94, P10536, DOI 10.1073/pnas.94.20.10536; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	50	45	46	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80496	10.1371/journal.pone.0080496	http://dx.doi.org/10.1371/journal.pone.0080496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244692	gold, Green Submitted, Green Published			2022-12-27	WOS:000327162900082
J	Eldesoqi, K; Seebach, C; Ngoc, CN; Meier, S; Nau, C; Schaible, A; Marzi, I; Henrich, D				Eldesoqi, Karam; Seebach, Caroline; Ngoc, Christina Nguyen; Meier, Simon; Nau, Christoph; Schaible, Alexander; Marzi, Ingo; Henrich, Dirk			High Calcium Bioglass Enhances Differentiation and Survival of Endothelial Progenitor Cells, Inducing Early Vascularization in Critical Size Bone Defects	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; BIOACTIVE GLASS; IN-VITRO; COMPOSITE SCAFFOLDS; STROMAL CELLS; PROMOTES; ANGIOGENESIS; REGENERATION; POLYMER; ACID)	Early vascularization is a prerequisite for successful bone healing and endothelial progenitor cells (EPC), seeded on appropriate biomaterials, can improve vascularization. The type of biomaterial influences EPC function with bioglass evoking a vascularizing response. In this study the influence of a composite biomaterial based on polylactic acid (PLA) and either 20 or 40% bioglass, BG20 and BG40, respectively, on the differentiation and survival of EPCs in vitro was investigated. Subsequently, the effect of the composite material on early vascularization in a rat calvarial critical size defect model with or without EPCs was evaluated. Human EPCs were cultured with beta-TCP, PLA, BG20 or BG40, and seeding efficacy, cell viability, cell morphology and apoptosis were analysed in vitro. BG40 released the most calcium, and improved endothelial differentiation and vitality best. This effect was mimicked by adding an equivalent amount of calcium to the medium and was diminished in the presence of the calcium chelator, EGTA. To analyze the effect of BG40 and EPCs in vivo, a 6-mm diameter critical size calvarial defect was created in rats (n = 12). Controls (n = 6) received BG40 and the treatment group (n = 6) received BG40 seeded with 5610 5 rat EPCs. Vascularization after 1 week was significantly improved when EPCs were seeded onto BG40, compared to implanting BG40 alone. This indicates that Ca2+ release improves EPC differentiation and is useful for enhanced early vascularization in critical size bone defects.	[Eldesoqi, Karam; Seebach, Caroline; Ngoc, Christina Nguyen; Meier, Simon; Nau, Christoph; Schaible, Alexander; Marzi, Ingo; Henrich, Dirk] Hosp Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Seebach, C (corresponding author), Hosp Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	caroline.seebach@kgu.de		Eldesoqi, Karam/0000-0001-5565-2565	DAAD [A109234]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by DAAD (grant # A109234), https://www.daad.de/de/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Arkudas A, 2007, TISSUE ENG, V13, P1549, DOI 10.1089/ten.2006.0387; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Dorozhkin SV, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-1; Doyle B, 2006, ENDOTHELIUM-J ENDOTH, V13, P403, DOI 10.1080/10623320601061656; Fan X, 2010, POLYM-PLAST TECHNOL, V49, P309, DOI 10.1080/03602550903284255; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Gehling UM, 2000, BLOOD, V95, P3106; Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]; He ZQ, 2009, POLYM-PLAST TECHNOL, V48, P1020, DOI 10.1080/03602550903092534; Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50; Henrich D, 2009, TISSUE ENG PART C-ME, V15, P551, DOI [10.1089/ten.tec.2008.0385, 10.1089/ten.TEC.2008.0385]; Henrich D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/364591; Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007; Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542; Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9; Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836; Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783; Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339; Leu A, 2008, PHARM RES-DORDR, V25, P1222, DOI 10.1007/s11095-007-9508-9; Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018; Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371; Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035; Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013; Lu HH, 2005, BIOMATERIALS, V26, P6323, DOI 10.1016/j.biomaterials.2005.04.005; Niemela T, 2008, ACTA BIOMATER, V4, P156, DOI 10.1016/j.actbio.2007.06.007; Oki A, 2006, MATER LETT, V60, P1; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Sander AL, 2011, J SURG RES, V165, P165, DOI 10.1016/j.jss.2009.07.003; Schultheiss J, 2011, EUR J TRAUMA EMERG S, V37, P635, DOI 10.1007/s00068-011-0119-0; Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Vila OF, 2013, J BIOMED MATER RES A, V101, P932, DOI 10.1002/jbm.a.34391; Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068; Zhang SJ, 2007, STEM CELLS DEV, V16, P683, DOI 10.1089/scd.2006.0062; Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075; Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X	49	29	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79058	10.1371/journal.pone.0079058	http://dx.doi.org/10.1371/journal.pone.0079058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244419	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800024
J	Li, J; Zhou, X; Huang, L; Fu, X; Liu, J; Zhang, XW; Sun, YY; Zuo, MX				Li, Jie; Zhou, Xin; Huang, Li; Fu, Xin; Liu, Jin; Zhang, Xinwen; Sun, Yingyu; Zuo, Mingxue			Alteration of CaBP Expression Pattern in the Nucleus Magnocellularis following Unilateral Cochlear Ablation in Adult Zebra Finches	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; CALCIUM-BINDING PROTEINS; LATERAL LEMNISCAL NUCLEI; BENGALESE FINCHES; NEURON NUMBER; BARN OWL; CALRETININ IMMUNOREACTIVITY; AFFERENT INFLUENCES; CALBINDIN D-28K; DEVELOPING RATS	Songbirds have the rare ability of auditory-vocal learning and maintenance. Up to now, the organization and function of the nucleus magnocellularis (NM), the first relay of the avian ascending auditory pathway is largely based on studies in non-vocal learning species, such as chickens and owls. To investigate whether NM exhibits different histochemical properties associated with auditory processing in songbirds, we examined the expression patterns of three calcium-binding proteins (CaBPs), including calretinin (CR), parvalbumin (PV) and calbindin-D28k (CB), and their relations to auditory inputs in NM in adult zebra finches. We found enriched and co-localized immunostaining of CR, PV and CB in the majority of NM neurons, without neuronal population preference. Furthermore, they were sensitive to adult deafferentation with differential plasticity patterns. After unilateral cochlear removal, CR staining in the ipsilateral NM decreased appreciably at 3 days after surgery, and continued to decline thereafter. PV staining showed down-regulation first at 3 days, but subsequently recovered slightly. CB staining did not significantly decrease until 7 days after surgery. Our findings suggest that the three CaBPs might play distinct roles in association with auditory processing in zebra finches. These results are in contrast to the findings in the NM of chickens where CR is the predominant CaBP and deafferentation had no apparent effect on its expression. Further extended studies in other avian species are required to establish whether the difference in CaBP patterns in NM is functionally related to the different auditory-vocal behaviors.	[Li, Jie; Zhou, Xin; Fu, Xin; Liu, Jin; Sun, Yingyu; Zuo, Mingxue] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Li; Zhang, Xinwen] Hainan Normal Univ, Dept Biol, Haikou, Peoples R China	Beijing Normal University; Hainan Normal University	Sun, YY (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Coll Life Sci, Beijing 100875, Peoples R China.	sunyingyu@bnu.edu.cn			 [30970360];  [30870307];  [31071923];  [30860087]	; ; ; 	Yingyu Sun (grant 30970360), Mingxue Zuo (grant 30870307 and 31071923) and Xinwen Zhang (grant 30860087). [http://www.nsfc.gov.cn] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Alvarado JC, 2005, NEUROSCIENCE, V136, P957, DOI 10.1016/j.neuroscience.2005.04.022; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Belekhova M G, 2008, Zh Evol Biokhim Fiziol, V44, P302; BORN DE, 1991, BRAIN RES, V557, P37, DOI 10.1016/0006-8993(91)90113-A; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; BRAUN K, 1990, PROG HISTOCHEM CYTOC, V21, pU1; Caicedo A, 1996, ANAT EMBRYOL, V194, P465; Caicedo A, 1997, J COMP NEUROL, V378, P1, DOI 10.1002/(SICI)1096-9861(19970203)378:1<1::AID-CNE1>3.0.CO;2-8; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; CARR CE, 1990, J NEUROSCI, V10, P3227; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chudinova TV, 2012, BRAIN RES, V1473, P87, DOI 10.1016/j.brainres.2012.07.022; Couchman K, 2010, J NEUROSCI, V30, P17111, DOI 10.1523/JNEUROSCI.1760-10.2010; Edmonds JL, 1999, HEARING RES, V127, P62, DOI 10.1016/S0378-5955(98)00180-4; Forster CR, 2000, J COMP NEUROL, V416, P173, DOI 10.1002/(SICI)1096-9861(20000110)416:2<173::AID-CNE4>3.0.CO;2-V; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; FRISINA RD, 1995, HEARING RES, V85, P53, DOI 10.1016/0378-5955(95)00029-4; Fuentes-Santamaria V, 2005, J COMP NEUROL, V483, P458, DOI 10.1002/cne.20437; Fukui I, 2004, J NEUROSCI, V24, P7514, DOI 10.1523/JNEUROSCI.0566-04.2004; Garcia-Calero E, 2013, J COMP NEUROL, V521, P326, DOI 10.1002/cne.23174; Harris JA, 2006, HEARING RES, V216, P127, DOI 10.1016/j.heares.2006.03.016; HASHISAKI GT, 1989, J COMP NEUROL, V283, P465, DOI 10.1002/cne.902830402; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2135, DOI 10.1002/cne.22324; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2109, DOI 10.1002/cne.22334; Kubke MF, 1999, J COMP NEUROL, V415, P189, DOI 10.1002/(SICI)1096-9861(19991213)415:2<189::AID-CNE4>3.0.CO;2-E; Kubke MF, 2002, HEARING RES, V164, P19, DOI 10.1016/S0378-5955(01)00387-2; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Logerot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020686; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; MARLER P, 1977, J COMP PHYSIOL PSYCH, V91, P8, DOI 10.1037/h0077303; Monsivais P, 2000, J NEUROSCI, V20, P2954; MOORE DR, 1990, J COMP NEUROL, V302, P810, DOI 10.1002/cne.903020412; Mostafapour SP, 2000, J COMP NEUROL, V426, P561, DOI 10.1002/1096-9861(20001030)426:4<561::AID-CNE5>3.0.CO;2-G; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Okanoya K, 1997, J NEUROBIOL, V33, P343; Park DL, 1998, HEARING RES, V126, P84, DOI 10.1016/S0378-5955(98)00157-9; Parks TN, 1997, J COMP NEUROL, V383, P112; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Pinaud R, 2007, J CHEM NEUROANAT, V34, P1, DOI 10.1016/j.jchemneu.2007.03.005; Por A, 2005, BRAIN RES, V1039, P63, DOI 10.1016/j.brainres.2005.01.057; ROGERS JH, 1989, NEUROSCIENCE, V31, P697, DOI 10.1016/0306-4522(89)90434-X; RUBEL EW, 1990, J NEUROBIOL, V21, P169, DOI 10.1002/neu.480210112; Smittkamp SE, 2005, HEARING RES, V204, P48, DOI 10.1016/j.heares.2004.12.011; Smittkamp SE, 2003, HEARING RES, V175, P101, DOI 10.1016/S0378-5955(02)00714-1; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Stack KE, 2000, BRAIN RES, V873, P135, DOI 10.1016/S0006-8993(00)02476-8; SULLIVAN WE, 1984, J NEUROSCI, V4, P1787; Teramitsu I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008548; Tierney TS, 1997, J COMP NEUROL, V387, P421; Tschida KA, 2012, NEURON, V73, P1028, DOI 10.1016/j.neuron.2011.12.038; VATER M, 1994, J COMP NEUROL, V341, P534, DOI 10.1002/cne.903410409; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Wild JM, 2010, J COMP NEUROL, V518, P2149, DOI 10.1002/cne.22325; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WINSKY L, 1995, J COMP NEUROL, V354, P564, DOI 10.1002/cne.903540407; Woolley SMN, 2004, ANN NY ACAD SCI, V1016, P208, DOI 10.1196/annals.1298.017; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Woolley SMN, 2002, J NEUROSCI, V22, P7774; Woolley SMN, 1999, J NEUROSCI, V19, P358, DOI 10.1523/JNEUROSCI.19-01-00358.1999; Yan K, 2010, J COMP NEUROL, V518, P3409, DOI 10.1002/cne.22428	68	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79297	10.1371/journal.pone.0079297	http://dx.doi.org/10.1371/journal.pone.0079297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244471	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800057
J	Mias, C; Coatrieux, C; Denis, C; Genet, G; Seguelas, MH; Laplace, N; Rouzaud-Laborde, C; Calise, D; Parini, A; Cussac, D; Pathak, A; Senard, JM; Gales, C				Mias, Celine; Coatrieux, Christelle; Denis, Colette; Genet, Gaeel; Seguelas, Marie-Helene; Laplace, Nathalie; Rouzaud-Laborde, Charlotte; Calise, Denis; Parini, Angelo; Cussac, Daniel; Pathak, Atul; Senard, Jean-Michel; Gales, Celine			Cardiac Fibroblasts Regulate Sympathetic Nerve Sprouting and Neurocardiac Synapse Stability	PLOS ONE			English	Article							GROWTH-FACTOR SYNTHESIS; MYOCARDIAL-INFARCTION; HEART-FAILURE; CELL; MECHANISMS; EXPRESSION; SURVIVAL; SYSTEM; NGF; NEUROTROPHINS	Sympathetic nervous system (SNS) plays a key role in cardiac homeostasis and its deregulations always associate with bad clinical outcomes. To date, little is known about molecular mechanisms regulating cardiac sympathetic innervation. The aim of the study was to determine the role of fibroblasts in heart sympathetic innervation. RT-qPCR and western-blots analysis performed in cardiomyocytes and fibroblasts isolated from healthy adult rat hearts revealed that Pro-Nerve growth factor (NGF) and pro-differentiating mature NGF were the most abundant neurotrophins expressed in cardiac fibroblasts while barely detectable in cardiomyocytes. When cultured with cardiac fibroblasts or fibroblast-conditioned medium, PC12 cells differentiated into/sympathetic-like neurons expressing axonal marker Tau-1 at neurites in contact with cardiomyocytes. This was prevented by anti-NGF blocking antibodies suggesting a paracrine action of NGF secreted by fibroblasts. When co-cultured with cardiomyocytes to mimic neurocardiac synapse, differentiated PC12 cells exhibited enhanced norepinephrine secretion as quantified by HPLC compared to PC12 cultured alone while co-culture with fibroblasts had no effect. However, when supplemented to PC12-cardiomyocytes co-culture, fibroblasts allowed long-term survival of the neurocardiac synapse. Activated fibroblasts (myofibroblasts) isolated from myocardial infarction rat hearts exhibited significantly higher mature NGF expression than normal fibroblasts and also promoted PC12 cells differentiation. Within the ischemic area lacking cardiomyocytes and neurocardiac synapses, tyrosine hydroxylase immunoreactivity was increased and associated with local anarchical and immature sympathetic hyperinnervation but tissue norepinephrine content was similar to that of normal cardiac tissue, suggesting depressed sympathetic function. Collectively, these findings demonstrate for the first time that fibroblasts are essential for the setting of cardiac sympathetic innervation and neurocardiac synapse stability. They also suggest that neurocardiac synapse functionality relies on a triptych with tight interaction between sympathetic nerve endings, cardiomyocytes and fibroblasts. Deregulations of this triptych may be involved in pathophysiology of cardiac diseases.	[Mias, Celine; Coatrieux, Christelle; Denis, Colette; Genet, Gaeel; Seguelas, Marie-Helene; Rouzaud-Laborde, Charlotte; Parini, Angelo; Cussac, Daniel; Pathak, Atul; Senard, Jean-Michel; Gales, Celine] Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc, U1048, F-31062 Toulouse, France; [Calise, Denis] Inst Natl Sante & Rech Med, Dept Microsurg, UMS006, Toulouse, France; [Laplace, Nathalie; Pathak, Atul; Senard, Jean-Michel] Ctr Hosp Univ Toulouse, Dept Pharmacol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Gales, C (corresponding author), Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc, U1048, F-31062 Toulouse, France.	celine.gales@inserm.fr	Denis, Colette/U-5267-2017; Pathak, Atul/ABC-5223-2020; Cussac, Daniel/AAP-1544-2020; Denis, Colette/K-1571-2019	Pathak, Atul/0000-0001-6151-0096; Denis, Colette/0000-0002-8376-8351; Mias, Celine/0000-0001-8055-8255; GENET, Gael/0000-0003-0016-5887; Senard, Jean-Michel/0000-0001-7679-1281; Cussac, Daniel/0000-0002-7227-898X; Parini, Angelo/0000-0002-9848-8838; GALES, Celine/0000-0002-4938-1583	Societe Francaise d'Hypertension Arterielle (SFHTA)	Societe Francaise d'Hypertension Arterielle (SFHTA)	This work was supported by grant from Societe Francaise d'Hypertension Arterielle (SFHTA) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2001, J MOL CELL CARDIOL, V33, P461, DOI 10.1006/jmcc.2000.1319; BAKHIT C, 1991, BRAIN RES, V560, P76, DOI 10.1016/0006-8993(91)91217-O; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; El-Helou V, 2008, J APPL PHYSIOL, V104, P150, DOI 10.1152/japplphysiol.00663.2007; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Esler M, 2010, J APPL PHYSIOL, V108, P227, DOI 10.1152/japplphysiol.00832.2009; Fanciulli A, 2013, EUR J NEUROL; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; FURUKAWA S, 1990, CEREBROVAS BRAIN MET, V2, P328; FURUKAWA Y, 1986, J BIOL CHEM, V261, P6039; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hasan W, 2006, BRAIN RES, V1124, P142, DOI 10.1016/j.brainres.2006.09.054; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; Hiltunen JO, 2001, J PATHOL, V194, P247, DOI 10.1002/path.878; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Ieda M, 2008, CURR MED CHEM, V15, P1731, DOI 10.2174/092986708784872339; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Kimura K, 2007, CIRC RES, V100, P1755, DOI 10.1161/01.RES.0000269828.62250.ab; Kimura K, 2012, CIRC RES, V110, P325, DOI 10.1161/CIRCRESAHA.111.257253; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LANGER A, 1995, J AM COLL CARDIOL, V25, P610, DOI 10.1016/0735-1097(94)00459-4; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorentz CU, 2011, AUTON NEUROSCI-BASIC, V164, P13, DOI 10.1016/j.autneu.2011.05.002; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Maule S, 2006, AM J HYPERTENS, V19, P1049, DOI 10.1016/j.amjhyper.2006.02.016; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Parrish DC, 2010, EXP PHYSIOL, V95, P304, DOI 10.1113/expphysiol.2009.049965; Pelat M, 2002, J HYPERTENS, V20, P957, DOI 10.1097/00004872-200205000-00031; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; SCHWARTZ JP, 1980, P NATL ACAD SCI-BIOL, V77, P1154, DOI 10.1073/pnas.77.2.1154; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Wernli G, 2009, BASIC RES CARDIOL, V104, P681, DOI 10.1007/s00395-009-0033-3; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	49	15	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79068	10.1371/journal.pone.0079068	http://dx.doi.org/10.1371/journal.pone.0079068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244423	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800025
J	van der Groen, O; van der Burg, E; Lunghi, C; Alais, D				van der Groen, Onno; van der Burg, Erik; Lunghi, Claudia; Alais, David			Touch Influences Visual Perception with a Tight Orientation-Tuning	PLOS ONE			English	Article							SPATIAL-FREQUENCY; RECEPTIVE-FIELDS; SIMPLE CELLS; CORTEX; ACTIVATION; ATTENTION; SELECTIVITY; VISION; AREAS; ORGANIZATION	Stimuli from different sensory modalities are thought to be processed initially in distinct unisensory brain areas prior to convergence in multisensory areas. However, signals in one modality can influence the processing of signals from other modalities and recent studies suggest this cross-modal influence may occur early on, even in 'unisensory' areas. Some recent psychophysical studies have shown specific cross-modal effects between touch and vision during binocular rivalry, but these cannot completely rule out a response bias. To test for genuine cross-modal integration of haptic and visual signals, we investigated whether congruent haptic input could influence visual contrast sensitivity compared to incongruent haptic input in three psychophysical experiments using a two-interval, two-alternative forced-choice method to eliminate response bias. The initial experiment demonstrated that contrast thresholds for a visual grating were lower when exploring a haptic grating that shared the same orientation compared to an orthogonal orientation. Two subsequent experiments mapped the orientation and spatial frequency tunings for the congruent haptic facilitation of vision, finding a clear orientation tuning effect but not a spatial frequency tuning. In addition to an increased contrast sensitivity for iso-oriented visual-haptic gratings, we found a significant loss of sensitivity for orthogonally oriented visual-haptic gratings. We conclude that the tactile influence on vision is a result of a tactile input to orientation-tuned visual areas.	[van der Groen, Onno] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van der Burg, Erik; Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Lunghi, Claudia] Univ Florence, Dept Neurosci Psychol Pharmacol & Child Hlth, Florence, Italy; [Lunghi, Claudia] Natl Res Council CNR, Inst Neurosci, Pisa, Italy	Vrije Universiteit Amsterdam; University of Sydney; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	van der Groen, O (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	vandergroen@gmail.com	van der Groen, Onno/B-1858-2017; Lunghi, Claudia/C-7274-2014	van der Groen, Onno/0000-0002-4509-7518; Lunghi, Claudia/0000-0003-3811-5404	Australian Research Council [DP12101474, DP130102336]; Discovery Early Career Research Award [DE130101663]; Italian Ministry of Universities and Research (PRIN); EC project "STANIB" (FP7 ERC)	Australian Research Council(Australian Research Council); Discovery Early Career Research Award(Australian Research Council); Italian Ministry of Universities and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EC project "STANIB" (FP7 ERC)	This research was funded by the Australian Research Council, grant number DP12101474, and Australian Research Council, Discovery Project (DP130102336) to DA, Discovery Early Career Research Award (DE130101663) to EVdB, and the Italian Ministry of Universities and Research (PRIN2009) and by EC project "STANIB" (FP7 ERC) supporting CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2011, J NEUROPHYSIOL, V106, P2108, DOI 10.1152/jn.00540.2011; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2003, J NEUROSCI, V23, P4005; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Falchier A, 2002, J NEUROSCI, V22, P5749; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fu KMG, 2003, J NEUROSCI, V23, P7510; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Graham NVS, 2001, VISUAL PATTERN ANAL; HUBEL D. H., 1962, J PHYSL, V160; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kleiner M, 2007, PERCEPTION, V36, P14; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Lunghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058754; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Melzer P, 2001, HUM BRAIN MAPP, V14, P186, DOI 10.1002/hbm.1051; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Mohr HM, 2009, NEUROIMAGE, V47, P384, DOI 10.1016/j.neuroimage.2009.03.045; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nasr S, 2012, J NEUROSCI, V32, P14921, DOI 10.1523/JNEUROSCI.2036-12.2012; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 1997, NEUROREPORT, P8; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Taylor-Clarke M, 2004, NEUROSCI LETT, V354, P22, DOI 10.1016/j.neulet.2003.09.068; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Van der Burg E, 2008, J EXPT PSYCHOL HUMAN, V34; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025277; Woodhead ZVJ, 2011, CEREB CORTEX, V21, P2307, DOI 10.1093/cercor/bhr008; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	69	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79558	10.1371/journal.pone.0079558	http://dx.doi.org/10.1371/journal.pone.0079558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244523	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800091
J	Wang, HY; Wen, JG; Chang, CC; Zhou, XB				Wang, Hongyan; Wen, Jianguo; Chang, Chung-che; Zhou, Xiaobo			Discovering Transcription and Splicing Networks in Myelodysplastic Syndromes	PLOS ONE			English	Article							GENE-EXPRESSION; SR PROTEINS; DATABASE; MUTATIONS; PATHWAY; TARGET; COEXPRESSION; REGRESSION; FAMILY; GROWTH	More and more transcription factors and their motifs have been reported and linked to specific gene expression levels. However, focusing only on transcription is not sufficient for mechanism research. Most genes, especially in eukaryotes, are alternatively spliced to different isoforms. Some of these isoforms increase the biodiversity of proteins. From this viewpoint, transcription and splicing are two of important mechanisms to modulate expression levels of isoforms. To integrate these two kinds of regulation, we built a linear regression model to select a subset of transcription factors and splicing factors for each co-expressed isoforms using least-angle regression approach. Then, we applied this method to investigate the mechanism of myelodysplastic syndromes (MDS), a precursor lesion of acute myeloid leukemia. Results suggested that expression levels of most isoforms were regulated by a set of selected regulatory factors. Some of the detected factors, such as EGR1 and STAT family, are highly correlated with progression of MDS. We discovered that the splicing factor SRSF11 experienced alternative splicing switch, and in turn induced different amino acid sequences between MDS and controls. This splicing switch causes two different splicing mechanisms. Polymerase Chain Reaction experiments also confirmed that one of its isoforms was over-expressed in MDS. We analyzed the regulatory networks constructed from the co-expressed isoforms and their regulatory factors in MDS. Many of these networks were enriched in the herpes simplex infection pathway which involves many splicing factors, and pathways in cancers and acute or chronic myeloid leukemia.	[Wang, Hongyan; Zhou, Xiaobo] Wake Forest Univ, Ctr Bioinformat & Syst Biol, Div Radiol Sci, Baptist Med Ctr, Winston Salem, NC 27109 USA; [Wen, Jianguo] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA; [Chang, Chung-che] Univ Cent Florida, Dept Pathol, Orlando, FL 32816 USA	Wake Forest University; Wake Forest Baptist Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; State University System of Florida; University of Central Florida	Zhou, XB (corresponding author), Wake Forest Univ, Ctr Bioinformat & Syst Biol, Div Radiol Sci, Baptist Med Ctr, Winston Salem, NC 27109 USA.	Xizhou@wakehealth.edu	shi, zhensheng/GXN-3967-2022		NIH [5R01LM010185-04]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is partially funded by grants from the NIH 5R01LM010185-04 (Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Estey E, 1997, BLOOD, V90, P2969, DOI 10.1182/blood.V90.8.2969; Fischer DC, 2004, ONCOL REP, V11, P1085; Follo MY, 2007, CANCER RES, V67, P4287, DOI 10.1158/0008-5472.CAN-06-4409; Froehlich H, 2012, GOSIM COMPUTATION FU; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Harris N L, 2000, Hematol J, V1, P53, DOI 10.1038/sj.thj.6200013; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ingram JL, 2006, J IMMUNOL, V177, P4141, DOI 10.4049/jimmunol.177.6.4141; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lorkovic Z. J., 2012, RNA BINDING PROTEINS; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609; Riva A, 2012, NUCLEIC ACIDS RES, V40, pD155, DOI 10.1093/nar/gkr1080; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Song LL, 2008, MOL CANCER RES, V6, P1732, DOI 10.1158/1541-7786.MCR-08-0208; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tang ZZ, 2011, J BIOL CHEM, V286, P10007, DOI 10.1074/jbc.M110.208116; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; WANG J, 1995, RNA, V1, P335; Wen JG, 2011, MOL CANCER THER, V10, P148, DOI 10.1158/1535-7163.MCT-10-0829; Yang SZ, 2006, J CELL BIOCHEM, V97, P1292, DOI 10.1002/jcb.20736; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	52	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79118	10.1371/journal.pone.0079118	http://dx.doi.org/10.1371/journal.pone.0079118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244432	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800031
J	Wegerer, M; Blechert, J; Kerschbaum, H; Wilhelm, FH				Wegerer, Melanie; Blechert, Jens; Kerschbaum, Hubert; Wilhelm, Frank H.			Relationship between Fear Conditionability and Aversive Memories: Evidence from a Novel Conditioned-Intrusion Paradigm	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANXIETY DISORDERS; VIRTUAL-REALITY; PANIC DISORDER; EXTINCTION; RESPONSES; TRAUMA; MECHANISMS; HUMANS; METAANALYSIS	Intrusive memories - a hallmark symptom of posttraumatic stress disorder (PTSD) - are often triggered by stimuli possessing similarity with cues that predicted or accompanied the traumatic event. According to learning theories, intrusive memories can be seen as a conditioned response to trauma reminders. However, direct laboratory evidence for the link between fear conditionability and intrusive memories is missing. Furthermore, fear conditioning studies have predominantly relied on standardized aversive stimuli (e.g. electric stimulation) that bear little resemblance to typical traumatic events. To investigate the general relationship between fear conditionability and aversive memories, we tested 66 mentally healthy females in a novel conditioned-intrusion paradigm designed to model real-life traumatic experiences. The paradigm included a differential fear conditioning procedure with neutral sounds as conditioned stimuli and short violent film clips as unconditioned stimuli. Subsequent aversive memories were assessed through a memory triggering task (within 30 minutes, in the laboratory) and ambulatory assessment (involuntary aversive memories in the 2 days following the experiment). Skin conductance responses and subjective ratings demonstrated successful differential conditioning indicating that naturalistic aversive film stimuli can be used in a fear conditioning experiment. Furthermore, aversive memories were elicited in response to the conditioned stimuli during the memory triggering task and also occurred in the 2 days following the experiment. Importantly, participants who displayed higher conditionability showed more aversive memories during the memory triggering task and during ambulatory assessment. This suggests that fear conditioning constitutes an important source of persistent aversive memories. Implications for PTSD and its treatment are discussed.	[Wegerer, Melanie; Blechert, Jens; Wilhelm, Frank H.] Salzburg Univ, Dept Psychol, Div Clin Psychol Psychotherapy & Hlth Psychol, A-5020 Salzburg, Austria; [Kerschbaum, Hubert] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Wegerer, M (corresponding author), Salzburg Univ, Dept Psychol, Div Clin Psychol Psychotherapy & Hlth Psychol, A-5020 Salzburg, Austria.	melanie.wegerer@sbg.ac.at	Blechert, Jens/X-4040-2019; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018	Blechert, Jens/0000-0002-3820-109X; Wilhelm, Frank H./0000-0002-4414-7085	Doctoral College "Imaging the Mind" by the Austrian Science Fund [FWF-W1233]	Doctoral College "Imaging the Mind" by the Austrian Science Fund	The first author was financially supported by the Doctoral College "Imaging the Mind" by the Austrian Science Fund (FWF-W1233), http:\\www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; APA, 1994, DIAGN STAT MAN MENT; Baas JM, 2004, BIOL PSYCHIAT, V55, P1056, DOI 10.1016/j.biopsych.2004.02.024; BAEYENS F, 1989, BEHAV RES THER, V27, P279, DOI 10.1016/0005-7967(89)90047-8; BAEYENS F, 1988, ADV BEHAV RES THER, V10, P179, DOI 10.1016/0146-6402(88)90014-8; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Blechert J, 2008, LEARN MOTIV, V39, P58, DOI 10.1016/j.lmot.2007.03.003; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; de Jong PJ, 2000, BEHAV RES THER, V38, P1055, DOI 10.1016/S0005-7967(99)00135-7; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Dunsmoor JE, 2011, NEUROIMAGE, V55, P1878, DOI 10.1016/j.neuroimage.2011.01.041; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 2002, BEHAV RES THER, V40, P995, DOI 10.1016/S0005-7967(01)00077-8; Ehlers A, 2012, J BEHAV THER EXP PSY, V43, pS67, DOI 10.1016/j.jbtep.2010.12.009; Ehlers A, 2010, Z PSYCHOL, V218, P141, DOI 10.1027/0044-3409/a000021; Ehring T, 2009, BEHAV THER, V40, P403, DOI 10.1016/j.beth.2008.10.001; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Graham BM, 2011, AM J PSYCHIAT, V168, P1255, DOI 10.1176/appi.ajp.2011.11040557; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Huff NC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00075; Kerkhof I, 2011, EXP PSYCHOL, V58, P31, DOI 10.1027/1618-3169/a000063; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Lau JYF, 2008, J AM ACAD CHILD PSY, V47, P94, DOI 10.1097/chi.0b01e31815a5f01; Laux L., 1981, STATE TRAIT ANGSTINV; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513; Lissek S, 2012, DEPRESS ANXIETY, V29, P257, DOI 10.1002/da.21922; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lommen MJJ, 2013, BEHAV RES THER, V51, P63, DOI 10.1016/j.brat.2012.11.004; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Maercker A, 1998, DIAGNOSTICA, V44, P130; McNally RJ, 2007, CLIN PSYCHOL REV, V27, P750, DOI 10.1016/j.cpr.2007.01.003; Michael T, 2007, J ABNORM PSYCHOL, V116, P612, DOI 10.1037/0021-843X.116.3.612; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pejic T, 2011, SOC COGN AFFECT NEUR, DOI [10.1093/scan/nsr1095., DOI 10.1093/SCAN/NSR1095]; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Reemtsma J. P., 1997, KELLER; Rottenberg J., 2007, HDB EMOTION ELICITAT; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Suendermann O, 2010, PSYCHOSOM MED, V72, P301, DOI 10.1097/PSY.0b013e3181d07db8; Wegerer M, 2013, Z PSYCHIATR PSYCH PS, V61, P93, DOI 10.1024/1661-4747/a000146; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilhelm FH., 2005, ANSLAB AUTONOMIC NER; Wilhelm FH, 2010, BIOL PSYCHOL, V84, P552, DOI 10.1016/j.biopsycho.2010.01.017; Zetsche U, 2009, J BEHAV THER EXP PSY, V40, P499, DOI 10.1016/j.jbtep.2009.07.001	66	53	54	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79025	10.1371/journal.pone.0079025	http://dx.doi.org/10.1371/journal.pone.0079025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244407	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800022
J	Zhao, M; Zhao, ZM				Zhao, Min; Zhao, Zhongming			CNVannotator: A Comprehensive Annotation Server for Copy Number Variation in the Human Genome	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; VARIANTS; CANCER; DATABASE; FEATURES; CATALOG; LOCI	Copy number variation (CNV) is one of the most prevalent genetic variations in the genome, leading to an abnormal number of copies of moderate to large genomic regions. High-throughput technologies such as next-generation sequencing often identify thousands of CNVs involved in biological or pathological processes. Despite the growing demand to filter and classify CNVs by factors such as frequency in population, biological features, and function, surprisingly, no online web server for CNV annotations has been made available to the research community. Here, we present CNVannotator, a web server that accepts an input set of human genomic positions in a user-friendly tabular format. CNVannotator can perform genomic overlaps of the input coordinates using various functional features, including a list of the reported 356,817 common CNVs, 181,261 disease CNVs, as well as, 140,342 SNPs from genome-wide association studies. In addition, CNVannotator incorporates 2,211,468 genomic features, including ENCODE regulatory elements, cytoband, segmental duplication, genome fragile site, pseudogene, promoter, enhancer, CpG island, and methylation site. For cancer research community users, CNVannotator can apply various filters to retrieve a subgroup of CNVs pinpointed in hundreds of tumor suppressor genes and oncogenes. In total, 5,277,234 unique genomic coordinates with functional features are available to generate an output in a plain text format that is free to download. In summary, we provide a comprehensive web resource for human CNVs. The annotated results along with the server can be accessed at http://bioinfo.mc.vanderbilt.edu/CNVannotator/.	[Zhao, Min; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, ZM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Zhao, Min/J-6588-2019	Zhao, Min/0000-0001-5498-3434	National Institutes of Health [R01LM011177, R21HG006037, R03CA167695, P30CA68485, P50CA095103]; NATIONAL CANCER INSTITUTE [R03CA167695, P50CA095103, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006037] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by grants from National Institutes of Health (R01LM011177, R21HG006037, R03CA167695, P30CA68485, and P50CA095103), The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (to ZZ), and Ingram Professorship Funds (to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buysse K, 2009, EUR J MED GENET, V52, P398, DOI 10.1016/j.ejmg.2009.09.002; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chen WX, 2013, GENOMICS, V102, P27, DOI 10.1016/j.ygeno.2013.02.003; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gai XW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-74; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jia PL, 2013, GENOME RES, V23, P1434, DOI 10.1101/gr.152322.112; Jia PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017162; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Ledet EM, 2013, PROSTATE, V73, P614, DOI 10.1002/pros.22602; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qiu FJ, 2012, HUM MUTAT, V33, pE2375, DOI 10.1002/humu.22163; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rodriguez-Revenga L, 2007, GENET MED, V9, P600, DOI 10.1097/GIM.0b013e318149e1e3; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Southard AE, 2012, PEDIATRICS, V129, P755, DOI 10.1542/peds.2011-2337; Vandeweyer G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-4; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao M, 2013, MOL BIOSYST, V9, P3187, DOI 10.1039/c3mb70172g; Zhao M, 2012, IEEE INT WORK GENOM, P101, DOI 10.1109/GENSIPS.2012.6507738; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044175	47	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80170	10.1371/journal.pone.0080170	http://dx.doi.org/10.1371/journal.pone.0080170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244640	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800130
J	Abou Ammar, G; Tryono, R; Doll, K; Karlovsky, P; Deising, HB; Wirsel, SGR				Abou Ammar, Ghada; Tryono, Reno; Doell, Katharina; Karlovsky, Petr; Deising, Holger B.; Wirsel, Stefan G. R.			Identification of ABC Transporter Genes of Fusarium graminearum with Roles in Azole Tolerance and/or Virulence	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; MULTIDRUG-RESISTANCE; HEAD BLIGHT; BOTRYTIS-CINEREA; MYCOSPHAERELLA-GRAMINICOLA; CULTIVAR RESISTANCE; GIBBERELLA-ZEAE; WHEAT; FUNGICIDE; SENSITIVITY	Fusarium graminearum is a plant pathogen infecting several important cereals, resulting in substantial yield losses and mycotoxin contamination of the grain. Triazole fungicides are used to control diseases caused by this fungus on a worldwide scale. Our previous microarray study indicated that 15 ABC transporter genes were transcriptionally upregulated in response to tebuconazole treatment. Here, we deleted four ABC transporter genes in two genetic backgrounds of F. graminearum representing the DON (deoxynivalenol) and the NIV (nivalenol) trichothecene chemotypes. Deletion of FgABC3 and FgABC4 belonging to group I of ABC-G and to group V of ABC-C subfamilies of ABC transporters, respectively, considerably increased the sensitivity to the class I sterol biosynthesis inhibitors triazoles and fenarimol. Such effects were specific since they did not occur with any other fungicide class tested. Assessing the contribution of the four ABC transporters to virulence of F. graminearum revealed that, irrespective of their chemotypes, deletion mutants of FgABC1 (ABC-C subfamily group V) and FgABC3 were impeded in virulence on wheat, barley and maize. Phylogenetic context and analyses of mycotoxin production suggests that FgABC3 may encode a transporter protecting the fungus from host-derived antifungal molecules. In contrast, FgABC1 may encode a transporter responsible for the secretion of fungal secondary metabolites alleviating defence of the host. Our results show that ABC transporters play important and diverse roles in both fungicide resistance and pathogenesis of F. graminearum.	[Abou Ammar, Ghada; Tryono, Reno; Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Doell, Katharina; Karlovsky, Petr] Univ Gottingen, Mol Phytopathol & Mycotoxin Res Sect, D-37073 Gottingen, Germany; [Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Interdisziplinares Zentrum Nutzpflanzenforsch, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; University of Gottingen; Martin Luther University Halle Wittenberg	Wirsel, SGR (corresponding author), Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	stefan.wirsel@landw.uni-halle.de		Deising, Holger Bruno/0000-0001-5789-4269; Wirsel, Stefan/0000-0003-2043-9494; Karlovsky, Petr/0000-0002-6532-5856	Islamic Development Bank [57/SYR/P29]; Deutscher Akademischer Austauschdienst [A/09/75891]; Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN)	Islamic Development Bank(Islamic Development Bank); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN)	This work was supported by stipends provided by the Islamic Development Bank (GAA, 57/SYR/P29) and the Deutscher Akademischer Austauschdienst (RT, A/09/75891). The work received additional support from the Interdisciplinary Center for Crop Plant Research (Interdisziplinares Zentrum fur Nutzpflanzenforschung, IZN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo TO, 2007, FOOD ADDIT CONTAM, V24, P993, DOI 10.1080/02652030701317285; Adejumo TO, 2007, INT J FOOD MICROBIOL, V116, P350, DOI 10.1016/j.ijfoodmicro.2007.02.009; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Becher R, 2013, MYCOTA IN PRESS, DOI [10.1007/1978-1003-1642-36821-36829_36828, DOI 10.1007/1978-1003-1642-36821-36829_36828]; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Becher R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-52; Becher R, 2010, PHYTOPATHOLOGY, V100, P444, DOI 10.1094/PHYTO-100-5-0444; Blandino M, 2012, FIELD CROP RES, V133, P139, DOI 10.1016/j.fcr.2012.04.004; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P368, DOI 10.1094/MPMI-09-10-0198; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148, DOI 10.1128/MMBR.53.1.148-170.1989; Fleissner A, 2002, MOL PLANT MICROBE IN, V15, P102, DOI 10.1094/MPMI.2002.15.2.102; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Hayashi K, 2002, PESTIC BIOCHEM PHYS, V73, P110, DOI 10.1016/S0048-3575(02)00015-9; Hulvey J, 2012, APPL ENVIRON MICROB, V78, P6674, DOI 10.1128/AEM.00417-12; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kang ZS, 2001, PEST MANAG SCI, V57, P491, DOI 10.1002/ps.310; Kim Y, 2013, GENOMICS, V101, P354, DOI 10.1016/j.ygeno.2013.04.003; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Klix MB, 2007, CROP PROT, V26, P683, DOI 10.1016/j.cropro.2006.06.006; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Lee S, 2011, CURR GENET, V57, P343, DOI 10.1007/s00294-011-0352-4; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Nakaune R, 1998, APPL ENVIRON MICROB, V64, P3983; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; Paul PA, 2010, PHYTOPATHOLOGY, V100, P160, DOI 10.1094/PHYTO-100-2-0160; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Skov J, 2004, PHYSIOL MOL PLANT P, V64, P245, DOI 10.1016/j.pmpp.2004.09.005; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Stergiopoulos I, 2003, MOL PLANT MICROBE IN, V16, P689, DOI 10.1094/MPMI.2003.16.8.689; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; Willyerd KT, 2012, PLANT DIS, V96, P957, DOI 10.1094/PDIS-09-11-0763; Yin Y, 2009, PHYTOPATHOLOGY, V99, P487, DOI 10.1094/PHYTO-99-5-0487; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zwiers LH, 2003, MOL GENET GENOMICS, V269, P499, DOI 10.1007/s00438-003-0855-x	45	58	60	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79042	10.1371/journal.pone.0079042	http://dx.doi.org/10.1371/journal.pone.0079042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244413	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600100
J	Hong, MG; Krauss, RS				Hong, Mingi; Krauss, Robert S.			Rescue of Holoprosencephaly in Fetal Alcohol-Exposed Cdon Mutant Mice by Reduced Gene Dosage of Ptch1	PLOS ONE			English	Article							4 BRAZILIAN PATIENTS; SONIC HEDGEHOG; CRANIOFACIAL MORPHOGENESIS; RISK-FACTORS; VENTRAL FOREBRAIN; SHH; MUTATIONS; EXPRESSION; PHENOTYPE; RECEPTOR	Holoprosencephaly (HPE) is a commonly occurring developmental defect in which midline patterning of the forebrain and midface is disrupted. Sonic hedgehog (SHH) signaling is required during multiple stages of rostroventral midline development, and heterozygous mutations in SHH pathway components are associated with HPE. However, clinical presentation of HPE is highly variable, and carriers of heterozygous mutations often lack apparent defects. It is therefore thought that such mutations must interact with more common modifiers, genetic and/or environmental. We have modeled this scenario in mice. Cdon mutant mice have a largely subthreshold defect in SHH signaling, rendering them sensitive to a wide spectrum of HPE phenotypes by additional hits that are themselves insufficient to produce HPE, including transient in utero exposure to ethanol. These variable HPE phenotypes may arise in embryos that fail to reach a threshold level of SHH signaling at a specific developmental stage. To provide evidence for this possibility, here we tested the effect of removing one copy of the negative regulator Ptch1 from Cdon(-/-) embryos and compared their response to ethanol with that of Cdon(-/-); Ptch1(+/+) embryos. Ptch1 heterozygosity decreased the penetrance of HPE in this system by>75%. The major effect of reduced Ptch1 gene dosage was on penetrance, as those Cdon(-/-); Ptch1(+/-) embryos that displayed HPE did not show major differences in phenotype from Cdon(-/-); Ptch1(+/+) embryos with ethanol-induced HPE. Our findings are consistent with the notion that even in an etiologically complex model of HPE, the level of SHH pathway activity is rate-limiting. Furthermore, the clinical outcome of an individual carrying a SHH pathway mutation will likely reflect the sum effect of both deleterious and protective modifier alleles and their interaction with non-genetic risk factors like fetal alcohol exposure.	[Hong, Mingi; Krauss, Robert S.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Krauss, RS (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	Robert.Krauss@mssm.edu			NIH [R01AA018825]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant R01AA018825 to RSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999; Hu D, 1999, DEVELOPMENT, V126, P4873; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson CY, 2010, AM J MED GENET C, V154C, P73, DOI 10.1002/ajmg.c.30242; Kiecker C, 2001, CURR OPIN NEUROBIOL, V11, P27, DOI 10.1016/S0959-4388(00)00170-7; Krauss Robert S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000440; Lindstrom E, 2006, HUMAN MUTATION, V27, P215; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mercier S, 2011, J MED GENET, V48, P752, DOI 10.1136/jmedgenet-2011-100339; Miller EA, 2010, AM J MED GENET C, V154C, P62, DOI 10.1002/ajmg.c.30244; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Mulieri PJ, 2002, DEV DYNAM, V223, P379, DOI 10.1002/dvdy.10063; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2584, DOI 10.1002/ajmg.a.31369; Ribeiro LA, 2010, AM J MED GENET A, V152A, P1688, DOI 10.1002/ajmg.a.33466; Roessler E, 2012, MOL GENET METAB, V105, P658, DOI 10.1016/j.ymgme.2012.01.005; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Shiota K, 2010, AM J MED GENET C, V154C, P22, DOI 10.1002/ajmg.c.30248; Solomon BD, 2010, AM J MED GENET C, V154C, P133, DOI 10.1002/ajmg.c.30240; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Warr N, 2008, HUM MOL GENET, V17, P2986, DOI 10.1093/hmg/ddn197; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79269	10.1371/journal.pone.0079269	http://dx.doi.org/10.1371/journal.pone.0079269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244464	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600121
J	Leondaritis, G; Siokos, J; Skaripa, I; Galanopoulou, D				Leondaritis, George; Siokos, John; Skaripa, Irini; Galanopoulou, Dia			Genome-Wide Analysis of the Phosphoinositide Kinome from Two Ciliates Reveals Novel Evolutionary Links for Phosphoinositide Kinases in Eukaryotic Cells	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-PHOSPHATE KINASE; TETRAHYMENA; PARAMECIUM; MEMBRANE; PROTEINS; BIOINFORMATICS; 4-PHOSPHATE; METABOLISM; EXPRESSION; INSIGHTS	Background: The complexity of phosphoinositide signaling in higher eukaryotes is partly due to expansion of specific families and types of phosphoinositide kinases (PIKs) that can generate all phosphoinositides via multiple routes. This is particularly evident in the PI3Ks and PIPKs, and it is considered an evolutionary trait associated with metazoan diversification. Yet, there are limited comprehensive studies on the PIK repertoire of free living unicellular organisms. Methodology/Principal Findings: We undertook a genome-wide analysis of putative PIK genes in two free living ciliated cells, Tetrahymena and Paramecium. The Tetrahymena thermophila and Paramecium tetraurelia genomes were probed with representative kinases from all families and types. Putative homologs were verified by EST, microarray and deep RNA sequencing database searches and further characterized for domain structure, catalytic efficiency, expression patterns and phylogenetic relationships. In total, we identified and characterized 22 genes in the Tetrahymena thermophila genome and 62 highly homologues genes in Paramecium tetraurelia suggesting a tight evolutionary conservation in the ciliate lineage. Comparison to the kinome of fungi reveals a significant expansion of PIK genes in ciliates. Conclusions/Significance: Our study highlights four important aspects concerning ciliate and other unicellular PIKs. First, ciliate-specific expansion of PI4KIII-like genes. Second, presence of class I PI3Ks which, at least in Tetrahymena, are associated with a metazoan-type machinery for PIP3 signaling. Third, expansion of divergent PIPK enzymes such as the recently described type IV transmembrane PIPKs. Fourth, presence of possible type II PIPKs and presumably inactive PIKs (hence, pseudo-PIKs) not previously described. Taken together, our results provide a solid framework for future investigation of the roles of PIKs in ciliates and indicate that novel functions and novel regulatory pathways of phosphoinositides may be more widespread than previously thought in unicellular organisms.	[Leondaritis, George] Univ Thessaly, Sch Med, Dept Pharmacol, Larisa, Greece; [Leondaritis, George; Siokos, John; Skaripa, Irini; Galanopoulou, Dia] Univ Athens, Dept Chem, Biochem Lab, GR-10680 Athens, Greece	University of Thessaly; National & Kapodistrian University of Athens	Leondaritis, G (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London, England.	georgios.leondaritis@kcl.ac.uk			University of Athens [KA 11109]	University of Athens	This work was partially supported by a University of Athens grant (KA 11109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akematsu T., 2012, JPN J PROTOZOOL, V45, P1; Anantharaman V, 2007, ANNU REV MICROBIOL, V61, P453, DOI 10.1146/annurev.micro.61.080706.093309; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Boss Wendy E., 2006, V39, P181; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bright LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001155; Brown JR, 2011, BMC EVOL BIOL, V5, p[11, 14]; Clarke Jonathan H, 2012, Adv Biol Regul, V52, P40; Cox SSE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-45; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Deli D, 2008, J EUKARYOT MICROBIOL, V55, P343, DOI 10.1111/j.1550-7408.2008.00329.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Engelmann JA, 2006, NAT REV GENETICS, V7, P606; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Galvao RM, 2008, BIOCHEM J, V409, P117, DOI 10.1042/BJ20070959; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hinchliffe KA, 2002, BIOCHEM J, V363, P563, DOI 10.1042/0264-6021:3630563; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kloppel C, 2009, EUR J CELL BIOL, V88, P577, DOI 10.1016/j.ejcb.2009.05.002; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Ladenburger EM, 2009, MOL CELL BIOL, V29, P3605, DOI 10.1128/MCB.01592-08; Leber W, 2009, INT J PARASITOL, V39, P645, DOI 10.1016/j.ijpara.2008.11.015; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Leondaritis G, 2000, LIPIDS, V35, P525, DOI 10.1007/s11745-000-552-8; Leondaritis G, 2005, BBA-MOL CELL RES, V1745, P330, DOI 10.1016/j.bbamcr.2005.06.011; Leondaritis George, 2011, Communicative & Integrative Biology, V4, P576, DOI 10.4161/cib.4.5.16295; Leondaritis G, 2011, EUKARYOT CELL, V10, P412, DOI 10.1128/EC.00272-10; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1337, DOI 10.1094/MPMI-19-1337; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Nusblat AD, 2012, METHOD CELL BIOL, V109, P141, DOI 10.1016/B978-0-12-385967-9.00006-2; Plattner H, 2010, PROTIST, V161, P497, DOI 10.1016/j.protis.2010.05.001; Plattner H, 2010, INT REV CEL MOL BIO, V280, P79, DOI 10.1016/S1937-6448(10)80003-6; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Ryals PE, 1999, J EUKARYOT MICROBIOL, V46, P77, DOI 10.1111/j.1550-7408.1999.tb04587.x; Ryals PE, 2009, ACTA PROTOZOOL, V48, P191; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; SUCHARD SJ, 1989, J PROTOZOOL, V36, P185, DOI 10.1111/j.1550-7408.1989.tb01072.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turkewitz Aaron P, 2011, Small GTPases, V2, P222; Turkewitz AP, 2004, TRAFFIC, V5, P63, DOI 10.1046/j.1600-0854.2003.00155.x; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yakisich JS, 2004, CELL DEATH DIFFER, V11, P1146, DOI 10.1038/sj.cdd.4401473	58	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78848	10.1371/journal.pone.0078848	http://dx.doi.org/10.1371/journal.pone.0078848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244373	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600070
J	Ye, WM; Giblin-Davis, RM				Ye, Weimin; Giblin-Davis, Robin M.			Molecular Characterization and Development of Real-Time PCR Assay for Pine-Wood Nematode Bursaphelenchus xylophilus (Nematoda: Parasitaphelenchidae)	PLOS ONE			English	Article							DIAGNOSTIC METHOD; SPECIES NEMATODA; SATELLITE DNA; B.-MUCRONATUS; 1ST REPORT; IDENTIFICATION; APHELENCHOIDIDAE; SAMPLES; RFLP; N.	Bursaphelenchus xylophilus, the pine-wood nematode (PWN), is the causal agent of pine wilt disease, one of the most damaging emerging pest problems to forests around the world. It is native to North America where it causes relatively minor damage to native conifers but is labeled an EPPO-A-2 pest and a quarantine nematode for many countries outside of the United States because of its potential for destruction to their native conifers. Exports of wood logs and commodities involving softwood packaging materials now require a lab test for the presence/absence of this regulated nematode species. We characterized the DNA sequences on the ribosomal DNA small subunit, large subunit D2/D3, internal transcribed spacer (ITS) and mitochondrial DNA cytochrome oxidase subunit one on the aphelenchid species and described the development of a real-time-PCR method for rapid and accurate identification of PWN targeting the ITS-1. A total of 97 nematode populations were used to evaluate the specificity and sensitivity of this assay, including 45 populations of B. xylophilus and 36 populations of 21 other species of Bursaphelenchus which belong to the abietinus, cocophilus, eggersi, fungivorus, hofmanni, kevini, leoni, sexdentati, and xylophilus groups and one unassigned group from a total of 13 groups in the genus Bursaphelenchus; 15 populations of Aphelenchoides besseyi, A. fragariae, Aphelenchoides species and Aphelenchus avenae; and one population of mixed nematode species from a soil sample. This assay proved to be specific to B. xylophilus only and was sensitive to a single nematode specimen regardless of the life stages present. This approach provides rapid species identification necessary to comply with the zero-tolerance export regulations.	[Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC 27699 USA; [Giblin-Davis, Robin M.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	State University System of Florida; University of Florida	Ye, WM (corresponding author), North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC 27699 USA.	weimin.ye@ncagr.gov		Giblin-Davis, Robin/0000-0002-8861-8678	North Carolina Tobacco Trust Fund Commission [2011-029-13]; United States Department of Defense; USDA/APHIS/PPQ [10-8100-1587-CA, 11-8100-1621-CA]	North Carolina Tobacco Trust Fund Commission; United States Department of Defense(United States Department of Defense); USDA/APHIS/PPQ(United States Department of Agriculture (USDA))	This work was supported by the North Carolina Tobacco Trust Fund Commission (Grant Number: 2011-029-13). It was initially supported by the United States Department of Defense and USDA/APHIS/PPQ (Project numbers: 10-8100-1587-CA and 11-8100-1621-CA) on a separate project which set the stage for the research leading to the development of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinion, finding conclusion or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view and policies of the North Carolina Tobacco Trust Fund Commission.	ABAD P, 1991, PARASITOLOGY, V102, P303, DOI 10.1017/S0031182000062636; Braasch H., 2011, Journal of Nematode Morphology and Systematics, V14, P77; Braasch H., 2009, Journal of Nematode Morphology and Systematics, V12, P65; Braasch Helen, 1999, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V51, P312; Braasch H, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P139, DOI 10.1007/978-1-4020-8455-3_12; Braasch Helen, 1995, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V47, P310; Burgermeister W, 2005, RUSS J NEMATOL, V13, P29; Burgermeister W, 2009, NEMATOLOGY, V11, P649, DOI 10.1163/156854108/399182; Cao AX, 2005, PHYTOPATHOLOGY, V95, P566, DOI 10.1094/PHYTO-95-0566; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; Chang Ruey-Jang, 1996, Taiwan Journal of Forest Science, V11, P201; Chen FM, 2011, FOREST PATHOL, V41, P376, DOI 10.1111/j.1439-0329.2010.00693.x; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; DWINELL LD, 1993, PLANT DIS, V77, P846, DOI 10.1094/PD-77-0846A; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Francois C, 2007, MOL PLANT PATHOL, V8, P803, DOI [10.1111/j.1364-3703.2007.00434.x, 10.1111/J.1364-3703.2007.00434.X]; Hoyer Ute, 1998, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V50, P273; Huang L, 2010, EUR J PLANT PATHOL, V127, P89, DOI 10.1007/s10658-009-9574-4; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Iwahori H, 1998, FUND APPL NEMATOL, V21, P655; Jiang LQ, 2005, RUSS J NEMATOL, V13, P115; Kang JS, 2009, NEMATOLOGY, V11, P289, DOI 10.1163/156854109X429619; Kang JS, 2004, NEMATOLOGY, V6, P279, DOI 10.1163/1568541041217915; Kanzaki N, 2012, NEMATOLOGY, V14, P395, DOI 10.1163/156854111X602974; Karssen G., 2013, Bulletin OEPP, V43, P105, DOI [10.1111/epp.12024, 10.1111/]; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Knowles K., 1983, FOREST CHRON, V59, P40; Leal I, 2005, NEMATOLOGY, V7, P833, DOI 10.1163/156854105776186398; Leal I, 2013, FOREST PATHOL, V43, P104, DOI 10.1111/efp.12003; Leal I, 2007, NEMATOLOGY, V9, P351, DOI 10.1163/156854107781352098; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Matsunaga K, 2004, NEMATOLOGY, V6, P273, DOI 10.1163/1568541041217960; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nunn G. B., 1992, THESIS U NOTTINGHAM; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Steiner G, 1934, J AGRIC RES, V48, P0949; Takeuchi Yuko, 2009, Japanese Journal of Nematology, V39, P9, DOI 10.3725/jjn.39.9; Tzean SS, 1997, PINE WOOD NEMATODE; Wang JinCheng, 2006, Acta Phytopathologica Sinica, V36, P281; WEBSTER J M, 1990, Revue de Nematologie, V13, P255; Yano S, 1913, SANRIN KOUHOU, V4, P1; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhuo K, 2011, FOREST PATHOL, V41, P66, DOI 10.1111/j.1439-0329.2009.00638.x	47	24	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78804	10.1371/journal.pone.0078804	http://dx.doi.org/10.1371/journal.pone.0078804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244367	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600065
J	Harder-Lauridsen, NM; Kuhn, KG; Erichsen, AC; Molbak, K; Ethelberg, S				Harder-Lauridsen, Nina Majlund; Kuhn, Katrin Gaardbo; Erichsen, Anders Christian; Molbak, Kare; Ethelberg, Steen			Gastrointestinal Illness among Triathletes Swimming in Non-Polluted versus Polluted Seawater Affected by Heavy Rainfall, Denmark, 2010-2011	PLOS ONE			English	Article							WATERBORNE DISEASE; FECAL POLLUTION; CLIMATE-CHANGE; UNITED-STATES; HEALTH; ASSOCIATION; OUTBREAKS; QUALITY; RISKS	Recent years have seen an increase in the frequency of extreme rainfall and subsequent flooding across the world. Climate change models predict that such flooding will become more common, triggering sewer overflows, potentially with increased risks to human health. In August 2010, a triathlon sports competition was held in Copenhagen, Denmark, shortly after an extreme rainfall. The authors took advantage of this event to investigate disease risks in two comparable cohorts of physically fit, long distance swimmers competing in the sea next to a large urban area. An established model of bacterial concentration in the water was used to examine the level of pollution in a spatio-temporal manner. Symptoms and exposures among athletes were examined with a questionnaire using a retrospective cohort design and the questionnaire investigation was repeated after a triathlon competition held in non-polluted seawater in 2011. Diagnostic information was collected from microbiological laboratories. The results showed that the 3.8 kilometer open water swimming competition coincided with the peak of post-flooding bacterial contamination in 2010, with average concentrations of 1.5x10(4) E. coli per 100 ml water. The attack rate of disease among 838 swimmers in 2010 was 42% compared to 8% among 931 swimmers in the 2011 competition (relative risk (RR) 5.0; 95% CI: 4.0-6.39). In 2010, illness was associated with having unintentionally swallowed contaminated water (RR 2.5; 95% CI: 1.8-3.4); and the risk increased with the number of mouthfuls of water swallowed. Confirmed aetiologies of infection included Campylobacter, Giardia lamblia and diarrhoeagenic E. coli. The study demonstrated a considerable risk of illness from water intake when swimming in contaminated seawater in 2010, and a small but measureable risk from non-polluted water in 2011. This suggests a significant risk of disease in people ingesting small amounts of flood water following extreme rainfall in urban areas.	[Harder-Lauridsen, Nina Majlund; Kuhn, Katrin Gaardbo; Molbak, Kare; Ethelberg, Steen] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Erichsen, Anders Christian] DHI Grp, Horsholm, Denmark	Statens Serum Institut	Ethelberg, S (corresponding author), Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark.	set@ssi.dk		Molbak, Kare/0000-0002-3100-4990; Ethelberg, Steen/0000-0002-9709-356X; Erichsen, Anders/0000-0003-3072-8839				Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003; ALEXANDER LM, 1992, J EPIDEMIOL COMMUN H, V46, P340, DOI 10.1136/jech.46.4.340; [Anonymous], 2012, ANN REPORT ZOONOSES; Cann K. F., 2012, EPIDEMIOL INFECT, V9, P1; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Dwight RH, 2004, AM J PUBLIC HEALTH, V94, P565, DOI 10.2105/AJPH.94.4.565; Field C.B., 2012, MAN RISKS EXTR EV DI, P582, DOI DOI 10.1017/CBO9781139177245.; IPCC, 2001, 3 IPCC; Kaas H, 2011, WATER NZ ANN C NOV 2; Kay D, 2004, WATER RES, V38, P1296, DOI 10.1016/j.watres.2003.11.032; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; Papastergiou P, 2009, J WATER HEALTH, V7, P514, DOI 10.2166/wh.2009.135; Pednekar AM, 2005, ENVIRON SCI TECHNOL, V39, P9071, DOI 10.1021/es0504789; Prieto MD, 2001, J EPIDEMIOL COMMUN H, V55, P442, DOI 10.1136/jech.55.6.442; Pruss A, 1998, INT J EPIDEMIOL, V27, P1, DOI 10.1093/ije/27.1.1; Shehane SD, 2005, J APPL MICROBIOL, V98, P1127, DOI 10.1111/j.1365-2672.2005.02554.x; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Bich TH, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6356; Turbow DJ, 2008, ENVIRON RES, V106, P101, DOI 10.1016/j.envres.2007.06.006; van Asperen IA, 1998, INT J EPIDEMIOL, V27, P309, DOI 10.1093/ije/27.2.309; Wojcik OP, 2012, EPIDEMIOL INFECT, V19, P1; Yoder Jonathan S, 2008, MMWR Surveill Summ, V57, P1	22	25	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78371	10.1371/journal.pone.0078371	http://dx.doi.org/10.1371/journal.pone.0078371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244306	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900013
J	Hu, P; Li, B; Zhang, WH; Li, YJ; Li, G; Jiang, XN; Wdzieczak-Bakala, J; Liu, JM				Hu, Ping; Li, Bin; Zhang, Wenhua; Li, Yijian; Li, Guang; Jiang, Xinnong; Wdzieczak-Bakala, Joanna; Liu, Jianmiao			AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; ANGIOGENESIS IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; PROLYL OLIGOPEPTIDASE; TETRAPEPTIDE ACSDKP; ACETYL; OVEREXPRESSION; METASTASIS; DOWNSTREAM; INHIBITOR	The natural tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) is generated from the N-terminus of thymosin-beta 4 through enzymatic cleavage by prolyl oligopeptidase (POP). AcSDKP regulation of proliferation of different cells is implicated in hematopoiesis and angiogenesis. This tetrapeptide present in almost all cells was recently detected at elevated concentrations in neoplastic diseases. However, previously reported in vitro and in vivo studies indicate that AcSDKP does not contribute to the pathogenesis of cancers. Here we show that exogenous AcSDKP exerts no effect on the proliferation of actively dividing malignant cells. Using S17092, a specific POP inhibitor (POPi), to suppress the biosynthesis of AcSDKP in U87-MG glioblastoma cells characterized by high intracellular levels of this peptide, we found that all tested doses of POPi resulted in an equally effective depletion of AcSDKP, which was not correlated with the dose-dependent decreases in the proliferation rate of treated cells. Interestingly, addition of exogenous AcSDKP markedly reversed the reduction in the proliferation of U87-MG cells treated with the highest dose of POPi, and this effect was associated with activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway. However, extracellular-regulated protein kinase (ERK) activation was unaltered by S17092 and AcSDKP co-treatment. Knockdown of individual PI3K catalytic subunits revealed that p110 alpha and p110 beta contributed differently to AcSDKP regulation of U87-MG cell proliferation. Disruption of p110a expression by small interfering RNA (siRNA) abrogated AcSDKP-stimulated Akt phosphorylation, whereas knockdown of p110 beta expression exhibited no such effect. Our findings indicate for the first time that the PI3KCA/Akt pathway mediates AcSDKP regulation of cell proliferation and suggest a role for this ubiquitous intracellular peptide in cell survival.	[Hu, Ping; Li, Bin; Zhang, Wenhua; Li, Yijian; Li, Guang; Jiang, Xinnong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys,Sino France Lab Drug Screenin, Wuhan 430074, Hubei, Peoples R China; [Wdzieczak-Bakala, Joanna; Liu, Jianmiao] CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	Huazhong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Liu, JM (corresponding author), CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France.	miao_l@yahoo.com		Li, Guang/0000-0003-4277-9844	National Science Foundation of China [30901816]; Ministry of Science and Technology [2012CB518000]; Program of Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program of Introducing Talents of Discipline to the Universities of the Ministry of Education	This work was supported by the National Science Foundation of China (grant 30901816), the Ministry of Science and Technology (grant 2012CB518000) and the Program of Introducing Talents of Discipline to the Universities of the Ministry of Education (grant B08029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNET D, 1992, EXP HEMATOL, V20, P1165; Boutonnat J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-120; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cavasin MA, 2004, HYPERTENSION, V43, P1140, DOI 10.1161/01.HYP.0000126172.01673.84; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kanasaki K, 2006, BIOCHEM BIOPH RES CO, V342, P758, DOI 10.1016/j.bbrc.2006.02.019; Kusinski M, 2006, LANGENBECK ARCH SURG, V391, P9, DOI 10.1007/s00423-005-0014-4; LAURET E, 1989, EXP HEMATOL, V17, P1081; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; Liu JM, 2008, ANTICANCER RES, V28, P2813; Liu JM, 2010, ANN NY ACAD SCI, V1194, P53, DOI 10.1111/j.1749-6632.2010.05488.x; Liu JM, 2003, BLOOD, V101, P3014, DOI 10.1182/blood-2002-07-2315; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Petit A, 2000, BRIT J PHARMACOL, V130, P1613, DOI 10.1038/sj.bjp.0703440; Pokharel S, 2002, HYPERTENSION, V40, P155, DOI 10.1161/01.HYP.0000025880.56816.FA; Rhaleb NE, 2001, HYPERTENSION, V37, P827, DOI 10.1161/01.HYP.37.3.827; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schulz I, 2002, EUR J BIOCHEM, V269, P5813, DOI 10.1046/j.1432-1033.2002.03297.x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Wymann MP, 1996, MOL CELL BIOL, V16, P1722	29	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79321	10.1371/journal.pone.0079321	http://dx.doi.org/10.1371/journal.pone.0079321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244481	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900037
J	Al-Dossary, AA; Strehler, EE; Martin-DeLeon, PA				Al-Dossary, Amal A.; Strehler, Emanuel E.; Martin-DeLeon, Patricia A.			Expression and Secretion of Plasma Membrane Ca2+-ATPase 4a (PMCA4a) during Murine Estrus: Association with Oviductal Exosomes and Uptake in Sperm	PLOS ONE			English	Article							MALE-FERTILITY; CA2+ PUMPS; JAM-A; SPAM1; MOUSE; MOTILITY; BINDING; PROTEIN; CELLS; EPIDIDYMOSOMES	PMCA4, a membrane protein, is the major Ca2+ efflux pump in murine sperm where its deletion leads to a severe loss of hyperactivated motility and to male infertility. We have previously shown that the PMCA4b splice variant interacts with CASK (Ca2+/CaM-dependent serine kinase) in regulating sperm Ca2+. More recently we detected that PMCA4a isoform, in addition to its presence in testis, is secreted in the epididymal luminal fluid and transferred to sperm. Here we show that Pmca4 mRNA is expressed in both the 4a and 4b variants in the vagina, uterus, and oviduct. Immunofluorescence reveals that PMCA4a is similarly expressed and is elevated during estrus, appearing in the glandular and luminal epithelia. Western analysis detected PMCA4a in all tissues and in the luminal fluids (LF) of the vagina (VLF), uterus (ULF), and the oviduct (OLF) collected during estrus. It was similar to 9- and 4-fold higher in OLF than in VLF and ULF, and only marginally present in LF collected at metestrus/diestrus. Fractionation of the LF collected at estrus, via ultracentrifugation, revealed that 100% of the PMCA4a resides in the vesicular fraction of the ULF and OLF. Transmission electron microscopy (TEM) revealed that OLF vesicles have an exosomal orientation (with the cytoplasmic-side inward), a size range of 25-100 nm, with the characteristic CD9 biomarker. Thus, we dubbed these vesicles "oviductosomes", to which PMCA4a was immunolocalized. Incubation of caudal sperm in the combined LF or exosomes resulted in up to a similar to 3-fold increase of sperm PMCA4a, as detected by flow cytometry, indicating in vitro uptake. Our results are consistent with the increased requirement of Ca2+ efflux in the oviduct. They show for the first time the presence of oviductal exosomes and highlight their role, along with uterosomes and vaginal exosomes, in post-testicular sperm acquisition of PMCA4a which is essential for hyperactivated motility and fertility.	[Al-Dossary, Amal A.; Martin-DeLeon, Patricia A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Strehler, Emanuel E.] Mayo Clin, Dept Biochem, Rochester, MN USA	University of Delaware; Mayo Clinic	Martin-DeLeon, PA (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	pdeleon@udel.edu		Al-Dossary, Amal/0000-0002-4634-6483	NIH [5P20RR015588]; Saudi Arabia Cultural Mission;  [NIH-RO3HD073523A]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; EPSCoR [0814251] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saudi Arabia Cultural Mission; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by: NIH-RO3HD073523A, NIH 5P20RR015588, and the Saudi Arabia Cultural Mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1994, BIOL REPROD, V51, P1238, DOI 10.1095/biolreprod51.6.1238; Aravindan RG, 2012, J CELL PHYSIOL, V227, P3138, DOI 10.1002/jcp.24000; BARRATT CLR, 1991, INT J ANDROL, V14, P394, DOI 10.1111/j.1365-2605.1991.tb01268.x; Belan PV, 1996, J BIOL CHEM, V271, P7615, DOI 10.1074/jbc.271.13.7615; Boilard M, 2002, BIOL REPROD, V67, P1125, DOI 10.1095/biolreprod67.4.1125; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Griffiths GS, 2008, MOL REPROD DEV, V75, P1627, DOI 10.1002/mrd.20907; Griffiths GS, 2008, REPRODUCTION, V135, P293, DOI 10.1530/REP-07-0340; Griffiths GS, 2009, BIOL REPROD, V81, P562, DOI 10.1095/biolreprod.108.075739; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Kirchhoff C, 1997, ADV EXP MED BIOL, V424, P221; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Morales P, 1996, HUM REPROD, V11, P1504; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Post H, 2002, PROSTATE, V52, P159, DOI 10.1002/pros.10109; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rodriguez-Martinez H, 2007, THERIOGENOLOGY, V68, pS138, DOI 10.1016/j.theriogenology.2007.03.018; Saez F, 2003, J ANDROL, V24, P149; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Shao MH, 2008, DEV BIOL, V313, P246, DOI 10.1016/j.ydbio.2007.10.013; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; YEUNG CH, 2002, ACQUISITION DEV SPER; Zhang H, 2003, BIOL REPROD, V69, P446, DOI 10.1095/biolreprod.102.013854	40	106	114	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80181	10.1371/journal.pone.0080181	http://dx.doi.org/10.1371/journal.pone.0080181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244642	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800132
J	Liu, M; Wang, Q; Liu, F; Cheng, XF; Wu, XL; Wang, H; Wu, MQ; Ma, Y; Wang, GJ; Hao, HP				Liu, Miao; Wang, Qiong; Liu, Fang; Cheng, Xuefang; Wu, Xiaolan; Wang, Hong; Wu, Mengqiu; Ma, Ying; Wang, Guangji; Hao, Haiping			UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells	PLOS ONE			English	Article							HUMAN LIVER; TOBACCO CARCINOGEN; QUINONE REDUCTION; BETA-LAPACHONE; IN-VITRO; GLUCURONIDATION; IDENTIFICATION; METABOLISM; EXPRESSION; APOPTOSIS	Background and Purpose: NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subsequent UDP-glucuronosyltransferases (UGTs) catalyzed glucuronidation is the dominant metabolic pathway of tanshinone IIA (TSA), a promising anti-cancer agent. UGTs are positively expressed in various tumor tissues and play an important role in the metabolic elimination of TSA. This study aims to explore the role of UGT1A in determining the intracellular accumulation and the resultant apoptotic effect of TSA. Experimental Approach: We examined TSA intracellular accumulation and glucuronidation in HT29 (UGT1A positive) and HCT116 (UGT1A negative) human colon cancer cell lines. We also examined TSA-mediated reactive oxygen species (ROS) production, cytotoxicity and apoptotic effect in HT29 and HCT116 cells to investigate whether UGT1A levels are directly associated with TSA anti-cancer effect. UGT1A siRNA or propofol, a UGT1A9 competitive inhibitor, was used to inhibit UGT1A expression or UGT1A9 activity. Key Results: Multiple UGT1A isoforms are positively expressed in HT29 but not in HCT116 cells. Cellular S9 fractions prepared from HT29 cells exhibit strong glucuronidation activity towards TSA, which can be inhibited by propofol or UGT1A siRNA interference. TSA intracellular accumulation in HT29 cells is much lower than that in HCT116 cells, which correlates with high expression levels of UGT1A in HT29 cells. Consistently, TSA induces less intracellular ROS, cytotoxicity, and apoptotic effect in HT29 cells than those in HCT116 cells. Pretreatment of HT29 cells with UGT1A siRNA or propofol can decrease TSA glucuronidation and simultaneously improve its intracellular accumulation, as well as enhance TSA anti-cancer effect. Conclusions and Implications: UGT1A can compromise TSA cytotoxicity via reducing its intracellular exposure and switching the NQO1-triggered redox cycle to metabolic elimination. Our study may shed a light in understanding the cellular pharmacokinetic and molecular mechanism by which UGTs determine the chemotherapy effects of drugs that are UGTs' substrates.	[Liu, Miao; Wang, Qiong; Liu, Fang; Cheng, Xuefang; Wu, Xiaolan; Wang, Hong; Wu, Mengqiu; Ma, Ying; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Hao, Haiping/L-8265-2019; Wu, Mengqiu/HHS-9267-2022	Hao, Haiping/0000-0003-2522-7546; Wu, Mengqiu/0000-0001-9488-5572; Liu, Miao/0000-0002-7975-6702; Wang, Hong/0000-0002-6192-3082	Foundation for the Author of National Excellent Doctoral Dissertation of China [200979]; Natural Science Foundation of China [91029746, 81273586]; Natural Science Foundation of Jiangsu province [BK2011065, BK2012026]; Program for New Century Excellent Talents in University [NCET-09-0770]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by a Foundation for the Author of National Excellent Doctoral Dissertation of China (Grant 200979), Natural Science Foundation of China (Grants 91029746 and 81273586), Natural Science Foundation of Jiangsu province (Grants BK2011065 and BK2012026), and the Program for New Century Excellent Talents in University (Grant NCET-09-0770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M. C., 2011, BIOCHEM PHARMACOL, V81, P60; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bowalgaha K, 2007, DRUG METAB DISPOS, V35, P363, DOI 10.1124/dmd.106.013052; Bushey RT, 2013, DRUG METAB DISPOS, V41, P170, DOI 10.1124/dmd.112.049171; Cheng XF, 2012, MOL PHARMACEUT, V9, P3476, DOI 10.1021/mp300296m; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cummings J, 2003, CANCER RES, V63, P8443; Desai AA, 2003, PHARMACOGENETICS, V13, P517, DOI 10.1097/00008571-200308000-00010; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hao HP, 2007, CURR DRUG METAB, V8, P137, DOI 10.2174/138920007779816011; Hao HP, 2006, PLANTA MED, V72, P1311, DOI 10.1055/s-2006-951698; Innocenti F, 2001, DRUG METAB DISPOS, V29, P686; Izumi K, 2012, MOL CARCINOG; Jiang BH, 2009, FOOD CHEM TOXICOL, V47, P1538, DOI 10.1016/j.fct.2009.03.038; Lewis AM, 2005, MOL CARCINOGEN, V43, P215, DOI 10.1002/mc.20107; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; Lu Q, 2009, INT J MOL MED, V24, P773, DOI 10.3892/ijmm_00000291; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Southwood HT, 2007, CHEM RES TOXICOL, V20, P1520, DOI 10.1021/tx700188x; Starlard-Davenport A, 2008, STEROIDS, V73, P611, DOI 10.1016/j.steroids.2008.01.019; Strassburg CP, 1997, CANCER RES, V57, P2979; Su CC, 2008, INT J MOL MED, V22, P847, DOI 10.3892/ijmm_00000094; Sun D, 2007, DRUG METAB DISPOS, V35, P2006, DOI 10.1124/dmd.107.017145; Tang YJ, 2012, J BIOL CHEM, V287, P14960, DOI 10.1074/jbc.M111.320093; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wang QO, 2010, DRUG METAB DISPOS, V38, P1132, DOI 10.1124/dmd.109.031864; Zhang ZC, 2009, BIOCHEM PHARMACOL, V78, P1316, DOI 10.1016/j.bcp.2009.06.110	34	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79172	10.1371/journal.pone.0079172	http://dx.doi.org/10.1371/journal.pone.0079172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244442	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800037
J	Mason, L; Nyothach, E; Alexander, K; Odhiambo, FO; Eleveld, A; Vulule, J; Rheingans, R; Laserson, KF; Mohammed, A; Phillips-Howard, PA				Mason, Linda; Nyothach, Elizabeth; Alexander, Kelly; Odhiambo, Frank O.; Eleveld, Alie; Vulule, John; Rheingans, Richard; Laserson, Kayla F.; Mohammed, Aisha; Phillips-Howard, Penelope A.			'We Keep It Secret So No One Should Know' - A Qualitative Study to Explore Young Schoolgirls Attitudes and Experiences with Menstruation in Rural Western Kenya	PLOS ONE			English	Article							TREATED BED NETS; ADOLESCENT GIRLS; DEMOGRAPHIC SURVEILLANCE; HYGIENE PRACTICES; SEXUAL-BEHAVIOR; PREMARITAL SEX; HIV-INFECTION; UNITED-STATES; MENARCHE; HEALTH	Background: Keeping girls in school offers them protection against early marriage, teen pregnancy, and sexual harms, and enhances social and economic equity. Studies report menstruation exacerbates school-drop out and poor attendance, although evidence is sparse. This study qualitatively examines the menstrual experiences of young adolescent schoolgirls. Methods and Findings: The study was conducted in Siaya County in rural western Kenya. A sample of 120 girls aged 14-16 years took part in 11 focus group discussions, which were analysed thematically. The data gathered were supplemented by information from six FGDs with parents and community members. Emergent themes were: lack of preparation for menarche; maturation and sexual vulnerability; menstruation as an illness; secrecy, fear and shame of leaking; coping with inadequate alternatives; paying for pads with sex; and problems with menstrual hygiene. Girls were unprepared and demonstrated poor reproductive knowledge, but devised practical methods to cope with menstrual difficulties, often alone. Parental and school support of menstrual needs is limited, and information sparse or inaccurate. Girls' physical changes prompt boys and adults to target and brand girls as ripe for sexual activity including coercion and marriage. Girls admitted 'others' rather than themselves were absent from school during menstruation, due to physical symptoms or inadequate sanitary protection. They described difficulties engaging in class, due to fear of smelling and leakage, and subsequent teasing. Sanitary pads were valued but resource and time constraints result in prolonged use causing chafing. Improvised alternatives, including rags and grass, were prone to leak, caused soreness, and were perceived as harmful. Girls reported 'other girls' but not themselves participated in transactional sex to buy pads, and received pads from boyfriends. Conclusions: In the absence of parental and school support, girls cope, sometimes alone, with menarche in practical and sometimes hazardous ways. Emotional and physical support mechanisms need to be included within a package of measures to enable adolescent girls to reach their potential.	[Mason, Linda; Alexander, Kelly; Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Nyothach, Elizabeth; Odhiambo, Frank O.; Vulule, John; Laserson, Kayla F.] Kenya Med Res Inst Ctr Dis Control Res & Publ Hlt, Kisumu, Nyanza Province, Kenya; [Eleveld, Alie] Safe Water & AIDS Project, Kisumu, Nyanza Province, Kenya; [Rheingans, Richard] Univ Florida, Ctr African Studies, Gainesville, FL USA; [Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Mohammed, Aisha] Minist Publ Hlth & Sanit, Div Reprod Hlth, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; State University System of Florida; University of Florida; Centers for Disease Control & Prevention - USA	Mason, L (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	Linda.Mason@liverpool.ac.uk	Rheingans, Richard D/P-1638-2017	Nyothach, Elizabeth/0000-0003-0904-9081; Phillips-Howard, Penelope A/0000-0003-1018-116X	UK Medical Research Council/Department for International Development/Wellcome Trust [G1100677/1]; British Council through the Prime Ministers Initiative; Medical Research Council [G1100677] Funding Source: researchfish; MRC [G1100677] Funding Source: UKRI	UK Medical Research Council/Department for International Development/Wellcome Trust; British Council through the Prime Ministers Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is part of the baseline phase of a proof of concept feasibility study on menstrual solutions for schoolgirls in western Kenya funded by the UK Medical Research Council/Department for International Development/Wellcome Trust Project Protect (G1100677/1). The British Council provided funding through the Prime Ministers Initiative (2) for workshops on water and sanitation and sexual and reproductive health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abioye-Kuteyi EA, 2000, J R SOC PROMO HEALTH, V120, P23, DOI 10.1177/146642400012000113; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Adudans Maureen K, 2011, Afr J Reprod Health, V15, P87; Ahmed R., 2008, CONSTRUCTION USE ALL; Ali TS, 2010, J ADOLESCENCE, V33, P531, DOI 10.1016/j.adolescence.2009.05.013; Allen CF, 2010, AIDS BEHAV, V14, P1169, DOI 10.1007/s10461-010-9750-8; APHRC, 2010, POL BRIEF ATT ACC ME; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Balamurugan Sangeetha S, 2012, Indian J Community Med, V37, P34, DOI 10.4103/0970-0218.94020; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; BHATIA JC, 1995, STUD FAMILY PLANN, V26, P203, DOI 10.2307/2137846; Biddlecom A, 2008, STUD FAMILY PLANN, V39, P337, DOI 10.1111/j.1728-4465.2008.00179.x; Blum RW, 2012, LANCET, V379, P1567, DOI 10.1016/S0140-6736(12)60407-3; Buckley T.L., 1988, BLOOD MAGIC ANTHR ME; Bundy D, 2011, RETHINKING SCH HLTH; Burrows A, 2005, J REPROD INFANT PSYC, V23, P235, DOI 10.1080/02646830500165846; CARE, 2000, COMM IN CHILD UNPUB; Cohen David William, 1989, SIAYA HISTORICAL ANT; Czerwinski BS, 2001, MIL MED, V166, P152, DOI 10.1093/milmed/166.2.152; Dasgupta A, 2008, Indian J Community Med, V33, P77, DOI 10.4103/0970-0218.40872; Demba E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-12; El-Gilany AH, 2005, REPROD HEALTH MATTER, V13, P147, DOI 10.1016/S0968-8080(05)26191-8; Erulkar AS, 2004, INT FAM PLAN PERSPEC, V30, P182, DOI 10.1363/3018204; Forde S., 2009, CREATESPACE; Gautam O, 2010, IS MENSTRUAL HYGIENE; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Irinoye O O, 2003, Niger J Med, V12, P43; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Kariuki M, 2000, CASE STUDY IMPACT I; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Khanna A, 2005, J HEALTH MANAG, V7, P91, DOI 10.1177/097206340400700103; Kilonzo N, 2008, AIDS CARE, V20, P188, DOI 10.1080/09540120701473849; Krippendorff K., 1980, CONTENT ANAL INTRO I; Lee J, 2009, SEX ROLES, V60, P615, DOI 10.1007/s11199-008-9569-1; Liu HL, 2012, J PEDIATR ADOL GYNEC, V25, P43, DOI 10.1016/j.jpag.2011.08.006; Lloyd CB, 2008, POP STUD-J DEMOG, V62, P1, DOI 10.1080/00324720701810840; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; Marvan ML, 2008, HEALTH CARE WOMEN IN, V29, P673, DOI 10.1080/07399330802188982; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Meltzer MI, 2003, AM J TROP MED HYG, V68, P149, DOI 10.4269/ajtmh.2003.68.149; Mensch BS, 1998, STUD FAMILY PLANN, V29, P167, DOI 10.2307/172157; Mensch BS, 2001, STUD FAMILY PLANN, V32, P285, DOI 10.1111/j.1728-4465.2001.00285.x; Montgomery P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048274; Njue C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-635; Nobelius AM, 2010, J SEX RES, V47, P490, DOI 10.1080/00224499.2010.494776; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Orringer K, 2010, HEALTH CARE WOMEN IN, V31, P831, DOI 10.1080/07399331003653782; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P3, DOI 10.4269/ajtmh.2003.68.3; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Rembeck GI, 2006, ACTA PAEDIATR, V95, P707, DOI 10.1080/08035250500531697; Rodriguez White L, 2012, FUNCTION ETHNICITY I; SCOTT CS, 1989, J NATL MED ASSOC, V81, P285; SEVERY LJ, 1993, WOMEN HEALTH, V20, P1, DOI 10.1300/J013v20n02_01; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; Stubbs ML, 2008, ANN NY ACAD SCI, V1135, P58, DOI 10.1196/annals.1429.008; Szarewski A, 2012, EUR J CONTRACEP REPR, V17, P270, DOI 10.3109/13625187.2012.684811; Tanfer K, 1996, SEX TRANSM DIS, V23, P395, DOI 10.1097/00007435-199609000-00009; Ten VA, 2007, MENSTRUAL HYGIENE NE; UWESO, 2012, AR OUR CHILDR LEARN; Vandenhoudt H, 2010, AIDS EDUC PREV, V22, P328, DOI 10.1521/aeap.2010.22.4.328; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; WHO, 2008, WHY IS GIV SPEC ATT; WorldBank, 2005, TOOLK HYG SAN WAT SC; ZIERLER S, 1991, AM J PUBLIC HEALTH, V81, P572, DOI 10.2105/AJPH.81.5.572	68	115	116	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79132	10.1371/journal.pone.0079132	http://dx.doi.org/10.1371/journal.pone.0079132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244435	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000327143800033
J	Moncla, LH; Ross, TM; Dinis, JM; Weinfurter, JT; Mortimer, TD; Schultz-Darken, N; Brunner, K; Capuano, SV; Boettcher, C; Post, J; Johnson, M; Bloom, CE; Weiler, AM; Friedrich, TC				Moncla, Louise H.; Ross, Ted M.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Schultz-Darken, Nancy; Brunner, Kevin; Capuano, Saverio V., III; Boettcher, Carissa; Post, Jennifer; Johnson, Michael; Bloom, Chalise E.; Weiler, Andrea M.; Friedrich, Thomas C.			A Novel Nonhuman Primate Model for Influenza Transmission	PLOS ONE			English	Article							MARMOSET CALLITHRIX-JACCHUS; COMMON MARMOSET; A VIRUS; CROSS-REACTIVITY; ANIMAL-MODELS; H1N1; INFECTION; ANTIBODIES; FERRETS; PATHOGENESIS	Studies of influenza transmission are necessary to predict the pandemic potential of emerging influenza viruses. Currently, both ferrets and guinea pigs are used in such studies, but these species are distantly related to humans. Nonhuman primates (NHP) share a close phylogenetic relationship with humans and may provide an enhanced means to model the virological and immunological events in influenza virus transmission. Here, for the first time, it was demonstrated that a human influenza virus isolate can productively infect and be transmitted between common marmosets (Callithrix jacchus), a New World monkey species. We inoculated four marmosets with the 2009 pandemic virus A/California/07/2009 (H1N1pdm) and housed each together with a naive cage mate. We collected bronchoalveolar lavage and nasal wash samples from all animals at regular intervals for three weeks post-inoculation to track virus replication and sequence evolution. The unadapted 2009 H1N1pdm virus replicated to high titers in all four index animals by 1 day post-infection. Infected animals seroconverted and presented human-like symptoms including sneezing, nasal discharge, labored breathing, and lung damage. Transmission occurred in one cohabitating pair. Deep sequencing detected relatively few genetic changes in H1N1pdm viruses replicating in any infected animal. Together our data suggest that human H1N1pdm viruses require little adaptation to replicate and cause disease in marmosets, and that these viruses can be transmitted between animals. Marmosets may therefore be a viable model for studying influenza virus transmission.	[Moncla, Louise H.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Friedrich, Thomas C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Moncla, Louise H.; Dinis, Jorge M.; Weinfurter, Jason T.; Mortimer, Tatum D.; Schultz-Darken, Nancy; Brunner, Kevin; Capuano, Saverio V., III; Boettcher, Carissa; Post, Jennifer; Johnson, Michael; Weiler, Andrea M.; Friedrich, Thomas C.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Ross, Ted M.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53706 USA; [Ross, Ted M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA; [Bloom, Chalise E.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vaccine & Gene Therapy Institute of Florida	Friedrich, TC (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	thomasf@primate.wisc.edu		Mortimer, Tatum/0000-0001-6255-690X; Weinfurter, Jason/0000-0001-8076-2598; Friedrich, Thomas/0000-0001-9831-6895; Ross, Ted/0000-0003-1947-7469	PATH Vaccine Solutions; NIH National Research Service Award [T32 GM07215]; National Science Foundation Graduate Research Fellowship [DGE-0718123]; NIH [RR000167/OD011106]; Research Facilities Improvement Program [RR015459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	PATH Vaccine Solutions; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by PATH Vaccine Solutions in a sponsored research award to Ted M. Ross. Louise H. Moncla and Tatum D. Mortimer were supported by NIH National Research Service Award T32 GM07215. Jorge M. Dinis was supported by National Science Foundation Graduate Research Fellowship DGE-0718123. This study was conducted in a facility supported in part by NIH grant RR000167/OD011106, which was constructed with additional support from Research Facilities Improvement Program grants RR015459-01 and RR020141-01 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brok HPM, 2001, CYTOMETRY, V45, P294, DOI 10.1002/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C; Carcione D, 2011, EUROSURVEILLANCE, V16, P1; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carter DM, 2013, J VIROL, V87, P1400, DOI 10.1128/JVI.02257-12; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chang H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000606; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edenborough KM, 2012, J VIROL, V86, P12544, DOI 10.1128/JVI.00859-12; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ince WL, 2013, J VIROL, V87, P4330, DOI 10.1128/JVI.02749-12; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jagessar SA, 2012, J NEUROIMMUNE PHARM, V7, P557, DOI 10.1007/s11481-012-9384-x; Jagessar SA, 2012, EUR J IMMUNOL, V42, P217, DOI 10.1002/eji.201141863; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Kap YS, 2010, J IMMUNOL, V185, P3990, DOI 10.4049/jimmunol.1001393; Kireta S, 2005, CELL IMMUNOL, V236, P115, DOI 10.1016/j.cellimm.2005.08.017; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Leibovitch E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003138; Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neubert R, 1995, LIFE SCI, V58, P317, DOI 10.1016/0024-3205(95)02291-0; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; NIH, 2013, NIH NONH PRIM REAG R; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Riecke K, 2000, J MED PRIMATOL, V29, P343, DOI 10.1034/j.1600-0684.2000.290506.x; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Smither S.J., 2013, INT J EXP PATHOL; TAJIMA F, 1983, GENETICS, V105, P437; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12	47	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78750	10.1371/journal.pone.0078750	http://dx.doi.org/10.1371/journal.pone.0078750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244352	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327143800011
J	Nordgren, M; Karlsson, T; Svensson, M; Koczy, J; Josephson, A; Olson, L; Tingstrom, A; Brene, S				Nordgren, Max; Karlsson, Tobias; Svensson, Maria; Koczy, Josefin; Josephson, Anna; Olson, Lars; Tingstroem, Anders; Brene, Stefan			Orchestrated Regulation of Nogo Receptors, Lotus, AMPA Receptors and BDNF in an ECT Model Suggests Opening and Closure of a Window of Synaptic Plasticity	PLOS ONE			English	Article							ADULT-RAT HIPPOCAMPUS; INDUCED RETROGRADE-AMNESIA; MESSENGER-RNA; ELECTROCONVULSIVE STIMULATION; GLUTAMATE RECEPTORS; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; DEPRESSED-PATIENTS; PRECURSOR PROTEIN; GLOBAL-ISCHEMIA	Electroconvulsive therapy (ECT) is an efficient and relatively fast acting treatment for depression. However, one severe side effect of the treatment is retrograde amnesia, which in certain cases can be long-term. The mechanisms behind the antidepressant effect and the amnesia are not well understood. We hypothesized that ECT causes transient downregulation of key molecules needed to stabilize synaptic structure and to prevent Ca2+ influx, and a simultaneous increase in neurotrophic factors, thus providing a short time window of increased structural synaptic plasticity. Here we followed regulation of NgR1, NgR3, LOTUS, BDNF, and AMPA subunits GluR1 and GluR2 flip and flop mRNA levels in hippocampus at 2, 4, 12, 24, and 72 hours after a single episode of induced electroconvulsive seizures (ECS) in rats. NgR1 and LOTUS mRNA levels were transiently downregulated in the dentate gyrus 2, 4, 12 and 4, 12, 24 h after ECS treatment, respectively. GluR2 flip, flop and GluR1 flop were downregulated at 4 h. GluR2 flip remained downregulated at 12 h. In contrast, BDNF, NgR3 and GluR1 flip mRNA levels were upregulated. Thus, ECS treatment induces a transient regulation of factors important for neuronal plasticity. Our data provide correlations between ECS treatment and molecular events compatible with the hypothesis that both effects and side effects of ECT may be caused by structural synaptic rearrangements.	[Nordgren, Max; Brene, Stefan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Karlsson, Tobias; Koczy, Josefin; Josephson, Anna; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Maria; Tingstroem, Anders] Univ Lund Hosp, Wallenberg Neurosci Ctr, Psychiat Neuromodulat Unit, S-22185 Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Skane University Hospital	Brene, S (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	stefan.brene@ki.se			Swedish Research Council [3474]; ERC [322744]; Swedish Brain Power; Karolinska Distinguished Professor Award; Karolinska institutet Foundations; Karolinska StratNeuro program	Swedish Research Council(Swedish Research CouncilEuropean Commission); ERC(European Research Council (ERC)European Commission); Swedish Brain Power; Karolinska Distinguished Professor Award; Karolinska institutet Foundations(Karolinska Institutet); Karolinska StratNeuro program	Swedish Research Council grant no 3474, ERC grant no. 322744, Swedish Brain Power, The Karolinska Distinguished Professor Award, Karolinska institutet Foundations, the Karolinska StratNeuro program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Altman J, 1997, DEV CEREBELLAR SYSTE; Andrade C, 2008, J NEURAL TRANSM, V115, P1063, DOI 10.1007/s00702-008-0063-2; Andrade C, 2008, J PSYCHIATR RES, V42, P837, DOI 10.1016/j.jpsychires.2007.08.009; Andrade C, 2012, J NEURAL TRANSM, V119, P337, DOI 10.1007/s00702-011-0712-8; Angelucci F, 2002, J ECT, V18, P138, DOI 10.1097/00124509-200209000-00005; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Buffo A, 2000, J NEUROSCI, V20, P2275; CAVALHEIRO EA, 1982, ELECTROEN CLIN NEURO, V53, P581, DOI 10.1016/0013-4694(82)90134-1; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Hellsten J, 2005, BIOL PSYCHIAT, V58, P871, DOI 10.1016/j.biopsych.2005.05.023; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsu R., 2007, PLOS ONE, V2, P1234, DOI [10.1371/journal.pone.0001234, DOI 10.1371/JOURNAL.PONE.0001234]; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Karlsson TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060892; Karlsson TE, 2013, J ALZHEIMERS DIS, V33, P145, DOI 10.3233/JAD-2012-120493; Lamont SR, 2001, BRAIN RES, V893, P53, DOI 10.1016/S0006-8993(00)03287-X; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Luo J, 2011, J ANESTH, V25, P657, DOI 10.1007/s00540-011-1199-z; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Merkl A, 2009, EXP NEUROL, V219, P20, DOI 10.1016/j.expneurol.2009.04.027; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Nations KR, 2012, J PSYCHOPHARMACOL, V26, P1525, DOI 10.1177/0269881112458728; Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Novak G, 2006, BRAIN RES, V1120, P161, DOI 10.1016/j.brainres.2006.08.071; Pagnin D, 2004, J ECT, V20, P13, DOI 10.1097/00124509-200403000-00004; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Paxinos G, 1994, ATLAS DEV RAT NERVOU; Paxinos G, 1998, RAT BRAIN; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Peng XM, 2011, J NEUROCHEM, V119, P1183, DOI 10.1111/j.1471-4159.2011.07520.x; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEWART C, 1994, NEUROREPORT, V5, P1041, DOI 10.1097/00001756-199405000-00006; Su XWW, 2009, PSYCHOPHARMACOLOGY, V206, P215, DOI 10.1007/s00213-009-1598-0; Vaidya VA, 1999, NEUROSCIENCE, V89, P157, DOI 10.1016/S0306-4522(98)00289-9; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Zhou XD, 2011, FASEB J, V25, P3146, DOI 10.1096/fj.11-184325; Zhu HY, 2007, HUM PATHOL, V38, P426, DOI 10.1016/j.humpath.2006.09.010	64	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78778	10.1371/journal.pone.0078778	http://dx.doi.org/10.1371/journal.pone.0078778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244357	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800016
J	Pujari, R; Eligar, SM; Kumar, N; Barkeer, S; Reddy, V; Swamy, BM; Inamdar, SR; Shastry, P				Pujari, Radha; Eligar, Sachin M.; Kumar, Natesh; Barkeer, Srikanth; Reddy, Vishwanath; Swamy, Bale M.; Inamdar, Shashikala R.; Shastry, Padma			Rhizoctonia Bataticola Lectin (RBL) Induces Caspase-8-Mediated Apoptosis in Human T-Cell Leukemia Cell Lines but Not in Normal CD3 and CD34 Positive Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SIGNALING PATHWAYS; OBLIMERSEN SODIUM; BCL-2 ANTISENSE; CANCER-CELLS; HUMAN PBMC; BINDING; DEATH; FAS	We have previously demonstrated immunostimulatory activity of a fungal lectin, Rhizoctonia bataticola lectin (RBL), towards normal human peripheral blood mononuclear cells. The present study aimed to explore the anticancer activities of RBL using human leukemic T-cell lines, Molt-4, Jurkat and HuT-78. RBL exhibited significant binding (>90%) to the cell membrane that was effectively inhibited by complex glycoproteins such as mucin (97% inhibition) and asialofetuin (94% inhibition) but not simple sugars such as N-acetyl-D-galactosamine, glucose and sucrose. RBL induced a dose and time dependent inhibition of proliferation and induced cytotoxicity in the cell lines. The percentage of apoptotic cells, as determined by hypodiploidy, was 33% and 42% in Molt-4 and Jurkat cells, respectively, compared to 3.11% and 2.92% in controls. This effect was associated with a concomitant decrease in the G0/G1 population. Though initiator caspase-8 and -9 were activated upon exposure to RBL, inhibition of caspase-8 but not caspase-9 rescued cells from RBL-induced apoptosis. Mechanistic studies revealed that RBL induced cleavage of Bid, loss of mitochondrial membrane potential and activation of caspase-3. The expression of the anti-apoptotic proteins Bcl-2 and Bcl-X was down regulated without altering the expression of pro-apoptotic proteins- Bad and Bax. In contrast to leukemic cells, RBL did not induce apoptosis in normal PBMC, isolated CD3+ve cells and undifferentiated CD34+ve hematopoietic stem and progenitor cells (HSPCs). The findings highlight the differential effects of RBL on transformed and normal hematopoietic cells and suggest that RBL may be explored for therapeutic applications in leukemia.	[Pujari, Radha; Kumar, Natesh; Shastry, Padma] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Eligar, Sachin M.; Barkeer, Srikanth; Reddy, Vishwanath; Swamy, Bale M.; Inamdar, Shashikala R.] Karnatak Univ, Dept Biochem, Dharwad, Karnataka, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Karnatak University	Shastry, P (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune, Maharashtra, India.	padma@nccs.res.in		Barkeer, Srikanth/0000-0001-9540-9033	DST-India; NCCS, Pune, India	DST-India(Department of Science & Technology (India)); NCCS, Pune, India	The project was partly funded by DST-India and the remaining by the in-house funding of NCCS, Pune, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; Bhutia SK, 2008, TOXICOL IN VITRO, V22, P344, DOI 10.1016/j.tiv.2007.09.016; BOGDANOV AA, 1989, EXP CELL RES, V181, P362, DOI 10.1016/0014-4827(89)90094-3; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chan YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038961; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Dharmu I, 2007, IN VITRO CELL DEV-AN, V43, P306, DOI 10.1007/s11626-007-9055-z; Durand G, 2000, CLIN CHEM, V46, P795; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Eligar SM, 2013, J GLYCOBIOL, pS1, DOI [10. 4172/2168-958X. S1-001, DOI 10.4172/2168-958X.S1-001]; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Flotho C, 2006, BLOOD, V108, P1050, DOI 10.1182/blood-2006-01-0322; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jones DT, 2001, BLOOD, V98, P2800, DOI 10.1182/blood.V98.9.2800; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kang TB, 2007, J BIOCHEM MOL BIOL, V40, P959; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li YR, 2008, BBA-GEN SUBJECTS, V1780, P51, DOI 10.1016/j.bbagen.2007.09.004; Liang Y, 2009, BIOCHEM BIOPH RES CO, V386, P437, DOI 10.1016/j.bbrc.2009.06.054; Liu B, 2009, BBA-GEN SUBJECTS, V1790, P840, DOI 10.1016/j.bbagen.2009.04.020; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Liu MJ, 2005, CANCER CHEMOTH PHARM, V55, P79, DOI 10.1007/s00280-004-0849-3; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANN KK, 1994, EUR J CELL BIOL, V65, P145; Mata JF, 2010, PEDIATR BLOOD CANCER, V55, P100, DOI 10.1002/pbc.22463; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nagre NN, 2010, GLYCOCONJUGATE J, V27, P375, DOI 10.1007/s10719-010-9285-2; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; O'Brien SM, 2005, J CLIN ONCOL, V23, P7697, DOI 10.1200/JCO.2005.02.4364; O'Brien S, 2007, J CLIN ONCOL, V25, P1114, DOI 10.1200/JCO.2006.07.1191; Pujari R, 2012, BIOCHEM BIOPH RES CO, V419, P708, DOI 10.1016/j.bbrc.2012.02.084; Pujari R, 2010, BBA-GEN SUBJECTS, V1800, P1268, DOI 10.1016/j.bbagen.2010.09.003; Sangeetha VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029383; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Sleiman RJ, 1998, BRIT J CANCER, V77, P40, DOI 10.1038/bjc.1998.7; STANLEY P, 1981, CELL, V23, P763, DOI 10.1016/0092-8674(81)90440-2; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Wang CL, 2012, CELL BIOCH BIOPHYS; Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2; ZANETTA JP, 1992, HISTOCHEM J, V24, P791, DOI 10.1007/BF01046351; Zhao JK, 2009, TOXICON, V53, P360, DOI 10.1016/j.toxicon.2008.12.009	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79311	10.1371/journal.pone.0079311	http://dx.doi.org/10.1371/journal.pone.0079311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244478	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800061
J	Steen, VM; Nepal, C; Ersland, KM; Holdhus, R; Naevdal, M; Ratvik, SM; Skrede, S; Havik, B				Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte			Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1	PLOS ONE			English	Article							BIPOLAR-DISORDER; SYNAPSE ELIMINATION; DRUG-NAIVE; RNA-SEQ; GENOME; MYELINATION; ASSOCIATION; POPULATION; PLASTICITY; MOLECULES	Recent meta-analyses of schizophrenia genome-wide association studies (GWASs) have identified the CUB and SUSHI multiple domains 1 (CSMD1) gene as a statistically strong risk factor. CSMD1 is a complement control-related protein suggested to inhibit the classical complement pathway, being expressed in developing neurons. However, expression of CSMD1 is largely uncharacterized and relevance for behavioral phenotypes is not previously demonstrated. Here, we assess neuropsychological behaviors of a Csmd1 knockout (KO) mouse in a selection of standard behavioral tests. Deregulation of neuropsychological responses were observed in both the open field and the elevated plus maze tests, in which KO mice spent 55% and 33% less time than WT littermate mice in open areas, respectively. Altered behaviors were also observed in tail suspension and to higher acoustic stimuli, for which Csmd1 KO mice showed helplessness and moderate increase in startle amplitude, respectively. Furthermore, Csmd1 KO mice also displayed increased weight-gain and glucose tolerance, similar to a major phenotype of the metabolic syndrome that also has been associated to the human CSMD1 locus. Consistent with a role in the control of behaviors, Csmd1 was found highly expressed in the central nervous system (CNS), and with some expression in visceral fat and ovary, under tissue-specific control by a novel promoter-associated lncRNA. In summary, disruption of Csmd1 induces behaviors reminiscent of blunted emotional responses, anxiety and depression. These observations suggest an influence of the CSMD1 schizophrenia susceptibility gene on psychopathology and endophenotypes of the negative symptom spectra.	[Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Univ Bergen, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, Bergen, Norway; [Steen, Vidar M.; Nepal, Chirag; Ersland, Kari M.; Holdhus, Rita; Naevdal, Marianne; Ratvik, Siri M.; Skrede, Silje; Havik, Bjarte] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Havik, B (corresponding author), Univ Bergen, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway.	bjarte.haavik@uib.no	Skrede, Silje/AAA-4453-2019; Nepal, Chirag/K-5866-2019	Ersland, Kari Merete/0000-0003-3674-4151; Nepal, Chirag/0000-0001-8402-3805	Research Council of Norway (Psykisk Helse Grant) [186001]; Research Council of Norway (FUGE Grant) [151904, 183327]; Bergen Medical Research Foundation (BMFS); Kristian Gerhard Jebsen Foundation; Helse Vest RHF; Dr. Einar Martens Fund	Research Council of Norway (Psykisk Helse Grant); Research Council of Norway (FUGE Grant); Bergen Medical Research Foundation (BMFS); Kristian Gerhard Jebsen Foundation; Helse Vest RHF; Dr. Einar Martens Fund	This study was supported by the Research Council of Norway (Psykisk Helse Grant No. 186001 and the FUGE Grant Nos. 151904 and 183327), Bergen Medical Research Foundation (BMFS), The Kristian Gerhard Jebsen Foundation, Helse Vest RHF and Dr. Einar Martens Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; de Morentin PBM, 2011, REV ENDOCR METAB DIS, V12, P127, DOI 10.1007/s11154-011-9165-5; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Dernovsek MZ, 2009, PSYCHIAT DANUB, V21, P43; Distler MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051235; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; Ferno J, 2011, FRONT BIOSCI-LANDMRK, V16, P49, DOI 10.2741/3675; Friddle CJ, 2003, COLD SPRING HARB SYM, V68, P311, DOI 10.1101/sqb.2003.68.311; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Juutinen J, 2008, EUR PSYCHIAT, V23, P521, DOI 10.1016/j.eurpsy.2008.06.002; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kirkpatrick B, 2012, SCHIZOPHRENIA BULL, V38, P280, DOI 10.1093/schbul/sbq058; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Matsui M, 2013, ACS CHEM BIOL, V8, P122, DOI 10.1021/cb300490j; Nock Nora L, 2009, BMC Proc, V3 Suppl 7, pS50; Ramos PS, 2012, ARTHRITIS RHEUM-US, V64, P4060, DOI 10.1002/art.34663; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ritsner MS, 2007, QUALITY LIFE IMPAIRM, P388; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Schulze TG, 2012, WORLD J BIOL PSYCHIA, P1; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sun PC, 2001, GENOMICS, V75, P17, DOI 10.1006/geno.2001.6587; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Thakore JH, 2002, INT J OBESITY, V26, P137, DOI 10.1038/sj.ijo.0801840; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217	47	43	48	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79501	10.1371/journal.pone.0079501	http://dx.doi.org/10.1371/journal.pone.0079501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244513	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800084
J	Atzema, CL; Austin, PC; Wu, LB; Brzozowski, M; Feldman, MJ; McDonnell, M; Mazurik, L				Atzema, Clare L.; Austin, Peter C.; Wu, Libo; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie			Speak Fast, Use Jargon, and Don't Repeat Yourself: A Randomized Trial Assessing the Effectiveness of Online Videos to Supplement Emergency Department Discharge Instructions	PLOS ONE			English	Article							CARE; COMPREHENSION; INFORMATION; QUALITY	Background: Emergency department discharge instructions are variably understood by patients, and in the setting of emergency department crowding, innovations are needed to counteract shortened interaction times with the physician. We evaluated the effect of viewing an online video of diagnosis-specific discharge instructions on patient comprehension and recall of instructions. Methods: In this prospective, single-center, randomized controlled trial conducted between November 2011 and January 2012, we randomized emergency department patients who were discharged with one of 38 diagnoses to either view (after they left the emergency department) a vetted online video of diagnosis-specific discharge instructions, or to usual care. Patients were subsequently contacted by telephone and asked three standardized questions about their discharge instructions; one point was awarded for each correct answer. Using an intention-to-treat analysis, differences between groups were assessed using univariate testing, and with logistic regression that accounted for clustering on managing physician. A secondary outcome measure was patient satisfaction with the videos, on a 10-point scale. Results: Among 133 patients enrolled, mean age was 46.1 (s.d.D. 21.5) and 55% were female. Patients in the video group had 19% higher mean scores (2.5, s.d. 0.7) than patients in the control group (2.1, s.d. 0.8) (p=0.002). After adjustment for patient age, sex, first language, triage acuity score, and clustering, the odds of achieving a fully correct score (3 out of 3) were 3.5 (95% CI, 1.7 to 7.2) times higher in the video group, compared to the control group. Among those who viewed the videos, median rating of the videos was 10 (IQR 8 to 10). Conclusions: In this single-center trial, patients who viewed an online video of their discharge instructions scored higher on their understanding of key concepts around their diagnosis and subsequent care. Those who viewed the videos found them to be a helpful addition to standard care.	[Atzema, Clare L.; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Atzema, Clare L.; Wu, Libo; Brzozowski, Michael; Feldman, Michael J.; McDonnell, Michael; Mazurik, Laurie] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Atzema, Clare L.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Atzema, CL (corresponding author), Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada.	clare.atzema@ices.on.ca		Austin, Peter/0000-0003-3337-233X; Atzema, Clare/0000-0002-7236-5522	Academic Physician's Fund (AFP); Department of Emergency Services at Sunnybrook Health Sciences Centre; Department of Medicine, University of Toronto; Sunnybrook Research Institute; Heart and Stroke Foundation	Academic Physician's Fund (AFP); Department of Emergency Services at Sunnybrook Health Sciences Centre; Department of Medicine, University of Toronto(University of Toronto); Sunnybrook Research Institute(University of Toronto); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This project was supported by a grant from the Academic Physician's Fund (AFP). Dr. Atzema is supported by the Practice Plan of the Department of Emergency Services at Sunnybrook Health Sciences Centre, the Department of Medicine, University of Toronto, and the Sunnybrook Research Institute. Dr. Austin is supported by a Career Investigator award from the Heart and Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambulatory and Hospital Care Statistics Branch, 2013, NAT HOSP AMB MED CAR; Atzema CL, 2012, INT J CLIN MED, V3, P758, DOI [10.4236/ijcm.2012.37A133, DOI 10.4236/IJCM.2012.37A133]; AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5; Beveridge R., 1998, IMPLEMENTATION GUIDE; Chan BT, 2001, ATLAS REPORT EMERGEN; Choi S, 2009, SOUTH MED J, V102, P239, DOI 10.1097/SMJ.0b013e318197f319; Clark PA, 2005, PATIENT EDUC COUNS, V59, P56, DOI 10.1016/j.pec.2004.09.010; Clarke Collin, 2005, CJEM, V7, P5; Dalkey NC, 1969, DELPHI METHOD EXPT A; Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS), 2008, REV APP A INT GUID H; Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; Institute of Medicine, 2006, HOSP BAS EM CAR BREA; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Johnson A., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003716; Kawano T, 2013, EMERG MED J; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1197/aemj.9.11.1131; Mace CA, 1962, PSYCHOL STUDY; Miro O, 1999, Eur J Emerg Med, V6, P105; Papa L, 2008, CAN J EMERG MED, V10, P347; Rhodes KV, 2004, ANN EMERG MED, V44, P262, DOI 10.1016/j.annemergmed.2004.02.035; Rowe B, 2006, FREQUENCY DETERMINEN; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; The World Bank, 2012, INT US PER 100 PEOPL; VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640; Waisman Y, 2003, ISRAEL MED ASSOC J, V5, P567; Waisman Y, 2005, EUR J EMERG MED, V12, P159, DOI 10.1097/00063110-200508000-00003	29	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77057	10.1371/journal.pone.0077057	http://dx.doi.org/10.1371/journal.pone.0077057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244272	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600006
J	Gandhi, AK; Shi, T; Li, MY; Jungnelius, U; Romano, A; Tabernero, J; Siena, S; Schafer, PH; Chopra, R				Gandhi, Anita K.; Shi, Tao; Li, Mingyu; Jungnelius, Ulf; Romano, Alfredo; Tabernero, Josep; Siena, Salvatore; Schafer, Peter H.; Chopra, Rajesh			Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients	PLOS ONE			English	Article							MULTIPLE-MYELOMA; CELL; CEREBLON; INHIBIT; CC-5013; CC-4047; TARGET	This study assessed the immunomodulatory effects in previously treated KRAS-mutant metastatic colorectal cancer patients participating in a phase II multicenter, open-label clinical trial receiving lenalidomide alone or lenalidomide plus cetuximab. The main findings show the T cell immunostimulatory properties of lenalidomide as the drug induced a decrease in the percentage CD45RA(+) naive T cells 3-fold while increasing the percentage HLA-DR+ activated T helper cells and percentage total CD45RO(+) CD8(+) memory T cytotoxic cells, 2.6- and 2.1-fold respectively (p<0.0001). In addition, lenalidomide decreased the percentage of circulating CD19(+) B cells 2.6-fold (p<0.0001). Lenalidomide increased a modest, yet significant, 1.4-fold change in the percentage of circulating natural killer cells. Our findings indicate that lenalidomide significantly activates T cells, suggestive of an immunotherapeutic role for this drug in settings of maintenance therapy and tumor immunity. Furthermore, reported for the first time is the effect of lenalidomide in combination with cetuximab on T cell function, including increases in circulating naive and central memory T cells. In summary, lenalidomide and cetuximab have significant effects on circulating immune cells in patients with colorectal carcinoma.	[Gandhi, Anita K.; Schafer, Peter H.; Chopra, Rajesh] Celgene Corp, Dept Translat Dev, Summit, NJ 07901 USA; [Shi, Tao] Celgene Corp, Dept Sci Informat Syst, San Diego, CA USA; [Li, Mingyu] Celgene Corp, Dept Biostat & Programming, Summit, NJ USA; [Jungnelius, Ulf; Romano, Alfredo] Celgene, Clin Res & Dev, Summit, NJ USA; [Tabernero, Josep] Vall dHebron Univ Hosp, Barcelona, Spain; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Inst Oncol, E-08193 Barcelona, Spain; [Siena, Salvatore] Osped Niguarda Ca Granda, Milan, Italy	Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Gandhi, AK (corresponding author), Celgene Corp, Dept Translat Dev, Summit, NJ 07901 USA.	agandhi@celgene.com	SIENA, SALVATORE/AAC-5806-2019; Tabernero, Josep/AAG-5026-2019	SIENA, SALVATORE/0000-0002-2681-2846; Tabernero, Josep/0000-0002-2495-8139; , Tao/0000-0001-5489-2655	Celgene Corporation; Oncologia Ca' Granda Onlus (OCGO) Fondazione; Cancer Research UK [11566] Funding Source: researchfish	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); Oncologia Ca' Granda Onlus (OCGO) Fondazione; Cancer Research UK(Cancer Research UK)	The authors would like to thank Robert Beck for coordinating data transfers and analysis. Medical editorial services were provided by Kim Grootscholten, MSc, of Excerpta Medica BV, funded by Celgene Corporation. Salvatore Siena is supported by Oncologia Ca' Granda Onlus (OCGO) Fondazione. The authors are fully responsible for content and editorial decisions for this manuscript. Celgene Corporation funded this study and was entirely responsible for study design, data collection and analysis and decision to publish.	Barbera-Guillem E, 2000, CANCER IMMUNOL IMMUN, V48, P541, DOI 10.1007/PL00006672; Bartlett JB, 2004, BRIT J CANCER, V90, P955, DOI 10.1038/sj.bjc.6601579; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botta C, 2012, J IMMUNOTHER, V35, P440, DOI 10.1097/CJI.0b013e31825943aa; Corral LG, 1999, J IMMUNOL, V163, P380; Ferrajoli A, 2008, BLOOD, V111, P5291, DOI 10.1182/blood-2007-12-130120; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Gandhi AK, 2010, CURR CANCER DRUG TAR, V10, P155; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; Hsu AK, 2011, BLOOD, V117, P1605, DOI 10.1182/blood-2010-04-278432; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kneppers E, 2011, BLOOD, V118, P2413, DOI 10.1182/blood-2011-04-348292; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; R Development Core Team, 2012, R LANG ENV STAT COMP; Schafer PH, 2003, J PHARMACOL EXP THER, V305, P1222, DOI 10.1124/jpet.102.048496; Siena S, 2013, PLOS ONE IN PRESS, V8; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Streetly MJ, 2008, BRIT J HAEMATOL, V141, P41, DOI 10.1111/j.1365-2141.2008.07013.x; Wu L, 2008, J CLIN ONCOL S15, V26; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Zhu D, 2008, CANCER IMMUNOL IMMUN, V57, P1849, DOI 10.1007/s00262-008-0512-7; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	22	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80437	10.1371/journal.pone.0080437	http://dx.doi.org/10.1371/journal.pone.0080437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244687	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600209
J	Goodwin, K; Syme, C; Abrahamowicz, M; Leonard, GT; Richer, L; Perron, M; Veillette, S; Gaudet, D; Paus, T; Pausova, Z				Goodwin, Katie; Syme, Catriona; Abrahamowicz, Michal; Leonard, Gabriel T.; Richer, Louis; Perron, Michel; Veillette, Suzanne; Gaudet, Daniel; Paus, Tomas; Pausova, Zdenka			Routine Clinical Measures of Adiposity as Predictors of Visceral Fat in Adolescence: A Population-Based Magnetic Resonance Imaging Study	PLOS ONE			English	Article							TOTAL-BODY FAT; NUTRITION-EXAMINATION-SURVEY; AMERICAN-HEART-ASSOCIATION; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; SUBCUTANEOUS FAT; SCIENTIFIC STATEMENT; ABDOMINAL ADIPOSITY	Objective: Visceral fat (VF) increases cardiometabolic risk more than fat stored subcutaneously. Here, we investigated how well routine clinical measures of adiposity, namely body mass index (BMI) and waist circumference (waist), predict VF and subcutaneous fat (SF) in a large population-based sample of adolescents. As body-fat distribution differs between males and females, we performed these analyses separately in each sex. Design and Methods: VF and SF were measured by magnetic resonance imaging in 1,002 adolescents (482 males, age 12-18 years). Relationships of BMI and waist with VF and SF were tested in multivariable analyses, which adjusted for potentially confounding effects of age and height. Results: In both males and females, BMI and waist were highly correlated with VF and SF, and explained 55-76% of their total variance. When VF was adjusted for SF, however, BMI and waist explained, respectively, only 0% and 4% of VF variance in males, and 4% and 11% of VF variance in females. In contrast, when SF was adjusted for VF, BMI and waist explained, respectively, 36% and 21% of SF variance in males, and 48% and 23% of SF variance in females. These relationships were similar during early and late puberty. Conclusions and Relevance: During adolescence, routine clinical measures of adiposity predict well SF but not VF. This holds for both sexes and throughout puberty. Further longitudinal studies are required to assess how well these measures predict changes of VF and SF over time. Given the clinical importance of VF, development of cost-effective imaging techniques and/or robust biomarkers of VF accumulation that would be suitable in everyday clinical practice is warranted.	[Goodwin, Katie; Syme, Catriona; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Abrahamowicz, Michal] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Leonard, Gabriel T.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Richer, Louis] Univ Quebec Chicoutimi, Dept Psychol, Chicoutimi, PQ, Canada; [Veillette, Suzanne] Univ Quebec Chicoutimi, Dept Human Sci, Chicoutimi, PQ, Canada; [Gaudet, Daniel] Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Chicoutimi, PQ, Canada; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal; University of Toronto; University Toronto Affiliates; Baycrest	Pausova, Z (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	zdenka.pausova@sickkids.ca		Goodwin, Katharine/0000-0002-4823-7491; Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The Canadian Institutes of Health Research (Zdenka Pausova, Tomas Paus), Heart and Stroke Foundation of Canada (Zdenka Pausova), and the Canadian Foundation for Innovation (Zdenka Pausova) support the Saguenay Youth Study. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University. Tomas Paus is the Tanenbaum Chair in Population Neuroscience at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; Arbatan T, 2012, ADV HEALTHC MATER, V1, P80, DOI 10.1002/adhm.201100016; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Benfield LL, 2008, INT J OBESITY, V32, P91, DOI 10.1038/sj.ijo.0803780; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; BOLINDER J, 1983, DIABETES, V32, P117, DOI 10.2337/diabetes.32.2.117; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Goran MI, 1998, INT J OBESITY, V22, P549, DOI 10.1038/sj.ijo.0800624; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Johnson WD, 2009, ARCH PEDIAT ADOL MED, V163, P371, DOI 10.1001/archpediatrics.2009.3; Katzmarzyk PT, 2012, PEDIATR OBES, V7, pE42, DOI 10.1111/j.2047-6310.2012.00073.x; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Liu A, 2009, OBES SURG, V19, P1564, DOI 10.1007/s11695-009-9949-9; MARSHALL WA, 1974, ANN HUM BIOL, V1, P29, DOI 10.1080/03014467400000031; McGill HC, 2003, JAMA-J AM MED ASSOC, V290, P2320, DOI 10.1001/jama.290.17.2320; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Pou KM, 2009, DIABETES CARE, V32, P481, DOI 10.2337/dc08-1359; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Shen W, 2011, INT J PEDIATR OBES, V6, P149, DOI 10.3109/17477166.2010.486833; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Siegel MJ, 2007, RADIOLOGY, V242, P846, DOI 10.1148/radiol.2423060111; Smith JD, 2012, J CLIN ENDOCR METAB, V97, P1517, DOI 10.1210/jc.2011-2550; Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Suliga E, 2009, NUTR RES REV, V22, P137, DOI 10.1017/S0954422409990096; Syme C, 2008, ARCH PEDIAT ADOL MED, V162, P453, DOI 10.1001/archpedi.162.5.453; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	53	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79896	10.1371/journal.pone.0079896	http://dx.doi.org/10.1371/journal.pone.0079896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244574	Green Accepted, Green Published, gold			2022-12-27	WOS:000327221600157
J	Healy, B; Field, D; O'Connor, PM; Hill, C; Cotter, PD; Ross, RP				Healy, Brian; Field, Des; O'Connor, Paula M.; Hill, Colin; Cotter, Paul D.; Ross, R. Paul			Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives	PLOS ONE			English	Article							PRECURSOR LIPID-II; LANTIBIOTIC NISIN; BIOSYNTHESIS; MODE; PEPTIDES; VARIANT; IDENTIFICATION; BACTERIOCINS; ANTIBIOTICS; IMMUNITY	Nisin A is the most extensively studied lantibiotic and has been used as a preservative by the food industry since 1953. This 34 amino acid peptide contains three dehydrated amino acids and five thioether rings. These rings, resulting from one lanthionine and four methyllanthionine bridges, confer the peptide with its unique structure. Nisin A has two mechanisms of action, with the N-terminal domain of the peptide inhibiting cell wall synthesis through lipid II binding and the C-terminal domain responsible for pore-formation. The focus of this study is the three amino acid 'hinge' region (N 20, M 21 and K 22) which separates these two domains and allows for conformational flexibility. As all lantibiotics are gene encoded, novel variants can be generated through manipulation of the corresponding gene. A number of derivatives in which the hinge region was altered have previously been shown to possess enhanced antimicrobial activity. Here we take this approach further by employing simultaneous, indiscriminate site-saturation mutagenesis of all three hinge residues to create a novel bank of nisin derivative producers. Screening of this bank revealed that producers of peptides with hinge regions consisting of AAK, NAI and SLS displayed enhanced bioactivity against a variety of targets. These and other results suggested a preference for small, chiral amino acids within the hinge region, leading to the design and creation of producers of peptides with hinges consisting of AAA and SAA. These producers, and the corresponding peptides, exhibited enhanced bioactivity against Lactococcus lactis HP, Streptococcus agalactiae ATCC 13813, Mycobacterium smegmatis MC2155 and Staphylococcus aureus RF122 and thus represent the first example of nisin derivatives that possess enhanced activity as a consequence of rational design.	[Healy, Brian; Field, Des; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O'Connor, Paula M.; Hill, Colin; Cotter, Paul D.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University College Cork; Teagasc	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.	c.hill@ucc.ie; paul.cotter@teagasc.ie	Cotter, Paul/B-7781-2008; Field, Des/AAU-6785-2021; Ross, Paul/A-7584-2015; Hill, Colin/A-5611-2012; Cotter, Paul/AAX-5449-2021; STANTON, CATHERINE/A-9549-2015	Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; O'Connor, Paula M./0000-0001-6462-2077; Healy, Brian/0000-0002-8752-0548	Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure [08/RD/C/691]; Science Foundation Investigator award [10/IN.1/B3027]	Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure; Science Foundation Investigator award	This work was financed by a grant from the Irish Department of Agriculture, Food and the Marine through the Food Institutional Research Measure (08/RD/C/691) and with Science Foundation Investigator award (10/IN.1/B3027). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MOL MICROBIOL, V78, P1077, DOI 10.1111/j.1365-2958.2010.07406.x; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Healy B, 2010, ADV M C M, P22, DOI 10.1079/9781845936570.0022; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Molloy EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058530; Molloy EM, 2012, BIOCHEM SOC T, V40, P1492, DOI 10.1042/BST20120193; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; Nov Y, 2012, APPL ENVIRON MICROB, V78, P258, DOI 10.1128/AEM.06265-11; Plat A, 2011, POLYMERS-BASEL, V3, P1282, DOI 10.3390/polym3031282; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1; Zendo T, 2003, BIOSCI BIOTECH BIOCH, V67, P1616, DOI 10.1271/bbb.67.1616; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P18361, DOI 10.1073/pnas.1210393109	35	53	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79563	10.1371/journal.pone.0079563	http://dx.doi.org/10.1371/journal.pone.0079563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244524	gold, Green Published			2022-12-27	WOS:000327221600134
J	Kneissl, S; Zhou, Q; Schwenkert, M; Cosset, FL; Verhoeyen, E; Buchholz, CJ				Kneissl, Sabrina; Zhou, Qi; Schwenkert, Michael; Cosset, Francois-Loic; Verhoeyen, Els; Buchholz, Christian J.			CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; CHAIN FV ANTIBODY; MEASLES-VIRUS; LENTIVIRAL VECTORS; GENE-TRANSFER; T-CELLS; CYCLE PROGRESSION; TRANSDUCTION; EXPRESSION; ENTRY	B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors. Lately, we demonstrated that lentiviral vectors pseudotyped with modified measles virus (MV) glycoproteins hemagglutinin, responsible for receptor recognition, and fusion protein were able to overcome this transduction block. They use either the natural MV receptors, CD46 and signaling lymphocyte activation molecule (SLAM), for cell entry (MV-LV) or the vector particles were further modified to selectively enter via the CD20 molecule, which is exclusively expressed on B lymphocytes (CD20-LV). It has been shown previously that transduction by MV-LV does not induce B lymphocyte activation. However, if this is also true for CD20-LV is still unknown. Here, we generated a vector specific for another B lymphocyte marker, CD19, and compared its ability to transduce resting B lymphocytes with CD20-LV. The vector (CD19ds-LV) was able to stably transduce unstimulated B lymphocytes, albeit with a reduced efficiency of about 10% compared to CD20-LV, which transduced about 30% of the cells. Since CD20 as well as CD19 are closely linked to the B lymphocyte activation pathway, we investigated if engagement of CD20 or CD19 molecules by the vector particles induces activating stimuli in resting B lymphocytes. Although, activation of B lymphocytes often involves calcium influx, we did not detect elevated calcium levels. However, the activation marker CD71 was substantially up-regulated upon CD20-LV transduction and most importantly, B lymphocytes transduced with CD20-LV or CD19ds-LV entered the G1b phase of cell cycle, whereas untransduced or MV-LV transduced B lymphocytes remained in G0. Hence, CD20 and CD19 targeting vectors induce activating stimuli in resting B lymphocytes, which most likely renders them susceptible for lentiviral vector transduction.	[Kneissl, Sabrina; Zhou, Qi; Buchholz, Christian J.] Paul Ehrlich Inst, Langen, Germany; [Schwenkert, Michael] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Cosset, Francois-Loic; Verhoeyen, Els] Univ Lyon 1, ENS Lyon, Inserm U1111, CIRI,Int Ctr Infectiol Res,EVIR Team,CNRS,UMR5308, F-69365 Lyon, France; [Verhoeyen, Els] Fac Med Nice, INSERM, U895, Ctr Med Mol C3M,Equipe 3, F-06034 Nice, France	Paul Ehrlich Institute; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Buchholz, CJ (corresponding author), Paul Ehrlich Inst, Langen, Germany.	Christian.Buchholz@pei.de	Cosset, François-Loïc/M-5862-2019; Verhoeyen, Els/AAW-4853-2021; Verhoeyen, Els/H-6360-2016	Cosset, François-Loïc/0000-0001-8842-3726; Verhoeyen, Els/0000-0001-9224-5491; Buchholz, Christian/0000-0002-9837-7345	Federal Ministry for Education and Research of Germany as part of Ci3 Cluster [031A024C]; LOEWE Center for Cell and Gene Therapy; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004 [2010]]; China Scholarship Council; DFG Graduiertenkolleg [GRK1172]	Federal Ministry for Education and Research of Germany as part of Ci3 Cluster; LOEWE Center for Cell and Gene Therapy; Hessisches Ministerium fur Wissenschaft und Kunst; China Scholarship Council(China Scholarship Council); DFG Graduiertenkolleg(German Research Foundation (DFG))	This work was supported by grant 031A024C of the Federal Ministry for Education and Research of Germany as part of the Ci3 Cluster and by the LOEWE Center for Cell and Gene Therapy Frankfurt funded by Hessisches Ministerium fur Wissenschaft und Kunst (III L 4-518/17.004 [2010]) to CJB. QZ was supported by the China Scholarship Council and is an associated member of the DFG Graduiertenkolleg GRK1172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Bruenke J, 2005, BRIT J HAEMATOL, V130, P218, DOI 10.1111/j.1365-2141.2005.05414.x; Bucheit AD, 2003, MOL THER, V7, P62, DOI 10.1016/S1525-0016(02)00033-3; Buchholz CJ, 2009, TRENDS BIOTECHNOL, V27, P259, DOI 10.1016/j.tibtech.2009.02.002; Cragg Mark S., 2005, V8, P140; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Frecha C, 2011, J VIROL, V85, P5975, DOI 10.1128/JVI.00324-11; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Frecha C, 2008, BLOOD, V112, P4843, DOI 10.1182/blood-2008-05-155945; Fujimoto M, 2001, J BIOL CHEM, V276, P44820, DOI 10.1074/jbc.M107559200; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Ginaldi L, 1998, J CLIN PATHOL, V51, P364, DOI 10.1136/jcp.51.5.364; GOLAY JT, 1985, J IMMUNOL, V135, P3795; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; ITOH K, 1989, EXP HEMATOL, V17, P145; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Kneissl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046667; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Kugler M, 2009, PROTEIN ENG DES SEL, V22, P135, DOI 10.1093/protein/gzn079; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Li XL, 1997, J IMMUNOL, V158, P5649; Munch RC, 2011, MOL THER, V19, P686, DOI 10.1038/mt.2010.298; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Peipp M, 2004, J IMMUNOL METHODS, V285, P265, DOI 10.1016/j.jim.2003.12.001; PEZZUTTO A, 1987, J IMMUNOL, V138, P2793; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; Serafini M, 2004, VIROLOGY, V325, P413, DOI 10.1016/j.virol.2004.04.038; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zanetti M, 2004, IMMUNOL REV, V199, P264, DOI 10.1111/j.0105-2896.2004.00152.x; Zhou Q, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22566; Zhou Q, 2012, BLOOD, V120, P4334, DOI 10.1182/blood-2012-02-412973; Zhou Q, 2011, VIROLOGY, V413, P149, DOI 10.1016/j.virol.2011.02.010; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79047	10.1371/journal.pone.0079047	http://dx.doi.org/10.1371/journal.pone.0079047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244415	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600102
J	Ren, Z				Ren, Zhong			Reaction Trajectory Revealed by a Joint Analysis of Protein Data Bank	PLOS ONE			English	Article							RESOLUTION CRYSTAL-STRUCTURES; QUATERNARY STRUCTURE; STRUCTURAL-CHANGES; HUMAN HEMOGLOBIN; ALLOSTERIC TRANSITIONS; LIGAND-BINDING; T-STATE; DYNAMICS; INSIGHTS; STEREOCHEMISTRY	Structural motions along a reaction pathway hold the secret about how a biological macromolecule functions. If each static structure were considered as a snapshot of the protein molecule in action, a large collection of structures would constitute a multidimensional conformational space of an enormous size. Here I present a joint analysis of hundreds of known structures of human hemoglobin in the Protein Data Bank. By applying singular value decomposition to distance matrices of these structures, I demonstrate that this large collection of structural snapshots, derived under a wide range of experimental conditions, arrange orderly along a reaction pathway. The structural motions along this extensive trajectory, including several helical transformations, arrive at a reverse engineered mechanism of the cooperative machinery (Ren, companion article), and shed light on pathological properties of the abnormal homotetrameric hemoglobins from alpha-thalassemia. This method of meta-analysis provides a general approach to structural dynamics based on static protein structures in this post genomics era.	[Ren, Zhong] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL 60439 USA; [Ren, Zhong] Renz Res Inc, Westmont, IL USA	University of Chicago	Ren, Z (corresponding author), Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL 60439 USA.	renzresearch@gmail.com			National Institutes of Health, National Center for Research Resources [RR007707]; National Institute of General Medical Sciences [8P41GM103543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103543] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research funding is provided by the National Institutes of Health, National Center for Research Resources (ncrr.nih.gov), under grant number RR007707, and by the National Institute of General Medical Sciences (nigms.nih.gov), under grant number 8P41GM103543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author declares no competing financial interests.	Abbruzzetti S, 2001, CHEM PHYS LETT, V346, P430, DOI 10.1016/S0009-2614(01)01027-2; Adachi S, 2003, P NATL ACAD SCI USA, V100, P7039, DOI 10.1073/pnas.1230629100; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Balasubramanian M, 2009, ACTA CRYSTALLOGR F, V65, P313, DOI 10.1107/S1744309109004503; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P831, DOI 10.1006/jmbi.1994.1192; BORGSTAHL GEO, 1994, J MOL BIOL, V236, P817, DOI 10.1006/jmbi.1994.1191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butts CP, 2011, ORG BIOMOL CHEM, V9, P177, DOI 10.1039/c0ob00479k; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; Dey S, 2011, PROTEINS, V79, P2861, DOI 10.1002/prot.23112; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; Fischer S, 2011, P NATL ACAD SCI USA, V108, P5608, DOI 10.1073/pnas.1011995108; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; GODZIK A, 1993, PROTEIN ENG, V6, P801, DOI 10.1093/protein/6.8.801; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Kidd RD, 2001, PROTEIN SCI, V10, P1739, DOI 10.1110/ps.11701; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kloczkowski Andrzej, 2009, Journal of Structural and Functional Genomics, V10, P67, DOI 10.1007/s10969-009-9062-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kroeger KS, 1997, STRUCTURE, V5, P227, DOI 10.1016/S0969-2126(97)00181-0; LIDDINGTON R, 1988, NATURE, V331, P725, DOI 10.1038/331725a0; Luo HY, 2004, AM J HEMATOL, V77, P384, DOI 10.1002/ajh.20209; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Papadimitriou C. H., 1977, Theoretical Computer Science, V4, P237, DOI 10.1016/0304-3975(77)90012-3; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Rajagopala S, 2004, ACTA CRYSTALLOGR D, V60, P860, DOI 10.1107/S0907444904004160; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ren Z, 2013, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0077363., DOI 10.1371/J0URNAL.P0NE.0077363]; Ren Z, 2013, ACTA CRYSTALLOGR D, V69, P946, DOI 10.1107/S0907444913003454; Ren Z, 2012, P NATL ACAD SCI USA, V109, P107, DOI 10.1073/pnas.1109213108; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Tekpinar M, 2013, PROTEINS, V81, P240, DOI 10.1002/prot.24180; Tsuneshige A, 2004, J BIOL CHEM, V279, P48959, DOI 10.1074/jbc.M405909200; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Wilson J, 1996, J MOL BIOL, V264, P743, DOI 10.1006/jmbi.1996.0674; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Ye JP, 2004, J COMPUT BIOL, V11, P986, DOI 10.1089/cmb.2004.11.986	52	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77141	10.1371/journal.pone.0077141	http://dx.doi.org/10.1371/journal.pone.0077141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244274	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600007
J	Xia, ZQ; Secor, E; Chibnik, LB; Bove, RM; Cheng, SC; Chitnis, T; Cagan, A; Gainer, VS; Chen, PJ; Liao, KP; Shaw, SY; Ananthakrishnan, AN; Szolovits, P; Weiner, HL; Karlson, EW; Murphy, SN; Savova, GK; Cai, TX; Churchill, SE; Plenge, RM; Kohane, IS; De Jager, PL				Xia, Zongqi; Secor, Elizabeth; Chibnik, Lori B.; Bove, Riley M.; Cheng, Suchun; Chitnis, Tanuja; Cagan, Andrew; Gainer, Vivian S.; Chen, Pei J.; Liao, Katherine P.; Shaw, Stanley Y.; Ananthakrishnan, Ashwin N.; Szolovits, Peter; Weiner, Howard L.; Karlson, Elizabeth W.; Murphy, Shawn N.; Savova, Guergana K.; Cai, Tianxi; Churchill, Susanne E.; Plenge, Robert M.; Kohane, Isaac S.; De Jager, Philip L.			Modeling Disease Severity in Multiple Sclerosis Using Electronic Health Records	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MEDICAL-RECORDS; INTEGRATING BIOLOGY; DISCOVERY RESEARCH; BRAIN ATROPHY; WHITE-MATTER; DISABILITY; INFORMATICS; ENTERPRISE; SCALE	Objective: To optimally leverage the scalability and unique features of the electronic health records (EHR) for research that would ultimately improve patient care, we need to accurately identify patients and extract clinically meaningful measures. Using multiple sclerosis (MS) as a proof of principle, we showcased how to leverage routinely collected EHR data to identify patients with a complex neurological disorder and derive an important surrogate measure of disease severity heretofore only available in research settings. Methods: In a cross-sectional observational study, 5,495 MS patients were identified from the EHR systems of two major referral hospitals using an algorithm that includes codified and narrative information extracted using natural language processing. In the subset of patients who receive neurological care at a MS Center where disease measures have been collected, we used routinely collected EHR data to extract two aggregate indicators of MS severity of clinical relevance multiple sclerosis severity score (MSSS) and brain parenchymal fraction (BPF, a measure of whole brain volume). Results: The EHR algorithm that identifies MS patients has an area under the curve of 0.958, 83% sensitivity, 92% positive predictive value, and 89% negative predictive value when a 95% specificity threshold is used. The correlation between EHR-derived and true MSSS has a mean R-2 = 0.38 +/- 0.05, and that between EHR-derived and true BPF has a mean R-2 = 0.22 +/- 0.08. To illustrate its clinical relevance, derived MSSS captures the expected difference in disease severity between relapsing-remitting and progressive MS patients after adjusting for sex, age of symptom onset and disease duration (p = 1.56x10(-12)). Conclusion: Incorporation of sophisticated codified and narrative EHR data accurately identifies MS patients and provides estimation of a well-accepted indicator of MS severity that is widely used in research settings but not part of the routine medical records. Similar approaches could be applied to other complex neurological disorders.	[Xia, Zongqi; Secor, Elizabeth; Chibnik, Lori B.; Bove, Riley M.; Chitnis, Tanuja; Weiner, Howard L.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Xia, Zongqi; Chibnik, Lori B.; Bove, Riley M.; Chitnis, Tanuja; Liao, Katherine P.; Shaw, Stanley Y.; Ananthakrishnan, Ashwin N.; Weiner, Howard L.; Karlson, Elizabeth W.; Murphy, Shawn N.; Savova, Guergana K.; Plenge, Robert M.; Kohane, Isaac S.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Xia, Zongqi; Chibnik, Lori B.; Bove, Riley M.; Plenge, Robert M.; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Cheng, Suchun] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Cagan, Andrew; Gainer, Vivian S.; Murphy, Shawn N.] Partners HealthCare, Res Comp & Informat Serv, Charlestown, MA USA; [Chen, Pei J.; Savova, Guergana K.; Kohane, Isaac S.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Liao, Katherine P.; Karlson, Elizabeth W.; Plenge, Robert M.; Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Szolovits, Peter] MIT, Comp Sci Lab, Cambridge, MA 02139 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Comp Sci Lab, Charlestown, MA USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Churchill, Susanne E.] Partners HealthCare, Natl Ctr Biomed Comp I2b2, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Partners Healthcare System; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Partners Healthcare System	De Jager, PL (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; Secor, Elizabeth/0000-0002-6957-5561; Chibnik, Lori/0000-0001-6293-806X; Szolovits, Peter/0000-0001-8411-6403	National Institutes of Health Office of the Director, National Library of Medicine and the National Institute of General Medical Sciences [NIH U54-LM008748]; National Multiple Sclerosis Society; American Academy of Neurology; NIH [K08-NS079493, K08 AR 060257, K23 DK097142]; Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052403, K08AR060257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS079493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG041906] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director, National Library of Medicine and the National Institute of General Medical Sciences; National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Academy of Neurology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The study was supported by NIH U54-LM008748 from the National Institutes of Health Office of the Director, National Library of Medicine and the National Institute of General Medical Sciences. ZX was a recipient of the Clinician Scientist Development Award from the National Multiple Sclerosis Society and the American Academy of Neurology and is supported by NIH K08-NS079493. KPL is supported by NIH K08 AR 060257 and the Harold and Duval Bowen Fund. ANA is supported by NIH K23 DK097142. PLD is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Efron B., 1994, INTRO BOOTSTRAP; Gauthier SA, 2006, AUTOIMMUN REV, V5, P532, DOI 10.1016/j.autrev.2006.02.012; Himes BE, 2009, J AM MED INFORM ASSN, V16, P371, DOI 10.1197/jamia.M2846; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kister I, 2013, NEUROLOGY, V80, P1018, DOI 10.1212/WNL.0b013e3182872855; Kohane IS, 2012, J AM MED INFORM ASSN, V19, P181, DOI 10.1136/amiajnl-2011-000492; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Liao KP, 2013, ARTHRITIS RHEUM-US, V65, P571, DOI 10.1002/art.37801; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2012, CTS-CLIN TRANSL SCI, V5, P281, DOI 10.1111/j.1752-8062.2011.00387.x; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Newton KM, 2013, J AM MED INFORMATICS; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 2000, MULT SCLER, V6, P365, DOI 10.1191/135245800701566322; Sampat MP, 2010, NEUROIMAGE, V52, P1367, DOI 10.1016/j.neuroimage.2010.03.075; Sanfilipo MP, 2005, NEUROIMAGE, V26, P1068, DOI 10.1016/j.neuroimage.2005.03.008; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Wei XC, 2002, J MAGN RESON IMAGING, V15, P203, DOI 10.1002/jmri.10053; Xia ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014169; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	32	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78927	10.1371/journal.pone.0078927	http://dx.doi.org/10.1371/journal.pone.0078927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244385	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600080
J	Zhang, Y; Tseng, CC; Tsai, YL; Fu, XY; Schiff, R; Lee, AS				Zhang, Yi; Tseng, Chun-Chih; Tsai, Yuan-Li; Fu, Xiaoyong; Schiff, Rachel; Lee, Amy S.			Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; RESPONSE REGULATOR GRP78/BIP; PROTEIN GRP78; ER CHAPERONE; ENDOTHELIAL-CELLS; DRUG-RESISTANCE; TERMINAL DOMAIN; BREAST-CANCER; RECEPTOR; GROWTH	Traditionally, GRP78 has been regarded as an endoplasmic reticulum (ER) lumenal protein due to its carboxyl KDEL retention motif. Recently, a subfraction of GRP78 is found to localize to the surface of specific cell types, serving as co-receptors and regulating signaling. However, the physiological relevance of cell surface GRP78 (sGRP78) expression in cancer and its functional interactions at the cell surface are just emerging. In this report, we combined biochemical, imaging and mutational approaches to address these issues. For detection of sGRP78, we utilized a mouse monoclonal antibody highly potent and specific for GRP78 or epitope-tagged GRP78, coupled with imaging and biochemical techniques that allowed detection of sGRP78 but not intracellular GRP78. Our studies revealed that breast and prostate cancer cells resistant to hormonal therapy actively promote GRP78 to the cell surface, which can be further elevated by a variety of ER stress-inducing conditions. We showed that sGRP78 forms complex with PI3K, and overexpression of sGRP78 promotes PIP3 formation, indicative of PI3K activation. We further discovered that an insertion mutant of GRP78 at its N-terminus domain, while retaining stable expression and the ability to translocate to the cell surface as the wild-type protein, exhibited reduced complex formation with p85 and production of PIP3. Thus, our studies provide a mechanistic explanation for the regulation of the PI3K/AKT signaling by sGRP78. Our findings suggest that targeting sGRP78 may suppress therapeutic resistance in cancer cells and offer a novel strategy to suppress PI3K activity.	[Zhang, Yi; Tseng, Chun-Chih; Tsai, Yuan-Li; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Fu, Xiaoyong; Schiff, Rachel] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA	University of Southern California; Baylor College of Medicine	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	amylee@ccnt.usc.edu	Tseng, Chun-Chih/AAS-3712-2020	Tseng, Chun-Chih/0000-0001-9285-0712; Lee, Amy/0000-0002-0378-5443	National Institutes of Health (NIH) [R01 CA027607, P01 AG034906]; Breast Cancer Research Foundation; SU2C/Breast program; USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core [P30 CA014089]; USC Research Center for Liver Diseases Cell and Tissue Imaging Core [P30 DK048522]; Breast Cancer SPORE [P50 CA058183, P01 CA030195]; NATIONAL CANCER INSTITUTE [R01CA027607, P30CA014089, P01CA030195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; SU2C/Breast program; USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core; USC Research Center for Liver Diseases Cell and Tissue Imaging Core; Breast Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants R01 CA027607 and P01 AG034906 to ASL; P50 CA058183 (Breast Cancer SPORE), P01 CA030195, The Breast Cancer Research Foundation and SU2C/Breast program to RS; P30 CA014089 (USC Norris Comprehensive Cancer Center's Cell and Tissue Imaging Core) and P30 DK048522 (USC Research Center for Liver Diseases Cell and Tissue Imaging Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Delie F, 2012, J ONCOL, V2012, DOI 10.1155/2012/468615; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu R, 2013, CLIN CANC R IN PRESS; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou H, 2011, J BIOL CHEM, V286, P25687, DOI 10.1074/jbc.M110.212944; Zhu GY, 2013, FASEB J, V27, P955, DOI 10.1096/fj.12-213330	50	88	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80071	10.1371/journal.pone.0080071	http://dx.doi.org/10.1371/journal.pone.0080071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244613	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600177
J	Conforti, A; Biagini, S; Del Bufalo, F; Sirleto, P; Angioni, A; Starc, N; Pira, GL; Moretta, F; Proia, A; Contoli, B; Genovese, S; Ciardi, C; Avanzini, MA; Rosti, V; Lo-Coco, F; Locatelli, F; Bernardo, ME				Conforti, Antonella; Biagini, Simone; Del Bufalo, Francesca; Sirleto, Pietro; Angioni, Adriano; Starc, Nadia; Pira, Giuseppina Li; Moretta, Francesca; Proia, Alessandra; Contoli, Benedetta; Genovese, Silvia; Ciardi, Claudia; Avanzini, Maria Antonietta; Rosti, Vittorio; Lo-Coco, Francesco; Locatelli, Franco; Bernardo, Maria Ester			Biological, Functional and Genetic Characterization of Bone Marrow-Derived Mesenchymal Stromal Cells from Pediatric Patients Affected by Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELLS; IN-VITRO; MICROENVIRONMENT; VIVO; CLASSIFICATION; ABERRATIONS; CHILDREN; SURVIVAL; PROFILE	Alterations in hematopoietic microenvironment of acute lymphoblastic leukemia patients have been claimed to occur, but little is known about the components of marrow stroma in these patients. In this study, we characterized mesenchymal stromal cells (MSCs) isolated from bone marrow (BM) of 45 pediatric patients with acute lymphoblastic leukemia (ALL-MSCs) at diagnosis (day+0) and during chemotherapy treatment (days: +15; +33; +78), the time points being chosen according to the schedule of BM aspirates required by the AIEOP-BFM ALL 2009 treatment protocol. Morphology, proliferative capacity, immunophenotype, differentiation potential, immunomodulatory properties and ability to support long-term hematopoiesis of ALL-MSCs were analysed and compared with those from 41 healthy donors (HD-MSCs). ALL-MSCs were also genetically characterized through array-CGH, conventional karyotyping and FISH analysis. Moreover, we compared ALL-MSCs generated at day+0 with those isolated during chemotherapy. Morphology, immunophenotype, differentiation potential and in vitro life-span did not differ between ALL-MSCs and HD-MSCs. ALL-MSCs showed significantly lower proliferative capacity (p<0.001) and ability to support in vitro hematopoiesis (p=0.04) as compared with HD-MSCs, while they had similar capacity to inhibit in vitro mitogen-induced T-cell proliferation (p=N.S.). ALL-MSCs showed neither the typical translocations carried by the leukemic clone (when present), nor other genetic abnormalities acquired during ex vivo culture. Our findings indicate that ALL-MSCs display reduced ability to proliferate and to support long-term hematopoiesis in vitro. ALL-MSCs isolated at diagnosis do not differ from those obtained during treatment.	[Conforti, Antonella; Biagini, Simone; Del Bufalo, Francesca; Starc, Nadia; Pira, Giuseppina Li; Moretta, Francesca; Proia, Alessandra; Contoli, Benedetta; Locatelli, Franco; Bernardo, Maria Ester] Bambino Gesu Pediat Hosp, IRCCS, Dept Pediat Hematol Oncol, Rome, Italy; [Sirleto, Pietro; Angioni, Adriano; Genovese, Silvia] Bambino Gesu Pediat Hosp, IRCCS, Cytogenet & Mol Genet Unit, Rome, Italy; [Ciardi, Claudia; Lo-Coco, Francesco] Univ Tor Vergata, Fdn Santa Lucia, Lab Neuro Oncohematol, Rome, Italy; [Avanzini, Maria Antonietta] Fdn IRCCS Policlin San Matteo, Dept Pediat Hematol Oncol, Pavia, Italy; [Rosti, Vittorio] Fdn IRCCS Policlin San Matteo, Ctr Studio Cura Mielofibrosi, Lab Sperimentali Ric, Area Biotecnol, Pavia, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Santa Lucia; University of Rome Tor Vergata; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia	Bernardo, ME (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Dept Pediat Hematol Oncol, Rome, Italy.	mariaester.bernardo@opbg.net	angioni, adriano/G-1160-2014; Pira, Giuseppina Li/F-7105-2012; Contoli, Benedetta/AAB-2696-2022; Moretta, Francesca/Z-3169-2019; Avanzini, Maria Antonietta/K-7839-2016; Rosti, Vittorio/K-1743-2018; Conforti, Antonella/H-2209-2012; Genovese, Silvia/AAH-9425-2019; sirleto, pietro/G-3902-2014; del bufalo, francesca/AAB-2436-2019; del bufalo, francesca/K-4314-2018	angioni, adriano/0000-0003-0862-2456; Pira, Giuseppina Li/0000-0002-6293-4314; Moretta, Francesca/0000-0002-1150-8622; Avanzini, Maria Antonietta/0000-0002-6056-9018; Rosti, Vittorio/0000-0003-4195-2289; Conforti, Antonella/0000-0001-8524-5936; Genovese, Silvia/0000-0002-5514-5018; sirleto, pietro/0000-0001-5292-3315; Contoli, Benedetta/0000-0003-0479-7822; Sirleto, Pietro/0000-0002-3569-4829; del bufalo, francesca/0000-0001-9643-3465	Istituto Superiore di Sanita (National Program on Stem Cells); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca; Progetti di Rilevante Interesse Nazionale, PRIN); AIRC [56x1000]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG9062]; Bando Giovani Ricercatori	Istituto Superiore di Sanita (National Program on Stem Cells); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Progetti di Rilevante Interesse Nazionale, PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Bando Giovani Ricercatori	This work has been partly supported by grants from Istituto Superiore di Sanita (National Program on Stem Cells), MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Rilevante Interesse Nazionale, PRIN) and by the special grant "56x1000'' from AIRC to FL; and grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) IG9062 and Bando Giovani Ricercatori 2008 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Barachini S, 2009, STEM CELLS DEV, V18, P293, DOI 10.1089/scd.2008.0017; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; BERTINO JR, 1963, CANCER RES, V23, P1286; Blau O, 2007, EXP HEMATOL, V35, P221, DOI 10.1016/j.exphem.2006.10.012; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Campioni D, 2012, ANN HEMATOL, V91, P1563, DOI 10.1007/s00277-012-1500-8; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dimitriou H, 2008, CYTOTHERAPY, V10, P125, DOI 10.1080/14653240701851332; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lecourt S, 2010, STEM CELLS DEV, V19, P203, DOI 10.1089/scd.2009.0062; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; McGookin R, 1985, Methods Mol Biol, V2, P113, DOI 10.1385/0-89603-064-4:113; Menendez P, 2009, J EXP MED, V206, P3131, DOI 10.1084/jem.20091050; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; NEUSS N, 1964, Adv Chemother, V12, P133; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ramakrishnan A, 2006, BLOOD, V108, P772, DOI 10.1182/blood-2006-02-001479; Shalapour S, 2010, J MOL MED, V88, P249, DOI 10.1007/s00109-009-0583-8; Soenen-Cornu V, 2005, ONCOGENE, V24, P2441, DOI 10.1038/sj.onc.1208405; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wiemels Joseph, 2009, V538, P7, DOI 10.1007/978-1-59745-418-6_2; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao ZG, 2006, LEUKEMIA RES, V30, P993, DOI 10.1016/j.leukres.2005.12.010	40	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e76989	10.1371/journal.pone.0076989	http://dx.doi.org/10.1371/journal.pone.0076989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244271	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900005
J	Feng, Y; Zhou, JP; Gu, CH; Ding, YJ; Wan, HY; Ni, L; Niu, WQ				Feng, Yun; Zhou, Jianping; Gu, Chaohao; Ding, Yongjie; Wan, Huanying; Ni, Lei; Niu, Wenquan			Association of Six Well-Characterized Polymorphisms in TNF-alpha and TNF-beta Genes with Sarcoidosis: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROGNOSIS; ALLELE	Backgrounds: In this study, we aimed to investigate the association of six well-characterized polymorphisms in tumor necrosis factor alpha and beta (TNF-alpha and TNF-beta) genes with the risk for sarcoidosis via a comprehensive meta-alpha nalysis. Methods And Findings: The electronic MEDLINE (Ovid) and PubMed databases covering the period from the earliest possible year to June 2013 were searched. Total 13 qualified articles including 1584 patients with sarcoidosis and 2636 controls were recruited. The data were analyzed by RevMan software, and risk estimates were expressed as odds ratios (ORs) and 95% confidence intervals (95% CIs). Analyses of the full data set failed to identify any significant association of TNF-alpha gene -307A (OR=1.25; 95% CI: 0.98-1.59), -1031C (OR=0.88; 95% CI: 0.71-1.1), -863A (OR=0.89; 95% CI: 0.72-1.11), -238A (OR=0.97; 95% CI: 0.71-1.32), and -857T (OR=1.14; 95% CI: 0.74-1.77) alleles, but a significant association for TNF-beta 252A allele (OR=1.65; 95% CI = 1.33-2.04; P<0.00001). Under a random-effects allelic model, there was marginally significant increased risk of sarcoidosis for -307A allele among Caucasians (OR=1.25; 95% CI: 0.96-1.62; P=0.09) but not among Asians (OR=2.12; 95% CI: 0.31-14.27; P=0.44). There was a low probability of publication bias as reflected by the fail-safe number. Conclusions: This meta-alpha nalysis extended previous findings on the association between the TNF-alpha and TNF-beta genetic polymorphisms and sarcoidosis, by showing that the TNF-beta gene A252G polymorphism might be a potential risk factor for the development of sarcoidosis.	[Feng, Yun; Zhou, Jianping; Ding, Yongjie; Wan, Huanying; Ni, Lei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Respirat, Shanghai 200030, Peoples R China; [Gu, Chaohao] Sichuan Univ, Coll Comp Sci, Chengdu 610064, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Sichuan University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Gu, CH (corresponding author), Sichuan Univ, Coll Comp Sci, Chengdu 610064, Peoples R China.	nilei_ruijin@163.com; niuwenquan_shcn@163.com			National Natural Science Foundation of China [81201837]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81201837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Kieszko R, 2010, SARCOIDOSIS VASC DIF, V27, P131; Labunski S, 2001, ACTA DERM-VENEREOL, V81, P18, DOI 10.1080/000155501750208128; Levin AM, 2013, GENES IMMUN, V14, P13, DOI 10.1038/gene.2012.48; Lynch JP, 2007, SEMIN RESP CRIT CARE, V28, P53, DOI 10.1055/s-2007-970333; Makrythanasis P, 2010, GENET TEST MOL BIOMA, V14, P577, DOI 10.1089/gtmb.2009.0198; Medica I, 2007, J HUM GENET, V52, P836, DOI 10.1007/s10038-007-0185-7; Milman N, 2011, CLIN RESPIR J, V5, P105, DOI 10.1111/j.1752-699X.2010.00206.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mrazek F, 2005, TISSUE ANTIGENS, V65, P163, DOI 10.1111/j.1399-0039.2005.00370.x; Muller-Quernheim J, 2008, CLIN CHEST MED, V29, P391, DOI 10.1016/j.ccm.2008.03.007; Nunes H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-46; Pandey JP, 2002, HUM IMMUNOL, V63, P485, DOI 10.1016/S0198-8859(02)00399-3; Petkovic TR, 2013, SRP ARK CELOK LEK, V141, P169, DOI 10.2298/SARH1304169R; Seitzer U, 1997, CYTOKINE, V9, P787, DOI 10.1006/cyto.1997.0224; Seyhan EC, 2008, INTERNAL MED, V47, P833, DOI 10.2169/internalmedicine.47.0703; Sharma S, 2008, CLIN EXP IMMUNOL, V151, P251, DOI 10.1111/j.1365-2249.2007.03564.x; Somoskovi A, 1999, CYTOKINE, V11, P882, DOI 10.1006/cyto.1999.0498; Takashige N, 1999, TISSUE ANTIGENS, V54, P191, DOI 10.1034/j.1399-0039.1999.540211.x; Yamaguchi E, 2001, CHEST, V119, P753, DOI 10.1378/chest.119.3.753	22	5	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80150	10.1371/journal.pone.0080150	http://dx.doi.org/10.1371/journal.pone.0080150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244632	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900064
J	Kumar, A; Casey, A; Odingo, J; Kesicki, EA; Abrahams, G; Vieth, M; Masquelin, T; Mizrahi, V; Hipskind, PA; Sherman, DR; Parish, T				Kumar, Anuradha; Casey, Allen; Odingo, Joshua; Kesicki, Edward A.; Abrahams, Garth; Vieth, Michal; Masquelin, Thierry; Mizrahi, Valerie; Hipskind, Philip A.; Sherman, David R.; Parish, Tanya			A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis	PLOS ONE			English	Article								The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis. It is essential for the in vitro growth of M. tuberculosis and for survival of the bacteria in the mouse model of infection. PanC is absent from mammals. We developed an enzyme-based assay to identify inhibitors of PanC, optimized it for high-throughput screening, and tested a large and diverse library of compounds for activity. Two compounds belonging to the same chemical class of 3-biphenyl-4-cyanopyrrole-2-carboxylic acids had activity against the purified recombinant protein, and also inhibited growth of live M. tuberculosis in manner consistent with PanC inhibition. Thus we have identified a new class of PanC inhibitors with whole cell activity that can be further developed.	[Kumar, Anuradha; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Casey, Allen; Odingo, Joshua; Kesicki, Edward A.; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Abrahams, Garth; Mizrahi, Valerie] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Vieth, Michal; Masquelin, Thierry; Hipskind, Philip A.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Center for Infectious Disease Research; University of Cape Town; Eli Lilly	Sherman, DR (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org; tanya.parish@idri.org		Abrahams, Garth/0000-0001-7246-0901	Lilly TB Drug Discovery Initiative; Eli Lilly and Company	Lilly TB Drug Discovery Initiative; Eli Lilly and Company(Eli Lilly)	This work was funded by the Lilly TB Drug Discovery Initiative (http://www.tbdrugdiscovery.org/). Funding for the Lilly TB Drug Discovery Initiative was provided by Eli Lilly and Company. The following authors are employed by Eli Lilly and Company and made the contributions to the paper noted in the authors' contribution - Michal Vieth, Thierry Masquelin, Philip A. Hipskind.	Abrahams GL, 2012, CHEM BIOL, V19, P844, DOI 10.1016/j.chembiol.2012.05.020; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Ciulli A, 2008, CHEMBIOCHEM, V9, P2606, DOI 10.1002/cbic.200800437; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Copeland R.A., 2002, TIGHT BINDING INHIBI, P305; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fernandez MC, 2006, BIOORG MED CHEM LETT, V16, P5057, DOI 10.1016/j.bmcl.2006.07.035; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; GRASSL SM, 1992, J BIOL CHEM, V267, P22902; Hung AW, 2009, ANGEW CHEM INT EDIT, V48, P8452, DOI 10.1002/anie.200903821; NCBI Website, 2004, ASSAY GUIDANCE MANUA; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; VALLARI DS, 1985, J BACTERIOL, V164, P136, DOI 10.1128/JB.164.1.136-142.1985; Velaparthi S, 2008, J MED CHEM, V51, P1999, DOI 10.1021/jm701372r; Vieth M, 2009, J MED CHEM, V52, P6456, DOI 10.1021/jm901147e; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang SS, 2006, BIOCHEMISTRY-US, V45, P1554, DOI 10.1021/bi051873e; Wang SS, 2003, PROTEIN SCI, V12, P1097, DOI 10.1110/ps.0241803; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; World Health Organization, 2011, GLOB TUB CONTR REP 2; Yang YH, 2011, BIOORG MED CHEM LETT, V21, P3943, DOI 10.1016/j.bmcl.2011.05.021; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	25	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e72786	10.1371/journal.pone.0072786	http://dx.doi.org/10.1371/journal.pone.0072786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244263	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900001
J	Villegas-Mendez, A; Findlay, EG; de Souza, JB; Grady, LM; Saris, CJ; Lane, TE; Riley, EM; Couper, KN				Villegas-Mendez, Ana; Findlay, Emily Gwyer; de Souza, J. Brian; Grady, Lisa-Marie; Saris, Christiaan J.; Lane, Thomas E.; Riley, Eleanor M.; Couper, Kevin N.			WSX-1 Signalling Inhibits CD4(+) T Cell Migration to the Liver during Malaria Infection by Repressing Chemokine-Independent Pathways	PLOS ONE			English	Article							RECEPTOR; IL-27; TH1; INFLAMMATION; RECRUITMENT; RESISTANCE; IMMUNOPATHOLOGY; CYCLOPHILIN; CHEMOTAXIS; ACTIVATION	IL-27 is an important and non-redundant regulator of effector T cell accumulation in non-lymphoid tissues during infection. Using malaria as a model systemic pro-inflammatory infection, we demonstrate that the aberrant accumulation of CD4(+) T cells in the liver of infected IL27R(-/-) (WSX-1(-/-)) mice is a result of differences in cellular recruitment, rather than changes in T cell proliferation or cell death. We show that IL-27 both inhibits the migratory capacity of infection-derived CD4(+) T cells towards infection-derived liver cells, but also suppresses the production of soluble liver-derived mediator(s) that direct CD4(+) T cell movement towards the inflamed tissue. Although CCL4 and CCL5 expression was higher in livers of infected WSX-1(-/-) mice than infected WT mice, and hepatic CD4(+) T cells from WSX-1(-/-) mice expressed higher levels of CCR5 than cells from WT mice, migration of CD4(+) T cells to the liver of WSX-1(-/-) mice during infection was not controlled by chemokine (R) signalling. However, anti-IL-12p40 treatment reduced migration of CD4(+) T cells towards infection-derived liver cells, primarily by abrogating the hepatotropic migratory capacity of T cells, rather than diminishing soluble tissue-derived migratory signals. These results indicate that IL-27R signalling restricts CD4(+) T cell accumulation within the liver during infection primarily by suppressing T cell chemotaxis, which may be linked to its capacity to repress Th1 differentiation, as well as by inhibiting the production of soluble, tissue-derived chemotaxins.	[Villegas-Mendez, Ana; Findlay, Emily Gwyer; de Souza, J. Brian; Riley, Eleanor M.; Couper, Kevin N.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Villegas-Mendez, Ana; Grady, Lisa-Marie; Couper, Kevin N.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [de Souza, J. Brian] UCL, Div Infect & Immun, London, England; [Saris, Christiaan J.] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA; [Lane, Thomas E.] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92717 USA	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; University of London; University College London; Amgen; University of California System; University of California Irvine	Couper, KN (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	kevin.couper@manchester.ac.uk	Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Couper, Kevin/0000-0003-4659-8960; Gwyer Findlay, Emily/0000-0002-2311-6589; villegas-mendez, ana/0000-0002-8363-680X	BBSRC [004161, 020950]; Medical Research Council Career Development Award [G0900487]; NIH [RO1 NS041249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041249] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I020950/2, BB/G004161/1] Funding Source: researchfish; Medical Research Council [G0900487] Funding Source: researchfish; BBSRC [BB/G004161/1, BB/I020950/2] Funding Source: UKRI; MRC [G0900487] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the BBSRC (004161 and 020950) and by a Medical Research Council Career Development Award to KNC (G0900487) and by the NIH (RO1 NS041249) to TEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Bancroft AJ, 2004, J IMMUNOL, V172, P7635, DOI 10.4049/jimmunol.172.12.7635; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Dear JW, 2011, J IMMUNOL, V187, P3347, DOI 10.4049/jimmunol.1100165; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Findlay EG, 2013, J IMMUNOL, V190, P4553, DOI 10.4049/jimmunol.1202916; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Oo YH, 2010, J AUTOIMMUN, V34, P45, DOI 10.1016/j.jaut.2009.07.011; Rochman I, 2005, J IMMUNOL, V174, P4761, DOI 10.4049/jimmunol.174.8.4761; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Veckman V, 2003, J LEUKOCYTE BIOL, V74, P395, DOI 10.1189/jlb.0402212; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78486	10.1371/journal.pone.0078486	http://dx.doi.org/10.1371/journal.pone.0078486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244314	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327162900019
J	Yan, YQ; Salazar, TE; Dominguez, JM; Nguyen, DV; Calzi, SL; Bhatwadekar, AD; Qi, XP; Busik, JV; Boulton, ME; Grant, MB				Yan, Yuanqing; Salazar, Tatiana E.; Dominguez, James M., II; Nguyen, Dung V.; Calzi, Sergio Li; Bhatwadekar, Ashay D.; Qi, Xiaoping; Busik, Julia V.; Boulton, Michael E.; Grant, Maria B.			Dicer Expression Exhibits a Tissue-Specific Diurnal Pattern That Is Lost during Aging and in Diabetes	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ENZYME DICER; MICRORNAS; CLOCK; DELETION; DISRUPTION; GENETICS; RELEASE; LIVER; HEART	Dysregulation of circadian rhythmicity is identified as a key factor in disease pathogenesis. Circadian rhythmicity is controlled at both a transcriptional and post-transcriptional level suggesting the role of microRNA (miRNA) and double-stranded RNA (dsRNA) in this process. Endonuclease Dicer controls miRNA and dsRNA processing, however the role of Dicer in circadian regulation is not known. Here we demonstrate robust diurnal oscillations of Dicer expression in central and peripheral clock control systems including suprachiasmatic nucleolus (SCN), retina, liver, and bone marrow (BM). The Dicer oscillations were either reduced or phase shifted with aging and Type 2 diabetes. The decrease and phase shift of Dicer expression was associated with a similar decrease and phase shift of miRNAs 146a and 125a-5p and with an increase in toxic Alu RNA. Restoring Dicer levels and the diurnal patterns of Dicer-controlled miRNA and RNA expression may provide new therapeutic strategies for metabolic disease and aging-associated complications.	[Yan, Yuanqing; Salazar, Tatiana E.] Univ Florida, Genet & Genom Grad Program, Gainesville, FL USA; [Yan, Yuanqing; Salazar, Tatiana E.; Dominguez, James M., II; Nguyen, Dung V.; Calzi, Sergio Li; Bhatwadekar, Ashay D.; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Yan, Yuanqing; Salazar, Tatiana E.; Grant, Maria B.] Univ Florida, Genet Inst, Gainesville, FL USA; [Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Michigan State University	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	grantma@ufl.edu	Busik, Julia V/A-2698-2010; Bhatwadekar, Ashay/AAT-5933-2020	Busik, Julia V/0000-0003-3453-7124; 	National Institutes of Health (NIH) [EY007739, EY012601, DK090730-02, U01HL087366, EY018358]; NATIONAL EYE INSTITUTE [R01EY018358, R01EY012601, R01EY007739, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were partially supported by National Institutes of Health (NIH) - EY007739, EY012601, DK090730-02, and U01HL087366 to MBG and EY018358 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brown SA, 2011, AGING-US, V3, P813, DOI 10.18632/aging.100366; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Debono M, 2013, CLIN ENDOCRINOL, V78, P659, DOI 10.1111/cen.12117; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hansen KF, 2011, GENOME MED, V3, DOI 10.1186/gm224; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hazra S, 2012, DIABETES, V61, P3270, DOI 10.2337/db11-1596; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li Calzi S, 2010, EPMA J, V1, P88, DOI 10.1007/s13167-010-0011-8; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mehta N, 2013, J MOL BIOL, V425, P3609, DOI 10.1016/j.jmb.2012.10.022; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Paddison PJ, 2008, CURR TOP MICROBIOL, V320, P1; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Zhang L, 2010, STEM CELLS, V28, P1260, DOI 10.1002/stem.455	53	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80029	10.1371/journal.pone.0080029	http://dx.doi.org/10.1371/journal.pone.0080029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244599	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900059
J	Au, A; Stuyt, JG; Chen, D; Alagramam, K				Au, Adrian; Stuyt, John Gerka; Chen, Daniel; Alagramam, Kumar			Ups and Downs of Viagra: Revisiting Ototoxicity in the Mouse Model	PLOS ONE			English	Article							HEARING-LOSS; C57BL/6J MICE; SILDENAFIL; GENE; DEAFNESS; IMPAIRMENT; INHIBITORS; MUTATIONS; CLARIN-1	Sildenafil citrate (Viagra), a phosphodiesterase 5 inhibitor (PDE5i), is a commonly prescribed drug for erectile dysfunction. Since the introduction of Viagra in 1997, several case reports have linked Viagra to sudden sensorineural hearing loss. However, these studies are not well controlled for confounding factors, such as age and noise-induced hearing loss and none of these reports are based on prospective double-blind studies. Further, animal studies report contradictory data. For example, one study (2008) reported hearing loss in rats after long-term and high-dose exposure to sildenafil citrate. The other study (2012) showed vardenafil, another formulation of PDE5i, to be protective against noise-induced hearing loss in mice and rats. Whether or not clinically relevant doses of sildenafil citrate cause hearing loss in normal subjects (animals or humans) is controversial. One possibility is that PDE5i exacerbates age-related susceptibility to hearing loss in adults. Therefore, we tested sildenafil citrate in C57BL/6J, a strain of mice that displays increased susceptibility to age-related hearing loss, and compared the results to those obtained from the FVB/N, a strain of mice with no predisposition to hearing loss. Six-week-old mice were injected with the maximum tolerated dose of sildenafil citrate (10 mg/kg/day) or saline for 30 days. Auditory brainstem responses (ABRs) were recorded pre- and post injection time points to assess hearing loss. Entry of sildenafil citrate in the mouse cochlea was confirmed by qRT-PCR analysis of a downstream target of the cGMP-PKG cascade. ABR data indicated no statistically significant difference in hearing between treated and untreated mice in both backgrounds. Results show that the maximum tolerated dose of sildenafil citrate administered daily for 4 weeks does not affect hearing in the mouse. Our study gives no indication that Viagra will negatively impact hearing and it emphasizes the need to revisit the issue of Viagra related ototoxicity in humans.	[Au, Adrian; Stuyt, John Gerka; Chen, Daniel; Alagramam, Kumar] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Alagramam, K (corresponding author), Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA.	kna3@case.edu	Au, Adrian/AAE-9654-2019	Au, Adrian/0000-0001-8110-9988	department of Otolaryngology at CWRU	department of Otolaryngology at CWRU	This work was supported by department of Otolaryngology at CWRU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir S, 2012, AM J OTOLARYNGOLOGY; Chance MR, 2010, HUM MOL GENET, V19, P1515, DOI 10.1093/hmg/ddq025; Cheitlin MD, 1999, J AM COLL CARDIOL, V33, P273, DOI 10.1016/S0735-1097(98)00656-1; Falco M, 2007, IMPOTENCE DRUGS MAY; FDA, 2011, INF HEALTHC PROF SIL; FDA, 2007, FDA ANN REV LAB CIAL; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Hampton LL, 2003, HEARING RES, V180, P67, DOI 10.1016/S0378-5955(03)00107-2; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Johnson KR, 2010, HEARING RES, V268, P85, DOI 10.1016/j.heares.2010.05.002; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Keith A, 2000, HEALTH AFFAIR, V19, P147, DOI 10.1377/hlthaff.19.2.147; Khan AS, 2011, LARYNGOSCOPE, V121, P1049, DOI 10.1002/lary.21450; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Mukherjee B, 2007, J LARYNGOL OTOL, V121, P395, DOI 10.1017/S0022215106005512; NIDCD, 2003, NIH PUB; Okuyucu S, 2009, J LARYNGOL OTOL, V123, P718, DOI 10.1017/S002221510900423X; Pfizer, 2012, 2012 FIN REP; Pfizer, 2010, VIAGR; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; SCHWEITZER VG, 1993, LARYNGOSCOPE, V103, P1, DOI 10.1288/00005537-199304000-00001; Uptodate, 2013, SILD DRUG INF; Yoo J, 2013, LARYNGOSCOPE; Zheng QY, 2012, HUM MOL GENET, V21, P2588, DOI 10.1093/hmg/dds084	30	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79226	10.1371/journal.pone.0079226	http://dx.doi.org/10.1371/journal.pone.0079226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244454	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800044
J	Bonyhay, I; Risk, M; Freeman, R				Bonyhay, Istvan; Risk, Marcelo; Freeman, Roy			High-Pass Filter Characteristics of the Baroreflex - A Comparison of Frequency Domain and Pharmacological Methods	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BLOOD-PRESSURE; SPECTRAL-ANALYSIS; SINOAORTIC DENERVATION; PHENYLEPHRINE METHOD; ARTERIAL-PRESSURE; SENSITIVITY; REFLEX; RESPONSES; GAIN	Pharmacological methods to assess baroreflex sensitivity evoke supra-physiological blood pressure changes whereas computational methods use spontaneous fluctuations of blood pressure. The relationships among the different baroreflex assessment methods are still not fully understood. Although strong advocates for each technique exist, the differences between these methods need further clarification. Understanding the differences between pharmacological and spontaneous baroreflex methods could provide important insight into the baroreflex physiology. We compared the modified Oxford baroreflex gain and the transfer function modulus between spontaneous RR interval and blood pressure fluctuations in 18 healthy subjects (age: 39+/-10 yrs., BMI: 26+/-4.9). The transfer function was calculated over the low-frequency range of the RR interval and systolic blood pressure oscillations during random-frequency paced breathing. The average modified Oxford baroreflex gain was lower than the average transfer function modulus (15.7+/-9.2 ms/mmHg vs. 19.4+/-10.5 ms/mmHg, P<0.05). The difference between the two baroreflex measures within the individual subjects comprised a systematic difference (relative mean difference: 20.7%) and a random variance (typical error: 3.9 ms/mmHg). The transfer function modulus gradually increased with the frequency within the low-frequency range (LF), on average from 10.4+/-7.3 ms/mmHg to 21.2+/-9.8 ms/mmHg across subjects. Narrowing the zone of interest within the LF band produced a decrease in both the systematic difference (relative mean difference: 0.5%) and the random variance (typical error: 2.1 ms/mmHg) between the modified Oxford gain and the transfer function modulus. Our data suggest that the frequency dependent increase in low-frequency transfer function modulus between RR interval and blood pressure fluctuations contributes to both the systematic difference (bias) and the random variance (error) between the pharmacological and transfer function baroreflex measures. This finding suggests that both methodological and physiological factors underlie the observed disagreement between the pharmacological and the transfer function method. Thus both baroreflex measures contribute complementary information and can be considered valid methods for baroreflex sensitivity assessment.	[Bonyhay, Istvan; Risk, Marcelo; Freeman, Roy] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Risk, Marcelo] ITBA, Buenos Aires, DF, Argentina; [Risk, Marcelo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bonyhay, I (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	ibonyhay@bidmc.harvard.edu			National Heart, Lung, and Blood Institute [1 R01 HL 59459]; Fundacion Maria Calderon de la Barca, Argentina;  [M01-RR01032]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059459] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fundacion Maria Calderon de la Barca, Argentina; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant 1 R01 HL 59459 from the National Heart, Lung, and Blood Institute and grant M01-RR01032 to Beth Israel Deaconess Medical General Clinical Research Center. MR was supported by Fundacion Maria Calderon de la Barca, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1985, AM J PHYSIOL, V249, pH867, DOI 10.1152/ajpheart.1985.249.4.H867; Badra LJ, 2001, AM J PHYSIOL-HEART C, V280, pH2674, DOI 10.1152/ajpheart.2001.280.6.H2674; Barthel P, 2012, HEART RHYTHM, V9, P1288, DOI 10.1016/j.hrthm.2012.04.017; Bassani T, 2013, AUTON NEUROSCI; Bernardi L, 2011, DIABETES METAB RES R; Blackman R.B., 1959, MEASUREMENT POWER SP; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BURKE SL, 1986, J PHYSIOL-LONDON, V378, P391, DOI 10.1113/jphysiol.1986.sp016226; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chatburn R L, 1996, AANA J, V64, P261; Colombo R, 1999, CLIN SCI, V97, P503, DOI 10.1042/CS19990035; Crandall CG, 2000, AM J PHYSIOL-HEART C, V279, pH2486, DOI 10.1152/ajpheart.2000.279.5.H2486; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; DI RIENZO M, 1991, AM J PHYSIOL, V261, pH1811, DOI 10.1152/ajpheart.1991.261.6.H1811; DiRienzo M, 1996, MED BIOL ENG COMPUT, V34, P133, DOI 10.1007/BF02520018; EBERT TJ, 1992, AM J PHYSIOL, V262, pH1372, DOI 10.1152/ajpheart.1992.262.5.H1372; ECKBERG DL, 1976, J PHYSIOL-LONDON, V258, P769, DOI 10.1113/jphysiol.1976.sp011445; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Farquhar WB, 2000, CIRCULATION, V102, P3086; FARRELL TG, 1992, BRIT HEART J, V67, P129; Frattola A, 1997, DIABETOLOGIA, V40, P1470, DOI 10.1007/s001250050851; Freeman R, 2006, CLIN NEUROPHYSIOL, V117, P716, DOI 10.1016/j.clinph.2005.09.027; FREEMAN R, 1995, MUSCLE NERVE, V18, P74, DOI 10.1002/mus.880180111; Gerritsen J, 2000, CLIN SCI, V99, P371, DOI 10.1042/CS19990374; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hunt BE, 2005, AM J PHYSL REGUL INT; Kawada T, 2003, AM J PHYSIOL-HEART C, V284, pH404, DOI 10.1152/ajpheart.00319.2002; La Rovere MT, 2013, NETH HEART J, V21, P61, DOI 10.1007/s12471-012-0349-8; La Rovere MT, 2011, J HYPERTENS, V29, P1546, DOI 10.1097/HJH.0b013e3283487827; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lipman RD, 2003, HYPERTENSION, V42, P481, DOI 10.1161/01.HYP.0000091370.83602.E6; Ludbrook J, 1997, CLIN EXP PHARMACOL P, V24, P193, DOI 10.1111/j.1440-1681.1997.tb01807.x; Mancia G, 1999, AM J PHYSIOL-HEART C, V276, pH1987, DOI 10.1152/ajpheart.1999.276.6.H1987; Morillo CA, 1997, CIRCULATION, V96, P2509, DOI 10.1161/01.CIR.96.8.2509; Parati G, 2004, HYPERTENSION, V43, pE32, DOI 10.1161/01.HYP.0000126689.12940.cd; Parati G, 2002, CLIN SCI, V103, P89; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Petiot E, 2001, J PHYSIOL-LONDON, V537, P949; Pinna GD, 2005, J AM COLL CARDIOL, V46, P1314, DOI 10.1016/j.jacc.2005.06.062; Pinna GD, 2002, CLIN SCI, V103, P81; Pitzalis MV, 1998, CIRCULATION, V97, P1362, DOI 10.1161/01.CIR.97.14.1362; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; Rosengard-Barlund M, 2011, DIABETES CARE, V34, P2424, DOI 10.2337/dc11-0629; Rudas L, 1999, AM J PHYSIOL-HEART C, V276, pH1691, DOI 10.1152/ajpheart.1999.276.5.H1691; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; Vallais F, 2009, PHYSIOL MEAS, V30, P201, DOI 10.1088/0967-3334/30/2/007; Watkins LL, 1996, HYPERTENSION, V28, P238, DOI 10.1161/01.HYP.28.2.238	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79513	10.1371/journal.pone.0079513	http://dx.doi.org/10.1371/journal.pone.0079513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244518	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800089
J	Ishii, Y; Nakahara, T; Kataoka, M; Kusumoto-Matsuo, R; Mori, S; Takeuchi, T; Kukimoto, I				Ishii, Yoshiyuki; Nakahara, Tomomi; Kataoka, Michiyo; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Takeuchi, Takamasa; Kukimoto, Iwao			Identification of TRAPPC8 as a Host Factor Required for Human Papillomavirus Cell Entry	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; SURFACE HEPARAN-SULFATE; HUMAN KERATINOCYTES; GAMMA SECRETASE; 31B INFECTION; L2; TYPE-16; AUTOPHAGY; PATHWAY; PSEUDOVIRIONS	Human papillomavirus (HPV) is a non-enveloped virus composed of a circular DNA genome and two capsid proteins, L1 and L2. Multiple interactions between its capsid proteins and host cellular proteins are required for infectious HPV entry, including cell attachment and internalization, intracellular trafficking and viral genome transfer into the nucleus. Using two variants of HPV type 51, the Ma and Nu strains, we have previously reported that MaL2 is required for efficient pseudovirus (PsV) transduction. However, the cellular factors that confer this L2 dependency have not yet been identified. Here we report that the transport protein particle complex subunit 8 (TRAPPC8) specifically interacts with MaL2. TRAPPC8 knockdown in HeLa cells yielded reduced levels of reporter gene expression when inoculated with HPV51Ma, HPV16, and HPV31 PsVs. TRAPPC8 knockdown in HaCaT cells also showed reduced susceptibility to infection with authentic HPV31 virions, indicating that TRAPPC8 plays a crucial role in native HPV infection. Immunofluorescence microscopy revealed that the central region of TRAPPC8 was exposed on the cell surface and colocalized with inoculated PsVs. The entry of Ma, Nu, and L2-lacking PsVs into cells was equally impaired in TRAPPC8 knockdown HeLa cells, suggesting that TRAPPC8-dependent endocytosis plays an important role in HPV entry that is independent of L2 interaction. Finally, expression of GFP-fused L2 that can also interact with TRAPPC8 induced dispersal of the Golgi stack structure in HeLa cells, a phenotype also observed by TRAPPC8 knockdown. These results suggest that during viral intracellular trafficking, binding of L2 to TRAPPC8 inhibits its function resulting in Golgi destabilization, a process that may assist HPV genome escape from the trans-Golgi network.	[Ishii, Yoshiyuki; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Takeuchi, Takamasa; Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Nakahara, Tomomi] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 104, Japan; [Kataoka, Michiyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Cancer Center - Japan; National Institute of Infectious Diseases (NIID)	Ishii, Y (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	yishii@nih.go.jp	Kukimoto, I/I-3995-2019	Kukimoto, I/0000-0001-9080-1642	Ministry of Education, Culture, Sports, Science, and Technology [22590425]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (C) 22590425 from the Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bergant M, 2013, J VIROL, V87, P1270, DOI 10.1128/JVI.01991-12; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Combita AL, 2001, FEMS MICROBIOL LETT, V204, P183, DOI 10.1111/j.1574-6968.2001.tb10883.x; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2013, J VIROL, V87, P3862, DOI 10.1128/JVI.03222-12; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Dziduszko A, 2013, J VIROL, V87, P7502, DOI 10.1128/JVI.00519-13; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; Huang HS, 2010, VIROLOGY, V407, P391, DOI 10.1016/j.virol.2010.09.002; Ishii Y, 2013, BIOCHEM BIOPH RES CO, V433, P385, DOI 10.1016/j.bbrc.2013.02.130; Ishii Y, 2010, VIROLOGY, V406, P181, DOI 10.1016/j.virol.2010.07.019; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kakuta S, 2012, J BIOL CHEM, V287, P44261, DOI 10.1074/jbc.M112.411454; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Karanam B, 2010, J VIROL, V84, P10661, DOI 10.1128/JVI.01081-10; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kondo K, 2009, VIROLOGY, V394, P259, DOI 10.1016/j.virol.2009.08.034; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Lipovsky A, 2013, P NATL ACAD SCI USA, V110, P7452, DOI 10.1073/pnas.1302164110; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Marusic MB, 2012, TRAFFIC, V13, P455, DOI 10.1111/j.1600-0854.2011.01320.x; McMillan NAJ, 1999, VIROLOGY, V261, P271, DOI 10.1006/viro.1999.9825; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Ozbun MA, 2002, J VIROL, V76, P11291, DOI 10.1128/JVI.76.22.11291-11300.2002; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Raff AB, 2013, J VIROL; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schelhaas M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000148; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; Wang JW, 2013, VIROLOGY; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519	60	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80297	10.1371/journal.pone.0080297	http://dx.doi.org/10.1371/journal.pone.0080297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244674	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800142
J	Kent, E; Neumann, S; Kummer, U; Mendes, P				Kent, Edward; Neumann, Stefan; Kummer, Ursula; Mendes, Pedro			What Can We Learn from Global Sensitivity Analysis of Biochemical Systems?	PLOS ONE			English	Article							ROBUSTNESS; MODELS; BIOLOGY; COPASI	Most biological models of intermediate size, and probably all large models, need to cope with the fact that many of their parameter values are unknown. In addition, it may not be possible to identify these values unambiguously on the basis of experimental data. This poses the question how reliable predictions made using such models are. Sensitivity analysis is commonly used to measure the impact of each model parameter on its variables. However, the results of such analyses can be dependent on an exact set of parameter values due to nonlinearity. To mitigate this problem, global sensitivity analysis techniques are used to calculate parameter sensitivities in a wider parameter space. We applied global sensitivity analysis to a selection of five signalling and metabolic models, several of which incorporate experimentally well-determined parameters. Assuming these models represent physiological reality, we explored how the results could change under increasing amounts of parameter uncertainty. Our results show that parameter sensitivities calculated with the physiological parameter values are not necessarily the most frequently observed under random sampling, even in a small interval around the physiological values. Often multimodal distributions were observed. Unsurprisingly, the range of possible sensitivity coefficient values increased with the level of parameter uncertainty, though the amount of parameter uncertainty at which the pattern of control was able to change differed among the models analysed. We suggest that this level of uncertainty can be used as a global measure of model robustness. Finally a comparison of different global sensitivity analysis techniques shows that, if high-throughput computing resources are available, then random sampling may actually be the most suitable technique.	[Kent, Edward; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Kent, Edward; Mendes, Pedro] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Neumann, Stefan; Kummer, Ursula] Das Ctr Organismal Studies Heidelberg BIOQUANT, Dept Modeling Biol Proc, Heidelberg, Germany; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University	Mendes, P (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	pedro.mendes@manchester.ac.uk		Mendes, Pedro/0000-0001-6507-9168	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G529859, BB/J019259]; European Union [289434]; BBSRC [BB/J019259/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019259/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EK thanks Pfizer and Biotechnology and Biological Sciences Research Council (BBSRC) (grant BB/G529859), PM thanks the BBSRC (grants BB/J019259), the European Union Framework Seven Programme (grant 289434, BioPreDyn) and the National Institute of General Medical Sciences (GM080219). UK thanks the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu ZH, 2010, IEEE T MED IMAGING, V29, P1870, DOI 10.1109/TMI.2010.2053044; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hubner K, 2011, FEBS J, V278, P2767, DOI 10.1111/j.1742-4658.2011.08217.x; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jacobsen EW, 2008, IET SYST BIOL, V2, P39, DOI 10.1049/iet-syb:20070008; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Murabito E, 2011, J R SOC INTERFACE, V8, P880, DOI 10.1098/rsif.2010.0540; Quinton-Tulloch MJ, 2011, THESIS U MANCHESTER; Rodriguez-Fernandez M, 2012, INT J ROBUST NONLIN, V22, P1082, DOI 10.1002/rnc.2797; Sahle S, 2008, PHILOS T R SOC A, V366, P3619, DOI 10.1098/rsta.2008.0108; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A., 2008, GLOBAL SENSITIVITY A, DOI [10.1002/9780470725184, DOI 10.1002/9780470725184]; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; Westerhoff HV, 2007, FEBS J, V274, P342; Yue H, 2008, INT J CHEM KINET, V40, P730, DOI 10.1002/kin.20369; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088; Zhou K., 1998, ESSENTIALS ROBUST CO	42	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79244	10.1371/journal.pone.0079244	http://dx.doi.org/10.1371/journal.pone.0079244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244458	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800047
J	Oe, M; Ogawa, H				Oe, Momoko; Ogawa, Hiroto			Neural Basis of Stimulus-Angle-Dependent Motor Control of Wind-Elicited Walking Behavior in the Cricket Gryllus bimaculatus	PLOS ONE			English	Article							CERCAL SENSORY SYSTEM; EVOKED ESCAPE BEHAVIOR; DIRECTIONAL SENSITIVITY; IDENTIFIED NEURONS; TERMINAL GANGLION; INTERNEURONS; INFORMATION; MECHANISMS; COCKROACH; DISCHARGE	Crickets exhibit oriented walking behavior in response to air-current stimuli. Because crickets move in the opposite direction from the stimulus source, this behavior is considered to represent 'escape behavior' from an approaching predator. However, details of the stimulus-angle-dependent control of locomotion during the immediate phase, and the neural basis underlying the directional motor control of this behavior remain unclear. In this study, we used a spherical-treadmill system to measure locomotory parameters including trajectory, turn angle and velocity during the immediate phase of responses to air-puff stimuli applied from various angles. Both walking direction and turn angle were correlated with stimulus angle, but their relationships followed different rules. A shorter stimulus also induced directionally-controlled walking, but reduced the yaw rotation in stimulus-angle-dependent turning. These results suggest that neural control of the turn angle requires different sensory information than that required for oriented walking. Hemi-severance of the ventral nerve cords containing descending axons from the cephalic to the prothoracic ganglion abolished stimulus-angle-dependent control, indicating that this control required descending signals from the brain. Furthermore, we selectively ablated identified ascending giant interneurons (GIs) in vivo to examine their functional roles in wind-elicited walking. Ablation of GI8-1 diminished control of the turn angle and decreased walking distance in the initial response. Meanwhile, GI9-1b ablation had no discernible effect on stimulus-angle-dependent control or walking distance, but delayed the reaction time. These results suggest that the ascending signals conveyed by GI8-1 are required for turn-angle control and maintenance of walking behavior, and that GI9-1b is responsible for rapid initiation of walking. It is possible that individual types of GIs separately supply the sensory signals required to control wind-elicited walking.	[Oe, Momoko] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Ogawa, Hiroto] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan; [Ogawa, Hiroto] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Ogawa, H (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan.	hogawa@sci.hokudai.ac.jp			Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO); JSPS; MEXT KAKENHI [24120502]	Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO)(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Science and Technology Agency (JST), Precursory Research for Embryonic Science and Technology (PRESTO), and JSPS and MEXT KAKENHI grant 24120502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baba Y, 1997, ZOOL SCI, V14, P587, DOI 10.2108/zsj.14.587; BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; BOYAN GS, 1986, J COMP PHYSIOL A, V159, P773, DOI 10.1007/BF00603731; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; Bullock T.H., 1984, P1; CAMHI JM, 1978, J COMP PHYSIOL, V128, P193, DOI 10.1007/BF00656852; Camhi JM, 1983, NEUROETHOLOGY NERVE; Casas J, 2010, ANNU REV ENTOMOL, V55, P505, DOI 10.1146/annurev-ento-112408-085342; COMER CM, 1985, BRAIN RES, V335, P342, DOI 10.1016/0006-8993(85)90490-1; Dangles O, 2007, J EXP BIOL, V210, P3165, DOI 10.1242/jeb.004648; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; GNATZY W, 1986, NATURWISSENSCHAFTEN, V73, P212, DOI 10.1007/BF00417728; Gras H, 1998, J COMP PHYSIOL A, V182, P351, DOI 10.1007/s003590050185; GRAS H, 1992, J EXP BIOL, V171, P189; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Hedrick AV, 2007, J NEUROSCI METH, V164, P86, DOI 10.1016/j.jneumeth.2007.04.004; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; HIROTA K, 1993, ZOOL SCI, V10, P705; Jacobs GA, 1996, J NEUROSCI, V16, P769; JACOBS GA, 1985, SCIENCE, V228, P344, DOI 10.1126/science.3983633; JACOBS GA, 1986, J NEUROSCI, V6, P2298; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; Kagaya K, 2010, J NEUROSCI, V30, P1348, DOI 10.1523/JNEUROSCI.4885-09.2010; Kalb J, 2006, J NEUROSCI, V26, P7898, DOI 10.1523/JNEUROSCI.1327-06.2006; KANOU M, 1985, ZOOL SCI, V2, P629; Kanou M, 1999, ZOOL SCI, V16, P71, DOI 10.2108/zsj.16.71; Kanou M, 1996, ZOOL SCI, V13, P35, DOI 10.2108/zsj.13.35; Miller JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027873; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1991, J NEUROPHYSIOL, V66, P1680, DOI 10.1152/jn.1991.66.5.1680; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MURPHEY RK, 1985, J COMP PHYSIOL A, V156, P357, DOI 10.1007/BF00610728; Ogawa H, 2006, J NEUROBIOL, V66, P293, DOI 10.1002/neu.20220; Ogawa H, 2004, NEUROSCI LETT, V358, P185, DOI 10.1016/j.neulet.2004.01.023; Ogawa H, 2008, J NEUROSCI, V28, P4592, DOI 10.1523/JNEUROSCI.5354-07.2008; PALKA J, 1977, J COMP PHYSIOL, V119, P267, DOI 10.1007/BF00656638; Paydar S, 1999, J NEUROSCI, V19, P1771; PEARSON KG, 1970, J EXP BIOL, V52, P139; SELVERSTON AI, 1985, J NEUROSCI, V5, P1283; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; TAUBER E, 1995, J EXP BIOL, V198, P1895; TROYER TW, 1994, MICROSC RES TECHNIQ, V29, P329, DOI 10.1002/jemt.1070290502; Vedenina VY, 1998, J COMP PHYSIOL A, V183, P553, DOI 10.1007/s003590050281; WINE JJ, 1972, J EXP BIOL, V56, P1; Witney AG, 2011, J EXP BIOL, V214, P69, DOI 10.1242/jeb.044800	50	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80184	10.1371/journal.pone.0080184	http://dx.doi.org/10.1371/journal.pone.0080184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244644	Green Published, gold			2022-12-27	WOS:000327143800134
J	Stark, BC; James, ML; Pollard, LW; Sirotkin, V; Lord, M				Stark, Benjamin C.; James, Michael L.; Pollard, Luther W.; Sirotkin, Vladimir; Lord, Matthew			UCS Protein Rng3p Is Essential for Myosin-II Motor Activity during Cytokinesis in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; CAENORHABDITIS-ELEGANS; UNC-45 CHAPERONE; HEAVY-CHAIN; V MYOSINS; CONTRACTILE RING; DOMAIN PROTEIN; BUDDING YEAST; LIGHT-CHAIN; ACTIN	UCS proteins have been proposed to operate as co-chaperones that work with Hsp90 in the de novo folding of myosin motors. The fission yeast UCS protein Rng3p is essential for actomyosin ring assembly and cytokinesis. Here we investigated the role of Rng3p in fission yeast myosin-II (Myo2p) motor activity. Myo2p isolated from an arrested rng3-65 mutant was capable of binding actin, yet lacked stability and activity based on its expression levels and inactivity in ATPase and actin filament gliding assays. Myo2p isolated from a myo2-E1 mutant (a mutant hyper-sensitive to perturbation of Rng3p function) showed similar behavior in the same assays and exhibited an altered motor conformation based on limited proteolysis experiments. We propose that Rng3p is not required for the folding of motors per se, but instead works to ensure the activity of intrinsically unstable myosin-II motors. Rng3p is specific to conventional myosin-II and the actomyosin ring, and is not required for unconventional myosin motor function at other actin structures. However, artificial destabilization of myosin-I motors at endocytic actin patches (using a myo1-E1 mutant) led to recruitment of Rng3p to patches. Thus, while Rng3p is specific to myosin-II, UCS proteins are adaptable and can respond to changes in the stability of other myosin motors.	[Stark, Benjamin C.; Pollard, Luther W.; Lord, Matthew] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [James, Michael L.; Sirotkin, Vladimir] SUNY Upstate Med Univ, Dept Cell & Dev Biol, New York, NY USA	University of Vermont; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lord, M (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	matthew.lord@uvm.edu	Stark, Benjamin/E-6095-2010	Stark, Benjamin/0000-0002-1799-5361; Pollard, Luther/0000-0002-3587-0714	National Institutes of Health-National Institute of General Medical Sciences NIH-GMS [RO1: GM097193]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097193] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of General Medical Sciences NIH-GMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health-National Institute of General Medical Sciences NIH-GMS RO1: GM097193 (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2009, EMBO REP, V10, P186, DOI 10.1038/embor.2008.228; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Attanapola SL, 2009, J CELL SCI, V122, P3856, DOI 10.1242/jcs.053959; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Bezanilla M, 2000, CURR BIOL, V10, P397, DOI 10.1016/S0960-9822(00)00420-6; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Bezanilla M, 2000, MOL BIOL CELL, V11, P79, DOI 10.1091/mbc.11.1.79; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Kaiser CM, 2012, BIOPHYS J, V102, P2212, DOI 10.1016/j.bpj.2012.03.013; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; May KM, 1997, CELL MOTIL CYTOSKEL, V38, P385, DOI 10.1002/(SICI)1097-0169(1997)38:4<385::AID-CM8>3.0.CO;2-2; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motegi F, 1997, FEBS LETT, V420, P161, DOI 10.1016/S0014-5793(97)01510-X; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Sladewski TE, 2009, MOL BIOL CELL, V20, P3941, DOI 10.1091/mbc.E09-04-0346; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Stark BC, 2010, MOL BIOL CELL, V21, P989, DOI 10.1091/mbc.E09-10-0852; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Toi H, 2003, MOL BIOL CELL, V14, P2237, DOI 10.1091/mbc.E02-09-0616; Toya M, 2001, GENES CELLS, V6, P187, DOI 10.1046/j.1365-2443.2001.00414.x; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; Win TZ, 2001, J CELL SCI, V114, P69; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79593	10.1371/journal.pone.0079593	http://dx.doi.org/10.1371/journal.pone.0079593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244528	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800092
J	Walker, B; Kording, K				Walker, Ben; Kording, Konrad			The Database for Reaching Experiments and Models	PLOS ONE			English	Article								Reaching is one of the central experimental paradigms in the field of motor control, and many computational models of reaching have been published. While most of these models try to explain subject data (such as movement kinematics, reaching performance, forces, etc.) from only a single experiment, distinct experiments often share experimental conditions and record similar kinematics. This suggests that reaching models could be applied to (and falsified by) multiple experiments. However, using multiple datasets is difficult because experimental data formats vary widely. Standardizing data formats promises to enable scientists to test model predictions against many experiments and to compare experimental results across labs. Here we report on the development of a new resource available to scientists: a database of reaching called the Database for Reaching Experiments And Models (DREAM). DREAM collects both experimental datasets and models and facilitates their comparison by standardizing formats. The DREAM project promises to be useful for experimentalists who want to understand how their data relates to models, for modelers who want to test their theories, and for educators who want to help students better understand reaching experiments, models, and data analysis.	[Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA; [Walker, Ben; Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Shirley Ryan AbilityLab	Kording, K (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	NIH [R01NS063399]; NSF CRCNS (Collaborative Research in Computational Neuroscience) grant [NSF 11-505]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1010336] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CRCNS (Collaborative Research in Computational Neuroscience) grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors received support from the following funding sources: NIH R01 grant R01NS063399 (http://grants.nih.gov/grants/funding/r01.htm), and NSF CRCNS (Collaborative Research in Computational Neuroscience) grant NSF 11-505 (http://www.nsf.gov/pubs/2011/nsf11505/nsf11505.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Corbett EA, 2012, IEEE ENG MED BIO, P739, DOI 10.1109/EMBC.2012.6346037; Fernandes HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043016; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Flint RD, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046006; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Mattar AAG, 2010, J NEUROPHYSIOL, V104, P426, DOI 10.1152/jn.00886.2009; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Stephenson A., 1999, MARS CLIMATE ORBITER; Stevenson IH, 2011, J NEUROPHYSIOL, V106, P764, DOI 10.1152/jn.00626.2010; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Wei KL, 2010, J NEUROPHYSIOL, V104, P3053, DOI 10.1152/jn.01025.2009; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wei Y, 2005, INT C REHAB ROBOT, P505; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Young SJ, 2009, J MOTOR BEHAV, V41, P339, DOI 10.3200/JMBR.41.4.339-346	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78747	10.1371/journal.pone.0078747	http://dx.doi.org/10.1371/journal.pone.0078747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244351	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800010
J	Omata, W; Ackerman, WE; Vandre, DD; Robinson, JM				Omata, Waka; Ackerman, William E.; Vandre, Dale D.; Robinson, John M.			Trophoblast Cell Fusion and Differentiation Are Mediated by Both the Protein Kinase C and A Pathways	PLOS ONE			English	Article							HUMAN PLACENTA; CYCLIC-AMP; DYSFERLIN; MEMBRANE; GENE; EXPRESSION; MYOPATHY; REPAIR; FER-1	The syncytiotrophoblast of the human placenta is an epithelial barrier that interacts with maternal blood and is a key for the transfer of nutrients and other solutes to the developing fetus. The syncytiotrophoblast is a true syncytium and fusion of progenitor cytotrophoblasts is the cardinal event leading to the formation of this layer. BeWo cells are often used as a surrogate for cytotrophoblasts, since they can be induced to fuse, and then express certain differentiation markers associated with trophoblast syncytialization. Dysferlin, a syncytiotrophoblast membrane repair protein, is up-regulated in BeWo cells induced to fuse by treatment with forskolin; this fusion is thought to occur through cAMP/protein kinase A-dependent mechanisms. We hypothesized that dysferlin may also be up-regulated in response to fusion through other pathways. Here, we show that BeWo cells can also be induced to fuse by treatment with an activator of protein kinase C, and that this fusion is accompanied by increased expression of dysferlin. Moreover, a dramatic synergistic increase in dysferlin expression is observed when both the protein kinase A and protein kinase C pathways are activated in BeWo cells. This synergy in fusion is also accompanied by dramatic increases in mRNA for the placental fusion proteins syncytin 1, syncytin 2, as well as dysferlin. Dysferlin, however, was shown to be dispensable for stimulus-induced BeWo cell syncytialization, since dysferlin knockdown lines fused to the same extent as control cells. The classical trophoblast differentiation marker human chorionic gonadotropin was also monitored and changes in the expression closely parallel that of dysferlin in all of the experimental conditions employed. Thus different biochemical markers of trophoblast fusion behave in concert supporting the hypothesis that activation of both protein kinase C and A pathways lead to trophoblastic differentiation.	[Omata, Waka; Vandre, Dale D.; Robinson, John M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Ackerman, William E.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Robinson, JM (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	robinson.21@osu.edu	Ackerman, William Edward/GRS-5804-2022	Ackerman, William Edward/0000-0001-7366-3903	NIH [HD058084]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by NIH grant HD058084 (J.M.R.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 1997, J CELL SCI, V110, P1073; ANDERSEN B, 1988, J BIOL CHEM, V263, P15578; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; FISCHER SM, 1991, CANCER RES, V51, P850; Gabbe SG, 2012, OBSTET NORMAL PROBLE; Han WQ, 2012, J CELL SCI, V125, P1225, DOI 10.1242/jcs.094565; Hohn HP, 1998, EXP CELL RES, V244, P249, DOI 10.1006/excr.1998.4184; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Karl PI, 1996, BIOCHEM J, V320, P831, DOI 10.1042/bj3200831; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Nishino R, 1991, Nihon Naibunpi Gakkai Zasshi, V67, P666; RITVOS O, 1987, ENDOCRINOLOGY, V120, P1521, DOI 10.1210/endo-120-4-1521; Robinson JM, 2001, HISTOCHEM CELL BIOL, V116, P119; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; Robinson JM, 2009, ANAL BIOCHEM, V387, P87, DOI 10.1016/j.ab.2009.01.012; Rote NS, 2005, PLACENTA, V26, P686, DOI 10.1016/j.placenta.2004.09.003; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190; Walton JR, 2013, HISTOCHEM CELL BIOL, V139, P487, DOI 10.1007/s00418-012-1040-2; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Weller AH, 1997, MUSCLE NERVE, V20, P72, DOI 10.1002/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7	33	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81003	10.1371/journal.pone.0081003	http://dx.doi.org/10.1371/journal.pone.0081003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236208	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700211
J	Chen, LH; Liu, M; Bao, J; Xia, YB; Zhang, JQ; Zhang, L; Huang, XQ; Wang, J				Chen, Lihua; Liu, Min; Bao, Jing; Xia, Yunbao; Zhang, Jiuquan; Zhang, Lin; Huang, Xuequan; Wang, Jian			The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis	PLOS ONE			English	Article							WEIGHTED MRI; CELL-DENSITY; SURROGATE MARKER; PROSTATE-CANCER; CARCINOMA; VALUES; BIOMARKER; LYMPHOMAS; GLIOMAS; LESIONS	Objective: To perform a meta-analysis exploring the correlation between the apparent diffusion coefficient (ADC) and tumor cellularity in patients. Materials and Methods: We searched medical and scientific literature databases for studies discussing the correlation between the ADC and tumor cellularity in patients. Only studies that were published in English or Chinese prior to November 2012 were considered for inclusion. Summary correlation coefficient (r) values were extracted from each study, and 95% confidence intervals (CIs) were calculated. Sensitivity and subgroup analyses were performed to investigate potential heterogeneity. Results: Of 189 studies, 28 were included in the meta-analysis, comprising 729 patients. The pooled r for all studies was 20.57 (95% CI: -0.62, -0.52), indicating notable heterogeneity (P<0.001). After the sensitivity analysis, two studies were excluded, and the pooled r was 20.61 (95% CI: -0.66, -0.56) and was not significantly heterogeneous (P = 0.127). Regarding tumor type subgroup analysis, there were sufficient data to support a strong negative correlation between the ADC and cellularity for brain tumors. There was no notable evidence of publication bias. Conclusions: There is a strong negative correlation between the ADC and tumor cellularity in patients, particularly in the brain. However, larger, prospective studies are warranted to validate these findings in other cancer types.	[Chen, Lihua; Liu, Min; Zhang, Jiuquan; Zhang, Lin; Huang, Xuequan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Chen, Lihua; Xia, Yunbao] Taihu Hosp, Dept Radiol, Wuxi, Peoples R China; [Liu, Min] Yangpu Dist Ctr Dis Control & Prevent, Dept Adm Off, Shanghai, Peoples R China; [Bao, Jing] Wuxi Ctr Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China	Army Medical University; Shanghai Center for Disease Control & Prevention	Huang, XQ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	hxuequan@163.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019	Zhang, Jiuquan/0000-0003-0239-6988; Chen, Lihua/0000-0001-5037-050X; Chen, Lihua/0000-0001-7249-2014; Hess, Christopher/0000-0002-5132-5302				[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Barajas RF, 2010, AM J NEURORADIOL, V31, P60, DOI 10.3174/ajnr.A1750; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Cabada T, 2009, RADIOLOGIA-MADRID, V51, P411, DOI 10.1016/j.rx.2009.01.017; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Chen Jun, 2005, Zhonghua Zhongliu Zazhi, V27, P309; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Fan GG, 2005, ACAD RADIOL, V12, P640, DOI 10.1016/j.acra.2005.01.024; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Gibbs P, 2009, INVEST RADIOL, V44, P572, DOI 10.1097/RLI.0b013e3181b4c10e; Ginat DT, 2012, AM J ROENTGENOL, V198, pW597, DOI 10.2214/AJR.11.7424; Goyal A, 2012, ACTA RADIOL, V53, P349, DOI 10.1258/ar.2011.110415; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; Hatakenaka M, 2008, MAGN RESON MED SCI, V7, P23; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; Jenkinson MD, 2010, J NEURO-ONCOL, V96, P385, DOI 10.1007/s11060-009-9970-9; Kikuchi T, 2009, NEUROL RES, V31, P1102, DOI 10.1179/174313209X382539; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Kyriazia S, 2010, CANCER BIOMARK, V7, P201, DOI 10.3233/CBM-2010-0194; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Manenti G, 2008, RADIOL MED, V113, P199, DOI 10.1007/s11547-008-0246-9; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Matsumoto Y, 2009, ONCOL REP, V22, P641, DOI 10.3892/or_00000484; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Plank C, 2007, NEURORADIOLOGY, V49, P977, DOI 10.1007/s00234-007-0275-4; Poptani H, 1998, CANCER GENE THER, V5, P101; Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; Wang XZ, 2009, J MAGN RESON IMAGING, V29, P1360, DOI 10.1002/jmri.21797; Wang Y, 2011, J MAGN RESON IMAGING, V33, P1071, DOI 10.1002/jmri.22541; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Wilson DB, 2001, PSYCHOL METHODS, V6, P413, DOI 10.1037//1082-989X.6.4.413; Woodhams R, 2009, AM J ROENTGENOL, V193, P260, DOI 10.2214/AJR.08.1670; Yamashita Y, 2009, NEUROL RES, V31, P940, DOI 10.1179/174313209X382520; Yoshikawa MI, 2008, RADIAT MED, V26, P222, DOI 10.1007/s11604-007-0218-3; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zelhof B, 2009, BJU INT, V103, P883, DOI 10.1111/j.1464-410X.2008.08130.x	50	163	168	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79008	10.1371/journal.pone.0079008	http://dx.doi.org/10.1371/journal.pone.0079008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244402	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600093
J	Chen, YP; Chen, MJ				Chen, Yen-Po; Chen, Ming-Ju			Effects of Lactobacillus kefiranofaciens M1 Isolated from Kefir Grains on Germ-Free Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LACTIC-ACID BACTERIA; MICROBIAL DIVERSITY; COMMENSAL BACTERIA; GUT MICROBIOTA; BARRIER; MODELS; TH1	Lactobacillus kefiranofaciens M1 is a novel probiotic strain that was isolated from kefir grains. Previously, we have demonstrated the immunoregulatory, anti-allergic, anti-asthmatic and anti-colitis abilities of L. kefiranofaciens M1 in a number of in-vitro and in-vivo experiments. However, whether the effects of L. kefiranofaciens M1 are elicited directly on the host or act by regulating the host's microbiota remains unknown. A number of studies have used germ-free or gnotobiotic animals to investigate the relationship between probiotics and colitis; therefore the aim of this study was to investigate the effects of L. kefiranofaciens M1 on germ-free mice. Such an approach should help in determining the direct effects of L. kefiranofaciens M1 on the host itself. Four-week-old female germ-free mice were inoculated intragastrically with 2x10(8) CFU/mouse L. kefiranofaciens M1 once or at 2-day intervals for 14 days. Bacterial colonization, the Th1/Th2 cytokine profile of the mice's splenocytes and the anti-colitis effect of L. kefiranofaciens M1 were investigated. The strongest response in terms of splenic Th1 cytokine IFN-gamma and IL-12 production upon TLR activation was detected in the continuous treatment group when comparing to the single inoculation group and the germ-free control. In addition, continuous inoculation with L. kefiranofaciens M1 was found to ameliorate the symptoms of DSS-induced colitis in germ-free mice. However, L. kefiranofaciens M1 failed to colonize the host. Thus it would seem that L. kefiranofaciens M1 is likely to act directly on the host and not be involved in microbiota regulation.	[Chen, Yen-Po; Chen, Ming-Ju] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Chen, Ming-Ju] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Chen, MJ (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan.	cmj@ntu.edu.tw	Chen, Yen Po/GLQ-6423-2022	Chen, Yen Po/0000-0003-0621-6219; CHEN, MING-JU/0000-0003-4403-6112	National Science Council in Taiwan	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, CRIT REV FOOD SCI, V53, P422, DOI 10.1080/10408398.2010.540360; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; Banasaz M, 2002, APPL ENVIRON MICROB, V68, P3031, DOI 10.1128/AEM.68.6.3031-3034.2002; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Chen KQ, 2011, INT IMMUNOPHARMACOL, V11, P1391, DOI 10.1016/j.intimp.2011.05.003; Chen YP, 2012, J DAIRY SCI, V95, P63, DOI 10.3168/jds.2011-4696; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; dos Santos LM, 2011, MED MICROBIOL IMMUN, V200, P29, DOI 10.1007/s00430-010-0170-1; Gangloff SC, 2004, CLIN REV ALLERG IMMU, V26, P115, DOI 10.1385/CRIAI:26:2:115; Guzel-Seydim ZB, 2011, CRIT REV FOOD SCI, V51, P261, DOI 10.1080/10408390903579029; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hong WS, 2011, J AGR FOOD CHEM, V59, P9022, DOI 10.1021/jf201913x; Hong WS, 2010, J FOOD SCI, V75, pH244, DOI 10.1111/j.1750-3841.2010.01787.x; Hong WS, 2009, INT DAIRY J, V19, P244, DOI 10.1016/j.idairyj.2008.10.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Krumbiegel D, 2007, HUM IMMUNOL, V68, P813, DOI 10.1016/j.humimm.2007.08.001; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Nikolic M, 2012, INT J FOOD MICROBIOL, V158, P155, DOI 10.1016/j.ijfoodmicro.2012.07.015; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Puhl NJ, 2012, ANAEROBE, V18, P67, DOI 10.1016/j.anaerobe.2011.12.007; Ruas-Madiedo P, 2006, J DAIRY SCI, V89, P2355, DOI 10.3168/jds.S0022-0302(06)72307-4; SHARMA R, 1995, GUT, V36, P209, DOI 10.1136/gut.36.2.209; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; THOMPSON GR, 1971, GUT, V12, P230, DOI 10.1136/gut.12.3.230; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Vereecke L, 2011, TRENDS MOL MED, V17, P584, DOI 10.1016/j.molmed.2011.05.011; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wang SY, 2012, FOOD MICROBIOL, V32, P274, DOI 10.1016/j.fm.2012.07.001; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; WOSTMANN BS, 1981, ANNU REV NUTR, V1, P257, DOI 10.1146/annurev.nu.01.070181.001353	39	44	44	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78789	10.1371/journal.pone.0078789	http://dx.doi.org/10.1371/journal.pone.0078789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244362	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600060
J	Joo, YH; Lee, YS; Cho, KJ; Park, JO; Nam, IC; Kim, CS; Kim, SY; Kim, MS				Joo, Young-Hoon; Lee, Youn-Soo; Cho, Kwang-Jae; Park, Jun-Ook; Nam, In-Chul; Kim, Chung-Soo; Kim, Sang-Yeon; Kim, Min-Sik			Characteristics and Prognostic Implications of High-Risk HPV-Associated Hypopharyngeal Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; POSTOPERATIVE RADIOTHERAPY; OROPHARYNGEAL CANCER; NECK; HEAD; PRESERVATION; EXPRESSION; SURGERY	Background: High-risk human papillomavirus (HPV) is an oncogenic virus that causes oropharyngeal cancers, and it has a favorable outcome after the treatment. Unlike in oropharyngeal cancer, the prevalence and role of high-risk HPV in the etiology of hypopharyngeal squamous cell carcinoma (HPSCC) is uncertain. Objective: The aim of the present study was to evaluate the effect and prognostic significance of high-risk HPV in patients with HPSCC. Methods: The study included 64 subjects with HPSCC who underwent radical surgery with or without radiation-based adjuvant therapy. Primary tumor sites were the pyriform sinus in 42 patients, posterior pharyngeal wall in 19 patients, and postcricoid area in 3 patients. High-risk HPV in situ hybridization was performed to detect HPV infection. Results: The positive rate of high-risk HPV in situ hybridization was 10.9% (7/64). There was a significant difference in the fraction of positive high-risk HPV among pyriform sinus cancer (16.7%), posterior pharyngeal wall cancer (0%), and postcricoid area cancer (0%) (p = 0.042). The laryngoscopic examination revealed a granulomatous and exophytic appearance in 85.7% (6/7) of patients with high-risk HPV-positive pyriform sinus cancer, but in only 31.4% (11/35) of patients with high-risk HPV-negative pyriform sinus cancer (p = 0.012). Significant correlations were found between positive high-risk HPV and younger age (p = 0.050) and non-smoking status (p = 0.017). HPV-positive patients had a significantly better disease-free survival (p = 0.026) and disease-specific survival (p = 0.047) than HPV-negative patients. Conclusions: High-risk HPV infection is significantly related to pyriform sinus cancer in patients with HPSCC.	[Joo, Young-Hoon; Cho, Kwang-Jae; Park, Jun-Ook; Nam, In-Chul; Kim, Chung-Soo; Kim, Sang-Yeon; Kim, Min-Sik] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Youn-Soo] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, MS (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	entkms@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916				Ferlito A, 2001, ACTA OTO-LARYNGOL, V121, P329, DOI 10.1080/000164801300102671; Joo YH, 2012, ORAL ONCOL, V48, P90, DOI 10.1016/j.oraloncology.2011.08.020; Joo YH, 2012, HEAD NECK-J SCI SPEC, V34, P10, DOI 10.1002/hed.21697; Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Krstevska V, 2012, INDIAN J CANCER, V49, P236, DOI 10.4103/0019-509X.102920; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Li W, 2004, HEAD NECK-J SCI SPEC, V26, P1, DOI 10.1002/hed.10335; Pytynia KB, 2004, J CLIN ONCOL, V22, P3981, DOI 10.1200/jco.2004.02.133; Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355; Shin A, 2013, LARYNGOSCOP IN PRESS; Urba SG, 2000, LARYNGOSCOPE, V110, P2074, DOI 10.1097/00005537-200012000-00019; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P2379, DOI 10.1158/1055-9965.EPI-10-0336; Zelefsky MJ, 1996, HEAD NECK-J SCI SPEC, V18, P405, DOI 10.1002/(SICI)1097-0347(199609/10)18:5<405::AID-HED3>3.0.CO;2-9	14	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78718	10.1371/journal.pone.0078718	http://dx.doi.org/10.1371/journal.pone.0078718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244346	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600053
J	Nadatani, Y; Watanabe, T; Tanigawa, T; Ohkawa, F; Takeda, S; Higashimori, A; Sogawa, M; Yamagami, H; Shiba, M; Watanabe, K; Tominaga, K; Fujiwara, Y; Takeuchi, K; Arakawa, T				Nadatani, Yuji; Watanabe, Toshio; Tanigawa, Tetsuya; Ohkawa, Fumikazu; Takeda, Shogo; Higashimori, Akira; Sogawa, Mitsue; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Kenji; Tominaga, Kazunari; Fujiwara, Yasuhiro; Takeuchi, Koji; Arakawa, Tetsuo			High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ISCHEMIA-REPERFUSION INJURY; SMALL-INTESTINAL DAMAGE; ISCHEMIA/REPERFUSION INJURY; PROINFLAMMATORY CYTOKINE; MURINE COLITIS; KINASE PATHWAY; UP-REGULATION; EARLY PHASE; PROTEIN	High-mobility group box 1 (HMGB1) was initially discovered as a nuclear protein that interacts with DNA as a chromatin-associated non-histone protein to stabilize nucleosomes and to regulate the transcription of many genes in the nucleus. Once leaked or actively secreted into the extracellular environment, HMGB1 activates inflammatory pathways by stimulating multiple receptors, including Toll-like receptor (TLR) 2, TLR4, and receptor for advanced glycation end products (RAGE), leading to tissue injury. Although HMGB1's ability to induce inflammation has been well documented, no studies have examined the role of HMGB1 in wound healing in the gastrointestinal field. The aim of this study was to evaluate the role of HMGB1 and its receptors in the healing of gastric ulcers. We also investigated which receptor among TLR2, TLR4, or RAGE mediates HMGB1's effects on ulcer healing. Gastric ulcers were induced by serosal application of acetic acid in mice, and gastric tissues were processed for further evaluation. The induction of ulcer increased the immunohistochemical staining of cytoplasmic HMGB1 and elevated serum HMGB1 levels. Ulcer size, myeloperoxidase (MPO) activity, and the expression of tumor necrosis factor alpha (TNF alpha) mRNA peaked on day 4. Intraperitoneal administration of HMGB1 delayed ulcer healing and elevated MPO activity and TNF alpha expression. In contrast, administration of anti-HMGB1 antibody promoted ulcer healing and reduced MPO activity and TNF alpha expression. TLR4 and RAGE deficiency enhanced ulcer healing and reduced the level of TNF alpha, whereas ulcer healing in TLR2 knockout (KO) mice was similar to that in wild-type mice. In TLR4 KO and RAGE KO mice, exogenous HMGB1 did not affect ulcer healing and TNF alpha expression. Thus, we showed that HMGB1 is a complicating factor in the gastric ulcer healing process, which acts through TLR4 and RAGE to induce excessive inflammatory responses.	[Nadatani, Yuji; Watanabe, Toshio; Tanigawa, Tetsuya; Takeda, Shogo; Higashimori, Akira; Sogawa, Mitsue; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Kenji; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Ohkawa, Fumikazu; Takeuchi, Koji] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Kyoto 607, Japan	Osaka Metropolitan University; Kyoto Pharmaceutical University	Watanabe, T (corresponding author), Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan.	watanabet@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637	Mitsubishi Tanabe Pharma Corporation; Abbott Japan Co., LTD.; Speaking and Teaching: Abbott Japan Co., LTD.; Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd; Otsuka Pharmaceutical Co. Ltd.	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Abbott Japan Co., LTD.(Abbott Laboratories); Speaking and Teaching: Abbott Japan Co., LTD.; Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd; Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	Kenji Watanabe - Grant/Research Support from the Mitsubishi Tanabe Pharma Corporation, Abbott Japan Co., LTD.; Mitsubishi Tanabe Pharma Corporation; Speaking and Teaching: Abbott Japan Co., LTD. Yasuhiro Fujiwara - Speaking and Teaching: Eisai Co. Ltd Tetsuo Arakawa - Advisory Committees or Review Panels: Eisai Co. Ltd, Otsuka Pharmaceutical Co. Ltd. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Esmon C, 2005, NAT MED, V11, P475, DOI 10.1038/nm0505-475; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inoue Y, 2013, ROLE SERUM HIGH MOBI; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lei C, 2013, NEUROSCIENCE, V229, P12, DOI 10.1016/j.neuroscience.2012.10.054; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Nagato M, 2009, CRIT CARE MED, V37, P2181, DOI 10.1097/CCM.0b013e3181a55184; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; Otani K, 2012, BIOCHEM BIOPH RES CO, V426, P342, DOI 10.1016/j.bbrc.2012.08.080; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Ranzato E, 2010, CELL BIOCHEM BIOPHYS, V57, P9, DOI 10.1007/s12013-010-9077-0; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shimizu N, 2000, DIGESTION, V61, P157, DOI 10.1159/000007752; Shimizu T, 2000, DIGESTION, V62, P87, DOI 10.1159/000007800; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7; Suzuki N, 1998, J PHYSIOL PHARMACOL, V49, P515; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takahashi M, 1997, BIOCHEM BIOPH RES CO, V234, P493, DOI 10.1006/bbrc.1997.5974; Tanigawa T, 2010, DIGESTION, V81, P86, DOI 10.1159/000243719; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; WATANABE T, 1995, DIGEST DIS SCI, V40, P1340, DOI 10.1007/BF02065548; Watanabe T, 2002, DIGEST DIS SCI, V47, P1582, DOI 10.1023/A:1015879421739; Watanabe T, 2012, AM J PHYSIOL-GASTR L, V303, pG324, DOI 10.1152/ajpgi.00075.2012; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zeng S, 2009, J HEPATOL, V50, P929, DOI 10.1016/j.jhep.2008.11.022; Zhang Q, 2012, J SURG RES, V176, P343, DOI 10.1016/j.jss.2011.06.069	58	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80130	10.1371/journal.pone.0080130	http://dx.doi.org/10.1371/journal.pone.0080130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244627	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600183
J	Seamons, A; Treuting, PM; Brabb, T; Maggio-Price, L				Seamons, Audrey; Treuting, Piper M.; Brabb, Thea; Maggio-Price, Lillian			Characterization of Dextran Sodium Sulfate-Induced Inflammation and Colonic Tumorigenesis in Smad3(-/-) Mice with Dysregulated TGF beta	PLOS ONE			English	Article							BOWEL-DISEASE; NEOPLASTIC PROGRESSION; GALECTIN-3 EXPRESSION; EXPERIMENTAL COLITIS; INTESTINAL CANCER; COLORECTAL-CANCER; MOUSE MODELS; MUTANT MICE; CARCINOGENESIS; INFECTION	There are few mouse models that adequately mimic large bowel cancer in humans or the gastrointestinal inflammation which frequently precedes it. Dextran sodium sulphate (DSS)-induces colitis in many animal models and has been used in combination with the carcinogen azoxymethane (AOM) to induce cancer in mice. Smad3(-/-) mice are deficient in the transforming growth factor beta (TGF beta) signaling molecule, SMAD3, resulting in dysregulation of the cellular pathway most commonly affected in human colorectal cancer, and develop inflammation-associated colon cancer. Previous studies have shown a requirement for a bacterial trigger for the colitis and colon cancer phenotype in Smad3(-/-) mice. Studies presented here in Smad3(-/-) mice detail disease induction with DSS, without the use of AOM, and show a) Smad3(-/-) mice develop a spectrum of lesions ranging from acute and chronic colitis, crypt herniation, repair, dysplasia, adenomatous polyps, disseminated peritoneal adenomucinosis, adenocarcinoma, mucinous adenocarcinoma (MAC) and squamous metaplasia; b) the colon lesions have variable galactin-3 (Mac2) staining c) increased DSS concentration and duration of exposure leads to increased severity of colonic lesions; d) heterozygosity of SMAD3 does not confer increased susceptibility to DSS-induced disease and e) disease is partially controlled by the presence of T and B cells as Smad3(-/-) Rag2(-/-) double knock out (DKO) mice develop a more severe disease phenotype. DSS-induced disease in Smad3(-/-) mice may be a useful animal model to study not only inflammation-driven MAC but other human diseases such as colitis cystica profunda (CCP) and pseudomyxomatous peritonei (PMP).	[Seamons, Audrey; Treuting, Piper M.; Brabb, Thea; Maggio-Price, Lillian] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Maggio-Price, L (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	lmprice@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Seamons, Audrey/0000-0003-2609-1230	CCFA [1579]; AICR [09A136-Rev]	CCFA; AICR	This research was supported in part by CCFA #1579 (L.M.P., http://www.ccfa.org/science-and-professionals/research/grants-fellowships/) and AICR 09A136-Rev (L.M.P., http://www.aicr.org/research/grant/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Arfaoui-Toumi A, 2010, B CANCER, V97, pE1, DOI 10.1684/bdc.2010.1032; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Becker C, 2006, CYTOKINE GROWTH F R, V17, P97, DOI 10.1016/j.cytogfr.2005.09.004; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Boulard O, 2012, J EXP MED, V209, P1309, DOI 10.1084/jem.20120239; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; COOPER HS, 1993, LAB INVEST, V69, P238; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Endo K, 2005, ANTICANCER RES, V25, P3117; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Hale LP, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-4; Hamilton S, 2000, WHO CLASSIFICATION T, P105; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Lencioni KC, 2011, COMPARATIVE MED, V61, P219; Loddenkemper C, 2006, INT J CANCER, V118, P2750, DOI 10.1002/ijc.21729; LOTZ MM, 1993, P NATL ACAD SCI USA, V90, P3466, DOI 10.1073/pnas.90.8.3466; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mladenova D, 2012, IN VIVO, V26, P627; Molavi D, 2008, ADV ANAT PATHOL, V15, P1, DOI 10.1097/PAP.0b013e31815e52aa; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Percy DH, 2007, PATHOLOGY LAB RODENT; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Radosavljevic G, 2012, IMMUNOL RES, V52, P100, DOI 10.1007/s12026-012-8286-6; Ronnett BM, 2001, CANCER, V92, P85, DOI 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R; Ronnett BM, 2003, CME J GYNECOL ONCOL, V8, P192; SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#; Suzuki R, 2005, HISTOL HISTOPATHOL, V20, P483, DOI 10.14670/HH-20.483; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Tokumasa A, 2004, BIOCHEM BIOPH RES CO, V317, P377, DOI 10.1016/j.bbrc.2004.03.047; Tsuboi K, 2007, ANTICANCER RES, V27, P2289; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	55	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79182	10.1371/journal.pone.0079182	http://dx.doi.org/10.1371/journal.pone.0079182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244446	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600116
J	Vos, M; Lovisa, B; Geens, A; Morais, VA; Wagnieres, G; van den Bergh, H; Ginggen, A; De Strooper, B; Tardy, Y; Verstreken, P				Vos, Melissa; Lovisa, Blaise; Geens, Ann; Morais, Vanessa A.; Wagnieres, Georges; van den Bergh, Hubert; Ginggen, Alec; De Strooper, Bart; Tardy, Yanik; Verstreken, Patrik			Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; MITOCHONDRIAL-FUNCTION; DISEASE; DROSOPHILA; PHOSPHORYLATION; DEFICIENCY; MECHANISMS; DEFECTS; THERAPY; FISSION	Mitochondrial electron transport chain (ETC) defects are observed in Parkinson's disease (PD) patients and in PD fly-and mouse-models; however it remains to be tested if acute improvement of ETC function alleviates PD-relevant defects. We tested the hypothesis that 808 nm infrared light that effectively penetrates tissues rescues pink1 mutants. We show that irradiating isolated fly or mouse mitochondria with 808 nm light that is absorbed by ETC-Complex IV acutely improves Complex IV-dependent oxygen consumption and ATP production, a feature that is wavelength-specific. Irradiating Drosophila pink1 mutants using a single dose of 808 nm light results in a rescue of major systemic and mitochondrial defects. Time-course experiments indicate mitochondrial membrane potential defects are rescued prior to mitochondrial morphological defects, also in dopaminergic neurons, suggesting mitochondrial functional defects precede mitochondrial swelling. Thus, our data indicate that improvement of mitochondrial function using infrared light stimulation is a viable strategy to alleviate pink1-related defects.	[Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] VIB Ctr Biol Dis, Louvain, Belgium; [Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Vos, Melissa; Geens, Ann; Morais, Vanessa A.; De Strooper, Bart; Verstreken, Patrik] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium; [Lovisa, Blaise; Tardy, Yanik] Medos Int Sarl, Le Locle, Switzerland; [Lovisa, Blaise; Wagnieres, Georges; van den Bergh, Hubert] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Chem Sci & Engn ISIC, Med Photon Grp, CH-1015 Lausanne, Switzerland; [Ginggen, Alec] Johnson & Johnson Serv Inc, Corp Off Sci & Technol, New Brunswick, NJ USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Johnson & Johnson	Verstreken, P (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	Patrik.verstreken@med.kuleuven.be	Verstreken, Patrik/AAC-7591-2022; de+Strooper, Bart/Z-1638-2019	Verstreken, Patrik/0000-0002-5073-5393; Wagnieres, Georges/0000-0002-9082-3099; Morais, Vanessa/0000-0002-0830-0548	IWT (OO); KU Leuven; ERC StG [260678]; FWO; Methusalem; CTI [14660.1 PFLS-LS, 13758.1 PFFLE-ES]; R'EQUIP program [206021_128677]; J. Jacobi Trust; Swiss National Science Foundation [205320 147141/1]; Hercules and Francqui Foundations; IUAP of BELSPO; VIB as well as a fellowships from IWT; Research fund KU Leuven (PDM)	IWT (OO); KU Leuven(KU Leuven); ERC StG; FWO(FWO); Methusalem; CTI; R'EQUIP program; J. Jacobi Trust; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hercules and Francqui Foundations; IUAP of BELSPO; VIB as well as a fellowships from IWT; Research fund KU Leuven (PDM)	Support was provided by IWT (O&O), research fund KU Leuven, ERC StG (260678), FWO grants, Methusalem grant, the CTI (14660.1 PFLS-LS and 13758.1 PFFLE-ES), the R'EQUIP program (206021_128677), the J. Jacobi Trust, the Swiss National Science Foundation (205320 147141/1), the Hercules and Francqui Foundations, an IUAP of BELSPO and VIB as well as a fellowships from IWT, Research fund KU Leuven (PDM) and FWO to MV. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; Esposito G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003478; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liu S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001237; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pecina P, 2004, PHYSIOL RES, V53, pS213; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x; Varghese M, 2009, J NEUROL SCI, V279, P39, DOI 10.1016/j.jns.2008.12.021; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Volkmann J, 2004, J CLIN NEUROPHYSIOL, V21, P6, DOI 10.1097/00004691-200401000-00003; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zhang HY, 2009, LASER MED SCI, V24, P549, DOI 10.1007/s10103-008-0609-4; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	38	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78562	10.1371/journal.pone.0078562	http://dx.doi.org/10.1371/journal.pone.0078562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244323	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600033
J	Chen, P; Ong, RTH; Tay, WT; Sim, XL; Ali, M; Xu, HY; Suo, C; Liu, JJ; Chia, KS; Vithana, E; Young, TL; Aung, T; Lim, WY; Khor, CC; Cheng, CY; Wong, TY; Teo, YY; Tai, ES				Chen, Peng; Ong, Rick Twee-Hee; Tay, Wan-Ting; Sim, Xueling; Ali, Mohammad; Xu, Haiyan; Suo, Chen; Liu, Jianjun; Chia, Kee-Seng; Vithana, Eranga; Young, Terri L.; Aung, Tin; Lim, Wei-Yen; Khor, Chiea-Chuen; Cheng, Ching-Yu; Wong, Tien-Yin; Teo, Yik-Ying; Tai, E-Shyong			A Study Assessing the Association of Glycated Hemoglobin A(1C) (HbA(1C)) Associated Variants with HbA(1C), Chronic Kidney Disease and Diabetic Retinopathy in Populations of Asian Ancestry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ETHNIC-DIFFERENCES; RISK-FACTORS; SUSCEPTIBILITY LOCI; NATIONAL-HEALTH; GLUCOSE; METAANALYSIS; PREVALENCE; COMPONENTS; EFFICIENCY	Glycated hemoglobin A(1C) (HbA(1C)) level is used as a diagnostic marker for diabetes mellitus and a predictor of diabetes associated complications. Genome-wide association studies have identified genetic variants associated with HbA(1C) level. Most of these studies have been conducted in populations of European ancestry. Here we report the findings from a meta-analysis of genome-wide association studies of HbA(1C) levels in 6,682 non-diabetic subjects of Chinese, Malay and South Asian ancestries. We also sought to examine the associations between HbA(1C) associated SNPs and microvascular complications associated with diabetes mellitus, namely chronic kidney disease and retinopathy. A cluster of 6 SNPs on chromosome 17 showed an association with HbA(1C) which achieved genome-wide significance in the Malays but not in Chinese and Asian Indians. No other variants achieved genome-wide significance in the individual studies or in the meta-analysis. When we investigated the reproducibility of the findings that emerged from the European studies, six loci out of fifteen were found to be associated with HbA(1C) with effect sizes similar to those reported in the populations of European ancestry and P-value <= 0.05. No convincing associations with chronic kidney disease and retinopathy were identified in this study.	[Chen, Peng; Ong, Rick Twee-Hee; Sim, Xueling; Xu, Haiyan; Suo, Chen; Chia, Kee-Seng; Lim, Wei-Yen; Khor, Chiea-Chuen; Cheng, Ching-Yu; Teo, Yik-Ying; Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tay, Wan-Ting; Vithana, Eranga; Aung, Tin; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Khor, Chiea-Chuen] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Ali, Mohammad; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Liu, Jianjun; Khor, Chiea-Chuen; Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Vithana, Eranga; Aung, Tin; Khor, Chiea-Chuen; Cheng, Ching-Yu; Wong, Tien-Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien-Yin; Tai, E-Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore; [Young, Terri L.] Duke Univ, Ctr Human Genet, Med Ctr, Durham, NC USA; [Tai, E-Shyong] Duke NUS Grad Med Sch, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; National University of Singapore; National University of Singapore; Duke University; National University of Singapore; National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	statyy@nus.edu.sg; e_shyong_tai@nuhs.edu.sg	Chen, Peng/E-5546-2015; Sim, Xueling/AAZ-6652-2020; Wong, Tien Yin/AAC-9724-2020; Cheng, Ching-Yu/Y-2229-2019; Liu, Jianjun/AAK-4989-2020	Chen, Peng/0000-0002-1422-4641; Sim, Xueling/0000-0002-1233-7642; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Liu, Jianjun/0000-0002-3255-3019	Yong Loo Lin School of Medicine; National University Health System; Life Sciences Institute from the National University of Singapore; National Research Foundation [NRF-RF-2010-05]; National Medical Research Council of Singapore; Biomedical Research Council of Singapore; National Medical Research Council [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council [08/1/35/19/550, 09/1/35/19/616]	Yong Loo Lin School of Medicine(National University of Singapore); National University Health System; Life Sciences Institute from the National University of Singapore(National University of Singapore); National Research Foundation; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This project acknowledges the support of the Yong Loo Lin School of Medicine, the National University Health System and the Life Sciences Institute from the National University of Singapore. The authors also acknowledge the support from the National Research Foundation (NRF-RF-2010-05), National Medical Research Council of Singapore (under the clinician scientist award, Singapore Translational Research Investigator Award and individual research grant schemes) and the Biomedical Research Council of Singapore (under the individual research grants scheme). SiMES, SINDI and SCES were funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008; CG/SERI/2010) and Biomedical Research Council (grants 08/1/35/19/550, 09/1/35/19/616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Franklin CS, 2010, ANN HUM GENET, V74, P471, DOI 10.1111/j.1469-1809.2010.00607.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grimsby JL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-30; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li C, 2008, GENET EPIDEMIOL, V32, P387, DOI 10.1002/gepi.20312; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Ong RTH, 2012, EUR J HUM GENET, V20, P1300, DOI 10.1038/ejhg.2012.88; Pare G, 2008, PLOS GENET, V4, DOI DOI 10.1007/s00726-014-1889-6; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ryu J, 2012, HUM MUTAT, V33, P655, DOI 10.1002/humu.22040; Sabanayagam C, 2009, DIABETOLOGIA, V52, P1279, DOI 10.1007/s00125-009-1360-5; Sabanayagam C, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-86; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Simonis-Bik AMC, 2008, TWIN RES HUM GENET, V11, P597, DOI 10.1375/twin.11.6.597; Sobrin L, 2011, INVEST OPHTH VIS SCI, V52, P7593, DOI 10.1167/iovs.11-7510; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Tanhauserova V, 2013, CLIN CHEM LAB MED, P1; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng YF, 2012, OPHTHALMOLOGY, V119, P2119, DOI 10.1016/j.ophtha.2012.04.027	41	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79767	10.1371/journal.pone.0079767	http://dx.doi.org/10.1371/journal.pone.0079767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244560	Green Published, gold			2022-12-27	WOS:000327162900052
J	Louchart, A; Sire, JY; Mourer-Chauvire, C; Geraads, D; Viriot, L; de Buffrenil, V				Louchart, Antoine; Sire, Jean-Yves; Mourer-Chauvire, Cecile; Geraads, Denis; Viriot, Laurent; de Buffrenil, Vivian			Structure and Growth Pattern of Pseudoteeth in Pelagornis mauretanicus (Aves, Odontopterygiformes, Pelagornithidae)	PLOS ONE			English	Article							BONY-TOOTHED BIRD; EOCENE; TISSUE; RECORD; TEETH	The extinct Odontopterygiformes are the sole birds known to possess strong and sharp bony pseudoteeth, the shape and location of which are closely mimetic of real teeth. The structure of the pseudoteeth is investigated here in a late Pliocene/early Pleistocene species, Pelagornis mauretanicus, using X-ray microtomography and thin sections. The results are interpreted with regard to the pseudotooth mode of growth, and have implications concerning aspects of Pelagornis ecology. The larger pseudoteeth are hollow and approximately cone-shaped, and the smaller ones are rostro-caudally constricted. The walls of pseudoteeth are composed of bone tissue of the fibro-lamellar type, which is intensively remodeled by Haversian substitution. The jaw bones display the same structure as the pseudoteeth, but their vascular canals are oriented parallel to the long axis of the bones, whereas they are perpendicular to this direction in the pseudoteeth. There is no hiatus or evidence of a fusion between the pseudoteeth and the jaw bones. Two possible models for pseudotooth growth are derived from the histological data. The most plausible model is that pseudotooth growth began after the completion of jaw bone growth, as a simple local protraction of periosteal osteogenic activity. Pseudotooth development thus occurred relatively late during ontogeny. The highly vascularized structure and the relative abundance of parallel-fibered bone tissue in the pseudoteeth suggest poor mechanical capabilities. The pseudoteeth were most likely covered and protected by the hardened, keratinized rhamphotheca in the adult during life. The late development of the pseudoteeth would involve a similarly late and/or partial hardening of the rhamphotheca, as displayed by extant Anseriformes, Apterygiformes and some Charadriiformes. This would add support to the hypothesis of a close phylogenetic relationship between Odontopterygiformes and Anseriformes. The late maturation of the Pelagornis feeding apparatus, and hence the delayed capability for efficient prey catching, suggests that Pelagornis was altricial.	[Louchart, Antoine; Viriot, Laurent] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5242, F-69365 Lyon, France; [Sire, Jean-Yves] Univ Paris 06, Unite Mixte Rech Syst Adaptat Evolut Equipe Evol, Paris, France; [Mourer-Chauvire, Cecile] Univ Lyon 1, Ecole Normale Super Lyon, Lab Geol Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5276, F-69365 Lyon, France; [Geraads, Denis] Museum Natl Hist Nat, Dept Hist Terre, Ctr Rech Palebiodiversite & Paleoenvironnem, Ctr Natl Rech Sci,Unit Mixte Rech 7207, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Louchart, A (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, Ctr Natl Rech Sci,Unite Mixte Rech 5242, F-69365 Lyon, France.	antoine.louchart@ens-lyon.fr	Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	GERAADS, Denis/0000-0003-2475-8011; Viriot, Laurent/0000-0003-2092-588X; Louchart, Antoine/0000-0003-3847-6007; de Buffrenil, Vivian/0000-0003-3414-0186	The French ANR-Jeune-chercheur Programme "PIAFS" [ANR-11-JSV7-004-01]	The French ANR-Jeune-chercheur Programme "PIAFS"(French National Research Agency (ANR))	The French ANR-Jeune-chercheur Programme "PIAFS", ANR-11-JSV7-004-01 to AL. The programme "Prehistoire du Grand Casablanca" of the Institut National des Sciences de l'Archeologie et du Patrimoine to DG for excavations at Ahl al Oughlam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boessenecker RW, 2011, J VERTEBR PALEONTOL, V31, P652, DOI 10.1080/02724634.2011.562268; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; Bourdon E, 2005, NATURWISSENSCHAFTEN, V92, P586, DOI 10.1007/s00114-005-0047-0; Bourdon E., 2011, LIVING DINOSAURS, P209; Bourdon E, 2010, AM MUS NOVIT, P1, DOI 10.1206/3704.2; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy Anusuya, 2002, P421; Coles B, 2007, ESSENTIALS AVIAN MED; Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Francillon-Vieillot H., 1990, P471; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Howard H., 1957, Santa Barbara Mus nat Hist Bull, Vno. 1, P1; HOWARD HILDEGARDE, 1962, LOS ANGELES COUNTY MUS CONTR SCI, V52, P1; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Mayr G, 2012, J VERTEBR PALEONTOL, V32, P914, DOI 10.1080/02724634.2012.676114; Mayr G, 2011, ZOOL SCR, V40, P448, DOI 10.1111/j.1463-6409.2011.00484.x; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; MEISTER W, 1962, ANAT REC, V143, P377, DOI 10.1002/ar.1091430408; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Mourer-Chauvire Cecile, 2008, Oryctos, V7, P169; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1991, Ornithological Monographs, P1; Owen R, 1873, Q J GEOL SOC LOND, V29, P511, DOI DOI 10.1144/GSL.JGS.1873.029.01-02.45; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Spulski B., 1910, Z DTSCH GEOLOGISCHEN, V62, P507; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P3; Stidham Thomas A., 2004, Paleobios, V24, P7; Wilson James W., 1994, P205; Zioupos P, 2000, CONNECT TISSUE RES, V41, P229, DOI 10.3109/03008200009005292; ZUSI R L, 1992, Natural History Museum of Los Angeles County Science Series, P351	37	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80372	10.1371/journal.pone.0080372	http://dx.doi.org/10.1371/journal.pone.0080372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244680	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800143
J	Messiaen, AS; Forier, K; Nelis, H; Braeckmans, K; Coenye, T				Messiaen, Anne-Sophie; Forier, Katrien; Nelis, Hans; Braeckmans, Kevin; Coenye, Tom			Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BACTERICIDAL EFFICACY; RESISTANT STRAINS; ENHANCED ACTIVITY; AMINOGLYCOSIDES; MECHANISM; AMIKACIN	Due to the intrinsic resistance of Burkholderia cepacia complex (Bcc) to many antibiotics and the production of a broad range of virulence factors, lung infections by these bacteria, primarily occurring in cystic fibrosis (CF) patients, are very difficult to treat. In addition, the ability of Bcc organisms to form biofilms contributes to their persistence in the CF lung. As Bcc infections are associated with poor clinical outcome, there is an urgent need for new effective therapies to treat these infections. In the present study, we investigated whether liposomal tobramycin displayed an increased anti-biofilm effect against Bcc bacteria compared to free tobramycin. Single particle tracking (SPT) was used to study the transport of positively and negatively charged nanospheres in Bcc biofilms as a model for the transport of liposomes. Negatively charged nanospheres became immobilized in close proximity of biofilm cell clusters, while positively charged nanospheres interacted with fiber-like structures, probably eDNA. Based on these data, encapsulation of tobramycin in negatively charged liposomes appeared promising for targeted drug delivery. However, the anti-biofilm effect of tobramycin encapsulated into neutral or anionic liposomes did not increase compared to that of free tobramycin. Probably, the fusion of the anionic liposomes with the negatively charged bacterial surface of Bcc bacteria was limited by electrostatic repulsive forces. The lack of a substantial anti-biofilm effect of tobramycin encapsulated in neutral liposomes could be further investigated by increasing the liposomal tobramycin concentration. However, this was hampered by the low encapsulation efficiency of tobramycin in these liposomes.	[Messiaen, Anne-Sophie; Nelis, Hans; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Tom.Coenye@Ugent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Braeckmans, Kevin/HCH-3119-2022	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Braeckmans, Kevin/0000-0002-7993-6295; Forier, Katrien/0000-0002-7003-3612	Interuniversity Attraction Poles Programme; Belgian Science Policy Office; Ghent University	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Ghent University(Ghent University)	This research has been funded by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office and by a concerted action grant by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulac C, 1998, J ANTIMICROB CHEMOTH, V41, P35, DOI 10.1093/jac/41.1.35; Braeckmans K, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Braeckmans K, 2010, NANO LETT, V10, P4435, DOI 10.1021/nl103264u; Brennan AL, 2002, CURR OPIN INFECT DIS, V15, P175, DOI 10.1097/00001432-200204000-00013; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Council of European, 2021, BRIT PHARMACOPOEIA, V10th; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cystic Fibrosis Foundation, 2011, ANN DAT REP CTR DIR; Forier K, 2013, NANOMEDICINE-UK, V8, P935, DOI [10.2217/NNM.12.129, 10.2217/nnm.12.129]; GIWERCMAN B, 1991, ANTIMICROB AGENTS CH, V35, P1008, DOI 10.1128/AAC.35.5.1008; Halwani M, 2007, J ANTIMICROB CHEMOTH, V60, P760, DOI 10.1093/jac/dkm289; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Li ZL, 2008, J AEROSOL MED PULM D, V21, P245, DOI 10.1089/jamp.2008.0686; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Mugabe C, 2006, INT J PHARMACEUT, V307, P244, DOI 10.1016/j.ijpharm.2005.10.005; Mugabe C, 2005, J ANTIMICROB CHEMOTH, V55, P269, DOI 10.1093/jac/dkh518; Mugabe C, 2006, ANTIMICROB AGENTS CH, V50, P2016, DOI 10.1128/AAC.01547-05; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Omri A, 2002, BIOCHEM PHARMACOL, V64, P1407, DOI 10.1016/S0006-2952(02)01346-1; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Seidler M, 2010, FEMS YEAST RES, V10, P492, DOI 10.1111/j.1567-1364.2010.00618.x; Sousa Silvia A, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/607575; Symens N, 2011, MOL PHARMACEUT, V8, P1757, DOI 10.1021/mp200120v; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC	31	66	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79220	10.1371/journal.pone.0079220	http://dx.doi.org/10.1371/journal.pone.0079220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244452	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800043
J	Osman, KA; Tang, B; Wang, YP; Chen, JH; Yu, F; Li, L; Han, XS; Zhang, ZX; Yan, JB; Zheng, YL; Yue, B; Qiu, FZ				Osman, Khalid A.; Tang, Bin; Wang, Yaping; Chen, Juanhua; Yu, Feng; Li, Liu; Han, Xuesong; Zhang, Zuxin; Yan, Jianbin; Zheng, Yonglian; Yue, Bing; Qiu, Fazhan			Dynamic QTL Analysis and Candidate Gene Mapping for Waterlogging Tolerance at Maize Seedling Stage	PLOS ONE			English	Article							ZEA-MAYS L.; QUANTITATIVE TRAIT LOCI; ADVENTITIOUS ROOT-FORMATION; DEVELOPMENTAL BEHAVIOR; AERENCHYMA FORMATION; FLOODING CONDITIONS; PLANT HEIGHT; LINKAGE MAP; IDENTIFICATION; RICE	Soil waterlogging is one of the major abiotic stresses adversely affecting maize growth and yield. To identify dynamic expression of genes or quantitative trait loci (QTL), QTL associated with plant height, root length, root dry weight, shoot dry weight and total dry weight were identified via conditional analysis in a mixed linear model and inclusive composite interval mapping method at three respective periods under waterlogging and control conditions. A total of 13, 19 and 23 QTL were detected at stages 3D|0D (the period during 0-3 d of waterlogging), 6D|3D and 9D|6D, respectively. The effects of each QTL were moderate and distributed over nine chromosomes, singly explaining 4.14-18.88% of the phenotypic variation. Six QTL (ph6-1, rl1-2, sdw4-1, sdw7-1, tdw4-1 and tdw7-1) were identified at two consistent stages of seedling development, which could reflect a continuous expression of genes; the remaining QTL were detected at only one stage. Thus, expression of most QTL was influenced by the developmental status. In order to provide additional evidence regarding the role of corresponding genes in waterlogging tolerance, mapping of Expressed Sequence Tags markers and microRNAs were conducted. Seven candidate genes were observed to co-localize with the identified QTL on chromosomes 1, 4, 6, 7 and 9, and may be important candidate genes for waterlogging tolerance. These results are a good starting point for understanding the genetic basis for selectively expressing of QTL in different stress periods and the common genetic control mechanism of the co-localized traits.	[Osman, Khalid A.; Tang, Bin; Wang, Yaping; Chen, Juanhua; Yu, Feng; Li, Liu; Han, Xuesong; Zhang, Zuxin; Yan, Jianbin; Zheng, Yonglian; Yue, Bing; Qiu, Fazhan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University	Qiu, FZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	qiufazhan@gmail.com	Yan, JianBin/AAE-3494-2022	Yu, Feng/0000-0001-5077-8003; yue, bing/0000-0002-2552-1668	National Natural Science Foundation of China [31071428]; Fundamental Research Funds for the Central University [2012SC12, 2013PY027]; Natural Science Funds for Distinguished Young Scholar of Hubei Province [2012FFA014]; National High Technology Research and Development Program of China [2012AA101104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; Natural Science Funds for Distinguished Young Scholar of Hubei Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (31071428), the Fundamental Research Funds for the Central University (no. 2012SC12 and no. 2013PY027), the Natural Science Funds for Distinguished Young Scholar of Hubei Province (2012FFA014), the National High Technology Research and Development Program of China (2012AA101104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; [Anonymous], 2003, STUDIES PHYSIOGENETI; Atchley WR, 1997, GENETICS, V147, P765; Cai HG, 2012, THEOR APPL GENET, V125, P1313, DOI 10.1007/s00122-012-1915-6; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Ghassemi F, 1995, SALINISATION LAND WA, P1; Han YP, 2011, THEOR APPL GENET, V122, P1481, DOI 10.1007/s00122-011-1547-2; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Huang J, 2012, PLANT MOL BIOL, V80, P337, DOI 10.1007/s11103-012-9955-5; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Jeppe R, 2003, TRENDS PLANT SCI, V8, P552; Karimova M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1037; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li JC, 2012, THEOR APPL GENET, V124, P1339, DOI 10.1007/s00122-012-1791-0; Li YB, 2007, PLANT BREEDING, V126, P541, DOI 10.1111/j.1439-0523.2007.01409.x; Littel R, 1987, GENOMICS; Littell R.C., 1991, SAS SYSTEM LINEAR MO, V3rd; Liu GF, 2009, THEOR APPL GENET, V118, P443, DOI 10.1007/s00122-008-0911-3; Liu JC, 2008, PLANT SOIL, V305, P253, DOI 10.1007/s11104-008-9562-z; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu YZ, 2010, AGR SCI CHINA, V9, P362, DOI 10.1016/S1671-2927(09)60105-X; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039786; Lopez CE, 2007, GENOME, V50, P1078, DOI 10.1139/G07-087; Mano Y, 2007, PLANT SOIL, V295, P103, DOI 10.1007/s11104-007-9266-9; Mano Y, 2006, PLANT PROD SCI, V9, P176, DOI 10.1626/pps.9.176; Mano Y, 2005, BREEDING SCI, V55, P343, DOI 10.1270/jsbbs.55.343; Mano Y, 2005, EUPHYTICA, V142, P33, DOI 10.1007/s10681-005-0449-2; Mano Y, 2008, BREEDING SCI, V58, P217, DOI 10.1270/jsbbs.58.217; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Mano Y, 2012, MOL BREEDING, V29, P137, DOI 10.1007/s11032-010-9532-z; Mano Y, 2009, BREEDING SCI, V59, P427, DOI 10.1270/jsbbs.59.427; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Mikkilineni V, 2003, THEOR APPL GENET, V106, P1326, DOI 10.1007/s00122-003-1190-7; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Patterson C, 2002, SCI STKE, V116, P4; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; Rahman H, 2011, GENET MOL RES, V10, P889, DOI 10.4238/vol10-2gmr1139; Rathore TR, 1998, P 2 AS REG MAIZ WORK, P23; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; St Burgos M, 2001, EUPHYTICA, V122, P287, DOI 10.1023/A:1012945902299; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Tang B, 2010, AGR SCI CHINA, V9, P651, DOI 10.1016/S1671-2927(09)60140-1; Teng W, 2009, HEREDITY, V102, P372, DOI 10.1038/hdy.2008.108; VanToai TT, 2001, CROP SCI, V41, P1247, DOI 10.2135/cropsci2001.4141247x; Wang Z, 2010, EUPHYTICA, V174, P447, DOI 10.1007/s10681-010-0166-3; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wu P, 2000, THEOR APPL GENET, V100, P1295, DOI 10.1007/s001220051438; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yan JB, 2003, CHINESE SCI BULL, V48, P2601, DOI 10.1360/03wc0044; Yan JQ, 1998, GENETICS, V150, P1257; Zaidi PH, 2004, FIELD CROP RES, V90, P189, DOI 10.1016/j.fcr.2004.03.002; Zhai LH, 2013, PHYSIOL PLANTARUM, V147, P181, DOI 10.1111/j.1399-3054.2012.01653.x; Zhang XB, 2013, PLANT MOL BIOL REP, V31, P594, DOI 10.1007/s11105-012-0526-3; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhang ZX, 2005, RUSS J PLANT PHYSL+, V52, P43, DOI 10.1007/s11183-005-0007-8; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215; ZHU J, 1995, GENETICS, V141, P1633; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	66	48	50	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79305	10.1371/journal.pone.0079305	http://dx.doi.org/10.1371/journal.pone.0079305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244474	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800059
J	Tsoumani, KT; Drosopoulou, E; Mavragani-Tsipidou, P; Mathiopoulos, KD				Tsoumani, Konstantina T.; Drosopoulou, Elena; Mavragani-Tsipidou, Penelope; Mathiopoulos, Kostas D.			Molecular Characterization and Chromosomal Distribution of a Species-Specific Transcribed Centromeric Satellite Repeat from the Olive Fruit Fly, Bactrocera oleae	PLOS ONE			English	Article							REAL-TIME PCR; GLAND POLYTENE CHROMOSOMES; IN-SITU HYBRIDIZATION; DROSOPHILA-MELANOGASTER; CYTOGENETIC ANALYSIS; DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; COPY-NUMBER; DNA; GENUS	Satellite repetitive sequences that accumulate in the heterochromatin consist a large fraction of a genome and due to their properties are suggested to be implicated in centromere function. Current knowledge of heterochromatic regions of Bactrocera oleae genome, the major pest of the olive tree, is practically nonexistent. In our effort to explore the repetitive DNA portion of B. oleae genome, a novel satellite sequence designated BoR300 was isolated and cloned. The present study describes the genomic organization, abundance and chromosomal distribution of BoR300 which is organized in tandem, forming arrays of 298 bp-long monomers. Sequence analysis showed an AT content of 60.4%, a CENP-B like-motif and a high curvature value based on predictive models. Comparative analysis among randomly selected monomers demonstrated a high degree of sequence homogeneity (88% - 97%) of BoR300 repeats, which are present at approximately 3,000 copies per haploid genome accounting for about 0.28% of the total genomic DNA, based on two independent qPCR approaches. In addition, expression of the repeat was also confirmed through RT-PCR, by which BoR300 transcripts were detected in both sexes. Fluorescence in situ hybridization (FISH) of BoR300 on mitotic metaphases and polytene chromosomes revealed signals to the centromeres of two out of the six chromosomes which indicated a chromosome-specific centromeric localization. Moreover, BoR300 is not conserved in the closely related Bactrocera species tested and it is also absent in other dipterans, but it's rather restricted to the B. oleae genome. This feature of species-specificity attributed to BoR300 satellite makes it a good candidate as an identification probe of the insect among its relatives at early development stages.	[Tsoumani, Konstantina T.; Mathiopoulos, Kostas D.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Drosopoulou, Elena; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki AUTH, Dept Genet Dev & Mol Biol, Thessaloniki, Greece	University of Thessaly; Aristotle University of Thessaloniki	Mathiopoulos, KD (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	kmathiop@bio.uth.gr	DROSOPOULOU, ELENA/N-2176-2015; Mathiopoulos, Kostas/K-9548-2019; Drosopoulou, Elena/AAX-6493-2020	Mathiopoulos, Kostas/0000-0002-2875-5697; Drosopoulou, Elena/0000-0001-9805-0572	Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly	Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly	This research was partially supported by the Graduate Programs of the Biochemistry and Biotechnology Department of University of Thessaly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Augustinos AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-618; Bizzaro D, 1996, CHROMOSOME RES, V4, P392, DOI 10.1007/BF02257275; BONACCORSI S, 1991, GENETICS, V129, P177; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; DIAZ MO, 1981, CELL, V24, P649, DOI 10.1016/0092-8674(81)90091-X; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Drosopoulou E, 2009, GENOME, V52, P210, DOI [10.1139/G08-110, 10.1139/g08-110]; FITZGERALD DJ, 1994, J BIOL CHEM, V269, P21303; Gabrieli P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017747; Galian J, 2003, GENOME, V46, P213, DOI 10.1139/G02-126; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kakani EG, 2013, B ENTOMOL RES, V103, P36, DOI 10.1017/S0007485312000478; King LM, 1997, MOL BIOL EVOL, V14, P1088, DOI 10.1093/oxfordjournals.molbev.a025718; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Kuhn GCS, 2005, GENE, V349, P77, DOI 10.1016/j.gene.2004.11.032; Kuhn GCS, 2003, HEREDITAS, V139, P161, DOI 10.1111/j.1601-5223.2003.01797.x; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lorite P, 2002, GENE, V297, P113, DOI 10.1016/S0378-1119(02)00875-2; Mavragani-Tsipidou P, 2002, GENETICA, V116, P45, DOI 10.1023/A:1020907624816; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Palomeque T, 2008, HEREDITY, V100, P564, DOI 10.1038/hdy.2008.24; Pezer Z, 2011, PROG MOL SUBCELL BIO, V51, P161, DOI 10.1007/978-3-642-16502-3_8; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stimpson KM, 2010, CURR OPIN CELL BIOL, V22, P772, DOI 10.1016/j.ceb.2010.07.002; Stratikopoulos EE, 2002, CHROMOSOME RES, V10, P287, DOI 10.1023/A:1016567624117; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsoumani KT, 2012, J APPL ENTOMOL, V136, P626, DOI 10.1111/j.1439-0418.2011.01684.x; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Ugarkovic D, 1996, MOL BIOL EVOL, V13, P1059, DOI 10.1093/oxfordjournals.molbev.a025668; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; Usakin L, 2007, GENETICS, V176, P1343, DOI 10.1534/genetics.107.071720; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zambetaki A, 1995, GENOME, V38, P1070, DOI 10.1139/g95-143; Zambetaki A, 1999, GENOME, V42, P744, DOI 10.1139/gen-42-4-744	46	17	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79393	10.1371/journal.pone.0079393	http://dx.doi.org/10.1371/journal.pone.0079393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244494	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800070
J	Lim, S; Peshenko, IV; Dizhoor, AM; Ames, JB				Lim, Sunghyuk; Peshenko, Igor V.; Dizhoor, Alexander M.; Ames, James B.			Structural Insights for Activation of Retinal Guanylate Cyclase by GCAP1	PLOS ONE			English	Article							NEURONAL CALCIUM SENSOR; CA2+-DEPENDENT CONFORMATIONAL-CHANGES; MYRISTOYL GROUP; PROTEINS GCAPS; CA2+-BINDING PROTEINS; MOLECULAR-STRUCTURE; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; LARGER PROTEINS; BINDING	Guanylyl cyclase activating protein 1 (GCAP1), a member of the neuronal calcium sensor (NCS) subclass of the calmodulin superfamily, confers Ca2+-sensitive activation of retinal guanylyl cyclase 1 (RetGC1) upon light activation of photoreceptor cells. Here we present NMR assignments and functional analysis to probe Ca2+-dependent structural changes in GCAP1 that control activation of RetGC. NMR assignments were obtained for both the Ca2+-saturated inhibitory state of GCAP1 versus a GCAP1 mutant (D144N/D148G, called EF4mut), which lacks Ca2+ binding in EF-hand 4 and models the Ca2+-free/Mg2+-bound activator state of GCAP1. NMR chemical shifts of backbone resonances for Ca2+-saturated wild type GCAP1 are overall similar to those of EF4mut, suggesting a similar main chain structure for assigned residues in both the Ca2+-free activator and Ca2+-bound inhibitor states. This contrasts with large Ca2+-induced chemical shift differences and hence dramatic structural changes seen for other NCS proteins including recoverin and NCS-1. The largest chemical shift differences between GCAP1 and EF4mut are seen for residues in EF4 (S141, K142, V145, N146, G147, G149, E150, L153, E154, M157, E158, Q161, L166), but mutagenesis of EF4 residues (F140A, K142D, L153R, L166R) had little effect on RetGC1 activation. A few GCAP1 residues in EF-hand 1 (K23, T27, G32) also show large chemical shift differences, and two of the mutations (K23D and G32N) each decrease the activation of RetGC, consistent with a functional conformational change in EF1. GCAP1 residues at the domain interface (V77, A78, L82) have NMR resonances that are exchange broadened, suggesting these residues may be conformationally dynamic, consistent with previous studies showing these residues are in a region essential for activating RetGC1.	[Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbames@ucdavis.edu		Dizhoor, Alexander/0000-0001-6770-9186	NIH [EY012347, EY11522, RR11973]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH grants EY012347 (J.B.A.), EY11522 (A. M. D.) and RR11973 (UC Davis NMR). The URL for NIH is www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 2000, METHOD ENZYMOL, V316, P121; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Behnen P, 2010, BIOL CHEM, V391, P631, DOI 10.1515/BC.2010.063; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Lim S, 2013, BIOMOL NMR ASSIGN, V7, P39, DOI 10.1007/s12104-012-9373-2; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, J BIOL CHEM, V279, P50342, DOI 10.1074/jbc.M408683200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Valentine KG, 2003, BIOCHEMISTRY-US, V42, P6333, DOI 10.1021/bi0206816; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu XZ, 2011, PROTEINS, V79, P1910, DOI 10.1002/prot.23014; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547	69	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81822	10.1371/journal.pone.0081822	http://dx.doi.org/10.1371/journal.pone.0081822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236217	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700220
J	Britto, RPD; Florencio, TMT; Silva, AAB; Sesso, R; Cavalcante, JC; Sawaya, AL				de Alencar Britto, Revilane Parente; Toledo Florencio, Telma Maria; Benedito Silva, Ana Amelia; Sesso, Ricardo; Cavalcante, Jairo Calado; Sawaya, Ana Lydia			Influence of Maternal Height and Weight on Low Birth Weight: A Cross-Sectional Study in Poor Communities of Northeastern Brazil	PLOS ONE			English	Article							BODY-MASS INDEX; LOW-INCOME POPULATION; FOR-GESTATIONAL-AGE; PRETERM BIRTH; SHORT STATURE; OBESITY; RISK; INFANT; FETAL; HEALTH	Background: Low birth weight (LBW) is associated with an increased risk of mortality, adverse metabolic conditions, and long-term chronic morbidities. The relationship between LWB and short maternal stature coupled with nutritional status was investigated in poor communities. Methods/Principal Findings: A cross-sectional population-based study involving 2226 mother-child pairs was conducted during the period 2009-2010 in shantytowns of Maceio, Alagoas, Brazil. Associations between LBW and maternal sociodemographics, stature and nutritional status were investigated. The outcome variable was birth weight (< 2500g and >= 2500g). The independent variables were the age, income, educational background, stature and nutritional status (eutrophic, underweight, overweight and obese) of the mother. The frequency of LBW was 10%. Short-statured mothers (1st quartile of stature <= 152cm) showed a tendency of increased risk of LBW children compared to mothers in the 4th quartile of stature (> 160.4cm) (OR: 1.42, 95% CI: 0.96 - 1.09, p = 0.078). Children from short-statured mothers weighed an average of 125g less than those from taller mothers (3.18 +/- 0.56kg vs. 3.30 +/- 0.58kg, respectively p = 0.002). Multivariate analyses showed that short stature, age < 20y (OR: 3.05, 95% CI: 1.44 - 6.47) or were underweight (OR: 2.26, 95% CI: 0.92 - 5.95) increased the risk of LBW, while overweight (OR: 0.38, 95% CI: 0.16 - 0.95) and obesity (OR: 0.39, 95% CI: 0.11 - 1.31) had lower risk for LBW. In taller mothers, lower income and underweight were associated with LBW (OR: 1.88, 95% CI: 1.07 - 3.29 and 2.85, 95% CI: 1.09 - 7.47, respectively), and obese mothers showed a trend of increased risk of LBW (OR: 1.66, 95% CI: 0.84 - 3.25). Conclusions/Significance: Overweight was found to have a protective effect in short-statured mothers, indicating that a surplus of energy may diminish the risk of LBW. Short-statured younger mothers, but not taller ones, showed higher risk of LBW. The mother being underweight, regardless of stature, was associated with LBW.	[de Alencar Britto, Revilane Parente; Sawaya, Ana Lydia] Univ Fed Sao Paulo, Escola Paulista Med, Programa Posgrad Ciencias Endocrinol, Sao Paulo, Brazil; [Toledo Florencio, Telma Maria] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil; [Benedito Silva, Ana Amelia] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Sesso, Ricardo] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Escola Paulista Med, Sao Paulo, Brazil; [Cavalcante, Jairo Calado] Univ Fed Alagoas, Fac Med, Maceio, Alagoas, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas	Britto, RPD (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Programa Posgrad Ciencias Endocrinol, Sao Paulo, Brazil.	rbrittof@uol.com.br	Florencio, Telma/AAE-3394-2019; Sawaya, Ana Lydia/D-3845-2014	Sawaya, Ana Lydia/0000-0002-2580-9557; Sesso, Ricardo/0000-0002-1062-0073	Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)	Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL))	The authors wish to thank the Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL) for financial support. The funding authority had no role in the study design, data collection and analysis, decision to publish the material or in the preparation of the manuscript.	[Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Baumann R, 2008, EMPREGO DESENVOLVIME; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Britto RPA, 2011, VER BRAS MED, V68, P277; Bryan SM, 2006, HORM RES, V65, P19, DOI 10.1159/000091502; Colen CG, 2006, AM J PUBLIC HEALTH, V96, P2032, DOI 10.2105/AJPH.2005.076547; da Saude Ministerio, SAUD IND IND DAD BAS; DdS Barbas, 2009, EPIDEMIOL SERV SAUDE; Dibben C, 2006, J EPIDEMIOL COMMUN H, V60, P1053, DOI 10.1136/jech.2005.042853; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Ferreira HD, 2010, REV SAUDE PUBL, V44, P377, DOI 10.1590/S0034-89102010005000001; Florencio TT, 2007, EUR J CARDIOV PREV R, V14, P346, DOI 10.1097/HJR.0b013e328010f24d; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Florencio TT, 2004, NUTR METAB CARDIOVAS, V14, P26, DOI 10.1016/S0939-4753(04)80044-9; Goplan C, 1995, NUTR CHILDREN DEV CO, P1; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Howson C, 2012, BORN TOO SOON GLOBAL; IBGE, 2010, BANC DAD EST AL; IBGE(Instituto Brasileiro de Geografia e Estatistica), 2010, CENS DEM 2010 AGL SU; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; IPEA, 2010, COM IPEA 58; Joseph KS, 2009, AM J EPIDEMIOL, V169, P616, DOI 10.1093/aje/kwn374; Kalk P, 2009, EUR J MED RES, V14, P216; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; KUH D, 1989, INT J EPIDEMIOL, V18, P663, DOI 10.1093/ije/18.3.663; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Olson ME, 2010, PEDIATRICS, V126, P1165, DOI 10.1542/peds.2009-3378; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Pandey M, 2009, MATERNAL HLTH CHILD; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; de Andrade CLT, 2008, CAD SAUDE PUBLICA, V24, P2564, DOI 10.1590/S0102-311X2008001100011; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Uchimura Taqueco Teruya, 2008, Rev Gaucha Enferm, V29, P33; Vasudevan C, 2011, ARCH DIS CHILD-FETAL, V96, pF378, DOI 10.1136/adc.2009.170928; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walton E, 2009, J HEALTH SOC BEHAV, V50, P427, DOI 10.1177/002214650905000404; WHO, 2011, HO ANTHR VERS 3 2 2; World Health Organization, 2006, CHILD GROWTH STAND; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; World Health Organization (WHO), 2004, LOW BIRTH WEIGHT COU	47	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80159	10.1371/journal.pone.0080159	http://dx.doi.org/10.1371/journal.pone.0080159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244636	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600187
J	Hao, X; Liu, X; Wang, WM; Ren, H; Xie, JY; Shen, PY; Lin, DH; Chen, N				Hao, Xu; Liu, Xia; Wang, Weiming; Ren, Hong; Xie, Jingyuan; Shen, Pingyan; Lin, Donghai; Chen, Nan			Distinct Metabolic Profile of Primary Focal Segmental Glomerulosclerosis Revealed by NMR-Based Metabolomics	PLOS ONE			English	Article							RENAL ORGANIC ANION; GLYCINE CONJUGATION; BENZOIC-ACID; OXIDATIVE STRESS; UREMIC TOXINS; RAT-KIDNEY; METABONOMICS; 3-METHYLHISTIDINE; TRANSPORT; URINE	Background: Primary focal segmental glomerulosclerosis (FSGS) is pathological entity which is characterized by idiopathic steroid-resistant nephrotic syndrome (SRNS) and progression to end-stage renal disease (ESRD) in the majority of affected individuals. Currently, there is no practical noninvasive technique to predict different pathological types of glomerulopathies. In this study, the role of urinary metabolomics in the diagnosis and pathogenesis of FSGS was investigated. Methods: NMR-based metabolomics was applied for the urinary metabolic profile in the patients with FSGS (n = 25), membranous nephropathy (MN, n = 24), minimal change disease (MCD, n = 14) and IgA nephropathy (IgAN, n = 26), and healthy controls (CON, n = 35). The acquired data were analyzed using principal component analysis (PCA) followed by orthogonal projections to latent structure discriminant analysis (OPLS-DA). Model validity was verified using permutation tests. Results: FSGS patients were clearly distinguished from healthy controls and other three types of glomerulopathies with good sensitivity and specificity based on their global urinary metabolic profiles. In FSGS patients, urinary levels of glucose, dimethylamine and trimethylamine increased compared with healthy controls, while pyruvate, valine, hippurate, isoleucine, phenylacetylglycine, citrate, tyrosine, 3-methylhistidine and b-hydroxyisovalerate decreased. Additionally, FSGS patients had lower urine N-methylnicotinamide levels compared with other glomerulopathies. Conclusions: NMR-based metabonomic approach is amenable for the noninvasive diagnosis and differential diagnosis of FSGS as well as other glomerulopathies, and it could indicate the possible mechanisms of primary FSGS.	[Hao, Xu; Wang, Weiming; Ren, Hong; Xie, Jingyuan; Shen, Pingyan; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Ruijin Hosp, Shanghai 200030, Peoples R China; [Liu, Xia; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Bimol NMR Lab, Shanghai 200031, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Xiamen University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Ruijin Hosp, Shanghai 200030, Peoples R China.	chen-nan@medmail.com.cn	xie, jing/GRY-1689-2022; Xie, Jingyuan/AAX-2708-2021		National Basic Research Program of China 973 Program [2012CB517600, 2012CB517604]; National Natural Science Foundation of China [81070568, 81000295, 81370015]; Shanghai Pujiang Program [11PJ1406700]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study was supported by grants from the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517604), National Natural Science Foundation of China (no. 81070568) and National Natural Science Foundation of China (No. 81000295, No. 81370015). J Xie is sponsored by the Shanghai Pujiang Program (11PJ1406700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger RD, 2008, PEDIATR NEPHROL, V23, P977, DOI 10.1007/s00467-008-0756-7; Beltowski J, 2006, PHARMACOL REP, V58, P159; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cameron JS, 2003, NEPHROL DIAL TRANSPL, V18, P45, DOI 10.1093/ndt/gfg1058; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; CHATTOPADHYAY D, 1953, J BIOL CHEM, V201, P529; CHIBA M, 1994, J PHARMACOL EXP THER, V268, P409; Cross AJ, 2011, CANCER EPIDEM BIOMAR, V20, P1107, DOI 10.1158/1055-9965.EPI-11-0048; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Gbadegesin R, 2011, PEDIATR NEPHROL, V26, P1001, DOI 10.1007/s00467-010-1692-x; HUSZAR G, 1983, BRIT J NUTR, V49, P287, DOI 10.1079/BJN19830037; Klawitter J, 2009, CHEM RES TOXICOL, V22, P118, DOI 10.1021/tx800253x; Kriz W, 2003, NEPHROL DIAL TRANSPL, V18, P39, DOI 10.1093/ndt.gfg1064; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Lin L, 2010, ANALYST, V135, P2970, DOI 10.1039/c0an00265h; LONG CL, 1975, METABOLISM, V24, P929, DOI 10.1016/0026-0495(75)90084-0; MAIZA A, 1992, NEPHRON, V60, P12, DOI 10.1159/000186698; MANDEL LJ, 1985, ANNU REV PHYSIOL, V47, P85; Mannon RB, 2010, KIDNEY INT, V78, pS59, DOI 10.1038/ki.2010.425; Mao HL, 2009, J PROTEOME RES, V8, P5423, DOI 10.1021/pr900576y; McDunn JE, 2013, PROSTATE, V73, P1547, DOI 10.1002/pros.22704; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Pasikanti KK, 2010, J PROTEOME RES, V9, P2988, DOI 10.1021/pr901173v; POON K, 1995, DRUG METAB DISPOS, V23, P255; POSTMA PW, 1973, BIOCHIM BIOPHYS ACTA, V318, P91, DOI 10.1016/0005-2736(73)90339-8; RICH AR, 1957, B JOHNS HOPKINS HOSP, V100, P173; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; STRAHL NR, 1971, J PHARM SCI, V60, P278, DOI 10.1002/jps.2600600227; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tsutsumi Y, 2002, J PHARMACOL EXP THER, V303, P880, DOI 10.1124/jpet.303.2.880; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Wang HY, 2012, CLIN CHIM ACTA, V413, P131, DOI 10.1016/j.cca.2011.09.007; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yu PH, 1998, J NEURAL TRANSM-SUPP, P201; Zhang J, 2009, ANAL CHIM ACTA, V650, P16, DOI 10.1016/j.aca.2009.02.027; Zira AN, 2010, J PROTEOME RES, V9, P4038, DOI 10.1021/pr100226m	42	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78531	10.1371/journal.pone.0078531	http://dx.doi.org/10.1371/journal.pone.0078531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244321	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600031
J	Stead, LF; Egan, P; Devery, A; Conway, C; Daly, C; Berri, S; Wood, H; Belvedere, O; Papagiannopoulos, K; Ryan, A; Rabbitts, P				Stead, Lucy F.; Egan, Philip; Devery, Aoife; Conway, Caroline; Daly, Catherine; Berri, Stefano; Wood, Henry; Belvedere, Ornella; Papagiannopoulos, Kostas; Ryan, Anderson; Rabbitts, Pamela			An Integrated Inspection of the Somatic Mutations in a Lung Squamous Cell Carcinoma Using Next-Generation Sequencing	PLOS ONE			English	Article							CANCER; P53; TOBACCO; BRCA2; SMOKING; GENOME; NEVER; SPECTRUM; VARIANTS; PATTERNS	Squamous cell carcinoma (SCC) of the lung kills over 350,000 people annually worldwide, and is the main lung cancer histotype with no targeted treatments. High-coverage whole-genome sequencing of the other main subtypes, small-cell and adenocarcinoma, gave insights into carcinogenic mechanisms and disease etiology. The genomic complexity within the lung SCC subtype, as revealed by The Cancer Genome Atlas, means this subtype is likely to benefit from a more integrated approach in which the transcriptional consequences of somatic mutations are simultaneously inspected. Here we present such an approach: the integrated analysis of deep sequencing data from both the whole genome and whole transcriptome (coding and non-coding) of LUDLU-1, a SCC lung cell line. Our results show that LUDLU-1 lacks the mutational signature that has been previously associated with tobacco exposure in other lung cancer subtypes, and suggests that DNA-repair efficiency is adversely affected; LUDLU-1 contains somatic mutations in TP53 and BRCA2, allelic imbalance in the expression of two cancer-associated BRCA1 germline polymorphisms and reduced transcription of a potentially endogenous PARP2 inhibitor. Functional assays were performed and compared with a control lung cancer cell line. LUDLU-1 did not exhibit radiosensitisation or an increase in sensitivity to PARP inhibitors. However, LUDLU-1 did exhibit small but significant differences with respect to cisplatin sensitivity. Our research shows how integrated analyses of high-throughput data can generate hypotheses to be tested in the lab.	[Stead, Lucy F.; Egan, Philip; Conway, Caroline; Daly, Catherine; Berri, Stefano; Wood, Henry; Belvedere, Ornella; Rabbitts, Pamela] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Devery, Aoife; Ryan, Anderson] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Papagiannopoulos, Kostas] St James Univ Hosp, Dept Thorac Surg, Leeds, W Yorkshire, England	University of Leeds; University of Oxford; Saint James's University Hospital	Rabbitts, P (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.	p.rabbitts@leeds.ac.uk	Ryan, Anderson J/O-7701-2015; Stead, Lucy Frances/H-7378-2019; RYAN, Anderson/ACG-0319-2022	Ryan, Anderson J/0000-0001-6241-7969; Stead, Lucy Frances/0000-0002-9550-4150; RYAN, Anderson/0000-0001-6241-7969; Berri, Stefano/0000-0001-7530-7611; Wood, Henry/0000-0003-3009-5904; Papagiannopoulos, Konstantinos/0000-0002-7088-8004	Yorkshire Cancer Research [L341PG]; Leeds Teaching Hospitals Charitable Foundation; Betty Woolsey Bequest for Thoracic Research; Medical Research Council [MC_PC_12006] Funding Source: researchfish; MRC [MC_PC_12006] Funding Source: UKRI	Yorkshire Cancer Research; Leeds Teaching Hospitals Charitable Foundation; Betty Woolsey Bequest for Thoracic Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Yorkshire Cancer Research, grant number L341PG to P. R. (http://yorkshirecancerresearch.org.uk), the Leeds Teaching Hospitals Charitable Foundation, and the Betty Woolsey Bequest for Thoracic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Alexandrov LB, 2013, NATURE, V502, DOI 10.1038/nature12666; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Boffetta P, 2001, INT J CANCER, V94, P591, DOI 10.1002/ijc.1507; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Complete Genomics Incorporated, 2012, CGAT METH SOFTW V1 3; de Marinisa F, 2008, ONCOLOGIST, V13, P14, DOI 10.1634/theoncologist.13-S1-14; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; GRENMAN R, 1989, INT J CANCER, V44, P131, DOI 10.1002/ijc.2910440123; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han YY, 2010, CANCER-AM CANCER SOC, V116, P940, DOI 10.1002/cncr.24747; Heller WD, 1998, J CLIN EPIDEMIOL, V51, P211, DOI 10.1016/S0895-4356(97)00279-5; International Agency for Research on Cancer (IARC), 2007, CANC INCIDENCE 5 CON, V9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Johnson N, 2007, HUM MOL GENET, V16, P1051, DOI 10.1093/hmg/ddm050; Ju YS, 2011, GENOME RES; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lewis SJ, 2003, BIOMARKERS, V8, P218, DOI 10.1080/1354750031000120125; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li K, 2010, ONCOTARGET, V1; Liu J, 2012, GENOME RES; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Pfeifer G, 2002, ONCOGENE, V21, P17; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts A, 2011, BIOINFORMATICS; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stead LF, 2012, NEOPLASIA, V14, P1075, DOI 10.1593/neo.121380; Stordal B, 2007, IUBMB LIFE, V59, P696, DOI 10.1080/15216540701636287; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; The Cancer Genome Project, 2012, CANC GEN CENS; The MARIE-GENICA Consortium, 2010, BREAST CANC RES TREA, V120, P10; Thilly W, 1980, GENE LOCUS MUTATION; Thu KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033003; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Yoon JH, 2001, CANCER RES, V61, P7110	59	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78823	10.1371/journal.pone.0078823	http://dx.doi.org/10.1371/journal.pone.0078823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244370	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600067
J	Luo, SJ; Wang, F; Li, ZD; Deng, JF				Luo, Shijian; Wang, Feng; Li, Zhendong; Deng, Jinfeng			Effect of the+781C/T Polymorphism in the Interleukin-8 Gene on Atherosclerotic Cerebral Infarction, and Its Interaction with Smoking and Drinking	PLOS ONE			English	Article							ISCHEMIC-STROKE; CAROTID ATHEROSCLEROSIS; DISEASE-SUSCEPTIBILITY; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; APOLIPOPROTEIN-E; YOUNG-ADULTS; HAN CHINESE; RISK; ASSOCIATION	Objective: The aims of this study were to investigate the association between the +781C/T polymorphism of interleukin-8 (IL-8) and atherosclerotic cerebral infarction and the interaction between the +781C/T polymorphism and smoking or drinking in cerebral infarction in the Han Chinese population. Methods: We investigated the +781C/T polymorphism of IL-8 in 308 consecutive Han Chinese patients who were diagnosed with atherosclerotic cerebral infarction and in 294 age-and gender-matched healthy control subjects. The patients were classified using the Oxfordshire Community Stroke Project (OCSP) classification. The patients and subjects' histories of smoking and drinking were recorded, and atherosclerosis (AS) of the internal carotid artery (ICA) was evaluated in the patients. The +781C/T polymorphism was determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. Results: The +781C/T polymorphism and allele frequencies were not significantly different between the patients and controls and were not significantly associated with the OCSP classifications. We found that the 781C allele was significantly associated with AS of the ICA in the patients (p = 0.017), and the CT genotype was more prevalent in patients without AS of the ICA (p = 0.035). No interactions were observed between the +781C/T polymorphism and smoking or drinking. Conclusion: Our results demonstrated that the +781C/T polymorphism of IL-8 did not play a role and had no interaction with smoking or drinking in the occurrence of cerebral infarction in the Han Chinese population. However, the C allele and the CT genotype might be associated with AS of the ICA in patients with ischemic stroke.	[Luo, Shijian; Wang, Feng; Li, Zhendong; Deng, Jinfeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Zhuhai, Guangdong, Peoples R China	Sun Yat Sen University	Li, ZD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Zhuhai, Guangdong, Peoples R China.	lizdsysu@163.com			Guangdong Provincial Natural Science Foundation [S2011010005416]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The Project of Guangdong Provincial Natural Science Foundation (No. S2011010005416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Chapman CML, 2001, ATHEROSCLEROSIS, V159, P209, DOI 10.1016/S0021-9150(01)00499-3; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Djousse L, 2009, J STROKE CEREBROVASC, V18, P384, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.008; Djuric T, 2008, CLIN BIOCHEM, V41, P1326, DOI 10.1016/j.clinbiochem.2008.08.081; Drogan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032176; Enquobahrie DA, 2008, AM J CARDIOL, V101, P1683, DOI 10.1016/j.amjcard.2008.02.052; Fatini C, 2004, EUR J VASC ENDOVASC, V27, P540, DOI 10.1016/j.ejvs.2004.02.008; Gao R, 2008, J BRAIN NERVOUS DIS, V16, P416; Grau AJ, 2001, J NEUROL SCI, V192, P41, DOI 10.1016/S0022-510X(01)00590-1; Grau AJ, 2001, EUR J CLIN INVEST, V31, P999, DOI 10.1046/j.1365-2362.2001.00923.x; Hacking D, 2004, GENES IMMUN, V5, P274, DOI 10.1038/sj.gene.6364067; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Kis Z, 2007, NEW MICROBIOL, V30, P213; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Kruman II, 2012, EXP BIOL MED, V237, P740, DOI 10.1258/ebm.2012.011421; Lee CR, 2006, PHARMACOGENET GENOM, V16, P891, DOI 10.1097/01.fpc.0000236324.96056.16; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Li ZD, 2012, J NEUROL SCI, V320, P12, DOI 10.1016/j.jns.2012.05.044; Lu X, 2008, TROP MED, V8, P218; Lu X, 2008, TROP MED, V8, P209; Matarin M, 2010, J INTERN MED, V267, P139, DOI 10.1111/j.1365-2796.2009.02202.x; Matsumoto T, 1997, LAB INVEST, V77, P119; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Ministry of Health of; China PR, 2008, 3 NAT SURV DEATH CAU; Oksala NKJ, 2007, STROKE, V38, P50, DOI 10.1161/01.STR.0000251719.59141.36; Pezzini A, 2004, STROKE, V35, P438, DOI 10.1161/01.STR.0000112973.00867.98; Pezzini A, 2005, STROKE, V36, P533, DOI 10.1161/01.STR.0000155741.31499.c2; Qureshi IA, 2013, ARCH NEUROL-CHICAGO, V67, P1316; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Savage SA, 2006, CANCER EPIDEM BIOMAR, V15, P589, DOI 10.1158/1055-9965.EPI-05-0887; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Villa P, 2007, MOL MED, V13, P125, DOI 10.2119/2007-00008.Villa; Yao Chung-Tay, 2011, Human Genomics, V5, P569; Zhang Lin-feng, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P954	40	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80246	10.1371/journal.pone.0080246	http://dx.doi.org/10.1371/journal.pone.0080246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244661	gold, Green Submitted, Green Published			2022-12-27	WOS:000327162900071
J	Peng, ZH; Zhang, CL; Zhang, Y; Hu, T; Mu, SH; Li, XP; Gao, J				Peng, Zhenhua; Zhang, Chunling; Zhang, Ying; Hu, Tao; Mu, Shaohua; Li, Xueping; Gao, Jian			Transcriptome Sequencing and Analysis of the Fast Growing Shoots of Moso Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; GENOME-WIDE ANALYSIS; ARF GENE FAMILY; MOLECULAR CHARACTERIZATION; INTERNODE ELONGATION; ARABIDOPSIS-THALIANA; ROOT TRANSCRIPTOME; CELL ELONGATION; SERIAL ANALYSIS; REGULATED GENE	Background: The moso bamboo, a large woody bamboo with the highest ecological, economic, and cultural value of all bamboos, has one of the highest growth speeds in the world. Genetic research into moso bamboo has been scarce, partly because of the lack of previous genomic resources. In the present study, for the first time, we performed de novo transcriptome sequencing and mapped to the moso bamboo genomic resources (reference genome and genes) to produce a comprehensive dataset for the fast growing shoots of moso bamboo. Results: The fast growing shoots mixed with six different heights and culms after leaf expansion of moso bamboo transcriptome were sequenced using the Illumina HiSeq (TM) 2000 sequencing platform, respectively. More than 80 million reads including 65,045,670 and 68,431,884 clean reads were produced in the two libraries. More than 81% of the reads were matched to the reference genome, and nearly 50% of the reads were matched to the reference genes. The genes with log 2 ratio > 2 or < -2 (P < 0.001) were characterized as the most differentially expressed genes. 6,076 up-regulated and 4,613 down-regulated genes were classified into functional categories. Candidate genes which mainly involved transcript factors, plant hormones, cell cycle regulation, cell wall metabolism and cell morphogenesis genes were further analyzed and they may form a network that regulates the fast growth of moso bamboo shoots. Conclusion: Firstly, our data provides the most comprehensive transcriptomic resource for moso bamboo to date. Candidate genes have been identified and they are potentially involved in the growth and development of moso bamboo. The results give a better insight into the mechanisms of moso bamboo shoots rapid growth and provide gene resources for improving plant growth.	[Peng, Zhenhua; Zhang, Chunling; Zhang, Ying; Hu, Tao; Mu, Shaohua; Li, Xueping; Gao, Jian] State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, J (corresponding author), State Forestry Adm, Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, Beijing, Peoples R China.	gaojian@icbr.ac.cn			State Forestry Administration '948' project of China [2012-4-49]; National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research" [2013AA102607-4]	State Forestry Administration '948' project of China; National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research"(National High Technology Research and Development Program of China)	This project was supported by the the State Forestry Administration '948' project of China (2012-4-49) and National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research" (grant No. 2013AA102607-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Adachi S, 2009, DEV BIOL, V329, P306, DOI 10.1016/j.ydbio.2009.03.002; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Byun YJ, 2009, PLANTA, V229, P1181, DOI 10.1007/s00425-009-0903-9; Chang ST, 2000, J WOOD SCI, V46, P40, DOI 10.1007/BF00779551; Chen CY, 2010, PHYTOCHEMISTRY, V71, P1270, DOI 10.1016/j.phytochem.2010.05.011; Chen TH, 2009, PHYTOCHEMISTRY, V70, P25, DOI 10.1016/j.phytochem.2008.10.004; Chiu WB, 2006, NEW PHYTOL, V170, P53, DOI 10.1111/j.1469-8137.2005.01638.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; Das M, 2005, ANN BOT-LONDON, V95, P835, DOI 10.1093/aob/mci088; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Ekman DR, 2003, PLANT PHYSIOL, V133, P1397, DOI 10.1104/pp.103.028019; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fizames C, 2004, PLANT PHYSIOL, V134, P67, DOI 10.1104/pp.103.030536; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Gao ZhiMin, 2010, Scientia Silvae Sinicae, V46, P45; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Genovesi V, 2008, J EXP BOT, V59, P875, DOI 10.1093/jxb/ern013; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Hsieh LS, 2011, MOL BIOL REP, V38, P283, DOI 10.1007/s11033-010-0106-2; Hsieh LS, 2010, PHYTOCHEMISTRY, V71, P1999, DOI 10.1016/j.phytochem.2010.09.019; Hsieh LS, 2010, PROTEIN EXPRES PURIF, V71, P224, DOI 10.1016/j.pep.2010.01.009; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jiang ZeHui, 2012, Scientia Silvae Sinicae, V48, P159; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; LEE C. L., 1960, ACTA BOT SINICA, V9, P76; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Lin JX, 2002, PHYSIOL PLANTARUM, V114, P296, DOI 10.1034/j.1399-3054.2002.1140216.x; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu MY, 2012, PLOS ONE, V10, P1; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Maria DL, 2011, BMC GENOMICS, V30, P1471; Miedes E, 2011, J PLANT PHYSIOL, V168, P196, DOI 10.1016/j.jplph.2010.06.029; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; MURPHY RJ, 1992, IAWA BULL, V13, P403, DOI 10.1163/22941932-90001296; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; PHILLIPS AL, 1994, PLANT MOL BIOL, V24, P603, DOI 10.1007/BF00023557; Poroyko V, 2005, PLANT PHYSIOL, V138, P1700, DOI 10.1104/pp.104.057638; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Sabelli PA, 2009, PLANT SCI, V177, P540, DOI 10.1016/j.plantsci.2009.09.012; Sauret-Gueto S, 2012, PLANT J, V69, P628, DOI 10.1111/j.1365-313X.2011.04817.x; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Science Press, 2006, PHYLLOSTACHYS, V22, P163; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Shani Z, 2006, PLANT CELL REP, V25, P1067, DOI 10.1007/s00299-006-0167-9; Sharma RK, 2008, GENOME, V51, P91, DOI [10.1139/G07-101, 10.1139/g07-101]; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YJ, 2006, PROTEOMICS, V6, P5898, DOI 10.1002/pmic.200600278; Xie LQ, 2011, J EXP BOT, V62, P4495, DOI 10.1093/jxb/err164; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhong RQ, 2002, PLANT CELL, V14, P165, DOI 10.1105/tpc.010278; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhou MB, 2011, PLANT MOL BIOL REP, V29, P224, DOI 10.1007/s11105-010-0222-0; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	94	73	94	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78944	10.1371/journal.pone.0078944	http://dx.doi.org/10.1371/journal.pone.0078944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244391	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900028
J	Carluccio, C; Fraternali, F; Salvatore, F; Fornili, A; Zagari, A				Carluccio, Carla; Fraternali, Franca; Salvatore, Francesco; Fornili, Arianna; Zagari, Adriana			Structural Features of the Regulatory ACT Domain of Phenylalanine Hydroxylase	PLOS ONE			English	Article							AMINO-ACID HYDROXYLASES; MOLECULAR-DYNAMICS; MISSENSE MUTATIONS; HYDRATION SITES; PHENYLKETONURIA; PROTEINS; BINDING; SIMULATIONS; STABILITY; WATER	Phenylalanine hydroxylase (PAH) catalyzes the conversion of L-Phe to L-Tyr. Defects in PAH activity, caused by mutations in the human gene, result in the autosomal recessively inherited disease hyperphenylalaninemia. PAH activity is regulated by multiple factors, including phosphorylation and ligand binding. In particular, PAH displays positive cooperativity for L-Phe, which is proposed to bind the enzyme on an allosteric site in the N-terminal regulatory domain (RD), also classified as an ACT domain. This domain is found in several proteins and is able to bind amino acids. We used molecular dynamics simulations to obtain dynamical and structural insights into the isolated RD of PAH. Here we show that the principal motions involve conformational changes leading from an initial open to a final closed domain structure. The global intrinsic motions of the RD are correlated with exposure to solvent of a hydrophobic surface, which corresponds to the ligand binding-site of the ACT domain. Our results strongly suggest a relationship between the Phe-binding function and the overall dynamic behaviour of the enzyme. This relationship may be affected by structure-disturbing mutations. To elucidate the functional implications of the mutations, we investigated the structural effects on the dynamics of the human RD PAH induced by six missense hyperphenylalaninemia-causing mutations, namely p.G46S, p.F39C, p.F39L, p.I65S, p.I65T and p.I65V. These studies showed that the alterations in RD hydrophobic interactions induced by missense mutations could affect the functionality of the whole enzyme.	[Carluccio, Carla; Salvatore, Francesco; Zagari, Adriana] Sca Rl, CEINGE Biotecnol Avanzate, Naples, Italy; [Carluccio, Carla] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Carluccio, Carla; Fraternali, Franca; Fornili, Arianna] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Salvatore, Francesco] SDN Ist Ric Diagnost & Nucl, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of London; King's College London; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Salvatore, F (corresponding author), Sca Rl, CEINGE Biotecnol Avanzate, Naples, Italy.	salvator@unina.it; arianna.fornili@kcl.ac.uk	Fraternali, Franca/D-4410-2011; Fraternali, Franca/C-8912-2009; Salvatore, Francesco/A-1966-2011	Fraternali, Franca/0000-0002-3143-6574; Salvatore, Francesco/0000-0002-2346-3564	Regione Campania (DGRC) [1901]; Ministry of University and Research [PON01_01802 2012]; Leverhulme Trust [F/07 040/AL]	Regione Campania (DGRC)(Regione Campania); Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Leverhulme Trust(Leverhulme Trust)	This study was supported by the Regione Campania (DGRC n. 1901 del 22/12/2009), Grant PON01_01802 2012 from the Ministry of University and Research and by the Leverhulme Trust (F/07 040/AL to AF and FF). The authors have declared that no competing interests exist.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Cerreto M, 2012, CURR GENE THER, V12, P48, DOI 10.2174/156652312799789280; Cerreto M, 2011, BBA-MOL BASIS DIS, V1812, P1435, DOI 10.1016/j.bbadis.2011.07.012; Daniele A, 2008, BBA-MOL BASIS DIS, V1782, P378, DOI 10.1016/j.bbadis.2008.01.012; Daniele A, 2009, FEBS J, V276, P2048, DOI 10.1111/j.1742-4658.2009.06940.x; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 2001, J INHERIT METAB DIS, V24, P213, DOI 10.1023/A:1010371002631; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fitzpatrick PF, 2000, ADV ENZYMOL RAMB, V74, P235; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Fornili A, 2012, METHODS MOL BIOL, V819, P375, DOI 10.1007/978-1-61779-465-0_23; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gersting SW, 2010, J BIOL CHEM, V285, P30686, DOI 10.1074/jbc.M110.124016; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Leandro J, 2011, BBA-MOL BASIS DIS, V1812, P106, DOI 10.1016/j.bbadis.2010.09.015; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; LOUNNAS V, 1994, PROTEINS, V18, P148, DOI 10.1002/prot.340180207; LOUNNAS V, 1994, BIOPHYS J, V66, P601, DOI 10.1016/S0006-3495(94)80835-5; Miranda FF, 2002, J BIOL CHEM, V277, P40937, DOI 10.1074/jbc.M112197200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlick Tamar, 2009, F1000 Biol Rep, V1, P51, DOI 10.3410/B1-51; Schrodinger L.L.C., 2009, PYMOL MOL GRAPHICS S; Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017; Shan JF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002473; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; Siltberg-Liberles J, 2009, AMINO ACIDS, V36, P235, DOI 10.1007/s00726-008-0057-2; SVENSSON E, 1994, J INHERIT METAB DIS, V17, P215, DOI 10.1007/BF00711621; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107	60	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79482	10.1371/journal.pone.0079482	http://dx.doi.org/10.1371/journal.pone.0079482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244510	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800081
J	Jeantet, Y; Cayzac, S; Cho, YH				Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.			beta Oscillation during Slow Wave Sleep and Rapid Eye Movement Sleep in the Electroencephalogram of a Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; THETA OSCILLATIONS; NOCTURNAL SLEEP; WAKE CYCLE; MICE; DEFICITS; STATE; GENE; SYNCHRONIZATION; PHENOTYPE	Study objectives: To search for early abnormalities in electroencephalogram (EEG) during sleep which may precede motor symptoms in a transgenic mouse model of hereditary neurodegenerative Huntington's disease (HD). Design: In the R6/1 transgenic mouse model of HD, rhythmic brain activity in EEG recordings was monitored longitudinally and across vigilance states through the onset and progression of disease. Measurements and results: Mice with chronic electrode implants were recorded monthly over wake-sleep cycles (4 hours), beginning at 9-11 weeks (presymptomatic period) through 6-7 months (symptomatic period). Recording data revealed a unique beta rhythm (20-35 Hz), present only in R6/1 transgenic mice, which evolves in close parallel with the disease. In addition, there was an unusual relationship between this beta oscillation and vigilance states: while nearly absent during the active waking state, the beta oscillation appeared with drowsiness and during slow wave sleep (SWS) and, interestingly, strengthened rather than dissipating when the brain returned to an activated state during rapid eye movement (REM) sleep. Conclusions: In addition to providing a new in vivo biomarker and insight into Huntington's disease pathophysiology, this serendipitous observation opens a window onto the rarely explored neurophysiology of the cortico-basal ganglia circuit during SWS and REM sleep.	[Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.] Univ Bordeaux, Talence, France; [Jeantet, Yannick; Cayzac, Sebastien; Cho, Yoon H.] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Cho, YH (corresponding author), Univ Bordeaux, Talence, France.	yoon.cho@u-bordeaux1.fr			University of Bordeaux 1 (BQR); Agence National de la Recherche [ANR-08-MNPS-019-01]; Hereditary Disease Foundation	University of Bordeaux 1 (BQR); Agence National de la Recherche(French National Research Agency (ANR)); Hereditary Disease Foundation	This work was supported by the University of Bordeaux 1 (BQR), Agence National de la Recherche [ANR-08-MNPS-019-01] and the Hereditary Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Degos B, 2009, CEREB CORTEX, V19, P1616, DOI 10.1093/cercor/bhn199; EMSER W, 1988, J NEUROL, V235, P177, DOI 10.1007/BF00314313; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; Fisher SP, 2013, BRAIN, V136, P2159, DOI 10.1093/brain/awt132; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; GERBRANDT LK, 1978, ELECTROEN CLIN NEURO, V45, P454, DOI 10.1016/0013-4694(78)90290-0; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Jeantet Y, 2003, J NEUROSCI METH, V129, P129, DOI 10.1016/S0165-0270(03)00172-9; Kantor S, 2013, BRAIN, V136, P2147, DOI 10.1093/brain/awt128; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; SILVERMAN D, 1956, ELECTROEN CLIN NEURO, V8, P317, DOI 10.1016/0013-4694(56)90123-7; Snowden JS, 2002, J CLIN EXP NEUROPSYC, V24, P133, DOI 10.1076/jcen.24.2.133.998; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Urrestarazu E, 2009, MOVEMENT DISORD, V24, P254, DOI 10.1002/mds.22351; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781	35	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79509	10.1371/journal.pone.0079509	http://dx.doi.org/10.1371/journal.pone.0079509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244517	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800088
J	Schwilk, DW; Gaetani, MS; Poulos, HM				Schwilk, Dylan W.; Gaetani, Maria S.; Poulos, Helen M.			Oak Bark Allometry and Fire Survival Strategies in the Chihuahuan Desert Sky Islands, Texas, USA	PLOS ONE			English	Article							TROPICAL SAVANNA; NATIONAL-PARK; FOREST; TREES; ECOLOGY; RESISTANCE; MOUNTAINS; STORAGE; PLANTS; TRAIT	Trees may survive fire through persistence of above or below ground structures. Investment in bark aids in above-ground survival while investment in carbohydrate storage aids in recovery through resprouting and is especially important following above-ground tissue loss. We investigated bark allocation and carbohydrate investment in eight common oak (Quercus) species of Sky Island mountain ranges in west Texas. We hypothesized that relative investment in bark and carbohydrates changes with tree age and with fire regime: We predicted delayed investment in bark (positive allometry) and early investment in carbohydrates (negative allometry) under lower frequency, high severity fire regimes found in wetter microclimates. Common oaks of the Texas Trans-Pecos region (Quercus emoryi, Q. gambelii, Q. gravesii, Q. grisea, Q. hypoleucoides, Q. muehlenbergii, and Q. pungens) were sampled in three mountain ranges with historically mixed fire regimes: the Chisos Mountains, the Davis Mountains and the Guadalupe Mountains. Bark thickness was measured on individuals representing the full span of sizes found. Carbohydrate concentration in taproots was measured after initial leaf flush. Bark thickness was compared to bole diameter and allometries were analyzed using major axis regression on log-transformed measurements. We found that bark allocation strategies varied among species that can co-occur but have different habitat preferences. Investment patterns in bark were related to soil moisture preference and drought tolerance and, by proxy, to expected fire regime. Dry site species had shallower allometries with allometric coefficients ranging from less than one (negative allometry) to near one (isometric investment). Wet site species, on the other hand, had larger allometric coefficients, indicating delayed investment to defense. Contrary to our expectation, root carbohydrate concentrations were similar across all species and sizes, suggesting that any differences in below ground storage are likely to be in total volume of storage tissue rather than in carbohydrate concentration.	[Schwilk, Dylan W.; Gaetani, Maria S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Poulos, Helen M.] Wesleyan Univ, Coll Environm, Middletown, CT USA	Texas Tech University System; Texas Tech University; Wesleyan University	Schwilk, DW (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	dylan.schwilk@ttu.edu			Texas Tech University	Texas Tech University	This work was funded by Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; ADAMS DC, 1995, AM MIDL NAT, V134, P99, DOI 10.2307/2426487; Adams DC, 1997, P BIOL SOC WASH, V110, P681; Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Barbaroux C, 2003, NEW PHYTOL, V157, P605, DOI 10.1046/j.1469-8137.2003.00681.x; Barton AM, 1999, FOREST ECOL MANAG, V120, P143, DOI 10.1016/S0378-1127(98)00531-3; Bauer G, 2010, J MATER SCI, V45, P5950, DOI 10.1007/s10853-010-4680-4; Bell TL, 1999, NEW PHYTOL, V144, P143, DOI 10.1046/j.1469-8137.1999.00489.x; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; BERGERON Y, 1991, ECOLOGY, V72, P1980, DOI 10.2307/1941553; Bond W.J., 1996, FIRE PLANTS POPULATI; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Burrows GE, 2002, NEW PHYTOL, V153, P111, DOI 10.1046/j.0028-646X.2001.00299.x; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chatziefstratiou EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070110; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Clarke PJ, 2002, J BIOGEOGR, V29, P677, DOI 10.1046/j.1365-2699.2002.00716.x; COWLING RM, 1987, J APPL ECOL, V24, P645, DOI 10.2307/2403899; Cruz A, 2001, OECOLOGIA, V128, P343, DOI 10.1007/s004420100664; Dathe J, 2013, THESIS TEXAS TU; El Omari B, 2003, PLANT SOIL, V252, P349, DOI 10.1023/A:1024792206369; Fule PZ, 2003, LANDSCAPE ECOL, V18, P465, DOI 10.1023/A:1026012118011; HARE ROBERT C., 1965, J FOREST, V63, P248; HARMON ME, 1984, ECOLOGY, V65, P796, DOI 10.2307/1938052; HARRINGTON MG, 1989, J RANGE MANAGE, V42, P504, DOI 10.2307/3899237; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Jackson JF, 1999, AM NAT, V153, P614, DOI 10.1086/303201; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keeley Jon E., 1998, P219; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lawes MJ, 2011, PLANT ECOL, V212, P2057, DOI 10.1007/s11258-011-9954-7; Lawes MJ, 2011, PLANT ECOL, V212, P1937, DOI 10.1007/s11258-011-9994-z; Lawes MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00204.1; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; Moreira F, 2009, PLANT ECOL, V201, P77, DOI 10.1007/s11258-008-9476-0; MULLER CORNELIUS H, 1940, AMER MIDLAND NAT, V24, P703, DOI 10.2307/2420868; Nixon K. C, 1993, ANN SCIENC FOR VOL, V50, p25s, DOI 10.1051/forest:19930701; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; PETERSON DL, 1986, ENVIRON MANAGE, V10, P797, DOI 10.1007/BF01867732; Pinheiro J., 2011, NLME LINEAR NONLINEA; Poulos HM, 2007, AM J BOT, V94, P809, DOI 10.3732/ajb.94.5.809; Poulos HM, 2013, FOREST ECOL MANAG, V298, P1, DOI 10.1016/j.foreco.2013.02.014; Poulos HM, 2009, CAN J FOREST RES, V39, P1236, DOI 10.1139/X09-052; Poulos HM, 2010, ECOLOGY, V91, P1140, DOI 10.1890/08-1808.1; POWELL A. M., 1997, TREES SHRUBS TRANSPE; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Sakulich J, 2007, FOREST ECOL MANAG, V241, P62, DOI 10.1016/j.foreco.2006.12.029; Sarkar D., 2019, NLME LINEAR NONLINEA; Schwilk DW, 2005, AM J BOT, V92, P404, DOI 10.3732/ajb.92.3.404; Schwilk DW, 2001, OIKOS, V94, P326, DOI 10.1034/j.1600-0706.2001.940213.x; Sparrow AD, 2001, OIKOS, V94, P195, DOI 10.1034/j.1600-0706.2001.t01-1-11319.x; Splat KW, 1962, 193 US FOR SERV SO F; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; van Mantgem P, 2003, FOREST ECOL MANAG, V178, P341, DOI 10.1016/S0378-1127(02)00554-6; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x	65	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79285	10.1371/journal.pone.0079285	http://dx.doi.org/10.1371/journal.pone.0079285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244469	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800055
J	Bui, TVL; Ross, IL; Jakob, G; Hankamer, B				Bui, Tony V. L.; Ross, Ian L.; Jakob, Gisela; Hankamer, Ben			Impact of Procedural Steps and Cryopreservation Agents in the Cryopreservation of Chlorophyte Microalgae	PLOS ONE			English	Article							PORPHYRA-YEZOENSIS; DIMETHYL-SULFOXIDE; BIOFUEL PRODUCTION; EUKARYOTIC ALGAE; CHLAMYDOMONAS; VIABILITY; VITRIFICATION; CONSERVATION; CONCHOCELIS; CRYOINJURY	The maintenance of traditional microalgae collections based on liquid and solid media is labour intensive, costly and subject to contamination and genetic drift. Cryopreservation is therefore the method of choice for the maintenance of microalgae culture collections, but success is limited for many species. Although the mechanisms underlying cryopreservation are understood in general, many technical variations are present in the literature and the impact of these are not always elaborated. This study describes two-step cryopreservation processes in which 3 microalgae strains representing different cell sizes were subjected to various experimental approaches to cryopreservation, the aim being to investigate mechanistic factors affecting cell viability. Sucrose and dimethyl sulfoxide (DMSO) were used as cryoprotectants. They were found to have a synergistic effect in the recovery of cryopreserved samples of many algal strains, with 6.5% being the optimum DMSO concentration. The effect of sucrose was shown to be due to improved cell survival and recovery after thawing by comparing the effect of sucrose on cell viability before or after cryopreservation. Additional factors with a beneficial effect on recovery were the elimination of centrifugation steps (minimizing cell damage), the reduction of cell concentration (which is proposed to reduce the generation of toxic cell wall components) and the use of low light levels during the recovery phase (proposed to reduce photooxidative damage). The use of the best conditions for each of these variables yielded an improved protocol which allowed the recovery and subsequent improved culture viability of a further 16 randomly chosen microalgae strains. These isolates included species from Chlorellaceae, Palmellaceae, Tetrasporaceae, Palmellopsis, Scenedesmaceae and Chlamydomonadaceae that differed greatly in cell diameter (3-50 mu m), a variable that can affect cryopreservation success. The collective improvement of each of these parameters yielded a cryopreservation protocol that can be applied to a broad range of microalgae.	[Bui, Tony V. L.; Ross, Ian L.; Jakob, Gisela; Hankamer, Ben] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Hankamer, B (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.hankamer@imb.uq.edu.au	Hankamer, Ben D/C-9688-2015; Ross, Ian/A-8622-2011	Hankamer, Ben D/0000-0001-9284-4929; Ross, Ian/0000-0002-2389-4292	Australian Research Council (ARC) [LP0883380]	Australian Research Council (ARC)(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) (http://www.arc.gov.au) Grant LP0883380. A student scholarship for TB was also provided by the ARC. The role of the funders was solely to provide funding for the project and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand JJ, 2004, NOVA HEDWIGIA, V79, P175, DOI 10.1127/0029-5035/2004/0079-0175; Crutchfield ALM, 1999, EUR J PHYCOL, V34, P43; Day JG, 2004, NOVA HEDWIGIA, V79, P191, DOI 10.1127/0029-5035/2004/0079-0191; Day JG, 2000, J APPL PHYCOL, V12, P369, DOI 10.1023/A:1008107229005; Day JG, 1997, J APPL PHYCOL, V9, P121, DOI 10.1023/A:1007991507314; Day JG, 2010, TAXON, V59, P3, DOI 10.1002/tax.591001; DOEBBLER GF, 1966, CRYOBIOLOGY, V3, P2, DOI 10.1016/S0011-2240(66)80144-X; Entwisle JT, 1997, FRESHWATER ALGAE AUS; Fischer G, 2010, BIOMASS BIOENERG, V34, P173, DOI 10.1016/j.biombioe.2009.07.009; Fleck RA, 2006, CRYOBIOLOGY, V52, P261, DOI 10.1016/j.cryobiol.2005.12.003; Forster B, 2005, BBA-BIOENERGETICS, V1709, P45, DOI 10.1016/j.bbabio.2005.05.012; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harding K, 2004, NOVA HEDWIGIA, V79, P207, DOI 10.1127/0029-5035/2004/0079-0207; Harding K, 2008, CRYOLETTERS, V29, P15; Harris EH, 2009, CHLAMYDOMONAS SOURCE, V1; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jain JK, 2006, FERTIL STERIL, V86, P1037, DOI 10.1016/j.fertnstert.2006.07.1478; Jo HY, 2003, ALGAE, V18, P321; Kuji N, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P1001; KUWANO K, 1992, NIPPON SUISAN GAKK, V58, P1793; KUWANO K, 1993, PLANT SCI, V94, P215, DOI 10.1016/0168-9452(93)90022-R; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Nakanishi K, 2012, J APPL PHYCOL, V24, P1381, DOI 10.1007/s10811-012-9790-8; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Osorio HC, 2004, NOVA HEDWIGIA, V79, P227, DOI 10.1127/0029-5035/2004/0079-0227; Palasz AT, 1996, BIOTECHNOL ADV, V14, P127, DOI 10.1016/0734-9750(96)00005-5; Piasecki BP, 2009, CRYOBIOLOGY, V58, P103, DOI 10.1016/j.cryobiol.2008.11.001; SAKAI A, 1991, J PLANT PHYSIOL, V137, P465, DOI 10.1016/S0176-1617(11)80318-4; Schilling S, 2007, BIOCHEM J, V406, P325, DOI 10.1042/BJ20070448; SHIER WT, 1995, IN VITRO CELL DEV-AN, V31, P336, DOI 10.1007/BF02634280; Tanaka JY, 2001, CRYOBIOLOGY, V42, P286, DOI 10.1006/cryo.2001.2334; Taylor R, 1998, J APPL PHYCOL, V10, P481, DOI 10.1023/A:1008094622412; Weng LD, 2011, J CHEM ENG DATA, V56, P3175, DOI 10.1021/je2002607; Xie Y, 2010, J PLAST RECONSTR AES, V63, P482, DOI 10.1016/j.bjps.2008.11.056; YU ZW, 1994, BIOSCIENCE REP, V14, P259, DOI 10.1007/BF01199051; Zhang WJ, 2010, BIOMED MICRODEVICES, V12, P89, DOI 10.1007/s10544-009-9363-z	36	24	28	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78668	10.1371/journal.pone.0078668	http://dx.doi.org/10.1371/journal.pone.0078668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244336	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600045
J	Gryseels, C; Uk, S; Erhart, A; Gerrets, R; Sluydts, V; Durnez, L; Ribera, JM; Muela, SH; Menard, D; Heng, S; Sochantha, T; D'Alessandro, U; Coosemans, M; Grietens, KP				Gryseels, Charlotte; Uk, Sambunny; Erhart, Annette; Gerrets, Rene; Sluydts, Vincent; Durnez, Lies; Ribera, Joan Muela; Muela, Susanna Hausmann; Menard, Didier; Heng, Somony; Sochantha, Tho; D'Alessandro, Umberto; Coosemans, Marc; Grietens, Koen Peeters			Injections, Cocktails and Diviners: Therapeutic Flexibility in the Context of Malaria Elimination and Drug Resistance in Northeast Cambodia	PLOS ONE			English	Article							FALCIPARUM-MALARIA; ANTIMALARIAL-DRUGS; COUNTERFEIT; AGE	Background: Adherence to effective malaria medication is extremely important in the context of Cambodia's elimination targets and drug resistance containment. Although the public sector health facilities are accessible to the local ethnic minorities of Ratanakiri province (Northeast Cambodia), their illness itineraries often lead them to private pharmacies selling "cocktails" and artemether injections, or to local diviners prescribing animal sacrifices to appease the spirits. Methods: The research design consisted of a mixed methods study, combining qualitative (in-depth interviews and participant observation) and quantitative methods (household and cross-sectional survey). Results: Three broad options for malaria treatment were identified: i) the public sector; ii) the private sector; iii) traditional treatment based on divination and ceremonial sacrifice. Treatment choice was influenced by the availability of treatment and provider, perceived side effects and efficacy of treatments, perceived etiology of symptoms, and patient-health provider encounters. Moreover, treatment paths proved to be highly flexible, changing mostly in relation to the perceived efficacy of a chosen treatment. Conclusions: Despite good availability of anti-malarial treatment in the public health sector, attendance remained low due to both structural and human behavioral factors. The common use and under-dosage of anti-malaria monotherapy in the private sector (single-dose injections, single-day drug cocktails) represents a threat not only for individual case management, but also for the regional plan of drug resistance containment and malaria elimination.	[Gryseels, Charlotte; Erhart, Annette; Sluydts, Vincent; Durnez, Lies; Coosemans, Marc; Grietens, Koen Peeters] Inst Trop Med, B-2000 Antwerp, Belgium; [Uk, Sambunny; Heng, Somony; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Gerrets, Rene] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Ribera, Joan Muela; Muela, Susanna Hausmann; Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Menard, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [D'Alessandro, Umberto] MRC, Fajara, Gambia; [Coosemans, Marc] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); National Center Parasitology, Entomology & Malaria Control; University of Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of London; London School of Hygiene & Tropical Medicine; University of Antwerp	Gryseels, C (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	cgryseels@itg.be	Peeters Grietens, Koen/G-7028-2019; Menard, Didier/O-3294-2013; Ribera, JM/B-8181-2009; Sluydts, Vincent/AAU-8776-2020; D'Alessandro, Umberto/D-3457-2015	Peeters Grietens, Koen/0000-0001-6570-9887; Menard, Didier/0000-0003-1357-4495; Ribera, JM/0000-0003-1042-6024; Sluydts, Vincent/0000-0001-5213-851X; D'Alessandro, Umberto/0000-0001-6341-5009; muela ribera, joan/0000-0003-2111-6275; Gryseels, Charlotte/0000-0002-8963-4469	Institute of Tropical Medicine (ITM), Antwerp, Belgium; National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia; Bill and Melinda Gates Foundation	Institute of Tropical Medicine (ITM), Antwerp, Belgium; National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The qualitative study and the household survey received financial support from the Belgian Cooperation within the Framework Agreement III consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), Antwerp, Belgium and the National Center for Parasitology, Entomology and Malaria Control (CNM), Phnom Penh, Cambodia. The cross-sectional survey was financially supported by the Bill and Melinda Gates Foundation within the framework of the project 'Repellents as an added control measure to LLINs in Southeast Asia'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EM RESP ART RES GREA; Asian Development Bank, 2002, IND PEOPL ETHN MIN P; Bourdier F., 2006, MOUNTAIN PRECIOUS ST; Bourdier F., 2009, DEV DOMINION INDIGEN; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Good CM., 1987, ETHNOMEDICAL SYSTEMS; Hausmann-Muela S, 2012, MALAR REP, V2, P17; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; Kingdom of Cambodia Ministry of Health Cambodia, 2011, TRAT PLAN EL MAL CAM; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; Montagu D, 2010, LARGE SCALE MALARIA; Muela SH, 2002, SOC SCI MED, V55, P403; National Center for Parasitology Entomology and Malaria Control, 2009, VILL MAL WORK PROJ S; National Center for Parasitology Entomology and Malaria Control Kingdom of Cambodia Ministry of Health Cambodia, 2012, MIS NAT MAL PROGR; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; O'Connell KA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-335; Ovesen J, 2004, CIVILIZING THE MARGINS: SOUTHEAST ASIAN GOVERNMENT POLICIES FOR THE DEVELOPMENT OF MINORITIES, P241; Ovesen J., 2007, MEDICAL IDENTITIES H, P36; Packard, 2016, HIST GLOBAL HLTH INT; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; SBJ (Statistics Bureau of Japan), 2008, REV 2008 GEN POPULAT; Shanks GD, 2006, J POSTGRAD MED, V52, P277; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Thriemer K, 2013, TROP MED INT HEALTH, V18, P66; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	34	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80343	10.1371/journal.pone.0080343	http://dx.doi.org/10.1371/journal.pone.0080343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244678	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600204
J	Muller, C; Busignies, V; Mazel, V; Forestier, C; Nivoliez, A; Tchoreloff, P				Muller, Claudia; Busignies, Virginie; Mazel, Vincent; Forestier, Christiane; Nivoliez, Adrien; Tchoreloff, Pierre			Mechanistic Approach to Stability Studies as a Tool for the Optimization and Development of New Products Based on L. rhamnosus Lcr35 (R) in Compliance with Current Regulations	PLOS ONE			English	Article							LACTOBACILLUS-CASEI-RHAMNOSUS; PROBIOTIC BACTERIA; VIABILITY; TEMPERATURE; MODEL; PH	Probiotics are of great current interest in the pharmaceutical industry because of their multiple effects on human health. To beneficially affect the host, an adequate dosage of the probiotic bacteria in the product must be guaranteed from the time of manufacturing to expiration date. Stability test guidelines as laid down by the ICH-Q1A stipulate a minimum testing period of 12 months. The challenge for producers is to reduce this time. In this paper, a mechanistic approach using the Arrhenius model is proposed to predict stability. Applied for the first time to laboratory and industrial probiotic powders, the model was able to provide a reliable mathematical representation of the effects of temperature on bacterial death (R-2>0.9). The destruction rate (k) was determined according to the manufacturing process, strain and storage conditions. The marketed product demonstrated a better stability (k = 0.08 months(-1)) than the laboratory sample (k = 0.80 months(-1)). With industrial batches, k obtained at 6 months of studies was comparable to that obtained at 12 months, evidence of the model's robustness. In addition, predicted values at 12 months were greatly similar (+/- 30%) to those obtained by real-time assessing the model's reliability. This method could be an interesting approach to predict the probiotic stability and could reduce to 6 months the length of stability studies as against 12 (ICH guideline) or 24 months (expiration date).	[Muller, Claudia; Nivoliez, Adrien] Probionov, Dept Rech & Dev, Aurillac, France; [Muller, Claudia; Busignies, Virginie; Mazel, Vincent; Tchoreloff, Pierre] Univ Paris Sud, Lab Mat & Sante EA401, Chatenay Malabry, France; [Forestier, Christiane] Univ Auvergne Clermont 1, UMR CNRS 6023, LMGE, Clermont Ferrand, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Muller, C (corresponding author), Probionov, Dept Rech & Dev, Aurillac, France.	c.muller@probionov.com	Mazel, Vincent/AAJ-2156-2020		ANRT (Association Nationale Recherche Technologie)	ANRT (Association Nationale Recherche Technologie)(French National Research Agency (ANR))	This work was supported by a grant from ANRT (Association Nationale Recherche Technologie) supporting the PhD thesis performed by CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, GUIDELINES EVALUATIO; [Anonymous], 2003, CPMPICH273699 EUR ME; [Anonymous], 2009, CHMOICH16706804 EUR; BERNER D, 2006, SCI PHARM, V74, P137; Carvalho AS, 2004, INT DAIRY J, V14, P835, DOI 10.1016/j.idairyj.2004.02.001; Cerf O, 1996, FOOD RES INT, V29, P219, DOI 10.1016/0963-9969(96)00039-7; Chan ES, 2002, T ICHEM E C, V80; Coudeyras S, 2008, APPL ENVIRON MICROB, V74, P2679, DOI 10.1128/AEM.02286-07; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; DAVEY KR, 1993, J IND MICROBIOL, V12, P172, DOI 10.1007/BF01584187; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Forssten SD, 2011, ANAEROBE, V17, P410, DOI 10.1016/j.anaerobe.2011.04.014; Grzeskowiak L, 2010, BRIT J NUTR, P1; Jennison MW, 1940, J BACTERIOL, V39, P389, DOI 10.1128/JB.39.4.389-397.1940; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kaur IP, 2002, EUR J PHARM SCI, V15, P1, DOI 10.1016/S0928-0987(01)00209-3; Kosin B, 2006, FOOD TECHNOL BIOTECH, V44, P371; Koutsoumanis K, 2006, APPL ENVIRON MICROB, V72, P124, DOI 10.1128/AEM.72.1.124-134.2006; La Saponara V, 2011, COMPOS STRUCT, V93, P2180, DOI 10.1016/j.compstruct.2011.03.005; Madras G, 2001, CHEM ENG SCI, V56, P5085, DOI 10.1016/S0009-2509(01)00186-5; Makinen K, 2012, J BIOTECHNOL, V162, P356, DOI 10.1016/j.jbiotec.2012.07.006; Nivoliez A, 2012, J BIOTECHNOL, V160, P236, DOI 10.1016/j.jbiotec.2012.04.005; Oliveira MN, 2001, INT DAIRY J, V11, P935, DOI 10.1016/S0958-6946(01)00142-X; Ouwehand AC, 1998, INT DAIRY J, V8, P749, DOI 10.1016/S0958-6946(98)00114-9; Petricevic L, 2008, BJOG-INT J OBSTET GY, V115, P1369, DOI 10.1111/j.1471-0528.2008.01882.x; Quigley EMM, 2010, PHARMACOL RES, V61, P213, DOI 10.1016/j.phrs.2010.01.004; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Savini M, 2010, NUTRIENTS, V2, P330, DOI 10.3390/nu2030330; Scheinbach S, 1998, BIOTECHNOL ADV, V16, P581, DOI 10.1016/S0734-9750(98)00002-0; SLATER JG, 1979, J PHARM SCI, V68, P49, DOI 10.1002/jps.2600680117; Sutton S., 2011, J VALID TECHNOL, V17, P42; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Waterman KC, 2005, INT J PHARMACEUT, V293, P101, DOI 10.1016/j.ijpharm.2004.12.013; Waterman KC, 2011, AAPS PHARMSCITECH, V12, P932, DOI 10.1208/s12249-011-9657-3; Zarate G, 2006, PROCESS BIOCHEM, V41, P1779, DOI 10.1016/j.procbio.2006.03.024	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79041	10.1371/journal.pone.0079041	http://dx.doi.org/10.1371/journal.pone.0079041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244412	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600099
J	Tanabe, N; Hoshino, Y; Marumo, S; Kiyokawa, H; Sato, S; Kinose, D; Uno, K; Muro, S; Hirai, T; Yodoi, J; Mishima, M				Tanabe, Naoya; Hoshino, Yuma; Marumo, Satoshi; Kiyokawa, Hirofumi; Sato, Susumu; Kinose, Daisuke; Uno, Kazuko; Muro, Shigeo; Hirai, Toyohiro; Yodoi, Junji; Mishima, Michiaki			Thioredoxin-1 Protects against Neutrophilic Inflammation and Emphysema Progression in a Mouse Model of Chronic Obstructive Pulmonary Disease Exacerbation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AIRWAY INFLAMMATION; INNATE IMMUNE; CT-SCAN; LUNG; RESPONSES; COPD; GLUCOCORTICOIDS; PHOSPHATASE-1; DEXAMETHASONE	Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are characterized by acute enhancement of airway neutrophilic inflammation under oxidative stress and can be involved in emphysema progression. However, pharmacotherapy against the neutrophilic inflammation and emphysema progression associated with exacerbation has not been established. Thioredoxin-1 has anti-oxidative and anti-inflammatory properties and it can ameliorate neutrophilic inflammation through anti-chemotactic effects and prevent cigarette smoke (CS)-induced emphysema. We aimed to determine whether thioredoxin-1 can suppress neutrophilic inflammation and emphysema progression in a mouse model of COPD exacerbation and if so, to reveal the underlying mechanisms. Results: Mice were exposed to CS and then challenged with polyinosine-polycytidylic acid [poly(I: C)], an agonist for virus-induced innate immunity. Airway neutrophilic inflammation, oxidative stress and lung apoptosis were enhanced in smoke-sensitive C57Bl/6, but not in smoke-resistant NZW mice. Exposure to CS and poly(I:C) challenge accelerated emphysema progression in C57Bl/6 mice. Thioredoxin-1 suppressed neutrophilic inflammation and emphysema progression. Poly(I:C) caused early neutrophilic inflammation through keratinocyte-derived chemokine and granulocyte-macrophage colony-stimulating factor (GM-CSF) release in the lung exposed to CS. Late neutrophilic inflammation was caused by persistent GMCSF release, which thioredoxin-1 ameliorated. Thioredoxin-1 enhanced pulmonary mRNA expression of MAP kinase phosphatase 1 (MKP-1), and the suppressive effects of thioredoxin-1 on prolonged GM-CSF release and late neutrophilic inflammation disappeared by inhibiting MKP-1. Conclusion: Using a mouse model of COPD exacerbation, we demonstrated that thioredoxin-1 ameliorated neutrophilic inflammation by suppressing GM-CSF release, which prevented emphysema progression. Our findings deepen understanding of the mechanisms underlying the regulation of neutrophilic inflammation by thioredoxin-1 and indicate that thioredoxin-1 could have potential as a drug to counteract COPD exacerbation.	[Tanabe, Naoya; Hoshino, Yuma; Marumo, Satoshi; Kiyokawa, Hirofumi; Sato, Susumu; Kinose, Daisuke; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 606, Japan; [Yodoi, Junji] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul, South Korea; [Yodoi, Junji] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	Kyoto University; Kyoto University; Ewha Womans University; Ewha Womans University	Hoshino, Y (corresponding author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan.	yuma@kuhp.kyoto-u.ac.jp	Sato, Susumu/R-8976-2019		National Institute of Biomedical Innovation, Japan; World Class University through Ewha Womans University [R31-10010]	National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); World Class University through Ewha Womans University	This work was supported by the Program for the Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation, Japan and by the World Class University Grant R31-10010 through the Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hoshino Y, 2007, AM J RESP CELL MOL, V37, P438, DOI 10.1165/rcmb.2006-0402OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Mercer PF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-151; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sato A, 2008, J PHARMACOL EXP THER, V325, P380, DOI 10.1124/jpet.107.134007; Sato A, 2007, P NATL ACAD SCI USA, V104, P2361, DOI 10.1073/pnas.0607882104; Sato A, 2006, ANTIOXID REDOX SIGN, V8, P1891, DOI 10.1089/ars.2006.8.1891; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Son A, 2009, ANTIOXID REDOX SIGN, V11, P2595, DOI 10.1089/ARS.2009.2522; TAGAYA Y, 1994, EMBO J, V13, P2244, DOI 10.1002/j.1460-2075.1994.tb06502.x; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Ueda S, 2006, LIFE SCI, V79, P1170, DOI 10.1016/j.lfs.2006.03.026; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Yodoi J, 1987, Adv Exp Med Biol, V213, P139	49	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79016	10.1371/journal.pone.0079016	http://dx.doi.org/10.1371/journal.pone.0079016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244404	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600094
J	Wahlin, KJ; Enke, RA; Fuller, JA; Kalesnykas, G; Zack, DJ; Merbs, SL				Wahlin, Karl J.; Enke, Raymond A.; Fuller, John A.; Kalesnykas, Giedrius; Zack, Donald J.; Merbs, Shannath L.			Epigenetics and Cell Death: DNA Hypermethylation in Programmed Retinal Cell Death	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; RD1 MOUSE; DEGENERATING PHOTORECEPTORS; TERMINAL DIFFERENTIATION; CHICK-EMBRYO; IN-SITU; METHYLATION; ACTIVATION; 5-HYDROXYMETHYLCYTOSINE; CASPASE-3	Background: Vertebrate genomes undergo epigenetic reprogramming during development and disease. Emerging evidence suggests that DNA methylation plays a key role in cell fate determination in the retina. Despite extensive studies of the programmed cell death that occurs during retinal development and degeneration, little is known about how DNA methylation might regulate neuronal cell death in the retina. Methods: The developing chicken retina and the rd1 and rhodopsin-GFP mouse models of retinal degeneration were used to investigate programmed cell death during retinal development and degeneration. Changes in DNA methylation were determined by immunohistochemistry using antibodies against 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). Results: Punctate patterns of hypermethylation paralleled patterns of caspase3-dependent apoptotic cell death previously reported to occur during development in the chicken retina. Degenerating rd1 mouse retinas, at time points corresponding to the peak of rod cell death, showed elevated signals for 5mC and 5hmC in photoreceptors throughout the retina, with the most intense staining observed in the peripheral retina. Hypermethylation of photoreceptors in rd1 mice was associated with TUNEL and PAR staining and appeared to be cCaspase3-independent. After peak rod degeneration, during the period of cone death, occasional hypermethylation was observed in the outer nuclear layer. Conclusion: The finding that cell-specific increases of 5mC and 5hmC immunostaining are associated with the death of retinal neurons during both development and degeneration suggests that changes in DNA methylation may play a role in modulating gene expression during the process of retinal degeneration. During retinal development, hypermethylation of retinal neurons associates with classical caspase-dependent apoptosis as well as caspase-3 independent cell death, while hypermethylation in the rd1 mouse photoreceptors is primarily associated with caspase-3 independent programmed cell death. These findings suggest a previously unrecognized role for epigenetic mechanisms in the onset and/or progression of programed cell death in the retina.	[Wahlin, Karl J.; Fuller, John A.; Zack, Donald J.; Merbs, Shannath L.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Kalesnykas, Giedrius] Univ Eastern Finland, Sch Med, Clin Res Unit, Dept Ophthalmol, Kuopio, Finland; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France; [Enke, Raymond A.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Eastern Finland; UDICE-French Research Universities; Sorbonne Universite; James Madison University	Merbs, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	smerbs@jhmi.edu	Kalesnykas, Giedrius/AAG-4084-2021	Zack, Don/0000-0002-7966-1973; Enke, Raymond/0000-0002-3605-2107; Fuller, John/0000-0002-6587-146X; Wahlin, Karl/0000-0002-0494-8304	National Eye Institute [R21EY018703, R01EY009769]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY018703, T32EY007143, R01EY009769] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Eye Institute (R21EY018703 to S. L. M, and R01EY009769 to D.J.Z.), unrestricted funding from the Research to Prevent Blindness and generous gifts from A. Nixon, the Guerrieri Family Foundation, and Mr. and Mrs. Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Borsello T, 2002, J COMP NEUROL, V453, P361, DOI 10.1002/cne.10411; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chavarria T, 2007, DEV NEUROBIOL, V67, P1777, DOI 10.1002/dneu.20554; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cook B, 1998, J COMP NEUROL, V396, P12, DOI 10.1002/(SICI)1096-9861(19980622)396:1<12::AID-CNE2>3.0.CO;2-L; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Doonan F, 2003, J NEUROSCI, V23, P5723; Fard SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059133; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garnier P, 2003, J NEUROSCI, V23, P7967; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kim DH, 2002, OPHTHALMIC RES, V34, P150, DOI 10.1159/000063659; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LAVAIL MM, 1974, ARCH OPHTHALMOL-CHIC, V91, P394; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mayordomo R, 2003, EUR J NEUROSCI, V18, P1744, DOI 10.1046/j.1460-9568.2003.02891.x; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Merbs SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032602; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Nasonkin IO, 2013, DEVELOPMENT, V140, P1330, DOI 10.1242/dev.086603; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Petkova TD, 2011, VISION RES, V51, P260, DOI 10.1016/j.visres.2010.09.022; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Ragoczy T, 2009, CELL, V137, P205, DOI 10.1016/j.cell.2009.04.006; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rhee KD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.165; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Valenciano AI, 2009, INT J DEV BIOL, V53, P1515, DOI 10.1387/ijdb.072446av; Wahlin KJ, 2008, J COMP NEUROL, V506, P822, DOI 10.1002/cne.21582; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P964, DOI 10.1167/iovs.03-0439; Zencak D, 2013, P NATL ACAD SCI USA, V110, pE593, DOI 10.1073/pnas.1108297110; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440	62	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79140	10.1371/journal.pone.0079140	http://dx.doi.org/10.1371/journal.pone.0079140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244436	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600112
J	Wang, F; Hou, HY; Xu, LQ; Jane, M; Peng, J; Lu, YJ; Zhu, YW; Sun, ZY				Wang, Feng; Hou, Hongyan; Xu, Lingqing; Jane, Munanie; Peng, Jing; Lu, Yanjun; Zhu, Yaowu; Sun, Ziyong			Mycobacterium Tuberculosis-Specific TNF-alpha Is a Potential Biomarker for the Rapid Diagnosis of Active Tuberculosis Disease in Chinese Population	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; INFECTION; HIV; RESPONSES; CYTOKINE	Interferon-gamma release assays (IGRAs) have proven to be useful to accurately detect Mycobacterium tuberculosis (Mtb) infection, but they cannot reliably discriminate between active tuberculosis (TB) and latent tuberculosis infection (LTBI). This study aims to test whether Mtb-specific tumor necrosis factor-alpha (TNF-alpha) could be used as a new tool for the rapid diagnosis of active TB disease. The secretion of TNF-alpha by Mtb-specific antigen-stimulated peripheral blood mononuclear cells (PBMCs) of sixty seven participants was investigated in the study. Our results showed that the total measurement of TNF-alpha secretion by Mtb-specific antigen-stimulated PBMCs is not a good biomarker for active TB diagnosis. However, we found that calculation of Mtb-specific TNF-alpha not only distinguish between active and latent TB infection, but also can differentiate active TB from non-TB patients. Using the cutoff value of 136.9 pg/ml for Mtb-specific TNF-alpha, we were able to differentiate active TB from LTBI. Sensitivity and specificity were 72% and 90.91%. These data suggest that Mtb-specific TNF-alpha could be a potential biomarker for the diagnosis of active TB disease.	[Wang, Feng; Hou, Hongyan; Xu, Lingqing; Jane, Munanie; Peng, Jing; Lu, Yanjun; Zhu, Yaowu; Sun, Ziyong] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Sun, ZY (corresponding author), Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	tjszyong@163.com			Ministry of Health of China [2012zx10004-207]	Ministry of Health of China	This work was supported by the Infectious Diseases Control Project from Ministry of Health of China (2012zx10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatidou V, 2012, EUR J CLIN MICROBIOL, V31, P1285, DOI 10.1007/s10096-011-1524-3; Anandaiah A, 2011, AM J RESP CRIT CARE, V183, P987, DOI 10.1164/rccm.201008-1246CI; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chiappini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046041; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Farnia P, 2002, J CLIN MICROBIOL, V40, P508, DOI 10.1128/JCM.40.2.508-511.2002; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Kupli E, 2008, RESPIRATION, V75, P73, DOI 10.1159/000110744; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Loddenkemper R, 2010, DTSCH ARZTEBL INT, V107, P10, DOI 10.3238/arztebl.2010.0010; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Milburn H, 2007, J ROY SOC MED, V100, P134, DOI 10.1258/jrsm.100.3.134; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Tahhan M, 2003, RESPIRATION, V70, P270, DOI 10.1159/000072008; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tincati Camilla, 2012, Cells, V1, P89, DOI 10.3390/cells1020089	23	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79431	10.1371/journal.pone.0079431	http://dx.doi.org/10.1371/journal.pone.0079431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244502	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600131
J	Klusza, S; Novak, A; Figueroa, S; Palmer, W; Deng, WM				Klusza, Stephen; Novak, Amanda; Figueroa, Shirelle; Palmer, William; Deng, Wu-Min			Prp22 and Spliceosome Components Regulate Chromatin Dynamics in Germ-Line Polyploid Cells	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; EXON JUNCTION COMPLEX; BOX RNA HELICASE; CHROMOSOME TERRITORY ORGANIZATION; MESSENGER-RNA; DROSOPHILA OOGENESIS; SPLICING FACTOR; RIBOSOME BIOGENESIS; NURSE CELLS; SEX-LETHAL	During Drosophila oogenesis, the endopolyploid nuclei of germ-line nurse cells undergo a dramatic shift in morphology as oogenesis progresses; the easily-visible chromosomes are initially polytenic during the early stages of oogenesis before they transiently condense into a distinct '5-blob' configuration, with subsequent dispersal into a diffuse state. Mutations in many genes, with diverse cellular functions, can affect the ability of nurse cells to fully decondense their chromatin, resulting in a '5-blob arrest' phenotype that is maintained throughout the later stages of oogenesis. However, the mechanisms and significance of nurse-cell (NC) chromatin dispersal remain poorly understood. Here, we report that a screen for modifiers of the 5-blob phenotype in the germ line isolated the spliceosomal gene peanuts, the Drosophila Prp22. We demonstrate that reduction of spliceosomal activity through loss of peanuts promotes decondensation defects in NC nuclei during mid-oogenesis. We also show that the Prp38 spliceosomal protein accumulates in the nucleoplasm of nurse cells with impaired peanuts function, suggesting that spliceosomal recycling is impaired. Finally, we reveal that loss of additional spliceosomal proteins impairs the full decondensation of NC chromatin during later stages of oogenesis, suggesting that individual spliceosomal subcomplexes modulate expression of the distinct subset of genes that are required for correct morphology in endopolyploid nurse cells.	[Klusza, Stephen; Novak, Amanda; Figueroa, Shirelle; Palmer, William; Deng, Wu-Min] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Deng, WM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	wumin@bio.fsu.edu	Klusza, Stephen/HGA-8857-2022	Klusza, Stephen/0000-0003-0943-1846; Palmer, William/0000-0002-0348-6339	National Institutes of Health (NIH) [R01 GM072562]; National Science Foundation [IOS-1052333]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072562, R01GM084947] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01 GM072562 (http://www.nih.gov) and National Science Foundation Grant IOS-1052333 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Andersen DS, 2008, J BIOL CHEM, V283, P31256, DOI 10.1074/jbc.M803512200; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Ashton-Beaucage D, 2011, FLY, V5, P224, DOI 10.4161/fly.5.3.15569; Bauer CR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002873; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Caceres L, 2005, DEVELOPMENT, V132, P2345, DOI 10.1242/dev.01820; CASTRILLON DH, 1993, GENETICS, V135, P489; Cauchi Ruben J, 2012, BMC Res Notes, V5, P120, DOI 10.1186/1756-0500-5-120; Cauchi RJ, 2010, EXP CELL RES, V316, P2354, DOI 10.1016/j.yexcr.2010.05.001; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Clelland AK, 2012, J CELL SCI, V125, P2626, DOI 10.1242/jcs.096867; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Dej KJ, 1999, DEVELOPMENT, V126, P293; Deng WM, 2000, CURR BIOL, V10, P683, DOI 10.1016/S0960-9822(00)00514-5; Deng WM, 2001, DEVELOPMENT, V128, P4737; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Glenn LE, 2001, MECH DEVELOP, V102, P181, DOI 10.1016/S0925-4773(01)00314-8; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Guasconi V, 2005, CANCER BIOL THER, V4, P134; Harnicarova A, 2006, EXP CELL RES, V312, P4019, DOI 10.1016/j.yexcr.2006.09.007; Hartl TA, 2008, SCIENCE, V322, P1384, DOI 10.1126/science.1164216; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Koncz C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00009; Koryakov DE, 2004, METH MOL B, V247, P139; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Lee L, 2009, DEV BIOL, V332, P142, DOI 10.1016/j.ydbio.2009.05.553; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Li CX, 2010, MOL BIOL REP, V37, P2347, DOI 10.1007/s11033-009-9740-y; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; McPheeters DS, 2000, NUCLEIC ACIDS RES, V28, P1313, DOI 10.1093/nar/28.6.1313; Mewborn SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014342; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Mitchell NC, 2010, DEVELOPMENT, V137, P2875, DOI 10.1242/dev.049585; Murata S, 2007, THYROID, V17, P489, DOI 10.1089/thy.2006.0328; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; Nagengast AA, 2001, NUCLEIC ACIDS RES, V29, P3841, DOI 10.1093/nar/29.18.3841; Ogienko A A, 2007, Genetika, V43, P1341; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; ONO W, 1994, MOL CELL BIOL, V14, P7611, DOI 10.1128/MCB.14.11.7611; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Salz HK, 2004, GENETICS, V168, P2059, DOI 10.1534/genetics.104.032532; Salz HK, 1996, GENETICS, V144, P95; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; STEINHAUER WR, 1992, GENE DEV, V6, P233, DOI 10.1101/gad.6.2.233; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4	70	3	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79048	10.1371/journal.pone.0079048	http://dx.doi.org/10.1371/journal.pone.0079048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244416	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900032
J	Park, MH; Park, JY; Lee, HJ; Kim, DH; Park, D; Jeong, HO; Park, CH; Chun, P; Moon, HR; Chung, HY				Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chun, Pusoon; Moon, Hyung Ryong; Chung, Hae Young			Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR alpha/gamma Dual Agonist in db/db Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROLIFERATOR-ACTIVATED RECEPTORS; OBESE ZUCKER RATS; INSULIN-RESISTANCE; METABOLIC ABNORMALITIES; DIABETES-MELLITUS; FATTY LIVER; GAMMA; ALPHA; LEPTIN	Peroxisome proliferator-activated receptor (PPAR) alpha/gamma dual agonists have been developed to alleviate metabolic disorders and have the potential to be used as therapeutic agents for the treatment of type 2 diabetes. In this study, we investigated the effects of a newly synthesized PPAR alpha/gamma dual agonist, 2-[4-(5-chlorobenzo [d] thiazol-2-yl) phenoxy]-2-methylpropanoic acid (MHY908) on type 2 diabetes in vitro and in vivo. To obtain initial evidence that MHY908 acts as a PPAR alpha/gamma dual agonist, ChIP and reporter gene assays were conducted in AC2F rat liver cells, and to investigate the anti-diabetic effects and molecular mechanisms, eight-week-old, male db/db mice were allowed to eat ad libitum, placed on calorie restriction, or administered MHY908 (1 mg or 3 mg/kg/day) mixed in food for 4 weeks. Age-matched male db/m lean mice served as non-diabetic controls. It was found that MHY908 enhanced the binding and transcriptional activity of PPAR alpha and gamma in AC2F cells, and it reduced serum glucose, triglyceride, and insulin levels, however increased adiponectin levels without body weight gain. In addition, MHY908 significantly improved hepatic steatosis by enhancing CPT-1 levels. Remarkably, MHY908 reduced endoplasmic reticulum (ER) stress and c-Jun N-terminal kinase (JNK) activation in the livers of db/db mice, and subsequently reduced insulin resistance. The study shows MHY908 has beneficial effects on type 2 diabetes by simultaneously activating PPAR alpha/gamma and improving ER stress, and suggests that MHY908 could have a potent anti-diabetic effect as a PPAR alpha/gamma dual agonist, and potential for the treatment of type 2 diabetes.	[Park, Min Hi; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging intervent MRCA, Coll Pharm, Pusan, South Korea; [Park, Min Hi; Kim, Dae Hyun; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Chung, Hae Young] Pusan Natl Univ, Biochem Lab, Pusan, South Korea; [Park, Ji Young; Lee, Hye Jin; Moon, Hyung Ryong] Pusan Natl Univ, Med Chem Lab, Coll Pharm, Pusan, South Korea; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Inje University	Moon, HR (corresponding author), Pusan Natl Univ, Med Chem Lab, Coll Pharm, Pusan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020	Park, Daeui/0000-0002-9452-5849	National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, no. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdella NA, 2005, DIABETIC MED, V22, P278, DOI 10.1111/j.1464-5491.2004.01405.x; Bailey C J, 2001, Curr Diab Rep, V1, P119, DOI 10.1007/s11892-001-0023-9; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chakrabarti R, 2003, BRIT J PHARMACOL, V140, P527, DOI 10.1038/sj.bjp.0705463; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen W, 2009, BRIT J PHARMACOL, V157, P724, DOI 10.1111/j.1476-5381.2009.00231.x; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Fagerberg B, 2005, DIABETOLOGIA, V48, P1716, DOI 10.1007/s00125-005-1846-8; Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972; Harrity T, 2006, DIABETES, V55, P240, DOI 10.2337/diabetes.55.01.06.db05-0648; Hegarty BD, 2004, ENDOCRINOLOGY, V145, P3158, DOI 10.1210/en.2004-0260; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Kolaczynski JW, 1996, J CLIN ENDOCR METAB, V81, P4162, DOI 10.1210/jc.81.11.4162; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Ljung B, 2002, J LIPID RES, V43, P1855, DOI 10.1194/jlr.M200127-JLR200; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muoio DM, 2004, SCIENCE, V306, P425, DOI 10.1126/science.1104680; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Oakes ND, 2005, AM J PHYSIOL-REG I, V289, pR938, DOI 10.1152/ajpregu.00252.2005; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pickavance LC, 2005, BRIT J PHARMACOL, V144, P308, DOI 10.1038/sj.bjp.0706041; Reifel-Miller A, 2005, MOL ENDOCRINOL, V19, P1593, DOI 10.1210/me.2005-0015; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; SILVERMAN JF, 1989, PATHOL ANNU, V24, P275; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe S, 2003, J BONE MINER METAB, V21, P166, DOI 10.1007/s007740300026; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yajima K, 2003, AM J PHYSIOL-ENDOC M, V284, pE966, DOI 10.1152/ajpendo.00149.2002; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	40	23	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78815	10.1371/journal.pone.0078815	http://dx.doi.org/10.1371/journal.pone.0078815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244369	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800019
J	Damion, RA; Radjenovic, A; Ingham, E; Jin, ZM; Ries, ME				Damion, Robin A.; Radjenovic, Aleksandra; Ingham, Eileen; Jin, Zhongmin; Ries, Michael E.			Orthogonal Invariant Sets of the Diffusion Tensor and the Development of a Curvilinear Set Suitable for Low-Anisotropy Tissues	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; MRI; CALCULUS; NOISE	We develop a curvilinear invariant set of the diffusion tensor which may be applied to Diffusion Tensor Imaging measurements on tissues and porous media. This new set is an alternative to the more common invariants such as fractional anisotropy and the diffusion mode. The alternative invariant set possesses a different structure to the other known invariant sets; the second and third members of the curvilinear set measure the degree of orthotropy and oblateness/prolateness, respectively. The proposed advantage of these invariants is that they may work well in situations of low diffusion anisotropy and isotropy, as is often observed in tissues such as cartilage. We also explore the other orthogonal invariant sets in terms of their geometry in relation to eigenvalue space; a cylindrical set, a spherical set (including fractional anisotropy and the mode), and a log-Euclidean set. These three sets have a common structure. The first invariant measures the magnitude of the diffusion, the second and third invariants capture aspects of the anisotropy; the magnitude of the anisotropy and the shape of the diffusion ellipsoid (the manner in which the anisotropy is realised). We also show a simple method to prove the orthogonality of the invariants within a set.	[Damion, Robin A.; Ries, Michael E.] Univ Leeds, Sch Phys & Astron, Leeds, W Yorkshire, England; [Damion, Robin A.; Ingham, Eileen; Jin, Zhongmin] Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds, W Yorkshire, England; [Radjenovic, Aleksandra] Univ Leeds, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Chapel Allerton Hosp, Leeds, W Yorkshire, England; [Jin, Zhongmin] Xi An Jiao Tong Univ, Sch Mech Engn, Xian 710049, Shaanxi, Peoples R China	University of Leeds; University of Leeds; Chapel Allerton Hospital; University of Leeds; Xi'an Jiaotong University	Radjenovic, A (corresponding author), Univ Leeds, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Chapel Allerton Hosp, Leeds, W Yorkshire, England.	aleksandra.radjenovic@glasgow.ac.uk; m.e.ries@leeds.ac.uk	Radjenovic, Aleksandra/F-2341-2014; Ries, Michael Edward/L-1346-2019; Damion, Robin A./W-1526-2019	Radjenovic, Aleksandra/0000-0002-1742-6863; Damion, Robin A./0000-0003-2630-9914; Ingham, Eileen/0000-0002-9757-3045; Ries, Michael/0000-0002-8050-3200	EPSRC [WT 088908/Z/09/Z]; WELMEC, a Centre of Excellence in Medical Engineering; Wellcome Trust; NIHR (National Institute for Health Research); LMBRU (Leeds Musculoskeletal Biomedical Research Unit); EPSRC [EP/I019103/1, EP/J017620/1, EP/G032483/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G032483/1, EP/I019103/1, EP/J017620/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); WELMEC, a Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR (National Institute for Health Research)(National Institute for Health Research (NIHR)); LMBRU (Leeds Musculoskeletal Biomedical Research Unit); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by EPSRC. It was partially funded through WELMEC, a Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC, under grant number WT 088908/Z/09/Z and additionally supported by the NIHR (National Institute for Health Research) as part of a collaboration with the LMBRU (Leeds Musculoskeletal Biomedical Research Unit). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Bahn MM, 1999, J MAGN RESON, V141, P68, DOI 10.1006/jmre.1999.1875; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Batchelor PG, 2005, MAGN RESON MED, V53, P221, DOI 10.1002/mrm.20334; Benson AP, 2011, INTERFACE FOCUS, V1, P101, DOI 10.1098/rsfs.2010.0005; Criscione JC, 2000, J MECH PHYS SOLIDS, V48, P2445, DOI 10.1016/S0022-5096(00)00023-5; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P83, DOI 10.1016/j.joca.2007.05.013; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Filidoro L, 2005, MAGN RESON MED, V53, P993, DOI 10.1002/mrm.20469; Fletcher PT, 2007, SIGNAL PROCESS, V87, P250, DOI 10.1016/j.sigpro.2005.12.018; Hasan KM, 2004, MAGN RESON MED, V51, P413, DOI 10.1002/mrm.10682; Jeffrey A, 1986, MATH ENG SCI, P444; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Meder R, 2006, OSTEOARTHR CARTILAGE, V14, P875, DOI 10.1016/j.joca.2006.03.002; Pasternak O, 2010, NEUROIMAGE, V49, P2190, DOI 10.1016/j.neuroimage.2009.10.071; Peled S, 1998, BRAIN RES, V780, P27, DOI 10.1016/S0006-8993(97)00635-5; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Sinha U, 2011, J APPL PHYSIOL, V110, P807, DOI 10.1152/japplphysiol.00923.2010; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1	21	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78798	10.1371/journal.pone.0078798	http://dx.doi.org/10.1371/journal.pone.0078798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244366	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327221600064
J	de Rotrou, J; Wu, YH; Mabire, JB; Moulin, F; de Jong, LW; Rigaud, AS; Hanon, O; Vidal, JS				de Rotrou, Jocelyne; Wu, Ya-Huei; Mabire, Jean-Bernard; Moulin, Florence; de Jong, Laura W.; Rigaud, Anne-Sophie; Hanon, Olivier; Vidal, Jean-Sebastien			Does Cognitive Function Increase over Time in the Healthy Elderly?	PLOS ONE			English	Article							GAINS; IQ	Background: In dementia screening, most studies have focused on early cognitive impairment by comparing patients suffering from mild dementia or mild cognitive impairment with normal subjects. Few studies have focused on modifications over time of the cognitive function in the healthy elderly. The objective of the present study was to analyze the cognitive function changes of two different samples, born > 15 years apart. Method: A first sample of 204 cognitively normal participants was recruited in the memory clinic of Broca hospital between 1991 and 1997. A second sample of 177 cognitively normal participants was recruited in 2008-2009 in the same institution. Both samples were from the same districts of Paris and were assessed with the same neuropsychological test battery. Mean cognitive test scores were compared between 1991 and 2008 samples, between < 80 years old and >= 80 years old in 1991 and 2008 samples, and finally between subjects < 80 year old of 1991 sample and subjects >= 80 years old of the 2008 sample. Means were compared with T-tests stratified on gender, age-groups and educational level. Results: Cognitive scores were significantly higher in the 2008 sample. Participants < 80 years old outperformed those >= 80 in both samples. However, participants < 80 years old in 1991 sample and subjects >= 80 in the 2008 sample, born on average in 1923, performed mostly identically. Conclusion: This study showed a significant increase of cognitive scores over time. Further, contemporary octogenarians in the later sample performed like septuagenarians in the former sample. These findings might be consistent with the increase in life expectancy and life span in good health. The study highlights the necessity to take into account factors which may contaminate and artificially inflate the age-related differences in favor of younger to the older adults.	[de Rotrou, Jocelyne; Wu, Ya-Huei; Mabire, Jean-Bernard; Moulin, Florence; Rigaud, Anne-Sophie; Hanon, Olivier; Vidal, Jean-Sebastien] Hop Broca, Assistance Publ Hop Paris, Serv Gerontol, Paris, France; [de Rotrou, Jocelyne; Wu, Ya-Huei; Moulin, Florence; Rigaud, Anne-Sophie; Hanon, Olivier; Vidal, Jean-Sebastien] Univ Paris 05, Sorbonne Paris Cite, Equipe Accueil 4468, Paris, France; [Mabire, Jean-Bernard] Univ Paris Ouest, Equipe Accueil 4430, Nanterre, France; [de Jong, Laura W.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Rotrou, J (corresponding author), Hop Broca, Assistance Publ Hop Paris, Serv Gerontol, Paris, France.	jocelyne.derotrou@brc.aphp.fr; jean-sebastien.vidal@brc.aphp.fr	Mabire, Jean-Bernard/AAF-2380-2020; Vidal, Jean-Sebastien/D-1941-2016; Hanon, Olivier/GWR-0220-2022	Mabire, Jean-Bernard/0000-0002-6885-354X; Vidal, Jean-Sebastien/0000-0001-6770-0720; Wu, Ya-Huei/0000-0001-9142-456X; Hanon, Olivier/0000-0002-4697-122X				American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; American Psychiatric Association, 1987, DSM 3 R DIAGN STAT M; Armitage PG, 2000, STAT METHODS MED RES, V3rd; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Baxendale S, 2010, J CLIN EXP NEUROPSYC, V32, P699, DOI 10.1080/13803390903493515; Christensen K, 2013, LANCET; De Rotrou J, 1998, DEMENCE LONGEVITE, P155; DEROTROU J, 1991, INT J GERIATR PSYCH, V6, P501, DOI 10.1002/gps.930060706; Dickinson MD, 2011, APPL NEUROPSYCHOL, V18, P136, DOI 10.1080/09084282.2010.547785; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heaton RK, 1991, COMPREHENSIVE NORMS; Hiscock M, 2007, J CLIN EXP NEUROPSYC, V29, P514, DOI 10.1080/13803390600813841; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Laslett P., 1991, FRESH MAP LIFE EMERG; MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398; Matthews FE, LANCET IN PRESS; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mills TM, 2012, MED J AUSTRALIA, V196, P311, DOI 10.5694/mja11.10627; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rey A, 1966, TROUBLES MEMOIRE LEU; Schaie K Warner, 2005, Res Hum Dev, V2, P43, DOI 10.1207/s15427617rhd0201&2_3; SIEGLER IC, 1979, J GERONTOL, V34, P242, DOI 10.1093/geronj/34.2.242; SULLIVAN EV, 1984, J GERONTOL, V39, P718, DOI 10.1093/geronj/39.6.718; Wechsler D., 1997, WECHSLER ADULT INTEL	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78646	10.1371/journal.pone.0078646	http://dx.doi.org/10.1371/journal.pone.0078646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244332	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600041
J	Holven, KB; Retterstol, K; Ueland, T; Ulven, SM; Nenseter, MS; Sandvik, M; Narverud, I; Berge, KE; Ose, L; Aukrust, P; Halvorsen, B				Holven, Kirsten B.; Retterstol, Kjetil; Ueland, Thor; Ulven, Stine M.; Nenseter, Marit S.; Sandvik, Marit; Narverud, Ingunn; Berge, Knut E.; Ose, Leiv; Aukrust, Pal; Halvorsen, Bente			Subjects with Low Plasma HDL Cholesterol Levels Are Characterized by an Inflammatory and Oxidative Phenotype	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; EFFLUX CAPACITY; FATTY-ACIDS; FOLLOW-UP; ATHEROSCLEROSIS; RISK; SUBFRACTIONS; INDIVIDUALS	Background: Epidemiological studies have shown that low plasma levels of high-density lipoprotein (HDL) cholesterol are associated with increased risk of cardiovascular disease, but the mechanisms for the possible atheroprotective effects of HDL cholesterol have still not been fully clarified, in particular in relation to clinical studies. Objective: To examine the inflammatory, anti-oxidative and metabolic phenotype of subjects with low plasma HDL cholesterol levels. Methods and Results: Fifteen subjects with low HDL cholesterol levels (eleven males and four females) and 19 subjects with high HDL (three males and 16 females) were recruited. Low HDL cholesterol was defined as <= 10th age/sex specific percentile and high HDL-C was defined as >= 90 age/sex specific percentile. Inflammatory markers in circulation and PBMC gene expression of cholesterol efflux mediators were measured. Our main findings were: (i) subjects with low plasma HDL cholesterol levels were characterized by increased plasma levels of CRP, MMP-9, neopterin, CXCL16 and ICAM-1 as well as low plasma levels of adiponectin, suggesting an inflammatory phenotype; (ii) these individuals also had reduced paraoxonase (PON)1 activity in plasma and PON2 gene expression in peripheral blood mononuclear cells (PBMC) accompanied by increased plasma levels of oxidized LDL suggesting decreased anti-oxidative capacity; and (iii) PBMC from low HDL subjects also had decreased mRNA levels of ABCA1 and ABCG1, suggesting impaired reverse cholesterol transport. Conclusion: Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype that could contribute to the increased risk of atherosclerotic disorders in these subjects with low HDL levels.	[Holven, Kirsten B.; Retterstol, Kjetil; Sandvik, Marit; Narverud, Ingunn; Ose, Leiv] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Retterstol, Kjetil; Nenseter, Marit S.; Ose, Leiv] Oslo Univ Hosp, Rikshosp, Lipid Clin, Oslo, Norway; [Ueland, Thor; Nenseter, Marit S.; Aukrust, Pal; Halvorsen, Bente] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ulven, Stine M.] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Holven, Kirsten B.; Retterstol, Kjetil; Ueland, Thor; Narverud, Ingunn; Ose, Leiv; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Berge, Knut E.] Oslo Univ Hosp, Rikshosp, Dept Genet, Med Genet Lab, Oslo, Norway; [Aukrust, Pal] Sect Clin Immunol & Infect Dis Oslo, Oslo, Norway; [Retterstol, Kjetil; Ueland, Thor; Nenseter, Marit S.; Berge, Knut E.; Ose, Leiv; Aukrust, Pal; Halvorsen, Bente] OsloUniv Hosp, Rikshosp, Oslo, Norway; [Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Holven, KB (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.	kirsten.holven@medisin.uio.no	Ulven, Stine Marie/ABD-7140-2020		Norwegian Association of Heart and Lung Patients; Throne Holst Foundation for Nutrition Research; Freia Chocolade Fabriks Medical Foundation; Johan H. Andresen Medical Foundation; University of Oslo; Nordic Center of Excellence (NCoE) "SYSDIET" by Nordforsk [070014]	Norwegian Association of Heart and Lung Patients; Throne Holst Foundation for Nutrition Research; Freia Chocolade Fabriks Medical Foundation; Johan H. Andresen Medical Foundation; University of Oslo; Nordic Center of Excellence (NCoE) "SYSDIET" by Nordforsk	This work was supported by grants from the Norwegian Association of Heart and Lung Patients, The Throne Holst Foundation for Nutrition Research, the Freia Chocolade Fabriks Medical Foundation, Johan H. Andresen Medical Foundation, University of Oslo, and the Nordic Center of Excellence (NCoE) "SYSDIET" by Nordforsk (070014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Bandeali S, 2012, CURR ATHEROSCLER REP, V14, P101, DOI 10.1007/s11883-012-0235-2; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Birjmohun RS, 2007, ARTERIOSCL THROM VAS, V27, P1153, DOI 10.1161/ATVBAHA.106.136325; Charles MA, 2001, AM J EPIDEMIOL, V153, P292, DOI 10.1093/aje/153.3.292; Eklund CM, 2009, ADV CLIN CHEM, V48, P111, DOI 10.1016/S0065-2423(09)48005-3; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; HUBSCH AP, 1993, CIRC SHOCK, V40, P14; JACOBS DR, 1990, AM J EPIDEMIOL, V131, P32, DOI 10.1093/oxfordjournals.aje.a115483; Jansson AM, 2012, ARTERIOSCL THROM VAS, V32, P3041, DOI 10.1161/ATVBAHA.112.300326; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Laurila PP, 2013, ARTERIOSCL THROM VAS, V33, P847, DOI 10.1161/ATVBAHA.112.300733; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; Mackness MI, 2002, ATHEROSCLEROSIS SUPP, V3, P49, DOI 10.1016/S1567-5688(02)00046-6; Matsuura F, 2007, BIOCHEM BIOPH RES CO, V358, P1091, DOI 10.1016/j.bbrc.2007.05.040; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Oku H, 2007, FEBS LETT, V581, P5029, DOI 10.1016/j.febslet.2007.09.038; Oram JF, 2001, J LIPID RES, V42, P1173; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SWEETNAM PM, 1994, CIRCULATION, V90, P769, DOI 10.1161/01.CIR.90.2.769; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Villard EF, 2013, ARTERIOSCL THROM VAS, V33, P822, DOI 10.1161/ATVBAHA.112.300979; WACHTER H, 1989, ADV CLIN CHEM, V27, P81, DOI 10.1016/S0065-2423(08)60182-1; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Williams DL, 1999, CURR OPIN LIPIDOL, V10, P329, DOI 10.1097/00041433-199908000-00007; Yu SC, 2003, ATHEROSCLEROSIS, V166, P331, DOI 10.1016/S0021-9150(02)00361-1	36	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78241	10.1371/journal.pone.0078241	http://dx.doi.org/10.1371/journal.pone.0078241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244297	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600020
J	Kaspar, K				Kaspar, Kai			A Weighty Matter: Heaviness Influences the Evaluation of Disease Severity, Drug Effectiveness, and Side Effects	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; EMBODIMENT; MEDICATION; METAPHORS; ERP	Peoples' perception of diseases and pharmaceutical drugs is a critical issue in health research. Beliefs about disease severity influence the compliance with recommendations for convalescence and the motivation to perform proper health-behavior. The estimated effectiveness of drugs and severity of side effects influence medication adherence and contribute to placebo effects. The present paper closes the gap between these effects and the concept of embodied cognition from a metaphor-enriched perspective. In five studies, we demonstrate that the bodily sensation of weight influences our evaluations of diseases and drugs. The experience of heaviness enhanced the estimated seriousness of diseases and the estimated effectiveness of drugs. The perceived seriousness of drug side effects was also affected by weight but only when drug effectiveness was not attended to. Moreover, the incidental sensation of weight shows a novel effect when evaluating weight-related drugs. The results are in line with the idea of embodied metaphors and reveal important boundary conditions which contribute to a better understanding of the underlying mechanisms.	[Kaspar, Kai] Univ Osnabruck, Inst Psychol, Osnabruck, Germany; [Kaspar, Kai] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	University Osnabruck; University Osnabruck	Kaspar, K (corresponding author), Univ Osnabruck, Inst Psychol, Osnabruck, Germany.	kkaspar@uos.de	Kaspar, Brian/E-3349-2011					Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; [Anonymous], 2003, ADHERENCE LONG TERM; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Blasko DG, 2006, METAPHOR SYMBOL, V21, P267, DOI 10.1207/s15327868ms2104_4; Blasko DG, 1999, J PRAGMATICS, V31, P1675, DOI 10.1016/S0378-2166(99)00009-0; Brinol P, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P184; Buckley S. R., 1990, Information Society, V7, P109, DOI 10.1080/01972243.1990.9960089; Bultman DC, 2000, PATIENT EDUC COUNS, V40, P173, DOI 10.1016/S0738-3991(99)00083-X; Chandler JJ, 2012, J EXP SOC PSYCHOL, V48, P948, DOI 10.1016/j.jesp.2012.03.003; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Felson RB, 1996, CRIMINOLOGY, V34, P433, DOI 10.1111/j.1745-9125.1996.tb01214.x; Fortin AH, 2002, ETHNICITY DIS, V12; Gnambs T, 2010, COMPUT HUM BEHAV, V26, P1625, DOI 10.1016/j.chb.2010.06.010; IJzerman H, 2011, PSYCHOL BULL, V137, P355, DOI 10.1037/a0022373; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; KAPLAN RM, 1993, J ROY SOC MED, V86, P277; Kaspar K, 2013, J NONVERBAL BEHAV; Kaspar K, 2013, SOC PSYCHOL PERS SCI, V4, P69, DOI 10.1177/1948550612443267; KATZ AN, 1989, J MEM LANG, V28, P486, DOI 10.1016/0749-596X(89)90023-5; Kawai S, 2007, EXP BRAIN RES, V179, P443, DOI 10.1007/s00221-006-0803-1; Kazmerski VA, 2003, MEM COGNITION, V31, P673, DOI 10.3758/BF03196107; Lakoff George, 2003, METAPHOR WE LIVE BY; Lan C. M., 2003, TZU CHI MED J, V15, P369; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lee SWS, 2012, J PERS SOC PSYCHOL, V103, P737, DOI 10.1037/a0029708; Lee SWS, 2010, SCIENCE, V328, P709, DOI 10.1126/science.1186799; Lee YS, 2005, J WOMEN AGING, V17, P55, DOI 10.1300/J074v17n01_05; Mazor KM, 2010, DRUG AGING, V27, P999, DOI 10.2165/11584790-000000000-00000; Meier BP, 2012, TOP COGN SCI, V4, P705, DOI 10.1111/j.1756-8765.2012.01212.x; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Pschyrembel W.H., 2001, KLIN WORTERBUCH; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Rose JL, 2013, 55 C EXP PSYCH, P413; Schneider IK, 2011, SOC PSYCHOL PERS SCI, V2, P474, DOI 10.1177/1948550610397895; THOMAS JR, 1988, QUEST, V40, P219, DOI 10.1080/00336297.1988.10483902; Walker P, 2010, EXP PSYCHOL, V57, P462, DOI 10.1027/1618-3169/a000057; WEKSEL W, 1967, MULTIVAR BEHAV RES, V2, P537, DOI 10.1207/s15327906mbr0204_9; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665	41	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78307	10.1371/journal.pone.0078307	http://dx.doi.org/10.1371/journal.pone.0078307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244302	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600025
J	Mao, YB; Xu, JF; Li, ZH; Zhang, NN; Yin, H; Liu, ZG				Mao, Yubin; Xu, Jinfei; Li, Zhihan; Zhang, Nini; Yin, Hao; Liu, Zuguo			The Role of Nuclear beta-Catenin Accumulation in the Twist2-Induced Ovarian Cancer EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGULATES E-CADHERIN; UP-REGULATION; TWIST2; SNAIL; PROGRESSION; INVASION; SIP1; CONTRIBUTES; METASTASIS	Background: Twist2 has been shown to promote human tumor invasion as in breast cancer and cervical cancer. However, whether Twist2 promotes human ovarian cancer progression remains to be elucidated. Here, we investigate the role of Twist2 in ovarian cancer invasion and metastasis as well as the underlying molecular mechanisms. Methods: Twist2 expression was detected by Immunohistochemistry (IHC) on tissue microarray of human ovarian cancers with scoring procedure according to the staining intensity and pattern. Twist2 gene was stably introduced into SKOV-3 ovarian cancer cells to examine the changes of cellular morphology, motility, invasiveness, and EMT molecular markers. Results: Twist2 expression is significantly increased in ovarian cancers along with the FIGO disease stage, indicating that Twist2 may be associated with ovarian cancer metastasis. Overexpression of Twist2 induced the EMT phenotype including downregulation of E-cadherin, and upregulation of N-cadherin and beta-catenin in human ovarian cancer cells, suggesting that Twist2 might promote beta-catenin release from the E-cadherin/beta-catenin complex through inhibition of E-cadherin. Thus, beta-catenin degradation was inhibited due to inhibition of APC, and the Wnt/beta-catenin pathway was then activated by nuclear beta-catenin accumulation, which may activate transcription of downstream target genes to promote tumor invasion and metastasis. Collectively, these data indicated that beta-catenin is involved in Twist2-induced EMT in ovarian cancer. Conclusion: Our data indicates that upregulation of Twist2 is correlated with the FIGO stage in human ovarian cancers. In this report, we demonstrated that nuclear beta-catenin is accumulated in Twist2-induced EMT cells to facilitates ovarian cancer invasion and metastasis.	[Mao, Yubin; Xu, Jinfei; Li, Zhihan; Zhang, Nini; Yin, Hao] Xiamen Univ, Coll Med, Dept Pathophysiol Basic Sci, Xiamen, Fujian, Peoples R China; [Liu, Zuguo] Xiamen Univ, Coll Med, Inst Eye, Xiamen, Fujian, Peoples R China; [Liu, Zuguo] Xiamen Univ, Coll Med, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Mao, YB (corresponding author), Xiamen Univ, Coll Med, Dept Pathophysiol Basic Sci, Xiamen, Fujian, Peoples R China.	maoyubin@xmu.edu.cn; zuguoliu@xmu.edu.cn			National Natural Science Foundation of China [30872515]; Fundamental Research Funds for the Central Universities of China [2011121062]; Natural Science Foundation of Fujian Province of China [2012J01417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn, No. 30872515, YB Mao) and the Fundamental Research Funds for the Central Universities of China (No. 2011121062, YB Mao), and the Natural Science Foundation of Fujian Province of China (No. 2012J01417, YB Mao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Beiter K, 2005, ONCOGENE, V24, P8200, DOI 10.1038/sj.onc.1208960; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Gasparotto D, 2011, ONCOTARGET, V2, P1165; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hsu YM, 2007, CANCER RES, V67, P11064, DOI 10.1158/0008-5472.CAN-07-2443; Huang W, 2008, AM J PATHOL, V172, P893, DOI 10.2353/ajpath.2008.070899; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Khalil I, 2010, GYNECOL ONCOL, V116, P282, DOI 10.1016/j.ygyno.2009.10.085; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Li Y, 2012, GYNECOL ONCOL, V124, P112, DOI 10.1016/j.ygyno.2011.09.003; Liang XH, 2011, ORAL ONCOL, V47, P92, DOI 10.1016/j.oraloncology.2010.11.014; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao YB, 2006, CELL BIOL INT, V30, P332, DOI 10.1016/j.cellbi.2005.12.008; Mao YB, 2013, ONCOL LETT, V6, P169, DOI 10.3892/ol.2013.1316; Mao YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048178; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Orsulic S, 1999, J CELL SCI, V112, P1237; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shimokawa M, 2012, BIOCH BIOPHYS RES CO; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Tran TH, 2010, DEVELOPMENT, V137, P3973, DOI 10.1242/dev.056473; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Xia WL, 2011, MOL CANCER THER, V10, P1367, DOI 10.1158/1535-7163.MCT-10-0991; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zhou CC, 2012, J ORAL PATHOL MED, V41, P424, DOI 10.1111/j.1600-0714.2011.01114.x; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199	36	50	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78200	10.1371/journal.pone.0078200	http://dx.doi.org/10.1371/journal.pone.0078200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244294	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600018
J	Nijboer, M; Taatgen, NA; Brands, A; Borst, JP; van Rijn, H				Nijboer, Menno; Taatgen, Niels A.; Brands, Annelies; Borst, Jelmer P.; van Rijn, Hedderik			Decision Making in Concurrent Multitasking: Do People Adapt to Task Interference?	PLOS ONE			English	Article							DUAL-TASK; PERFORMANCE; BOTTLENECK	While multitasking has received a great deal of attention from researchers, we still know little about how well people adapt their behavior to multitasking demands. In three experiments, participants were presented with a multicolumn subtraction task, which required working memory in half of the trials. This primary task had to be combined with a secondary task requiring either working memory or visual attention, resulting in different types of interference. Before each trial, participants were asked to choose which secondary task they wanted to perform concurrently with the primary task. We predicted that if people seek to maximize performance or minimize effort required to perform the dual task, they choose task combinations that minimize interference. While performance data showed that the predicted optimal task combinations indeed resulted in minimal interference between tasks, the preferential choice data showed that a third of participants did not show any adaptation, and for the remainder it took a considerable number of trials before the optimal task combinations were chosen consistently. On the basis of these results we argue that, while in principle people are able to adapt their behavior according to multitasking demands, selection of the most efficient combination of strategies is not an automatic process.	[Nijboer, Menno; Taatgen, Niels A.; Brands, Annelies] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Borst, Jelmer P.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [van Rijn, Hedderik] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands	University of Groningen; Carnegie Mellon University; University of Groningen	Nijboer, M (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	m.nijboer@rug.nl	Borst, Jelmer/C-4666-2008; van Rijn, Hedderik/L-3685-2014; Taatgen, Niels/A-3216-2008	Borst, Jelmer/0000-0002-4493-8223; van Rijn, Hedderik/0000-0002-0461-9850; Taatgen, Niels/0000-0001-7286-3460	European Research Council [283597]	European Research Council(European Research Council (ERC)European Commission)	This research was funded by European Research Council Starting Grant 283597 awarded to Niels Taatgen (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Borst J, ACTA PSYCHOL; Borst JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012966; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Bratzke D, 2009, J EXP PSYCHOL HUMAN, V35, P1413, DOI 10.1037/a0015874; Brumby D.P., 2011, P SIGCHI C HUM FACT, P473; Green AL, 2011, EXP BRAIN RES, V215, P307, DOI 10.1007/s00221-011-2898-2; Green DM, 1966, SIGNAL DETECTION THE; Horrey WJ, 2006, HUM FACTORS, V48, P196, DOI 10.1518/001872006776412135; Janssen CP, 2012, J COGN ENG DECIS MAK, V6, P5, DOI 10.1177/1555343411432339; Junco R, 2012, COMPUT EDUC, V59, P505, DOI 10.1016/j.compedu.2011.12.023; Kushleyeva Y, 2005, COGN SYST RES, V6, P41, DOI 10.1016/j.cogsys.2004.09.005; Lesch MF, 2004, ACCIDENT ANAL PREV, V36, P471, DOI 10.1016/S0001-4575(03)00042-3; Mark G., 2005, P SIGCHI C HUMAN FAC, P321, DOI [10.1145/1054972.1055017, DOI 10.1145/1054972.1055017]; Marti S, 2012, NEUROIMAGE, V59, P2883, DOI 10.1016/j.neuroimage.2011.09.063; Martin-Emerson R., 1992, HUM FACT SOC ANN M 3, P1409; Meyer D. E., 1997, PSYCHOL REV, P1109; Navon D, 1979, PSYCHOL REV, V86, P254, DOI DOI 10.1037/0033-295X.86.3.214; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Rescorla R., 1972, CLASSICAL CONDITION, P64; Salvucci D, 2002, COGNITIVE SYSTEMS RE, V3, P1; Salvucci D.D., 2011, MULTITASKING MIND, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Salvucci DD, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P85; Salvucci DD, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1819; Sanbonmatsu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054402; Sigman M, 2008, J NEUROSCI, V28, P7585, DOI 10.1523/JNEUROSCI.0948-08.2008; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Van Rossum MCW, 1997, QUAERENDO, V27, P141; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]	33	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79583	10.1371/journal.pone.0079583	http://dx.doi.org/10.1371/journal.pone.0079583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244527	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600137
J	Ong, SJ; Huang, YC; Tan, HY; Ma, DHK; Lin, HC; Yeh, LK; Chen, PYF; Chen, HC; Chuang, CC; Chang, CJ; Hsiao, CH				Ong, Sherine Jue; Huang, Yhu-Chering; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Chuang, Chih-Chun; Chang, Chee-Jen; Hsiao, Ching-Hsi			Staphylococcus aureus Keratitis: A Review of Hospital Cases	PLOS ONE			English	Review							METHICILLIN-RESISTANT; BACTERIAL KERATITIS; MOLECULAR EPIDEMIOLOGY; MICROBIAL KERATITIS; OCULAR INFECTIONS; SHIFTING TRENDS; RISK-FACTORS; TAIWAN; LEVOFLOXACIN; BACTEREMIA	Background: Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important public health issue. The study aimed to characterize the patient demographics, clinical features, antibiotic susceptibility, and clinical outcomes of keratitis caused by S. aureus, and to make a comparison between MRSA and methicillin-sensitive S. aureus (MSSA) isolates. Methodology/Principal findings: Patients (n = 59) with culture-proven S. aureus keratitis treated in Chang Gung Memorial Hospital between January 1, 2006, and December 31, 2010, were included in our study. Patients' demographic and clinical data were retrospectively reviewed. Twenty-six MRSA (44%) and 33 MSSA (56%) isolates were collected. The MRSA keratitis was significantly more common among the patients with healthcare exposure (P = 0.038), but 46.2% (12/26) of patients with MRSA keratitis were considered to have community-associated infections. All isolates were susceptible to vancomycin. MRSA isolates were significantly more resistant to clindamycin, erythromycin, and sulfamethoxazole/trimethoprim. Ocular surface disease was a significant risk factor for MRSA keratitis (P = 0.011). Visual outcome did not differ significantly between the MRSA and MSSA groups. However, age (B = 0.01, P = 0.035, 95% confidence interval [CI]: 0.001-0.019) and visual acuity at presentation (B = 0.749, P<0.001, 95% CI: 0.573-0.926) were significantly correlated with visual outcome. Conclusions/Significance: Ocular surface disease is an important predisposing factor for S. aureus keratitis, especially for MRSA infections. Advanced age and poor visual acuity at presentation are important prognostic indicators for poor visual outcome in S. aureus keratitis. Oxacillin resistance may not be a significant prognostic indicator.	[Ong, Sherine Jue; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Hsiao, Ching-Hsi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Dept Pediat, Linkou, Taiwan; [Huang, Yhu-Chering; Tan, Hsin-Yuan; Ma, David H. K.; Lin, Hsin-Chiung; Yeh, Lung-Kun; Chen, Phil Y. F.; Chen, Hung-Chi; Hsiao, Ching-Hsi] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chuang, Chih-Chun] Yuan Sheng Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chuang, Chih-Chun] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; Chang Gung University; Chang Gung University	Hsiao, CH (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	hsiao.chinghsi@gmail.com			Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG381511]	Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported in part by Chang Gung Memorial Hospital, Linkou, Taiwan, grant number CMRPG381511. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1497, DOI 10.1016/S0161-6420(00)00179-2; Asbell PA, 2008, AM J OPHTHALMOL, V145, P951, DOI 10.1016/j.ajo.2008.01.025; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Blomquist Preston Howard, 2006, Trans Am Ophthalmol Soc, V104, P322; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Chuang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042437; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; De Kaspar HM, 2008, AM J OPHTHALMOL, V145, P136, DOI 10.1016/j.ajo.2007.08.031; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Fukuda M, 2002, CORNEA, V21, pS86, DOI 10.1097/01.ico.0000263125.99262.42; Goldstein MH, 1999, OPHTHALMOLOGY, V106, P1313, DOI 10.1016/S0161-6420(99)00716-2; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hori Y, 2008, J CATARACT REFR SURG, V34, P711, DOI 10.1016/j.jcrs.2007.12.028; Hori Y, 2009, JPN J OPHTHALMOL, V53, P61, DOI 10.1007/s10384-008-0616-9; Hsiao CH, 2012, OPHTHALMOLOGY, V119, P522, DOI 10.1016/j.ophtha.2011.08.038; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Kato T, 1998, JPN J OPHTHALMOL, V42, P461; Lichtinger A, 2012, OPHTHALMOLOGY, V119, P1785, DOI 10.1016/j.ophtha.2012.03.031; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; Marangon FB, 2004, AM J OPHTHALMOL, V137, P453, DOI 10.1016/j.ajo.2003.10.026; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Miedziak AI, 1999, OPHTHALMOLOGY, V106, P1166, DOI 10.1016/S0161-6420(99)90250-6; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nomi N, 2008, JPN J OPHTHALMOL, V52, P440, DOI 10.1007/s10384-008-0537-7; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otri AM, 2012, ACTA OPHTHA IN PRESS; Rubinfeld RS, 2001, J CATARACT REFR SURG, V27, P1523, DOI 10.1016/S0886-3350(00)00783-5; Rudd JC, 2001, J CATARACT REFR SURG, V27, P471, DOI 10.1016/S0886-3350(00)00882-8; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SCOTT IU, 1994, ARCH OPHTHALMOL-CHIC, V112, P329, DOI 10.1001/archopht.1994.01090150059023; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Solomon R, 2007, AM J OPHTHALMOL, V143, P629, DOI 10.1016/j.ajo.2006.12.029; Sotozono C, 2002, CORNEA, V21, pS94, DOI 10.1097/01.ico.0000263127.84015.3f; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995	38	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80119	10.1371/journal.pone.0080119	http://dx.doi.org/10.1371/journal.pone.0080119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244625	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600182
J	Toth, TI; Schmidt, J; Buschges, A; Daun-Gruhn, S				Toth, Tibor Istvan; Schmidt, Joachim; Bueschges, Ansgar; Daun-Gruhn, Silvia			A Neuro-Mechanical Model of a Single Leg Joint Highlighting the Basic Physiological Role of Fast and Slow Muscle Fibres of an Insect Muscle System	PLOS ONE			English	Article							COXAL DEPRESSOR MUSCLES; EXTENSOR TIBIAE MUSCLE; STICK INSECT; FILTER CHARACTERISTICS; NEUROMECHANICAL MODEL; SEARCHING MOVEMENTS; CARAUSIUS-MOROSUS; MOTONEURONS; WALKING; INNERVATION	In legged animals, the muscle system has a dual function: to produce forces and torques necessary to move the limbs in a systematic way, and to maintain the body in a static position. These two functions are performed by the contribution of specialized motor units, i.e. motoneurons driving sets of specialized muscle fibres. With reference to their overall contraction and metabolic properties they are called fast and slow muscle fibres and can be found ubiquitously in skeletal muscles. Both fibre types are active during stepping, but only the slow ones maintain the posture of the body. From these findings, the general hypothesis on a functional segregation between both fibre types and their neuronal control has arisen. Earlier muscle models did not fully take this aspect into account. They either focused on certain aspects of muscular function or were developed to describe specific behaviours only. By contrast, our neuro-mechanical model is more general as it allows functionally to differentiate between static and dynamic aspects of movement control. It does so by including both muscle fibre types and separate motoneuron drives. Our model helps to gain a deeper insight into how the nervous system might combine neuronal control of locomotion and posture. It predicts that (1) positioning the leg at a specific retraction angle in steady state is most likely due to the extent of recruitment of slow muscle fibres and not to the force developed in the individual fibres of the antagonistic muscles; (2) the fast muscle fibres of antagonistic muscles contract alternately during stepping, while co-contraction of the slow muscle fibres takes place during steady state; (3) there are several possible ways of transition between movement and steady state of the leg achieved by varying the time course of recruitment of the fibres in the participating muscles.	[Toth, Tibor Istvan; Daun-Gruhn, Silvia] Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany; [Schmidt, Joachim; Bueschges, Ansgar] Univ Cologne, Dept Anim Physiol, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Daun-Gruhn, S (corresponding author), Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany.	sgruhn@uni-koeln.de		Daun, Silvia/0000-0001-7342-1015	Emmy Noether Programme [DA 1182/1-1]	Emmy Noether Programme(German Research Foundation (DFG))	Funding provided by Emmy Noether Programme DA 1182/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	BALLANTYNE D, 1981, J COMP PHYSIOL, V143, P111, DOI 10.1007/BF00606074; Bassler D, 1996, J EXP BIOL, V199, P2169; BASSLER U, 1991, BIOL CYBERN, V65, P507, DOI 10.1007/BF00204664; Bassler U, 1996, J EXP BIOL, V199, P2185; Berg E, 2013, J EXP BIOL, V216, P1064, DOI 10.1242/jeb.076406; Blumel M, 2012, BIOL CYBERN, V106, P559, DOI 10.1007/s00422-012-0530-6; Blumel M, 2012, BIOL CYBERN, V106, P543, DOI 10.1007/s00422-012-0531-5; Blumel M, 2012, BIOL CYBERN, V106, P573, DOI 10.1007/s00422-011-0460-8; DUCH C, 1995, J EXP BIOL, V198, P1963; Gabriel JP, 2003, J NEUROBIOL, V56, P237, DOI 10.1002/neu.10237; Godlewska E, 2012, THESIS U COLOGNE GER; Goldammer J, 2012, J COMP NEUROL, V520, P230, DOI 10.1002/cne.22676; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P599, DOI 10.1152/jn.1965.28.3.599; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOYLE G, 1978, J EXP BIOL, V73, P205; ILES JF, 1971, J EXP BIOL, V55, P151; KARG G, 1991, BIOL CYBERN, V64, P329, DOI 10.1007/BF00199597; Kernell D., 2003, Neural Plasticity, V10, P69, DOI 10.1155/NP.2003.69; Knops S, 2013, J NEUROPHYSIOL, V109, P679, DOI 10.1152/jn.00648.2012; Monti RJ, 2001, MUSCLE NERVE, V24, P848, DOI 10.1002/mus.1083.abs; MULLER AR, 1992, J COMP PHYSIOL B, V162, P5, DOI 10.1007/BF00257930; PEARSON KG, 1971, J EXP BIOL, V54, P215; PFLUGER HJ, 1977, J COMP PHYSIOL, V120, P181, DOI 10.1007/BF00619314; Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594; RATHMAYER W, 1985, J EXP BIOL, V116, P291; RATHMAYER W, 1987, AM ZOOL, V27, P1067; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Toth TI, 2012, J NEUROPHYSIOL, V107, P3267, DOI 10.1152/jn.01124.2011; Wilson E, 2013, BIOMECH MODEL MECHAN, V12, P581, DOI 10.1007/s10237-012-0427-2; Wilson E, 2011, BIOL CYBERN, V104, P121, DOI 10.1007/s00422-011-0423-0; WOLF H, 1990, J EXP BIOL, V152, P281; Zakotnik J, 2006, J NEUROSCI, V26, P4995, DOI 10.1523/JNEUROSCI.0161-06.2006	35	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78247	10.1371/journal.pone.0078247	http://dx.doi.org/10.1371/journal.pone.0078247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244298	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600021
J	Wang, HZ; Zhang, K; Zhu, J; Song, WW; Zhao, L; Zhang, XG				Wang, Huizheng; Zhang, Kai; Zhu, Jie; Song, Weiwei; Zhao, Li; Zhang, Xiuguo			Structure Reveals Regulatory Mechanisms of a MaoC-Like Hydratase from Phytophthora capsici Involved in Biosynthesis of Polyhydroxyalkanoates (PHAs)	PLOS ONE			English	Article							COENZYME-A HYDRATASE; ENOYL-COA HYDRATASE; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; PROTEIN; GENES; CLONING; THIOESTERASE; DEHYDRATASE	Background: Polyhydroxyalkanoates (PHAs) have attracted increasing attention as "green plastic" due to their biodegradable, biocompatible, thermoplastic, and mechanical properties, and considerable research has been undertaken to develop low cost/high efficiency processes for the production of PHAs. MaoC-like hydratase (MaoC), which belongs to (R)-hydratase involved in linking the beta-oxidation and the PHA biosynthetic pathways, has been identified recently. Understanding the regulatory mechanisms of (R)-hydratase catalysis is critical for efficient production of PHAs that promise synthesis an environment-friendly plastic. Methodology/Principal Findings: We have determined the crystal structure of a new MaoC recognized from Phytophthora capsici. The crystal structure of the enzyme was solved at 2.00 angstrom resolution. The structure shows that MaoC has a canonical (R)-hydratase fold with an N-domain and a C-domain. Supporting its dimerization observed in structure, MaoC forms a stable homodimer in solution. Mutations that disrupt the dimeric MaoC result in a complete loss of activity toward crotonyl-CoA, indicating that dimerization is required for the enzymatic activity of MaoC. Importantly, structure comparison reveals that a loop unique to MaoC interacts with an alpha-helix that harbors the catalytic residues of MaoC. Deletion of the loop enhances the enzymatic activity of MaoC, suggesting its inhibitory role in regulating the activity of MaoC. Conclusions/Significance: The data in our study reveal the regulatory mechanism of an (R)-hydratase, providing information on enzyme engineering to produce low cost PHAs.	[Wang, Huizheng; Zhu, Jie; Song, Weiwei; Zhao, Li; Zhang, Xiuguo] Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China; [Zhang, Kai] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, XG (corresponding author), Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China.	zhxg@sdau.edu.cn		Zhu, Jie/0000-0002-5217-6249; Zhang, Kai/0000-0001-8617-2855	Special Fund for Agro-Scientific Research in the Public interest of China [201003004]	Special Fund for Agro-Scientific Research in the Public interest of China	This research was supported by Special Fund for Agro-Scientific Research in the Public interest of China (201003004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYROM D, 1992, FEMS MICROBIOL LETT, V103, P247, DOI 10.1016/0378-1097(92)90316-G; Castell A, 2005, PROTEIN SCI, V14, P1850, DOI 10.1110/ps.051442305; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fiedler S, 2002, ARCH MICROBIOL, V178, P149, DOI 10.1007/s00203-002-0444-0; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Li J, 2000, NAT STRUCT BIOL, V7, P555; Li R, 2007, BIORESOURCE TECHNOL, V98, P2313, DOI 10.1016/j.biortech.2006.09.014; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MOTHES G, 1995, CAN J MICROBIOL, V41, P68, DOI 10.1139/m95-170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209, DOI 10.1007/s002530050010; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Tsuge T, 2000, FEMS MICROBIOL LETT, V184, P193, DOI 10.1111/j.1574-6968.2000.tb09013.x; Tsuge T, 2003, APPL ENVIRON MICROB, V69, P4830, DOI 10.1128/AEM.69.8.4830-4836.2003; Tsuge T, 2003, INT J BIOL MACROMOL, V31, P195, DOI 10.1016/S0141-8130(02)00082-X; Wang HZ, 2010, ACTA CRYSTALLOGR F, V66, P272, DOI 10.1107/S1744309109053391	40	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80024	10.1371/journal.pone.0080024	http://dx.doi.org/10.1371/journal.pone.0080024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244597	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600173
J	Dihal, AA; Boot, A; van Roon, EH; Schrumpf, M; Farina-Sarasqueta, A; Fiocco, M; Zeestraten, ECM; Kuppen, PJK; Morreau, H; van Wezel, T; Boer, JM				Dihal, Ashwin A.; Boot, Arnoud; van Roon, Eddy H.; Schrumpf, Melanie; Farina-Sarasqueta, Arantza; Fiocco, Marta; Zeestraten, Eliane C. M.; Kuppen, Peter J. K.; Morreau, Hans; van Wezel, Tom; Boer, Judith M.			The Homeobox Gene MEIS1 Is Methylated in BRAF(p.V600E) Mutated Colon Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; BRAF MUTATION; CELL-LINES; PROMOTER METHYLATION; DNA METHYLATION; MESSENGER-RNA; EXPRESSION; CARCINOMA; SUBGROUPS	Development of colorectal cancer (CRC) can occur both via gene mutations in tumor suppressor genes and oncogenes, as well as via epigenetic changes, including DNA methylation. Site-specific methylation in CRC regulates expression of tumor-associated genes. Right-sided colon tumors more frequently have BRAF(p.V600E) mutations and have higher methylation grades when compared to left-sided malignancies. The aim of this study was to identify DNA methylation changes associated with BRAF(p.V600E) mutation status. We performed methylation profiling of colon tumor DNA, isolated from frozen sections enriched for epithelial cells by macro-dissection, and from paired healthy tissue. Single gene analyses comparing BRAF(p.V600E) with BRAF wild type revealed MEIS1 as the most significant differentially methylated gene (log(2) fold change: 0.89, false discovery rate-adjusted P-value 2.8*10(-9)). This finding was validated by methylation-specific PCR that was concordant with the microarray data. Additionally, validation in an independent cohort (n=228) showed a significant association between BRAF(p.V600E) and MEIS1 methylation (OR: 13.0, 95% CI: 5.2 - 33.0, P<0.0001). MEIS1 methylation was associated with decreased MEIS1 gene expression in both patient samples and CRC cell lines. The same was true for gene expression of a truncated form of MEIS1, MEIS1(D27), which misses exon 8 and has a proposed tumor suppression function. To trace the origin of MEIS1 promoter methylation, 14 colorectal tumors were flow-sorted. Four out of eight BRAF(p.V600E) tumor epithelial fractions (50%) showed MEIS1 promoter methylation, as well as three out of eight BRAF(p.V600E) stromal fractions (38%). Only one out of six BRAF wild type showed MEIS1 promoter methylation in both the epithelial tumor and stromal fractions (17%). In conclusion, BRAF(p.V600E) colon tumors showed significant MEIS1 promoter methylation, which was associated with decreased MEIS1 gene expression.	[Dihal, Ashwin A.; Boot, Arnoud; van Roon, Eddy H.; Boer, Judith M.] Leiden Univ Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Boot, Arnoud; van Roon, Eddy H.; Schrumpf, Melanie; Farina-Sarasqueta, Arantza; Morreau, Hans; van Wezel, Tom] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ Med Ctr, Dept Med Stat, Leiden, Netherlands; [Zeestraten, Eliane C. M.; Kuppen, Peter J. K.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Boer, Judith M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol, Rotterdam, Netherlands; [Boer, Judith M.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	van Wezel, T (corresponding author), Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands.	t.van_wezel@lumc.nl; j.m.boer@erasmusmc.nl	van Wezel, Tom/Z-3092-2019; Dijkstra, Sander/F-2513-2017; van Wezel, Tom/A-9599-2008; Kuppen, Peter/J-2342-2016; van Wezel, Tom/AAL-5626-2021	van Wezel, Tom/0000-0001-5773-7730; Dijkstra, Sander/0000-0001-5368-757X; van Wezel, Tom/0000-0001-5773-7730; Kuppen, Peter/0000-0002-0294-3251; Boot, Arnoud/0000-0002-7717-7416; Farina Sarasqueta, Aranzazu/0000-0002-6173-592X; Boer, Judith/0000-0003-4848-7789; Farina Sarasqueta, Arantza/0000-0002-4307-1568	Centre for Medical Systems Biology, a Centre of Excellence; Netherlands Genomics Initiative	Centre for Medical Systems Biology, a Centre of Excellence; Netherlands Genomics Initiative	This work was supported by the Centre for Medical Systems Biology, a Centre of Excellence supported by the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Crist RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023665; Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Miranda NFCC, 2012, MUTAGENESIS, V27, P247, DOI 10.1093/mutage/ger077; DEXTER DL, 1979, CANCER RES, V39, P1020; DREWINKO B, 1976, CANCER RES, V36, P467; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Gavin PG, 2012, CLIN CANCER RES, V18, P6531, DOI 10.1158/1078-0432.CCR-12-0605; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; LILIENBAUM A, 1986, EMBO J, V5, P2809, DOI 10.1002/j.1460-2075.1986.tb04572.x; Lombaerts M, 2004, BIOCHEM BIOPH RES CO, V319, P697, DOI 10.1016/j.bbrc.2004.05.041; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; QUINN LA, 1979, CANCER RES, V39, P4914; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sarasqueta AF, 2011, CELL ONCOL, V34, P523, DOI 10.1007/s13402-011-0054-4; Serrano E, 2006, ACTA HAEMATOL-BASEL, V116, P77, DOI 10.1159/000093636; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SUARDET L, 1992, CANCER RES, V52, P3705; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Puijenbroek M, 2005, J MOL DIAGN, V7, P623, DOI 10.1016/S1525-1578(10)60596-X; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; van Wezel T, 2005, BREAST CANCER RES, V7, pR998, DOI 10.1186/bcr1337; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79898	10.1371/journal.pone.0079898	http://dx.doi.org/10.1371/journal.pone.0079898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244575	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900057
J	Goss, EM; Press, CM; Grunwald, NJ				Goss, Erica M.; Press, Caroline M.; Gruenwald, Niklaus J.			Evolution of RXLR-Class Effectors in the Oomycete Plant Pathogen Phytophthora ramorum	PLOS ONE			English	Article							SUDDEN OAK DEATH; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SITES; RESISTANCE GENES; CLONAL LINEAGES; GENOME SEQUENCE; AVIRULENCE; PROTEIN; VIRULENCE; EXPRESSION	Phytophthora plant pathogens contain many hundreds of effectors potentially involved in infection of host plants. Comparative genomic analyses have shown that these effectors evolve rapidly and have been subject to recent expansions. We examined the recent sequence evolution of RXLR-class effector gene families in the sudden oak death pathogen, P. ramorum. We found that P. ramorum RXLR effectors have taken multiple evolutionary paths, including loss or gain of repeated domains, recombination or gene conversion among paralogs, and selection on point mutations. Sequencing of homologs from two subfamilies in P. ramorum's closest known relatives revealed repeated gene duplication and divergence since speciation with P. lateralis. One family showed strong signatures of recombination while the other family has evolved primarily by point mutation. Comparison of a small number of the hundreds of RXLR-class effectors across three clonal lineages of P. ramorum shows striking divergence in alleles among lineages, suggesting the potential for functional differences between lineages. Our results suggest future avenues for examination of rapidly evolving effectors in P. ramorum, including investigation of the functional and coevolutionary significance of the patterns of sequence evolution that we observed.	[Goss, Erica M.; Press, Caroline M.; Gruenwald, Niklaus J.] ARS, Hort Crops Res Lab, Dept Agr, Corvallis, OR USA		Goss, EM (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	emgoss@ufl.edu	Grunwald, Niklaus` J/K-6041-2013	Grunwald, Niklaus` J/0000-0003-1656-7602; Press, Caroline/0000-0003-4741-9776	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS [5358-22000-030-00D]; ARS [ARS-0423109] Funding Source: Federal RePORTER	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided by the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS 5358-22000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; BRASIER CM, 2006, PROGR RES PHYTOPHTHO, P166; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FLOR HH, 1953, PHYTOPATHOLOGY, V43, P624; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2009, PHYTOPATHOLOGY, V99, P792, DOI 10.1094/PHYTO-99-7-0792; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Na R, 2013, MOL PLANT MICROBE IN, V26, P969, DOI 10.1094/MPMI-02-13-0036-R; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Quinn L, 2013, FEMS MICROBIOL LETT, V344, P179, DOI 10.1111/1574-6968.12179; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rozen S, 2000, Methods Mol Biol, V132, P365; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomlinson JA, 2005, APPL ENVIRON MICROB, V71, P6702, DOI 10.1128/AEM.71.11.6702-6710.2005; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Van Poucke Kris, 2012, Fungal Biol, V116, P1178, DOI 10.1016/j.funbio.2012.09.003; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097	65	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79347	10.1371/journal.pone.0079347	http://dx.doi.org/10.1371/journal.pone.0079347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244484	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900038
J	Maksimov, P; Zerweck, J; Dubey, JP; Pantchev, N; Frey, CF; Maksimov, A; Reimer, U; Schutkowski, M; Hosseininejad, M; Ziller, M; Conraths, FJ; Schares, G				Maksimov, Pavlo; Zerweck, Johannes; Dubey, Jitender P.; Pantchev, Nikola; Frey, Caroline F.; Maksimov, Aline; Reimer, Ulf; Schutkowski, Mike; Hosseininejad, Morteza; Ziller, Mario; Conraths, Franz J.; Schares, Gereon			Serotyping of Toxoplasma gondii in Cats (Felis domesticus) Reveals Predominance of Type II Infections in Germany	PLOS ONE			English	Article							HIGHLY MOUSE-VIRULENT; GENETIC-CHARACTERIZATION; CONGENITAL TOXOPLASMOSIS; POLYMORPHIC PEPTIDES; TISSUE DISTRIBUTION; EPIGENETIC FACTORS; RISK-FACTORS; BLACK BEAR; STRAINS; SEROPREVALENCE	Background: Cats are definitive hosts of Toxoplasma gondii and play an essential role in the epidemiology of this parasite. The study aims at clarifying whether cats are able to develop specific antibodies against different clonal types of T. gondii and to determine by serotyping the T. gondii clonal types prevailing in cats as intermediate hosts in Germany. Methodology: To establish a peptide-microarray serotyping test, we identified 24 suitable peptides using serological T. gondii positive (n=21) and negative cat sera (n=52). To determine the clonal type-specific antibody response of cats in Germany, 86 field sera from T. gondii seropositive naturally infected cats were tested. In addition, we analyzed the antibody response in cats experimentally infected with non-canonical T. gondii types (n=7). Findings: Positive cat reference sera reacted predominantly with peptides harbouring amino acid sequences specific for the clonal T. gondii type the cats were infected with. When the array was applied to field sera from Germany, 98.8% (85/86) of naturally-infected cats recognized similar peptide patterns as T. gondii type II reference sera and showed the strongest reaction intensities with clonal type II-specific peptides. In addition, naturally infected cats recognized type II-specific peptides significantly more frequently than peptides of other type-specificities. Cats infected with non-canonical types showed the strongest reactivity with peptides presenting amino-acid sequences specific for both, type I and type III. Conclusions: Cats are able to mount a clonal type-specific antibody response against T. gondii. Serotyping revealed for most seropositive field sera patterns resembling those observed after clonal type II-T. gondii infection. This finding is in accord with our previous results on the occurrence of T. gondii clonal types in oocysts shed by cats in Germany.	[Maksimov, Pavlo; Maksimov, Aline; Conraths, Franz J.; Schares, Gereon] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Zerweck, Johannes; Reimer, Ulf] Peptide Technol GmbH, JPT, Berlin, Germany; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, USDA, ANRI,BARC East, Beltsville, MD USA; [Pantchev, Nikola] Vet Med Labor GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Frey, Caroline F.] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Schutkowski, Mike] Univ Halle Wittenberg, Dept Enzymol, Inst Biochem & Biotechnol, D-06108 Halle, Saale, Germany; [Hosseininejad, Morteza] Univ Shahrekord, Fac Vet Med, Shahrekord, Iran; [Ziller, Mario] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Workgrp Biomath, Greifswald, Germany	Friedrich Loeffler Institute; United States Department of Agriculture (USDA); Vet Med Labor GmbH; University of Bern; Martin Luther University Halle Wittenberg; Shahrekord University; Friedrich Loeffler Institute	Maksimov, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany.	pavlo_maksimov@gmx.de; gereon.schares@fli.bund.de	Schares, Gereon R.M./F-9850-2019; Maksimov, Pavlo/AAC-3916-2019	Schares, Gereon R.M./0000-0002-3217-289X; Maksimov, Pavlo/0000-0002-9457-0658; Reimer, Ulf/0000-0002-3375-6889; Frey, Caroline/0000-0002-6478-7493; Conraths, Franz/0000-0002-7400-9409; Schutkowski, MIke/0000-0003-0919-7076	German Federal Ministry of Education and Research [Toxonet01, Toxonet02, 01KI0765, 01KI1002F]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Federal Ministry of Education and Research (Toxonet01 and Toxonet02) by funds to G. Schares (01KI0765; 01KI1002F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg Daniel, 2011, Expert Rev Anti Infect Ther, V9, P169, DOI 10.1586/eri.10.169; Al-Kappany YM, 2010, J PARASITOL, V96, P1115, DOI 10.1645/GE-2554.1; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Buydens LMC, 2007, J STAT SOFTW, P21; Chen ZW, 2011, VET PARASITOL, V183, P166, DOI 10.1016/j.vetpar.2011.06.013; Conraths FJ, 2006, VET PARASITOL, V136, P91, DOI 10.1016/j.vetpar.2005.12.004; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; de Azevedo SS, 2010, REV BRAS PARASITOL V, V19, P80, DOI 10.1590/S1984-29612010000200002; de Kok JB, 2002, CANCER RES, V62, P2695; Demar M, 2012, CLIN MICROBIOL INFEC, V18, pE221, DOI 10.1111/j.1469-0691.2011.03648.x; Dubey JP, 2010, J PARASITOL, V96, P713, DOI 10.1645/GE-2429.1; Dubey JP, 2009, PARASITOLOGY, V136, P589, DOI 10.1017/S0031182009006015; Dubey JR, 2008, J PARASITOL, V94, P42, DOI 10.1645/GE-1349.1; Dubey JR, 2007, J PARASITOL, V93, P710, DOI 10.1645/GE-1120R.1; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1995, J PARASITOL, V81, P410, DOI 10.2307/3283823; Dubey JP, 2004, J PARASITOL, V90, P721, DOI 10.1645/GE-382R; Dubey JP, 1996, J PARASITOL, V82, P957, DOI 10.2307/3284206; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dubremetz JF, 2012, MICROBES INFECT, V14, P1403, DOI 10.1016/j.micinf.2012.09.005; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Fazaeli A, 2007, PARASITOL RES, V101, P99, DOI 10.1007/s00436-006-0449-8; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Fekkar A, 2011, J CLIN MICROBIOL, V49, P1513, DOI 10.1128/JCM.02196-10; Fischer HG, 1998, MOL BIOCHEM PARASIT, V91, P251, DOI 10.1016/S0166-6851(97)00227-2; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Herrmann DC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-39; Hosseininejad M, 2012, EXP PARASITOL, V132, P556, DOI 10.1016/j.exppara.2012.09.009; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jamieson SE, 2010, GENES IMMUN, V11, P374, DOI 10.1038/gene.2010.31; Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285; Jamieson SE, 2009, MEM I OSWALDO CRUZ, V104, P162, DOI 10.1590/S0074-02762009000200006; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Latifi SM, 2006, J BABOL U MED SCI, V8, P55; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Lin SYH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S10; LUNDE MN, 1983, J PARASITOL, V69, P806, DOI 10.2307/3281034; Maksimov P, 2011, VET PARASITOL, V182, P140, DOI 10.1016/j.vetpar.2011.05.049; Maksimov P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034212; Maksimov P, 2012, CLIN VACCINE IMMUNOL, V19, P865, DOI 10.1128/CVI.00119-12; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; MELSSEN W, 2006, SUPERVISED KOHONEN N, V83, P99; Meyer D, 2006, J STAT SOFTW, P17; Montoya A, 2009, VET PARASITOL, V160, P159, DOI 10.1016/j.vetpar.2008.10.029; Morisset S, 2008, MICROBES INFECT, V10, P742, DOI 10.1016/j.micinf.2008.04.001; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Ngo Y, 2009, J IMMUNOL METHODS, V343, P68, DOI 10.1016/j.jim.2008.12.004; Nowakowska D, 2006, J CLIN MICROBIOL, V44, P1382, DOI 10.1128/JCM.44.4.1382-1389.2006; Opsteegh M, 2012, PREV VET MED, V104, P317, DOI 10.1016/j.prevetmed.2012.01.003; Pamelard F, 2009, METHODS MOL BIOL, V570, P413, DOI 10.1007/978-1-60327-394-7_24; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Peyron F, 2006, MICROBES INFECT, V8, P2333, DOI 10.1016/j.micinf.2006.03.023; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Schares G, 2008, VET PARASITOL, V152, P34, DOI 10.1016/j.vetpar.2007.12.004; Schares G, 1998, VET PARASITOL, V80, P87, DOI 10.1016/S0304-4017(98)00195-2; Sousa S, 2008, CLIN VACCINE IMMUNOL, V15, P1380, DOI 10.1128/CVI.00186-08; Sousa S, 2010, VET PARASITOL, V169, P24, DOI 10.1016/j.vetpar.2009.12.025; Sousa S, 2009, CLIN VACCINE IMMUNOL, V16, P1158, DOI 10.1128/CVI.00092-09; Spycher A, 2011, J VET DIAGN INVEST, V23, P104, DOI 10.1177/104063871102300117; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447; Wang JB, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-36; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80213	10.1371/journal.pone.0080213	http://dx.doi.org/10.1371/journal.pone.0080213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244652	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900067
J	Shu, HKG; Yoon, Y; Hong, S; Xu, KM; Gao, HY; Hao, CH; Torres-Gonzalez, E; Nayra, C; Rojas, M; Shim, H				Shu, Hui-Kuo G.; Yoon, Younghyoun; Hong, Samuel; Xu, Kaiming; Gao, Huiying; Hao, Chunhai; Torres-Gonzalez, Edilson; Nayra, Cardenes; Rojas, Mauricio; Shim, Hyunsuk			Inhibition of the CXCL12/CXCR4-Axis as Preventive Therapy for Radiation-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							LUNG INJURY; PATHOGENESIS; ANTAGONISTS; CELLS; MICE	Background: A devastating late injury caused by radiation is pulmonary fibrosis. This risk may limit the volume of irradiation and compromise potentially curative therapy. Therefore, development of a therapy to prevent this toxicity can be of great benefit for this patient population. Activation of the chemokine receptor CXCR4 by its ligand stromal cell-derived factor 1 (SDF-1/CXCL12) may be important in the development of radiation-induced pulmonary fibrosis. Here, we tested whether MSX-122, a novel small molecule and partial CXCR4 antagonist, can block development of this fibrotic process. Methodology/Principal Findings: The radiation-induced lung fibrosis model used was C57BL/6 mice irradiated to the entire thorax or right hemithorax to 20 Gy. Our parabiotic model involved joining a transgenic C57BL/6 mouse expressing GFP with a wild-type mouse that was subsequently irradiated to assess for migration of GFP+ bone marrow-derived progenitor cells to the irradiated lung. CXCL12 levels in the bronchoalveolar lavage fluid (BALF) and serum after irradiation were determined by ELISA. CXCR4 and CXCL12 mRNA in the irradiated lung was determined by RNase protection assay. Irradiated mice were treated daily with AMD3100, an established CXCR4 antagonist; MSX-122; and their corresponding vehicles to determine impact of drug treatment on fibrosis development. Fibrosis was assessed by serial CTs and histology. After irradiation, CXCL12 levels increased in BALF and serum with a corresponding rise in CXCR4 mRNA within irradiated lungs consistent with recruitment of a CXCR4+ cell population. Using our parabiotic model, we demonstrated recruitment of CXCR4+ bone marrow-derived mesenchymal stem cells, identified based on marker expression, to irradiated lungs. Finally, irradiated mice that received MSX-122 had significant reductions in development of pulmonary fibrosis while AMD3100 did not significantly suppress this fibrotic process. Conclusions/Significance: CXCR4 inhibition by drugs such as MSX-122 may alleviate potential radiation-induced lung injury, presenting future therapeutic opportunities for patients requiring chest irradiation.	[Shu, Hui-Kuo G.; Xu, Kaiming; Gao, Huiying] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Shu, Hui-Kuo G.; Shim, Hyunsuk] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Yoon, Younghyoun; Hong, Samuel; Shim, Hyunsuk] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA; [Hao, Chunhai] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Torres-Gonzalez, Edilson; Nayra, Cardenes; Rojas, Mauricio] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Emory University; Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shu, HKG (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	hgshu@emory.edu; hshim@emory.edu			National Institutes of Health [RC1AI081273, R21HL092518]; NATIONAL CANCER INSTITUTE [R01CA165306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI081273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grants RC1AI081273 and R21HL092518 (to HGS and HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Hallahan DE, 2002, J NATL CANCER I, V94, P733; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haston CK, 1997, CANCER RES, V57, P5286; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Liang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034038; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Plathow C, 2004, INVEST RADIOL, V39, P600, DOI 10.1097/01.rli.0000138134.89050.a5; SCHUETZ AW, 1964, ENDOCRINOLOGY, V75, P383, DOI 10.1210/endo-75-3-383; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; Tsutsumi H, 2007, BIOPOLYMERS, V88, P279, DOI 10.1002/bip.20653; Vujaskovic Z, 1998, EXP LUNG RES, V24, P137, DOI 10.3109/01902149809099578; Watanabe M, 2007, J IMMUNOL, V178, P5888, DOI 10.4049/jimmunol.178.9.5888; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g	18	62	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79768	10.1371/journal.pone.0079768	http://dx.doi.org/10.1371/journal.pone.0079768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244561	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327162900053
J	Klocker, A; Wiertlewski, M; Theate, V; Hayward, V; Thonnard, JL				Kloecker, Anne; Wiertlewski, Michael; Theate, Vincent; Hayward, Vincent; Thonnard, Jean-Louis			Physical Factors Influencing Pleasant Touch during Tactile Exploration	PLOS ONE			English	Article							AFFERENTS; ROUGHNESS; PERCEPTION; MAGNITUDE	Background: When scanning surfaces, humans perceive some of their physical attributes. These percepts are frequently accompanied by a sensation of (un)pleasantness. We therefore hypothesized that aspects of the mechanical activity induced by scanning surfaces with fingertips could be objectively associated with a pleasantness sensation. Previously, we developed a unidimensional measure of pleasantness, the Pleasant Touch Scale, quantifying the pleasantness level of 37 different materials. Findings of this study suggested that the sensation of pleasantness was influenced by the average magnitude of the frictional forces brought about by sliding the finger on the surface, and by the surface topography. In the present study, we correlated (i) characteristics of the fluctuations of frictional forces resulting from the interaction between the finger and the surface asperities as well as (ii) the average friction with the sensation of pleasantness. Results: Eight blindfolded participants tactually explored twelve materials of the Pleasant Touch Scale through lateral sliding movements of their index fingertip. During exploration, the normal and tangential interaction force components, f(N) and f(T), as well as the fingertip trajectory were measured. The effect of the frictional force on pleasantness sensation was investigated through the analysis of the ratio f(T) to f(N), i. e. the net coefficient of kinetic friction, mu. The influence of the surface topographies was investigated through analysis of rapid f(T) fluctuations in the spatial frequency domain. Results showed that high values of mu were anticorrelated with pleasantness. Furthermore, surfaces associated with fluctuations of f(T) having higher amplitudes in the low frequency range than in the high one were judged to be less pleasant than the surfaces yielding evenly distributed amplitudes throughout the whole spatial frequency domain. Conclusion: Characteristics of the frictional force fluctuations and of the net friction taking place during scanning can reliably be correlated with the pleasantness sensation of surfaces.	[Kloecker, Anne; Theate, Vincent; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Wiertlewski, Michael; Hayward, Vincent] Univ Paris 06, Inst Syst Intelligents & Robot, Paris, France	Universite Catholique Louvain; UDICE-French Research Universities; Sorbonne Universite	Thonnard, JL (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	jean-louis.thonnard@uclouvain.be	Hayward, Vincent/A-4646-2010	Hayward, Vincent/0000-0002-2102-1965; Wiertlewski, Michael/0000-0002-1298-2115	Commission of the European Union [EU-FP7-NMP4-SL-2009-228844]; European Research Council [247300]	Commission of the European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a grant from the Commission of the European Union under contract number EU-FP7-NMP4-SL-2009-228844, NanoBioTouch. This work was supported by the European Research Council, Advanced Grant PATCH, agreement number 247300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Chen XJ, 2009, INT J DES, V3, P67; Delhaye B, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00037; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Greenspan JD, 2003, SOMATOSENS MOT RES, V20, P19, DOI 10.1080/0899022031000083807; Guest S, 2009, ACTA PSYCHOL, V130, P115, DOI 10.1016/j.actpsy.2008.10.007; GWOSDOW AR, 1986, TEXT RES J, V56, P574, DOI 10.1177/004051758605600909; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2000, PERCEPTION, V29, P1455, DOI 10.1068/p3044; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; JOHANSSON RS, 1988, EXP BRAIN RES, V72, P204, DOI 10.1007/BF00248518; Kitada R, 2012, PERCEPTION, V41, P204, DOI 10.1068/p7168; Klocker A, 2012, FRONT NEUROROBOTICS, V6, P1; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Libouton X, 2012, BEHAV BRAIN RES, V229, P273, DOI 10.1016/j.bbr.2012.01.018; Major DR, 1895, AM J PSYCHOL, V7, P57; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; MELLERS BA, 1983, PERCEPT PSYCHOPHYS, V33, P523, DOI 10.3758/BF03202933; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Rasch G., 1960, PROBABILISTIC MODELS; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; Tomlinson SE, 2007, P I MECH ENG J-J ENG, V221, P841, DOI 10.1243/13506501JET313; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Verrillo RT, 1999, SOMATOSENS MOT RES, V16, P352; Wheat HE, 2010, J NEUROPHYSIOL, V103, P950, DOI 10.1152/jn.00502.2009; Wiertlewski M, 2011, P WORLD HAPT C; Wiertlewski M, 2011, IEEE T ROBOT, V27, P461, DOI 10.1109/TRO.2011.2132830; WILLS CE, 1994, RES NURS HEALTH, V17, P231, DOI 10.1002/nur.4770170310; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	37	48	48	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79085	10.1371/journal.pone.0079085	http://dx.doi.org/10.1371/journal.pone.0079085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244425	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800027
J	Linker, S; Hedges, D				Linker, Sara; Hedges, Dale			Linear Decay of Retrotransposon Antisense Bias across Genes Is Contingent upon Tissue Specificity	PLOS ONE			English	Article							ALU ELEMENTS; L1 RETROTRANSPOSON; TRANSCRIPTION; BINDING; SITES; IDENTIFICATION; ORGANIZATION; EVOLUTION; REPEATS; GENOME	Retrotransposons comprise approximately half of the human genome and contribute to chromatin structure, regulatory motifs, and protein-coding sequences. Since retrotransposon insertions can disrupt functional genetic elements as well as introduce new sequence motifs to a region, they have the potential to affect the function of genes that harbour insertions as well as those nearby. Partly as a result of these effects, the distribution of retrotransposons across the genome is non-uniform and there are observed imbalances in the orientation of insertions with respect to the transcriptional direction of the containing gene. Although some of the factors underlying the observed distributions are understood, much of the variability remains unexplained. Detailed characterization of retrotransposon density in genes could help inform predictions of the functional consequence of de novo as well as polymorphic insertions. In order to characterize the relationship between genes and inserted elements, we have examined the distribution of retrotransposons and their internal motifs within tissue-specific and housekeeping genes. We have identified that the previously established retrotransposon antisense bias decays at a linear rate across genes, resulting in an equal density of sense and antisense retrotransposons near the 3'-UTR. In addition, the decay of antisense bias across genes is less pronounced among tissue-specific genes. Our results provide support for the scenario in which this linear decay in antisense bias is established by natural selection shortly after retrotransposon integration, and that total antisense bias observed is above and beyond any bias introduced by the integration process itself. Finally, we provide an example of a retrotransposon acting as an eQTL on a coincident gene, highlighting one of several possible avenues through which insertions may modulate gene function.	[Linker, Sara] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Hussman Inst Human Genom,Dept Human Genet, Miami, FL 33136 USA; [Hedges, Dale] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA	University of Miami; University System of Ohio; Ohio State University	Hedges, D (corresponding author), Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA.	dale.hedges@osumc.edu			NSF [GRF: 2011132548]	NSF(National Science Foundation (NSF))	This work was supported by NSF GRF: 2011132548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; CHANG C, 2011, FILM COMMENT, V47, P6; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; ENGLANDER EW, 1995, J BIOL CHEM, V270, P10091, DOI 10.1074/jbc.270.17.10091; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FUHRMAN SA, 1981, NUCLEIC ACIDS RES, V9, P6439, DOI 10.1093/nar/9.23.6439; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Grover D, 2003, MOL BIOL EVOL, V20, P1420, DOI 10.1093/molbev/msg153; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026099; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Liu W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001075; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Omar MFM, 2012, PATHOL ONCOL RES, V18, P783, DOI 10.1007/s12253-011-9485-5; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pavlicek A, 2001, GENE, V276, P39, DOI 10.1016/S0378-1119(01)00645-X; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Putku M, 2011, HUM MUTAT, V32, P806, DOI 10.1002/humu.21508; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; ROBINS DM, 1992, GENETICA, V86, P191, DOI 10.1007/BF00133720; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; SHAKHMURADOV I A, 1989, Genetika, V25, P1682; Shephard EA, 2007, BIOCHEM J, V406, P491, DOI 10.1042/BJ20070523; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Wagstaff BJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002842; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yu Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-308; Zingler N, 2005, GENOME RES, V15, P780, DOI 10.1101/gr.3421505	57	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79402	10.1371/journal.pone.0079402	http://dx.doi.org/10.1371/journal.pone.0079402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244495	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800071
J	Mengel-From, J; Thinggaard, M; Lindahl-Jacobsen, R; McGue, M; Christensen, K; Christiansen, L				Mengel-From, Jonas; Thinggaard, Mikael; Lindahl-Jacobsen, Rune; McGue, Matt; Christensen, Kaare; Christiansen, Lene			CLU Genetic Variants and Cognitive Decline among Elderly and Oldest Old	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE RISK; IDENTIFIES VARIANTS; CLUSTERIN GENE; PICALM; CR-1; POLYMORPHISMS; HERITABILITY; BINDING; LINKAGE	The CLU gene is one of the prime genetic candidates associated with Alzheimers disease. In the present study CLU genotypes and haplotypes were associated with baseline cognition and the rate of cognitive decline in two cohorts, the Danish 1905 birth cohort (93 years of age in 1998) and the Longitudinal Study of Aging Danish twins (LSADT) (73-83 year old twins in 1997). Both Mini Mental State Examination (MMSE) and a cognitive composite score was attained up to six times for up to 10 years and analysed using random effects models and vital status. The rs11136000 T allele was associated with better baseline cognitive performance both in the LSADT (effect on intercept: 0.41 95% CI [-0.04; 0.87]) and the 1905 birth cohort (effect on intercept: 0.28 95% CI [0.01; 0.55]), although it did not reach significance in the LSADT cohort. However, the rs11136000 T allele was significantly associated with a steeper decline (effect on slope: -0.06 95% CI [-0.11; -0.01]) in the LSADT cohort, but not in the 1905 birth cohort. Haplotype analyses revealed that carriers of the common rs11136000, rs1532278 and rs9331888 TTC haplotype (36%) in the CLU gene performed cognitively better than non-carriers in the 1905 birth cohort (effect on intercept: 0.50 95% CI [0.12; 0.91]) and carriers of a rare TCC haplotype (1%) performed worse on the cognitive composite score (effect on intercept: -1.51 95% CI [-2.92; -0.06]). The association between the TTC haplotype and better cognitive composite score was higher among those surviving past the age of 98 (p = 0.014), and among these the TTC haplotype was borderline associated with a steep decline (effect on slope: -0.13 95% CI [-0.27; 0.00]). In summery CLU genetic variants associate with cognition in two cohorts, but the genetic effect of CLU seems to regress toward the mean when aging.	[Mengel-From, Jonas; Thinggaard, Mikael; Lindahl-Jacobsen, Rune; McGue, Matt; Christensen, Kaare; Christiansen, Lene] Univ So Denmark, Danish Aging Res Ctr, Odense, Denmark; [Mengel-From, Jonas; Thinggaard, Mikael; Lindahl-Jacobsen, Rune; McGue, Matt; Christensen, Kaare; Christiansen, Lene] Univ So Denmark, Danish Twin Registry, Epidemiol Unit, Inst Publ Hlth, Odense, Denmark; [Mengel-From, Jonas; Christensen, Kaare; Christiansen, Lene] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Christensen, Kaare; Christiansen, Lene] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [McGue, Matt] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Minnesota System; University of Minnesota Twin Cities	Mengel-From, J (corresponding author), Univ So Denmark, Danish Aging Res Ctr, Odense, Denmark.	jmengel-from@health.sdu.dk	Lindahl-Jacobsen, Rune/J-2985-2012; Andersen, Mette Adalheidur/D-5608-2017; Christensen, Kaare/C-2360-2009	Lindahl-Jacobsen, Rune/0000-0002-4622-9826; Christensen, Kaare/0000-0002-5429-5292; Mengel-From, Jonas/0000-0003-1573-8908; Thinggaard, Mikael/0000-0002-7029-453X	US National Institutes of Health/National Institute on Aging [P01 AG08761]; Danish Agency for Science, Technology and Innovation [09-070081]; Brodrene Hartmanns foundation; Horslev foundation; Aase and Ejnar Danielsens foundation; Christian D 10. foundation; VELUX Foundation; NATIONAL INSTITUTE ON AGING [P01AG008761, P01AG031719] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Danish Agency for Science, Technology and Innovation; Brodrene Hartmanns foundation; Horslev foundation; Aase and Ejnar Danielsens foundation; Christian D 10. foundation; VELUX Foundation(Velux Fonden); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by a grant from the US National Institutes of Health/National Institute on Aging, Grant No. P01 AG08761; by a grant from The Danish Agency for Science, Technology and Innovation, Grant No. 09-070081, and by grants from Brodrene Hartmanns foundation and Horslev foundation, Aase and Ejnar Danielsens foundation, Christian D 10. foundation. The Danish Aging Research Center is supported by a grant from the VELUX Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron M, 2012, ALZ DIS ASSOC DIS, V26, P91, DOI 10.1097/WAD.0b013e318215aaf4; Barral S, 2012, NEUROLOGY, V78, P1464, DOI 10.1212/WNL.0b013e3182553c48; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERTRAM L, 2009, ALZGENE DATABASE; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bettens K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-3; Bralten J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.017; Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Christensen K, 2002, AM J EPIDEMIOL, V155, P132, DOI 10.1093/aje/155.2.132; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; DAS G, 1988, J BIOL CHEM, V263, P18290; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gu HY, 2011, DEMENT GERIATR COGN, V32, P198, DOI 10.1159/000331276; Guerreiro RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009510; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016616; Jones Nick, 2010, Nat Rev Neurol, V6, P469, DOI 10.1038/nrneurol.2010.122; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; McGue M, 2002, EXP AGING RES, V28, P435, DOI 10.1080/03610730290080416; McGue M, 2001, PSYCHOL AGING, V16, P272, DOI 10.1037//0882-7974.16.2.272; Mengel-From J, 2011, GENES BRAIN BEHAV, V10, P876, DOI 10.1111/j.1601-183X.2011.00728.x; Mengel-From J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.07.016; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Nybo H, 2001, J AGING HEALTH, V13, P32, DOI 10.1177/089826430101300102; Pedersen CB, 2006, DAN MED BULL, V53, P441; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Schurmann B, 2011, J ALZHEIMERS DIS, V25, P421, DOI 10.3233/JAD-2011-110251; Sillen A, 2011, J ALZHEIMERS DIS, V23, P13, DOI 10.3233/JAD-2010-101359; Skytthe A, 2002, TWIN RES, V5, P352; Szymanski M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.17; Xia ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014169; Yu JT, 2010, CLIN CHIM ACTA, V411, P1516, DOI 10.1016/j.cca.2010.06.013	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79105	10.1371/journal.pone.0079105	http://dx.doi.org/10.1371/journal.pone.0079105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244428	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800029
J	Mill, DJ; Bito-Onon, JJ; Simms, JA; Li, R; Bartlett, SE				Mill, Douglas J.; Bito-Onon, Jade J.; Simms, Jeffrey A.; Li, Rui; Bartlett, Selena E.			Fischer Rats Consume 20% Ethanol in a Long-Term Intermittent-Access Two-Bottle-Choice Paradigm	PLOS ONE			English	Article							ALCOHOL-DRINKING; ANIMAL-MODELS; NEUROBIOLOGY; DEPRIVATION; STRAINS	The 20% ethanol intermittent-access (IAE) two-bottle-choice drinking procedure has been shown to produce high voluntary ethanol consumption in a number of rat strains. For this study, we applied this procedure to male Fischer (F344) rats, a strain previously reported to exhibit low levels of ethanol consumption. We also subjected these animals to a two-week ethanol-deprivation- period to see if they would exhibit an alcohol deprivation effect (ADE) signified by a transient increase in alcohol consumption following deprivation. Our data show a separation between high and low consuming animals within this strain, with high-consumers exhibiting an escalation in consumption. In contrast, Fischer rats did not show a significant separation between high and low consumers or any significant escalation in consumption, using the 20% ethanol continuous-access two-bottle-choice drinking protocol. Following the two-week deprivation period, animals in the high (but not the low) IAE group exhibited the transient increase in ethanol consumption and preference typically associated with an ADE. Together, the data suggest that the intermittent access protocol is a useful protocol for increasing ethanol consumption.	[Bartlett, Selena E.] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia; [Bartlett, Selena E.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Mill, Douglas J.; Bito-Onon, Jade J.; Simms, Jeffrey A.; Li, Rui] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Bartlett, SE (corresponding author), Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia.	selena.bartlett@qut.edu.au	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958	State of California for Medical Research through University of California San Francisco; Australian Research Council; Department of Defense [W81XWH-10-1-0247]	State of California for Medical Research through University of California San Francisco; Australian Research Council(Australian Research Council); Department of Defense(United States Department of Defense)	This work was supported by funding from the State of California for Medical Research through University of California San Francisco to SEB and Australian Research Council to SEB and the Department of Defense Grant W81XWH-10-1-0247 to SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Ciccocioppo R, 2006, ADDICT BIOL, V11, P339, DOI 10.1111/j.1369-1600.2006.00032.x; GEORGE FR, 1987, PHARMACOL BIOCHEM BE, V27, P379, DOI 10.1016/0091-3057(87)90586-7; Heyser CJ, 1997, ALCOHOL CLIN EXP RES, V21, P784; KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; LI TK, 1984, ALCOHOL CLIN EXP RES, V8, P485; Oster SM, 2006, ALCOHOL, V38, P155, DOI 10.1016/j.alcohol.2006.06.001; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sommer W, 2006, ADDICT BIOL, V11, P289, DOI 10.1111/j.1369-1600.2006.00037.x; Spanagel R, 1999, ALCOHOL ALCOHOLISM, V34, P231, DOI 10.1093/alcalc/34.2.231; Stewart RB, 1997, ALCOHOL HEALTH RES W, V21, P169; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034	15	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79824	10.1371/journal.pone.0079824	http://dx.doi.org/10.1371/journal.pone.0079824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244567	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800102
J	Deng, BC; Zhou, B; Zhang, SJ; Zhu, Y; Han, LQ; Geng, YZ; Jin, ZN; Liu, HB; Wang, DL; Zhao, YT; Wen, Y; Cui, W; Zhou, Y; Gu, QH; Sun, CM; Lu, X; Wang, W; Wang, Y; Li, CB; Wang, YL; Yao, WQ; Liu, P				Deng, Baocheng; Zhou, Bo; Zhang, Shujun; Zhu, Ying; Han, Leqiang; Geng, Yingzhi; Jin, Zhenan; Liu, Hongbo; Wang, Donglei; Zhao, Yitong; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Sun, Cuiming; Lu, Xu; Wang, Wen; Wang, Yu; Li, Chengbo; Wang, Yanli; Yao, Wenqing; Liu, Pei			Clinical Features and Factors Associated with Severity and Fatality among Patients with Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection in Northeast China	PLOS ONE			English	Article							CONGO HEMORRHAGIC-FEVER; RISK-FACTORS; RIBAVIRIN THERAPY; RENAL SYNDROME; VIRUS; OUTBREAK; OUTCOMES; REGION; TURKEY; ADULTS	Background: In 2009, severe fever with thrombocytopenia syndrome virus (SFTSV) was identified as a novel member of the genus phlebovirus in the Bunyaviridae family in China. The detailed clinical features of cases with SFTSV infection have not been well described, and the risk factors for severity among patients and fatality among severe patients remain to be determined. Methodology/Principal Findings: Clinical and laboratory features of 115 hospitalized patients with SFTSV infection during the period from June 2010 to December 2011 in Northeast China were retrospectively reviewed. We assessed the risk factors associated with severity in confirmed cases and fatality in severe cases by multivariate analysis. One hundred and three (89.6%) of 115 patients presented with multiple organ dysfunction, and 22 (19.1%) of 115 proceeded to the stage of life threatening multiple organ failure. Of the 115 patients, 14 fatalities (12.2%) were reported. Multivariate analysis demonstrated that the independent predictors of risk for severity were: albumin <= 30 g/l (OR, 8.09; 95% CI, 2.58-25.32), APTT >= 66 seconds (OR, 14.28; 95% CI, 3.28-62.24), sodium <= 130 mmol/l (OR, 5.44; 95% CI, 1.38-21.40), and presence of neurological manifestations (OR, 7.70; 95% CI, 1.91-31.12). Among patients with severe disease, presence of acute lung injury/acute respiratory distress syndrome (HR, 4.59; 95% CI, 1.48-14.19) and disseminated intravascular coagulation (HR, 4.24; 95% CI, 1.38-13.03) were independently associated with fatality. Conclusions/Significance: SFTSV infection may present with more severe symptoms and laboratory abnormalities than hitherto reported. Due to infection with a novel bunyavirus, the patients may sufferer multiple organ dysfunction and die of multiple organ failure. In the clinical assessment of any case of SFTS, independent factors relating to prognosis need to be taken into account by clinicians.	[Deng, Baocheng; Wang, Donglei; Zhao, Yitong; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Sun, Cuiming; Lu, Xu; Wang, Wen; Wang, Yu; Li, Chengbo; Wang, Yanli; Liu, Pei] China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China; [Zhou, Bo] China Med Univ, Affiliated Hosp 1, Dept Clin Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Shujun] Kuandian Country Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Zhu, Ying] Dalian Med Univ, Affiliated Hosp 1, Dept Infect Dis, Dalian, Liaoning Provin, Peoples R China; [Han, Leqiang] Dalian Municipal Infect Dis Hosp, Dalian, Liaoning Provin, Peoples R China; [Geng, Yingzhi; Yao, Wenqing] Liaoning Prov CDC, Shenyang, Liaoning Provin, Peoples R China; [Jin, Zhenan] Donggang Infect Dis Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Liu, Hongbo] Liaoning Prov Peoples Hosp, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; Dalian Medical University	Liu, P (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China.	wenqingyao@sina.com; syliupei2013@163.com			Ministry of Science and Technology [2012ZX10004209-005]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by China Mega-Project for Infectious Diseases grants (2012ZX10004209-005) from the Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; Avsic-Zupanc T, 1999, CLIN INFECT DIS, V28, P860, DOI 10.1086/515185; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Castillo C, 2001, CHEST, V120, P548, DOI 10.1378/chest.120.2.548; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Deng B, 2012, J CLIN VIROL; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Ergonul O, 2006, CLIN MICROBIOL INFEC, V12, P551, DOI 10.1111/j.1469-0691.2006.01445.x; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Ergonul O, 2004, CLIN INFECT DIS, V39, P284, DOI 10.1086/422000; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hassan OA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001229; HUGGINS JW, 1991, J INFECT DIS, V164, P1119, DOI 10.1093/infdis/164.6.1119; Li SB, 2011, BIOSCI TRENDS, V5, P273, DOI 10.5582/bst.2011.v5.6.273; Lin JJ, 2012, J CHILD NEUROL; [刘力 Liu Li], 2012, [中华流行病学杂志, Chinese Journal of Epidemiology], V33, P168; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Ministry of Health, 2011, CHIN J CLIN INFECT D, V4, P193; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Parkash O, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-43; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Spoelstra-de Man AME, 2008, INTENS CARE MED, V34, P1160, DOI 10.1007/s00134-008-1089-5; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Tufan ZK, 2011, J INFECTION, V63, P375, DOI 10.1016/j.jinf.2011.07.011; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang Ling-ling, 2012, Zhonghua Xue Ye Xue Za Zhi, V33, P250; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	38	98	115	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80802	10.1371/journal.pone.0080802	http://dx.doi.org/10.1371/journal.pone.0080802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236203	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700206
J	de Stoppelaar, SF; Bootsma, HJ; Zomer, A; Roelofs, JJTH; Hermans, PWM; van 't Veer, C; van der Poll, T				de Stoppelaar, Sacha F.; Bootsma, Hester J.; Zomer, Aldert; Roelofs, Joris J. T. H.; Hermans, Peter W. M.; van 't Veer, Cornelis; van der Poll, Tom			Streptococcus pneumoniae Serine Protease HtrA, but Not SFP or PrtA, Is a Major Virulence Factor in Pneumonia	PLOS ONE			English	Article							CONTRIBUTES; COMPETENCE; PROTEINS; PATHWAY; PLAYS	Streptococcus (S.) pneumoniae is a common causative pathogen in pneumonia. Serine protease orthologs expressed by a variety of bacteria have been found of importance for virulence. Previous studies have identified two serine proteases in S. pneumoniae, HtrA (high-temperature requirement A) and PrtA (cell wall-associated serine protease A), that contributed to virulence in models of pneumonia and intraperitoneal infection respectively. We here sought to identify additional S. pneumoniae serine proteases and determine their role in virulence. The S. pneumoniae D39 genome contains five putative serine proteases, of which HtrA, Subtilase Family Protein (SFP) and PrtA were selected for insertional mutagenesis because they are predicted to be secreted and surface exposed. Mutant D39 strains lacking serine proteases were constructed by in-frame insertion deletion mutagenesis. Pneumonia was induced by intranasal infection of mice with wild-type or mutant D39. After high dose infection, only D39 Delta htrA showed reduced virulence, as reflected by strongly reduced bacterial loads, diminished dissemination and decreased lung inflammation. D39 Delta prtA induced significantly less lung inflammation together with smaller infiltrated lung surface, but without influencing bacterial loads. After low dose infection, D39 Delta htrA again showed strongly reduced bacterial loads; notably, pneumococcal burdens were also modestly lower in lungs after infection with D39 Delta sfp. These data confirm the important role for HtrA in S. pneumoniae virulence. PrtA contributes to lung damage in high dose pneumonia; it does not however contribute to bacterial outgrowth in pneumococcal pneumonia. SFP may facilitate S. pneumoniae growth after low dose infection.	[de Stoppelaar, Sacha F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Stoppelaar, Sacha F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Zomer, Aldert; Hermans, Peter W. M.] Radboud Univ Nijmegen Med Ctr, Lab Pediat Infect Dis, Nijmegen, Netherlands; [Zomer, Aldert] Radboud Univ Nijmegen Med Ctr, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Stoppelaar, SF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.f.destoppelaar@amc.uva.nl	Hermans, Peter W.M./H-8042-2014	Zomer, Aldert/0000-0002-0758-5190; Roelofs, Joris/0000-0001-9595-6571	AMC	AMC	This work was supported by an AMC PhD Scholarship to S. F. de Stoppelaar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Cassone M, 2012, J BIOL CHEM, V287, P38449, DOI 10.1074/jbc.M112.391482; COURTNEY HS, 1991, BIOCHEM BIOPH RES CO, V175, P1023, DOI 10.1016/0006-291X(91)91667-2; Dawid S, 2009, J BACTERIOL, V191, P1509, DOI 10.1128/JB.01213-08; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dockrell DH, 2012, CHEST, V142, P482, DOI 10.1378/chest.12-0210; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Garau J, 2002, LANCET INFECT DIS, V2, P404, DOI 10.1016/S1473-3099(02)00316-X; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Kochan TJ, 2013, J BACTERIOL; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Rijneveld AW, 2003, BLOOD, V102, P934, DOI 10.1182/blood-2003-01-0227; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	26	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80062	10.1371/journal.pone.0080062	http://dx.doi.org/10.1371/journal.pone.0080062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244609	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600176
J	Ji, Q; Liu, X; Fu, XL; Zhang, L; Sui, H; Zhou, LH; Sun, J; Cai, JF; Qin, JM; Ren, JL; Li, Q				Ji, Qing; Liu, Xuan; Fu, Xiaoling; Zhang, Long; Sui, Hua; Zhou, Lihong; Sun, Jian; Cai, Jianfeng; Qin, Jianmin; Ren, Jianlin; Li, Qi			Resveratrol Inhibits Invasion and Metastasis of Colorectal Cancer Cells via MALAT1 Mediated Wnt/beta-Catenin Signal Pathway	PLOS ONE			English	Article							POLYGONUM-CUSPIDATUM; NONCODING RNA; DOWN-REGULATION; EXPRESSION; EXTRACT; GROWTH; ANTIOXIDANT; TARGET	Resveratrol, extracted from Chinese herbal medicine Polygonum cuspidatum, is known to inhibit invasion and metastasis of human colorectal cancer (CRC), in which long non-coding Metastasis Associated Lung Adenocarcinoma Transcript 1 (RNA-MALAT1) also plays an important role. Using MALAT1 lentiviral shRNA and over-expression constructs in CRC derived cell lines, LoVo and HCT116, we demonstrated that the anti-tumor effects of resveratrol on CRC are through inhibiting Wnt/beta-catenin signaling, thus the expression of its target genes such as c-Myc, MMP-7, as well as the expression of MALAT1. In detail, resveratrol down-regulates MALAT1, resulting in decreased nuclear localization of beta-catenin thus attenuated Wnt/beta-catenin signaling, which leads to the inhibition of CRC invasion and metastasis. This finding of ours surely provides important pre-clinical evidence supporting future use of resveratrol in prevention and treatment of CRC.	[Ji, Qing; Liu, Xuan; Fu, Xiaoling; Sui, Hua; Zhou, Lihong; Li, Qi] Shanghai Univ Tradit Chinese Med, Dept Med Oncol, Shuguang Hosp, Shanghai, Peoples R China; [Ji, Qing; Zhang, Long; Sun, Jian; Qin, Jianmin] Shanghai Univ Tradit Chinese Med, Intervent Canc Inst, Shanghai, Peoples R China; [Ji, Qing; Zhang, Long; Sun, Jian; Qin, Jianmin] Shanghai Univ Tradit Chinese Med, Dept Gen Surg, Shanghai, Peoples R China; [Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Ren, Jianlin] Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; State University System of Florida; University of South Florida	Ren, JL (corresponding author), Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.	renjianlin666@126.com; Lzwf@hotmail.com		Li, Qi/0000-0003-2004-6885	National Natural Science Foundation of China [81202812, 81303102, 81303103]; Shanghai Municipal Education Commission [2011JW57, 12YZ058]; Shanghai Municipal Health Bureau [ZYSNXD-CC-YJXYY-JS20, 2011ZJ030, 20114Y001, 20114037]; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine [C10dz2220200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Municipal Health Bureau; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine	This work was supported by National Natural Science Foundation of China (81202812, 81303102, 81303103), Program of Shanghai Municipal Education Commission (2011JW57, 12YZ058), Shanghai Municipal Health Bureau (ZYSNXD-CC-YJXYY-JS20, 2011ZJ030, 20114Y001, 20114037), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine (C10dz2220200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Back JH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1165, DOI 10.1111/j.1751-1097.2012.01097.x; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2000, VERH DEUT G, V84, P175; Chang JS, 2005, ANTIVIR RES, V66, P29, DOI 10.1016/j.antiviral.2004.12.006; Feng Lei, 2006, Zhong Yao Cai, V29, P689; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Guo Q, 2010, ACTA BIOCH BIOPH SIN, V42, P450, DOI 10.1093/abbs/gmq049; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Hsu CY, 2007, BIOL RES, V40, P13, DOI 10.4067/S0716-97602007000100002; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; JAYATILAKE GS, 1993, J NAT PROD, V56, P1805, DOI 10.1021/np50100a021; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Li ZR, 2011, CELL BIOL INT, V35, P799, DOI 10.1042/CBI20110099; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Nessa MU, 2012, ANTICANCER RES, V32, P53; Olas B, 2005, PLATELETS, V16, P251, DOI 10.1080/09537100400020591; Panaro MA, 2012, BRIT J NUTR, V108, P1623, DOI 10.1017/S0007114511007227; Riles WL, 2006, WORLD J GASTROENTERO, V12, P5628, DOI 10.3748/wjg.v12.i35.5628; Shin JA, 2011, ORAL DIS, V17, P162, DOI 10.1111/j.1601-0825.2010.01710.x; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu XB, 2012, J ETHNOPHARMACOL, V141, P934, DOI 10.1016/j.jep.2012.03.040; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Xu TM, 2008, CHINESE MED J-PEKING, V121, P1394, DOI 10.1097/00029330-200808010-00012; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang JD, 2012, HUM PATHOL, V43, P1044, DOI 10.1016/j.humpath.2011.08.013	36	261	282	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78700	10.1371/journal.pone.0078700	http://dx.doi.org/10.1371/journal.pone.0078700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244343	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600052
J	Kovalenko, PL; Yuan, LS; Sun, KL; Kunovska, L; Seregin, S; Amalfitano, A; Basson, MD				Kovalenko, Pavlo L.; Yuan, Lisi; Sun, Kelian; Kunovska, Lyudmyla; Seregin, Sergey; Amalfitano, Andrea; Basson, Marc D.			Regulation of Epithelial Differentiation in Rat Intestine by Intraluminal Delivery of an Adenoviral Vector or Silencing RNA Coding for Schlafen 3	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; SHORT-BOWEL SYNDROME; COLON-CANCER CELLS; PARENTERAL-NUTRITION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CYCLIC STRAIN; CACO-2 CELLS; BRUSH-BORDER; MOUSE MODEL	Although we stimulate enterocytic proliferation to ameliorate short gut syndrome or mucosal atrophy, less effort has been directed at enterocytic differentiation. Schlafen 3 (Slfn3) is a poorly understood protein induced during IEC-6 enterocytic differentiation. We hypothesized that exogenous manipulation of Slfn3 would regulate enterocytic differentiation in vivo. Adenoviral vector coding for Slfn3 cDNA (Ad-GFP-Slfn3) or silencing RNA for Slfn3 (siSlfn3) was introduced intraluminally into rat intestine. We assessed Slfn3, villin, sucrase-isomaltase (SI), Dpp4, and Glut2 by qRT-PCR, Western blot, and immunohistochemistry. We also studied Slfn3 and these differentiation markers in atrophic defunctionalized jejunal mucosa and the crypt-villus axis of normal jejunum. Ad-GFP-Slfn3 but not Ad-GFP increased Slfn3, villin and Dpp4 expression in human Caco-2 intestinal epithelial cells. Injecting Ad-GFP-Slfn3 into rat jejunum in vivo increased mucosal Slfn3 mRNA three days later vs. intraluminal Ad-GFP. This Slfn3 overexpression was associated with increases in all four differentiation markers. Injecting siSlfn3 into rat jejunum in vivo substantially reduced Slfn3 and all four intestinal mucosal differentiation markers three days later, as well as Dpp4 specific activity. Endogenous Slfn3 was reduced in atrophic mucosa from a blind-end Rouxen-Y anastomosis in parallel with differentiation marker expression together with AKT and p38 signaling. Slfn3 was more highly expressed in the villi than the crypts, paralleling Glut2, SI and Dpp4. Slfn3 is a key intracellular regulator of rat enterocytic differentiation. Understanding how Slfn3 works may identify targets to promote enterocytic differentiation and maintain mucosal function in vivo, facilitating enteral nutrition and improving survival in patients with mucosal atrophy or short gut syndrome.	[Kovalenko, Pavlo L.; Yuan, Lisi; Sun, Kelian; Kunovska, Lyudmyla; Basson, Marc D.] Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA; [Yuan, Lisi; Basson, Marc D.] John D Dingell Vet Affairs Med Ctr, Res Serv, Detroit, MI USA; [Seregin, Sergey; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Basson, MD (corresponding author), Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA.	marc.basson@hc.msu.edu			NIH [1 R56 DK096137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK096137, R01DK096137] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part by NIH 1 R56 DK096137 (MDB). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPIN M, 1988, MOL ASPECTS MED, V10, P257, DOI 10.1016/0098-2997(88)90012-X; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; Basson MD, 1998, CELL TISSUE RES, V292, P553, DOI 10.1007/s004410051084; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; BROWN HO, 1963, AM J PHYSIOL, V205, P868, DOI 10.1152/ajplegacy.1963.205.5.868; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010; Condamine T, J LEUKOC BIOL, V87, P451; Dahly EM, 2004, J NUTR, V134, P530, DOI 10.1093/jn/134.3.530; DARMOUL D, 1992, J BIOL CHEM, V267, P4824; DUDOUET B, 1987, J CELL BIOL, V105, P359, DOI 10.1083/jcb.105.1.359; Efsen E, 2011, Minerva Gastroenterol Dietol, V57, P405; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Flanigan TL, 2009, J SURG RES, V156, P103, DOI 10.1016/j.jss.2009.03.053; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Gayer CP, 2009, AM J PHYSIOL-GASTR L, V296, pG876, DOI 10.1152/ajpgi.90648.2008; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Gespach C, 2005, ONCOGENE, V24, P7953, DOI 10.1038/sj.onc.1209084; Gross I, 2005, ONCOGENE, V24, P7955, DOI 10.1038/sj.onc.1208945; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; HO SB, 1992, J CELL BIOCHEM, P119; IMAI K, 1992, HUM REPROD, V7, P1189, DOI 10.1093/oxfordjournals.humrep.a137824; Jeppesen PB, 2005, GUT, V54, P1224, DOI 10.1136/gut.2004.061440; Kato M, 2004, J CANCER RES CLIN, V130, P73, DOI 10.1007/s00432-003-0510-2; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Kovalenko PL, 2012, AM J PHYSIOL-GASTR L, V303, pG951, DOI 10.1152/ajpgi.00158.2012; Kovalenko PL, 2012, J SURG RES, V177, P63, DOI 10.1016/j.jss.2012.03.011; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Lee NK, 2008, CELL SIGNAL, V20, P2302, DOI 10.1016/j.cellsig.2008.08.019; Lemieux E, 2011, AM J PHYSIOL-GASTR L, V301, pG719, DOI 10.1152/ajpgi.00508.2010; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; MOLL R, 1987, VIRCHOWS ARCH B, V54, P155, DOI 10.1007/BF02899208; Murali SG, 2005, J NUTR, V135, P2553, DOI 10.1093/jn/135.11.2553; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Niwa T, 2005, J HISTOCHEM CYTOCHEM, V53, P75, DOI 10.1369/jhc.4A6443.2005; Oh PS, 2011, AM J PHYSIOL-GASTR L, V301, pG347, DOI 10.1152/ajpgi.00403.2010; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; POULLAIN MG, 1991, CLIN NUTR, V10, P49, DOI 10.1016/0261-5614(91)90081-M; Quaroni A, 2000, AM J PHYSIOL-CELL PH, V279, pC1045, DOI 10.1152/ajpcell.2000.279.4.C1045; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Salerno-Goncalves R, 2011, GASTROENTEROLOGY, V141, pE18, DOI 10.1053/j.gastro.2011.04.062; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Seetharam P, 2011, SAUDI J GASTROENTERO, V17, P229, DOI 10.4103/1319-3767.82573; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Tan EY, 2006, AM J PHYSIOL-CELL PH, V291, pC433, DOI 10.1152/ajpcell.00238.2005; Turner HL, 2010, GUT MICROBES, V1, P22, DOI 10.4161/gmic.1.1.11427; Walsh MF, 2012, AM J SURG, V204, P598, DOI 10.1016/j.amjsurg.2012.07.004; Weih S, 2012, LANGENBECK ARCH SURG, V397, P1043, DOI 10.1007/s00423-011-0874-8; Yang H, 2003, CRIT CARE MED, V31, P1118, DOI 10.1097/01.CCM.0000053523.73064.8A; YOSHIOKA M, 1991, INT J CANCER, V47, P916, DOI 10.1002/ijc.2910470622; Yuan LS, 2010, AM J PHYSIOL-GASTR L, V298, pG994, DOI 10.1152/ajpgi.00517.2009; Zhang JH, 2003, BIOCHEM BIOPH RES CO, V306, P746, DOI 10.1016/S0006-291X(03)01044-1; Ziegler TR, 2003, GASTROENTEROLOGY, V124, P1950, DOI 10.1016/S0016-5085(03)00405-0	60	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79745	10.1371/journal.pone.0079745	http://dx.doi.org/10.1371/journal.pone.0079745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244554	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600149
J	Mogami, T; Yokota, N; Asai-Sato, M; Yamada, R; Koizume, S; Sakuma, Y; Yoshihara, M; Nakamura, Y; Takano, Y; Hirahara, F; Miyagi, Y; Miyagi, E				Mogami, Tae; Yokota, Naho; Asai-Sato, Mikiko; Yamada, Roppei; Koizume, Shiro; Sakuma, Yuji; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Takano, Yasuo; Hirahara, Fumiki; Miyagi, Yohei; Miyagi, Etsuko			Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR MARKER; CARCINOMA; CANCER; IV; CHEMORESISTANCE; RECEPTOR; IDENTIFICATION; HYALURONAN; ACTIVATION	Ovarian clear cell adenocarcinoma (CCC) is the second most common subtype of ovarian cancer after high-grade serous adenocarcinomas. CCC tends to develop resistance to the standard platinum-based chemotherapy, and has a poor prognosis when diagnosed in advanced stages. The ANXA4 gene, along with its product, a Ca++-binding annexin A4 (ANXA4) protein, has been identified as the CCC signature gene. We reported two subtypes of ANXA4 with different isoelectric points (IEPs) that are upregulated in CCC cell lines. Although several in vitro investigations have shown ANXA4 to be involved in cancer cell proliferation, chemoresistance, and migration, these studies were generally based on its overexpression in cells other than CCC. To elucidate the function of the ANXA4 in CCC cells, we established CCC cell lines whose ANXA4 expressions are stably knocked down. Two parental cells were used: OVTOKO contains almost exclusively an acidic subtype of ANXA4, and OVISE contains predominantly a basic subtype but also a detectable acidic subtype. ANXA4 knockdown (KO) resulted in significant growth retardation and greater sensitivity to carboplatin in OVTOKO cells. ANXA4-KO caused significant loss of migration and invasion capability in OVISE cells, but this effect was not seen in OVTOKO cells. We failed to find the cause of the different IEPs of ANXA4, but confirmed that the two subtypes are found in clinical CCC samples in ratios that vary by patient. Further investigation to clarify the mechanism that produces the subtypes is needed to clarify the function of ANXA4 in CCC, and might allow stratification and improved treatment strategies for patients with CCC.	[Mogami, Tae; Yamada, Roppei; Koizume, Shiro; Sakuma, Yuji; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Takano, Yasuo; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Yokohama, Kanagawa 2410815, Japan; [Mogami, Tae; Yokota, Naho; Asai-Sato, Mikiko; Hirahara, Fumiki; Miyagi, Etsuko] Yokohama City Univ, Grad Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa 232, Japan	Kanagawa Prefectural Cancer Center; Yokohama City University	Miyagi, Y (corresponding author), Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	miyagi@gancen.asahi.yokohama.jp; emiyagi@med.yokohama-cu.ac.jp	Mogami, Tae/GXZ-7026-2022		Japan Society for the Promotion of Science [22591860, 25462602]; Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research [23501280, 25462602] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html): grant number 22591860 to EM and 25462602 to EM, YM and RY; and by a grant from the Yokohama Foundation for Advancement of Medical Science to EM (http://igakuz.sakura.ne.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Choi CH, 2013, HUM PATHOL, V44, P1017, DOI 10.1016/j.humpath.2012.08.024; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Foley JP, 2012, J BIOL CHEM, V287, P37406, DOI 10.1074/jbc.M112.360982; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gurung A, 2013, HISTOPATHOLOGY, V62, P59, DOI 10.1111/his.12033; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Han EKH, 2000, BRIT J CANCER, V83, P83; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kim A, 2010, EXPERT OPIN THER TAR, V14, P963, DOI 10.1517/14728222.2010.511180; Kim A, 2009, INT J CANCER, V125, P2316, DOI 10.1002/ijc.24587; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Lin LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044615; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Morita A, 2006, PROTEOMICS, V6, P5880, DOI 10.1002/pmic.200500708; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Sarafian V, 1998, INT J CANCER, V75, P105, DOI 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.3.CO;2-L; Schwartz DR, 2002, CANCER RES, V62, P4722; Shigetomi H, 2012, CANCER INVEST, V30, P473, DOI 10.3109/07357907.2012.681821; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yanagibashi T, 1997, BRIT J CANCER, V76, P829, DOI 10.1038/bjc.1997.471; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	33	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80359	10.1371/journal.pone.0080359	http://dx.doi.org/10.1371/journal.pone.0080359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244679	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600205
J	Tantikanlayaporn, D; Wichit, P; Weerachayaphorn, J; Chairoungdua, A; Chuncharunee, A; Suksamrarn, A; Piyachaturawat, P				Tantikanlayaporn, Duangrat; Wichit, Patsorn; Weerachayaphorn, Jittima; Chairoungdua, Arthit; Chuncharunee, Aporn; Suksamrarn, Apichart; Piyachaturawat, Pawinee			Bone Sparing Effect of a Novel Phytoestrogen Diarylheptanoid from Curcuma comosa Roxb. in Ovariectomized Rats	PLOS ONE			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; ESTROGEN THERAPY; TRABECULAR BONE; FRACTURES; PATHOGENESIS; ACTIVATION; TURNOVER; MECHANISMS; DAIDZEIN; DENSITY	Phytoestrogens have been implicated in the prevention of bone loss in postmenopausal osteoporosis. Recently, an active phytoestrogen from Curcuma comosa Roxb, diarylheptanoid (DPHD), (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol, was found to strongly promote human osteoblast function in vitro. In the present study, we demonstrated the protective effect of DPHD on ovariectomy-induced bone loss (OVX) in adult female Sprague-Dawley rats with 17 beta-estradiol (E-2, 10 mu g/kg Bw) as a positive control. Treatment of OVX animals with DPHD at 25, 50, and 100 mg/kg Bw for 12 weeks markedly increased bone mineral density (BMD) of tibial metaphysis as measured by peripheral Quantitative Computed Tomography (pQCT). Histomorphometric analysis of bone structure indicated that DPHD treatment retarded the ovariectomy-induced deterioration of bone microstructure. Ovariectomy resulted in a marked decrease in trabecular bone volume, number and thickness and these changes were inhibited by DPHD treatment, similar to that seen with E-2. Moreover, DPHD decreased markers of bone turnover, including osteocalcin and tartrate resistant acid phosphatase (TRAP) activity. These results suggest that DPHD has a bone sparing effect in ovariectomy-induced trabecular bone loss and prevents deterioration of bone microarchitecture by suppressing the rate of bone turnover. Therefore, DPHD appears to be a promising candidate for preserving bone mass and structure in the estrogen deficient women with a potential role in reducing postmenopausal osteoporosis.	[Tantikanlayaporn, Duangrat; Wichit, Patsorn; Weerachayaphorn, Jittima; Chairoungdua, Arthit; Piyachaturawat, Pawinee] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand; [Chuncharunee, Aporn] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok, Thailand	Mahidol University; Mahidol University; Ramkhamhaeng University	Piyachaturawat, P (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand.	pawinee.pia@mahidol.ac.th	Piyachaturawat, Pawinee/R-5817-2019; Suksamrarn, Apichart/R-8782-2019; Tantikanlayaporn, Duangrat/AAB-3358-2021	Tantikanlayaporn, Duangrat/0000-0002-1197-4957	Thailand Research Fund (TRF) [PHD/0103/2549]; TRF; Office of the Higher Education Commission; Mahidol University under the National Research and Universities Initiative; National Research Council of Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Office of the Higher Education Commission; Mahidol University under the National Research and Universities Initiative; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study was supported by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (grant PHD/0103/2549 to DT and PP), the Strategic Basic Research Grant of TRF (to PP and to AS), the Office of the Higher Education Commission and Mahidol University under the National Research and Universities Initiative, and The National Research Council of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhukhai K, 2012, J BIOL CHEM, V287, P36168, DOI 10.1074/jbc.M112.344747; Blair HC, 1996, J CELL BIOCHEM, V61, P629, DOI 10.1002/(SICI)1097-4644(19960616)61:4<629::AID-JCB17>3.0.CO;2-A; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Breen SA, 1996, CALCIFIED TISSUE INT, V58, P449, DOI 10.1007/s002239900074; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dang ZC, 2005, TRENDS ENDOCRIN MET, V16, P207, DOI 10.1016/j.tem.2005.05.001; Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; GASSER JA, 1995, BONE, V17, pS145, DOI 10.1016/8756-3282(95)00287-N; Habermann B, 2007, ACTA ORTHOP, V78, P221, DOI 10.1080/17453670710013717; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; LAU KHW, 1987, CLIN CHEM, V33, P458; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Messina MJ, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-17; Ott SM, 2008, CLIN J AM SOC NEPHRO, V3, pS151, DOI 10.2215/CJN.04301206; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Peng XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058361; Piyachaturawat P, 1995, INT J PHARMACOGN, V33, P334, DOI 10.3109/13880209509065388; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Ren P, 2007, PHARMACOLOGY, V79, P129, DOI 10.1159/000098115; Sample SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043215; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Sugimoto E, 2000, BIOCHEM PHARMACOL, V59, P471, DOI 10.1016/S0006-2952(99)00351-2; Suksamrarn A, 2008, BIOORGAN MED CHEM, V16, P6891, DOI 10.1016/j.bmc.2008.05.051; Suntornsaratoon P, 2010, AM J PHYSIOL-ENDOC M, V299, pE426, DOI 10.1152/ajpendo.00134.2010; Tantikanlayaporn D, 2013, PHYTOMEDICINE, V20, P676, DOI 10.1016/j.phymed.2013.02.008; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; Thampithak A, 2009, NEUROSCI LETT, V462, P171, DOI 10.1016/j.neulet.2009.06.094; Urasopon N, 2007, MATURITAS, V56, P322, DOI 10.1016/j.maturitas.2006.09.007; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Weerachayaphorn J, 2011, J ETHNOPHARMACOL, V137, P956, DOI 10.1016/j.jep.2011.06.040; WEINSTEIN RS, 1994, J BONE MINER RES, V9, P1797; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Winuthayanon W, 2009, J AGR FOOD CHEM, V57, P840, DOI 10.1021/jf802702c; WRONSKI TJ, 1988, ENDOCRINOLOGY, V123, P681, DOI 10.1210/endo-123-2-681; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317	40	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78739	10.1371/journal.pone.0078739	http://dx.doi.org/10.1371/journal.pone.0078739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244350	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600057
J	Vignaud, H; Bobo, C; Lascu, I; Sorgjerd, KM; Zako, T; Maeda, M; Salin, B; Lecomte, S; Cullin, C				Vignaud, Helene; Bobo, Claude; Lascu, Ioan; Soergjerd, Karin Margareta; Zako, Tamotsu; Maeda, Mizuo; Salin, Benedicte; Lecomte, Sophie; Cullin, Christophe			A Structure-Toxicity Study of A beta(42) Reveals a New Anti-Parallel Aggregation Pathway	PLOS ONE			English	Article							ANTIPARALLEL BETA-SHEET; ALZHEIMERS-DISEASE; SACCHAROMYCES-CEREVISIAE; PROTEIN OLIGOMERS; COMMON MECHANISM; YEAST MODEL; PEPTIDE; NEURODEGENERATION; FIBRILS; NEUROTOXICITY	Amyloid beta (A beta) peptides produced by APP cleavage are central to the pathology of Alzheimer's disease. Despite widespread interest in this issue, the relationship between the auto-assembly and toxicity of these peptides remains controversial. One intriguing feature stems from their capacity to form anti-parallel beta-sheet oligomeric intermediates that can be converted into a parallel topology to allow the formation of protofibrillar and fibrillar A beta. Here, we present a novel approach to determining the molecular aspects of A beta assembly that is responsible for its in vivo toxicity. We selected A beta mutants with varying intracellular toxicities. In vitro, only toxic A beta (including wild-type A beta(42)) formed urea-resistant oligomers. These oligomers were able to assemble into fibrils that are rich in anti-parallel beta-sheet structures. Our results support the existence of a new pathway that depends on the folding capacity of A beta.	[Vignaud, Helene; Bobo, Claude; Lascu, Ioan; Salin, Benedicte; Cullin, Christophe] Univ Bordeaux Segalen, CNRS UMR 5095, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Soergjerd, Karin Margareta; Zako, Tamotsu; Maeda, Mizuo] Bioengn Lab RIKEN Inst, Wako, Saitama, Japan; [Lecomte, Sophie] Univ Bordeaux 1, CNRS UMR 5248, IPB, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Cullin, C (corresponding author), Univ Bordeaux Segalen, CNRS UMR 5095, Inst Biochim & Genet Cellulaires, Bordeaux, France.	Christophe.Cullin@IBGC.CNRS.Fr	Zako, Tamotsu/C-3004-2012; cullin, christophe/AAM-2179-2020; Maeda, Mizuo/I-3498-2014	cullin, christophe/0000-0003-4110-4677; 	PEPS IDEX; JSPS KAKENHI [24570143]; RIKEN; Grants-in-Aid for Scientific Research [24570143] Funding Source: KAKEN	PEPS IDEX; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the PEPS IDEX 2012 "Analyse structure-toxicite du peptide A beta implique dans l'apparition de la maladie d'Alzheimer" and by JSPS KAKENHI (No. 24570143) and RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Berthelot K, 2009, FASEB J, V23, P2254, DOI 10.1096/fj.08-125724; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Couthouis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004539; CULLIN C, 1994, YEAST, V10, P105, DOI 10.1002/yea.320100110; D'Angelo F, 2013, DIS MODEL MECH, V6, P206, DOI 10.1242/dmm.010108; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	52	28	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80262	10.1371/journal.pone.0080262	http://dx.doi.org/10.1371/journal.pone.0080262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244667	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600198
J	Wang, H; Gao, JE; Zhang, SL; Zhang, MJ; Li, XH				Wang, Hong; Gao, Jian-en; Zhang, Shao-long; Zhang, Meng-jie; Li, Xing-hua			Modeling the Impact of Soil and Water Conservation on Surface and Ground Water Based on the SCS and Visual Modflow	PLOS ONE			English	Article							CLIMATE-CHANGE; RIVER-BASIN; STREAMFLOW; RESOURCES; CATCHMENT; RUNOFF; RECHARGE; SYSTEM	Soil and water conservation measures can impact hydrological cycle, but quantitative analysis of this impact is still difficult in a watershed scale. To assess the effect quantitatively, a three-dimensional finite-difference groundwater flow model (MODFLOW) with a surface runoff model-the Soil Conservation Service (SCS) were calibrated and applied based on the artificial rainfall experiments. Then, three soil and water conservation scenarios were simulated on the sand-box model to assess the effect of bare slope changing to grass land and straw mulching on water volume, hydraulic head, runoff process of groundwater and surface water. Under the 120 mm rainfall, 60 mm/h rainfall intensity, 5 m(2) area, 3 degrees slope conditions, the comparative results indicated that the trend was decrease in surface runoff and increase in subsurface runoff coincided with the land-use converted from bare slope to grass land and straw mulching. The simulated mean surface runoff modulus was 3.64x10(-2) m(3)/m(2)/h in the bare slope scenario, while the observed values were 1.54x10(-2) m(3)/m(2)/h and 0.12x10(-2) m(3)/m(2)/h in the lawn and straw mulching scenarios respectively. Compared to the bare slope, the benefits of surface water reduction were 57.8% and 92.4% correspondingly. At the end of simulation period (T = 396 min), the simulated mean groundwater runoff modulus was 2.82x10(-2) m(3)/m(2)/h in the bare slope scenario, while the observed volumes were 3.46x10(-2) m(3)/m(2)/h and 4.91x10(-2) m(3)/m(2)/h in the lawn and straw mulching scenarios respectively. So the benefits of groundwater increase were 22.7% and 60.4% correspondingly. It was concluded that the soil and water conservation played an important role in weakening the surface runoff and strengthening the underground runoff. Meanwhile the quantitative analysis using a modeling approach could provide a thought for the study in a watershed scale to help decision-makers manage water resources.	[Wang, Hong; Gao, Jian-en] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Jian-en; Zhang, Shao-long; Li, Xing-hua] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en; Zhang, Meng-jie] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Northwest A&F University - China	Gao, JE (corresponding author), Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	gaojianen@126.com			National Technology Support Project [2011BAD31B05]; Natural Science Foundation of China [41371276]; Subject of National Science and Technology Major Project [2009ZX07212-002-003-02]; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project) [A315021304]	National Technology Support Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Subject of National Science and Technology Major Project; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project)	This paper was supported by National Technology Support Project (2011BAD31B05), by Natural Science Foundation of China (41371276), by the Subject of National Science and Technology Major Project (2009ZX07212-002-003-02) and by Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (Soil and Water Conservation Project) (A315021304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2001, HYDROGEOL J, V9, P390, DOI 10.1007/s100400100148; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; BOUGHTON WC, 1989, AUST J SOIL RES, V27, P511, DOI 10.1071/SR9890511; BOUGHTON WC, 1985, J ARID ENVIRON, V9, P13, DOI 10.1016/S0140-1963(18)31268-0; Candela L, 2012, SCI TOTAL ENVIRON, V440, P253, DOI 10.1016/j.scitotenv.2012.06.062; Cho J, 2009, AGR WATER MANAGE, V96, P1, DOI 10.1016/j.agwat.2008.07.005; COOPER JD, 1980, 66 I HYDR; Dams J, 2008, HYDROL EARTH SYST SC, V12, P1369, DOI 10.5194/hess-12-1369-2008; Ferrer J, 2012, SCI TOTAL ENVIRON, V440, P42, DOI 10.1016/j.scitotenv.2012.08.032; FREEZE RA, 1969, WATER RESOUR RES, V5, P153, DOI 10.1029/WR005i001p00153; Guo XJ, 2010, SCI SOIL WATER CONSE, V8, P14; Harbaugh A.W., 1996, USERS DOCUMENTATION; Hill M.C., 2000, MODFLOW 2000, DOI [10.3133/ofr00184, DOI 10.3133/OFR200092]; Hydrogeologic Water, 2005, VISUAL MODFLOW V 4 1; Jain MK, 2006, WATER RESOUR MANAG, V20, P531, DOI 10.1007/s11269-006-3086-1; Kim J, 2013, SCI TOTAL ENVIRON, V452, P181, DOI 10.1016/j.scitotenv.2013.02.005; LAFLEN JM, 1981, T ASAE, V24, P605, DOI 10.13031/2013.34308; [李勉 Li Mian], 2005, [地球科学进展, Advance in Earth Sciences], V20, P74; LI Y, 1997, B SOIL WATER CONSERV, V17, P41; [李裕元 Li Yuyuan], 2004, [水利学报, Journal of Hydraulic Engineering], V0, P48; [李子君 LI Zijun], 2006, [地理科学进展, Progress in geography], V25, P49; Pan P., 2007, LAKE SCI, V19, P710; Paul MJ, 2006, CHINESE GEOGR SCI, V16, P229, DOI 10.1007/s11769-006-0229-5; Pouget L, 2012, SCI TOTAL ENVIRON, V440, P186, DOI 10.1016/j.scitotenv.2012.07.036; [綦俊谕 Qi Junyu], 2011, [地理科学进展, Progress in Geography], V30, P95; Qi S, 2009, T ASABE, V52, P739, DOI 10.13031/2013.27395; Rallison R. E., 1980, S WATERSHED MANAGEME, P912; [冉大川 RAN Dachuan], 2006, [资源科学, Resources science], V28, P93; [任美锷 Ren Meie], 2006, [地球科学进展, Advance in Earth Sciences], V21, P551; Shaanxi Provincial Bureau of Soil and Water Conservation, 1976, SHAANX PROV RUN SED; Shi PJ, 2007, CATENA, V69, P31, DOI 10.1016/j.catena.2006.04.015; Skaggs RW, 2006, NOTES; Sun G, 2004, SRS75198 SO FOR SCI; [唐涛 TANG Tao], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P9; Wang ML, 2004, J WATER RESOURCES RE, V2, P002; WEST LT, 1991, SOIL SCI SOC AM J, V55, P460, DOI 10.2136/sssaj1991.03615995005500020027x; Yellow River Conservancy Commission of MWR, 2010, YELL RIV SED B; Yu B, 1998, J IRRIG DRAIN ENG, V124, P306, DOI 10.1061/(ASCE)0733-9437(1998)124:6(306); Zhang H, 2010, J HYDROL, V392, P136, DOI 10.1016/j.jhydrol.2010.08.002; Zhang WZ, 1983, CALCULATION GROUNDWA; Zhu X., 1960, ACTA PEDOLOGICA SINI, V8, P110; Zhu XM, 1984, B SOIL WATER CONSERV, V1, P15	42	12	12	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79103	10.1371/journal.pone.0079103	http://dx.doi.org/10.1371/journal.pone.0079103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244427	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600108
J	Wisaksana, R; de Mast, Q; Alisjahbana, B; Jusuf, H; Sudjana, P; Indrati, AR; Sumantri, R; Swinkels, D; van Crevel, R; van der Ven, A				Wisaksana, Rudi; de Mast, Quirijn; Alisjahbana, Bachti; Jusuf, Hadi; Sudjana, Primal; Indrati, Agnes R.; Sumantri, Rachmat; Swinkels, Dorine; van Crevel, Reinout; van der Ven, Andre			Inverse Relationship of Serum Hepcidin Levels with CD4 Cell Counts in HIV-Infected Patients Selected from an Indonesian Prospective Cohort Study	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; IRON HOMEOSTASIS; ANEMIA; TUBERCULOSIS; FERROPORTIN; INDIVIDUALS; EXPRESSION; SURVIVAL; REQUIRES	Background: Distortion of iron homeostasis may contribute to the pathogenesis of human immunodeficiency virus (HIV) infection and tuberculosis (TB). We studied the association of the central iron-regulatory hormone hepcidin with the severity of HIV and the association between hepcidin and other markers of iron homeostasis with development of TB. Methods: Three groups of patients were selected from a prospective cohort of HIV-infected subjects in Bandung, Indonesia. The first group consisted of HIV-infected patients who started TB treatment more than 30 days after cohort enrollment (cases). The second group consisted of HIV-infected patients who were matched for age, gender and CD4 cell count to the cases group (matched controls). The third group consisted of HIV-infected patients with CD4 cell counts above 200 cells/mm(3) (unmatched controls). Iron parameters including hepcidin were compared using samples collected at cohort enrollment, and compared with recently published reference values for serum hepcidin. Results: A total of 127 HIV-infected patients were included, 42 cases together with 42 matched controls and 43 unmatched controls. Patients with advanced HIV infection had elevated serum hepcidin and ferritin levels. Hepcidin levels correlated inversely with CD4 cells and hemoglobin. Cases had significantly higher hepcidin and ferritin concentrations at cohort enrollment compared to matched controls, but these differences were fully accounted for by the cases who started TB treatment between day 31 and 60 after enrollment. Hepcidin levels were not different in those with or without hepatitis C infection. Conclusion: Iron metabolism is distorted in advanced HIV infection with CD4 cell counts correlating inversely with serum hepcidin levels. High serum hepcidin levels and hyperferritinemia were found in patients starting TB treatment shortly after cohort enrollment, suggesting that these parameters have a predictive value for development of manifest TB in HIV-infected patients.	[Wisaksana, Rudi; Alisjahbana, Bachti; Jusuf, Hadi; Sudjana, Primal; Sumantri, Rachmat] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia; [Wisaksana, Rudi; Alisjahbana, Bachti; Indrati, Agnes R.] Padjadjaran State Univ, Fac Med, Hlth Res Unit, Bandung, Indonesia; [de Mast, Quirijn; van Crevel, Reinout; van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Indrati, Agnes R.] Padjadjaran State Univ, Hasan Sadikin Hosp, Clin Pathol Fac Med, Bandung, Indonesia; [Swinkels, Dorine] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Universitas Padjadjaran; Radboud University Nijmegen; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Wisaksana, R (corresponding author), Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia.	rudiw98@gmail.com	van der Ven, A.J.A.M./H-8102-2014; van Crevel, reinout/A-6636-2010; de Mast, Quirijn/H-3427-2015; Swinkels, Dorine W./H-8098-2014	van der Ven, A.J.A.M./0000-0003-1833-3391; van Crevel, reinout/0000-0002-6233-6410; Swinkels, Dorine W./0000-0002-1040-9446; de Mast, Quirijn/0000-0001-6056-157X	European Commisssion [SANTE/2005/105-033]	European Commisssion(European Commission)	This study was supported by the European Commisssion (SANTE/2005/105-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2012, J INFECT DIS, V205, P1043, DOI 10.1093/infdis/jis026; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Camaschella C, 2009, HAEMATOL-HEMATOL J, V94, P307, DOI 10.3324/haematol.2008.005405; Chartier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021212; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Dallalio G, 2006, BLOOD, V107, P2702, DOI 10.1182/blood-2005-07-2854; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Hearnshaw S, 2006, WORLD J GASTROENTERO, V12, P5866, DOI 10.3748/wjg.v12.i36.5866; Kanda J, 2008, HAEMATOL-HEMATOL J, V93, P1550, DOI 10.3324/haematol.12399; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Masaisa F, 2012, ANN HEMATOL, V91, P911, DOI 10.1007/s00277-011-1400-3; McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498, DOI 10.1097/QAI.0b013e31815b2d4b; Nekhai S, 2013, FUTURE VIROL, V8, P301, DOI 10.2217/FVL.13.6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Parwati I, 2003, J CLIN MICROBIOL, V41, P5350, DOI 10.1128/JCM.41.11.5350-5351.2003; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Silva VSS, 2005, J GASTROEN HEPATOL, V20, P243, DOI [10.1111/j.1400-1746.2004.03549.x, 10.1111/j.1440-1746.2004.03549.x]; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Stop TB, 2006, IMPR DIAGN TREATM SM; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tripathi Prachi B, 2009, Trop Gastroenterol, V30, P35; Visser A, 2011, CLIN INFECT DIS, V52, P273, DOI 10.1093/cid/ciq126; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Wisaksana R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-213; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104	39	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79904	10.1371/journal.pone.0079904	http://dx.doi.org/10.1371/journal.pone.0079904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244576	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600158
J	Goyet, L; Nishibayashi, LL; Nazzi, T				Goyet, Louise; Nishibayashi, Leo-Lyuki; Nazzi, Thierry			Early Syllabic Segmentation of Fluent Speech by Infants Acquiring French	PLOS ONE			English	Article							WORD SEGMENTATION; LANGUAGE DISCRIMINATION; CUES; STRESS; STATISTICS; PATTERNS; ABILITY; GERMAN; UNITS	Word form segmentation abilities emerge during the first year of life, and it has been proposed that infants initially rely on two types of cues to extract words from fluent speech: Transitional Probabilities (TPs) and rhythmic units. The main goal of the present study was to use the behavioral method of the Headturn Preference Procedure (HPP) to investigate again rhythmic segmentation of syllabic units by French-learning infants at the onset of segmentation abilities (around 8 months) given repeated failure to find syllabic segmentation at such a young age. The second goal was to explore the interaction between the use of TPs and syllabic units for segmentation by French-learning infants. The rationale was that decreasing TP cues around target syllables embedded in bisyllabic words would block bisyllabic word segmentation and facilitate the observation of syllabic segmentation. In Experiments 1 and 2, infants were tested in a condition of moderate TP decrease; no evidence of either syllabic or bisyllabic word segmentation was found. In Experiment 3, infants were tested in a condition of more marked TP decrease, and a novelty syllabic segmentation effect was observed. Therefore, the present study first establishes early syllabic segmentation in French-learning infants, bringing support from a syllable-based language to the proposal that rhythmic units are used at the onset of segmentation abilities. Second, it confirms that French-learning infants are sensitive to TP cues. Third, it demonstrates that they are sensitive to the relative weight of TP and rhythmic cues, explaining why effects of syllabic segmentation are not observed in context of high TPs. These findings are discussed in relation to theories of word segmentation bootstrapping, and the larger debate about statistically- versus prosodically-based accounts of early language acquisition.	[Goyet, Louise; Nishibayashi, Leo-Lyuki; Nazzi, Thierry] Univ Paris 05, Paris, France; [Nazzi, Thierry] CNRS, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Goyet, L (corresponding author), Univ Paris 05, Paris, France.	louise.goyet@gmail.com; thierry.nazzi@parisdescartes.fr		Nishibayashi, Leo-Lyuki/0000-0001-7991-3213; Nazzi, Thierry/0000-0002-4378-3661	Agence Nationale de la Recherche (ANR) [07-BLAN-0014-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This study was conducted with the support of Agence Nationale de la Recherche (ANR) grant #07-BLAN-0014-01. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D., 1967, ELEMENTS GEN PHONETI; ASLIN RN, 1993, NATO ADV SCI INST SE, V69, P305; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Bernard C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00451; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Curtin S, 2005, COGNITION, V96, P233, DOI 10.1016/j.cognition.2004.08.005; Echols CH, 1997, J MEM LANG, V36, P202, DOI 10.1006/jmla.1996.2483; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Gleitman L., 1982, LANG ACQUIS, P3; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Gonzalez Gomez N, 2013, J SPEECH LA IN PRESS; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; Gout A, 2001, THESIS ECOLE HAUTES; Goyet L, 2010, BRAIN RES, V1332, P75, DOI 10.1016/j.brainres.2010.03.047; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hay JH, 2012, INFANCY, V17, P1; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Hohle B, 2003, DEVELOPMENTAL SCI, V6, P122, DOI 10.1111/1467-7687.00261; Houston DM, 2000, PSYCHON B REV, V7, P504, DOI 10.3758/BF03214363; Houston DM, 2004, LANG COGNITIVE PROC, V19, P97, DOI 10.1080/01690960344000143; Johnson EK, 2001, J MEM LANG, V44, P548, DOI 10.1006/jmla.2000.2755; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Jusczyk PW, 1999, PERCEPT PSYCHOPHYS, V61, P1465, DOI 10.3758/BF03213111; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kern S., 2003, GLOSSA, V85, P48; Kooijman V, 2005, COGNITIVE BRAIN RES, V24, P109, DOI 10.1016/j.cogbrainres.2004.12.009; Kooijman V, 2007, THESIS RADBOUD U NIJ; Kooijman V, 2009, INFANCY, V14, P591, DOI 10.1080/15250000903263957; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2001, COGNITION, V78, P91, DOI 10.1016/S0010-0277(00)00109-8; Mattys SL, 2001, J EXP PSYCHOL HUMAN, V27, P644, DOI 10.1037//0096-1523.27.3.644; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Mersad K, 2012, LANG LEARN DEV, V8, P303, DOI 10.1080/15475441.2011.609106; MORGAN JL, 1995, CHILD DEV, V66, P911, DOI 10.2307/1131789; Morgan JL, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P1; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Nazzi T, 2006, J MEM LANG, V54, P283, DOI 10.1016/j.jml.2005.10.004; Nazzi T, 2005, LANG SPEECH, V48, P279, DOI 10.1177/00238309050480030201; Nazzi T, 2000, J MEM LANG, V43, P1, DOI 10.1006/jmla.2000.2698; Nazzi T, J CHILD LAN IN PRESS; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Newman R, 2006, DEV PSYCHOL, V42, P643, DOI 10.1037/0012-1649.42.4.643; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Polka L, 2012, INFANCY, V17, P198, DOI 10.1111/j.1532-7078.2011.00075.x; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Seidl A, 2006, DEVELOPMENTAL SCI, V9, P565, DOI 10.1111/j.1467-7687.2006.00534.x; Shi RS, 2006, PROC ANN BUCLD, P549; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; van de Weijer J., 1998, THESIS U NIJMEGEN	57	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79646	10.1371/journal.pone.0079646	http://dx.doi.org/10.1371/journal.pone.0079646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244536	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900042
J	Mehrotra, H; Vatsa, M; Singh, R; Majhi, B				Mehrotra, Hunny; Vatsa, Mayank; Singh, Richa; Majhi, Banshidhar			Does Iris Change Over Time?	PLOS ONE			English	Article								Iris as a biometric identifier is assumed to be stable over a period of time. However, some researchers have observed that for long time lapse, the genuine match score distribution shifts towards the impostor score distribution and the performance of iris recognition reduces. The main purpose of this study is to determine if the shift in genuine scores can be attributed to aging or not. The experiments are performed on the two publicly available iris aging databases namely, ND-Iris-Template-Aging-2008-2010 and ND-TimeLapseIris-2012 using a commercial matcher, VeriEye. While existing results are correct about increase in false rejection over time, we observe that it is primarily due to the presence of other covariates such as blur, noise, occlusion, and pupil dilation. This claim is substantiated with quality score comparison of the gallery and probe	[Mehrotra, Hunny; Majhi, Banshidhar] Natl Inst Technol NIT Rourkela, Rourkela, India; [Vatsa, Mayank; Singh, Richa] Indraprastha Inst Informat Technol IIIT Delhi, Delhi, India	National Institute of Technology (NIT System); National Institute of Technology Rourkela; Indraprastha Institute of Information Technology Delhi	Vatsa, M (corresponding author), Indraprastha Inst Informat Technol IIIT Delhi, Delhi, India.	mayank@iiitd.ac.in	Vatsa, Mayank/AAR-7199-2020; Vatsa, Mayank/I-5050-2013; Singh, Richa/M-9961-2017	Vatsa, Mayank/0000-0001-5952-2274; Vatsa, Mayank/0000-0001-5952-2274; Singh, Richa/0000-0003-4060-4573				[Anonymous], 2013, IRIS; Baker S.E., 2013, CHAP 11, P205; Baker SE, 2009, LECT NOTES COMPUT SC, V5558, P1170, DOI 10.1007/978-3-642-01793-3_118; Czajka Adam, 2013, Proceedings of the 6th International Conference on Bio-inspired Systems and Signal Processing. BIOSIGNALS 2013, P70; Daugman J, 2003, PATTERN RECOGN, V36, P279, DOI 10.1016/S0031-3203(02)00030-4; Daugman J, 2007, IEEE T SYST MAN CY B, V37, P1167, DOI 10.1109/TSMCB.2007.903540; Daugman J, 2013, PATTERN RECOGN, V46, P609, DOI 10.1016/j.patcog.2012.08.005; Ellavarason E, 2013, HDADASEC2013001 CTR; Fairhurst M, 2011, IET COMPUT VIS, V5, P358, DOI 10.1049/iet-cvi.2010.0165; Fenker S.P., 2012, P 2012 IEEE COMP VIS, P45; Fenker SP, 2013, IEEE ACCESS, V1, P266, DOI 10.1109/ACCESS.2013.2262916; Fenker SP, 2011, P IEEE WORKSH APPL C, P232, DOI DOI 10.1109/WACV.2011.5711508; Kalka ND, 2006, SPIE C BIOM TECHN HU; Masek L., 2003, MATLAB SOURCE CODE B; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Rankin DM, 2012, PATTERN RECOGN, V45, P145, DOI 10.1016/j.patcog.2011.07.019; Sazonova N, 2012, PROC SPIE, V8371, DOI 10.1117/12.919642; Tome-Gonzalez P., 2008, 2 IEEE INT C BIOM TH, P1	18	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78333	10.1371/journal.pone.0078333	http://dx.doi.org/10.1371/journal.pone.0078333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244305	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900012
J	Paiva, G; Proenca, DN; Francisco, R; Verissimo, P; Santos, SS; Fonseca, L; Abrantes, IMO; Morais, PV				Paiva, Gabriel; Proenca, Diogo Neves; Francisco, Romeu; Verissimo, Paula; Santos, Susana S.; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.			Nematicidal Bacteria Associated to Pinewood Nematode Produce Extracellular Proteases	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; ENDOPHYTIC BACTERIA; SERRATIA-MARCESCENS; TRAPPING FUNGUS; PATHOGENICITY; IDENTIFICATION; STRAINS; DISEASE; CUTICLE	Bacteria associated with the nematode Bursaphelenchus xylophilus, a pathogen of trees and the causal agent of pine wilt disease (PWD) may play a role in the disease. In order to evaluate their role (positive or negative to the tree), strains isolated from the track of nematodes from infected Pinus pinaster trees were screened, in vitro, for their nematicidal potential. The bacterial products, from strains more active in killing nematodes, were screened in order to identify and characterize the nematicidal agent. Forty-seven strains were tested and, of these, 21 strains showed capacity to produce extracellular products with nematicidal activity. All Burkholderia strains were non-toxic. In contrast, all Serratia strains except one exhibited high toxicity. Nematodes incubated with Serratia strains showed, by SEM observation, deposits of bacteria on the nematode cuticle. The most nematicidal strain, Serratia sp. A88copa13, produced proteases in the supernatant. The use of selective inhibitors revealed that a serine protease with 70 kDa was majorly responsible for the toxicity of the supernatant. This extracellular serine protease is different phylogenetically, in size and biochemically from previously described proteases. Nematicidal assays revealed differences in nematicidal activity of the proteases to different species of Bursaphelenchus, suggesting its usefulness in a primary screen of the nematodes. This study offers the basis for further investigation of PWD and brings new insights on the role bacteria play in the defense of pine trees against B. xylophilus. Understanding all the factors involved is important in order to develop strategies to control B. xylophilus dispersion.	[Paiva, Gabriel; Proenca, Diogo Neves; Francisco, Romeu; Santos, Susana S.; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, Marine & Environm Res Ctr, IMAR, Coimbra, Portugal; [Verissimo, Paula] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Verissimo, Paula; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), Univ Coimbra, Marine & Environm Res Ctr, IMAR, Coimbra, Portugal.	pvmorais@ci.uc.pt	Verissimo, Paula/AAB-2281-2021; Morais, Paula Vasconcelos/C-9756-2014; Francisco, Romeu/I-1080-2012; Santos, Susana Silva/V-3922-2019; Santos, Susana/I-9588-2019; Abrantes, Isabel/CAG-1426-2022; Proença, Diogo Neves/K-1801-2015	Verissimo, Paula/0000-0003-0532-4242; Morais, Paula Vasconcelos/0000-0002-1939-6389; Francisco, Romeu/0000-0002-4643-6075; Abrantes, Isabel/0000-0002-8761-2151; Proença, Diogo Neves/0000-0002-1284-9082; Fonseca, Luis/0000-0001-7405-8916	Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional; FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-CFL/115373/2009, SFRH/BD/61311/2009]	Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional; FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This research was partially supported by Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional, through a national project 'O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' and by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and by national funds through the Fundacao para a Ciencia e Tecnologia (FCT), Portugal, under the project PTDC/AGR-CFL/115373/2009. D.N.P. was supported by FCT, Portugal, graduate fellowship SFRH/BD/61311/2009. G.P. was supported by FCT, Portugal, fellowship PTDC/AGR-CFL/115373/2009. The authors thank A. P. Piedade, FCTUC, Coimbra, Portugal for support at SEM analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Decraemer W, 2003, BIOL REV, V78, P465, DOI 10.1017/S1464793102006115; Doronina NV, 2010, INT J SYST EVOL MICR, V60, P1044, DOI 10.1099/ijs.0.003152-0; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Guo QQ, 2007, J NEMATOL, V39, P243; Hague N. G. M., 1987, Principles and practice of nematode control in crops., P131; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; HIGGINS D, 1999, JAP SHOK SHOT P INT, P23; Huang XW, 2009, CAN J MICROBIOL, V55, P934, DOI [10.1139/W09-045, 10.1139/w09-045]; Huang XW, 2005, RES MICROBIOL, V156, P719, DOI 10.1016/j.resmic.2005.02.006; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Kim HS, 2007, J IND MICROBIOL BIOT, V34, P715, DOI 10.1007/s10295-007-0245-1; Kong LY, 2010, ARCH MICROBIOL, V192, P585, DOI 10.1007/s00203-010-0585-5; KUSUNOKI M, 1987, Annals of the Phytopathological Society of Japan, V53, P622, DOI 10.3186/jjphytopath.53.622; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Llorcz LV, 2002, MYCOL RES, V106, P499, DOI 10.1017/S0953756202005798; Massaoud MK, 2010, APPL ENVIRON MICROB, V76, P6901, DOI 10.1128/AEM.01567-10; Mossialos D, 2000, APPL ENVIRON MICROB, V66, P487, DOI 10.1128/AEM.66.2.487-492.2000; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Niu QH, 2006, APPL MICROBIOL BIOT, V69, P722, DOI 10.1007/s00253-005-0019-5; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Ovcharenko L. P., 2010, Biopolymers and Cell, V26, P279; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; PROENCA DN, 2011, MICR 11 BRAG PORT MI, P90415; SHAHEEN F, 1984, J NEMATOL, V16, P57; Shimazu Mitsuaki, 2009, V6, P141; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; Stirling G. R., 1991, Biological control of plant parasitic nematodes.; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vleesschauwer D, 2007, CAB REV PERSPECT AGR, V2; Wang M, 2006, CAN J MICROBIOL, V52, P130, DOI 10.1139/W05-110; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yuan Weimin, 2011, Weishengwu Xuebao, V51, P1071; Zhang Q, 2005, APPL ENVIRON MICROB, V71, P7716, DOI 10.1128/AEM.71.12.7716-7723.2005; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817	43	42	44	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79705	10.1371/journal.pone.0079705	http://dx.doi.org/10.1371/journal.pone.0079705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244546	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900045
J	Fjell, CD; Thair, S; Hsu, JL; Walley, KR; Russell, JA; Boyd, J				Fjell, Christopher D.; Thair, Simone; Hsu, Joseph L.; Walley, Keith R.; Russell, James A.; Boyd, John			Cytokines and Signaling Molecules Predict Clinical Outcomes in Sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; INFLAMMATORY MARKERS; PLASMA CYTOKINE; VASOPRESSIN; PNEUMONIA	Introduction: Inflammatory response during sepsis is incompletely understood due to small sample sizes and variable timing of measurements following the onset of symptoms. The vasopressin in septic shock trial (VASST) compared the addition of vasopressin to norepinephrine alone in patients with septic shock. During this study plasma was collected and 39 cytokines measured in a 363 patients at both baseline (before treatment) and 24 hours. Clinical features relating to both underlying health and the acute organ dysfunction induced by the severe infection were collected during the first 28 days of admission. Hypothesis: Cluster analysis of cytokines identifies subgroups of patients at differing risk of death and organ failure. Methods: Circulating cytokines and other signaling molecules were measured using a Luminex multi-bead analyte detection system. Hierarchical clustering was performed on plasma values to create patient subgroups. Enrichment analysis identified clinical outcomes significantly different according to these chemically defined patient subgroups. Logistic regression was performed to assess the importance of cytokines for predicting patient subgroups. Results: Plasma levels at baseline produced three subgroups of patients, while 24 hour levels produced two subgroups. Using baseline cytokine data, one subgroup of 47 patients showed a high level of enrichment for severe septic shock, coagulopathy, renal failure, and risk of death. Using data at 24 hours, a larger subgroup of 81 patients that largely encompassed the 47 baseline subgroup patients had a similar enrichment profile. Measurement of two cytokines, IL2 and CSF2 and their product were sufficient to classify patients into these subgroups that defined clinical risks. Conclusions: A distinct pattern of cytokine levels measured early in the course of sepsis predicts disease outcome. Subpopulations of patients have differing clinical outcomes that can be predicted accurately from small numbers of cytokines. Design of clinical trials and interventions may benefit from consideration of cytokine levels.	[Fjell, Christopher D.; Thair, Simone; Walley, Keith R.; Russell, James A.; Boyd, John] Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Hsu, Joseph L.] Stanford Univ, Stanford, CA 94305 USA	University of British Columbia; Stanford University	Fjell, CD (corresponding author), Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	chris.fjell@hli.ubc.ca		Fjell, Christopher/0000-0001-6304-2628	Canadian Institutes of Health Research [MCT 44152]; Providence Health Care Research Scholarship; MITACS Fellowship; CIHR Fellowship; Department of Anesthesia; Department of Medicine, Division of Pulmonary and Critical Care, Stanford University; UBC/PHC; Canadian Institutes of Health Research (CIHR)(SONRIS)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Providence Health Care Research Scholarship; MITACS Fellowship; CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); Department of Anesthesia; Department of Medicine, Division of Pulmonary and Critical Care, Stanford University; UBC/PHC; Canadian Institutes of Health Research (CIHR)(SONRIS)	Support for VASST provided by the Canadian Institutes of Health Research, Grant number: MCT 44152, Registration: ISRCTN94845869. John Boyd is a recipient of a Providence Health Care Research Scholarship. Simone Thair is a recipient of a MITACS Fellowship. Christopher Fjell is a recipient of a CIHR Fellowship. Support for current study provided by the Department of Anesthesia and Department of Medicine, Division of Pulmonary and Critical Care, Stanford University; James A. Russell (overhead funds UBC/PHC); Canadian Institutes of Health Research (CIHR)(SONRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Heper Y, 2006, EUR J CLIN MICROBIOL, V25, P481, DOI 10.1007/s10096-006-0168-1; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lvovschi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028870; Lyn-Kew K, 2008, CURR PHARM DESIGN, V14, P1870, DOI 10.2174/138161208784980545; MARCHANT A, 1995, J CLIN IMMUNOL, V15, P266, DOI 10.1007/BF01540884; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2013, SHOCK, V39, P127, DOI 10.1097/SHK.0b013e31827dafa7; Rongione AJ, 2000, J GASTROINTEST SURG, V4, P70, DOI 10.1016/S1091-255X(00)80035-9; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2011, CRIT CARE, V15, DOI 10.1186/cc8224; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC	16	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79207	10.1371/journal.pone.0079207	http://dx.doi.org/10.1371/journal.pone.0079207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244449	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800041
J	Huang, D; Lu, N; Fan, QH; Sheng, WQ; Bu, H; Jin, XL; Li, GM; Liu, YH; Li, XH; Sun, WY; Zhang, HZ; Li, XB; Zhou, ZG; Yan, M; Wang, X; Sha, WH; Ji, JF; Cheng, XD; Zhou, ZW; Xu, JM; Du, X				Huang, Dan; Lu, Ning; Fan, Qinhe; Sheng, Weiqi; Bu, Hong; Jin, Xiaolong; Li, Guimei; Liu, Yanhui; Li, Xianghong; Sun, Wenyong; Zhang, Huizhong; Li, Xiaobing; Zhou, Zongguang; Yan, Min; Wang, Xuan; Sha, Weihong; Ji, Jiafu; Cheng, Xiangdong; Zhou, Zhiwei; Xu, Jianming; Du, Xiang			HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SCORING SYSTEM; EXPRESSION; MORTALITY; ESOPHAGEAL; VALIDATION; CARCINOMA; BREAST	Trastuzumab has been approved for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric and gastroesophageal junction cancers (GC and GJC) in combination with chemotherapy. The aim of this HER2 early/advanced gastric epidemiology (HER-EAGLE) study was to evaluate the frequency of HER2 over-expression and to evaluate agreement on HER2 status assessment in GC and GJC patients in local laboratories versus a central laboratory in China. Tumor samples from 734 GC or GJC patients who were enrolled at 11 different hospitals in China were examined. HER2 status was assessed by immunohistochemistry (IHC), and followed by dual-color silver-enhanced in Situ hybridization (DSISH) in IHC 2+ cases. Clinicopathologic characteristics were collected from all of the patients. HER2-positive tumors were identified in 12.0% (88/734) of the GC and GJC cases. There were significantly higher rates of HER2 positivity in patients with GJC (GJC: 18.1%, GC: 9.7%, P=0.002), and intestinal-type cancers using the Lauren classification (intestinal: 23.6%, diffuse/mixed: 4.3%, P<0.0001). No significant difference in HER2 positivity was identified between resection and biopsy samples, or between early and advanced disease stages. The agreement between local laboratories and the central laboratory on HER2 status scoring was good (kappa=0.86). The main reason of HER2 status discordance between local and the central laboratories was IHC result mis-interpretation in local laboratories. These results suggest that IHC followed by DSISH testing is an accurate and cost-effective procedure in China.	[Huang, Dan; Sheng, Weiqi; Du, Xiang] Fudan Univ, Ctr Canc, Dept Pathol, Shanghai 200433, Peoples R China; [Huang, Dan; Sheng, Weiqi; Du, Xiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Lu, Ning] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Fan, Qinhe] Jiangsu Prov Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Bu, Hong] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610064, Peoples R China; [Jin, Xiaolong] Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Li, Guimei] PLA Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Liu, Yanhui] Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Li, Xianghong] Beijing Canc Hosp, Dept Pathol, Beijing, Peoples R China; [Sun, Wenyong] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Huizhong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiaobing] PLA 307 Hosp, Dept Pathol, Beijing, Peoples R China; [Zhou, Zongguang] Sichuan Univ, West China Hosp, Ctr Gastrointestinal Surg, Chengdu 610064, Peoples R China; [Yan, Min] Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Yan, Min] Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Wang, Xuan] PLA Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China; [Sha, Weihong] Guangdong Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Ji, Jiafu] Beijing Canc Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China; [Cheng, Xiangdong] Zhejiang Canc Hosp, Dept Abdominal Surg, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhiwei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Jianming] PLA 307 Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China	Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Nanjing Medical University; Sichuan University; Shanghai Jiao Tong University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Peking University; Zhejiang Cancer Hospital; Sun Yat Sen University; Fifth Medical Center of Chinese PLA General Hospital; Sichuan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Peking University; Zhejiang Cancer Hospital; Sun Yat Sen University; Fifth Medical Center of Chinese PLA General Hospital	Du, X (corresponding author), Fudan Univ, Ctr Canc, Dept Pathol, Shanghai 200433, Peoples R China.	dx2008cn@163.com		, Zongguang/0000-0002-7616-1199; JI, JIAFU/0000-0001-6878-5543	Shanghai ROCHE pharmaceuticals Ltd.	Shanghai ROCHE pharmaceuticals Ltd.	This study was sponsored by Shanghai ROCHE pharmaceuticals Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abrams JA, 2011, CANCER EPIDEM BIOMAR, V20, P183, DOI 10.1158/1055-9965.EPI-10-0802; American Joint Committee on Cancer, 2010, HE TNM STAG CLASS; Babic A, 2010, METHODS, V52, P287, DOI 10.1016/j.ymeth.2010.08.012; Bang YJ, 2010, LANCET, V376, P1302; Garcia-Garcia E, 2011, HISTOPATHOLOGY, V59, P8, DOI 10.1111/j.1365-2559.2011.03894.x; Gomez L, 2012, J CLIN ONCOL, P4089; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing JJ, 2012, WORLD J GASTROENTERO, V18, P1262, DOI 10.3748/wjg.v18.i11.1262; Kataoka Y, 2013, GASTRIC CANCER, V16, P84, DOI 10.1007/s10120-012-0150-9; Lacroix-Triki M, 2006, EUR J CANCER, V42, P2946, DOI 10.1016/j.ejca.2006.06.020; Lindblad M, 2006, ANN SURG, V243, P479, DOI 10.1097/01.sla.0000205825.34452.43; Park YS, 2012, HUM PATHOL, V43, P413, DOI 10.1016/j.humpath.2011.05.019; Ruschoff J, 2010, PATHOLOGE, V31, P208, DOI 10.1007/s00292-010-1278-1; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Sheng WQ, 2013, ANN ONCOL, V24, P2360, DOI 10.1093/annonc/mdt232; Yamashita K, 2011, WORLD J GASTROENTERO, V17, P3390, DOI 10.3748/wjg.v17.i29.3390; Yamashita-Kashima Y, 2011, CLIN CANCER RES, V17, P5060, DOI 10.1158/1078-0432.CCR-10-2927; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang JJ, 2012, EUR J CANCER PREV, V21, P480, DOI 10.1097/CEJ.0b013e328351c732; Zhang M, 2012, HEPATO-GASTROENTEROL, V59, P930, DOI 10.5754/hge09356	24	34	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80290	10.1371/journal.pone.0080290	http://dx.doi.org/10.1371/journal.pone.0080290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244671	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800140
J	Kang, BY; Park, KK; Green, DE; Bijli, KM; Searles, CD; Sutliff, RL; Hart, CM				Kang, Bum-Yong; Park, Kathy K.; Green, David E.; Bijli, Kaiser M.; Searles, Charles D.; Sutliff, Roy L.; Hart, C. Michael			Hypoxia Mediates Mutual Repression between microRNA-27a and PPAR gamma in the Pulmonary Vasculature	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; RANDOMIZED CONTROLLED-TRIALS; SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; EXPRESSION; LUNG; METAANALYSIS; DIFFERENTIATION; ENDOTHELIN-1; ANGIOGENESIS	Pulmonary hypertension (PH) is a serious disorder that causes significant morbidity and mortality. The pathogenesis of PH involves complex derangements in multiple pathways including reductions in peroxisome proliferator-activated receptor gamma (PPAR gamma). Hypoxia, a common PH stimulus, reduces PPAR gamma in experimental models. In contrast, activating PPAR gamma attenuates hypoxia-induced PH and endothelin 1 (ET-1) expression. To further explore mechanisms of hypoxia-induced PH and reductions in PPAR gamma, we examined the effects of hypoxia on selected microRNA (miRNA or miR) levels that might reduce PPAR gamma expression leading to increased ET-1 expression and PH. Our results demonstrate that exposure to hypoxia (10% O-2) for 3-weeks increased levels of miR-27a and ET-1 in the lungs of C57BL/6 mice and reduced PPAR gamma levels. Hypoxia-induced increases in miR-27a were attenuated in mice treated with the PPAR gamma ligand, rosiglitazone (RSG, 10 mg/kg/d) by gavage for the final 10 d of exposure. In parallel studies, human pulmonary artery endothelial cells (HPAECs) were exposed to control (21% O-2) or hypoxic (1% O-2) conditions for 72 h. Hypoxia increased HPAEC proliferation, miR-27a and ET-1 expression, and reduced PPAR gamma expression. These alterations were attenuated by treatment with RSG (10 mu M) during the last 24 h of hypoxia exposure. Overexpression of miR-27a or PPAR gamma knockdown increased HPAEC proliferation and ET-1 expression and decreased PPAR gamma levels, whereas these effects were reversed by miR-27a inhibition. Further, compared to lungs from littermate control mice, miR-27a levels were upregulated in lungs from endothelial-targeted PPAR gamma knockout (ePPAR gamma KO) mice. Knockdown of either SP1 or EGR1 was sufficient to significantly attenuate miR-27a expression in HPAECs. Collectively, these studies provide novel evidence that miR-27a and PPAR gamma mediate mutually repressive actions in hypoxic pulmonary vasculature and that targeting PPAR gamma may represent a novel therapeutic approach in PH to attenuate proliferative mediators that stimulate proliferation of pulmonary vascular cells.	[Hart, C. Michael] Atlanta Vet Affairs Med Ctr, Dept Med, Atlanta, GA USA; Emory Univ, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Hart, CM (corresponding author), Atlanta Vet Affairs Med Ctr, Dept Med, Atlanta, GA USA.	michael.hart3@va.gov		Hart, C. Michael/0000-0002-9145-9938	Veterans Affairs Merit Review Award [1I01BX001910]; NIH [DK 074518, HL102167]; American Heart Association National Scientist Development Grant [13SDG14150004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074518] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by funding from a Veterans Affairs Merit Review Award (1I01BX001910 to CMH), from NIH grants DK 074518 and HL102167 (to CMH and RLS), and from an American Heart Association National Scientist Development Grant (13SDG14150004 to BYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Brock M., 2012, EUR HEART J; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Green David E, 2012, Pulm Circ, V2, P483, DOI 10.4103/2045-8932.105037; Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009; Guo L, 2012, HYPERTENSION, V59, P1006, DOI 10.1161/HYPERTENSIONAHA.111.185413; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hassan T, 2012, EXPERT REV ANTI-INFE, V10, P359, DOI [10.1586/ERI.11.175, 10.1586/eri.11.175]; He B, 2010, CIRC J, V74, P1458, DOI 10.1253/circj.CJ-09-0971; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Joshi Sachindra R, 2011, Pulm Circ, V1, P357, DOI 10.4103/2045-8932.87301; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Lilienfeld DE, 2000, CHEST, V117, P796, DOI 10.1378/chest.117.3.796; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Macchia A, 2007, AM HEART J, V153, P1037, DOI 10.1016/j.ahj.2007.02.037; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; Min S, 2012, GENES IMMUN, V13, P621, DOI 10.1038/gene.2012.45; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Okada M, 2002, FASEB J, V16, P1861, DOI 10.1096/fj.02-0503com; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Ryerson CJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-12; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/867517; White Kevin, 2012, Pulm Circ, V2, P278, DOI 10.4103/2045-8932.101395; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	60	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79503	10.1371/journal.pone.0079503	http://dx.doi.org/10.1371/journal.pone.0079503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244514	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800085
J	Serra-Negra, JM; Paiva, SM; Abreu, MH; Flores-Mendoza, CE; Pordeus, IA				Serra-Negra, Junia Maria; Paiva, Saul Martins; Abreu, Mauro Henrique; Flores-Mendoza, Carmen Elvira; Pordeus, Isabela Almeida			Relationship between Tasks Performed, Personality Traits, and Sleep Bruxism in Brazilian School Children - A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							TEMPOROMANDIBULAR DISORDERS; PHYSICAL-ACTIVITY; PREVALENCE; LABOR; NEUROTICISM; CHILDHOOD; SYMPTOMS; WORK	Background: Tasks can be instruments of stress and may affect the health of children. Sleep bruxism is a multifactorial sleep-related movement disorder that affects children and adults. The aim of the present study was to analyze the association between children's tasks, personality traits and sleep bruxism. Methods And Findings: A cross-sectional, population-based study of 652 randomly selected Brazilian schoolchildren (52% of whom were female), aged from 7 to 10 years was conducted in the city of Belo Horizonte, Brazil. A questionnaire based on criteria proposed by the American Academy of Sleep Medicine (AASM) was completed by parents. In addition, the Neuroticism and Responsibility sub-scales of the Big Five Questionnaire for Children (BFQ-C) were administered to the children. Psychological tests were administered and evaluated by psychologists. The Social Vulnerability Index from the city council database was used to determine the social classification of the families. Chi-square and Poisson regression statistical tests were used with a 95% confidence interval. The majority of families were classified as having low social vulnerability (61.3%), whereas, 38.7% were classified as having high social vulnerability. Regarding extracurricular activities, the majority of girls performed household work (56.4%) and some artistic activity (51.3%) while sporting activities were most common among boys (61%). The results of the Poisson regression model indicated that sleep bruxism was most prevalent in children who scored highly in the Neuroticism sub-scale, and who frequently performed household tasks. Conclusion: Children whose personality domain has a high level of Neuroticism and who perform household chores imposed by the family are more vulnerable to sleep bruxism.	[Serra-Negra, Junia Maria; Paiva, Saul Martins; Pordeus, Isabela Almeida] Univ Fed Minas Gerais, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Flores-Mendoza, Carmen Elvira] Univ Fed Minas Gerais, Dept Psychol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Serra-Negra, JM (corresponding author), Univ Fed Minas Gerais, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	juniaserranegra@hotmail.com	PORDEUS, ISABELA A/B-1570-2013; Flores-Mendoza, Carmen/GXH-1100-2022; Paiva, Saul Martins/H-5757-2012; SERRA-NEGRA, JÚNIA MARIA CHEIB/I-1419-2012; Abreu, Mauro Henrique/G-6502-2012	PORDEUS, ISABELA A/0000-0002-5902-7481; Paiva, Saul Martins/0000-0002-3968-1638; SERRA-NEGRA, JÚNIA MARIA CHEIB/0000-0001-6098-3027; Abreu, Mauro Henrique/0000-0001-8794-5725	National Council for Scientific and Technological Development (CNPq); State of Minas Gerais Research Foundation (FAPEMIG)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the following Brazilian funding agencies: the National Council for Scientific and Technological Development (CNPq) and the State of Minas Gerais Research Foundation (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2003, J APPL DEV PSYCHOL, V24, P241, DOI 10.1016/S0193-3973(03)00046-7; Barbaranelli C, 2003, PERS INDIV DIFFER, V34, P645, DOI 10.1016/S0191-8869(02)00051-X; Barros AJD, 2003, BMC MED RES METHODOL, P3, DOI DOI 10.1186/1471-2288-3-21; Berridge CW, 2011, J FAM ISSUES, V32, P157, DOI 10.1177/0192513X10380832; Braga LD, 2010, CAD SAUDE PUBLICA, V26, P2306; Breslin G, 2012, J PHYS ACT HEALTH, V9, P394, DOI 10.1123/jpah.9.3.394; Buysse DJ, 2003, SLEEP, V26, P48; Camparis CM, 2006, ORAL SURG ORAL MED O, V101, P190, DOI 10.1016/j.tripleo.2005.01.014; Cederquist AV, 2006, ACTA PAEDIATR, V95, P901, DOI 10.1080/080335250600786753; Cheifetz AT, 2005, J DENT CHILD, V72, P67; Cohen R, 2001, INT J COMP SOCIOL, V42, P353, DOI 10.1163/156851801753290379; Degirmencioglu SM, 2008, CHILD SOC, V22, P191, DOI 10.1111/j.1099-0860.2008.00150.x; Dias DM, 2010, ENG SANIT AMBIENT, V15, P155, DOI 10.1590/S1413-41522010000200008; Emodi-Perlman A, 2012, J ORAL REHABIL, V39, P126, DOI 10.1111/j.1365-2842.2011.02254.x; Gager CT, 2009, J FAM ISSUES, V30, P1459, DOI 10.1177/0192513X09336647; Grist RM, 2012, J BEHAV THER EXP PSY, V43, P801, DOI 10.1016/j.jbtep.2011.11.002; Habib RR, 2006, SEX ROLES, V55, P321, DOI 10.1007/s11199-006-9086-z; Kelly RJ, 2011, J FAM PSYCHOL, V25, P412, DOI 10.1037/a0023789; Lam MHB, 2011, SLEEP MED, V12, P641, DOI 10.1016/j.sleep.2010.11.013; Lavigne GJ, 2007, ARCH ORAL BIOL, V52, P381, DOI 10.1016/j.archoralbio.2006.11.017; Manfredini D, 2013, J ORAL REHABIL, V40, P631, DOI 10.1111/joor.12069; Mansur-Alves Marcela, 2009, Psicol. Estud., V14, P807; Mansur-Alves Marcela, 2010, Estud. psicol. (Campinas), V27, P315, DOI 10.1590/S0103-166X2010000300004; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; Ng D. K.-K., 2002, SMJ Singapore Medical Journal, V43, P554; Pai M, 2010, J HEALTH SOC BEHAV, V51, P183, DOI 10.1177/0022146510368933; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Petit D, 2007, PEDIATRICS, V119, pE1016, DOI 10.1542/peds.2006-2132; Potkin KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042191; Restrepo CC, 2008, J ORAL REHABIL, V35, P585, DOI 10.1111/j.1365-2842.2007.01838.x; Schreiber S, 2009, SLEEP MED, V10, P13, DOI 10.1016/j.sleep.2008.02.003; Serra-Negra JM, 2010, EUR ARCH PAEDIATR DE, V11, P192, DOI 10.1007/BF03262743; Serra-Negra JM, 2012, PEDIATR DENT, V34, P30; Serra-Negra JM, 2009, INT J PAEDIATR DENT, V19, P309, DOI 10.1111/j.1365-263X.2009.00973.x; Sharpe JP, 2011, PERS INDIV DIFFER, V51, P946, DOI 10.1016/j.paid.2011.07.033; Shiner R, 2003, J CHILD PSYCHOL PSYC, V44, P2, DOI 10.1111/1469-7610.00101; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Tanaka H, 2012, BIOPSYCHOSOC MED, V6, P20; van de Glind H, 2008, CHILD SOC, V22, P150, DOI 10.1111/j.1099-0860.2008.00147.x; van de Vijver FJR, 2007, SEX ROLES, V57, P813, DOI 10.1007/s11199-007-9316-z; Vreeke LJ, 2012, CHILD PSYCHIAT HUM D, V43, P884, DOI 10.1007/s10578-012-0302-5	42	31	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80075	10.1371/journal.pone.0080075	http://dx.doi.org/10.1371/journal.pone.0080075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244614	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800119
J	Zhang, SW; Li, JJ; Lea, R; Amaya, E; Dorey, K				Zhang, Siwei; Li, Jingjing; Lea, Robert; Amaya, Enrique; Dorey, Karel			A Functional Genome-Wide In Vivo Screen Identifies New Regulators of Signalling Pathways during Early Xenopus Embryogenesis	PLOS ONE			English	Article							MESODERM INDUCTION; TGF-BETA; MAPK PATHWAY; EXPRESSION; GENE; FGF; EMBRYOS; NEURONS; BINDING; ARREST	Embryonic development requires exquisite regulation of several essential processes, such as patterning of tissues and organs, cell fate decisions, and morphogenesis. Intriguingly, these diverse processes are controlled by only a handful of signalling pathways, and mis-regulation in one or more of these pathways may result in a variety of congenital defects and diseases. Consequently, investigating how these signalling pathways are regulated at the molecular level is essential to understanding the mechanisms underlying vertebrate embryogenesis, as well as developing treatments for human diseases. Here, we designed and performed a large-scale gain-of-function screen in Xenopus embryos aimed at identifying new regulators of MAPK/Erk, PI3K/Akt, BMP, and TGF-beta/Nodal signalling pathways. Our gain-of-function screen is based on the identification of gene products that alter the phosphorylation state of key signalling molecules, which report the activation state of the pathways. In total, we have identified 20 new molecules that regulate the activity of one or more signalling pathways during early Xenopus development. This is the first time that such a functional screen has been performed, and the findings pave the way toward a more comprehensive understanding of the molecular mechanisms regulating the activity of important signalling pathways under normal and pathological conditions.	[Zhang, Siwei; Li, Jingjing; Lea, Robert; Amaya, Enrique; Dorey, Karel] Univ Manchester, Fac Life Sci, Healing Fdn Ctr, Manchester, Lancs, England	University of Manchester	Amaya, E (corresponding author), Univ Manchester, Fac Life Sci, Healing Fdn Ctr, Manchester, Lancs, England.	enrique.amaya@manchester.ac.uk; karel.dorey@manchester.ac.uk	Zhang, Siwei/AAM-7361-2021	Zhang, Siwei/0000-0002-1646-063X; Li, Jingjing/0000-0003-4435-7573; Amaya, Enrique/0000-0002-1805-8548; Dorey, Karel/0000-0003-0846-5286; Lea, Robert/0000-0003-0522-3601	Biotechnology and Biological Science Research Council [BB/J005983/1]; Royal Society [55057]; Wellcome Trust [WT082450MA]; Healing Foundation; BBSRC [BB/J005983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005983/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Healing Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant from the Biotechnology and Biological Science Research Council [BB/J005983/1] and a Royal Society Research Grant [ref 55057] to KD, and a Wellcome Trust Programme Grant (WT082450MA) and a project grant from The Healing Foundation to EA. SZ and JL were supported by PhD studentships from The Healing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2002, INT J BIOCHEM CELL B, V34, P699, DOI 10.1016/S1357-2725(01)00150-9; Agius E, 2000, DEVELOPMENT, V127, P1173; Amaya E, 2005, GENOME RES, V15, P1683, DOI 10.1101/gr.3801805; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Callery EM, 2010, DEV BIOL, V340, P75, DOI 10.1016/j.ydbio.2010.01.013; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JA, 2005, MECH DEVELOP, V122, P307, DOI 10.1016/j.mod.2004.11.008; Chung HA, 2004, GENES CELLS, V9, P749, DOI 10.1111/j.1356-9597.2004.00761.x; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Fujitomo T, 2012, CANCER RES, V72, P4110, DOI 10.1158/0008-5472.CAN-12-0159; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Gilchrist MJ, 2004, DEV BIOL, V271, P498, DOI 10.1016/j.ydbio.2004.04.023; Goh SH, 2011, ONCOGENE, V30, P398, DOI 10.1038/onc.2010.422; Greenberg AJ, 2013, LEUKEMIA, V27, P515, DOI 10.1038/leu.2012.232; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hyde CE, 2000, DEVELOPMENT, V127, P1221; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; JONES CM, 1992, DEVELOPMENT, V115, P639; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Komuta Y, 2007, J COMP NEUROL, V503, P454, DOI 10.1002/cne.21401; Lassy RAL, 2000, J BACTERIOL, V182, P2536, DOI 10.1128/JB.182.9.2536-2543.2000; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lou X, 2006, CELL RES, V16, P771, DOI 10.1038/sj.cr.7310093; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Massague J, 2000, GENE DEV, V14, P627; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pollet N, 2000, NUCLEIC ACIDS RES, V28, P139, DOI 10.1093/nar/28.1.139; Rieden PMJID, 2010, DEV DYNAM, V239, P126, DOI 10.1002/dvdy.22020; Rorth P, 1998, DEVELOPMENT, V125, P1049; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schmidt A, 2004, MOL BIOL CELL, V15, p256A; Schohl A, 2002, DEVELOPMENT, V129, P37; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; Smith JC, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002477; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Tsuji Shoji, 2007, Nihon Ronen Igakkai Zasshi, V44, P154; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Uchiyama H, 2001, DEV GROWTH DIFFER, V43, P657; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xing YL, 2012, G3-GENES GENOM GENET, V2, P343, DOI 10.1534/g3.111.001651; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507; Zhong B, 2003, BLOOD, V101, P3240, DOI 10.1182/blood-2001-12-0180; Zhu MY, 2005, GENETICS, V170, P767, DOI 10.1534/genetics.104.039750	81	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79469	10.1371/journal.pone.0079469	http://dx.doi.org/10.1371/journal.pone.0079469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244509	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800080
J	Aradska, J; Smidak, R; Turkovicova, L; Turna, J; Lubec, G				Aradska, Jana; Smidak, Roman; Turkovicova, Lenka; Turna, Jan; Lubec, Gert			Proteomic Differences between Tellurite-Sensitive and Tellurite-Resistant E.coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; IN-VIVO; REDUCTASE; PHAGE; GLUTATHIONE; TOXICITY; PROTECTS; ROLES	Tellurite containing compounds are in use for industrial processes and increasing delivery into the environment generates specific pollution that may well result in contamination and subsequent potential adverse effects on public health. It was the aim of the current study to reveal mechanism of toxicity in tellurite-sensitive and tellurite-resistant E. coli at the protein level. In this work an approach using gel-based mass spectrometrical analysis to identify a differential protein profile related to tellurite toxicity was used and the mechanism of ter operon-mediated tellurite resistance was addressed. E. coli BL21 was genetically manipulated for tellurite-resistance by the introduction of the resistance-conferring ter genes on the pLK18 plasmid. Potassium tellurite was added to cultures in order to obtain a final 3.9 micromolar concentration. Proteins from tellurite-sensitive and tellurite-resistant E. coli were run on 2-D gel electrophoresis, spots of interest were picked, in-gel digested and subsequently analysed by nano-LC-MS/MS (ion trap). In addition, Western blotting and measurement of enzymatic activity were performed to verify the expression of certain candidate proteins. Following exposure to tellurite, in contrast to tellurite-resistant bacteria, sensitive cells exhibited increased levels of antioxidant enzymes superoxide dismutases, catalase and oxidoreductase YqhD. Cysteine desulfurase, known to be related to tellurite toxicity as well as proteins involved in protein folding: GroEL, DnaK and EF-Tu were upregulated in sensitive cells. In resistant bacteria, several isoforms of four essential Ter proteins were observed and following tellurite treatment the abovementioned protein levels did not show any significant proteome changes as compared to the sensitive control. The absence of general defense mechanisms against tellurite toxicity in resistant bacteria thus provides further evidence that the four proteins of the ter operon function by a specific mode of action in the mechanism of tellurite resistance probably involving protein cascades from antioxidant and protein folding pathways.	[Aradska, Jana; Smidak, Roman; Turkovicova, Lenka; Turna, Jan] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Lubec, Gert] Med Univ Vienna, Dept Pediat, Vienna, Austria	Comenius University Bratislava; Medical University of Vienna	Lubec, G (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at	Turňa, Ján/T-2942-2019; Jánošíková, Lenka/AAP-1185-2021	Turňa, Ján/0000-0001-5813-566X; Lubec, Gert/0000-0002-6333-9461; Lubec, Jana/0000-0003-0657-7647	Aktion Osterreich - Slowakei	Aktion Osterreich - Slowakei	Sponsored by a scholarship grant by the Aktion Osterreich - Slowakei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; BEERS RF, 1952, J BIOL CHEM, V195, P133; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; Boudvillain M, 2013, CURR OPIN MICROBIOL, V16, P118, DOI 10.1016/j.mib.2012.12.003; Burian J, 1998, FOLIA MICROBIOL, V43, P589, DOI 10.1007/BF02816374; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Gao YX, 2013, METALLOMICS, V5, P913, DOI 10.1039/c3mt20279h; Garberg P, 1999, INT J BIOCHEM CELL B, V31, P291, DOI 10.1016/S1357-2725(98)00113-7; Italiani VCS, 2002, MOL MICROBIOL, V44, P181, DOI 10.1046/j.1365-2958.2002.02865.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Kuczynska-Wisnik D, 2010, MICROBIOL-SGM, V156, P148, DOI 10.1099/mic.0.032334-0; Lee C, 2010, J BACTERIOL, V192, P4205, DOI 10.1128/JB.01127-09; Lohmeier-Vogel EM, 2004, APPL ENVIRON MICROB, V70, P7342, DOI 10.1128/AEM.70.12.7342-7347.2004; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; St Denis TG, 2011, PHOTOCHEM PHOTOBIOL, V87, P707, DOI 10.1111/j.1751-1097.2011.00902.x; Sunyer B, 2008, J PROTEOME RES, V7, P5237, DOI 10.1021/pr800594b; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Toptchieva A, 2003, MICROBIOL-SGM, V149, P1285, DOI 10.1099/mic.0.25981-0; Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; Venancio TM, 2010, MOL BIOSYST, V6, P1475, DOI 10.1039/c002567b; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; WHELAN KF, 1995, J BACTERIOL, V177, P5016, DOI 10.1128/jb.177.17.5016-5027.1995; Whelan KF, 1997, J BACTERIOL, V179, P63, DOI 10.1128/jb.179.1.63-71.1997; Yao XH, 2006, BIOMED ENVIRON SCI, V19, P309	36	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78010	10.1371/journal.pone.0078010	http://dx.doi.org/10.1371/journal.pone.0078010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244285	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600013
J	Blanco-Fontao, B; Sandercock, BK; Obeso, JR; McNew, LB; Quevedo, M				Blanco-Fontao, Beatriz; Sandercock, Brett K.; Ramon Obeso, Jose; McNew, Lance B.; Quevedo, Mario			Effects of Sexual Dimorphism and Landscape Composition on the Trophic Behavior of Greater Prairie-Chicken	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; ISOTOPE RATIOS PROVIDE; STABLE-ISOTOPES; SIZE DIMORPHISM; BODY-SIZE; NICHE; DIET; FRAGMENTATION; CONSEQUENCES; POPULATION	Partitioning of ecological niche is expected in lekking species that show marked sexual size dimorphism as a consequence of sex-specific ecological constraints. However, niche partitioning is uncertain in species with moderate sexual dimorphism. In addition, the ecological niche of a species may also be affected by landscape composition; particularly, agricultural fragmentation may greatly influence the trophic behavior of herbivores. We studied trophic niche variation in Greater Prairie-Chickens (Tympanuchus cupido), a grouse species that shows moderate sex-dimorphism. Greater Prairie-Chickens are native to tallgrass prairies of North America, although populations persist in less natural mosaics of cropland and native habitats. We used stable isotope analysis of carbon and nitrogen in blood, claws and feathers to assess seasonal differences in trophic niche breadth and individual specialization between male and female Greater Prairie-Chickens, and between birds living in continuous and fragmented landscapes. We found that females showed broader niches and higher individual specialization than males, especially in winter and autumn. However, differences between females and males were smaller in spring when birds converge at leks, suggesting that females and males may exhibit similar feeding behaviors during the lekking period. In addition, we found that birds living in native prairies showed greater annual trophic variability than conspecifics in agricultural mosaic landscapes. Native habitats may provide greater dietary diversity, resulting in greater diversity of feeding strategies.	[Blanco-Fontao, Beatriz; Ramon Obeso, Jose; Quevedo, Mario] UO CSIC PA, Res Unit Biodivers, Asturias, Spain; [Blanco-Fontao, Beatriz; Ramon Obeso, Jose; Quevedo, Mario] Univ Oviedo, Area Ecol, Dpt Biol Organismos & Sistemas, Asturias, Spain; [Sandercock, Brett K.; McNew, Lance B.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Kansas State University	Blanco-Fontao, B (corresponding author), UO CSIC PA, Res Unit Biodivers, Asturias, Spain.	beablancofontao@gmail.com	Sandercock, Brett K/L-1644-2016; Quevedo, Mario/I-2493-2015	Sandercock, Brett K/0000-0002-9240-0268; Quevedo, Mario/0000-0002-6067-3237; Blanco Fontao, Beatriz/0000-0002-5492-2399	PFPU-MEC fellowship; Asturian Environmental Agency [CN-07-174]; Oviedo University [UNOV-08-MB-2]	PFPU-MEC fellowship; Asturian Environmental Agency; Oviedo University	The project was financially supported by a PFPU-MEC fellowship to BBF, grant CN-07-174, from the Asturian Environmental Agency to JRO, and grant UNOV-08-MB-2 from Oviedo University to MQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; [Anonymous], 1994, SEXUAL SELECTION; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Banuelos MJ, 2008, J ORNITHOL, V149, P245, DOI 10.1007/s10336-007-0267-5; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; BJORKLUND M, 1990, J EVOLUTION BIOL, V3, P171, DOI 10.1046/j.1420-9101.1990.3030171.x; Blanco-Fontao B, 2012, J ORNITHOL, V153, P555, DOI 10.1007/s10336-011-0776-0; Blanco-Fontao B, 2010, J ORNITHOL, V151, P269, DOI 10.1007/s10336-009-0452-9; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bulte G, 2008, CAN J ZOOL, V86, P1235, DOI 10.1139/Z08-107; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Catry P, 2005, SEXUAL SEGREGATION V; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Crawley M.J., 2007, R BOOK; de Juana E., 1994, HDB BIRDS WORLD, V2, P376; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; Durell SEALD, 2000, BIOL REV, V75, P503; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gotelli NJ, 2013, ECOSIMR 1 00; Gregory AJ, 2011, STUD AVIAN BIOL, P21; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Jonhson JA, 2011, BIRDS N AM ONLINE; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Madge S., 2002, PHEASANTS PARTRIDGES; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McNew LB, 2011, STUD AVIAN BIOL, P209; McNew LB, 2012, J WILDLIFE MANAGE, V76, P987, DOI 10.1002/jwmg.369; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Payne R.B., 1984, ORNITHOLOGICAL MONOG, V33, P1, DOI DOI 10.2307/40166729; Pekar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014603; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robb L.A., 2005, GREATER PRAIRIE CHIC; ROBEL RJ, 1970, J WILDLIFE MANAGE, V34, P286, DOI 10.2307/3799013; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHROEDER MA, 1991, J FIELD ORNITHOL, V62, P378; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Silvy Nova J., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P374; Storch I., 2007, GROUSE STATUS SURVEY; SUTHERLAND RA, 1993, SOIL SCI SOC AM J, V57, P169, DOI 10.2136/sssaj1993.03615995005700010031x; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P233; Svedarsky W.D., 2022, US GEOLOGICAL SURVEY, P1842; Svedarsky WD, 2000, WILDLIFE BIOL, V6, P277, DOI 10.2981/wlb.2000.027; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Van Gils JA, 2007, ECOLOGY, V88, P2926, DOI 10.1890/06-0904.1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; VANKESSEL C, 1994, SOIL SCI SOC AM J, V58, P382, DOI 10.2136/sssaj1994.03615995005800020020x; Watson A, 2008, GROUSE; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Zuur Alain F., 2009, P1	74	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79986	10.1371/journal.pone.0079986	http://dx.doi.org/10.1371/journal.pone.0079986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244588	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600166
J	Lu, F; Huang, LL; Lei, CT; Sha, GQ; Zheng, H; Liu, XQ; Yang, JY; Shi, Y; Lin, Y; Gong, B; Zhu, XJ; Ma, S; Qiao, LF; Lin, H; Cheng, J; Yang, ZL				Lu, Fang; Huang, Lulin; Lei, Chuntao; Sha, Guiquan; Zheng, Hong; Liu, Xiaoqi; Yang, Jiyun; Shi, Yi; Lin, Ying; Gong, Bo; Zhu, Xianjun; Ma, Shi; Qiao, Lifeng; Lin, He; Cheng, Jing; Yang, Zhenglin			A Novel PRPF31 Mutation in a Large Chinese Family with Autosomal Dominant Retinitis Pigmentosa and Macular Degeneration	PLOS ONE			English	Article							MESSENGER-RNA; STARGARDTS-DISEASE; ABCA4 GENE; RPE65; RP11; EXPRESSION; TRUNCATION; BINDING; LOCUS; ROD	Purpose: This study was intended to identify the disease causing genes in a large Chinese family with autosomal dominant retinitis pigmentosa and macular degeneration. Methods: A genome scan analysis was conducted in this family for disease gene preliminary mapping. Snapshot analysis of selected SNPs for two-point LOD score analysis for candidate gene filter. Candidate gene PRPF31 whole exons' sequencing was executed to identify mutations. Results: A novel nonsense mutation caused by an insertion was found in PRPF31 gene. All the 19 RP patients in 1085 family are carrying this heterozygous nonsense mutation. The nonsense mutation is in PRPF31 gene exon9 at chr19:5462996154629961, inserting nucleotide "A" that generates the coding protein frame shift from p. 307 and early termination at p. 322 in the snoRNA binding domain (NOP domain). Conclusion: This report is the first to associate PRPF31 gene's nonsense mutation and adRP and JMD. Our findings revealed that PRPF31 can lead to different clinical phenotypes in the same family, resulting either in adRP or syndrome of adRP and JMD. We believe our identification of the novel "A" insertion mutation in exon9 at chr19:54629961-54629961 in PRPF31 can provide further genetic evidence for clinical test for adRP and JMD.	[Lu, Fang; Huang, Lulin; Zheng, Hong; Liu, Xiaoqi; Yang, Jiyun; Shi, Yi; Lin, Ying; Gong, Bo; Zhu, Xianjun; Ma, Shi; Lin, He; Cheng, Jing; Yang, Zhenglin] Sichuan Acad Med Sci, Inst Lab Med, Ctr Human Mol Biol & Genet, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Huang, Lulin; Lei, Chuntao; Zheng, Hong; Liu, Xiaoqi; Yang, Jiyun; Shi, Yi; Lin, Ying; Gong, Bo; Zhu, Xianjun; Ma, Shi; Qiao, Lifeng; Lin, He; Cheng, Jing; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Huang, Lulin; Zheng, Hong; Liu, Xiaoqi; Yang, Jiyun; Shi, Yi; Lin, Ying; Gong, Bo; Zhu, Xianjun; Ma, Shi; Lin, He; Cheng, Jing; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Res Hosp, Chengdu, Sichuan, Peoples R China; [Lei, Chuntao; Qiao, Lifeng] Sichuan Acad Med Sci, Affiliated Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Sha, Guiquan] Dechang Cty Hosp Tradit Chinese Med, Liangshan, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Chinese Academy of Sciences; Sichuan Provincial People's Hospital	Yang, ZL (corresponding author), Sichuan Acad Med Sci, Inst Lab Med, Ctr Human Mol Biol & Genet, Chengdu, Sichuan, Peoples R China.	zliny@yahoo.com	Yang, Jiyun/AAS-3937-2020	Zhu, Xianjun/0000-0002-2531-7552	National natural science foundation of China [81070761, 81241001, 81025006, 81271048]; youth science & technology foundation of Sichuan province	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); youth science & technology foundation of Sichuan province	The authors acknowledge the following grants support: National natural science foundation of China (No. 81070761 and 81241001 to FL; No. 81025006 to ZY; No. 81271048 to JY) and youth science & technology foundation of Sichuan province (to FL and to ZY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P351, DOI 10.1093/hmg/3.2.351; AlMaghtheh M, 1996, AM J HUM GENET, V59, P864; Ayyagari R, 2002, GENOMICS, V80, P166, DOI 10.1006/geno.2002.6815; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Deery EC, 2002, HUM MOL GENET, V11, P3209, DOI 10.1093/hmg/11.25.3209; FRANCOIS J, 1979, KLIN MONATSBL AUGENH, V175, P715; Fujita R, 1996, Mol Vis, V2, P4; Gamundi MJ, 2005, MOL VIS, V11, P922; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Golovleva I, 2010, ADV EXP MED BIOL, V664, P255, DOI 10.1007/978-1-4419-1399-9_29; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Khani SC, 2003, INVEST OPHTH VIS SCI, V44, P3570, DOI 10.1167/iovs.02-1287; Lim KP, 2009, ARCH OPHTHALMOL-CHIC, V127, P784, DOI 10.1001/archophthalmol.2009.112; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Lu Sha-Sha, 2005, Zhonghua Yan Ke Za Zhi, V41, P305; Maia-Lopes S, 2008, HUM GENET, V123, P110; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; Michaelides M, 2010, INVEST OPHTH VIS SCI, V51, P4771, DOI 10.1167/iovs.09-4561; Moiseyev G, 2010, P NATL ACAD SCI USA, V107, P17551, DOI 10.1073/pnas.1008769107; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Mullins RF, 2012, INVEST OPHTH VIS SCI, V53, P1883, DOI 10.1167/iovs.12-9477; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Rossi S, 2012, CASE REP OPHTHALM, V3, P410, DOI 10.1159/000345415; Rudolph G, 2002, KLIN MONATSBL AUGENH, V219, P590, DOI 10.1055/s-2002-34425; Safieh LA, 2006, MOL VIS, V12, P384; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P4579, DOI 10.1167/iovs.06-0440; Taira K, 2007, JPN J OPHTHALMOL, V51, P45, DOI 10.1007/s10384-006-0394-1; TALMUD PJ, 1992, CLIN GENET, V42, P62; Tanackovic G, 2009, OPHTHALMIC GENET, V30, P76, DOI 10.1080/13816810902744621; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Wada Y, 2003, ARCH OPHTHALMOL-CHIC, V121, P1613, DOI 10.1001/archopht.121.11.1613; Wang LJ, 2003, AM J MED GENET A, V121A, P235, DOI 10.1002/ajmg.a.20224; Wilkie SE, 2006, BBA-MOL BASIS DIS, V1762, P304, DOI 10.1016/j.bbadis.2005.12.004; Yin J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-56	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78274	10.1371/journal.pone.0078274	http://dx.doi.org/10.1371/journal.pone.0078274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244300	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600023
J	Pachel, C; Mathes, D; Bayer, B; Dienesch, C; Wangorsch, G; Heitzmann, W; Lang, I; Ardehali, H; Ertl, G; Dandekar, T; Wajant, H; Frantz, S				Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Wangorsch, Gaby; Heitzmann, Wolfram; Lang, Isabell; Ardehali, Hossein; Ertl, Georg; Dandekar, Thomas; Wajant, Harald; Frantz, Stefan			Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-INDUCIBLE 14; MONOCYTE CHEMOATTRACTANT PROTEIN-1; B SUBUNIT P50; WEAK INDUCER; NEUTROPHIL DEPLETION; CHEMOKINE RECEPTOR; INTERFERON-GAMMA; APOPTOSIS TWEAK; HEART-FAILURE	Background: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) are upregulated after myocardial infarction (MI) in both humans and mice. They modulate inflammation and the extracellular matrix, and could therefore be important for healing and remodeling after MI. However, the function of TWEAK after MI remains poorly defined. Methods and results: Following ligation of the left coronary artery, mice were injected twice per week with a recombinant human serum albumin conjugated variant of TWEAK (HSA-Flag-TWEAK), mimicking the activity of soluble TWEAK. Treatment with HSA-Flag-TWEAK resulted in significantly increased mortality in comparison to the placebo group due to myocardial rupture. Infarct size, extracellular matrix remodeling, and apoptosis rates were not different after MI. However, HSA-Flag-TWEAK treatment increased infiltration of proinflammatory cells into the myocardium. Accordingly, depletion of neutrophils prevented cardiac ruptures without modulating all-cause mortality. Conclusion: Treatment of mice with HSA-Flag-TWEAK induces myocardial healing defects after experimental MI. This is mediated by an exaggerated neutrophil infiltration into the myocardium.	[Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Heitzmann, Wolfram; Ertl, Georg; Frantz, Stefan] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Pachel, Christina; Mathes, Denise; Bayer, Barbara; Dienesch, Charlotte; Heitzmann, Wolfram; Ertl, Georg; Frantz, Stefan] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Wangorsch, Gaby; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Lang, Isabell; Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Ardehali, Hossein] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Northwestern University	Frantz, S (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	frantz_s@ukw.de	Frantz, Stefan/G-1723-2012; Dandekar, Thomas/A-4431-2017; Wajant, Harald/A-3020-2017	Dandekar, Thomas/0000-0003-1886-7625; Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973; Wangorsch, Gaby/0000-0003-3200-5394	Bundesministerium fur Bildung und Forschung [BMBF01 EO1004]; Deutsche Krebshilfe [DKH 109922]; Deutsche Forschungsgemeinschaft [Da 208/12-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by grants of the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004, to Drs Ertl and Frantz), Deutsche Krebshilfe (DKH 109922, to Dr. Wajant) and Deutsche Forschungsgemeinschaft (Da 208/12-1, to Dr. Dandekar/Dr. Wajant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyanova Desislava, 2012, Blood, V119, pe22, DOI 10.1182/blood-2011-10-387308; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; CHARNEY RH, 1992, CIRCULATION, V85, P1483, DOI 10.1161/01.CIR.85.4.1483; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; CURTIS WE, 1993, ANN THORAC SURG, V56, P1069, DOI 10.1016/0003-4975(95)90015-2; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Echeverry R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-45; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frantz S, 2005, FASEB J, V19, P591, DOI 10.1096/fj.04-2459fje; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; Frantz S, 2007, AM J PATHOL, V171, P507, DOI 10.2353/ajpath.2007.061042; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Haile WB, 2010, J CEREBR BLOOD F MET, V30, P1147, DOI 10.1038/jcbfm.2009.280; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; JOLLY SR, 1986, AM HEART J, V112, P682, DOI 10.1016/0002-8703(86)90461-8; Liehn EA, 2008, J CELL MOL MED, V12, P496, DOI 10.1111/j.1582-4934.2007.00194.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARFAINGKOKA A, 1995, J IMMUNOL, V154, P1870; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; McMurray JJV, 2013, EUR HEART J, V34, P158, DOI 10.1093/eurheartj/ehs370; Meier Karen, 2006, Expert Opin Emerg Drugs, V11, P23, DOI 10.1517/14728214.11.1.23; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Muller N, 2010, BIOCHEM BIOPH RES CO, V396, P793, DOI 10.1016/j.bbrc.2010.04.134; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Shi JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054054, 10.1371/journal.pone.0077651]; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Stephan D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-9; TAUB DD, 1995, J IMMUNOL, V155, P3877; Weir RAP, 2010, CYTOKINE, V50, P158, DOI 10.1016/j.cyto.2010.02.020; Zamilpa R, 2011, AM J PHYSIOL-HEART C, V300, pH1418, DOI 10.1152/ajpheart.01002.2010; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922; Zhu LX, 2012, CHINESE MED J-PEKING, V125, P3898, DOI 10.3760/cma.j.issn.0366-6999.2012.21.028; Zidar N, 2005, CARDIOVASC PATHOL, V14, P247, DOI 10.1016/j.carpath.2005.04.002	56	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78938	10.1371/journal.pone.0078938	http://dx.doi.org/10.1371/journal.pone.0078938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244389	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600083
J	Renard, LM; Bocquet, V; Vidal-Trecan, G; Lair, ML; Blum-Boisgard, C				Renard, Laurence M.; Bocquet, Valery; Vidal-Trecan, Gwenaelle; Lair, Marie-Lise; Blum-Boisgard, Claudine			Adherence to International Follow-Up Guidelines in Type 2 Diabetes: A Longitudinal Cohort Study in Luxembourg	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAM; QUALITY-OF-CARE; GENERAL-PRACTICE; EFFICIENCY; MELLITUS; OUTCOMES; IMPACT	Introduction: Type 2 diabetes is associated with severe micro-and macro-vascular complications. Physicians' and patients' adherence to follow-up guidelines permits postponing or reducing these complications. The objectives were to assess the level of adherence to fundamental follow-up guidelines and determine patients' characteristics associated with this level of adherence in the context of Luxembourg, where no guidelines were implemented. Study population: The exhaustive residing population treated for type 2 diabetes in Luxembourg during the 2000-2006 period (N = 21,068). Methods: Seven fundamental criteria were extracted from international guidelines (consultation with the treating physician, HbA1c tests, electrocardiogram, retinal, dental, lipid and renal check-ups). The factors associated with the level of adherence to those criteria were identified using a partial proportional odds model. Results: In 2006, despite 90% of the patients consulted at least 4 times their treating physician, only 0.6% completed all criteria; 55.0% had no HbA1c test (-8.6 points since 2000) and 31.1% had a renal check-up (+21.6 points). The sex (ORmale: 0.87 [95%CI, 0.83-0.92]), the nationality (ORNonEU: 0.64 [0.52-0.78]), the type of antidiabetic treatment (ORoral: 1.48 [1.35-1.63], ORmixed: 1.35 [1.20-1.52]) and the type of treating physician (ORG-ID: 0.47 [0.42-0.53]) were the main factors associated with the level of adherence in 2006 (3 or more criteria). Conclusion: A large percentage of patients were not provided with a systematic annual follow-up between 2000 and 2006. This study highlighted the necessity to promote guidelines in Luxembourg, education for physicians and to launch a national discussion on a disease management program for diabetic patients.	[Renard, Laurence M.; Lair, Marie-Lise] Publ Res Ctr Hlth, Ctr Hlth Studies, Strassen, Luxembourg; [Renard, Laurence M.; Vidal-Trecan, Gwenaelle; Blum-Boisgard, Claudine] Univ Paris 05, EA Epidemiol Assessment & Hlth Policies 4069, Paris, France; [Bocquet, Valery] Publ Res Ctr Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Vidal-Trecan, Gwenaelle; Blum-Boisgard, Claudine] Univ Paris 05, Dept Publ Hlth, Fac Med, Paris, France; [Vidal-Trecan, Gwenaelle] Cochin St Vincent de Paul Hosp, AP HP, Risk Management & Qual Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Renard, LM (corresponding author), Publ Res Ctr Hlth, Ctr Hlth Studies, Strassen, Luxembourg.	laurence.renard@crp-sante.lu	Bocquet, Valéry/GWC-0796-2022	bocquet, valery/0000-0002-3089-2877; Vidal-Trecan, Gwenaelle/0000-0002-2010-0207	National Fund for Research, Luxembourg [EXT-BFR07-146]	National Fund for Research, Luxembourg	Laurence M. Renard received a grant from the National Fund for Research, Luxembourg (EXT-BFR07-146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.D. Association, 2003, DIABETES CARE, V26, pS33, DOI DOI 10.2337/DIACARE.26.2007.S33; AFSSAPS HAS, 2007, DIABETES METABOLISM, V32; Allison PD, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P631; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS1, DOI 10.2337/dc10-S001; [Anonymous], 2005, DIABETES CARE, V28, pS4; Austin Sam, 2011, WMJ, V110, P132; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Bovier PA, 2007, SWISS MED WKLY, V137, P173; Bruni ML, 2009, HEALTH POLICY, V90, P140, DOI 10.1016/j.healthpol.2008.09.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conseil Scientifique, CONS SCI DOM SANT; de Sante Haute Autorite, 2007, PRIS CHARG VOTR MAL; de Sante Haute Autorite, 2007, GUID AFF LONG DUR DI; Drabik A, 2012, Z EVIDENZ FORTBILD Q, V106, P649, DOI 10.1016/j.zefq.2011.12.007; Flamm M, 2012, WIEN KLIN WOCHENSCHR, V124, P639, DOI 10.1007/s00508-012-0226-x; Flamm M, 2012, EUR J PUBLIC HEALTH, V22, P625, DOI 10.1093/eurpub/ckr147; Flanders WD, 2005, J HEALTH CARE POOR U, V16, P720; German Diabetes Association German Geriatric Society, 2006, EV BAS GUID DIAGN TR; Gravely S, 2012, CAN J CARDIOL, V28, P490, DOI 10.1016/j.cjca.2012.01.004; Gross R, 2003, FAM PRACT, V20, P563, DOI 10.1093/fampra/cmg512; HAS AFSSAPS, 2006, TRAIT MED DIAB TYP 2; Institut national de la statistique et des etudes economiques, 2010, LUX CHIFFR 2010; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Juul L, 2012, PRIM CARE DIABETES, V6, P221, DOI 10.1016/j.pcd.2012.04.001; Kanavos P, 2012, DIABETES EXPENDITURE; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Kramer HU, 2012, AM J MANAG CARE, V18, P362; Levin A, 2008, BLOOD PURIFICAT, V26, P67, DOI 10.1159/000110568; Linder R, 2011, DTSCH ARZTEBL INT, V108, P155, DOI 10.3238/arztebl.2011.0155; Louazel V, 2008, ENJEUX SANTE; Marissal JP, 2005, REV EPIDEMIOL SANTE, V53, P67, DOI 10.1016/S0398-7620(05)84760-1; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; Oh SW, 2011, INT J QUAL HEALTH C, V23, P413, DOI 10.1093/intqhc/mzr036; Ohman-Strickland PA, 2008, ANN FAM MED, V6, P14, DOI 10.1370/afm.758; Ostermann H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-490; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Ratsep A, 2007, Prim Care Diabetes, V1, P93, DOI 10.1016/j.pcd.2007.03.002; Renard L, BMC MED INFORM DECIS; Renard LM, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-23; Renard LM, 2013, RAPPORT NATL DIABETE; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Robert J., 2009, Bulletin Epidemiologique Hebdomadaire, P455; Rothe U, 2008, DIABETES CARE, V31, P863, DOI 10.2337/dc07-0858; Rubin DB., 2004, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Scott A, 2009, HEALTH ECON, V18, P1091, DOI 10.1002/hec.1536; Simon D, 2009, DIABETE DEFINITION D, P3; Sloan Frank A, 2004, Rev Diabet Stud, V1, P29, DOI 10.1900/RDS.2004.1.29; Sonnichsen AC, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-86; Sohn C, 2006, VILLES AGGLOMERATION, P1; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Steuten LMG, 2007, DIABETIC MED, V24, P1112, DOI 10.1111/j.1464-5491.2007.02202.x; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020; Tchicaya A, 2011, 201119 CEPS; Wens J, 2007, RECOMMANDATIONS BONN; WHO Collaborating Centre for Drug Statistics Methodology, 2011, ATC DDD IND 2011; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yamashita T, 2011, J BEHAV MED	61	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80162	10.1371/journal.pone.0080162	http://dx.doi.org/10.1371/journal.pone.0080162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244637	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600188
J	Takahashi, A; Hirohashi, Y; Torigoe, T; Tamura, Y; Tsukahara, T; Kanaseki, T; Kochin, V; Saijo, H; Kubo, T; Nakatsugawa, M; Asanuma, H; Hasegawa, T; Kondo, T; Sato, N				Takahashi, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Tamura, Yasuaki; Tsukahara, Tomohide; Kanaseki, Takayuki; Kochin, Vitaly; Saijo, Hiroshi; Kubo, Terufumi; Nakatsugawa, Munehide; Asanuma, Hiroko; Hasegawa, Tadashi; Kondo, Toru; Sato, Noriyuki			Ectopically Expressed Variant Form of Sperm Mitochondria-Associated Cysteine-Rich Protein Augments Tumorigenicity of the Stem Cell Population of Lung Adenocarcinoma Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DRUG EFFLUX CAPACITY; SIDE POPULATION; CANCER-CELLS; PROSPECTIVE IDENTIFICATION; INITIATING CELLS; T-LYMPHOCYTES; ANTIGEN; GROWTH; TUMORS	Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cancer cells that have self-renewal ability, differentiation ability and high tumor-initiating ability. CSCs/CICs are resistant to cancer therapies including chemotherapy and radiotherapy. Therefore, CSCs/CICs are thought to be responsible for cancer recurrence and distant metastasis after treatment. However, the molecular mechanisms of CSCs/CICs are still elusive. In this study, we isolated CSCs/CICs as side population (SP) cells from lung carcinoma, colon carcinoma and breast carcinoma cells and analyzed the molecular mechanisms of CSCs/CICs. cDNA micro-array screening and RT-PCR analysis revealed that sperm mitochondria-associated cysteine-rich protein (SMCP) is ectopically expressed in SP cells. 5'-Rapid amplification of cDNA end (RACE) analysis revealed that the SMCP transcript in SP cells was a variant form (termed vt2) which is composed from only one exon. SMCP vt2 was detected in only cancer cells, whereas the wild-type (vt1) form of SMCP was expressed in the testis. SMCP was shown to have a role in tumor initiation by SMCP overexpression and SMCP knockdown using siRNAs in lung cancer cells. Taken together, the initiation results indicate that an ectopically expressed variant form of SMCP has a role in tumor initiation of CSCs/CICs and that the variant form of SMCP might be a novel CSC/CIC marker and a potential and promising target of CSC/CIC-targeting therapy.	[Takahashi, Akari; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Tamura, Yasuaki; Tsukahara, Tomohide; Kanaseki, Takayuki; Kochin, Vitaly; Saijo, Hiroshi; Kubo, Terufumi; Nakatsugawa, Munehide; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Kondo, Toru] Hokkaido Univ, Grad Sch Med, Dept Stem Cell Biol, Kita Ku, Sapporo, Hokkaido, Japan; [Takahashi, Akari] Japan Sci & Technol Agcy, Canc Diag Lab, Kita Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Japan Science & Technology Agency (JST)	Hirohashi, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022	Kanaseki, Takayuki/0000-0001-7294-6880	Ministry of Education, Culture, Sports, Science and Technology of Japan [16209013, 17016061, 15659097]; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan [15-17, 19-14]; Ono Cancer Research Fund; Takeda Science Foundation; National Cancer Center Research and Development Fund [23-A-44]; Grants-in-Aid for Scientific Research [24659165] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ono Cancer Research Fund(Ono Cancer Research Fund); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant Nos. 16209013, 17016061 and 15659097) for Practical Application Research from the Japan Science and Technology Agency, and for Cancer Research (15-17 and 19-14) from the Ministry of Health, Labor and Welfare of Japan, Ono Cancer Research Fund (to NS) and Takeda Science Foundation (to YH). This work was supported in part by the National Cancer Center Research and Development Fund (23-A-44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho H, 1996, GENOMICS, V32, P184, DOI 10.1006/geno.1996.0104; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herr JC, 1999, BIOL REPROD, V61, P428, DOI 10.1095/biolreprod61.2.428; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI 10.2217/IMT.10.10; Hirohashi Y, 2010, EXP MOL PATHOL, V88, P128, DOI 10.1016/j.yexmp.2009.09.021; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mori T, 2012, EXP MOL PATHOL, V92, P27, DOI 10.1016/j.yexmp.2011.09.016; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2009, CANCER SCI, V100, P1485, DOI 10.1111/j.1349-7006.2009.01187.x; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	56	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e69095	10.1371/journal.pone.0069095	http://dx.doi.org/10.1371/journal.pone.0069095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244262	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600002
J	Zheng, XG; Chen, L; Li, MS; Lou, QJ; Xia, H; Wang, P; Li, TM; Liu, HY; Luo, LJ				Zheng, Xiaoguo; Chen, Liang; Li, Mingshou; Lou, Qiaojun; Xia, Hui; Wang, Pei; Li, Tiemei; Liu, Hongyan; Luo, Lijun			Transgenerational Variations in DNA Methylation Induced by Drought Stress in Two Rice Varieties with Distinguished Difference to Drought Resistance	PLOS ONE			English	Article							SENSITIVE AMPLIFICATION POLYMORPHISM; EPIGENETIC INHERITANCE; CYTOSINE METHYLATION; AGRONOMIC TRAITS; GENE-EXPRESSION; SALT TOLERANCE; GENOME; ARABIDOPSIS; PATTERNS; ADAPTATION	Adverse environmental conditions have large impacts on plant growth and crop production. One of the crucial mechanisms that plants use in variable and stressful natural environments is gene expression modulation through epigenetic modification. In this study, two rice varieties with different drought resistance levels were cultivated under drought stress from tilling stage to seed filling stage for six successive generations. The variations in DNA methylation of the original generation (G0) and the sixth generation (G6) of these two varieties in normal condition (CK) and under drought stress (DT) at seedling stage were assessed by using Methylation Sensitive Amplification Polymorphism (MSAP) method. The results revealed that drought stress had a cumulative effect on the DNA methylation pattern of both varieties, but these two varieties had different responses to drought stress in DNA methylation. The DNA methylation levels of II-32B (sensitive) and Huhan-3 (resistant) were around 39% and 32%, respectively. Genome-wide DNA methylation variations among generations or treatments accounted for around 13.1% of total MSAP loci in II-32B, but was only approximately 1.3% in Huhan-3. In II-32B, 27.6% of total differentially methylated loci (DML) were directly induced by drought stress and 3.2% of total DML stably transmitted their changed DNA methylation status to the next generation. In Huhan-3, the numbers were 48.8% and 29.8%, respectively. Therefore, entrainment had greater effect on Huhan-3 than on II-32B. Sequence analysis revealed that the DML were widely distributed on all 12 rice chromosomes and that it mainly occurred on the gene's promoter and exon region. Some genes with DML respond to environmental stresses. The inheritance of epigenetic variations induced by drought stress may provide a new way to develop drought resistant rice varieties.	[Zheng, Xiaoguo; Luo, Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zheng, Xiaoguo; Chen, Liang; Li, Mingshou; Lou, Qiaojun; Xia, Hui; Wang, Pei; Li, Tiemei; Liu, Hongyan; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Huazhong Agricultural University	Luo, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	lijun@sagc.org.cn	Xia, Hui/L-7129-2019	Xia, Hui/0000-0003-2446-5171	National High-Tech Research and Development Program of China (863 Plan) [2012AA101102]; National Natural Science Foundation of China [31200279]; National Basic Research Program of China (973 Plan) [2012CB114305]; Postdoctoral Science Foundation of Shanghai [12R21421300]; Talented Person Project [2010CI120]	National High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Plan)(National Basic Research Program of China); Postdoctoral Science Foundation of Shanghai(China Postdoctoral Science Foundation); Talented Person Project	This research was supported by the National High-Tech Research and Development Program of China (863 Plan) (Grant No. 2012AA101102), National Natural Science Foundation of China (Grant no. 31200279), National Basic Research Program of China (973 Plan) (Grant No. 2012CB114305), the Postdoctoral Science Foundation of Shanghai (No. 12R21421300) and Talented Person Project (2010CI120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2010, NEW PHYTOL, V185, P867, DOI 10.1111/j.1469-8137.2010.03189.x; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bhardwaj J, 2013, BIOCHEM GENET, V51, P493, DOI 10.1007/s10528-013-9580-2; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Casas-Mollano JA, 2008, P NATL ACAD SCI USA, V105, P6486, DOI 10.1073/pnas.0711310105; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cui KH, 2008, PHYSIOL PLANTARUM, V132, P53, DOI 10.1111/j.1399-3054.2007.00991.x; DeBolt S, 2010, GENOME BIOL EVOL, V2, P441, DOI 10.1093/gbe/evq033; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Fan Jian-cheng, 2010, Huanjing Kexue, V31, P793; Fu BY, 2007, MOL GENET GENOMICS, V278, P599, DOI 10.1007/s00438-007-0276-3; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lafitte HR, 2006, FIELD CROP RES, V97, P77, DOI 10.1016/j.fcr.2005.08.017; Lavrov SA, 2003, ZH OBSHCH BIOL, V64, P403; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu CF, 1997, THEOR APPL GENET, V94, P145, DOI 10.1007/s001220050393; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mastan SG, 2012, GENE, V508, P125, DOI 10.1016/j.gene.2012.07.063; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Migicovsky Z, 2013, BIOCHEM CELL BIOL, V91, P1, DOI 10.1139/bcb-2012-0046; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakaminami K, 2012, BBA-GENE REGUL MECH, V1819, P149, DOI 10.1016/j.bbagrm.2011.07.015; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Rahavi MR, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00091; Sano H, 2010, PLANT SIGNAL BEHAV, V5, P346, DOI 10.4161/psb.5.4.10803; Saze H, 2012, GENES GENET SYST, V87, P145, DOI 10.1266/ggs.87.145; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shen SL, 2006, SCI CHINA SER C, V49, P97, DOI 10.1007/s11427-006-0097-3; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smita S, 2013, BIOINFORMATION, V9, P72, DOI 10.6026/97320630009072; Steimer A, 2004, CURR OPIN PLANT BIOL, V7, P11, DOI 10.1016/j.pbi.2003.11.008; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WANG GL, 1994, GENETICS, V136, P1421; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Yadav RS, 2002, THEOR APPL GENET, V104, P67, DOI 10.1007/s001220200008; Yi H, 2004, COLD SPRING HARB SYM, V69, P155, DOI 10.1101/sqb.2004.69.155; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076; Zong W, 2013, PLANT MOL BIOL, V81, P175, DOI 10.1007/s11103-012-9990-2	77	60	63	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80253	10.1371/journal.pone.0080253	http://dx.doi.org/10.1371/journal.pone.0080253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244664	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600197
J	Leong, GC; Uda, H				Leong, Gan Chong; Uda, Hashim			Comparative Reliability Studies and Analysis of Au, Pd-Coated Cu and Pd-Doped Cu Wire in Microelectronics Packaging	PLOS ONE			English	Article							COPPER WIRE; BALL BONDS	This paper compares and discusses the wearout reliability and analysis of Gold (Au), Palladium (Pd) coated Cu and Pd-doped Cu wires used in fineline Ball Grid Array (BGA) package. Intermetallic compound (IMC) thickness measurement has been carried out to estimate the coefficient of diffusion (Do) under various aging conditions of different bonding wires. Wire pull and ball bond shear strengths have been analyzed and we found smaller variation in Pd-doped Cu wire compared to Au and Pd-doped Cu wire. Au bonds were identified to have faster IMC formation, compared to slower IMC growth of Cu. The obtained weibull slope, beta of three bonding wires are greater than 1.0 and belong to wearout reliability data point. Pd-doped Cu wire exhibits larger time-to-failure and cycles-to-failure in both wearout reliability tests in Highly Accelerated Temperature and Humidity (HAST) and Temperature Cycling (TC) tests. This proves Pd-doped Cu wire has a greater potential and higher reliability margin compared to Au and Pd-coated Cu wires.	[Leong, Gan Chong; Uda, Hashim] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar, Perlis, Malaysia	Universiti Malaysia Perlis	Leong, GC (corresponding author), Spansion Penang Sdn Bhd, Bayan Lepas, Penang, Malaysia.	clgan_pgg@yahoo.com	Gan, Chong Leong/C-3028-2013	Gan, Chong Leong/0000-0002-2951-1192				[Anonymous], 2010, 22A103D JEDEC JESD; [Anonymous], 2010, JESD22A110D JEDEC; Chauhan P, 2013, J ELECTRON MATER, V42, P2415, DOI 10.1007/s11664-013-2576-1; Classe F., 2011, IEEE INT REL PHYS S, P685; Gan CL, 2013, J MATER SCI-MATER EL, V24, P2803, DOI 10.1007/s10854-013-1174-6; Gan CL, 2013, J NANOMATER, V2013, DOI 10.1155/2013/486373; Gan CL, 2012, J NANOMATER, V2012, DOI 10.1155/2012/173025; Gan C. L., 2010, P 34 IEEE CPMT IEMT, P1; Gan CL, 2013, MICROELECTRON INT, V30, P169, DOI 10.1108/MI-11-2012-0074; Gan CL, 2013, GOLD BULL, V46, P103, DOI 10.1007/s13404-013-0087-8; Gan CL, 2012, IEEE IMPACT 2012 TAI; Gan CL, 2012, IEEE IMPACT 2012 TAI, P18; Harman GG, 1999, WIREBONDING MICROELE; Heraues, 2012, HIGH REL CU WIR PRES; JEDEC, 2009, JESD22A104D JEDEC; Kouters MHM, 2013, MICROELECTRON RELIAB, V53, P1068, DOI 10.1016/j.microrel.2013.02.020; Lassnig A, 2013, MICROELECTRON ENG, V106, P188, DOI 10.1016/j.mee.2013.02.015; Liu PS, 2012, MICROELECTRON RELIAB, V52, P1092, DOI 10.1016/j.microrel.2011.12.013; McPherson JW, 2010, RELIABILITY PHYSICS AND ENGINEERING: TIME-TO-FAILURE MODELING, P1, DOI 10.1007/978-1-4419-6348-2; Uno T, 2011, MICROELECTRON RELIAB, V51, P148, DOI 10.1016/j.microrel.2010.03.006; Wei TC, 2002, J MATER ENG PERFORM, V11, P283, DOI 10.1361/105994902770344088; Xu H, 2013, ACTA MATER, V61, P79, DOI 10.1016/j.actamat.2012.09.030; Yeung Johnny, 2012, Proceedings of the 2012 13th International Conference on Electronic Packaging Technology & High Density Packaging (ICEPT-HDP), P346, DOI 10.1109/ICEPT-HDP.2012.6474631; Zeng Y, 2013, MICROELECTRON RELIAB, DOI [10.1016/j.micro-rel.2013.03.006, DOI 10.1016/J.MICR0-REL.2013.03.006]; Zhong ZW, 2009, MICROELECTRON INT, V26, P10, DOI 10.1108/13565360910923115	25	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78705	10.1371/journal.pone.0078705	http://dx.doi.org/10.1371/journal.pone.0078705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244344	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900023
J	Odhiambo, FO; Beynon, CM; Ogwang, S; Hamel, MJ; Howland, O; van Eijk, AM; Norton, R; Amek, N; Slutsker, L; Laserson, KF; De Cock, KM; Phillips-Howard, PA				Odhiambo, Frank O.; Beynon, Caryl M.; Ogwang, Sheila; Hamel, Mary J.; Howland, Olivia; van Eijk, Anne M.; Norton, Robyn; Amek, Nyaguara; Slutsker, Laurence; Laserson, Kayla F.; De Cock, Kevin M.; Phillips-Howard, Penelope A.			Trauma-Related Mortality among Adults in Rural Western Kenya: Characterising Deaths Using Data from a Health and Demographic Surveillance System	PLOS ONE			English	Article							GLOBAL BURDEN; INTERPERSONAL VIOLENCE; WOMENS HEALTH; INJURY; DISEASE; AFRICA; PEOPLE; ADOLESCENTS; QUALITY; ALCOHOL	Background: Information on trauma-related deaths in low and middle income countries is limited but needed to target public health interventions. Data from a health and demographic surveillance system (HDSS) were examined to characterise such deaths in rural western Kenya. Methods And Findings: Verbal autopsy data were analysed. Of 11,147 adult deaths between 2003 and 2008, 447 (4%) were attributed to trauma; 71% of these were in males. Trauma contributed 17% of all deaths in males 15 to 24 years; on a population basis mortality rates were greatest in persons over 65 years. Intentional causes accounted for a higher proportion of male than female deaths (RR 2.04, 1.37-3.04) and a higher proportion of deaths of those aged 15 to 65 than older people. Main causes in males were assaults (n=79, 25%) and road traffic injuries (n=47, 15%); and falls for females (n=17, 13%). A significantly greater proportion of deaths from poisoning (RR 5.0, 2.7-9.4) and assault (RR 1.8, 1.2-2.6) occurred among regular consumers of alcohol than among non-regular drinkers. In multivariate analysis, males had a 4-fold higher risk of death from trauma than females (Adjusted Relative Risk; ARR 4.0; 95% CI 1.7-9.4); risk of a trauma death rose with age, with the elderly at 7-fold higher risk (ARR 7.3, 1.1-49.2). Absence of care was the strongest predictor of trauma death (ARR 12.2, 9.4-15.8). Trauma-related deaths were higher among regular alcohol drinkers (ARR 1.5, 1.1-1.9) compared with non-regular drinkers. Conclusions: While trauma accounts for a small proportion of deaths in this rural area with a high prevalence of HIV, TB and malaria, preventive interventions such as improved road safety, home safety strategies for the elderly, and curbing harmful use of alcohol, are available and could help diminish this burden. Improvements in systems to record underlying causes of death from trauma are required.	[Odhiambo, Frank O.; Ogwang, Sheila; Amek, Nyaguara; Laserson, Kayla F.; De Cock, Kevin M.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Beynon, Caryl M.; Howland, Olivia] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Hamel, Mary J.; Slutsker, Laurence] Ctr Dis Control & Prevent, Dept Parasit Dis, Atlanta, GA USA; [van Eijk, Anne M.; Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Norton, Robyn] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Norton, Robyn] Univ Oxford, Oxford, England; [Laserson, Kayla F.] Ctr Dis Control & Prevent, India Epidem Intelligence Serv Programme, New Delhi, India; [De Cock, Kevin M.] Ctr Dis Control & Prevent, Nairobi, Kenya	Liverpool John Moores University; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool; George Institute for Global Health; University of Sydney; University of Oxford	Odhiambo, FO (corresponding author), KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya.	FOdhiambo@kemricdc.org	van Eijk, Anna Maria/AAQ-9894-2021	Phillips-Howard, Penelope A/0000-0003-1018-116X; Howland, Olivia/0000-0003-4109-7833; van Eijk, Anna Maria/0000-0003-1635-1289	KEMRI/CDC Cooperative Agreement grant; Medical Research Council [G1100677] Funding Source: researchfish; MRC [G1100677] Funding Source: UKRI	KEMRI/CDC Cooperative Agreement grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The HDSS and field staff support has been funded through the KEMRI/CDC Cooperative Agreement grant, with supplemental support from project-specific grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2011, WORLD HLTH STAT; Azetsop J, 2010, PUBLIC HEALTH ETH-UK, V3, P115, DOI 10.1093/phe/phq013; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Bhalla K, 2010, B WORLD HEALTH ORGAN, V88, P831, DOI 10.2471/BLT.09.068809; Borse NN, 2009, INDIAN J MED RES, V129, P321; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2011, B WORLD HEALTH ORGAN, V89, P2, DOI 10.2471/BLT.10.085217; Garrib A, 2011, TROP MED INT HEALTH, V16, P439, DOI 10.1111/j.1365-3156.2011.02730.x; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Lo TQ, 2013, TROP MED INT HEALTH, V18, P506, DOI 10.1111/tmi.12066; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Norman R, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-32; Odero W, 2007, East Afr Med J, V84, P367; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Otieno T, 2004, INJURY, V35, P1228, DOI 10.1016/j.injury.2004.03.013; Papas RK, 2010, AIDS BEHAV, V14, P836, DOI 10.1007/s10461-008-9492-z; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Ranney ML, 2009, INJURY PREV, V15, P36, DOI 10.1136/ip.2008.019547; Rehm J, 2010, DRUG ALCOHOL REV, V29, P426, DOI 10.1111/j.1465-3362.2009.00140.x; Ribeiro PS, 2008, INT J GYNECOL OBSTET, V102, P82, DOI 10.1016/j.ijgo.2008.01.025; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; WHO, 2004, GLOB STAT REP ALC 20; World Health Organization, 2007, WHO GLOB REP FALLP	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79840	10.1371/journal.pone.0079840	http://dx.doi.org/10.1371/journal.pone.0079840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244569	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327162900055
J	Pluchon, PF; Fouqueau, T; Creze, C; Laurent, S; Briffotaux, J; Hogrel, G; Palud, A; Henneke, G; Godfroy, A; Hausner, W; Thomm, M; Nicolas, J; Flament, D				Pluchon, Pierre-Francois; Fouqueau, Thomas; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Hausner, Winfried; Thomm, Michael; Nicolas, Jacques; Flament, Didier			An Extended Network of Genomic Maintenance in the Archaeon Pyrococcus abyssi Highlights Unexpected Associations between Eucaryotic Homologs	PLOS ONE			English	Article							REPLICATION PROTEIN-A; HYPERTHERMOPHILIC ARCHAEON; DNA-POLYMERASES; HETERODIMERIC PRIMASE; HALOPHILIC ARCHAEON; EXCISION-REPAIR; HELICASE; BINDING; FAMILY; MRE11	In Archaea, the proteins involved in the genetic information processing pathways, including DNA replication, transcription, and translation, share strong similarities with those of eukaryotes. Characterizations of components of the eukaryotic-type replication machinery complex provided many interesting insights into DNA replication in both domains. In contrast, DNA repair processes of hyperthermophilic archaea are less well understood and very little is known about the intertwining between DNA synthesis, repair and recombination pathways. The development of genetic system in hyperthermophilic archaea is still at a modest stage hampering the use of complementary approaches of reverse genetics and biochemistry to elucidate the function of new candidate DNA repair gene. To gain insights into genomic maintenance processes in hyperthermophilic archaea, a protein-interaction network centred on informational processes of Pyrococcus abyssi was generated by affinity purification coupled with mass spectrometry. The network consists of 132 interactions linking 87 proteins. These interactions give insights into the connections of DNA replication with recombination and repair, leading to the discovery of new archaeal components and of associations between eucaryotic homologs. Although this approach did not allow us to clearly delineate new DNA pathways, it provided numerous clues towards the function of new molecular complexes with the potential to better understand genomic maintenance processes in hyperthermophilic archaea. Among others, we found new potential partners of the replication clamp and demonstrated that the single strand DNA binding protein, Replication Protein A, enhances the transcription rate, in vitro, of RNA polymerase. This interaction map provides a valuable tool to explore new aspects of genome integrity in Archaea and also potentially in Eucaryotes.	[Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] Univ Bretagne Occidentale, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Pluchon, Pierre-Francois; Creze, Christophe; Laurent, Sebastien; Briffotaux, Julien; Hogrel, Gaelle; Palud, Adeline; Henneke, Ghislaine; Godfroy, Anne; Flament, Didier] CNRS, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Fouqueau, Thomas; Hausner, Winfried; Thomm, Michael] Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; [Nicolas, Jacques] IRISA INRIA, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; University of Regensburg; UDICE-French Research Universities; Universite Paris Saclay	Nicolas, J (corresponding author), IRISA INRIA, Campus Beaulieu, Rennes, France.	Jacques.Nicolas@irisa.fr; dflament@ifremer.fr	Anne, Godfroy/J-9897-2017; LAURENT, Sébastien/ABF-4382-2020; Godfroy, Anne/X-1992-2018; Briffotaux, Julien/AAG-2189-2021; , Protim/C-4687-2012	Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Briffotaux, Julien/0000-0002-0084-5818; Fouqueau, Thomas/0000-0003-1539-093X; Henneke, Ghislaine/0000-0002-2985-5526; flament, didier/0000-0002-9847-2342; Hogrel, Gaelle/0000-0003-4078-0577	Ifremer; French National Research Agency [ANR-07-BLAN-0371]; Brittany regional council, CREATE program [REPAR] [4852]; Deutsche Forschungsgemeinschaft [TH 422/11-1]	Ifremer; French National Research Agency(French National Research Agency (ANR)); Brittany regional council, CREATE program [REPAR](Region Bretagne); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Ifremer; French National Research Agency [ANR-07-BLAN-0371 to D.F.]; Brittany regional council, CREATE program [REPAR No4852 to D.F.]; Deutsche Forschungsgemeinschaft [TH 422/11-1 to M.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Atomi H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00337; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beattie TR, 2011, CURR OPIN CHEM BIOL, V15, P614, DOI 10.1016/j.cbpa.2011.07.017; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Busch CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009045; Chan PP, 2012, NUCLEIC ACIDS RES, V40, pD646, DOI 10.1093/nar/gkr990; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; Creze C, 2012, J BIOL CHEM; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Duxin JP, 2012, J BIOL CHEM, V287, P21980, DOI 10.1074/jbc.M112.359018; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Godfroy A, 2006, METHOD MICROBIOL, V35, P93, DOI 10.1016/S0580-9517(05)35004-5; Gouge J, 2012, J MOL BIOL, V423, P315, DOI 10.1016/j.jmb.2012.07.025; Grogan DW, 2004, CURR ISSUES MOL BIOL, V6, P137; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Hu JC, 2012, NUCLEIC ACIDS RES, V40, P3470, DOI 10.1093/nar/gkr1256; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; King NP, 2008, J MOL BIOL, V380, P181, DOI 10.1016/j.jmb.2008.04.073; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Lin YY, 2008, J BACTERIOL, V190, P5766, DOI 10.1128/JB.01930-07; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; MacNeill SA, 2011, BIOCHEM SOC T, V39, P163, DOI 10.1042/BST0390163; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Palud A, 2008, MOL MICROBIOL, V70, P746, DOI 10.1111/j.1365-2958.2008.06446.x; Pan M, 2011, BIOCHEM SOC T, V39, P20, DOI 10.1042/BST0390020; Perugino G, 2012, J BIOL CHEM, V287, P4222, DOI 10.1074/jbc.M111.308320; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Ren B, 2007, ACTA CRYSTALLOGR F, V63, P406, DOI 10.1107/S1744309107015278; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Richard DJ, 2004, NUCLEIC ACIDS RES, V32, P1065, DOI 10.1093/nar/gkh259; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sartori AA, 2003, J BIOL CHEM, V278, P24563, DOI 10.1074/jbc.M302397200; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shin JH, 2007, J BIOL CHEM, V282, P4908, DOI 10.1074/jbc.M606847200; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Skowyra A, 2012, NUCLEIC ACIDS RES, V40, P1077, DOI 10.1093/nar/gkr838; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108	75	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79707	10.1371/journal.pone.0079707	http://dx.doi.org/10.1371/journal.pone.0079707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244547	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900046
J	Arope, S; Harraghy, N; Pjanic, M; Mermod, N				Arope, Salina; Harraghy, Niamh; Pjanic, Milos; Mermod, Nicolas			Molecular Characterization of a Human Matrix Attachment Region Epigenetic Regulator	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSGENE EXPRESSION; CHROMATIN LOOP; MAR ELEMENTS; CELL-LINES; ORGANIZATION; ASSOCIATION; PREDICTION; PROTEINS; DYNAMICS	Matrix attachment regions (MAR) generally act as epigenetic regulatory sequences that increase gene expression, and they were proposed to partition chromosomes into loop-forming domains. However, their molecular mode of action remains poorly understood. Here, we assessed the possible contribution of the AT-rich core and adjacent transcription factor binding motifs to the transcription augmenting and anti-silencing effects of human MAR 1-68. Either flanking sequences together with the AT-rich core were required to obtain the full MAR effects. Shortened MAR derivatives retaining full MAR activity were constructed from combinations of the AT-rich sequence and multimerized transcription factor binding motifs, implying that both transcription factors and the AT-rich microsatellite sequence are required to mediate the MAR effect. Genomic analysis indicated that MAR AT-rich cores may be depleted of histones and enriched in RNA polymerase II, providing a molecular interpretation of their chromatin domain insulator and transcriptional augmentation activities.	[Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Lausanne, Switzerland; UNIL EPFL, Ctr Biotechnol, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mermod, N (corresponding author), Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Lausanne, Switzerland.	nicolas.mermod@unil.ch	Pjanic, Milos/AAH-1262-2019	Pjanic, Milos/0000-0001-9746-8838	Swiss Commission for Technology and Innovation, Selexis SA; Etat de Vaud	Swiss Commission for Technology and Innovation, Selexis SA; Etat de Vaud	This work was supported by grants from the Swiss Commission for Technology and Innovation, Selexis SA, and by the Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Boulikas T, 1995, INT REV CYTOL, V162A, P279; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Esnault G, 2009, MOL CELL BIOL, V29, P2409, DOI 10.1128/MCB.00779-08; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Galbete JL, 2009, MOL BIOSYST, V5, P143, DOI 10.1039/b813657b; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Girod PA, 2003, N COMP BIOC, V38, P359; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Gorman C, 2009, CELL ENG, V6, P1, DOI 10.1007/978-90-481-2245-5_1; Grandjean M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr436; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Heng HHQ, 2001, CYTOGENET CELL GENET, V93, P155, DOI 10.1159/000056977; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kim JD, 2005, BIOTECHNOL PROGR, V21, P933, DOI 10.1021/bp049598v; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; KLEHR D, 1991, BIOCHEMISTRY-US, V30, P1264, DOI 10.1021/bi00219a015; Kumar R, 2004, MOL CARCINOGEN, V41, P221, DOI 10.1002/mc.20056; KUMAR S, 1986, BIOCHEMISTRY-US, V25, P2055, DOI 10.1021/bi00356a033; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Linnemann AK, 2009, NUCLEIC ACIDS RES, V37, P2779, DOI 10.1093/nar/gkp135; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; PhiVan L, 1996, BIOCHEMISTRY-US, V35, P10735, DOI 10.1021/bi9603783; Pjanic M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-99; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Puttini S, 2009, MOL THER, V17, P19, DOI 10.1038/mt.2008.239; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; VONKRIES JP, 1990, NUCLEIC ACIDS RES, V18, P3881; Wang DM, 1996, J LIPID RES, V37, P2117; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	44	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79262	10.1371/journal.pone.0079262	http://dx.doi.org/10.1371/journal.pone.0079262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244463	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800050
J	Duarte, JH; Di Meglio, P; Hirota, K; Ahlfors, H; Stockinger, B				Duarte, Joao H.; Di Meglio, Paola; Hirota, Keiji; Ahlfors, Helena; Stockinger, Brigitta			Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo	PLOS ONE			English	Article							REGULATORY T-CELLS; AH RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; SELF-TOLERANCE; ROR-GAMMA; ACTIVATION; INDUCTION; LIGAND; DIOXIN	The aryl hydrocarbon receptor (AhR) has been attributed with anti-inflammatory effects in the development of pathological immune responses leading to experimental autoimmune encephalomyelitis (EAE) via the induction of regulatory T cells. In agreement with previously published findings, we find that TCDD administration confers protection from EAE, however, this immuno-modulatory effect was not the consequence of de novo Treg generation, but the inhibition of Th17 cell differentiation. Systemic application of FICZ at the time of immunization also reduced EAE pathology albeit to a lesser degree than TCDD. In vitro Th17 differentiation in the presence of AhR agonists, including TCDD, promoted IL-17 and IL-22 expression, but did not induce Treg differentiation. AhR affinity influenced the amounts of IL-17 and IL-22 protein that was secreted by Th17 cells, but did not seem to affect susceptibility to EAE in vivo. Making use of conditional AhR-deficient mice, we show that the anti-inflammatory effect of TCDD depends on AhR activation in both T cells and dendritic cells, further emphasising the ability of TCDD to interfere with T effector cell differentiation in vivo. The dichotomy between the in vivo and in vitro effects of AhR reveals the complexity of the AhR pathway, which has the capacity of affecting different AhR-expressing cell types involved in mounting immune responses, thus participating in defining their outcome.	[Duarte, Joao H.; Di Meglio, Paola; Hirota, Keiji; Ahlfors, Helena; Stockinger, Brigitta] MRC Natl Inst Med Res, Div Mol Immunol, London, England	MRC National Institute for Medical Research	Stockinger, B (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, London, England.	bstocki@nimr.mrc.ac.uk		Di Meglio, Paola/0000-0002-2066-7780; Ahlfors, Helena/0000-0002-8183-0895; Duarte, Joao H./0000-0001-7186-4947; Hirota, Keiji/0000-0002-4737-0661; Stockinger, Brigitta/0000-0001-8781-336X	ERC [232782]	ERC(European Research Council (ERC)European Commission)	This study is funded by an ERC Advanced Grant (No. 232782) to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bourgeois C, 2006, IMMUNOL LETT, V107, P89, DOI 10.1016/j.imlet.2006.08.001; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Connor KT, 2006, J TOXICOL ENV HEAL B, V9, P147, DOI 10.1080/15287390500196487; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Funatake CJ, 2009, J IMMUNOTOXICOL, V6, P194, DOI 10.1080/15476910903124454; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Miniero R, 2001, CHEMOSPHERE, V43, P839, DOI 10.1016/S0045-6535(00)00442-2; Mitchell KA, 2009, BIOCHEM PHARMACOL, V77, P947, DOI 10.1016/j.bcp.2008.10.028; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; POLAND A, 1994, MOL PHARMACOL, V46, P915; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Schiffenbauer J, 2000, CLIN IMMUNOL, V95, P117, DOI 10.1006/clim.2000.4851; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singh N, 2010, J IMMUNOL, V184, P94, DOI 10.4049/jimmunol.0900753; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993	51	90	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79819	10.1371/journal.pone.0079819	http://dx.doi.org/10.1371/journal.pone.0079819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244565	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800100
J	Fernandes, C; Goncalves, HS; Cabral, PB; Pinto, HC; Pinto, MIM; Camara, LMC				Fernandes, Camila; Goncalves, Heitor Sa; Cabral, Paula Brito; Pinto, Helena Camara; Moraes Pinto, Maria Isabel; Carneiro Camara, Lilia Maria			Increased Frequency of CD4 and CD8 Regulatory T Cells in Individuals under 15 Years with Multibacillary Leprosy	PLOS ONE			English	Article							EXPANSION; FOXP3; UNRESPONSIVENESS; CHALLENGES	Background: Leprosy is a chronic disease, caused by Mycobacterium leprae, which poses a serious public health problem worldwide. Its high incidence in people under 15 years old in Ceara state, Brazil, reflects the difficulty of its control. The spectrum of clinical manifestations is associated with the immune response developed, with the Th1 and Th2 responses being related to the paucibacillary and multibacillary forms, respectively. Regulatory T cells (Treg), which can suppress Th1 and Th2 response, have received special attention in the literature and have been associated with development of chronic infections. However, their role in leprosy in individuals under 15 years old has not yet been elucidated. We evaluated the frequency of CD4(+)/CD8(+)CD25(high)FOXP3(+) and CD4(+)/CD8(+)CD25(high)FOXP3(high) cells in leprosy patients and household contacts, in both cases under 15 years old. Methodology/Principal Findings: PBMC from 12 patients and 17 contacts were cultured for 72 hours with anti-CD3 and anti-CD28 (activators) or with activators associated with total sonicated fraction of M. leprae. After culture, the frequency of CD4(+)/CD8(+) Treg was identified by flow cytometry. Cells stimulated by activators and antigen from multibacillary patients showed Treg frequencies almost two times that of the contacts: CD4(+)FOXP3(+) (21.93 +/- 8.43 vs. 13.79 +/- 8.19%, p = 0.0500), CD4(+)FOXP3(high) (10.33 +/- 5.69 vs. 5.57 +/- 4.03%, p = 0.0362), CD8(+)FOXP3(+) (13.88 +/- 9.19 vs. 6.18 +/- 5.56%, p = 0.0230) and CD8(+)FOXP3(high) (5.36 +/- 4.17 vs. 2.23 +/- 2.68%, p = 0.0461). Furthermore, the mean fluorescence intensity of FOXP3 in Treg was higher in multibacillary patients than in the contacts. Interestingly, there was a positive correlation of the bacillary index and number of lesions with the frequency of all Treg evaluated in patients. Conclusions/Significance: We have demonstrated for the first time that multibacillary leprosy patients under 15 years old have greater CD4(+) and CD8(+) Treg frequencies and these correlate with clinical and laboratorial aspects of disease. These findings suggest the involvement of these cells in the perpetuation of M. leprae infection.	[Fernandes, Camila; Carneiro Camara, Lilia Maria] Univ Fed Ceara, Dept Pathol & Legal Med, Med Lab Immunol, Fortaleza, Ceara, Brazil; [Goncalves, Heitor Sa] Dermatol Ctr Dona Libania, Fortaleza, Ceara, Brazil; [Cabral, Paula Brito] Walter Cantidio Univ Hosp, Fortaleza, Ceara, Brazil; [Pinto, Helena Camara] Univ Fortaleza, Fortaleza, Ceara, Brazil; [Moraes Pinto, Maria Isabel] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil	Universidade Federal do Ceara; Universidade Fortaleza; Universidade Federal de Sao Paulo (UNIFESP)	Fernandes, C (corresponding author), Univ Fed Ceara, Dept Pathol & Legal Med, Med Lab Immunol, Fortaleza, Ceara, Brazil.	camilabantim@hotmail.com			Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico; Post-Graduation Program in Medical Microbiology	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Post-Graduation Program in Medical Microbiology	The authors are grateful to Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico and Post-Graduation Program in Medical Microbiology for financial support, especially for Dr. Jose Julio Costa Sidrim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Andersen MH, 2012, CANCER IMMUNOL IMMUN, V61, P1289, DOI 10.1007/s00262-012-1234-4; Attia EAS, 2010, INT J DERMATOL, V49, P1152, DOI 10.1111/j.1365-4632.2010.04535.x; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; BLOOM BR, 1984, IMMUNOL REV, V80, P5, DOI 10.1111/j.1600-065X.1984.tb00493.x; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Dagur PK, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-119; Sales JD, 2011, CLIN EXP IMMUNOL, V165, P251, DOI 10.1111/j.1365-2249.2011.04412.x; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Geluk A, 2006, HUM IMMUNOL, V67, P439, DOI 10.1016/j.humimm.2006.03.009; Governo do Estado do Ceara, 2013, INF EP HANS, P1; Governo do Estado do Ceara, 2012, INF EP HANS, P1; Gunnlaugsdottir B, 2013, SCAND J IMMUNOL, V77, P125, DOI 10.1111/sji.12009; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Kumar S, 2011, CLIN IMMUNOL, DOI [10.1016/j.clim.2011.06.007, DOI 10.1016/J.CLIM.2011.06.007.+]; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Li KK, 2013, LANCET, V381, P64; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Massone C, 2010, AM J DERMATOPATH, V32, P251, DOI 10.1097/DAD.0b013e3181b7fc56; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; MODLIN RL, 1986, NATURE, V322, P459, DOI 10.1038/322459a0; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; Palermo ML, 2012, AM J TROP MED HYG, V86, P878, DOI 10.4269/ajtmh.2012.12-0088; Presicce P, 2010, CYTOM PART A, V77A, P571, DOI 10.1002/cyto.a.20875; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; REA TH, 1983, CLIN EXP IMMUNOL, V54, P298; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Souza AD, 2009, INT J DERMATOL, V48, P109, DOI 10.1111/j.1365-4632.2009.03918.x; Spencer JS, 2005, J IMMUNOL, V175, P7930, DOI 10.4049/jimmunol.175.12.7930; Taylor AL, 2012, IMMUNOLOGY, V135, P158, DOI 10.1111/j.1365-2567.2011.03529.x; Tsai S, 2011, CELL MOL LIFE SCI, V68, P3781, DOI 10.1007/s00018-011-0738-y; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114	44	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79072	10.1371/journal.pone.0079072	http://dx.doi.org/10.1371/journal.pone.0079072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244424	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800026
J	Makino, H; Kushiro, A; Ishikawa, E; Kubota, H; Gawad, A; Sakai, T; Oishi, K; Martin, R; Ben-Amor, K; Knol, J; Tanaka, R				Makino, Hiroshi; Kushiro, Akira; Ishikawa, Eiji; Kubota, Hiroyuki; Gawad, Agata; Sakai, Takafumi; Oishi, Kenji; Martin, Rocio; Ben-Amor, Kaouther; Knol, Jan; Tanaka, Ryuichiro			Mother-to-Infant Transmission of Intestinal Bifidobacterial Strains Has an Impact on the Early Development of Vaginally Delivered Infant's Microbiota	PLOS ONE			English	Article							MILK OLIGOSACCHARIDES; GUT MICROBIOTA; BACTERIAL; MICROFLORA; DIVERSITY; IDENTIFICATION; COLONIZATION; MECONIUM; NEWBORNS; SEQUENCE	Objectives: Bifidobacterium species are one of the major components of the infant's intestine microbiota. Colonization with bifidobacteria in early infancy is suggested to be important for health in later life. However, information remains limited regarding the source of these microbes. Here, we investigated whether specific strains of bifidobacteria in the maternal intestinal flora are transmitted to their infant's intestine. Materials and Methods: Fecal samples were collected from healthy 17 mother and infant pairs (Vaginal delivery: 12; Cesarean section delivery: 5). Mother's feces were collected twice before delivery. Infant's feces were collected at 0 (meconium), 3, 7, 30, 90 days after birth. Bifidobacteria isolated from feces were genotyped by multilocus sequencing typing, and the transitions of bifidobacteria counts in infant's feces were analyzed by quantitative real-time PCR. Results: Stains belonging to Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium longum subsp. longum, and Bifidobacterium pseudocatenulatum, were identified to be monophyletic between mother's and infant's intestine. Eleven out of 12 vaginal delivered infants carried at least one monophyletic strain. The bifidobacterial counts of the species to which the monophyletic strains belong, increased predominantly in the infant's intestine within 3 days after birth. Among infants delivered by C-section, monophyletic strains were not observed. Moreover, the bifidobacterial counts were significantly lower than the vaginal delivered infants until 7 days of age. Conclusions: Among infants born vaginally, several Bifidobacterium strains transmit from the mother and colonize the infant's intestine shortly after birth. Our data suggest that the mother's intestine is an important source for the vaginal delivered infant's intestinal microbiota.	[Makino, Hiroshi; Kushiro, Akira; Ishikawa, Eiji; Kubota, Hiroyuki; Sakai, Takafumi; Oishi, Kenji; Tanaka, Ryuichiro] Yakult Cent Inst Microbiol Res, Tokyo, Japan; [Kubota, Hiroyuki; Gawad, Agata; Oishi, Kenji] ESV, Yakult Honsha European Res Ctr Microbiol, Ghent, Belgium; [Martin, Rocio; Knol, Jan] Ctr Specialised Nutr, Danone Res, Utrecht, Netherlands; [Ben-Amor, Kaouther] Ctr Specialised Nutr, Danone Res, Singapore, Singapore; [Knol, Jan] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited; Danone Nutricia; Danone Nutricia; Wageningen University & Research	Makino, H (corresponding author), Yakult Cent Inst Microbiol Res, Tokyo, Japan.	hiroshi-makino@yakult.co.jp	Knol, Jan/A-2178-2010; Knol, Jan/AAL-6487-2020	Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961; Ishikawa, Eiji/0000-0002-4179-9010	Yakult Honsha European Research Center for Microbiology ESV and Danone Research (Centre for Specialised Nutrition, Wageningen, Netherlands); Yakult Honsha European Research Center for Microbiology ESV and Danone Research (Centre Daniel Carasso, Palaiseau, France)	Yakult Honsha European Research Center for Microbiology ESV and Danone Research (Centre for Specialised Nutrition, Wageningen, Netherlands); Yakult Honsha European Research Center for Microbiology ESV and Danone Research (Centre Daniel Carasso, Palaiseau, France)	This work was supported by Yakult Honsha European Research Center for Microbiology ESV and Danone Research (Centre for Specialised Nutrition, Wageningen, Netherlands, and Centre Daniel Carasso, Palaiseau, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Antonio MAD, 2005, J INFECT DIS, V192, P394, DOI 10.1086/430926; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Chen HY, 2011, ENVIRON HEALTH PERSP, V119, P351, DOI 10.1289/ehp.1002124; Delcenserie V, 2005, J MICROBIOL METH, V61, P55, DOI 10.1016/j.mimet.2004.11.001; Deletoile A, 2010, RES MICROBIOL, V161, P82, DOI 10.1016/j.resmic.2009.12.006; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; FRYKLUND B, 1992, INFECTION, V20, P253, DOI 10.1007/BF01710789; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Inoue R, 2003, FEMS MICROBIOL ECOL, V46, P213, DOI 10.1016/S0168-6496(03)00215-0; Iwaya A, 2006, HEPATO-GASTROENTEROL, V53, P55; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lundell AC, 2012, J IMMUNOL, V188, P4315, DOI 10.4049/jimmunol.1103223; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Matsuki T, 1998, FEMS MICROBIOL LETT, V167, P113, DOI 10.1111/j.1574-6968.1998.tb13216.x; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; Mikami K, 2009, PEDIATR RES, V65, P669, DOI 10.1203/PDR.0b013e31819ed7a8; Miyake T, 1998, MICROBIOL IMMUNOL, V42, P661, DOI 10.1111/j.1348-0421.1998.tb02337.x; MURONO K, 1993, J PEDIATR-US, V122, P120, DOI 10.1016/S0022-3476(05)83504-8; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Takahashi H, 2010, J PEDIATR GASTR NUTR, V51, P653, DOI 10.1097/MPG.0b013e3181f0e032; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Turroni F, 2011, APPL ENVIRON MICROB, V77, P7408, DOI 10.1128/AEM.05336-11; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Watanabe K, 2009, INT J SYST EVOL MICR, V59, P1535, DOI 10.1099/ijs.0.006247-0; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; ZHU H, 1993, NUCLEIC ACIDS RES, V21, P5279, DOI 10.1093/nar/21.22.5279; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	49	173	182	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78331	10.1371/journal.pone.0078331	http://dx.doi.org/10.1371/journal.pone.0078331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244304	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800008
J	Palazzo, A; Marconi, S; Specchia, V; Bozzetti, MP; Ivics, Z; Caizzi, R; Marsano, RM				Palazzo, Antonio; Marconi, Simona; Specchia, Valeria; Bozzetti, Maria Pia; Ivics, Zoltan; Caizzi, Ruggiero; Marsano, Rene Massimiliano			Functional Characterization of the Bari1 Transposition System	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; SLEEPING-BEAUTY TRANSPOSON; UNFOLDED PROTEIN RESPONSE; DNA-BINDING DOMAIN; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; SUBCELLULAR-LOCALIZATION; TC1-LIKE TRANSPOSONS; TRANSCRIPTION FACTOR; MARINER TRANSPOSASE	The transposons of the Bari family are mobile genetic elements widespread in the Drosophila genus. However, despite a broad diffusion, virtually no information is available on the mechanisms underlying their mobility. In this paper we report the functional characterization of the Bari elements transposition system. Using the Bari1 element as a model, we investigated the subcellular localization of the transposase, its physical interaction with the transposon, and its catalytic activity. The Bari1 transposase localized in the nucleus and interacted with the terminal sequences of the transposon both in vitro and in vivo, however, no transposition activity was detected in transposition assays. Profiling of mRNAs expressed by the transposase gene revealed the expression of abnormal, internally processed transposase transcripts encoding truncated, catalytically inactive transposase polypeptides. We hypothesize that a post-transcriptional control mechanism produces transposase-derived polypeptides that effectively repress transposition. Our findings suggest further clues towards understanding the mechanisms that control transposition of an important class of mobile elements, which are both an endogenous source of genomic variability and widely used as transformation vectors/biotechnological tools.	[Palazzo, Antonio; Marconi, Simona; Caizzi, Ruggiero; Marsano, Rene Massimiliano] Univ Bari, Dipartimento Biol, Bari, Italy; [Specchia, Valeria; Bozzetti, Maria Pia] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy; [Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	Universita degli Studi di Bari Aldo Moro; University of Salento; Paul Ehrlich Institute	Marsano, RM (corresponding author), Univ Bari, Dipartimento Biol, Bari, Italy.	renemassimiliano.marsano@uniba.it	Palazzo, Antonio/AAW-2480-2021; Specchia, Valeria/AAS-8179-2020; Marsano, René Massimiliano/B-9640-2012; Palazzo, Antonio/AAH-1352-2020	Specchia, Valeria/0000-0002-1051-6014; Marsano, René Massimiliano/0000-0001-8450-1010; Palazzo, Antonio/0000-0003-0961-6832; Caizzi, Ruggiero/0000-0002-4360-2808	EMBO [ASTF 182-2004];  [RBFR10V8K6]	EMBO(European Molecular Biology Organization (EMBO)); 	This work was carried out despite the strong and indiscriminate cut to Italian public research. This work was carried out using residual material from previously approved projects in part from Universita degli Studi di Bari and in part from Ministero dell'Istruzione e Ricerca. VS acknowledges the grant "Futuro in ricerca 2010'' no. RBFR10V8K6. RMM was formerly supported by an EMBO short term fellowship ASTF 182-2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P58, DOI 10.1007/s004380000386; Benjamin B, 2007, GENETICA, V130, P105, DOI 10.1007/s10709-006-0025-2; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BOEHM U, 1995, PLANT J, V7, P441, DOI 10.1046/j.1365-313X.1995.7030441.x; Bouuaert CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053690; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAGGESE C, 1995, GENETICA, V96, P269, DOI 10.1007/BF01439581; CAIZZI R, 1993, GENETICS, V133, P335; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; COLLOMS SD, 1994, NUCLEIC ACIDS RES, V22, P5548, DOI 10.1093/nar/22.25.5548; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Craig NL, 2002, MOBILE DNA, pxviii; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Fischer SEJ, 1999, MOL GEN GENET, V262, P268, DOI 10.1007/PL00008641; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; FRASER MJ, 1985, VIROLOGY, V145, P356, DOI 10.1016/0042-6822(85)90172-2; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Ivics Z, MOB DNA, V1, P25; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; Junakovic N, 1997, GENETICA, V100, P149, DOI 10.1023/A:1018325427405; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lampe DJ, 1998, GENETICS, V149, P179; Liu D, 1998, GENETICS, V149, P693; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Marsano RM, 2005, GENE, V357, P122, DOI 10.1016/j.gene.2005.06.005; Marsano RM, 2003, GENETICA, V117, P281; Marsano RM, 2003, GENE, V307, P167, DOI 10.1016/S0378-1119(03)00458-X; MERRIMAN PJ, 1995, GENETICS, V141, P1425; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Mikitani K, 2000, J BIOL CHEM, V275, P37725, DOI 10.1074/jbc.M005271200; Moschetti R, 1998, GENETICS, V150, P239; Moschetti R, 2008, MOL GENET GENOMICS, V279, P451, DOI 10.1007/s00438-008-0324-7; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ono A, 2002, PLANT MOL BIOL, V50, P599, DOI 10.1023/A:1019970206057; OSBORNE BI, 1995, CURR OPIN CELL BIOL, V7, P406, DOI 10.1016/0955-0674(95)80097-2; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; PRUDHOMME N, 1995, GENETICS, V139, P697; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROCHE SE, 1995, GENE DEV, V9, P1278, DOI 10.1101/gad.9.10.1278; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shao HG, 2001, GENETICS, V159, P1103; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zamparini AL, 2011, DEVELOPMENT, V138, P4039, DOI 10.1242/dev.069187	70	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79385	10.1371/journal.pone.0079385	http://dx.doi.org/10.1371/journal.pone.0079385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244492	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800068
J	Arbiv, A; Yurist-Doutsch, S; Guan, ZQ; Eichler, J				Arbiv, Adi; Yurist-Doutsch, Sophie; Guan, Ziqiang; Eichler, Jerry			AglQ Is a Novel Component of the Haloferax volcanii N-Glycosylation Pathway	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; ARCHAEA; GLYCOPROTEIN	N-glycosylation is a post-translational modification performed by members of all three domains of life. Studies on the halophile Haloferax volcanii have offered insight into the archaeal version of this universal protein-processing event. In the present study, AglQ was identified as a novel component of the pathway responsible for the assembly and addition of a pentasaccharide to select Asn residues of Hfx. volcanii glycoproteins, such as the S-layer glycoprotein. In cells deleted of aglQ, both dolichol phosphate, the lipid carrier used in Hfx. volcanii N-glycosylation, and modified S-layer glycoprotein Asn residues only presented the first three pentasaccharide subunits, pointing to a role for AglQ in either preparing the third sugar for attachment of the fourth pentasaccharide subunit or processing the fourth sugar prior to its addition to the lipid-linked trisaccharide. To better define the precise role of AglQ, shown to be a soluble protein, bioinformatics tools were recruited to identify sequence or structural homologs of known function. Site-directed mutagenesis experiments guided by these predictions identified residues important for AglQ function. The results obtained point to AglQ acting as an isomerase in Hfx. volcanii N-glycosylation.	[Arbiv, Adi; Yurist-Doutsch, Sophie; Eichler, Jerry] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Ben Gurion University; Duke University	Eichler, J (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	jeichler@bgu.ac.il	EICHLER, JERRY/F-2351-2012; Guan, Ziqiang/AAE-5110-2019	EICHLER, JERRY/0000-0001-9409-8026; 	US Army Research Office [W911NF-11-1-520]; Israel Science Foundation [08/11]; LIPID MAPS Large Scale Collaborative Grant from NIH [GM-069338]; Negev-Faran Associates Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	US Army Research Office; Israel Science Foundation(Israel Science Foundation); LIPID MAPS Large Scale Collaborative Grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Negev-Faran Associates Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.E. is supported by the US Army Research Office (W911NF-11-1-520) and by the Israel Science Foundation (grant 08/11). The mass spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. are supported by the LIPID MAPS Large Scale Collaborative Grant number GM-069338 from NIH. S.Y.-D. held a Negev-Faran Associates Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, J BACTERIOL, V190, P3140, DOI 10.1128/JB.00056-08; Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; GHOSH S, 1965, J BIOL CHEM, V240, P1531; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh Takafumi, 2006, Biochem Biophys Res Commun, V344, P253, DOI 10.1016/j.bbrc.2006.03.141; Kaminski L, 2012, BBA-GEN SUBJECTS, V1820, P1664, DOI 10.1016/j.bbagen.2012.06.014; Kaminski L, 2010, ARCHAEA, V2010, DOI 10.1155/2010/315108; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Lichi T, 2004, EUR J BIOCHEM, V271, P1382, DOI 10.1111/j.1432-1033.2004.04050.x; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Plavner N, 2008, J BACTERIOL, V190, P8045, DOI 10.1128/JB.01200-08; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Sprott GD, 2003, BBA-MOL CELL BIOL L, V1633, P179, DOI 10.1016/j.bbalip.2003.08.001; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x; Yurist-Doutsch S, 2009, J BACTERIOL, V191, P3068, DOI 10.1128/JB.01838-08	26	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81782	10.1371/journal.pone.0081782	http://dx.doi.org/10.1371/journal.pone.0081782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236216	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700219
J	Blount, RJ; Djawe, K; Daly, KR; Jarlsberg, LG; Fong, S; Balmes, J; Miller, RF; Walzer, PD; Huang, L				Blount, Robert J.; Djawe, Kpandja; Daly, Kieran R.; Jarlsberg, Leah G.; Fong, Serena; Balmes, John; Miller, Robert F.; Walzer, Peter D.; Huang, Laurence		Int HIV Assoc Opportunistic Pneumo	Ambient Air Pollution Associated with Suppressed Serologic Responses to Pneumocystis jirovecii in a Prospective Cohort of HIV-Infected Patients with Pneumocystis Pneumonia	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; X-LINKED AGAMMAGLOBULINEMIA; DIESEL EXHAUST PARTICLES; HOSPITAL ADMISSIONS; CARINII-PNEUMONIA; RISK-FACTORS; ALVEOLAR MACROPHAGES; ANTIBODY PROPHYLAXIS; MICE; IMMUNIZATION	Background: Ambient air pollution (AAP) may be associated with increased risk for Pneumocystis pneumonia (PCP). The mechanisms underlying this association remain uncertain. Objectives: To determine if real-life exposures to AAP are associated with suppressed IgM antibody responses to P. jirovecii in HIV-infected (HIV+) patients with active PCP, and to determine if AAP, mediated by suppressed serologic responses to Pneumocystis, is associated with adverse clinical outcomes. Methods: We conducted a prospective cohort study in HIV+ patients residing in San Francisco and admitted to San Francisco General Hospital with microscopically confirmed PCP. Our AAP predictors were ambient air concentrations of particulate matter of < 10 mu m in diameter (PM10) and < 2.5 mu m in diameter (PM2.5), nitrogen dioxide (NO2), ozone (O-3), and sulfur dioxide (SO2) measured immediately prior to hospital admission and 2 weeks prior to admission. Our primary outcomes were the IgM serologic responses to four recombinant P. jirovecii major surface glycoprotein (Msg) constructs: MsgC1, MsgC3, MsgC8, and MsgC9. Results: Elevated PM10 and NO2 exposures immediately prior to and two weeks prior to hospital admission were associated with decreased IgM antibody responses to P. jirovecii Msg. For exposures immediately prior to admission, every 10 mu g/m(3) increase in PM10 was associated with a 25 to 35% decrease in IgM responses to Msg (statistically significant for all the Msg constructs), and every 10 ppb increase in NO2 was associated with a 19-45% decrease in IgM responses to Msg (statistically significant for MsgC8 and MsgC9). Similar findings were seen with exposures two weeks prior to admission, but for fewer of the Msg constructs. Conclusions: Real life exposures to PM(1)0 and NO2 were associated with suppressed IgM responses to P. jirovecii Msg in HIV+ patients admitted with PCP, suggesting a mechanism of immunotoxicity by which AAP increases host susceptibility to pulmonary infection.	[Blount, Robert J.; Jarlsberg, Leah G.; Balmes, John; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Djawe, Kpandja; Daly, Kieran R.; Walzer, Peter D.] Univ Cincinnati, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA; [Djawe, Kpandja; Walzer, Peter D.] Univ Cincinnati, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Daly, Kieran R.; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Balmes, John] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Miller, Robert F.] UCL, Inst Epidemiol & Healthcare, Res Dept Infect & Populat Hlth, London, England; [Miller, Robert F.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Fong, Serena; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of California System; University of California Berkeley; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blount, RJ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAE-1590-2019; blount, robert/ABI-5978-2020; Balmes, John/L-6281-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Fong, Serena/0000-0002-9803-3016; Miller, Robert/0000-0003-2067-4291; Blount, Robert/0000-0001-6177-7436; Jarlsberg, Leah/0000-0001-6548-6337	National Institute of Environmental Health Science (NIEHS) [F32ES022582]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007185, K24HL087713, R01HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, T32HL007185, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES022582] Funding Source: NIH RePORTER	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the following: National Institute of Environmental Health Science (NIEHS) www.niehs.nih.gov, F32ES022582(Blount); National Heart, Lung, and Blood Institute (NHLBI) www.nhlbi.nih.gov, T32HL007185 (Sheppard, Nadel, Huang), K24HL087713 (Huang), R01HL090335 (Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hegelan M, 2011, IMMUNOL RES, V49, P173, DOI 10.1007/s12026-010-8180-z; Alibrahim A, 1998, J ALLERGY CLIN IMMUN, V101, P552, DOI 10.1016/S0091-6749(98)70363-X; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Blount RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051545; Cheng MF, 2007, J TOXICOL ENV HEAL A, V70, P2021, DOI 10.1080/15287390701601020; Cheng MF, 2009, INHAL TOXICOL, V21, P1092, DOI 10.3109/08958370902744855; Chiu HF, 2009, INHAL TOXICOL, V21, P32, DOI 10.1080/08958370802441198 ; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Deng XB, 2013, TOXICOL IN VITRO, V27, P1762, DOI 10.1016/j.tiv.2013.05.004; Dittrich AM, 2003, EUR J PEDIATR, V162, P432, DOI 10.1007/s00431-003-1200-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; Empey KM, 2004, INFECT IMMUN, V72, P6211, DOI 10.1128/IAI.72.11.6211-6220.2004; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; FURUTA T, 1985, INFECT IMMUN, V47, P544, DOI 10.1128/IAI.47.2.544-548.1985; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gigliotti F, 1997, J INFECT DIS, V176, P1322, DOI 10.1086/514128; Gigliotti F, 2002, INFECT IMMUN, V70, P1069, DOI 10.1128/IAI.70.3.1069-1074.2002; HARMSEN AG, 1991, J PROTOZOOL, V38, pS44; Harris AM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-93; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Manzo ND, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-43; Marcotte H, 1996, J INFECT DIS, V173, P1034, DOI 10.1093/infdis/173.4.1034; Mei Q, 1998, INFECT IMMUN, V66, P4268; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; SCHWARTZ J, 1994, ARCH ENVIRON HEALTH, V49, P366, DOI 10.1080/00039896.1994.9954989; SCHWARTZ J, 1994, AM J EPIDEMIOL, V139, P589, DOI 10.1093/oxfordjournals.aje.a117048; Schwartz J, 2011, AM J PUBLIC HEALTH, V101, pS88, DOI 10.2105/AJPH.2011.300268; WALZER PD, 1981, J LAB CLIN MED, V97, P820; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803; Wells J, 2006, INFECT IMMUN, V74, P2446, DOI 10.1128/IAI.74.4.2446-2448.2006; Wells J, 2006, INFECT IMMUN, V74, P390, DOI 10.1128/IAI.74.1.390-393.2006; WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834; Zheng MQ, 2001, J CLIN INVEST, V108, P1469, DOI 10.1172/JCI13826; Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC	48	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80795	10.1371/journal.pone.0080795	http://dx.doi.org/10.1371/journal.pone.0080795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236202	gold, Green Published			2022-12-27	WOS:000327254700205
J	Pellom, ST; Michalek, RD; Crump, KE; Langston, PK; Juneau, DG; Grayson, JM				Pellom, Samuel Troy; Michalek, Ryan D.; Crump, Katie E.; Langston, P. Kent; Juneau, Daniel G.; Grayson, Jason M.			Increased Cell Surface Free Thiols Identify Effector CD8(+) T Cells Undergoing T Cell Receptor Stimulation	PLOS ONE			English	Article							VIRAL-INFECTION; IN-VIVO; ACTIVATION; LYMPHOCYTES; PROLIFERATION; PERSISTENCE; EXPRESSION; OXIDATION; KLRG1	Recognition of peptide Major Histocompatibility Complexes (MHC) by the T cell receptor causes rapid production of reactive oxygen intermediates (ROI) in naive CD8(+) T cells. Because ROI such as H2O2 are membrane permeable, mechanisms must exist to prevent overoxidation of surface proteins. In this study we used fluorescently labeled conjugates of maleimide to measure the level of cell surface free thiols (CSFT) during the development, activation and differentiation of CD8(+) T cells. We found that during development CSFT were higher on CD8 SP compared to CD4 SP or CD4CD8 DP T cells. After activation CSFT became elevated prior to division but once proliferation started levels continued to rise. During acute viral infection CSFT levels were elevated on antigen-specific effector cells compared to memory cells. Additionally, the CSFT level was always higher on antigen-specific CD8(+) T cells in lymphoid compared to nonlymphoid organs. During chronic viral infection, CSFT levels were elevated for extended periods on antigen-specific effector CD8+ T cells. Finally, CSFT levels on effector CD8(+) T cells, regardless of infection, identified cells undergoing TCR stimulation. Taken together these data suggest that CD8(+) T cells upregulate CSFT following receptor ligation and ROI production during infection to prevent overoxidation of surface proteins.	[Pellom, Samuel Troy] Meharry Med Coll, Lab Lymphocyte Funct, Nashville, TN 37208 USA; [Michalek, Ryan D.] Metabolon Corp, Durham, NC USA; [Crump, Katie E.; Langston, P. Kent; Juneau, Daniel G.; Grayson, Jason M.] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27109 USA	Meharry Medical College; Metabolon; Wake Forest University	Grayson, JM (corresponding author), Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27109 USA.	jgrayson@wakehealth.edu		Langston, Paul/0000-0001-6655-1911	National Institute of Allergy and Infectious Diseases (NIAD) [RO1-AI068952]; NIAID [5T32AI007401-20]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068952, T32AI007401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAD); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAD) grant RO1-AI068952 to J.M.G. K. E. C. and R. D. M. were supported by NIAID grant 5T32AI007401-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; CHAUDHRI G, 1986, J IMMUNOL, V137, P2646; Corral L, 2000, EUR J IMMUNOL, V30, P920, DOI 10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.0.CO;2-P; Crump KE, 2012, EUR J IMMUNOL, V42, P2152, DOI 10.1002/eji.201142289; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Di Rosa F, 1999, J IMMUNOL, V163, P1253; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; Kaur N, 2011, CYTOKINE, V55, P307, DOI [10.1016/j.cyto.2011.04.014., DOI 10.1016/J.CYT0.2011.04.014.PUBMED:21602054]; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; REDELMAN D, 1980, J IMMUNOL, V124, P870; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; SMITH S, 1992, CLIN EXP IMMUNOL, V88, P169; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81134	10.1371/journal.pone.0081134	http://dx.doi.org/10.1371/journal.pone.0081134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236211	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700214
J	Aoki, H; Mogi, C; Hisada, T; Nakakura, T; Kamide, Y; Ichimonji, I; Tomura, H; Tobo, M; Sato, K; Tsurumaki, H; Dobashi, K; Mori, T; Harada, A; Yamada, M; Mori, M; Ishizuka, T; Okajima, F				Aoki, Haruka; Mogi, Chihiro; Hisada, Takeshi; Nakakura, Takashi; Kamide, Yosuke; Ichimonji, Isao; Tomura, Hideaki; Tobo, Masayuki; Sato, Koichi; Tsurumaki, Hiroaki; Dobashi, Kunio; Mori, Tetsuya; Harada, Akihiro; Yamada, Masanobu; Mori, Masatomo; Ishizuka, Tamotsu; Okajima, Fumikazu			Proton-Sensing Ovarian Cancer G Protein-Coupled Receptor 1 on Dendritic Cells Is Required for Airway Responses in a Murine Asthma Model	PLOS ONE			English	Article							EXTRACELLULAR ACIDIFICATION; SMOOTH-MUSCLE; ACIDIC PH; INFLAMMATION; OGR1; HYPERRESPONSIVENESS; RESPONSIVENESS; INHIBITION; EXPRESSION; TDAG8	Ovarian cancer G protein-coupled receptor 1 (OGR1) stimulation by extracellular protons causes the activation of G proteins and subsequent cellular functions. However, the physiological and pathophysiological roles of OGR1 in airway responses remain largely unknown. In the present study, we show that OGR1-deficient mice are resistant to the cardinal features of asthma, including airway eosinophilia, airway hyperresponsiveness (AHR), and goblet cell metaplasia, in association with a remarkable inhibition of Th2 cytokine and IgE production, in an ovalbumin (OVA)-induced asthma model. Intratracheal transfer to wild-type mice of OVA-primed bone marrow-derived dendritic cells (DCs) from OGR1-deficient mice developed lower AHR and eosinophilia after OVA inhalation compared with the transfer of those from wild-type mice. Migration of OVA-pulsed DCs to peribronchial lymph nodes was also inhibited by OGR1 deficiency in the adoption experiments. The presence of functional OGR1 in DCs was confirmed by the expression of OGR1 mRNA and the OGR1-sensitive Ca2+ response. OVA-induced expression of CCR7, a mature DC chemokine receptor, and migration response to CCR7 ligands in an in vitro Transwell assay were attenuated by OGR1 deficiency. We conclude that OGR1 on DCs is critical for migration to draining lymph nodes, which, in turn, stimulates Th2 phenotype change and subsequent induction of airway inflammation and AHR.	[Aoki, Haruka; Mogi, Chihiro; Nakakura, Takashi; Ichimonji, Isao; Tomura, Hideaki; Tobo, Masayuki; Sato, Koichi; Tsurumaki, Hiroaki; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 371, Japan; [Aoki, Haruka; Hisada, Takeshi; Kamide, Yosuke; Tsurumaki, Hiroaki; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Dobashi, Kunio] Gunma Univ, Sch Hlth Sci, Maebashi, Gunma 371, Japan; [Mori, Tetsuya] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Allergy & Immunol, Takasaki, Gunma, Japan; [Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka, Japan; [Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan	Gunma University; Gunma University; Gunma University; Osaka University; University of Fukui	Ishizuka, T (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan.	tamotsui@u-fukui.ac.jp; okajima@gunma-u.ac.jp	Tsurumaki, Hiroaki/HDL-6889-2022	Nakakura, Takashi/0000-0003-1898-563X; Tsurumaki, Hiroaki/0000-0003-0837-9329; Sato, Koichi/0000-0001-7694-4014	Japan Society for the Promotion of Science (JSPS); Institute for Molecular and Cellular Regulation, Gunma University [12023]; Grants-in-Aid for Scientific Research [23591456] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Grant-in-Aid for Scientific Research (B) (to FO), Grant-in-Aid for Challenging Exploratory Research (to FO), Grant-in-Aid for Scientific Research (C) (to TI and CM), and Grant-in-Aid for Young Scientists (B) (to HA) from the Japan Society for the Promotion of Science (JSPS). This work was also supported in part by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (12023) (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Koya T, 2006, AM J RESP CELL MOL, V35, P147, DOI 10.1165/rcmb.2005-0394OC; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liu CY, 2013, RESP PHYSIOL NEUROBI, V185, P265, DOI 10.1016/j.resp.2012.10.003; Liu JP, 2010, AM J PHYSIOL-HEART C, V299, pH731, DOI 10.1152/ajpheart.00977.2009; Liu JP, 2010, PHARMACOL RES, V61, P499, DOI 10.1016/j.phrs.2010.02.013; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuzaki S, 2011, BIOCHEM BIOPH RES CO, V413, P499, DOI 10.1016/j.bbrc.2011.08.087; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Murata N, 2009, CELL IMMUNOL, V259, P21, DOI 10.1016/j.cellimm.2009.05.008; Nakakura T, 2012, ENDOCRINOLOGY, V153, P4171, DOI 10.1210/en.2012-1164; Okajima F, 2013, CELL SIGNAL; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Ricciardolo FLM, 2004, J ALLERGY CLIN IMMUN, V113, P610, DOI 10.1016/j.jaci.2003.12.034; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Tsuchiya K, 2012, AM J PHYSIOL-LUNG C, V303, pL54, DOI 10.1152/ajplung.00208.2011; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	36	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79985	10.1371/journal.pone.0079985	http://dx.doi.org/10.1371/journal.pone.0079985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244587	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600165
J	Fan, JK; Jiang, K; Liu, YJ; Jia, JH				Fan, Junkai; Jiang, Kai; Liu, Yajuan; Jia, Jianhang			Hrs Promotes Ubiquitination and Mediates Endosomal Trafficking of Smoothened in Drosophila Hedgehog Signaling	PLOS ONE			English	Article							C-TERMINAL TAIL; ANIMAL DEVELOPMENT; ESCRT MACHINERY; PRIMARY CILIUM; PHOSPHORYLATION; TRANSDUCTION; CANCER; ENDOCYTOSIS; PROTEINS; RECEPTOR	In Hedgehog (Hh) signaling, the seven-transmembrane protein Smoothened (Smo) acts as a signal transducer that is regulated by phosphorylation, ubiquitination, and cell surface accumulation. However, it is not clear how Smo cell surface accumulation and intracellular trafficking are regulated. Here, we demonstrate that inactivation of Hrs by deletion or RNAi accumulates Smo in the late endosome that is marked by late endosome markers. Inactivation of Hrs enhances the wing defects caused by dominant-negative Smo. We show that Hrs promotes Smo ubiquitination, deleting the ubiquitin-interacting-motif (UIM) in Hrs abolishes the ability of Hrs to regulate Smo ubiquitination. However, the UIM domain neither recognizes the ubiquitinated Smo nor directly interacts with Smo. Hrs lacking UIM domain still downregulates Smo activity even though to a less extent. We have characterized that the N-terminus of Hrs directly interacts with the PKA/CK1 phosphorylation clusters to prevent Smo phosphorylation and activation, indicating an ubiquitin-independent regulation of Smo by Hrs. Finally, we found that knockdown of Tsg101 accumulates Smo that is co-localized with Hrs and other late endosome markers. Taken together, our data indicate that Hrs mediates Smo trafficking in the late endosome by not only promoting Smo ubiquitination but also blocking Smo phosphorylation.	[Fan, Junkai; Jiang, Kai; Liu, Yajuan; Jia, Jianhang] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Jia, JH (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA.	Jianhang.jia@uky.edu		Jia, Jianhang/0000-0002-9313-3843; Jiang, Kai/0000-0002-8507-1945	National Institutes of Health [GM079684]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (GM079684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fan JK, 2012, DEV BIOL, V366, P172, DOI 10.1016/j.ydbio.2012.04.007; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Molnar C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001335; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yang X, 2013, J CELL SCI; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	36	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79021	10.1371/journal.pone.0079021	http://dx.doi.org/10.1371/journal.pone.0079021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244405	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600095
J	Fu, W; Ding, LR; Zhuang, C; Zhou, YH				Fu, Wei; Ding, Li-Ren; Zhuang, Cheng; Zhou, Yu-Hao			Effects of Zinc Supplementation on the Incidence of Mortality in Preschool Children: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							DOUBLE-BLIND; INFANTS; PNEUMONIA; MORBIDITY; DIARRHEA	Background: Previous trials have shown that zinc supplementation can decrease the risk of diarrhea, pneumonia, and malaria in children; however, the effects of zinc supplementation on mortality remain unclear. This study aimed at evaluating the benefits and risks of zinc supplementation on both total mortality and cause-specific mortality. Methodology and Principal Findings: We searched PubMed, EmBase, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials in preschool children reporting total mortality or cause-specific mortality. Relative risk (RR) was used as a measure of the effect of zinc supplementation on the risk of mortality using a random effect model. Of the 1,520 identified articles, we included 8 trials reporting data on 87,854 children. Overall, zinc supplementation had no effect on total mortality (RR, 0.76; 95% CI: 0.56-1.04; P = 0.084), diarrhea-related mortality (RR, 0.80; 95% CI: 0.53-1.20; P = 0.276), pneumonia-related mortality (RR, 0.52; 95% CI: 0.11-2.39; P = 0.399), malaria-related mortality (RR, 0.90; 95% CI: 0.77-1.06; P = 0.196), or other causes of mortality (RR, 0.98; 95% CI: 0.67-1.44; P = 0.917). Subgroup analysis indicated that zinc supplementation was associated with a reduction in total mortality risk if the participants were boys, aged greater than 12 months, and the duration of the follow-up period was less than 12 months. Conclusions/Significance: Zinc supplementation does not have an effect on total mortality, diarrhea-related mortality, pneumonia-related mortality, malaria-related mortality, or other causes of mortality. Subgroup analysis suggested that zinc supplementation can effectively reduce the risk of total mortality if the participants were boys, aged greater than 12 months, and the duration of the follow-up period was less than 12 months.	[Fu, Wei; Ding, Li-Ren; Zhuang, Cheng] Shanghai Seventh Peoples Hosp, Dept Pediat, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bobat R, 2005, LANCET, V366, P1862, DOI 10.1016/S0140-6736(05)67756-2; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Deeks JJ, 2008, COCHRANE COCHRANE HD; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Iqbal A. S. M., 2001, Indian Journal of Pediatrics, V68, P523, DOI 10.1007/BF02723246; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KREBS NF, 1986, AM J CLIN NUTR, V43, P288, DOI 10.1093/ajcn/43.2.288; Luabeya KKA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000541; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; The Zinc Investigators' Collaborative Group, 1999, J PEDIAT, V135, P689, DOI DOI 10.1016/S0022-3476(99)70086-7.PUBMED:10586170; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79998	10.1371/journal.pone.0079998	http://dx.doi.org/10.1371/journal.pone.0079998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244591	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600168
J	Miyauchi, O; Iwase, K; Itoh, K; Kato, M; Seki, N; Braissant, O; Bachmann, C; Shozu, M; Sekiya, S; Osada, H; Takiguchi, M				Miyauchi, Osamu; Iwase, Katsuro; Itoh, Kanako; Kato, Masaki; Seki, Naohiko; Braissant, Olivier; Bachmann, Claude; Shozu, Makio; Sekiya, Souei; Osada, Hisao; Takiguchi, Masaki			Efficient Subtractive Cloning of Genes Activated by Lipopolysaccharide and Interferon gamma in Primary-Cultured Cortical Cells of Newborn Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; INNATE IMMUNITY; MESSENGER-RNA; PERIVENTRICULAR LEUKOMALACIA; MICROARRAY ANALYSIS; PIVOTAL ROLE; EXPRESSION	Innate immune responses play a central role in neuroprotection and neurotoxicity during inflammatory processes that are triggered by pathogen-associated molecular pattern-exhibiting agents such as bacterial lipopolysaccharide (LPS) and that are modulated by inflammatory cytokines such as interferon gamma (IFN gamma). Recent findings describing the unexpected complexity of mammalian genomes and transcriptomes have stimulated further identification of novel transcripts involved in specific physiological and pathological processes, such as the neural innate immune response that alters the expression of many genes. We developed a system for efficient subtractive cloning that employs both sense and antisense cRNA drivers, and coupled it with in-house cDNA microarray analysis. This system enabled effective direct cloning of differentially expressed transcripts, from a small amount (0.5 mu g) of total RNA. We applied this system to isolation of genes activated by LPS and IFN gamma in primary-cultured cortical cells that were derived from newborn mice, to investigate the mechanisms involved in neuroprotection and neurotoxicity in maternal/perinatal infections that cause various brain injuries including periventricular leukomalacia. A number of genes involved in the immune and inflammatory response were identified, showing that neonatal neuronal/glial cells are highly responsive to LPS and IFN gamma. Subsequent RNA blot analysis revealed that the identified genes were activated by LPS and IFN gamma in a cooperative or distinctive manner, thereby supporting the notion that these bacterial and cellular inflammatory mediators can affect the brain through direct but complicated pathways. We also identified several novel clones of apparently non-coding RNAs that potentially harbor various regulatory functions. Characterization of the presently identified genes will give insights into mechanisms and interventions not only for perinatal infection-induced brain damage, but also for many other innate immunity-related brain disorders.	[Miyauchi, Osamu; Iwase, Katsuro; Itoh, Kanako; Takiguchi, Masaki] Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Japan; [Miyauchi, Osamu; Shozu, Makio; Sekiya, Souei; Osada, Hisao] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan; [Kato, Masaki; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan; [Braissant, Olivier; Bachmann, Claude] CHU Vaudois, Lab Cent Chim Clin, CH-1011 Lausanne, Switzerland	Chiba University; Chiba University; Chiba University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Takiguchi, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Japan.	mtak@faculty.chiba-u.jp	Kato, Masaki/B-5846-2018	Kato, Masaki/0000-0002-5184-1841	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Grants-in-Aid for Scientific Research [25670115, 23390048] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Science, Sports, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi-Uehara N, 2006, EXP EYE RES, V83, P849, DOI 10.1016/j.exer.2006.04.012; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Albright AV, 2004, J NEUROIMMUNOL, V157, P27, DOI 10.1016/j.jneuroim.2004.09.007; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Barna M, 1996, VIROLOGY, V223, P331, DOI 10.1006/viro.1996.0484; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chao CC, 1996, GLIA, V16, P276, DOI 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; GALEA E, 1994, J NEUROSCI RES, V37, P406, DOI 10.1002/jnr.490370313; GILLY M, 1992, J IMMUNOL, V148, P3275; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Iwase K, 2000, J BIOL CHEM, V275, P11929, DOI 10.1074/jbc.275.16.11929; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Lee E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-7; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu JA, 2011, P NATL ACAD SCI USA, V108, P4465, DOI 10.1073/pnas.1019020108; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; McKimmie CS, 2006, J NEUROIMMUNOL, V175, P128, DOI 10.1016/j.jneuroim.2006.03.012; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Ohtsuka S, 2004, GENOMICS, V84, P715, DOI 10.1016/j.ygeno.2004.06.012; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Pang Y, 2001, BRAIN RES, V914, P15, DOI 10.1016/S0006-8993(01)02766-4; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SAUNDERS NR, 1977, EXP EYE RES, V25, P523, DOI 10.1016/S0014-4835(77)80046-8; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581; XU J, 1994, J ANAT, V184, P227; Yoshikawa T, 2000, BIOCHEM BIOPH RES CO, V275, P532, DOI 10.1006/bbrc.2000.3330; Yuan TM, 2010, J NEUROIMMUNOL, V229, P16, DOI 10.1016/j.jneuroim.2010.08.008; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang WY, 1999, BRAIN RES, V849, P78, DOI 10.1016/S0006-8993(99)01987-3	79	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79236	10.1371/journal.pone.0079236	http://dx.doi.org/10.1371/journal.pone.0079236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244457	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600118
J	Pinelli, M; Acquaviva, F; Barbetti, F; Caredda, E; Cocozza, S; Delvecchio, M; Mozzillo, E; Pirozzi, D; Prisco, F; Rabbone, I; Sacchetti, L; Tinto, N; Toni, S; Zucchini, S; Iafusco, D				Pinelli, Michele; Acquaviva, Fabio; Barbetti, Fabrizio; Caredda, Elisabetta; Cocozza, Sergio; Delvecchio, Maurizio; Mozzillo, Enza; Pirozzi, Daniele; Prisco, Francesco; Rabbone, Ivana; Sacchetti, Lucia; Tinto, Nadia; Toni, Sonia; Zucchini, Stefano; Iafusco, Dario		ISPED	Identification of Candidate Children for Maturity-Onset Diabetes of the Young Type 2 (MODY2) Gene Testing: A Seven-Item Clinical Flowchart (7-iF)	PLOS ONE			English	Article							PRACTICE GUIDELINES; GLUCOKINASE GENE; MUTATIONS; DIAGNOSIS; MELLITUS	MODY2 is the most prevalent monogenic form of diabetes in Italy with an estimated prevalence of about 0.5-1.5%. MODY2 is potentially indistinguishable from other forms of diabetes, however, its identification impacts on patients' quality of life and healthcare resources. Unfortunately, DNA direct sequencing as diagnostic test is not readily accessible and expensive. In addition current guidelines, aiming to establish when the test should be performed, proved a poor detection rate. Aim of this study is to propose a reliable and easy-to-use tool to identify candidate patients for MODY2 genetic testing. We designed and validated a diagnostic flowchart in the attempt to improve the detection rate and to increase the number of properly requested tests. The flowchart, called 7-iF, consists of 7 binary "yes or no" questions and its unequivocal output is an indication for whether testing or not. We tested the 7-iF to estimate its clinical utility in comparison to the clinical suspicion alone. The 7-iF, in a prospective 2-year study (921 diabetic children) showed a precision of about the 76%. Using retrospective data, the 7-iF showed a precision in identifying MODY2 patients of about 80% compared to the 40% of the clinical suspicion. On the other hand, despite a relatively high number of missing MODY2 patients, the 7-iF would not suggest the test for 90% of the non-MODY2 patients, demonstrating that a wide application of this method might 1) help less experienced clinicians in suspecting MODY2 patients and 2) reducing the number of unnecessary tests. With the 7-iF, a clinician can feel confident of identifying a potential case of MODY2 and suggest the molecular test without fear of wasting time and money. A Qaly-type analysis estimated an increase in the patients' quality of life and savings for the health care system of about 9 million euros per year.	[Pinelli, Michele; Acquaviva, Fabio; Cocozza, Sergio; Pirozzi, Daniele; Sacchetti, Lucia; Tinto, Nadia] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Barbetti, Fabrizio] Bambino Gesu Pediat Hosp, Inst Sci, Lab Mendelian Diabet, Lab Mol Endocrinol & Metab, Rome, Italy; [Caredda, Elisabetta; Prisco, Francesco; Iafusco, Dario] Univ Naples 2, Dept Pediat, Naples, Italy; [Delvecchio, Maurizio] IRCCS Casa Sollievo Sofferenza, Pediat Unit, San Giovanni Rotondo, FG, Italy; [Mozzillo, Enza] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Pirozzi, Daniele; Sacchetti, Lucia; Tinto, Nadia] CEINGE Adv Biotechnol SC RL, Naples, Italy; [Rabbone, Ivana] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Toni, Sonia] Meyer Children Hosp, Pediat Diabetol Unit, Florence, Italy; [Zucchini, Stefano] Univ Bologna, Dept Pediat, Bologna, Italy	University of Naples Federico II; IRCCS Bambino Gesu; Universita della Campania Vanvitelli; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Turin; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Bologna	Iafusco, D (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	dario.iafusco@unina2.it	Galderisi, Alfonso/G-3259-2018; Acquaviva, Fabio/N-6402-2016; Rabbone, Ivana/AAC-4250-2020; Barbetti, Fabrizio/AAK-9106-2021; Barbetti, Fabrizio/I-7351-2018; Picariello, Stefania/AAC-5357-2022; Pinelli, Michele/A-1584-2010; Delvecchio, Maurizio/K-8762-2012; Cocozza, Sergio/F-6488-2010; Comberiati, Pasquale/P-6904-2018; Zuccotti, Gianvincenzo/H-8572-2017	Galderisi, Alfonso/0000-0001-8885-3056; Acquaviva, Fabio/0000-0001-9192-1232; Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Pinelli, Michele/0000-0002-5927-1185; Delvecchio, Maurizio/0000-0002-1528-0012; Comberiati, Pasquale/0000-0001-5209-9733; CALCATERRA, VALERIA/0000-0002-2137-5974; Valerio, Giuliana/0000-0001-5063-4333; Salzano, Giuseppina/0000-0003-2180-4510; cardella, francesca/0000-0001-7219-392X; cherubini, valentino/0000-0002-7664-1475; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Calcaterra, Valeria/0000-0003-3862-7872; CAPPA, MARCO/0000-0001-5647-7519; Rabbone, Ivana/0000-0003-4173-146X; MOZZILLO, ENZA/0000-0002-8437-8494; Zanfardino, Angela/0000-0003-0641-1321; Picariello, Stefania/0000-0001-5013-1138; Piccini, Barbara/0000-0002-2684-8638; Iafusco, Dario/0000-0002-9398-3856				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Gill Carey OJ, 2007, DIABETIC MED, V24, P1; Hameed S, 2011, PEDIATR DIABETES, V12, P142, DOI 10.1111/j.1399-5448.2010.00681.x; Iafusco D, 2011, DIABETOLOGIA, V54, P1583, DOI 10.1007/s00125-011-2113-9; Incani M, 2010, DIABETIC MED, V27, P1332, DOI 10.1111/j.1464-5491.2010.03095.x; Italian Barometer Diabetes Observatory, 2012, BAR REP 2012 FACTS F; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Massa O, 2001, DIABETOLOGIA, V44, P898; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Naylor R, 2011, CLIN ENDOCRINOL, V75, P422, DOI 10.1111/j.1365-2265.2011.04049.x; Russo L, 2011, DIABETOLOGIA, V54, P1693, DOI 10.1007/s00125-011-2094-8; Salina A, 2012, DIABETES RES CLIN PR, V95, pE29, DOI 10.1016/j.diabres.2011.10.031; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Shields BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/s00125-011-2418-8; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; Tinto N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001870; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974	22	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79933	10.1371/journal.pone.0079933	http://dx.doi.org/10.1371/journal.pone.0079933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244580	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600161
J	Schlernitzauer, A; Oiry, C; Hamad, R; Galas, S; Cortade, F; Chabi, B; Casas, F; Pessemesse, L; Fouret, G; Feillet-Coudray, C; Cros, G; Cabello, G; Magous, R; Wrutniak-Cabello, C				Schlernitzauer, Audrey; Oiry, Catherine; Hamad, Raphael; Galas, Simon; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cros, Gerard; Cabello, Gerard; Magous, Richard; Wrutniak-Cabello, Chantal			Chicoric Acid Is an Antioxidant Molecule That Stimulates AMP Kinase Pathway in L6 Myotubes and Extends Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FREE FATTY-ACIDS; GLUCOSE-PRODUCTION; MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; STRESS RESISTANCE; CAFFEIC ACID; C. ELEGANS; RESVERATROL; PGC-1-ALPHA	Chicoric acid (CA) is a caffeoyl derivative previously described as having potential anti-diabetic properties. As similarities in cellular mechanism similarities between diabetes and aging have been shown, we explored on L6 myotubes the effect of CA on the modulation of intracellular pathways involved in diabetes and aging. We also determined its influence on lifespan of Caenorhabditis elegans worm (C. elegans). In L6 myotubes, CA was a potent reactive oxygen species (ROS) scavenger, reducing ROS accumulation under basal as well as oxidative stress conditions. CA also stimulated the AMP-activated kinase (AMPK) pathway and displayed various features associated with AMPK activation: CA (a) enhanced oxidative enzymatic defences through increase in glutathion peroxidase (GPx) and superoxide dismutase (SOD) activities, (b) favoured mitochondria protection against oxidative damage through up-regulation of MnSOD protein expression, (c) increased mitochondrial biogenesis as suggested by increases in complex II and citrate synthase activities, along with up-regulation of PGC-1 alpha mRNA expression and (d) inhibited the insulin/Akt/mTOR pathway. As AMPK stimulators (e. g. the anti-diabetic agent meformin or polyphenols such as epigallocatechingallate or quercetin) were shown to extend lifespan in C. elegans, we also determined the effect of CA on the same model. A concentration-dependant lifespan extension was observed with CA (5-100 mu M). These data indicate that CA is a potent antioxidant compound activating the AMPK pathway in L6 myotubes. Similarly to other AMPK stimulators, CA is able to extend C. elegans lifespan, an effect measurable even at the micromolar range. Future studies will explore CA molecular targets and give new insights about its possible effects on metabolic and aging-related diseases.	[Schlernitzauer, Audrey; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cabello, Gerard; Wrutniak-Cabello, Chantal] INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France; [Schlernitzauer, Audrey; Oiry, Catherine; Cros, Gerard; Magous, Richard] CNRS, UMR 5247, IBMM, Montpellier, France; [Hamad, Raphael; Galas, Simon] UFR Pharm, Toxicol Lab, Montpellier, France; [Schlernitzauer, Audrey; Oiry, Catherine; Hamad, Raphael; Galas, Simon; Cortade, Fabienne; Chabi, Beatrice; Casas, Francois; Pessemesse, Laurence; Fouret, Gilles; Feillet-Coudray, Christine; Cros, Gerard; Cabello, Gerard; Magous, Richard; Wrutniak-Cabello, Chantal] Univ Montpellier 1 & 2, Montpellier, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Wrutniak-Cabello, C (corresponding author), INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France.	wrutniak@supagro.inra.fr	Chabi, Beatrice/AAI-6545-2020	Chabi, Beatrice/0000-0002-5604-5668	INRA	INRA	This work was funded by INRA. AS was recipient of The Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Andary C, 2007, Patent, Patent No. [US 20110015140 A1, 20110015140]; Andary C, 2007, Patent, Patent No. [EP2056802 B1, 2056802]; Asano T, 2007, BIOL PHARM BULL, V30, P1610, DOI 10.1248/bpb.30.1610; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRENNER S, 1974, GENETICS, V77, P71; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fink BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004250; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hwang YP, 2013, MOL NUTR FOOD RES, V57, P471, DOI 10.1002/mnfr.201200529; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Lee ES, 2007, BIOCHEM BIOPH RES CO, V361, P854, DOI 10.1016/j.bbrc.2007.07.068; Lee YK, 2010, ONCOL REP, V24, P1471, DOI 10.3892/or_00001007; Lee YK, 2010, ONCOL REP, V24, P1493, DOI 10.3892/or_00001010; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Robb EL, 2008, BIOCHEM BIOPH RES CO, V367, P406, DOI 10.1016/j.bbrc.2007.12.138; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stiernagle Theresa, 2006, WormBook, P1; Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007	73	59	66	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78788	10.1371/journal.pone.0078788	http://dx.doi.org/10.1371/journal.pone.0078788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244361	Green Published, gold			2022-12-27	WOS:000327221600059
J	Tyrrell, J; Galloway, TS; Abo-Zaid, G; Melzer, D; Depledge, MH; Osborne, NJ				Tyrrell, Jessica; Galloway, Tamara S.; Abo-Zaid, Ghada; Melzer, David; Depledge, Michael H.; Osborne, Nicholas J.			High Urinary Tungsten Concentration Is Associated with Stroke in the National Health and Nutrition Examination Survey 1999-2010	PLOS ONE			English	Article							MASS-SPECTROMETRY; CELL BIOLOGY; METALS; TOXICITY; EXPOSURE; DISEASE; PLASMA	Background: In recent years there has been an exponential increase in tungsten demand, potentially increasing human exposure to the metal. Currently, the toxicology of tungsten is poorly understood, but mounting evidence suggests that both the elemental metal and its alloys have cytotoxic effects. Here, we investigate the association between tungsten and cardiovascular disease (CVD) or stroke using six waves of the National Health and Nutrition Examination Survey (NHANES). Methods: We investigated associations using crude and adjusted logistic regression models in a cohort of 8614 adults (18-74 years) with 193 reported stroke diagnoses and 428 reported diagnoses of CVD. We also stratified our data to characterize associations in a subset of younger individuals (18-50 years). Results: Elevated tungsten concentrations were strongly associated with an increase in the prevalence of stroke, independent of typical risk factors (Odds Ratio (OR): 1.66, 95% Confidence Interval (95% CI): 1.17, 2.34). The association between tungsten and stroke in the young age category was still evident (OR: 2.17, 95% CI: 1.33, 3.53). Conclusion: This study represents the most comprehensive analysis of the human health effects of tungsten to date. Individuals with higher urinary tungsten concentrations have double the odds of reported stroke. We hypothesize that the pathological pathway resulting from tungsten exposure may involve oxidative stress.	[Tyrrell, Jessica; Abo-Zaid, Ghada; Depledge, Michael H.; Osborne, Nicholas J.] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England; [Galloway, Tamara S.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Melzer, David] Univ Exeter, Sch Med, Exeter, Devon, England	University of Exeter; University of Exeter; University of Exeter	Osborne, NJ (corresponding author), Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England.	N.J.Osborne@exeter.ac.uk	Osborne, Nicholas/D-2086-2011; Abo-Zaid, Ghada/AAY-7516-2020	Osborne, Nicholas/0000-0002-6700-2284; Depledge, Michael/0000-0002-7216-0439	University of Exeter Medical School; ERDF (European Regional Development Fund); ESF (European Social Fund) Convergence Programmed for Cornwall and the Isles of Scilly	University of Exeter Medical School; ERDF (European Regional Development Fund)(European Commission); ESF (European Social Fund) Convergence Programmed for Cornwall and the Isles of Scilly	This work was supported by funding from University of Exeter Medical School. No funding organization or sponsor played any part in the design or conduct of the study, in the analysis or interpretation of the data, or preparation, review, or approval of the manuscript. The European Centre for the Environment and Human Health (part of the University of Exeter Medical School) is supported by investment from the ERDF (European Regional Development Fund) and ESF (European Social Fund) Convergence Programmed for Cornwall and the Isles of Scilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, ANGIOLOGY, V62, P422, DOI 10.1177/0003319710395562; Agency for Toxic Substances and Disease Registry (ATSDR), 2005, TOX PROF TUNGST; Barr DB, 2004, ENV HLTH PERSPECT, V113; Environmental Protection Agency, 2010, EM CONT TUNGST; Fenoglio I, 2008, FREE RADICAL RES, V42, P737, DOI 10.1080/10715760802350904; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Harper EM, 2008, ENVIRON SCI TECHNOL, V42, P3835, DOI 10.1021/es070646s; Harris RM, 2011, TOXICOL APPL PHARM, V250, P19, DOI 10.1016/j.taap.2010.09.020; Johnson DR, 2010, TOXICOL SCI, V116, P523, DOI 10.1093/toxsci/kfq124; Kalinich JF, 2005, ENVIRON HEALTH PERSP, V113, P729, DOI 10.1289/ehp.7791; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kodali P, 2012, METALLOMICS, V4, P1077, DOI 10.1039/c2mt20092a; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; Moulin JJ, 1998, AM J EPIDEMIOL, V148, P241; MULLIGAN KJ, 1990, J ANAL ATOM SPECTROM, V5, P301, DOI 10.1039/ja9900500301; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Rashid Parveen A, 2003, J Stroke Cerebrovasc Dis, V12, P82, DOI 10.1053/jscd.2003.9; Roedel EQ, 2012, TOXICOL APPL PHARM, V259, P74, DOI 10.1016/j.taap.2011.12.008; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Survey USG, 2012, MIN COMM SUMM TUNGST; Witten ML, 2012, CHEM-BIOL INTERACT, V196, P87, DOI 10.1016/j.cbi.2011.12.002; Yoshida M, 2012, CLIN CHIM ACTA, V413, P753, DOI 10.1016/j.cca.2012.01.020	23	32	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77546	10.1371/journal.pone.0077546	http://dx.doi.org/10.1371/journal.pone.0077546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244278	Green Published, gold			2022-12-27	WOS:000327221600008
J	Arnoldini, M; Heck, T; Blanco-Fernandez, A; Hammes, F				Arnoldini, Markus; Heck, Tobias; Blanco-Fernandez, Alfonso; Hammes, Frederik			Monitoring of Dynamic Microbiological Processes Using Real-Time Flow Cytometry	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIA; VIABILITY; PRODUCT; GROWTH	We describe a straightforward approach to continuously monitor a variety of highly dynamic microbiological processes in millisecond resolution with flow cytometry, using standard bench-top instrumentation. Four main experimental examples are provided, namely: (1) green fluorescent protein expression by antibiotic-stressed Escherichia coli, (2) fluorescent labeling of heat-induced membrane damage in an autochthonous freshwater bacterial community, (3) the initial growth response of late stationary E. coli cells inoculated into fresh growth media, and (4) oxidative disinfection of a mixed culture of auto-fluorescent microorganisms. These examples demonstrate the broad applicability of the method to diverse biological experiments, showing that it allows the collection of detailed, time-resolved information on complex processes.	[Arnoldini, Markus; Hammes, Frederik] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, Dubendorf, Switzerland; [Arnoldini, Markus] ETH, Dept Environm Syst Sci, Zurich, Switzerland; [Heck, Tobias] Empa Swiss Fed Labs Mat Sci & Technol, Lab Biomat, St Gallen, Switzerland; [Blanco-Fernandez, Alfonso] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Flow Cytometry Core Facil, Dublin 2, Ireland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University College Dublin	Hammes, F (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, Dubendorf, Switzerland.	frederik.hammes@eawag.ch		Blanco, Alfonso/0000-0003-0439-0838	SNF [31003A_130735]	SNF	Markus Arnoldini was supported by SNF grant 31003A_130735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Broger T, 2011, J BIOTECHNOL, V154, P240, DOI 10.1016/j.jbiotec.2011.05.003; Cooper S., 1991, BACTERIAL GROWTH DIV; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GUDAS LJ, 1977, P NATL ACAD SCI USA, V74, P5280, DOI 10.1073/pnas.74.12.5280; Hammes F, 2006, WATER RES, V40, P2275, DOI 10.1016/j.watres.2006.04.029; Hammes F, 2012, CYTOM PART A, V81A, P508, DOI 10.1002/cyto.a.22048; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; JUAN G, 1994, CYTOMETRY, V15, P335, DOI 10.1002/cyto.990150409; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Lage OM, 2001, CYTOMETRY, V44, P226, DOI 10.1002/1097-0320(20010701)44:3<226::AID-CYTO1115>3.0.CO;2-9; Lequerica JL, 2006, J PHYSIOL BIOCHEM, V62, P253, DOI 10.1007/BF03165754; MARTIN JC, 1980, SCIENCE, V207, P199, DOI 10.1126/science.6153131; Monteiro MD, 1999, CYTOMETRY, V35, P302; Nolan JP, 1998, NAT BIOTECHNOL, V16, P633, DOI 10.1038/nbt0798-633; Olofsson SK, 2006, J ANTIMICROB CHEMOTH, V57, P1116, DOI 10.1093/jac/dkl135; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; PREMAZZI G, 1989, WATER RES, V23, P431, DOI 10.1016/0043-1354(89)90134-6; PREST EI, 2013, WATER RES, P83559; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; Rohacova J, 2009, CHEMMEDCHEM, V4, P466, DOI 10.1002/cmdc.200800383; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; SHAPIRO HM, 1983, CYTOMETRY, V3, P227, DOI 10.1002/cyto.990030402; Shi L, 2007, CYTOM PART A, V71A, P592, DOI 10.1002/cyto.a.20402; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Vines A, 2010, CYTOM PART A, V77A, P1091, DOI 10.1002/cyto.a.20974; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	34	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80117	10.1371/journal.pone.0080117	http://dx.doi.org/10.1371/journal.pone.0080117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244624	Green Published, gold			2022-12-27	WOS:000327143800124
J	Chen, ZW; Pereira, JH; Liu, HB; Tran, HM; Hsu, NSY; Dibble, D; Singh, S; Adams, PD; Sapra, R; Hadi, MZ; Simmons, BA; Sale, KL				Chen, Zhiwei; Pereira, Jose H.; Liu, Hanbin; Tran, Huu M.; Hsu, Nathan S. Y.; Dibble, Dean; Singh, Seema; Adams, Paul D.; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.			Improved Activity of a Thermophilic Cellulase, Cel5A, from Thermotoga maritima on Ionic Liquid Pretreated Switchgrass	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; ENDOGLUCANASE CEL5A; RANDOM MUTAGENESIS; BIOFUELS; BIOMASS; OPTIMIZATION; PLANTS; FUELS	Ionic liquid pretreatment of biomass has been shown to greatly reduce the recalcitrance of lignocellulosic biomass, resulting in improved sugar yields after enzymatic saccharification. However, even under these improved saccharification conditions the cost of enzymes still represents a significant proportion of the total cost of producing sugars and ultimately fuels from lignocellulosic biomass. Much of the high cost of enzymes is due to the low catalytic efficiency and stability of lignocellulolytic enzymes, especially cellulases, under conditions that include high temperatures and the presence of residual pretreatment chemicals, such as acids, organic solvents, bases, or ionic liquids. Improving the efficiency of the saccharification process on ionic liquid pretreated biomass will facilitate reduced enzyme loading and cost. Thermophilic cellulases have been shown to be stable and active in ionic liquids but their activity is typically at lower levels. Cel5A_Tma, a thermophilic endoglucanase from Thermotoga maritima, is highly active on cellulosic substrates and is stable in ionic liquid environments. Here, our motivation was to engineer mutants of Cel5A_Tma with higher activity on 1-ethyl-3-methylimidazolium acetate ([C(2)mim][OAc]) pretreated biomass. We developed a robotic platform to screen a random mutagenesis library of Cel5A_Tma. Twelve mutants with 25-42% improvement in specific activity on carboxymethyl cellulose and up to 30% improvement on ionic-liquid pretreated switchgrass were successfully isolated and characterized from a library of twenty thousand variants. Interestingly, most of the mutations in the improved variants are located distally to the active site on the protein surface and are not directly involved with substrate binding.	[Chen, Zhiwei; Pereira, Jose H.; Liu, Hanbin; Tran, Huu M.; Dibble, Dean; Singh, Seema; Adams, Paul D.; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Chen, Zhiwei; Liu, Hanbin; Tran, Huu M.; Dibble, Dean; Singh, Seema; Sapra, Rajat; Hadi, Masood Z.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Livermore, CA USA; [Pereira, Jose H.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Hsu, Nathan S. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Sale, KL (corresponding author), Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA.	klsale@sandia.gov	Simmons, Blake/N-6022-2016; Adams, Paul David/A-1977-2013	Simmons, Blake/0000-0002-1332-1810; Adams, Paul David/0000-0001-9333-8219	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [B0946381]	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This project also received support from the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense under Grant No. B0946381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Bharadwaj R, 2010, ANAL CHEM, V82, P9513, DOI 10.1021/ac102243f; Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferdjani S, 2011, BIOTECHNOL LETT, V33, P1215, DOI 10.1007/s10529-011-0560-5; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hughes SR, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-10; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; Kim YS, 2000, APPL ENVIRON MICROB, V66, P788, DOI 10.1128/AEM.66.2.788-793.2000; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Lee D, 2007, COMPOSITION HERBACEO; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Li H, 2010, ANNU REV CHEM BIOMOL, V1, P19, DOI 10.1146/annurev-chembioeng-073009-100938; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liu HB, 2010, FEBS LETT, V584, P3431, DOI 10.1016/j.febslet.2010.06.041; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Lloyd TA, 2005, BIORESOURCE TECHNOL, V96, P1967, DOI 10.1016/j.biortech.2005.01.011; Mahadevan SA, 2008, FEMS MICROBIOL LETT, V287, P205, DOI 10.1111/j.1574-6968.2008.01324.x; McCarthy JK, 2004, J BIOL CHEM, V279, P11495, DOI 10.1074/jbc.M305642200; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P1986, DOI 10.1016/j.biortech.2005.01.013; Murashima K, 2002, MOL MICROBIOL, V45, P617, DOI 10.1046/j.1365-2958.2002.03049.x; Navarro D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-58; Ohgren K, 2007, BIORESOURCE TECHNOL, V98, P2503, DOI 10.1016/j.biortech.2006.09.003; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun N, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-39; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; U.S. Department of Energy Biomass Program, BIOM FEEDST COMP PRO; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Warshel A, 2007, BIOCHEMISTRY; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Wiselogel AE, 1996, BIORESOURCE TECHNOL, V56, P103, DOI 10.1016/0960-8524(95)00171-9; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	55	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79725	10.1371/journal.pone.0079725	http://dx.doi.org/10.1371/journal.pone.0079725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244549	Green Published, gold			2022-12-27	WOS:000327143800098
J	Fischer, S; Nolte, I; Schilling, N				Fischer, Stefanie; Nolte, Ingo; Schilling, Nadja			Adaptations in Muscle Activity to Induced, Short-Term Hindlimb Lameness in Trotting Dogs	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; KINEMATIC GAIT ANALYSIS; LONGISSIMUS-DORSI MUSCLES; GROUND REACTION FORCE; 2 SURGICAL TECHNIQUES; PELVIC LIMB; ELECTROMYOGRAPHIC ACTIVITY; SURFACE ELECTROMYOGRAPHY; TREADMILL INCLINATION; MOVEMENT ADAPTATIONS	Muscle tissue has a great intrinsic adaptability to changing functional demands. Triggering more gradual responses such as tissue growth, the immediate responses to altered loading conditions involve changes in the activity. Because the reduction in a limb's function is associated with marked deviations in the gait pattern, understanding the muscular responses in laming animals will provide further insight into their compensatory mechanisms as well as help to improve treatment options to prevent musculoskeletal sequelae in chronic patients. Therefore, this study evaluated the changes in muscle activity in adaptation to a moderate, short-term, weight-bearing hindlimb lameness in two leg and one back muscle using surface electromyography (SEMG). In eight sound adult dogs that trotted on an instrumented treadmill, bilateral, bipolar recordings of the m. triceps brachii, the m. vastus lateralis and the m. longissimus dorsi were obtained before and after lameness was induced. Consistent with the unchanged vertical forces as well as temporal parameters, neither the timing nor the level of activity changed significantly in the m. triceps brachii. In the ipsilateral m. vastus lateralis, peak activity and integrated SEMG area were decreased, while they were significantly increased in the contralateral hindlimb. In both sides, the duration of the muscle activity was significantly longer due to a delayed offset. These observations are in accordance with previously described kinetic and kinematic changes as well as changes in muscle mass. Adaptations in the activity of the m. longissimus dorsi concerned primarily the unilateral activity and are discussed regarding known alterations in trunk and limb motions.	[Fischer, Stefanie; Nolte, Ingo] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Schilling, Nadja] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Schilling, N (corresponding author), Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany.	nadja.schilling@icloud.com			Graduiertenkolleg Biomedizintechnik of the SFB 599; German Research Foundation; Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V.; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt	Graduiertenkolleg Biomedizintechnik of the SFB 599(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V.; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt	This study was supported by the Graduiertenkolleg Biomedizintechnik of the SFB 599 funded by the German Research Foundation (scholarship to SF) and the Hannoversche Gesellschaft zur Forderung der Kleintiermedizin e.V. (both to IN) as well as the Berufsgenossenschaft Nahrungsmittel und Gastgewerbe Erfurt (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052202; Abdelhadi J, 2013, AM J VET RES, V74, P34, DOI 10.2460/ajvr.74.1.34; ALLEN K, 1994, VET COMP ORTHOPAED, V7, P148; Alvarez CBG, 2008, EQUINE VET J, V40, P147, DOI 10.2746/042516408X250184; ARMSTRONG RB, 1982, AM J ANAT, V163, P87, DOI 10.1002/aja.1001630107; Bennett RL, 1996, AM J VET RES, V57, P966; Bockstahler B, 2012, VET SURG, V41, P54, DOI 10.1111/j.1532-950X.2011.00932.x; Bockstahler BA, 2012, AM J VET RES, V73, P1371, DOI 10.2460/ajvr.73.9.1371; Bockstahler BB, 2009, VET SURG, V38, P754, DOI 10.1111/j.1532-950X.2009.00561.x; Boddeker J, 2012, VET COMP ORTHOPAED, V25, P11, DOI 10.3415/VCOT-10-02-0025; Buchner H H, 2001, Equine Vet J Suppl, P122; Buchner HHF, 1996, EQUINE VET J, V28, P63, DOI 10.1111/j.2042-3306.1996.tb01591.x; Buchner HHF, 1996, EQUINE VET J, V28, P71, DOI 10.1111/j.2042-3306.1996.tb01592.x; BUDSBERG SC, 1988, AM J VET RES, V49, P1522; CARLSON H, 1979, ACTA PHYSIOL SCAND, V105, P251, DOI 10.1111/j.1748-1716.1979.tb06338.x; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; Carrier DR, 2006, J EXP BIOL, V209, P2224, DOI 10.1242/jeb.02236; Carroll AM, 2009, J EXP BIOL, V212, P3349, DOI 10.1242/jeb.033639; Chapman AR, 2008, J ELECTROMYOGR KINES, V18, P359, DOI 10.1016/j.jelekin.2005.12.007; Corr S, 2009, IN PRACTICE, V31, P164; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1996, AM J VET RES, V57, P120; DECAMP CE, 1993, AM J VET RES, V54, P627; DUPUIS J, 1994, VET SURG, V23, P1, DOI 10.1111/j.1532-950X.1994.tb00436.x; ENGBERG I, 1969, ACTA PHYSIOL SCAND, V75, P614, DOI 10.1111/j.1748-1716.1969.tb04415.x; ENGLISH AW, 1978, J EXP BIOL, V76, P105; Evans H. W., 1993, Miller's anatomy of the dog., P1; Fischer S, 2013, VET J, V197, P746, DOI 10.1016/j.tvjl.2013.04.009; Goldspink G, 2005, BRIT J SPORT MED, V39, P787, DOI 10.1136/bjsm.2004.015826; Goldspink G, 2002, BIOCHEM SOC T, V30, P285, DOI 10.1042/bst0300285; GOSLOW GE, 1981, J EXP BIOL, V94, P15; Harrison SM, 2012, J EXP BIOL, V215, P2980, DOI 10.1242/jeb.065441; Hasler EM, 1998, J BIOMECH, V31, P253, DOI 10.1016/S0021-9290(97)00119-X; Herzog W, 2003, LANGENBECK ARCH SURG, V388, P305, DOI 10.1007/s00423-003-0402-6; Innes JF, 1998, J SMALL ANIM PRACT, V39, P325, DOI 10.1111/j.1748-5827.1998.tb03723.x; Jevens DJ, 1996, AM J VET RES, V57, P389; JOHNSON JM, 1993, VET CLIN N AM-SMALL, V23, P717, DOI 10.1016/S0195-5616(93)50078-5; Katic N, 2009, AM J VET RES, V70, P118, DOI 10.2460/ajvr.70.1.118; KORVICK DL, 1994, J BIOMECH, V27, P77, DOI 10.1016/0021-9290(94)90034-5; Lamoth CJC, 2004, CLIN BIOMECH, V19, P551, DOI 10.1016/j.clinbiomech.2003.10.006; Lauer SK, 2009, AM J VET RES, V70, P658, DOI 10.2460/ajvr.70.5.658; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka TF, 2004, AM J VET RES, V65, P155, DOI 10.2460/ajvr.2004.65.155; Miller A., 1996, In Practice, V18, P98; Moseley GL, 2004, BRAIN, V127, P2339, DOI 10.1093/brain/awh248; Mostafa AA, 2010, VET SURG, V39, P380, DOI 10.1111/j.1532-950X.2010.00657.x; Nomura S., 1966, Japanese Journal Zootechnical Science, V37, P221; PERRY AK, 1988, J EXP BIOL, V137, P207; Poy NSJ, 2000, AM J VET RES, V61, P974, DOI 10.2460/ajvr.2000.61.974; Ragetly CA, 2010, VET SURG, V39, P513, DOI 10.1111/j.1532-950X.2010.00680.x; RASMUSSEN S, 1978, J MORPHOL, V155, P253, DOI 10.1002/jmor.1051550302; Ritter DA, 2001, J EXP BIOL, V204, P3053; Robert C, 2002, EQUINE VET J, V34, P295; Robert C, 2001, EQUINE VET J, V33, P466, DOI 10.2746/042516401776254745; Robert C, 1999, CELLS TISSUES ORGANS, V165, P113, DOI 10.1159/000016681; RUMPH PF, 1995, VET SURG, V24, P384, DOI 10.1111/j.1532-950X.1995.tb01348.x; RUMPH PF, 1993, AM J VET RES, V54, P365; Sanchez-Bustinduy M, 2010, VET SURG, V39, P523, DOI 10.1111/j.1532-950X.2010.00672.x; Schaeffer PJ, 2013, COMPR PHYSIOL, V3, P289, DOI 10.1002/cphy.c110059; Schilling N, 2010, J EXP BIOL, V213, P1490, DOI 10.1242/jeb.039487; Schilling N, 2009, J EXP BIOL, V212, P1053, DOI 10.1242/jeb.020248; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Scholle HC, 2001, EXP BRAIN RES, V138, P26, DOI 10.1007/s002210100685; Sutherland DH, 2001, GAIT POSTURE, V14, P61, DOI 10.1016/S0966-6362(01)00100-X; TOKURIKI M, 1973, JPN J VET SCI, V35, P525; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; VILENSKY JA, 1994, J ELECTROMYOGR KINES, V4, P181, DOI 10.1016/1050-6411(94)90019-1; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; WENTINK GH, 1978, ANAT EMBRYOL, V152, P261, DOI 10.1007/BF00350524; WENTINK GH, 1976, ACTA ANAT, V96, P70, DOI 10.1159/000144662; Wickler SJ, 2000, J EXP BIOL, V203, P2195; Wickler SJ, 2005, J EXP BIOL, V208, P1191, DOI 10.1242/jeb.01485; Zaneb H, 2009, AM J VET RES, V70, P1129, DOI 10.2460/ajvr.70.9.1129	73	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80987	10.1371/journal.pone.0080987	http://dx.doi.org/10.1371/journal.pone.0080987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236207	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700210
J	Chapple, DG; Ritchie, PA				Chapple, David G.; Ritchie, Peter A.			A Retrospective Approach to Testing the DNA Barcoding Method	PLOS ONE			English	Article							SCINCIDAE SPECIES COMPLEX; PARASITOID FLIES DIPTERA; MITOCHONDRIAL-DNA; COMPARATIVE PHYLOGEOGRAPHY; IDENTIFYING SPIDERS; TAXONOMIC REVISION; SKINK; OLIGOSOMA; REPTILIA; GENUS	A decade ago, DNA barcoding was proposed as a standardised method for identifying existing species and speeding the discovery of new species. Yet, despite its numerous successes across a range of taxa, its frequent failures have brought into question its accuracy as a short-cut taxonomic method. We use a retrospective approach, applying the method to the classification of New Zealand skinks as it stood in 1977 (primarily based upon morphological characters), and compare it to the current taxonomy reached using both morphological and molecular approaches. For the 1977 dataset, DNA barcoding had moderate-high success in identifying specimens (78-98%), and correctly flagging specimens that have since been confirmed as distinct taxa (77-100%). But most matching methods failed to detect the species complexes that were present in 1977. For the current dataset, there was moderate-high success in identifying specimens (53-99%). For both datasets, the capacity to discover new species was dependent on the methodological approach used. Species delimitation in New Zealand skinks was hindered by the absence of either a local or global barcoding gap, a result of recent speciation events and hybridisation. Whilst DNA barcoding is potentially useful for specimen identification and species discovery in New Zealand skinks, its error rate could hinder the progress of documenting biodiversity in this group. We suggest that integrated taxonomic approaches are more effective at discovering and describing biodiversity.	[Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Chapple, David G.; Ritchie, Peter A.] Victoria Univ Wellington, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Wellington, New Zealand	Monash University; Victoria University Wellington	Chapple, DG (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	David.Chapple@monash.edu	; Chapple, David/B-9073-2008	Ritchie, Peter/0000-0002-8351-7931; Chapple, David/0000-0002-7720-6280	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington	The study was funded by the Allan Wilson Centre for Molecular Ecology and Evolution, and a University Research Fund grant from Victoria University of Wellington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bell TP, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1882.1.3; Berry O, 2005, BIOL CONSERV, V123, P197, DOI 10.1016/j.biocon.2004.11.007; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Chapple DG, 2008, BIOL J LINN SOC, V95, P388, DOI 10.1111/j.1095-8312.2008.01062.x; Chapple DG, 2008, J HERPETOL, V42, P437, DOI 10.1670/07-110.1; Chapple DG, 2008, NEW ZEAL J ZOOL, V35, P129, DOI 10.1080/03014220809510110; Chapple DG, 2007, NEW ZEAL J ZOOL, V34, P347, DOI 10.1080/03014220709510094; Chapple DG, 2011, ZOOTAXA, P1; Chapple DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034599; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; Chapple DG, 2009, NZ J ZOOLOGY, V36, P59, DOI [10.1080/03014220909510140, DOI 10.1080/03014220909510140]; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Collins RA, 2013, MOL ECOL RESOUR, DOI [10.1111/1755-0998.12046, DOI 10.1111/1755-0998.12046.PUBMED:23280099]; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Daugherty C.M., 1990, Herpetological Monographs, P61; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2011, ENEIOUS V5 4; Dubey S, 2012, J EVOLUTION BIOL, V25, P220, DOI 10.1111/j.1420-9101.2011.02417.x; Dubey S, 2011, BIOL LETTERS, V7, P96, DOI 10.1098/rsbl.2010.0557; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Greaves SNJ, 2008, J BIOGEOGR, V35, P853, DOI 10.1111/j.1365-2699.2007.01848.x; Greaves SNJ, 2007, MOL PHYLOGENET EVOL, V45, P729, DOI 10.1016/j.ympev.2007.06.008; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARDY GS, 1977, NEW ZEAL J ZOOL, V4, P221, DOI 10.1080/03014223.1977.9517956; Hare KM, 2008, MOL PHYLOGENET EVOL, V46, P303, DOI 10.1016/j.ympev.2007.08.012; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hitchmough RA, 2010, NEW ZEAL J ZOOL, V37, P203, DOI 10.1080/03014223.2010.496487; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liggins L, 2008, MOL ECOL, V17, P3668, DOI 10.1111/j.1365-294X.2008.03864.x; Liggins L, 2008, MOL ECOL, V17, P3290, DOI 10.1111/j.1365-294X.2008.03832.x; Meier R, 2004, CLADISTICS, V20, P600; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; O'Neill SB, 2008, MOL PHYLOGENET EVOL, V48, P1168, DOI 10.1016/j.ympev.2008.05.008; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; PATTERSON GB, 1990, J ROY SOC NEW ZEAL, V20, P65, DOI 10.1080/03036758.1990.10426733; Patterson GB, 1997, J ROY SOC NEW ZEAL, V27, P439, DOI 10.1080/03014223.1997.9517547; Patterson GB, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2271.1.4; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rodman JE, 2003, SYST BIOL, V52, P428, DOI 10.1080/10635150390197055; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SEBERG O, 2004, SYSTEMATIST, V23, P2; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vos ME, 1988, THESIS VICTORIA U WE; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	93	18	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77882	10.1371/journal.pone.0077882	http://dx.doi.org/10.1371/journal.pone.0077882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244283	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600011
J	Lee, S; Ashizawa, AT; Kim, KS; Falk, DJ; Notterpek, L				Lee, Sooyeon; Ashizawa, Ana Tari; Kim, Kwang Sik; Falk, Darin J.; Notterpek, Lucia			Liposomes to Target Peripheral Neurons and Schwann Cells	PLOS ONE			English	Article							CAVEOLAE-MEDIATED ENDOCYTOSIS; CLATHRIN; TRANSPORT; PROTEIN; MICE	While a wealth of literature for tissue-specific liposomes is emerging, optimal formulations to target the cells of the peripheral nervous system (PNS) are lacking. In this study, we asked whether a novel formulation of phospholipid-based liposomes could be optimized for preferential uptake by microvascular endothelia, peripheral neurons and Schwann cells. Here, we report a unique formulation consisting of a phospholipid, a polymer surfactant and cholesterol that result in enhanced uptake by targeted cells. Using fluorescently labeled liposomes, we followed particle internalization and trafficking through a distinct route from dextran and escape from degradative compartments, such as lysosomes. In cultures of non-myelinating Schwann cells, liposomes associate with the lipid raft marker Cholera toxin, and their internalization is inhibited by disruption of lipid rafts or actin polymerization. In contrast, pharmacological inhibition of clathrin-mediated endocytosis does not significantly impact liposome entry. To evaluate the efficacy of liposome targeting in tissues, we utilized myelinating explant cultures of dorsal root ganglia and isolated diaphragm preparations, both of which contain peripheral neurons and myelinating Schwann cells. In these models, we detected preferential liposome uptake into neurons and glial cells in comparison to surrounding muscle tissue. Furthermore, in vivo liposome administration by intramuscular or intravenous injection confirmed that the particles were delivered to myelinated peripheral nerves. Within the CNS, we detected the liposomes in choroid epithelium, but not in myelinated white matter regions or in brain parenchyma. The described nanoparticles represent a novel neurophilic delivery vehicle for targeting small therapeutic compounds, biological molecules, or imaging reagents into peripheral neurons and Schwann cells, and provide a major advancement toward developing effective therapies for peripheral neuropathies.	[Lee, Sooyeon; Ashizawa, Ana Tari; Notterpek, Lucia] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Notterpek, Lucia] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Kim, Kwang Sik] Johns Hopkins Childrens Ctr, Eudowood Div Pediat Infect Dis, Baltimore, MD USA; [Falk, Darin J.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of Florida	Ashizawa, AT (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.	anamtari@ufl.edu; notterpek@ufl.edu			University of Florida Research Opportunity Seed Fund; NIH [NS041012]; Trigeminal Neuralgia Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041012] Funding Source: NIH RePORTER	University of Florida Research Opportunity Seed Fund(University of Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trigeminal Neuralgia Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by University of Florida Research Opportunity Seed Fund, NIH grant NS041012 and the Trigeminal Neuralgia Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chekhonin VP, 2008, B EXP BIOL MED+, V146, P451, DOI 10.1007/s10517-009-0301-0; Chen G, 2012, GLIA, V60, P295, DOI 10.1002/glia.21263; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Frank PG, 2009, CELL TISSUE RES, V335, P41, DOI 10.1007/s00441-008-0659-8; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; Gutierrez-Puente Y, 2003, LEUKEMIA LYMPHOMA, V44, P1979, DOI 10.1080/1042819031000099733; Harris JR, 2010, CHOLRESTEROL MYELIN, P489; Hirling H, 2009, NEUROSCIENCE, V158, P36, DOI 10.1016/j.neuroscience.2008.02.057; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Mikol DD, 1999, GLIA, V27, P39; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rejman J, 2006, J LIPOSOME RES, V16, P237, DOI 10.1080/08982100600848819; Sahay G, 2010, BIOMATERIALS, V31, P1757, DOI 10.1016/j.biomaterials.2009.11.020; Saheki Y, 2012, COLD SPRING HARBOR P, V4; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Tahara K, 2011, EUR J PHARM BIOPHARM, V77, P84, DOI 10.1016/j.ejpb.2010.11.002; Tari AM, 1999, ONCOGENE, V18, P1325, DOI 10.1038/sj.onc.1202422; Tari AM, 2007, INT J ONCOL, V31, P1243; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015	29	18	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78724	10.1371/journal.pone.0078724	http://dx.doi.org/10.1371/journal.pone.0078724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244347	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600054
J	Souza, TML; Resende, PC; Fintelman-Rodrigues, N; Gregianini, TS; Ikuta, N; Fernandes, SB; Cury, ALF; Rosa, MDD; Siqueira, MM				Souza, Thiago Moreno L.; Resende, Paola C.; Fintelman-Rodrigues, Natalia; Gregianini, Tatiana Schaffer; Ikuta, Nilo; Fernandes, Sandra Bianchini; Furtado Cury, Ana Luisa; Debur Rosa, Maria do Carmo; Siqueira, Marilda M.			Detection of Oseltamivir-Resistant Pandemic Influenza A(H1N1)pdm2009 in Brazil: Can Community Transmission Be Ruled Out?	PLOS ONE			English	Article							DRUG-RESISTANCE; VIRUS	Although surveillance efforts that monitor the emergence of drug-resistant strains of influenza are critical, systematic analysis is overlooked in most developing countries. We report on the occurrence of strains of pandemic influenza A(H1N1)pdm09 with resistance and decreased susceptibility to oseltamivir (OST) in Brazil in 2009, 2011 and 2012. We found 7 mutant viruses, 2 with the mutation S247N and other 5 with the mutation H275Y. Most of these viruses were from samples concentrated in the southern region of Brazil. Some of these resistant viruses were detected prior to the initiation of OST treatment, suggesting that community transmission of mutant viruses may exist. Moreover, we show that one of these OST-resistant (H275Y) strains of A(H1N1) pdm09 was discovered in the tri-border region between Brazil, Argentina and Paraguay, highlighting that this strain could also be found in other Latin American countries. Our findings reinforce the importance of enhanced antiviral resistance surveillance in Brazil and in other Latin American countries to confirm or rule out the community transmission of OST-resistant strains of A(H1N1)pdm09.	[Souza, Thiago Moreno L.; Resende, Paola C.; Fintelman-Rodrigues, Natalia; Siqueira, Marilda M.] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil; [Gregianini, Tatiana Schaffer] Fundacao Estadual Prod & Pesquisa Saude Secao Vir, Lab Cent Saude Publ Estado Rio de Grande do Sul, Porto Alegre, RS, Brazil; [Fernandes, Sandra Bianchini] Lab Cent Saude Publ Estado Santa Catarina, Florianopolis, SC, Brazil; [Furtado Cury, Ana Luisa] Inst Octavio Magalhaes Fundacao Ezequiel Dias, Lab Cent Saude Publ Estado Minas Gerais, Belo Horizonte, MG, Brazil; [Debur Rosa, Maria do Carmo] Lab Cent Saude Publ Estado Parana, Curitiba, Parana, Brazil; [Ikuta, Nilo] Univ Luterana Brasil, Porto Alegre, RS, Brazil	Fundacao Oswaldo Cruz; Universidade Luterana do Brasil	Souza, TML (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil.	tmoreno@ioc.fiocruz.br	Resende, Paola Cristina/P-5002-2015; Souza, Thiago Moreno L./G-2900-2012	Resende, Paola Cristina/0000-0002-2884-3662; Souza, Thiago Moreno L./0000-0003-2212-3899; Ikuta, Nilo/0000-0002-5598-5340	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; SVS; CNPq; FAPERJ; IOC/Fiocruz	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; SVS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IOC/Fiocruz	The work was supported by Instituto Oswaldo Cruz/Fiocruz (www.ioc.fiocruz.br) and Brazilian Ministry of Health/Decit and SVS (http://dtr2001.saude.gov.br/sctie/decit/index.htm). MMS was supported in part by individual research grants from CNPq (www.cnpq.br). MMS and TLMS used, in part, individual research grants from FAPERJ (www.faperj.br) and CNPq. Thanks are also due to IOC/Fiocruz for providing PCR and NFR fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Fry AM, 2012, J INFECT DIS, V206, P145, DOI 10.1093/infdis/jis338; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; *MIN SAUD, 2009, PROT MAN CLIN VIG EP; Ministerio da Saude, 2012, INF TECN CAMP NAC VA; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Roseira AM, 2006, FOZ IGUACU CIDADE RE, P171; Seibert CW, 2012, J VIROL, V86, P5386, DOI 10.1128/JVI.00151-12; Souza TML, 2011, DIAGN MICR INFEC DIS, V71, P98, DOI 10.1016/j.diagmicrobio.2011.05.006; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; WHO, 2012, LAB METH TEST ANT SU; WHO Global Influenza Network, 2011, AN LAB DIAGN VIR SUR, P153; World Health Organization, 2009, CDC PROT REALT RTPCR	18	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80081	10.1371/journal.pone.0080081	http://dx.doi.org/10.1371/journal.pone.0080081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244615	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600178
J	Steiner, AM; Bulaj, G; Puillandre, N				Steiner, Andrew M.; Bulaj, Grzegorz; Puillandre, Nicolas			On the Importance of Oxidative Folding in the Evolution of Conotoxins: Cysteine Codon Preservation through Gene Duplication and Adaptation	PLOS ONE			English	Article							CONE SNAILS; DISULFIDE BRIDGES; IN-VITRO; SUPERFAMILY CONOTOXINS; ENDOPLASMIC-RETICULUM; OMEGA-CONOTOXIN; RAPID EVOLUTION; VENOM PEPTIDES; RICH PEPTIDES; DIVERSIFICATION	Conotoxin genes are among the most rapidly evolving genes currently known; however, despite the well-established hypervariability of the intercysteine loops, the cysteines demonstrate significant conservation, with a site-specific codon bias for each cysteine in a family of conotoxins. Herein we present a novel rationale behind the codon-level conservation of the cysteines that comprise the disulfide scaffold. We analyze cysteine codon conservation using an internal reference and phylogenetic tools; our results suggest that the established codon conservation can be explained as the result of selective pressures linked to the production efficiency and folding of conotoxins, driving the conservation of cysteine at the amino-acid level. The preservation of cysteine has resulted in maintenance of the ancestral codon in most of the daughter lineages, despite the hypervariability of adjacent residues. We propose that the selective pressures acting on the venom components of cone snails involve an interplay of biosynthetic efficiency, activity at the target receptor and the importance of that activity to effective prey immobilization. Functional redundancy in the venom can thus serve as a buffer for the energy expenditure of venom production.	[Steiner, Andrew M.; Bulaj, Grzegorz] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Puillandre, Nicolas] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France	Utah System of Higher Education; University of Utah; Museum National d'Histoire Naturelle (MNHN)	Steiner, AM (corresponding author), Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA.	steiner.andrew@utah.edu			NIH Program Project [GM 48677]; Johnson & Johnson Pharmaceutical Research and Development Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIH Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson Pharmaceutical Research and Development Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Program Project Grant GM 48677. G.B. acknowledges support from the Johnson & Johnson Pharmaceutical Research and Development Funding. We confirm that neither funding agency had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chang D, 2012, MOL BIOL EVOL, V29, P2019, DOI 10.1093/molbev/mss068; Chang SG, 2003, MOL CELLS, V16, P323; Chun JBS, 2012, TOXICON, V60, P83, DOI 10.1016/j.toxicon.2012.03.019; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Conticello SG, 2000, TRENDS GENET, V16, P57, DOI 10.1016/S0168-9525(99)01956-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Duda TF, 2008, MOL ECOL, V17, P3018, DOI 10.1111/j.1365-294X.2008.03804.x; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gowd KH, 2012, BIOPOLYMERS, V98, P212, DOI 10.1002/bip.22047; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Maddison W., 2018, MESQUITE MODULAR SYS; Mirazimi A, 2000, J VIROL, V74, P8048, DOI 10.1128/JVI.74.17.8048-8052.2000; MYERS RA, 1993, CHEM REV, V93, P1923, DOI 10.1021/cr00021a013; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; OHNO S, 1970, EVOLUTION GENE DUPLI, P59; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Price-Carter M, 1998, BIOCHEMISTRY-US, V37, P9851, DOI 10.1021/bi9803978; PriceCarter M, 1996, BIOCHEMISTRY-US, V35, P15537, DOI 10.1021/bi961574c; Puillandre N, 2010, J MOL EVOL, V70, P190, DOI 10.1007/s00239-010-9321-7; Quinton L, 2009, J PROTEOMICS, V72, P219, DOI 10.1016/j.jprot.2009.01.021; Safavi-Hemami H, 2012, J BIOL CHEM, V287, P34288, DOI 10.1074/jbc.M112.366781; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Schoenfeld RA, 1999, THESIS U UTAH SALT L; Steiner AM, 2011, J PEPT SCI, V17, P1, DOI 10.1002/psc.1283; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Wang Q, 2008, TOXICON, V51, P813, DOI 10.1016/j.toxicon.2007.12.007; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yuan DD, 2007, TOXICON, V49, P1135, DOI 10.1016/j.toxicon.2007.02.011; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78456	10.1371/journal.pone.0078456	http://dx.doi.org/10.1371/journal.pone.0078456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244311	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600027
J	Babelova, A; Jansen, F; Sander, K; Lohn, M; Schafer, L; Fork, C; Ruetten, H; Plettenburg, O; Stark, H; Daniel, C; Amann, K; Pavenstadt, H; Jung, O; Brandes, RP				Babelova, Andrea; Jansen, Felix; Sander, Kerstin; Loehn, Matthias; Schaefer, Liliana; Fork, Christian; Ruetten, Hartmut; Plettenburg, Oliver; Stark, Holger; Daniel, Christoph; Amann, Kerstin; Pavenstaedt, Hermann; Jung, Oliver; Brandes, Ralf P.			Activation of Rac-1 and RhoA Contributes to Podocyte Injury in Chronic Kidney Disease	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; KINASE INHIBITION; ANGIOTENSIN-II; IN-VITRO; MECHANICAL STRAIN; ACE-INHIBITORS; DEFICIENT MICE; RENAL-DISEASE; TGF-BETA; APOPTOSIS	Rho-family GTPases like RhoA and Rac-1 are potent regulators of cellular signaling that control gene expression, migration and inflammation. Activation of Rho-GTPases has been linked to podocyte dysfunction, a feature of chronic kidney diseases (CKD). We investigated the effect of Rac-1 and Rho kinase (ROCK) inhibition on progressive renal failure in mice and studied the underlying mechanisms in podocytes. SV129 mice were subjected to 5/6-nephrectomy which resulted in arterial hypertension and albuminuria. Subgroups of animals were treated with the Rac-1 inhibitor EHT1846, the ROCK inhibitor SAR407899 and the ACE inhibitor Ramipril. Only Ramipril reduced hypertension. In contrast, all inhibitors markedly attenuated albumin excretion as well as glomerular and tubulo-interstitial damage. The combination of SAR407899 and Ramipril was more effective in preventing albuminuria than Ramipril alone. To study the involved mechanisms, podocytes were cultured from SV129 mice and exposed to static stretch in the Flexcell device. This activated RhoA and Rac-1 and led via TGF beta to apoptosis and a switch of the cells into a more mesenchymal phenotype, as evident from loss of WT-1 and nephrin and induction of alpha-SMA and fibronectin expression. Rac-1 and ROCK inhibition as well as blockade of TGF beta dramatically attenuated all these responses. This suggests that Rac-1 and RhoA are mediators of podocyte dysfunction in CKD. Inhibition of Rho-GTPases may be a novel approach for the treatment of CKD.	[Babelova, Andrea; Jansen, Felix; Schaefer, Liliana; Fork, Christian; Jung, Oliver; Brandes, Ralf P.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Sander, Kerstin; Stark, Holger] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany; [Loehn, Matthias; Ruetten, Hartmut; Plettenburg, Oliver] Sanofi Deutschland GmbH, Frankfurt, Germany; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Pavenstaedt, Hermann] Univ Hosp Munster, Dept Internal Med D, Munster, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Sanofi-Aventis; University of Erlangen Nuremberg; University of Munster	Brandes, RP (corresponding author), Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.	brandes@zphys1.uni-frankfurt.de	Stark, Holger/A-4235-2009; Daniel, Christoph/AAK-2136-2021; Plettenburg, Oliver/AAY-8083-2020; Brandes, Ralf P/L-3058-2017; Babelova, Andrea/E-7768-2018	Stark, Holger/0000-0003-3336-1710; Brandes, Ralf P/0000-0002-8035-0048; Babelova, Andrea/0000-0001-9548-6602; Daniel, Christoph/0000-0002-6803-4755; Schaefer, Liliana/0000-0002-3318-3005	Goethe University; Sanofi-Aventis	Goethe University; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the Goethe University and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Anderson RJ, 2000, KIDNEY INT, V58, P1996; Binker MG, 2008, EXP PHYSIOL, V93, P1091, DOI 10.1113/expphysiol.2008.043141; BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Dessapt C, 2009, NEPHROL DIAL TRANSPL, V24, P2645, DOI 10.1093/ndt/gfp204; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; Giunti S, 2010, AM J PHYSIOL-RENAL, V299, pF528, DOI 10.1152/ajprenal.00127.2010; Haas CS, 2003, J AM SOC NEPHROL, V14, P2288, DOI 10.1097/01.ASN.0000082999.46030.FE; HOSTETTER TH, 1982, AM J MED, V72, P375, DOI 10.1016/0002-9343(82)90490-9; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; Kanda T, 2003, KIDNEY INT, V64, P2009, DOI 10.1046/j.1523-1755.2003.00300.x; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; KRIZ W, 1994, KIDNEY INT, V45, pS64; Kshirsagar AV, 2000, AM J KIDNEY DIS, V35, P695, DOI 10.1016/S0272-6386(00)70018-7; Leblond B, 2004, PCT/IB2004/000926, Patent No. 2004000926; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liu YZ, 2012, BIOL RES NURS; Lohn M, 2009, HYPERTENSION, V54, P676, DOI 10.1161/HYPERTENSIONAHA.109.134353; Lv Z, 2012, INT J BIOCHEM CELL B, V45, P255; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Meyer-Schwesinger C, 2009, AM J PHYSIOL-RENAL, V296, pF1088, DOI 10.1152/ajprenal.90746.2008; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Petermann AT, 2005, KIDNEY INT, V67, P157, DOI 10.1111/j.1523-1755.2005.00066.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riser BL, 2000, CURR OPIN NEPHROL HY, V9, P43, DOI 10.1097/00041552-200001000-00008; Sawada N, 2010, CURR OPIN PHARMACOL, V10, P116, DOI 10.1016/j.coph.2009.11.004; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thamilselvan V, 2012, UROL RES, V40, P415, DOI 10.1007/s00240-011-0405-7; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Yao HY, 2011, BBA-GEN SUBJECTS, V1810, P666, DOI 10.1016/j.bbagen.2011.03.020; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033	54	59	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80328	10.1371/journal.pone.0080328	http://dx.doi.org/10.1371/journal.pone.0080328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244677	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900077
J	Fuchs, JC; Zinnamon, FA; Taylor, RR; Ivins, S; Scambler, PJ; Forge, A; Tucker, AS; Linden, JF				Fuchs, Jennifer C.; Zinnamon, Fhatarah A.; Taylor, Ruth R.; Ivins, Sarah; Scambler, Peter J.; Forge, Andrew; Tucker, Abigail S.; Linden, Jennifer F.			Hearing Loss in a Mouse Model of 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							OTITIS-MEDIA; VELOCARDIOFACIAL SYNDROME; RISK-FACTORS; BOX GENE; MICE; DIGEORGE; TBX1; REGION; MANIFESTATIONS; CHILDREN	22q11.2 Deletion Syndrome (22q11DS) arises from an interstitial chromosomal microdeletion encompassing at least 30 genes. This disorder is one of the most significant known cytogenetic risk factors for schizophrenia, and can also cause heart abnormalities, cognitive deficits, hearing difficulties, and a variety of other medical problems. The Df1/+ hemizygous knockout mouse, a model for human 22q11DS, recapitulates many of the deficits observed in the human syndrome including heart defects, impaired memory, and abnormal auditory sensorimotor gating. Here we show that Df1/+ mice, like human 22q11DS patients, have substantial rates of hearing loss arising from chronic middle ear infection. Auditory brainstem response (ABR) measurements revealed significant elevation of click-response thresholds in 48% of Df1/+ mice, often in only one ear. Anatomical and histological analysis of the middle ear demonstrated no gross structural abnormalities, but frequent signs of otitis media (OM, chronic inflammation of the middle ear), including excessive effusion and thickened mucosa. In mice for which both in vivo ABR thresholds and post mortem middle-ear histology were obtained, the severity of signs of OM correlated directly with the level of hearing impairment. These results suggest that abnormal auditory sensorimotor gating previously reported in mouse models of 22q11DS could arise from abnormalities in auditory processing. Furthermore, the findings indicate that Df1/+ mice are an excellent model for increased risk of OM in human 22q11DS patients. Given the frequently monaural nature of OM in Df1/+ mice, these animals could also be a powerful tool for investigating the interplay between genetic and environmental causes of OM.	[Fuchs, Jennifer C.; Tucker, Abigail S.] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London, England; [Zinnamon, Fhatarah A.; Taylor, Ruth R.; Forge, Andrew; Linden, Jennifer F.] UCL, Ear Inst, London, England; [Ivins, Sarah; Scambler, Peter J.] UCL, Inst Child Hlth, London, England; [Linden, Jennifer F.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London	Linden, JF (corresponding author), UCL, Ear Inst, London, England.	j.linden@ucl.ac.uk	Tucker, Abigail S/K-1788-2016; Scambler, Peter/AAZ-6026-2020	Tucker, Abigail S/0000-0001-8871-6094; Scambler, Peter/0000-0002-1487-4628; Linden, Jennifer/0000-0003-2210-1374; Forge, Andrew/0000-0002-0995-0219	Gatsby Charitable Foundation; Wellcome Trust; UCL MSc Neuroscience programme; Medical Research Council; British Heart Foundation; Action on Hearing Loss; Deafness Research UK; MRC [G1001232] Funding Source: UKRI; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Medical Research Council [G1001232] Funding Source: researchfish; RNID [S24] Funding Source: researchfish	Gatsby Charitable Foundation; Wellcome Trust(Wellcome Trust); UCL MSc Neuroscience programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Action on Hearing Loss; Deafness Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	Work by JFL and FAZ was supported by the Gatsby Charitable Foundation, the Wellcome Trust, Deafness Research UK, and the UCL MSc Neuroscience programme. AST, RRT, and AF are funded by the Medical Research Council and JCF is funded by Action on Hearing Loss. PJS and SI are supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNING GG, 2010, CLIN OTOLARYNGOL, V35, P490, DOI DOI 10.1111/J.1749-4486.2010.02230.X.PUBMED:20927726; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Digilio MC, 1999, BRIT J AUDIOL, V33, P329, DOI 10.3109/03005369909090116; Dyce O, 2002, ARCH OTOLARYNGOL, V128, P1408, DOI 10.1001/archotol.128.12.1408; Epstein J A, 2001, Trends Genet, V17, pS13, DOI 10.1016/S0168-9525(01)02450-7; Ford LC, 2000, LARYNGOSCOPE, V110, P362, DOI 10.1097/00005537-200003000-00006; Galili N, 1997, GENOME RES, V7, P17, DOI 10.1101/gr.7.1.17; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; LANNIGAN FJ, 1993, J LARYNGOL OTOL, V107, P12, DOI 10.1017/S0022215100122005; Lazaridis E, 2008, J CLIN INVEST, V118, P471, DOI [10.1172/JCI33716, 10.1172/JC133716]; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lindsay EA, 1998, MOL MED TODAY, V4, P350, DOI 10.1016/S1357-4310(98)01302-1; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Parham K, 1997, HEARING RES, V112, P216, DOI 10.1016/S0378-5955(97)00124-X; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, BIOL PSYCHIAT, V59, P1172, DOI 10.1016/j.biopsych.2006.01.018; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Reyes MRT, 1999, INT J PEDIATR OTORHI, V47, P227, DOI 10.1016/S0165-5876(98)00180-3; Richter CA, 2010, HUM MOL GENET, V19, P1551, DOI 10.1093/hmg/ddq028; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Sobin C, 2005, AM J PSYCHIAT, V162, P1090, DOI 10.1176/appi.ajp.162.6.1090; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sutherland HF, 1998, GENOMICS, V52, P37, DOI 10.1006/geno.1998.5414; Taddei I, 2001, P NATL ACAD SCI USA, V98, P11428, DOI 10.1073/pnas.201127298; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Vitelli F, 2002, COLD SPRING HARB SYM, V67, P327, DOI 10.1101/sqb.2002.67.327; Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80104	10.1371/journal.pone.0080104	http://dx.doi.org/10.1371/journal.pone.0080104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244619	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800122
J	Hoskins, AJ; Arnould, JPY				Hoskins, Andrew J.; Arnould, John P. Y.			Temporal Allocation of Foraging Effort in Female Australian Fur Seals (Arctocephalus pusillus doriferus)	PLOS ONE			English	Article							BREATH-HOLD DIVERS; DIVING BEHAVIOR; NEW-ZEALAND; SEASONAL-CHANGES; MARINE PREDATOR; METABOLIC-RESPONSE; TIME ALLOCATION; PUP PRODUCTION; DYNAMIC ACTION; ENERGETICS	Across an individual's life, foraging decisions will be affected by multiple intrinsic and extrinsic drivers that act at differing timescales. This study aimed to assess how female Australian fur seals allocated foraging effort and the behavioural changes used to achieve this at three temporal scales: within a day, across a foraging trip and across the final six months of the lactation period. Foraging effort peaked during daylight hours (57% of time diving) with lulls in activity just prior to and after daylight. Dive duration reduced across the day (196 s to 168 s) but this was compensated for by an increase in the vertical travel rate (1500-1600 m.h(-1)) and a reduction in postdive duration (111-90 s). This suggests physiological constraints (digestive costs) or prey availability may be limiting mean dive durations as a day progresses. During short trips (<2.9 d), effort remained steady at 55% of time diving, whereas, on long trips (>2.9 d) effort increased up to 2-3 d and then decreased. Dive duration decreased at the same rate in short and long trips, respectively, before stabilising (long trips) between 4-5 d. Suggesting that the same processes (digestive costs or prey availability) working at the daily scale may also be present across a trip. Across the lactation period, foraging effort, dive duration and vertical travel rate increased until August, before beginning to decrease. This suggests that as the nutritional demands of the suckling pup and developing foetus increase, female effort increases to accommodate this, providing insight into the potential constraints of maternal investment in this species.	[Hoskins, Andrew J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	Deakin University	Hoskins, AJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	ajhos@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Australian Research Council; Sea World Research and Rescue Foundation Incorporated; Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Sea World Research and Rescue Foundation Incorporated; Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Funding for this project was provided through research grants from the Australian Research Council, Sea World Research and Rescue Foundation Incorporated, Winifred Violet Scott Charitable Trust and Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1984, AM NAT, V124, P80, DOI 10.1086/284253; Annese DM, 2005, ENVIRON BIOL FISH, V72, P161, DOI 10.1007/s10641-004-0774-7; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 1996, J ZOOL, V239, P769, DOI 10.1111/j.1469-7998.1996.tb05477.x; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; ARONSON RB, 1983, ECOLOGY, V64, P395, DOI 10.2307/1937085; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; Boyd IL, 1997, BEHAV ECOL SOCIOBIOL, V40, P135, DOI 10.1007/s002650050326; BOYD IL, 1992, CAN J ZOOL, V70, P919, DOI 10.1139/z92-131; BOYD IL, 1991, J ANIM ECOL, V60, P577, DOI 10.2307/5299; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; Carpentieri P, 2006, J MAR BIOL ASSOC UK, V86, P853, DOI 10.1017/S0025315406013798; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; Costa D.P., 1986, P79; Costa Daniel P., 1993, Symposia of the Zoological Society of London, V66, P293; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Costa DP, 2000, J EXP BIOL, V203, P3655; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; FRASER WR, 1989, POLAR BIOL, V10, P37; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; GALLIVAN GJ, 1981, COMP BIOCHEM PHYS A, V69, P579, DOI 10.1016/0300-9629(81)93024-3; Gentry R. L., 1982, EQUIPMENT TECHNIQUES; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Gibbens J, 2009, MAR MAMMAL SCI, V25, P573, DOI 10.1111/j.1748-7692.2008.00270.x; HARCOURT RG, 1995, CAN J ZOOL, V73, P678, DOI 10.1139/z95-080; HIGGINS LV, 1993, CAN J ZOOL, V71, P2047, DOI 10.1139/z93-290; Hipfner JM, 2006, CAN J ZOOL, V84, P931, DOI 10.1139/Z06-066; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; KARASOV WH, 1988, BIOSCIENCE, V38, P602, DOI 10.2307/1310825; Kato A, 2003, POLAR BIOL, V26, P389, DOI 10.1007/s00300-003-0493-0; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; Kirkwood R, 2011, AUST J ZOOL, V59, P216, DOI 10.1071/ZO11080; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; Kuiter RH, 1996, GUIDE SEA FISHES AUS; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Littnan Charles L., 2002, Australian Mammalogy, V24, P65; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MARKUSSEN NH, 1994, J COMP PHYSIOL B, V164, P89, DOI 10.1007/BF00301648; Mattlin RH, 1998, CAN J ZOOL, V76, P350, DOI 10.1139/cjz-76-2-350; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; Mori Y, 2004, ECOLOGY, V85, P398, DOI 10.1890/03-4005; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Nichol LM, 1996, CAN J ZOOL, V74, P983, DOI 10.1139/z96-111; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; O'Driscoll RL, 2013, 1 NZ FISH ASS; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Orians G.H., 1979, P155; Overgaard J, 2002, PHYSIOL BIOCHEM ZOOL, V75, P360, DOI 10.1086/342769; Pan ZC, 2005, COMP BIOCHEM PHYS A, V141, P470, DOI 10.1016/j.cbpb.2005.07.003; PEMBERTON D, 1994, WILDLIFE RES, V21, P341, DOI 10.1071/WR9940341; Pinheiro J, 2001, MIXED EFFECTS MODELS; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Core Team, 2012, R LANG ENV STAT COMP; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; RIJNSDORP A, 1981, OECOLOGIA, V50, P391, DOI 10.1007/BF00344982; Rosen DAS, 1997, COMP BIOCHEM PHYS A, V118, P877, DOI 10.1016/S0300-9629(97)00039-X; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; Sparling CE, 2004, EUR RES CET P 18 ANN, V18; Spence-Bailey LM, 2007, J COMP PHYSIOL B, V177, P483, DOI 10.1007/s00360-007-0146-7; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Villegas-Amtmann S, 2012, COMP BIOCHEM PHYS A, V162, P413, DOI 10.1016/j.cbpa.2012.04.019; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; WILLIAMS H, 1993, AUST J MAR FRESH RES, V44, P577; Williams TM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P433, DOI 10.1086/518346; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	88	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79484	10.1371/journal.pone.0079484	http://dx.doi.org/10.1371/journal.pone.0079484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244511	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800082
J	Montigny, C; Castellanos-Ryan, N; Whelan, R; Banaschewski, T; Barker, GJ; Buchel, C; Gallinat, J; Flor, H; Mann, K; Paillere-Martinot, ML; Nees, F; Lathrop, M; Loth, E; Paus, T; Pausova, Z; Rietschel, M; Schumann, G; Smolka, MN; Struve, M; Robbins, TW; Garavan, H; Conrod, PJ				Montigny, Chantale; Castellanos-Ryan, Natalie; Whelan, Robert; Banaschewski, Tobias; Barker, Gareth J.; Buechel, Christian; Gallinat, Juergen; Flor, Herta; Mann, Karl; Paillere-Martinot, Marie-Laure; Nees, Frauke; Lathrop, Mark; Loth, Eva; Paus, Tomas; Pausova, Zdenka; Rietschel, Marcella; Schumann, Gunter; Smolka, Michael N.; Struve, Maren; Robbins, Trevor W.; Garavan, Hugh; Conrod, Patricia J.		IMAGEN Consortium	A Phenotypic Structure and Neural Correlates of Compulsive Behaviors in Adolescents	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; INFERIOR FRONTAL GYRUS; RESPONSE-INHIBITION; PREFRONTAL CORTEX; ANOREXIA-NERVOSA; EATING-DISORDERS; COGNITIVE CONTROL; PERSONALITY DIMENSIONS	Background: A compulsivity spectrum has been hypothesized to exist across Obsessive-Compulsive disorder (OCD), Eating Disorders (ED), substance abuse (SA) and binge-drinking (BD). The objective was to examine the validity of this compulsivity spectrum, and differentiate it from an externalizing behaviors dimension, but also to look at hypothesized personality and neural correlates. Method: A community-sample of adolescents (N=1938; mean age 14.5 years), and their parents were recruited via high-schools in 8 European study sites. Data on adolescents' psychiatric symptoms, DSM diagnoses (DAWBA) and substance use behaviors (AUDIT and ESPAD) were collected through adolescent-and parent-reported questionnaires and interviews. The phenotypic structure of compulsive behaviors was then tested using structural equation modeling. The model was validated using personality variables (NEO-FFI and TCI), and Voxel-Based Morphometry (VBM) analysis. Results: Compulsivity symptoms best fit a higher-order two factor model, with ED and OCD loading onto a compulsivity factor, and BD and SA loading onto an externalizing factor, composed also of ADHD and conduct disorder symptoms. The compulsivity construct correlated with neuroticism (r=0.638; p <= 0.001), conscientiousness (r=0.171; p <= 0.001), and brain gray matter volume in left and right orbitofrontal cortex, right ventral striatum and right dorsolateral prefrontal cortex. The externalizing factor correlated with extraversion (r=0.201; p <= 0.001), novelty-seeking (r=0.451; p <= 0.001), and negatively with gray matter volume in the left inferior and middle frontal gyri. Conclusions: Results suggest that a compulsivity spectrum exists in an adolescent, preclinical sample and accounts for variance in both OCD and ED, but not substance-related behaviors, and can be differentiated from an externalizing spectrum.	[Montigny, Chantale; Castellanos-Ryan, Natalie; Conrod, Patricia J.] Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ, Canada; [Loth, Eva; Schumann, Gunter] MRC Social Genet & Dev Psychiat SGDP Ctr, London, England; [Banaschewski, Tobias; Flor, Herta; Mann, Karl; Nees, Frauke; Rietschel, Marcella; Struve, Maren] Cent Inst Mental Hlth, Mannheim, Germany; [Buechel, Christian] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Barker, Gareth J.; Loth, Eva; Schumann, Gunter; Conrod, Patricia J.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Gallinat, Juergen] Univ Med Berlin, Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Whelan, Robert; Garavan, Hugh] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Paillere-Martinot, Marie-Laure] Univ Paris 11, INSERM CEA Unit Imaging & Psychiat 1000, Inst Natl Sante & Rech Med, Orsay, France; [Paillere-Martinot, Marie-Laure] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, Paris, France; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, Dresden, Germany; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England; [Banaschewski, Tobias; Flor, Herta; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Heidelberg Univ, Mannheim Med Fac, Heidelberg, Germany; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Banaschewski, Tobias; Flor, Herta; Mann, Karl; Nees, Frauke] Heidelberg Univ, Dept Addict Behav & Addict Med, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Whelan, Robert; Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Whelan, Robert; Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA	Universite de Montreal; Central Institute of Mental Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Trinity College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; McGill University; Technische Universitat Dresden; Technische Universitat Dresden; University of Cambridge; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Vermont; University of Vermont	Montigny, C (corresponding author), Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ, Canada.	chantale.montigny@umontreal.ca	Poustka, Luise/D-9299-2017; Robbins, Trevor W/A-7551-2008; Smolka, Michael/B-4865-2011; Stacey, David/AFX-6013-2022; Moreno, Margarita/K-9869-2014; Artiges, Eric/AAT-7219-2021; Desrivieres, Sylvane/B-7399-2011; Vollstädt-Klein, Sabine/C-6744-2012; Banaschewski, Tobias/ABE-5985-2020; Nees, Frauke/AAZ-2150-2020; Conrod, Patricia J/P-4187-2018; Whelan, Robert/E-5365-2010; Ströhle, Andreas/E-4286-2012; Artiges, Eric/C-2815-2019; Ryan, Natalie Castellanos/J-3272-2012; Lawrence, Claire/P-1058-2018; Lourdusamy, Anbarasu/P-6606-2014; Finsterbusch, Jürgen/M-2969-2016; Barker, Gareth J/C-9616-2009; Heinz, Andreas/ABB-7736-2020	Smolka, Michael/0000-0001-5398-5569; Stacey, David/0000-0002-9392-9235; Moreno, Margarita/0000-0001-7336-6167; Artiges, Eric/0000-0003-4461-7646; Desrivieres, Sylvane/0000-0002-9120-7060; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Banaschewski, Tobias/0000-0003-4595-1144; Whelan, Robert/0000-0002-2790-7281; Artiges, Eric/0000-0003-4461-7646; Ryan, Natalie Castellanos/0000-0002-7077-1340; Lawrence, Claire/0000-0001-6787-9716; Barker, Gareth J/0000-0002-5214-7421; Heinz, Andreas/0000-0001-5405-9065; Loth, Eva/0000-0001-9458-9167; Robbins, Trevor/0000-0003-0642-5977; MIRANDA, RUBEN/0000-0002-9445-7348; Lemaitre, Herve/0000-0002-5952-076X; Nees, Frauke/0000-0002-7796-8234; Schirmbeck, Frederike/0000-0003-1700-0958; Flor, Herta/0000-0003-4809-5398	European Community [LSHM-CT-2007-037286]; FP7 projects ADAMS [242257]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse' [93558]; German Bundesministerium fur Bildung und Forschung (NGFN Plus) [FKZ : 01GS08152]; Fondation de Recherche Sante Quebec [Chercheur-Boursier Pc 20393]; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G1000183B, G0001354, G0901858, G0001354B] Funding Source: researchfish	European Community(European Commission); FP7 projects ADAMS; Innovative Medicine Initiative Project EU-AIMS; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse'(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung (NGFN Plus)(Federal Ministry of Education & Research (BMBF)); Fondation de Recherche Sante Quebec; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IMAGEN study receives research funding from the European Community's Sixth Framework Programme (LSHM-CT-2007-037286). Further support was provided by the FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations; 242257), the Innovative Medicine Initiative Project EU-AIMS (115300-2), the UK National Institute for Health Research Biomedical Research Centre Mental Health, the Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse' (93558), the German Bundesministerium fur Bildung und Forschung (NGFN Plus; FKZ : 01GS08152), as well as the Fondation de Recherche Sante Quebec (Chercheur-Boursier Pc 20393). The poster"A phenotypic structure for compulsive-like behaviors in adolescents was presented in three occasions : Canadian College of Neuropharmacology Conference (Montreal, Canada; May May 20-23rd 2011), University of Montreal Psychiatry Departmental Research Day (Montreal, Canada; October 7th 2011) and International Association for Child and Adolescent Psychiatry and Allied Professions Conference (Paris, France; July 21-25 th 2012). The Association des Medecins Psychiatres du Quebec awarded this paper the "Prix de la Recherche des Residents", along with a 1500$ prize to its first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2013, NATURE, V496, P416, DOI 10.1038/496416a; Altman SE, 2009, CLIN PSYCHOL REV, V29, P638, DOI 10.1016/j.cpr.2009.08.001; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Armstrong TD, 2002, J CONSULT CLIN PSYCH, V70, P1224, DOI 10.1037/0022-006X.70.6.1224; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2003, NAT NEUROSCI, V6, P1329, DOI 10.1038/nn1203-1329a; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Asparouhov T., 2005, P FCMS 2005 RES C; Atmaca M, 2007, PROG NEURO-PSYCHOPH, V31, P46, DOI 10.1016/j.pnpbp.2006.06.008; Atmaca M, 2006, PROG NEURO-PSYCHOPH, V30, P1051, DOI 10.1016/j.pnpbp.2006.03.033; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Brooks SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-179; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Castellanos-Ryan N, 2011, J ABNORM CHILD PSYCH, V39, P563, DOI 10.1007/s10802-010-9481-3; Castellini G, 2013, EUR PSYCHIAT, V28, P427, DOI 10.1016/j.eurpsy.2012.06.006; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Choi JS, 2004, J PSYCHIATR RES, V38, P193, DOI 10.1016/j.jpsychires.2003.08.001; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Connolly CG, 2012, DRUG ALCOHOL DEPEN, V121, P45, DOI 10.1016/j.drugalcdep.2011.08.007; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Denys Damiaan, 2011, Philos Ethics Humanit Med, V6, P3, DOI 10.1186/1747-5341-6-3; Durston S, 2002, NEUROIMAGE, V16, P449, DOI 10.1006/nimg.2002.1074; Eisen JL, 2006, J PERS DISORD, V20, P294, DOI 10.1521/pedi.2006.20.3.294; Engel SG, 2005, INT J EAT DISORDER, V38, P244, DOI 10.1002/eat.20169; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; FICHTER MM, 1993, INT J EAT DISORDER, V14, P1, DOI 10.1002/1098-108X(199307)14:1&lt;1::AID-EAT2260140102&gt;3.0.CO;2-3; Fineberg NA, 2011, BRIT J PHARMACOL, V164, P1044, DOI 10.1111/j.1476-5381.2011.01422.x; Fineberg NA, 2007, CNS SPECTRUMS, V12, P467, DOI 10.1017/S1092852900015340; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Friedman I, 2000, J NERV MENT DIS, V188, P155, DOI 10.1097/00005053-200003000-00005; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gizewski ER, 2010, NEUROPSYCHOBIOLOGY, V62, P182, DOI 10.1159/000319360; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Grant JE, 2013, CNS SPECTRUMS, P1; Grilo CM, 2000, COMPR PSYCHIAT, V41, P163, DOI 10.1016/S0010-440X(00)90042-7; Harrop EN, 2010, ADDICT BEHAV, V35, P392, DOI 10.1016/j.addbeh.2009.12.016; Hibell B., 2009, 2007 ESPAD REPORT SU, P1; Hibell B., 2004, ESPAD REPORT 2003 AL; Hollander E, 2007, CNS SPECTRUMS, V12, P5, DOI 10.1017/S1092852900002467; Humphreys Joy D, 2007, Eat Disord, V15, P247, DOI 10.1080/10640260701323508; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Kang DH, 2004, J NEUROPSYCH CLIN N, V16, P342, DOI 10.1176/appi.neuropsych.16.3.342; Karwautz A, 2003, J PERS DISORD, V17, P73, DOI 10.1521/pedi.17.1.73.24057; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Loo SK, 2003, J AM ACAD CHILD PSY, V42, P986, DOI 10.1097/01.CHI.0000046890.27264.88; Ma J, 2012, J NEURAL TRANSM, V119, P613, DOI 10.1007/s00702-011-0744-0; MacMaster FP, 2008, J AM ACAD CHILD PSY, V47, P1262, DOI 10.1097/CHI.0b013e318185d2be; Maia TV, 2008, DEV PSYCHOPATHOL, V20, P1251, DOI 10.1017/S0954579408000606; McNamara R, 2010, PSYCHOPHARMACOLOGY, V212, P453, DOI 10.1007/s00213-010-1974-9; Melloni M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00259; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Moreno-Lopez L, 2012, DRUG ALCOHOL DEPEN, V125, P208, DOI 10.1016/j.drugalcdep.2012.02.012; Muthen B., 2010, MPLUS USERS GUIDE; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Nilsson EW, 1999, J AM ACAD CHILD PSY, V38, P1389, DOI 10.1097/00004583-199911000-00013; Pinto A, 2006, J CLIN PSYCHIAT, V67, P703, DOI 10.4088/JCP.v67n0503; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Rosenberg H, 2007, ADDICT BEHAV, V32, P2811, DOI 10.1016/j.addbeh.2007.04.019; Rotge JY, 2010, NEUROPSYCHOPHARMACOL, V35, P686, DOI 10.1038/npp.2009.175; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Sadock BJ, 2015, CLIN PSYCHIATR, V11, P1118; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Sallet PC, 2010, INT J EAT DISORDER, V43, P315, DOI 10.1002/eat.20697; Samuel DB, 2010, J PERS ASSESS, V92, P232, DOI 10.1080/00223891003670182; Samuels J, 2000, BRIT J PSYCHIAT, V177, P457, DOI 10.1192/bjp.177.5.457; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schafer A, 2010, NEUROIMAGE, V50, P639, DOI 10.1016/j.neuroimage.2009.12.063; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Speranza M, 2001, Eat Behav, V2, P193, DOI 10.1016/S1471-0153(01)00035-6; Suda M, 2010, J PSYCHIATR RES, V44, P547, DOI 10.1016/j.jpsychires.2009.11.005; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Szeszko PR, 2008, AM J PSYCHIAT, V165, P1299, DOI 10.1176/appi.ajp.2008.08010033; Szeszko PR, 1999, ARCH GEN PSYCHIAT, V56, P913, DOI 10.1001/archpsyc.56.10.913; Tapert SF, 2007, PSYCHOPHARMACOLOGY, V194, P173, DOI 10.1007/s00213-007-0823-y; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021; Vasic N, 2012, J ATTEN DISORD; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Whitwell JL, 2013, NEUROBIOL AGING, V34, P636, DOI 10.1016/j.neurobiolaging.2012.03.009; World Health Organization, 1992, ICD 10 CLASS MENT BE, P3; Young SE, 2000, AM J MED GENET, V96, P684, DOI 10.1002/1096-8628(20001009)96:5<684::AID-AJMG16>3.3.CO;2-7	105	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80151	10.1371/journal.pone.0080151	http://dx.doi.org/10.1371/journal.pone.0080151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244633	Green Published, gold			2022-12-27	WOS:000327143800128
J	Narola, J; Pandey, SN; Glick, A; Chen, YW				Narola, Jigna; Pandey, Sachchida Nand; Glick, Adam; Chen, Yi-Wen			Conditional Expression of TGF-beta 1 in Skeletal Muscles Causes Endomysial Fibrosis and Myofibers Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DUCHENNE-MUSCULAR-DYSTROPHY; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; MDX-MOUSE; INFLAMMATORY RESPONSE; CELL-DIFFERENTIATION; COLLAGEN-SYNTHESIS; DIAPHRAGM; MICE	To study the effects of transforming growth factor beta 1 (TGF-beta 1) on fibrosis and failure of regeneration of skeletal muscles, we generated a tet-repressible muscle-specific TGF-beta 1 transgenic mouse in which expression of TGF-beta 1 is controlled by oral doxycycline. The mice developed muscle weakness and atrophy after TGF-beta 1 over-expression. We defined the group of mice that showed phenotype within 2 weeks as early onset (EO) and the rest as late onset (LO), which allowed us to further examine phenotypic differences between the groups. While only mice in the EO group showed significant muscle weakness, pathological changes including endomysial fibrosis and smaller myofibers were observed in both groups at two weeks after the TGF-beta 1 was over-expressed. In addition, the size of the myofibers and collagen accumulation were significantly different between the two groups. The amount of latent and active TGF-beta 1 in the muscle and circulation were significantly higher in the EO group compared to the LO or control groups. The up-regulation of the latent TGF-beta 1 indicated that endogenous TGF-beta 1 was induced by the expression of the TGF-beta 1 transgene. Our studies showed that the primary effects of TGF-beta 1 over-expression in skeletal muscles are muscle wasting and endomysial fibrosis. In addition, the severity of the pathology is associated with the total amount of TGF-beta 1 and the expression of endogenous TGF-beta 1. The findings suggest that an auto-feedback loop of TGF-beta 1 may contribute to the severity of phenotypes.	[Narola, Jigna; Pandey, Sachchida Nand; Chen, Yi-Wen] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Glick, Adam] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Chen, Yi-Wen] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Chen, Yi-Wen] George Washington Univ, Dept Pediat, Washington, DC 20052 USA	Children's National Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; George Washington University	Chen, YW (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	ychen@childrensnational.org		Pandey, Sachchida/0000-0002-0567-5344	National Institutes of Health/NICHD [U54HD05317701]; Department of Defense [W81XWH-10-1-0659];  [NIH/NIAMS1R01AR052027];  [NIH/NICHD1R24HD050846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052027] Funding Source: NIH RePORTER	National Institutes of Health/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study is supported by National Institutes of Health/NICHD U54HD05317701, Department of Defense W81XWH-10-1-0659, NIH/NIAMS1R01AR052027 and NIH/NICHD1R24HD050846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; Dale PD, 1997, B MATH BIOL, V59, P1077; GRAINGER DJ, 1994, BIOCHEM J, V299, P227, DOI 10.1042/bj2990227; HATHAWAY MR, 1994, J ANIM SCI, V72, P2001, DOI 10.2527/1994.7282001x; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ishitobi M, 2000, NEUROREPORT, V11, P4033, DOI 10.1097/00001756-200012180-00026; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Lynch GS, 1997, AM J PHYSIOL-CELL PH, V272, pC2063, DOI 10.1152/ajpcell.1997.272.6.C2063; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Nakamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02183; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Noirez P, 2006, J MUSCLE RES CELL M, V27, P1, DOI 10.1007/s10974-005-9014-9; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Rodriguez-Barbero A, 2002, FEBS LETT, V513, P282, DOI 10.1016/S0014-5793(02)02337-2; Rout UK, 2002, FERTIL STERIL, V78, P154, DOI 10.1016/S0015-0282(02)03176-X; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SMITH PEM, 1987, NEW ENGL J MED, V316, P1197, DOI 10.1056/NEJM198705073161906; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845, DOI 10.1152/ajpgi.2000.279.5.G845; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	50	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79356	10.1371/journal.pone.0079356	http://dx.doi.org/10.1371/journal.pone.0079356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244485	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800063
J	Peng, JX; He, F; Zhang, Y; Liu, QH; Miao, DM; Xiao, W				Peng, Jiaxi; He, Fei; Zhang, Yan; Liu, Quanhui; Miao, Danmin; Xiao, Wei			Differences in Simulated Doctor and Patient Medical Decision Making: A Construal Level Perspective	PLOS ONE			English	Article							SOCIAL DISTANCE; CHOICE; ADVICE; REPRESENTATION; INFORMATION; BEHAVIOR; FOREST	Background: Patients are often confronted with diverse medical decisions. Often lacking relevant medical knowledge, patients fail to independently make medical decisions and instead generally rely on the advice of doctors. Objective: This study investigated the characteristics of and differences in doctor-patient medical decision making on the basis of construal level theory. Methods: A total of 420 undergraduates majoring in clinical medicine were randomly assigned to six groups. Their decisions to opt for radiotherapy and surgery were investigated, with the choices described in a positive/neutral/negative frame 6 decision making for self/others. Results: Compared with participants giving medical advice to patients, participants deciding for themselves were more likely to select radiotherapy (F-1,F- 404 = 13.92, p = 011). Participants from positive or neutral frames exhibited a higher tendency to choose surgery than did those from negative frames (F-2,F- 404 = 22.53, p < .001). The effect of framing on independent decision making was nonsignificant (F-2,F- 404 = 1.07, p = 35); however the effect of framing on the provision of advice to patients was significant (F-2,F- 404 = 12.95, p < .001). The effect of construal level was significant in the positive frame (F-1,F- 404 = 8.06, p = 005) and marginally significant in the neutral frame (F-2,F- 404 = 3.31, p = 07) but nonsignificant in the negative frame (F-2,F- 404 = .29, p = 59). Conclusion: Both social distance and framing depiction significantly affected medical decision making and exhibited a significant interaction. Differences in medical decision making between doctors and patients need further investigation.	[Peng, Jiaxi; Zhang, Yan; Liu, Quanhui; Miao, Danmin; Xiao, Wei] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Peoples R China; [He, Fei] Northwest Univ, Sch Publ Management, Xian, Peoples R China	Air Force Military Medical University; Northwest University Xi'an	Miao, DM (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian 710032, Peoples R China.	psych@fmmu.edu.cn; xiaoweifmmu@yahoo.com.cn			Social Science foundation of the People's Republic of China [13XRK004]	Social Science foundation of the People's Republic of China	This study was supported by Social Science foundation of the People's Republic of China (13XRK004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almashat S, 2008, PATIENT EDUC COUNS, V71, P102, DOI 10.1016/j.pec.2007.11.004; Armstrong K, 2002, MED DECIS MAKING, V22, P76, DOI 10.1177/02729890222062946; Bigman CA, 2010, PATIENT EDUC COUNS, V81, pS70, DOI 10.1016/j.pec.2010.08.014; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; Davison BJ, 2012, PATIENT EDUC COUNS, V87, P369, DOI 10.1016/j.pec.2011.11.009; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Dhar R, 2007, J CONSUM PSYCHOL, V17, P96, DOI 10.1016/S1057-7408(07)70014-1; Druckman JN, 2001, J ECON PSYCHOL, V22, P91, DOI 10.1016/S0167-4870(00)00032-5; Eyal T, 2004, J PERS SOC PSYCHOL, V86, P781, DOI 10.1037/0022-3514.86.6.781; Garcia-Retamero R, 2010, J GEN INTERN MED, V25, P1323, DOI 10.1007/s11606-010-1484-9; Gerend MA, 2008, J EXP SOC PSYCHOL, V44, P1167, DOI 10.1016/j.jesp.2008.02.007; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Highhouse S, 1996, PERS SOC PSYCHOL B, V22, P124, DOI 10.1177/0146167296222002; JACKSON SE, 1988, ADMIN SCI QUART, V33, P370, DOI 10.2307/2392714; Jiang J., 2012, MED PHILOS, V33, P18; Kray L, 1999, J BEHAV DECIS MAKING, V12, P207, DOI 10.1002/(SICI)1099-0771(199909)12:3<207::AID-BDM322>3.0.CO;2-P; Li J, 2012, LANCET, V379, P19; Liberman N, 1998, J PERS SOC PSYCHOL, V75, P5, DOI 10.1037/0022-3514.75.1.5; Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; LLEWELLYNTHOMAS HA, 1995, MED DECIS MAKING, V15, P4, DOI 10.1177/0272989X9501500103; MAHESWARAN D, 1990, J MARKETING RES, V27, P361, DOI 10.2307/3172593; Malkoc SA, 2005, PSYCHOL SCI, V16, P411, DOI 10.1111/j.0956-7976.2005.01549.x; MARTEAU TM, 1989, BRIT J SOC PSYCHOL, V28, P89, DOI 10.1111/j.2044-8309.1989.tb00849.x; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Nan XL, 2007, HUM COMMUN RES, V33, P489, DOI 10.1111/j.1468-2958.2007.00309.x; Nussbaum S, 2003, J PERS SOC PSYCHOL, V84, P485, DOI 10.1037/0022-3514.84.3.485; Pennington GL, 2003, J EXP SOC PSYCHOL, V39, P563, DOI 10.1016/S0022-1031(03)00058-1; Qian MZ, 2008, MED PHILOS CLIN DEC, V29, P3; Rogers T, 2008, ORGAN BEHAV HUM DEC, V106, P1, DOI 10.1016/j.obhdp.2007.08.001; Sagristano MD, 2002, J EXP PSYCHOL GEN, V131, P364, DOI 10.1037//0096-3445.131.3.364; Sieck W, 1997, ORGAN BEHAV HUM DEC, V70, P207, DOI 10.1006/obhd.1997.2706; STAW BM, 1981, ADMIN SCI QUART, V26, P501, DOI 10.2307/2392337; THOMAS JB, 1993, ACAD MANAGE J, V36, P239, DOI 10.2307/256522; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Wakslak CJ, 2006, J EXP PSYCHOL GEN, V135, P641, DOI 10.1037/0096-3445.135.4.641; Yaniv I, 2007, ORGAN BEHAV HUM DEC, V103, P104, DOI 10.1016/j.obhdp.2006.05.006; Zhao M, 2007, J MARKETING RES, V44, P379, DOI 10.1509/jmkr.44.3.379; [钟毅平 Zhong Yiping], 2009, [心理科学, Psychological Science], V32, P920	42	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79181	10.1371/journal.pone.0079181	http://dx.doi.org/10.1371/journal.pone.0079181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244445	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800039
J	Alashti, FA; Minuchehr, Z				Alashti, Fariborz Asghari; Minuchehr, Zarrin			MiRNAs Which Target CD3 Subunits Could Be Potential Biomarkers for Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; MICRORNA SIGNATURES; GASTRIC-CANCER; OVARIAN-CANCER; EXPRESSION; SERUM; PROLIFERATION; METASTASIS	Background: T-cells play an important role in the immune response and are activated in response to the presentation of antigens bound to major histocompatibility complex (MHC) molecules participating with the T-cell receptor (TCR). T-cell receptor complexes also contain four CD3 (cluster of differentiation 3) subunits. The TCR-CD3 complex is vital for T-cell development and plays an important role in intervening cell recognition events. Since microRNAs (miRNAs) are highly stable in blood serum, some of which may target CD3 molecules, they could serve as good biomarkers for early cancer detection. The aim of this study was to see whether there is a relationship between cancers and the amount of miRNAs -targeted CD3 molecules. Methods: Bioinformatics tools were used in order to predict the miRNA targets for these genes. Subsequently, these highly conserved miRNAs were evaluated to see if they are implicated in various kinds of cancers. Consequently, human disease databases were used. According to the latest research, this study attempted to investigate the possible down-or upregulation of miRNAs cancer patients. Results: We identified miRNAs which target genes producing CD3 subunit molecules. The most conserved miRNAs were identified for the CD3G gene, while CD247 and CD3EAP genes had the least number and there were no conserved miRNA associated with the CD3D gene. Some of these miRNAs were found to be responsible for different cancers, following a certain pattern. Conclusions: It is highly likely that miRNAs affect the CD3 molecules, impairing the immune system, recognizing and destroying cancer tumor; hence, they can be used as suitable biomarkers in distinguishing cancer in the very early stages of its development.	[Alashti, Fariborz Asghari; Minuchehr, Zarrin] Natl Inst Genet Engn & Biotechnol, Dept Bioinformat, Tehran, Iran		Alashti, FA (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Bioinformat, Tehran, Iran.	faalashti@yahoo.fr; minuchehr@nigeb.ac.ir		Minuchehr, Zarrin/0000-0002-3734-745X	National Institute of Genetic Engineering and Biotechnology Tehran, Iran [303, 346]	National Institute of Genetic Engineering and Biotechnology Tehran, Iran	This work was supported by the National Institute of Genetic Engineering and Biotechnology Tehran, Iran (Grant number 303 and 346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Bano R, 2011, AFR J BIOTECHNOL, V10, P3633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hauser S, 2012, CANCER EPIDEMIOL, V36, P391, DOI 10.1016/j.canep.2012.04.001; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Huang SD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-51; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ito T, 2011, INT J CANCER, V129, P2134, DOI 10.1002/ijc.25874; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Knowlton DL, 2011, J CANCER, V2, P490, DOI 10.7150/jca.2.490; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin J, 2001, J CELL SCI, V114, P243; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Olaru AV, 2011, HEPATOLOGY, V54, P2089, DOI 10.1002/hep.24591; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Sarma NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050826; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Schwertheim S, 2009, HORM METAB RES, V41, P475, DOI 10.1055/s-0029-1215593; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Sun L, 2009, J UROLOGY, V182, P2242, DOI 10.1016/j.juro.2009.07.034; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang Ping, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P535; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78790	10.1371/journal.pone.0078790	http://dx.doi.org/10.1371/journal.pone.0078790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244363	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600061
J	Bennett, CL; Chen, YZ; Vignali, M; Lo, RS; Mason, AG; Unal, A; Saifee, NPH; Fields, S; La Spada, AR				Bennett, Craig L.; Chen, Yingzhang; Vignali, Marissa; Lo, Russell S.; Mason, Amanda G.; Unal, Asli; Saifee, Nabiha P. Huq; Fields, Stanley; La Spada, Albert R.			Protein Interaction Analysis of Senataxin and the ALS4 L389S Mutant Yields Insights into Senataxin Post-Translational Modification and Uncovers Mutant-Specific Binding with a Brain Cytoplasmic RNA-Encoded Peptide	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OCULOMOTOR APRAXIA TYPE-2; DENDRITIC BC1 RNA; BC200 RNA; POLY(A)-BINDING PROTEIN; TRANSLATIONAL CONTROL; FUNCTIONAL-ROLE; NONCODING RNAS; DNA-REPAIR; FRAGILE-X	Senataxin is a large 303 kDa protein linked to neuron survival, as recessive mutations cause Ataxia with Oculomotor Apraxia type 2 (AOA2), and dominant mutations cause amyotrophic lateral sclerosis type 4 (ALS4). Senataxin contains an amino-terminal protein-interaction domain and a carboxy-terminal DNA/RNA helicase domain. In this study, we focused upon the common ALS4 mutation, L389S, by performing yeast two-hybrid screens of a human brain expression library with control senataxin or L389S senataxin as bait. Interacting clones identified from the two screens were collated, and redundant hits and false positives subtracted to yield a set of 13 protein interactors. Among these hits, we discovered a highly specific and reproducible interaction of L389S senataxin with a peptide encoded by the antisense sequence of a brain-specific non-coding RNA, known as BCYRN1. We further found that L389S senataxin interacts with other proteins containing regions of conserved homology with the BCYRN1 reverse complement-encoded peptide, suggesting that such aberrant protein interactions may contribute to L389S ALS4 disease pathogenesis. As the yeast two-hybrid screen also demonstrated senataxin self-association, we confirmed senataxin dimerization via its amino-terminal binding domain and determined that the L389S mutation does not abrogate senataxin self-association. Finally, based upon detection of interactions between senataxin and ubiquitin-SUMO pathway modification enzymes, we examined senataxin for the presence of ubiquitin and SUMO monomers, and observed this post-translational modification. Our senataxin protein interaction study reveals a number of features of senataxin biology that shed light on senataxin normal function and likely on senataxin molecular pathology in ALS4.	[Bennett, Craig L.] James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Bennett, Craig L.; Mason, Amanda G.; Unal, Asli; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Chen, Yingzhang] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Vignali, Marissa; Lo, Russell S.; Fields, Stanley] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA; [Saifee, Nabiha P. Huq] Univ Washington, Med Ctr, Dept Pharmacol, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [La Spada, Albert R.] Rady Childrens Hosp, La Jolla, CA USA	James Cook University; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Bennett, CL (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia.	crbennett@ucsd.edu	La Spada, Albert/AAG-8809-2020	Huq Saifee, Nabiha/0000-0003-1646-9201; Lipton, Stuart/0000-0002-3490-1259; Bennett, CRAIG/0000-0002-5847-1687; Vignali, Marissa/0000-0002-7319-3371	NHMRC [APP1045520];  [R01 GM094384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094384, T32GM007266, T32GM008666, P41GM103533] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM094384 to C. L. B. and A. R. L., and by NHMRC project grant APP1045520 to C. L. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERUCCIO F, 1991, J EXP MED, V173, P941, DOI 10.1084/jem.173.4.941; Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Avemaria F, 2011, AMYOTROPH LATERAL SC, V12, P228, DOI 10.3109/17482968.2011.566930; Banerjee A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006193; Bassuk AG, 2007, NEUROGENETICS, V8, P45, DOI 10.1007/s10048-006-0067-8; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; De Amicis A, 2011, DNA REPAIR, V10, P199, DOI 10.1016/j.dnarep.2010.10.012; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Myrianthopoulos NC, 1960, BRAIN, V83, P589; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Rabin BA, 1999, BRAIN, V122, P1539, DOI 10.1093/brain/122.8.1539; Rudnik-Schoneborn S, 2011, EUR J HUM G IN PRESS; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1995, MOL GEN GENET, V249, P571, DOI 10.1007/BF00418026; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vantaggiato C, 2011, BRAIN, V134, P1808, DOI 10.1093/brain/awr084; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang HD, 2004, NEUROSCIENTIST, V10, P456, DOI 10.1177/1073858404265866; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	56	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78837	10.1371/journal.pone.0078837	http://dx.doi.org/10.1371/journal.pone.0078837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244371	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000327221600068
J	Lee, MK; Xu, SW; Fitzpatrick, EH; Sharma, A; Graves, HL; Czerniecki, BJ				Lee, Major K.; Xu, Shuwen; Fitzpatrick, Elizabeth H.; Sharma, Anupama; Graves, Holly L.; Czerniecki, Brian J.			Inhibition of CD4+CD25+Regulatory T Cell Function and Conversion into Th1-Like Effectors by a Toll-Like Receptor-Activated Dendritic Cell Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSES; IN-VITRO; MULTIPLE VACCINATIONS; SUPPRESSIVE FUNCTION; ANTITUMOR IMMUNITY; TUMOR-IMMUNITY; IFN-GAMMA; DEPLETION; CANCER; ENHANCEMENT	Despite the success of vaccines against some microbial pathogens, their utility in the prevention and treatment of cancer has thus far been limited. We have previously demonstrated that vaccination with dendritic cells activated with the TLR-4 ligand LPS and IFN-gamma promotes an antigen-specific anti-tumor response that prevents tumor recurrence. To evaluate this mechanistically, we here studied the effects of this TLR-activated DC on regulatory T cell activity. Dendritic cells activated with LPS and IFN-gamma negated the effects of regulatory T cells on responder cell proliferation. Restoration of responder cell proliferation was noted when TLR-activated dendritic cells were separated from both regulators and responders by a semipermeable membrane. The effect is therefore mediated by a soluble factor but was independent of both IL-6 and IL-12. Furthermore, the soluble mediator appeared to act at least in part on the regulators themselves rather than responder cells exclusively. Because recent studies have demonstrated conversion of T regulatory cells into IL-17-producing effectors, we further questioned whether the TLR-activated dendritic cell would induce cytokine production and effector function in our system. We found that regulators produced a substantial amount of IFN-gamma in the presence of TLR-activated dendritic cells but not immature dendritic cells. IFN-gamma production was associated with upregulation of the Th1 transcriptional regulator T-bet, and a significant fraction of IFN-gamma-producing regulators coexpressed T-bet and FoxP3. While the effects of the LPS-activated dendritic cell on responder cell proliferation were IL-12 independent, upregulation of T-bet was inhibited by a neutralizing anti-IL-12 antibody. Collectively, these and prior data suggest that varying innate immune signals may direct the phenotype of the immune response in part by inhibiting suppressor T cells and promoting differentiation of these regulators into particular subsets of effectors.	[Lee, Major K.; Xu, Shuwen; Fitzpatrick, Elizabeth H.; Sharma, Anupama; Graves, Holly L.; Czerniecki, Brian J.] Hosp Univ Penn, Harrison Dept Surg Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Czerniecki, BJ (corresponding author), Hosp Univ Penn, Harrison Dept Surg Res, 3400 Spruce St, Philadelphia, PA 19104 USA.	Brian.Czerniecki@uphs.upenn.edu			NIH [RO1-CA096997-02]; NATIONAL CANCER INSTITUTE [R01CA096997] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The manuscript was supported by NIH Grant RO1-CA096997-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Brinster C, 2005, J IMMUNOL, V175, P7332, DOI 10.4049/jimmunol.175.11.7332; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Delluc S, 2009, CANCER IMMUNOL IMMUN, V58, P1669, DOI 10.1007/s00262-009-0678-7; Eggermont AMM, 2009, CLIN CANCER RES, V15, P6745, DOI 10.1158/1078-0432.CCR-09-2377; Francois V, 2009, CANCER RES, V69, P4335, DOI 10.1158/0008-5472.CAN-08-3726; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Koski GK, 2008, IMMUNOL REV, V222, P256, DOI 10.1111/j.1600-065X.2008.00617.x; LaCelle MG, 2009, CLIN CANCER RES, V15, P6881, DOI 10.1158/1078-0432.CCR-09-1113; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Porrett PM, 2008, J IMMUNOL, V181, P1692, DOI 10.4049/jimmunol.181.3.1692; Porrett PM, 2008, ARCH IMMUNOL THER EX, V56, P193, DOI 10.1007/s00005-008-0019-0; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Shimizu J, 1999, J IMMUNOL, V163, P5211; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Urry Z, 2009, J CLIN INVEST, V119, P387, DOI 10.1172/JCI32354; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Yamamoto M, 2009, ONCOL REP, V22, P337, DOI 10.3892/or_00000442; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62	38	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e74698	10.1371/journal.pone.0074698	http://dx.doi.org/10.1371/journal.pone.0074698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244265	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600004
J	Lin, XZ; Luo, J; Zhang, LP; Wang, W; Gou, DM				Lin, Xianzi; Luo, Jun; Zhang, Liping; Wang, Wei; Gou, Deming			MiR-103 Controls Milk Fat Accumulation in Goat (Capra hircus) Mammary Gland during Lactation	PLOS ONE			English	Article							MICRORNA EXPRESSION; TRIGLYCERIDE ACCUMULATION; CONSERVED MICRORNAS; ACID-COMPOSITION; GENE NETWORKS; IDENTIFICATION; DIFFERENTIATION; CELLS; COW; TRANSCRIPTION	Milk is the primary source of nutrition for young mammals including humans. The nutritional value of milk is mainly attributable to fats and proteins fractions. In comparison to cow milk, goat milk contains greater amounts of total fat, including much higher levels of the beneficial unsaturated fatty acids. MicroRNAs (miRNAs), a well-defined group of small RNAs containing about 22 nucleotides (nt), participate in various metabolic processes across species. However, little is known regarding the role of miRNAs in regulating goat milk composition. In the present study, we performed high-throughput sequencing to identify mammary gland-enriched miRNAs in lactating goats. We identified 30 highly expressed miRNAs in the mammary gland, including miR-103. Further studies revealed that miR-103 expression correlates with the lactation. Further functional analysis showed that over-expression of miR-103 in mammary gland epithelial cells increases transcription of genes associated with milk fat synthesis, resulting in an up-regulation of fat droplet formation, triglyceride accumulation, and the proportion of unsaturated fatty acids. This study provides new insight into the functions of miR-103, as well as the molecular mechanisms that regulate milk fat synthesis.	[Lin, Xianzi; Luo, Jun; Zhang, Liping] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Wang, Wei] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Gou, Deming] Shenzhen Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Northwest A&F University - China; University of Alabama System; University of Alabama Tuscaloosa; Shenzhen University	Luo, J (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	luojun@nwsuaf.edu.cn		Wang, Wei/0000-0001-9511-3611	Special Fund for Agro-scientific Research in the Public Interest [201103038]; National Natural Science Foundation of China [31072013]; Transgenic New Species Breeding Program of China [2009ZX08009-162B]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transgenic New Species Breeding Program of China	Solexa sequencing was funded by the Special Fund for Agro-scientific Research in the Public Interest (201103038); qRT-PCR was funded by the National Natural Science Foundation of China (31072013); fatty acid analysis was funded by the Transgenic New Species Breeding Program of China (2009ZX08009-162B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuGhazaleh AA, 2009, J DAIRY SCI, V92, P6156, DOI 10.3168/jds.2009-2400; Alferez MJM, 2001, J DAIRY RES, V68, P451, DOI 10.1017/S0022029901004903; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; BABAYAN VK, 1981, J AM OIL CHEM SOC, V58, pA49, DOI 10.1007/BF02666072; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Cheng YX, 2011, INFLAMMATION, V34, P698, DOI 10.1007/s10753-010-9281-5; Chilliard Y, 2004, REPROD NUTR DEV, V44, P467, DOI 10.1051/rnd:2004052; Chilliard Y, 2000, ANN ZOOTECH, V49, P181, DOI 10.1051/animres:2000117; Clegg RA, 2001, LIVEST PROD SCI, V70, P3, DOI 10.1016/S0301-6226(01)00194-4; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Cortes C, 2010, J DAIRY SCI, V93, P3146, DOI 10.3168/jds.2009-2905; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; Doreau M, 2011, ANIM PROD SCI, V51, P19, DOI 10.1071/AN10043; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Ecker J, 2007, BIOCHEM BIOPH RES CO, V352, P805, DOI 10.1016/j.bbrc.2006.11.087; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fielding BA, 1998, BRIT J NUTR, V80, P495, DOI 10.1017/S0007114598001585; Fontanesi L, 2007, ITAL J ANIM SCI, V6, P133, DOI 10.4081/ijas.2007.1s.133; Frost RJA, 2010, J CARDIOVASC TRANSL, V3, P280, DOI 10.1007/s12265-010-9173-y; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; German T, 2002, IN VITRO CELL DEV-AN, V38, P282; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Haenlein GFW, 2001, J DAIRY SCI, V84, P2097, DOI 10.3168/jds.S0022-0302(01)74655-3; HANSEN HO, 1984, BIOCHEM J, V220, P513, DOI 10.1042/bj2200513; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Jeppesen J, 2012, J PHYSIOL-LONDON, V590, P1059, DOI 10.1113/jphysiol.2011.225011; Ji ZB, 2012, MOL BIOL RE IN PRESS; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Juarez M., 1987, INT DAIRY FED, V202, P54; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KNIGHT CH, 1982, J REPROD FERTIL, V65, P521, DOI 10.1530/jrf.0.0650521; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson L., 2013, LACT COMPR TREATISE, V2, P31, DOI [10.1016/B978-0-12-436702-9.50008-8, DOI 10.1016/B978-0-12-436702-9.50008-8]; Lee S, 2011, J CLIN VIROL, V52, P272, DOI 10.1016/j.jcv.2011.08.012; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morand-Fehr P, 2007, SMALL RUMINANT RES, V68, P20, DOI 10.1016/j.smallrumres.2006.09.019; Mosley EE, 2002, J LIPID RES, V43, P290; Moura RR, 2011, BRAZ ARCH BIOL TECHN, V54, P927, DOI 10.1590/S1516-89132011000500010; NICKERSON TA, 1960, J DAIRY SCI, V43, P598, DOI 10.3168/jds.S0022-0302(60)90210-1; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; PATTON S, 1973, J AM OIL CHEM SOC, V50, P178, DOI 10.1007/BF02640487; Ramsay TG, 2003, J ANIM SCI, V81, P3008; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; REBUFFESCRIVE M, 1985, J CLIN INVEST, V75, P1973, DOI 10.1172/JCI111914; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sahlu T, 1999, SMALL RUMINANT RES, V33, P25, DOI 10.1016/S0921-4488(99)00003-6; Sahlu T, 2005, SMALL RUMINANT RES, V60, P7, DOI 10.1016/j.smallrumres.2005.06.002; Samkova E, 2012, S AFR J ANIM SCI, V42, P83, DOI 10.4314/sajas.v42i2.1; Sanchez-Hidalgo M, 2007, AM J PHYSIOL-REG I, V292, pR2208, DOI 10.1152/ajpregu.00013.2007; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Serment A, 2011, J DAIRY SCI, V94, P3960, DOI 10.3168/jds.2010-4041; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; SONNENBERG A, 1986, J HISTOCHEM CYTOCHEM, V34, P1037, DOI 10.1177/34.8.2426332; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Teleman AA, 2010, CELL METAB, V11, P8, DOI 10.1016/j.cmet.2009.12.004; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Binsbergen R, 2012, J DAIRY SCI, V95, P2132, DOI 10.3168/jds.2011-4725; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/G11-069, 10.1139/g11-069]; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Zhang Y, 2011, J AGR FOOD CHEM, V59, P11526, DOI 10.1021/jf2028494; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P	97	67	75	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79258	10.1371/journal.pone.0079258	http://dx.doi.org/10.1371/journal.pone.0079258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244462	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600120
J	Neves, FH; Carmona, MJ; Auler, JOC; Rodrigues, RR; Rouby, JJ; Malbouisson, LMS				Neves, Flavio H.; Carmona, Maria J.; Auler, Jose O. C., Jr.; Rodrigues, Roseny R.; Rouby, Jean Jacques; Malbouisson, Luiz M. S.			Cardiac Compression of Lung Lower Lobes after Coronary Artery Bypass Graft with Cardiopulmonary Bypass	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PULMONARY-FUNCTION; GAS-EXCHANGE; VERTICAL GRADIENT; LEFT ATRIUM; ATELECTASIS; VENTILATION; ANESTHESIA; HEART; PRESSURE	Background: Atelectasis is a major cause of hypoxemia after coronary artery bypass grafting (CABG) and is commonly ascribed to general anesthesia, high inspiratory oxygen concentration and cardiopulmonary bypass (CPB). The objective of this study was to evaluate the role of heart-induced pulmonary compression after CABG with CPB. Methods: Seventeen patients without pre-operative cardiac failure who were scheduled for coronary artery bypass graft underwent pre-and postoperative thoracic computed tomography. The cardiac mass, the pressure exerted on the lungs by the right and left heart and the fraction of collapsed lower lobe segments below and outside of the heart limits were evaluated on a computed tomography section 1 cm above the diaphragmatic cupola. Results: In the postoperative period, cardiac mass increased by 32% (117 +/- 31 g versus 155 +/- 35 g, p<0.001), leading to an increase in the pressure that was exerted on the lungs by the right (2.2 +/- 0.6 g.cm(-2) versus 3.2 +/- 1.2 g.cm(-2), p<0.05) and left heart (2.4 +/- 0.7 g.cm(-2) versus 4.261.8 g.cm(-2), p, 0.001). The proportion of collapsed lung segments beneath the heart markedly increased [from 6.7% to 32.9% on the right side (p<0.001) and from 6.2% to 29% on the left side (p<0.001)], whereas the proportion of collapsed lung segments outside of the heart limits slightly increased [from 0.7% to 10.8% on the right side (p<0.001) and from 1.5% to 12.6% on the left side (p<0.001)]. Conclusion: The pressure that is exerted by the heart on the lungs increased postoperatively and contributed to the collapse of subjacent pulmonary segments.	[Neves, Flavio H.; Carmona, Maria J.; Auler, Jose O. C., Jr.; Rodrigues, Roseny R.; Malbouisson, Luiz M. S.] Univ Sao Paulo, Fac Med, Hosp Clin, Div Anestesia, Sao Paulo, Brazil; [Rouby, Jean Jacques] Univ Paris 06, Multidisciplinary Intens Care Unit, Dept Anesthesiol, Hop La Pitie Salpetriere, Paris, France	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Malbouisson, LMS (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Div Anestesia, Sao Paulo, Brazil.	luiz.malbouisson@hc.fm.usp.br	Auler, José Otavio Costa/C-4492-2017; Rodrigues, Roseny/P-6341-2014; CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Sa Malbouisson, Luiz Marcelo/F-4819-2012	Auler, José Otavio Costa/0000-0002-3919-1743; CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Rouby, Jean-Jacques/0000-0001-9092-4642; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/0174-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - process number 2005/0174-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MSM, 1992, CHEST, V101, P1189, DOI 10.1378/chest.101.5.1189; ALEXANDER MSM, 1989, BRIT MED J, V299, P94, DOI 10.1136/bmj.299.6691.94; AULERJUNIOR JOC, 1986, BRAZ J MED BIOL RES, V19, P707; Belhaj Asmae, 2012, Recent Pat Cardiovasc Drug Discov, V7, P165; CORR L, 1988, PEDIATR RADIOL, V18, P459, DOI 10.1007/BF00974079; Daganou M, 1998, CHEST, V113, P1285, DOI 10.1378/chest.113.5.1285; DAILEY ME, 1990, INT J PEDIATR OTORHI, V19, P33, DOI 10.1016/0165-5876(90)90193-U; de Vroege R, 1997, PERFUSION-UK, V12, P369, DOI 10.1177/026765919701200605; DERY RAYNALD, 1965, CAN ANAESTH SOC J, V12, P531, DOI 10.1007/BF03004416; FROESE AB, 1974, ANESTHESIOLOGY, V41, P242, DOI 10.1097/00000542-197409000-00006; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Gorlach G, 1986, Adv Exp Med Biol, V194, P439; HACHENBERG T, 1992, ACTA ANAESTH SCAND, V36, P800, DOI 10.1111/j.1399-6576.1992.tb03568.x; HEDENSTIERNA G, 1994, ANESTHESIOLOGY, V80, P751, DOI 10.1097/00000542-199404000-00006; HEDENSTIERNA G, 1989, EUR RESPIR J, V2, P528; Hedenstierna G, 1994, Monaldi Arch Chest Dis, V49, P315; Hedenstierna G, 1999, J APPL PHYSIOL, V86, P1114, DOI 10.1152/jappl.1999.86.4.1114; HOFFMAN EA, 1985, J APPL PHYSIOL, V59, P468, DOI 10.1152/jappl.1985.59.2.468; HOFFMAN EA, 1987, ANN BIOMED ENG, V15, P241, DOI 10.1007/BF02584282; HYATT RE, 1985, J APPL PHYSIOL, V58, P52, DOI 10.1152/jappl.1985.58.1.52; IVERSON LIG, 1978, ANN THORAC SURG, V25, P197, DOI 10.1016/S0003-4975(10)63521-7; LINDBERG P, 1992, ACTA ANAESTH SCAND, V36, P546, DOI 10.1111/j.1399-6576.1992.tb03516.x; Lundstrom LH, 2005, CHEST, V128, P1564, DOI 10.1378/chest.128.3.1564; Magnusson L, 1997, ANESTHESIOLOGY, V87, P1153, DOI 10.1097/00000542-199711000-00020; Malbouisson LM, 2000, AM J RESP CRIT CARE, V161, P2005, DOI 10.1164/ajrccm.161.6.9907067; MEHLHORN U, 1995, AM J PHYSIOL-HEART C, V268, pH178, DOI 10.1152/ajpheart.1995.268.1.H178; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; PELOSI P, 1994, AM J RESP CRIT CARE, V149, P8, DOI 10.1164/ajrccm.149.1.8111603; Puybasset L, 2000, INTENS CARE MED, V26, P857, DOI 10.1007/s001340051274; Puybasset L, 1998, AM J RESP CRIT CARE, V158, P1644, DOI 10.1164/ajrccm.158.5.9802003; Raffa GM, 2011, J CARDIOVASC MED, V12, P745, DOI 10.2459/JCM.0b013e32834a65b1; Rodrigues RR, 2011, BRAZ J MED BIOL RES, V44, P598, DOI 10.1590/S0100-879X2011007500048; ROTHEN HU, 1995, ANESTHESIOLOGY, V82, P832, DOI 10.1097/00000542-199504000-00004; Rouby JJ, 2003, EUR RESPIR J, V22, p27S, DOI 10.1183/09031936.03.00420503; ROUBY JJ, 1989, J APPL PHYSIOL, V66, P1984, DOI 10.1152/jappl.1989.66.4.1984; Schlensak C, 2000, ANN THORAC SURG, V70, P337, DOI 10.1016/S0003-4975(00)01474-0; SECKERWALKER RH, 1981, J NUCL MED, V22, P212; Tenling A, 1998, ANESTHESIOLOGY, V89, P371, DOI 10.1097/00000542-199808000-00013; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tukey JW, 1977, EXPLORATORY DATA ANA; Vargas FS, 1997, RESP MED, V91, P629, DOI 10.1016/S0954-6111(97)90010-X; VARGAS FS, 1993, CHEST, V104, P434, DOI 10.1378/chest.104.2.434; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Westerdahl E, 2005, CHEST, V128, P3482, DOI 10.1378/chest.128.5.3482; WIENER CM, 1990, AM REV RESPIR DIS, V141, P150, DOI 10.1164/ajrccm/141.1.150	45	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78643	10.1371/journal.pone.0078643	http://dx.doi.org/10.1371/journal.pone.0078643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244331	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600040
J	Ran, JH; Shen, TT; Liu, WJ; Wang, XQ				Ran, Jin-Hua; Shen, Ting-Ting; Liu, Wen-Juan; Wang, Xiao-Quan			Evolution of the bHLH Genes Involved in Stomatal Development: Implications for the Expansion of Developmental Complexity of Stomata in Land Plants	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; ADIANTUM-CAPILLUS-VENERIS; WATER-USE EFFICIENCY; GENOME-WIDE; ARABIDOPSIS; FERN; SELECTION; SEQUENCE; CO2; MECHANISMS	Stomata play significant roles in plant evolution. A trio of closely related basic Helix-Loop-Helix (bHLH) subgroup Ia genes, SPCH, MUTE and FAMA, mediate sequential steps of stomatal development, and their functions may be conserved in land plants. However, the evolutionary history of the putative SPCH/MUTE/FAMA genes is still greatly controversial, especially the phylogenetic positions of the bHLH Ia members from basal land plants. To better understand the evolutionary pattern and functional diversity of the bHLH genes involved in stomatal development, we made a comprehensive evolutionary analysis of the homologous genes from 54 species representing the major lineages of green plants. The phylogenetic analysis indicated: (1) All bHLH Ia genes from the two basal land plants Physcomitrella and Selaginella were closely related to the FAMA genes of seed plants; and (2) the gymnosperm 'SPCH' genes were sister to a clade comprising the angiosperm SPCH and MUTE genes, while the FAMA genes of gymnosperms and angiosperms had a sister relationship. The revealed phylogenetic relationships are also supported by the distribution of gene structures and previous functional studies. Therefore, we deduce that the function of FAMA might be ancestral in the bHLH Ia subgroup. In addition, the gymnosperm "SPCH'' genes may represent an ancestral state and have a dual function of SPCH and MUTE, two genes that could have originated from a duplication event in the common ancestor of angiosperms. Moreover, in angiosperms, SPCHs have experienced more duplications and harbor more copies than MUTEs and FAMAs, which, together with variation of the stomatal development in the entry division, implies that SPCH might have contributed greatly to the diversity of stomatal development. Based on the above, we proposed a model for the correlation between the evolution of stomatal development and the genes involved in this developmental process in land plants.	[Ran, Jin-Hua; Shen, Ting-Ting; Liu, Wen-Juan; Wang, Xiao-Quan] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Ran, JH (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	jinhua_ran@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [30870166, 30990240, 30425028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant numbers 30870166, 30990240 and 30425028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakos P, 1997, PROTOPLASMA, V198, P93, DOI 10.1007/BF01282135; Bateman RM, 1998, ANNU REV ECOL SYST, V29, P263, DOI 10.1146/annurev.ecolsys.29.1.263; Beerling DJ, 2009, NEW PHYTOL, V183, P921, DOI 10.1111/j.1469-8137.2009.02973.x; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; Chater C, 2011, CURR BIOL, V21, P1025, DOI 10.1016/j.cub.2011.04.032; Croxdale JL, 2000, AM J BOT, V87, P1069, DOI 10.2307/2656643; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Darwin F, 1898, PHILOS T R S LONDON, V190, P531, DOI DOI 10.1098/RSTB.1898.0009; de Boer HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2217; Delaux PM, 2012, PERSPECT PLANT ECOL, V14, P49, DOI 10.1016/j.ppees.2011.09.001; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Doi M, 2006, PLANT CELL PHYSIOL, V47, P748, DOI 10.1093/pcp/pcj048; Doyle J. J., 1987, PHYTOCHEM B, P11; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOHNSON RW, 1981, AM J BOT, V68, P260, DOI 10.2307/2442858; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; MacAlister CA, 2011, EVOL DEV, V13, P182, DOI 10.1111/j.1525-142X.2011.00468.x; Maddison W.P., MESQUITE MODULAR SYS; McAdam SAM, 2013, NEW PHYTOL, V198, P429, DOI 10.1111/nph.12190; McAdam SAM, 2012, ECOL LETT, V15, P1, DOI 10.1111/j.1461-0248.2011.01700.x; McAdam SAM, 2011, J EXP BOT, V62, P195, DOI 10.1093/jxb/erq260; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; PAYNE WW, 1979, TAXON, V28, P117, DOI 10.2307/1219566; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Ran JH, 2010, MOL PHYLOGENET EVOL, V54, P136, DOI 10.1016/j.ympev.2009.09.011; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; ROBINSON JM, 1994, PLANT CELL ENVIRON, V17, P345, DOI 10.1111/j.1365-3040.1994.tb00303.x; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rudall PJ, 2013, NEW PHYTOL, V200, P598, DOI 10.1111/nph.12406; Rudall PJ, 2012, INT J PLANT SCI, V173, P849, DOI 10.1086/667230; Ruszala EM, 2011, CURR BIOL, V21, P1030, DOI 10.1016/j.cub.2011.04.044; SACK FD, 1985, AM J BOT, V72, P1325, DOI 10.2307/2443504; SACK FD, 1994, AM J BOT, V81, P339, DOI 10.2307/2445461; STEBBINS GL, 1960, DEV BIOL, V2, P409, DOI 10.1016/0012-1606(60)90025-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Torii Keiko U., 2008, V9, P343, DOI 10.1007/7089_2007_135; Vaten A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-11; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	61	28	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78997	10.1371/journal.pone.0078997	http://dx.doi.org/10.1371/journal.pone.0078997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244399	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600091
J	Nassirpour, R; Mehta, PP; Yin, MJ				Nassirpour, Rounak; Mehta, Pramod P.; Yin, Min-Jean			RETRACTED: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3 (Retracted article. See vol. 12, art no e0184778, 2017)	PLOS ONE			English	Article; Retracted Publication							HEPATITIS-C VIRUS; MICRORNA; EXPRESSION; GENOMICS; KINASE	MicroRNAs (miRNAs) have been implicated in the orchestration of diverse cellular processes including differentiation, proliferation, and apoptosis and are believed to play pivotal roles as oncogenes and tumor suppressors. miR-122, a liver specific miRNA, is significantly down-regulated in most hepatocellular carcinomas (HCCs) but its role in tumorigenesis remains poorly understood. Here we identify AKT3 as a novel and direct target of miR-122. Restoration of miR-122 expression in HCC cell lines decreases AKT3 levels, inhibits cell migration and proliferation, and induces apoptosis. These anti-tumor phenotypes can be rescued by reconstitution of AKT3 expression indicating the essential role of AKT3 in miR-122 mediated HCC transformation. In vivo, restoration of miR-122 completely inhibited xenograft growth of HCC tumor in mice. Our data strongly suggest that miR-122 is a tumor suppressor that targets AKT3 to regulate tumorigenesis in HCCs and a potential therapeutic candidate for liver cancer.	[Nassirpour, Rounak; Mehta, Pramod P.; Yin, Min-Jean] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA	Pfizer	Yin, MJ (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	min-jean.yin@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	All authors are current full time employees of Pfizer Inc., whose company funded this study. There are no patents, products in development or marked products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027	29	67	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79655	10.1371/journal.pone.0079655	http://dx.doi.org/10.1371/journal.pone.0079655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244539	gold, Green Published			2022-12-27	WOS:000327162900043
J	Owais, A; Faruque, AG; Das, SK; Ahmed, S; Rahman, S; Stein, AD				Owais, Aatekah; Faruque, Abu Syed Golam; Das, Sumon K.; Ahmed, Shahnawaz; Rahman, Shahed; Stein, Aryeh D.			Maternal and Antenatal Risk Factors for Stillbirths and Neonatal Mortality in Rural Bangladesh: A Case-Control Study	PLOS ONE			English	Article							CONFOUNDER-SELECTION; HEALTH; DEATHS; CARE; EPIDEMIOLOGY; PREVENTION; PREDICTORS; SURVIVAL; SEPSIS; SEX	Objective: To identify maternal and antenatal factors associated with stillbirths and neonatal deaths in rural Bangladesh. Study Design: A prospective cohort study is being conducted to evaluate a maternal and child nutrition program in rural Bangladesh. Cases were all stillbirths and neonatal deaths that occurred in the cohort between March 7, 2011 and December 30, 2011. Verbal autopsies were used to determine cause of death. For each case, four controls were randomly selected from cohort members alive at age 3-months. Multivariable logistic regression was used to identify factors associated with these deaths. Results: Overall, 112 adverse pregnancy outcomes (44 stillbirths, 19/1,000 births; 68 neonatal deaths, 29/1,000 live births) were reported. Of the stillbirths 25 (56.8%) were fresh. The main causes of neonatal death were birth asphyxia (35%), sepsis (28%) and preterm birth (19%). History of bleeding during pregnancy was the strongest risk factor for stillbirths (adjusted odds ratio 22.4 [95% confidence interval 2.5, 197.5]) and neonatal deaths (adjusted odds ratio 19.6 [95% confidence interval 2.1, 178.8]). Adequate maternal nutrition was associated with decreased risk of neonatal death (adjusted odds ratio 0.4 [95% confidence interval 0.2, 0.8]). Conclusions: Identifying high-risk pregnancies during gestation and ensuring adequate antenatal and obstetric care needs to be a priority for any community-based maternal and child health program in similar settings.	[Owais, Aatekah] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Owais, Aatekah] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Faruque, Abu Syed Golam; Das, Sumon K.; Ahmed, Shahnawaz] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Rahman, Shahed] CARE Bangladesh, Dhaka, Bangladesh; [Stein, Aryeh D.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; International Centre for Diarrhoeal Disease Research (ICDDR); Emory University	Stein, AD (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Das, Sumon Kumar/T-6384-2019; Das, Sumon Kumar/AAD-1551-2019	Stein, Aryeh/0000-0003-1138-6458; Ahmed, Shahnawaz/0000-0001-8339-4137; Owais, Aatekah/0000-0002-9148-843X				Adetola AO, 2011, PEDIATR NEONATOL, V52, P243, DOI 10.1016/j.pedneo.2011.06.001; ANKER M, 1999, STANDARD VERBAL AUTO; [Anonymous], 2011, STAT WORLDS CHILDR 2; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bapat U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-39; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Budtz-Jorgensen E, 2007, ANN EPIDEMIOL, V17, P27, DOI 10.1016/j.annepidem.2006.05.007; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Fretts R, 2010, CLIN OBSTET GYNECOL, V53, P588, DOI 10.1097/GRF.0b013e3181eb63fc; GOLDENBERG RL, 1993, OBSTET GYNECOL, V81, P444; Hirst JE, 2010, INT J GYNECOL OBSTET, V110, P109, DOI 10.1016/j.ijgo.2010.03.028; Hodgins S, 2010, J PERINATOL, V30, P388, DOI 10.1038/jp.2009.181; Kayode GA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-10; Khatun F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-84; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LeVine RA, 2009, J DEV BEHAV PEDIATR, V30, P340, DOI 10.1097/DBP.0b013e3181b0eeff; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; MCMILLEN MM, 1979, SCIENCE, V204, P89, DOI 10.1126/science.571144; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; National Institute of Population Research and Training (NIPORT) and ICF. 2019, BANGL DEM HLTH SURV; Onwuanaku Caroline A, 2011, BMC Res Notes, V4, P562, DOI 10.1186/1756-0500-4-562; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Reddy UM, 2007, OBSTET GYNECOL, V110, P1151, DOI 10.1097/01.AOG.0000287616.71602.d0; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Ulizzi L, 2002, HUM BIOL, V74, P879, DOI 10.1353/hub.2003.0012; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; World Health Organization, 2006, INT STAT CLASS DIS R	39	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80164	10.1371/journal.pone.0080164	http://dx.doi.org/10.1371/journal.pone.0080164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244638	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900065
J	Srinivasan, P; Subramanian, VS; Said, HM				Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.			Effect of the Cigarette Smoke Component, 4(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK), on Physiological and Molecular Parameters of Thiamin Uptake by Pancreatic Acinar Cells	PLOS ONE			English	Article							DEFICIENCY; EXPRESSION; NICOTINE; SLC19A2; INFLAMMATION; CARCINOGEN; SECRETION; INSULIN; GLUCOSE; ANEMIA	Thiamin is indispensable for the normal function of pancreatic acinar cells. These cells take up thiamin via specific carrier-mediated process that involves thiamin transporter-1 and -2 (THTR-1 and THTR-2; products of SLC19A2 and SLC19A3 genes, respectively). In this study we examined the effect of chronic exposure of pancreatic acinar cells in vitro (pancreatic acinar 266-6 cells) and in vivo (wild-type and transgenic mice carrying the SLC19A2 and SLC19A3 promoters) to the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on physiological and molecular parameters of the thiamin uptake process. The results show that chronic exposure of 266-6 cells to NNK (3 mu M, 24 h) leads to a significant inhibition in thiamin uptake. The inhibition was associated with a significant decrease in the level of expression of THTR-1 and -2 at the protein and mRNA levels as well as in the activity of SLC19A2 and SLC19A3 promoters. Similarly chronic exposure of mice to NNK (IP 10 mg/100 g body weight, three times/week for 2 weeks) leads to a significant inhibition in thiamin uptake by freshly isolated pancreatic acinar cells, as well as in the level of expression of THTR-1 and -2 protein and mRNA. Furthermore, activity of the SLC19A2 and SLC19A3 promoters expressed in transgenic mice were significantly suppressed by chronic exposure to NNK. The effect of NNK on the activity of the SLC19A2 and SLC19A3 promoters was not mediated via changes in their methylation profile, rather it appears to be exerted via an SP1/GG and SP1/GC cis-regulatory elements in these promoters, respectively. These results demonstrate, for the first time, that chronic exposure of pancreatic acinar cells to NNK negatively impacts the physiological and molecular parameters of thiamin uptake by pancreatic acinar cells and that this effect is exerted, at least in part, at the level of transcription of the SLC19A2 and SLC19A3 genes.	[Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Vet Adm Med Ctr, Dept Med Res, Long Beach, CA 90822 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Said, HM (corresponding author), Vet Adm Med Ctr, Dept Med Res, Long Beach, CA 90822 USA.	hmsaid@uci.edu	Srinivasan, Padmanabhan/A-9227-2016	Srinivasan, Padmanabhan/0000-0003-2067-7273	National Institutes of Health [AA018071, DK56061]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056061, R37DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institutes of Health (AA018071 and DK56061) and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre M, 2012, AM J PHYSIOL-GASTR L, V303, pG696, DOI 10.1152/ajpgi.00138.2012; Alexandre M, 2011, PANCREATOLOGY, V11, P469, DOI 10.1159/000332196; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Berdanier C.D., 2018, ADV NUTR MACRONUTRIE; BETTENDORFF L, 1995, J NEUROCHEM, V64, P2013; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; HECHT SS, 1978, J NATL CANCER I, V60, P819, DOI 10.1093/jnci/60.4.819; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li YY, 2011, METHODS MOL BIOL, V791, P11, DOI 10.1007/978-1-61779-316-5_2; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Mee L, 2009, AM J PHYSIOL-GASTR L, V297, pG197, DOI 10.1152/ajpgi.00092.2009; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; PRASANNAN KG, 1977, EXPERIENTIA, V33, P169, DOI 10.1007/BF02124046; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; RATHANASWAMI P, 1991, BIOCHEM INT, V24, P1057; RATHANASWAMI P, 1991, BIOCHEM INT, V25, P577; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; Said HM, 2010, AM J PHYSIOL-GASTR L, V298, pG985, DOI 10.1152/ajpgi.00068.2010; SINGH M, 1982, AM J CLIN NUTR, V36, P500, DOI 10.1093/ajcn/36.3.500; Subramanian VS, 2012, AM J PHYSIOL-GASTR L, V302, pG572, DOI 10.1152/ajpgi.00484.2011; Subramanya SB, 2011, AM J PHYSIOL-GASTR L, V301, pG896, DOI 10.1152/ajpgi.00308.2011; Tanphaichitr V., 1994, MODERN NUTR HLTH DIS, P359; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Word B, 2013, INT J TOXICOL, V32, P23, DOI 10.1177/1091581812465902; Xu H, 2007, EUR RESPIR J, V30, P633, DOI 10.1183/09031936.00014107	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78853	10.1371/journal.pone.0078853	http://dx.doi.org/10.1371/journal.pone.0078853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244374	Green Published, gold			2022-12-27	WOS:000327162900025
J	Tiittanen, M; Keto, J; Haiko, J; Matto, J; Partanen, J; Lahteenmaki, K				Tiittanen, Minna; Keto, Joni; Haiko, Johanna; Matto, Jaana; Partanen, Jukka; Lahteenmaki, Kaarina			Interaction with Intestinal Epithelial Cells Promotes an Immunosuppressive Phenotype in Lactobacillus casei	PLOS ONE			English	Article							REGULATORY T-CELLS; LACTIC-ACID BACTERIA; MONONUCLEAR-CELLS; IMMUNOMODULATORY PROPERTIES; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; GUT MICROBIOTA; IN-VITRO; INDUCTION; PROBIOTICS	Maintenance of the immunological tolerance and homeostasis in the gut is associated with the composition of the intestinal microbiota. We here report that cultivation of Lactobacillus casei ATCC 334 in the presence of human intestinal epithelial cells promotes functional changes in bacteria. In particular, the interaction enhanced the immunosuppressive phenotype of L. casei as demonstrated by the ability of L. casei to generate functional regulatory T cells (CD4+CD25+FoxP3+) and production of the anti-inflammatory cytokine interleukin-10 by human peripheral blood mononuclear cells. The results indicate microbe-host cross-talk that changes features of microbes, and suggest that in vitro simulation of epithelial cell interaction can reveal functional properties of gut microbes more accurately than conventional cultivation.	[Tiittanen, Minna; Keto, Joni; Haiko, Johanna; Matto, Jaana; Partanen, Jukka; Lahteenmaki, Kaarina] Finnish Red Cross Blood Serv, Helsinki, Finland		Lahteenmaki, K (corresponding author), Finnish Red Cross Blood Serv, Helsinki, Finland.	Kaarina.Lahteenmaki@bts.redcross.fi	Partanen, Jukka/B-7207-2014	Partanen, Jukka/0000-0001-6681-4734; Keto, Joni/0000-0002-7353-8843	EVO research fund of the Finnish Red Cross Blood Service	EVO research fund of the Finnish Red Cross Blood Service	The study was partly funded by the EVO research fund of the Finnish Red Cross Blood Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Castillo NA, 2013, J APPL MICROBIOL, V114, P861, DOI 10.1111/jam.12074; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; de Roock S, 2011, CLIN NUTR, V30, P845, DOI 10.1016/j.clnu.2011.05.005; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Izcue A, 2008, IMMUNOLOGY, V123, P6, DOI 10.1111/j.1365-2567.2007.02778.x; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Lopez P, 2012, APPL ENVIRON MICROB, V78, P2850, DOI 10.1128/AEM.07581-11; Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024776; Makivuokko Harri, 2012, Microbial Ecology in Health and Disease, V23, P28, DOI 10.3402/mehd.v23i0.18578; Matsuzaki T, 2000, IMMUNOL CELL BIOL, V78, P67, DOI 10.1046/j.1440-1711.2000.00887.x; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Pietila M, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt144; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rodrigues DM, 2012, J INFECT DIS, V206, P99, DOI 10.1093/infdis/jis177; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shida K, 2011, GUT MICROBES, V2, P109, DOI 10.4161/gmic.2.2.15661; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Tuovinen E, 2013, ANAEROBE, V19, P70, DOI 10.1016/j.anaerobe.2012.11.002; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Vissers YM, 2010, FEMS IMMUNOL MED MIC, V59, P60, DOI 10.1111/j.1574-695X.2010.00662.x; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961	43	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78420	10.1371/journal.pone.0078420	http://dx.doi.org/10.1371/journal.pone.0078420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244309	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900015
J	Ribeiz, SRI; Duran, F; Oliveira, MC; Bezerra, D; Castro, CC; Steffens, DC; Busatto, G; Bottino, CMC				Ribeiz, Salma R. I.; Duran, Fabio; Oliveira, Melaine C.; Bezerra, Diana; Castro, Claudio Campi; Steffens, David C.; Busatto Filho, Geraldo; Bottino, Cassio M. C.			Structural Brain Changes as Biomarkers and Outcome Predictors in Patients with Late-Life Depression: A CrossSectional and Prospective Study	PLOS ONE			English	Article							GRAY-MATTER CHANGES; HUMAN ORBITOFRONTAL CORTEX; VOXEL-BASED MORPHOMETRY; ANTERIOR CINGULATE; CORTICAL THICKNESS; HIPPOCAMPAL VOLUME; SAO-PAULO; SCALE; MRI; REGISTRATION	The relationship between structural changes in grey matter and treatment response in patients with late-life depression remains an intriguing area of research. This magnetic resonance imaging (MRI) study compares the baseline grey matter volume of elderly people with and without major depression (according to the DSM-IV-TR criteria) and assesses its association with antidepressant treatment response. Brain MRI scans were processed using statistical parametric mapping and voxel-based morphometry. The sample consisted of 30 patients with depression and 22 healthy controls. We found a significant volumetric reduction in the orbitofrontal cortex bilaterally in patients in comparison with controls. According to their remission status after antidepressant treatment, patients were classified as remitted or not remitted. Compared with controls, remitted patients showed a volumetric reduction in the orbitofrontal cortex bilaterally and in another cluster in the right middle temporal pole. Non-remitted patients showed an even greater volumetric reduction in the orbitofrontal cortex bilaterally compared with controls. To investigate predictive factors of remission after antidepressant treatment, we used a logistic regression. Both baseline Mini Mental State Examination score and baseline left superior lateral orbitofrontal cortex volume (standardized to the total grey matter volume) were associated with remission status. Our findings support the use of regional brain atrophy as a potential biomarker for depression. In addition, baseline cognitive impairment and regional grey matter abnormalities predict antidepressant response in patients with late-life depression.	[Ribeiz, Salma R. I.; Bezerra, Diana; Bottino, Cassio M. C.] Univ Sao Paulo, Sch Med, Inst Psychiat, Old Age Res Grp PROTER, Sao Paulo, Brazil; [Duran, Fabio; Busatto Filho, Geraldo] Univ Sao Paulo, Inst Psychiat, Lab Psychiat Neuroimaging LIM 21, Sao Paulo, Brazil; [Duran, Fabio; Busatto Filho, Geraldo] Univ Sao Paulo, Dept Psychiat, Lab Psychiat Neuroimaging LIM 21, Sao Paulo, Brazil; [Oliveira, Melaine C.] Univ Sao Paulo, Inst Math & Stat IME, Sao Paulo, Brazil; [Castro, Claudio Campi] Univ Sao Paulo, Sch Med, Heart Inst InCor, Dept Diagnost Imaging, Sao Paulo, Brazil; [Steffens, David C.] Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Connecticut	Ribeiz, SRI (corresponding author), Univ Sao Paulo, Sch Med, Inst Psychiat, Old Age Res Grp PROTER, Sao Paulo, Brazil.	salma.ribeiz@usp.br	Busatto, Geraldo F/D-4431-2009; Duran, Fabio L S/I-5704-2012; DE CASTRO, CLAUDIO CAMPI/AAN-5220-2020; Souza-Duran, Fabio Luis/L-1371-2013; Ribeiz, Salma/D-1794-2014	Busatto, Geraldo F/0000-0003-4749-4602; Duran, Fabio L S/0000-0003-2494-7250; Souza-Duran, Fabio Luis/0000-0002-7603-6152; Ribeiz, Salma/0000-0002-2214-4318	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/09586-9]; "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2); United States National Institute of Mental Health [K24 MH 070027]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2); United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) no. 04/09586-9. Dr. Salma R. I. Ribeiz is supported by a research fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Dr. C~ssio M. C. Bottino is a researcher of the "National Counsel of Technological and Scientific Development" (CNPq-Researcher Level 2). Dr. David Steffens is supported by United States National Institute of Mental Health grant K24 MH 070027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P347, DOI 10.1002/gps.1939; Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P687, DOI 10.1176/appi.ajgp.10.6.687; *AM PSYCH ASS E, 2000, DIAGN STAT MAN MENT; Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avila R, 2011, NEUROBIOL AGING, V32, P1857, DOI 10.1016/j.neurobiolaging.2009.11.004; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Ballmaier M, 2004, BIOL PSYCHIAT, V55, P382, DOI 10.1016/j.biopsych.2003.09.004; Barcelos-Ferreira R, 2009, AM J GERIAT PSYCHIAT, V17, P582, DOI 10.1097/JGP.0b013e3181a76ddc; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Bottino CMC, 2012, CURR PSYCHIAT REP, V14, P289, DOI 10.1007/s11920-012-0281-z; BOTTINO CMC, 2001, JORNAL OFICIAL ACAD, P20; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; COFFEY CE, 1993, ARCH GEN PSYCHIAT, V50, P7; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; CRAIGHEAD WES, 2007, GUIDE TREATMENTS WOR, P271; Disabato BM, 2012, CURR PSYCHIAT REP, V14, P273, DOI 10.1007/s11920-012-0279-6; Egger K, 2008, PSYCHIAT RES-NEUROIM, V164, P237, DOI 10.1016/j.pscychresns.2007.12.018; Folquitto JC, 2007, REV BRAS PSIQUIATR, V29, P350, DOI 10.1590/S1516-44462006005000037; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gunning FM, 2009, INT J GERIATR PSYCH, V24, P829, DOI 10.1002/gps.2290; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hsieh MH, 2002, INT J GERIATR PSYCH, V17, P519, DOI 10.1002/gps.611; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Koolschijn PCMP, 2010, EUR NEUROPSYCHOPHARM, V20, P398, DOI 10.1016/j.euroneuro.2010.02.010; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lai TJ, 2000, BIOL PSYCHIAT, V48, P971, DOI 10.1016/S0006-3223(00)01042-8; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Lehfeld H, 1997, ALZ DIS ASSOC DIS, V11, pS39; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Masi G, 2011, CNS DRUGS, V25, P913, DOI 10.2165/11595900-000000000-00000; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; NEMEROFF CB, 2007, GUIDE TREATMENTS WOR, P271; OBrien JT, 1997, INT J GERIATR PSYCH, V12, P211, DOI 10.1002/(SICI)1099-1166(199702)12:2<211::AID-GPS558>3.0.CO;2-K; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; RIBEIZ SR, 2012, INT J GERIATR PSYCHI; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Sexton CE, 2012, AM J GERIATR PSYCHIA; Sexton CE, 2012, ARCH GEN PSYCHIAT, V69, P680, DOI 10.1001/archgenpsychiatry.2011.1862; Sheline YI, 2012, AM J PSYCHIAT, V169, P1185, DOI 10.1176/appi.ajp.2012.12010122; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; Steffens David C, 2002, Psychopharmacol Bull, V36, P58; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor WD, 2007, PSYCHOL MED, V37, P1763, DOI 10.1017/S0033291707000128; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001837	58	25	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80049	10.1371/journal.pone.0080049	http://dx.doi.org/10.1371/journal.pone.0080049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244606	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800113
J	Auld, SC; Click, ES; Heilig, CM; Miramontes, R; Cain, KP; Bisson, GP; Mac Kenzie, WR				Auld, Sara C.; Click, Eleanor S.; Heilig, Charles M.; Miramontes, Roque; Cain, Kevin P.; Bisson, Gregory P.; Mac Kenzie, William R.			Tuberculin Skin Test Result and Risk of Death among Persons with Active TB	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANERGY; CHILDREN; HIV; ADULTS; IMPACT; PERU	Background: Although the tuberculin skin test (TST) is frequently used to aid in the diagnosis of tuberculosis (TB) disease and to identify persons with latent TB infection, it is an imperfect test and approximately 10-25% of persons with microbiologically confirmed TB disease have a negative TST. Previous studies have suggested that persons with a negative TST are more likely to present with severe TB disease and have an increased rate of TB-related death. Methods: We analyzed culture-confirmed TB cases captured in US TB surveillance data from 1993 to 2008 and performed multivariate logistic regression analysis to determine the association between TST result and death. Results: Of 284,866 cases of TB reported in the US, 58,180 persons were eligible for inclusion in the analysis and 3,270 of those persons died after initiating TB treatment. Persons with a negative TST accounted for only 14% of the eligible cases but accounted for 42% of the deaths. Persons with a TST >= 15 mm had 67% lower odds of death than persons with a negative TST (adjusted odds ratio 0.33, 95% confidence interval 0.30-0.36). Conclusions: A negative TST is associated with an increased risk of death among persons with culture-confirmed TB disease, even after adjustment for HIV status, site of TB disease, sputum smear AFB status, drug susceptibility, age, sex, and origin of birth. In addition to indicating risk of developing disease, the TST may also be a marker for increased risk of death.	[Auld, Sara C.; Click, Eleanor S.; Heilig, Charles M.; Miramontes, Roque; Mac Kenzie, William R.] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; [Auld, Sara C.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Cain, Kevin P.] US Ctr Dis Control & Prevent, Kisumu, Kenya; [Bisson, Gregory P.] Univ Penn, Dept Med, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Pennsylvania; Pennsylvania Medicine	Auld, SC (corresponding author), US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	via1@cdc.gov	Heilig, Charles M/C-2753-2008; Kenzie, William R Mac/F-1528-2013	Heilig, Charles M/0000-0003-1075-1310; Kenzie, William R Mac/0000-0001-7723-0339; Miramontes, Roque/0000-0001-9535-460X	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention. No direct funding was received for this study. No funding bodies had any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 2000, MORBITIDITY MORTALIT, V49, P1; [Anonymous], 2012, RED BOOK 2012 REP CO, P736; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; CDC, 2008, REP TUB US 2008; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Daley CL, 1998, AM J RESP CRIT CARE, V157, P19, DOI 10.1164/ajrccm.157.1.9701111; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America September 1999, 2000, AM J RESP CRITICAL C, V161, P1376; Drobac PC, 2012, PEDIATRICS, V130, pE373, DOI 10.1542/peds.2011-3048; HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LEDWITH JW, 1961, AM REV RESPIR DIS, V84, P268; Lewinsohn DA, 2004, INT J TUBERC LUNG D, V8, P658; NASH DR, 1980, CHEST, V77, P32, DOI 10.1378/chest.77.1.32; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; Prevention CfDCa, 2009, REP VER CAS TUB RVCT; Qu HQ, 2011, INT J INFECT DIS, V15, pE305, DOI 10.1016/j.ijid.2011.01.004; Richardson RMA, 2012, SEMIN DIALYSIS, V25, P419, DOI 10.1111/j.1525-139X.2012.01093.x; Rooney Jr JJ, 1976, AM J MED, V60; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; STEAD WW, 1995, ANN INTERN MED, V122, P906, DOI 10.7326/0003-4819-122-12-199506150-00003; THYE T, 2009, PLOS ONE, V4; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; Zembrzuski VM, 2010, TUBERCULOSIS, V90, P44, DOI 10.1016/j.tube.2009.11.002	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78779	10.1371/journal.pone.0078779	http://dx.doi.org/10.1371/journal.pone.0078779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244358	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600058
J	Beaudrie, CEH; Satterfield, T; Kandlikar, M; Harthorn, BH				Beaudrie, Christian E. H.; Satterfield, Terre; Kandlikar, Milind; Harthorn, Barbara H.			Expert Views on Regulatory Preparedness for Managing the Risks of Nanotechnologies	PLOS ONE			English	Article							LAY JUDGMENTS; INTUITIVE TOXICOLOGY; CHEMICAL RISKS; SCIENTISTS; SAFETY; RESPONSIBILITY; ATTRIBUTION; PERCEPTIONS; SCIENCE	The potential and promise of nanotechnologies depends in large part on the ability for regulatory systems to assess and manage their benefits and risks. However, considerable uncertainty persists regarding the health and environmental implications of nanomaterials, hence the capacity for existing regulations to meet this challenge has been widely questioned. Here we draw from a survey (N=254) of US-based nano-scientists and engineers, environmental health and safety scientists, and regulatory scientists and decision-makers, to ask whether nano experts regard regulatory agencies as prepared for managing nanomaterial risks. We find that all three expert groups view regulatory agencies as unprepared. The effect is strongest for regulators themselves, and less so for scientists conducting basic, applied, or health and safety work on nanomaterials. Those who see nanotechnology risks as novel, uncertain, and difficult to assess are particularly likely to see agencies as unprepared. Trust in regulatory agencies, views of stakeholder responsibility regarding the management of risks, and socio-political values were also found to be small but significant drivers of perceived agency preparedness. These results underscore the need for new tools and methods to enable the assessment of nanomaterial risks, and to renew confidence in regulatory agencies' ability to oversee their growing use and application in society.	[Beaudrie, Christian E. H.; Satterfield, Terre; Kandlikar, Milind] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Kandlikar, Milind] Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V5Z 1M9, Canada; [Harthorn, Barbara H.] Univ Calif Santa Barbara, Natl Sci Fdn Ctr Nanotechnol Soc, Santa Barbara, CA 93106 USA	University of British Columbia; University of British Columbia; University of California System; University of California Santa Barbara	Beaudrie, CEH (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	christian.beaudrie@alumni.ubc.ca			U.S. National Science Foundation (NSF) [DBI-0830117]; U.S. Environmental Protection Agency (EPA); NSF [SES 0531184, SES 0938099]; Natural Sciences and Engineering Research Council of Canada (NSERC)	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Coop. Agreement DBI-0830117 from the U.S. National Science Foundation (NSF) and the U.S. Environmental Protection Agency (EPA) to the University of California Center for Environmental Implications of Nano-Technology; and by Coop. Agreements SES 0531184 and SES 0938099 from the NSF to the Center for Nanotechnology in Society at the University of California, Santa Barbara. Any opinions, findings, and conclusions or recommendations expressed in the material are those of the authors and do not necessarily reflect the views of the NSF or the EPA. This work has not been subjected to EPA review and no official endorsement should be inferred. The authors also thank the Natural Sciences and Engineering Research Council of Canada (NSERC) for their generous support through an Alexander Graham Bell Canada Graduate Scholarship (CGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudrie CEH, 2013, ENVIRON SCI TECHNOL, V47, P5524, DOI 10.1021/es303591x; Besley JC, 2008, J NANOPART RES, V10, P549, DOI 10.1007/s11051-007-9323-6; Burgman M, 2011, CONSERV LETT, V4, P81, DOI 10.1111/j.1755-263X.2011.00165.x; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Conti J, 2011, SOC STUD NAN EM TECH; Conti JA, 2008, ENVIRON SCI TECHNOL, V42, P3155, DOI 10.1021/es702158q; Corley EA, 2009, J NANOPART RES, V11, P1573, DOI 10.1007/s11051-009-9671-5; Engeman CD, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0749-0; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gaskell G, 2004, RISK ANAL, V24, P185, DOI 10.1111/j.0272-4332.2004.00421.x; Harthorn BH, 2007, NAN EM RISKS SOC RES; Ho SS, 2011, SCI COMMUN, V33, P167, DOI 10.1177/1075547010380386; Inc S.P.S.S, 2009, PASW STAT WIND VERS; IYENGAR S, 1989, AM J POLIT SCI, V33, P878, DOI 10.2307/2111113; KRAUS N, 1992, RISK ANAL, V12, P215, DOI 10.1111/j.1539-6924.1992.tb00669.x; KRINITZSKY EL, 1993, ENG GEOL, V33, P257, DOI 10.1016/0013-7952(93)90030-G; Lazo JK, 2000, RISK ANAL, V20, P179, DOI 10.1111/0272-4332.202019; MCDANIELS T, 1995, RISK ANAL, V15, P575, DOI 10.1111/j.1539-6924.1995.tb00754.x; Mertz CK, 1998, RISK ANAL, V18, P391, DOI 10.1111/j.1539-6924.1998.tb00353.x; Meyer M, 2006, RES POLICY, V35, P1646, DOI 10.1016/j.respol.2006.09.013; Morgan M G, 1995, Environ Sci Technol, V29, p468A, DOI [10.1021/es00010a753, 10.1021/es00010a003]; NEIL N, 1994, TOXICOL PATHOL, V22, P198, DOI 10.1177/019262339402200214; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; Powell MC, 2007, HEALTH RISK SOC, V9, P173, DOI 10.1080/13698570701306872; Renn O, 2006, J NANOPART RES, V8, P153, DOI 10.1007/s11051-006-9092-7; Rickard LN, 2011, HEALTH RISK SOC, V13, P527, DOI 10.1080/13698575.2011.613983; Risbey JS, 2002, B AM METEOROL SOC, V83, P1317, DOI 10.1175/1520-0477-83.9.1317; Risbey JS, 2000, CLIM RES, V16, P61, DOI 10.3354/cr016061; Rowe G, 2001, RISK ANAL, V21, P341, DOI 10.1111/0272-4332.212116; Savadori L, 2004, RISK ANAL, V24, P1289, DOI 10.1111/j.0272-4332.2004.00526.x; Scheufele DA, 2007, NAT NANOTECHNOL, V2, P732, DOI 10.1038/nnano.2007.392; Siegrist M, 2007, RISK ANAL, V27, P59, DOI 10.1111/j.1539-6924.2006.00859.x; Slovic P, 1995, RISK ANAL, V15, P661, DOI 10.1111/j.1539-6924.1995.tb01338.x; Slovic P, 1997, HUM EXP TOXICOL, V16, P289, DOI 10.1177/096032719701600601; Swierstra Tsjalling, 2007, NANOETHICS, V1, P3, DOI [10.1007/s11569-007-0005-8, DOI 10.1007/S11569-007-0005-8]; WEINER B, 1993, AM PSYCHOL, V48, P957, DOI 10.1037/0003-066X.48.9.957; Weiner B., 2005, SOCIAL MOTIVATION JU	38	16	18	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80250	10.1371/journal.pone.0080250	http://dx.doi.org/10.1371/journal.pone.0080250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244662	Green Published, gold			2022-12-27	WOS:000327221600196
J	Chen, H; Bai, M; Qi, XS; Liu, L; He, CY; Yin, ZX; Fan, DM; Han, GH				Chen, Hui; Bai, Ming; Qi, Xingshun; Liu, Lei; He, Chuangye; Yin, Zhanxin; Fan, Daiming; Han, Guohong			Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; POLYTETRAFLUOROETHYLENE-COVERED STENT; VASOPRESSIN RECEPTOR ANTAGONIST; SERUM SODIUM CONCENTRATION; MELD SCORE; MULTICENTER TRIAL; VEIN THROMBOSIS; LIVER-CIRRHOSIS; EARLY MORTALITY; WAITING-LIST	Background and Aim: Several models have been developed to predict survival in patients with cirrhosis undergoing TIPS; however, few of these models have gained widespread acceptance, especially in the era of covered stents. The aim of this study was to establish an evidence-based model for predicting survival after TIPS procedures. Methods: A total of 210 patients with cirrhosis treated with TIPS were considered in the study. We comprehensively investigated factors associated with one-year survival and developed a new predictive model using the Cox regression model. Results: In the multivariate analysis, the Child-Pugh score and serum sodium levels were independent predictors of one-year survival. A new score incorporating serum sodium into the Child-Pugh score was developed: Child-Na score. We compared the predictive accuracy of Child-Na score with that of other scores; only the Child-Na and MELD-Na scores had adequate predictive ability in patients with serum Na levels,138 mmol/L. The best Child-Na cut-off score (15.5) differentiated two groups of patients with distinct prognoses (one-year cumulative survival rates of 80.6% and 45.5%); this finding was confirmed in a validation cohort (n = 86). In a subgroup analysis stratifying patients by indication for TIPS, the Child-Na score distinguished patients with different prognoses. Conclusions: Patients with variceal bleeding and a Child-Na score <= 15 had a better prognosis than patients with a score >= 16. Patients with refractory ascites and a Child-Na score >= 16 had a high risk of death after the TIPS procedures; caution should be used when treating these patients with TIPS.	[Chen, Hui; Bai, Ming; Qi, Xingshun; Liu, Lei; He, Chuangye; Yin, Zhanxin; Han, Guohong] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Han, GH (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China.	guohhan@126.com	Qi, Xingshun/M-7063-2013	Qi, Xingshun/0000-0002-9448-6739; Liu, Lei/0000-0002-3570-2219				Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; Angermayr B, 2003, HEPATOLOGY, V38, P1043, DOI 10.1053/jhep.2003.50423; Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; Barrio J, 2005, EUR J RADIOL, V55, P120, DOI 10.1016/j.ejrad.2004.10.007; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Brensing KA, 2002, EUR J GASTROEN HEPAT, V14, P723, DOI 10.1097/00042737-200207000-00003; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Bureau C, 2007, LIVER INT, V27, P742, DOI 10.1111/j.1478-3231.2007.01522.x; Bureau C, 2011, J HEPATOL, V54, P901, DOI 10.1016/j.jhep.2010.08.025; Chalasani N, 2000, GASTROENTEROLOGY, V118, P138, DOI 10.1016/S0016-5085(00)70422-7; Charon JPM, 2004, J VASC INTERV RADIOL, V15, P1219, DOI 10.1097/01.RVI.0000137434.19522.E5; Chen H, 2013, THROMB RES, V131, P173, DOI 10.1016/j.thromres.2012.11.003; Gaba RC, 2013, J VASC INTERV RADIOL, V24, P411, DOI 10.1016/j.jvir.2012.10.026; Gerbes AL, 2003, GASTROENTEROLOGY, V124, P933, DOI 10.1053/gast.2003.50143; Giannini E, 2004, LIVER INT, V24, P465, DOI 10.1111/j.1478-3231.2004.0949.x; Han GH, 2011, J HEPATOL, V54, P78, DOI 10.1016/j.jhep.2010.06.029; Hausegger KA, 2004, J VASC INTERV RADIOL, V15, P239, DOI 10.1097/01.RVI.0000116194.44877.C1; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Maleux G, 2004, EUR RADIOL, V14, P1842, DOI 10.1007/s00330-004-2359-4; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Montgomery A, 2005, CARDIOVASC INTER RAD, V28, P307, DOI 10.1007/s00270-004-0145-y; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Qi XS, 2012, DIGEST DIS SCI, V57, P1072, DOI 10.1007/s10620-011-1975-5; Reuben A, 2002, HEPATOLOGY, V35, P244, DOI 10.1053/jhep.2002.0350244; RUBIN RA, 1995, AM J GASTROENTEROL, V90, P556; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Schepke M, 2003, AM J GASTROENTEROL, V98, P1167, DOI 10.1016/S0002-9270(03)00295-8; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Thompson C, 2012, BEST PRACT RES CL EN, V26, pS1, DOI 10.1016/S1521-690X(12)00019-X; Vignali C, 2005, AM J ROENTGENOL, V185, P472, DOI 10.2214/ajr.185.2.01850472; Wong F, 2003, HEPATOLOGY, V37, P182, DOI 10.1053/jhep.2003.50021	33	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79637	10.1371/journal.pone.0079637	http://dx.doi.org/10.1371/journal.pone.0079637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244533	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600141
J	Haack, KKV; Mitra, AK; Zucker, IH				Haack, Karla K. V.; Mitra, Amit K.; Zucker, Irving H.			NF-kappa B and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; SMOOTH-MUSCLE-CELLS; HEART-FAILURE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CAMP-RESPONSE; HYDROXYLASE GENE; OXIDATIVE STRESS; ACTIVATION; KINASE	Nuclear factor kappa B (NF-kappa B) and the Ets like gene-1 (Elk-1) are two transcription factors that have been previously established to contribute to the Angiotensin II mediated upregulation of Angiotensin II type 1 receptor (AT1R) in neurons. The cAMP response element binding protein (CREB) is another transcription factor that has also been implicated in AT1R gene transcription. The goal of the current study was to determine if NF-kappa B and CREB association was required for AT1R upregulation. We hypothesized that the transcription of the AT1R gene occurs via an orchestration of transcription factor interactions including NF-kappa B, CREB, and Elk-1. The synergistic role of CREB and NF-kappa B in promoting AT1R gene expression was determined using siRNA-mediated silencing of CREB. Electrophorectic Mobility Shift Assay studies employing CREB and NF-kappa B demonstrated increased protein - DNA binding as a result of Ang II stimulation which was blunted by siRNA silencing of CREB. Upstream inhibition of p38 mitogen activated protein kinase (p38 MAPK) with SB203580 or inhibition of the calmodulin kinase (CAMK) pathway using KN-62 blunted changes in CREB and NF-kappa B expression. These findings suggest that Ang II may activate multiple signaling pathways involving p38 MAPK leading to the activation of NF-kappa B and CREB, which feed back to upregulate the AT1R gene. This study provides insight into the molecular mechanisms involving multiple transcription factor activation in a coordinated fashion which may be partially responsible for sympathoexcitation in clinical conditions associated with increased activation of the renin angiotensin system.	[Haack, Karla K. V.; Mitra, Amit K.; Zucker, Irving H.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Zucker, IH (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.	izucker@unmc.edu			National Heart, Lung and Blood Institute [PO-1 62222]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062222] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Heart, Lung and Blood Institute Grant PO-1 62222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Blume A, 1999, J MOL MED, V77, P339, DOI 10.1007/s001090050360; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Coven E, 1998, J NEUROCHEM, V71, P1865; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Ganea D, 2003, CURR PHARM DESIGN, V9, P997, DOI 10.2174/1381612033455116; Gao L, 2008, HYPERTENSION, V52, P708, DOI 10.1161/HYPERTENSIONAHA.108.116228; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Haack KKV, 2012, HYPERTENSION, V60, P354, DOI 10.1161/HYPERTENSIONAHA.112.195693; Ju HS, 2003, J PHARMACOL EXP THER, V307, P932, DOI 10.1124/jpet.103.057422; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; La Porta CAM, 1998, ANTICANCER RES, V18, P2591; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Li JY, 1996, MOL ENDOCRINOL, V10, P252, DOI 10.1210/me.10.3.252; Liu DM, 2008, CIRC RES, V103, P186, DOI 10.1161/CIRCRESAHA.108.179408; Liu DM, 2006, CIRC RES, V99, P1004, DOI 10.1161/01.RES.0000247066.19878.93; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Schmeisser A, 2004, BIOCHEM BIOPH RES CO, V325, P532, DOI 10.1016/j.bbrc.2004.10.059; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; STECKELINGS U, 1992, J CARDIOVASC PHARM, V19, pS72, DOI 10.1097/00005344-199219006-00012; Stefano L, 2006, J NEUROCHEM, V97, P92, DOI 10.1111/j.1471-4159.2006.03749.x; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Swanson DJ, 1998, J BIOL CHEM, V273, P24065, DOI 10.1074/jbc.273.37.24065; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; WALKER WH, 1995, ENDOCRINOLOGY, V136, P3534, DOI 10.1210/en.136.8.3534; Widnell KL, 1996, J NEUROCHEM, V66, P1770; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Yoshimoto T, 2005, HYPERTENS RES, V28, P165, DOI 10.1291/hypres.28.165; Zucker IH, 2009, AM J PHYSIOL-HEART C, V297, pH1557, DOI 10.1152/ajpheart.00073.2009	43	33	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78695	10.1371/journal.pone.0078695	http://dx.doi.org/10.1371/journal.pone.0078695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244341	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600050
J	Lesser, MP; Slattery, M				Lesser, Michael P.; Slattery, Marc			Ecology of Caribbean Sponges: Are Top-Down or Bottom-Up Processes More Important?	PLOS ONE			English	Article							PREDATORY REEF FISH; CORAL-REEF; CALLYSPONGIA-VAGINALIS; COMMUNITY REGULATION; CHEMICAL DEFENSES; PHASE-SHIFTS; DIVERSITY; ABUNDANCE; GROWTH; WATER	Benthic-pelagic coupling and the role of bottom-up versus top-down processes are recognized as having a major impact on the structure of marine communities. While the roles of bottom-up processes are better appreciated they are still viewed as principally affecting the outcome of top-down processes. Sponges on coral reefs are important members of the benthic community and provide a critically important functional linkage between water-column productivity and the benthos. As active suspension feeders sponges utilize the abundant autotrophic and heterotrophic picoplankton in the water column. As a result sponges across the Caribbean basin exhibit a consistent and significant pattern of greater biomass, tube extension rate, and species numbers with increasing depth. Likewise, the abundance of their food supply also increases along a depth gradient. Using experimental manipulations it has recently been reported that predation is the primary determinant of sponge community structure. Here we provide data showing that the size and growth of the sponge Callyspongia vaginalis are significantly affected by food availability. Sponges increased in size and tube extension rate with increasing depth down to 46 m, while simultaneously exposed to the full range of potential spongivores at all depths. Additionally, we point out important flaws in the experimental design used to demonstrate the role of predation and suggest that a resolution of this important question will require well-controlled, multi-factorial experiments to examine the independent and interactive effects of predation and food abundance on the ecology of sponges.	[Lesser, Michael P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Slattery, Marc] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA	University System Of New Hampshire; University of New Hampshire; University of Mississippi	Lesser, MP (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	mpl@unh.edu			Caribbean Coral Reef Ecosystems program at the Smithsonian Institute; NOAAs National Institute of Undersea Science and Technology; National Science Foundation	Caribbean Coral Reef Ecosystems program at the Smithsonian Institute; NOAAs National Institute of Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF))	This project was funded by grants from the Caribbean Coral Reef Ecosystems program at the Smithsonian Institute, NOAAs National Institute of Undersea Science and Technology and the National Science Foundation. The funders had no role in the design of study, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the views of the Smithsonian Institute, National Oceanic and Atmospheric Administration, their sub agencies or the National Science Foundation.	Alcolado P.M., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P297; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Cardoso Sonia C., 2009, Marine Biodiversity Records, V2, pe148, DOI 10.1017/S1755267209990662; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Connell SD, 1997, J EXP MAR BIOL ECOL, V213, P181, DOI 10.1016/S0022-0981(96)02773-6; Diamond J., 1986, COMMUNITY ECOL, P3; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; DUFFY JE, 1992, OECOLOGIA, V90, P333, DOI 10.1007/BF00317689; Erwin PM, 2007, J MAR BIOL ASSOC UK, V87, P1683, DOI 10.1017/S0025315407058213; Fiore CL, 2010, INVERTEBR BIOL, V129, P105, DOI 10.1111/j.1744-7410.2010.00184.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V24, P105, DOI 10.1007/BF00001281; Hughes T, 1999, LIMNOL OCEANOGR, V44, P1583; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Lehnert Helmut, 1999, Memoirs of the Queensland Museum, V44, P307; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Liddell W.D., 1997, P 8 INT COR REEF S P, V1, P437; Lopez-Legentil S, 2010, SCI MAR, V74, P445, DOI 10.3989/scimar.2010.74n3445; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; PALUMBI SR, 1986, ECOLOGY, V67, P208, DOI 10.2307/1938520; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pawlik J.R., 1997, P1255; Pawlik JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062573; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Perea-Blazquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029569; Pile A.J., 1997, P1403; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Reed John K., 1997, P1387; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; Rutzler K, 1982, SMITHSON CONTRIB MAR, V12, P9; Schmahl G. P., 1990, NEW PERSPECTIVES SPO, P384; Slattery M, 2001, MAR BIOL, V138, P1183; Slattery M, 2012, P 12 INT COR REEF S; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Steele MA, 1996, J EXP MAR BIOL ECOL, V198, P249, DOI 10.1016/0022-0981(96)00011-1; Suchanek TH, 1984, S SERIES UNDERSEA RE, P55; Thoms Carsten, 2007, V28, P627; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WILKINSON CR, 1979, J EXP MAR BIOL ECOL, V37, P91, DOI 10.1016/0022-0981(79)90028-5; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1990, MAR ECOL PROG SER, V67, P285, DOI 10.3354/meps067285; WILKINSON CR, 1987, SCIENCE, V236, P1654, DOI 10.1126/science.236.4809.1654; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Wulff JL, 2005, J ANIM ECOL, V74, P313, DOI 10.1111/j.1365-2656.2005.00925.x; Wulff JL, 1997, MAR BIOL, V129, P41, DOI 10.1007/s002270050144	87	48	48	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79799	10.1371/journal.pone.0079799	http://dx.doi.org/10.1371/journal.pone.0079799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244563	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600152
J	Martinez-Garcia, PJ; Parfitt, DE; Bostock, RM; Fresnedo-Ramirez, J; Vazquez-Lobo, A; Ogundiwin, EA; Gradziel, TM; Crisosto, CH				Martinez-Garcia, Pedro J.; Parfitt, Dan E.; Bostock, Richard M.; Fresnedo-Ramirez, Jonathan; Vazquez-Lobo, Alejandra; Ogundiwin, Ebenezer A.; Gradziel, Thomas M.; Crisosto, Carlos H.			Application of Genomic and Quantitative Genetic Tools to Identify Candidate Resistance Genes for Brown Rot Resistance in Peach	PLOS ONE			English	Article							PRUNUS-PERSICA L.; MONILINIA-FRUCTICOLA; PECTIN METHYLESTERASE; IDENTIFICATION; INFECTIONS; PATHOGENS; PROTEINS; QUALITY; SNPS	The availability of a complete peach genome assembly and three different peach genome sequences created by our group provide new opportunities for application of genomic data and can improve the power of the classical Quantitative Trait Loci (QTL) approaches to identify candidate genes for peach disease resistance. Brown rot caused by Monilinia spp., is the most important fungal disease of stone fruits worldwide. Improved levels of peach fruit rot resistance have been identified in some cultivars and advanced selections developed in the UC Davis and USDA breeding programs. Whole genome sequencing of the Pop-DF parents lead to discovery of high-quality SNP markers for QTL genome scanning in this experimental population. Pop-DF created by crossing a brown rot moderately resistant cultivar 'Dr. Davis' and a brown rot resistant introgression line, 'F8,1-42', derived from an initial almond x peach interspecific hybrid, was evaluated for brown rot resistance in fruit of harvest maturity over three seasons. Using the SNP linkage map of Pop-DF and phenotypic data collected with inoculated fruit, a genome scan for QTL identified several SNP markers associated with brown rot resistance. Two of these QTLs were placed on linkage group 1, covering a large (physical) region on chromosome 1. The genome scan for QTL and SNP effects predicted several candidate genes associated with disease resistance responses in other host-pathogen systems. Two potential candidate genes, ppa011763m and ppa026453m, may be the genes primarily responsible for M. fructicola recognition in peach, activating both PAMP-triggered immunity (PTI) and effector-triggered immunity (ETI) responses. Our results provide a foundation for further genetic dissection, marker assisted breeding for brown rot resistance, and development of peach cultivars resistant to brown rot.	[Martinez-Garcia, Pedro J.; Parfitt, Dan E.; Fresnedo-Ramirez, Jonathan; Ogundiwin, Ebenezer A.; Gradziel, Thomas M.; Crisosto, Carlos H.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Bostock, Richard M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Vazquez-Lobo, Alejandra] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	University of California System; University of California Davis; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Martinez-Garcia, PJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	pjmartinezgarcia@ucdavis.edu	Fresnedo-Ramírez, Jonathan/C-2811-2011; Martinez-Garcia, Pedro Jose/AAK-1814-2020; Vazquez-Lobo, Alejandra/HDO-0323-2022	Fresnedo-Ramírez, Jonathan/0000-0003-1985-2513; Martinez-Garcia, Pedro Jose/0000-0002-7647-5235; Vazquez-Lobo, Alejandra/0000-0002-7828-1653; Gradziel, Thomas/0000-0002-2206-3438	California Cling Peach Board; University of California ANR Core Issues program; National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2008-35300-04432]; University of California Agricultural Experiment Station; USDA-Cooperative State Research, Education, and Extension Service	California Cling Peach Board; University of California ANR Core Issues program(French National Research Agency (ANR)); National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA); University of California Agricultural Experiment Station(University of California System); USDA-Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research supported by grants from the California Cling Peach Board, the University of California ANR Core Issues program, the National Research Initiative of the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) grant #2008-35300-04432, and funds from the University of California Agricultural Experiment Station and USDA-Cooperative State Research, Education, and Extension Service.	Adaskaveg JE, 2005, PHYTOPATHOLOGY, V95, pS140; Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; [Anonymous], 1989, JMP VERS 7; Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189; Bostock RM, 1994, CENTRAL VALLER POSTH, V3, P16; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Cantoni L., 1996, Rivista di Frutticoltura e di Ortofloricoltura, V58, P59; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; FELICIANO A, 1987, PHYTOPATHOLOGY, V77, P776, DOI 10.1094/Phyto-77-776; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; GRADZIEL TM, 1994, HORTSCIENCE, V29, P33, DOI 10.21273/HORTSCI.29.1.33; Gradziel TM, 2003, ACTA HORTIC, P249, DOI 10.17660/ActaHortic.2003.622.22; GRADZIEL TM, 1993, J AM SOC HORTIC SCI, V118, P675, DOI 10.21273/JASHS.118.5.675; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; He CZ, 1999, MOL PLANT MICROBE IN, V12, P1064, DOI 10.1094/MPMI.1999.12.12.1064; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Lee MH, 2010, MOL PLANT MICROBE IN, V23, P176, DOI 10.1094/MPMI-23-2-0176; Lytle BL, 2009, PROTEINS, V76, P237, DOI 10.1002/prot.22396; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P19, DOI 10.1007/s11295-012-0522-7; Martinez-Garcia PJ, 2013, PLANT MOL BIOL, V81, P161, DOI 10.1007/s11103-012-9989-8; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; NESSLER CL, 1985, PLANT PHYSIOL, V79, P499, DOI 10.1104/pp.79.2.499; Ogawa J., 1991, U CALIFORNIA DIV AGR, V3345, P461; Ogawa JM, 1985, MANAGEMENT BROWN ROT, P5; Ogundiwin EA, 2008, P 4 INT ROS GEN C PU; Padmanabhan MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003235; Prusky D, 2007, FEMS MICROBIOL LETT, V268, P1, DOI 10.1111/j.1574-6968.2006.00603.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Ooijen JW, 1997, ADV BIOM GEN P 10 M; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wietholter N, 2003, MOL PLANT MICROBE IN, V16, P945, DOI 10.1094/MPMI.2003.16.10.945; Zimaro T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/354801; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; ZUCKERKANDL EMILE, 1965, P97	47	47	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78634	10.1371/journal.pone.0078634	http://dx.doi.org/10.1371/journal.pone.0078634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244329	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600039
J	Meyer, MR; Fredette, NC; Barton, M; Prossnitz, ER				Meyer, Matthias R.; Fredette, Natalie C.; Barton, Matthias; Prossnitz, Eric R.			Regulation of Vascular Smooth Muscle Tone by Adipose-Derived Contracting Factor	PLOS ONE			English	Article							SLOW-REACTING SUBSTANCE; ANTI-INFLAMMATORY DRUGS; HIGH-FAT DIET; GENE-EXPRESSION; DEPENDENT VASOCONSTRICTION; ENDOTHELIAL DYSFUNCTION; ARACHIDONIC-ACID; PERIVASCULAR FAT; RELAXING FACTOR; KNOCKOUT MICE	Obesity and arterial hypertension, important risk factors for atherosclerosis and coronary artery disease, are characterized by an increase in vascular tone. While obesity is known to augment vasoconstrictor prostanoid activity in endothelial cells, less is known about factors released from fat tissue surrounding arteries (perivascular adipose). Using lean controls and mice with either monogenic or diet-induced obesity, we set out to determine whether and through which pathways perivascular adipose affects vascular tone. We unexpectedly found that in the aorta of obese mice, perivascular adipose potentiates vascular contractility to serotonin and phenylephrine, indicating activity of a factor generated by perivascular adipose, which we designated "adipose-derived contracting factor" (ADCF). Inhibition of cyclooxygenase (COX) fully prevented ADCF-mediated contractions, whereas COX-1 or COX-2-selective inhibition was only partially effective. By contrast, inhibition of superoxide anions, NO synthase, or endothelin receptors had no effect on ADCF activity. Perivascular adipose as a source of COX-derived ADCF was further confirmed by detecting increased thromboxane A(2) formation from perivascular adipose-replete aortae from obese mice. Taken together, this study identifies perivascular adipose as a novel regulator of arterial vasoconstriction through the release of COX-derived ADCF. Excessive ADCF activity in perivascular fat under obese conditions likely contributes to increased vascular tone by antagonizing vasodilation. ADCF may thus propagate obesity-dependent hypertension and the associated increased risk in coronary artery disease, potentially representing a novel therapeutic target.	[Meyer, Matthias R.; Fredette, Natalie C.; Prossnitz, Eric R.] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Barton, Matthias] Univ Zurich, Zurich, Switzerland	University of New Mexico; University of New Mexico's Health Sciences Center; University of Zurich	Barton, M (corresponding author), Univ Zurich, Zurich, Switzerland.	barton@access.uzh.ch; eprossnitz@salud.unm.edu	Prossnitz, Eric R./B-4543-2008; Prossnitz, Eric/I-4599-2019	Prossnitz, Eric/0000-0001-9190-8302; Meyer, Matthias/0000-0003-3206-3244	NIH [R01 CA127731, CA163890, T32 HL07736]; Dedicated Health Research Funds of the University of New Mexico School of Medicine; Swiss National Science Foundation [135874, 141501, 108258, 122504]; NATIONAL CANCER INSTITUTE [R01CA163890, R01CA127731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007736] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dedicated Health Research Funds of the University of New Mexico School of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH (R01 CA127731 and CA163890 to ERP), Dedicated Health Research Funds of the University of New Mexico School of Medicine allocated to the Signature Program in Cardiovascular and Metabolic Disease (to ERP), and the Swiss National Science Foundation (grants 135874 & 141501 to MRM and 108258 & 122504 to MB). NCF was supported by an NIH training grant T32 HL07736. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh R, 2012, ANN MED, V44, pS74, DOI 10.3109/07853890.2012.663928; BAILEY JM, 1979, ATHEROSCLEROSIS, V32, P195; Baretella O, 2013, PFLUGERS ARCH, DOI [10.1007/s00424-00013-01323-z, DOI 10.1007/S00424-00013-01323-Z]; Barton M, 2000, HYPERTENSION, V35, P329, DOI 10.1161/01.HYP.35.1.329; Barton M, 2013, CURR OPIN PHARMACOL, V13, P226, DOI 10.1016/j.coph.2013.05.005; Barton M, 2012, BRIT J PHARMACOL, V165, P591, DOI 10.1111/j.1476-5381.2011.01472.x; BERRY PA, 1964, BRIT J PHARM CHEMOTH, V23, P201, DOI 10.1111/j.1476-5381.1964.tb01579.x; Campbell DH, 1940, J IMMUNOL, V39, P103; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; Cardillo C, 2004, HYPERTENSION, V43, P36, DOI 10.1161/01.HYP.0000103868.45064.81; Chang L, 2013, CIRC J, V77, P11, DOI 10.1253/circj.CJ-12-1393; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; CHIOU WL, 1978, J PHARMACOKINET BIOP, V6, P539, DOI 10.1007/BF01062108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEMEY JG, 1982, CIRC RES, V51, P439, DOI 10.1161/01.RES.51.4.439; Eringa EC, 2012, VASC PHARMACOL, V56, P204, DOI 10.1016/j.vph.2012.02.003; Farb MG, 2013, OBESITY SIL IN PRESS, DOI [10.1002/oby.20505, DOI 10.1002/0BY.20505]; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; FERREIRA SH, 1974, BRIT J PHARMACOL, V50, P543, DOI 10.1111/j.1476-5381.1974.tb08587.x; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Ghiadoni L, 2008, HYPERTENSION, V51, P440, DOI 10.1161/HYPERTENSIONAHA.107.103093; Gollasch M, 2012, BRIT J PHARMACOL, V165, P633, DOI 10.1111/j.1476-5381.2011.01430.x; Goodwill AG, 2008, AM J PHYSIOL-HEART C, V295, pH1522, DOI 10.1152/ajpheart.00596.2008; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; GRYGLEWSKI R, 1972, BRIT J PHARMACOL, V46, P449, DOI 10.1111/j.1476-5381.1972.tb08142.x; GRYGLEWSKI R, 1972, BRIT J PHARMACOL, V45, P37, DOI 10.1111/j.1476-5381.1972.tb09574.x; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005; Kellaway CH, 1940, Q J EXP PHYSIOL CMS, V30, P121; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Ma LQ, 2010, HYPERTENS RES, V33, P446, DOI 10.1038/hr.2010.11; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Meyer MR, 2012, LIFE SCI, V91, P623, DOI 10.1016/j.lfs.2012.01.007; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; NIJKAMP FP, 1976, NATURE, V263, P479, DOI 10.1038/263479a0; Ohman MK, 2011, ATHEROSCLEROSIS, V219, P33, DOI 10.1016/j.atherosclerosis.2011.07.012; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; PIPER PJ, 1969, NATURE, V223, P29, DOI 10.1038/223029a0; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Sharma G, 2013, ENDOCRINOLOGY, V154, P4136, DOI 10.1210/en.2013-1357; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith AD, 2006, PROSTAG LEUKOTR ESS, V75, P43, DOI 10.1016/j.plefa.2006.03.008; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Traupe T, 2002, CLIN SCI, V103, p13S, DOI 10.1042/CS103S013S; Traupe T, 2002, J HYPERTENS, V20, P2239, DOI 10.1097/00004872-200211000-00024; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Xu JW, 2012, MOL BIOL REP, V39, P8177, DOI 10.1007/s11033-012-1665-1; Xu L, 2007, PROSTAG OTH LIPID M, V83, P213, DOI 10.1016/j.prostaglandins.2007.01.009; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	69	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79245	10.1371/journal.pone.0079245	http://dx.doi.org/10.1371/journal.pone.0079245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244459	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600119
J	Ouedraogo, A; Tiono, AB; Kargougou, D; Yaro, JB; Ouedraogo, E; Kabore, Y; Kangoye, D; Bougouma, EC; Gansane, A; Henri, N; Diarra, A; Sanon, S; Soulama, I; Konate, AT; Watson, NL; Brown, V; Hendriks, J; Pau, MG; Versteege, I; Wiesken, E; Sadoff, J; Nebie, I; Sirima, SB				Ouedraogo, Alphonse; Tiono, Alfred B.; Kargougou, Desire; Yaro, Jean Baptiste; Ouedraogo, Esperance; Kabore, Youssouf; Kangoye, David; Bougouma, Edith C.; Gansane, Adama; Henri, Noelie; Diarra, Amidou; Sanon, Souleymane; Soulama, Issiaka; Konate, Amadou T.; Watson, Nora L.; Brown, Valerie; Hendriks, Jenny; Pau, Maria Grazia; Versteege, Isabella; Wiesken, Edison; Sadoff, Jerald; Nebie, Issa; Sirima, Sodiomon B.			A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM ANTIGENS; HEPARAN-SULFATE PROTEOGLYCANS; CYTOTOXIC T-CELLS; RECOMBINANT ADENOVIRUS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; ORAL SALMONELLA; PROTEIN; PROTECTION; VECTORS	Background: Ad35.CS.01 is a pre-erythrocytic malaria candidate vaccine. It is a codon optimized nucleotide sequence representing the P. falciparum circumsporozoite (CS) surface antigen inserted in a replication deficient Adenovirus 35 backbone. A Phase 1a trial has been conducted in the USA in nave adults and showed that the vaccine was safe. The aim of this study is to assess the safety and immunogenicity of ascending dosages in sub Saharan Africa. Methods: A double blind, randomized, controlled, dose escalation, phase Ib trial was conducted in a rural area of Balonghin, the Sapone health district (Burkina Faso). Forty-eight healthy adults aged 18-45 years were randomized into 4 cohorts of 12 to receive three vaccine doses (day 0, 28 and 84) of 10(9), 10(10), 5X10(10), 10(11) vp of Ad35.CS.01 or normal saline by intra muscular injection. Subjects were monitored carefully during the 14 days following each vaccination for non serious adverse events. Severe and serious adverse events were collected throughout the participant study duration (12 months from the first vaccination). Humoral and cellular immune responses were measured on study days 0, 28, 56, 84, 112 and 140. Results: Of the forty-eight subjects enrolled, forty-four (91.7%) received all three scheduled vaccine doses. Local reactions, all of mild severity, occurred in thirteen (27.1%) subjects. Severe (grade 3) laboratory abnormalities occurred in five (10.4%) subjects. One serious adverse event was reported and attributed to infection judged unrelated to vaccine. The vaccine induced both antibody titers and CD8 T cells producing IFN gamma and TNF alpha with specificity to CS while eliciting modest neutralizing antibody responses against Ad35. Conclusion: Study vaccine Ad35.CS.01 at four different dose levels was well-tolerated and modestly immunogenic in this population. These results suggest that Ad35.CS.01 should be further investigated for preliminary efficacy in human challenge models and as part of heterologous prime-boost vaccination strategies.	[Ouedraogo, Alphonse; Tiono, Alfred B.; Kargougou, Desire; Yaro, Jean Baptiste; Ouedraogo, Esperance; Kabore, Youssouf; Kangoye, David; Bougouma, Edith C.; Gansane, Adama; Henri, Noelie; Diarra, Amidou; Sanon, Souleymane; Soulama, Issiaka; Konate, Amadou T.; Nebie, Issa; Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Watson, Nora L.; Brown, Valerie] EMMES Corp, Rockville, MD USA; [Hendriks, Jenny; Pau, Maria Grazia; Versteege, Isabella; Wiesken, Edison; Sadoff, Jerald] Crucell Holland BV, Leiden, Netherlands; [Sirima, Sodiomon B.] Grp Act & Rech Sante, Ouagadougou, Burkina Faso	Emmes Corporation; Johnson & Johnson	Sirima, SB (corresponding author), Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	SOULAMA, Issiaka/Z-1254-2019; OUEDRAOGO, Alphonse/F-7859-2019	SOULAMA, Issiaka/0000-0002-0993-0525; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Nebie, Issa/0000-0003-3051-3600; Tiono, B. Alfred/0000-0002-5104-3946; Ouedraogo, Alphonse/0000-0002-3520-6637	NIAID/DMID [HHSN266200400016C]; DMID [N01-AI05421]; NIAID, NIH, Bethesda; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005421] Funding Source: NIH RePORTER	NIAID/DMID; DMID; NIAID, NIH, Bethesda; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIAID/DMID contract# HHSN266200400016C to NMIMR with a subcontract to CNRFP. Ad35.CS.01 vaccine product was produced by Crucell Holland BV, Leiden under DMID-supported contract N01-AI05421, NIAID, NIH, Bethesda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Ballou WR, 2002, CHEM IMMUNOL, V80, P253; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gantt SM, 1997, J BIOL CHEM, V272, P19205, DOI 10.1074/jbc.272.31.19205; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Hoft DF, 2012, VACCINE, V30, P2098, DOI 10.1016/j.vaccine.2012.01.048; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; John CC, 2008, J INFECT DIS, V197, P519, DOI 10.1086/526787; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Kostense S, 2011, CLIN VACCINE IMMUNOL, V18, P776, DOI 10.1128/CVI.00547-10; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rea D, 2001, J IMMUNOL, V166, P5236, DOI 10.4049/jimmunol.166.8.5236; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; SADOFF JC, 1988, SCIENCE, V240, P336, DOI 10.1126/science.3281260; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Sultan A A, 1999, Int Microbiol, V2, P155; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003	40	34	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78679	10.1371/journal.pone.0078679	http://dx.doi.org/10.1371/journal.pone.0078679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244339	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600048
J	Sempo, G; Canonge, S; Deneubourg, JL				Sempo, Gregory; Canonge, Stephane; Deneubourg, Jean-Louis			From Aggregation to Dispersion: How Habitat Fragmentation Prevents the Emergence of Consensual Decision Making in a Group	PLOS ONE			English	Article							PUBLIC INFORMATION; SHELTER SELECTION; SOCIAL-BEHAVIOR; COCKROACH; DYNAMICS; INTEGRATION; SETTLEMENT; DENSITY; PATTERN	In fragmented landscape, individuals have to cope with the fragmentation level in order to aggregate in the same patch and take advantage of group-living. Aggregation results from responses to environmental heterogeneities and/or positive influence of the presence of congeners. In this context, the fragmentation of resting sites highlights how individuals make a compromise between two individual preferences: (1) being aggregated with conspecifics and (2) having access to these resting sites. As in previous studies, when the carrying capacity of available resting sites is large enough to contain the entire group, a single aggregation site is collectively selected. In this study, we have uncoupled fragmentation and habitat loss: the population size and total surface of the resting sites are maintained at a constant value, an increase in fragmentation implies a decrease in the carrying capacity of each shelter. For our model organism, Blattella germanica, our experimental and theoretical approach shows that, for low fragmentation level, a single resting site is collectively selected. However, for higher level of fragmentation, individuals are randomly distributed between fragments and the total sheltered population decreases. In the latter case, social amplification process is not activated and consequently, consensual decision making cannot emerge and the distribution of individuals among sites is only driven by their individual propensity to find a site. This intimate relation between aggregation pattern and landscape patchiness described in our theoretical model is generic for several gregarious species. We expect that any group-living species showing the same structure of interactions should present the same type of dispersion-aggregation response to fragmentation regardless of their level of social complexity.	[Sempo, Gregory; Canonge, Stephane; Deneubourg, Jean-Louis] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Sempo, G (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	gsempo@ulb.ac.be			ARC; FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture)	ARC(Australian Research Council); FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	GS is supported by the project ARC: Individual and collective issues in dispersal and aggregation: from proximal causes to ultimate consequences at contrasting scales. SC was funded by a PhD grant from FRIA (Fonds pour la Recherche dans l'Industrie et dans l'Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Ame JM, 2006, LECT NOTES COMPUT SC, V4095, P713; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; Bell W. J., 2007, COCKROACHES ECOLOGY; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Breithaupt T, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P1, DOI 10.1007/978-0-387-77101-4; Brown C. R., 1996, COLONIALITY CLIFF SW; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Canonge S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019748; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Childress MJ, 2001, ANIM BEHAV, V62, P465, DOI 10.1006/anbe.2001.1760; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Danchin E, 1998, ECOLOGY; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; EGGLESTON DB, 1992, ECOLOGY, V73, P992, DOI 10.2307/1940175; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; Fraenkel GS, 1961, ORIENTATION ANIMALS; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Giraldeau L.A., 2000, MG BEH ECOL; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Heinrich B., 1981, INSECT THERMOREGULAT, P159; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2007, AM NAT, V170, P47, DOI 10.1086/518570; Krause J, 2002, LIVING GROUPS; Lihoreau M, 2012, INSECT SOC, V59, P1; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; MEYER DJ, 1981, J NEUROBIOL, V12, P93, DOI 10.1002/neu.480120109; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; MOTE MI, 1970, J EXP ZOOL, V173, P137, DOI 10.1002/jez.1401730203; Muller KL, 1998, ANIM BEHAV, V56, P479, DOI 10.1006/anbe.1998.0806; Nichols J., 2001, DISPERSAL; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; RIVAULT C, 1990, J ETHOL, V8, P53, DOI 10.1007/BF02350274; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sempo G, 2006, LECT NOTES COMPUT SC, V4095, P703; Sempo G, 2013, J APPL ECOL, V50, P1081, DOI 10.1111/1365-2664.12140; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stamps J, 2005, ECOLOGY, V86, P2860, DOI 10.1890/05-0290; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; VanVuren D, 1996, ETHOLOGY, V102, P686; Vasquez RA, 2000, P ROY SOC B-BIOL SCI, V267, P157, DOI 10.1098/rspb.2000.0981; Wang Z, 2012, SCI REPORTS, V2; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	62	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78951	10.1371/journal.pone.0078951	http://dx.doi.org/10.1371/journal.pone.0078951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244392	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600085
J	Wang, YC; Chen, SL; Deng, NY; Wang, Y				Wang, Yongcui; Chen, Shilong; Deng, Naiyang; Wang, Yong			Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data	PLOS ONE			English	Article							PROTEIN FUNCTION; PREDICTION; SEQUENCE; IDENTIFICATION; KNOWLEDGEBASE	Computational inference of novel therapeutic values for existing drugs, i.e., drug repositioning, offers the great prospect for faster and low-risk drug development. Previous researches have indicated that chemical structures, target proteins, and side-effects could provide rich information in drug similarity assessment and further disease similarity. However, each single data source is important in its own way and data integration holds the great promise to reposition drug more accurately. Here, we propose a new method for drug repositioning, PreDR (Predict Drug Repositioning), to integrate molecular structure, molecular activity, and phenotype data. Specifically, we characterize drug by profiling in chemical structure, target protein, and side-effects space, and define a kernel function to correlate drugs with diseases. Then we train a support vector machine (SVM) to computationally predict novel drug-disease interactions. PreDR is validated on a well-established drug-disease network with 1,933 interactions among 593 drugs and 313 diseases. By cross-validation, we find that chemical structure, drug target, and side-effects information are all predictive for drug-disease relationships. More experimentally observed drug-disease interactions can be revealed by integrating these three data sources. Comparison with existing methods demonstrates that PreDR is competitive both in accuracy and coverage. Follow-up database search and pathway analysis indicate that our new predictions are worthy of further experimental validation. Particularly several novel predictions are supported by clinical trials databases and this shows the significant prospects of PreDR in future drug treatment. In conclusion, our new method, PreDR, can serve as a useful tool in drug discovery to efficiently identify novel drug-disease interactions. In addition, our heterogeneous data integration framework can be applied to other problems.	[Wang, Yongcui; Chen, Shilong] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China; [Deng, Naiyang] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Wang, Yong] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Wang, Yong] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan	Chinese Academy of Sciences; China Agricultural University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; National Institute of Advanced Industrial Science & Technology (AIST)	Wang, Y (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	ywang@amss.ac.cn			National Natural Science Foundation of China [11201470, 31270270, 61171007, 11131009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 11201470, No. 31270270, No. 61171007, and No. 11131009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Basilico J., 2004, 27 ANN INT ACM SIGIR; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen B, 2009, J CHEM INF MODEL, V49, P2044, DOI 10.1021/ci9001876; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dobson PD, 2004, CURR MED CHEM, V11, P2135, DOI 10.2174/0929867043364702; Duran-Frigola M, 2012, GENOME MED, V4, DOI 10.1186/gm302; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hue M, 2010, P 27 INT C MACH LEAR, P463; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kinnings SL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000423; Kotelnikova Ekaterina, 2010, Journal of Bioinformatics and Computational Biology, V8, P593, DOI 10.1142/S0219720010004732; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; Oyama S, 2004, LECT NOTES COMPUT SC, V3201, P322; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Scholkopf B, 2004, SUPPORT VECTOR MACHI, P71; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang YC, 2013, BIOINFORMATICS, V29, P1317, DOI 10.1093/bioinformatics/btt158; Wang YC, 2010, LETT DRUG DES DISCOV, V7, P370, DOI 10.2174/157018010791163433; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu G, 2003, ICML 2003 WORKSH LEA, P49, DOI DOI 10.5753/SBRC.2019.7416; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764	47	86	88	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78518	10.1371/journal.pone.0078518	http://dx.doi.org/10.1371/journal.pone.0078518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244318	Green Published, gold			2022-12-27	WOS:000327221600028
J	Xie, CZ; Drenberg, C; Edwards, H; Caldwell, JT; Chen, W; Inaba, H; Xu, XL; Buck, SA; Taub, JW; Baker, SD; Ge, YB				Xie, Chengzhi; Drenberg, Christina; Edwards, Holly; Caldwell, J. Timothy; Chen, Wei; Inaba, Hiroto; Xu, Xuelian; Buck, Steven A.; Taub, Jeffrey W.; Baker, Sharyn D.; Ge, Yubin			Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; DNA-DAMAGE RESPONSE; ACUTE MYELOGENOUS LEUKEMIA; GENE-EXPRESSION; VALPROIC ACID; PHASE-I; CHEMOTHERAPY SENSITIVITY; TARGETED THERAPY; COMBINATION; VORINOSTAT	Acute myeloid leukemia (AML) remains a challenging disease to treat and urgently requires new therapies to improve its treatment outcome. In this study, we investigated the molecular mechanisms underlying the cooperative antileukemic activities of panobinostat and cytarabine or daunorubicin (DNR) in AML cell lines and diagnostic blast samples in vitro and in vivo. Panobinostat suppressed expression of BRCA1, CHK1, and RAD51 in AML cells in a dose-dependent manner. Further, panobinostat significantly increased cytarabine-or DNR-induced DNA double-strand breaks and apoptosis, and abrogated S and/or G2/M cell cycle checkpoints. Analogous results were obtained by shRNA knockdown of BRCA1, CHK1, or RAD51. Cotreatment of NOD-SCID-IL2R gamma(null) mice bearing AML xenografts with panobinostat and cytarabine significantly increased survival compared to either cytarabine or panobinostat treatment alone. Additional studies revealed that panobinostat suppressed the expression of BRCA1, CHK1, and RAD51 through downregulation of E2F1 transcription factor. Our results establish a novel mechanism underlying the cooperative antileukemic activities of these drug combinations in which panobinostat suppresses expression of BRCA1, CHK1, and RAD51 to enhance cytarabine and daunorubicin sensitivities in AML cells.	[Xie, Chengzhi; Edwards, Holly; Chen, Wei; Xu, Xuelian; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Xie, Chengzhi; Edwards, Holly; Xu, Xuelian; Taub, Jeffrey W.; Ge, Yubin] Wayne State Univ, Sch Med, Mol Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Xie, Chengzhi; Ge, Yubin] Jilin Univ, Coll Life Sci, State Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Drenberg, Christina; Baker, Sharyn D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, MD PhD Program, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, Canc Biol Program, Detroit, MI USA; [Inaba, Hiroto] St Jude Childrens Res Hosp, Dept Oncol, Div Leukemia Lymphoma, Memphis, TN 38105 USA; [Buck, Steven A.; Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Jilin University; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Wayne State University; Wayne State University; St Jude Children's Research Hospital; Children's Hospital of Michigan; Wayne State University	Ge, YB (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.	gey@karmanos.org	, Wei/AAN-6343-2020	, Wei/0000-0001-6048-1860; Guttke, Christina/0000-0001-7759-8213; Baker, Sharyn/0000-0003-3062-3252; Ge, Yubin/0000-0002-8748-716X	Barbara Ann Karmanos Cancer Institute; St. Baldrick's Foundation, American Cancer Society [11-053-01-IRG]; Herrick Foundation; National Natural Science Foundation of China [NSFC 31271477, 81200363]; Leukemia Research Life, National Cancer Institute [CA120772]; Elana Fund; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute [T32 CA009531]; NATIONAL CANCER INSTITUTE [P30CA022453, T32CA009531, R01CA120772] Funding Source: NIH RePORTER	Barbara Ann Karmanos Cancer Institute; St. Baldrick's Foundation, American Cancer Society; Herrick Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leukemia Research Life, National Cancer Institute; Elana Fund; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Start-up Fund from the Barbara Ann Karmanos Cancer Institute, grants from the St. Baldrick's Foundation, American Cancer Society (IRG # 11-053-01-IRG), the Herrick Foundation, the National Natural Science Foundation of China (NSFC 31271477 and 81200363), Leukemia Research Life, National Cancer Institute (CA120772), Elana Fund, Justin's Gift Charity, the Buric Family, Sehn Family Foundation, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Ge YB, 2006, BLOOD, V107, P1570, DOI 10.1182/blood-2005-06-2219; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Gimsing P, 2008, EUR J HAEMATOL, V81, P170, DOI 10.1111/j.1600-0609.2008.01102.x; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Gojo I, 2013, CLIN CANCER RES, V19, P1838, DOI 10.1158/1078-0432.CCR-12-3165; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hu SY, 2011, J NATL CANCER I, V103, P893, DOI 10.1093/jnci/djr107; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kakuda H, 1996, BRIT J HAEMATOL, V95, P306, DOI 10.1046/j.1365-2141.1996.d01-1909.x; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Klimek VM, 2008, CLIN CANCER RES, V14, P826, DOI 10.1158/1078-0432.CCR-07-0318; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Meshinchi S, 2007, ONCOLOGIST, V12, P341, DOI 10.1634/theoncologist.12-3-341; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nolan L, 2008, BRIT J CANCER, V99, P689, DOI 10.1038/sj.bjc.6604557; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Taub JW, 1996, BLOOD, V87, P3395, DOI 10.1182/blood.V87.8.3395.bloodjournal8783395; ten Cate B, 2007, LEUKEMIA, V21, P248, DOI 10.1038/sj.leu.2404477; Venkitaraman AR, 2009, CANCER CELL, V16, P89, DOI 10.1016/j.ccr.2009.07.011; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Xie C, 2012, PEDIAT BLOOD CANC; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Zwaan CM, 2004, BRIT J HAEMATOL, V127, P264, DOI 10.1111/j.1365-2141.2004.05167.x	52	68	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79106	10.1371/journal.pone.0079106	http://dx.doi.org/10.1371/journal.pone.0079106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244429	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600109
J	Zhu, ZD; Fan, YY; Feng, GY; Huang, RW; Wang, SP				Zhu, Zude; Fan, Yuanyuan; Feng, Gangyi; Huang, Ruiwang; Wang, Suiping			Large Scale Brain Functional Networks Support Sentence Comprehension: Evidence from Both Explicit and Implicit Language Tasks	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; SMALL-WORLD; NEURAL-NETWORK; ANTERIOR; CONNECTIVITY; SPEECH; FMRI; CORTEX; ORGANIZATION; INTEGRATION	Previous studies have indicated that sentences are comprehended via widespread brain regions in the fronto-temporoparietal network in explicit language tasks (e.g., semantic congruency judgment tasks), and through restricted temporal or frontal regions in implicit language tasks (e.g., font size judgment tasks). This discrepancy has raised questions regarding a common network for sentence comprehension that acts regardless of tasks effect and whether different tasks modulate network properties. To this end, we constructed brain functional networks based on 27 subjects' fMRI data that was collected while performing explicit and implicit language tasks. We found that network properties and network hubs corresponding to the implicit language tasks were similar to those associated with the explicit language task. We also found common hubs in occipital, temporal and frontal regions in both tasks. Compared with the implicit language task, the explicit language task resulted in greater global efficiency and increased integrated betweenness centrality of the left interior frontal gyrus, which is a key region related to sentence comprehension. These results suggest that brain functional networks support both explicit and implicit sentence comprehension; in addition, these two types of language tasks may modulate the properties of brain functional networks.	[Huang, Ruiwang] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Huang, RW (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	ruiwang.huang@gmail.com; suiping@scnu.edu.cn		Wang, Suiping/0000-0001-8726-169X; Feng, Gangyi/0000-0003-2239-5296	Natural Science Foundation of China [31100811, 31271086, 81071149, 81271548]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Key Laboratory of Mental Health and Cognitive Science; South China Normal University; Scientific Research Foundation for Returned Overseas Chinese Scholar; State Education Ministry	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Key Laboratory of Mental Health and Cognitive Science; South China Normal University; Scientific Research Foundation for Returned Overseas Chinese Scholar(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry	This work was supported by grants from the Natural Science Foundation of China (Grant numbers: 31100811, 31271086, 81071149, and 81271548), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2012), Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University, and Scientific Research Foundation for Returned Overseas Chinese Scholar (RH), State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Braze D, 2011, CORTEX, V47, P416, DOI 10.1016/j.cortex.2009.11.005; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caplan D, 2008, CORTEX, V44, P257, DOI 10.1016/j.cortex.2006.06.005; Cheung H, 2012, INT J PSYCHOPHYSIOL, V83, P357, DOI 10.1016/j.ijpsycho.2011.12.002; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cooke A, 2006, BRAIN LANG, V96, P14, DOI 10.1016/j.bandl.2005.07.072; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Crinion JT, 2003, BRAIN, V126, P1193, DOI 10.1093/brain/awg104; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Diaz MT, 2011, NEUROPSYCHOLOGIA, V49, P320, DOI 10.1016/j.neuropsychologia.2010.12.004; Faria AV, 2012, NEUROIMAGE, V61, P613, DOI 10.1016/j.neuroimage.2012.03.078; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Green JJ, 2011, J NEUROSCI, V31, P3560, DOI 10.1523/JNEUROSCI.5758-10.2011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jin H, 2009, INT J PSYCHOPHYSIOL, V71, P142, DOI 10.1016/j.ijpsycho.2008.08.009; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Liu Y, 1990, MODERN FREQUENCY DIC; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Newman SD, 2009, HUM BRAIN MAPP, V30, P2499, DOI 10.1002/hbm.20684; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Rodd JM, 2012, CEREB CORTEX, V22, P1761, DOI 10.1093/cercor/bhr252; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruff I, 2008, BRAIN LANG, V105, P41, DOI 10.1016/j.bandl.2008.01.003; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Snijders TM, 2010, NEUROIMAGE, V52, P1633, DOI 10.1016/j.neuroimage.2010.05.035; Spitsyna G, 2006, J NEUROSCI, V26, P7328, DOI 10.1523/JNEUROSCI.0559-06.2006; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ye Z, 2014, HUM BRAIN MAPP, V35, P367, DOI 10.1002/hbm.22182; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Zempleni MZ, 2007, NEUROIMAGE, V34, P1270, DOI 10.1016/j.neuroimage.2006.09.048; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhu ZD, 2013, NEUROIMAGE, V76, P325, DOI 10.1016/j.neuroimage.2013.02.060; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; [朱祖德 ZHU ZuDe], 2011, [心理科学进展, Advances in Psychological Science], V19, P1147; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	74	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80214	10.1371/journal.pone.0080214	http://dx.doi.org/10.1371/journal.pone.0080214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244653	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600193
J	Aberg, E; Holst, S; Neagu, A; Ogren, SO; Lavebratt, C				Aberg, Elin; Holst, Sarah; Neagu, Alexandru; Ogren, Sven Ove; Lavebratt, Catharina			Prenatal Exposure to Carbamazepine Reduces Hippocampal and Cortical Neuronal Cell Population in New-Born and Young Mice without Detectable Effects on Learning And Memory	PLOS ONE			English	Article							UNBIASED STEREOLOGICAL ESTIMATION; MAJOR CONGENITAL-MALFORMATIONS; DRUGS IN-UTERO; ANTIEPILEPTIC DRUGS; CHILDREN BORN; ANTICONVULSANT DRUGS; DEVELOPING BRAIN; WATER-MAZE; EPILEPSY; PREGNANCY	Pregnant women with epilepsy have to balance maternal and fetal risks associated with uncontrolled seizures against the potential teratogenic effects from antiepileptic drugs (AEDs). Carbamazepine (CBZ) is among the four most commonly used AEDs for treatment of pregnant epileptic women. We previously reported that new-born children had a decreased head circumference after in utero CBZ exposure. This study investigates how prenatal exposure of CBZ influences the number of neurons in new-born and young mouse hippocampus, amygdala and cortex cerebri. Clinical studies describe inconclusive results on if prenatal CBZ treatment influences cognition. Here we investigate this issue in mice using two well characterized cognitive tasks, the passive avoidance test and the Morris water maze test. Prenatal exposure of CBZ reduced the number of neurons (NeuN-immunoreactive cells) in the new-born mouse hippocampus with 50% compared to non-exposed mice. A reduction of neurons (20%) in hippocampus was still observed when the animals were 5 weeks old. These mice also displayed a 25% reduction of neurons in cortex cerebri. Prenatal CBZ treatment did not significantly impair learning and memory measured in the passive avoidance test and in the Morris water maze. However, these mice displayed a higher degree of thigmotaxic behaviour than the control mice. The body weight of prenatally CBZ exposed five-week old mice were lower compared to control mice not exposed to CBZ (p = 0.001). In conclusion, prenatal exposure to CBZ reduces the number of neurons dramatically in areas important for cognition such as hippocampus and cortex, without severe impairments on learning and memory. These results are in line with some clinical studies, reporting that CBZ has minor negative effects on cognition. The challenge for future studies are to segment out what possible effects a reduction of neurons could have on different types of cognition, like intellectual ability and social interaction.	[Aberg, Elin; Neagu, Alexandru; Lavebratt, Catharina] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Aberg, Elin; Neagu, Alexandru; Lavebratt, Catharina] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Holst, Sarah; Ogren, Sven Ove] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Aberg, E (corresponding author), Karolinska Inst, AstraZeneca Translat Sci Ctr, Stockholm, Sweden.	elin.aberg@astrazeneca.com		Ogren, Sven Ove/0000-0003-2573-5276; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Medical Research Council, Ahlen Foundation; Fredrik and Ingrid Thuring's Foundation	Swedish Medical Research Council, Ahlen Foundation; Fredrik and Ingrid Thuring's Foundation	This work was supported by the Swedish Medical Research Council, Ahlen Foundation and Fredrik and Ingrid Thuring's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Adab N, 2001, J NEUROL NEUROSUR PS, V70, P15, DOI 10.1136/jnnp.70.1.15; Adab N, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]; Almgren M, 2009, SEIZURE-EUR J EPILEP, V18, P672, DOI 10.1016/j.seizure.2009.09.002; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Banach R, 2010, DRUG SAFETY, V33, P73, DOI 10.2165/11317640-000000000-00000; BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bromley RL, 2009, CURR OPIN NEUROL, V22, P162, DOI 10.1097/WCO.0b013e3283292401; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Chen J, 2009, J NEUROSCI RES, V87, P2898, DOI 10.1002/jnr.22125; Crawford P, 1999, SEIZURE-EUR J EPILEP, V8, P201, DOI 10.1053/seiz.1999.0295; Crepel V, 2003, J CELL MOL MED, V7, P401, DOI 10.1111/j.1582-4934.2003.tb00242.x; Cummings C, 2011, ARCH DIS CHILD, V96, P643, DOI 10.1136/adc.2009.176990; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dean JCS, 2002, J MED GENET, V39, P251, DOI 10.1136/jmg.39.4.251; Dessens A, 1998, ACTA NEUROBIOL EXP, V58, P221; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eriksson K, 2005, EPILEPSY RES, V65, P189, DOI 10.1016/j.eplepsyres.2005.06.001; Eriksson TM, 2008, NEUROPHARMACOLOGY, V54, P1041, DOI 10.1016/j.neuropharm.2008.02.007; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Galbally M, 2010, AUST NZ J PSYCHIAT, V44, P967, DOI 10.3109/00048674.2010.506637; Gentile S, 2011, CURR OPIN PSYCHIATR, V24, P34, DOI 10.1097/YCO.0b013e3283413451; Gentile S, 2010, DEPRESS ANXIETY, V27, P675, DOI 10.1002/da.20706; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; Kaneko S, 1999, EPILEPSY RES, V33, P145, DOI 10.1016/S0920-1211(98)00084-9; Kaplan PW, 2007, EPILEPSY BEHAV, V11, P283, DOI 10.1016/j.yebeh.2007.08.012; Kim J, 2007, J PHARMACOL EXP THER, V323, P165, DOI 10.1124/jpet.107.126250; Lavebratt C, 2006, NEUROBIOL DIS, V24, P374, DOI 10.1016/j.nbd.2006.07.018; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Lepicard EM, 2000, PHARMACOL BIOCHEM BE, V67, P739, DOI 10.1016/S0091-3057(00)00419-6; Madjid N, 2006, J PHARMACOL EXP THER, V316, P581, DOI 10.1124/jpet.105.092262; Martin JMP, 2008, MUTAT RES-FUND MOL M, V637, P124, DOI 10.1016/j.mrfmmm.2007.07.014; Meador KJ, 2008, NEUROLOGY, V71, P1109, DOI 10.1212/01.wnl.0000316199.92256.af; Meador KJ, 2007, EPILEPSY BEHAV, V11, P292, DOI 10.1016/j.yebeh.2007.08.009; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Olafsson E, 1998, EPILEPSIA, V39, P887, DOI 10.1111/j.1528-1157.1998.tb01186.x; Ornoy A, 1996, ARCH DIS CHILD, V75, P517, DOI 10.1136/adc.75.6.517; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pennell PB, 2008, EPILEPSIA, V49, P43, DOI 10.1111/j.1528-1167.2008.01926.x; Pennell PB, 2004, NEUROL CLIN, V22, P799, DOI 10.1016/j.ncl.2004.07.004; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; REINISCH JM, 1995, JAMA-J AM MED ASSOC, V274, P1518, DOI 10.1001/jama.274.19.1518; Samren EB, 1999, ANN NEUROL, V46, P739; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; SCOLNIK D, 1994, JAMA-J AM MED ASSOC, V271, P767, DOI 10.1001/jama.271.10.767; Stiedl O, 2000, J NEUROSCI, V20, P8515, DOI 10.1523/JNEUROSCI.20-22-08515.2000; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; Thomas SV, 2008, EPILEPSY BEHAV, V13, P229, DOI 10.1016/j.yebeh.2008.01.010; Titze K, 2008, DEV MED CHILD NEUROL, V50, P117, DOI 10.1111/j.1469-8749.2007.02020.x; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69; Vinten J, 2009, EPILEPSY BEHAV, V14, P197, DOI 10.1016/j.yebeh.2008.10.011; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80497	10.1371/journal.pone.0080497	http://dx.doi.org/10.1371/journal.pone.0080497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244693	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800149
J	Carpenter, K; DiCroce, T; Kinneer, B; Simon, R				Carpenter, Kenneth; DiCroce, Tony; Kinneer, Billy; Simon, Robert			Pelvis of Gargoyleosaurus (Dinosauria: Ankylosauria) and the Origin and Evolution of the Ankylosaur Pelvis	PLOS ONE			English	Article							ORNITHISCHIA; PHYLOGENY; REDESCRIPTION; OSTEOLOGY	Discovery of a pelvis attributed to the Late Jurassic armor-plated dinosaur Gargoyleosaurus sheds new light on the origin of the peculiar non-vertical, broad, flaring pelvis of ankylosaurs. It further substantiates separation of the two ankylosaurs from the Morrison Formation of the western United States, Gargoyleosaurus and Mymoorapelta. Although horizontally oriented and lacking the medial curve of the preacetabular process seen in Mymoorapelta, the new ilium shows little of the lateral flaring seen in the pelvis of Cretaceous ankylosaurs. Comparison with the basal thyreophoran Scelidosaurus demonstrates that the ilium in ankylosaurs did not develop entirely by lateral rotation as is commonly believed. Rather, the preacetabular process rotated medially and ventrally and the postacetabular process rotated in opposition, i.e., lateral and ventrally. Thus, the dorsal surfaces of the preacetabular and postacetabular processes are not homologous. In contrast, a series of juvenile Stegosaurus ilia show that the postacetabular process rotated dorsally ontogenetically. Thus, the pelvis of the two major types of Thyreophora most likely developed independently. Examination of other ornithischians show that a non-vertical ilium had developed independently in several different lineages, including ceratopsids, pachycephalosaurs, and iguanodonts. Therefore, a separate origin for the non-vertical ilium in stegosaurs and ankylosaurs does have precedent.	[Carpenter, Kenneth] Utah State Univ Eastern, Prehist Museum, Price, UT 84501 USA; [Carpenter, Kenneth] Univ Colorado Museum, Geol Sect, Boulder, CO 80309 USA; [DiCroce, Tony; Kinneer, Billy] Denver Museum Nat & Sci, Denver, CO USA; [Simon, Robert] Dinosaur Safaris Inc, Ashland, VA USA	Utah System of Higher Education; Utah State University; Utah State University College of Eastern Utah; University of Colorado System; University of Colorado Boulder	Carpenter, K (corresponding author), Utah State Univ Eastern, Prehist Museum, Price, UT 84501 USA.	Ken.Carpenter@ceu.edu						Arbour VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062421; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2011, PALAEONTOGR ABT A, V294, P1; Carpenter K, 2010, J IBER GEOL, V36, P145, DOI 10.5209/rev_JIGE.2010.v36.n2.3; Carpenter K, 2001, LIFE O PAST, P455; Carpenter K, 1998, NATURE, V393, P782, DOI 10.1038/31684; Carpenter K., 1990, DINOSAUR SYSTEMATICS, P282; Carpenter K, 1999, UTAH GEOL SURV MISC, V99-1, P244; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; COOMBS WP, 1979, J PALEONTOL, V53, P666; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; GALTON PM, 1974, J PALEONTOL, V48, P1048; Gilmore C. W., 1930, Proceedings of the United States National Museum, V77, P1; Godefroit P, 2009, GEODIVERSITAS, V31, P525, DOI 10.5252/g2009n3a3; Hatcher JB, 1907, MONOGRAPHS US GEOLOG, V49; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hulke J. W., 1887, PHILOS T ROY SOC LON, V178, DOI [10.1098/rstb.1887.0007, DOI 10.1098/RSTB.1887.0007]; Kilbourne B, 2005, NEUES JAHRB GEOL P-A, V237, P111, DOI 10.1127/njgpa/237/2005/111; Kirkland James I., 1994, Brigham Young University Geology Studies, V40, P25; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Lull RS, 1921, AM J SCI, V1, P97; Maidment SCR, 2006, GEOL MAG, V143, P621, DOI 10.1017/S0016756806002500; Maidment SCR, 2012, P ROY SOC B-BIOL SCI, V279, P3765, DOI 10.1098/rspb.2012.1040; Maleev E. A., 1954, Travaux de l'Institut Paleozoologique Acad Sci URSS, V48, P142; Maleev E.A., 1956, T PALEONTOL I AKAD N, V62, P51; Maryanska T, 1968, PALAEONT POL, V19, P1; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Norman David B., 2001, Journal of Vertebrate Paleontology, V21, p84A; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; Norman DB, 1984, 3 S MES TERR EC; Osborn H. F., 1899, tt cc, P191; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Owen R., 1866, ANATOMY VERTEBRATES, V1; Owen Richard, 1847, ARCHETYPE HOMOLOGIES; PARISH JC, 2005, THESIS U OXFORD; ROMER ALFRED S., 1927, ACTA ZOOL [STOCKHOLM], V8, P225; Rosenbaum Jason N., 2000, Paleobios, V20, P13; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Zhou S.W, 1984, MIDDLE JURASSIC DINO	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79887	10.1371/journal.pone.0079887	http://dx.doi.org/10.1371/journal.pone.0079887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244573	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800103
J	Delle Monache, S; Angelucci, A; Sanita, P; Iorio, R; Bennato, F; Mancini, F; Gualtieri, G; Colonna, RC				Delle Monache, Simona; Angelucci, Adriano; Sanita, Patrizia; Iorio, Roberto; Bennato, Francesca; Mancini, Fabrizio; Gualtieri, Giancaterino; Colonna, Rosella Cardigno			Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNAL-REGULATED KINASE; HEAT-SHOCK PROTEINS; ELECTROMAGNETIC-FIELDS; CELLS; HSP70; EXPOSURE; CANCER; ACTIVATION; EXPRESSION	The formation of new blood vessels is an essential therapeutic target in many diseases such as cancer, ischemic diseases, and chronic inflammation. In this regard, extremely low-frequency (ELF) electromagnetic fields (EMFs) seem able to inhibit vessel growth when used in a specific window of amplitude. To investigate the mechanism of anti-angiogenic action of ELF-EMFs we tested the effect of a sinusoidal magnetic field (MF) of 2 mT intensity and frequency of 50 Hz on endothelial cell models HUVEC and MS-1 measuring cell status and proliferation, motility and tubule formation ability. MS-1 cells when injected in mice determined a rapid tumor-like growth that was significantly reduced in mice inoculated with MF-exposed cells. In particular, histological analysis of tumors derived from mice inoculated with MF-exposed MS-1 cells indicated a reduction of hemangioma size, of blood-filled spaces, and in hemorrhage. In parallel, in vitro proliferation of MS-1 treated with MF was significantly inhibited. We also found that the MF-exposure down-regulated the process of proliferation, migration and formation of tubule-like structures in HUVECs. Using western blotting and immunofluorescence analysis, we collected data about the possible influence of MF on the signalling pathway activated by the vascular endothelial growth factor (VEGF). In particular, MF exposure significantly reduced the expression and activation levels of VEGFR2, suggesting a direct or indirect influence of MF on VEGF receptors placed on cellular membrane. In conclusion MF reduced, in vitro and in vivo, the ability of endothelial cells to form new vessels, most probably affecting VEGF signal transduction pathway that was less responsive to activation. These findings could not only explain the mechanism of anti-angiogenic action exerted by MFs, but also promote the possible development of new therapeutic applications for treatment of those diseases where excessive angiogenesis is involved.	[Delle Monache, Simona; Angelucci, Adriano; Sanita, Patrizia; Iorio, Roberto; Bennato, Francesca; Gualtieri, Giancaterino; Colonna, Rosella Cardigno] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Mancini, Fabrizio] Univ Aquila, Dept Ind & Informat Engn & Econ, I-67100 Laquila, Italy	University of L'Aquila; University of L'Aquila	Delle Monache, S (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	simona.dellemonache@univaq.it	Delle Monache, Simona/M-5618-2014; Angelucci, Adriano/B-7134-2013	Delle Monache, Simona/0000-0002-8153-915X; Angelucci, Adriano/0000-0002-8755-1889; Iorio, Roberto/0000-0003-1863-5752; Bennato, Francesca/0000-0001-9030-4881	MURST ex-60% Grant from Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica	MURST ex-60% Grant from Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by MURST ex-60% Grant from "Ministero dell'Universita'e della Ricerca Scientifica e Tecnologica''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2000, AM J PATHOL, V156, P1469, DOI 10.1016/S0002-9440(10)65015-8; Bekhite MM, 2010, STEM CELLS DEV, V19, P731, DOI 10.1089/scd.2008.0266; Bernardini C, 2007, BIOELECTROMAGNETICS, V28, P231, DOI 10.1002/bem.20299; Blank Martin, 2009, Pathophysiology, V16, P71, DOI 10.1016/j.pathophys.2009.01.006; Blei F, 2005, CURR OPIN PEDIATR, V17, P501, DOI 10.1097/01.mop.0000171322.76429.80; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Bruns AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048539; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Carmody S, 2000, J CELL BIOCHEM, V79, P453, DOI 10.1002/1097-4644(20001201)79:3<453::AID-JCB100>3.0.CO;2-M; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Delle Monache S, 2008, BIOELECTROMAGNETICS, V29, P640, DOI 10.1002/bem.20430; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Goodman R, 2009, INT J RADIAT BIOL, V85, P851, DOI [10.3109/09553000903072488, 10.1080/09553000903072488]; Grothey A, 2008, CANCER J, V14, P170, DOI 10.1097/PPO.0b013e318178d9de; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; HANNAN CJ, 1994, ANTICANCER RES, V14, P1517; Iorio R, 2007, BIOELECTROMAGNETICS, V28, P72, DOI 10.1002/bem.20278; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lee JS, 2005, J BIOL CHEM, V280, P6634, DOI 10.1074/jbc.M412393200; Liang YY, 1997, ANTICANCER RES, V17, P2083; Lin H, 2001, J CELL BIOCHEM, V81, P143, DOI 10.1002/1097-4644(20010401)81:1<143::AID-JCB1030>3.0.CO;2-4; Lin H, 1998, J CELL BIOCHEM, V69, P181, DOI 10.1002/(SICI)1097-4644(19980501)69:2<181::AID-JCB8>3.0.CO;2-O; Markov M., 2006, BIOELECTROMAGNETICS, P1, DOI [10.1007/1-4020- 4278-7_1, DOI 10.1007/1-4020-4278-7_1]; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Markov MS, 2010, CARDIOLOGY, V117, P54, DOI 10.1159/000315433; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Nie K, 2003, J CELL BIOCHEM, V90, P1197, DOI 10.1002/jcb.10704; Okano H, 2008, BIOELECTROMAGNETICS, V29, P233, DOI 10.1002/bem.20376; Okano H, 2007, BIOELECTROMAGNETICS, V28, P497, DOI 10.1002/bem.20330; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARADISI S, 1993, BIOELECTROMAGNETICS, V14, P247, DOI 10.1002/bem.2250140308; PASSANITI A, 1992, LAB INVEST, V67, P519; Pilla Arthur A., 1994, Reviews on Environmental Health, V10, P155; Robertson JA, 2007, BIOELECTROMAGNETICS, V28, P16, DOI 10.1002/bem.20258; Ruggiero M, 2004, BIOELECTROMAGNETICS, V25, P390, DOI 10.1002/bem.20008; Salvatore J. R., 1994, Reviews on Environmental Health, V10, P197; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Sun WJ, 2008, CELL PHYSIOL BIOCHEM, V22, P507, DOI 10.1159/000185524; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Tanaka K, 1999, JPN J CANCER RES, V90, P647, DOI 10.1111/j.1349-7006.1999.tb00796.x; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; Wei M, 2000, TOXICOL APPL PHARM, V162, P166, DOI 10.1006/taap.1999.8825; Williams CD, 2001, ANTICANCER RES, V21, P3887; Yang XS, 2012, BRAIN RES BULL, V88, P371, DOI 10.1016/j.brainresbull.2012.04.002; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	54	33	33	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79309	10.1371/journal.pone.0079309	http://dx.doi.org/10.1371/journal.pone.0079309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244477	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800060
J	Gao, HL; Li, C; Nabeka, H; Shimokawa, T; Kobayashi, N; Saito, S; Wang, ZY; Cao, YM; Matsuda, S				Gao, Hui-ling; Li, Cheng; Nabeka, Hiroaki; Shimokawa, Tetsuya; Kobayashi, Naoto; Saito, Shouichiro; Wang, Zhan-You; Cao, Ya-ming; Matsuda, Seiji			Decrease in Prosaposin in the Dystrophic mdx Mouse Brain	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; FACIAL-NERVE TRANSECTION; MESSENGER-RNA; IN-VIVO; MOLECULAR-MECHANISMS; MUSCLE REGENERATION; NEUROTROPHIC FACTOR; ACTIVATOR PROTEIN; GENE-EXPRESSION; 18-MER PEPTIDE	Background: Duchenne muscular dystrophy caused by a mutation in the X-linked dystrophin gene induces metabolic and structural disorders in the brain. A lack of dystrophin in brain structures is involved in impaired cognitive function. Prosaposin (PS), a neurotrophic factor, is abundant in the choroid plexus and various brain regions. We investigated whether PS serves as a link between dystrophin loss and gross and/or ultrastructural brain abnormalities. Methodology/Principal Findings: The distribution of PS in the brains of juvenile and adult mdx mice was investigated by immunochemistry, Western blotting, and in situ hybridization. Immunochemistry revealed lower levels of PS in the cytoplasm of neurons of the cerebral cortex, hippocampus, cerebellum, and choroid plexus in mdx mice. Western blotting confirmed that PS levels were lower in these brain regions in both juveniles and adults. Even with low PS production in the choroids plexus, there was no significant PS decrease in cerebrospinal fluid (CSF). In situ hybridization revealed that the primary form of PS mRNA in both normal and mdx mice was Pro+ 9, a secretory-type PS, and the hybridization signals for Pro+ 9 in the above-mentioned brain regions were weaker in mdx mice than in normal mice. We also investigated mitogen-activated protein kinase signalling. Stronger activation of ERK1/2 was observed in mdx mice, ERK1/2 activity was positively correlated with PS activity, and exogenous PS18 stimulated both p-ERK1/2 and PS in SH-SY5Y cells. Conclusions/Significance: Low levels of PS and its receptors suggest the participation of PS in some pathological changes in the brains of mdx mice.	[Gao, Hui-ling; Li, Cheng; Nabeka, Hiroaki; Shimokawa, Tetsuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu, Japan; [Gao, Hui-ling; Wang, Zhan-You] Northeastern Univ, Coll Life & Hlth Sci, Shenyang, Peoples R China; [Li, Cheng; Cao, Ya-ming] China Med Univ, Dept Immunol, Shenyang, Peoples R China	Ehime University; Ehime University; Gifu University; Northeastern University - China; China Medical University	Nabeka, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	nabeka@m.ehime-u.ac.jp		Wang, Zhan-You/0000-0003-0807-9916	Ministry of Education, Culture, Sports, Science and Technology of Japan [22591637, 19659380, 22591979]; Ehime University [021000]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime University	This study was supported in part by Grants to SM (22591637, 19659380) and NK (22591979) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and to CL (021000) from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BILLARD C, 1992, NEUROMUSCULAR DISORD, V2, P371, DOI 10.1016/S0960-8966(06)80008-8; BRESOLIN N, 1994, NEUROMUSCULAR DISORD, V4, P359, DOI 10.1016/0960-8966(94)90072-8; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cohen T, 2005, MOL CELL BIOL, V25, P2431, DOI 10.1128/MCB.25.6.2431-2440.2005; Cohen T, 2004, MOL BRAIN RES, V129, P8, DOI 10.1016/j.molbrainres.2004.06.027; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; GORECKI D, 1991, NEUROREPORT, V2, P773, DOI 10.1097/00001756-199112000-00011; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HIRAIWA M, 1993, J BIOCHEM-TOKYO, V114, P901, DOI 10.1093/oxfordjournals.jbchem.a124274; Hiraiwa M, 1997, BIOCHEM BIOPH RES CO, V240, P415, DOI 10.1006/bbrc.1997.7673; Hnia K, 2007, AM J PATHOL, V170, P633, DOI 10.2353/ajpath.2007.060344; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7556; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; KREDA SM, 1994, DEV NEUROSCI-BASEL, V16, P90, DOI 10.1159/000112093; LAMONTAGNE S, 1994, J BIOL CHEM, V269, P20528; Li C, 2013, HISTOL HISTOPATHOL, V28, P875, DOI 10.14670/HH-28.875; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Liu L., 2008, J VIS EXP; LOVE DR, 1993, NEUROMUSCULAR DISORD, V3, P5, DOI 10.1016/0960-8966(93)90037-K; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nico B, 2004, NEUROSCIENCE, V125, P921, DOI 10.1016/j.neuroscience.2004.02.008; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; SUN Y, 1994, AM J PATHOL, V145, P1390; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Zhao Q, 1997, MOL REPROD DEV, V48, P1, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;1::AID-MRD1&gt;3.0.CO;2-N	69	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80032	10.1371/journal.pone.0080032	http://dx.doi.org/10.1371/journal.pone.0080032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244600	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800109
J	Gerlach, RL; Camp, JV; Chu, YK; Jonsson, CB				Gerlach, Rachael L.; Camp, Jeremy V.; Chu, Yong-Kyu; Jonsson, Colleen B.			Early Host Responses of Seasonal and Pandemic Influenza A Viruses in Primary Well-Differentiated Human Lung Epithelial Cells	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; H1N1 VIRUS; INNATE IMMUNITY; RNA VIRUSES; RIG-I; HUMAN ALVEOLAR; INFECTION; INDUCTION; APOPTOSIS; H5N1	Replication, cell tropism and the magnitude of the host's antiviral immune response each contribute to the resulting pathogenicity of influenza A viruses (IAV) in humans. In contrast to seasonal IAV in human cases, the 2009 H1N1 pandemic IAV (H1N1pdm) shows a greater tropism for infection of the lung similar to H5N1. We hypothesized that host responses during infection of well-differentiated, primary human bronchial epithelial cells (wd-NHBE) may differ between seasonal (H1N1 A/BN/59/07) and H1N1pdm isolates from a fatal (A/KY/180/10) and nonfatal (A/KY/136/09) case. For each virus, the level of infectious virus and host response to infection (gene expression and apical/basal cytokine/chemokine profiles) were measured in wd-NHBE at 8, 24, 36, 48 and 72 hours post-infection (hpi). At 24 and 36 hpi, KY/180 showed a significant, tenfold higher titer as compared to the other two isolates. Apical cytokine/chemokine levels of IL-6, IL-8 and GRO were similar in wd-NHBE cells infected by each of these viruses. At 24 and 36 hpi, NHBE cells had greater levels of pro-inflammatory cytokines including IFN-alpha, CCL2, TNF-alpha, and CCL5, when infected by pandemic viruses as compared with seasonal. Polarization of IL-6 in wd-NHBE cells was greatest at 36 hpi for all isolates. Differential polarized secretion was suggested for CCL5 across isolates. Despite differences in viral titer across isolates, no significant differences were observed in KY/180 and KY/136 gene expression intensity profiles. Microarray profiles of wd-NHBE cells diverged at 36 hpi with 1647 genes commonly shared by wd-NHBE cells infected by pandemic, but not seasonal isolates. Significant differences were observed in cytokine signaling, apoptosis, and cytoskeletal arrangement pathways. Our studies revealed differences in temporal dynamics and basal levels of cytokine/chemokine responses of wd-NHBE cells infected with each isolate; however, wd-NHBE cell gene intensity profiles were not significantly different between the two pandemic isolates suggesting post-transcriptional or later differences in viral-host interactions.	[Gerlach, Rachael L.; Camp, Jeremy V.; Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chu, Yong-Kyu; Jonsson, Colleen B.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; 	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Funding support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to CBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Camp JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056602; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; EBISAWA IT, 1969, AM REV RESPIR DIS, V99, P507; Fowlkes AL, 2011, CLIN INFECT DIS   S1, V52, pS60; Frank JA, 2007, AM J PHYSIOL-LUNG C, V293, pL52, DOI 10.1152/ajplung.00256.2006; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Jeffery PK, 1997, EUR RESPIR J, V10, P1655, DOI 10.1183/09031936.97.10071655; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Patel JR, 2011, VIRAL IMMUNOL, V24, P89, DOI 10.1089/vim.2010.0122; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Price GE, 1997, J GEN VIROL, V78, P2821, DOI 10.1099/0022-1317-78-11-2821; Proudfoot AG, 2011, DIS MODEL MECH, V4, P145, DOI 10.1242/dmm.006213; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Song BM, 2011, VIRAL IMMUNOL, V24, P179, DOI 10.1089/vim.2010.0125; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang Q, 2012, INFLAMM RES, V61, P977, DOI 10.1007/s00011-012-0490-2; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3; Yang XX, 2010, BIOMED ENVIRON SCI, V23, P259, DOI 10.1016/S0895-3988(10)60061-X; Zeng H, 2011, J VIROL, V85, P686, DOI 10.1128/JVI.01568-10	58	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78912	10.1371/journal.pone.0078912	http://dx.doi.org/10.1371/journal.pone.0078912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244384	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800020
J	Kalle, R; Ramesh, T; Qureshi, Q; Sankar, K				Kalle, Riddhika; Ramesh, Tharmalingam; Qureshi, Qamar; Sankar, Kalyanasundaram			Predicting the Distribution Pattern of Small Carnivores in Response to Environmental Factors in the Western Ghats	PLOS ONE			English	Article							SPECIES DISTRIBUTION; CONSERVATION; RARE; PERFORMANCE; MODELS; AUC	Due to their secretive habits, predicting the pattern of spatial distribution of small carnivores has been typically challenging, yet for conservation management it is essential to understand the association between this group of animals and environmental factors. We applied maximum entropy modeling (MaxEnt) to build distribution models and identify environmental predictors including bioclimatic variables, forest and land cover type, topography, vegetation index and anthropogenic variables for six small carnivore species in Mudumalai Tiger Reserve. Species occurrence records were collated from camera-traps and vehicle transects during the years 2010 and 2011. We used the average training gain from forty model runs for each species to select the best set of predictors. The area under the curve (AUC) of the receiver operating characteristic plot (ROC) ranged from 0.81 to 0.93 for the training data and 0.72 to 0.87 for the test data. In habitat models for F. chaus, P. hermaphroditus, and H. smithii "distance to village'' and precipitation of the warmest quarter emerged as some of the most important variables. "Distance to village'' and aspect were important for V. indica while "distance to village'' and precipitation of the coldest quarter were significant for H. vitticollis. "Distance to village'', precipitation of the warmest quarter and land cover were influential variables in the distribution of H. edwardsii. The map of predicted probabilities of occurrence showed potentially suitable habitats accounting for 46 km(2) of the reserve for F. chaus, 62 km(2) for V. indica, 30 km(2) for P. hermaphroditus, 63 km(2) for H. vitticollis, 45 km(2) for H. smithii and 28 km(2) for H. edwardsii. Habitat heterogeneity driven by the east-west climatic gradient was correlated with the spatial distribution of small carnivores. This study exemplifies the usefulness of modeling small carnivore distribution to prioritize and direct conservation planning for habitat specialists in southern India.	[Kalle, Riddhika; Ramesh, Tharmalingam] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Qureshi, Qamar] Wildlife Inst India, Dept Landscape Ecol, Dehra Dun, Uttarakhand, India; [Sankar, Kalyanasundaram] Wildlife Inst India, Dept Habitat Ecol, Dehra Dun, Uttarakhand, India	Wildlife Institute of India; Wildlife Institute of India; Wildlife Institute of India	Kalle, R (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	riddhikalle@gmail.com			Wildlife Institute of India	Wildlife Institute of India	The research project was supported by the Wildlife Institute of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan M., 2007, SMALL CARNIVORE CONS, V36, P9; BEERS TW, 1966, J FOREST, V64, P691; Burneo Santiago F., 2009, Small Carnivore Conservation, V41, P41; Champion H. G., 1968, REVISED SURVEY FORES, P404; Choudhury A, 2011, IUCN 2012 IUCN RED L; Choudhury A, 2008, IUCN 2011 IUCN RED L; Duckworth J.W., 2008, NAEMORHEDUS GRISEUS, DOI [10.2305/IUCN.UK.2008.RLTS.T14303A4430834.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14303A4430834.EN]; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gerber B, 2010, ORYX, V44, P219, DOI 10.1017/S0030605309991037; Gupta S., 2011, THESIS SAURASHTRA U; Hanfee F, 1999, ENVIS B WILDLIFE PRO, P113; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Jackson P., 1996, BIOL CONSERVATION; Jennings AP, 2011, J MAMMAL, V92, P316, DOI 10.1644/10-MAMM-A-155.1; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; JOSHI AR, 1995, J MAMMAL, V76, P1205, DOI 10.2307/1382613; Kalle R., 2012, J SCI T ENV TECHNOVA, V6, P44; Krishnakumar Hema, 2003, Small Carnivore Conservation, V28, P10; Kumar A., 1999, ENVIS B, V2, P74; Kumar A, 1999, ENVIS B WILDLIFE PRO, P87; Kumara H. N., 2007, Journal of the Bombay Natural History Society, V104, P153; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Monk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034558; Monterroso P, 2009, J ZOOL, V279, P27, DOI 10.1111/j.1469-7998.2009.00585.x; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Mudappa D, 1999, ENVIS B WILDLIFE PRO, P65; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; Mudappa D, 2001, THESIS S ALI CTR ORN; Mukherjee S, 2004, J ZOOL, V262, P405, DOI 10.1017/S0952836903004783; Mukherjee S, 1998, THESIS U SAURASHTRA; Mukherjee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013724; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon AMA, 2010, CIVET CHRONICLES SEA; Patel Kunal, 2006, Cat News, V45, P27; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pillay Rajeev, 2009, Small Carnivore Conservation, V40, P36; Prakash N, 2012, TROP CONSERV SCI, V5, P67, DOI 10.1177/194008291200500107; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Ramesh T., 2010, THESIS SAURASHTRA U; Ramesh T, 2013, EUR J WILDLIFE RES, V59, P271, DOI 10.1007/s10344-012-0676-5; Trabucco A., 2010, GLOBAL HIGH RESOLUTI; Van Rompaey Harry, 2003, Small Carnivore Conservation, V28, P14; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Yoganand T.R.K., 1995, Small Carnivore Conservation, V13, P1	55	39	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79295	10.1371/journal.pone.0079295	http://dx.doi.org/10.1371/journal.pone.0079295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244470	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800056
J	Zhou, H; Cheng, FY; Wang, R; Zhong, Y; He, CY				Zhou, Hua; Cheng, Fang-Yun; Wang, Rong; Zhong, Yuan; He, Chaoying			Transcriptome Comparison Reveals Key Candidate Genes Responsible for the Unusual Reblooming Trait in Tree Peonies	PLOS ONE			English	Article							FLOWERING-LOCUS-T; RNA-SEQ; MOLECULAR-MECHANISM; GIBBERELLIN; TIME; ARABIDOPSIS; TOOL; VERNALIZATION; ANNOTATION; TRANSITION	Tree peonies are important ornamental plants worldwide, but growing them can be frustrating due to their short and concentrated flowering period. Certain cultivars exhibit a reblooming trait that provides a valuable alternative for extending the flowering period. However, the genetic control of reblooming in tree peonies is not well understood. In this study, we compared the molecular properties and morphology of reblooming and non-reblooming tree peonies during the floral initiation and developmental processes. Using transcriptome sequencing technology, we generated 59,275 and 63,962 unigenes with a mean size of 698 bp and 699 bp from the two types of tree peonies, respectively, and identified eight differentially expressed genes that are involved in the floral pathways of Arabidopsis thaliana. These differentially regulated genes were verified through a detailed analysis of their expression pattern during the floral process by real time RT-PCR. From this combined analysis, we identified four genes, PsFT, PsVIN3, PsCO and PsGA20OX, which likely play important roles in the regulation of the reblooming process in tree peonies. These data constitute a valuable resource for the discovery of genes involved in flowering time and insights into the molecular mechanism of flowering to further accelerate the breeding of tree peonies and other perennial woody plants.	[Zhou, Hua; Cheng, Fang-Yun; Wang, Rong; Zhong, Yuan] Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China; [Zhou, Hua] Jiangxi Acad Sci, Inst Biol & Resources, Nanchang, Peoples R China; [He, Chaoying] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Cheng, FY (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China.	chengfy8@263.net; chaoying@ibcas.ac.cn			National High Technology Research and Development Program of China (863 Program) [2011AA100207]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2011AA100207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani MC, 2004, THEOR APPL GENET, V109, P571, DOI 10.1007/s00122-004-1654-4; Amasino R, 2004, PLANT CELL, V16, P2553, DOI 10.1105/tpc.104.161070; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barzilay A, 2002, HORTSCIENCE, V37, P300, DOI 10.21273/HORTSCI.37.2.300; Battey NH, 1998, GENETICS AND ENVIRONMENTAL MANIPULATION OF HORTICULTURAL CROPS, P111; Benjamini Y, 2001, ANN STAT, V29, P1165; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dennis ES, 2006, DEV CELL, V11, P1, DOI 10.1016/j.devcel.2006.06.007; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hartweck LM, 2006, PLANT CELL, V18, P278, DOI 10.1105/tpc.105.039958; HEMPEL FD, 1995, PLANT J, V8, P725, DOI 10.1046/j.1365-313X.1995.08050725.x; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Homolka A, 2010, AM J BOT, V97, pE42, DOI 10.3732/ajb.1000127; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jiang Zhuo, 2007, Acta Horticulturae Sinica, V34, P683; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jones HG, 1987, TREES-STRUCT FUNCT, V1, P135; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li JJ, 2011, TREE PEONY CHINESE; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; LORD EM, 1987, BOT GAZ, V148, P17, DOI 10.1086/337623; MCDANIEL CN, 1992, DEV BIOL, V153, P59, DOI 10.1016/0012-1606(92)90091-T; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Mornya PMP, 2011, HORTIC SCI, V38, P104, DOI 10.17221/11/2011-HORTSCI; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouhu K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-122; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Ren XiaoLin, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P895; Roberts AV, 1999, J PLANT GROWTH REGUL, V18, P113, DOI 10.1007/PL00007058; Rogers A., 1995, PEONIES; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; SEMENIUK, 1971, J HERED, V62, P203; Shu QY, 2009, PHYSIOL PLANTARUM, V135, P436, DOI 10.1111/j.1399-3054.2009.01206.x; Shu QY, 2012, GENE, V493, P113, DOI 10.1016/j.gene.2011.11.008; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sonsteby A, 2007, J HORTIC SCI BIOTECH, V82, P266, DOI 10.1080/14620316.2007.11512228; Srinivasan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040715; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Suh SS, 2003, PLANT CELL PHYSIOL, V44, P836, DOI 10.1093/pcp/pcg109; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wang L., 1986, Acta Horticulturae Sinica, V13, P203; Wang LY., 1998, CHINESE TREE PEONY; Wang YanJie, 2012, Journal of Agricultural Biotechnology, V20, P521; Wang Z.Z., 1987, J SHANDONG AGR U, V3, P9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Wister JC, 1962, PEONIES; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang XX, 2005, STUDIES FORCING CULT; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48	83	22	26	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79996	10.1371/journal.pone.0079996	http://dx.doi.org/10.1371/journal.pone.0079996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244590	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800107
J	Schoborg, T; Kuruganti, S; Rickels, R; Labrador, M				Schoborg, Todd; Kuruganti, Srilalitha; Rickels, Ryan; Labrador, Mariano			The Drosophila gypsy Insulator Supports Transvection in the Presence of the vestigial Enhancer	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; LONG-RANGE INTERACTION; PROMOTER INTERACTIONS; TRANSCRIPTIONAL ENHANCERS; TRANSPOSABLE ELEMENT; REGULATORY REGIONS; TRANS-INACTIVATION; BROWN GENE; MELANOGASTER; GENOME	Though operationally defined as cis-regulatory elements, enhancers can also communicate with promoters on a separate homolog in trans, a mechanism that has been suggested to account for the ability of certain alleles of the same gene to complement one another in a process otherwise known as transvection. This homolog-pairing dependent process is facilitated in Drosophila by chromatin-associated pairing proteins, many of which remain unknown and their mechanism of action uncharacterized. Here we have tested the role of the gypsy chromatin insulator in facilitating pairing and communication between enhancers and promoters in trans using a transgenic eGFP reporter system engineered to allow for targeted deletions in the vestigial Boundary Enhancer (vgBE) and the hsp70 minimal promoter, along with one or two flanking gypsy elements. We found a modest 2.5-3x increase in eGFP reporter levels from homozygotes carrying an intact copy of the reporter on each homolog compared to unpaired hemizygotes, although this behavior was independent of gypsy. However, detectable levels of GFP protein along the DV wing boundary in trans-heterozygotes lacking a single enhancer and promoter was only observed in the presence of two flanking gypsy elements. Our results demonstrate that gypsy can stimulate enhancer-promoter communication in trans throughout the genome in a context-dependent manner, likely through modulation of local chromatin dynamics once pairing has been established by other elements and highlights chromatin structure as the master regulator of this phenomenon.	[Schoborg, Todd; Kuruganti, Srilalitha; Rickels, Ryan; Labrador, Mariano] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Labrador, M (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	labrador@utk.edu		Labrador-San Jose, Mariano/0000-0002-8075-2717; Schoborg, Todd/0000-0003-0017-0942	BCMB Department, the College of Arts and Sciences at the University of Tennessee; Office of Research at the University of Tennessee; NIH [GM78132-2]; NSF [MCB-0616081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078132] Funding Source: NIH RePORTER	BCMB Department, the College of Arts and Sciences at the University of Tennessee; Office of Research at the University of Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the BCMB Department, the College of Arts and Sciences and Office of Research at the University of Tennessee for support in addition to US Public Health Service Award GM78132-2 from the NIH and MCB-0616081 from NSF to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Babu P, 1980, Basic Life Sci, V16, P35; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bateman JR, 2012, GENETICS, V191, P1143, DOI 10.1534/genetics.112.140954; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Buratovich MA, 1997, DEV BIOL, V185, P244, DOI 10.1006/dbio.1997.8562; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Casares F, 1997, GENETICS, V145, P123; Chen JL, 2002, P NATL ACAD SCI USA, V99, P3723, DOI 10.1073/pnas.062447999; CONDIE JM, 1989, DEV BIOL, V135, P31, DOI 10.1016/0012-1606(89)90155-3; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; DREESEN TD, 1991, GENE DEV, V5, P331, DOI 10.1101/gad.5.3.331; DUNAWAY M, 1989, NATURE, V341, P657, DOI 10.1038/341657a0; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fritsch C, 2006, CHROMOSOME RES, V14, P451, DOI 10.1007/s10577-006-1068-z; GELBART WM, 1982, P NATL ACAD SCI-BIOL, V79, P2636, DOI 10.1073/pnas.79.8.2636; GEORGIEV PG, 1995, P NATL ACAD SCI USA, V92, P5184, DOI 10.1073/pnas.92.11.5184; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gibson JB, 1999, BIOCHEM GENET, V37, P301, DOI 10.1023/A:1018707226595; Gohl D, 2008, GENETICS, V178, P127, DOI 10.1534/genetics.107.077768; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; HENIKOFF S, 1989, P NATL ACAD SCI USA, V86, P6704, DOI 10.1073/pnas.86.17.6704; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; JACK JW, 1979, P NATL ACAD SCI USA, V76, P1368, DOI 10.1073/pnas.76.3.1368; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kennison JA, 2002, ADV GENET, V46, P399; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LEISERSON WM, 1994, GENETICS, V138, P1171; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Liu H, 2008, J EXP MED, V205, P1843, DOI 10.1084/jem.20072102; LOCKE J, 1994, MOL GEN GENET, V243, P234, DOI 10.1007/BF00280321; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; MARTINEZLABORDA A, 1992, EMBO J, V11, P3645, DOI 10.1002/j.1460-2075.1992.tb05449.x; Matzke M, 2001, GENETICS, V158, P451; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Mellert DJ, 2012, GENETICS, V191, P1129, DOI 10.1534/genetics.112.140475; MODOLELL J, 1983, P NATL ACAD SCI-BIOL, V80, P1678, DOI 10.1073/pnas.80.6.1678; Morris JR, 1999, GENETICS, V151, P633; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Oh SW, 2003, GENETICS, V163, P195; PARKHURST SM, 1988, GENE DEV, V2, P1205, DOI 10.1101/gad.2.10.1205; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; PATTATUCCI AM, 1991, GENETICS, V129, P443; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Saint Phalle B, 2003, DROSOPHILA CYTOGENET, P373; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoborg TA, 2010, J MOL EVOL, V70, P74, DOI 10.1007/s00239-009-9310-x; SCHOLZ H, 1993, GENETICS, V135, P455; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sipos L, 1998, GENETICS, V149, P1031; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Spradling AC, 1999, GENETICS, V153, P135; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; Williams BR, 2007, GENETICS, V177, P31, DOI 10.1534/genetics.107.076356; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; WU CT, 1989, MOL GEN GENET, V218, P559, DOI 10.1007/BF00332424; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Zimmerman JE, 2000, GENETICS, V154, P237	83	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81331	10.1371/journal.pone.0081331	http://dx.doi.org/10.1371/journal.pone.0081331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236213	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700216
J	Adane, AA; Alene, KA; Koye, DN; Zeleke, BM				Adane, Akilew Awoke; Alene, Kefyalew Addis; Koye, Digsu Negese; Zeleke, Berihun Megabiaw			Non-Adherence to Anti-Tuberculosis Treatment and Determinant Factors among Patients with Tuberculosis in Northwest Ethiopia	PLOS ONE			English	Article							TB TREATMENT; ADHERENCE; THERAPY	Background: Non-adherence to anti tuberculosis treatment is one of the crucial challenges in improving tuberculosis cure-rates and reducing further healthcare costs. The poor adherence to anti-tuberculosis treatment among patients with tuberculosis is a major problem in Ethiopia. Hence, this study assessed level of non-adherence to anti-tuberculosis therapy and associated factors among patients with tuberculosis in northwest Ethiopia. Methods: An institution based cross-sectional survey was conducted among tuberculosis patients who were following anti-tuberculosis treatment in North Gondar zone from February 20 - March 30, 2013. Data were collected by trained data collectors using a structured and pre-tested questionnaire. Data were entered to EPI INFO version 3.5.3 and analyzed using statistical package for social sciences (SPSS) version 20. Multiple logistic regressions were fitted to identify associations and to control potential confounding variables. Odds ratio (OR) with 95% confidence interval was calculated and p-values <0.05 were considered statistically significant. Results: A total of 280 tuberculosis patients were interviewed; 55.7% were males and nearly three quarters (72.5%) were urban dwellers. The overall non-adherence for the last one month and the last four days before the survey were 10% and 13.6% respectively. Non-adherence was high if the patients had forgetfulness (AOR 7.04, 95% CI 1.40-35.13), is on the continuation phase of chemotherapy (AOR: 6.95, 95% CI 1.81-26.73), had symptoms of tuberculosis during the interview (AOR: 4.29, 95% CI 1.53-12.03), and had co-infection with HIV (AOR: 4.06, 95% CI 1.70-9.70). Conclusions: Non-adherence to anti-tuberculosis treatment was high. Forgetfulness, being in the continuation phases of chemotherapy, having symptoms of tuberculosis during the interview, and co-infected with HIV were significantly associated with non-adherence to anti-tuberculosis therapy. Special attention on adherence counseling should be given to symptomatic patients, TB/HIV co-infected patients, and those in the continuation phase of the tuberculosis therapy.	[Adane, Akilew Awoke; Alene, Kefyalew Addis; Koye, Digsu Negese; Zeleke, Berihun Megabiaw] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar	Adane, AA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia.	akilew24@gmail.com	Alene, Dr Kefyalew Addis/V-8240-2018; Adane, Akilew/AAG-3286-2019	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; Adane, Akilew Awoke/0000-0002-3022-5230; zeleke, BERIHUN/0000-0001-9369-3915; Koye, Digsu Negese/0000-0002-8442-3048	Research and Community Service Vice President office of the University of Gondar	Research and Community Service Vice President office of the University of Gondar	This research article was funded by Research and Community Service Vice President office of the University of Gondar. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abula T., 2001, Ethiopian Journal of Health Development, V15, P185; Amuha MG, 2009, AFR HEALTH SCI, V9, pS8; Awofeso N., 2008, B WHO, V86; Castelnuovo B, 2010, AFR HEALTH SCI, V10, P320; de Steenwinkel JEM, 2012, ANTIMICROB AGENTS CH, V56, P4937, DOI 10.1128/AAC.00124-12; Ethiopia FMoH, 2008, TUB LEPR TB HIV PREV; Fauci A, 2008, TUBERCULOSIS HARRISO; Garrido MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039134; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Govender S, 2009, S AFR FAM PRACT, V51, P512, DOI 10.1080/20786204.2009.10873916; Harries AD, 2004, TB HIV CLIN MANUAL; Kebede A, 2012, N AM J MED SCI, V4, P67, DOI 10.4103/1947-2714.93376; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Rocha M, 2003, EUR RESPIR J, V21, P785, DOI 10.1183/09031936.03.00077302; Sabate E, 2003, ADHERNECE LONG TERM; Sardar P, 2010, J COMMUN HEALTH, V35, P471, DOI 10.1007/s10900-009-9215-z; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Weiguo X, 2009, BMC HEALTH SERV RES, V9, P1472; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2011, WHO REP 2011	21	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78791	10.1371/journal.pone.0078791	http://dx.doi.org/10.1371/journal.pone.0078791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244364	Green Published, gold			2022-12-27	WOS:000327221600062
J	Chaudhuri, AD; Yelamanchili, SV; Fox, HS				Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Fox, Howard S.			MicroRNA-142 Reduces Monoamine Oxidase A Expression and Activity in Neuronal Cells by Downregulating SIRT1	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; A GENE PROMOTER; DOPAMINERGIC SYNAPSES; HIV-ENCEPHALITIS; DRUG-ABUSE; BRAIN; NEURODEGENERATION; DIFFERENTIATION; POLYMORPHISM; ASSOCIATION	Aberrant expression of microRNAs (miRs) has been implicated in the pathogenesis of several neurodegenerative disorders. In HIV-associated neurocognitive disorders (HAND), miR-142 was found to be upregulated in neurons and myeloid cells in the brain. We investigated the downstream effects of chronic miR-142 upregulation in neuronal cells by comparing gene expression in stable clones of the human neuroblastoma cell line BE(2) M17 expressing miR-142 to controls. Microarray analysis revealed that miR-142 expression led to a reduction in monoamine oxidase (MAO) A mRNA, which was validated by qRT-PCR. In addition to the mRNA, the MAOA protein level and enzyme activity were also reduced. Examination of primary human neurons revealed that miR-142 expression indeed resulted in a downregulation of MAOA protein level. Although MAOA is not a direct target of miR-142, SIRT1, a key transcriptional upregulator of MAOA is, thus miR-142 downregulation of MAOA expression is indirect. MiR-142 induced decrease in MAOA expression and activity may contribute to the changes in dopaminergic neurotransmission reported in HAND.	[Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Fox, HS (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hfox@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH [R01 MH073490, P30 MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, R01MH073490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by NIH grants R01 MH073490 and P30 MH062261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chaudhuri AD, 2013, FASEB J; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Gaskill PJ, 2013, J NEUROIMMUNE PHARM, V8, P621, DOI 10.1007/s11481-013-9443-y; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; Gersten M, 2009, J NEUROSCI, V29, P12467, DOI 10.1523/JNEUROSCI.3180-09.2009; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Jin HL, 2012, MOL CELLS, V34, P177, DOI 10.1007/s10059-012-0090-6; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kumar AM, 2009, J NEUROVIROL, V15, P257, DOI 10.1080/13550280902973952; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Naoi M, 2011, INT REV NEUROBIOL, V100, P85, DOI 10.1016/B978-0-12-386467-3.00005-4; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Pacifici M, 2013, J CELL PHYSIOL, V228, P1070, DOI 10.1002/jcp.24254; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Scheller C, 2010, J NEURAL TRANSM, V117, P699, DOI 10.1007/s00702-010-0415-6; Schulze TG, 2000, AM J MED GENET, V96, P801, DOI 10.1002/1096-8628(20001204)96:6<801::AID-AJMG21>3.3.CO;2-W; Shende VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065300; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tobon KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049288; Wang X., 2009, J VIS EXP; Winkler JM, 2012, J NEUROIMMUNE PHARM, V7, P372, DOI 10.1007/s11481-012-9344-5; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Yelamanchili SV, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.56; Yu YWY, 2005, NEUROPSYCHOPHARMACOL, V30, P1719, DOI 10.1038/sj.npp.1300785; Zhou L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677	39	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79579	10.1371/journal.pone.0079579	http://dx.doi.org/10.1371/journal.pone.0079579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244526	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600136
J	Fox, JW; Legault, G; Vasseur, DA; Einarson, JA				Fox, Jeremy W.; Legault, Geoff; Vasseur, David A.; Einarson, Jodie A.			Nonlinear Effect of Dispersal Rate on Spatial Synchrony of Predator-Prey Cycles	PLOS ONE			English	Article							POPULATION-DYNAMICS; PHASE-LOCKING; STABILITY; MODEL; PATTERNS; PERSISTENCE; EXTINCTION; ASYNCHRONY	Spatially-separated populations often exhibit positively correlated fluctuations in abundance and other population variables, a phenomenon known as spatial synchrony. Generation and maintenance of synchrony requires forces that rapidly restore synchrony in the face of desynchronizing forces such as demographic and environmental stochasticity. One such force is dispersal, which couples local populations together, thereby synchronizing them. Theory predicts that average spatial synchrony can be a nonlinear function of dispersal rate, but the form of the dispersal rate-synchrony relationship has never been quantified for any system. Theory also predicts that in the presence of demographic and environmental stochasticity, realized levels of synchrony can exhibit high variability around the average, so that ecologically-identical metapopulations might exhibit very different levels of synchrony. We quantified the dispersal rate-synchrony relationship using a model system of protist predator-prey cycles in pairs of laboratory microcosms linked by different rates of dispersal. Paired predator-prey cycles initially were anti-synchronous, and were subject to demographic stochasticity and spatially-uncorrelated temperature fluctuations, challenging the ability of dispersal to rapidly synchronize them. Mean synchrony of prey cycles was a nonlinear, saturating function of dispersal rate. Even extremely low rates of dispersal (<0.4% per prey generation) were capable of rapidly bringing initially anti-synchronous cycles into synchrony. Consistent with theory, ecologically-identical replicates exhibited very different levels of prey synchrony, especially at low to intermediate dispersal rates. Our results suggest that even the very low rates of dispersal observed in many natural systems are sufficient to generate and maintain synchrony of cyclic population dynamics, at least when environments are not too spatially heterogeneous.	[Fox, Jeremy W.; Legault, Geoff; Einarson, Jodie A.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Vasseur, David A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of Calgary; Yale University	Fox, JW (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jefox@ucalgary.ca		Legault, Geoffrey/0000-0003-2136-587X; Vasseur, David/0000-0003-1706-9613	National Sciences Foundation (NSF) DEB grant [2050803]; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant [RGPIN/311728-2010]	National Sciences Foundation (NSF) DEB grant(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Sciences Foundation (NSF) DEB grant 2050803 to David A. Vasseur. (www.nsf.gov). Natural Sciences and Engineering Research Council (NSERC) Discovery Grant RGPIN/311728-2010 to Jeremy W. Fox. (www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Abrams PA, 2011, J THEOR BIOL, V277, P99, DOI 10.1016/j.jtbi.2011.02.019; Bjornstad ON, 2000, J ANIM ECOL, V69, P869, DOI 10.1046/j.1365-2656.2000.00444.x; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Bowne DR, 2004, LANDSCAPE ECOL, V19, P1, DOI 10.1023/B:LAND.0000018357.45262.b9; Bressloff PC, 2013, J MATH BIOL, V67, P1669, DOI 10.1007/s00285-012-0607-9; Bunnell DB, 2010, OECOLOGIA, V162, P641, DOI 10.1007/s00442-009-1487-6; Crone EE, 2013, ECOL RES, V28, P133, DOI 10.1007/s11284-012-0942-8; de Valpine P, 2010, ECOL APPL, V20, P1926, DOI 10.1890/09-0468.1; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Donahue MJ, 2003, AM NAT, V162, P302, DOI 10.1086/377185; Fellous S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048436; Fox JW, 2007, AM NAT, V170, P396, DOI 10.1086/519855; Fox JW, 2011, ECOL LETT, V14, P163, DOI 10.1111/j.1461-0248.2010.01567.x; Goldwyn EE, 2008, THEOR POPUL BIOL, V73, P395, DOI 10.1016/j.tpb.2007.11.012; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; Holyoak M, 2000, ECOLOGY, V81, P3312, DOI 10.2307/177496; HUDSON DJ, 1971, J ROY STAT SOC B, V33, P256; Kaitala V, 2001, P ROY SOC B-BIOL SCI, V268, P1655, DOI 10.1098/rspb.2001.1721; Kendall BE, 1998, ECOL LETT, V1, P160; Koenig WD, 2002, ECOGRAPHY, V25, P283, DOI 10.1034/j.1600-0587.2002.250304.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; LUCKINBILL LS, 1979, ECOLOGY, V60, P1098, DOI 10.2307/1936956; LUCKINBILL LS, 1973, ECOLOGY, V54, P1320, DOI 10.2307/1934194; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Simonis JL, 2012, ECOLOGY, V93, P1517, DOI 10.1890/11-0460.1; Sutcliffe OL, 1996, J ANIM ECOL, V65, P85, DOI 10.2307/5702; Vasseur DA, 2007, OIKOS, V116, P1726, DOI 10.1111/j.2007.0030-1299.16101.x; Vasseur DA, 2009, NATURE, V460, P1007, DOI 10.1038/nature08208; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Yaari G, 2012, ECOLOGY, V93, P1214, DOI 10.1890/11-1077.1	34	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79527	10.1371/journal.pone.0079527	http://dx.doi.org/10.1371/journal.pone.0079527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244520	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600132
J	Gorska, A; Swiatkowska, A; Dutkiewicz, M; Ciesiolka, J				Gorska, Agnieszka; Swiatkowska, Agata; Dutkiewicz, Mariola; Ciesiolka, Jerzy			Modulation of p53 Expression Using Antisense Oligonucleotides Complementary to the 5 '-Terminal Region of p53 mRNA In Vitro and in the Living Cells	PLOS ONE			English	Article							SECONDARY STRUCTURE; NUCLEIC-ACIDS; TRANSLATION; ISOFORMS; OLIGODEOXYNUCLEOTIDES; PROTEIN; STRESS; TARGET; MUTATIONS; SOFTWARE	The p53 protein is a key player in cell response to stress events and cancer prevention. However, up-regulation of p53 that occurs during radiotherapy of some tumours results in radio-resistance of targeted cells. Recently, antisense oligonucleotides have been used to reduce the p53 level in tumour cells which facilitates their radiation-induced apoptosis. Here we describe the rational design of antisense oligomers directed against the 5'-terminal region of p53 mRNA aimed to inhibit the synthesis of p53 protein and its Delta Np53 isoform. A comprehensive analysis of the sites accessible to oligomer hybridization in this mRNA region was performed. Subsequently, translation efficiency from the initiation codons for both proteins in the presence of selected oligomers was determined in rabbit reticulocyte lysate and in MCF-7 cells. The antisense oligomers with 2'-OMe and LNA modifications were used to study the mechanism of their impact on translation. It turned out that the remaining RNase H activity of the lysate contributed to modulation of protein synthesis efficiency which was observed in the presence of antisense oligomers. A possibility of changing the ratio of the newly synthetized p53 and DNp53 in a controlled manner was revealed which is potentially very attractive considering the relationship between the functioning of these two proteins. Selected antisense oligonucleotides which were designed based on accessibility mapping of the 5'-terminal region of p53 mRNA were able to significantly reduce the level of p53 protein in MCF-7 cells. One of these oligomers might be used in the future as a support treatment in anticancer therapy.	[Gorska, Agnieszka; Swiatkowska, Agata; Dutkiewicz, Mariola; Ciesiolka, Jerzy] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Ciesiolka, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	jerzy.ciesiolka@ibch.poznan.pl	Swiatkowska, Agata/W-4117-2018; Dutkiewicz, Mariola/AAG-5242-2021; Dutkiewicz, Mariola/M-5588-2016	Swiatkowska, Agata/0000-0002-3100-2952; Dutkiewicz, Mariola/0000-0003-1098-0308; Dutkiewicz, Mariola/0000-0003-1098-0308	Polish Ministry of Science and Higher Education [NN301272037]; Foundation for Polish Science [HOMING PLUS/2012-6/15]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the Polish Ministry of Science and Higher Education (Grant no. NN301272037) to JC and by a grant from the Foundation for Polish Science (HOMING PLUS/2012-6/15) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Alvarez-Salas LM, 2008, CURR TOP MED CHEM, V8, P1379, DOI 10.2174/156802608786141133; Blaszczyk L, 2011, BIOCHEMISTRY-US, V50, P7080, DOI 10.1021/bi200659b; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; CAZENAVE C, 1993, BIOCHIMIE, V75, P113, DOI 10.1016/0300-9084(93)90032-N; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dias N, 2002, MOL CANCER THER, V1, P347; Evers MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024308; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; HAEUPTLE MT, 1986, NUCLEIC ACIDS RES, V14, P1427, DOI 10.1093/nar/14.3.1427; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kirsebom LA, 2013, HDB RNA BIOCH; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liao FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059112; Liu XF, 2006, CELL BIOL INT, V30, P283, DOI 10.1016/j.cellbi.2005.11.010; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Mescalchin A, 2011, MOLECULES, V16, P1271, DOI 10.3390/molecules16021271; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Mitrpant C, 2009, MOL THER, V17, P1418, DOI 10.1038/mt.2009.49; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Ravichandran LV, 2004, OLIGONUCLEOTIDES, V14, P49, DOI 10.1089/154545704322988058; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Sak A, 2003, CANCER GENE THER, V10, P926, DOI 10.1038/sj.cgt.7700649; Swiatkowska A, 2007, BIOCHEMISTRY-US, V46, P5523, DOI 10.1021/bi6024287; Tian H, 2000, CANCER RES, V60, P679; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Wrzesinski J, 2000, NUCLEIC ACIDS RES, V28, P1785, DOI 10.1093/nar/28.8.1785; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78863	10.1371/journal.pone.0078863	http://dx.doi.org/10.1371/journal.pone.0078863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244378	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600074
J	Harriff, MJ; Burgdorf, S; Kurts, C; Wiertz, EJHJ; Lewinsohn, DA; Lewinsohn, DM				Harriff, Melanie J.; Burgdorf, Sven; Kurts, Christian; Wiertz, Emmanuel J. H. J.; Lewinsohn, Deborah A.; Lewinsohn, David M.			TAP Mediates Import of Mycobacterium tuberculosis-Derived Peptides into Phagosomes and Facilitates Loading onto HLA-I	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGENS; MACROPHAGES; CELLS; TRAFFICKING; COMPARTMENT; ORGANELLES; INFECTION; ACCESS	Processing and presentation of antigen on MHC-I class I molecules serves to present peptides derived from cytosolic proteins to CD8(+) T cells. Infection with bacteria that remain in phagosomal compartments, such as Mycobacterium tuberculosis (Mtb), provides a challenge to this immune recognition as bacterial proteins are segregated from the cytosol. Previously we identified the Mtb phagosome itself as an organelle capable of loading MHC Class I molecules with Mtb antigens. Here, we find that the TAP transporter, responsible for importing peptides into the ER for loading in Class I molecules, is both present and functional in Mtb phagosomes. Furthermore, we describe a novel peptide reagent, representing the N-terminal domain of the bovine herpes virus UL49.5 protein, which is capable of specifically inhibiting the lumenal face of TAP. Together, these results provide insight into the mechanism by which peptides from intra-phagosomal pathogens are loaded onto Class I molecules.	[Harriff, Melanie J.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR 97239 USA; [Harriff, Melanie J.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Burgdorf, Sven] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Burgdorf, Sven; Kurts, Christian] Univ Bonn, IMMEI, Bonn, Germany; [Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Lewinsohn, Deborah A.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; University of Bonn; University of Bonn; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Oregon Health & Science University; Oregon Health & Science University	Harriff, MJ (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	harriffm@ohsu.edu; lewinsod@ohsu.edu; lewinsod@ohsu.edu	Lewinsohn, David/I-4936-2013	Lewinsohn, David/0000-0001-9906-9494	National Institutes of Health [R01AI048090, T32HL083808]; Veterans Affairs Hospitals Merit Review Grant; Portland Veterans Affairs Medical Center; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [S10-RR023432]; Oregon Health & Sciences University MMI Imaging Core; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Hospitals Merit Review Grant; Portland Veterans Affairs Medical Center; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oregon Health & Sciences University MMI Imaging Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health Grants R01AI048090 and T32HL083808, a Veterans Affairs Hospitals Merit Review Grant, and the Portland Veterans Affairs Medical Center. The microscopy in this publication was made possible in part by Grant Number S10-RR023432 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and the Oregon Health & Sciences University MMI Imaging Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Grotzke JE, 2010, J IMMUNOL, V185, P4336, DOI 10.4049/jimmunol.1000801; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Horst D, 2011, IMMUNOL CELL BIOL; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437; Loch S, 2008, J BIOL CHEM, V283, P13428, DOI 10.1074/jbc.M800226200; Mazzaccaro RJ, 1996, P NATL ACAD SCI USA, V93, P11786, DOI 10.1073/pnas.93.21.11786; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Ramachandra L, 1999, J IMMUNOL, V162, P3263; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verweij MC, 2008, J IMMUNOL, V181, P4894, DOI 10.4049/jimmunol.181.7.4894; XU SM, 1994, J IMMUNOL, V153, P2568	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79571	10.1371/journal.pone.0079571	http://dx.doi.org/10.1371/journal.pone.0079571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244525	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600135
J	Hartmann, S; Doring, C; Jakobus, C; Rengstl, B; Newrzela, S; Tousseyn, T; Sagaert, X; Ponzoni, M; Facchetti, F; de Wolf-Peeters, C; Steidl, C; Gascoyne, R; Kuppers, R; Hansmann, ML				Hartmann, Sylvia; Doering, Claudia; Jakobus, Christina; Rengstl, Benjamin; Newrzela, Sebastian; Tousseyn, Thomas; Sagaert, Xavier; Ponzoni, Maurilio; Facchetti, Fabio; de Wolf-Peeters, Chris; Steidl, Christian; Gascoyne, Randy; Kueppers, Ralf; Hansmann, Martin-Leo			Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; REED-STERNBERG CELLS; DIFFERENTIAL-DIAGNOSIS; CLINICAL PRESENTATION; PROGNOSTIC-FACTORS; HISTIOCYTE-RICH; EXPRESSION; PATTERNS; SURVIVAL; PROTEIN	In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis. Besides the different clinical presentations of these lymphoma entities, there are variants of NLPHL with considerable histopathologic overlap compared to THRLBCL. Especially THRLBCL-like NLPHL, a diffuse form of NLPHL, often presents a histopathologic pattern similar to THRLBCL, suggesting a close relationship between both lymphoma entities. To corroborate this hypothesis, we performed gene expression profiling of microdissected tumor cells of NLPHL, THRLBCL-like NLPHL and THRLBCL. In unsupervised analyses, the lymphomas did not cluster according to their entity. Moreover, even in supervised analyses, very few consistently differentially expressed transcripts were found, and for these genes the extent of differential expression was only moderate. Hence, there are no clear and consistent differences in the gene expression of the tumor cells of NLPHL, THRLBCL-like NLPHL and THRLBCL. Based on the gene expression studies, we identified BAT3/BAG6, HIGD1A, and FAT10/UBD as immunohistochemical markers expressed in the tumor cells of all three lymphomas. Characterization of the tumor microenvironment for infiltrating T cells and histiocytes revealed significant differences in the cellular composition between typical NLPHL and THRLBCL cases. However, THRLBCL-like NLPHL presented a histopathologic pattern more related to THRLBCL than NLPHL. In conclusion, NLPHL and THRLBCL may represent a spectrum of the same disease. The different clinical behavior of these lymphomas may be strongly influenced by differences in the lymphoma microenvironment, possibly related to the immune status of the patient at the timepoint of diagnosis.	[Hartmann, Sylvia; Doering, Claudia; Jakobus, Christina; Rengstl, Benjamin; Newrzela, Sebastian; Hansmann, Martin-Leo] Goethe Univ Frankfurt, Dr Senckenberg Inst Pathol, D-60054 Frankfurt, Germany; [Tousseyn, Thomas; Sagaert, Xavier; de Wolf-Peeters, Chris] Univ Hosp KU Leuven, Dept Pathol, Louvain, Belgium; [Ponzoni, Maurilio] Ist Sci San Raffaele, Dept Pathol, Unit Lymphoid Malignancies, I-20132 Milan, Italy; [Facchetti, Fabio] Univ Brescia, Dept Pathol, Brescia, Italy; [Steidl, Christian; Gascoyne, Randy] Univ British Columbia, British Columbia Canc Agcy, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Steidl, Christian; Gascoyne, Randy] Univ British Columbia, British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 1M9, Canada; [Kueppers, Ralf] Univ Duisburg Essen, Fac Med, Inst Cell Biol Canc Res, Essen, Germany	Goethe University Frankfurt; KU Leuven; University Hospital Leuven; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of Duisburg Essen	Hartmann, S (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Pathol, D-60054 Frankfurt, Germany.	s.hartmann@em.uni-frankfurt.de	Hartmann, Sylvia/AAJ-4376-2021; FACCHETTI, Fabio/E-7190-2010	Kuppers, Ralf/0000-0002-6691-7191; Tousseyn, Thomas/0000-0002-0397-1086; FACCHETTI, Fabio/0000-0003-4975-2388	Deutsche Forschungsgemeinschaft [HA 6145/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft grant HA 6145/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten R, 2002, HISTOPATHOLOGY, V40, P31, DOI 10.1046/j.1365-2559.2002.01291.x; Achten R, 2002, J CLIN ONCOL, V20, P1269, DOI 10.1200/JCO.20.5.1269; Bouabdallah R, 2003, J CLIN ONCOL, V21, P1271, DOI 10.1200/JCO.2003.06.046; Boudova L, 2003, BLOOD, V102, P3753, DOI 10.1182/blood-2003-02-0626; Braeuninger A, 1997, P NATL ACAD SCI USA, V94, P9337, DOI 10.1073/pnas.94.17.9337; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; CHITTAL SM, 1988, AM J SURG PATHOL, V12, P9, DOI 10.1097/00000478-198801000-00002; Churchill HRO, 2010, HUM PATHOL, V41, P1726, DOI 10.1016/j.humpath.2010.05.010; Diehl V, 1999, J CLIN ONCOL, V17, P776, DOI 10.1200/JCO.1999.17.3.776; Dogan A, 2003, AM J SURG PATHOL, V27, P903, DOI 10.1097/00000478-200307000-00005; Fan Z, 2003, AM J SURG PATHOL, V27, P1346, DOI 10.1097/00000478-200310000-00007; Felgar RE, 1997, AM J PATHOL, V150, P1893; Fraga M, 2002, HISTOPATHOLOGY, V41, P216, DOI 10.1046/j.1365-2559.2002.01466.x; Franke S, 2002, AM J PATHOL, V161, P1861, DOI 10.1016/S0002-9440(10)64462-8; Franke S, 2001, BLOOD, V97, P1845, DOI 10.1182/blood.V97.6.1845; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Grogg KL, 2006, MODERN PATHOL, V19, P1101, DOI 10.1038/modpathol.3800625; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040836; Hartmann S, 2013, MOD PATHOL; Hartmann S, INT J CANC IN PRESS; Hartmann S, 2011, HISTOPATHOLOGY, V59, P1173, DOI 10.1111/j.1365-2559.2011.04069.x; Hayashi H, 2012, FASEB J, V26, P2306, DOI 10.1096/fj.11-196063; Hentrich M, 2012, J CLIN ONCOL, V30, P4117, DOI 10.1200/JCO.2012.41.8137; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Jin K, 2002, NEUROCHEM RES, V27, P1105, DOI 10.1023/A:1020913123054; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kasper LH, 2006, CELL CYCLE, V5, P142, DOI 10.4161/cc.5.2.2353; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Kraus MD, 2000, AM J SURG PATHOL, V24, P1068, DOI 10.1097/00000478-200008000-00004; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Maggio EM, 2002, INT J CANCER, V99, P665, DOI 10.1002/ijc.10399; Marafioti T, 2004, HAEMATOLOGICA, V89, P957; Marafioti T, 2010, HAEMATOL-HEMATOL J, V95, P432, DOI 10.3324/haematol.2009.010991; Mourad Walid A, 2008, Hematol Oncol Stem Cell Ther, V1, P22; Nam-Cha SH, 2008, AM J SURG PATHOL, V32, P1252, DOI 10.1097/PAS.0b013e318165b0d6; Nathwani B, 2013, HUM PATHOL; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; RAMSAY AD, 1988, AM J SURG PATHOL, V12, P433, DOI 10.1097/00000478-198806000-00003; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Rudiger T, 2002, ANN ONCOL, V13, P44, DOI 10.1093/annonc/13.S1.44; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; SCHMID C, 1991, AM J PATHOL, V139, P1281; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tousseyn T, 2011, VIRCHOWS ARCH, V459, P557, DOI 10.1007/s00428-011-1165-z; Tzankov A, 2010, PATHOBIOLOGY, V77, P301, DOI 10.1159/000321567; Van Loo P, 2010, HAEMATOL-HEMATOL J, V95, P440, DOI 10.3324/haematol.2009.009647; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wlodarska I, 2003, BLOOD, V101, P706, DOI 10.1182/blood-2002-05-1592	58	66	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78812	10.1371/journal.pone.0078812	http://dx.doi.org/10.1371/journal.pone.0078812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244368	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600066
J	Horjales-Araujo, E; Demontis, D; Lund, EK; Finnerup, NB; Borglum, AD; Jensen, TS; Svensson, P; Vase, L				Horjales-Araujo, Emilia; Demontis, Ditte; Lund, Ellen Kielland; Finnerup, Nanna Brix; Borglum, Anders D.; Jensen, Troels Staehelin; Svensson, Peter; Vase, Lene			Polymorphism in Serotonin Receptor 3B Is Associated with Pain Catastrophizing	PLOS ONE			English	Article							LOW-BACK-PAIN; TRANSPORTER PROMOTER POLYMORPHISM; PLATELET MONOAMINE-OXIDASE; BIPOLAR AFFECTIVE-DISORDER; BIASED ATTENTION; FUNCTIONAL POLYMORPHISM; ANTIDEPRESSANT RESPONSE; COLORECTAL DISTENSION; 5-HTTLPR POLYMORPHISM; GENE POLYMORPHISMS	Pain catastrophizing, a coping style characterized by excessively negative thoughts and emotions in relation to pain, is one of the psychological factors that most markedly predicts variability in the perception of pain; however, only little is known about the underlying neurobiology. The aim of this study was to test for associations between psychological variables, such as pain catastrophizing, anxiety and depression, and selected polymorphisms in genes related to monoaminergic neurotransmission, in particular serotonin pathway genes. Three hundred seventy-nine healthy participants completed a set of psychological questionnaires: the Pain Catastrophizing Scale (PCS), the State-Trait Anxiety Inventory and Beck's Depression Inventory, and were genotyped for 15 single nucleotide polymorphisms (SNPs) in nine genes. The SNP rs1176744 located in the serotonin receptor 3B gene (5-HTR3B) was found to be associated with pain catastrophizing scores: both the global score and the subscales of magnification and helplessness. This is the first study to show an association between 5-HTR3B and PCS scores, thus suggesting a role of the serotonin pathway in pain catastrophizing. Since 5-HTR3B has previously been associated with descending pain modulation pathways, future studies will be of great interest to elucidate the molecular pathways involved in the relation between serotonin, its receptors and pain catastrophizing.	[Horjales-Araujo, Emilia; Lund, Ellen Kielland; Finnerup, Nanna Brix; Jensen, Troels Staehelin; Vase, Lene] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark; [Horjales-Araujo, Emilia; Svensson, Peter] Aarhus Univ Hosp, MindLab, CFIN, DK-8000 Aarhus, Denmark; [Demontis, Ditte; Borglum, Anders D.] Aarhus Univ, Dept Biomed, iPSYCH, Aarhus, Denmark; [Demontis, Ditte; Borglum, Anders D.] Aarhus Univ, Ctr Integrat Sequencing iSEQ, Aarhus, Denmark; [Vase, Lene] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Jensen, Troels Staehelin] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Svensson, Peter] Aarhus Univ, Sect Clin Oral Physiol, Dept Dent, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University; Aarhus University; Aarhus University	Horjales-Araujo, E (corresponding author), Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark.	emilia.horjales@ki.au.dk	Svensson, Peter/H-6735-2012; Finnerup, Nanna Brix/ABA-8219-2020; Jensen, Troels Staehelin/A-3418-2009	Finnerup, Nanna Brix/0000-0001-5541-0240; Jensen, Troels Staehelin/0000-0002-3487-6380; /0000-0002-3503-8338; Vase, Lene/0000-0002-0379-2256; Demontis, Ditte/0000-0001-9124-2766; Borglum, Anders/0000-0001-8627-7219; Schaldemose, Ellen/0000-0002-0994-648X	MindLab; Center for Functionally Integrative Neuroscience (CFIN); Aarhus University Hospital; Faculty of Health Sciences, Aarhus University, Aarhus, Denmark	MindLab; Center for Functionally Integrative Neuroscience (CFIN); Aarhus University Hospital; Faculty of Health Sciences, Aarhus University, Aarhus, Denmark	The study has received economic support from MindLab, Center for Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital and from the Faculty of Health Sciences, Aarhus University, Aarhus, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2011, PSYCHIAT RES, V187, P312, DOI 10.1016/j.psychres.2010.09.015; Aoki J, 2010, J CLIN NEUROSCI, V17, P574, DOI 10.1016/j.jocn.2009.08.020; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bayerer B, 2010, HEADACHE, V50, P319, DOI 10.1111/j.1526-4610.2009.01553.x; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bee LA, 2008, PAIN, V140, P209, DOI 10.1016/j.pain.2008.08.008; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Benedetti F, 2008, J CLIN PSYCHOPHARM, V28, P249, DOI 10.1097/JCP.0b013e318167461e; Bilge SS, 2012, EUR J PHARMACOL, V681, P44, DOI 10.1016/j.ejphar.2012.01.043; Bloch MH, 2008, AM J MED GENET B, V147B, P850, DOI 10.1002/ajmg.b.30699; Bouchard TJ, 2001, BEHAV GENET, V31, P243; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; BUCHSBAUM MS, 1977, ACTA PSYCHIAT SCAND, V56, P69, DOI 10.1111/j.1600-0447.1977.tb06665.x; Calati R, 2011, INT J EAT DISORDER, V44, P191, DOI 10.1002/eat.20811; Campbell CM, 2009, TRANSL RES, V153, P97, DOI 10.1016/j.trsl.2008.12.002; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Contini V, 2012, DRUG ALCOHOL DEPEN, V122, P100, DOI 10.1016/j.drugalcdep.2011.09.020; Costa P.T., 1992, PSYCHOL ASSESS RES; CRISP T, 1991, GEN PHARMACOL-VASC S, V22, P247, DOI 10.1016/0306-3623(91)90441-8; DANZEBRINK RM, 1991, BRAIN RES, V538, P64, DOI 10.1016/0006-8993(91)90377-8; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dlugos AM, 2009, J NEURAL TRANSM, V116, P1323, DOI 10.1007/s00702-009-0281-2; Doehring A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017724; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; Edwards RR, 2008, PAIN, V140, P135, DOI 10.1016/j.pain.2008.07.024; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Fowler JS, 2000, AM J PSYCHIAT, V157, P1864, DOI 10.1176/appi.ajp.157.11.1864; Fox E, 2010, BIOL PSYCHIAT, V67, P371, DOI 10.1016/j.biopsych.2009.11.018; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Frazer A, 1994, BASIC NEUROCHEMISTRY, P304; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; GLAUM SR, 1988, NEUROSCI LETT, V95, P313, DOI 10.1016/0304-3940(88)90677-5; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Graeff FG, 2002, PSYCHOPHARMACOLOGY, V163, P467, DOI 10.1007/s00213-002-1112-4; Graeff FG, 1997, NEUROSCI BIOBEHAV R, V21, P791, DOI 10.1016/S0149-7634(96)00059-0; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Gyawali S, 2010, BIOL PSYCHIAT, V67, P331, DOI 10.1016/j.biopsych.2009.10.015; Hammer C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.30; Hammer C, 2009, PHARMACOGENET GENOM, V19, P790, DOI 10.1097/FPC.0b013e32833132b3; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Horjales-Araujo E, 2013, PAIN; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Iordanidou M, 2010, DRUG ALCOHOL DEPEN, V108, P70, DOI 10.1016/j.drugalcdep.2009.11.015; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kato M, 2009, AM J MED GENET B, V150B, P115, DOI 10.1002/ajmg.b.30783; Kenntner-Mabiala R, 2005, PSYCHOPHYSIOLOGY, V42, P559, DOI 10.1111/j.1469-8986.2005.00310.x; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kim H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-24; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2008, PHARMACOGENET GENOM, V18, P1027, DOI 10.1097/FPC.0b013e328310f950; Lei XM, 2012, J PSYCHIATR RES, V46, P1153, DOI 10.1016/j.jpsychires.2012.05.002; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li J, 2008, AM J MED GENET B, V147B, P370, DOI 10.1002/ajmg.b.30606; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018252; Lucae S, 2010, EUR NEUROPSYCHOPHARM, V20, P65, DOI 10.1016/j.euroneuro.2009.08.006; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; McAuley EZ, 2009, PSYCHIAT GENET, V19, P244, DOI 10.1097/YPG.0b013e32832ceea9; McBride WJ, 2004, ALCOHOL CLIN EXP RES, V28, P257, DOI 10.1097/01.ALC.0000113419.99915.DA; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Meagher MW, 2001, PSYCHOSOM MED, V63, P79, DOI 10.1097/00006842-200101000-00010; Melke J, 2003, ARCH GEN PSYCHIAT, V60, P1017, DOI 10.1001/archpsyc.60.10.1017; Meltzer H Y, 1986, Ann N Y Acad Sci, V487, P271, DOI 10.1111/j.1749-6632.1986.tb27906.x; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; MILLAN MJ, 1994, PAIN, V58, P45, DOI 10.1016/0304-3959(94)90184-8; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Nyegaard M, 2010, AM J MED GENET B, V153B, P582, DOI 10.1002/ajmg.b.31023; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; PLETSCHER A, 1991, EXPERIENTIA, V47, P4, DOI 10.1007/BF02041242; Porcelli S, 2011, CLIN NEUROPSYCHIATR, V8, P99; Porcelli S, 2011, J PSYCHIATR NEUROSCI, V36, P87, DOI 10.1503/jpn.100059; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Rahman W, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-45; Rhudy JL, 2007, J PAIN, V8, P325, DOI 10.1016/j.jpain.2006.10.003; Rockett MP, 2013, BR J ANAESTH; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Roy M, 2009, P NATL ACAD SCI USA, V106, P20900, DOI 10.1073/pnas.0904706106; Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Seneviratne C, 2009, ALCOHOL CLIN EXP RES, V33, P332, DOI 10.1111/j.1530-0277.2008.00837.x; Serretti A, 2007, PROG NEURO-PSYCHOPH, V31, P1275, DOI 10.1016/j.pnpbp.2007.05.008; Serretti A, 2007, CURR MED CHEM, V14, P2053; Shih JC, 1999, POL J PHARMACOL, V51, P25; Spielberger CD, 1997, MANUAL STATA TRAIT A; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tander B, 2008, RHEUMATOL INT, V28, P685, DOI 10.1007/s00296-008-0525-8; Treister R, 2011, J PAIN, V12, P875, DOI 10.1016/j.jpain.2011.02.348; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Turner TJ, 2004, NEUROSCIENCE, V129, P703, DOI 10.1016/j.neuroscience.2004.08.020; Umriukhin AE, 2002, STRESS, V5, P299, DOI 10.1080/1025389021000061200; Urata T, 2007, NEUROSCI LETT, V414, P209, DOI 10.1016/j.neulet.2006.12.018; van Tulder MW, 2001, SPINE, V26, P270, DOI 10.1097/00007632-200102010-00012; Vase L, 2011, PAIN, V152, P157, DOI 10.1016/j.pain.2010.10.013; Vervoort T, 2010, EUR J PAIN, V14, P90, DOI 10.1016/j.ejpain.2009.03.001; Vijayan NN, 2009, J HUM GENET, V54, P538, DOI 10.1038/jhg.2009.76; Villafuerte SM, 2009, PSYCHIAT GENET, V19, P281, DOI 10.1097/YPG.0b013e32832a506e; Villemure C, 2009, J NEUROSCI, V29, P705, DOI 10.1523/JNEUROSCI.3822-08.2009; VONKNORRING AL, 1991, ALCOHOL ALCOHOLISM, V26, P409, DOI 10.1093/oxfordjournals.alcalc.a045132; Walstab J, 2008, PHARMACOGENET GENOM, V18, P793, DOI 10.1097/FPC.0b013e3283050117; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; WISE CD, 1972, SCIENCE, V177, P180, DOI 10.1126/science.177.4044.180; Xiang XH, 2012, PHYSIOL GENOMICS, V44, P318, DOI 10.1152/physiolgenomics.00162.2011; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Zachariae R, 2001, AM HEART J, V142, P63, DOI 10.1067/mhj.2001.115794; ZISOOK S, 1985, PSYCHOSOMATICS, V26, P240, DOI 10.1016/S0033-3182(85)72877-0	120	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78889	10.1371/journal.pone.0078889	http://dx.doi.org/10.1371/journal.pone.0078889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244382	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600078
J	Yao, HW; Sundar, IK; Gorbunova, V; Rahman, I				Yao, Hongwei; Sundar, Isaac K.; Gorbunova, Vera; Rahman, Irfan			P21-PARP-1 Pathway Is Involved in Cigarette Smoke-Induced Lung DNA Damage and Cellular Senescence	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; INFLAMMATORY CYTOKINE SECRETION; OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR EPITHELIAL-CELLS; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE-1; HOMOLOGOUS RECOMBINATION; OXIDATIVE STRESS; IN-VIVO; NUCLEAR ANTIGEN	Persistent DNA damage triggers cellular senescence, which may play an important role in the pathogenesis of cigarette smoke (CS)-induced lung diseases. Both p21(CDKN1A) (p21) and poly(ADP-ribose) polymerase-1 (PARP-1) are involved in DNA damage and repair. However, the role of p21-PARP-1 axis in regulating CS-induced lung DNA damage and cellular senescence remains unknown. We hypothesized that CS causes DNA damage and cellular senescence through a p21-PARP-1 axis. To test this hypothesis, we determined the levels of gamma H2AX (a marker for DNA double-strand breaks) as well as non-homologous end joining proteins (Ku70 and Ku80) in lungs of mice exposed to CS. We found that the level of gamma H2AX was increased, whereas the level of Ku70 was reduced in lungs of CS-exposed mice. Furthermore, p21 deletion reduced the level of gamma H2AX, but augmented the levels of Ku70, Ku80, and PAR in lungs by CS. Administration of PARP-1 inhibitor 3-aminobenzamide increased CS-induced DNA damage, but lowered the levels of Ku70 and Ku80, in lungs of p21 knockout mice. Moreover, 3-aminobenzamide increased senescence-associated beta-galactosidase activity, but decreased the expression of proliferating cell nuclear antigen in mouse lungs in response to CS. Interestingly, 3-aminobenzamide treatment had no effect on neutrophil influx into bronchoalveolar lavage fluid by CS. These results demonstrate that the p21-PARP-1 pathway is involved in CS-induced DNA damage and cellular senescence.	[Yao, Hongwei; Sundar, Isaac K.; Rahman, Irfan] Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Gorbunova, Vera] Univ Rochester, Med Ctr, Dept Biol, Rochester, NY 14642 USA	University of Rochester	Yao, HW (corresponding author), Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Hongwei_Yao@urmc.rochester.edu; irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010	Sundar, Isaac K/0000-0001-6742-3460; Gorbunova, Vera/0000-0001-8979-0333	National Institutes of Health (NIH) [1R01HL092842, 2R01HL085613, 1R01HL097751]; American Lung Association [RG-266456-N]; NIEHS Environmental Health Science Center [P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, R01HL092842, R01HL097751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027237] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NIEHS Environmental Health Science Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (NIH) 1R01HL092842, 2R01HL085613, 1R01HL097751 (to IR), American Lung Association RG-266456-N (to HY), and NIEHS Environmental Health Science Center grant P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Caramori G, 2011, THORAX, V66, P521, DOI 10.1136/thx.2010.156448; Cazzalini O, 2010, DNA REPAIR, V9, P627, DOI 10.1016/j.dnarep.2010.02.011; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Ceylan E, 2006, RESP MED, V100, P1270, DOI 10.1016/j.rmed.2005.10.011; Claybon A, 2010, NUCLEIC ACIDS RES, V38, P7538, DOI 10.1093/nar/gkq624; Cooper MP, 1999, MOL BIOL CELL, V10, P2119, DOI 10.1091/mbc.10.7.2119; Couto CAM, 2011, J CELL BIOL, V194, P367, DOI 10.1083/jcb.201012132; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Dolan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055190; Efimova EV, 2010, CANCER RES, V70, P6277, DOI 10.1158/0008-5472.CAN-09-4224; Genovese T, 2005, J PHARMACOL EXP THER, V313, P529, DOI 10.1124/jpet.104.080705; Hageman GJ, 2003, FREE RADICAL BIO MED, V35, P140, DOI 10.1016/S0891-5849(03)00237-5; Herbig U, 2003, AGING CELL, V2, P295, DOI 10.1046/j.1474-9728.2003.00067.x; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jakob B, 2002, INT J RADIAT BIOL, V78, P75, DOI 10.1080/09553000110090007; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kamp DW, 2001, J INVEST MED, V49, P68, DOI 10.2310/6650.2001.34092; Koike M, 2011, BIOCHEM BIOPH RES CO, V412, P39, DOI 10.1016/j.bbrc.2011.07.032; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Lee JY, 2009, BIOCHEM BIOPH RES CO, V390, P1361, DOI 10.1016/j.bbrc.2009.10.160; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Liu XD, 2005, AM J RESP CELL MOL, V33, P121, DOI 10.1165/rcmb.2003-0341OC; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marwick JA, 2002, ANN NY ACAD SCI, V973, P278, DOI 10.1111/j.1749-6632.2002.tb04649.x; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Neofytou E, 2012, INT J MOL SCI, V13, P16853, DOI 10.3390/ijms131216853; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Oit-Wiscombe I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070333; Pagano A, 2007, AM J PHYSIOL-LUNG C, V293, pL619, DOI 10.1152/ajplung.00037.2007; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pastukh VM, 2011, INT J CHRONIC OBSTR, V6, P209, DOI 10.2147/COPD.S15922; Perucca P, 2006, J CELL SCI, V119, P1517, DOI 10.1242/jcs.02868; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shi Y, 2012, AM J RESP CRIT CARE, V186, P412, DOI 10.1164/rccm.201111-2023OC; Stivala LA, 2001, ONCOGENE, V20, P563, DOI 10.1038/sj.onc.1204132; te Poele RH, 2002, CANCER RES, V62, P1876; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022	64	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80007	10.1371/journal.pone.0080007	http://dx.doi.org/10.1371/journal.pone.0080007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244594	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600171
J	Chen, HH; Zha, JM; Liang, XF; Bu, JH; Wang, M; Wang, ZJ				Chen, Huihui; Zha, Jinmiao; Liang, Xuefang; Bu, Jihong; Wang, Miao; Wang, Zijian			Sequencing and De Novo Assembly of the Asian Clam (Corbicula fluminea) Transcriptome Using the Illumina GAIIx Method	PLOS ONE			English	Article							FRESH-WATER CLAM; MOLECULAR-CLONING; EXPRESSION; PROTEIN; BIVALVIA; GENE; EVOLUTIONARY; GENERATION; EXPOSURE; STRESS	Background: The Asian clam (Corbicula fluminea) is currently one of the most economically important aquatic species in China and has been used as a test organism in many environmental studies. However, the lack of genomic resources, such as sequenced genome, expressed sequence tags (ESTs) and transcriptome sequences has hindered the research on C. fluminea. Recent advances in large-scale RNA-Seq enable generation of genomic resources in a short time, and provide large expression datasets for functional genomic analysis. Methodology/Principal Findings: We used a next-generation high-throughput DNA sequencing technique with an Illumina GAIIx method to analyze the transcriptome from the whole bodies of C. fluminea. More than 62,250,336 high-quality reads were generated based on the raw data, and 134,684 unigenes with a mean length of 791 bp were assembled using the Velvet and Oases software. All of the assembly unigenes were annotated by running BLASTx and BLASTn similarity searches on the Nt, Nr, Swiss-Prot, COG and KEGG databases. In addition, the Clusters of Orthologous Groups (COGs), Gene Ontology (GO) terms and Kyoto Encyclopedia of Gene and Genome (KEGG) annotations were also assigned to each unigene transcript. To provide a preliminary verification of the assembly and annotation results, and search for potential environmental pollution biomarkers, 15 functional genes (five antioxidase genes, two cytochrome P450 genes, three GABA receptor-related genes and five heat shock protein genes) were cloned and identified. Expressions of the 15 selected genes following fluoxetine exposure confirmed that the genes are indeed linked to environmental stress. Conclusions/Significance: The C. fluminea transcriptome advances the underlying molecular understanding of this freshwater clam, provides a basis for further exploration of C. fluminea as an environmental test organism and promotes further studies on other bivalve organisms.	[Chen, Huihui; Zha, Jinmiao; Liang, Xuefang; Bu, Jihong; Wang, Miao; Wang, Zijian] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Zha, JM (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing, Peoples R China.	jmzha@rcees.ac.cn; wangzj@rcees.ac.cn	Chen, Huihui/L-8521-2019; Wang, Zijian/A-1538-2009; Wang, Zhiquan/HHS-6768-2022; Liang, Xuefang/GSJ-2769-2022; liang, xuefang/R-6169-2017	Wang, Zijian/0000-0002-9847-9691; cha, jin miao/0000-0003-4928-8992	National Basic Research Program of China [2009CB421605]; National Natural Science Foundation of China [21007086]; National High-tech RD Program [2012AA06A302]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD Program(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2009CB421605); the National Natural Science Foundation of China (21007086); the National High-tech R&D Program (2012AA06A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard-Joris M, 2006, ENVIRON TOXICOL CHEM, V25, P527, DOI 10.1897/05-211R.1; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAUJO R, 1993, AM MALACOL BULL, V10, P39; Bai RY, 2012, FISH SHELLFISH IMMUN, V33, P675, DOI 10.1016/j.fsi.2012.05.003; Beran L, 2006, HELDIA, V6, P6; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bigot A, 2009, ECOTOX ENVIRON SAFE, V72, P382, DOI 10.1016/j.ecoenv.2008.04.014; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3; Cara JB, 2005, COMP BIOCHEM PHYS B, V142, P426, DOI 10.1016/j.cbpb.2005.09.005; Chijimatsu T, 2013, FOOD CHEM, V136, P328, DOI 10.1016/j.foodchem.2012.08.070; Cooper NL, 2006, AQUAT TOXICOL, V76, P258, DOI 10.1016/j.aquatox.2005.09.012; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Doyen P, 2005, COMP BIOCHEM PHYS C, V140, P300, DOI 10.1016/j.cca.2005.02.013; Farcy E, 2007, SCI TOTAL ENVIRON, V374, P328, DOI 10.1016/j.scitotenv.2006.11.014; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frenzel M, 2012, J STRUCT BIOL, V178, P8, DOI 10.1016/j.jsb.2012.02.005; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gao XG, 2013, COMP BIOCHEM PHYS D, V8, P103, DOI 10.1016/j.cbd.2012.12.005; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gonzalez-Rey M, 2013, ENVIRON POLLUT, V173, P200, DOI 10.1016/j.envpol.2012.10.018; Graczyk TK, 1997, APPL ENVIRON MICROB, V63, P2910, DOI 10.1128/AEM.63.7.2910-2912.1997; Hazelton PD, 2013, SCI TOTAL ENVIRON, V445, P94, DOI 10.1016/j.scitotenv.2012.12.026; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Korniushin AV, 2004, HYDROBIOLOGIA, V529, P251; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lazzara R, 2012, AQUAT TOXICOL, V106, P123, DOI 10.1016/j.aquatox.2011.11.003; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liao NB, 2013, FOOD FUNCT, V4, P539, DOI 10.1039/c2fo30178d; Liu HC, 2012, FISH PHYSIOL BIOCHEM, V38, P745, DOI 10.1007/s10695-011-9556-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunt G.G., 1991, Seminars in the Neurosciences, V3, P251, DOI 10.1016/1044-5765(91)90022-G; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martins JC, 2009, TOXICON, V53, P409, DOI 10.1016/j.toxicon.2008.12.022; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Mcleod PB, 2008, ENVIRON SCI TECHNOL, V42, P484, DOI 10.1021/es070139a; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Morton B., 1986, American Malacological Bulletin Special Edition, P113; Mouthon J, 2001, ARCH HYDROBIOL, V151, P571; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Pfenninger M, 2002, J EVOLUTION BIOL, V15, P818, DOI 10.1046/j.1420-9101.2002.00440.x; Renard E, 2000, MOL ECOL, V9, P2009, DOI 10.1046/j.1365-294X.2000.01104.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosa IC, 2011, ECOL ECON, V70, P1805, DOI 10.1016/j.ecolecon.2011.05.006; Saavedra C, 2006, AQUACULTURE, V256, P1, DOI 10.1016/j.aquaculture.2006.02.023; Santos HM, 2007, ENVIRON TOXICOL, V22, P502, DOI 10.1002/tox.20303; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spann N, 2011, AQUAT TOXICOL, V105, P589, DOI 10.1016/j.aquatox.2011.08.010; Syvaranta J, 2011, HYDROBIOLOGIA, V658, P383, DOI 10.1007/s10750-010-0512-4; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tran D, 2003, ENVIRON TOXICOL CHEM, V22, P914, DOI [10.1897/1551-5028(2003)022&lt;0914:EOPALO&gt;2.0.CO;2, 10.1002/etc.5620220432]; Vrankovic J, 2011, ARCH BIOL SCI, V63, P37, DOI 10.2298/ABS1101037V; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; ZAMAN SH, 1992, FEBS LETT, V307, P351, DOI 10.1016/0014-5793(92)80711-O; Zanette J, 2013, AQUAT TOXICOL, V128, P101, DOI 10.1016/j.aquatox.2012.11.017; Zanette J, 2010, MAR ENVIRON RES, V69, pS1, DOI 10.1016/j.marenvres.2009.10.013; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058	70	47	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79516	10.1371/journal.pone.0079516	http://dx.doi.org/10.1371/journal.pone.0079516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244519	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900041
J	Husen, P; Tarasov, K; Katafiasz, M; Sokol, E; Vogt, J; Baumgart, J; Nitsch, R; Ekroos, K; Ejsing, CS				Husen, Peter; Tarasov, Kirill; Katafiasz, Maciej; Sokol, Elena; Vogt, Johannes; Baumgart, Jan; Nitsch, Robert; Ekroos, Kim; Ejsing, Christer S.			Analysis of Lipid Experiments (ALEX): A Software Framework for Analysis of High-Resolution Shotgun Lipidomics Data	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MULTIPLE PRECURSOR; HUMAN BRAIN; MOUSE; TOOL; QUANTIFICATION; FRAGMENTATION; INFORMATICS; CHOLESTEROL; ACQUISITION	Global lipidomics analysis across large sample sizes produces high-content datasets that require dedicated software tools supporting lipid identification and quantification, efficient data management and lipidome visualization. Here we present a novel software-based platform for streamlined data processing, management and visualization of shotgun lipidomics data acquired using high-resolution Orbitrap mass spectrometry. The platform features the ALEX framework designed for automated identification and export of lipid species intensity directly from proprietary mass spectral data files, and an auxiliary workflow using database exploration tools for integration of sample information, computation of lipid abundance and lipidome visualization. A key feature of the platform is the organization of lipidomics data in "database table format" which provides the user with an unsurpassed flexibility for rapid lipidome navigation using selected features within the dataset. To demonstrate the efficacy of the platform, we present a comparative neurolipidomics study of cerebellum, hippocampus and somatosensory barrel cortex (S1BF) from wild-type and knockout mice devoid of the putative lipid phosphate phosphatase PRG-1 (plasticity related gene-1). The presented framework is generic, extendable to processing and integration of other lipidomic data structures, can be interfaced with post-processing protocols supporting statistical testing and multivariate analysis, and can serve as an avenue for disseminating lipidomics data within the scientific community. The ALEX software is available at www.msLipidomics.info.	[Tarasov, Kirill; Ekroos, Kim] Zora Biosci Oy, Espoo, Finland; [Husen, Peter; Katafiasz, Maciej; Sokol, Elena; Ejsing, Christer S.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Vogt, Johannes; Baumgart, Jan; Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany	University of Southern Denmark; Johannes Gutenberg University of Mainz	Ekroos, K (corresponding author), Zora Biosci Oy, Espoo, Finland.	kim.ekroos@zora.fi; cse@bmb.sdu.dk	Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/O-4289-2019; Husen, Peter/F-9693-2016; Ejsing, Christer S/R-5922-2016; Vogt, Johannes/K-2278-2015	Husen, Peter/0000-0001-9583-8751; Ejsing, Christer S./0000-0003-4963-0276; Vogt, Johannes/0000-0003-2439-8247; Baumgart, Jan/0000-0003-1996-4267	Lundbeckfonden [R44-A4342]; Danish Council for Independent Research \ Natural Sciences [09-072484]	Lundbeckfonden(Lundbeckfonden); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	The work was supported by Lundbeckfonden (R44-A4342) and the Danish Council for Independent Research vertical bar Natural Sciences (09-072484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2012, LIPIDOMICS, P147; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Hubner G, 2009, J MASS SPECTROM, V44, P1676, DOI 10.1002/jms.1673; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Leavell MD, 2006, ANAL CHEM, V78, P5497, DOI 10.1021/ac0604179; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; OBRIEN JS, 1965, J LIPID RES, V6, P537; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sandhoff R, 1999, J LIPID RES, V40, P126; Schuhmann K, 2012, J MASS SPECTROM, V47, P96, DOI 10.1002/jms.2031; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Song H, 2007, J AM SOC MASS SPECTR, V18, P1848, DOI 10.1016/j.jasms.2007.07.023; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	38	116	118	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e79736	10.1371/journal.pone.0079736	http://dx.doi.org/10.1371/journal.pone.0079736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244551	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900047
J	McNamee, T; Hyland, T; Harrington, J; Cadogan, S; Honari, B; Perera, K; Fitzgerald, AP; Perry, IJ; Cahill, MR				McNamee, Therese; Hyland, Trish; Harrington, Janas; Cadogan, Sharon; Honari, Bahman; Perera, Kanthi; Fitzgerald, Anthony P.; Perry, Ivan J.; Cahill, Mary R.			Haematinic Deficiency and Macrocytosis in Middle-Aged and Older Adults	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; IRON-DEFICIENCY; FOLIC-ACID; POPULATION; VITAMIN-B-12; FOLATE; PREVALENCE; SMOKING; PEOPLE; HEALTH	Objective: To assess the prevalence and determinants of haematinic deficiency (lack of B12 folate or iron) and macrocytosis in blood from a national population-based study of middle-aged and older adults. Methods: A cross-sectional study involving 1,207 adults aged >= 45 years, recruited from a sub-study of the Irish National Survey of Lifestyle Attitudes and Nutrition (SLAN 2007). Participants completed a health and lifestyle questionnaire and a standard food frequency questionnaire. Non-fasting blood samples were obtained for measurement of full blood count and expert morphological assessment, serum ferritin, soluble transferrin receptor assay (sTfR), B12, folate and coeliac antibodies. Blood samples were also assayed for thyroid function (T4, TSH), liver function, aminotransferase (AST) and gamma-glutamyl transferase (GGT). Results: The overall prevalence (95% C. I.) of anaemia (Hb <13.5g/dl men and 11.3 g/dl women) was 4.6% (2.9%-6.4%) in men and 1.0% (0.2%-1.9%) in women. Iron deficiency (ferritin <17ng/ml men and <11ng/ml in women) was detected in 6.3% of participants (3.7% in males and 8.7% in females, p<0.001). Based on both low ferritin and raised sTfR (>21nmol/ml) only 2.3% were iron-deficient. 3.0% and 2.7% were found to have low levels of serum folate (<2.3ng/ml) and serum B12 (<120ng/l) respectively. Clinically significant macrocytosis (MCV>99fl) was detected in 8.4% of subjects. Strong, significant and independent associations with macrocytosis were observed for lower social status, current smoking status, moderate to heavy alcohol intake, elevated GGT levels, deficiency of folate and vitamin B12, hypothyroidism and coeliac disease. The population attributable fraction (PAF) for macrocytosis associated with elevated GGT (25.0%) and smoking (24.6%) was higher than for excess alcohol intake (6.3%), folate deficiency (10.5%) or vitamin B12 (3.4%). Conclusions: Haematinic deficiency and macrocytosis are common in middle-aged/older adults in Ireland. Macrocytosis is more likely to be attributable to an elevated GGT and smoking than vitamin B12 or folate deficiency.	[McNamee, Therese; Harrington, Janas; Cadogan, Sharon; Fitzgerald, Anthony P.; Perry, Ivan J.] UCC, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Hyland, Trish; Cahill, Mary R.] CUH, Dept Haematol, Cork, Ireland; [Honari, Bahman] Univ Coll Dublin, CSTAR, Dublin 2, Ireland; [Perera, Kanthi] Tullamore Gen Hosp, Dept Haematol, Tullamore, Ireland	University College Cork; University College Dublin	Cahill, MR (corresponding author), CUH, Dept Haematol, Cork, Ireland.	maryr.cahill@hse.ie	Fitzgerald, Tony/AAB-5331-2020; Harrington, Janas/AAV-8123-2021	Harrington, Janas/0000-0002-6238-7031; Cahill, Mary R/0000-0002-1655-3078; Perry, Ivan/0000-0002-4965-9792; Fitzgerald, Tony/0000-0001-6437-5686; Cadogan, Sharon/0000-0002-4213-7094	Irish Health Research Board under the aegis of the HRB Centre for Health & Diet Research: Grant Reference HRC	Irish Health Research Board under the aegis of the HRB Centre for Health & Diet Research: Grant Reference HRC	This work was supported by the Irish Health Research Board under the aegis of the HRB Centre for Health & Diet Research: Grant Reference HRC (http://www.hrb.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY H M, 1989, Reviews on Environmental Health, V8, P25; Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Basora M, 2006, CLIN LAB HAEMATOL, V28, P370, DOI 10.1111/j.1365-2257.2006.00821.x; Bates CJ, 2003, EUR J CLIN NUTR, V57, P349, DOI 10.1038/sj.ejcn.1601540; Boilson A, 2012, AM J CLIN NUTR, V96, P613, DOI 10.3945/ajcn.111.026633; CHALMERS DM, 1979, BRIT J HAEMATOL, V43, P631, DOI 10.1111/j.1365-2141.1979.tb03796.x; Clarke R, 2003, AM J CLIN NUTR, V77, P1241, DOI 10.1093/ajcn/77.5.1241; Cook HB, 2000, J GASTROEN HEPATOL, V15, P1032, DOI 10.1046/j.1440-1746.2000.02290.x; ESCHWEGE E, 1978, J CLIN PATHOL, V31, P654, DOI 10.1136/jcp.31.7.654; Flood VM, 2006, AUST NZ J PUBL HEAL, V30, P38, DOI 10.1111/j.1467-842X.2006.tb00084.x; Germing U, 2012, LEUKEMIA RES, V36, P727, DOI 10.1016/j.leukres.2012.02.014; Harrington J, 2011, PUBLIC HEALTH NUTR, V1, P1; Harrington J, 2010, EUR J PUBLIC HEALTH, V20, P91, DOI 10.1093/eurpub/ckp102; Harroun J, 2008, PSYCHOL REP, P6; Hin H, 2006, AGE AGEING, V35, P416, DOI 10.1093/ageing/afl033; Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference I. its Panel on Folate O. B. V. & Choline, 1998, DIETARY REFERENCE IN; JOOSTEN E, 1993, AM J CLIN NUTR, V58, P468, DOI 10.1093/ajcn/58.4.468; Kaferle J, 2009, AM FAM PHYSICIAN, V79, P203; Kung CM, 2008, CLIN INVEST MED, V31, pE138; MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230; Malouf R, 2003, COCHRANE DB SYST REV, V2003; McDowell Margaret A, 2008, NCHS Data Brief, P1; Morgan K, 2008, SLAN 2007 SURVEY LIF; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rose D, 2007, EUR SOC, V9, P459, DOI 10.1080/14616690701336518; Simek M, 2002, Bratisl Lek Listy, V103, P449; SKIKNE BS, 1990, BLOOD, V75, P1870; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Takala TI, 2003, CLIN CHEM LAB MED, V41, P203, DOI 10.1515/CCLM.2003.033; Wahlin A, 2002, PUBLIC HEALTH NUTR, V5, P505, DOI 10.1079/PHN200167; [WHO UNICEF], 2004, FOC AN INT APPR EFF; World Health Organization, 2006, IR SUPPL YOUNG CHILD; World Health Organization, 2011, GUID INT IR FOL AC S	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e77743	10.1371/journal.pone.0077743	http://dx.doi.org/10.1371/journal.pone.0077743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244281	gold, Green Published, Green Submitted			2022-12-27	WOS:000327162900008
J	Rellstab, C; Zoller, S; Tedder, A; Gugerli, F; Fischer, MC				Rellstab, Christian; Zoller, Stefan; Tedder, Andrew; Gugerli, Felix; Fischer, Martin C.			Validation of SNP Allele Frequencies Determined by Pooled Next-Generation Sequencing in Natural Populations of a Non-Model Plant Species	PLOS ONE			English	Article							ADAPTATION; DIFFERENTIATION; VARIANTS; MARKERS	Sequencing of pooled samples (Pool-Seq) using next-generation sequencing technologies has become increasingly popular, because it represents a rapid and cost-effective method to determine allele frequencies for single nucleotide polymorphisms (SNPs) in population pools. Validation of allele frequencies determined by Pool-Seq has been attempted using an individual genotyping approach, but these studies tend to use samples from existing model organism databases or DNA stores, and do not validate a realistic setup for sampling natural populations. Here we used pyrosequencing to validate allele frequencies determined by Pool-Seq in three natural populations of Arabidopsis halleri (Brassicaceae). The allele frequency estimates of the pooled population samples (consisting of 20 individual plant DNA samples) were determined after mapping Illumina reads to (i) the publicly available, high-quality reference genome of a closely related species (Arabidopsis thaliana) and (ii) our own de novo draft genome assembly of A. halleri. We then pyrosequenced nine selected SNPs using the same individuals from each population, resulting in a total of 540 samples. Our results show a highly significant and accurate relationship between pooled and individually determined allele frequencies, irrespective of the reference genome used. Allele frequencies differed on average by less than 4%. There was no tendency that either the Pool-Seq or the individual-based approach resulted in higher or lower estimates of allele frequencies. Moreover, the rather high coverage in the mapping to the two reference genomes, ranging from 55 to 284x, had no significant effect on the accuracy of the Pool-Seq. A resampling analysis showed that only very low coverage values (below 10-20x) would substantially reduce the precision of the method. We therefore conclude that a pooled re-sequencing approach is well suited for analyses of genetic variation in natural populations.	[Rellstab, Christian; Gugerli, Felix] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Zoller, Stefan] Swiss Fed Inst Technol, Genet Divers Ctr, Zurich, Switzerland; [Tedder, Andrew] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Tedder, Andrew] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Fischer, Martin C.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fischer, MC (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	martin.fischer@env.ethz.ch	Gugerli, Felix/U-7195-2019; Fischer, Martin C/D-4326-2012; Fischer, Martin C./AAE-7287-2019; Tedder, Andrew/B-3830-2015; Rellstab, Christian/D-6460-2012; Tedder, Andrew/H-6678-2019; Gugerli, Felix/C-9369-2009	Gugerli, Felix/0000-0003-3878-1845; Fischer, Martin C/0000-0002-1888-1809; Fischer, Martin C./0000-0002-1888-1809; Rellstab, Christian/0000-0002-0221-5975; Tedder, Andrew/0000-0002-7378-4673; Gugerli, Felix/0000-0003-3878-1845	Swiss National Science Foundation [CRSI33_127155]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (project CRSI33_127155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Feder AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048588; Fischer MC, 2013, MOL ECOL, DOI [10.1111/mec.12521, DOI 10.1111/MEC.12521.PUBMED:24102711]; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kessner D, 2013, MOL BIOL EVOL, V30, P1145, DOI 10.1093/molbev/mst016; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer CL, 2010, NEW PHYTOL, V185, P130, DOI 10.1111/j.1469-8137.2009.03062.x; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pauwels M, 2006, J EVOLUTION BIOL, V19, P1838, DOI 10.1111/j.1420-9101.2006.01178.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Shimizu KK, 2011, ANN BOT-LONDON, V108, P777, DOI 10.1093/aob/mcr180; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Zavodna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061471; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	44	64	64	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80422	10.1371/journal.pone.0080422	http://dx.doi.org/10.1371/journal.pone.0080422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244686	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900080
J	Shaukat, S; Angez, M; Alam, MM; Sharif, S; Khurshid, A; Mahmood, T; Zaidi, SSZ				Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Mahmood, Tariq; Zaidi, Syed Sohail Zahoor			Characterization of a Novel Enterovirus Serotype and an Enterovirus EV-B93 Isolated from Acute Flaccid Paralysis Patients	PLOS ONE			English	Article							NILE-VIRUS-INFECTION; POLIO ERADICATION; CHILDREN; IDENTIFICATION; EPIDEMIOLOGY; PAKISTAN; INDIA; PCR	Non-polio enteroviruses (NPEVs) are among the most common viruses infecting humans worldwide. Most of these infections are asymptomatic but few can lead to systemic and neurological disorders like Acute Flaccid Paralysis (AFP). Acute Flaccid Paralysis is a clinical syndrome and NPEVs have been isolated frequently from the patients suffering from AFP but little is known about their causal relationship. The objective of this study was to identify and characterize the NPEV serotypes recovered from 184 stool samples collected from AFP patients in Federally Administered Tribal Areas (FATA) in north-west of Pakistan. Overall, 44 (95.6 %) isolates were successfully typed through microneutralization assay as a member of enterovirus B species including echovirus (E)-2, E-3, E-4, E-6, E-7, E-11, E-13, E-14, E-21 and E-29 while two isolates (PAK NIH SP6545B and PAK NIH SP1202B) remained untypeable. The VP1 and capsid regions analysis characterized these viruses as EV-B93 and EV-B106. Phylogenetic analysis confirmed that PAK NIH isolates had high genetic diversity and represent distinct genotypes circulating in the country. Our findings highlight the role of NPEVs in AFP cases to be thoroughly investigated especially in high disease risk areas, with limited surveillance activities and health resources.	[Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Shaukat, Shahzad] Quaid I Azam Univ, Fac Biol Sci, Dept Biotechnol, Islamabad, Pakistan; [Mahmood, Tariq] Quaid I Azam Univ, Fac Biol Sci, Dept Plant Sci, Islamabad, Pakistan	Quaid I Azam University; Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	sohailz@live.com	Zaidi, Syed Sohail Zahoor/F-7432-2015; Mahmood, Tariq/O-8742-2019; Shaukat, Shahzad/HHZ-1088-2022; Angez, Mehar/J-3792-2015	Mahmood, Tariq/0000-0001-9083-1702; 				Abbasian F, 2012, J GASTROEN HEPATOL, V1, P44; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Chen CY, 2001, AM J NEURORADIOL, V22, P200; Dhole TN, 2009, J PAEDIATR CHILD H, V45, P409, DOI 10.1111/j.1440-1754.2009.01529.x; Dietz V, 1995, B WORLD HEALTH ORGAN, V73, P597; FIGUEROA JP, 1989, J MED VIROL, V29, P315, DOI 10.1002/jmv.1890290418; Francis PT, 2008, INDIAN PEDIATR, V45, P422; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kapoor A, 2004, INDIAN J MED RES, V119, P149; Kapoor Amit, 2001, Indian Journal of Pediatrics, V68, P927, DOI 10.1007/BF02722583; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Li J, 2003, ANN NEUROL, V53, P703, DOI 10.1002/ana.10575; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Liu Kun, 2012, Zhonghua Yi Xue Za Zhi, V92, P1742; Mark A, 2001, ENTEROVIRUSES POLIOV, P839; Mascola L., 2008, Morbidity and Mortality Weekly Report, V57, P553; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Persu Ana, 2009, Roum Arch Microbiol Immunol, V68, P20; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Saeed M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-6; Santti J, 2000, J GEN VIROL, V81, P1361, DOI 10.1099/0022-1317-81-5-1361; Saskia L, 2013, EMERG INFECT DIS, V19; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shaukat S, 2012, VIRUS RES, V170, P164, DOI 10.1016/j.virusres.2012.09.010; Tan le V, 2013, MBIO, V4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torno M, 2007, NEUROLOGY, V68, pE5, DOI 10.1212/01.wnl.0000253223.07720.bb; World Health Organization, 2004, WHOIVB0410; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80040	10.1371/journal.pone.0080040	http://dx.doi.org/10.1371/journal.pone.0080040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244603	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900060
J	Gerbaba, TK; Gedamu, L				Gerbaba, Teklu Kuru; Gedamu, Lashitew			Cathepsin B Gene Disruption Induced Leishmania donovani Proteome Remodeling Implies Cathepsin B Role in Secretome Regulation	PLOS ONE			English	Article							PROTEINASE-DEFICIENT MUTANTS; TRYPANOSOMA-BRUCEI; CYSTEINE PROTEASES; CYTOSOLIC TRYPAREDOXIN; PATHOGEN LEISHMANIA; DRUG-RESISTANCE; CELL-DEATH; EXPRESSION; VIRULENCE; MEXICANA	Leishmania cysteine proteases are potential vaccine candidates and drug targets. To study the role of cathepsin B cysteine protease, we have generated and characterized cathepsin B null mutant L. donovani parasites. L. donovani cathepsin B null mutants grow normally in culture, but they show significantly attenuated virulence inside macrophages. Quantitative proteome profiling of wild type and null mutant parasites indicates cathepsin B disruption induced remodeling of L. donovani proteome. We identified 83 modulated proteins, of which 65 are decreased and 18 are increased in the null mutant parasites, and 66% (55/83) of the modulated proteins are L. donovani secreted proteins. Proteins involved in oxidation-reduction (trypanothione reductase, peroxidoxins, tryparedoxin, cytochromes) and translation (ribosomal proteins) are among those decreased in the null mutant parasites, and most of these proteins belong to the same complex network of proteins. Our results imply virulence role of cathepsin B via regulation of Leishmania secreted proteins.	[Gerbaba, Teklu Kuru; Gedamu, Lashitew] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Gedamu, L (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	lgedamu@ucalgary.ca		Gerbaba, Teklu/0000-0002-0319-2824	University of Calgary, Canada; Natural Sciences and Engineering Council of Canada (NSERC) [12034]	University of Calgary, Canada; Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant provided to LG (University of Calgary, Canada) by the Natural Sciences and Engineering Council of Canada (NSERC; Grant No. 12034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Alexander J, 1998, J IMMUNOL, V161, P6794; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Bart G, 1997, MOL BIOCHEM PARASIT, V88, P53, DOI 10.1016/S0166-6851(97)00072-8; BRUN R, 1979, ACTA TROP, V36, P387; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; Chong PK, 2006, J PROTEOME RES, V5, P1232, DOI 10.1021/pr060018u; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; Daifalla NS, 2011, EXP PARASITOL, V129, P292, DOI 10.1016/j.exppara.2011.07.001; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Ghosh M, 2003, MOL CELL BIOCHEM, V253, P199, DOI 10.1023/A:1026047429604; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; Iyer JP, 2008, MOL MICROBIOL, V68, P372, DOI 10.1111/j.1365-2958.2008.06154.x; Jayanarayan KG, 2002, J CLIN PHARM THER, V27, P313, DOI 10.1046/j.1365-2710.2002.00431.x; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Mundodi V, 2002, GENE, V282, P257, DOI 10.1016/S0378-1119(01)00851-4; Omara-Opyene AL, 1997, MOL BIOCHEM PARASIT, V90, P247, DOI 10.1016/S0166-6851(97)00158-8; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Park J, 2010, FUNCT PLANT BIOL, V37, P1, DOI 10.1071/FP09074; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; ROBERTSON CD, 1993, MOL BIOCHEM PARASIT, V62, P271, DOI 10.1016/0166-6851(93)90116-F; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santarem N, 2013, J PROTEOMICS; Selzer PM, 1997, EXP PARASITOL, V87, P212, DOI 10.1006/expr.1997.4220; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Zhang WW, 1997, P NATL ACAD SCI USA, V94, P8807, DOI 10.1073/pnas.94.16.8807; Zhu Y, 2011, CELL RES	51	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79951	10.1371/journal.pone.0079951	http://dx.doi.org/10.1371/journal.pone.0079951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244582	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800105
J	Haque, F; Kundu, SK; Islam, MS; Hasan, SMM; Khatun, A; Gope, PS; Mahmud, ZH; Alamgir, ASM; Islam, MS; Rahman, M; Luby, SP				Haque, Farhana; Kundu, Subodh Kumar; Islam, Md Saiful; Hasan, S. M. Murshid; Khatun, Asma; Gope, Partha Sarathi; Mahmud, Zahid Hayat; Alamgir, A. S. M.; Islam, M. Sirajul; Rahman, Mahmudur; Luby, Stephen P.			Outbreak of Mass Sociogenic Illness in a School Feeding Program in Northwest Bangladesh, 2010	PLOS ONE			English	Article							PSYCHOGENIC ILLNESS; EPIDEMIC HYSTERIA; FOOD	Background: In 2010, an acute illness outbreak was reported in school students eating high-energy biscuits supplied by the school feeding programme in northwest Bangladesh. We investigated this outbreak to describe the illness in terms of person, place and time, develop the timeline of events, and determine the cause and community perceptions regarding the outbreak. Methods: We defined case-patients as students from affected schools reporting any two symptoms including abdominal pain, heartburn, bitter taste, and headache after eating biscuits on the day of illness. We conducted in-depth interviews and group discussions with students, teachers, parents and community members to explore symptoms, exposures, and community perceptions. We conducted a questionnaire survey among case-patients to determine the symptoms and ascertain food items eaten 12 hours before illness onset, and microbiological and environmental investigations. Results: Among 142 students seeking hospital care, 44 students from four schools qualified as case-patients. Of these, we surveyed 30 who had a mean age of 9 years; 70% (21/30) were females. Predominant symptoms included abdominal pain (93%), heartburn (90%), and bitter taste (57%). All students recovered within a few hours. No pathogenic Vibrio cholerae, Shigella or Salmonella spp. were isolated from collected stool samples. We found no rancid biscuits in schools and storage sites. The female index case perceived the unusually darker packet label as a "devil's deed" that made the biscuits poisonous. Many students, parents and community members reported concerns about rumors of students dying from biscuit poisoning. Conclusions: Rapid onset, followed by rapid recovery of symptoms; female preponderance; inconsistent physical, microbiological and environmental findings suggested mass sociogenic illness rather than a foodborne or toxic cause. Rumours of student deaths heightening community anxiety apparently propagated this outbreak. Sharing investigation results and reassuring students and parents through health communication campaigns could limit similar future outbreaks and help retain beneficiaries' trust on nutrition supplementation initiatives.	[Haque, Farhana; Islam, Md Saiful; Hasan, S. M. Murshid; Luby, Stephen P.] CCD, Icddr b, Dhaka, Bangladesh; [Haque, Farhana; Kundu, Subodh Kumar; Khatun, Asma; Alamgir, A. S. M.; Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh; [Gope, Partha Sarathi; Mahmud, Zahid Hayat; Islam, M. Sirajul] Ctr Food & Waterborne Dis, Icddr b, Dhaka, Bangladesh; [Luby, Stephen P.] Ctr Dis Control & Prevent CDC, Global Dis Detect Program, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Haque, F (corresponding author), CCD, Icddr b, Dhaka, Bangladesh.	drfarhana2007@gmail.com	Islam, Saiful/GOH-2641-2022; Haque, Farhana/M-2483-2017	Haque, Farhana/0000-0002-4308-2857; Islam, Md Saiful/0000-0002-5690-5971	Government of the People's Republic of Bangladesh; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA	Government of the People's Republic of Bangladesh; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This investigation was funded by the Government of the People's Republic of Bangladesh and the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. icddr,b acknowledges with gratitude the commitment of the Government of Bangladesh and the CDC to its research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A., 2004, IMPACT FEEDING CHILD; AliGombe A, 1996, BRIT J PSYCHIAT, V168, P633, DOI 10.1192/bjp.168.5.633; Amin Y, 1997, INT J SOC PSYCHIATR, V43, P303, DOI 10.1177/002076409704300408; Balaratnasingam S, 2006, CURR OPIN PSYCHIATR, V19, P171, DOI 10.1097/01.yco.0000214343.59872.7a; BANERJI A, 2013, CONTAMINATED SCH MEA; BARRELL RAE, 1979, T ROY SOC TROP MED H, V73, P85, DOI 10.1016/0035-9203(79)90136-6; Bartholomew RE, 2005, MED J AUSTRALIA, V183, P564, DOI 10.5694/j.1326-5377.2005.tb00035.x; Bartholomew RE, 2002, BRIT J PSYCHIAT, V180, P300, DOI 10.1192/bjp.180.4.300; BARTHOLOMEW RE, 1994, PSYCHOL MED, V24, P281, DOI 10.1017/S0033291700027288; Boss LP, 1997, EPIDEMIOL REV, V19, P233, DOI 10.1093/oxfordjournals.epirev.a017955; Broderick Joan E, 2011, Am J Disaster Med, V6, P163; *CHAMB CM, 1991, CAJUNAS, V24, P92; CHANDLER AMK, 1995, J NUTR, V125, P894; Clements CJ, 2003, DRUG SAFETY, V26, P599, DOI 10.2165/00002018-200326090-00001; DHADPHALE M, 1983, BRIT J PSYCHIAT, V142, P85, DOI 10.1192/bjp.142.1.85; DOWNING TE, 1994, FOOD POLICY, V19, P99, DOI 10.1016/0306-9192(94)90063-9; Flick U, 2012, J MIX METHOD RES, V6, P97, DOI 10.1177/1558689812437183; FORMAN MJ, 1965, AM J PUBLIC HEALTH N, V55, P1199, DOI 10.2105/AJPH.55.8.1199; Gallay A, 2002, AM J EPIDEMIOL, V155, P140, DOI 10.1093/aje/155.2.140; Gelli A, 2011, FOOD NUTR BULL, V32, P324, DOI 10.1177/156482651103200403; GOYLE A, 2011, J NUTR, V17, P143; Grantham-McGregor SM, 1998, AM J CLIN NUTR, V67, p785S, DOI 10.1093/ajcn/67.4.785S; HENRY FJ, 1990, EPIDEMIOL INFECT, V104, P253, DOI 10.1017/S0950268800059422; HIEU NT, 2012, BR J NUTR, P1; *ICDDRB, 2008, HLTH SCI B, V6; *IEDCR, 2012, OUTBR, P2007; JACOBY E, 1996, FOOD NUTR B, V17; Jomaa LH, 2011, NUTR REV, V69, P83, DOI 10.1111/j.1753-4887.2010.00369.x; Jones TF, 2000, NEW ENGL J MED, V342, P96, DOI 10.1056/NEJM200001133420206; Kharabsheh S, 2001, B WORLD HEALTH ORGAN, V79, P764; Khiem HB, 2003, VACCINE, V21, P4527, DOI 10.1016/S0264-410X(03)00498-5; Levitsky David A., 2005, Food and Nutrition Bulletin, V26, pS286; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Mattoo Surendra K, 2002, Psychiatry Clin Neurosci, V56, P643, DOI 10.1046/j.1440-1819.2002.01069.x; MERSON M, 2006, COMPLEX EMERGENCIES; *NIH, 2010, FOOD ALL OV; Pazola Z, 1982, Probl Med Wieku Rozwoj, V11a Suppl, P132; POLLIT E, 1995, J AM DIET ASS, V95; POLLITT EM, 1978, AM J PUBLIC HLTH, V68; POWELL C, 1983, HUM NUTR CLIN NUTR C, V37; READ MS, 1973, J AM DIET ASSOC, V63, P386; SESHADRI S, 1989, AM J CLIN NUTR S, V50; SMALL GW, 1983, NEW ENGL J MED, V308, P632, DOI 10.1056/NEJM198303173081105; Steinberg EB, 2006, J FOOD PROTECT, V69, P1690, DOI 10.4315/0362-028X-69.7.1690; TEOH JI, 1975, PSYCHIATRY, V38, P258, DOI 10.1080/00332747.1975.11023855; WESSELY S, 1987, PSYCHOL MED, V17, P109, DOI 10.1017/S0033291700013027; Wessely S, 2000, NEW ENGL J MED, V342, P129, DOI 10.1056/NEJM200001133420212; *WFP, 2012, SCH MEALS OUR WORK; 1979, BMJ-BRIT MED J, V2, P408, DOI DOI 10.1136/BMJ.2.6187.408-A	49	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80420	10.1371/journal.pone.0080420	http://dx.doi.org/10.1371/journal.pone.0080420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254DJ	24244685	Green Published, gold			2022-12-27	WOS:000327143800145
J	Li, WD; Jia, L; Ou, Y; Huang, YX; Jiang, SM				Li, Wei-Dong; Jia, Lin; Ou, Ya; Huang, Yao-Xing; Jiang, Shu-man			Surveillance of Intra-Abdominal Pressure and Intestinal Barrier Function in a Rat Model of Acute Necrotizing Pancreatitis and Its Potential Early Therapeutic Window	PLOS ONE			English	Article							CRITICALLY-ILL; GUT; HYPERTENSION; OCTREOTIDE; INJURY; TIME	Objectives: To monitor intra-abdominal pressure (IAP) and intestinal barrier function in a rat model of acute necrotizing pancreatitis (ANP) to elucidate a potential relevant therapeutic window. Methods: Sprague-Dawley rats were randomly divided into experimental or control groups. The ANP group (n = 40) was injected with 4.5% sodium taurocholate into the pancreatic duct to induce ANP. The controls received only abdominal opening surgery (sham-operated, SO; n = 40) or no treatment or surgery (baseline; 0 h, n = 20). The SO and ANP groups were then randomly subdivided into 3, 6, 12 and 24 h groups (n = 10 each). IAP was measured at each time point and the rats were sacrificed to measure the weight of accumulated ascites fluid and the amylase, endogenous creatinine (Cr), total bilirubin (TB), tumor necrosis factor- alpha (TNF-alpha), diamine oxidase (DAO), and D-lactate. Mortality and the development of pathological changes in the pancreas and intestines were also monitored. Results: IAP showed a continuous upward trend in the ANP group, with values 2 to 3 times higher than those in the SO group at the corresponding time points and the rising rate was peaking at 6 h. The levels of plasma amylase, TNF-alpha, Cr, TB, DAO, and D-lactate also gradually increased in the ANP group over time and were significantly higher than in the SO group at 3, 6, 12 and 24 h (all P<0.05). Moreover, the rising rate of TNF-alpha, DAO, and D-lactate also peaked at 6 h. Conclusions: The ANP-induced changes in IAP, inflammatory factors and intestinal barrier that we observed in the rat model were especially obvious at 6 h post-induction, suggesting an early therapeutic window for the treatment of ANP in humans.	[Li, Wei-Dong; Jia, Lin; Ou, Ya; Huang, Yao-Xing] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Li, Wei-Dong; Jia, Lin; Jiang, Shu-man] Guangzhou Nansha Cent Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Jia, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	jialin@medmail.com.cn						AHO HJ, 1980, SCAND J GASTROENTERO, V15, P1027, DOI 10.3109/00365528009181808; Al-Bahrani AZ, 2010, PANCREAS, V39, P1064, DOI 10.1097/MPA.0b013e3181da8d51; Ammori Basil J, 2002, J Hepatobiliary Pancreat Surg, V9, P411, DOI 10.1007/s005340200050; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Huang YX, 2012, PANCREAS, V41, P849, DOI 10.1097/MPA.0b013e31823fbdc3; Jha RK, 2008, MED SCI MONITOR, V14, pBR14; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Li WD, 2013, PANCREAS, V42, P366, DOI 10.1097/MPA.0b013e31825c5273; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; McKay CJ, 2003, PANCREATOLOGY, V3, P111, DOI 10.1159/000070078; Morel DR, 2006, INTENS CARE MED, V32, P1872, DOI 10.1007/s00134-006-0264-9; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Servin-Torres E, 2009, CIR CIR, V77, P407; Song WB, 2009, WORLD J GASTROENTERO, V15, P3916, DOI 10.3748/wjg.15.3916; Takryama Y, 2005, J GASTROENTEROL, V40, P1; Wilson PG, 1998, J ANTIMICROB CHEMOTH, V41, P51, DOI 10.1093/jac/41.suppl_1.51; Zhang QH, 2001, CHINESE MED J-PEKING, V114, P738; Zhang XP, 2008, DIGEST DIS SCI, V53, P581, DOI 10.1007/s10620-007-9868-3	22	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78975	10.1371/journal.pone.0078975	http://dx.doi.org/10.1371/journal.pone.0078975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244397	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800021
J	Silva, CC; Mendonca, C; Mouta, S; Silva, R; Campos, JC; Santos, J				Silva, Carlos Cesar; Mendonca, Catarina; Mouta, Sandra; Silva, Rosa; Campos, Jose Creissac; Santos, Jorge			Depth Cues and Perceived Audiovisual Synchrony of Biological Motion	PLOS ONE			English	Article							PERCEPTION; INTEGRATION; DISTANCE	Background: Due to their different propagation times, visual and auditory signals from external events arrive at the human sensory receptors with a disparate delay. This delay consistently varies with distance, but, despite such variability, most events are perceived as synchronic. There is, however, contradictory data and claims regarding the existence of compensatory mechanisms for distance in simultaneity judgments. Principal Findings: In this paper we have used familiar audiovisual events - a visual walker and footstep sounds and manipulated the number of depth cues. In a simultaneity judgment task we presented a large range of stimulus onset asynchronies corresponding to distances of up to 35 meters. We found an effect of distance over the simultaneity estimates, with greater distances requiring larger stimulus onset asynchronies, and vision always leading. This effect was stronger when both visual and auditory cues were present but was interestingly not found when depth cues were impoverished. Significance: These findings reveal that there should be an internal mechanism to compensate for audiovisual delays, which critically depends on the depth information available.	[Silva, Carlos Cesar] Univ Minho, Dept Informat, Braga, Portugal; [Mendonca, Catarina] Carl Ossietzky Univ, Sch Med & Hlth Sci, Dept Psychol, Oldenburg, Lower Saxony, Germany; [Mouta, Sandra] Univ Barcelona, Dept Psicol Basica, Barcelona, Catalonia, Spain; [Mouta, Sandra] INESC, Inst Engn Sistemas & Comp, Porto, Portugal; [Silva, Rosa; Santos, Jorge] Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal; [Campos, Jose Creissac] Univ Minho, Sch Engn, Dept Informat, Braga, Portugal; [Campos, Jose Creissac] INESC TEC, HASLab, Porto, Portugal; [Santos, Jorge] Univ Minho, Ctr Algoritmi, Braga, Portugal; [Santos, Jorge] Ctr Comp Graf, Braga, Portugal	Universidade do Minho; Carl von Ossietzky Universitat Oldenburg; University of Barcelona; INESC TEC; Universidade do Porto; Universidade do Minho; Universidade do Minho; INESC TEC; Universidade do Minho	Silva, CC (corresponding author), Univ Minho, Dept Informat, Braga, Portugal.	carlos.cl.silva@gmail.com	Mouta, Sandra/H-8112-2013; Campos, José Creissac/B-2506-2008; Silva, Carlos/K-8821-2014; Mendonça, Catarina/L-8877-2013	Mouta, Sandra/0000-0002-0119-2329; Campos, José Creissac/0000-0001-9163-580X; Silva, Carlos/0000-0003-1973-2343; Mendonça, Catarina/0000-0002-4333-898X; Loureiro Silva, Carlos Cesar/0000-0002-4886-9405; Silva, Rosa Mariana/0000-0002-9902-6205; Santos, Jorge/0000-0001-5881-8567	Portuguese Foundation for Science and Technology [PTDC/EEA-ELC/112137/2009, SFRH/BPD/63393/2009]; FEDER grants through the Operational Competitiveness Program -COMPETE; national grants through FCT -Portuguese Foundation for Science and Technology [FCOMP-01-0124-FEDER-022674, PEst-C/CTM/U10264/2011, FCOMP-01-0124-FEDER-037281, PEst-C/EEI/LA0014/2013, FCOMP-01-0124-FEDER-015095]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER grants through the Operational Competitiveness Program -COMPETE; national grants through FCT -Portuguese Foundation for Science and Technology	This research was financed by the Portuguese Foundation for Science and Technology [PTDC/EEA-ELC/112137/2009; SFRH/BPD/63393/2009]. This work was financed by FEDER grants through the Operational Competitiveness Program -COMPETE and by national grants through FCT -Portuguese Foundation for Science and Technology, with the following projects: FCOMP-01-0124-FEDER-022674 and PEst-C/CTM/U10264/2011; FCOMP-01-0124-FEDER-037281 and PEst-C/EEI/LA0014/2013; and FCOMP-01-0124-FEDER-015095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Arnold DH, 2005, VISION RES, V45, P1275, DOI 10.1016/j.visres.2004.11.014; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; BEGAULT DR, 2000, SOUND VIRTUAL REALIT, pD3; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Harris L., 2010, SPACE TIME PERCEPTIO, P232, DOI DOI 10.1017/CB09780511750540.015; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; PETRINI K, 2010, J VIS, V10, P14, DOI DOI 10.1167/10.5.2.PUBMED:20616143; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Virsu V, 2008, EXP BRAIN RES, V186, P525, DOI 10.1007/s00221-007-1254-z; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80096	10.1371/journal.pone.0080096	http://dx.doi.org/10.1371/journal.pone.0080096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244617	Green Submitted, gold, Green Published			2022-12-27	WOS:000327143800121
J	Tsai, CH; Baranowski, C; Livny, J; McDonough, KA; Wade, JT; Contreras, LM				Tsai, Chen-Hsun; Baranowski, Catherine; Livny, Jonathan; McDonough, Kathleen A.; Wade, Joseph T.; Contreras, Lydia M.			Identification of Novel sRNAs in Mycobacterial Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; NONCODING RNA; REGULATORY RNAS; HIGH-THROUGHPUT; TUBERCULOSIS; DISCOVERY; BACTERIA; REVEALS; ANNOTATION; EXPRESSION	Bacterial small RNAs (sRNAs) are short transcripts that typically do not encode proteins and often act as regulators of gene expression through a variety of mechanisms. Regulatory sRNAs have been identified in many species, including Mycobacterium tuberculosis, the causative agent of tuberculosis. Here, we use a computational algorithm to predict sRNA candidates in the mycobacterial species M. smegmatis and M. bovis BCG and confirmed the expression of many sRNAs using Northern blotting. Thus, we have identified 17 and 23 novel sRNAs in M. smegmatis and M. bovis BCG, respectively. We have also applied a high-throughput technique (Deep-RACE) to map the 59 and 39 ends of many of these sRNAs and identified potential regulators of sRNAs by analysis of existing ChIP-seq datasets. The sRNAs identified in this work likely contribute to the unique biology of mycobacteria.	[Tsai, Chen-Hsun; Contreras, Lydia M.] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA; [Baranowski, Catherine; McDonough, Kathleen A.; Wade, Joseph T.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Livny, Jonathan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [McDonough, Kathleen A.; Wade, Joseph T.] SUNY Albany, Dept Biomed Sci, Albany, NY USA	University of Texas System; University of Texas Austin; State University of New York (SUNY) System; Wadsworth Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Contreras, LM (corresponding author), Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA.	lcontrer@che.utexas.edu	Contreras, Lydia/AAS-8845-2021	Wade, Joseph/0000-0002-9779-3160	Welch foundation; DTRA Young Investigator program; National Institutes of Health (NIH) [1DP2OD007188]; Emerging Infectious Diseases (EID) Fellowship Program; Centers for Disease Control and Prevention (CDC); NIH [GM39422, GM44844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, R01GM044844, R01GM039422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007188] Funding Source: NIH RePORTER	Welch foundation(The Welch Foundation); DTRA Young Investigator program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Infectious Diseases (EID) Fellowship Program; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Welch foundation, the DTRA Young Investigator program, National Institutes of Health (NIH) grant 1DP2OD007188 (JTW), and by an appointment (CB) to the Emerging Infectious Diseases (EID) Fellowship Program administered by the Association of Public Health Laboratories (APHL) and funded by the Centers for Disease Control and Prevention (CDC). Initial funding for preliminary studies was provided by (NIH) grants GM39422 and GM44844 to Dr. Marlene Belfort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Khoo JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S13; Lamichhane G, 2013, TUBERCULOSIS, V93, P26, DOI 10.1016/j.tube.2012.11.010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SK, 2013, RNA, V19, P74, DOI 10.1261/rna.034116.112; Livny J, 2012, BACTERIAL REGULATORY, V905, P3; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lu XJ, 2011, RNA, V17, P1635, DOI 10.1261/rna.2689811; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Pelly S, 2012, GENE, V500, P85, DOI 10.1016/j.gene.2012.03.044; Postic G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-625; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xia L, 2012, NUCLEIC ACID THER, V22, P177, DOI 10.1089/nat.2011.0339	33	25	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79411	10.1371/journal.pone.0079411	http://dx.doi.org/10.1371/journal.pone.0079411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244498	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800074
J	Payne, C; Bachevalier, J				Payne, Christa; Bachevalier, Jocelyne			Crossmodal Integration of Conspecific Vocalizations in Rhesus Macaques	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; PERVASIVE DEVELOPMENTAL DISORDER; CHIMPANZEE PAN-TROGLODYTES; MULTISENSORY INTEGRATION; AMYGDALA DAMAGE; EMOTION RECOGNITION; FACIAL EXPRESSIONS; MACACA-MULATTA; GAZE BEHAVIOR; EYE-MOVEMENTS	Crossmodal integration of audio/visual information is vital for recognition, interpretation and appropriate reaction to social signals. Here we examined how rhesus macaques process bimodal species-specific vocalizations by eye tracking, using an unconstrained preferential looking paradigm. Six adult rhesus monkeys (3M, 3F) were presented two side-by-side videos of unknown male conspecifics emitting different vocalizations, accompanied by the audio signal corresponding to one of the videos. The percentage of time animals looked to each video was used to assess crossmodal integration ability and the percentages of time spent looking at each of the six a priori ROIs (eyes, mouth, and rest of each video) were used to characterize scanning patterns. Animals looked more to the congruent video, confirming reports that rhesus monkeys spontaneously integrate conspecific vocalizations. Scanning patterns showed that monkeys preferentially attended to the eyes and mouth of the stimuli, with subtle differences between males and females such that females showed a tendency to differentiate the eye and mouth regions more than males. These results were similar to studies in humans indicating that when asked to assess emotion-related aspects of visual speech, people preferentially attend to the eyes. Thus, the tendency for female monkeys to show a greater differentiation between the eye and mouth regions than males may indicate that female monkeys were slightly more sensitive to the socio-emotional content of complex signals than male monkeys. The current results emphasize the importance of considering both the sex of the observer and individual variability in passive viewing behavior in nonhuman primate research.	[Payne, Christa; Bachevalier, Jocelyne] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Payne, Christa; Bachevalier, Jocelyne] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA	Emory University	Payne, C (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	christa.payne@emory.edu		Payne, Christa/0000-0002-6281-1269	National Institute of Child Health and Human Development [35471]; National Institute Mental Health [58846, T32-MH0732505]; Yerkes Base Grant [NIH RR00165]; Office of Research Infrastructure Programs/OD [P51OD11132]; Center for Behavioral Neuroscience [NSF IBN-9876754]; Robert W. Woodruff Health Sciences Center Fund, Emory University; Autism Speaks Mentor-Based Predoctoral Fellowship [1657]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058846] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute Mental Health; Yerkes Base Grant; Office of Research Infrastructure Programs/OD; Center for Behavioral Neuroscience; Robert W. Woodruff Health Sciences Center Fund, Emory University; Autism Speaks Mentor-Based Predoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by National Institute of Child Health and Human Development 35471; National Institute Mental Health 58846; Yerkes Base Grant NIH RR00165 (currently supported by the Office of Research Infrastructure Programs/OD P51OD11132); Center for Behavioral Neuroscience grant NSF IBN-9876754; The Robert W. Woodruff Health Sciences Center Fund, Emory University; National Institute of Mental Health T32-MH0732505; Autism Speaks Mentor-Based Predoctoral Fellowship Grant: 1657. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; [Anonymous], 2005, EMOTIONAL DEV RECENT; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Brothers Leslie, 1995, P1107; Buchan JN, 2007, SOC NEUROSCI-UK, V2, P1, DOI 10.1080/17470910601043644; Buchan JN, 2008, BRAIN RES, V1242, P162, DOI 10.1016/j.brainres.2008.06.083; Byrne R., 1988, MACHIAVELLIAN INTELL; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; de Gelder B, 2005, SCHIZOPHR RES, V72, P195, DOI 10.1016/j.schres.2004.02.013; de Jong JJ, 2010, SCHIZOPHR RES, V122, P136, DOI 10.1016/j.schres.2010.04.010; de Jong JJ, 2009, SCHIZOPHR RES, V107, P286, DOI 10.1016/j.schres.2008.10.001; De Waal, 1989, PEACEMAKING PRIMATES; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; Farzin F, 2009, J AUTISM DEV DISORD, V39, P946, DOI 10.1007/s10803-009-0744-1; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Goursaud APS, 2007, BEHAV BRAIN RES, V176, P75, DOI 10.1016/j.bbr.2006.09.020; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hinde R, 1962, P ROY SOC LON B, V138; HOBSON RP, 1988, PSYCHOL MED, V18, P911, DOI 10.1017/S0033291700009843; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lansing CR, 1999, J SPEECH LANG HEAR R, V42, P526, DOI 10.1044/jslhr.4203.526; Lansing IR, 2003, PERCEPT PSYCHOPHYS, V65, P536, DOI 10.3758/BF03194581; Loveland K, 1995, DEV PSYCHOPATHOL, V7; Loveland K. A., 2005, INT M AUT RES BOST M; Machado CJ, 2011, AM J PRIMATOL, V73, P562, DOI 10.1002/ajp.20928; Magnee MJCM, 2008, J CHILD PSYCHOL PSYC, V49, P995, DOI 10.1111/j.1469-7610.2008.01902.x; Magnee MJCM, 2007, J CHILD PSYCHOL PSYC, V48, P1122, DOI 10.1111/j.1469-7610.2007.01779.x; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; Parr LA, 2004, ANIM COGN, V7, P171, DOI 10.1007/s10071-004-0207-1; Partan SR, 2004, HDB MULTISENSORY PRO, P225; Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Roma PG, 2006, CHILD DEV, V77, P118, DOI 10.1111/j.1467-8624.2006.00860.x; Romanski Lizabeth M., 2010, P500; Sackett GP, 2002, AM J PRIMATOL, V56, P165, DOI 10.1002/ajp.1072; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Vatikiotis-Bateson E, 1998, PERCEPT PSYCHOPHYS, V60, P926, DOI 10.3758/BF03211929	53	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81825	10.1371/journal.pone.0081825	http://dx.doi.org/10.1371/journal.pone.0081825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236218	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700221
J	Trevisi, P; Gandolfi, G; Priori, D; Messori, S; Colombo, M; Mazzoni, M; Lalles, JP; Bosi, P				Trevisi, Paolo; Gandolfi, Greta; Priori, Davide; Messori, Stefano; Colombo, Michela; Mazzoni, Maurizio; Lalles, Jean-Paul; Bosi, Paolo			Age-Related Expression of the Polymeric Immunoglobulin Receptor (pIgR) in the Gastric Mucosa of Young Pigs	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; ADAPTIVE IMMUNE-RESPONSES; GENE-EXPRESSION; IG RECEPTOR; SECRETORY COMPONENT; RNA EXPRESSION; GUT; SYSTEM; TOLERANCE; TISSUES	To date few studies have addressed the development and function of the porcine gastric mucosal immune system and this is a major limitation to understanding the immunopathogenesis of infections occurring in young pigs. The polymeric immunoglobulin receptor (pIgR) mediates the transport of secretory immunoglobulins until luminal surface of the gut mucosa and the aim of this study was to investigate the time course of pIgR expression and to determine its localization in three functionally different porcine gastric sites during the suckling period and after weaning. An additional goal was to investigate the time course expression of toll-like receptors (TLRs) in relation to pIgR expression. Gastric samples were collected from the cardiac-to-oxyntic transition (Cd), the oxyntic (Ox), and the pyloric (Py) regions in 84 pigs, slaughtered before weaning (14, 21 and 28 days of age; 23, 23 and 19 pigs, respectively) and 14 days post-weaning (42 days of age, 23 pigs). PIgR was expressed in the mucosa of all the three gastric sites, and its transcript levels were modulated during suckling and after weaning, with regional differences. PIgR expression increased linearly during suckling (P=0.019) and also increased post-weaning (P=0.001) in Cd, it increased post-weaning in Py (P=0.049) and increased linearly during suckling in Ox (P=0.036). TLRs expression was also modulated during development: in Cd, TLR2 increased linearly during suckling (P=0.003); in Ox, TLR2 decreased after weaning (P=0.038) while TLR4 increased linearly during suckling(P=0.008). The expression of TLR2, 3 and 4 in Ox was positively correlated with pIgR expression (P<0.001). Importantly, both pIgR protein and mRNA were localized, by immunohistochemistry and in situ hybridization, respectively, in the gastric glands of the lamina propria. These results indicate that pIgR is actively synthesized in the gastric mucosa and suggest that pIgR could play a crucial role in gastric mucosal immune defense of growing pigs.	[Trevisi, Paolo; Gandolfi, Greta; Priori, Davide; Messori, Stefano; Colombo, Michela; Bosi, Paolo] Univ Bologna, Dept Agr & Food Sci, Reggio Emilia, Italy; [Mazzoni, Maurizio] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy; [Lalles, Jean-Paul] INRA, Cent & Behav Adaptat Dept, Food & Digest, St Gilles, France	University of Bologna; University of Bologna; INRAE	Trevisi, P (corresponding author), Univ Bologna, Dept Agr & Food Sci, Reggio Emilia, Italy.	paolo.trevisi@unibo.it	Messori, Stefano/G-2425-2016; Mazzoni, Maurizio/J-1918-2016	Messori, Stefano/0000-0002-6988-7960; Mazzoni, Maurizio/0000-0002-7384-5990; TREVISI, PAOLO/0000-0001-7019-6828; Gandolfi, Greta/0000-0001-7498-424X; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]	European Union(European Commission)	This research was funded by the European Union Seventh Framework Program (FP7/2007-2013) under the grant agreement no. 227549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2004, SCAND J IMMUNOL, V60, P267, DOI 10.1111/j.0300-9475.2004.01456.x; Asano Masatake, 2011, J Oral Sci, V53, P147; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bjorkholm BM, 2002, J BIOL CHEM, V277, P34191, DOI 10.1074/jbc.M203613200; Bosi P, 2006, J NUTR, V136, P1229, DOI 10.1093/jn/136.5.1229; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Bruno MEC, 2010, IMMUNOL INVEST, V39, P356, DOI 10.3109/08820131003622809; Burkey TE, 2009, J ANIM SCI, V87, P1493, DOI 10.2527/jas.2008-1330; Diebel LN, 2011, J TRAUMA, V70, P691, DOI 10.1097/TA.0b013e31820c780e; Goebel M, 2011, PHYSIOL GENOMICS, V43, P237, DOI 10.1152/physiolgenomics.00193.2010; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; HULING S, 1992, P NATL ACAD SCI USA, V89, P4260, DOI 10.1073/pnas.89.10.4260; Jenkins SL, 2003, AM J PHYSIOL-GASTR L, V285, pG714, DOI 10.1152/ajpgi.00130.2003; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Karlsson MR, 2010, ALLERGY, V65, P561, DOI 10.1111/j.1398-9995.2009.02225.x; KRAJCI P, 1989, BIOCHEM BIOPH RES CO, V158, P783, DOI 10.1016/0006-291X(89)92790-3; Mazzoni M, 2011, J ANAT, V219, P611, DOI 10.1111/j.1469-7580.2011.01415.x; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Pan ZY, 2011, J ANIM VET ADV, V10, P2312, DOI 10.3923/javaa.2011.2312.2316; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Resendiz-Albor AA, 2010, IMMUNOL LETT, V128, P59, DOI 10.1016/j.imlet.2009.11.005; ROTHKOTTER HJ, 1991, PEDIATR RES, V29, P237, DOI 10.1203/00006450-199103000-00004; Sang Y, 2008, VET IMMUNOL IMMUNOP, V125, P162, DOI 10.1016/j.vetimm.2008.04.017; Schneeman TA, 2005, J IMMUNOL, V175, P376, DOI 10.4049/jimmunol.175.1.376; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Trevisi P, 2008, NUTRITION, V24, P1023, DOI 10.1016/j.nut.2008.04.008; Uddin MJ, 2013, RES VET SCI, V95, P92, DOI 10.1016/j.rvsc.2013.01.027; VALNES K, 1984, GASTROENTEROLOGY, V86, P402; VEGALOPEZ MA, 1995, VET IMMUNOL IMMUNOP, V44, P319, DOI 10.1016/0165-2427(94)05309-G	30	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81473	10.1371/journal.pone.0081473	http://dx.doi.org/10.1371/journal.pone.0081473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236214	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700217
J	Sethi, V; Muhlert, N; Ron, M; Golay, X; Wheeler-Kingshott, CA; Miller, DH; Chard, DT; Yousry, TA				Sethi, Varun; Muhlert, Nils; Ron, Maria; Golay, Xavier; Wheeler-Kingshott, Claudia A.; Miller, David H.; Chard, Declan T.; Yousry, Tarek A.			MS Cortical Lesions on DIR: Not Quite What They Seem?	PLOS ONE			English	Article							SENSITIVE INVERSION-RECOVERY; MULTIPLE-SCLEROSIS PATIENTS; INTRACORTICAL LESIONS; COGNITIVE DYSFUNCTION; IMPAIRMENT; MRI; DEMYELINATION; FREQUENCY	Objective: Accurate identification and localization of cortical gray matter (CGM) lesions in MS is important when determining their clinical relevance. Double inversion recovery (DIR) scans have been widely used to detect MS CGM lesions. Phase sensitive inversion recovery (PSIR) scans have a higher signal to noise, and can therefore be obtained at a higher resolution within clinically acceptable times. This enables detection of more CGM lesions depicting a clearer cortical and juxtacortical anatomy. In this study, we systematically investigated if the use of high resolution PSIR scans changes the classification of CGM lesions, when compared with standard resolution DIR scans. Methods: 60 patients [30 RR(Relapsing remitting) and 15 each with PP(Primary progressive) and SP(Secondary progressive) MS] were scanned on a 3T Philips Achieva MRI scanner. Images acquired included DIR (16163 mm resolution) and PSIR (0.5x0.5x2 mm). CGM lesions were detected and classified on DIR as intracortical (IC) or leucocortical (LC). We then examined these lesions on corresponding slices of the high resolution PSIR scans and categorized them as IC, LC, Juxtacortical white matter (JC-WM, abutting but not entering cortex) and other white matter (WM, not juxtacortical). Classifications using both scans were noted. Results: 282 IC and 483 LC were identified on DIR. Of the IC lesions, 61% were confirmed as IC on PSIR, 35.5% were reclassified as LC and 3.5% as JC-WM or other WM only. Of the LC DIR lesions, 43.9% were confirmed at LC on PSIR, 16.1% were reclassified as IC and 40% as JC-WM or other WM only. Overall, 50% (381/765) of CGM lesions seen on DIR were reclassified, and 26.5% (203/765) affected WM only. Conclusions: When compared with higher resolution PSIR, a significant proportion of lesions classified as involving CGM on DIR appear to either contain more white matter than expected or to not involve CGM at all.	[Sethi, Varun; Muhlert, Nils; Ron, Maria; Golay, Xavier; Wheeler-Kingshott, Claudia A.; Miller, David H.; Chard, Declan T.; Yousry, Tarek A.] UCL Inst Neurol, Queen Sq MS Ctr, London, England; [Sethi, Varun; Muhlert, Nils; Ron, Maria; Wheeler-Kingshott, Claudia A.; Miller, David H.; Chard, Declan T.] UCL Inst Neurol, Dept Neuroinflammat, London, England; [Golay, Xavier; Yousry, Tarek A.] UCL Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Yousry, Tarek A.] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Sethi, V (corresponding author), UCL Inst Neurol, Queen Sq MS Ctr, London, England.	varun.sethi.09@ucl.ac.uk	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019; Golay, Xavier/AAJ-8094-2021; Muhlert, Nils/A-7907-2013	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Golay, Xavier/0000-0002-6447-4446; Muhlert, Nils/0000-0002-6414-5589; Chard, Declan/0000-0003-3076-2682	MS Society of Great Britain and Northern Ireland [917-09]; UCL UCLH Comprehensive Biomedical Research Centre	MS Society of Great Britain and Northern Ireland; UCL UCLH Comprehensive Biomedical Research Centre	The NMR Research Unit is supported by the MS Society of Great Britain and Northern Ireland and the UCL UCLH Comprehensive Biomedical Research Centre; the MS Society of Great Britain and Northern Ireland has provided financial support for staff and research costs (Grant number 917-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Calabrese M, 2012, J NEUROL NEUROSUR PS, V83, P49, DOI 10.1136/jnnp-2011-300414; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2008, NEUROIMAGE, V42, P1324, DOI 10.1016/j.neuroimage.2008.06.028; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2011, EXPERT REV NEUROTHER, V11, P425, DOI 10.1586/ERN.10.155; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Lazeron RHC, 2000, MULT SCLER J, V6, P280, DOI 10.1177/135245850000600410; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Simon B, 2010, EUR RADIOL, V20, P1675, DOI 10.1007/s00330-009-1705-y	19	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78879	10.1371/journal.pone.0078879	http://dx.doi.org/10.1371/journal.pone.0078879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244381	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327221600076
J	Shelef, O; Helman, Y; Friedman, ALL; Behar, A; Rachmilevitch, S				Shelef, Oren; Helman, Yael; Friedman, Ariel-Leib-Leonid; Behar, Adi; Rachmilevitch, Shimon			Tri-Party Underground Symbiosis between a Weevil, Bacteria and a Desert Plant	PLOS ONE			English	Article							NITROGEN-FIXATION; NATURAL-POPULATIONS; BIOLOGICAL-CONTROL; HOST-SPECIFICITY; CURCULIONIDAE; ENDOSYMBIONTS; RHIZOBIUM; COL.	Inhabitants of arid ecosystems face severe nitrogen and water limitations. Inventive adaptations by organisms occupying such habitats are essential for survival. This study describes a tri-party symbiotic interaction between a plant (Salsola inermis), a beetle (Conorhynchus pistor), and a bacterium (Klebsiella pneumonia). The weevil survives by living within a mud structure affixed to the plant roots, thus benefiting from increased carbon and water, and refuge from predators and parasites. Active nitrogen-fixing bacteria harbored within the weevil's gut mediate this interaction, by supplying nitrogen to the system, which eventually promotes seed development. We studied the correlation between the weevil's existence and (i) root carbon and nitrogen content, (ii) soil water content and (iii) seed weight. Roots hosting weevils contained more nitrogen, heavier seeds and less carbon. In addition, water content was higher around the roots than in open spaces a short distance from the plant stem. Bacterial studies and nitrogen-fixation analyses, including molecular and chemical assays, indicated atmospheric nitrogen fixation in the larval stage and identified the bacterium. The coexistence of weevil and bacterial behavior coinciding with the plant's life cycle was revealed here by a long period of field observations. Out of over 60,000 known weevils, this is the only report of a weevil living most of its life underground without harming plants. The unique tri-party interaction described herein shows the important ecological role of desert plant roots and provides an example of a sustainable consortium of living organisms coping with the challenging desert environment.	[Shelef, Oren; Rachmilevitch, Shimon] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Helman, Yael; Behar, Adi] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Friedman, Ariel-Leib-Leonid] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Ben Gurion University; Hebrew University of Jerusalem; Tel Aviv University	Rachmilevitch, S (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	rshimon@bgu.ac.il	Shelef, Oren/ABD-9396-2020; Rachmilevitch, Shimon/F-1329-2012	Rachmilevitch, Shimon/0000-0003-3600-5949; Friedman, Ariel-Leib-Leonid/0000-0003-4389-6858	Israeli Science Foundation [8554122]; French Associates Institute for Agriculture & Biotechnology of Drylands	Israeli Science Foundation(Israel Science Foundation); French Associates Institute for Agriculture & Biotechnology of Drylands	This work was partially supported by the Israeli Science Foundation grant no. 8554122 and by the French Associates Institute for Agriculture & Biotechnology of Drylands. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NITROGEN FIXATION; Begon M., 2009, ECOLOGY INDIVIDUALS; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; BENEMANN JR, 1973, SCIENCE, V181, P164, DOI 10.1126/science.181.4095.164; BOULOS L, 1994, J U KUWAIT-SCI, V21, P203; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Esser HG, 2010, J PLANT NUTR SOIL SC, V173, P757, DOI 10.1002/jpln.200900188; EVENARI M., 1966, Zeitschrift fur Pflanzenphysiologie, V54, P1; Feinbrun-Dothan N., 1998, ANAL FLORA ERETZ ISR; FRASER NHC, 1993, P ROY SOC B-BIOL SCI, V252, P135, DOI 10.1098/rspb.1993.0057; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; GUTTERMAN Y, 1994, BOT REV, V60, P373, DOI 10.1007/BF02857924; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; NARDON P, 1993, ANN SOC ENTOMOL FR, V29, P113; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Okon Y., 1988, Biological nitrogen fixation: recent developments., P175; Perrine-Walker F, 2011, CURR PROTEIN PEPT SC, V12, P156, DOI 10.2174/138920311795684896; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Rewald B, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P196, DOI 10.1079/9781845938147.0196; Shelef O, 2011, J ARID ENVIRON, V75, P960, DOI 10.1016/j.jaridenv.2011.04.016; Sobhian R, 2003, J APPL ENTOMOL, V127, P322, DOI 10.1046/j.1439-0418.2003.00761.x; Sobhian R, 1999, J APPL ENTOMOL, V123, P205, DOI 10.1046/j.1439-0418.1999.00351.x; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; TOKGAEV T., 1964, IZV AKAD NAUK TURKM SSR SER BIOL NAUK, V1, P53; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0; Vaishampayan A, 2001, BOT REV, V67, P453, DOI 10.1007/BF02857893; Wallace A., 1978, US/IBP Synthesis Series, V9, P130; Wallace A, 1974, US IBP DESERT BIOME, P36; West NE, 1978, NITROGEN DESERT ECOS	39	17	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e76588	10.1371/journal.pone.0076588	http://dx.doi.org/10.1371/journal.pone.0076588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244267	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600005
J	Smeeton, NJ; Huys, R; Jacobs, DM				Smeeton, Nicholas J.; Huys, Raoul; Jacobs, David M.			When Less Is More: Reduced Usefulness Training for the Learning of Anticipation Skill in Tennis	PLOS ONE			English	Article							VISUAL-SEARCH STRATEGY; INFORMATION PICK-UP; MOVEMENT PATTERNS; SHOT DIRECTION; PERCEPTION; EXPERTISE; ATTENTION; TASK; VARIABILITY; AWARENESS	Participants in this study practiced with feedback to anticipate the left-right direction of forehand tennis shots played by stick-figure players. A technique based on principal component analysis was used to remove dynamical differences that are associated with shots to different directions. Different body regions of the stick-figure players were neutralized with this procedure in the pretests and posttests, and in the practice phases. Experiment 1 showed that training is effective if during practice information is consistently present in the whole body of the player, but not if the information is neutralized in the whole body in half of the practice trials. Experiment 2 showed that training is effective if the variance associated with the direction of the shots is consistently present in one body region but neutralized in others, and that transfer occurs from practice with information in one body region to performance in conditions with information preserved only in other regions. Experiment 3 showed that occlusion has a much larger detrimental effect on learning than the applied neutralization technique, and that transfer between body regions occurs also with occlusion. Discussed are theoretical implications for understanding how biological motion is perceived and possible applications in a type of training referred to as reduced usefulness training.	[Smeeton, Nicholas J.] Univ Brighton, Fac Educ & Sport, Eastbourne, England; [Huys, Raoul] Aix Marseille Univ, Inst Neurosci Syst, Marseille, France; [Huys, Raoul] INSERM, UMR S 1106, F-13258 Marseille, France; [Huys, Raoul] Univ Autonoma Madrid, CNRS, E-28049 Madrid, Spain; [Jacobs, David M.] Univ Autonoma Madrid, Fac Psicol, E-28049 Madrid, Spain	University of Brighton; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Autonomous University of Madrid; Autonomous University of Madrid	Smeeton, NJ (corresponding author), Univ Brighton, Fac Educ & Sport, Eastbourne, England.	n.j.smeeton@brighton.ac.uk	Jacobs, David M/C-5216-2011	Jacobs, David M/0000-0003-2954-5293; Smeeton, Nicholas/0000-0003-3371-3237				ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Abernethy B, 2012, J EXP PSYCHOL-APPL, V18, P143, DOI 10.1037/a0028452; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; [Anonymous], 1997, DYNAMIC PATTERNS SEL; Beek P. J., 2003, EXPERT PERFORMANCE S, P321; Bernstein NA, 1967, COREGULATION MOVEMEN; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Farrow D, 2002, J SPORT SCI, V20, P471, DOI 10.1080/02640410252925143; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Hagemann N, 2006, J SPORT EXERCISE PSY, V28, P143, DOI 10.1123/jsep.28.2.143; Huet M, 2011, J EXP PSYCHOL HUMAN, V37, P1841, DOI 10.1037/a0024386; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; Huys R, 2009, J MOTOR BEHAV, V41, P158, DOI 10.3200/JMBR.41.2.158-171; Jackson RC, 2007, J MOTOR BEHAV, V39, P341, DOI 10.3200/JMBR.39.5.341-352; Jacobs DM, 2007, ECOL PSYCHOL, V19, P321, DOI 10.1080/10407410701432337; Jacobs DM, 2009, ECOL PSYCHOL, V21, P245, DOI 10.1080/10407410903058302; Jacobs DM, 2001, J EXP PSYCHOL HUMAN, V27, P1019, DOI 10.1037/0096-1523.27.5.1019; Muller S, 2012, RES Q EXERCISE SPORT, V83, P175; Muller S, 2010, PERCEPTION, V39, P745, DOI 10.1068/p6438; Poulter DR, 2005, HUM MOVEMENT SCI, V24, P345, DOI 10.1016/j.humov.2005.06.005; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; RUNESON S, 1981, J EXP PSYCHOL HUMAN, V7, P733, DOI 10.1037/0096-1523.7.4.733; Savelsbergh GJP, 2010, INT J SPORT PSYCHOL, V41, P24; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Smeeton NJ, 2011, HUM MOVEMENT SCI, V30, P957, DOI 10.1016/j.humov.2010.07.012; Smeeton NJ, 2005, J EXP PSYCHOL-APPL, V11, P98, DOI 10.1037/1076-898X.11.2.98; Ward P, 2002, RES Q EXERCISE SPORT, V73, P107, DOI 10.1080/02701367.2002.10608997; Williams AM, 2009, HUM MOVEMENT SCI, V28, P362, DOI 10.1016/j.humov.2008.10.006; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Williams AM, 2002, J EXP PSYCHOL-APPL, V8, P259, DOI 10.1037/1076-898X.8.4.259; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	34	18	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79811	10.1371/journal.pone.0079811	http://dx.doi.org/10.1371/journal.pone.0079811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255EG	24244564	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600153
J	Braesch-Andersen, S; Paulie, S; Smedman, C; Mia, S; Kumagai-Braesch, M				Braesch-Andersen, Sten; Paulie, Staffan; Smedman, Christian; Mia, Sohel; Kumagai-Braesch, Makiko			ApoE Production in Human Monocytes and Its Regulation by Inflammatory Cytokines	PLOS ONE			English	Article							HUMAN APOLIPOPROTEIN-E; E-DEFICIENT MICE; IN-VIVO; APOPROTEIN-E; E SECRETION; REDUCES ATHEROSCLEROSIS; TRANSPORT PROTEIN; IMMUNE-RESPONSES; GENE-EXPRESSION; E SUPPRESSES	The apoE production by tissue macrophages is crucial for the prevention of atherosclerosis and the aim of this study was to further elucidate how this apolipoprotein is regulated by cytokines present during inflammation. Here we studied apoE production in peripheral blood mononuclear cells (PBMC) and analysis was made with a newly developed apoE ELISpot assay. In PBMC, apoE secretion was restricted to monocytes with classical (CD14(++) CD16(-)) and intermediate (CD14(+) CD16(+)) monocytes being the main producers. As earlier described for macrophages, production was strongly upregulated by TGF-beta and downregulated by bacterial lipopolysaccharide (LPS) and the inflammatory cytokines IFN-gamma, TNF-alpha and IL-1 beta. We could here show that a similar down-regulatory effect was also observed with the type I interferon, IFN-alpha, while IL-6, often regarded as one of the more prominent inflammatory cytokines, did not affect TGF-beta-induced apoE production. The TNF-alpha inhibitor Enbrel could partly block the down-regulatory effect of IFN-gamma, IFN-alpha and IL-1 beta, indicating that inhibition of apoE by these cytokines may be dependent on or synergize with TNF-alpha. Other cytokines tested, IL-2, IL-4, IL-12, IL-13, IL-17A and IL23, had no inhibitory effect on apoE production. In contrast to the effect on monocytes, apoE production by primary hepatocytes and the hepatoma cell line HepG2 was more or less unaffected by treatment with cytokines or LPS.	[Braesch-Andersen, Sten; Paulie, Staffan] Mabtech, Nacka Strand, Sweden; [Smedman, Christian] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit L8 01, Mabtech, Stockholm, Sweden; [Smedman, Christian] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit L8 01, Ctr Mol Med, Stockholm, Sweden; [Mia, Sohel] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Mabtech, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Div Transplantat Surg, CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Braesch-Andersen, S (corresponding author), Mabtech, Nacka Strand, Sweden.	sten@mabtech.com		Kumagai-Braesch, Makiko/0000-0001-6011-0744				Aleong R, 2008, CURR ALZHEIMER RES, V5, P33; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; AVILA EM, 1982, J BIOL CHEM, V257, P5900; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; DUAN HW, 1995, J CLIN INVEST, V96, P915, DOI 10.1172/JCI118139; Fazio S, 2002, J LIPID RES, V43, P1602, DOI 10.1194/jlr.M200108-JLR200; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Frostegard J, 2005, ARTERIOSCL THROM VAS, V25, P1776, DOI 10.1161/01.ATV.0000174800.78362.ec; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; HANSSON GK, 1993, BRIT HEART J, V69, pS38; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; KELLY ME, 1994, CELL IMMUNOL, V159, P124, DOI 10.1006/cimm.1994.1302; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Laskowitz DT, 2000, J LIPID RES, V41, P613; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; RALL SC, 1982, J BIOL CHEM, V257, P4171; Roselaar SE, 1998, J LIPID RES, V39, P1740; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Smedman C, 2012, SCAND J IMMUNOL, V75, P249, DOI 10.1111/j.1365-3083.2011.02641.x; Song H, 1998, CYTOKINE, V10, P275, DOI 10.1006/cyto.1997.0291; Taleb S, 2010, CURR OPIN PHARMACOL, V10, P197, DOI 10.1016/j.coph.2010.02.003; UTERMANN G, 1975, H-S Z PHYSIOL CHEM, V356, P1113, DOI 10.1515/bchm2.1975.356.2.1113; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; WEISGRABER KH, 1978, J BIOL CHEM, V253, P6281; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; WERB Z, 1986, CIBA F SYMP, V118, P155, DOI 10.1002/9780470720998.ch11; WERB Z, 1983, J BIOL CHEM, V258, P642; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; ZANNIS VI, 1986, J BIOL CHEM, V261, P3415; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585; ZUCKERMAN SH, 1992, ATHEROSCLEROSIS, V96, P203, DOI 10.1016/0021-9150(92)90066-P; ZUCKERMAN SH, 1994, J LEUKOCYTE BIOL, V55, P743, DOI 10.1002/jlb.55.6.743	47	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79908	10.1371/journal.pone.0079908	http://dx.doi.org/10.1371/journal.pone.0079908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244577	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800104
J	Deschasaux, M; Zelek, L; Pouchieu, C; His, M; Hercberg, S; Galan, P; Latino-Martel, P; Touvier, M				Deschasaux, Melanie; Zelek, Laurent; Pouchieu, Camille; His, Mathilde; Hercberg, Serge; Galan, Pilar; Latino-Martel, Paule; Touvier, Mathilde			Prospective Association between Dietary Fiber Intake and Breast Cancer Risk	PLOS ONE			English	Article							INSULIN; FOOD; PREMENOPAUSAL; INFLAMMATION; PROTEIN; METAANALYSIS; NUTRITION; SU.VI.MAX; ESTROGEN; COHORT	Background: Mechanistic hypotheses suggest a potential effect of dietary fiber on breast carcinogenesis through the modulation of insulin-like growth factor bioactivity, estrogen metabolism and inflammation. An association between dietary fiber intake and breast cancer risk has been suggested in epidemiological studies but remains inconclusive. In particular, data is lacking regarding the different types of dietary fibers. Objective: The objective was to investigate the prospective relationship between dietary fiber intake and breast cancer risk, taking into account different types of dietary fiber (overall, insoluble, soluble and from different food sources: cereals, vegetables, fruits and legumes). Design: 4684 women from the SU.VI.MAX cohort were included in this analysis as they completed at least three 24h-dietary records within the first two years of follow-up. Among them, 167 incident invasive breast cancers were diagnosed during a median follow-up of 12.6 years (between 1994 and 2007). The associations between quartiles of dietary fiber intake and breast cancer risk were characterized using multivariate Cox proportional hazards models. Results: Total fiber intake was not associated with breast cancer risk (HRQuartile4vs.Quartile1 = 1.29 (95% CI 0.66-2.50), P-trend = 0.5), nor was fiber intake from cereals (P-trend = 0.1), fruits (P-trend = 0.9) and legumes (P-trend = 0.3). In contrast, vegetable fiber intake was related to a decreased risk of breast cancer (HRQ4vs.Q1 = 0.50 (0.29-0.88), P-trend = 0.03). Overall vegetable intake (in g/day) was not associated with breast cancer risk (P-trend = 0.2). Conclusion: This prospective study suggests that vegetable fiber intake may contribute to reduce breast cancer risk, in line with experimental mechanistic data.	[Deschasaux, Melanie; Zelek, Laurent; Pouchieu, Camille; His, Mathilde; Hercberg, Serge; Galan, Pilar; Latino-Martel, Paule; Touvier, Mathilde] Univ Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr, INSERM,INRA,Cnam,U557,U1125,SMPH Paris 13, Bobigny, France; [Zelek, Laurent] Avicenne Hosp, Dept Oncol, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Deschasaux, M (corresponding author), Univ Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr, INSERM,INRA,Cnam,U557,U1125,SMPH Paris 13, Bobigny, France.	m.deschasaux@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Touvier, Mathilde/E-8817-2017; Deschasaux, Mélanie/AAK-9116-2020; Laurent, Zelek/F-2906-2017; Latino-Martel, Paule/O-1549-2019; HERCBERG, Serge/B-4429-2008; Latino-Martel, Paule/W-1437-2017; Latino-Martel, Paule/F-2706-2017; Serge, Hercberg/F-3038-2017	Pilar, Galan/0000-0003-1706-3107; Touvier, Mathilde/0000-0002-8322-8857; Deschasaux, Mélanie/0000-0002-3359-420X; Laurent, Zelek/0000-0001-7455-2009; Latino-Martel, Paule/0000-0003-4581-852X; HERCBERG, Serge/0000-0002-3168-1350; Latino-Martel, Paule/0000-0003-4581-852X; Latino-Martel, Paule/0000-0003-4581-852X; Serge, Hercberg/0000-0002-3168-1350; His, Mathilde/0000-0003-3850-8291	Canceropole Ile-de-France; Paris region	Canceropole Ile-de-France(Region Ile-de-France); Paris region(Region Ile-de-France)	Melanie Deschasaux was supported by a grant from the "Canceropole Ile-de-France" (public funding from the Paris region). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; ANDERSON JW, 1994, AM J CLIN NUTR, V59, p1242S, DOI 10.1093/ajcn/59.5.1242S; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Aubertin-Leheudre M, 2008, J STEROID BIOCHEM, V112, P32, DOI 10.1016/j.jsbmb.2008.08.002; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Belle FN, 2011, CANCER EPIDEM BIOMAR, V20, P890, DOI 10.1158/1055-9965.EPI-10-1278; BOURQUIN LD, 1993, J NUTR, V123, P860, DOI 10.1093/jn/123.5.860; Cohen LA, 1996, J NATL CANCER I, V88, P899, DOI 10.1093/jnci/88.13.899; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Dahm CC, 2010, JNCI-J NATL CANCER I, V102, P614, DOI 10.1093/jnci/djq092; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dong JY, 2011, AM J CLIN NUTR, V94, P900, DOI 10.3945/ajcn.111.015578; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Ferrari P, 2013, AM J CLIN NUTR, V97, P344, DOI 10.3945/ajcn.112.034025; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; Gerber M, 1996, J NATL CANCER I, V88, P857, DOI 10.1093/jnci/88.13.857; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Gross A, 2013, CANC EPIDEMIOL BIOMA; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Hercberg S, 2005, TABLE COMPOSITION SU; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; James SL, 2003, INTERN MED J, V33, P291, DOI 10.1046/j.1445-5994.2003.00404.x; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kantor ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067833; Kerver JM, 2010, AM J CLIN NUTR, V91, P643, DOI 10.3945/ajcn.2009.28205; Key TJ, 2011, STEROIDS, V76, P812, DOI 10.1016/j.steroids.2011.02.029; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim J, 1978, FACTOR ANAL STAT MET; King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502; Lairon D, 2003, P NUTR SOC, V62, P11, DOI 10.1079/PNS2002210; Longcope C, 2000, J CLIN ENDOCR METAB, V85, P293, DOI 10.1210/jc.85.1.293; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Moore MA, 1998, CRIT REV ONCOL HEMAT, V27, P229, DOI 10.1016/S1040-8428(98)00006-7; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Probst-Hensch NM, 2003, CANCER EPIDEM BIOMAR, V12, P739; PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Walker K, 2011, BRIT J CANCER, V105, P1451, DOI 10.1038/bjc.2011.358; WCRF/AIRC, 2010, SYST LIT REV CONT UP; Willett WC, 2001, J INTERN MED, V249, P395, DOI 10.1046/j.1365-2796.2001.00822.x; World Health Organization (WHO), 2010, ICD 10 INT CLASS DIS; Zhang CX, 2011, EUR J CLIN NUTR, V65, P929, DOI 10.1038/ejcn.2011.57	52	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79718	10.1371/journal.pone.0079718	http://dx.doi.org/10.1371/journal.pone.0079718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244548	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800097
J	Hu, LY; Liu, CJ; Lu, T; Hu, TM; Tsai, CF; Hu, YW; Shen, CC; Chang, YS; Chen, MH; Teng, CJ; Chiang, HL; Yeh, CM; Su, VYF; Wang, WS; Chen, PM; Chen, TJ; Su, TP				Hu, Li-Yu; Liu, Chia-Jen; Lu, Ti; Hu, Tsung-Ming; Tsai, Chia-Fen; Hu, Yu-Wen; Shen, Cheng-Che; Chang, Yu-Sheng; Chen, Mu-Hong; Teng, Chung-Jen; Chiang, Huey-Ling; Yeh, Chiu-Mei; Su, Vincent Yi-Fong; Wang, Wei-Shu; Chen, Pan-Ming; Chen, Tzeng-Ji; Su, Tung-Ping			Delayed Onset Urticaria in Depressive Patients with Bupropion Prescription: A Nationwide Population-Based Study	PLOS ONE			English	Article							GENERALIZED ACUTE URTICARIA; SMOKING-CESSATION; SERUM; ASSOCIATION; ALPHA	Background: Bupropion, which is widely used in patients with depressive disorder, may cause allergic reactions. However, the real prevalence of these side effects may be overlooked and underreported due to the delayed onset phenomenon. Objective: This study aimed to estimate the real incidence of bupropion-induced urticaria and clarify the delayed onset phenomenon. Methods: We conducted a nationwide cohort study between 2000 and 2009 using Taiwan's National Health Insurance Dataset. Among 65,988 patients with depressive disorders, we identified new users of bupropion with depressive disorders (bupropion cohort, n = 2,839) and matched them at a ratio of 1: 4 regarding age and sex (non-bupropion matched cohort, n = 11,356). The risk of urticaria was compared between the two cohorts. Results: The risk of urticaria occurrence was higher in bupropion users than in matched controls within 4 weeks of starting the medication (risk ratio 1.81; 95% confidence interval 1.28-2.54; p = 0.001). The occurrence of urticaria in the bupropion cohort were more frequent on Days 15-28 than Day 1-14 (p = 0.002). Cox proportional hazards model showed that a history of urticaria was an independent risk factor for developing bupropion-induced urticaria. Conclusions: Of the antidepressants, bupropion may pose a higher risk of drug-induced urticaria, and this condition might be ignored due to the delayed onset phenomenon. Depressive patients with a history of urticaria are at higher risk of the adverse drug reaction. This study emphasizes the need for increased clinical awareness of this adverse outcome to bupropion use.	[Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Hu, Tsung-Ming] Yuli Vet Hosp, Dept Psychiat, Yuli, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Hu, Li-Yu; Liu, Chia-Jen; Hu, Yu-Wen; Chang, Yu-Sheng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Liu, Chia-Jen; Wang, Wei-Shu] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Tsai, Chia-Fen; Chen, Mu-Hong; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Chang, Yu-Sheng] Shuang Ho Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, New Taipei City, Taiwan; [Chang, Yu-Sheng] Taipei Med Univ, New Taipei City, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Div Hematol & Oncol, Dept Med, New Taipei City, Taiwan; [Chiang, Huey-Ling] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Chiang, Huey-Ling] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Su, Vincent Yi-Fong] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Dept Psychiat, Su Ao & Yuanshan Branch, Taipei, Taiwan; [Hu, Li-Yu; Tsai, Chia-Fen; Shen, Cheng-Che; Teng, Chung-Jen; Wang, Wei-Shu; Chen, Tzeng-Ji; Su, Tung-Ping] Natl Yang Ming Univ, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Su, TP (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tomsu0402@gmail.com	Chen, TJ/AAH-8430-2021; Chen, MuHong/ACJ-6131-2022	Chen, MuHong/0000-0001-6516-1073; CHIANG, HUEY-LING/0000-0002-2979-6108; Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V102D-001-1, V102D-001-2]; Yuli Veterans Hospital [VHYL-102-08]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Yuli Veterans Hospital	This study was supported by grants from Taipei Veterans General Hospital (V102D-001-1 and V102D-001-2) and Yuli Veterans Hospital (VHYL-102-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson E, 2001, MED J AUSTRALIA, V174, P650, DOI 10.5694/j.1326-5377.2001.tb143479.x; Beyens MN, 2008, DRUG SAFETY, V31, P1017, DOI 10.2165/00002018-200831110-00006; Bhella R, 2010, Acute Med, V9, P70; Boshier A, 2003, EUR J CLIN PHARMACOL, V59, P767, DOI 10.1007/s00228-003-0693-0; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Chiaverini C, 2003, ANN DERMATOL VENER, V130, P208; Crain Dominique, 2010, Hosp Pract (1995), V38, P53; Dadic-Hero E, 2011, PSYCHIAT DANUB, V23, P120; Fava Maurizio, 2005, Prim Care Companion J Clin Psychiatry, V7, P106; Fays S, 2003, BRIT J DERMATOL, V148, P177, DOI 10.1046/j.1365-2133.2003.50768.x; Hack S, 2004, J CHILD ADOL PSYCHOP, V14, P478, DOI 10.1089/cap.2004.14.478; Huang KL, 2009, PSYCHIAT CLIN NEUROS, V63, P401, DOI 10.1111/j.1440-1819.2009.01974.x; Kast RE, 2005, LEUKEMIA RES, V29, P1459, DOI 10.1016/j.leukres.2005.05.006; Lin CE, 2010, GEN HOSP PSYCHIAT, V32, pe341; Lineberry MTW, 2001, MAYO CLIN PROC, V76, P664; Loo WJ, 2003, BRIT J DERMATOL, V149, P660, DOI 10.1046/j.1365-2133.2003.05509.x; McCollom RA, 2000, ANN PHARMACOTHER, V34, P471, DOI 10.1345/aph.19297; Milionis HJ, 2000, POSTGRAD MED J, V76, P361, DOI 10.1136/pmj.76.896.361; Ornetti P, 2004, JOINT BONE SPINE, V71, P583, DOI 10.1016/j.jbspin.2003.10.004; Peloso PM, 1999, JAMA-J AM MED ASSOC, V282, P1817, DOI 10.1001/jama.282.19.1817; ROGER D, 1995, DERMATOLOGY, V191, P164, DOI 10.1159/000246539; Sheng LX, 2012, NICOTINE TOB RES; Staubach P, 2011, ACTA DERM-VENEREOL, V91, P557, DOI 10.2340/00015555-1109; Stockli Simone Schwarzenbach, 2007, J Dtsch Dermatol Ges, V5, P303, DOI 10.1111/j.1610-0387.2007.06270.x; Surovik J, 2010, J DRUGS DERMATOL, V9, P1010; Tackett AE, 2008, AM J HEALTH-SYST PH, V65, P1627, DOI 10.2146/ajhp070575; Tripathi A, 1999, ANN ALLERG ASTHMA IM, V83, P165, DOI 10.1016/S1081-1206(10)62630-0; Tsuboi I, 2012, EXP BIOL MED, V237, P1289, DOI 10.1258/ebm.2012.012158; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; Welsh John Patrick, 2006, J Drugs Dermatol, V5, P1012; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	33	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80064	10.1371/journal.pone.0080064	http://dx.doi.org/10.1371/journal.pone.0080064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244611	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800117
J	Lee, C; Oostenveld, R; Lee, SH; Kim, LH; Sung, H; Choi, JH				Lee, Chungki; Oostenveld, Robert; Lee, Soo Hyun; Kim, Lae Hyun; Sung, Hokun; Choi, Jee Hyun			Dipole Source Localization of Mouse Electroencephalogram Using the Fieldtrip Toolbox	PLOS ONE			English	Article							BOUNDARY-ELEMENT METHOD; INVERSE PROBLEM; MINIMUM NORM; HUMAN SKULL; IN-VIVO; EEG; MEG; BRAIN; EPILEPSY; CRITERIA	The mouse model is an important research tool in neurosciences to examine brain function and diseases with genetic perturbation in different brain regions. However, the limited techniques to map activated brain regions under specific experimental manipulations has been a drawback of the mouse model compared to human functional brain mapping. Here, we present a functional brain mapping method for fast and robust in vivo brain mapping of the mouse brain. The method is based on the acquisition of high density electroencephalography (EEG) with a microarray and EEG source estimation to localize the electrophysiological origins. We adapted the Fieldtrip toolbox for the source estimation, taking advantage of its software openness and flexibility in modeling the EEG volume conduction. Three source estimation techniques were compared: Distribution source modeling with minimum-norm estimation (MNE), scanning with multiple signal classification (MUSIC), and single-dipole fitting. Known sources to evaluate the performance of the localization methods were provided using optogenetic tools. The accuracy was quantified based on the receiver operating characteristic (ROC) analysis. The mean detection accuracy was high, with a false positive rate less than 1.3% and 7% at the sensitivity of 90% plotted with the MNE and MUSIC algorithms, respectively. The mean center-to-center distance was less than 1.2 mm in single dipole fitting algorithm. Mouse microarray EEG source localization using microarray allows a reliable method for functional brain mapping in awake mouse opening an access to cross-species study with human brain.	[Lee, Chungki; Kim, Lae Hyun] Korea Inst Sci & Technol, Ctr Bion, Biomed Res Inst, Seoul, South Korea; [Oostenveld, Robert] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Lee, Soo Hyun; Choi, Jee Hyun] Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea; [Lee, Soo Hyun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Sung, Hokun] Korea Adv Nano Fab Ctr, Nano Proc Div, Suwon, Gyeonggi, South Korea; [Choi, Jee Hyun] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea	Korea Institute of Science & Technology (KIST); Radboud University Nijmegen; Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH)	Choi, JH (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea.	jeechoi@kist.re.kr	Oostenveld, Robert/D-3259-2009	Oostenveld, Robert/0000-0002-1974-1293	National Research Foundation [2012M3A6A3055699, 2010-0018944]; Ministry of Education, Science and Technology of South Korea; Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	National Research Foundation; Ministry of Education, Science and Technology of South Korea; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	CL and JHC were supported by Global Frontier R&D program 2012M3A6A3055699 and Brain Research Program 2010-0018944 through the National Research Foundation funded by the Ministry of Education, Science and Technology of South Korea. This project was also supported in part by the Brain Gain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science to RO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens H, 2012, ADV RADIO SCI, V10, P99, DOI 10.5194/ars-10-99-2012; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Baillet S, 2001, PHYS MED BIOL, V46, P77, DOI 10.1088/0031-9155/46/1/306; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cho JH, 2011, BRAIN TOPOGR, V24, P91, DOI 10.1007/s10548-011-0173-2; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despotovic I, 2012, HUMAN BRAIN MAPPING; Duchowny M, 2000, EPILEPTIC DISORD, V2, P219; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P137, DOI 10.1159/000336337; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Flemming L, 2005, CLIN NEUROPHYSIOL, V116, P1141, DOI 10.1016/j.clinph.2005.01.007; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hwang E, 2010, J NEUROSCI METH, V188, P14, DOI 10.1016/j.jneumeth.2010.01.028; Im CH, 2003, PHYS MED BIOL, V48, P2561, DOI 10.1088/0031-9155/48/15/320; Isotani T, 2001, INT J PSYCHOPHYSIOL, V41, P143, DOI 10.1016/S0167-8760(00)00197-5; KATO A, 1991, J NEUROSURG, V74, P845, DOI 10.3171/jns.1991.74.5.0845; Khemakhem R, 2009, INT J COMPUT SCI NET, V9, P408; Lee M, 2011, JOVE-J VIS EXP, DOI 10.3791/2562; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Megevand P, 2008, NEUROIMAGE, V42, P591, DOI 10.1016/j.neuroimage.2008.05.016; METZ CE, 1973, RADIOLOGY, V109, P297, DOI 10.1148/109.2.297; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Ochi A, 2001, EPILEPSIA, V42, P483, DOI 10.1046/j.1528-1157.2001.27000.x; Oostendorp TF, 2000, IEEE T BIO-MED ENG, V47, P1487, DOI 10.1109/TBME.2000.880100; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ou WM, 2009, NEUROIMAGE, V44, P932, DOI 10.1016/j.neuroimage.2008.05.063; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Scherg M, 1990, ADV AUDIOL, P40, DOI DOI 10.1016/J.BSPC.2015.01.004; Snead OC, 2001, BRAIN DEV-JPN, V23, P199, DOI 10.1016/S0387-7604(01)00204-2; Stefan H, 2011, EPILEPSIA, V52, P2233, DOI 10.1111/j.1528-1167.2011.03265.x; Storchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035850; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Yamazaki M, 2012, ISRN NEUROLOGY, V2012, P9	51	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79442	10.1371/journal.pone.0079442	http://dx.doi.org/10.1371/journal.pone.0079442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244506	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800077
J	Lodi, S; Fisher, M; Phillips, A; De Luca, A; Ghosn, J; Malyuta, R; Zangerle, R; Moreno, S; Vanhems, P; Boufassa, F; Guiguet, M; Porter, K				Lodi, Sara; Fisher, Martin; Phillips, Andrew; De Luca, Andrea; Ghosn, Jade; Malyuta, Ruslan; Zangerle, Robert; Moreno, Santiago; Vanhems, Philippe; Boufassa, Faroudy; Guiguet, Marguerite; Porter, Kholoud		CASCADE Collaboration EuroCoord	Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection	PLOS ONE			English	Article							PLASMA VIRAL LOAD; ANTIRETROVIRAL THERAPY; SET-POINT; DISEASE PROGRESSION; AIDS; PREDICTORS; PROGNOSIS; DEATH; TIME; RNA	Background: The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking. Methods: CASCADE patients with HIV test interval <6 months were classified as severe and non-severe PHI based on whether the following traits were recorded in the first 6 months following seroconversion: severe specific pre-defined symptoms, central nervous system-implicated illness, and >= 1, >= 2 CD4<350 (and <500) cells/mm(3). For each definition, we used Kaplan-Meier curves and Cox survival models to compare time to AIDS/death, censoring at the earlier of last clinic visit or 1/1/1997, when combination antiretroviral therapy (cART) became available. Results: Among 1108 included patients mostly males (85%) infected through sex between men (71%), 366 were diagnosed with AIDS/died. The risk of AIDS/death was significantly higher for individuals with severe symptoms, those with >= 1 CD4<350 cells/mm(3) or >= 2 CD4 <500 cells/mm(3) in the first 6 months [aHR (95% confidence interval) 2.1 (1.4,3.2), 2.0 (1.5,2.7), and 2.3, (1.5-3.5) respectively]. Median [interquantile range] survival for patients with >= 2, >= 1 and no CD4<350 cells/mm(3) within 6 months of seroconversion was 3.9 [2.7,6.5], 5.4 [4.5,8.4] and 8.1 [4.3,10.3] years, respectively. The diagnosis of CNS-implicated symptoms was rare and did not appear to be prognostic. Conclusion: One CD4 count <350 or two <500 cells/mm(3) within 6 months of seroconversion and/or severe illness in PHI may be useful early indicators of individuals at high risk of disease progression.	[Lodi, Sara] Inst Salud Carlos III, Madrid, Spain; [Fisher, Martin] Brighton & Sussex Univ Hosp Natl Hlth Serv Trust, Brighton, E Sussex, England; [Phillips, Andrew] UCL, London, England; [De Luca, Andrea] Univ Hosp Siena, Univ Div Infect Dis, Siena, Italy; [Ghosn, Jade] Univ Paris 05, EA 3620, Paris, France; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Zangerle, Robert] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Moreno, Santiago] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Vanhems, Philippe] Hop Edouard Herriot, Lyon, France; [Vanhems, Philippe] Univ Lyon 1, F-69365 Lyon, France; [Boufassa, Faroudy] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France; [Guiguet, Marguerite] INSERM, Paris, France; [Guiguet, Marguerite] Univ Paris 06, UPMC, UMR S 943, Paris, France; [Porter, Kholoud] UCL, MRC, Clin Trials Unit, London, England	Instituto de Salud Carlos III; University of London; University College London; University of Siena; University Hospital of Siena; UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck; Hospital Universitario Ramon y Cajal; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Medical Research Council Clinical Trials Unit; University of London; University College London	Lodi, S (corresponding author), Inst Salud Carlos III, Madrid, Spain.	slodi@hsph.harvard.edu	lutsar, irja/H-3177-2015; De Luca, Andrea/G-8810-2011; DEL AMO VALERO, JULIA/M-7020-2015; DORRUCCI, MARIA/C-6485-2016; Guiguet, Marguerite/L-8480-2018; rezza, giovanni/D-4393-2016; Muga, Roberto/AAY-8655-2021; Perez Hoyos, Santiago/O-1075-2019; Phillips, Andrew N/B-4427-2008	De Luca, Andrea/0000-0002-9561-9193; DEL AMO VALERO, JULIA/0000-0002-3104-540X; DORRUCCI, MARIA/0000-0002-8543-6430; rezza, giovanni/0000-0003-0268-6790; Muga, Roberto/0000-0001-6301-431X; Perez Hoyos, Santiago/0000-0001-9797-4917; Phillips, Andrew N/0000-0003-2384-4807; Porter, Kholoud/0000-0002-9226-6206	European Union [260694]; Juan de la Cierva Fellowship [JCI 2010-08151]; Medical Research Council [MC_UU_12023/15, MC_U122886351] Funding Source: researchfish; MRC [MC_UU_12023/15, MC_U122886351] Funding Source: UKRI	European Union(European Commission); Juan de la Cierva Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no. 260694. Sara Lodi is holder of a Juan de la Cierva Fellowship (grant number JCI 2010-08151). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCELLEPARK R, 1993, LANCET, V341, P441, DOI 10.1016/0140-6736(93)93040-8; BOUFASSA F, 1995, J INFECT DIS, V171, P1190, DOI 10.1093/infdis/171.5.1190; Buchacz K, 2004, JAIDS-J ACQ IMM DEF, V36, P853, DOI 10.1097/00126334-200407010-00013; COOPER DA, 1985, LANCET, V1, P537; Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, pE6, DOI 10.1097/QAI.0b013e3181e2d6c1; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Douvoyiannis M, 2009, INT J INFECT DIS, V13, pE299, DOI 10.1016/j.ijid.2009.01.005; EACS. European AIDS Clinical Society, 2012, EUR GUID TREATM HIV; Educational Testing Service, 2012, GUID DOC PSYCH DIS A; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hamlyn E, 2011, EFFECT SHORT COURSE; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; JONES HR, 1988, ANN NEUROL, V23, P519, DOI 10.1002/ana.410230515; Katzenstein TL, 1996, AIDS, V10, P167, DOI 10.1097/00002030-199602000-00006; Kaufmann GR, 2000, AIDS, V14, P2643, DOI 10.1097/00002030-200012010-00003; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; LINDBACK S, 1994, BRIT MED J, V309, P1535, DOI 10.1136/bmj.309.6968.1535; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Mahnke YD, 2013, AIDS, V27, P697, DOI 10.1097/QAD.0b013e32835ce2e9; Meersseman W, 2005, LANCET, V366, P866, DOI 10.1016/S0140-6736(05)67220-0; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; PEDERSEN C, 1989, BRIT MED J, V299, P154, DOI 10.1136/bmj.299.6692.154; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Sabin CA, 2001, EPIDEMIOL INFECT, V127, P91; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; Wolbers M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000239	34	11	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e78642	10.1371/journal.pone.0078642	http://dx.doi.org/10.1371/journal.pone.0078642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244330	Green Published, gold			2022-12-27	WOS:000327143800009
J	Syamsunarno, MRAA; Iso, T; Hanaoka, H; Yamaguchi, A; Obokata, M; Koitabashi, N; Goto, K; Hishiki, T; Nagahata, Y; Matsui, H; Sano, M; Kobayashi, M; Kikuchi, O; Sasaki, T; Maeda, K; Murakami, M; Kitamura, T; Suematsu, M; Tsushima, Y; Endo, K; Hotamisligil, GS; Kurabayashi, M				Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Hanaoka, Hirofumi; Yamaguchi, Aiko; Obokata, Masaru; Koitabashi, Norimichi; Goto, Kosaku; Hishiki, Takako; Nagahata, Yoshiko; Matsui, Hiroki; Sano, Motoaki; Kobayashi, Masaki; Kikuchi, Osamu; Sasaki, Tsutomu; Maeda, Kazuhisa; Murakami, Masami; Kitamura, Tadahiro; Suematsu, Makoto; Tsushima, Yoshito; Endo, Keigo; Hotamisligil, Goekhan S.; Kurabayashi, Masahiko			A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting	PLOS ONE			English	Article							METABOLIC-RESPONSES; INSULIN-RESISTANCE; RAT-LIVER; MICE; RECEPTOR; OBESITY; OXIDATION; ALPHA; MOUSE	During prolonged fasting, fatty acid (FA) released from adipose tissue is a major energy source for peripheral tissues, including the heart, skeletal muscle and liver. We recently showed that FA binding protein 4 (FABP4) and FABP5, which are abundantly expressed in adipocytes and macrophages, are prominently expressed in capillary endothelial cells in the heart and skeletal muscle. In addition, mice deficient for both FABP4 and FABP5 (FABP4/5 DKO mice) exhibited defective uptake of FA with compensatory up-regulation of glucose consumption in these tissues during fasting. Here we showed that deletion of FABP4/5 resulted in a marked perturbation of metabolism in response to prolonged fasting, including hyperketotic hypoglycemia and hepatic steatosis. Blood glucose levels were reduced, whereas the levels of non-esterified FA (NEFA) and ketone bodies were markedly increased during fasting. In addition, the uptake of the I-125-BMIPP FA analogue in the DKO livers was markedly increased after fasting. Consistent with an increased influx of NEFA into the liver, DKO mice showed marked hepatic steatosis after a 48-hr fast. Although gluconeogenesis was observed shortly after fasting, the substrates for gluconeogenesis were reduced during prolonged fasting, resulting in insufficient gluconeogenesis and enhanced hypoglycemia. These metabolic responses to prolonged fasting in DKO mice were readily reversed by re-feeding. Taken together, these data strongly suggested that a maladaptive response to fasting in DKO mice occurred as a result of an increased influx of NEFA into the liver and pronounced hypoglycemia. Together with our previous study, the metabolic consequence found in the present study is likely to be attributed to an impairment of FA uptake in the heart and skeletal muscle. Thus, our data provided evidence that peripheral uptake of FA via capillary endothelial FABP4/5 is crucial for systemic metabolism and may establish FABP4/5 as potentially novel targets for the modulation of energy homeostasis.	[Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Obokata, Masaru; Koitabashi, Norimichi; Goto, Kosaku; Matsui, Hiroki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan; [Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 371, Japan; [Hanaoka, Hirofumi; Yamaguchi, Aiko] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 371, Japan; [Tsushima, Yoshito; Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan; [Murakami, Masami] Gunma Univ, Grad Sch Med, Dept Clin Lab Med, Maebashi, Gunma 371, Japan; [Matsui, Hiroki] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 371, Japan; [Kobayashi, Masaki; Kikuchi, Osamu; Sasaki, Tsutomu; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan; [Hishiki, Takako; Nagahata, Yoshiko; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Hishiki, Takako; Nagahata, Yoshiko; Suematsu, Makoto] Keio Univ, Sch Med, Suematsu Gas Biol Project, JST,ERATO,Shinjuku Ku, Tokyo, Japan; [Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Maeda, Kazuhisa; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis & Nutr, Broad Inst Harvard & MIT, Boston, MA 02115 USA	Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Keio University; Japan Science & Technology Agency (JST); Keio University; Keio University; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Iso, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan.	isot@gunma-u.ac.jp	Matsui, Hiroki/P-4033-2019; Suematsu, Makoto/I-8135-2013; Hanaoka, Hirofumi/T-6261-2019; Sano, Motoaki/L-3405-2013; Yamaguchi, Aiko/AAJ-1588-2021; Suematsu, Makoto/O-5762-2018; Koitabashi, Norimichi/AAM-8788-2020	Matsui, Hiroki/0000-0003-3243-333X; Suematsu, Makoto/0000-0002-7165-6336; Hanaoka, Hirofumi/0000-0003-2421-7397; Suematsu, Makoto/0000-0002-7165-6336; Iso, Tatsuya/0000-0001-5045-1676; Sasaki, Tsutomu/0000-0001-8041-1915; Yamaguchi, Aiko/0000-0002-7631-3164; Obokata, Masaru/0000-0002-5473-0688	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Takeda Science Foundation; Therapeutic Research for Metabolic Syndrome; Astra Zeneca; Vehicle Racing Commemorative Foundation; Institute for Molecular and Cellular Regulation, Gunma University [13011]; Japan Science and Technology Agency; Exploratory Research for Advanced Technology; Suematsu Gas Biology Project; National Institutes of Health [DK064360]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK064360] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25504002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Therapeutic Research for Metabolic Syndrome; Astra Zeneca(AstraZeneca); Vehicle Racing Commemorative Foundation; Institute for Molecular and Cellular Regulation, Gunma University; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Exploratory Research for Advanced Technology; Suematsu Gas Biology Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MK and TI), a grant from the Japan Cardiovascular Foundation (to MK) and grants from Takeda Science Foundation, Therapeutic Research for Metabolic Syndrome, Astra Zeneca and the Vehicle Racing Commemorative Foundation (to TI). This study was carried out by the joint research program (#13011) of the Institute for Molecular and Cellular Regulation, Gunma University. MS is supported in part by the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Suematsu Gas Biology Project. GSH is supported in part by the National Institutes of Health (DK064360). The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Blaxter K, 1989, ENERGY METABOLISM AN; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Goto K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004861; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iso T, 2013, ARTERIOSCLER THROMB; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Marray R. K., 2009, HARPERS ILLUSTRATED; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Matsui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033283; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91; Salway JG, 2004, METABOLISM GLANCE; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011	34	21	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79386	10.1371/journal.pone.0079386	http://dx.doi.org/10.1371/journal.pone.0079386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244493	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800069
J	Chen, J; Tian, Y; Liao, YX; Yang, SS; Li, ZT; He, C; Tu, DH; Sun, XY				Chen, Juan; Tian, Ye; Liao, Yixing; Yang, Shuaishuai; Li, Zhuoting; He, Chao; Tu, Dahong; Sun, Xinying			Salt-Restriction-Spoon Improved the Salt Intake among Residents in China	PLOS ONE			English	Article							MAJOR CAUSES; LIFE EXPECTANCY; BLOOD-PRESSURE; DEATH; HEALTH; WOMEN; MEN; DISEASE; SODIUM; ADULTS	Objective: To evaluate the effect of an improved salt-restriction spoon on the attitude of salt-restriction, the using rate of salt-restriction-spoon, the actual salt intake, and 24-hour urinary sodium excretion (24HUNa). Design: A community intervention study. Setting: Two villages in Beijing. Participants: 403 local adult residents being responsible for home cooking. Intervention: Participants were randomly assigned to the intervention group or the control group. Those in the intervention group were provided with an improved salt-restriction-spoon and health education, and were informed of their actual salt intake and 24HUNa. Not any intervention was given to those in the control group. Main Outcome Measures: The scores on the variables of Health Belief Model, the using rate of salt-restriction-spoon, the actual salt intake, and 24HUNa. Analysis: Covariance analyses, Chi-square tests, Student's t tests, and repeated measures analyses of variance. Results: After 6 months of intervention, the intervention group felt significantly less objective barriers, and got access to significantly more cues to action as compared to the control group. The using rate and the correctly using rate of salt-restriction-spoon were significantly higher in the intervention group. The daily salt intake decreased by 1.42 g in the intervention group and by 0.28 g in the control group, and repeated measures analysis of variance showed significant change over time (F = 7.044, P<0.001) and significant difference between groups by time (F = 2.589, P = 0.041). The 24HUNa decreased by 34.84 mmol in the intervention group and by 33.65 mmol in the control group, and repeated measures analysis of variance showed significant change over time (F = 14.648, P<0.001) without significant difference between groups by time (F = 0.222, P = 0.870). Conclusions: The intervention effect was acceptable, therefore, the improved salt-restriction-spoon and corresponding health education could be considered as an alternative for salt reduction strategy in China and other countries where salt intake comes mainly from home cooking.	[Chen, Juan; Liao, Yixing; Yang, Shuaishuai; Sun, Xinying] Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; Peking Univ, Sch Publ Hlth, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China; [Li, Zhuoting] Beijing Union Med Coll Hosp, VIP Med Serv Dept, Beijing, Peoples R China; [He, Chao] Shun Yi Ctr Dis Prevent & Control, Dept Hlth Educ, Beijing, Peoples R China; [Tu, Dahong] Beijing Shijitan Hosp, Community Med Ctr, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Sun, XY (corresponding author), Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China.	xysun@bjmu.edu.cn		Sun, Xinying/0000-0001-6638-1473	National Natural Science Foundation of China [81102176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Project No. 81102176). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailan F, 2008, CHINESE J HLTH ED, P345; Alu C, 2005, J COMMUNITY MED, P61; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; CCDC, 2012, MON REP CHRON DIS RE; China Ministry of Health, 2010, ANN REP HLTH STAT; Feng L, 2007, PUBLIC HLTH MANAGEME, P542; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; Fujino Y, 2005, PREV MED, V40, P444, DOI 10.1016/j.ypmed.2004.07.002; HARRISON JA, 1992, HEALTH EDUC RES, V7, P107, DOI 10.1093/her/7.1.107; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Lee CMY, 2009, INT J EPIDEMIOL, V38, P1060, DOI 10.1093/ije/dyp150; Tuorila H, 2002, FOOD QUAL PREFER, V13, P561, DOI 10.1016/S0950-3293(01)00076-3; Wang GD, 2013, PUBLIC HEALTH, V127, P348, DOI 10.1016/j.puhe.2013.01.005; Wang YH, 2009, BIOMED ENVIRON SCI, V22, P430, DOI 10.1016/S0895-3988(10)60022-0; Wenlan D, 2011, CHINESE J PREVENTIVE, V10, P952; Yang S, 2013, PLOS ONE UNPUB	19	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78963	10.1371/journal.pone.0078963	http://dx.doi.org/10.1371/journal.pone.0078963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244395	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600088
J	Connelly, WM; Errington, AC; Crunelli, V				Connelly, William M.; Errington, Adam C.; Crunelli, Vincenzo			gamma-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABA(A) Receptors	PLOS ONE			English	Article							MOUSE DENTATE GYRUS; RAT-BRAIN; BINDING-SITES; SUBUNIT ISOFORMS; TONIC INHIBITION; PROTEIN-KINASE; HIGH-AFFINITY; A RECEPTOR; NEURONS; ACTIVATION	gamma-Hydroxybutyric acid (GHB) is an endogenous compound and a drug used clinically to treat the symptoms of narcolepsy. GHB is known to be an agonist of GABA(B) receptors with millimolar affinity, but also binds with much higher affinity to another site, known as the GHB receptor. While a body of evidence has shown that GHB does not bind to GABA(A) receptors widely, recent evidence has suggested that the GHB receptor is in fact on extrasynaptic alpha 4 beta 1 delta GABA(A) receptors, where GHB acts as an agonist with an EC50 of 140 nM. We investigated three neuronal cell types that express a tonic GABA(A) receptor current mediated by extrasynaptic receptors: ventrobasal (VB) thalamic neurons, dentate gyrus granule cells and striatal medium spiny neurons. Using whole-cell voltage clamp in brain slices, we found no evidence that GHB (10 mu M) induced any GABAA receptor mediated current in these cell types, nor that it modulated inhibitory synaptic currents. Furthermore, a high concentration of GHB (3 mM) was able to produce a GABA(B) receptor mediated current, but did not induce any other currents. These results suggest either that GHB is not a high affinity agonist at native alpha 4 beta 1 delta receptors, or that these receptors do not exist in classical areas associated with extrasynaptic currents.	[Connelly, William M.; Errington, Adam C.; Crunelli, Vincenzo] Cardiff Univ, Div Neurosci, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Connelly, WM (corresponding author), Cardiff Univ, Div Neurosci, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	connellywm@cardiff.ac.uk; crunelli@cardiff.ac.uk	; Errington, Adam/D-1678-2011	Connelly, William/0000-0002-0986-6260; Errington, Adam/0000-0002-2171-389X; Crunelli, Vincenzo/0000-0001-7154-9752	Wellcome Trust [91882]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant 91882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalom N, 2012, P NATL ACAD SCI USA, V109, P13404, DOI 10.1073/pnas.1204376109; Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Brancucci A, 2004, NEUROPSYCHOPHARMACOL, V29, P537, DOI 10.1038/sj.npp.1300344; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Carai MAM, 2008, J PHARMACOL SCI, V106, P199, DOI 10.1254/jphs.FP0071487; Carter LP, 2005, DRUG ALCOHOL DEPEN, V78, P91, DOI 10.1016/j.drugalcdep.2004.10.002; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Connelly WM, 2013, J NEUROSCI, V33, P3780, DOI 10.1523/JNEUROSCI.4989-12.2013; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; DOHERTY JD, 1978, J PHARMACOL EXP THER, V207, P130; Emri Z, 1996, NEUROSCI LETT, V216, P121; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Felmlee MA, 2010, J PHARMACOL EXP THER, V333, P764, DOI 10.1124/jpet.109.165381; Gervasi N, 2003, J NEUROSCI, V23, P11469; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Jacobson LH, 2006, J PHARMACOL EXP THER, V319, P1317, DOI 10.1124/jpet.106.111971; Jensen K, 2001, CEREB CORTEX, V11, P424, DOI 10.1093/cercor/11.5.424; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Li Q, 2007, NEUROSCIENCE, V150, P82, DOI 10.1016/j.neuroscience.2007.08.023; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mehta AK, 2001, J PHARMACOL EXP THER, V299, P1148; Molnar T, 2009, NEUROSCIENCE, V162, P268, DOI 10.1016/j.neuroscience.2009.05.017; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHMIDT C, 1991, EUR J PHARMACOL, V203, P393, DOI 10.1016/0014-2999(91)90896-X; Schweitzer P, 2004, J PHARMACOL EXP THER, V311, P172, DOI 10.1124/jpet.104.069534; SERRA M, 1991, PSYCHOPHARMACOLOGY, V104, P351, DOI 10.1007/BF02246035; SNEAD OC, 1976, NEUROLOGY, V26, P51, DOI 10.1212/WNL.26.1.51; SNEAD OC, 1992, NEUROCHEM RES, V17, P201; SNEAD OC, 1987, NEUROPHARMACOLOGY, V26, P1519, DOI 10.1016/0028-3908(87)90173-0; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wellendorph P, 2005, J PHARMACOL EXP THER, V315, P346, DOI 10.1124/jpet.105.090472; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001	45	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79062	10.1371/journal.pone.0079062	http://dx.doi.org/10.1371/journal.pone.0079062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244421	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327221600106
J	Ford, N; Shubber, Z; Hill, A; Vitoria, M; Doherty, M; Mills, EJ; Gray, A				Ford, Nathan; Shubber, Zara; Hill, Andrew; Vitoria, Marco; Doherty, Meg; Mills, Edward J.; Gray, Andy			Comparative Efficacy of Lamivudine and Emtricitabine: A Systematic Review and Meta-Analysis of Randomized Trials	PLOS ONE			English	Review							FIXED-DOSE ZIDOVUDINE/LAMIVUDINE; RETROVIRAL-NAIVE PATIENTS; HIV-INFECTED PATIENTS; HIV-1-INFECTED PATIENTS; TENOFOVIR-EMTRICITABINE; ANTIRETROVIRAL-NAIVE; SUPPRESSED PATIENTS; PROTEASE INHIBITOR; DOUBLE-BLIND; ABACAVIR/LAMIVUDINE	Introduction: Lamivudine and emtricitabine are considered equivalent by several guidelines, but evidence of comparable efficacy is conflicting. Methods: We searched two databases up to June 30 2013 to identify randomized and quasi-randomized trials in which lamivudine and emtricitabine were used as part of combination antiretroviral therapy for treatment-naive or experienced HIV-positive adult patients. We only included trials where partner drugs in the regimen were identical or could be considered to be comparable. We allowed for comparisons between tenofovir and abacavir provided the study population did not begin treatment with a viral load >100,000 copies/ml. Results: 12 trials contributed 15 different randomized comparisons providing data on 2251 patients receiving lamivudine and 2662 patients receiving emtricitabine. Treatment success was not significantly different in any of the 12 trials. In the three trials that directly compared lamivudine and emtricitabine, the relative risk for achieving treatment success was nonsignificant (RR 1.03 95% CI 0.96-1.10). For all trials combined, the pooled relative risk for treatment success was not significantly different (RR 1.00, 95% CI 0.97-1.02). No heterogeneity was observed (I-2 = 0). Similarly, there was no difference in the pooled relative risk for treatment failure (RR 1.08, 95% CI 0.94-1.22, I-2 = 3.4%). Conclusions: The findings of this systematic review suggest that lamivudine and emtricitabine are clinically equivalent.	[Ford, Nathan; Vitoria, Marco; Doherty, Meg] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Shubber, Zara] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; [Hill, Andrew] Univ Liverpool, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Gray, Andy] Univ KwaZulu Natal, Sch Hlth Sci, Div Pharmacol, Durban, South Africa	World Health Organization; Imperial College London; University of Liverpool; University of Ottawa; University of Kwazulu Natal	Ford, N (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	Fordn@who.int	Gray, Andrew/F-2104-2013	Gray, Andrew/0000-0001-7815-8180	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by funds from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CONSOLIDARED GUIDELI; [Anonymous], 2013, UNTANGLING WEB ANTIR, P16; [Anonymous], 2013, GUID US ANT AG HIV 1; [Anonymous], 2012, TECHNICAL UPDATE TRE; Benson CA, 2004, AIDS, V18, P2269, DOI 10.1097/00002030-200411190-00007; Calza L, 2009, AIDS PATIENT CARE ST, V23, P691, DOI 10.1089/apc.2009.0039; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Campo R, 2013, CLIN INFECT DIS, V56, P1637, DOI 10.1093/cid/cis1203; CHANG CN, 1992, J BIOL CHEM, V267, P13938; DeJesus E, 2008, HIV CLIN TRIALS, V9, P103, DOI 10.1310/hct0902-103; Fisher M, 2009, JAIDS-J ACQ IMM DEF, V51, P562, DOI 10.1097/QAI.0b013e3181ae2eb9; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hill A, 2009, HIV MED, V10, P527, DOI 10.1111/j.1468-1293.2009.00724.x; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Martinez E, 2013, AIDS RES HUM RETROV, V29, P235, DOI [10.1089/aid.2012.0150, 10.1089/AID.2012.0150]; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mulenga L, 2013, 7 IAS C HIV PATH TRE; Nishijima T, 2013, INTERNAL MED, V52, P735, DOI 10.2169/internalmedicine.52.9155; PAFF MT, 1994, ANTIMICROB AGENTS CH, V38, P1230, DOI 10.1128/AAC.38.6.1230; Palacios R, 2009, EUR J CLIN MICROBIOL, V28, P399, DOI 10.1007/s10096-008-0636-x; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Robertson K, 2012, CLIN INFECT DIS, V55, P868, DOI 10.1093/cid/cis507; Saag MS, 2004, JAMA-J AM MED ASSOC, V292, P180, DOI 10.1001/jama.292.2.180; Sanne I., 2002, 14 INT AIDS C; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Scaglione F, 2012, INT J ANTIMICROB AG, V39, P458, DOI 10.1016/j.ijantimicag.2011.11.013; Schinazi RF, 2003, JAIDS-J ACQ IMM DEF, V34, P243, DOI 10.1097/00126334-200310010-00017; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tan DHS, 2011, JAIDS-J ACQ IMM DEF, V58, P38, DOI 10.1097/QAI.0b013e3182282cfc; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Walensky RP, 2013, ANN INTERN MED, V158, P776, DOI 10.7326/0003-4819-158-10-201305210-00016; Walmsley S, 2012, 52 INT C ANT AG CHEM	40	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79981	10.1371/journal.pone.0079981	http://dx.doi.org/10.1371/journal.pone.0079981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244586	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600164
J	Freilich, RW; Woodbury, ME; Ikezu, T				Freilich, Robert W.; Woodbury, Maya E.; Ikezu, Tsuneya			Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INHIBIT INFLAMMATORY RESPONSES; NITRIC-OXIDE PRODUCTION; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; MYELOID CELLS	Neuroinflammation contributes to many neurologic disorders including Alzheimer's disease, multiple sclerosis, and stroke. Microglia is brain resident myeloid cells and have emerged as a key driver of the neuroinflammatory responses. MicroRNAs (miRNAs) provide a novel layer of gene regulation and play a critical role in regulating the inflammatory response of peripheral macrophages. However, little is known about the miRNA in inflammatory activation of microglia. To elucidate the role that miRNAs have on microglial phenotypes under classical (M1) or alternative (M2) activation under lipopolysaccharide ('M1'-skewing) and interleukin-4 ('M2a'-skewing) stimulation conditions, we performed microarray expression profiling and bioinformatics analysis of both mRNA and miRNA using primary cultured murine microglia. miR-689, miR-124, and miR-155 were the most strongly associated miRNAs predicted to mediate pro-inflammatory pathways and M1-like activation phenotype. miR-155, the most strongly up-regulated miRNA, regulates the signal transducer and activator of transcription 3 signaling pathway enabling the late phase response to M1-skewing stimulation. Reduced expression in miR-689 and miR-124 are associated with dis-inhibition of many canonical inflammatory pathways. miR-124, miR-711, miR-145 are the strongly associated miRNAs predicted to mediate anti-inflammatory pathways and M2-like activation phenotype. Reductions in miR-711 and miR-124 may regulate inflammatory signaling pathways and peroxisome proliferator-activated receptor-gamma pathway. miR-145 potentially regulate peripheral monocyte/macrophage differentiation and faciliate the M2-skewing phenotype. Overall, through combined miRNA and mRNA expression profiling and bioinformatics analysis we have identified six miRNAs and their putative roles in M1 and M2-skewing of microglial activation through different signaling pathways.	[Freilich, Robert W.; Woodbury, Maya E.; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Lab Mol NeuroTherapeut, Boston, MA 02118 USA; [Woodbury, Maya E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Lab Mol NeuroTherapeut, Boston, MA 02118 USA.	tikezu@bu.edu		Ikezu, Tsuneya/0000-0002-3979-8596	National Institutes of Health (NIH) [5T32GM008541]; PhRMA Foundation Paul Calabresi Medical Student Research Fellowship; Faculty Recruit Fund; NIH [UL1 TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation Paul Calabresi Medical Student Research Fellowship; Faculty Recruit Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is partly funded by National Institutes of Health (NIH) 5T32GM008541 (RWF, MEW), PhRMA Foundation Paul Calabresi Medical Student Research Fellowship (RWF), Faculty Recruit Fund (TI), and NIH UL1 TR000157 (BU-CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Cormier SA, 2002, AM J RESP CELL MOL, V27, P678, DOI 10.1165/rcmb.4882; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Dushkin MI, 2007, B EXP BIOL MED+, V144, P713, DOI 10.1007/s10517-007-0413-3; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; Fenn AM, 2011, BRAIN BEHAV IMMUN; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Freilich RW, 2011, J NEUROIMMUNE PHARM, V6, P41, DOI 10.1007/s11481-010-9250-7; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Jang YS, 2009, CYTOKINE, V47, P43, DOI 10.1016/j.cyto.2009.04.005; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Leah Emma, 2011, Nat Rev Rheumatol, V7, P437, DOI 10.1038/nrrheum.2011.101; Leonard BE, 2009, HUM PSYCHOPHARM CLIN, V24, P165, DOI 10.1002/hup.1011; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MATSUI M, 1990, ANN NEUROL, V27, P647, DOI 10.1002/ana.410270611; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Paludan SR, 1999, SCAND J IMMUNOL, V49, P169; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Saijo K, 2012, GLIA; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Schaier M, 2004, J MOL MED, V82, P116, DOI 10.1007/s00109-003-0510-3; Schnegg CI, 2011, PPAR RES, V2011, DOI 10.1155/2011/373560; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shahab SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022508; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Vaksman O, 2011, J CELL MOL MED, V15, P1593, DOI 10.1111/j.1582-4934.2010.01148.x; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yin R, 2011, ONCOL REP, V25, P1747, DOI 10.3892/or.2011.1252; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Zhang-Gandhi CX, 2007, J NEUROIMMUNOL, V183, P50, DOI 10.1016/j.jneuroim.2006.11.007	84	106	112	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79416	10.1371/journal.pone.0079416	http://dx.doi.org/10.1371/journal.pone.0079416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244499	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600128
J	Lelong, N; Vecellio, L; de Gelicourt, YS; Tanguy, C; Diot, P; Junqua-Moullet, A				Lelong, Nicolas; Vecellio, Laurent; de Gelicourt, Yann Sommer; Tanguy, Christian; Diot, Patrice; Junqua-Moullet, Alexandra			Comparison of Numerical Simulations to Experiments for Atomization in a Jet Nebulizer	PLOS ONE			English	Article							AEROSOL; DYNAMICS	The development of jet nebulizers for medical purposes is an important challenge of aerosol therapy. The performance of a nebulizer is characterized by its output rate of droplets with a diameter under 5 mu m. However the optimization of this parameter through experiments has reached a plateau. The purpose of this study is to design a numerical model simulating the nebulization process and to compare it with experimental data. Such a model could provide a better understanding of the atomization process and the parameters influencing the nebulizer output. A model based on the Updraft nebulizer (Hudson) was designed with ANSYS Workbench. Boundary conditions were set with experimental data then transient 3D calculations were run on a 4 mm mesh with ANSYS Fluent. Two air flow rate (2 L/min and 8 L/min, limits of the operating range) were considered to account for different turbulence regimes. Numerical and experimental results were compared according to phenomenology and droplet size. The behavior of the liquid was compared to images acquired through shadowgraphy with a CCD Camera. Three experimental methods, laser diffractometry, phase Doppler anemometry (PDA) and shadowgraphy were used to characterize the droplet size distributions. Camera images showed similar patterns as numerical results. Droplet sizes obtained numerically are overestimated in relation to PDA and diffractometry, which only consider spherical droplets. However, at both flow rates, size distributions extracted from numerical image processing were similar to distributions obtained from shadowgraphy image processing. The simulation then provides a good understanding and prediction of the phenomena involved in the fragmentation of droplets over 10 mu m. The laws of dynamics apply to droplets down to 1 mu m, so we can assume the continuity of the distribution and extrapolate the results for droplets between 1 and 10 mu m. So, this model could help predicting nebulizer output with defined geometrical and physical parameters.	[Lelong, Nicolas; Vecellio, Laurent] Univ Tours, Fac Med, DTF Aerodrug, Tours, France; [Lelong, Nicolas; Vecellio, Laurent; Diot, Patrice] Univ Tours, Fac Med, Ctr Etud Pathol Resp, INSERM,U1100,EA 6305, Tours, France; [de Gelicourt, Yann Sommer] ANSYS France, Montigny Le Bretonneux, France; [Tanguy, Christian] Dantec Dynam, Nozay, France; [Junqua-Moullet, Alexandra] CEA Le Ripault, Monts, France	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Ansys, Inc.; CEA	Lelong, N (corresponding author), Univ Tours, Fac Med, DTF Aerodrug, Tours, France.	nicolas.lelong@etu.univ-tours.fr	Patrice, DIOT/R-8972-2016		french region Centre; national agency for research and technology (ANRT); Diffusion Technique Francaise	french region Centre(Region Centre-Val de Loire); national agency for research and technology (ANRT); Diffusion Technique Francaise	This study was funded by the french region Centre (www.regioncentre.fr), the national agency for research and technology (ANRT, www.anrt.asso.fr) and the Diffusion Technique Francaise (www.dtf.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLARK AR, 1995, INT J PHARM, V115, P69, DOI 10.1016/0378-5173(94)00255-4; Dehbi A, 2008, NUCL ENG DES, V238, P707, DOI 10.1016/j.nucengdes.2007.02.055; Gobel G, 1998, J AEROSOL SCI, V29, P1063, DOI 10.1016/S0021-8502(98)80003-7; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Le Brun PPH, 2000, PHARM WORLD SCI, V22, P75, DOI 10.1023/A:1008786600530; Liu XF, 2010, INT J PHARMACEUT, V388, P82, DOI 10.1016/j.ijpharm.2009.12.041; McCallion ONM, 1996, INT J PHARMACEUT, V130, P1, DOI 10.1016/0378-5173(95)04233-4; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; NIVEN RW, 1994, INT J PHARM, V104, P73, DOI 10.1016/0378-5173(94)90338-7; Pope SB, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/035; REITZ RD, 1995, PROG ENERG COMBUST, V21, P173, DOI 10.1016/0360-1285(95)00003-Z; Ren KF, 1996, PART PART SYST CHAR, V13, P156, DOI 10.1002/ppsc.19960130215; Shan Y, 2007, J THERM SPRAY TECHN, V16, P698, DOI 10.1007/s11666-007-9102-z; Steckel H, 2003, EUR J PHARM SCI, V19, P443, DOI 10.1016/S0928-0987(03)00148-9; Uhrner U, 2007, ATMOS ENVIRON, V41, P7440, DOI 10.1016/j.atmosenv.2007.05.057	16	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78659	10.1371/journal.pone.0078659	http://dx.doi.org/10.1371/journal.pone.0078659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244334	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600043
J	Liu, X; Wang, YN; Wang, C; Shi, CG; Cheng, CL; Chen, JX; Ma, HJ; Lv, LS; Li, L; Lou, TQ				Liu, Xun; Wang, Yanni; Wang, Cheng; Shi, Chenggang; Cheng, Cailian; Chen, Jinxia; Ma, Huijuan; Lv, Linsheng; Li, Lin; Lou, Tanqi			A New Equation to Estimate Glomerular Filtration Rate in Chinese Elderly Population	PLOS ONE			English	Article							SERUM CREATININE; GFR	Background: We sought to develop a new equation to estimate glomerular filtration rate (GFR) in Chinese elderly population. Methods: A total of 668 Chinese elderly participants, including the development cohort (n = 433), the validation cohort (n = 235) were enrolled. The new equation using the generalized additive model, and age, gender, serum creatinine as predictor variables was developed and the performances was compared with the CKD-EPI equation. Results: In the validation data set, both bias and precision were improved with the new equation, as compared with the CKD-EPI equation (median difference, 21.5 ml/min/1.73 m 2 vs. 7.4 ml/min/1.73 m(2) for the new equation and the CKD-EPI equation, [P<0.001]; interquartile range [IQR] for the difference, 16.2 ml/min/1.73 m(2) vs. 19.0 ml/min/1.73 m(2) [P<0.001]), as were accuracies (15% accuracy, 40.4% vs. 30.6% [P = 0.02]; 30% accuracy, 71.1% vs. 47.2%, [P<0.001]; 50% accuracy, 90.2% vs. 75.7%, [P<0.001]), allowing improvement in GFR categorization (GFR category misclassification rate, 37.4% vs. 53.2% [P = <0.001]). Conclusions: A new equation was developed in Chinese elderly population. In the validation data set, the new equation performed better than the original CKD-EPI equation. The new equation needs further external validations. Calibration of the GFR referent standard to a more accurate one should be an useful way to improve the performance of GFR estimating equations.	[Liu, Xun; Wang, Yanni; Wang, Cheng; Shi, Chenggang; Cheng, Cailian; Chen, Jinxia; Ma, Huijuan; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xun] S China Univ Technol, Coll Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Li, Lin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Sun Yat Sen University; Sun Yat Sen University	Li, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China.	lilin5786@263.net; lou.tq@163.com	wang, cheng/A-4225-2017		National Natural Science Foundation of China [81370866, 81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [2011B031800084]; Fundamental Research Funds for the Central Universities [11ykpy38]; Ministry of Science & Technology of China [2011BAI10B00]; National Project of Scientific and Technical Supporting Programs	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Project of Scientific and Technical Supporting Programs	Project 81370866 and 81070612 supported by National Natural Science Foundation of China. This work was also supported by the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant No. 2011B031800084), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38) and the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (Grant No. 2011BAI10B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaufox MD, 1996, J NUCL MED, V37, P1883; DANZIGER RS, 1990, J AM GERIATR SOC, V38, P1127, DOI 10.1111/j.1532-5415.1990.tb01376.x; Dean AG, OPENEPI OPEN SOURCE; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Heikkinen JO, 2001, NUCL MED COMMUN, V22, P987, DOI 10.1097/00006231-200109000-00008; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058242; Liu X, 2012, CLIN INTERV AGING, V7, P409, DOI 10.2147/CIA.S36152; Liu X, 2010, ARCH GERONTOL GERIAT, V51, P13, DOI 10.1016/j.archger.2009.06.005; Ma YC, 2011, CLIN NEPHROL, V76, P296, DOI 10.5414/CN106912; Ma YC, 2007, NEPHROL DIAL TRANSPL, V22, P417, DOI 10.1093/ndt/gfl603; Pei XH, 2012, SCAND J UROL NEPHROL, V46, P223, DOI 10.3109/00365599.2012.660985; Pei XH, 2012, INT UROL NEPHROL, V44, P1877, DOI 10.1007/s11255-012-0278-x; The State Council of the People's Republic of China, CHIN AG DEV 12 5 YEA; World Health Organization (WHO), AG LIF COURS; Xie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062328	20	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79675	10.1371/journal.pone.0079675	http://dx.doi.org/10.1371/journal.pone.0079675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244543	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600146
J	Nacher, M; Basurko, C; Adenis, A; Gaubert-Marechal, E; Mosnier, E; Edouard, S; Vantilcke, V; Sivapregassam, S; Tressieres, B; Cabie, A; Couppie, P				Nacher, Mathieu; Basurko, Celia; Adenis, Antoine; Gaubert-Marechal, Emilie; Mosnier, Emilie; Edouard, Sophie; Vantilcke, Vincent; Sivapregassam, Sindou; Tressieres, Benoit; Cabie, Andre; Couppie, Pierre			Predictive Factors of Herpes Zoster HIV-Infected Patients: Another Adverse Effect of Crack Cocaine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; RISK-FACTORS; AIDS; COHORT; PROGRESSION; VARICELLA; DISEASE; ERA	A retrospective cohort study was conducted on 1541 HIV-infected patients to determine variables associated with the incidence of herpes zoster. A single failure Cox model showed that herpes zoster incidence increased following the first 6 months of antiretroviral treatment adjusted hazard ratio (AHR)=5 (95%CI=2.6-9.2), P<0.001; in the >60 years age group AHR=2 (95%CI=1-4), P=0.04; in patients in the top CD8 quartile AHR=2.1 (95%CI=1.3-3.6), P<0.001; and in patients previously reported to use crack cocaine AHR=5.9, (95%CI=1.4-25), P=0.02. Herpes zoster incidence increased in patients with CD4 counts<500 per mm(3) and gradually declined since 1992-1996, with AHR=0.3 (95%CI=0.2-0.5), P<0.001 for the 1997-2002 period and AHR=0.24 (95%CI=0.14-0.4), P<0.001 for the 2002-2008 period. Contrary to what has been described elsewhere, there was no specific effect of protease inhibitors on herpes zoster incidence. The present study is the first to suggest that crack cocaine is associated with an increased incidence of herpes zoster. The neurological or immunological effects of crack are discussed.	[Nacher, Mathieu; Basurko, Celia; Adenis, Antoine; Sivapregassam, Sindou] Ctr Hosp Cayenne, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Cayenne, French Guiana; [Nacher, Mathieu] Univ Antilles Guyane, EA 3593, Cayenne, French Guiana; [Nacher, Mathieu] COREVIH Guyane, Cayenne, French Guiana; [Nacher, Mathieu; Gaubert-Marechal, Emilie] Ctr Hosp Cayenne, Cayenne, French Guiana; [Mosnier, Emilie; Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol Venereol, Cayenne, French Guiana; [Vantilcke, Vincent] Ctr Hosp Franck Ouest Guyanais, Med Serv, St Laurent Du Maroni, French Guiana; [Tressieres, Benoit] Ctr Hosp Univ Martinique, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Fort De France, Martinique, France; [Cabie, Andre] Ctr Hosp Univ Martinique, Serv Malad Infect & Trop, Fort De France, Martinique, France	CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Martinique	Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Epidemiol Clin Antilles Guyane IN, DGOS CIE 802, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	TRESSIERES, Benoit/ABH-1085-2020; Basurko, Célia/AAM-8297-2021; nacher, mathieu/AAH-4796-2021; MOSNIER, Emilie/GXV-4053-2022	nacher, mathieu/0000-0001-9397-3204; MOSNIER, Emilie/0000-0002-6004-3323; Couppie, Pierre/0000-0002-4213-2867; Cabie, Andre/0000-0003-0117-3061; adenis, antoine/0000-0003-4000-4981				Aldeen T, 1998, AIDS, V12, P1719; Alliegro MB, 1996, CLIN INFECT DIS, V23, P990, DOI 10.1093/clinids/23.5.990; Blank LJ, J ACQ IMMUN DEF SYND, V61, P203, DOI [10.1097/QAI.0b013e318266cd3c, DOI 10.1097/QAI.0B013E318266CD3C.PUBMED:22766968]; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Carr A, 1996, J ACQ IMMUN DEF SYND, V13, P320, DOI 10.1097/00042560-199612010-00004; CAUDA R, 1987, J IMMUNOL, V138, P1229; Domingo P, 2001, AM J MED, V110, P605, DOI 10.1016/S0002-9343(01)00703-3; Engels EA, 1999, J INFECT DIS, V180, P1784, DOI 10.1086/315146; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P169, DOI 10.1097/01.qai.0000178408.62675.b0; GLESBY MJ, 1993, J INFECT DIS, V168, P1264, DOI 10.1093/infdis/168.5.1264; MAHALINGAM R, 1990, NEW ENGL J MED, V323, P627, DOI 10.1056/NEJM199009063231002; Martinez E, 1998, CLIN INFECT DIS, V27, P1510, DOI 10.1086/515019; Moanna A, 2013, CLIN INFECT DIS, V57, P122, DOI 10.1093/cid/cit165; Molton J, 2010, J INFECTION, V61, P73, DOI 10.1016/j.jinf.2010.04.004; Murdoch DM, 2008, AIDS, V22, P1689, DOI 10.1097/QAD.0b013e328308de33; Nacher M, 2009, AIDS, V23, P2223, DOI 10.1097/QAD.0b013e32833147c2; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; ROGUES AM, 1993, J INFECT DIS, V168, P245, DOI 10.1093/infdis/168.1.245; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006; Wood SM, 2008, PEDIATRICS, V121, pE150, DOI 10.1542/peds.2007-0564	21	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80187	10.1371/journal.pone.0080187	http://dx.doi.org/10.1371/journal.pone.0080187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244647	gold, Green Published			2022-12-27	WOS:000327221600190
J	Oneyama, C; Kito, Y; Asai, R; Ikeda, J; Yoshida, T; Okuzaki, D; Kokuda, R; Kakumoto, K; Takayama, K; Inoue, S; Morii, E; Okada, M				Oneyama, Chitose; Kito, Yoriko; Asai, Rei; Ikeda, Jun-ichiro; Yoshida, Takuya; Okuzaki, Daisuke; Kokuda, Rie; Kakumoto, Kyoko; Takayama, Ken-ichi; Inoue, Satoshi; Morii, Eiichi; Okada, Masato			MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression	PLOS ONE			English	Article							MTOR COMPLEX 2; C-SRC; AKT PHOSPHORYLATION; DOWN-REGULATION; MICRORNA; GROWTH; CANCER; RAPTOR; TRANSFORMATION; PATHWAY	mTOR complex 2 (mTORC2) signaling is upregulated in multiple types of human cancer, but the molecular mechanisms underlying its activation and regulation remain elusive. Here, we show that microRNA-mediated upregulation of Rictor, an mTORC2-specific component, contributes to tumor progression. Rictor is upregulated via the repression of the miR-424/503 cluster in human prostate and colon cancer cell lines that harbor c-Src upregulation and in Src-transformed cells. The tumorigenicity and invasive activity of these cells were suppressed by re-expression of miR-424/503. Rictor upregulation promotes formation of mTORC2 and induces activation of mTORC2, resulting in promotion of tumor growth and invasion. Furthermore, downregulation of miR-424/503 is associated with Rictor upregulation in colon cancer tissues. These findings suggest that the miR-424/503-Rictor pathway plays a crucial role in tumor progression.	[Oneyama, Chitose; Kito, Yoriko; Asai, Rei; Kokuda, Rie; Kakumoto, Kyoko; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Ikeda, Jun-ichiro; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Yoshida, Takuya] Osaka Univ, Grad Sch Pharmaceut Sci, Biophys Chem Lab, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; University of Tokyo; University of Tokyo; Saitama Medical University	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan.	coneyama@biken.osaka-u.ac.jp	Takayama, Kenichi/AAK-9238-2020; Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X; Yoshida, Takuya/0000-0002-3491-9344	Ministry of Education, Culture, Sports, Science and Technology of Japan; Exciting Leading-Edge Research Project at Osaka University; Grants-in-Aid for Scientific Research [25670678] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exciting Leading-Edge Research Project at Osaka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by The Exciting Leading-Edge Research Project at Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lowy DR, 2012, NAT MED, V18, P28, DOI [10.1038/nm0112-28, 10.1038/nm.3040]; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80300	10.1371/journal.pone.0080300	http://dx.doi.org/10.1371/journal.pone.0080300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244675	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600202
J	Qi, YY; Jiang, Q; Chen, C; Cao, Y; Qian, LL				Qi, Yuanyuan; Jiang, Qian; Chen, Chao; Cao, Yun; Qian, Liling			Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide	PLOS ONE			English	Article							BONE-MARROW; PRETERM INFANTS; PULMONARY-HYPERTENSION; LUNG GROWTH; ANGIOGENESIS; SYNTHASE; NO; VEGF; STEM; PATHOGENESIS	Background: Impairment of endothelial progenitor cells (EPCs) has been shown to contribute to the development of bronchopulmonary dysplasia (BPD). In the current study, the relationship between EPC changes of after birth and the development of BPD was investigated, and the effects of inhaled nitric oxide (iNO) on EPCs were evaluated. Methods: Sixty infants with a gestational age of less than 32 weeks and a birth weight of less than 1500 g were studied. NO was administered to infants who were receiving mechanical ventilation or CPAP for at least 2 days between the ages of 7 and 21 days. EPC level was determined by flow cytometry at birth, 7, 21 and 28 days of age and 36 weeks' postmenstrual age (PMA), before and after the iNO treatment. Plasma concentrations of vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 and granulocyte-macrophage colony-stimulating factor were determined via immunochemical assay. Results: Twenty-five neonates developed BPD, 35 neonates survived and did not develop BPD. EPC level was decreased on day 7 and 21 in infants who later developed BPD compared with infants that did not develop BPD. From birth to 21 days of age, BPD infants had a persistently lower VEGF concentration compared with non-BPD infants. No difference was found between the two groups at day 28 or 36 weeks PMA. In infants that later developed BPD, iNO raised the KDR(+)CD133(+) and CD34(+)KDR(+)CD133(+) EPC numbers along with increasing the level of plasma VEGF. Conclusion: EPC level was reduced at 7 days of age in infants with BPD, and iNO increased the EPC number along with increasing the level of VEGF. Further studies are needed to elucidate the mechanism leading to the decrease of EPCs in infants with BPD and to investigate the role of iNO treatment in the prevention of BPD.	[Qi, Yuanyuan; Jiang, Qian; Chen, Chao; Cao, Yun; Qian, Liling] Fudan Univ, Childrens Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University	Qian, LL (corresponding author), Fudan Univ, Childrens Hosp, Dept Pediat, Shanghai 200433, Peoples R China.	llqian@126.com			National Natural Science Foundation of China [81070517]; Program for New Century Excellent Talents in University from Ministry of Education [NCET-12-0126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Natural Science Foundation of China (No. 81070517) and the Program for New Century Excellent Talents in University from Ministry of Education (No. NCET-12-0126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Acarregui MJ, 1999, AM J RESP CELL MOL, V20, P14, DOI 10.1165/ajrcmb.20.1.3251; Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baker CD, 2012, EUR RESPIR J, V40, P1516, DOI 10.1183/09031936.00017312; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bizzarro MJ, 2007, ACTA PAEDIATR, V96, P521, DOI 10.1111/j.1651-2227.2007.00194.x; Borghesi A, 2009, AM J RESP CRIT CARE, V180, P540, DOI 10.1164/rccm.200812-1949OC; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Dani C, 2006, ACTA PAEDIATR, V95, P1116, DOI 10.1080/08035250600702594; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fujinaga H, 2009, AM J PHYSIOL-LUNG C, V297, pL1160, DOI 10.1152/ajplung.00234.2009; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Javanmard SH, 2010, INT J CARDIOL, V143, P213, DOI 10.1016/j.ijcard.2008.11.203; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kheirandish-Gozal L, 2010, AM J RESP CRIT CARE, V182, P92, DOI 10.1164/rccm.200912-1845OC; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Paviotti G, 2011, EARLY HUM DEV, V87, P461, DOI 10.1016/j.earlhumdev.2011.03.011; Qi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033859; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Safranow K, 2012, J PERINAT MED, V40, P455, DOI 10.1515/jpm-2011-0199; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Stevens TP, 2010, PEDIATR PULM, V45, P371, DOI 10.1002/ppul.21199; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Van Marter LJ, 2009, SEMIN FETAL NEONAT M, V14, P358, DOI 10.1016/j.siny.2009.08.007; Walsh MC, 2006, PEDIATRICS, V117, pS52, DOI 10.1542/peds.2005-0620I; Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058	41	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79060	10.1371/journal.pone.0079060	http://dx.doi.org/10.1371/journal.pone.0079060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244420	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600105
J	Ramsey, JM; Schwarz, E; Guest, PC; van Beveren, NJM; Leweke, FM; Rothermundt, M; Bogerts, B; Steiner, J; Bahn, S				Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; van Beveren, Nico J. M.; Leweke, F. Markus; Rothermundt, Matthias; Bogerts, Bernhard; Steiner, Johann; Bahn, Sabine			Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients	PLOS ONE			English	Article							BIOMARKERS; ASSOCIATIONS; 1ST-EPISODE; AUTOIMMUNE; ELEVATION; GENDER; SERUM; ONSET; RISK	Background: In schizophrenia, sex specific dimorphisms related to age of onset, course of illness and response to antipsychotic treatment may be mirrored by sex-related differences in the underlying molecular pathways. Methodology/Principal Findings: Here, we have carried out multiplex immunoassay profiling of sera from 4 independent cohorts of first episode antipsychotic naive schizophrenia patients (n = 133) and controls (n = 133) to identify such sex-specific illness processes in the periphery. The concentrations of 16 molecules associated with hormonal, inflammation and growth factor pathways showed significant sex differences in schizophrenia patients compared with controls. In female patients, the inflammation-related analytes alpha-1-antitrypsin, B lymphocyte chemoattractant BLC and interleukin-15 showed negative associations with positive and negative syndrome scale (PANSS) scores. In male patients, the hormones prolactin and testosterone were negatively associated with PANSS ratings. In addition, we investigated molecular changes in a subset of 33 patients before and after 6 weeks of treatment with antipsychotics and found that treatment induced sex-specific changes in the levels of testosterone, serum glutamic oxaloacetic transaminase, follicle stimulating hormone, interleukin-13 and macrophage-derived chemokine. Finally, we evaluated overlapping and distinct biomarkers in the sex-specific molecular signatures in schizophrenia, major depressive disorder and bipolar disorder. Conclusions/Significance: We propose that future studies should investigate the common and sex-specific aetiologies of schizophrenia, as the current findings suggest that different therapeutic strategies may be required for male and female patients.	[Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [Leweke, F. Markus] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Leweke, F. Markus] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Rothermundt, Matthias] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Bogerts, Bernhard; Steiner, Johann] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; [Bahn, Sabine] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; University of Cologne; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munster; Otto von Guericke University; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Leweke, Markus/GVS-7897-2022; Leweke, F. Markus/D-5435-2009	guest, paul/0000-0002-5030-7137; Steiner, Johann/0000-0002-2611-2268; Leweke, F. Markus/0000-0002-8163-195X	Stanley Medical Research Institute; European Union [223427]; Dutch Fund for Economic Structure Reinforcement [0908]; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust	Stanley Medical Research Institute; European Union(European Commission); Dutch Fund for Economic Structure Reinforcement; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust	This work was supported by the Stanley Medical Research Institute; the European Union FP7 SchizDX research programme (grant reference 223427); and the Dutch Fund for Economic Structure Reinforcement, under grant agreement number 0908 (NeuroBasic PharmaPhenomics project). JMR was funded by the Edmonton Churchill Scholarship and the Cambridge Commonwealth Trust for the duration of the study. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2004, ANN NY ACAD SCI, V1012, P224, DOI 10.1196/annals.1306.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Birkenaes AB, 2009, J CLIN PSYCHOPHARM, V29, P109, DOI 10.1097/JCP.0b013e31819b95fc; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; Bossuyt PM, 2003, LANCET, V361, P71, DOI 10.1016/S0140-6736(03)12122-8; CASTLE DJ, 1993, SCHIZOPHRENIA BULL, V19, P691, DOI 10.1093/schbul/19.4.691; Corey DM, 1998, J GEN PSYCHOL, V125, P245, DOI 10.1080/00221309809595548; Delaleu N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2375; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; GOLDSTEIN JM, 1990, SCHIZOPHRENIA BULL, V16, P263, DOI 10.1093/schbul/16.2.263; Guest PC, 2011, PSYCHONEUROENDOCRINO, V36, P1092, DOI 10.1016/j.psyneuen.2010.12.018; HAFNER H, 1991, EUR ARCH PSY CLIN N, V241, P65, DOI 10.1007/BF02193758; Kulkarni J, 1996, SCHIZOPHR RES, V20, P247, DOI 10.1016/0920-9964(96)82949-5; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Markham JA, 2012, REV ENDOCR METAB DIS, V13, P187, DOI 10.1007/s11154-011-9184-2; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Mendrek A, 2007, MED HYPOTHESES, V69, P896, DOI 10.1016/j.mehy.2007.01.064; Mendrek A, 2011, PSYCHONEUROENDOCRINO, V36, P1422, DOI 10.1016/j.psyneuen.2011.03.016; MURRAY RM, 1992, SCHIZOPHRENIA BULL, V18, P319, DOI 10.1093/schbul/18.2.319; Newcomer JW, 2007, JAMA-J AM MED ASSOC, V298, P1794, DOI 10.1001/jama.298.15.1794; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Park S, 2012, NEUROENDOCRINOLOGY, V95, P332, DOI 10.1159/000336501; Rettenbacher MA, 2006, J CLIN PSYCHOPHARM, V26, P500, DOI 10.1097/01.jcp.0000236654.85791.ae; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Schwarz E, 2010, BIOMARK INSIGHTS, V5, P39; Smith S, 2002, J CLIN PSYCHOPHARM, V22, P109, DOI 10.1097/00004714-200204000-00002; Turrone P, 2002, AM J PSYCHIAT, V159, P133, DOI 10.1176/appi.ajp.159.1.133; Umstead TM, 2012, ARTIF ORGANS, V36, pE1, DOI 10.1111/j.1525-1594.2011.01412.x; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963	34	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78729	10.1371/journal.pone.0078729	http://dx.doi.org/10.1371/journal.pone.0078729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244349	gold, Green Submitted, Green Published			2022-12-27	WOS:000327221600056
J	Bottcher, C; Fernandez-Klett, F; Gladow, N; Rolfes, S; Priller, J				Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef			Targeting Myeloid Cells to the Brain Using Non-Myeloablative Conditioning	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BONE-MARROW; MOUSE MODEL; RAT MODEL; MICROGLIA; CONTRIBUTE; MONOCYTES; GENE; MICE	Bone marrow-derived cells (BMDCs) are able to colonize the central nervous system (CNS) at sites of damage. This ability makes BMDCs an ideal cellular vehicle for transferring therapeutic genes/molecules to the CNS. However, conditioning is required for bone marrow-derived myeloid cells to engraft in the brain, which so far has been achieved by total body irradiation (TBI) and by chemotherapy (e. g. busulfan treatment). Unfortunately, both regimens massively disturb the host's hematopoietic compartment. Here, we established a conditioning protocol to target myeloid cells to sites of brain damage in mice using non-myeloablative focal head irradiation (HI). This treatment was associated with comparatively low inflammatory responses in the CNS despite cranial radiation doses which are identical to TBI, as revealed by gene expression analysis of cytokines/chemokines such as CCL2, CXCL10, TNF-alpha and CCL5. HI prior to bone marrow transplantation resulted in much lower levels of blood chimerism defined as the percentage of donor-derived cells in peripheral blood (< 5%) compared with TBI (> 95%) or busulfan treatment (>50%). Nevertheless, HI effectively recruited myeloid cells to the area of motoneuron degeneration in the brainstem within 7 days after facial nerve axotomy. In contrast, no donor-derived cells were detected in the lesioned facial nucleus of busulfan-treated animals up to 2 weeks after transplantation. Our findings suggest that myeloid cells can be targeted to sites of brain damage even in the presence of very low levels of peripheral blood chimerism. We established a novel non-myeloablative conditioning protocol with minimal disturbance of the host's hematopoietic system for targeting BMDCs specifically to areas of pathology in the brain.	[Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef] Charite, Dept Neuropsychiat, D-13353 Berlin, Germany; [Boettcher, Chotima; Fernandez-Klett, Francisco; Gladow, Nadine; Rolfes, Simone; Priller, Josef] Charite, Lab Mol Psychiat, D-13353 Berlin, Germany; [Priller, Josef] Cluster Excellence NeuroCure, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Priller, J (corresponding author), Charite, Dept Neuropsychiat, D-13353 Berlin, Germany.	josef.priller@charite.de	Priller, Josef/ABW-3835-2022	Priller, Josef/0000-0001-7596-0979; Bottcher, Chotima/0000-0002-6226-586X	Deutsche Forschungsgemeinschaft [FOR 1336, TRR43]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants FOR 1336 and TRR43. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; CLIFT RA, 1990, BLOOD, V76, P1867; CLIFT RA, 1991, BLOOD, V77, P1660; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Flugel A, 2001, J CEREBR BLOOD F MET, V21, P69; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOOGERBRUGGE PM, 1988, SCIENCE, V239, P1035, DOI 10.1126/science.3278379; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lewis CAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060661; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Ye M, 2007, BRAIN RES, V1142, P206, DOI 10.1016/j.brainres.2006.12.061; Zhang SZ, 2008, CELL MOL NEUROBIOL, V28, P529, DOI 10.1007/s10571-007-9191-8	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80260	10.1371/journal.pone.0080260	http://dx.doi.org/10.1371/journal.pone.0080260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244666	Green Submitted, gold, Green Published			2022-12-27	WOS:000327162900074
J	Mortier, V; Dauwe, K; Vancoillie, L; Staelens, D; Van Wanzeele, F; Vogelaers, D; Vandekerckhove, L; Chalmet, K; Verhofstede, C				Mortier, Virginie; Dauwe, Kenny; Vancoillie, Leen; Staelens, Delfien; Van Wanzeele, Filip; Vogelaers, Dirk; Vandekerckhove, Linos; Chalmet, Kristen; Verhofstede, Chris			Frequency and Predictors of HIV-1 Co-receptor Switch in Treatment Naive Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; INFECTED PATIENTS; INTERACTIVE TREE; PROGNOSTIC VALUE; TROPISM; DISEASE; PROGRESSION; POPULATION; USAGE	Background: Determination of HIV-1 co-receptor use is a necessity before initiation of a CCR5 antagonist but the longevity of a CCR5-use prediction remains unknown. Methods: Genotypic co-receptor tropism determination was performed in 225 newly diagnosed individuals consulting an AIDS Reference Centre. Samples were collected at diagnosis and at initiation of antiretroviral therapy or just before closure of the study for patients who did not initiate therapy. For individuals with a discordant tropism prediction on the two longitudinal samples, analysis of intermediate samples and single genome sequencing of proviral DNA was performed to confirm the tropism switch. Deep sequencing was done to identify minor CXCR4 or CCR5-using populations in the initial sample. Results: Overall, tropism switches were rare (7.6%). Only a geno2pheno false positive rate of <50% at baseline was retained as predictive for a subsequent switch from CCR5-use only to predicted CXCR4-use. Minor CXCR4-using virus populations were detected in the first sample of 9 of the 14 R5-to-X4 switchers but the subsequent outgrowth of these minor populations was documented in only 3. Conclusions: With the current guidelines for treatment initiation at CD4(+) T cell counts of <500 cells/mm(3), co-receptor switch between diagnosis and starting antiretroviral therapy is rare. Patients with R5 viruses and a geno2pheno FPR of <50% are more prone to subsequent co-receptor switch than patients with an FPR of >50% and will need repeat tropism testing if initiation of maraviroc is considered and previous testing dates from more than a year before.	[Mortier, Virginie; Dauwe, Kenny; Vancoillie, Leen; Staelens, Delfien; Chalmet, Kristen; Verhofstede, Chris] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Aids Reference Lab, B-9000 Ghent, Belgium; [Van Wanzeele, Filip; Vogelaers, Dirk; Vandekerckhove, Linos] Ghent Univ Hosp, Aids Reference Ctr, Dept Gen Internal Med & Infect Dis, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Verhofstede, C (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, Aids Reference Lab, B-9000 Ghent, Belgium.	Chris.Verhofstede@UGent.be	Vandekerckhove, Linos/J-6420-2013	Vandekerckhove, Linos/0000-0002-8600-1631	Belgian Ministry of Social Affairs within the Health Insurance System; Research Foundation - Flanders (FWO) [1.8.020.09.N.00]	Belgian Ministry of Social Affairs within the Health Insurance System; Research Foundation - Flanders (FWO)(FWO)	The Aids Reference Laboratory of Ghent receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. Linos Vandekerckhove is supported by the Research Foundation - Flanders (FWO) (Grant n: 1.8.020.09.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BOZZETTE SA, 1993, J INFECT DIS, V168, P1374, DOI 10.1093/infdis/168.6.1374; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Dybowski JN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-41; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; FENYO EM, 1989, AIDS, V3, pS5, DOI 10.1097/00002030-198901001-00002; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mild M, 2010, INFECT GENET EVOL, V10, P356, DOI 10.1016/j.meegid.2009.05.003; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poveda E, 2010, AIDS REV, V12, P135; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Sing T, 2007, ANTIVIR THER, V12, P1097; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Waters LJ, 2011, CLIN INFECT DIS, V52, P671, DOI 10.1093/cid/ciq198; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80259	10.1371/journal.pone.0080259	http://dx.doi.org/10.1371/journal.pone.0080259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244665	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900073
J	Penn, AS; Knight, CJK; Lloyd, DJB; Avitabile, D; Kok, K; Schiller, F; Woodward, A; Druckman, A; Basson, L				Penn, Alexandra S.; Knight, Christopher J. K.; Lloyd, David J. B.; Avitabile, Daniele; Kok, Kasper; Schiller, Frank; Woodward, Amy; Druckman, Angela; Basson, Lauren			Participatory Development and Analysis of a Fuzzy Cognitive Map of the Establishment of a Bio-Based Economy in the Humber Region	PLOS ONE			English	Article							BAYESIAN NETWORKS; SYSTEM DYNAMICS; RIVER-BASIN; MANAGEMENT; KNOWLEDGE; MODELS	Fuzzy Cognitive Mapping (FCM) is a widely used participatory modelling methodology in which stakeholders collaboratively develop a 'cognitive map' (a weighted, directed graph), representing the perceived causal structure of their system. This can be directly transformed by a workshop facilitator into simple mathematical models to be interrogated by participants by the end of the session. Such simple models provide thinking tools which can be used for discussion and exploration of complex issues, as well as sense checking the implications of suggested causal links. They increase stakeholder motivation and understanding of whole systems approaches, but cannot be separated from an intersubjective participatory context. Standard FCM methodologies make simplifying assumptions, which may strongly influence results, presenting particular challenges and opportunities. We report on a participatory process, involving local companies and organisations, focussing on the development of a bio-based economy in the Humber region. The initial cognitive map generated consisted of factors considered key for the development of the regional bio-based economy and their directional, weighted, causal interconnections. A verification and scenario generation procedure, to check the structure of the map and suggest modifications, was carried out with a second session. Participants agreed on updates to the original map and described two alternate potential causal structures. In a novel analysis all map structures were tested using two standard methodologies usually used independently: linear and sigmoidal FCMs, demonstrating some significantly different results alongside some broad similarities. We suggest a development of FCM methodology involving a sensitivity analysis with different mappings and discuss the use of this technique in the context of our case study. Using the results and analysis of our process, we discuss the limitations and benefits of the FCM methodology in this case and in general. We conclude by proposing an extended FCM methodology, including multiple functional mappings within one participant-constructed graph.	[Penn, Alexandra S.; Knight, Christopher J. K.; Schiller, Frank; Woodward, Amy] Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England; [Penn, Alexandra S.; Druckman, Angela; Basson, Lauren] Univ Surrey, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England; [Knight, Christopher J. K.; Lloyd, David J. B.] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Avitabile, Daniele] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Kok, Kasper] Wageningen Univ, Land Dynam Grp, NL-6700 AP Wageningen, Netherlands	University of Surrey; University of Surrey; University of Surrey; University of Nottingham; Wageningen University & Research	Penn, AS (corresponding author), Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England.	a.penn@surrey.ac.uk	; Avitabile, Daniele/Q-3855-2018	Druckman, Angela/0000-0002-2515-0369; Schiller, Frank/0000-0003-3315-1377; Kok, Kasper/0000-0002-6319-9227; Lloyd, David/0000-0002-1902-0007; Avitabile, Daniele/0000-0003-3714-7973	United Kingdom Engineering and Physical Sciences Research Council [EP/H021450/1]; EPSRC [EP/H021779/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H021779/1] Funding Source: researchfish	United Kingdom Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The partial support of the United Kingdom Engineering and Physical Sciences Research Council for programme grant EP/H021450/1 (Evolution and Resilience of Industrial Ecosystems) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aguilera PA, 2011, ENVIRON MODELL SOFTW, V26, P1376, DOI 10.1016/j.envsoft.2011.06.004; Alcamo J., 2001, 24 EUR ENV AG; [Anonymous], 2003, J ARTIFICIAL SOC SOC; Asakawa T, 2002, SIMULATION GAMING, V34, P10; Axelrod R., 2015, STRUCTURE DECISION C; Banini GA, 1998, INT J MINER PROCESS, V52, P233, DOI 10.1016/S0301-7516(97)00071-9; Barreteau O, 2003, JASSS-J ARTIF SOC S, V6; Barreteau O, 2001, JASSS-J ARTIF SOC S, V4; Batten DF, 2009, J IND ECOL, V13, P197, DOI 10.1111/j.1530-9290.2009.00115.x; Bousquet F., 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P401; Butler AA, 1996, INT J COMPUTATIONAL, V1, P120; Castelletti A, 2007, ENVIRON MODELL SOFTW, V22, P1114, DOI 10.1016/j.envsoft.2006.05.018; Castelletti A, 2007, ENVIRON MODELL SOFTW, V22, P1075, DOI 10.1016/j.envsoft.2006.06.003; COLEMAN JS, 1958, HUM ORGAN, V17, P28, DOI 10.17730/humo.17.4.q5604m676260q8n7; Duspohl M, 2012, J SUSTAINABLE DEV, V5, P1075; Energy A Group E, 2007, STATUS BIOFUELS YORK; Fons S, 2004, J INTELL FUZZY SYST, V15, P75; Glykas M., 2010, FUZZY COGNITIVE MAPS, P401; Hobbs BF, 2002, ECOL APPL, V12, P1548, DOI 10.2307/3099990; Hull Forward Limited, 2009, REN EN OPP HUMB AR H; Jetter A, FUTURES UNPUB; Khan MS, 2004, GROUP DECIS NEGOT, V13, P463, DOI 10.1023/B:GRUP.0000045748.89201.f3; Knight CJK, 2014, APPL SOFT COMPUT, V15, P193, DOI 10.1016/j.asoc.2013.10.030; Kok K, 2009, GLOBAL ENVIRON CHANG, V19, P122, DOI 10.1016/j.gloenvcha.2008.08.003; KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2; Kosko B., 1992, NEURAL NETWORKS FUZZ; McNeil FM, RICH COLLECTION SQUA; Mendoza GA, 2006, FOREST POLICY ECON, V9, P179, DOI 10.1016/j.forpol.2005.06.006; Mouratiadou I, 2007, ECOL ECON, V62, P66, DOI 10.1016/j.ecolecon.2007.01.009; Ozesmi U, 2004, ECOL MODEL, V176, P43, DOI 10.1016/j.ecolmodel.2003.10.027; Papageorgiou EI, 2005, APPL SOFT COMPUT, V5, P409, DOI 10.1016/j.asoc.2004.08.008; Pelaez CE, 1996, INFORM SCIENCES, V88, P177, DOI 10.1016/0020-0255(95)00161-1; Ramanath A.M., 2004, J ARTIF SOC SOC SIMU, V7, P1; Ramanath MA, 2004, J ARTIFICIAL SOC SOC; Schneider M, 1998, FUZZY SET SYST, V93, P161, DOI 10.1016/S0165-0114(96)00218-7; Soler LS, 2012, J LAND USE SCI, V7, P149, DOI 10.1080/1747423X.2010.542495; TABER R, 1991, EXPERT SYST APPL, V2, P83, DOI 10.1016/0957-4174(91)90136-3; Tsadiras AK, 2008, INFORM SCIENCES, V178, P3880, DOI 10.1016/j.ins.2008.05.015; University of Surrey Ethics Committee, 2011, FAC ARTS HUM SCI ETH; Voinov A, 2010, ENVIRON MODELL SOFTW, V25, P1268, DOI 10.1016/j.envsoft.2010.03.007; Yorkshire and the Humber Regional Committee H. o. C, 2010, CARB EM YORKSH HUMB	41	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78319	10.1371/journal.pone.0078319	http://dx.doi.org/10.1371/journal.pone.0078319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	254KD	24244303	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327162900011
J	Rashid, MH; Heinzelmann, G; Huq, R; Tajhya, RB; Chang, SC; Chhabra, S; Pennington, MW; Beeton, C; Norton, RS; Kuyucak, S				Rashid, M. Harunur; Heinzelmann, Germano; Huq, Redwan; Tajhya, Rajeev B.; Chang, Shih Chieh; Chhabra, Sandeep; Pennington, Michael W.; Beeton, Christine; Norton, Raymond S.; Kuyucak, Serdar			A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation	PLOS ONE			English	Article							SEA-ANEMONE TOXIN; MEMORY T-CELLS; AUTOIMMUNE-DISEASES; SHK TOXIN; MOLECULAR-DYNAMICS; POTASSIUM CHANNELS; MULTIPLE-SCLEROSIS; K+ CHANNELS; PROTEIN; LYMPHOCYTES	The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune diseases. ShK peptide from a sea anemone is one of the most potent blockers of Kv1.3 but its application as a therapeutic agent for autoimmune diseases is limited by its lack of selectivity against other Kv channels, in particular Kv1.1. Accurate models of Kv1.x-ShK complexes suggest that specific charge mutations on ShK could considerably enhance its specificity for Kv1.3. Here we evaluate the K18A mutation on ShK, and calculate the change in binding free energy associated with this mutation using the path-independent free energy perturbation and thermodynamic integration methods, with a novel implementation that avoids convergence problems. To check the accuracy of the results, the binding free energy differences were also determined from path-dependent potential of mean force calculations. The two methods yield consistent results for the K18A mutation in ShK and predict a 2 kcal/mol gain in Kv1.3/Kv1.1 selectivity free energy relative to wild-type peptide. Functional assays confirm the predicted selectivity gain for ShK[K18A] and suggest that it will be a valuable lead in the development of therapeutics for autoimmune diseases.	[Rashid, M. Harunur; Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Huq, Redwan; Tajhya, Rajeev B.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Huq, Redwan; Tajhya, Rajeev B.] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Chang, Shih Chieh; Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Pennington, Michael W.] Peptides Int, Louisville, KY USA	University of Sydney; Baylor College of Medicine; Baylor College of Medicine; Monash University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	ray.norton@monash.edu; serdar@physics.usyd.edu.au	chhabra, sandeep/R-9942-2017; Chhabra, Sandeep/T-5468-2018; Heinzelmann, Germano/C-3460-2016; Kuyucak, Serdar/AAH-8417-2021; Tajhya, Rajeev/C-7321-2016	Chhabra, Sandeep/0000-0002-5225-1333; Heinzelmann, Germano/0000-0001-7168-6941; Norton, Raymond/0000-0001-8893-0584; Beeton, Christine/0000-0002-2500-5874; Kuyucak, Serdar/0000-0003-4315-9532; pennington, michael/0000-0001-5446-3447; Tajhya, Rajeev/0000-0002-5363-2293	National Institutes of Health [NS073712]; Australian Research Council [DP1092729]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in parts by grants from the National Institutes of Health (NS073712 to CB, MWP and RSN) and the Australian Research Council (DP1092729) to SK. RSN acknowledges the award of a fellowship by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C., 2007, JOVE-J VIS EXP, V8, P325; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Beeton Christine, 2007, J Vis Exp, P237, DOI 10.3791/237; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pennington MW, 2012, FEBS LETT, V586, P3996, DOI 10.1016/j.febslet.2012.09.038; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; ZACHARIAS M, 1994, J CHEM PHYS, V100, P9025, DOI 10.1063/1.466707	33	45	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78712	10.1371/journal.pone.0078712	http://dx.doi.org/10.1371/journal.pone.0078712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244345	gold, Green Published			2022-12-27	WOS:000327162900024
J	Scaria, J; Mao, CH; Chen, JW; McDonough, SP; Sobral, B; Chang, YF				Scaria, Joy; Mao, Chunhong; Chen, Jenn-Wei; McDonough, Sean P.; Sobral, Bruno; Chang, Yung-Fu			Differential Stress Transcriptome Landscape of Historic and Recently Emerged Hypervirulent Strains of Clostridium difficile Strains Determined Using RNA-seq	PLOS ONE			English	Article							TOXIN PRODUCTION; DEFINED MEDIUM; ETHANOLAMINE UTILIZATION; SALMONELLA-TYPHIMURIUM; SEVERE-DISEASE; GROEL HSP60; PAN-GENOME; INFECTION; EPIDEMIOLOGY; PATHOGEN	C. difficile is the most common cause of nosocomial diarrhea in North America and Europe. Genomes of individual strains of C. difficile are highly divergent. To determine how divergent strains respond to environmental changes, the transcriptomes of two historic and two recently isolated hypervirulent strains were analyzed following nutrient shift and osmotic shock. Illumina based RNA-seq was used to sequence these transcriptomes. Our results reveal that although C. difficile strains contain a large number of shared and strain specific genes, the majority of the differentially expressed genes were core genes. We also detected a number of transcriptionally active regions that were not part of the primary genome annotation. Some of these are likely to be small regulatory RNAs.	[Scaria, Joy; Chen, Jenn-Wei; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA; [Mao, Chunhong; Sobral, Bruno] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [McDonough, Sean P.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Cornell University; Virginia Polytechnic Institute & State University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA.	yc42@cornell.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Scaria, Joy/0000-0002-5299-8074	Virginia Tech [62078/A001]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900040C]; USDA Animal Health and Disease Research Program [NYCV-478820]; USDA formula fund [NYC-478499]	Virginia Tech; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA Animal Health and Disease Research Program; USDA formula fund(United States Department of Agriculture (USDA))	This work was partially supported by a subcontract (project no. 62078/A001) from the Virginia Tech, which has been funded from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900040C, a grant (NYCV-478820) from the USDA Animal Health and Disease Research Program and a grant (NYC-478499) from the USDA formula fund. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gerding DN, 2012, DISCOV MED, V13, P75; Gerding DN, 2010, INFECT CONT HOSP EP, V31, pS32, DOI 10.1086/655998; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Ikeda D, 1998, ZBL BAKT-INT J MED M, V287, P375; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Karasawa T, 1997, MICROBIOL IMMUNOL, V41, P581, DOI 10.1111/j.1348-0421.1997.tb01895.x; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karlsson S, 2000, INFECT IMMUN, V68, P5881, DOI 10.1128/IAI.68.10.5881-5888.2000; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056545; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; Maegavva T, 2002, J MED MICROBIOL, V51, P34, DOI 10.1099/0022-1317-51-1-34; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Noren T, 2010, METHODS MOL BIOL, V646, P9, DOI 10.1007/978-1-60327-365-7_2; Pacheco SM, 2013, CURR OPIN GASTROEN, V29, P42, DOI 10.1097/MOG.0b013e32835a68d4; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Peterkofsky A, 2006, ARCH BIOCHEM BIOPHYS, V453, P101, DOI 10.1016/j.abb.2006.01.004; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; Rupnik M, 2005, J MED MICROBIOL, V54, P113, DOI 10.1099/jmm.0.45810-0; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Scaria J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015147; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; STOCK JB, 1982, J BIOL CHEM, V257, P4543; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waligora AJ, 1999, APPL ENVIRON MICROB, V65, P4234; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; YAMAKAWA K, 1994, J MED MICROBIOL, V41, P319, DOI 10.1099/00222615-41-5-319; Yamakawa K, 1998, J MED MICROBIOL, V47, P767, DOI 10.1099/00222615-47-9-767	67	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e78489	10.1371/journal.pone.0078489	http://dx.doi.org/10.1371/journal.pone.0078489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244315	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900020
J	Ningshen, TJ; Aparoy, P; Ventaku, VR; Dutta-Gupta, A				Ningshen, Thuirei Jacob; Aparoy, Polamarasetty; Ventaku, Venkat Rao; Dutta-Gupta, Aparna			Functional Interpretation of a Non-Gut Hemocoelic Tissue Aminopeptidase N (APN) in a Lepidopteran Insect Pest Achaea janata	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY; BORDER MEMBRANE-VESICLES; RNA-INTERFERENCE; BOMBYX-MORI; FAT-BODY; HELICOVERPA-ARMIGERA; CRYSTAL-STRUCTURES; DELTA-ENDOTOXIN; TOXIN BINDING; APPLE MOTH	Insect midgut membrane-anchored aminopeptidases N (APNs) are Zn++ dependent metalloproteases. Their primary role in dietary protein digestion and also as receptors in Cry toxin-induced pathogenesis is well documented. APN expression in few non-gut hemocoelic tissues of lepidopteran insects has also been reported but their functions are widely unknown. In the present study, we observed specific in vitro interaction of Cry1Aa toxin with a 113 kDa AjAPN1 membrane protein of larval fat body, Malpighian tubule and salivary gland of Achaea janata. Analyses of 3D molecular structure of AjAPN1, the predominantly expressed APN isoform in these non-gut hemocoelic tissues of A. janata showed high structural similarity to the Cry1Aa toxin binding midgut APN of Bombyx mori, especially in the toxin binding region. Structural similarity was further substantiated by in vitro binding of Cry1Aa toxin. RNA interference (RNAi) resulted in significant down-regulation of AjAPN1 transcript and protein expression in fat body and Malpighian tubule but not in salivary gland. Consequently, reduced AjAPN1 expression resulted in larval mortality, larval growth arrest, development of lethal larval-pupal intermediates, development of smaller pupae and emergence of viable defective adults. In vitro Cry1Aa toxin binding analysis of non-gut hemocoelic tissues of AjAPN1 knockdown larvae showed reduced interaction of Cry1Aa toxin with the 113 kDa AjAPN1 protein, correlating well with the significant silencing of AjAPN1 expression. Thus, our observations suggest AjAPN1 expression in non-gut hemocoelic tissues to play important physiological role(s) during post-embryonic development of A. janata. Though specific interaction of Cry1Aa toxin with AjAPN1 of non-gut hemocoelic tissues of A. janata was demonstrated, evidences to prove its functional role as a Cry1Aa toxin receptor will require more in-depth investigation.	[Ningshen, Thuirei Jacob; Ventaku, Venkat Rao; Dutta-Gupta, Aparna] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Aparoy, Polamarasetty] Cent Univ Himachal Pradesh, Sch Life Sci, Ctr Computat Biol & Bioinformat, Dharamshala, Himachal Prades, India	University of Hyderabad; Central University of Himachal Pradesh	Dutta-Gupta, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	apdgsl@uohyd.ernet.in		Polamarasetty, Aparoy/0000-0002-4030-5699	University Grants Commission, India [36-305/2008/SR]	University Grants Commission, India(University Grants Commission, India)	This work was supported by University Grants Commission, India (Grant No. 36-305/2008/SR). The funder had no role in study design, conduct of experiments, results analysis, decision to publish, or preparation of the manuscript.	Albiston AL, 2004, PROTEIN PEPTIDE LETT, V11, P491, DOI 10.2174/0929866043406643; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1999, PROF 3D US GUID; Aparoy P, 2008, J COMPUT AID MOL DES, V22, P611, DOI 10.1007/s10822-008-9180-0; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Atsumi S, 2005, APPL ENVIRON MICROB, V71, P3966, DOI 10.1128/AEM.71.7.3966-3977.2005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Budatha M, 2007, BIOTECHNOL LETT, V29, P1651, DOI 10.1007/s10529-007-9453-z; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Cerstiaens A, 2001, APPL ENVIRON MICROB, V67, P3923, DOI 10.1128/AEM.67.9.3923-3927.2001; Cheon Hyang Mi, 1997, Korean Journal of Biological Sciences, V1, P507; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hara H, 2003, FEBS LETT, V538, P29, DOI 10.1016/S0014-5793(03)00117-0; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MK, 1996, APPL ENVIRON MICROB, V62, P2845, DOI 10.1128/AEM.62.8.2845-2849.1996; LEE MK, 1992, J BIOL CHEM, V267, P3115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik K., 2001, J BIOL SCI, V1, P782; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Nakanishi K, 1999, BBA-PROTEIN STRUCT M, V1432, P57, DOI 10.1016/S0167-4838(99)00086-2; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; Ningshen TJ, 2013, COMP BIOC B IN PRESS; Pazos SA, 2008, REV ACAD COLOMB CIEN, V32, P139; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Shinkawa A, 1999, CURR MICROBIOL, V39, P14, DOI 10.1007/PL00006820; Simpson RM, 2008, INSECT SCI, V15, P505, DOI 10.1111/j.1744-7917.2008.00239.x; Singh A, 2009, BIOINFORMATION, V3, P321, DOI 10.6026/97320630003321; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; Wang P, 2005, INSECT BIOCHEM MOLEC, V35, P611, DOI 10.1016/j.ibmb.2005.02.002; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475, DOI 10.1007/BF01954236; Yang G, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P27; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Yaoi K, 1999, BBA-GENE STRUCT EXPR, V1444, P131, DOI 10.1016/S0167-4781(98)00250-4; Yu N., 2012, INSECT SCI, P1, DOI [10.1111/J/1744-7917.2012.01534.X., DOI 10.1111/J/1744-7917.2012.01534.X]; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	67	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79468	10.1371/journal.pone.0079468	http://dx.doi.org/10.1371/journal.pone.0079468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244508	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800079
J	Peng, H; Luo, PL; Li, YQ; Wang, C; Liu, X; Ye, ZC; Li, CM; Lou, TQ				Peng, Hui; Luo, Pengli; Li, Yuanqing; Wang, Cheng; Liu, Xun; Ye, Zengchun; Li, Canming; Lou, Tanqi			Simvastatin Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage Diabetic Nephropathy by Inhibition of RhoA/ROCK1	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; MATRIX METALLOPROTEINASES; BARRIER DYSFUNCTION; EPITHELIAL BARRIER; GROWTH-FACTOR; RECEPTOR 1; PERMEABILITY; ACTIVATION; PHOSPHORYLATION; OCCLUDIN	Background: Endothelial dysfunction is an early sign of diabetic cardiovascular disease and may contribute to progressive diabetic nephropathy (DN). There is increasing evidence that dysfunction of the endothelial tight junction is a crucial step in the development of endothelial hyperpermeability, but it is unknown whether this occurs in glomerular endothelial cells (GEnCs) during the progression of DN. We examined tight junction dysfunction of GEnCs during early-stage DN and the potential underlying mechanisms. We also examined the effect of simvastatin (3-Hydroxy-3-methylglutaryl CoA reductase inhibitor) on dysfunction of the tight junctions of cultured GEnCs and in db/db mice with early-stage DN. Methods: We assessed the expression of occludin and ZO-1, two major components of the tight junction complex, in cultured rat GEnCs treated with high glucose and in 12 week-old db/db mice with early-stage DN. We also investigated activation of RhoA/ROCK1 signaling, GEnC permeability, and renal function of the mice. Results: High glucose suppresses occludin expression and disrupts occludin/ZO-1 translocation in GEnCs. These changes were associated with increased permeability to albumin and activation of RhoA/ROCK1 signaling. Occludin and ZO-1 dysregulation also occurred in the glomeruli of mice with early-stage DN, and these abnormalities were accompanied by albuminuria and activation of RhoA/ROCK1 in isolated glomeruli. Simvastatin prevented high glucose or hyperglycemia-induced dysregulation of occludin and ZO-1 by inhibition of RhoA/ROCK1 signaling in cultured GEnCs and in db/db mice with early-stage DN. Conclusion: Our results indicate that activation of RhoA/ROCK1 by high glucose disrupts the expression and translocation of occludin/ZO-1 and that simvastatin alleviates occludin/ZO-1 dysregulation and albuminuria by suppressing RhoA/ROCK1 signaling during early-stage DN. These results suggest a potential therapeutic strategy for preventing the onset of albuminuria in early-stage DN.	[Peng, Hui; Luo, Pengli; Li, Yuanqing; Wang, Cheng; Liu, Xun; Ye, Zengchun; Li, Canming; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017		"National Natural Science Funds of China'' [30800408, 30771011, 81170678]; "Fundamental Research Funds for the Central Universities''	"National Natural Science Funds of China''(National Natural Science Foundation of China (NSFC)); "Fundamental Research Funds for the Central Universities''(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the "National Natural Science Funds of China'' (No. 30800408, No. 30771011 and No. 81170678) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the "Fundamental Research Funds for the Central Universities'' (http://jkw.mof.gov.cn/zhengwuxinxi/zhengcefabu/201106/t20110620_563835.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Badiola N, 2009, NEUROBIOL DIS, V35, P438, DOI 10.1016/j.nbd.2009.06.005; Bhattacharjee PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052152; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Colhoun HM, 2005, DIABETOLOGIA, V48, P2482, DOI 10.1007/s00125-005-0029-y; Collins R, 2004, LANCET, V363, P757; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fried LF, 2001, J DIABETES COMPLICAT, V15, P113, DOI 10.1016/S1056-8727(01)00140-4; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; HEILIG CW, 1995, J CLIN INVEST, V96, P1802, DOI 10.1172/JCI118226; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Ho JE, 2003, STROKE, V34, P2812, DOI 10.1161/01.STR.0000102901.41780.5C; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Mangialardi G, 2013, ARTERIOSCL THROM VAS, V33, P555, DOI 10.1161/ATVBAHA.112.300424; Martini S, 2009, J AM SOC NEPHROL, V20, P1420, DOI 10.1681/ASN.2009050514; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Peng H, 2010, ACTA DIABETOL, V47, pS57, DOI 10.1007/s00592-009-0121-8; Pieper GM, 1997, CARDIOVASC RES, V34, P169, DOI 10.1016/S0008-6363(97)00007-2; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Spoerri PE, 2006, MOL VIS, V12, P32; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Street CA, 2011, ANTICANCER RES, V31, P3645; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Xie H, 2012, J MOL NEUROSCI, V46, P666, DOI 10.1007/s12031-011-9564-9; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zoja C, 2010, AM J PHYSIOL-RENAL, V299, pF1203, DOI 10.1152/ajprenal.00045.2010	60	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80009	10.1371/journal.pone.0080009	http://dx.doi.org/10.1371/journal.pone.0080009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244596	gold, Green Submitted, Green Published			2022-12-27	WOS:000327143800108
J	Ramirez-Velez, R; Bustamante, J; Czerniczyniec, A; de Plata, ACA; Lores-Arnaiz, S				Ramirez-Velez, Robinson; Bustamante, Juanita; Czerniczyniec, Analia; Aguilar de Plata, Ana C.; Lores-Arnaiz, Silvia			Effect of Exercise Training on Enos Expression, NO Production and Oxygen Metabolism in Human Placenta	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AEROBIC EXERCISE; PREGNANCY; PREECLAMPSIA; IMPACT; CELLS; WOMEN; HEART	Objective: To determine the effects of combined aerobic and resistance exercise training during the second half of pregnancy on endothelial NOS expression (eNOS), nitric oxide (NO) production and oxygen metabolism in human placenta. Methods: The study included 20 nulliparous in gestational week 16-20, attending prenatal care at three tertiary hospitals in Colombia who were randomly assigned into one of two groups: The exercise group (n = 10) took part in an exercise session three times a week for 12 weeks which consisted of: aerobic exercise at an intensity of 55-75% of their maximum heart rate for 60 min and 25 mins. Resistance exercise included 5 exercise groups circuit training (50 repetitions of each) using barbells (1-3 kg/exercise) and low-to-medium resistance bands. The control group (n = 10) undertook their usual physical activity. Mitochondrial and cytosol fractions were isolated from human placental tissue by differential centrifugation. A spectrophotometric assay was used to measure NO production in cytosolic samples from placental tissue and Western Blot technique to determine eNOS expression. Mitochondrial superoxide levels and hydrogen peroxide were measured to determine oxygen metabolism. Results: Combined aerobic and resistance exercise training during pregnancy leads to a 2-fold increase in eNOS expression and 4-fold increase in NO production in placental cytosol (p = 0.05). Mitochondrial superoxide levels and hydrogen peroxide production rate were decreased by 8% and 37% respectively in the placental mitochondria of exercising women (p = 0.05). Conclusion: Regular exercise training during the second half of pregnancy increases eNOS expression and NO production and decreases reactive oxygen species generation in human placenta. Collectively, these data demonstrate that chronic exercise increases eNOS/NO production, presumably by increasing endothelial shear stress. This adaptation may contribute to the beneficial effects of exercise on the vascular and antioxidant system and in turn reduce the risk of preeclampsia, diabetes or hypertension during pregnancy.	[Ramirez-Velez, Robinson] Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Bogota, DC, Colombia; [Bustamante, Juanita; Czerniczyniec, Analia; Lores-Arnaiz, Silvia] Univ Valle, Fac Salud, Dept Ciencias Fisiol, Cali, Colombia; [Aguilar de Plata, Ana C.] Univ Buenos Aires, Fac Farm & Bioquim, UBA CONICET, Inst Bioquim & Med Mol, RA-1113 Buenos Aires, DF, Argentina	Universidad Santo Tomas USTA; Universidad del Valle; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ramirez-Velez, R (corresponding author), Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Bogota, DC, Colombia.	robin640@hotmail.com	Ramírez-Vélez, Robinson/D-5311-2016	Ramírez-Vélez, Robinson/0000-0003-3075-6960	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS [Nu 110645921540]; Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" [Colciencias/Icetex Nu 067/2002]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas"(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was funded by Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS (Grant Nu 110645921540). Robinson Ramirez-Velez received a grant from Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas") to do a doctorate (Grant Colciencias/Icetex Nu 067/2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bergmann A, 2004, PLACENTA, V25, P694, DOI 10.1016/j.placenta.2004.02.005; Bo H, 2008, FREE RADICAL BIO MED, V44, P1373, DOI 10.1016/j.freeradbiomed.2007.12.033; Boveris A, 2003, ANTIOXID REDOX SIGN, V5, P691, DOI 10.1089/152308603770379982; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; Brown CM, 2011, CURR HYPERTENS REP, V13, P338, DOI 10.1007/s11906-011-0214-y; Clapp JF, 2006, PLACENTA, V27, P527, DOI 10.1016/j.placenta.2005.07.010; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Echeverri JG, 2009, COLOMB MEDICA, V40, P448; Fortner RT, 2011, MED SCI SPORT EXER, V43, P639, DOI 10.1249/MSS.0b013e3181f58d3e; Genest DS, 2012, HYPERTENSION, V60, P1104, DOI 10.1161/HYPERTENSIONAHA.112.194050; Gilbert JS, 2012, AM J PHYSIOL-REG I, V303, pR520, DOI 10.1152/ajpregu.00253.2012; Han SS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009021.pub2; Hegaard HK, 2007, ACTA OBSTET GYN SCAN, V86, P1290, DOI 10.1080/00016340701647341; *I MED NAT AC COMM, 2006, DIET REF INT ESS REF, P87; JACKSON MR, 1995, PLACENTA, V16, P179, DOI 10.1016/0143-4004(95)90007-1; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Lores-Arnaiz S, 2004, ARCH BIOCHEM BIOPHYS, V430, P170, DOI 10.1016/j.abb.2004.07.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZ F, 1993, PLACENTA, V14, P321, DOI 10.1016/S0143-4004(05)80430-8; Martinez F, 1996, PLACENTA, V17, P345, DOI 10.1016/S0143-4004(96)90059-4; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; MYATT L, 1993, PLACENTA, V14, P487, DOI 10.1016/S0143-4004(05)80202-4; Oostdam N, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-1; Ramirez-Velez R, 2013, ENDOCRINOL NUTR, V60, P279, DOI 10.1016/j.endonu.2012.05.012; Ramirez-Velez R, 2011, J OBSTET GYNAECOL RE, V37, P1601, DOI 10.1111/j.1447-0756.2011.01582.x; Ramirez-Velez R, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-104; Rossmanith WG, 1999, MOL HUM REPROD, V5, P487, DOI 10.1093/molehr/5.5.487; Sierra-Laguado J, 2006, INT J GYNECOL OBSTET, V93, P60, DOI 10.1016/j.ijgo.2006.01.015; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Wang Y, 2001, PLACENTA, V22, P206, DOI 10.1053/plac.2000.0608; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M; Yeo S, 2008, HYPERTENS PREGNANCY, V27, P113, DOI 10.1080/10641950701826778	34	35	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80225	10.1371/journal.pone.0080225	http://dx.doi.org/10.1371/journal.pone.0080225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244656	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800138
J	Stegger, M; Liu, CM; Larsen, J; Soldanova, K; Aziz, M; Contente-Cuomo, T; Petersen, A; Vandendriessche, S; Jimenez, JN; Mammina, C; van Belkum, A; Salmenlinna, S; Laurent, F; Skov, RL; Larsen, AR; Andersen, PS; Price, LB				Stegger, Marc; Liu, Cindy M.; Larsen, Jesper; Soldanova, Katerina; Aziz, Maliha; Contente-Cuomo, Tania; Petersen, Andreas; Vandendriessche, Stien; Jimenez, Judy N.; Mammina, Caterina; van Belkum, Alex; Salmenlinna, Saara; Laurent, Frederic; Skov, Robert L.; Larsen, Anders R.; Andersen, Paal S.; Price, Lance B.			Rapid Differentiation between Livestock-Associated and Livestock-Independent Staphylococcus aureus CC398 Clades	PLOS ONE			English	Article							METHICILLIN-RESISTANT; COMPLEMENT INHIBITOR; NEW-YORK; ST398; INFECTIONS; EMERGENCE; HUMANS; PIGS	Staphylococcus aureus clonal complex 398 (CC398) isolates cluster into two distinct phylogenetic clades based on single-nucleotide polymorphisms (SNPs) revealing a basal human clade and a more derived livestock clade. The scn and tet(M) genes are strongly associated with the human and the livestock clade, respectively, due to loss and acquisition of mobile genetic elements. We present canonical single-nucleotide polymorphism (canSNP) assays that differentiate the two major host-associated S. aureus CC398 clades and a duplex PCR assay for detection of scn and tet(M). The canSNP assays correctly placed 88 S. aureus CC398 isolates from a reference collection into the human and livestock clades and the duplex PCR assay correctly identified scn and tet(M). The assays were successfully applied to a geographically diverse collection of 272 human S. aureus CC398 isolates. The simple assays described here generate signals comparable to a whole-genome phylogeny for major clade assignment and are easily integrated into S. aureus CC398 surveillance programs and epidemiological studies.	[Stegger, Marc; Larsen, Jesper; Petersen, Andreas; Skov, Robert L.; Larsen, Anders R.; Andersen, Paal S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Stegger, Marc; Liu, Cindy M.; Soldanova, Katerina; Aziz, Maliha; Contente-Cuomo, Tania; Andersen, Paal S.; Price, Lance B.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Vandendriessche, Stien] Free Univ Brussels, Hop Erasme, Lab Reference MRSA Staphylocoques, B-1070 Brussels, Belgium; [Jimenez, Judy N.] Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot GD Alessandro, Palermo, Italy; [van Belkum, Alex] Microbiol R&D, BioMerieux, La Balme Les Grottes, France; [Salmenlinna, Saara] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Laurent, Frederic] Hop Croix Rousse, Bacteriol Lab, Natl Reference Ctr Staphylococci, Inserm U851, F-69317 Lyon, France; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA	Statens Serum Institut; Translational Genomics Research Institute; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universidad de Antioquia; University of Palermo; bioMerieux; Finland National Institute for Health & Welfare; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); George Washington University	Stegger, M (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	mtg@ssi.dk	LAURENT, Frederic/AGM-0706-2022; Larsen, Jesper/AAJ-3161-2021; Andersen, Paal S/H-2087-2015; Liu, Cindy/ABF-7427-2020; Laurent, Frederic/M-4719-2014; Mammina, Caterina/M-9339-2013; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Andersen, Paal S/0000-0001-5656-0427; Mammina, Caterina/0000-0003-2881-8018; Skov, Robert/0000-0002-6079-5381; Petersen, Andreas/0000-0002-6864-0624; Jimenez, J Natalia/0000-0002-9183-1912; Papp, Katerina/0000-0001-8126-4822; Larsen, Anders Rhod/0000-0002-1713-8765; Stegger, Marc/0000-0003-0321-1180; laurent, frederic/0000-0003-0609-9091	TGen Foundation; National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI101371-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER	TGen Foundation; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the TGen Foundation and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (project number 1R01AI101371-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mammina C, 2010, SCAND J INFECT DIS, V42, P955, DOI 10.3109/00365548.2010.524662; Mammina C, 2010, EMERG INFECT DIS, V16, P730, DOI 10.3201/eid1604.091584; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Jimenez JN, 2011, EMERG INFECT DIS, V17, P1970, DOI 10.3201/eid1710.110638; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Resch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058187; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Salmenlinna S, 2010, EMERG INFECT DIS, V16, P1626, DOI 10.3201/eid1610.091571; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Warsa UC, 1996, J ANTIBIOT, V49, P1127, DOI 10.7164/antibiotics.49.1127; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x	29	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79645	10.1371/journal.pone.0079645	http://dx.doi.org/10.1371/journal.pone.0079645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244535	Green Published, gold, Green Submitted			2022-12-27	WOS:000327143800094
J	Beghe, B; Verduri, A; Bottazzi, B; Stendardo, M; Fucili, A; Balduzzi, S; Leuzzi, C; Papi, A; Mantovani, A; Fabbri, LM; Ceconi, C; Boschetto, P				Beghe, Bianca; Verduri, Alessia; Bottazzi, Barbara; Stendardo, Mariarita; Fucili, Alessandro; Balduzzi, Sara; Leuzzi, Chiara; Papi, Alberto; Mantovani, Alberto; Fabbri, Leonardo M.; Ceconi, Claudio; Boschetto, Piera			Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEART-FAILURE; CORONARY-ARTERY-DISEASE; VENTRICULAR DYSFUNCTION; CIRCULATING LEVELS; ELDERLY-PATIENTS; CYTOKINES; ASSOCIATION; GUIDELINES; DIAGNOSIS	Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) may coexist in elderly patients with a history of smoking. Low-grade systemic inflammation induced by smoking may represent the link between these 2 conditions. In this study, we investigated left ventricular dysfunction in patients primarily diagnosed with COPD, and nonreversible airflow limitation in patients primarily diagnosed with CHF. The levels of circulating high-sensitive C-reactive protein (Hs-CRP), pentraxin 3 (PTX3), interleukin-1 beta (IL-1 beta), and soluble type II receptor of IL-1 (sIL-1RII) were also measured as markers of systemic inflammation in these 2 cohorts. Patients aged >= 50 years and with >= 10 pack years of cigarette smoking who presented with a diagnosis of stable COPD (n=70) or stable CHF (n=124) were recruited. All patients underwent echocardiography, N-terminal pro-hormone of brain natriuretic peptide measurements, and post-bronchodilator spirometry. Plasma levels of Hs-CRP, PTX3, IL-1 beta, and sIL-1RII were determined by using a sandwich enzyme-linked immuno-sorbent assay in all patients and in 24 healthy smokers (control subjects). Although we were unable to find a single COPD patient with left ventricular dysfunction, we found nonreversible airflow limitation in 34% of patients with CHF. On the other hand, COPD patients had higher plasma levels of Hs-CRP, IL1 beta, and sIL-1RII compared with CHF patients and control subjects (p < 0.05). None of the inflammatory biomarkers was different between CHF patients and control subjects. In conclusion, although the COPD patients had no evidence of CHF, up to one third of patients with CHF had airflow limitation, suggesting that routine spirometry is warranted in patients with CHF, whereas echocardiography is not required in well characterized patients with COPD. Only smokers with COPD seem to have evidence of systemic inflammation.	[Beghe, Bianca; Verduri, Alessia; Balduzzi, Sara; Leuzzi, Chiara; Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy; [Bottazzi, Barbara; Mantovani, Alberto] Humanitas Clin & Res Ctr, Lab Res Immunol & Inflammat, Rozzano, Italy; [Bottazzi, Barbara; Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Stendardo, Mariarita; Fucili, Alessandro; Papi, Alberto; Ceconi, Claudio; Boschetto, Piera] Univ Ferrara, Dept Med Sci, I-44100 Ferrara, Italy	Universita di Modena e Reggio Emilia; IRCCS Humanitas Research Hospital; University of Milan; University of Ferrara	Boschetto, P (corresponding author), Univ Ferrara, Dept Med Sci, I-44100 Ferrara, Italy.	bsp@unife.it	Balduzzi, Sara/S-2887-2019; Papi, alberto/AAC-1888-2019; Fabbri, Leonardo M/I-4055-2012; bottazzi, barbara/ABH-9274-2020; Boschetto, Piera/AAM-3247-2020; Mantovani, Alberto/HCI-7449-2022	Balduzzi, Sara/0000-0003-1205-1895; Fabbri, Leonardo M/0000-0001-8894-1689; bottazzi, barbara/0000-0002-1930-9257; Boschetto, Piera/0000-0003-3889-1681; Mantovani, Alberto/0000-0001-5578-236X; PAPI, ALBERTO/0000-0002-6924-4500; Ceconi, Claudio/0000-0002-6381-1404; Stendardo, Mariarita/0000-0002-9872-1599	Italian Ministry of Health (Ricerca Finalizzata grant); Italian Ministry of Health (CCM grant); Chiesi Foundation (Parma, Italy); A.S.T.M.P. (Padova, Italy); ARCA (Padova, Italy); Consorzio Ferrara Ricerche (Ferrara, Italy)	Italian Ministry of Health (Ricerca Finalizzata grant); Italian Ministry of Health (CCM grant); Chiesi Foundation (Parma, Italy); A.S.T.M.P. (Padova, Italy); ARCA (Padova, Italy); Consorzio Ferrara Ricerche (Ferrara, Italy)	This study was supported by Italian Ministry of Health (Ricerca Finalizzata grant, and CCM grant), Chiesi Foundation (Parma, Italy), A.S.T.M.P. (Padova, Italy), ARCA (Padova, Italy), and Consorzio Ferrara Ricerche (Ferrara, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Alonso-Martinez JL, 2002, EUR J HEART FAIL, V4, P331, DOI 10.1016/S1388-9842(02)00021-1; Boschetto P, 2013, RESPIROLOGY, V18, P125, DOI 10.1111/j.1440-1843.2012.02264.x; Boschetto P, 2012, RESPIROLOGY, V17, P422, DOI 10.1111/j.1440-1843.2011.02118.x; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; CHAPMAN KR, 1985, AM REV RESPIR DIS, V132, P845; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dentener MA, 2001, THORAX, V56, P721, DOI 10.1136/thorax.56.9.721; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Flu WJ, 2010, RESP MED, V104, P690, DOI 10.1016/j.rmed.2009.11.013; Freixa X, 2013, EUR RESPIR J, V41, P784, DOI 10.1183/09031936.00222511; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guder G, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-13; Hawkins NM, 2009, EUR J HEART FAIL, V11, P130, DOI 10.1093/eurjhf/hfn013; Iversen KK, 2010, EUR J HEART FAIL, V12, P685, DOI 10.1093/eurjhf/hfq050; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Latini R, 2012, EUR J HEART FAIL, V14, P992, DOI 10.1093/eurjhf/hfs092; Macchia A, 2012, EUR RESPIR J, V39, P51, DOI 10.1183/09031936.00044411; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Mascarenhas J, 2008, AM HEART J, V155, P521, DOI 10.1016/j.ahj.2007.10.040; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Munger MA, 1996, AM J CARDIOL, V77, P723, DOI 10.1016/S0002-9149(97)89206-5; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Sapey E, 2008, THORAX, V63, P493, DOI 10.1136/thx.2007.086751; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; Ukena C, 2010, INT J CARDIOL, V145, P172, DOI 10.1016/j.ijcard.2010.04.082; Van Pottelberge GR, 2012, EUR RESPIR J, V39, P830, DOI 10.1183/09031936.00138110	33	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80166	10.1371/journal.pone.0080166	http://dx.doi.org/10.1371/journal.pone.0080166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244639	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600189
J	Darkoh, C; Brown, EL; Kaplan, HB; DuPont, HL				Darkoh, Charles; Brown, Eric L.; Kaplan, Heidi B.; DuPont, Herbert L.			Bile Salt Inhibition of Host Cell Damage by Clostridium Difficile Toxins	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; A-INDUCED APOPTOSIS; HYDROLASE ACTIVITY; RHO-PROTEINS; URSODEOXYCHOLATE PROTECT; CONTROLLED TRIAL; SMALL-INTESTINE; INFECTION; DISEASE; ACID	Virulent Clostridium difficile strains produce toxin A and/or toxin B that are the etiological agents of diarrhea and pseudomembranous colitis. Treatment of C. difficile infections (CDI) has been hampered by resistance to multiple antibiotics, sporulation, emergence of strains with increased virulence, recurrence of the infection, and the lack of drugs that preserve or restore the colonic bacterial flora. As a result, there is new interest in non-antibiotic CDI treatments. The human conjugated bile salt taurocholate was previously shown in our laboratory to inhibit C. difficile toxin A and B activities in an in vitro assay. Here we demonstrate for the first time in an ex vivo assay that taurocholate can protect Caco-2 colonic epithelial cells from the damaging effects of the C. difficile toxins. Using caspase-3 and lactate dehydrogenase assays, we have demonstrated that taurocholate reduced the extent of toxin B-induced apoptosis and cell membrane damage. Confluent Caco-2 cells cultured with toxin B induced elevated caspase-3 activity. Remarkably, addition of 5 mM taurocholate reduced caspase-3 activity in cells treated with 2, 4, 6, and 12 mg/ml of toxin B by 99%, 78%, 64%, and 60%, respectively. Furthermore, spent culture medium from Caco-2 cells incubated with both toxin B and taurocholate exhibited significantly decreased lactate dehydrogenase activity compared to spent culture medium from cells incubated with toxin B only. Our results suggest that the mechanism of taurocholate-mediated inhibition functions at the level of toxin activity since taurocholate did not affect C. difficile growth and toxin production. These findings open up a new avenue for the development of non-antibiotic therapeutics for CDI treatment.	[Darkoh, Charles; Brown, Eric L.; DuPont, Herbert L.] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA; [Darkoh, Charles; Kaplan, Heidi B.; DuPont, Herbert L.] Univ Texas Grad Sch Biomed Sci, Houston, TX USA; [Kaplan, Heidi B.; DuPont, Herbert L.] Univ Texas Med Sch, Houston, TX USA; [DuPont, Herbert L.] St Lukes Episcopal Hosp, Houston, TX 77030 USA; [DuPont, Herbert L.] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Saint Lukes Episcopal Hospital; Baylor College of Medicine	Darkoh, C (corresponding author), Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA.	Charles.darkoh@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021	Darkoh, Charles/0000-0003-0063-7856	University of Texas School of Public Health; Texas Medical Center Digestive Diseases Center (Public Health Service Grant) [DK56338]; United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	University of Texas School of Public Health; Texas Medical Center Digestive Diseases Center (Public Health Service Grant)(United States Department of Health & Human ServicesUnited States Public Health Service); United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part, by discretionary funds from The University of Texas School of Public Health, Texas Medical Center Digestive Diseases Center (Public Health Service Grant DK56338), and United Negro College Fund-MERCK Science Initiative (University of Michigan School of Information). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Aspevall O, 2006, ANTIMICROB AGENTS CH, V50, P1890, DOI 10.1128/AAC.50.5.1890-1892.2006; BAILEY ME, 1976, BRIT J SURG, V63, P774, DOI 10.1002/bjs.1800631011; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bartlett John G, 2009, Curr Infect Dis Rep, V11, P21, DOI 10.1007/s11908-009-0004-8; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Bishara J, 2006, DIAGN MICR INFEC DIS, V54, P141, DOI 10.1016/j.diagmicrobio.2005.09.008; BORRIELLO SP, 1985, J MED MICROBIOL, V19, P339, DOI 10.1099/00222615-19-3-339; Brandes V, 2011, BIOL CHEM; Brandt Lawrence J, 2012, Gastroenterol Hepatol (N Y), V8, P191; Brito GAC, 2002, J INFECT DIS, V186, P1438, DOI 10.1086/344729; Brown EL, 2010, ANTIMICROB AGENTS CH, V54, P388, DOI 10.1128/AAC.00691-09; Carneiro BA, 2006, INFECT IMMUN, V74, P81, DOI 10.1128/IAI.74.1.81-87.2006; Darkoh C, 2011, J CLIN MICROBIOL, V49, P4219, DOI 10.1128/JCM.01033-11; Darkoh C, 2011, J CLIN MICROBIOL, V49, P2933, DOI 10.1128/JCM.00037-11; DESMET I, 1995, J APPL BACTERIOL, V79, P292; DILLON ST, 1995, INFECT IMMUN, V63, P1421, DOI 10.1128/IAI.63.4.1421-1426.1995; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Dowling R H, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P59; DuPont HL, 2011, NEW ENGL J MED, V364, P473, DOI 10.1056/NEJMe1013236; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; GOUMA DJ, 1986, AM J SURG, V151, P476, DOI 10.1016/0002-9610(86)90107-8; HEUMAN DM, 1991, GASTROENTEROLOGY, V100, P203, DOI 10.1016/0016-5085(91)90602-H; HEUMAN DM, 1991, HEPATOLOGY, V14, P920, DOI 10.1002/hep.1840140527; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck SC, 2009, CELL MOTIL CYTOSKEL, V66, P967, DOI 10.1002/cm.20390; HUIJGHEBAERT SM, 1982, APPL ENVIRON MICROB, V43, P185, DOI 10.1128/AEM.43.1.185-192.1982; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; LILLIENAU J, 1991, AM J PHYSIOL, V261, pG1065, DOI 10.1152/ajpgi.1991.261.6.G1065; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Moser SA, 2001, APPL ENVIRON MICROB, V67, P3476, DOI 10.1128/AEM.67.8.3476-3480.2001; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; QUENEAU PE, 1993, TRANSPLANTATION, V56, P530, DOI 10.1097/00007890-199309000-00008; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Shikita M, 1999, BIOCHEM J, V341, P725, DOI 10.1042/0264-6021:3410725; SHUBEITA HE, 1987, P NATL ACAD SCI USA, V84, P5645, DOI 10.1073/pnas.84.16.5645; SUNG JY, 1993, DIGEST DIS SCI, V38, P2104, DOI 10.1007/BF01297092; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; VANELDERE J, 1988, APPL ENVIRON MICROB, V54, P2112, DOI 10.1128/AEM.54.8.2112-2117.1988; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WILSON KH, 1983, J INFECT DIS, V147, P733, DOI 10.1093/infdis/147.4.733; Yuan Junying, 2004, Cell, VS116, pS53, DOI 10.1016/S0092-8674(04)00028-5	71	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79631	10.1371/journal.pone.0079631	http://dx.doi.org/10.1371/journal.pone.0079631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244530	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600138
J	Lee, J; Rha, E; Yeom, SJ; Lee, DH; Choi, ES; Lee, SG				Lee, Jeongmin; Rha, Eugene; Yeom, Soo-Jin; Lee, Dae-Hee; Choi, Eui-Sung; Lee, Seung-Goo			Generating In Vivo Cloning Vectors for Parallel Cloning of Large Gene Clusters by Homologous Recombination	PLOS ONE			English	Article							PCR; EXPRESSION; GENOME	A robust method for the in vivo cloning of large gene clusters was developed based on homologous recombination (HR), requiring only the transformation of PCR products into Escherichia coli cells harboring a receiver plasmid. Positive clones were selected by an acquired antibiotic resistance, which was activated by the recruitment of a short ribosome-binding site plus start codon sequence from the PCR products to the upstream position of a silent antibiotic resistance gene in receiver plasmids. This selection was highly stringent and thus the cloning efficiency of the GFPuv gene (size: 0.7 kb) was comparable to that of the conventional restriction-ligation method, reaching up to 4.3 x 10(4) positive clones per mu g of DNA. When we attempted parallel cloning of GFPuv fusion genes (size: 2.0 kb) and carotenoid biosynthesis pathway clusters (sizes: 4 kb, 6 kb, and 10 kb), the cloning efficiency was similarly high regardless of the DNA size, demonstrating that this would be useful for the cloning of large DNA sequences carrying multiple open reading frames. However, restriction analyses of the obtained plasmids showed that the selected cells may contain significant amounts of receiver plasmids without the inserts. To minimize the amount of empty plasmid in the positive selections, the sacB gene encoding a levansucrase was introduced as a counter selection marker in receiver plasmid as it converts sucrose to a toxic levan in the E. coli cells. Consequently, this method yielded completely homogeneous plasmids containing the inserts via the direct transformation of PCR products into E. coli cells.	[Lee, Jeongmin; Rha, Eugene; Yeom, Soo-Jin; Lee, Dae-Hee; Choi, Eui-Sung; Lee, Seung-Goo] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Lee, Seung-Goo] Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SG (corresponding author), KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea.	sglee@kribb.re.kr	Yeom, Soojin/AAE-3558-2022; Lee, Seung-Goo/AAR-9823-2021; Lee, Seung-Goo/AAS-1613-2021; LEE, DAE-HEE/O-5243-2018	Lee, Seung-Goo/0000-0003-4539-9812; LEE, DAE-HEE/0000-0002-0423-9057; Yeom, Soo-Jin/0000-0001-7307-237X	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944]; Korea Research Council of Fundamental Science and Technology Grant [Seed-10-3]; Next-Generation Biogreen 21 Program [PJ009524]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of Global Frontier Project; Korea Research Council of Fundamental Science and Technology Grant; Next-Generation Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031944), the Korea Research Council of Fundamental Science and Technology Grant (Seed-10-3), the Next-Generation Biogreen 21 Program (PJ009524), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Das A, 2007, APPL MICROBIOL BIOT, V77, P505, DOI 10.1007/s00253-007-1206-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dutton G, 2005, SCIENTIST, V19, P32; Ha JS, 2007, APPL ENVIRON MICROB, V73, P7408, DOI 10.1128/AEM.01080-07; Keasling JD, 1999, TRENDS BIOTECHNOL, V17, P452, DOI 10.1016/S0167-7799(99)01376-1; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; McArthur GH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/459760; Muyrers Joep P P, 2004, Methods Mol Biol, V256, P107; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Spiliotis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035407; Tao LA, 2006, METAB ENG, V8, P523, DOI 10.1016/j.ymben.2006.06.001; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Visser H, 2003, FEMS YEAST RES, V4, P221, DOI 10.1016/s1567-1356(03)00158-2; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Yosef I, 2004, APPL ENVIRON MICROB, V70, P7156, DOI 10.1128/AEM.70.12.7156-7160.2004; Young E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/130781; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79979	10.1371/journal.pone.0079979	http://dx.doi.org/10.1371/journal.pone.0079979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244585	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600163
J	Lustrek, M; Lorenz, P; Kreutzer, M; Qian, ZL; Steinbeck, F; Wu, D; Born, N; Ziems, B; Hecker, M; Blank, M; Shoenfeld, Y; Cao, ZW; Glocker, MO; Li, YX; Fuellen, G; Thiesen, HJ				Lustrek, Mitja; Lorenz, Peter; Kreutzer, Michael; Qian, Zilliang; Steinbeck, Felix; Wu, Di; Born, Nadine; Ziems, Bjoern; Hecker, Michael; Blank, Miri; Shoenfeld, Yehuda; Cao, Zhiwei; Glocker, Michael O.; Li, Yixue; Fuellen, Georg; Thiesen, Hans-Juergen			Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins	PLOS ONE			English	Article							B-CELL EPITOPES; RECEPTOR; ANTIGENICITY; INDUCTION; PEPTIDES; DISEASE; SERUM; MODEL	Epitope-antibody-reactivities (EAR) of intravenous immunoglobulins (IVIGs) determined for 75,534 peptides by microarray analysis demonstrate that roughly 9% of peptides derived from 870 different human protein sequences react with antibodies present in IVIG. Computational prediction of linear B cell epitopes was conducted using machine learning with an ensemble of classifiers in combination with position weight matrix (PWM) analysis. Machine learning slightly outperformed PWM with area under the curve (AUC) of 0.884 vs. 0.849. Two different types of epitope-antibody recognitionmodes (Type I EAR and Type II EAR) were found. Peptides of Type I EAR are high in tyrosine, tryptophan and phenylalanine, and low in asparagine, glutamine and glutamic acid residues, whereas for peptides of Type II EAR it is the other way around. Representative crystal structures present in the Protein Data Bank (PDB) of Type I EAR are PDB 1TZI and PDB 2DD8, while PDB 2FD6 and 2J4W are typical for Type II EAR. Type I EAR peptides share predicted propensities for being presented by MHC class I and class II complexes. The latter interaction possibly favors T cell-dependent antibody responses including IgG class switching. Peptides of Type II EAR are predicted not to be preferentially presented by MHC complexes, thus implying the involvement of T cell-independent IgG class switch mechanisms. The high extent of IgG immunoglobulin reactivity with human peptides implies that circulating IgG molecules are prone to bind to human protein/peptide structures under non-pathological, non-inflammatory conditions. A webserver for predicting EAR of peptide sequences is available at www.sysmed-immun.eu/EAR.	[Lustrek, Mitja; Fuellen, Georg] Univ Rostock, Univ Med Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Lustrek, Mitja] Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia; [Lorenz, Peter; Kreutzer, Michael; Qian, Zilliang; Steinbeck, Felix; Wu, Di; Born, Nadine; Thiesen, Hans-Juergen] Univ Rostock, Univ Med Rostock, Inst Immunol, D-18055 Rostock, Germany; [Qian, Zilliang; Wu, Di; Li, Yixue] Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ziems, Bjoern] Gesell Individualisierte Med GmbH, Rostock, Germany; [Hecker, Michael] Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany; [Blank, Miri; Shoenfeld, Yehuda] Sheba Med Ctr, Zabludovicz Ctr Autoimmune Dis, Ramat Gan, Israel; [Cao, Zhiwei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Glocker, Michael O.] Univ Rostock, Proteome Ctr Rostock, D-18055 Rostock, Germany	University of Rostock; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Rostock; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chaim Sheba Medical Center; Tongji University; University of Rostock	Thiesen, HJ (corresponding author), Univ Rostock, Univ Med Rostock, Inst Immunol, D-18055 Rostock, Germany.	HJ.Thiesen@gmx.de	Wu, Di/J-4483-2012	Wu, Di/0000-0001-9565-1217; Lorenz, Peter A./0000-0001-7925-1002; Hecker, Michael/0000-0001-7015-3094	Autorome [LSHM-CT-2004-005264]; E-RARE [01GM0803]; BMBF [0315450D]; State of Mecklenburg-Vorpommern MV-Excellence [UR08051, UR09012]	Autorome; E-RARE; BMBF(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern MV-Excellence	EU funded Autorome (LSHM-CT-2004-005264) and E-RARE (01GM0803); BMBF support through Med-Sys (0315450D), and funding by the State of Mecklenburg-Vorpommern MV-Excellence: (UR08051 und UR09012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2011, CELLULAR MOL IMMUNOL; Al-Majdoub M, 2013, J MASS SPECTROM, V48, P651, DOI 10.1002/jms.3208; Almqvist N, 2012, SCAND J IMMUNOL, V76, P256, DOI 10.1111/j.1365-3083.2012.02751.x; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Clark MR, 2011, MOL IMMUNOL, V48, P1281, DOI 10.1016/j.molimm.2010.10.024; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Fujita Y, 2012, THER DELIV, V3, P749, DOI 10.4155/TDE.12.52; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hecker M, 2012, AUTOIMMUN REV, V11, P180, DOI 10.1016/j.autrev.2011.05.010; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Hoffmann MH, 2011, J AUTOIMMUN, V36, P288, DOI 10.1016/j.jaut.2011.02.007; Inaba K, 2005, INT J HEMATOL, V81, P181, DOI 10.1532/IJH97.04200; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kracker S, 2011, IMMUNOL LETT, V138, P97, DOI 10.1016/j.imlet.2011.02.004; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Linnebacher M, 2012, ANAL BIOANAL CHEM, V403, P227, DOI 10.1007/s00216-012-5781-5; Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Nielsen CH, 2012, ADV EXP MED BIOL, V750, P116, DOI 10.1007/978-1-4614-3461-0_9; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pasquali JL, 2012, ADV EXP MED BIOL, V750, P145, DOI 10.1007/978-1-4614-3461-0_11; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; Pone EJ, 2012, FRONT BIOSCI-LANDMRK, V17, P2594, DOI 10.2741/4073; Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Saul F A, 1996, Methods Mol Biol, V66, P11; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Seewald A. K., 2002, 19 INT C MACH LEARN, P554, DOI DOI 10.1017/CBO9781107415324.004; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Sun J, 2011, IMMUNOME RES, V7, P1; Suri A, 2006, CURR OPIN IMMUNOL, V18, P70, DOI 10.1016/j.coi.2005.11.002; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935; Watanabe K, 2008, BIOCHEM BIOPH RES CO, V374, P274, DOI 10.1016/j.bbrc.2008.07.013; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78605	10.1371/journal.pone.0078605	http://dx.doi.org/10.1371/journal.pone.0078605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244326	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600036
J	Mutoh, R; Nishimura, A; Yasui, S; Onai, K; Ishiura, M				Mutoh, Risa; Nishimura, Atsuhito; Yasui, So; Onai, Kiyoshi; Ishiura, Masahiro			The ATP-Mediated Regulation of KaiB-KaiC Interaction in the Cyanobacterial Circadian Clock	PLOS ONE			English	Article							N-TERMINAL DOMAIN; PROTEIN KAIB; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; COMPLEX; RHYTHM; ROLES; RING; OSCILLATION	The cyanobacterial circadian clock oscillator is composed of three clock proteins-KaiA, KaiB, and KaiC, and interactions among the three Kai proteins generate clock oscillation in vitro. However, the regulation of these interactions remains to be solved. Here, we demonstrated that ATP regulates formation of the KaiB-KaiC complex. In the absence of ATP, KaiC was monomeric (KaiC(1mer)) and formed a complex with KaiB. The addition of ATP plus Mg2+ (Mg-ATP), but not that of ATP only, to the KaiB-KaiC(1mer) complex induced the hexamerization of KaiC and the concomitant release of KaiB from the KaiB-KaiC(1mer) complex, indicating that Mg-ATP and KaiB compete each other for KaiC. In the presence of ATP and Mg2+ (Mg-ATP), KaiC became a homohexameric ATPase (KaiC(6mer)) with bound Mg-ATP and formed a complex with KaiB, but KaiC hexamerized by unhydrolyzable substrates such as ATP and Mg-ATP analogs, did not. A KaiC N-terminal domain protein, but not its C-terminal one, formed a complex with KaiB, indicating that KaiC associates with KaiB via its N-terminal domain. A mutant KaiC(6mer) lacking N-terminal ATPase activity did not form a complex with KaiB whereas a mutant lacking C-terminal ATPase activity did. Thus, the N-terminal domain of KaiC is responsible for formation of the KaiB-KaiC complex, and the hydrolysis of the ATP bound to N-terminal ATPase motifs on KaiC(6mer) is required for formation of the KaiB-KaiC(6mer) complex. KaiC(6mer) that had been hexamerized with ADP plus aluminum fluoride, which are considered to mimic ADP-Pi state, formed a complex with KaiB, suggesting that KaiB is able to associate with KaiC(6mer) with bound ADP-Pi.	[Mutoh, Risa; Nishimura, Atsuhito; Yasui, So; Onai, Kiyoshi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan; [Nishimura, Atsuhito; Yasui, So; Ishiura, Masahiro] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ishiura, M (corresponding author), Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan.	ishiura@gene.nagoya-u.ac.jp	Mutoh, Risa/L-6494-2017	Mutoh, Risa/0000-0003-0069-8931; Onai, Kiyoshi/0000-0001-9062-2548	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science Society; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to MI and RM and the Sasakawa Scientific Research Grant from the Japan Science Society to AN. RM was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; GROBBELAAR N, 1986, FEMS MICROBIOL LETT, V37, P173, DOI 10.1111/j.1574-6968.1986.tb01788.x; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; LUNARDI J, 1988, P NATL ACAD SCI USA, V85, P8958, DOI 10.1073/pnas.85.23.8958; MILNER P, 1990, P ROY SOC B-BIOL SCI, V241, P245, DOI 10.1098/rspb.1990.0092; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Mutoh R, 2011, APPL MAGN RESON, V40, P525, DOI 10.1007/s00723-011-0228-2; Mutoh R, 2010, GENES CELLS, V15, P269, DOI 10.1111/j.1365-2443.2009.01377.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V104, P16377; Valencia J, 2012, GENES CELLS, V17, P398, DOI 10.1111/j.1365-2443.2012.01597.x; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	43	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80200	10.1371/journal.pone.0080200	http://dx.doi.org/10.1371/journal.pone.0080200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244649	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600191
J	Ng, THH; Mossey, JM; Lee, BK				Ng, Tsz Hin H.; Mossey, Jana M.; Lee, Brian K.			Total Blood Mercury Levels and Depression among Adults in the United States: National Health and Nutrition Examination Survey 2005-2008	PLOS ONE			English	Article							METHYLMERCURY EXPOSURE; FISH CONSUMPTION; SYMPTOMS; LIFE; RESIDENTS; TOXICITY; OUTCOMES; MICE	Background: Mercury is a neurotoxicant linked with psychiatric symptoms at high levels of exposure. However, it is unclear whether an association is present at the low exposure levels in the US adult population. Materials and Methods: Cross-sectional associations of total blood mercury and depression were assessed in 6,911 adults age >= 20 in the National Health and Nutrition Examination Survey (NHANES), 2005-2008. The Patient Health Questionnaire-9 was used to assess depression (high likelihood of a depressive spectrum disorder diagnosis; score 5-27). Results: Unadjusted survey weighted logistic regression suggested that higher total blood mercury was associated with lower odds of depression (Odds Ratio =0.49, 95% Confidence Interval: 0.36-0.65, comparing the highest and lowest mercury quintiles). This association largely disappeared after adjustment for sociodemographic variables (income-poverty ratio, education, marital status). However, in age-stratified analyses, this inverse relationship remained in older adults (age >= 40) even after adjustment for sociodemographic variables. Simulation analyses adjusting for expected confounding effects of fish intake suggested that the inverse relationship among older adults may be plausibly attributed to residual confounding (Odds Ratio =0.75, 95% Confidence Interval: 0.50-1.12, comparing the highest and lowest mercury quintiles). Conclusions: Higher total blood mercury was not associated with increased odds of depression. The lower odds of depression in older adults with higher total blood mercury may be due to residual confounding.	[Ng, Tsz Hin H.; Mossey, Jana M.; Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Drexel University	Lee, BK (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	bklee@drexel.edu		Lee, Brian/0000-0002-3635-8034				Akbaraly TN, 2008, BRIT J NUTR, V100, P1116, DOI 10.1017/S0007114508971312; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; Bates MN, 2004, INT J EPIDEMIOL, V33, P894, DOI 10.1093/ije/dyh164; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bourdineaud JP, 2011, ENVIRON INT, V37, P303, DOI 10.1016/j.envint.2010.09.003; Bourdineaud JP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-53; Centers for Disease Control and Prevention, 2009, 4 CDCP; Choi AL, 2008, CRIT REV TOXICOL, V38, P877, DOI [10.1080/10408440802273164, 10.1080/10408440802273164 ]; Division of Nutrition Physical Activity and Obesity Centers for Disease Control and Prevention, 2011, BOD MASS IND; Environmental Protection Agency, 2010, MERC HUM EXP; FDA, 2011, MERC LEV COMM FISH S; GOYER RA, 2003, CASARETT DOULLS ESSE, P348; Heyer NJ, 2004, TOXICOL SCI, V81, P354, DOI 10.1093/toxsci/kfh220; Kokayi K, 2006, EXPLORE-NY, V2, P400, DOI 10.1016/j.explore.2006.06.008; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Krishnan KRR, 2010, BIOL PSYCHIAT, V68, P116, DOI 10.1016/j.biopsych.2010.05.009; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Maximino C, 2011, NEUROTOXICOL TERATOL, V33, P727, DOI 10.1016/j.ntt.2011.08.006; Moreira PA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-58; National Academy of Sciences, 2000, TOX EFF METH; National Center for Health Statistics, 2010, NHANES 2007 2008 PUB; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; National Center for Health Statistics Centers for Disease Control and Prevention, 2011, NCHS RES ETH REV BOA; National Center for Health Statistics Centers for Disease Control and Prevention, 2004, LAB PROC MAN TOT MER; National Center for Health Statistics Centers for Disease Control and Prevention, 2011, SAMPL DES; National Center for Health Statistics Centers for Disease Control and Prevention, 2009, 2007 2008 DAT DOC CO; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, 2007 2008 DAT DOC CO; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, TASK 2 KEY CONC UND; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, 2007 2008 DAT DO CCO; National Center for Toxicological Research, 2009, WHIT PAP FDA UPD REV; Onishchenko N, 2007, TOXICOL SCI, V97, P428, DOI 10.1093/toxsci/kfl199; Pasco JA, 2012, COMPLEMENT THER MED, V20, P119, DOI 10.1016/j.ctim.2011.12.008; Seabrook JA, 2012, CAN REV SOCIOL, V49, P50, DOI 10.1111/j.1755-618X.2011.01280.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tran NL, 2004, RISK ANAL, V24, P19, DOI 10.1111/j.0272-4332.2004.00408.x; United Nations Environment Programme International Labour Organisation World Health Organization, 1990, ENV HLTH CRIT; United Nations Environment Programme World Health Organization, 1976, ENV HLTH CRIT; US Department of Health and Human Services, 2012, POV GUID RES MEAS; US National Center for Health Statistics, 2012, 2007 2008 NAT HLTH N; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; Yaginuma-Sakurai K, 2012, J TOXICOL SCI, V37, P123, DOI 10.2131/jts.37.123; Yorifuji T, 2011, ENVIRON INT, V37, P907, DOI 10.1016/j.envint.2011.03.008; Zachi EC, 2007, BRAZ J MED BIOL RES, V40, P425, DOI 10.1590/S0100-879X2007000300019	46	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79339	10.1371/journal.pone.0079339	http://dx.doi.org/10.1371/journal.pone.0079339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244482	Green Published, Green Submitted, gold			2022-12-27	WOS:000327221600125
J	Pepper, M; Doughty, P; Fujita, MK; Moritz, C; Keogh, JS				Pepper, Mitzy; Doughty, Paul; Fujita, Matthew K.; Moritz, Craig; Keogh, J. Scott			Speciation on the Rocks: Integrated Systematics of the Heteronotia spelea Species Complex (Gekkota; Reptilia) from Western and Central Australia	PLOS ONE			English	Article							GEKKONIDAE; EVOLUTION; DELIMITATION; SQUAMATA; GECKOS; DIVERSIFICATION; DIVERSITY; RADIATION; ENDEMISM; MODELS	The isolated uplands of the Australian arid zone are known to provide mesic refuges in an otherwise xeric landscape, and divergent lineages of largely arid zone taxa have persisted in these regions following the onset of Miocene aridification. Geckos of the genus Heteronotia are one such group, and have been the subject of many genetic studies, including H. spelea, a strongly banded form that occurs in the uplands of the Pilbara and Central Ranges regions of the Australian arid zone. Here we assess the systematics of these geckos based on detailed examination of morphological and genetic variation. The H. spelea species complex is a monophyletic lineage to the exclusion of the H. binoei and H. planiceps species complexes. Within the H. spelea complex, our previous studies based on mtDNA and nine nDNA loci found populations from the Central Ranges to be genetically divergent from Pilbara populations. Here we supplement our published molecular data with additional data gathered from central Australian samples. In the spirit of integrative species delimitation, we combine multi-locus, coalescent-based lineage delimitation with extensive morphological analyses to test species boundaries, and we describe the central populations as a new species, H. fasciolatus sp. nov. In addition, within the Pilbara there is strong genetic evidence for three lineages corresponding to northeastern (type), southern, and a large-bodied melanic population isolated in the northwest. Due to its genetic distinctiveness and extreme morphological divergence from all other Heteronotia, we describe the melanic form as a new species, H. atra sp. nov. The northeastern and southern Pilbara populations are morphologically indistinguishable with the exception of a morpho-type in the southeast that has a banding pattern resembling H. planiceps from the northern monsoonal tropics. Pending more extensive analyses, we therefore treat Pilbara H. spelea as a single species with phylogenetic structure and morphological heterogeneity.	[Pepper, Mitzy; Moritz, Craig; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Doughty, Paul] Western Australian Museum, Dept Terr Zool, Perth, WA 6000, Australia; [Fujita, Matthew K.] Harvard Univ, Cambridge, MA 02138 USA; [Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Australian National University; Western Australian Museum; Harvard University; University of Texas System; University of Texas Arlington	Pepper, M (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	mitzy.pepper@anu.edu.au	Keogh, Scott/C-8441-2009	Keogh, Scott/0000-0002-1373-6186; Pepper, Mitzy/0000-0003-4828-9977	MCZ Putnam Exploration Grant; Australian Research Council [DP0985054]	MCZ Putnam Exploration Grant; Australian Research Council(Australian Research Council)	Fieldwork was supported by the MCZ Putnam Exploration Grant to MKF (http://www.mcz.harvard.edu/grants_and_funding/putnam-expedition.html). Labwork was supported by the Australian Research Council grant DP0985054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN C, 1981, BIOL J LINN SOC, V15, P235, DOI 10.1111/j.1095-8312.1981.tb00761.x; [Anonymous], 2010, COMPLETE GUIDE REPTI; Bauer Aaron M., 1997, Proceedings of the California Academy of Sciences, V49, P447; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bittner TD, 2002, COPEIA, P477, DOI 10.1643/0045-8511(2002)002[0477:EOBSAM]2.0.CO;2; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Cogger H, 2000, REPTILES AMPHIBIANS; Cogger H. G., 1983, REPTILES AMPHIBIANS; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doughty Paul, 2011, Records of the Western Australian Museum, P315; Doughty Paul, 2012, Records of the Western Australian Museum, V27, P117; Doughty Paul, 2011, Records of the Western Australian Museum, V26, P115; Doughty Paul, 2010, Zootaxa, V2393, P33; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Galimberti DF, 2012, MOL ECOL RES; Glaw Frank, 2010, Zootaxa, V2383, P1; Gray J.E., 1845, CATALOGUE SPECIMENS; Heinicke MP, 2011, ZOOL SCR, V40, P584, DOI 10.1111/j.1463-6409.2011.00495.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; Horner Paul, 2005, Beagle, V21, P165; Jackman TR, 2008, ACTA HERPETOL, V3, P1; KING M, 1979, AUST J ZOOL, V27, P373, DOI 10.1071/ZO9790373; King M, 1983, AMPHIBIA-REPTILIA, P4147; KLUGE ARNOLD G., 1963, JOUR ROY SOC W AUSTRALIA, V46, P63; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; LEWIS TH, 1949, COPEIA, P181; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; McKenzie N.L., 2009, RECORDS W AUSTR MU S, V78, P3, DOI DOI 10.18195/ISSN.0313-122X.78(1).2009.003-089; Miller GH, 1997, NATURE, V385, P241, DOI 10.1038/385241a0; MORITZ C, 1986, SYST ZOOL, V35, P46, DOI 10.2307/2413290; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; MORITZ C, 1990, COPEIA, P333, DOI 10.2307/1446339; NORRIS KS, 1964, ECOLOGY, V45, P565; Oliver Paul, 2010, Zootaxa, V2354, P45; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; Pepper M, 2011, MOL ECOL, V20, P1529, DOI 10.1111/j.1365-294X.2011.05036.x; Pepper M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-152; R Development Core Team, 2007, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Shoo LP, 2008, MOL PHYLOGENET EVOL, V48, P528, DOI 10.1016/j.ympev.2008.03.022; Sistrom M, 2012, J EVOLUTION BIOL, V25, P647, DOI 10.1111/j.1420-9101.2012.02460.x; Sistrom MJ, 2009, ZOOTAXA, P14, DOI 10.11646/zootaxa.2277.1.2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart DA, 1996, THESIS U QUEENSLAND; STORR G M, 1989, Records of the Western Australian Museum, V14, P269; STORR G.M., 1990, LIZARDS W AUSTR; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wermuth H., 1965, Tierreich, V80, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	62	25	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78110	10.1371/journal.pone.0078110	http://dx.doi.org/10.1371/journal.pone.0078110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244289	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600016
J	Sanphui, P; Pramanik, SK; Chatterjee, N; Moorthi, P; Banerji, B; Biswas, SC				Sanphui, Priyankar; Pramanik, Sumit Kumar; Chatterjee, Nandini; Moorthi, Ponnusamy; Banerji, Biswadip; Biswas, Subhas Chandra			Efficacy of Cyclin Dependent Kinase 4 Inhibitors as Potent Neuroprotective Agents against Insults Relevant to Alzheimer's Disease	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURONAL CELL-DEATH; NF-KAPPA-B; GENE-EXPRESSION; BIM; MECHANISMS; PROTEIN; NEURODEGENERATION; MOLECULES; APOPTOSIS	Alzheimer's disease (AD) is a progressive neurodegenerative disease with no cure till today. Aberrant activation of cell cycle regulatory proteins is implicated in neurodegenerative diseases including AD. We and others have shown that Cyclin dependent kinase 4 (Cdk4) is activated in AD brain and is required for neuron death. In this study, we tested the efficiency of commercially available Cdk4 specific inhibitors as well as a small library of synthetic molecule inhibitors targeting Cdk4 as neuroprotective agents in cellular models of neuron death. We found that several of these inhibitors significantly protected neuronal cells against death induced by nerve growth factor (NGF) deprivation and oligomeric beta amyloid (Ab) that are implicated in AD. These neuroprotective agents inhibit specifically Cdk4 kinase activity, loss of mitochondrial integrity, induction of pro-apoptotic protein Bim and caspase3 activation in response to NGF deprivation. The efficacies of commercial and synthesized inhibitors are comparable. The synthesized molecules are either phenanthrene based or naphthalene based and they are synthesized by using Pschorr reaction and Buchwald coupling respectively as one of the key steps. A number of molecules of both kinds block neurodegeneration effectively. Therefore, we propose that Cdk4 inhibition would be a therapeutic choice for ameliorating neurodegeneration in AD and these synthetic Cdk4 inhibitors could lead to development of effective drugs for AD.	[Sanphui, Priyankar; Chatterjee, Nandini; Moorthi, Ponnusamy; Biswas, Subhas Chandra] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata, India; [Pramanik, Sumit Kumar; Banerji, Biswadip] Indian Inst Chem Biol, CSIR, Div Chem, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Banerji, B (corresponding author), Indian Inst Chem Biol, CSIR, Div Chem, Kolkata, India.	biswadip.banerji@gmail.com; biswassc@gmail.com		Ponnusamy, Moorthi/0000-0002-3275-6473	CSIR-EMPOWER; DST, Govt. of India	CSIR-EMPOWER; DST, Govt. of India(Department of Science & Technology (India))	This work was supported in part by grants from CSIR-EMPOWER (SCB & BB) and DST (SCB), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Calissano P, 2010, CELL DEATH DIFFER, V17, P1126, DOI 10.1038/cdd.2010.38; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Copani A, 2008, CURR MED CHEM, V15, P2420, DOI 10.2174/092986708785909030; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Fors BP, 2008, ORG LETT, V10, P3505, DOI 10.1021/ol801285g; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Karran E, 2012, J NEUROCHEM, V123, P647, DOI 10.1111/jnc.12009; Kim D, 2009, ANN NY ACAD SCI, V1170, P674, DOI 10.1111/j.1749-6632.2009.04105.x; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee HG, 2009, AM J PATHOL, V174, P891, DOI 10.2353/ajpath.2009.080583; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Massoud F, 2010, CURR NEUROPHARMACOL, V8, P69, DOI 10.2174/157015910790909520; Neve RL, 2007, BBA-MOL BASIS DIS, V1772, P430, DOI 10.1016/j.bbadis.2006.10.008; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Rao HV, 2007, J NEUROCHEM, V101, P498, DOI 10.1111/j.1471-4159.2006.04389.x; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Ruberti F, 2000, J NEUROSCI, V20, P2589; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Spires TL, 2004, REV NEUROSCIENCE, V15, P267, DOI 10.1515/REVNEURO.2004.15.4.267; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Troy CM, 2000, J NEUROSCI, V20, P1386; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Xie YL, 2008, TETRAHEDRON LETT, V49, P2320, DOI 10.1016/j.tetlet.2008.01.136; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2003, J NEUROSCI, V23, P2557; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78842	10.1371/journal.pone.0078842	http://dx.doi.org/10.1371/journal.pone.0078842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244372	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600069
J	Singh, S; Kumar, S; Kolte, AP; Kumar, S				Singh, Sachin; Kumar, Satish, Jr.; Kolte, Atul P.; Kumar, Satish			Extensive Variation and Sub-Structuring in Lineage A mtDNA in Indian Sheep: Genetic Evidence for Domestication of Sheep in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; CONTROL REGION; OVIS-ARIES; ORIGIN; DIVERSITY; SEQUENCE; PHYLOGEOGRAPHY; BREEDS; WILD	Previous studies on mitochondrial DNA analysis of sheep from different regions of the world have revealed the presence of two major-A and B, and three minor-C, D and E maternal lineages. Lineage A is more frequent in Asia and lineage B is more abundant in regions other than Asia. We have analyzed mitochondrial DNA sequences of 330 sheep from 12 different breeds of India. Neighbor-joining analysis revealed lineage A, B and C in Indian sheep. Surprisingly, multidimensional scaling plot based on F-ST values of control region of mtDNA sequences showed significant breed differentiation in contrast to poor geographical structuring reported earlier in this species. The breed differentiation in Indian sheep was essentially due to variable contribution of two major lineages to different breeds, and sub-structuring of lineage A, possibly the latter resulting from genetic drift. Nucleotide diversity of this lineage was higher in Indian sheep (0.014 +/- 0.007) as compared to that of sheep from other regions of the world (0.009 +/- 0.005 to 0.01 +/- 0.005). Reduced median network analysis of control region and cytochrome b gene sequences of Indian sheep when analyzed along with available published sequences of sheep from other regions of the world showed that several haplotypes of lineage A were exclusive to Indian sheep. Given the high nucleotide diversity in Indian sheep and the poor sharing of lineage A haplotypes between Indian and non-Indian sheep, we propose that lineage A sheep has also been domesticated in the east of Near East, possibly in Indian sub-continent. Finally, our data provide support that lineage B and additional lineage A haplotypes of sheep might have been introduced to Indian sub-continent from Near East, probably by ancient sea trade route.	[Singh, Sachin; Kumar, Satish] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Kumar, Satish, Jr.] ICAR Cent Sheep & Wool Res Inst, Avikanagar, India; [Kolte, Atul P.] ICAR Natl Inst Anim Nutr & Physiol, Bangaluru, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Indian Council of Agricultural Research (ICAR); ICAR - Central Sheep & Wool Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology	Kumar, S (corresponding author), DBT Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India.	satishk@ccmb.res.in			Centre for Cellular and Molecular Biology, Hyderabad; Central Sheep and Wool Research Institute, Avikanagar	Centre for Cellular and Molecular Biology, Hyderabad; Central Sheep and Wool Research Institute, Avikanagar	This study was supported by in-house research funds from the Centre for Cellular and Molecular Biology, Hyderabad and the Central Sheep and Wool Research Institute, Avikanagar. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R M, 1982, SHEEP GOAT BREEDS IN; Babar ME, 2012, ANIM GENET, V43, P315, DOI 10.1111/j.1365-2052.2011.02250.x; BANDELT HJ, 1995, GENETICS, V141, P743; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Fu YX, 1997, GENETICS, V147, P915; Giuffra E, 2000, GENETICS, V154, P1785; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kumar S, 2007, ANIM GENET, V38, P227, DOI 10.1111/j.1365-2052.2007.01602.x; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; McIntosh J., 2008, MCINTOSH; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Pardeshi VC, 2007, ANIM GENET, V38, P460, DOI 10.1111/j.1365-2052.2007.01636.x; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider S, 1999, GENETICS, V152, P1079; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; TEMPLETON AR, 1995, GENETICS, V140, P767; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Wang X, 2007, SMALL RUMINANT RES, V72, P232, DOI 10.1016/j.smallrumres.2006.10.016; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	46	21	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e77858	10.1371/journal.pone.0077858	http://dx.doi.org/10.1371/journal.pone.0077858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244282	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600010
J	Sun, X; Zhou, W; Liu, H; Zhang, AJ; Ai, CR; Zhou, SS; Zhou, CX; Wang, MQ				Sun, Xiao; Zhou, Wen; Liu, Hao; Zhang, Aijun; Ai, Chao-Ren; Zhou, Shuang-Shuang; Zhou, Chang-Xiang; Wang, Man-Qun			Transgenic Bt Rice Does Not Challenge Host Preference of the Target Pest of Rice Leaffolder, Cnaphalocrocis medinalis (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							ELECTRONIC NOSE; INDICA RICE; STEM BORER; CRY2A RICE; VOLATILES; COTTON; LEAF; RESISTANCE; RESPONSES; BOLLWORM	Background: Transgenic Bt rice line T2A-1 expresses a synthesized cry2A gene that shows high resistance to Lepidoptera pests, including Cnaphalocrocis medinalis (Guenee) (Lepidoptera: Pyralidae). Plant volatile orientation cues and the physical characteristics of the leaf surface play key roles in host location or host-plant acceptance of phytophagous insects. These volatile compounds and physical traits may become altered in Bt rice and it is not known whether this influences the behavior of C. medinalis when searching for oviposition sites. Results: The results of electronic nose analysis showed that the Radar map of Bt rice cultivars was analogous to the non-Bt rice cultivars at each growing stage. PCA analysis was able to partly discriminate between some of the Bt vs. non-Bt rice sensors, but could not to separate Bt cultivars from non-Bt cultivars. The total ion chromatogram between Bt and non-Bt rice cultivars at the seedling, booting and tillering stages were similar and 25 main compounds were identified by GC-MS. For most compounds, there was no significant difference in compound quantities between Bt and non-Bt rice cultivars at equivalent growth stages. The densities of the tubercle papicles and the trichomes on the upper and lower surfaces were statistically equal in Bt and non-Bt rice. The target pest, C. medinalis, was attracted to host rice plants, but it could not distinguish between the transgenic and the isogenic rice lines. Conclusions: There were no significant differences between the Bt rice line, T2A-1 and the non-Bt rice for volatiles produced or in its physical characteristics and there were no negative impacts on C. medinalis oviposition behavior. These results add to the mounting evidence that Bt rice has no negative impact on the target insect oviposition behavior.	[Sun, Xiao; Zhou, Wen; Liu, Hao; Ai, Chao-Ren; Zhou, Shuang-Shuang; Zhou, Chang-Xiang; Wang, Man-Qun] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA	Huazhong Agricultural University; United States Department of Agriculture (USDA)	Wang, MQ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	mqwang@mail.hzau.edu.cn	Wang, Man-Qun/AAO-3802-2020		National Genetically Modified Organisms Breeding Major Projects of China [2011ZZX08001-001]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Ministry of Agriculture of China [200903051]	National Genetically Modified Organisms Breeding Major Projects of China; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This study was supported and funded by the National Genetically Modified Organisms Breeding Major Projects of China (No: 2011ZZX08001-001), Huazhong Agricultural University Scientific & Technological Self-innovation Foundation and The Industry Project of the Ministry of Agriculture of China (200903051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bai Yao-yu, 2005, Acta Phytophylacica Sinica, V32, P225; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Bondada BR, 2000, ANN BOT-LONDON, V86, P1143, DOI 10.1006/anbo.2000.1283; BRYSON CT, 1983, CROP SCI, V23, P369, DOI 10.2135/cropsci1983.0011183X002300020043x; Camurati E, 2006, RIV ITAL SOSTANZE GR, V83, P205; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen M, 2006, ENVIRON ENTOMOL, V35, P127, DOI 10.1603/0046-225X-35.1.127; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Dean JM, 2006, J CHEM ECOL, V32, P713, DOI 10.1007/s10886-006-9040-0; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Eifler J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021026; Fettig CJ, 2009, J APPL ENTOMOL, V133, P143, DOI 10.1111/j.1439-0418.2008.01317.x; Gallego D, 2008, J APPL ENTOMOL, V132, P654, DOI 10.1111/j.1439-0418.2008.01304.x; Han Y, 2011, AGR SCI CHINA, V10, P1739, DOI 10.1016/S1671-2927(11)60172-7; HEATH RR, 1994, J CHEM ECOL, V20, P593, DOI 10.1007/BF02059600; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Ibrahim MA, 2008, PLANT BIOLOGY, V10, P97, DOI 10.1111/j.1438-8677.2007.00013.x; Jaffe G, 2009, COMPLACENCY FARM; Jyothi KN, 2002, J APPL ENTOMOL, V126, P175, DOI 10.1046/j.1439-0418.2002.00628.x; KAMEL SA, 1965, J ECON ENTOMOL, V58, P209, DOI 10.1093/jee/58.2.209; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; de Lerma NL, 2012, FOOD CHEM, V130, P447, DOI 10.1016/j.foodchem.2011.07.058; Lou YG, 2005, J CHEM ECOL, V31, P2357, DOI 10.1007/s10886-005-7106-z; Lu BQ, 2011, ENTOMOL EXP APPL, V140, P17, DOI 10.1111/j.1570-7458.2011.01135.x; Lu K, 2010, CHINESE SCI BULL, V55, P2925; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; Obonyo D, 2008, J APPL BIOSCIENCES, V10, P424; Obonyo DN, 2009, THESIS; Perkowski J, 2008, INT J FOOD MICROBIOL, V126, P127, DOI 10.1016/j.ijfoodmicro.2008.05.028; Peterson JA, 2011, J ARACHNOL, V39, P1, DOI 10.1636/M10-98.1; RAMACHANDRAN R, 1990, J CHEM ECOL, V16, P2647, DOI 10.1007/BF00988076; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; SCARPATI ML, 1993, J CHEM ECOL, V19, P881, DOI 10.1007/BF00985017; Schuler TH, 1999, TRENDS BIOTECHNOL, V17, P210, DOI 10.1016/S0167-7799(98)01298-0; SPADONE JC, 1990, J AGR FOOD CHEM, V38, P226, DOI 10.1021/jf00091a050; Sun X, 2013, J INSECT SCI; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Turlings TCJ, 2005, TRANSGENIC RES, V14, P807, DOI 10.1007/s11248-005-0008-6; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; Van den Berg J, 2007, ENTOMOL EXP APPL, V122, P45, DOI 10.1111/j.1570-7458.2006.00492.x; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vogler U, 2010, TRANSGENIC RES, V19, P77, DOI 10.1007/s11248-009-9294-8; Wang YM, 2010, CROP PROT, V29, P128, DOI 10.1016/j.cropro.2009.10.004; Wechgama K., 2008, Biotechnology, V7, P718; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu XL, 2011, SCI CHINA LIFE SCI, V54, P1019, DOI 10.1007/s11427-011-4234-2; Xue K, 2008, SCI CHINA SER C, V51, P145, DOI 10.1007/s11427-008-0028-6; Yan F, 2004, J APPL ENTOMOL, V128, P354, DOI 10.1111/j.1439-0418.2004.00857.x; Yan Feng, 2010, Chinese Bulletin of Entomology, V47, P96; Ye GY, 2000, B ENTOMOL RES, V90, P179, DOI 10.1017/S0007485300000298; Yu HC, 2007, SENSOR ACTUAT B-CHEM, V122, P134, DOI 10.1016/j.snb.2006.05.019; Zhuge PP, 2010, J APPL ENTOMOL, V134, P600, DOI 10.1111/j.1439-0418.2010.01540.x	60	24	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79032	10.1371/journal.pone.0079032	http://dx.doi.org/10.1371/journal.pone.0079032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244410	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600098
J	Tseng, JR; Ho, TY; Lin, CY; Lee, LY; Wang, HM; Liao, CT; Yen, TC				Tseng, Jing-Ren; Ho, Tsung-Ying; Lin, Chien-Yu; Lee, Li-Yu; Wang, Hung-Ming; Liao, Chun-Ta; Yen, Tzu-Chen			Clinical Outcomes of Patients with Oral Cavity Squamous Cell Carcinoma and Retropharyngeal Lymph Node Metastasis Identified by FDG PET/CT	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; NECK RECURRENCE; F-18-FDG PET; CANCER; HEAD; CT	Purpose: Retropharyngeal lymph node (RPLN) metastasis is an uncommon finding in patients with oral cavity squamous carcinoma (OSCC). We sought to investigate the clinical outcomes, clinicopathological characteristics, and the priority of treatment with curative intent in OSCC patients with RPLN involvement. Methods and Materials: Between January 2007 and January 2011, we identified 36 patients with primary RPLN metastases (n = 10) or RPLN relapse (n = 26). The follow-up continued until June 2013. Disease-specific survival (DSS), disease-free survival (DFS), and the potential benefits of salvage therapy served as the main outcome measures. Results: The 2-year DSS and DFS rates of untreated patients with RPLN involvement were 20% and 24%, respectively. Level IV/V neck lymph node involvement was an adverse prognostic factor for DSS (P = 0.048) and DFS (P = 0.018). All of the patients presenting with neck lymph node involvement at level IV/V died within 6 months. Among patients who were treated for RPLN relapse, the 2-year DSS and DFS rates from the relapse day were 12.8% and 9.6%, respectively. Concomitant contralateral neck lymph node metastases (N2c) were associated with lower 2-year DSS (P = 0.005) and DFS (P = 0.011) rates. Moreover, five (55%) of the nine patients with recurrent disease in the contralateral RPLN had distant metastases within 6 months. Salvage therapy yielded the maximum survival benefit in patients without N2c disease and ipsilateral RPLN involvement alone (P = 0.005). Conclusion: OSCC patients with RPLN involvement have poor outcomes. The risk factor for definitive treatment in OSCC patients with FDG PET/CT defined RPLN disease in primary disease was neck lymph node involvement at level IV/V and N2c and/or contralateral RPLN disease in recurrent disease. Treatment efforts with curative intent should be tailored according to individual risk factors.	[Tseng, Jing-Ren; Ho, Tsung-Ying; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Dept Nucl Med, Tao Yuan, Taiwan; [Tseng, Jing-Ren; Ho, Tsung-Ying; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Mol Imaging Ctr, Tao Yuan, Taiwan; [Liao, Chun-Ta] Chang Gung Mem Hosp Linkou, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Lin, Chien-Yu] Chang Gung Mem Hosp Linkou, Dept Radiat Oncol, Tao Yuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp Linkou, Dept Pathol, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp Linkou, Dept Med Oncol, Tao Yuan, Taiwan; [Tseng, Jing-Ren; Ho, Tsung-Ying; Lin, Chien-Yu; Lee, Li-Yu; Wang, Hung-Ming; Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Dept Head & Neck Oncol Grp, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liao, CT (corresponding author), Chang Gung Mem Hosp Linkou, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan.	liaoct@cgmh.org.tw; yen1110@adm.cgmh.org.tw	Li-yu, Lee/G-5055-2010	Ho, Tsung-Ying/0000-0002-8468-2226; Tseng, Jing-Ren/0000-0002-2232-9347				BALLANTYNE AJ, 1964, AM J SURG, V108, P500, DOI 10.1016/0002-9610(64)90143-6; Chan SC, 2010, NUCL MED COMMUN, V31, P260, DOI 10.1097/MNM.0b013e3283360133; Chu HR, 2009, OTOLARYNG HEAD NECK, V141, P633, DOI 10.1016/j.otohns.2009.08.008; Dirix P, 2006, INT J RADIAT ONCOL, V65, P739, DOI 10.1016/j.ijrobp.2006.02.027; Kimura Y, 1998, AM J NEURORADIOL, V19, P1221; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2013, ANN SURG ONCOL, V20, P257, DOI 10.1245/s10434-012-2580-3; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; Liao CT, 2009, ANN SURG ONCOL, V16, P159, DOI 10.1245/s10434-008-0196-4; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; Morrissey DD, 2000, ARCH OTOLARYNGOL, V126, P1478, DOI 10.1001/archotol.126.12.1478; Ng SH, 1997, NEURORADIOLOGY, V39, P741, DOI 10.1007/s002340050499; Nishida M, 2005, J ORAL MAXIL SURG, V63, P410, DOI 10.1016/j.joms.2004.04.035; Okumura K, 1998, Nihon Jibiinkoka Gakkai Kaiho, V101, P573; Umeda M, 2009, INT J ORAL MAX SURG, V38, P1004, DOI 10.1016/j.ijom.2009.04.015; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570	16	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e79766	10.1371/journal.pone.0079766	http://dx.doi.org/10.1371/journal.pone.0079766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244559	Green Submitted, gold, Green Published			2022-12-27	WOS:000327221600151
J	Bergiers, I; Bridoux, L; Nguyen, N; Twizere, JC; Rezsohazy, R				Bergiers, Isabelle; Bridoux, Laure; Nguyen, Nathan; Twizere, Jean-Claude; Rezsohazy, Rene			The Homeodomain Transcription Factor Hoxa2 Interacts with and Promotes the Proteasomal Degradation of the E3 Ubiquitin Protein Ligase RCHY1	PLOS ONE			English	Article							DNA-POLYMERASE ETA; HOMEOTIC TRANSFORMATION; GENES; PIRH2; EXPRESSION; CELLS; HINDBRAIN; MOUSE; NETWORK; ROLES	Hox proteins are conserved homeodomain transcription factors known to be crucial regulators of animal development. As transcription factors, the functions and modes of action (co-factors, target genes) of Hox proteins have been very well studied in a multitude of animal models. However, a handful of reports established that Hox proteins may display molecular activities distinct from gene transcription regulation. Here, we reveal that Hoxa2 interacts with 20S proteasome subunits and RCHY1 (also known as PIRH2), an E3 ubiquitin ligase that targets p53 for degradation. We further show that Hoxa2 promotes proteasome-dependent degradation of RCHY1 in an ubiquitin-independent manner. Correlatively, Hoxa2 alters the RCHY1-mediated ubiquitination of p53 and promotes p53 stabilization. Together, our data establish that Hoxa2 can regulate the proteasomal degradation of RCHY1 and stabilization of p53.	[Bergiers, Isabelle; Bridoux, Laure; Nguyen, Nathan; Rezsohazy, Rene] Catholic Univ Louvain, Inst Life Sci, Mol & Cellular Anim Embryol Grp, B-1348 Louvain, Belgium; [Twizere, Jean-Claude] Univ Liege, GIGA R, Lab Signaling & Prot Interact, Liege, Belgium	Universite Catholique Louvain; University of Liege	Rezsohazy, R (corresponding author), Catholic Univ Louvain, Inst Life Sci, Mol & Cellular Anim Embryol Grp, B-1348 Louvain, Belgium.	rene.rezsohazy@uclouvain.be	Twizere, Jean-Claude/AAG-3706-2019; Nguyen, Nathan/AAV-9430-2021	TWIZERE, Jean-Claude/0000-0002-8683-705X; Bergiers, Isabelle/0000-0001-9622-7960; Nguyen, Nathan/0000-0001-6969-3894	Fonds de la Recherche Scientifique Medicale (FRSM) from Belgian National Fund for Scientific Research (FRS-FNRS) [3.4.536.06 F]; FRS-FNRS	Fonds de la Recherche Scientifique Medicale (FRSM) from Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds de la Recherche Scientifique Medicale (FRSM grant #3.4.536.06 F) from the Belgian National Fund for Scientific Research (FRS-FNRS). IB and LB hold a FRIA fellowship from the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Bertrand N, 2011, DEV BIOL, V353, P266, DOI 10.1016/j.ydbio.2011.02.029; Bobola N, 2003, DEVELOPMENT, V130, P3403, DOI 10.1242/dev.00554; Brison N, 2012, EUR J MED GENET, V55, P1, DOI 10.1016/j.ejmg.2011.06.003; Cardoso WV, 1996, DEV DYNAM, V207, P47, DOI 10.1002/(SICI)1097-0177(199609)207:1<47::AID-AJA6>3.0.CO;2-W; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Chatelin L, 1996, MECH DEVELOP, V55, P111, DOI 10.1016/0925-4773(95)00478-5; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; Cillo C, 2011, INT J CANCER, V129, P2577, DOI 10.1002/ijc.25941; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Donaldson IJ, 2012, NUCL ACIDS RES; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Fernandez CC, 2009, J CELL BIOCHEM, V106, P427, DOI 10.1002/jcb.22023; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Gavalas A, 1997, DEVELOPMENT, V124, P3693; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Grier DG, 2009, NEONATOLOGY, V96, P50, DOI 10.1159/000201739; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kutejova E, 2005, DEVELOPMENT, V132, P469, DOI 10.1242/dev.01536; Lambert B, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-29; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Massip L, 2007, DIFFERENTIATION, V75, P256, DOI 10.1111/j.1432-0436.2006.00132.x; Matis C, 2007, DEV DYNAM, V236, P2675, DOI 10.1002/dvdy.21266; McGonigle GJ, 2008, FRONT BIOSCI, V13, P4297, DOI 10.2741/3006; Miguez A, 2012, J NEUROSCI, V32, P17172, DOI 10.1523/JNEUROSCI.0885-12.2012; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Narita Y, 2009, CURR TOP DEV BIOL, V88, P139, DOI 10.1016/S0070-2153(09)88005-8; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P21529, DOI 10.1073/pnas.1011054107; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; Pachkowski BF, 2011, MUTAT RES-REV MUTAT, V728, P35, DOI 10.1016/j.mrrev.2011.05.003; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Salsi V, 2009, MOL CELL BIOL, V29, P5775, DOI 10.1128/MCB.00509-09; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tavella S, 2010, DIFFERENTIATION, V79, P194, DOI 10.1016/j.diff.2009.11.004; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Wang M, 2011, CELL MOL NEUROBIOL, V31, P875, DOI 10.1007/s10571-011-9685-2; Wellik DM, 2011, PEDIATR NEPHROL, V26, P1559, DOI 10.1007/s00467-011-1902-1; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Williams TM, 2005, DEV BIOL, V279, P462, DOI 10.1016/j.ydbio.2004.12.015; Yang X, 2008, DEV BIOL, V314, P171, DOI 10.1016/j.ydbio.2007.11.032; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zheng G, 2007, BIOCHEM BIOPH RES CO, V364, P344, DOI 10.1016/j.bbrc.2007.10.003; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	76	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80387	10.1371/journal.pone.0080387	http://dx.doi.org/10.1371/journal.pone.0080387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24244684	Green Published, gold, Green Submitted			2022-12-27	WOS:000327162900079
J	Beck-Johnson, LM; Nelson, WA; Paaijmans, KP; Read, AF; Thomas, MB; Bjornstad, ON				Beck-Johnson, Lindsay M.; Nelson, William A.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.			The Effect of Temperature on Anopheles Mosquito Population Dynamics and the Potential for Malaria Transmission	PLOS ONE			English	Article							GAMBIAE GILES COMPLEX; CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; GENERATION SEPARATION; DEPENDENT DEVELOPMENT; IMMATURE STAGES; AQUATIC STAGES; BODY-SIZE; DIPTERA; MODEL	The parasites that cause malaria depend on Anopheles mosquitoes for transmission; because of this, mosquito population dynamics are a key determinant of malaria risk. Development and survival rates of both the Anopheles mosquitoes and the Plasmodium parasites that cause malaria depend on temperature, making this a potential driver of mosquito population dynamics and malaria transmission. We developed a temperature-dependent, stage-structured delayed differential equation model to better understand how climate determines risk. Including the full mosquito life cycle in the model reveals that the mosquito population abundance is more sensitive to temperature than previously thought because it is strongly influenced by the dynamics of the juvenile mosquito stages whose vital rates are also temperature-dependent. Additionally, the model predicts a peak in abundance of mosquitoes old enough to vector malaria at more accurate temperatures than previous models. Our results point to the importance of incorporating detailed vector biology into models for predicting the risk for vector borne diseases.	[Beck-Johnson, Lindsay M.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Beck-Johnson, Lindsay M.; Read, Andrew F.; Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Read, Andrew F.; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Beck-Johnson, LM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	lmb404@psu.edu	Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016; de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013	Peijnenburg, Katja TCA/0000-0001-7544-1079; de Voogd, Nicole/0000-0002-7985-5604; Erpenbeck, Dirk/0000-0003-2716-1085	United States Department of Agriculture National Research Initiative [2006-35302-17149]; National Science Foundation-EID program grant [EF-0914384]	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation-EID program grant	This research was supported by United States Department of Agriculture National Research Initiative 2006-35302-17149 to ONB, www.usda.gov, and by National Science Foundation-EID program grant EF-0914384 to MBT and AFR, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bayoh MN, 2001, THESIS U DURHAM; Beaty B.J., 1996, BIOL DIS VECTORS; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Centers for Disease Control and Prevention (CDC), 2012, MAL FACTS; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Clements AN., 1992, BIOL MOSQUITOES DEV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Mukiama TK, 1989, FIELD STUDIES LARVAL; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; NISBET RM, 1983, THEOR POPUL BIOL, V23, P114, DOI 10.1016/0040-5809(83)90008-4; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2009, ENV HLTH PERSPECT, V118; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; REISEN WK, 1975, MOSQ NEWS, V35, P473; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Ross R., 1910, PREVENTION MALARIA; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201; [No title captured]	60	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79276	10.1371/journal.pone.0079276	http://dx.doi.org/10.1371/journal.pone.0079276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24098416	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800053
J	Cunningham, SJ; Kruger, AC; Nxumalo, MP; Hockey, PAR				Cunningham, Susan J.; Kruger, Andries C.; Nxumalo, Mthobisi P.; Hockey, Philip A. R.			Identifying Biologically Meaningful Hot-Weather Events Using Threshold Temperatures That Affect Life-History	PLOS ONE			English	Article							CLIMATE-CHANGE; MORTALITY; EXTREMES; FITNESS; RANGE; BIRDS	Increases in the frequency, duration and intensity of heat waves are frequently evoked in climate change predictions. However, there is no universal definition of a heat wave. Recent, intense hot weather events have caused mass mortalities of birds, bats and even humans, making the definition and prediction of heat wave events that have the potential to impact populations of different species an urgent priority. One possible technique for defining biologically meaningful heat waves is to use threshold temperatures (T-thresh) above which known fitness costs are incurred by species of interest. We set out to test the utility of this technique using T-thresh values that, when exceeded, affect aspects of the fitness of two focal southern African bird species: the southern pied babbler Turdiodes bicolor (T-thresh = 35.5 degrees C) and the common fiscal Lanius collaris (T-thresh = 33 degrees C). We used these T-thresh values to analyse trends in the frequency, duration and intensity of heat waves of magnitude relevant to the focal species, as well as the annual number of hot days (maximum air temperature > T-thresh), in north-western South Africa between 1961 and 2010. Using this technique, we were able to show that, while all heat wave indices increased during the study period, most rapid increases for both species were in the annual number of hot days and in the maximum intensity (and therefore intensity variance) of biologically meaningful heat waves. Importantly, we also showed that warming trends were not uniform across the study area and that geographical patterns in warming allowed both areas of high risk and potential climate refugia to be identified. We discuss the implications of the trends we found for our focal species, and the utility of the T-thresh technique as a conservation tool.	[Cunningham, Susan J.; Hockey, Philip A. R.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Kruger, Andries C.; Nxumalo, Mthobisi P.] South African Weather Serv, Climate Serv, Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; South African Weather Service (SAWS)	Cunningham, SJ (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa.	susie.j.c@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	DST/NRF Centre of Excellence grant	DST/NRF Centre of Excellence grant(Department of Science & Technology (India))	The work was supported by DST/NRF Centre of Excellence grant to PARH and SJC. www.fitzpatrick.uct.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoon I., 2011, S AFRICAN RISK VULNE; Angert AL, 2011, INTEGR COMP BIOL, V51, P733, DOI 10.1093/icb/icr048; Angilletta MJ, 2011, INTEGR COMP BIOL, V51, P653, DOI 10.1093/icb/icr091; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Calder W.A., 1974, AVIAN BIOL, V4, P259; Cunningham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074613; Dean W. R. J., 2005, ROBERTS BIRDS SO AFR, P811; Donald PF, 2012, J ORNITHOL, V153, P1031, DOI 10.1007/s10336-012-0832-4; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; FINLAYSON H. H., 1932, SO AUSTRALIAN ORNITHOL, V11, P158; Harrison J. A., 1997, ATLAS SO AFRICAN BIR, VII; Herremans M, 1997, ATLAS SO AFRICAN BIR, V2, P128; Immelmann K., 1973, P121; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Klein Tank A.M.G., 2009, 72 WCDMP, P49; Kruger AC, 2013, INT J CLIMATOL, V33, P661, DOI 10.1002/joc.3455; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; McKechnie AE, 2012, EMU, V112, pI, DOI 10.1071/MUv112n2_ED; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moise AF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009250; Moses MR, 2012, OECOLOGIA, V168, P257, DOI 10.1007/s00442-011-2073-2; New M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006289; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Towie N, 2009, 1000 BIRDS DIE SWELT; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wolf BO, 1996, J EXP BIOL, V199, P451; [No title captured]	35	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82492	10.1371/journal.pone.0082492	http://dx.doi.org/10.1371/journal.pone.0082492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24244601	Green Published, gold, Green Submitted			2022-12-27	WOS:000327949300156
J	Cheng, XB; Sato, N; Kohi, S; Yamaguchi, K				Cheng, Xiao-Bo; Sato, Norihiro; Kohi, Shiro; Yamaguchi, Koji			Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							PROSTATE-CANCER; TUMOR MICROENVIRONMENT; BREAST-CANCER; EXPRESSION; BIOMARKERS; CELLS; HYAL1; CARCINOMAS; PROGRESSION; SYNTHASES	Background: Although pancreatic ductal adenocarcinoma is characterized by an abundant stroma enriched with hyaluronan (HA), the prognostic impact of HA and its regulators remains unknown. Methods: Using immunohistochemistry, expression patterns of HA and its regulators, including a synthesizing enzyme (HAS2), and a degrading enzyme (HYAL1) were investigated in patients who received surgical resection. The prognostic significance of these markers and other clinicopathological variables was determined using univariate and multivariate analyses. The HA levels were determined quantitatively by enzyme-linked immunosorbent assay (ELISA). Results: We found that strong expressions of HA (P=0.008) and HAS2 (P=0.022) were significantly associated with shorter survival time after surgery. By contrast, weak expression of HYAL1 was significantly associated with poor survival (P=0.001). In multivariate analysis, tumor stage (hazard ratio (HR)=2.76, 95% confidence interval (CI): 1.14-6.66 P=0.024), strong HA expression (HR=6.04, 95% CI: 1.42-25.69 P=0.015), and weak HYAL1 expression (HR=3.16, 95% CI: 1.19-8.40 P=0.021) were independent factors predicting poor survival. ELISA revealed higher concentration of HA in pancreatic cancer tissues than in normal pancreatic tissues (P=0.001). Conclusion: These findings suggest, for the first time, that HA and its regulators may have prognostic impact in patients with pancreatic cancer.	[Cheng, Xiao-Bo; Sato, Norihiro; Kohi, Shiro; Yamaguchi, Koji] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan; [Cheng, Xiao-Bo] China Med Univ, Affiliated Hosp 4, Dept Breast Surg, Shenyang, Peoples R China	University of Occupational & Environmental Health - Japan; China Medical University	Sato, N (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan.	norisato@med.uoeh-u.ac.jp			Pancreas Research Foundation of Japan	Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	The study was supported by a grant from the Pancreas Research Foundation of Japan (http://www.jprf.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; Assmann V, 1996, CLIN CANCER RES, V2, P1607; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Erkan M., 2010, Experimental Oncology, V32, P128; FRIES H, 1994, VIRCHOWS ARCH, V424, P7; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; MAHLBACHER V, 1992, EUR J CELL BIOL, V58, P28; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Nykopp TK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-143; Posey JT, 2003, CANCER RES, V63, P2638; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ropponen K, 1998, CANCER RES, V58, P342; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Setala LP, 1997, BRIT J CANCER, V79, P1133; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Tan JX, 2011, INT J CANCER, V128, P1303, DOI 10.1002/ijc.25460; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192	31	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80765	10.1371/journal.pone.0080765	http://dx.doi.org/10.1371/journal.pone.0080765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244714	gold, Green Published, Green Submitted			2022-12-27	WOS:000327221600216
J	Muller, L; Goncalves, GL; Cordeiro-Estrela, P; Marinho, JR; Althoff, SL; Testoni, AF; Gonzalez, EM; Freitas, TRO				Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Marinho, Jorge R.; Althoff, Sergio L.; Testoni, Andre F.; Gonzalez, Enrique M.; Freitas, Thales R. O.			DNA Barcoding of Sigmodontine Rodents: Identifying Wildlife Reservoirs of Zoonoses	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; TRYPANOSOMA-CRUZI; SPECIES DELIMITATION; DELTAMYS-KEMPI; HANTAVIRUS; GENUS; TRANSMISSION; CRICETIDAE; MAMMALS; AREAS	Species identification through DNA barcoding is a tool to be added to taxonomic procedures, once it has been validated. Applying barcoding techniques in public health would aid in the identification and correct delimitation of the distribution of rodents from the subfamily Sigmodontinae. These rodents are reservoirs of etiological agents of zoonoses including arenaviruses, hantaviruses, Chagas disease and leishmaniasis. In this study we compared distance-based and probabilistic phylogenetic inference methods to evaluate the performance of cytochrome c oxidase subunit I (COI) in sigmodontine identification. A total of 130 sequences from 21 field-trapped species (13 genera), mainly from southern Brazil, were generated and analyzed, together with 58 GenBank sequences (24 species; 10 genera). Preliminary analysis revealed a 9.5% rate of misidentifications in the field, mainly of juveniles, which were reclassified after examination of external morphological characters and chromosome numbers. Distance and model-based methods of tree reconstruction retrieved similar topologies and monophyly for most species. Kernel density estimation of the distance distribution showed a clear barcoding gap with overlapping of intraspecific and interspecific densities < 1% and 21 species with mean intraspecific distance < 2%. Five species that are reservoirs of hantaviruses could be identified through DNA barcodes. Additionally, we provide information for the description of a putative new species, as well as the first COI sequence of the recently described genus Drymoreomys. The data also indicated an expansion of the distribution of Calomys tener. We emphasize that DNA barcoding should be used in combination with other taxonomic and systematic procedures in an integrative framework and based on properly identified museum collections, to improve identification procedures, especially in epidemiological surveillance and ecological assessments.	[Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil; [Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Cordeiro-Estrela, Pedro] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, Brazil; [Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Dept Sistemat & Ecol, Lab Mamiferos, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Marinho, Jorge R.] Univ Reg Integrada Alto Uruguai & Missoes, Erechim, RS, Brazil; [Althoff, Sergio L.; Testoni, Andre F.] Fundacao Univ Reg Blumenau, Blumenau, SC, Brazil; [Gonzalez, Enrique M.] Museo Nacl Hist Nat, Montevideo, Uruguay	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Universidade Federal da Paraiba; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Regional de Blumenau (FURB)	Cordeiro-Estrela, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil.	pedroestrela@yahoo.com	Goncalves, Gislene Lopes/D-3567-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012; Köstler, Herbert/B-2089-2010; Nichols, Thomas E./N-9902-2017; Althoff, Sérgio Luiz/AAE-5820-2020; Cordeiro-Estrela, Pedro/A-2913-2015; Marinho, Jorge/AAC-1097-2019	Goncalves, Gislene Lopes/0000-0002-1459-4888; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Köstler, Herbert/0000-0001-6207-9226; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Cordeiro-Estrela, Pedro/0000-0003-3383-571X; Testoni, Andre Filipe/0000-0002-4680-0092	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES-CNPq-PROTAX; PDJ CNPq FIOCRUZ [500091/2010-2]; CNPq [141604/2007-7]; BrBOL: Brazilian Barcoding of Life under project Tetrapoda	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-CNPq-PROTAX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDJ CNPq FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BrBOL: Brazilian Barcoding of Life under project Tetrapoda	This research was financially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). PCE was funded by CAPES-CNPq-PROTAX and by PDJ CNPq FIOCRUZ 500091/2010-2. G. L. Goncalves received CNPq fellowship (141604/2007-7). This study was supported by BrBOL: Brazilian Barcoding of Life under project Tetrapoda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrellos R, 2012, ZOOTAXA, P1; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Badzinski C, 2012, CHECK LIST, V8, P264, DOI DOI 10.15560/8.2.264; Bonvicino CR, 2010, ZOOTAXA, P19, DOI 10.11646/zootaxa.2336.1.2; Bonvicino CR, 2008, GUIA ROEDORES BRASIL; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Castro E.C., 1991, Cytobios, V68, P153; Chu YK, 2006, AM J TROP MED HYG, V75, P1127, DOI 10.4269/ajtmh.2006.75.1127; Chu YK, 2009, EMERG INFECT DIS, V15, P1977, DOI 10.3201/eid1512.090338; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; de Oliveira JA, 2002, ACTA THERIOL, V47, P307, DOI 10.1007/BF03194149; de Oliveira RC, 2012, MEM I OSWALDO CRUZ, V107, P424, DOI 10.1590/S0074-02762012000300020; DEFRONZA TMLG, 1981, CARYOLOGIA, V34, P457, DOI 10.1080/00087114.1981.10796914; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Doyle J. J., 1987, PHYTOCHEM B, P11; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Firth C, 2012, J VIROL, V86, P13756, DOI 10.1128/JVI.02341-12; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goncalves Pablo Rodrigues, 2007, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Goncalves PR, 2005, MAMM BIOL, V70, P46, DOI 10.1078/1616-5047-00175; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag T, 2007, J MAMMAL, V88, P769, DOI 10.1644/05-MAMM-A-319R1.1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Ittig REG, 2004, HEREDITY, V93, P535, DOI 10.1038/sj.hdy.6800546; Jayat J. Pablo, 2010, Zootaxa, V2409, P1; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P522, DOI 10.1073/pnas.77.1.522; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Nylander J.A.A., 2004, MRAIC PL; Oliveira RC, 2011, VECTOR-BORNE ZOONOT, V3, P301; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Percequillo AR, 2008, AM MUS NOVIT, P1, DOI 10.1206/495.1; Percequillo AR, 2005, J MAMMAL, V86, P873, DOI 10.1644/1545-1542(2005)86[873:ANSONI]2.0.CO;2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porcasi Ximena, 2005, Mastozool. neotrop., V12, P199; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raboni SM, 2012, AM J TROP MED HYG, V87, P371, DOI 10.4269/ajtmh.2012.11-0762; Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0; Rambaut A., 2009, FIGTREE TREE FIGURE; Rivera PC, 2007, ZOOL SCR, V36, P231, DOI 10.1111/j.1463-6409.2007.00273.x; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Rocha Rita G., 2011, Zootaxa, V2789, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Salazar-Bravo J, 2002, INFECT GENET EVOL, V1, P191, DOI 10.1016/S1567-1348(02)00026-6; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SBALQUEIRO IJ, 1984, CYTOGENET CELL GENET, V38, P50, DOI 10.1159/000132029; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith Margaret F., 1999, Journal of Mammalian Evolution, V6, P89, DOI 10.1023/A:1020668004578; Stahls G, 2008, MOL PHYLOGENET EVOL, V46, P82, DOI 10.1016/j.ympev.2007.09.009; Steiner-Souza F, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1824.1.3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; da Rosa EST, 2012, EMERG INFECT DIS, V18, P982, DOI 10.3201/eid1806.110948; Ventura K, 2011, CYTOGENET GENOME RES, V135, P126, DOI 10.1159/000331584; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	73	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80282	10.1371/journal.pone.0080282	http://dx.doi.org/10.1371/journal.pone.0080282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24040262	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600200
J	Suarez-Rubio, M; Wilson, S; Leimgruber, P; Lookingbill, T				Suarez-Rubio, Marcela; Wilson, Scott; Leimgruber, Peter; Lookingbill, Todd			Threshold Responses of Forest Birds to Landscape Changes around Exurban Development	PLOS ONE			English	Article							POPULATION-CHANGE; UNITED-STATES; RESIDENTIAL DEVELOPMENT; HABITAT FRAGMENTATION; RELATIVE IMPORTANCE; SPECIES RICHNESS; COMMUNITIES; PATTERNS; CONSERVATION; TRENDS	Low-density residential development (i.e., exurban development) is often embedded within a matrix of protected areas and natural amenities, raising concern about its ecological consequences. Forest-dependent species are particularly susceptible to human settlement even at low housing densities typical of exurban areas. However, few studies have examined the response of forest birds to this increasingly common form of land conversion. The aim of this study was to assess whether, how, and at what scale forest birds respond to changes in habitat due to exurban growth. We evaluated changes in habitat composition (amount) and configuration (arrangement) for forest and forest-edge species around North America Breeding Bird Survey (BBS) stops between 1986 and 2009. We used Threshold Indicator Taxa Analysis to detect change points in species occurrence at two spatial extents (400-m and 1-km radius buffer). Our results show that exurban development reduced forest cover and increased habitat fragmentation around BBS stops. Forest birds responded nonlinearly to most measures of habitat loss and fragmentation at both the local and landscape extents. However, the strength and even direction of the response changed with the extent for several of the metrics. The majority of forest birds' responses could be predicted by their habitat preferences indicating that management practices in exurban areas might target the maintenance of forested habitats, for example through easements or more focused management for birds within existing or new protected areas.	[Suarez-Rubio, Marcela] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA; [Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Lookingbill, Todd] Univ Richmond, Dept Geog & Environm, Richmond, VA 23173 USA	University System of Maryland; University of Maryland Center for Environmental Science; Environment & Climate Change Canada; Canadian Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Richmond	Suarez-Rubio, M (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA.	marcela.suarezrubio@boku.ac.at	Wilson, Scott/AAC-7144-2021; Leimgruber, Peter/O-1304-2015; NUNEZ-PENA, MARIA ISABEL/B-3883-2011; Suarez Pellicioni, Macarena/H-5527-2015; colome, angels/H-2522-2015	Leimgruber, Peter/0000-0002-3682-0153; Lookingbill, Todd/0000-0003-4946-6429; NUNEZ-PENA, MARIA ISABEL/0000-0002-3677-859X; Suarez Pellicioni, Macarena/0000-0002-9056-9561; Suarez-Rubio, Marcela/0000-0002-0596-2626; colome, angels/0000-0002-2976-1853	Appalachian Laboratory, University of Maryland Center for Environmental Science	Appalachian Laboratory, University of Maryland Center for Environmental Science	This work was supported by Appalachian Laboratory, University of Maryland Center for Environmental Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], BIRDS N AM ONLINE; ASKINS RA, 1995, SCIENCE, V267, P1956, DOI 10.1126/science.267.5206.1956; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; BURNLEY IH, 1995, J PLAN EDUC RES, V14, P245, DOI 10.1177/0739456X9501400402; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chace JF, 2003, LANDSCAPE URBAN PLAN, V64, P179, DOI 10.1016/S0169-2046(02)00220-7; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Dauphine N, 2009, IMPACTS FREE RANGING, P205; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; ENGELS TM, 1994, CONSERV BIOL, V8, P286, DOI 10.1046/j.1523-1739.1994.08010286.x; Engle David M., 1999, Great Plains Research, V9, P55; Erskine AJ, 1978, CANADIAN WILDLIFE SE, V42, P1; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans M, 2011, BIRDS N AM ONLINE; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fraterrigo JM, 2005, LANDSCAPE URBAN PLAN, V71, P263, DOI 10.1016/S0169-2046(04)00080-5; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd; Graber JW, 1985, BIOL NOTES; Greenlaw JS, 1996, E TOWHEE PIPILO ERYT; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; HAGAN JM, 1993, AUK, V110, P863; Halkin SL, 1999, BIRDS N AM ONLINE; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; HILL SR, 1988, AM MIDL NAT, V120, P313, DOI 10.2307/2426003; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hunt PD, 1998, CONSERV BIOL, V12, P1377, DOI 10.1046/j.1523-1739.1998.97005.x; Jones KB, 2000, ENVIRON MONIT ASSESS, V63, P159, DOI 10.1023/A:1006415029890; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kim KK, 2005, GROWTH CHANGE, V36, P273, DOI 10.1111/j.1468-2257.2005.00277.x; Krementz DG, 2000, WILSON BULL, V112, P243, DOI 10.1676/0043-5643(2000)112[0243:BSDAMO]2.0.CO;2; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lang JD, 2002, AUK, V119, P109, DOI 10.1642/0004-8038(2002)119[0109:WTMAHU]2.0.CO;2; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mancke RG, 2000, ECOL APPL, V10, P598, DOI 10.1890/1051-0761(2000)010[0598:BBDIWE]2.0.CO;2; Marzluff John M., 2001, P19; Matlack GR, 1997, J BIOGEOGR, V24, P281, DOI 10.1046/j.1365-2699.1997.00108.x; Mazerolle DF, 2004, CAN J ZOOL, V82, P1774, DOI 10.1139/Z04-175; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McGranahan D.A., 1999, NATURAL AMENITIES DR; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merenlender AM, 2009, LANDSCAPE URBAN PLAN, V92, P255, DOI 10.1016/j.landurbplan.2009.05.004; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; PETERJOHN PG, 1994, WILDLIFE SOC B, V22, P155; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; R Core Team, 2021, R LANGUAGE ENV STAT; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robbins C.S., 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sauer JR, 1995, MONITORING BIRD POPU, P151; Sherry TW, 1997, BIRDS N AM; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith RJ, 2011, BIRDS N AM ONLINE; Smith WB, 2004, FOREST RESOURCES US; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Struyk RJ, 1996, HOUSING STUD, V11, P233, DOI 10.1080/02673039608720854; Suarez-Rubio M, 2012, REMOTE SENS ENVIRON, V124, P360, DOI 10.1016/j.rse.2012.03.029; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Theobald DM, 2005, ECOL SOC, V10; U.S. NABCI Committee, 2009, STAT BIRDS; US Census Bureau, 2010, STAT COUNT QUICK FAC; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; van den Berg L, 2000, LANDSCAPE URBAN PLAN, V48, P169, DOI 10.1016/S0169-2046(00)00040-2; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wakamiya SW, 2012, NATURAL RESOURCE DAT; Weeks Jr HP, 2011, E PHOEBE SAYORNIS PH; Weldon Cooper Center, 2010, FIN 2008 PROV 2009 P; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	104	39	40	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67593	10.1371/journal.pone.0067593	http://dx.doi.org/10.1371/journal.pone.0067593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826325	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400161
J	Cunningham, SJ; Corfield, JR; Iwaniuk, AN; Castro, I; Alley, MR; Birkhead, TR; Parsons, S				Cunningham, Susan J.; Corfield, Jeremy R.; Iwaniuk, Andrew N.; Castro, Isabel; Alley, Maurice R.; Birkhead, Tim R.; Parsons, Stuart			The Anatomy of the bill Tip of Kiwi and Associated Somatosensory Regions of the Brain: Comparisons with Shorebirds	PLOS ONE			English	Article							ANAS-PLATYRHYNCHOS L; OYSTERCATCHERS HAEMATOPUS-OSTRALEGUS; NUCLEUS BASALIS PROSENCEPHALI; PIGEON COLUMBA-LIVIA; TRIGEMINAL SYSTEM; FORAGING BEHAVIOR; PREY-DETECTION; FRONTAL TELENCEPHALON; SENSORY PROJECTIONS; PRIMARY AFFERENTS	Three families of probe-foraging birds, Scolopacidae (sandpipers and snipes), Apterygidae (kiwi), and Threskiornithidae (ibises, including spoonbills) have independently evolved long, narrow bills containing clusters of vibration-sensitive mechanoreceptors (Herbst corpuscles) within pits in the bill-tip. These 'bill-tip organs' allow birds to detect buried or submerged prey via substrate-borne vibrations and/or interstitial pressure gradients. Shorebirds, kiwi and ibises are only distantly related, with the phylogenetic divide between kiwi and the other two taxa being particularly deep. We compared the bill-tip structure and associated somatosensory regions in the brains of kiwi and shorebirds to understand the degree of convergence of these systems between the two taxa. For comparison, we also included data from other taxa including waterfowl (Anatidae) and parrots (Psittaculidae and Cacatuidae), non-apterygid ratites, and other probe-foraging and non probe-foraging birds including non-scolopacid shorebirds (Charadriidae, Haematopodidae, Recurvirostridae and Sternidae). We show that the bill-tip organ structure was broadly similar between the Apterygidae and Scolopacidae, however some inter-specific variation was found in the number, shape and orientation of sensory pits between the two groups. Kiwi, scolopacid shorebirds, waterfowl and parrots all shared hypertrophy or near-hypertrophy of the principal sensory trigeminal nucleus. Hypertrophy of the nucleus basorostralis, however, occurred only in waterfowl, kiwi, three of the scolopacid species examined and a species of oystercatcher (Charadriiformes: Haematopodidae). Hypertrophy of the principal sensory trigeminal nucleus in kiwi, Scolopacidae, and other tactile specialists appears to have co-evolved alongside bill-tip specializations, whereas hypertrophy of nucleus basorostralis may be influenced to a greater extent by other sensory inputs. We suggest that similarities between kiwi and scolopacid bill-tip organs and associated somatosensory brain regions are likely a result of similar ecological selective pressures, with inter-specific variations reflecting finer-scale niche differentiation.	[Cunningham, Susan J.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Cunningham, Susan J.; Castro, Isabel] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand; [Corfield, Jeremy R.; Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Alley, Maurice R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Corfield, Jeremy R.; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	National Research Foundation - South Africa; University of Cape Town; Massey University; University of Lethbridge; Massey University; University of Sheffield; University of Auckland	Corfield, JR (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	jr.corfield@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	NSERC Discovery Grant [372237]; Tertiary Education Commission New Zealand grant;  [380284-2009]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tertiary Education Commission New Zealand grant; 	Funding for this study was provided in part by an NSERC Discovery Grant (372237) and Accelerator Supplement (380284-2009) to ANI and in part through a Tertiary Education Commission New Zealand grant to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JJA, 1984, NEUROSCIENCE, V13, P781, DOI 10.1016/0306-4522(84)90096-4; ARENDS JJA, 1986, BRAIN RES, V398, P375, DOI 10.1016/0006-8993(86)91499-X; Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BANG BG, 1968, AUK, V85, P55; Barbosa A, 1999, AUK, V116, P712; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BERKHOUDT H, 1981, J COMP NEUROL, V196, P407, DOI 10.1002/cne.901960305; BERKHOUDT H, 1980, NETH J ZOOL, V30, P1; BOATES JS, 1992, CAN J ZOOL, V70, P2398, DOI 10.1139/z92-321; BOATES JS, 1989, CAN J ZOOL, V67, P2225, DOI 10.1139/z89-314; BOIRE D, 1989, COMP QUANTITATIVE EN; BOLZE G, 1968, Zoologischer Anzeiger, V181, P313; Corfield J, 2008, AUK, V125, P326, DOI 10.1525/auk.2008.06234; Corfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023771; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; Corfield JR, 2012, JARO-J ASSOC RES OTO, V13, P629, DOI 10.1007/s10162-012-0341-4; Craigie EH, 1940, J COMP NEUROL, V73, P179, DOI 10.1002/cne.900730202; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; Cramp S., 1983, BIRDS W PALEARCTIC, V3, P444; Cunningham S, 2007, J ANAT, V211, P493, DOI 10.1111/j.1469-7580.2007.00786.x; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Cunningham SJ, 2010, J AVIAN BIOL, V41, P350, DOI 10.1111/j.1600-048X.2010.05138.x; Cunningham SJ, 2010, AUK, V127, P308, DOI 10.1525/auk.2009.09117; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; DELIUS JD, 1979, EXP NEUROL, V63, P594, DOI 10.1016/0014-4886(79)90174-2; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DUBBELDAM JL, 1978, J COMP NEUROL, V180, P661, DOI 10.1002/cne.901800402; DUBBELDAM JL, 1980, J COMP NEUROL, V191, P557, DOI 10.1002/cne.901910404; DUBBELDAM JL, 1990, NETH J ZOOL, V40, P241; Dubbeldam JL, 1998, ARCH PHYSIOL BIOCHEM, V106, P338, DOI 10.1076/apab.106.5.338.4367; DUBBELDAM JL, 1981, J COMP NEUROL, V196, P391, DOI 10.1002/cne.901960304; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; FUNKE K, 1989, EXP BRAIN RES, V76, P603, DOI 10.1007/BF00248917; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GERRITSEN AFC, 1986, NETH J ZOOL, V36, P530, DOI 10.1163/002829686X00216; Gill F, 2013, IOC WORLD BIRD LIST; Gooders J, 1982, COLLINS BRIT BIRDS; Gottschaldt K.-M., 1985, P375; GOTTSCHALDT KM, 1974, CELL TISSUE RES, V153, P477; Goujon D, 1869, J ANAT PHYSL, V6, P449; Gutierrez-Ibanez C, 2011, BRAIN BEHAV EVOLUT, V78, P286, DOI 10.1159/000330359; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HALL WS, 1993, BRAIN BEHAV EVOLUT, V41, P97, DOI 10.1159/000113827; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Heather B., 2005, FIELD GUIDE BIRDS NZ; IGGO A, 1974, P153; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; Jerison HJ., 1973, EVOLUTION BRAIN INTE; KEPPIE DM, 1994, BIRDS N AM NUMBER 10; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Maddison WP, 2011, MESQUITE MODULAR SYS; MAEKAWA M, 1987, HEARING RES, V27, P231, DOI 10.1016/0378-5955(87)90004-9; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martin GR, 2009, P ROY SOC B-BIOL SCI, V276, P437, DOI 10.1098/rspb.2008.1110; Midford P. E., 2010, PDAP PDTREE PACKAGE; MOURITSEN KN, 1994, J AVIAN BIOL, V25, P55, DOI 10.2307/3677294; Nebel S, 2005, ECOL RES, V20, P503, DOI 10.1007/s11284-005-0061-x; Nisbet I.C, 2002, COMMON TERN STERNA H; PETTIGREW JD, 1985, BRAIN BEHAV EVOLUT, V26, P185, DOI 10.1159/000118775; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Piersma T, 1996, HDB BIRDS WORLD, V3, P444; Piersma T, 2011, IBIS, V153, P659, DOI 10.1111/j.1474-919X.2011.01170.x; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RASBAND WS, 1997, MAGEJ; SANTOS ESA, 2010, SO LAPWING VANELLUS; SCHALL U, 1986, CELL TISSUE RES, V245, P539; STINGELI.W, 1965, BIBL ANAT, P1; Swennen Cornelis, 2004, Ornithological Science, V3, P119, DOI 10.2326/osj.3.119; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Tuckwell J, 1997, CAN J ZOOL, V75, P170, DOI 10.1139/z97-024; Ward BJ, 2012, BIOL LETTERS, V8, P657, DOI 10.1098/rsbl.2011.1180; Wild JM, 2008, J COMP NEUROL, V509, P156, DOI 10.1002/cne.21731; Wild JM, 1996, J COMP NEUROL, V368, P136, DOI 10.1002/(SICI)1096-9861(19960422)368:1<136::AID-CNE9>3.0.CO;2-4; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; WILD JM, 1987, BRAIN RES, V412, P205; WILD JM, 1985, J COMP NEUROL, V234, P441, DOI 10.1002/cne.902340404; Wild JM, 2001, BRAIN BEHAV EVOLUT, V57, P39, DOI 10.1159/000047225; WILD JM, 1981, J COMP NEUROL, V203, P351, DOI 10.1002/cne.902030304; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; WITKOVSKY P, 1973, J COMP NEUROL, V147, P119, DOI 10.1002/cne.901470106; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zweers G.A, 1977, Contributions vert. Evol., V3, P1; Zweers GA, 1997, NETH J ZOOL, V47, P161, DOI 10.1163/156854297X00166	92	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80036	10.1371/journal.pone.0080036	http://dx.doi.org/10.1371/journal.pone.0080036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244601	Green Published, Green Accepted, gold			2022-12-27	WOS:000327143800110
J	Zeller, M; Muller, A; Gutberlet, M; Nichols, T; Hahn, D; Kostler, H; Bartsch, AJ				Zeller, Mario; Mueller, Alexander; Gutberlet, Marcel; Nichols, Thomas; Hahn, Dietbert; Koestler, Herbert; Bartsch, Andreas J.			Boosting BOLD fMRI by K-Space Density Weighted Echo Planar Imaging	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; TO-NOISE RATIO; PHYSIOLOGICAL NOISE; GEOMETRIC DISTORTION; BLOOD OXYGENATION; SIGNAL CHANGES; TIME-SERIES; HUMAN BRAIN; RESONANCE; ROBUST	Functional magnetic resonance imaging (fMRI) has become a powerful and influential method to non-invasively study neuronal brain activity. For this purpose, the blood oxygenation level-dependent (BOLD) effect is most widely used. T-2* weighted echo planar imaging (EPI) is BOLD sensitive and the prevailing fMRI acquisition technique. Here, we present an alternative to its standard Cartesian recordings, i.e. k-space density weighted EPI, which is expected to increase the signal-to-noise ratio in fMRI data. Based on in vitro and in vivo pilot measurements, we show that fMRI by k-space density weighted EPI is feasible and that this new acquisition technique in fact boosted spatial and temporal SNR as well as the detection of local fMRI activations. Spatial resolution, spatial response function and echo time were identical for density weighted and conventional Cartesian EPI. The signal-to-noise ratio gain of density weighting can improve activation detection and has the potential to further increase the sensitivity of fMRI investigations.	[Zeller, Mario; Mueller, Alexander; Hahn, Dietbert; Koestler, Herbert] Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany; [Gutberlet, Marcel] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Nichols, Thomas] Univ Warwick, Dept Stat, Warwick, England; [Nichols, Thomas; Bartsch, Andreas J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Koestler, Herbert] Univ Wurzburg, Comprehens Heart Failure Ctr, Bavaria, Germany; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany	University of Wurzburg; Hannover Medical School; University of Warwick; University of Oxford; University of Wurzburg; Ruprecht Karls University Heidelberg	Zeller, M (corresponding author), Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany.	zeller@roentgen.uni-wuerzburg.de	Goncalves, Gislene Lopes/D-3567-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012; Köstler, Herbert/B-2089-2010; Nichols, Thomas E./N-9902-2017; Althoff, Sérgio Luiz/AAE-5820-2020; Cordeiro-Estrela, Pedro/A-2913-2015; Marinho, Jorge/AAC-1097-2019	Goncalves, Gislene Lopes/0000-0002-1459-4888; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Köstler, Herbert/0000-0001-6207-9226; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Cordeiro-Estrela, Pedro/0000-0003-3383-571X; Testoni, Andre Filipe/0000-0002-4680-0092	Deutsche Forschungsgemeinschaft (dfg.de) [DFG KO 2938/3-1]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (dfg.de); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grant sponsor Deutsche Forschungsgemeinschaft (dfg.de), Grant number: DFG KO 2938/3-1. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Bartsch AJ, 2006, J MAGN RESON IMAGING, V23, P921, DOI 10.1002/jmri.20579; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clare S, 2001, MAGNET RESON MED, V45, P930, DOI 10.1002/mrm.1124; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; Feinberg DA, 2002, MAGN RESON MED, V48, P1, DOI 10.1002/mrm.10227; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fujita N, 2001, MAGN RESON MED, V46, P723, DOI 10.1002/mrm.1251; Geier OM, 2007, MAGN RESON MATER PHY, V20, P19, DOI 10.1007/s10334-006-0065-8; Greiser A, 2003, MAGN RESON MED, V50, P1266, DOI 10.1002/mrm.10647; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gutberlet M, 2010, MAGN RESON IMAGING, V28, P341, DOI 10.1016/j.mri.2009.11.007; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kasper L, 2011, P INT SOC MAG RES ME, V19, P1634; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Man LC, 1997, MAGNET RESON MED, V37, P785, DOI 10.1002/mrm.1910370523; MARECI TH, 1984, J MAGN RESON, V57, P157, DOI 10.1016/0022-2364(84)90249-X; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PARKER DL, 1987, MED PHYS, V14, P640, DOI 10.1118/1.596032; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Wu GH, 2005, MAGN RESON MED, V53, P1046, DOI 10.1002/mrm.20451; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zeller M, 2012, P ESMRMB 29 ANN M, P510; Zeller M, 2014, MAGN RESON MED, V71, P1117, DOI 10.1002/mrm.24737; Zeller M, 2013, J MAGN RESON IMAGING, V37, P965, DOI 10.1002/jmri.23872; Zellhuber M, 2012, PROCEEDINGS OF THE ASME TURBO EXPO 2012, VOL 2, PTS A AND B, P243	53	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74501	10.1371/journal.pone.0074501	http://dx.doi.org/10.1371/journal.pone.0074501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040262	gold, Green Published, Green Submitted			2022-12-27	WOS:000327538600096
J	Zhang, C; Kong, LX; Liu, Q; Lei, X; Zhu, T; Yin, J; Lin, BR; Deng, ZX; You, DL				Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Lin, Birun; Deng, Zixin; You, Delin			In Vitro Characterization of Echinomycin Biosynthesis: Formation and Hydroxylation of L-Tryptophanyl-S-Enzyme and Oxidation of (2S,3S) beta- Hydroxytryptophan	PLOS ONE			English	Article							MBTH-LIKE PROTEINS; ESCHERICHIA-COLI; CROSS-TALK; ANTIBIOTICS; GENE; 2,3-DIOXYGENASE; THIOCORALINE; ACID; ADENYLATION; SEQUENCE	Quinoxaline-2-carboxylic acid (QXC) and 3-hydroxyquinaldic acid (HQA) feature in quinomycin family and confer anticancer activity. In light of the significant potency against cancer, the biosynthetic gene clusters have been reported from many different Streptomyces strains, and the biosynthetic pathway were proposed mainly based on the in vivo feeding experiment with isotope labeled putative intermediates. Herein we report another gene cluster from Streptomyces griseovariabilis subsp. bandungensis subsp. nov responsible for the biosynthesis of echinomycin (a member of quinomycin family, also named quinomycin A) and presented in vitro evidence to corroborate the previous hypothesis on QXC biosynthesis, showing that only with the assistance of a MbtH-like protein Qui5, did the didomain NRPS protein (Qui18) perform the loading of a L-tryptophan onto its own PCP domain. Particularly, it was found that Qui5 and Qui18 subunits form a functional tetramer through size exclusion chromatography. The subsequent hydroxylation on beta-carbon of the loaded L-tryptophan proved in vitro to be completed by cytochrome P450-dependent hydroxylase Qui15. Importantly, only the Qui18 loaded L-tryptophan can be hydroxylated by Qui15 and the enzyme was inactive on free L-tryptophan. Additionally, the chemically synthesized (2S,3S) b-hydroxytryptophan was detected to be converted by the tryptophan 2,3-dioxygenase Qui17 through LC-MS, which enriched our previous knowledge that tryptophan 2,3-dioxygenase nearly exclusively acted on L-tryptophan and 6-fluoro-tryptophan.	[Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lin, Birun] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangdong Academy of Agricultural Sciences	You, DL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	dlyou@sjtu.edu.cn	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	National Science Foundation of China (973 Program); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology	National Science Foundation of China (973 Program)(National Basic Research Program of ChinaNational Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 Programs), Shanghai Pujiang Program from the Shanghai Municipal Council of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESS KJ, 1994, BIOCHEMISTRY-US, V33, P12386, DOI 10.1021/bi00207a005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Furuya K, 1998, FEMS MICROBIOL LETT, V168, P243, DOI 10.1111/j.1574-6968.1998.tb13280.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HUANG CH, 1982, BIOCHEMISTRY-US, V21, P3704, DOI 10.1021/bi00258a028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koketsu K, 2006, ORG LETT, V8, P4719, DOI 10.1021/ol061738+; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Praseuth AP, 2008, BIOTECHNOL PROGR, V24, P1226, DOI 10.1002/btpr.34; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Watanabe K, 2009, CURR OPIN CHEM BIOL, V13, P189, DOI 10.1016/j.cbpa.2009.02.012; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	27	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56772	10.1371/journal.pone.0056772	http://dx.doi.org/10.1371/journal.pone.0056772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	24236209	Green Submitted, Green Published, gold			2022-12-27	WOS:000315186000044
J	Kong, J; Cooper, LAD; Wang, FS; Gao, JJ; Teodoro, G; Scarpace, L; Mikkelsen, T; Schniederjan, MJ; Moreno, CS; Saltz, JH; Brat, DJ				Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Scarpace, Lisa; Mikkelsen, Tom; Schniederjan, Matthew J.; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.			Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates	PLOS ONE			English	Article							MICROSCOPY IMAGES; NUCLEAR-STRUCTURE; CLASSIFICATION; OLIGODENDROGLIOMA; SURVIVAL; RECONSTRUCTION; SEGMENTATION; FRAMEWORK; COMPONENT; UPDATE	Pathologic review of tumor morphology in histologic sections is the traditional method for cancer classification and grading, yet human review has limitations that can result in low reproducibility and inter-observer agreement. Computerized image analysis can partially overcome these shortcomings due to its capacity to quantitatively and reproducibly measure histologic structures on a large-scale. In this paper, we present an end-to-end image analysis and data integration pipeline for large-scale morphologic analysis of pathology images and demonstrate the ability to correlate phenotypic groups with molecular data and clinical outcomes. We demonstrate our method in the context of glioblastoma (GBM), with specific focus on the degree of the oligodendroglioma component. Over 200 million nuclei in digitized pathology slides from 117 GBMs in the Cancer Genome Atlas were quantitatively analyzed, followed by multiplatform correlation of nuclear features with molecular and clinical data. For each nucleus, a Nuclear Score (NS) was calculated based on the degree of oligodendroglioma appearance, using a regression model trained from the optimal feature set. Using the frequencies of neoplastic nuclei in low and high NS intervals, we were able to cluster patients into three well-separated disease groups that contained low, medium, or high Oligodendroglioma Component (OC). We showed that machine-based classification of GBMs with high oligodendroglioma component uncovered a set of tumors with strong associations with PDGFRA amplification, proneural transcriptional class, and expression of the oligodendrocyte signature genes MBP, HOXD1, PLP1, MOBP and PDGFRA. Quantitative morphologic features within the GBMs that correlated most strongly with oligodendrocyte gene expression were high nuclear circularity and low eccentricity. These findings highlight the potential of high throughput morphologic analysis to complement and inform human-based pathologic review.	[Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Teodoro, George] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Scarpace, Lisa; Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Schniederjan, Matthew J.; Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Henry Ford Health System; Henry Ford Hospital; Emory University; Emory University	Kong, J (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	jun.kong@emory.edu	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	PHS from the Clinical and Translational Science Award Program, National Institutes of Health [UL 1RR025008]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant [P30 CA138292]	PHS from the Clinical and Translational Science Award Program, National Institutes of Health; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant	This work was supported in part by PHS Grant UL 1RR025008 from the Clinical and Translational Science Award Program, National Institutes of Health, Contract No. HHSN261200800001E from the National Cancer Institute, National Institutes of Health, the Georgia Cancer Coalition, and the Winship Cancer Institute Cancer Center Support Grant P30 CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cooper LAD, 2012, J AM MED INFORM ASSN, V19, P317, DOI 10.1136/amiajnl-2011-000700; Cooper LAD, 2011, I S BIOMED IMAGING, P1624, DOI 10.1109/ISBI.2011.5872714; Cooper LAD, 2010, IEEE T BIO-MED ENG, V57, P2617, DOI 10.1109/TBME.2010.2060338; DAVID H, 2005, LINEAR RANK TESTS SU; Deb P, 2005, NEUROL INDIA, V53, P329; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FOX J, 2002, ROBUST REGRESSION; Freedman D. A., 2005, STAT MODELS THEORY P; Gupta M, 2005, AM J CLIN PATHOL, V124, P755, DOI 10.1309/6JNX4PA60TQ5U5VG; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Hu MX, 2007, LECT NOTES COMPUT SC, V4791, P68; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kong J, 2011, I S BIOMED IMAGING, P2128, DOI 10.1109/ISBI.2011.5872833; Kong J, 2011, IEEE ENG MED BIO, P6605, DOI 10.1109/IEMBS.2011.6091629; Kong J, 2011, IEEE ENG MED BIO, P87, DOI 10.1109/IEMBS.2011.6089903; Kong J, 2011, IEEE T BIO-MED ENG, V58, P3469, DOI 10.1109/TBME.2011.2169256; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *NCI, 2001, HE CANC GEN ATL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PASTORINO S, 2012, P 103 ANN M AM ASS C, V72; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Pytel P, 2009, ARCH PATHOL LAB MED, V133, P1062, DOI 10.1043/1543-2165-133.7.1062; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang W, 2011, IEEE T MED IMAGING, V30, P621, DOI 10.1109/TMI.2010.2089693; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853	40	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81049	10.1371/journal.pone.0081049	http://dx.doi.org/10.1371/journal.pone.0081049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236209	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700212
J	Becking, LE; Erpenbeck, D; Peijnenburg, KTCA; de Voogd, NJ				Becking, Leontine E.; Erpenbeck, Dirk; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.			Phylogeography of the Sponge Suberites diversicolor in Indonesia: Insights into the Evolution of Marine Lake Populations	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; HALOCARIDINA-RUBRA; LIFE-HISTORY; CORAL-REEFS; PORIFERA; BIODIVERSITY; DEMOSPONGIAE; SPECIATION; DYNAMICS; PATTERNS	The existence of multiple independently derived populations in landlocked marine lakes provides an opportunity for fundamental research into the role of isolation in population divergence and speciation in marine taxa. Marine lakes are landlocked water bodies that maintain a marine character through narrow submarine connections to the sea and could be regarded as the marine equivalents of terrestrial islands. The sponge Suberites diversicolor (Porifera: Demospongiae: Suberitidae) is typical of marine lake habitats in the Indo-Australian Archipelago. Four molecular markers (two mitochondrial and two nuclear) were employed to study genetic structure of populations within and between marine lakes in Indonesia and three coastal locations in Indonesia, Singapore and Australia. Within populations of S. diversicolor two strongly divergent lineages (A & B) (COI: p = 0.4% and ITS: p = 7.3%) were found, that may constitute cryptic species. Lineage A only occurred in Kakaban lake (East Kalimantan), while lineage B was present in all sampled populations. Within lineage B, we found low levels of genetic diversity in lakes, though there was spatial genetic population structuring. The Australian population is genetically differentiated from the Indonesian populations. Within Indonesia we did not record an East-West barrier, which has frequently been reported for other marine invertebrates. Kakaban lake is the largest and most isolated marine lake in Indonesia and contains the highest genetic diversity with genetic variants not observed elsewhere. Kakaban lake may be an area where multiple putative refugia populations have come into secondary contact, resulting in high levels of genetic diversity and a high number of endemic species.	[Becking, Leontine E.; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands; [Becking, Leontine E.] Inst Marine Resources & Ecosyst Studies IMARES, Maritime Dept, Den Helder, Netherlands; [Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	Naturalis Biodiversity Center; Wageningen University & Research; University of Munich; University of Munich; University of Amsterdam	Becking, LE (corresponding author), Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands.	lisa.becking@naturalis.nl	Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016; de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013	Peijnenburg, Katja TCA/0000-0001-7544-1079; de Voogd, Nicole/0000-0002-7985-5604; Erpenbeck, Dirk/0000-0003-2716-1085	Netherlands Organisation for Scientific Research (NWO) [817.01.008, 825.12.007]; NWO-VENI grant [863.08.024]; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation; Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO-VENI grant; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	L. Becking is supported by the Netherlands Organisation for Scientific Research (NWO) (ALW# 817.01.008; Rubicon# 825.12.007). K. Peijnenburg was supported by NWO-VENI grant #863.08.024. Fieldwork in Indonesia was made possible through additional financial support of De Beukelaar- van der Hucht Stichting, World Wildlife Foundation Netherlands-INNO Fund, the Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW), Conservation International Ecosystem Based Management program (funded by The David and Lucile Packard Foundation), the Treub-Maatschappij Fund, the Leiden University Fund (LUF)/Slingelands, Singapore Airlines, the A.M. Buitendijk Fund and the J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Arp G, 1996, RES REPORTS S, V2, P1; Azzini Francesca, 2007, V28, P157; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Bauza-Ribot MM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-221; Becking L. E., 2009, Zoologische Mededelingen (Leiden), V83, P853; Becking LE, 2013, MAR ECOL PROG SER, V481, P105, DOI 10.3354/meps10155; Becking LE, 2011, HYDROBIOLOGIA, V677, P89, DOI 10.1007/s10750-011-0742-0; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Blanquer A, 2008, MAR ECOL PROG SER, V371, P109, DOI 10.3354/meps07679; Botello A, 2010, BIOL J LINN SOC, V99, P315, DOI 10.1111/j.1095-8312.2009.01355.x; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Chombard Catherine, 1999, Memoirs of the Queensland Museum, V44, P100; Colin P. L., 2009, MARINE ENV PALAU, P416; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Dawson M. N., 2009, ENCY ISLANDS, P603; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P679, DOI 10.1017/S0025315405011604; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; Dawson MN, 2006, JMBA GLOBAL MARINE E, V3, P26; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2005, J ZOOL SYST EVOL RES, V43, P93, DOI 10.1111/j.1439-0469.2005.00306.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GEYH MA, 1979, NATURE, V278, P441, DOI 10.1038/278441a0; Goto TV, 2011, ZOOL SCI, V28, P568, DOI 10.2108/zsj.28.568; Gotoh RO, 2009, GENES GENET SYST, V84, P287, DOI 10.1266/ggs.84.287; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hamner WM, 1998, PHYS GEOGR, V19, P175, DOI 10.1080/02723646.1998.10642647; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hoeksema Bert W., 2007, V29, P117; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lim SC, 2009, RAFFLES B ZOOL, P41; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; MAC ARTHUR ROBERT H., 1967; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Mariani S, 2005, J PLANKTON RES, V27, P249, DOI 10.1093/plankt/fbh173; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO, P378; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nuryanto A, 2009, CORAL REEFS, V28, P607, DOI 10.1007/s00338-009-0483-y; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRONZATO R, 1994, B ZOOL, V61, P395, DOI 10.1080/11250009409355912; Rambaut A., 2007, TRACER V1 4; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Russ A, 2010, REV BIOL TROP, V58, P159; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Santos SR, 2011, HYDROBIOLOGIA, V677, P53, DOI 10.1007/s10750-010-0588-x; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Tomascik T, 1997, ECOLOGY INDONESIA 2, P752; Tomascik Tomas, 1994, Tropical Biodiversity, V2, P385; Uriz MJ, 2012, ADV MAR BIOL, V61, P345, DOI 10.1016/B978-0-12-387787-1.00006-4; Vogler C, 2013, CORAL REEFS, V32, P515, DOI 10.1007/s00338-012-1003-z; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Whittaker RJ, 2008, ISLAND BIOGEOGRAPHY; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	94	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75996	10.1371/journal.pone.0075996	http://dx.doi.org/10.1371/journal.pone.0075996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098416	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100034
J	Huang, LN; Liu, Y; Zhang, P; Kang, RT; Liu, Y; Li, XZ; Bo, LJ; Dong, ZM				Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming			In Vitro Dose-Dependent Inhibition of the Intracellular Spontaneous Calcium Oscillations in Developing Hippocampal Neurons by Ketamine	PLOS ONE			English	Article							REGIONAL EXPRESSION; CA2+ OSCILLATIONS; NMDA RECEPTORS; RAT; NEUROTOXICITY; INVOLVEMENT; MECHANISMS; GABA(A); CHANNEL; BRAIN	Spatial and temporal abnormalities in the frequency and amplitude of the cytosolic calcium oscillations can impact the normal physiological functions of neuronal cells. Recent studies have shown that ketamine can affect the growth and development and even induce the apoptotic death of neurons. This study used isolated developing hippocampal neurons as its study subjects to observe the effect of ketamine on the intracellular calcium oscillations in developing hippocampal neurons and to further explore its underlying mechanism using Fluo-4-loaded laser scanning confocal microscopy. Using a semi-quantitative method to analyze the spontaneous calcium oscillatory activities, a typical type of calcium oscillation was observed in developing hippocampal neurons. In addition, the administration of NMDA (N-Methyl-D-aspartate) at a concentration of 100 mu M increased the calcium oscillation amplitude. The administration of MK801 at a concentration of 40 mu M inhibited the amplitude and frequency of the calcium oscillations. Our results demonstrated that an increase in the ketamine concentration, starting from 30 mu M, gradually decreased the neuronal calcium oscillation amplitude. The inhibition of the calcium oscillation frequency by 300 mu M ketamine was statistically significant, and the neuronal calcium oscillations were completely eliminated with the administration of 3,000 mu M Ketamine. The administration of 100, 300, and 1,000 mu M NMDA to the 1 mM ketamine-pretreated hippocampal neurons restored the frequency and amplitude of the calcium oscillations in a dose-dependent manner. In fact, a concentration of 1,000 mu M NMDA completely reversed the decrease in the calcium oscillation frequency and amplitude that was induced by 1 mM ketamine. This study revealed that ketamine can inhibit the frequency and amplitude of the calcium oscillations in developing hippocampal neurons though the NMDAR (NMDA receptor) in a dose-dependent manner, which might highlight a possible underlying mechanism of ketamine toxicity on the rat hippocampal neurons during development.	[Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming] Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University	Dong, ZM (corresponding author), Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China.	dongzhenmingmzk@yahoo.com.cn		Mo, Jinhan/0000-0002-3178-6507	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society [CSA2010LB017]; Key Medicine Scientific Developing Program of Hebei Province [20110338]	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society; Key Medicine Scientific Developing Program of Hebei Province	This work was supported by Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society (CSA2010LB017) and Key Medicine Scientific Developing Program of Hebei Province (No. 20110338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Dunn RJ, 1999, J EXP BIOL, V202, P1319; Gomes LMRS, 2011, PAIN PHYSICIAN, V14, P83; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; IRIFUNE M, 1992, BRAIN RES, V596, P1, DOI 10.1016/0006-8993(92)91525-J; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; JACOBSON I, 1990, EXP BRAIN RES, V80, P409; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LIN LH, 1992, J PHARMACOL EXP THER, V263, P569; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Paupard MC, 1997, NEUROSCIENCE, V79, P399, DOI 10.1016/S0306-4522(96)00677-X; Przewlocki R, 1999, J NEUROSCI, V19, P9705; Sinner B, 2005, ANESTH ANALG, V100, P1660, DOI 10.1213/01.ANE.0000150946.18875.48; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Tang FJ, 2003, J NEUROSCI, V23, P927; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P877, DOI 10.1007/s10571-004-6927-6; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010; Zou XJ, 2009, TOXICOL SCI, V108, P149, DOI 10.1093/toxsci/kfn270	40	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59804	10.1371/journal.pone.0059804	http://dx.doi.org/10.1371/journal.pone.0059804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	24244522	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200040
J	Yu, H; Jin, HW; Sun, LD; Zhang, LR; Sun, G; Wang, ZL; Yu, YC				Yu, Hui; Jin, Hongwei; Sun, Lidan; Zhang, Liangren; Sun, Gang; Wang, Zhanli; Yu, Yongchun			Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies	PLOS ONE			English	Article							TLR7; RECOGNITION; INFECTION; PATTERNS; LIGANDS	Chemical feature based pharmacophore models were generated for Toll-like receptors 7 (TLR7) agonists using HypoGen algorithm, which is implemented in the Discovery Studio software. Several methods tools used in validation of pharmacophore model were presented. The first hypothesis Hypo1 was considered to be the best pharmacophore model, which consists of four features: one hydrogen bond acceptor, one hydrogen bond donor, and two hydrophobic features. In addition, homology modeling and molecular docking studies were employed to probe the intermolecular interactions between TLR7 and its agonists. The results further confirmed the reliability of the pharmacophore model. The obtained pharmacophore model (Hypo1) was then employed as a query to screen the Traditional Chinese Medicine Database (TCMD) for other potential lead compounds. One hit was identified as a potent TLR7 agonist, which has antiviral activity against hepatitis virus in vitro. Therefore, our current work provides confidence for the utility of the selected chemical feature based pharmacophore model to design novel TLR7 agonists with desired biological activity.	[Yu, Hui; Yu, Yongchun] Tongji Univ, Affiliated Peoples Hosp 10, Dept Lab Ctr, Shanghai 200092, Peoples R China; [Jin, Hongwei; Sun, Lidan; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Hui; Sun, Gang] Second Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China; [Wang, Zhanli] First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China	Tongji University; Peking University; Baotou Medical College; Baotou Medical College	Wang, ZL (corresponding author), First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China.	wang.zhanli@hotmail.com; yyc@tongji.edu.cn	Zhang, Liang/GWM-6088-2022; Patel, Hemal/C-7325-2019	Westenbrink, B. Daan/0000-0002-1362-7019; Patel, Hemal/0000-0001-6722-9625; van Gilst, Wiek/0000-0003-2968-8585	National Natural Science Foundation of China [20902068]; Ministry of Education of China [20090001120049]; Natural Science Foundation of Inner Mongolia Autonomous Region, China [2011BS1201]; State Key Laboratory of Natural and Biomimetic Drugs [K20110103]; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Inner Mongolia Autonomous Region, China; State Key Laboratory of Natural and Biomimetic Drugs; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	This work was supported in part by grants from the National Natural Science Foundation of China (No. 20902068), Doctoral Fund of Ministry of Education of China (No. 20090001120049), Natural Science Foundation of Inner Mongolia Autonomous Region, China (No. 2011BS1201), Project of State Key Laboratory of Natural and Biomimetic Drugs (No. K20110103), and Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2005, TRAD CHIN MED DAT TC; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHONG L, 2008, Patent No. 200805555; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; COOK A, 2008, Patent No. 2008004948; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gong J, 2010, J MOL MODEL, V16, P1283, DOI 10.1007/s00894-009-0640-9; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iavarone C, 2011, J IMMUNOL, V186, P4213, DOI 10.4049/jimmunol.1003585; JONES P, 2006, Patent No. 2006117670; JONES P, 2007, Patent No. 200709301; Jones P, 2011, BIOORG MED CHEM LETT, V21, P5939, DOI 10.1016/j.bmcl.2011.07.076; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li H, 2000, IUL BIOTECH, V2, P171; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Pryde DC, 2011, MEDCHEMCOMM, V2, P185, DOI 10.1039/c0md00197j; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TD, 2011, BIOORG MED CHEM LETT, V21, P2389, DOI 10.1016/j.bmcl.2011.02.092; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Yu H, 2012, CURR MED CHEM, V19, P1365, DOI 10.2174/092986712799462603	34	69	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56514	10.1371/journal.pone.0056514	http://dx.doi.org/10.1371/journal.pone.0056514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526932	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600005
J	Yang, Y; Wang, Q				Yang, Yong; Wang, Qi			The Earliest Fleshy Cone of Ephedra from the Early Cretaceous Yixian Formation of Northeast China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GNETALES; AGE; CHLOROPLAST; FOSSIL; MORPHOLOGY; ANGIOSPERM; DISPERSAL; DIVERSITY; PORTUGAL	Bracts of female cones of extant gymnosperm Ephedra (Joint fir) are either colorful and fleshy (section Ephedra), or dry-winged and membranous (section Alatae), or dry and coriaceous (section Asarca), which have played a crucial role in long-distance seed dispersal that is responsible for a wide distribution of the genus in semiarid and arid areas of Eurasia, North Africa, North America, and South America. Recent molecular systematic studies on Ephedra have suggested that the fleshy bracts in character evolution may be plesiomorphic relative to the dry, membranous and coriaceous bracts. However, little is known about when the fleshy bracts of Ephedra have made their debut in the geological past. Herein, we describe a novel, fleshy bract-bearing female cone macrofossil from the Early Cretaceous (ca. 120-125 Ma) Yixian Formation in Liaoning, northeastern China. This cone bears three ellipsoid seeds subtended by only one whorl of fleshy bracts. Each seed has a thin outer envelope and an inner integument that extends upward and passes through the opening of the outer envelope, forming a thin and straight micropylar tube. Such a syndrome shows the closest similarity to an extant triovulate species Ephedra intermedia in the section Ephedra, but the latter bears a whorl of terminal fertile bracts and more than one whorl of inferior sterile bracts, and a thick outer envelope. Hence, we establish a new fossil species Ephedra carnosa. Our discovery provides the first direct macrofossil evidence for the previous molecular systematics of Ephedra, implying that the origin of fleshy bracts in Ephedra should not have been later than that of the membranous and coriaceous bracts by at least the Early Cretaceous.	[Yang, Yong; Wang, Qi] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, Q (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	happyking@ibcas.ac.cn	Yang, Yong/S-1202-2019	Kang, Hong-Yo/0000-0003-0626-5037; Fu, Hung-Chun/0000-0002-0660-9349	National Natural Science Foundation of China [30970177, 30600035, 40830209, 40972015]; State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences [56176G1044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National Natural Science Foundation of China (no. 30970177, 30600035, 40830209, 40972015), the State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences (no. 56176G1044) to WQ and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, STRELITZIA, V20, P1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Caveney S, 2001, AM J BOT, V88, P1199, DOI 10.2307/3558330; Cladera Gerardo, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P49; Duan SY, 1998, SCI CHINA SER D, V41, P14, DOI 10.1007/BF02932415; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Fu LK, 1999, FLORA CHINA, P97; Gifford E.M., 1989, COMP MORPHOLOGY VASC; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guo S.X., 2000, ACTA PALAEONTOLOGICA, V39, P81; Hollander JL, 2010, EVOL ECOL, V24, P333, DOI 10.1007/s10682-009-9309-1; Hollander JL, 2009, INT J PLANT SCI, V170, P323, DOI 10.1086/596334; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krassilov VA, 2009, PALEONTOL J+, V43, P1272, DOI 10.1134/S0031030109100098; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kubitzki K., 1990, FAMILIES GENERA VASC, V1, P378; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Liu HM, 2008, TAXON, V57, P577, DOI 10.2307/25066023; Pearson HHW, 1929, GNETALES; Price RA, 1996, INT J PLANT SCI, V157, pS40, DOI 10.1086/297402; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rydin C, 2006, PLANT SYST EVOL, V262, P239, DOI 10.1007/s00606-006-0481-2; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-183; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Stapf O., 1889, MATHEMATISCH NATURWI, V56, P1; Stevenson D.W., 1993, FLORA N AM, V2, P428; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Yang Y, 2005, BOT BULL ACAD SINICA, V46, P363; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231; Yang Y, 2004, AM J BOT, V91, P361, DOI 10.3732/ajb.91.3.361; Yang Y, 2001, ACTA BOT SIN, V43, P1011; Yang Y., 2002, CHIN ACAD SCI, P1; Yang Y, 2007, TAXON, V56, P1271, DOI 10.2307/25065920; Yang Yong, 2011, Journal of Tropical and Subtropical Botany, V19, P1; [杨永 Yang Yong], 2011, [地质论评, Geological Review], V57, P9; Yang Yong, 2010, Taiwania, V55, P346; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 王鑫, 2010, [科学通报, Chinese Science Bulletin], V55, P675	54	37	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53652	10.1371/journal.pone.0053652	http://dx.doi.org/10.1371/journal.pone.0053652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	24244503	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400058
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-27	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600036
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24349335	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24349335	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600043
